>AAS90622.1|FEATURES|farme|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MPSMADDDDTPFDRRSMPCRAVGVLADTFWRMPGVLRSDSPHAFAAIGPQAERITLPHPV
DVPHGLGSPPGRVYELGGQVLLLGVGHDANTTIHVAENIAGVRYRQAKHATVLEGGRPKR
YEYGETDHCCENFRLLDDWLEAEGRQRLGRVGNAEARLARSRDIVSAALERLRRNETVFL
HAGGSCGECDTARAGAVPFGA
>AAS90617.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MKIASLSRDDSHLIEQVAQLLVDAFREHWPDAWPTLNEALKEVHEMLESERICRIALDEQ
GHLIGIIGGIPGYDGKVWELHPLAIQPSLQGKGIGAALVDDFEEQVRMKGGLTITLGSDD
EDNMTSLSDVDLYENLWEKIRDIRNLKKHPFEFYQKMGYVITGVVPDANGRGKPDILMGK
KI
>AAS90627.1|FEATURES|farme|aminoglycoside|AAC(6')-Ii|antibiotic inactivation|1
MIPQFTISNLPSDDTDAVEQCAALLVEGFKQHWPAAWPDLDSARKEVHEMLAENRICRVA
VDREANVIGWIGGIPEYDGNVWELHPLVVKPEQQQQGIGRTLVIDFEAQVQARGGLTIRL
GSDDEDGMTSLSNVNLFEDTWEQIAGIENLKGHPYEFYQKCGYVIVGVVPDANGPGKPDI
LMAKSVRRPGETRW
>ACN18084.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MFQIYERNERSFGARRFNVKKEEHLSIPKNEEPNLTRRVILKTAGAAVIAGWTSSAAFDT
MASAEETPAISAAQQNNGSLGARLQGVQHFGLTVQNMDRAFAFYTEVLGGTEIMRDGDFQ
GELIHNTLLTDQEIEARSRQVNPRTMGIPDLKGGAQRLDVRFIQFDNVVIELLQYRDADQ
PTGGGVSFAEPLDHMSPAFPRMMHICFHIRDDVDFNKFIADLESESARRGMTQVKSNRII
TVKSEQERRAAPIEANSNGISEGKSNGWRLIYCKGPEGEQLEFVQALGPVKRIFDNAREA
RRKAGSR
>ACN58871.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MADYLLEMKNIVKEFGGVRALNGIDIKLKAGECAGLCGENGAGKSTLMKVLSAVYPHGTW
DGEILWDGKPLRAQSIRETEAAGIVIIHQELMLVPELSVAENIFLGNEIKLPGGRMDYAA
MNRRAEELLAELDIRDVNVVLPVKQYGGGYQQLIEIAKALNKNARLLILDEPSSSLTASE
IKVLLRIIHSLKAKGVTCVYISHKLDEVADICDTIVVIRDGQHIATTPMADMNIERIIAQ
MVGREMNQLYPERSHVPGEVIFEARNVSCYDADNPQRKRVDNISFKLRKGEILGIAGLVG
AGRTELVSALFGAYPGPSEAEVWLNGVKLDTRTPLKAIRAGLAMVPEDRKQHGIVPDLGV
GHNMTLAVLNDFVRATRIDQQAELATIHKEIKSVKLKTATPFLPITSLSGGNQQKAVLSK
MLLTKPKILILDEPTRGVDVGAKFEIYQLMFDLAAQGMSIIMVSSELAEVLGISDRVLVV
GEGKLRGDFVNDNLSQETVLAAALDHTQPALH
>ACH58991.1|FEATURES|farme|beta_lactam|LRA-13|antibiotic inactivation|1
MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISL
MGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFA
DYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMT
AQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVL
ARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAV
TSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTA
GDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAM
ENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRF
VDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFE
SNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAW
HILDQLDQR
>ACH58987.1|FEATURES|farme|beta_lactam|LRA-3|antibiotic inactivation|1
MKSKLLLAAALAALAGTSMAAQAAELQYKPPPITNKEWETPFPGFKIVGNMYYVGTYDLG
CYLIDTGAGLILINSGADGSYPLIKANIEKLGFKTSDIKIITSTHGHGDHVGDLAAFQKD
APAAKTYMNFRDAPTIESGGNIDYRRPEGRGFYPYHPVKVDVRTKPGDHIKLGNTDLTLH
QAYGHTPGATSFTFTVQDGGRNYNVLIVNMNGINAGVKLLGSPGYPTIVEDFASTLKEQA
TYTPDLWVSSHAGQFNLHQVYKPGDPYNPARFGDLAAYKLKIANATKAYEKQLAEERAAK
AK
>ACN58748.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MPRWVWRVLPMPSVLATRKPLLSRQIDGPSGPVSIHQGGSGTMEKFIDRLIRQFESGALG
RREFCQMLGIAAAITAAGGAEANAAPAGRGFKGLGVNHVSYVCPDYTKARDFYSSMFGMQ
VVNDKGKGRANLAFGPAPDKGGNFLVVHNPGANPPKPSEAIIDHVAYTISNWDEGKVRGA
LKAKGFDKPTGRDGSLHVYDPFDYDVQIANAVQENAFRRGA
>ACN58991.1|FEATURES|NCBI|multidrug|cmeB|antibiotic efflux|1
MKNDRGEMVPFSAFMTIKKKQGANEINRYNMYNTAAIRGGPATGYSSGEAIKAVQEVAAK
NLPNGFDIDWAALSYDETRRGNEAVYIFLIVLAFVYLVLAAQYESFIIPLAVVFSLPAGV
FGSFLLIKGMGLANDIYAQVGLVMLVGLLGKNAVLIVEFAVQKQQQGATVFEAAIEGARV
RFRPILMTSFAFIAGLIPLVFAHGAGAIGNKTIGSSALGGMFFGTVFGVIVVPGLYYVFG
SWAEGRKLIRGEDHDPLTENLVHQMDNFPQSDDK
>ACN58741.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|0
MTQPAQGGGAAGGAWAPLRHAEFALLWFAALISNTGSWMHDLAAGWFMTTLDPTPYMVAL
VQAANTLPVCLLAIPAGTLADRMDKRRLLLLVQVVMLVLAGLLGALVLAGRAGETTLLLA
TLGIGSCVAVMSPTWQSIIPGLVPKPDLQQAVALHAVGMNISRAIGPAIAGLVIATVGIA
WPFLINAASFLAVILALWWWKPRTSAPVVHADSYLSALRIAFTQTRTNQALRHTLWRSVL
FFLFGSCYWALLPLVAREQLQGGPKLFGVLVGCIGAGAVMAALGLPSVRARWGLDRLLNV
GTLATAAALAGYALLRLPVLGMLTSLLAGAAWLASLSTLNVAAQLAVPDALRARGMALFT
AVLYGSLALGSLFWGQVATHLDLTSALLIAAGGLLLALTIARRLPLRA
>ACS83703.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
MPSNPTLMPYPDIILVNGSSSSGKSTLCRALQARILHPYLCIGFDDFVFLSAPRYYRGAD
TSRQALADDFTAQGVQMISDTQPGTPPCVTAQFGPVFRHIIDSMAPAVRALVDGGNSIIF
DHVLHDRGMVESCRRVFEGLDVFTVGVTCPIEILEARERSRGDRVIGRARGLVNVVHSFC
DYDVWVDTASDDVDSCVNKVIAAMASTNSRKWSSP
>ACS83744.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MTGIRKLAQLQRGSQRRKHMRITNLPQDNESIIEQTARVLYDAFKDHSPSWTTMEAAIEE
VRESFAEHRISRIAIDDDGAVAGWIGGQPMYDGHVWEIHPLAVAPRAQGRGIGRKLVEDL
EAQVAARGGVTLWMGSDDEGDRTSLGGVDLYPNPLAHLANIKNLRGHPYEFYQKLGFAIV
GVLPDANGAGKPDIFLAKRVRQK
>ACS83731.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
MRKNIVVAILSVILFASCAETRIKEHADWGKFFESRGIKKACFMLRDNNHESIHYYNKAR
CTERFMPASTFKVFNSLVALETAIAPDDQLVITWDSVARREDCDKDLTMREAFKASCLGY
YQEIARRIGPTKMQHYLDTVKYGNMKMGGRIDNFWINQSLQISADEQTGFLKRMYFAELP
FAERSQRIVKTMMLQEQTPRYNLYYKTGTGPIGDKYIYWVVGFAERIEHVKEPKGSMNKS
DVRNYPYFFALNFEMPQADTSQDWFKARIEILHDVLKEYGAIPK
>ACS83721.1|FEATURES|farme|beta_lactam|SMB-1|antibiotic inactivation|1
MKVIASLILAAFATVAHVASAQERDWSAPQQPFAIYGNTHYVGTAGISAILLTSPQGHIL
LDGTTGKGASVVAANIQALGYRLKDVKYILGSHSHEDHAGGIAALQKLTGAQVLVGAANV
ASMRSGVSPSTDPQFGSLSNFAGAAKVRGVADGEVVKLGPLVVTAHSTPGHTAGGTSWSW
QSCEAGQCRNVVYVDSVTAVSADGYRFSDHPELVAQFRNTFSIVEGLSCEVAIAAHPEFN
DLWGRQQRAAQEGSAAYVDSKGCRIIAEAGRKRLETRLASEQR
>ACS83694.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MTHILARAIIFTAFFISVFGELQAQEKDVKDKIEQIIDRSNGNIGVGVFDFASGLTVLIN
NAHQFPMQSVFKFPLGMAVLDMVDRGKLKLDQQVYVSKNDLQPTYSPLRDKFPDGNVNVT
LADLLTYSVSLSDNNACDILFRLVGGTQVVNDYIRGLGIKDMAIVATEMQMSKGWDVQFE
NYSTPEAMLDLLKVFQSGKKLSASSSGFLWKIMTESPTGLKRIKGKLPSTAKVTHKTGTS
GKNHKGITAATNDVGIMTLPNGNQIAIVVFVSNSEANETAREMVIADIAKVTWDEFSAK
>BAG82729.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MGAESDLLALYMAQTYLGSILTSLSLVLMRGRRTKTFAVWCWMAARSLFLVFAFVSEVYW
VMVVMAFFWLLEAFPNPAYTRIIQAIYPAGVRGKALSLVRLGMTGAILLTTPFAGWMLDH
WGFRVIFPVAALLGMLSTWQFNRLDVEEGTLPPRETRSVTSLVGLVRSNRNFAIHLLSFT
FFGLGGLIGVAFYPIVQVDRLGLSYTTIGLLGMAQSVTWLLGFVYWGRAVDRLGGVWVMR
VNLAIGVLVPFSYIWAENAWMLLPAFIAQGIISAGIDLGLINTTIQLAEPEKLVEYAAVQ
ATVIGIRGMIGPFIGVALVNLGVEQSVIFALGAGLTAVAWWVSGYIQLPLSPEEMRAKRE
RLRFRWPLRFRHPRV
>ACT97656.1|FEATURES|farme|beta_lactam|CTX-M-15|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ACT97611.1|FEATURES|farme|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQ
IPTIIFINKIDRAGVNLERLYMDIKTNLSQDVLFMQTVVDGSVYPVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQVASSKAITDLQKLMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSMSLK
>ACT97554.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELVVSLRSAQGLYSFIDKERYNLYIVEMEGHRWEVVLPDGSKTPID
RNDFSFMENGEKKHFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTC
NQYLKGFGIRVAESLILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQP
AIEKAFEESDEVMIEAFMRGTEITCGCYKTSDKEVVFPITEVVSANEFFDYGAKYNGESQ
EITPARLPEDTAERVRLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENKF
>ACT97549.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MELSMKITVLAGGFSPERDVSLLSGALIANSLCRSGHLVALTDVFYPYRGALSDDAFTSD
GNFMYTVPKEPPDLKALRAEVPGSALIGDGVLELCRLSDIVFLALHGGMGEDGSIQAALS
SMGIPYTGSDFAACLVAMDKSLSKLLFRAHGIPTADFTLLKKGDSTDGIPLPCVVKPCSC
GSSVGVSIVDTKEALAGALETAYQYEEKVLAEDKICGREFSVGVLLGRALPAIEIRPKDG
FYDYERKYQSGMTEEICPADLPEAEAASLGALALKVHRALGLGSYSRIDFIREEKTGKFI
CLEANTLPGMTPMSLLPQEAAAAGIGYDALCLAIAQAAKNGQK
>ACT97545.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMKETIAVLFGGQSSEHVVSCMSAANVIDQIDKDKYDLLLIGITEEGEWILTPSVEEIRN
DTWRDGRTHAVLSPDATRKCVIISEGDATKEVRVDVVFPVLHGLRGEDGTVQGLLELARI
PYVGCGVLASAVSMDKLYTKLIVDSLGIRQADYVPVRRSQLQDMNSVIASVENKLSYPVF
VKPSNAGSSRGVNKADNREELVFALNEAAKHDRKILVEETIIGHEVECAVFGGGLQEVKA
SGVGEIMAAAEFYDFDAKYYNAESKTVVDPELPGHAAEDINKAAVEIFKAVDGYGLSRVD
FFVTDAGEVVFNEINTLPGFTAISMYPMLWEARGISKSRLVDDLINHAKERYDV
>ACT97531.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MDYDKLIAPAAAAMRPSGIRKFFDLAADMPECISLGVGEPDFKTPWAVREAGIESLEHGR
TRYTANAGLKELRAEICRYLERRMNLHYDPLSQVLVTVGGSEAIDMCIRTVVQPGDEVVI
PEPCFVCYEPITTLSGGVPVHVACRQEDEFRLRPEALKAAITPRTKLLIMPFPNNPTGAV
MEKEDLEAIADVLRDTNVLVLSDEIYAELNYGLRPHVSIATLPGMAERTIVVNGFSKSYA
MTGWRLGYACGPAPIIKIMTKIHQSAIMSAPTTQPVCRHHGSEGLRRRDRPDAG
>ACT97529.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MENSKRTIAIVCGGDSSEHDVSLRSGQGLYSFFDKERYNIYLVDVKGTDWHVALDNGETI
EIDKNDFSFVMNGKHVYFDYAYITIHGQPGENGVMQGYFDLIHLPYSTSGVLVEAMTFDK
YVLNNYLRGFGINVADSILLRRGEAYDEEEIAKRIGMPCFVKPAADGSSFGVSKVKNADQ
LAPALRVAFMESNEVMIEGFLDGTEISQGIYKTAEKTVVLPATEVVTNNEFFDYDAKYNG
QVQEITPARLSPETAEEVAKTTSRIYDILHANGIIRIDYIISKDKDGKDKVNMLEINTTP
GMTVTSFIPQQVRAAGLDIKDVLSEIVVKGF
>ACT97447.1|FEATURES|farme|beta_lactam|TLA-2|antibiotic inactivation|1
MKKYFSFCLLGIFIFCFSQQNLKRDITKIIQSKNALVAVSVMNSKGKTEVNINGNKKVPM
LSVFKFHIALAVLDLVDRGILDLEQNIFVKKSELLENTWSPIRDKYPNGNVNIPLREIIE
YTVSQSDNNGCDILLRLIGGVDTVQKFIESKGIKDFAIKYNEEEMNKNGKSIYSNYTTAN
ASSRLLQKFYNGEIISESSRDFLFRIMYETSTGADRLISLLPPDVIVAHKTGTSGIVSGI
QAATNDVGIIILPDDEYYTISVFVINSKENTSTNEKIIADISKTVWDYYFRNK
>ACT97377.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>ACT97373.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKSRSLLSKAVVSSLLLFQVLSVSASDLTSDIQEVIKGKKAQVGVAVLYKDDAFTANNDD
QYPLMSVFKFHIALAVLKKMEKEGIPLTAVVTLGPSDIDTKTWSPMYKKYKSKKITLSYG
DLINYMVSQSDNNACNWLINFVGGIQNVNDFIKNLGIDRIQLIETEKSMGAGHQKKLQQL
VNAVVCNSALEKGLHRKGPF
>ACT97573.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICRTLLERGHDAFLLDVFLGLENAPEDLEDVFTMPGH
GLEIAKNISEEEPDLAAVKASRPDQSDCFLGPNVIELCRLADITFLGLHGGEGENGKLQA
TFDLLGIRYTGPDSLGCAVAMDKGFTKQVFLQAGIDTPDGVCLHKNDADRSLASLGLSLP
VVVKPCSGGSSIGVYIVNTEDEYKDALEKSFRYEDEIVIETFIKGREFACGIIDGEALPP
IEIIPKTGFFDYANKYQDGATDEVCPADIPKDIEERMMELTVRAFHALKLNVYSRADFLL
DDQGSLYCLEMNTLPGMTAASLLPKEAKVAGIEYGDLCELIIQKSIEARYSD
>ACT97568.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKNLKRTIAIVCGGDSSEHDVSLRSAQGLYSFFDKERYDVYIVDVRGTDWRVQLPDGEEA
KIDRNDFSFVKTDGTAVVFDYAYITIHGQPGENGPMQGYFDLIHVPYSTSGVLVEAMTFD
KFVLNRYLGSFGIHVADSVLLRRGETYNEEEIAKRIGMPCFVKPANDGSSFGVSKVKNAD
QLEPALRVAFMESSDVMVEAYLDGTEITQGIYKTRERSVPFPITEVVTTNEFFDYDAKYN
GQVDEITPARISPETAERVTEITSRIYDILHANGIIRIDYIITHDAEGNEVINMLEVNTT
PGMTTTSFIPQQVRAAGLDIKDVLTEIIENQL
>ADI87853.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKKFVLFCERNGIALIPIVLILLGCGLWPEMELLVPSLPDMQRAFNIQDAQIQQLLTANF
VGFLIGVLFAGPLCDSAGRRTVMMIGTIGYLVSSVLCPFCNDFVLLMIARFFQGLFMTGP
VIAGGVLLMEATEGVKQIFWMSIGNAAITFCMAAGPIVGSWINTGFGYVGNLWSILILGL
IGCLPALFLVPESLPVEKRAAFHPKLLFKGYFALLKDFRFMCLAIPMCALAAAYWIYVGV
SALYMVNQLGIAQEMFGRYQGPIVGCFSIISLGSSKLLQRFGLMKCLRAGIVSMFTGMLL
LLGMSILSLDHAVATTVFMMFFVGGMAPICSMLFPYALGHLPVDLKGNAQAMVQAIRLFF
ASIGTSLVGVFYKSAFLPVALIMFAILLFSCYFLWKGRRYLKEGLGADHILSVGH
>CBI71209.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIVGVAKNGVIGSDQTIPWRVPSDMAFFKRTTMGKPVVMGRKQYETVGKPLPGRTNIVIT
RQQDYQPEGVLVFHDIDSALQRAREIAQADGVDEIMIIGGGELYAQLMSRADRLYVSHID
LSPPGDVRFPAIAPEQWTVVDLPEVAPSPRDEATYRVKVYERRRDAAH
>CBI71182.1|FEATURES|farme|beta_lactam|VEB-3|antibiotic inactivation|1
MVSLVVRSCSVAAVAVGLLFPACAAPVGATATTAPVAELDSVPQVSSGRLGVAILDFQTS
KTYHINGKDRFPMQSVFKAMSAVVVMREVDEGKLTLDQEIPVGPDDISVYWSPIAEEFKG
TTQTYTVRELLEKSVGMSDNTAADVLMELTGGPQAVTQLLKDAGIEGVRVDRYERQFQAE
LEGLPPFELGEVINRKAFVEAAKAVPAEVKRPILERYVAGKDERDTATPLGAVDFLVKLQ
EGKLLSAESTRVLLQIMTDVKTGAGRLKAGLPEGSKLAHKTGTGGDILGVNTATNDIGIA
TLPDGRKFAVAVFLTGSKESEEKRDAIHADVVRQFVDQLLAEAKE
>CBI71171.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKRIFPAYILLTAFLLACSSNATTQNANQSNKPAAAQEAKADDKQNRELQKQIEQIASAA
RGRVGVHAVVLETGESVSLDEQGRFPMQSVYKFPIGMAVLAQVDAGKLKLDERVRVEKSE
YVREGMHSPLRDKNPNEAEVSVRELLRLAVSESDGTASDVLFRLAGGSEAITRYLSDLKV
TEIIVADTEKEIGQDWDTQYRNWASPKGAVMLLRAFHEGRGLSAESRALLLKLMTDTPTG
PKRLKGLLPKGTVVAHKTGTSGANASGISAATNDIGIVTLPNGRHLAIAVFVSDSPADLT
TREGVIAKVAKAAWDQWGK
>AET35523.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRYMFQKVM
>AET35507.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGLSTERDVSFKTGDMVAKALRENGHQVILLDVFMGYSDKKEDLTGIFDRSEE
VSVKVSGIPEIAPDLAKVKASRKDQSDNFFGPNVIELCQMSDIVFMALHGENGENGKIQA
AFDLFGIRYTGTGYLSSALAMDKEMSKKLFLSAGIPAPKGASMKKADCSDDITKLGIQFP
CVVKPCCGGSSIGVSIAHNAEEYKAALDEAFRWEENLIVEEYVKGREFSVGVIEGKALPI
IEIAPVQGFYDYKNKYKAGSAVETCPAELSEAVTEKMQHYAEQVAQVLGLDTYSRTDFLL
DENENIYCLEANTLPGMTPTSLLPQEAQVVGVNFNELCEKLIQISLDKYEK
>AET35501.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKKKIAVLFGGQSSEHVVSCVSAANVIDQINKEKYDLLLIGITEEGHWVKAESVEDIRS
GAWRESSVEVVISPDATKKCALITENGVTREERIDVAFPVLHGLYGEDGTVQGLFELAKI
PYVGCGVLASAVSMDKLYTKIIVDTLGIRQAKYVPVMRWEMEKDMDIAVAAVETHFQYPV
FVKPSNAGSSRGVNKAETRKELIGALKEAAKHDRKILVEETIVGHEVECAVLGGGQNPVK
ASGVGEILAAAEFYDFDAKYNNAESRTVIGPELPGDSAERVREAAAKIFNAVDGYGLSRV
DFFVTSDGEVIFNEINTMPGFTAISMYPMLWEAAGISKPELVDRLIDLAFER
>AET35492.1|FEATURES|farme|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFES
LGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFFPPPTVKSALL
NIKRKQLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQI
VCLSPSQWVNCFLEMLEVVPEKFHPS
>AET35493.1|FEATURES|farme|beta_lactam|OXA-347|antibiotic inactivation|1
MKNILFVVFISMIFLFVCCNTTTNKNIIETEISDFDKILDSFQVNGSILIYDNDKNTFYS
NDFDWAKNGKLPASTFKIPNSIIAVELGIIENDTTILKWNGEQRKMDIWEKDLSFKDAFR
ISCVPCYQEIARKIGTIKMKEYLEKFEYKNMIFDSLTIDNFWLEGNSKISQKQQIDFLRK
FYFSKFPISDRTIKIVKNIMEIERTENYILSGKTGLSSIEEKYNGWFVGYVETKSNVYFF
ATNVIPTDGLNVDDFISSRINVTKNALKQMNIMK
>AET35489.1|FEATURES|NCBI|multidrug|MexB|antibiotic efflux|1
VAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNS
IRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLAT
VYIPNFYELMQKLQEKFSKKQ
>AET35511.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MSKLTAAVIFGGQSSEHIVSCMSAANVIEHIDRTRYNVLLVGITEEGHWIKADSLDDVKT
GAWRGGTVTALLSPDATRKCMILMDGDKIEEVKLDVVFPVLHGLYGEDGTIQGLLELARI
PYVGCGVLASAVSMDKLYTKIIVSDLGIRQAEYEAVYREELSAMDQVAERIEKHFPYPVF
IKPSNAGSSRGISKADNRRELMDGLTEAARHDRKILVEETIVGREIECAVFGGGASAVEA
SGVGEILAAAEFYDFDAKYFNEDSRTVTDPELPDGAAQRVRRAAMDIFRAVDGYGLARVD
FFVKDDGEVVFNEINTMPGFTAISMYPMLWEARGISKDQLVEKLLSHGMERYA
>ACI02025.1|FEATURES|farme|tetracycline|tet40|antibiotic efflux|1
MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFE
IPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAW
IASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPVILGGSLCLLLGLVMVR
IMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLST
AHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSA
GYILCLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLD
SFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD
>ACI02017.1|FEATURES|farme|tetracycline|tetC|antibiotic efflux|1
MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCA
PVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYI
ADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFL
MQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDR
FRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVCLAFATRG
WMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIFTAIYA
ASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST
>AFH53879.1|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MTSVRLTTALRAIVFALAATGASAAACAQDAERRISEMTAGKPAEVGVAWIADGKAHAVN
NADGYPMMSVFKLHGAVAELRQMERRGTPADTLITVRAAEMEKDTYSPMLKRYGGRDFTI
RLDSLLRYSVAESDNNACDIIMRLAGGTDGVNAEMRAIGLTGYAITETEASMHADPTRSY
NNRSTPLAVAELFRKLYEGGILGEPYATLLKDILLSTSTGPNKIKAALPPGATLAHKTGT
GFTLHDGTITADNDAGAITLADGRRIYIAVLVKDSKLGADGNARLIKEIAEAVIYSEVKF
>AGC09651.1|FEATURES|farme|aminoglycoside|sat-4|antibiotic inactivation|0
MTDITYAISPPVTNDHINALFLASWPDWREGDFQPVLSHSLLYVCAYEGGRLVGFVNVAW
DGGIHGFILDTTVHPDVRRRGIGVQLVRRAAEAARTRGLHWLHVDYEPRLKSFYEACGFF
HTEAGLMHLNG
>AHN92779.1|FEATURES|farme|aminoglycoside|BN682_00261|antibiotic inactivation|1
MLCVSFHSAASVEDRLLKFAVIAARYQNQWVFCRHKDRSTWEIPGGHREPGEQILQTAQR
ELREETGAVSAMLKPLTVYAVTQDEQTTYGMLYLAEILELEPLSDSVEIGEIRLFDDLPE
RLTYAAIQPKLFARALEELAISIEKATLKDAKSVSTLAAKLWNHHEIEELEAEFSDFLQQ
EDAAVFLCKRTGAAVGFAQCGLRRDYVEGTETSPVGYLEGIFVEEGCRGRGFAKALLKHC
EAWAREKGCTEFASDCELCNDTSLRFHLRMGFQEANRIICFTKKL
>AHN92766.1|FEATURES|farme|aminoglycoside|LS81_08155|antibiotic inactivation|1
MEIRRAAIDDVRAVAWLACLLWPHHTLAEMEEEMETFLTDEDSAIFLAWEDNAAVGFAQA
SLRRDYVEGSTSSPTGYLEGIYVMEAYRSRGFAAKLLSACEAWAREKNCLQFA
>AHN92755.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRQATVSDAAAVAALSLRLWPDHTMEEMTAEFAALLASPEAAVFLAEDGAPVGFAQCQL
RHDYVEGASASPTGYLEGVYVAPSHQHRGIAGQLLAACEVWAKARGCTEFASDCEIDNAA
SLAFHLAKGFTEASRNIHFIKPL
>AHN92743.1|FEATURES|farme|aminoglycoside|LS69_04805|antibiotic inactivation|1
MVRIAINGDSRVLAEMAVQMWDSHTVDELEAEFAETLNDKQSAFFIKYINELPVGFAQCG
LRTDYVEGTESSPVGYLEGIFVKEEYRKNGYAKELLLACEIWAKEIGCSEFASDCEIDNI
DSFKFHMAMGFDEANRIICFKKRL
>AHN92738.1|FEATURES|farme|aminoglycoside|LS69_04805|antibiotic inactivation|1
MVRIAINGDSRVLAEMAVQMWDSHTVDELEAEFAETLNDKQSAFFIKYINDLPVGFAQCG
LRTDYVEGTESSPVGYLEGIFVKEEYRKNGYAKELLLACEIWAKEIGCSEFASDCEIDNI
DSFKFHMAMGFDEANRIICFKKRL
>AHN92721.1|FEATURES|farme|chloramphenicol|cat26|antibiotic inactivation|1
MAFQFIDLENWERREFYEHFIKEVVCTYSVVVNLDITHLKGQKLYPAMIWLLTKTVNAMP
EFRTSLTPEGLGIYDDMHPMYTVFNKENKNFSGIWAYFSEDYETFLKAYEDDVARYGTST
RYTPKAGTPANSFNISMVPWVEFTGFNINVFDEGKFLLPIFTMGKFFERDGKRLLPLAIQ
VHHAVCDGYHIGVFVEKLQGYIDAFNQ
>AHN92711.1|FEATURES|farme|chloramphenicol|cat5|antibiotic inactivation|1
MAFRLIDIENWERKEFYEHFINQVVCTYSVVVNLDITNLKNHRLYPAMIWLLTKTVNDIP
EFRTSLTSEGLGIYDEMHPMYTVFNKENKNFSGIWSYFSEDYDAFLKDYEVDAEKYRTST
CYAPKDGTPSNSFNISMVPWLEFTGFNINVFDDGHFLLPIFTMGKYFEREGKRMLPLAIQ
VHHAVCDGYHVGLFVEKLQKHIDHFG
>AHN92709.1|FEATURES|farme|chloramphenicol|cat21|antibiotic inactivation|1
MAFRLIDLENWERREFYEHFIKEVVCTYSVVVNLDITNLKGQKLYPAMIWLLTKTVNDMP
EFRTALSEEGPGIYDDMHPMYTVFNKENKNFSGIWAYFSEDYETFLKDYEDDVARYSTST
RYAPKDGTPANSFNISMVPWVEFTGFNINVFDEGKFLLPIFTMGKFFERDGKRLLPLAIQ
VHHAVCDGYHVGVFVEKLQDHINEFTQ
>AHN92707.1|FEATURES|farme|chloramphenicol|cat14|antibiotic inactivation|1
MAFRLIDIENWERKEFYEHFINQVVCTYSVVVNLDITNLKNHKLYPAMIWLLTKAVNDMP
EFRTSLTSEGLGIYDDMHPMYTVFNKDKKNFSGIWSYFSEDYDTFLKNYEIDAEKYSSST
RYAPKDGTPSNSFNISMVPWLEFSGFNINVFDDGHFLLPIFTMGKYFDRDGKRMLPLAIQ
VHHAVCDGYHVGLFVEKLQKYIDHFS
>AHN92703.1|FEATURES|farme|chloramphenicol|cat24|antibiotic inactivation|1
MAFHLIDMENWDRREFYEHFINEVVCSYSITVNLDITNLRDARLYPAMIWLLTKTVNEMP
EFRTSLTKAGLGIYDSMHPMYTVFNKENKNFSGIWSYYSENYIEFLKNYDEDVCVYSKSK
RYAPKDGTPENSFNISMVPWLEFTSCNLNIYDDGKFLLPIFTMGKYFERDGKRLLPLAIQ
VHHAVCDGYHVGMFVELLQTNIIRFSAK
>AIA18796.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MTVEVSGLGKRYGDQWALRDLDLSVPKGTILGLLGHNGAGKTTTIRILTTLSEPTEGTAS
VAGFDVAKHPGDVRRRIGVAAQQQTVDGLLSARLNLEMVGRLNGFTKKEARARAEQLLVQ
FDLVESTNKLAKALSGGMRRRLDLAASLITRPEVLFLDEPTTGLDPRSRNDLWAMLRDIV
RDGSTIILTTQYLEEADRLADDVVVLDHGRTVAHGTPLELKQQIGNDRIDIKVRSEEELS
QVQKVGASFATNAISADVDLLVATVPVAADARLIDIVRLLDENGIDAVDINRRQASLDDV
FLSLTTPKGMTR
>AIA16595.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSSSYLRNAVVLGLLSAIGPFAIDMYLPALPSISTDLGTTTAATQMTLMAFFIAFGLCQI
VYGPVADMIGRKPPLYFGLSVFALGGIGCGLAPTVEWLIFFRFVQGIGAAAGMVIPRAII
RDLHTGVEATRLMSLVMLVFSVSPILAPLTGSGLIAAFSWRAVFVAVTIAALLGIVLLAL
LLPETRPVAARIRSGLGSVLAGYGGLIRDLRFLGLTFIGGLGMASFFAFLASSSFIYIDH
FGLTPTEYAFAFSVNAVGFIGASQFSASLATRFGISRVVSAAVSCYAATAVLLFVVTLAG
VDSLPVLMAMLFFAFACLGLVIPSTMVLALEEHGSIAGMASALGGTLQFLTGALMIVVSS
AFFDGTSFAMVATIVICAIGAFTLSRLTLGGRREAEAQPEPAE
>AIA15168.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MFRLFEDKALRMRAMTVMIVVGMSGFVLGPVLGGSVLTHVRWEWLLVVNAPIALIACVGV
RLGVPADRPEDLTDDVLDLPGALLSVTTIGLACYSLTSGVEHGWLSALTLASIVGAVLAA
VAFVRHERRSASPMLDLGVFSDGIVRGASIAQIGTSIAMASVMFGLILHFQYAYGWSPMR
AGLATLPIIVTMIAATPLSEWLAQRFGHRIACLVGAGFLGGSLAGLSWGVDHGYLAIAVC
MVAMTIGLRTVMTICAVALVDAMPSNRTSLGAALNDTAQEVGTSVGTAVVGTLIAALVTT
RLPAGVWSSELVASFFHGERITYAVLAVVVGLVAAGGALTLTDSRAVEEHPEP
>AIA14791.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MSSRSARPASSSPCAPHSAWPWLLVVNAPIALIAFIGVRLGVPADRPEDLTNDKLDLPGA
VLSIITIGLACYAATSGVEHGWLSPITLASIVGAVAAGIAFVRHERRTASPMLDLDLFSN
GTVRGAAIAQIATSIAMASVMFGLILHFQYAYGWSPVRAGLANLPLIVTMIAAMPVSEWL
AKRFGHRVACLVGAALLAGSLGGMAWGVSHGYLAIAVCMVVMTVGLRTVMTICAVALVSA
MPDNRTSIGAALNDTAQEVGTSVGTAVVGTMIALLVTTRLPAGTWSTDLVASFFHGERIT
YAVLAVVVGVIAAYGALSLTDSHAVEEPA
>AIA13097.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MAKHAISVKNLYKSFGKVEVLKGVTFNVEPGTILALLGPNGAGKTTTVRILSTLLKADKG
DVNVSGYDVRKDADKVRTVIGLTGQSAAIDELLTGRENLVMMGRLYRLTKNSAVERADEL
LEEFDLVKAADRPAKTYSGGMRRRLDLAVSLIATPPVIFLDEPTTGLDPRSRMAMWEIIK
NLVAKGTTILLTTQYLEEADQLADQIVVIDNGVVIAQGTATELKSKIGNDRLELTFRNEK
TLNEAKKALGKSVIDDGDKELTAVVLIKDTNSDVRNTLDVLSKNKISIASMDIRKPTLDD
VFLSLTGKQKKSEDSEEEK
>AIA13049.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKGDRTGTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNINYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRSSDGRTIDQISPLIEQIK
STPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRALPQMKINPAVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA12694.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNFSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRAADGRTIDQISQLTEQIK
SNPDSRRLIINAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYLNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA12624.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MDEKRGIGKAGGLPWRLSADMRRFRELTMGHHIIVGRKTFQSIGRPLPGRQTIIVTRNES
FKPEGCFVAGSVRQAISLAESRGESEAFICGGAEIYAHSLGRADRMLLTLVHADCDADIF
FPEWDRDEWIEVESEHHAADEKNQYSFT
>AIA12473.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNQWADERGDLGPVYGAQWRAWRAADGRTIDQISLLIEQIK
SNPDSRRLIINAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYLNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA12006.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSISDAISFARERGESELFICGGAEIYAQMLGVADRMYLTVVH
ADSEADTFFPEWDKDEWVELESEHRTADEKNQYSFTFKVLARRSQV
>AIA10815.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAIDEKRGIGKAGHLPWRLSSDLKRFRELTMGHHIVVGRKTFESIGKPLPGRQM
IVVTRNESIAFEGCFVAHSVEAAIGLARERGESELFICGGAEIYAQSLGAADRMYLTLVH
ADCDADTFFPEWDGDEWVEVEREHRTADEKNQYSFTFKVLARKKRNSNI
>AIA19161.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MFYYRTRFDQRTSFDTPGATAMTTLPATGARTYPSLRAAWIPLAALCLAFFVEMVDNTLL
TVALPTIARDLHSDTTSLQWVTSAYSLTFGGLLLTAGSIADRFGRKRVLLYGLAAFGIIS
LGVAMVSSSGELIALRAALGLAAAAMAPITNSLVFRLFDSPTLRMRAMTVMIVVGMSGFV
LGPVLGGTVLAHFQWQWLL
>AIA19144.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MLVVLTMLTVIGMTVVLPVLPFVVLQYVSNENDLAIWVGVLEAINGLCAFLVAPFLGRLS
DRFGRRPVIIAAAFGAAFAMSLFGIGGALWVLVLARAIQGLTAGDLPALFAYLADITPPE
QRARRFGILGALSGIGMMIGPALGGLLAAVSINLPVFITAGVSLTVAVLSVFLLPESLKP
E
>AIA18887.1|FEATURES|farme|beta_lactam|CGB-1|antibiotic inactivation|1
MKKSIPFFIISMLLSPLGNAQTTQVRDFVIEPQIQPNFYIYKTFGVFGGKEYSTNAVYLV
TKKGVVLFDVPWQKTQYQSLMDTIQKRHNLPVIAVFATHSHEDRAGDLSFYNKKGIKTYA
TAKTNELLKKEGKATSTELIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYKILDGG
CLVKSNAAVDLGYTGEANVAEWPKTMTKLKNKYSQATLIIPGHDEWKGGGHVEHTLDLLN
KK
>AIA17603.1|FEATURES|farme|beta_lactam|PMI41_04644|antibiotic inactivation|1
MNLKLLAPILAAFVSATAASPVGAAENQRDNVEVWVNDTVRPVMSQYDIPGMAVGVILEG
KSYVFNYGRMAKEGGKPITDKTLFEIGSVSKTFTATLATYAQANGDLALTEPAGKYVPAL
QGSPFGDVEILHLATHTPGGFPLQVPDNVKNEQQMLKYFKEWQPAYLPGTHRTYANPSIG
MLGYITAHSMKGDFATLVDQKLFRPMGMANSYINVPRDRMADYAQGYTKAGKPVRMSNAV
LSSEAYGVRTTAADLIQFVKANMNLVPLDEKLARAISDTHAGYFGVGEMTQDLVWEQYDY
PVALPTLLEGNSQRTSKPALPVKRISPPMPPREDVLINKTGSTNGFGAYVAFVPHKQMGI
VILANRFYPNEDRVKIVHQLFARFDSGGAGHESAPVE
>AIA17452.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MKRRLPVYILLFVALVSACSGSATTQNNNSAGASAGSQQAKTADNQNRELQKELEQIAAA
AKGRVGVQAVVIETGETVSLNPNEHFPMQSVYKFPIGMAVLQQVDAGKLKLEQRVRVEKS
DFVREGQRSPVRDKNPQGVELSVGELLRFAVSESDGTASDVLLKLAGGAEAVNGYLKQLE
VTDLVVANSEKEIGQDWETQYRNWASPESAVKLLRALYDGRGLSAQSQKLLLKLMTETPT
GPKRLKGLLPVGTIVAHKTGTSGANASGINAATNDIGIVTLPNGRHLAIAVFVSDSPANE
ATREGVIAKVARAVWDKWSK
>AIA16275.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MATPATLRPDPAIVCSACAEWNAPRQPFKVFGNTYYVGSLGLSSVLIAGDQGLILIDVAL
PQSAPLIDANITALGFRTADIKMILTSHAHYDHVGGVRSLQRFTGATVGGSARTVEALAL
GHPTPDDPQFATDSSVRFPAVTNGARVVKDGETLRVGNIAITAHYTPGHTPGATSWTWQS
CEGTRCLAMAYVDSITPVSNDTFKYTAQPGLVDKFRKSIDVVSNLPCDVLLTTHPSASGM
DEKVKQRAQASGADPFIEAGACKALAQQSLAAFEKRVTEERAR
>AIA16192.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIAALAQNHVIGKDNDLPWHLPDDMKFFMQTTKGHHCIMGRKNYDSIPEKFRPLPN
RTNIVVTRQKGFHAAGCIVVNSIEDALGIARNNGEQEAFIIGGADIYKLGFGFADRLYLT
EIQTTLQGDTYFPEFTKDEWRETSRKHHGADERHAYGFDFVIYDRIVNR
>AIA15298.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MHSAHYLRNAILLGLLTAVGPFAVDMYLPALPAIGTSLDAPANTVMLSLTSYFVSFGLFQ
LLFGSLADVYGRKLPLYGGIALFVLAGIGCALANSIEALIVLRFLQGIGGAAGIIVPRAI
VRDMYSGVEEVKMMSMLMLVFSVSPLLAPLAGSFLIQDFGWRAVFWVLTAIGIASPWHAG
HLGQGNVAA
>AIA15005.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTTPASPSPQVDQSAPSDASVEPQPIPTGSRVYPSLRAAWIPLAALCLAFFVEMVDNTLL
TIALPTIGRDLQGTTTSLQWITGAYSLTFGGLLLTAGSIADRFGRRRVLQVGLAAFGLMS
LAVLAVTSTGELIALRAGLGIAAAAMAPITNSLVFRLFDDQALRMRAMTVMIVVGMSGFI
LGPLIGGTALAHVSWEWLLLANAPIALIAFVGVRFGVAKDRPEDLTADVLDIPGAALTIL
GIGLACYTLTSGVEHGWTSLPTLLSAAGAVVAIVGFVLRERSAAFPMLDLRLLRNRTVRG
ATLAQIGTSIAMAGVMFSLILHFQYASGWSPIRAGLANLPFIVTMLAASPLTERLVTRFG
RRMACLAGAVALTVGLGWLSWAVDQGYLAIAIGMVVMTIGLRTVMTICAVGLIDAMPSNR
TSLGAALNDAAQEVGTSVGTALIGTLIAALVVTALPSGAWSPALVTSYFHGEHVAYLVLT
VLVGVVAVLGALTLDDSRSTDEHHEEQAG
>AIA14797.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNASAIIRTENISKAYGKTTVLKNIDLSVMAGEFTAVMGPSGSGKSTLMNVLSTIDRFTG
GDVWLEGQSLLALDKKELRRFRKERMGFIFQEYNLLDTLTVKENILLPLSLRKVKAGELN
GKLMPIVQALNIADLLDKYPSELSGGQKQRTACARAIITQPAIVFADEPTGALDSRSATQ
LLEELTSLNRLFGTTLLMVTHDVYAASYCKRVIFLRDGAIVNELYAGEHSQQAFYDRILE
TQRP
>AIA13690.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|1
MAQPAPAPQPVAPAASSAWSPLRHTLFRSVWIATIASNVGTYMQDVGAGWLMTSLSSSPA
LVALVEAADSIPVMLLAMPAGAMADIVDRRRLLIGTQIYLMIVTAILGVLTLTGAMSAWL
LLGFIFVLGLGSAMMMPAWSAIVPDLVPSQELSAAVGLNSVAVNISRAVGPAIAGVLVAA
VGPWLVFVLNALSYVGIIAVLMAWKHEHRKSTLPAERFLSAIRMGLRFVMHTRPLQAVLI
RGVAFFVFASATWSLFPLVVRNELRRGPEIYGLLLTCIGIGAVSGAILLPRVRARFSRDV
LVAGASVLYALAALVLGYSENISLLIVAMLATGVAWIAILAALQVSAQTTLPPWVRARGL
AAFVVAFMGGMAFGSILWGQVATRYGIPYALSAAATGMVIAATLTWRFKLGQHELLDFTP
AMDIPLPVLAETPETDLPVMVSIRYTVQSDKRAEFVEAMQAVREMRRRNGAYLWQLFHDS
ENPTRYVEVFMDESWIEHLRQHERASVADREVLNHAKVYLVKGTSTQSSHWLGDREN
>AIA13609.1|FEATURES|farme|multidrug|emra|antibiotic efflux|0
MHKPRFYVINSVLHNPTSTSLSAAKAFQILKIAEQHDFTIVEDDIYCDLHPGSAVQPATR
IASLDQLNRVIYLGGFSKTLAANLRVGFIATSEDMAKRLSDRKMLSTLTTSDIGERIVYK
ILSEGHYRKHVDRLRSKLDTVRDKTVKQLERVGLTIDITTPAGMFVWADTGRDTHVLTEK
ALEHGILLAPGSLFSPSQLPSTRMRVNVASASDVSVLRFLERELGKP
>AIA13100.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MSSTRVTTPTAPTRTYPSLRAAAIPLFALCLAFFVEMVDNTLMGVALPTIGRDLGGGTLS
LQWVTSAYALTFGGLLLTAGSAADRLGRRRVLLVGLAVFGGVSLGVLAVDSTGQLIGLRA
TLGVAAAMMAPITNSLVFRLFDDDVLRRKAFTVMITVGMTGFILGPVLGGSALAHLDWQW
LLIANAPIALIAWVGVRIGVPADHPEDLTHEKLDLPGALLSIAAIGLGCFTFTSGVLYGW
TSWQTLGSAIGALLALAGFVIHERRTPQPMVDLSLFSRGTIRGASLAQLATAVAMAAVMF
GLILHFQYAYGWSPMKAGLANLPLIVTMLVASPLAENLVTRFGHRVACLIGSGFLAGSMA
GMAWAVGHGYLAIAVFMVTFTIGLRVVMTTCAVALVDAMPSNRTSLATSLNDTAQEVGTS
IGTAFIGTMIAVLVTKVLPDGVWSDDLASSYFHGEQVAFLALAVIVGTIAAWGSLTLTDS
HATDEH
>AIA10902.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MKRIAFLLSYALAALPAFAAAAEWEGPQDPFQLYGNSYYVGTQGLSSVLITSKAGHILID
GASPKSAVMIAAHIRRLGFRLEDIRYILVSHEHLDHAGGIAELQALSGATVITSPAAQPV
LASGKADKGDPQAGNDMPDMKPVGAIRTVRDGETVELGTLSIKANYTPGHTQGGISWTWK
AVENGRAMNMVYADSLNAIAGPGFRYSANTLYPTAKADIERSIARVAALPCDILVTAHPD
AVDLIERQAKGKAALVDPGACQRYAETGRARLAKTLAEEKR
>AIA10555.1|FEATURES|farme|aminoglycoside|ERS370000_04144|antibiotic inactivation|0
MIRLAHADDLLIMQDIERAAGQVFRALGMDLVADDEPLTVDQLHGYAVAGRAWVYVDGLD
YPVAYLLADIVDGAGHVEQVSVHPDYARQGLGRELLHAARVWTRGHGMQRQTLSTFRDVP
WNAPYYRRLGFEVLDAGSWGPQLTRLTEHEAGLGLTHWPRVAMWRPAVPPT
>AIA19300.1|FEATURES|farme|multidrug|floR|antibiotic efflux|1
MAPFDLLASLAMDIYLPVVPVMPDALGTSATVVQLTLSVYMLGLGFGQILFGPVSDRIGR
RPVVLGGAAVFALASAFLPLIVWAPGFVALRLVQALGASAALVATFATVRDLYADRPESV
VIYGLFSSMLAFVPALGPILGALLAENWGWHAIFWLLALGTTPPFLHAVARWHETLPPGQ
PQVRSAWPILKSKPFWFYTLAFGTAMGTFFVFFSIAPRILVDRVGYSELEFSFAFASVAL
VMTVTARFAKCYVERWGIYGSIQRGMWLLLIGAAILAVVWTIADPGFATFILPMWIMAVG
IVFTVSVTANGALASFGDRAGLAVSIYFAGQSVIVSVIGTFAVAALDGSTPWPLVVFSTV
LGLSVLCAMRLK
>AIA19280.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MRQYLELLEDIKTNGVKKPNRTGVDQITVFGRQLRFDLSKGFPAMTTKKLFMRSITHELI
WFLKGSTNIKYLVDNDVHIWDEWPYKHYLMVRGKAVPDSSSDEWKKGIQKFTEKIKKDYK
FADKWGELGPVYGYQWRKWPTTDGKHIDQIANAIDLIKNNPAPAG
>AIA19224.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MSRSLLVIICVVCLDAIGIGLIFPILPSLLEELTGSGQVSTIYGLILAAYAAMQFVFSPI
LGMLSDRIGRRPVLIVSLAGAAIDYLIMAFAPMLWVLVVGRIIAGITSASMSVAGAYIAD
ISDEKDRAKRSSWMSAAFGVGFIVGPVLGGLLSTYFLRAPFLVAAGLNGLNLVLALTVLK
ESRVPSREKLDLASLNPFAPLKWAFSFRTLAPLLAMFLIFAINGDIPGTIAVLYGTAKFH
FDGMTVGLWLAAFGACHFLAQAFVTGPLAERLGERWTLVVGIGADVLAFLGFGFATQGWM
AFALSPLSAIGGVGLPALQSLMSAQAGEDRQGELQGVLASAQSLTSIIGPLLGTTIFALT
PGFPGAVWLVAAALYLLAIPVLARLFRQGRAVPAT
>AIA19200.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GTGTLSIFGYQMRFNLNAGFPLLTTKKLHTRSIVHELLWFLKGDTNIQYLKDNKVTIWDE
WADENGELGPVYGKQWRSWQAPDGRQIDQISSVISEIKSNPNSRRLLVVAFNPGEIEKMA
LPPCHAFFQFYVAQGRLSCQLYQRSADIFLGVPFNIASYALLTHMIAQVCDLQVGEFIHT
LGDAHLYSNHLEQAQLLLTREPKPLPQLVLNPEIKNIFDFKYDDIKIENYESHPAIKAEV
AI
>AIA19182.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MISIIVAVDEKRGIGKNNNLLFKIPEDFKRMQQITTGHPIIMGKKTFESIGRVLPNRTNI
VVTRDPDFEFDKTLVVHSLEDAVRQAQTCSGNEEIFIFGGGQIFKESIEKGLVDRMYLTV
VKGDYHADTFFPDYSEFTKVIEKEEKDADGFTYTFLTLEK
>AIA19165.1|FEATURES|farme|beta_lactam|SPG-1|antibiotic inactivation|1
MKIFQMLSVLLVSSLAFADGPANPVLTHDPSWSAPHAPYQITDNIYAVGTDGIGVYLITT
PKGHILLDAATEQGAAVVEANIQSLGFKLKDIKYLIENHAHSDHAGGLAQLKKSTGAKLI
ASQGDRYSLEHGTLDSETNWEDKFPPVKVDKIIADGKDVILGGIHMQAIMTPGHTKGCTS
WLTESEDKGVKRKVIFACSITTAGNKLIDNKIYPNIVNDFRNTFARLIKIQADILLTGHP
SMAGLEEKYQAQKNGKKDAFVDPMGLQNLVENAEEKFEEELKKQREKGANNIVR
>AIA19047.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRNIASQPYLPHYALSFQQFLRRIVMKRLNMIAAVGAQDRVIGRDNQLPWSQYLVPDLQR
FKRLTMGCVLLVGRNTWFSFPPKMRPLPGRITFIVSTTLTPADVPEGVLICPTLDDAIVL
ATSLYPKLEGFIIGGQRMYEEGMAYADRLEITEVGEKPPGNVFFPDYSAFSKVIEETVET
YEGIELKYRTLERP
>AIA19021.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRVSYFLFVLSASQCIIGPMTKPRVSVIAVLSKESRAVGIKNGLLWKIKGDLPRFKELTT
GHPIIMGRKTYESIGRPLPDRVNIVITRNPDYHPEGVLVVSSLEEALDLAKQKESEEIFV
IGGGEIWKMAMPFIDRLYLTVVDDEPIADVFFPEYSQFKKEISREEHLEHHPPFTYITLE
K
>AIA19007.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRHVLDKGATKTDRTGTGTVSVFGYQMRFDLQEGFPMMTTKKVHMKSILHELLWFLKGDT
NIKYLKDNGVSIWDEWADENGNLGPVYGSQWRSWPTADGRHIDQITQVINQIKNTPDSRR
MIVSAWNVGEIEKMKLPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYAILTLM
VAQVCNLQPGEFIHTLGDAHLYSNHIEQAKLQLSRDLRKLPVLKINPDVKDIFGFKFEDF
TLEGYDPHPHIKASVAV
>AIA18988.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FDLRKGFPIVTTKKVPFRWIAEELFWFLSGDTDEANLRARGVDIWAEWADAEHTTKFGRQ
AGDLGPVYGYLWRSFGGNYPNRDGVDQVARLIDEIKNNPDSRRLIITGWDPRQADNVDLP
PCHTLFQFKVENHKRLHCQLYQRSADAFLGVPFNISSYALLIHLVAHVTELEVGEFVYTL
GDYHIYQNHMDQVDELLAREP
>AIA18924.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYIDLLRHVMEHGTEKSDRTGTGTKSVFGYQMRFDLADGFPLLTTKKVHTKSIFHELL
WFLKGETNIRYLKENGVSIWDEWADEDGNLGPVYGSQWRSWQAADGNTIDQITEVISQIK
KNPDSRRLIVSAWNVGEISKMKLPPCHAFFQFYVAEGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPGEFVHTLGDAHIYSNHFEQVALQLSRTPKALPTMKLNPDIKNIF
DFKYEDFTLENYEPHPGIKAPVAV
>AIA18848.1|FEATURES|farme|aminoglycoside|Krm|antibiotic target alteration|1
MARSPENDITELIASVRGSSKYGSISEAMIRSIGLRELAARRNLKEAIKATKNKLHQVAG
AYLDGRLPYDDWLALLDEARQADGVIDAGGSPTLHAQFRLACRQIMRNHASTRERLPILE
DFYAATLASLGQVSSVLDLACGLNPLTLPWMPLAPDARYYACDIYADMIAFLNGFFTRAG
LEGQTEECALAAGAPNVQVDLALVLKALPPLDQQAKHAGRDLLRALNARHILVSFPAQSL
GGRGKGMAENYEQRFRTLADSEGWAIERFVFPTELAFLVRKG
>AIA18838.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMRHVLEQGAKKEDRTGIGTLSIFGYQMRFDLQQGFPLVTTKRLHLKSIIYELL
WFLRGETNVRYLREHGVTIWDEWADANGELGEGIYGSQWRAWPNPDGTHIDQISQVIEQI
KRNPNSRRLLVMAYNPSFADKTPLPPCHSFFQFYVANGKLSCQMYQRSADIFLGGPFNIA
SYALLTMMIARVCDLQPGDFVHTFADAHLYLNHLEQARLQLAREPHPLPQMKLNPEVKDI
FAFKYEDFELVNYQFHPHIKAAVAV
>AIA18813.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTLPLILVVAVAENGVIGRDNQLLWRLKTDLGRFRRLTMGKPMIMGRKTFQSIGKPLLGR
ETIVLTRDAGFAAEGVHVVHTWEEAVAKGAELATRMGADSVAVAGGAEIYALALPQVQSI
FLTKVQAEPEGDAVFPDFDRSQFRETRREDHPKGGDDEHSFTFIDLERRR
>AIA18714.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRTYLDLLQHVIDHGVEKSDRTGTGTLSVFGHQLRFDLTEGFPLLTTKKVHVRSVVAELL
WFLQGSTNVKWLHEQGVTIWDEWADDSGELGPIYGYQWRSWPTPDERHVDQIAAVIHGLK
TNPDSRRHLVSAWNVGDLEQMALPPCHTMFQFYVAPAPADSADRRGRLSCQLYQRSADIF
LGVPFNIASYALLTHLVAQVCDLAVGDFVHTLGDAHLYLNHLDQARRQLAREPRPLAPLG
LDPGVSDIDGFGLEHIVFEGYDPHPGIKAPIAV
>AIA18703.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGEREGPGIDQIREAISLIKKDPTSRRIIVSAWNVADLPHMALPPCHAFFQFYVNRGRLD
MQLYQRSADIALGVPFNIASYALLLMMMAQECELTPGVFVHTLGDAHIYLNHVEGLKQQL
TRAPLPPPRVEIAKKPLDEIQFEDIRLLEYQHHPFIRFEVSV
>AIA18651.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NVIQQIKTNPDSRRHLVIAFNPGDVDKMALPPCHAFFQFYVANGKLSCQLYQRSADIFLG
VPFNIASYALLVHMVAQVCDLEVGDIHTLGDAHIYSNHMEQVHTLLAREPRPLPKLVLNP
AIKNIFDFKYEDIQIVGYDPHPVIKAEVAV
>AIA18623.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLEDIKTNGTEKSDRTGTGTKSVFGRQMRFDLSEGFPAVTTKKLFLRGIIHELL
WFLQGDSNIEYLVKNDVHIWDEWPYKAYLQSTGQEVPASGSEAWKTGIKEFTEKIKVDHE
FAKKYGELGPVYGSQWRHWPARDGGEIDQIQEAIDTIKNNPDSRRIIVSAWNVADIQEMA
KAGLPPCHSLFQFYVNDGKLSCQLYQRSADTFLGVPFNIASYALLTMMVAHVTGLKPGEF
VHTLGDAHLYLNHLEQVDLQLSREPKPLPKMILNPEVKSIFDFTIDDFTLEGYESYPSIK
APIAV
>AIA18609.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIAAVAENGVIGKDNKLPWHIKSEWQYFMRMTRHKPVIMGRLTFESLGAPLKDRANIIVT
RNAGYKHEGIIVTATLEKALDIARKIAAETRQDEIMIGGGAEIYRLALPLADTLYLTEIH
LKPEGDTKFPAFDRSGWVETKREFHKAQAGETADYTIIVLERKK
>AIA18469.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNRKIRVGVVFGGKSGEHEVSLQSAQSVVENLNLDLFEVLPIGISKEGTWHVGIGAYNAL
GAPVPAQLLTDGISEEEIKHIQPITQGPVLPEMSLSSIDVVIPVLHGPFGEDGTVQGLFE
LMNIPYVGAGVLASAVSMDKAMMKAVFAQAGLRQCKYEVVLRSNYERDAAPILEHIENSL
GYPCFVKPANLGSSVGISKAKDRSELAQAIEVAAGYDRKIVIEEAVDGREIEVSVLGNDN
PQASLPGEIISGNEEFYDYNAKYVDGSSTMVIPAPLSSEQTEEVRALAMQAYRAVDGSGL
SRVDFFLDRKTGEFLINEINTFPGFTKYSMYPKMWEVSGLPYPELIETLIHLAIERHEDK
NRNR
>AIA18441.1|FEATURES|farme|aminoglycoside|TO66_29130|antibiotic inactivation|0
MPNTIHSAHDITDQEWDALRTLYVEAFVAMSSTLSACDLALMDNHPEQFWAGVFDRDKPQ
STAKNYTFSLTKEGERIIAYGLYTYVNGTQYLYIHHFVVHPDYQGQGLGKRLMCAIEELH
SEAKKVGLLTRTYNVLAQNFYERLGFSATSDVPALIREYYSNDRVYMERSK
>AIA18420.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MRQYLELLEDIKKNGVKKADRTGVGTTSVFGRQLRFDLSKGFPAVTTKKLFMRGIIHELI
WFLQGSTNIKYLVDKDIHIWDEWPYRAYLMKQGKKVPDSGSDDVISCFSSMLQMVN
>AIA18414.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTLSIIVAVSENNLIGVNNDLPWHLSADLKRMKTITMGHHLIMGRKTFESLGKPLPGRTS
IIITRNKNYQVPPECIVVPSLKEALAAVKNDNEPFIVGGGEIFREALPLVNKIYLTRIHQ
RFEGDTYFPELNEKEWKQVSRNDFQRDEKNNYAYSFINLERIRKS
>AIA18378.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISTIVAVAKNGVIGKEGGLPWYLPAELARFKEVTMGHPIIMGRKTHESIGRPLPGRTNI
VVTRNKGFKADGCIVVDSLEKAIVEAKKGEGADEIFIIGGEQIYKEAMPMLNRIYLTNVD
AEVAGDKFFKYDLKKWKEISSEKHSADEKNRHNFEFTVLDRI
>AIA18340.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SRRMIVSAWNVADLDKMALMPCHAFFQFYVADGRLSCQLYQRSADIFLGVPFNIASYALL
TMMIAQVCGLKLGDFVHTFGDTHLYTNHLEQARAQLSRGPRTMPTMRLNPNVKNLFDFQY
EDFTLENYDPHPAIKAPVAV
>AIA18335.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRGKGHDVTPMDPARGVISAAEERELSTGKVGT
EPPSLEALSRFAEGTFLSNLIAMKEIKDADVVFLALHGGQGEDGTLQALLDMAHVKYTGS
GHLSSALAMDKDLSKKLFRMEDVKTADWLMAPATTEQVEGILGLPVIVKPSKQGSTVGLS
LVKKREDLAPAIAEASKYDDEVMVEQFIPGRELTVGILGDVALPVGEIFPKHEIYDYECK
YTAGMASEEFPAKLSKEATEKVQQQALLAFKALKLRGYARIDFRLTTEGEFYCLEANTLP
GMTELSLIPQGAAAMGIGFPELCERIVRLALG
>AIA18273.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EGFPLLTTKKVHTKSIIHELLWFLKGDTNIKYLKENGVSIWDEWADENGNLGPVYGSQWR
SWQAADGRTIDQITQVIEQIKKNPDSRRLIVSAWNVGEIDKMKLPPCHAFFQFYVAEGKL
SCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLRPGEFVHTLGDAHIYSNHFDQVELQ
LSRDIRPLPTMKLNPAVKNIFDFKFEDFTLENYNPHPAIKAPVAV
>AIA18259.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIEQIKTNPDSRRLIVSAWNVAEISKMALPPCHLLFQFYVACHLLFQFYVANGKLSCQLY
QRSADIFLGLPFNIASYSLLTMMVAQACDLQPGEFVLTLGDAHLYSNHFEQARLQLSREP
LKLPAM
>AIA18208.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MISFIWAMDRNRVIGKENKLPWHIPEDLKFFKSSTMGHPIAMGRKTFVSIGRPLPGRENI
IITRNKEYSYDGCTVVHSIEEFVEYCREKEEEYFVIGGAEIFKEMFPFADKLYITLIDEE
FEGDTFFPEFDLGEWELHSFEKGPRNEKNPYDYEFRIYARKTEQ
>AIA18209.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELCRHVLENGTEKDDRTGTGTISTFGYQMRFDLNEGFPLITTKKLHLRSIIHELL
WFLNGDTNIQYLQDNGVRIWNEWADENGDLGPVYGKQWRSWEGADGKVVDQISELIMQIK
TNPDSRRMIVNAWNVAEIDNMALAPCHCMFQFYVADGKLSCQLYQRSADLFLGVPFNIAS
YALLTLMVAQVCDLKPGEFVHTFGDVHIYKNHIDQVNEQMSREPRKLPTMAINPEVKDIF
SFKFDDFTLEGYDPLPHIKGAVSV
>AIA18186.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIAVLKGGPSAEREVSLRSGAAVGKALREAGHEVEEIDVHGPDFLVPEKTEVVFLALHG
TFGEDGQIQAILEKRGLPYTGSGIESSRLAFDKTATKKKFEASGVPTPPCRIMKKGDREV
PRLKEPFPWVVKPSKQGSSVGVTIVQKEEDLEKAVKLGFESDDEVLIEAFIDGREMTIAV
LGEEALKIVEIKPKSGWYDYQNKYTKGATEYLVPAPLTKHQELCLQTLAVQAHKCLGCRD
VSRVDVRMDPNENNFVLEVNTLPGMTETSLLPKAAAAAGISFSQLCDSLAKMAAKRGARS
>AIA18155.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSTSPKISLVAAVAENGVIGDGTGMPWRIRSELKHFMQTTLHKPVIMGRKTFETLKAPLK
DRANIVVTRDAAYKKPGAIVATSLDKALEIARAIAAETGADEIIVAGGAEIYRQALPFAD
RLHLTEIHAKPEGSVLFPSFDRKAWKQTRHEPRKALEGESADYTITVLERA
>AIA18133.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GTLSVFGHQMRFNLAEGFPLLTTKKLHIKSIVYELLWFLRGDTNVKYLQEHGVNIWNEWA
RENGELGPVYGAQWRSWKTPDGRAIDQISQVIDQIKSNPDSRRLIVNAWNVGEIPSMALP
PCHLLFQFYVADGKLSCQLYQRSADIFLGLPFNIASYSLLTMMVAQVCDLEPGEFIITLG
DAHLYSNHFEQARLQLSREPLQLPQMRINRSVRSIFEFDYDDFELAGYEAHPHIKAEVAV
>AIA17994.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISAIVAMSQNRVIGVNNQLPWKIPEDLKRFKTLTLGHPVIMGRKTYESIGKVLPGREN
IIITRQPHYSVPGATVVSSVEEAIRHCEGKSGEIFMIGGAEIYRQVMPKIQRLYLTLIEK
QFEGDAFFPTWGKDEFKEVSREERSDPISFSFLVLERKK
>AIA17940.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MQHKTFDVVVAADAKLGIGKGGTLPWKLPGDMAYFKRVTSTTSDPAKRNAVVMGRKTWDS
IPAKFRPLPNRLNIVISRQSPEALGLPDSVLHAGDLSEALSKADADSIETVFVIGGGEIF
AAAMRHAACRLLYLTDIQADFDCDTFLPDFQQDFVPAPGTEKVRETDNGIEYEFKVFARR
SNHPASDASSVCAAESQRGART
>AIA17941.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRYVLENGEERQDRTGTGTIAAFGLQAKYDLREGFPLVTTKKVLFGSVVRELL
WFLRGSTNINDDLTQHTPIWDAWADENGELGPIYGYQWRFWPKYVPEEGQPGLYRREHVD
QIKDIIHRIKTDPTSRRLIVSAWNVSDLDKMALPPCHAFYQFFVSNGRLDCQLYQRSADM
ALGVPFNIASYALLMMMVAQECNLTPGIFTHTLGDAHIYANHLDGVKAQLEREPKALPTV
KIAQKGIFDLRFEDFELLNYNPHPFIKFPISV
>AIA17934.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FGHQMRFDLSEGFPLVTTKKLHLRSIIHELLWFLKGDTNIRYLKENGVSIWDEWADENGD
LGPVYGKQWRSWAKPDGGSVDQIRWVLDEIRRNPDSRRLIVSAWNPAELDKMALAPCHCL
FQFYVAEGRLSCQLYQRSADVFLGVPFNIASYALLTHMMAQATGLQPGDFVHSFGDAHLY
LNHLEQARLQLSRDPRPLPKLRLNPAVRSLFDFTFDDIAIEDYDPHPAIKAPVAV
>AIA17880.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNQYLQLCQHILDHGTVKSDRTGTGTISVFGCQMRFDLSKGFPVVTTKKLHLKSIIYELL
WFLRGETNVAYLQEHGVRIWNEWADENGDLGPVYGKQWRSWPTEEGGAVDQIAEVLNQIR
DNPDSRRMIVCSWNVAQLPEMALAPCHCLFQFYVADGKLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVCGLMPGEFVHTLGDAHIYANHIEQVKLQLSRDPKPLPEMKINPDVKSLY
DFQYEDFVLAGYDAHPHIKGEVSV
>AIA17877.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MENISNVGEQVLNNKNNKILVMTGLMIGIIFSELDETVVNTAMPTIIRDLGGLSMYGWVA
GIYMLALSAFMPILGKLADLFSRKKVYFASMAFFIGGSIICGLSHSMIMLLIGRGIQGLG
AGGLMPLAMTISSDLFPVEQRAKVQAFMGPVMFIPMLLGPLMGGFFVDQASWHWIFFVNI
PVGLIAVIFLASGLKEVHERKKVTIDWAGAILLVAAIISLLITPVLVENEGYTWSSPFIV
SLLCVGVILIGLFIWVESKVIEPIVPLHLFRNRNILVLSLLVFTVGCGLMGSFSSFPYFA
QNVLGLTPTESGYLTLPMMVGAVATSIVSGFLLTKVRYRELFVISFIMPVIGFYLFSKLD
ISTTTLQVIIFFFITGLGLGVMFGGDNLIVQESVEKEHKGIALATVPLFQSIGATVGVSM
FGTLLSSTLTSNLSSLGDELPKSMANNMNSLAAGGIPSGLTPELFMKIKVLFIESFQHIY
TYAFVLTIIAFVLCFFLKKEVLSSKSEE
>AIA17851.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRFPTMNVIKGVRLKARGSGLGGTMKQYLEHAVKILSDKYTGYKPNRTGIDTISRFGHEN
EYDLSEGLPLLTTKKLFSKGIIHELIWFMRGDTNLKYLVDNNVRIWDEWGYKRYLQSLGK
DKEITPNTPAWDEGMNAYRARIKSDENFAKDHGELGPVYGRQWRKWEGPNNKVVDQFGDL
INGLKKSPSSRRLIVSAWNPIEVPNMALPPCHTIWHVNVQDKDLTLKLYQRSCDMFLGVP
FNIASYAMLAHVLAQEANLNPGRFVHSFGDAHFYCGKGERGAWYGKNLDELKERVRNVET
LETLEGYLDVKDWIERNAPPEPQGYELMDHIPLILEQLSREEKPLPTLQLAAKPYDQLTV
DDFKIENYNPHPAIKGKVAV
>AIA17843.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIAALGKNRVIGKGNDLLWHIPDDMKRFKALTNGHPVVMGRKTWESLPARFRPLPNRTNI
VITRKSDYVAEGAQVVGSIEEALRASSNAPGAEEVFVIGGGEVYALALPFATRLYLTIIS
DEKDGDIYFPAYEHCFTRVIAREMRESTGLSYQFVTLER
>AIA17826.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MPQKLKAVLIYGGQSTEHEVSRRSAAYIWKNIDRQRFDAYAIAVDKQGRWHAQNRQALEG
SQPKEMPLESGDRADADSAAVLKKIWTQGADTSDLVGFDIAHGTTGEDGMMQGFFDLQRI
PYVGPGILGSAVAMDKVVAKQLVEYAGVPVVPYVALRLHDWLERKSALLQECSSKLKFPM
FVKPSSLGSSVGISKVENVTALEKAINHALEFDDRVLIETGVSAREIEYACLGGYAPKLT
FPGEVGVPEGFYTYDEKYSNASKAEVLVPAPLSKELADQGREISRKVFQALNLYGLARID
LFLEKSTNTFYFNEANTLPGMTAISQYPKLWEHEGMTGKDLISQLLDTALERRKLQLGLK
RSI
>AIA17802.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTLPLILVVAVAENGVIGRDNQLLWRLKTDLGRFRRLTMGKPMIMGRKTFQSIGKPLPGR
ETIVLTRDAGFAAEGVHVVHTWEEAVAKGAELATRMGADSVAVAGGAEIYALALPQVQSI
FLTKVQAVPEGDAVFPDFDRSQFRETRREDHPKGGDDEHSFTFIDLERRR
>AIA17751.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MTKREELPRKIAVLMGGPGSEREVSLATGRGVAKALRSLGTEVVEIDVRDENFQLPDDVD
LAFITIHGTFGEDGQLQKILERRGIPYTGEGVNGSEIAFDKIRTKEKFREHDVTTPPSEV
IEPGQRPTIALPMVVKAPRQGSTVGVVIVKDESELESAINEAGKYGRELLIEKFVSGREL
TIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQAGGGAEHVCPANIDAGKTKEIQELAL
RAFRAAGLQVYARVDAILSDSGKPYILEINTIPGMTEASLLPEAAAAAGIGYANLCARII
ALSRARTEGKR
>AIA17726.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKKIALITGGYSGEAVISYKSASTIEKNLDTEKWETYKIDINPQGWYYMAPGDEKIPVD
KNDFSIIVGGNKINFDAVLVGLHGTPGEDGKLQGYFDTLNIPYTSCDTATSALTFNKRYT
VAVASFAGMHVARSMHLFKHIPVTPQTILNELKLPVFVKPNNGGSSIGMSKVKEAGALQA
ALDKAFREDDQVLVEEFITGRELTIGVFKSKGEVIALPITEIIAKNEFFDYEAKYEGASE
EITPAQVDGSIAEKIRSEARKAYSIFNCNGLIRIDFIYDEASGNPYMLEINTVPGQSEAS
IVPQQVVAMGWTLKQFYSALLEECFR
>AIA17714.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDGLRAIMEKGEDVLEDRTGVGRRKLFAYQMRFNLKEGLPVLTTKSVHTKSVFHEL
IWLLSGSTNIKYLVDNGVRIWNEWPYENWLQKNGWSKDFPKYSESWTEKMKEFVELMKTD
SAFAKQWGELGPTYAHQWRNFGATLGPDGSYNHDGFDQIANVINLLKTNPASTRIIVTGW
HAVEATQVALPPCHTLFQFNTVGKKIITHLYMRSADAFLGVPFNIASYATLANMIAQVTD
MEATELVITFNDFHIYLNHFDQVKEQLTREPKALPILKLNPAINNIFDFKFEDLTLENYE
PMPAIPAPVAV
>AIA17700.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MAASENGVIGKDNKLPWHLPDDLKYFKNLTWGLPILMGRKTFDSIGKPLPGRKSIVITRD
KAWQHEGVAVVHSLDEAIQKAESFGAKEIFVIGGAQIFNTTLQTADRIYLTRIHSEFEGD
VFFPEISETDWSLSSSRFLTADEKNAYDHTYQVWERKKPSS
>AIA17696.1|FEATURES|farme|multidrug|MFS|antibiotic efflux|0
MISYKEALRNERWHAFEVFLATPSLVVIQQYVPVLVTRLGASPLLLGILTSGAAVMLVIA
SSLGPLWLQHMPSWRPAMFIPLMLWRSALLIIPLMLLLPAKQAEAIVLVVVALNFAAGFS
NYTFTSYLPRMTLPDRLARLVSTRWTMLGIGMALFTVVLAAMLDFFAIPLNYAIVCALAF
VIGLAGAWCLMQTKPEPISRTGKGKPRASVREILSHGPARKYLLITLLAQIALNAPGPLI
TLQMVRVLGATNVE
>AIA17578.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MREERFLASMIKPVSDRTPDAQYQNLLRSILEKGVRTNSQQGVDALTLMGPGPMHFKFDN
GFPIINERNMAPQESERLPVTVWKQAVAEICAFANGVRTQEGLEQFGCTWWKSWVTKEKC
EKRGLAEGDLGPGSYGAAFHDFPTSEGGTYNQFQNIIEQIREFPHLRTHFISPWIPQYII
RGTGKQQKVVVAPCHGWIRLRVLDNKLTLHMFQR
>AIA17570.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
RSPYDIVNSVRLAYTQRFILIEAALMTTPRLSAIVAMSDNRVIGDKNQLPWHLPADLKYF
KNLTSGHPILMGRKTYESIGRPLPNRTNIILTRNAEFTAPGCLVVTTIEEAMECAREAQS
DEIFIIGGAEVYKQLLPHIERIYLTIVHDQFDGDAFFPELDEDQWQEVSRQNHDADENN
>AIA17548.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIKSIVVAASTNNAIGKNNQLLWHLPNDLKFFKNVTWGMPVLMGRKTYESLGNKPLNGRV
NMILTTQKNFKREGVVTVNKIKDAIFFAGEHDYKELMILGGANVYSQTIGDANKIYITRV
HHVFEDADAFFPVIDENKWKLVSNQDFFKDEKHAYDYSFQLWQRR
>AIA17501.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVRDVLDNGKPDENEARSDRTGVGTYSVFGRQARFNLEEGFPLVTTKKVHLKSI
IYELLWFLNGDTNVKYLNDHKVTIWDEWANSEGDLGSIYGKQWRSWQGPDGVKVDQIANV
VEQIRTNPHSRRMLVIAYNPGDLPKIAPPGCHTLFQFYVAHGKLSLQLYQRSADLMLGVP
FNIASYALLLMMVAQVTGLKPYEFVHTFGDLHIYANHVEGAREQLKREPKALPTMKINPE
VRDLFSFTYEDFTLEGYDAHERIKFDIAV
>AIA17495.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSLIVALDRRYGIGKDNRLPWRLSADLKRFRELTMGHHLIVGRKTFESIGKPLPGRQM
IIVTRQAGFQVEGCFVVNSIDQALRLARERGDSEVFVIGGAEIYAQTLALADRLYLTLVE
AEVAADTFFPKFDKSEWLAQEMDQHEADEKNQYPFTFKLLVKT
>AIA17492.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MKFKIQSLFFPFLLAGYEFSTYLSNDMYLPALPDMMREMHLTTQQVQFTLTSWFLGLASM
PLFLGVLSDRFGRRPILLIGGIIYIIATVICALTHNHQVLLIARFLQGGMTSSMLVAGYA
TVHEMYDHKEAVRMIALMGSISVLAPTLGPLLGSIVLLFTSWRGIFWFIAIWATIAILLL
IKIMPETLNKEQQNKINIPTLLKSYKKIISNYRFMALTSVLGCIFAGFITWIAAGPLLVI
EVFQHSAIAFGLFQLAIFIAYIIGNYLVRYLVEKIKVVHLLHWGMSIAQIGVFMMLMSSF
FFPQFLYGFIFSMMVFSFGTAFCFPLLNRMIIESSQETMGIRVSLFTVFLTLFSSLGSAA
SGLFFSGTIFSLACLVTGFVVLAYLFYFFVK
>AIA17488.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MIHTEKLTRTFTTGKQVVEAVKGIDLDVQKGELVALLGPNGAGKSTTLRMLTSLLPPTSG
TARVAGIDVTKNPAGVRQKIGYIGQNPGAGYNYRVWDELRMQGRFYGLSKDEVSERGKEL
LSTLALEGMELRKVSTLSGGQKRRLDIALGLIHSPELLFLDEPSTGMDPQNRANLWEHIT
RLREERGTTIVLTTHYLEEADSMAERIVIIDHGRIIADDTAERLKAQQAGDRITVTVDES
DVQLASEVVANAGTILDTTSNTINVRVDAGDRTLPKLLNALHNKGIDVLSATLHQPTLDD
VFLNLTGRSLREGGDA
>AIA17446.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
GDMRRVKRLTMGTTLIMGRITWESLGGRPLPGRRNLVVTQRDLPGVECFRDIRAALAVAE
GPVWFFGGARIYQEAMSLANLIDMVYVPDHVTDPAAVKFPVIDPLEWDEGPLLPHEDEPA
LQRRVYTRRRRS
>AIA17410.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDKIKIGIVFGGRSGEHEISVRSAKSVIEQIDKDKYEIVPLAITREGKWLNPVESLGLLP
PPTQELLINDIGSFPRNSVALVGDTNYKGLLKLEAEKGEARVERLDVIFPVLHGTYGEDG
TIQGLLEMAGIPYVGCGVLASSCGMDKAFMKILFRDAGLPICKYVWFLRSEWETDNEATI
RQIEQQLGYPCFVKPANLGSSVGVSKAADEISLREAITLAAEYDRKIIVEECLDMREIEC
AVIGNDEPRASLPGEYIIRDESKKFLDYTEKYSGTGNNEFVVPAPISEELAKKIQQMAIT
AFKAVDGSGFARVDFFLRKDNGALLVNEINTIPGLTDASGFPKMWAGSGLEFSQVIDALV
ALAIERHKDKSRNKTSY
>AIA17379.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNGTKPFTVCVIVAMDQARVIGFKNRLPWHIPEDMKRFAKLTTGHTVLMGRKTYESLPDK
FRPLPKRKNMVITRSPAQFRAAEVVLVFSSPGAAIEHLHHHSEDVSGGQLWIIGGGEIYR
ENMEYVDQIYLTVVDGTHEGDVYFPEFEQDFVLAEWETHEGFEYRLYRRKTQASAPD
>AIA17277.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISFLAAMDRNLVIGDEKGIPWHLPADLKRFRKLTLGKPIVMGRTTFEHIGRPLDKRTN
IVMTRKLDYQPGGVIVAHSVDEALLFAGDVEELVIVGGGEVYRAFLPFVNRIYLTFVDGK
FPGTAYFPAEIPTPTGHAWRETHREEHFADEKNPFDHTYLVVERSLASGSPGGPLEIRSL
IA
>AIA17263.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRQGAIGKGGKLPWHYSADMKFFKETTIGNACVMGYKTWLTLKRPLPNRLNI
VLSRSAEIEPLESVVVLRDVESVLQKADELTRDLFVIGGAQVYHAFLPHIDKWIVTEVPL
TVEGADTFIPENYLEGFSLADTKDLGEGLRVSSYIRSPAA
>AIA17239.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEIVLIVAVAENGVIGRDNAIPWRLKSDQQRLKAITLNKPVVMGRKTFESLRRPLPGRTN
IVVTRDPNYRAHGAVVATSFENARAIAIGDALRRFATEIAVIGGAEIYAQWMASATRLEI
TEVHARPEGDTHLAAIDLAAWEEVARVRNPAGPDDSVDFSYVTYRRRQQR
>AIA17164.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MINVALLCGGDSSEREISLKSARAMHSALDAQRFNVRLYDVSQVQSISTVLPLDESLLAA
EEVASLRDWWQGAANAQSVAWGNLTAQLKADETAVVLSSLHGGWGEDGTVQTLLQIADIP
FAGSPARASMIAMDKRLCKALVRESGVVAPRGVVVSSPDAPMFDGACVVKPNGGGSSMGV
SFLREFDEVQWRTAIKNALSDGSDALVEELIEGVEVTAAVMGEGESAQALPIVEVVPQDA
TFYDYKAKYAAGGSEHICPARLDEATTQRIQRDALAVYRALGCRGVARSDFLVKADGMPV
FLEINTLPGMTQTSLVPDAARAAGISFSALVENLVVGALQ
>AIA17077.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMKHIIDHGTRKDDRTGTGTLSVFGHQMRFDLSEGFPLLTTKKLHLKSIIYELL
WFLKGDSNVKYLKDHGVNIWNEWADEAGNLGPVYGVQWRSWRTADSGAIDQIALVVDQIR
TNPNSRRLIVSAWNVGEIEKMALPPCHVVFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YSLLTLMVAAVCDLKPGEFIHTFGDVHLYLNHLEQAQIQLRREPLALPRMKLNPSVKSIF
DFDYSDFEITSYEAHPHIKAEVAV
>AIA17063.1|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
MKQKKIVFLFGGPGAEHEVSVATAKSALPKFDAQYSILPVFITKDNAWVASQEYMPPAES
WAVAQKLITQSGIAQDVAIDMIEHTDPYVVFIGLHGTYGEDGTLQALLESHGLAFTGSNA
EASSLAMDKPKVLQILQDEEITVPEFLELTSEMPEGAALEFGHYHGFPVVVLPADSGSSV
GVTIVRNQEQLPMAIDTARQYSDRILLSQFIPGREVSCGMLVTDKNELTALPPTELIPNE
NYEFFDYDAKYKPGATKEITPPHMDDAIIAEIKSLARRVHHLLEADGYSRTDMIVGEDGK
IYVLELNTLPGLTETSILPQQAAAFGLNFTDFLTTICENVDRSSREYLTAV
>AIA17038.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
FFLKRLPRGGVGGSVPVFTRPAPGQSDFYMTDTVATSREPSRVEFIVLVAALMALNALAI
DVMLPALPYMGEALGIANENERQLVVGFYMFGFGIAQLAFGPLTDRFGRRGPLLVGLAIY
LFCAFAATFAPNFGALLALRFVQGMGAAGTRVIATAVVRDRFEGREMAEVMSLTFMIFMA
IPIIAPGIGQVILLTGPWQYIFLFMGGLASLIGLWGYFRLPETMHPEYRRALSFKSVVEG
FRIVVTNRPALFYGLAGTFLFGAMFGFITASQQIFVELYGLGPYFPVAFAVMAGTIAIAQ
FINSRVVRRVGMRRLAHTANLVYLAAAAIWLILALAGPVPFAVFFGLFMVIQFFFGWAAS
NMNSLSMEPLGNVAGTAASVFGFTQTVGGALIGTYIGQQYNGTLVPNAIGYASMGALVLI
CVLIAENGRLFGVGVQYARGAGTGR
>AIA16951.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGLQPYLELLRDVMTNGVNKTDRTGTGTLSVFGRQLRFDLAEGLPLVTTKKLHMKSIIHE
LLWFLSGDTNIRYIRENGVTIWDEWADEAGQLGAVYGSQWRSWKTPDGRVVDQISQVLRQ
IQSYPDSRRHLVNAWNVAEVDSMALPPCHYAFQFYVAEQKLSCLFNMRSVDTFLGLPFNL
ASYAILTHMVAAQCGLGVGELIWSGGDVHIYLNHLEQVKLQLTREPYPLPQLHIKRKPDT
IFDYVYDDFEIVNYQAHPRIKAPIAI
>AIA16934.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRSRGHVVTALDPARGVISAAEERELSTGKVGT
EPPSLETLSKFAEGAFLPNLTSMKEVKDADVAFLALHGGQGEDGTIQALLDMANVKYTGS
GHLSSALAMDKDLSKKLFRSEDVKTADWLMAPVTVEQVEGMLGLPVVVKPSKQGSTVGLS
LVKKREDLAKAIEEASKYDDEVMVESFVPGRELTVGILGDVALPVGEILPKHEIYDYECK
YTAGMATEEFPAKLSPEATEKVQQQALAAFRALKLRGYARIDFRLTSEGEFYCLEANTLP
GMTELSLIPQGAAAMGISFPELCERIVRLALG
>AIA16912.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRNEQQYLDLLTHVINHGTRKADRTGTGTLSTFGYQMRFDLNEGFPLLTTKRVPMRLIT
SELIWFIRGDTNIRYLLEHNNNIWNEWAFKRWTKSAEYDGPDMTDFWLRAEQDEAFAVEY
EEQMERFKQRVLSDDAFAAQYGELGDVYGKQWRAWRTTRGETIDQLQDVIQTIKTNPDSR
RLIVTAWNPEDVPTMALPPCHTMFQFYVADGKLSCQLYQRSADSFLGVPFNIASYSLLTH
LIAHECGLGVGEFVHTLGDAHIYLNHIEQIGEQLSREPRPLPELVLNEEVKSVFDIEVSD
VRVEGYDPHPTIKAPVAV
>AIA16851.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTTREKLPKKIAVLMGGPGSEREVSLATGRGVAKALRSLGAEVVEIDVQNEDFQLPNDVD
LAFNTIHGTFGEDGHLQTILEGRGIAYTGEGVVASEIAFDKIRTKEKFQEHGVTTPPSEV
IHAGQRPTIPLPIVVKAPRQGSTVGVVIVKNESELESAIAEASKYGRELLIEKFVAGREL
TIGILGDQALPILEIIPKGGVYDFNNKYPFLNPQGGGGAEHVCPANIDAGKTKEIQELAL
RAFRSAGLQVYARVDAILSDDGQPYILEINTIPGMTEASLLPEAAAAAGIGYPDLCARII
ALSSLRQGYGGQAGAGTEGKR
>AIA16765.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHQYLDLLARIRNTGTRKDDRTNTGTLSIFGHQMRFDLAEGFPLVTTKKLHVKSIIHELL
WFLQGSTNVRYLREHGVTIWAEWADENGDLGPVYGRQWRAWPTLDGRHIDQIARVVESLK
GDPDSRRHIVSAWNVGELDKMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTHLVAQVCDLEVGDFVHTLGDAHLYLNHLDQARLQLKREPRALPKLVLNAGVSSID
EFTSDDIAIEGYDPHPGIRAPIAV
>AIA16750.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MPGDIRISLVAAMAQNRVIGDGPNIPWRIPGEQKIFRRLTEGGIIAMGRKTFESIGRALP
NRETVVISRQRGYNAPGCTVVGAFDEAVEFARDRGGELFVAGGAEIYSQAMGRADRIYLT
EIHRQFAGDALFPEIDASFTLVSTEEVAAEIPYTFKVYQRTRSADGRFRI
>AIA16706.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLKSILLHGKEHEDRTGVGTISHFGFQTRFDLREGFPIVTTKKIPFRWVAEELF
WFLSGDTNEANLRARGVDIGAEWADEAHTKRFARKPGDLGPVYGYLWRSFGGHYPEHDGV
DQIARLVGEIKNNPHSRRLIVTGWGPREADNVDLPPCHTLFQFKVENGSTLHCQLYQRSA
DAFLGVPFNISSYALLLRMVAHVCELAVGEFVYTLGDYHIYKNHLDQVNELLSRDPLPLP
RLEIVDPTKRLRGLQGLLDMRYEDLNLSGYQSHGKIAAAVAV
>AIA16580.1|FEATURES|farme|peptide|vph|antibiotic inactivation|0
MTKTASKTPITEPMTLADKVLHAYGLEYSRILTPQKGYRNQSFPVVLASGEMRNLILYKR
EPGIVKRIKAANAVSDFLAGQNFPTRQTADERIIKLDSGSGRPAQYGALYSYLDGHTIPW
EAYTQDHIKALGEMMGNMHAALAAFPPRAADSLPAVTDEYLAIVARMKRYFGEAPVQRSL
GQKLQLAVGLERLEYFEQLLVGANMLPGQQALHMDFVRGNILFVREPVEESGPRITGILD
FEKTAYGHPLMDVARTLAFLYIDCKYKPEEKVRKYFLGSGYAKRSAAPLPARLSAALLGP
LVDLFLCYDFYKFLRHNPYESLRQNEHFVRTRDMLLARGVVTSSTP
>AIA16513.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHQYLDLLARIRNTGTRKDDRTNTGTLSIFGHQMRFDLAEGFPLVTTKKLHVKSIIHELI
WFLQGSTNVRYLREHGVTIWEEWADENGDLGPVYGRQWRAWPTLDGRHIDQIARVVESLK
GDPDSRRHIVSAWNVGELDKMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTQMMARVTGFEPGEFVHTFGDAHLYLTHPDQADEQLKRSPRALPRMEINPEVRSLF
DFAYEDFKLAGYDPHPAISAKVAV
>AIA16450.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRGKGHEVTPMDPARGVINSAEERELSTGKVGA
EPPSLESLSKFAEGTFLPNLTGMKEIRNADVVFLALHGGQGEDGTLQALLDMAHVKYTGS
GHLSSALAMDKDLSKKLFRMEDVKTADWLMAPATTEQVEGILGLPVIVKPSKQGSTVGLS
LVKKREDIAPAIEEASKYDDEVMIEQFIPGRELTVGILGDIALPVGEIFPKHEIYDYECK
YTAGMASEEFPAKLSKEATEKVQQQALQAFKALKLRGYARIDFRLTTEGEFYCLEANTLP
GMTELSLIPQGAAAMGIGFPELCERIVKLALG
>AIA16397.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKPYLDLMRHVLEQGTPKTDRTGTGTLSVFGHQLRFDLREGFPLLTTKKLHMRSIIYELL
WFLRGDTNIGYLQEHGVRIWNEWSDEQGELGPVYGRQWRSWQAADGRSIDQISQVVEQIK
TNPDSRRLIVSAWNVGELERMALMPCHLLFQFYVANGRLSCQMYQRSADIFLGVPFNIAS
YALLTMMMA
>AIA16395.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSMKKHPEYQYLELCKDILDNGADKELFFNDVVLEEYKKKGEQPPFIRSVFGRQMRFDLS
DGFPLLTTKKTFWRGIVTELLWFLSGSSNIKPLLDVKNHIWDEWAWKHFQMWSSDDEKKM
LPEMTQEALIAKLTELPATDPFVLKWGDLITIYGRMWRRWPAKDGREIDQLAWVIKGLKT
KPDRKSYVVSAWNPDFIYEMASEGQKSHVPPFCHTMFQFQVANGKLNLGLYQRSGDLFLG
VPFNIASYALLLIMVSHVTKIPPGEFVHTLGDVHIYSNHFDQVKEQLLREPYPFPKVTLN
PAIDDIDKFTAEDITLENYQSHDSIKAAIANIGGFVEKKT
>AIA16390.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLVVAIDEKRGIGKEGKLPWRLSADLKRFREVTMGHHLIVGRKTFESIGRPLPGRQT
ILVTRNPDLKPEGVVVVHSVEDAIALAQERGETEAFVIGGAEIYARTIEAADRIYLTEVH
AEVAADVFFPEFYRDEWIETQRIEHSKDEKNEHAFTFVVLERVTP
>AIA16354.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MTSSKAFQITNTILASKKYQDLYPQTVERIVIDCIKRYGEKRAEKEARNKLHQIWGAYWS
TRPDFTKLFEKVLPQIQENPSQALKELMALQSSTKERTPLLETFYTQIFMTIGEAINSVS
EYGCGLNPLTYLWIPNAQEKEFIAYDIDLAEVSFLNTLFEEFTLNITARPNDILQGCDKY
TDVVFMLKLLPCLEQQQKNVSKTILAQLQCKYAVISFPTKTIGGKPKGMDEFYSGQFEEV
ITELKLNTKKIHFSSELVYIIKFH
>AIA16342.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIILGPVAVAKNGVIGGGNDLPWYFPEDLKHFKEITMGKTVLMGRKTYDSIFKRLGKPLP
GRKNVVITRDQNGVYPEGVLVFNDPEAAVAALPNEDIYVIGGAQIYSLFLPKAEKMFMTH
VHKEYPGDAFFPEVNWDEWEKIEEEPHDQYTYSTYIRK
>AIA16248.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISIIVAASENNVIGRNNDLPWHLPADLKYFKDTTMGHCVVMGRKNFESIPPKYSPLVG
RTNIVITRQKDYNANGAIVVNSIQEAIDFSRNQNETECFITGGGEIFKQSIRLCNRIYLT
RIHAVIEGDIYFPELNKEEWKEVSRKDIEPDEKNKFPFSFLIYERI
>AIA16200.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GMLVSMLEKDPSSRHGVVVTWDPANDGLGGASKANVPCPYTFTVNIMGGRLNMMNVVRSN
DVILGLPHDVAGFCLLQLILAQRLGVKPGIYTHTIANAHVYDIHYDAAKEMIGRKSDMPK
VSVKLPANTFARAEAKDTQLVEDINTPLTEQYQPGEAIKGLRIVL
>AIA16201.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFIVAALTADGFIARNTTELADWTGTEDKKLFVELTKRAGVMVMGRTTFETIGRALPG
RKTIVYSHRPLDIPDVEVTDEAPVDLLRRLEQDGHQEVAICGGAAVYTQFMEAGLVDELY
LTMIPCLFGGGVRLFNASLESKLHLLDTRRLSDDVIMLQYEVEK
>AIA16134.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRERGHEVIALDPARGVISAAEEKELSTGKVGT
KPPSLESLSKVAEGAFLPNLTSMKEIRNADVVFLALHGGQGEDGTIQALLDMAHVKYTGS
GHLSSALAMDKDLSKKLFRAEDVKTADWLMAPVEIEQVEGILGLPVIVKPSKQGSTVGLS
IVKKREELLPAIEEASKYDDEVMIERFVPGRELTVGVLGDIALPVGEIISKHEIYDYECK
YTPGMAREEFPAKLSPEATARVQQQALDGFRALKLRGYARIDFRLTEEGEFYCLEANTLP
GMTELSLIPQGAAAMGISFPDLCERIVKLALA
>AIA16113.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVSAWNVGEIPQMALPPCHAFFQFYVADQKLSCQLYQRSADLFLGVPFNIASYALLTHMM
AAQAGLGVGEFVWTGGDCHIYDNHVDQVALQLGREPRPYPELVLAHRDSIFDYQYEDIAI
LNYDPHPAIKAPVAV
>AIA16080.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RRIIVSAWNVADVEEMAISGLPPCHLLFQFYVANGKLSCQMYQRSADTFLGVPFNIASYA
LLTLMMAHVAGLKPGDFVHTLGDTHLYANHLKQVEQQLKRKPRPLPKMKLNQDVKSIFDF
TIDDFELSGYNPDPAIYAPIAV
>AIA15885.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKQPEKITKQTRIGVLYGGLSNEREVSLRSGSNCHAALKRLGYENAELIDVGHDIAIVLQ
QKKIEIAFLALHGKYGEDGTMQGLLEFMQIPYTGSGVLASALALSKPLTKAVLKAQGLPS
AETIVIDQHDAKNFRQMIGDIKWAPAMVKPLSEGSSVGVSKVDDSSALVATVEETITKYG
GAIVEKYIKGQEITVGVLEELGASKNGKGIFALPILELRPKSKAGFYDYEAKYTKGMTEF
VLPAELSPEVTALAQDLAIKTFRALQCCGYARVDMMVDASGQPFVLEVNTLPGMTDTSDL
PAMCEEYGISYDELVERIVQSSGLDK
>AIA15855.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MGSTGGNMQKKKISIIAALGKNTRAIGKKNGLIWKIKGDLPRFQKITTGHPIIMGRKTFE
SLPKGALPDRLNIVVTRQEMNIPGAVTATSLDNAIMLAAKENADEIFVIGGGEIFKQALM
LADRLYLTVVDSDEPGDIFFPDYSIFRKVISEERHNEHDPKFSYLVLER
>AIA15800.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLRETLEHGSAKSDRTGTGTRSVFGRQLRFDLAQGFPLITTKRVHFKSIAYELLWFLRGD
SNVGWLREHGVSIWDEWADQSGDLGPVYGVQWRSWPTPDGGHIDQIAQVIETLRTNPDSR
RMIVSAWNVSEIPAMALAPCHALFQFYVADGKLSCQLYQRSADLFLGVPFNIASYALLTL
MVADQVGLAPGEFVWTGGDCHIYDNHVEQVTEQLRREPFPAPTLRILRHPESIFDYRFED
FEVVDYQHHPAIRGAVAV
>AIA15780.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|0
MDTPRIILLAAITADGKMARNTAHLSDWTSPEDKRVFVAESRRAGVIILGNNTYKTLPRP
LPGRLHIVLTSSTADKTDIPGVVEYTSATPAEIAASLGSRGYTSAVLAGGAQINTLFLAH
DMVDEIWLTVEPLIFGTGVHVFEGAAFDLRLRLISLEQINANAFLAKYSTRHEVAAPSNL
AQPSRE
>AIA15760.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVIEAAVARPEVIGIAAVARNGVIGTGNDIPWRIPEDWARFKAITMGHVLIMGRRTYDSI
GRPLPGRTTVVVTRNQSWHADGVIVAADLDEAFARSGELSPERVFVAGGGQIYAAAWDRL
DRLEITEVDAEPVGDVRFPTIGPEWTETARESRNGFAFITFEKR
>AIA15609.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MSLSYIFAMDRNRVIGNENKLPWHLPADLKFFKKTTMGHPILMGRKTYESIGKPLPGRQN
IVLTRSADYEADGCDIVHTAPEAIARFGESEEAFVIGGAELFHLFMPYADKMYITRIDHS
FEGDTFFPEIREEEWRLIHVEQGVRDEQNPYAYRFEIYEKNK
>AIA15566.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAPPRQFEVNLPNQAIPEQGSEEWKTAKDAYLQKIKSDADFAKEYGNLGPIYGHQWRAWA
DRDGNPIDQLRIAQEQIRSGKASRRIIVSAWNVGDIDEMSKAGLPPCHTLFQFNASNQTD
PKTGKKYLDMKMYQRSADWFLGVPFNMVQYAMLLSAMAQTTGRTPRYFYHTFGSAHIYKN
HIEQIKEQLSRANNLYDAPRLKLNPDVTDIGDFEAEDFKIIGYKHHASIKGQVAI
>AIA15516.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MKIAVMFGGTSEERDVSIASGSQVVRALRSRGHEVIPTDTAVGVLDAAAEEKLLSSDVRS
APPGSEQLDVLRTGDATSITRAPEMQGVDVIFLALHGGAGEGGTLQALLELTGLPFTGSG
MLGSAMAMDKDVAKRLFEIAGVPTPAWPMAPVGIHDADAQIGWPAVVKPSKQGSTVGLTI
VKKPEDLAKAIELAYQFDDEVMIERFIPGRELTVPVMGDDVLPVGEIFPKNEIFDYESKY
QAGGAEEVFPADLTGPETVAVQMLAMKAHRALKLRGFSRIDFRLDEHGCFWCLEANTLPG
LTAASLFPKGAAAAGIPFPDLCERLCQLAIEEHAGRRRV
>AIA15489.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGNQTPTGARRDPVARERRPEVIGIAAVARNGVIGAGNDIPWRIREDWGRFKAITMGHVL
IMGRKTYDSIGRPLPGRTTVVVTRDPAWRADGVIVAADLDSAFDRAFALTPTKVFVAGGG
QVYAAAWDRLDTLEITEVDAEPDGDITFPAIGADWHETDRDAREGFAFITFRRQSP
>AIA15463.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AVGPGRSDAKLTRSKNANTMNQYHDLLERILGDGAEKHDRTGTGTLSIFGHQMRFNLASG
FPMLTTKKLPLKSIVHELLWFLKGDTNIKYLKDHGVSIWDEWADENGDLGPVYGSQWRSW
PAPDGQSIDQIANVIDLIKRNPDSRRLIVSAWNPADVDKMALPPCHCLFQFYVANGKLSC
QLYQRSADVFLGVPFNIASYALLTTMVAQVTGFEPGDFVHSLGDAHLYLNHLEQARLQLT
RPTRPLPTMTINPEVKDIFAFHFEDFKLENYNPHPHIKAEVAV
>AIA15392.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MALNALAIDVMLPALPYMGEDLGVDNENERQLVVSAYMIGFGLAQLAFGPLTDRFGRRAP
LFFGIGLYVVCAFAATFAPTFAILLGLRFVQGLGAASTRVIATSIVRDRFSGREMAEVMS
LTFMVFMAIPIVAPGIGQIILLTGPWHYIFLFMAGLSAAIWVWAWFRLPETLHPEYRREL
KLSVIVEGFRMVFTNRVAFFYGLAGMFLFGAMFGFIISTQQIFVGIYGLGPWFPLAFATM
AGFMAVSSFLNSRIVKHFGMRRLSHTAMLVYVTCAVILLVLSLTMSVVPFWLFFLLLMII
QVSFGNAASNMNSLSMEPLGAVAGTAASVFGFCQTVGGAILGTFIGQQFNGTLTPNATGY
VVMGTLVLCCVLIAEKGKLFGVGKEYERPATAAAE
>AIA15370.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MAANKYVIEAQGLTKSYGSTKVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLAFE
SGTVTVEGHNVTTESDKVRAVIGLTGQSAAIDELLTGRENLVMMGRLYRLTVPSAKARAQ
ELLEEFDLIDAAERPAKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRLAMWGI
IKNLLAAGTSILLTTQYLEEADQLADRIVVIDDGKVIAEGTASELKSKVGKDRLELTFKD
SRTLANAVKALGKKVIDADEKEFSATVIIKDTNADVRETLDVLAREKISIHAMTIHKPTL
DDAFLSLTGKQKSLKKERSN
>AIA15330.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MPTKNIALIAGGFTGEYEVSINSAKNIAANLDPAKFKVYTVLITRADWFYDTGHEHISID
KNDFSLTLNGEKIKFDFAFITVHGTPGEDGKLQGYFDMLGIPYNTCDATTSAITMNKAFT
KTLVHGIHGLNAAKSMQLHRKDGHDVATIAANLKFPLFIKPNNGGSSVGMSKVHNIAGLP
EALERAFHEDDQVLVEEFIKGREYSRGIARLNGEIMVLPATEIISHKEFFDYEAKYTAGA
SDEITPADLSNEQNEKIANILTEIYLRLNCKGMVRIDFILLEGSQDFYFIEVNTTPGQSS
ASLIPQQVRAAGMDLMKFYGDLIEGTF
>AIA15294.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MLNRSSSGNRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYNAGIEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQNIEQFTLLRFLQGVSLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFVLFALL
AAISFFGLHRAMPETATRLGEKLSLKELGRDYKLVLKNVRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQLSSYEYGLLQVPIFGALILGNLVLARLTARRTVRSLIVMGGWPIAAGLM
VAAVATVASSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIEVSKHAYAFGSNGLFSLFNLANGLLWVGLMVVFLKDKRVGSALQP
>AIA15161.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIALIVAVDKQGVIGREHMIPWRLRDDLIKLKELTAGRAVILGRKTYDSMLTYYDRSGRP
MPGALYIVVTRNRSYKPARDNATVAHSIEDAIEAAENFGDDIMVIGGEQIFTAMLPCAQR
IYLTEVQTVAAGDAHFPVIDKKLWWEISREHHSKDVHNDHDYDFVVFERNKS
>AIA15098.1|FEATURES|farme|multidrug|norb|antibiotic efflux|0
LEVVFYGLGAVTGPVVASIMLDWQHTAIPTIWGGAVLATVLIPGVFVMTLPPVVAREHIT
GSRATSLYRSPILWTLAAIFLLYVGLEVGTGGWIAVYIHITTPLSLSVGALIASGYWLAL
TGGRLLATLFGGRLSPARLLLVCLCGAVVGGFLLALSTGDAPLTIGAVVVLGVSFGPIFP
TAFAITTAEFPRAPGQAASTVVALGSIGGVVFPWLQGLILTRISPQTSVVFVAALALLLL
LVSRAIPAKHRPHPLAPSPF
>AIA15094.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTIEISFVVAIAENNVIGRDGGLPWRLSTDLKRFKALTLGRPVVMGRVCYDSIGKPLPGR
PNIVITRNPDFHPEGVIVAHSLEVALEKATAEAKRLGVDEICVIGGGVVYREAMKLATIL
RVTHIRAKIEGDTFFPEIDPAIWQAGEAEDVPAGEKDDFPTRFVTYRRKTAGV
>AIA15074.1|FEATURES|farme|aminoglycoside|APH(2'')-IIIa|antibiotic inactivation|1
MTDEREHLALPIFTLTNGHIPPVTTASWLGEGDFCFCYLVNGEYVLRFAKHATASAANVR
EACVLSVIAPLLSVAVPQPEARGINNETGEQLQYYPLVPGTILESEVLESLPPAVQASLI
AQMADFMRQVHAIPLEAVSACGIPTFQTLTHFGEVMERARDTLRPHLTDAVWNHHEALLA
RATANPRFDHYTPVLLHGDLSPDHFLADLDTGKLTGVIDFGDVCIGDPAWDFVYILEDYG
ADVLTAFLAHYDSDNAAFLAEKVRTYQHLNNVAYGVSALAEGNDDDFAEAMAILTEQAR
>AIA14986.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MAINEEKIKVALVSGGDSSEREVCFMSAKAMANALSPERYAVTVFDVASTETRAHSFNYG
GDVLGKKPRHAVAAVEWNQLVTTLYTTGYDVVLPALHGGRGEDGTLQALLEVAGIPYVGS
AQHTSAIAIDKQICKAVLAEHGIPVPRGQVFNSLGEFDAAKPALEPCVVKPNGGGSSVGV
TIFREVPTAG
>AIA14958.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKSIVVAYDMERTIGRDNDIPWAGKIPADMRHFKELTEGTSVIMGRNTWDSIPEAYRPLP
RRQNIVVSLTQQAFKGALAAQSLEEAFSLAEHEIMVIGGAQIYAQALPLVDRVYATEINT
HTEGGDTFFPELPSAEWYVDEAEMHLPEGKNLLPYNFFTYLRHDPLES
>AIA14933.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNKTRIGVIFGGRSGEHEVSIRSARSVIEAIDKERYEIVPMAIAKNGKWLSPAESALLFP
AETRQLLAEQNSVKETRAVALIGDPTYQGLTLLEKSDERAQPLDVVFPVLHGTYGEDGTI
QGLFEMAGIPYIGCGVLASSCGMDKVAMKVLFRDAGLPMCRYTWFLRRDFEAAPEAAIER
IKNEIGFPVFVKPANLGSSVGISRADDDESLRKAIELAAHFDRKIIVEEGLDAREIEVA
>AIA14919.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MAIGEDISTKTKGDATGEEFVSARINSVPPSGIRKFFDIVATMKDVISLGIGEPDFVTPE
PILNAGIESLRAGHTAYTSNSGILELRQLIAAQLKHHYNVKYDPDTELLITVGVSEALLL
ALMAVVEAGSEVIVPEPCFVAYQPTVIFAGGVPVPVPTYVSQDFQVTVEDLEKARTPRTR
ALLLGYPNNPTGAVLDRSRMAEIAAWAEEHDLLVVSDEIYDRLVYGIEHTCFSSLPGMWK
RTILLSGFSKSHAMTGWRIGYAAAPPAILAAMRKIHQFIIMSAPTTGQEAAIEALKSGEP
YVESMRQEYDRRRRLIVDGFNRLGLTCFEPRGAFYAFPSIESTGLDEEEFCERLLMEEKV
AVIPGSAFGASGKGHVRASYATSYANLQEALVRIERFLGKLK
>AIA14781.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MASADNVISVKGLKKSYDKLQVLKGVSFDVQRGQILALLGPNGAGKTTTIRILSTLLESD
GGSASINGFDVGHNAGKVRESIGLTGQYAAVDEYLTGEENLYMMGRLYRLSKKDTKRRTQ
ELLEQVDLVEASKRPVKNYSGGMKRRIDMAMSLIASPPVLFLDEPTTGLDPRSRAGMWSL
IKKLAKAGTTILLTTQYMDEADQLADNIVVIDKGKVIAEGTSTQLKAKVGSDRLELTISS
KSEFSDAISAVKGEKAEIDEEARTISVVASKGGVQKLKQVLQNLETAKIQVDNVSLHRPT
LDDVFMSLTGHVTAKTEPEKANKKVKK
>AIA14728.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MGKIDDKVAGRVVFGGKSAEHEVSLQSAKNILEAIDKTRFDVVLLGIDKQGHWRLNDASN
FLLNAENPALIALNHAAEDVALVPGTTQQQIITRHNAHPLSQIDVIFPIVHGTLGEDGSL
QGLLRMASLPFVRFRRAGLCGQHG
>AIA14723.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSATTLTQSEIKELGKVAVLFGGRSAEREISILSGTGVLQALQSKGVDAHAFDPAERSLG
ELAAEKFDRAFIALHGRYGEDGSLQGALEQLGIPYTGSGVMASSVGMDKITTKIVWLANG
VSTPKYAVIDTDTDLDQVVADLGLPLIVKAPLEGSSIGITKVTRREELQAAVELSRKYDA
RVLAEQFIEGREFSVPLLGTGPTARALPIVEIVAPEGKYDYQNKYFTDDTKYHCPAPLDA
ATTGAIQREVEKAYRALGCEGWSRIDVLLRESDQQFFLLEVNTSPGMTTHSLVPMAARAE
GTSYEDLCVAILRSASLKIGQNKKEKA
>AIA14691.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MGCVVEKKLSILVLCGGQSTEHEVSILSSKNVVAGLDPNKYSVNVVYITHQGVWHYLSDI
PSYLSHGPEVLVKQGKTIPVLCHLGAKVPTLVAFSSPNKAFTMDCIIPILHGTNGEDGSI
QGLFQLMNVAYVGSDVLSSSMCMNKAITKQLLRANGIPTTPWNLLSRDQIIKGTYSKLVE
QLGAELFVKPVSLGSSVGISRVASEAEFLQAAHQVLRYDHQVLVEQSIRGREIECAVLGN
ENPVASLPCEIISHRDFYDYDAKYLDPKGATTVVPADLSPVAVDRICQMSRDAFRIMQCR
GMLRVDFFMINEEAILVNEVNTIPGFTNISMYPKMWQASGITYSELLEQLINLALQRQAM
QNQLERVYVRLGAVEAVNRDSLSS
>AIA14659.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSAAELKNEFGKVGVLFGGRSAEREVSLMSGNGVLTALRSKGIDAHPFDPAERSLAELAA
EKFDRVFIALHGSYGEDGTLQGALEQLGIPYTGPGVMASAIAMDKIMTKRICMSHGVPTP
KFVALDASATSAARLQEVASELGLPLMLKAPHEGSTIGIARVEDAAGLQAGFDLCAKYDS
VVLAEQFVKGRELTVPVIGSGRNARALPIVEIRAPQGNYDYQHKYFSDDTQYLCPAPLDE
AFTKRVQKLAVDAFNAVGCTGWSRVDFMVRESDNEPFLLEINTSPGMTSHSLVPMSAKVA
GTVYEDLCVEILRLARLDLKPAQHVKKD
>AIA14653.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MGRTEFIALAAALMALNALAIDIMLPGLQEIGASLGVDNENHRQYVISAYLIGFGISQLF
YGPIADRFGRRKPMLFGLGIYIISSIAVIFVPSFAGLLVLRFIQGIGSAATRVITISIVR
DIYGGRQMAEVMSLIMMVFMVVPVIAPGTGQIVLFFGDWHLIFGFMAGIAAIVTVWMYLR
LPEPLHAEDVRPLTVSSVLAGFKIVLTNRVALCYTIASTIIFGALFGFINSAEQVYKGIY
GLGPWFAAAFAGVALFMALSSFLNSRLVGRFGMRKLSHGSLIGFICITFVWLVLQIVGPQ
PMPFFLFILMFALAMFQFGLIGSNFNSLAMEPLGHVAGTASSVIGFMSTIGGSLIGAAIG
QAFNGTALPMVAGFFVVSVLGLVFVLIGEKGVLFQPQNKPTH
>AIA14613.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KSAEHEVSLQSAKNIYDALDKDKYDVELIGIDKEGKWHLNHAGSYLTNEHDPKLISLNKS
NEGIAVVPGEDQKQLVNLSSKEALSSLDVIFPILHGTLGEDGSIQGMLRLANIPFVGTNV
LGSAVCMDKEITKRLLRDAGIPNAKYVTATTWNRDSLSFSDIEKELGTPLFIKPANQGSS
VGVSKVSDEKAFKAALDTAFKFDHKVLIEECIIGREIECAVLGNENPKASIPGEILPQND
FYSYEAKYIDESGALLAIPADLTEEQSNAVRELSVSAFRTLNCEGMARVDVFLKENGEIV
VNEVNTIPGFTKISMYPKLWEISGISYKSLIDELIQLAIERHERDNRLHHNAFE
>AIA14596.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVRDILEHGRPEDGGVRSDRTGVGTYSVFGRQLRFNLEEGFPLVTTKKTHMRSI
IHELLWFLSGDTNTKYLTDNKVSIWNEWADKNGELGPVYGKQWRRWEGPRGERIDQIQRA
VDTIKKSPNSRRILVVAYNPADLPEVAPPACHTLFQFYVSGNRLSLQLYQRSADLMLGVP
FNIASYSLLLMMVAQVTGLKPYEFVHTFGDVHIYSNHIQGAELQLTREPRPLPKMILNPD
VKDLFKFRYEDFKLVGYEPHELIKFDIAV
>AIA14597.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MTDLRVSALVAMDENRIIGSNNQLPWHIPEDLKRFKELTTGHTVVMGRKTYESIPGKVRP
LPNRKNVVVSRTPESLDVPAGVDAISSVKEWLDSCREGTVVLPSPEIWIIGGAQIYEETK
SLWDELYLTVVHSTHQGDVYFPRFEDSFELVSQEDRPGYSFMRYKRL
>AIA14582.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMRHVLDHGAVKTDRTGTGTRSVFGYQMRFDLGEGFPLVTTKKLHLKSIIHELL
WFLSGDTNIRYLQEHGVRIWDEWADADGNLGPVYGAEWRSWPTPDGGSIDQIAHVVDQIR
RTPDSRRLIVTAWNPADVDRQALPPCHCLFQFYVADGKLSCQMYQRSADIFLGVPFNIAS
YALLTLMMAQVTGLRPGDFVHTLGDAHLYANHLDQARLQLGRDPRPLPAMRINREVNSIF
DFVYSDFVLEGYDPHPHIKAEVAV
>AIA14488.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MAQSTYVIEAKNLQKSYGTNNVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLGFD
GGSVTVEGYDVIKQADKVRGVIGLTGQSAAVDELLTGRENLIMMGRLYRLTTESAKTRAQ
ELLEEFDLVKAADRPAKTYSGGMRRRLDLAVSLIATPPVIFLDEPTTGLDPRSRLAMWDI
IKRLMENGTTILLTTQYLEEADQLADKIVVIDGGRVIANGTANELKSKIGNDRLELTFAD
QETFKKALQTLGKAVIDTNDKEHTVTVVIKDTNADVKAVLEKLSQANIVITSMDIHKPTL
DDVFLSLTGTQKAATSEETK
>AIA14441.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GTQKHDRTGTGTISVFGYQMRFNLQEGFPMVTTKKLHLKSIIHELIWFLTGDTNIKYLKD
NGVRIWDEWADENGNLGPVYGYQWRSWPTPNGGHIDQISQVINQIKNNPDSRRMMVSAWN
VADVNQMALPPCHSLFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTMMVAQVCGL
QYG
>AIA14428.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MIKAFIIAAVTADGFIAKDQNHAAFWTSKEDKARFVELTKKAGVVVMGSQTYKTLPRPLQ
ERVNIVYSRDKNFEGAEVTQDDPYELMRKLEARGFSEVAICGGSQIYSMFMKAKLVDKLY
LTIEPLVFGSGITLFKEDMLFDLTLLSHTKTDKHTLLLEYKVNHHGGQSY
>AIA14323.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRTYLNLLQHILDHGVKKADRTGTGTLSVFGYQMRFNLAEGFPLVTTKKCHLTSIIHELL
WFLQGDTNIKYLNDNKVRIWNEWADANGDLGPVYGKQWRAWSAADGQFIDQISQLIHDLK
TNPDSRRLIVSAWNVGQIPQMALAPCHTLFQFYVAEGRLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVTNLQLGDFVHTLGDAHLYLNHREQANTQLVRTPYQLPTMQLNPAINNIF
DFKFEDFSLQNYVCHESIKAPIAV
>AIA14242.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNLDEGFPLLTTKKLHVKSIIYELL
WFLRGETNIKYLKERGVNIWNEWADERGDLGPVYGAQWRAGRAGDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRALPLMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA14109.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKSGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVM
IIITRNESTAFEGCFIARSIEEAVSLARERGESELFICGGAEIYAQTLGAADRLYLTLVH
ADCDADTFFPDWNSDEWIETESEHHTADEKNQYSFTFKVLERKHVDLLQSPGEH
>AIA14092.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MLHCFIIAVETLDGFIAEDKTQISTSWNSKEDKKSFVEITKRAGVVVMGSSTYETFMRPL
KDRLNIIYSRSKKFEGVEMTNDLPEILLQKLEARGFKEVAICGGASIYTKFLKAGVVDTL
YLTIEPVIFGQGVKFFNENLNLKLSLVSEEKTPSGALFLEYKVLK
>AIA14088.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TGTLSVFGYQMRFNLGDGFPLLTTKKLHTRSIFHELLWFLKGDTNIKYLKDNKVTIWDEW
ADEKGDLGPVYGKQWRAWETADGRTIDQISNVIHQIKTNPDSRRLLVVAFNPSEIERMAL
PPCHAFFQFYVANGTLSCQLYQRSADVFLGVPFNIASYALLIHMVAQVAGRCAPLFKSY
>AIA14077.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MSGLPKRIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPQNIDVAF
LTIHGTFGEDGQIQQILEDRGVPYTGDGVNESRTAFDKIESKKKFEAAGVTTPRWEIIGS
NERPTLPLPFVVKAPRQGSTVGIYIIRSADQLETGLAEARKFDRRLLVEEFVPGRELTVG
ILGDQALPIIEIIPKSGFYDFTNKYPFLNPQAGGGAEHGLSGQD
>AIA14061.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTRSIIGELLWFIQGCGDL
GPVYGAQWRTWRACDGQTVDQISRVIEQIKSDPDSRRLIVNAWNVGELSKMRLAPRHLLF
QFYVADGHLSCQLYQRSADVFFGVPFNIASYALLTMMIAQVCDLQPGEFVHTLGDAHLYS
NHLEQARLQLARAPRALPQMKINPSVKSIFEFD
>AIA14053.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MITRFKILSSCAVFACLVCACNASVSPTLQTSTTASPGAAVQTPTPAVCSATSLQKQFEE
IASVAAGPVGVAVLEIETGELVTLSGKQHFPMQSVYKLPIGMAVLQQVDKGLLKLDQIVH
VKPADLVPANLGSPLRDRHPQGADVTLSELLSLMVKDSDGTASDVLLNLIGGPDAATKYL
RELGVEDIVVATSERDMAGDVQVQYRNWSTPEAMVGLLKLLHEGRGLTAASRTLLLDWMV
KTQTFPTRLKGMLPEGTIVAHKTGSSGARDGVARATNDVGLITLPNGHHLAIAVFVSDTK
ADAKTRDAVIARSARAAWDCWVTSEKK
>AIA14029.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSTDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVM
IIITRNESTAFEGCFIARSIEEAVSLARERGESELFICGGAEIYAETLGAADRLYLTLVH
AACDADTFFPEWDSSEWIEVESEHRTADEKNQYPFTFKVLARKSQV
>AIA14009.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MIAAGLSFLNFFYGLFILPESLPKDQRRSFDWKRANPVGSVVRLRRYPQILSLIISMMLI
YIAGHAAQSTWTYYTMLKFNWSVRWVSYSLAFVGLSIAAVQGGLVRLIIPKIGQRNAVYA
GLGLYIVGFLLFAFATKGWMMFAFLIPYALAGISGPAMQGIMSSQVSASEQGELQGALTS
LVSLTSILGPLLMTGLFHHFTDKNTPVYFPGAPFAMGAVLTGVSLILAIRSFSLHRNT
>AIA13998.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIRIGVIFGGRSGEHEISIRSAKTVIEQIDRDKYDVVPIAISEEGKWLNPIEALALLPS
PTQELLTKEVGNFPREAVALLGDTSFKGLTRLEAVDGEERTSLLDVVFPVLHGTFGEDGT
IQGLFEMADIPYVGCGVLASACGMDKAVMKTLFRDAGLPICRYVWFLRSEWERAGEAAVE
QVKAKIGFPCFVKPANLGSSVGVSRADDEISLREAVELAARYDRKIIVEEALDMREIECA
VMGNDEPRASLPGEYVIKDESKKFLDYTEKYDGTGNNDFVVPAPISEELTRKIQEMAIRA
FKAIDGAGLARVDFFLRN
>AIA13991.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MLGGPSAEREVSLRSGSAVAKALRSLGHQVTEIDPKDGTFSLPPKTDVVFLALHGTFGED
GTVQEELEKLGVPYTGCNPEASRIAFDKVLTKKRCVEAGVPTARFEIFAKSSAPWPANWQ
PPVVLKPVRQGSSVGLQFVNNVQEWSEKLSESLNYDSEVLMEEKIVGRETTVGILDGKPL
PIVEVRVKQGEFDYKNKYTPGASEHFCPADFDPATTRGIQEAALRAFKAIGGRDYSRVDV
MVKTNGDPIVLEVNTLPGMTETSLLPDAAKAAGISYEQLCQKMVELALRRKK
>AIA13973.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKSGSLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVM
IIITRNESTAFEGCFIARSIEEAVSLARERGESELFICGGAEIYAETLGAADRLYLTLVH
ADCDADTFFPDCNSGEWIETESEHHAADEKNQYSFTFKVLERKHEA
>AIA13950.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKSNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVAGGKLSCQLYQRSADIFLGLPFNI
ASYSLLTMMMAQVCGLRPGDFIHTLGDAHLYSNHLEQARLQLAREPRRLPQMRINPSVKS
IFEFDYSDFELSGYEPHPHIKAEVAV
>AIA13923.1|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|1
MLLEIKNLHAGIDGKEILKGLNLQVDMGEVHAIMGPNGSGKSTLAKVLAGHPSYEVLQGE
VVYEGKNLLELEPDERAKEGIFMAFQYPVEVPGVSNAQFLRLAYNEKMKHLGEEELDPLE
FNDYLKEKAKVVDMSPEFFKRSVNEGFSGGEKKRNEILQMAVLEPKLAVLDETDSGLDID
ALRIVAEGVNYLRSADKAIILVTHYQRLLNYIEPDFVHVLADGKIVKEGGKELALELEEK
GYDWVKAATK
>AIA13901.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLGEGFPLLTTKKLHVKSIIYELLWFLRGDT
NINYLQAHGVNIWNQWADETGDLGPVYGAQWRAWRAADGRTIDQISQVIEQIKTSPDSRR
LIVNAWNVGELDKMRLAPCHLLFEFYVVHGKLSLHMVQRSCDMFLGVPFNIASYSLLLHM
VAQVTGTTADECILTLNDAHIYHPHFDAVNEQLSREPMKLCSLWLNPEIKDINDFTMDDI
RLENYESHPTIPAEMIE
>AIA13857.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTLPLILVVAVAENGVIGRDNQLLWRLKTDLGRFRRLTMGKPMIMGRKTFQSIGKPLPGR
ETIVLTRDAGFAAEGVHVVHTWEEAVARGAEVAARMGADSVAVAGGAEIYALALPHVQSI
FLTKVQVAPDGDAVFPDFDRSQFRETRREEHPKGPDDEHPFTFIDLERRR
>AIA13822.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRTWRACDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRALPLMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA13781.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRDIRDNGEEKGDRTGTGTRSVFGRQVRYNLSEGFPAVTTKKLYFNSVVHELI
WFLKGTGNIEYLAQNNVHIWDEWPYKAYLQKNNMEIPDPNSGEWREGMKEFINKIATDHE
FAKKWGNLGPVYGVQWRHWPDGKGGEVDQVARAIDMIKNSPTSRRIIVSAWNAAEIDEIV
ETGGLPPCHTLFQFNVRDDKLDLHLYQRSANTFLGVPFNIASYSPLLAMVAQVTGKQPGD
FVHTLADTHLYLNHLEQVEEQLSRKPFPLPTLKLNPDIKSIDGFKFEDIELVGYQSHPPI
KAPIAV
>AIA13776.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EGFPIVTTKKIPFRWVAEELFWFLSGDTNEASLRTRGVDIWKEWADLEHTSRFGRAAGDL
GPVYGYLWRSFGGHYPERDGVDQIARLIHNIEHEPNSRRLIVTGWDPAQSELVDLPPCHT
LFQFKVEEDAKLIHCQLYQRSADAFLGVPFNISSYALLTHLIAHVCDLRVGDFIYTLGDY
HIYQNHLTQVEELLAREPLPLPQLEIKDEDGRLRGLPGLLSFRYEHLNLIGYKSHSKIAA
PVAV
>AIA13770.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSTDLKRFRNLTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPAGCFIAHSISDAINLARERGESELFVCGGAEIYAQMFGVADRMYLTLVH
ADSEADTFFPEWDSSEWIEVESEHRTADEKNQYPFTFKVLARKSQV
>AIA13707.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYYIYNQVGGEVRQYLDLLQDIKVNGAEKADRTGTGTRSVFGRQIRFDLNEGFPAVTTK
KLFLRGIIHELLWFLQGNSNIEYLVKNNVNIWNEWPFKAYLKATNQSIPEQNSDEWKEKL
AAFIENIKNNADFAKKYGELGPVYGYQWRHWPDGKGGEIDQIQEAIDTIKNNPDSRRIIV
SAWNVADIKEMAKAGLPPCHSLFQFYVNDDKLSCQLYQRSADTLLGVPFNIASYALLTMM
VAQVTGLKLGEFVHTFGDAHIYLNHLEQIDIQLSRTPKALPTMVINPNVTSIFDFTIEDF
TLEGYDPYPAIKAPIAV
>AIA13616.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MKHDDYSIVVQDLRKSFGKLDVLKGINLTVKRGTILAVLGPNGAGKTTTVRILTTLLEAD
SGIATIEGYDVAKQADEVRSVIGLTGQNAAVDEFLTARENLLMMGRLYHLSKKDSQMRAE
QLLEQFGLVEAADRVAKTYSGGMRRRLDLAASLIATPPVLFLDEPTTGLDPRSRLAMWDI
IQKLADHGSTILLTTQYMEEADQLANRIVVIDGGKVIAEGTPDELKEQIGKERVEFTFDS
DTQFQKAHKALADG
>AIA13426.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIMPEIMKSKIIGPKIIGIAAVAANGVIGSDNDIPWRISADWQRFKALTMGNVLIMGRKT
YDSIGRALPGRTTFVITRDRMWRGNGVRVVSSVDEAIDQAMLLDVQKIFVAGGGEIYRAV
WNRLNGLEITEVDQYPRGDVRFPDINPNDWTETGRERHEGYSFVSYRRRSRRESTV
>AIA13384.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPFEDDLMTTTSTPSRNVEGPASNAAEPAPTGAAMRLSIVAAVASNRAIGRDNALLWRLP
GDMRHFRETTTGAPVIMGRKTWDSIGRPLPGRRNIVVTRQAGWSAVGAFTAGSLSEAIAL
ASRPGDDVAVSGKAYVIGGAELYAQALPLADEMIITEVDGDFEGDTFFPLWEPQSFDGAA
RGERLEENGLGYRFVTYRRRR
>AIA13356.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTRVGVIFGGRSGEHEISIRSAKTVIEQIDKDKYDVIPIAIGKNGNWLNPTESVGLLPA
TSGEALGDSIDSYTQDSVVVAGDTSYKGLTRLGGSDDEERTLALDVIFPVLHGTYGEDGT
VQGLLEMAGLPYVGGGVLASACGMDKVVMKTLFRDADLPICKYVWFLRSEWEGDNDAVIR
QVEAKLGYPCFVKPANLGSSVGVSRAEDADSLRRAIELAAEYDRKIIVEEALDMREIECA
VMGNDEPEASLPGEYIINDDAKKFLDYTEKYASTGNNEFHLRPSMDRGSPGSTFS
>AIA13308.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIWAQSSSGVIGRDNGIPWHVPEDMVRFKELTIGHTVIMGRLTWESLPAKFRPLPGRRNV
VVTRQAGYTAEGAEIVTSLEDAPLDDAWVIGGSQIYGLALPLATRCEVTEVDMDLHREDD
DALAPLLDEAWAGTEGPWQDSSSGLRYRYYSYKRI
>AIA13024.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKSIIVAVDKNMGIGAKNDLLWMRDLPDDLAHFKKMTTGASVIMGRNTFDSIGKPLPNRE
NIVVSHRPVGVDGVLTAADLPSAYQLARYPIFVIGGGRIYADAITDMDRLYVTEVVEEFP
QATVFFPAIDKSVWREVSREHHDADERNKYAFDFVVYDRI
>AIA13016.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTHPELQYLNLLNEVLSKGYRKVDRGTGDASYSLFGRQLHFDLAQGFPLLTTKKVYWKG
VIHELYWFISGKSNIKYLVDNNVHIWDDYPYKIYNLKRAKDKELREFTKQEFIEKIKTDH
KFAKQWGDLPRIYGELWRRWPTSVPLSGTTTGKPIKKRTIDQLKWAIKEITEDPNAHNAI
VNSWNPEYLYTMARYEDTSHFPICHNMYQLNVIDGKLCLQLYQRSADLFLGVPFNIASYA
LLTLIIAKITGYQPGTFVHTFGDVHIYEIHKEQVREQLKRKPKALPQIKFIKDFKTIDEF
KPEYLELINYDPHPPIKASLSVSGGFFKKK
>AIA13003.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKPRLVIIAAVSRNGVIGRDGDMPWRLSTDLKRFKALTLGKPMLMGRKTFLSIGKSLPG
RTTLVLTRDPAWQAEGVIAVRSVEEALQKIGDAPELCVVGGAEIYALTLPVTDVIHLTRI
HASIPGDTRFPALDTSEWRETERVEHPADERHAYAMTFSTLERRRA
>AIA12928.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTNDTSQKEFIFLVALLTALVAMSIDTMLPALGTMASEFGVSDPNKRQYIIGSFFAGMTV
GTLLSGPISDSTGRKPAIFAGLLIYVAGSLLCLFSTSFEMLLAGRALQGVGAASPRIVSM
AMVRDGQGGAAMARIMSFVMSVFMLVPILAPSIGQLVLFVASWRMIFVGFLFMAIIAAIF
LQIRQEETLPKEKRVAFSSGNLFRSAVEFFHFPSAWGYTVAVGFVFASFICYLGTSQQIF
AEQYAQGEWFAVWFGGFAIAIAFAMIFNGRMVMRHGMRLLSKWAVRGCIVFSAIFLAVAL
SFAGHPPLWTLGLYLFGTFFCSGILFGNYNAMAMEHVGHIAGMAAAISGTLSTLVALSIG
TWFGQQYDGTVMPLVYAFLSMSVAAMLVSEGVEWAKRRR
>AIA12854.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FQFKVEEGRVLHCQLYQRSADAFLGVPFNISSYALLTEAVAHVCGLRAGEFIYTLGDYHI
YQNHLKQVEELLSREPLALPRLEIRDEEGGPQKQQLLRGLEGLLSLRYEHLNLVGYKSHG
KIDAPVAV
>AIA12845.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNAKILGTAVILGLLSVVGPVAIDMYLPALPEIGGQLGASTSAVQLSLMSFMAAFAVGQL
FYGPVSDMVGRKPPLYFGLGIFMLGSIGCALAPSIEWLIVARFVQGIGACASASLPRAIV
RDQYTGAEAAQLFSLIMLVFSVSPILAPLTGSLVIAFGDWRLLFWVMTVVGLLGLALTVF
ALRETRPAHLRTESSIGGALRSYGTLLKDWNFIGLVMIGAFGMSSFMAFIGNSSFIYIEH
YGLTPTQYSFAFAANAISFFAVSQSTGYMVKRFGLQRLVRWAVTGFASAMVLLAALFVAG
IDSMWVLSGLMFVAFGFLGLVIPTTGVLAMEEHGAIAGTASALMGTLQMISGAVVMGIVG
AFHDGTAIPMVLGFAICALAAFLIAQVTIRTTTTQVVGAPAE
>AIA12552.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTIPLILVVAVAENGVIGRDNHLLWRIKTDLGRFRRLTMGKPMIMGRKTFQSIGKPLPGR
ETIVLTRDAGFAADGVHVVHTWEEAVARGAEIAARMGADSVAVAGGAEIYALALPQVQSI
FLTKVQATPEGDAVFPDFDRAQFRETKREHHPKGPDDEHPFTFIDLERRR
>AIA12549.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MVALVVAIAENGAIGKGGGLPWRLSSDMRYFRKITMGKPVIMGRRTFKSLPRVLDGRLNI
VLTRDRGFVAPDAVMAYSLEEGLAAARASAERTGAGEIMVIGGEDVFREVLPQARRIYLT
EVHASPDADTWFSDFDKRGWREVFRERYEAGPRDDHAFSFVVLERT
>AIA12511.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKPYLDLMRQVLEHGTPKDDRTGTGTLSVFGHQMRFDLQAGFPLLTTKKLHTRSIIYELL
WFLRGDTNVRYLQEHGVRIWNEWADEQGELGPVYGAQWRSWPAADGRRIDQISQVIEQIK
INPDSRRLIVSAWNVGELNRMALAPCHLLFQFYVANGQLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYLNHLEQARLQLTREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA12461.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MQQYHDLLRSILSNGTEHQDRTGVGTISHFGYQTRFDLRAGFPIVTTKRIPFRWVAEELF
WFLSGDTNEANLRARGVDIWAEWADEDHTRRFGRESGDLGPVYGYLWRSFGGHYPSRDGR
SQDS
>AIA12415.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
SVVDIYFVSRLGANAVAVVGLTESLMTIVYVIAMGLGIGASAVVARRIGEGDEDGAAHSA
AQAVLLGVTFSVMISVAGVLLAPALLRVMGGEPSVVSLGTPYTTLMLGGNMVVVVLFLVN
AVFRGAGDAAVAMRALFIANIINIVLCPCLILGIGPFPDLGLVGAATATTIGRGIGAIYA
FVRLRQKSGRLRVSAAHFALDPALMLRILRIAGSGMFQLFIAMASWVGLVRIVSGFGSDA
VAGYTIGIRIIIFALMPSFGMSNAAATLVGQALGAGRPERAEKSVWTAALWNMCFLGAVG
LLFIVIPDALVGIFTHDPAVMPYAVDCLRIVACGFLFYAYEMVITQAFNGAGDTRTPT
>AIA12359.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTVDTQYERLLRKVLETGTPKGDRTGTGTVSLFGERLRYDLSAGFPLITTKRVHFKSVAV
ELLWFLRGDSNTAYLKEHGVRIWDEWADENGELGPVYGYQWWNWPTPDGGHIDQVAKLLE
TLRGNPDSRRMIVSAWNVADLPGMALEPCHAMFQFYVADGRLSCQLYQRSADMFLGVPFN
IASYSLLTRMIADQVGLLPGEFIWVGGDCHIYSNHVEQVREQLTREAYPFPRLSLSPRPT
LFDYAWDDFELVDYHHHPTLKAPIAV
>AIA12333.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKNDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTRSIITELL
WFLRGDTNVRYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRSSDGRTIDQISQVIEQIK
SNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVAGGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPGDFVHTLGDAHLYSNHLEQARLQLAREPRPLP
>AIA12327.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MTTVGLIWAQSTSGIIGRGGGIPWRLPEDQARFKEITMGRTVVMGRLTWESLPERVRPLP
GRKNVVLTRQADYMADGAHVVPTLQDALTDDITWVIGGEQIYSLALPIATRCEVTEVEID
LPRDDGDAVAPVLDESWIGNEGEWLTSAAGLRYRFFSYVRP
>AIA12317.1|FEATURES|farme|beta_lactam|LRA-18|antibiotic inactivation|1
MGSGFADAVESRILPGLGLKHTYLRVPAGAMGDYAWGYDKANKPGRMGPGPLAAETYGIR
SSAADMIRYLQANIAPSRLDTPLRRAVEGTHVGYFKIDGMVQGLGWEQYPYPVSLKDLEA
GNSQKMIWEANPASALVPPQTPPPATLFNKTGSTSRFGAYAAFVPAKKIGVVILANKNYP
IPARVKAAHAILVNLEARRAD
>AIA12305.1|FEATURES|farme|beta_lactam|LRA-18|antibiotic inactivation|1
MIISSTLRAFLTGGALSALLAASACHAADANAALRAIVDRAVRPVIAEYDLPGVAVAVTV
DGKASFFNYGLASLEDKTPVSENTLFELGSISKTFTATLASYAQVTGKLSLDDHPGKYLP
ELKGSAIDNATVLHLGTYAPGGLPLQFPDEVPDDGMLAYFKQWKADAAPGTQRRYSNPSL
GLFGHVAALSMGSGFADAVESRILPGLGLKHTYLRVPAGAMGDYAWGYDKANKPGRMGPG
PLAAETYGIRSSAADMIRYLQANIAPSRLDTPLRRAVEGTHVGYFKIDGMVQGLGWEQYP
YPVSLKDLEAGNSQKMIWEANPASALVPPQTPPPATLFNKTGSTSRFGAYAAFVPAKKIG
VVILANKNYPIPARVKAAHAILVNLEARRAD
>AIA12299.1|FEATURES|farme|puromycin|pur8|antibiotic efflux|1
MAQTIGLIVLLSWQLMVVLDGTIVNIALADIRQNLGFSDTSLSWVVNAYALAFGGLLMLG
SRAGDMFGRRRLLITGVVVFTVASALGGIASNQEMLIIARVLQGVGAAMAAPSTLSLIVT
NFEAGAARNRALSLFASVSGVGASIGLILGGVLTSWLSWHWIFFVNVPIGIAVAVLAPRF
VAEAPLQPGRLDIGGAIASTLGVTALVYGFIRAAEVNWTDPLTIASFVAAVILLGAFVAI
ERRVAQPILPFRLFNERKRSIAFINQLLVPATLFGVFFFLTQYLQVVLGMSAVQSGFAFL
PFSATIVIGSRLVPRAVARFGPRTVMIFGGLAVATGLVLMSRLDETASYFPLVFISMVIM
ASGAVASFVSLSLAIMGTISPEDSGPASGLMQTNQQIGGAIGLAVLVTVFGTVNANALAD
GSNRIEAMVAGMQRGFLTAAGIALLVTVIAAVGYRSSNRDQQLGS
>AIA12249.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTKMRIGLLFGGRSGEHEVSISSARAIARALAAEENASKYEVLPFYIQKNGRWLSGTLPQ
QVLATGKPLEIEEQPGQDDSPASGQFPNFNAVDVWFPVLHGPNGEDGTVQGLLKLMQLPF
VGSGVLGSALGMDKIAMKMAFAHAGLPQVKYIAVNRSEIWSNPCVFPKLCDKIEAALGYP
CFVKPANLGSSVGISKARSRAELEAALDSAASYDRRIIVEAGVVAREIECAVLGNDNPKA
STVGEITFQSDFYDYETKYTEGQAEWSIPAKVSGAIASQIQEMAVQAFLAVDAAGLARVD
FFYIESTGEVLINEINTFPGFTATSMYPQMWAADGISFPELVDRLIQLALERHGEKG
>AIA12167.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTRVGVIFGGRSGEHEISVRSAKSVIELIDKDKYDVIPIAIGKSGNWLSPAESVGLLPS
TSGAALGNSVESYPQDAMVVAGDTSYKGLTRLGGGGDEERIGLDVIFPVLHGTYGEDGTV
QGLLEMAGIPYVGGGVLASACGMDKVVMKTLFRDADLPICKYVWFLRSEWERAGDAVIKQ
VEIKLGYPCFVKPANLGSSVGVSRADNAASLRAAIELAAEYDRKIIVEEALDMREIECAV
MGNDEPEASLPGEYIIRDDSKKFLDYTEKYAGTGNNEFVVPAPISGELSDKIRKMAVTAF
KAVDGSGLARVDFFLRNDNGMLLVNEINTMPGLTDASGFPKMWAGTGKSFAEVIDNLIDL
AVERHKDRSRNKTSY
>AIA12100.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MPEIIGIAAVAANGVIGTGNDIPWRISADWQRFKALTMGHVLIMGRKTYDSIGRPLPGRT
TFVITRDRMWRGKGVRAVPSVSEALDQAVQLDSGIVFVAGGGEIYRAAWDRLTGLEITEV
EQYPDGDVTFPEIDPNEWIETARQAGDGYSFVSYRRRSLEQSTV
>AIA11926.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTRGVREVNKRTGHETAALPGLSFSIDLEKDGFPLLALRKIPTKLFIAEQIWFVSGARKP
EIFLREFTHIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGKLVELLAKDPSSRHGVIVTWD
PSSDGLGGVSKSNVPCPYTFTINIIGGRLNMMNVVRSNDMILGFPHDVGGFALLQLMLAQ
KLGVKPGVYTHTIANAHIYDTHYAAAEELMARPTDSQKIALKLPKDSYDRAEAKDASLVT
EINDVLSAQYNPAEAIKGLKIVL
>AIA11879.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNDLPWRLPDDMKYFMTTTRGHHAIMGRKNYDSLPDAYKPLPN
RTNIVVTRQRAFHAPGCIVVHDIDHALKLARTHGESETFVIGGAEIYALAMTQANRLYLT
EIDAEIQGDTYFPSFDTTQWQEVSRKHHDVDDKHAYAFDFVIYERIA
>AIA11868.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLIAALTRNRVIGANGGIPWRIPEDATWFRQKTKGHPVLMGRKTYDSMGEPLKNRTN
IVVTRNREFAPPNVLVAPTIQAGIQMAEGTPGSEELFVIGGQTIYEETLKLADRLYLTHL
DVELTGDTFFPDFDTDDWTIIYEEPRPPVATFPHAFKFVIYERT
>AIA11869.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQEYLKLLRYVRDHGTEKHDRTGTGTRSVFGYQMRFDLNQGFPLLTTKKVHFRSVAHELI
WFIAGDTNIEYLHKNGVTIWDEWADERGNLGPVYGSQWRSWATPDHQTIDQFANVIQEIK
RNPDSRRLIVNAWNVADIEKMALPPCHTMFQFYVANGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAHVCDLGVGDFVHTLGDAHLYLNHFEQADIQLAREPRPLPHVELNPNVKDIF
AFTYEDIVLHDYHPYPGIKAVVAV
>AIA11838.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVSLIAALDRGNAIGRDNDLPWRLPDDLKRFKALTLGKPVLMGRKTAQSLGRALPGRRN
LVLTRSGAVPFDGMEAVSSVEEALRLAQAGGASELCVIGGGEVYAQTLSAATHLFLTHVE
THVEGAEAFFPAFDAKQWRVVSRERHEADAKHAFAFEFVDYERV
>AIA11787.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MANTANDSVISVKGLKKSYKDLQVLKGITFDVKRGKITALLGPNGAGKTTMIRILSTLLD
SDGGSAAINGFDVVKQAGKVRENIGLTGQYAAVDEYLTGEENLRMMGRLYRLSKKDTKRR
TAELLEQVDLIEASKRPVKTYSGGMKRRIDMAMSLIASPPVLFLDEPTTGLDPRSRAGMW
DLIRKLSDSGTTILLTTQYMDEADQLADDIVVIDNGKVIAEGTSTELKAKVGSDRLELTI
SSKSDFSTAVSAVKGEKAEIDEEARTISVVASKSGVQKLKQVLQKLDTAKIQVDNVSLHR
PTLDDVFMSLTGHTTVKAEAEKTSKKGKK
>AIA11764.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MTNTEQPRVIFIAALDEGRGIGKGGEIPWKIPEDLKRYMRLTTGHPLIVGRTTFEAIGKP
LPNRTSIVVTRQEGYTVPEGHFVAHTIEEALQQAQELGDPTIYINGGGDIYRLALPYATD
LQLTYVAGKHDADAFFPEFDPGDFKEVWSEDHPDHDPA
>AIA11761.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSVTLIAAVASNGIIGKDNTLIWRLPADQAFFKSQTIGKTVLMGRKTFESLKKPLIDRTN
VILSRNLSVAPEGCELVRSISEALEKYSEEELMVIGGADIYAQTIDVADRLILTEIEQPF
EGDTSFPDFDRSQWKLVSRTPGVQDERNLLPYSFCIYERE
>AIA11752.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNQYHDLLERILADGAEKHDRTGTGTLSIFGHQMRFNLAAGFPMLTTKRLPLKAIVHELL
WFLAGDTNIKYLKDNGVSIWDEWADENGDLGPVYGSQWRSWPAPDGRSIDQISNVIDMIR
RNPDSRRLIVSAWNPADVDKMALPPCHCLFQFYVANGKLSCQLYQRSADVFLGVPFNIAS
YSLLTMMVAQVTGLKPGDFVHSFGDAHLYSNHLEQARLQLTRPTRQLPVMKINPDVKDIF
AFRYEDFALEGYDPHPHIKAAVAV
>AIA11754.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEIVLIVAVADNGVIGRDNAIPWRLKSDLQRFKAITLNKPVVMGRKTFQSLRRPLPGRTN
IVMTRDPDYRAADAVVTTSFENARAVAHGDALRRFATEIAVIGGAEIYAQWMASASRLEI
TEVHTRPKGDTHLAAIDPVAWEEVARVRNPAGPDDSADFSYVTYRRRQQR
>AIA11740.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGEDLHASTAAVQMSLLIFFLSMGFGQI
VVGPISDMVGRKLPLYGGLVLFMIGGVGSALAPTIEWLIAFRFLQGLGASAGMAVPRAIV
RDLHTGTEAAKLMSLLMLVFSVSPILAPLTGSQIIENFGWRAVFWTVTGAALLATILLAT
SLKETRPVEERVGSSFSTALSGYRFLLGDRNFLGLVAIAGFGIASFFVYLSSSSFILIDH
YGLSPSVYSVFFSINAVAFIGMSQLTGLLAERFGLRRVVRVAVTGYATTMVVLFAVMATG
VDRLDVMAALLFAGYGFLGLVIPTTSVLAMEEHGEIAGTASALMGTLHFAIGAVAMGVAG
IFFDGTPLPMVAGITLCAVISFTLAKVTLGRSRDAVEAPAE
>AIA11690.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSSRSKIWDAFTNPGDVVTVAYGYRWRKHFGRDQLQLLIDLLRNEPGSRHGVIVTWDPSQ
DGLSLAKKKNVPCPYTFTVNIIGGRLHLHNIVRSNDVILGVPFDVLGFALLQCLLAQELG
VRPGIYSHSISNAHIYDSHFEAAKELMSRKNNHKKITLELPENAFKEIEKRNRNVVDAII
ENLTKQYEPSQAIAGIKIVPY
>AIA11642.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDLKRFRQLTMGHHIIVGRKTFESIGRPLPGRVM
IIITRSESIAVEGCFIARSVEEAVSLARERGESELFICGGAEIYAQTLGAADRLYLTLVH
ADCDADTFFPDCNSGEWIETESEHHAADEKNQYSFTFKVLERKHEA
>AIA11627.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESIAVEGCFIVRSVEAAIGLARERGESELFVCGGAEIYAQTLGLADRLYLTLVH
ADCAADTFFPEWNSDDWIEMESEPRAADEKNQYSFTFKVLERKHEA
>AIA11544.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LMKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELLWFLRGD
TNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRASDGRTIDQISQLSEQIKSNPDSR
RLIINAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFL
>AIA11499.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MEIEFDKKSERPIELFDDQPHVVLSTVSRRMVTAGILLGSFLAALETTVVGTAMPTIIAS
MGGLNVYSWVFSAYLLTSTVTVPVWGRLSDLLGRRNLYLAAIIIFLVGSGLSGAATNIWQ
LIIFRAVQGLGAGGIIPLGMTINGDIYTWKERARVQGLFSMVWGVASILGPLAGGFITDH
FSWRWVFYINIPFGIAAMLFVVLALKEPAKTGKPAIDYAGASYLTIAITLLLIVLVETSD
ARAWTNPLMLVAAASVLLFSWLFVRAEQRAAEPIVPFAIFRNRIVAIGSLTSFLVGTAMF
GCISFVPLFVQGTFGGSATESGSVLTPLLLGWVVLALIGGRLMIKVGYRPTVLAGLILVF
VSFAILSRFGTWTPRWMLLADIGLLGSGMGLVMLALIIATQNSVGRSQLGIATSLNQFAR
SIGGAIGVAVMGTVMTIGLASQQEAIQAASGLPEAEVAAIVHNPSALIDPAARSALKPEL
LHSMEKALASALHDVFLVGAIFAGLAVVAGFFLPKSWDAPAANQTKDRENDEMKCPATVE
ASEKFLLAEMTTIDPDNEPSIH
>AIA11500.1|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|0
MDAPLQPFILRPVMPADEPFLWEMLYQALYVAEGDLPFPRDIIGHPDIRRYVEGWGQPDD
SGFIAVEETTGQPVGAVWVRLMTGAYRGYGYVDEITPELTIAVLPDYRGRGVGKRLLEEL
LAAVRPAYPAICLSVSAANPALRLYQRLGFEIVKSSADSATMRMAFAGESYDETKI
>AIA11304.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIVSAIAALSKNRVIGKNNDLPWRLPDDMKFFMETTKGHHVIMGRKNYDSLHAKFKPLPQ
RTNIVITRQKDLHAPGCIVLHAVEPGLEIARKNSETECFIIGGAEIYKLAMPYTTRLYLT
EIDADIDGDTFFPEIDRKQWKEVARRHHPADAKHAHAFDIVTYDRVS
>AIA11232.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKEMNALPKKIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPQNVD
IAFLTIHGTFGEDGQIQQILEDRGVPYTGDGVNESRIAFDKIESKKKFDAAGVTTPRWQI
VAADERPTFSPPIVIKAPRQGSSVGVYIIKSADQLENGLAEARKFDRRLLVEEFVPGREL
TVGILGDQALPVIEMIPKSGFYDFTNKYPFLNPKAGGGAEHVCPANIEETLTHQIQELAL
RAYRSIGLCVYSRVDVLLPENGVPTVLEVNTIPGMTEASLLPEAAAAAGISYEDLCLRII
ELSRARREDAK
>AIA11022.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKRFQHVAVLMGGWSSEREVSLRSGKACADALERKGYRVTRIDVKRDIATVLEALKPDVA
LVMLHGRPGEDGTIQGVLETLGVPYSHSGVLASSLAMQKDLAKTVMATAGVPVAQGLTLS
RAEVAKGHVMAPPYVIKPVADGSSVGVFIVTESHAHPPQELFRGDWPHGEQLLVEKYVAG
KELTCAVINGEPTGVIEIVPLIKFYDYEAKYSPGASNHILPAPILPFVYQEVRRLTLAAH
VALGCRGVSRADFRYDDRIEGTGGLICLDVNTQPGMTETSLVPELAAHAGVTFDELVQWM
VEDASLGR
>AIA10892.1|FEATURES|farme|tetracycline|tet34|antibiotic target alteration|0
MSDKTTVYGMHDFDWLHDHAADTKTKQLVDRIVAIEKSHKAGKPLPVGTDLMKLKLDDMV
VWTRENTAHSIPHGYVQIFKLLDEILPAEFRQPMEGLIVDVGANEGHWSMYMHQHHPKAR
LVAIEPNPTALDLLRRNFEANGMQDVAVRAVAVSDKNELQQMETT
>AIA10862.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSALPKRIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFEVPQNIDVAF
LTIHGTFGEDGQIQQILEDRGVPYTGDGVNESRTAFDKIELKKKFEAAGVTTPRWQIIGS
NERPTLPLPFVVKAPRQGSTVGIYIIRSADQLETGLAEARKFDRRLLVEEFVPGRELTVG
ILGDQALPIIEIIPKSGFYDFTNKYPFLNPQAGGGAEHVCPAKIEEKLTRQIQDLALRAY
RSIGLRVYSRVDVLLPENAAPTVLEVNTIPGMTEASLLPEAAAAAGISYEDLCLQIIELS
RVRRGSGK
>AIA10829.1|FEATURES|farme|beta_lactam|PER-6|antibiotic inactivation|1
MDSVKSEADGRLGKAQVVAAQPNTTRLQEQLNNLDLSSAQGDVGIGVLDLDTGERWFRNG
KQRFPMQSVFKLPVGIVVLKLVDEGKLSLNQTVTITREQFVPAWSPILKEIKGDRGQFTV
QYLLQRAVGDSDNTAADALVRLVGGPEQVTANLGKLNLRDIRVDRLEQQLQPDTVGLTNF
RPELVDKQKYEEAVQQIPDAVKKAAMERYLTDPRDTATPEGMIDLLAKLQSRQLLSEDST
ALLLKIMTDSPTGQQRLKAGLPPGWSIAHKTGTGAEVVGIGIATNDVGLISSPTGKRIAI
AVFIAGSKAPLEQRESVMSAVASAVI
>AIA10755.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MLKTNKDVELARLVQDIQQSGKYGDICLALIEHVGRQELSKRRNVKEALKATKNKLHQIG
GAYLDGREQYQQWLRMLAEAQAEQGTDNETFKAVSLQLMGKHASTRERRSILPDFYPRIF
AELPPIHSVIDIACGLNPLAHPWMPLAPAATYDAYDIYQGMMTFLNDYFALRNIRGTASA
CDVIQSCPTQEVDVALLLKVLPCLEQLEKWAAHHLLHTLNARYLIVSYPIQSLGGKSKGM
STYYESHFRSLISDTPWTIKKLEFANEMVFVVAK
>AIA10570.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKTKISLIVAMSENRVIGKENSIPWHIPGELPRFKRITSGHPIIMGRKTFESIGRPLPQR
LNIVITRDQAYTLEGAVVVHSLAEALEEAKLYYVAGSKYQENESKISLEPHPDPLLKGEG
NDTFGEVFIIGGGQIFKDAMSLADKLYLTIIHKTIEGDTYFPEYPEFTKEVFREEHEHDG
YRYTFLELER
>AIA10497.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MSASQVTKSADLDELVIAIRASKKYAHISEATLRHLGQIELSKRRTLKDAIKETRNKLHQ
IGGAYQDAMHYAAWLGELEAAEPGARTTILSRIMHHHASTRERLPILDPFYTTIFEALRE
NPGEVHSILDVACGLNPLAIPWMPLLPDTTYHALDIYADMIQFVGRCLALMQVKGTADTC
DVVAALADPTSEAAQVLRRPVDVAFVLKTIPCLEQVDKRIGSSLLDILGAKQLVVSFPIQ
SLGGKRKGMLQHYSAHFAELMAGRPWPVQRLEFESELVFIVRKM
>AIA10436.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MQPGFLRTAVILGLLSAIGPFAIDMYLPALPSIGADLGAEPFTVQMSLLIFFLSMGFAQL
AVGPLSDMYGRKAPLYAGLAVFAIGSVGSALAPTIESLIAFRFLQGLGASAGMVVPRAVV
RDMHTGVQAARLMSLLMLVFSISPILAPLTGSFIIAAAGWRWVFWAVLIAAAIATVLLSF
GLDETRPVEERSGSSLSSALKGYAFLMRDRNFLGLALIGGFGISSFFVYLANSPFVLIGH
YGLSPSVYSLFFSVNAVAFFAVSQMTGYLTERFGLKRVVWVAVSAYAAVMAVLFAVTLAG
FESLAIMAPLLFVGYGFLGLVIPTTSVLAMEDHGEIAGTASALMGTLHFAAGAAAMIISG
LLADGTPLPMITGITACALIAFGLGAVVLGRRRETAEMEENAVPAE
>AIA19295.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RPLVEQGVHIWTDWPLDRYRRETGEAIDRDAFEARIIADDHFAREWGDLGPVYGKQWVAW
PDGKGGTIDQIAQLVDGLRNNPASRRHIFTGWNVAELDRMALPPCHMTYQYHVADGRLSG
ILYQRSCDLGLGFGFNIFEAALLLRMLAQQCDLEPGEIVWMGADVHVYLNHEHLVAEQVA
RTPRPFPKLEFTRRPDSIFDYRLEDVAITGYDPHPHIAAPVAV
>AIA19234.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MITGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGSKTWRSIGKALPGRQSI
VLSRTELEDLPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVDDADVYMPLQFLDDFELVDSKEIDQGLIVETFDRRT
>AIA19220.1|FEATURES|farme|quinolone|qacB|antibiotic efflux|0
VVNAKVLTTLLIIVAVINWRCGKLIGGFVDRFGEQKVLTVGYALHGVTFLGFALSQNVWM
LYGFYILYNFLFLFSVGTTTYLRKICKREDLAPSLAMGVSLSHVTAIVVPIVGATLWKQL
GYQFPFLFGTVFVALSLIATQKINKSKEALAHHAT
>AIA19168.1|FEATURES|farme|glycopeptide|Usp|antibiotic target alteration|0
MKIPIMLRVLIPTDLSRGAANALRYAMQLTQGMDVELILFQGNVIPVPMAEMPIVTDMPN
KDDTVKSMNEEVQKVAASLQQKDNKNISCMVSAGLSLAPMIEDAAAQAKADLIVMGTHGA
TGIIKVLIGSNTVSVIETSKHPVLIVPEHYE
>AIA19145.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
APVALIAWLGVRIGVPGDRPEDLTHDRLDLPGAVLSMATIGLACYSLTSGVQHGWAAPLT
IASMIGAGAALVGFILRERTADSPMLDLTLLSRGPVRGAAVAQAGTAIAMAGVMFALILH
FQFAWGWSPMRAGLANLPLILTMIAATPISEGLAKRFGHRIACLVGAGFLVAGLIGLAWG
VEQNYLAIAASMVVMTVGLRTVMTICAVALVG
>AIA19142.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
LGGVLGDIWVRAPFLAAAALNGLNLLLALFVLPESRPGSRNARFDANTLNPFVPLAWAVS
LKGLLPLIAVFFILNFVGNMYGTVWALFGVDAFEWNGLMVGLSLAGYGLFHALVQALLPG
LIVKRIGERNALLVGMAFESAGLLLTAVATQGWVVFAVLPLYALGGVGV
>AIA19138.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNDLPWSLPDDSKYFMVTTRGHHAIMGRKNYDSLPDAYKPLPN
RTNIVVTRQRAFSAPGCIVVHNIDDALNLARTRGESEAFVIGGAEIYTLALANANRLYLT
EIEADVEGDTYFPSFDKTQWKEVSRKHHDADQRHTYAFDFVVYERIA
>AIA19101.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MIIPVMPELISSLKHIPANEASAEGGWLLFVYALMQFIFAPIMGNLGDRYGRRPVILFSL
FGFGVDYLFLALAPTYGWLFVGRTIAGITGASFTTASAYIADVSTAENRAKNFGMVGAAF
GLGFIIGPAIGGLLSGFGLRAPFYAAAVLTLLNWLYGYFILPESLSLEHRRPFDWRRANP
LGALMHLRKYPAISGLIFSLVLVYLAVHAVQSNWNYFTVYRFNWTPKTVGISLAVVGLLV
AAVQAGLIRIITPKIGNERSIYFGLAFYSLGLFLFAFATQSWMMFAFLVPYCLGGIAGPS
LQATMTGHVPPNEQGELQGALTSLMSVTSIVGPPLMTNLFAYFTSTKAPIHFPGAAFLLG
GILMLISTFIAYNSLKTERAQ
>AIA19083.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MKKFYNVLINTLIANVTTSFLWFALTFWVYLETRSVLATAIIGGTYMLFVALFSIMFGTI
VDHNKKKKVMLISSGITLAAYLIAGFVFLSFSKAQLTDYTTIAFWLFGLIILIGGVVENM
RNIALSTTVTLLVPEKDHARANGLVGAVQGVAFLVTSVFSGLSIGFLGMGWTLTIAIILT
AVAFIHLLFVPIPEEKILHDPELANKKIDIKGSIAAIRAVPGLFGLIIFSTFNNLIGGVY
MALMDPYGLNLFSVQIWGVVLGITSIGFIAGGILIGKLGLGKNPIRTLLIVNIAIGALGM
LFTIREFWLLYVVGIFVFMMLIPFAEAAEQTVIQKVIPFKRQGRVFGFAQTIETAAAPIT
AFLIGPIAQFGLIPYMNSDAGKSQLGWLLGDGSARGIALVFLIAGFIGIIITIFAFYTKS
YKHLSESYQKKS
>AIA19076.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|1
MEHIPANKFQYIQEYLHLFPGFYGELRSARGYFENHSAHILGYMSEVDQNKIDQSGGIYV
PGDYCGSTGVESNYENLLRGTKGAQYILKDNLGREIESLDGGKHDSLAISGDNVILSLDH
VLQEYGQALLQNKRGSIVAIEPSTGEILAMISSPGYDPNELSISRLRGDVFAKLQKDTLN
PLFDRSVMAMYPPGSIFKPILALAAMQEGVLDENKTVFCNGSYNLGGFRRGCHNHPAIHN
VSQAIQYSCNTYFFTVYKDVIDDAGYTLPEIGMRKLNSFLTEFGFGRKISVDLPAEKSGN
LPGPDYFDELYGSGKWRSSYILSMGIGQGELQLTTLQMAHAAAIIANEGTYTDPHILKAK
VPAGGEPKSEFYPRRRVSIDYRYFDPVIEGMAGAVRAGTATLASHPDYEVCGKTGTSENP
HGADHSVFFGFAPRNQPKIAIAVYIENAGWGGSFATPVGGLMMEKYLKGEIIEAHKAIEK
RMLETDLIHKEKS
>AIA19053.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MNVFLIAAITLDGFIAEETSQVSTSWTSPEDKKWFNERTKKAKVIVMGSSTYKTIGRPLP
GRLTIVMTRSSIPEATSNSTELRTFQGDPGELIDMLEKEGYEEVAICGGAQIYTQFLKAR
IINKTLSDS
>AIA19052.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRISAVVAMSEDRVIGKDNHLLWHLPADLKHFKTITMGKPILMGRKTHQSIGRVLPGRCN
VVLTHDVNFQACGCVVAHSIETALAAVEYSDEVFVIGGAVLYQEMLPKIQRIYMTIVHHP
FVGDAYFPETSPGDWYEADRAFYPADEKNNYDFSFLTLDRK
>AIA19043.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
RKLKPMIIGIVAVDRNLAIGKGGQLPWHYSADMKFFKATTTGNAVVMGRRTWLTLKGPLK
DRQNIVLSRSGDVSNHDSVMVMKDVEAVLEFARTIDQHLFVMGGAHVYESFLPYVERWVV
TEIPLNVEGADTFMPANFLDGFEMYEMRQLDEGLRVKFYERV
>AIA19035.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKKGTDIDMKKKGAVISAIAAFGKNRALGKDNDLLWHIPDDLKRFKELTSGHPVIMGRKT
WESLPEKFRPLPGRTNVVVTRQVGYAADGAIVVDGLSDAFLTAQDTPGAEETFIIGGAQI
YAEALPYTTRLYLTVIDDGKEADVFFPEYETEFTKIISNESREWNGLKYRWVTLER
>AIA19033.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIIFVVAASENNALGKDNDLPWHLPDDFKRFKMLTAGHHIIMGRKTFESLPGKLPNRTHI
IITRQKDYHPEGCIVVSSLEQALAAIPENEDAFIIGGGEIFKMAMPVADKIELTRVHANI
EADAFFPEIDPAQWKLDFEEFHPKDERHAFDFTFQTFIRK
>AIA19014.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MIRFARILVLILLFPILAFAQQAKLKSEIETISKDAKGIVGVGVMDLKTRETLLMNQEHK
FPMQSTFKFPLAIAVLDLVDKGKYKINQKIHVKSAGLDPETHSPMRDKRPNQDFDITIGE
LLSYSVSESDNNACDILFELAGGTKKVNEYIHSLGVKDIAIVATEKEMKAGWDVQYTNYA
RPSAYLQLLQIAYERRKLSKASHDYLWKMMVEGPTGLKRIKGLLPKGTEVAHKTGTSGTN
DKGISAATNDAGIIRLPNGKDIAVVVFVSDAAANMDTRELVIARIAKAVWDYYGSK
>AIA18965.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIILGPVAIARNNVIGKNNELPWYIPEDLKHFKELTTGHTVIMGRKTYESIIARLGKPLP
NRRSVVITSNTEYPVAEGVVKYTNLEEAIAAEDGPDKQVFLIGGQRIFAEGLQFANTIYT
TEIHKDFDGDIYFPEFDK
>AIA18942.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MPHTKKILVIGASVAGPALCYWLNHYGFQPTLVEKNQSTRKGGYAIDLRGIAVDVAKQMG
IYDSVCAMRTSLQCVRYVDAAGNLLFEEHGEKGGFRQGDEVEIVRGDLVDILMKTITDIP
CFYDHAIESLTQHDDHVTVQFKNGKTENYDLVIAADGLHSATRRMVFSKDDYHLRNLGCY
ISVFSIPNYLQLDHCETLLEAKQKLVSITSDKDSTKAFAGFMFRSSNSPNDIRDEASQKD
FLRENFTNHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQ
GTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFGVWVSESFLADEPLSAE
QAEERNNIVLGIMKKATHAIELPEY
>AIA18928.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGAVGRLPWYLPEDLRRFRKLTMGHAMVMGRKTFSSLGRALPGRRNLVVSRNPDPPEVAG
VEWFNSLDAALAFARQSGESECFIAGGTEIYAEALEKSNRMYVTYVQRDFPFQGDTYFPM
WDQKQWRGISHELGKDLEFVVYERAQGDVAGASEVEMEAGN
>AIA18925.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|0
VPSEKTGNLPGPSYFDQVYGSGKWRSPYILSMGIGQGELQLTTLQMAHAAAIIANEGTYT
DPHILKARVPAGELPQQEFYPRRRVSIDYRHFEPVIEGMSGAVRAGTATLAYIPDIEVCG
KTGTSENPHGGGSLSVLWICTKGSTEDCYCCVH
>AIA18903.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLVVAASENNVIGKDNQLLWHLPKDMKFFKNVTWAMPVVMGRKTFASIGNKPLPGRK
NIVITRQPGWTAEGVAVVDSVDAAAALAEQLNYKEIFIIGGGVIYMIAFDRSNKIYMTRV
HADLEGDTYFPVIEKDDWKLVSNTDNAADDKHAYAFSFQLWERKSN
>AIA18899.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSLIAALDRKRGIGINNQLPWRLSADLKKFRELTMGHHIVVGRKTYESIGKPLAGRTM
IVVTRDESYRADGCDVVHSPEAAIEMARGRNESEVFVCGGAEIYAQSIGIADRMYLTFVD
AEVAADTFFPQFNEDKWREAESVYQPADEKNQYSFTFKLLVSAR
>AIA18880.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNKVSIIAAIDEKRGLGKNNDLLFRIPEDGKRVRTLTSGHPLIMGRKTFESLGRLLPNRS
HIVITRDPNSLKHLSFQPDVIVSSLEEGLEKAKEYPGAEEIFIFGGGQIFTEAVKKDLVD
RLYMTIVKGDFGADTFFPDYSMFTKVIKKEDHEEAGYKYTFLDIEKQ
>AIA18859.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFIVAALTADGFIGRDSGHSADWTGGEDKKVFVRLTKEAGTIVMGSRTFATIGRALPG
RRNIVYTSRPDQITAEGVETTSEPAKDLIARLQKEGSKAVAICGGATIYDLFMREGLIDE
LYLTYVPIVFGKGVTLFSDGLDAKLDLQEQTKLDDGSVLLHYIVKK
>AIA18851.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MEKLIVLKAREVVKTYGKKENTFVALKGISLAIKEGESVAIIGKSGSGKSTLMHILAALD
RPDSGELEFNGKNVDNFKDRDLDRLRNHDFGFIFQQFFLNYRETVLENVMLPLKIAGVGR
RERKKRAMEALAEVDMTNKADNKASDLSGGQKQRVCIARALVTNPKVIFADEPTGNLDSE
NGQRVEGMLFDLNRKKGMTLIIVTHDDDLAAKCDRRLYMKDGILTEGNDNEAARPRANRK
PKPVTL
>AIA18852.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MICIVAAIDRNRAIGKADRIPWRLQRDLRMLKQLTERQVVILGRKTYDSMVWYYDRSGRP
MPGKMYLIVTRNAEYQPVRDNARTAASPEDALRQAHELGDDAFVIGGEHIFEAFLPYTDR
VYLTEVDTEADGDAYFPTLRPEEWYEVSREHFEADEKNDHASDVVILQRS
>AIA18826.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefC|antibiotic efflux|1
MSNQTPETTEVNSTSTEDKAQSPAFKTLMRNRNFRSLWLAQVVSDFGDGLTNIALLFLIN
SLTGSAAAIATMFVVLTIPQVTIGLVAGVYVDRLDRKKIMIFSDLTRGLLVLALIFAGSR
DLLWLMFVIAFLQASVGTFFTPARAALLPNIVPADTLLSANSLSQVSRIIFGLLGTAAAG
LLIGAFGLYWPAFLVDALTFFASMLLVSRIVAQTRAKGVNTEATARAIFAQLVDGIKLVV
RTRTLLGTLVAAGVAMLGVGAVNVLLVPLIVNDLHVSPAWFGAVEFAQTSSMVLSGGLVA
ILARRLKPTGMLSTSMVVLGVVIASLSLVTDVWHILVILFAAGWAVTPMQASIATIMQTY
VDDNLRGRTAASLNTMISTASLVSMGAAGVLASAIGVRTVFVAGGALVIVAGIASALVFR
GIVQTRQNKPQAAIAGESLSGGTV
>AIA18806.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSDFSIRAAAPSDAPAIVSLLQEFAVYAKLLEHFALTEEQVVRDMFGAACHCDLAFQGAE
AVGIAAWYWTYKSFRARRGLFVEDLYVRPDRRGRGLGKALLTHLAAKARAAGGFLEWQVL
DWNAPSIAFYKSLGAQPLEGWLNYRLDGDALESLTA
>AIA18807.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIVLVVAIAQNGVIGKDGLIPWHISDDMKRFKALTLGHTVVMGRKTWDSLPRKPLPGR
INVVVTRQKDWQAEGAVVAHSLDQAMAGTSGTVMVIGGAEIYERALPLASRIELTEVHQD
VDGDAHFVFDRTGWRETLREDHVTPDGLRYSYVTLTR
>AIA18790.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MKYLLNFSLLIRNRNYGLLFIGQFISFLGTMITGVALPYQIYHETQSTLIVGLLGFFQLM
PLIVTALLGGVFADRYHRRMLLLVTESILALGSVLLAFNATLATPHIGFIFVVAVLMSAV
NGLHRPALESITQQIVSKADYPAVGALMTFKYSIAMIAGPAIGGLIIAHFGLVVTFIVDF
ISFGISLMALCLMTHIPKPERSAEDLSTWSSVKQGFVYAASRQELIGTYMVDFVAMIFGM
PTALFPAIAQSYGGVKTLGLLYAAPAVGALVISFFSGWSQKVKRHGAAVAISAGFMVVFN
YLFWLSK
>AIA18782.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKLSLIVAVAQNNVIGRNNELPWYLPQDLQYFKSVTLGKPIIMGRKTFESIGKPLPGRTN
IVITRQANWQFSGVLVAQSVQEAIRIAEQFCSEQNQRAEEVMVIGGAEIYSHALTIADRV
YLTRIDIKVEDGDAFFPELSVTEWQKISEIPGEADASLRHSFSIYERKVI
>AIA18778.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FAAVIQQIKERPHLRTHFISPWIPQYNFRIEGRTQKVVVCPCHGWIHLRILDGKLTLHMF
QRSADVPVGVPANMVQYAALLMMIAHVTGYEPYEYVHSFSDAHIYVDQIDRVKEIIAREA
RPFPTVKMITTHDNIFDFRKDDFELSDYNPHPAIKDIPVAI
>AIA18735.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVSKNNAIGKQGKLPWHYSADMKFFRETTTGHAVVMGRKTWVSLGKPLKNRLNI
VLSRDSNIEPQESLVVLRDLDSVLSLNSSLQTDLFVIGGAQIYTEFLPHIERWHVTEVPI
DVEGADAFMPLHYLEGFKRVATKKLEDDLRVVTYEKS
>AIA18731.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKGWCKAMSISFIFAMDRNRAIGKDNGLPWHLPADLKFFRKVTMGNPILMGRKTYDSIGK
PLPGRENVILTRNKTFTAEGCVVVHTVAEAIERYRDQELFVIGGVEAFRLFLPHVSRMYI
TEIEHEFEADTFFTQLDLTGWELVSSEQGPQDEKNPYEYYFRVYEKK
>AIA18700.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MVLSIIVAAAENNVIGKDNRLIWRLPADMKFFKEKTTGHVIITGRKNYESIPEKFRPLPD
RKNIVITRQKNYHAPGAIAVSSIENALQYVSENHADEEVFIIGGAEIYKQTLSACDKIYL
TRIHHSFEGDAFFSELNEKEWNLTLSEEFPKDEKNIYDFTIQTWLKRK
>AIA18668.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MGASSIGVRPELVERILRAYGLEWRRIHQPQKGYRNNSFPVEFADGQVLNLIFYKSELGI
LGLIQASNRVSDYLAAQGLPCRRTLGPIACLQPTGKTDQPVRKRYAGLYTYLTGQTIPWE
AYTRDHIKALGMTMSNMHAALKPLPQGSLPDAAEIYLAILGRMEKYFKDPGVCQALTVKL
QLGAPRPELFKHYAALLKACRRLPGQQPLHLDFVRGNILFRNRPDSAHGLKVTITGILDL
EKTAFGHPLLDIARTLAFLLVDCKSKPAAKVRKHFLHSGYSKRGRAADLE
>AIA18631.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELMQRVLKEGTRKDDRTGTGTLSVFGHQMRFNLAEGFPLVTTKKCHMKSIVHELL
WFLMGESNIKYLKDNGVSIWDEWADEEGNLGPVYGVQWRSWKTHDGRTVDQIKNLIEMIK
RNPDSRRLIVSAWNVSDVDKMALPPCHTMFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCGLKPGDFVHTFGDAHLYINHIDQTQLQLSREPFPLPTMKINPEVKDIF
DFKFSDFELVNYQAHPHIKAPVAV
>AIA18606.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
NNDLIYKIPQDLKRFKELTLNHPVVMGRKTFDSLKRPQGLPQRLNIIISRTPGQNSENVM
WVSSLEEALHHAANYKDNVSDEVFILGGAQIFEQVMDKADKLYLTIIDDIPEADVYFPDY
SEFNKEEIVEKGNWNNLSYTFVNLEK
>AIA18595.1|FEATURES|farme|beta_lactam|BcII|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINSVVPGH
GEVGDRGLLLHTLDLLK
>AIA18551.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MLLLGRLIQGLGVSGPTTVCVAVIADIYTGDRQVKLLSFMNSAITVVMASAPILGAYLSA
AFGWRANFLVIFASAVLATLLIAFTVPEGHPVEHRKPFAVKQLIKNYGTLLRSKLYMTTV
VGLIFLITPYFVFIATIPFLFIETLKLPISEYVYYQGSVVGMFALLSLIVPSLVGKFDAD
KMTIRSTIVSLLASLALCLVGLLLPDNALTITVLMCVLVLGQVWPCSLLFPATMEFFPEL
RGSAAALFQSMRMLVMAAAISISGHIYNDTFMPVGVLMFILVAIGVPILAIALR
>AIA18546.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MTQRKAAIRFIFVTLLIDIIGWGIIIPVMPELLKQMEHVDTGTASSLNGWLLFAFSITQF
LFAPVIGNLSDKYGRRPILLMSLFGFGLDYIMLSWAPSVEWLYVGRIIAGITGASFTTAS
AYIADISTNENRAQNFGMIGAAFGLGFILGPILGGLLGTLGPRVPFIAAAILCFVNCLWG
YFILPESLDKAHRRPFDWKRANPVGSLLHLRKYPDLNYLIFAMILVYLASHAVQSNWSFY
TIERFHWGEGMIGISLGVVGFLVGGVQAGLTRVVNPKLGNARSIYIGLILYTIGMFLFGI
ATEGWMMLVFLVPYCLGGIAGPALQATISSQVNVKEQGELQGALTSLMSATSIVGPPMMT
NLFAWAVRPGNPIYLPGAPFFLGSILMAASAVIAFISFHKGKGAKKTVDAG
>AIA18535.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MCIDGKDFFVSILRDNVLPSVEVHTPGGFYDYQAKYESDETKYLCPAPISVDKERELREL
SYKAFCALGCEGWGRVDLIQDEAGKFWVLEVNTIPGMTSHSLVPMSAKAAGIGFDEVVMT
ILASTIREENFSTIVGEVAQA
>AIA18522.1|FEATURES|farme|beta_lactam|NPS|antibiotic inactivation|1
MENIEERLDARVGLLIRDSGTGWSWGHRADERFLMNSTAKVPLCGAVLAQVDKGAMRLTD
GLDVRAEDMVEYAPVTELRIGDTMQVGELCFAALDMSDNAAANILIDHLGGPQEVTAFMR
QIGDDVSRLDRREPDLNRFETGDPRDTTSPAAVVDTPERLLVGDALSPSSRAQLTEWMTP
GGVTGALLRAFTPDSWRVADKSGSGSVTRNIVGMIAPPQGGPYFVAIYLSEAEADFDTRN
AAVVAISAAVVELIASR
>AIA18508.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
TMGHHIIMGRNTWESIGRLLPGRTTVIVTRQRDYNVAGALIAESLEAALSMCRGDDEIFV
IGGGQLYVGALPVSNRIYLTEVDAEVRGDTFMPEFSLSDWRAVSVESHPADDRNQYNYKL
TVYDRIVS
>AIA18436.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYHDLIQHILDRGEERTDRTGTGTISVFGLQAKYDLREGFPLLTTKKVLFSAVVRELL
WFLRGATNINDDLTQHTPIWDAWAGPNGELGPIYGYQWRSWPRYVRIEGTDHYAREHVDQ
IRNLIDEIKTNPDSRRLLVSAWNVADLPQMALPPCHLLFQFYVINGRLDCQLYQRSADMA
LGVPFNIASYALLMIMVAQECNLTPGVFTHTLGDAHIYLNHVEGLRKQLQREHRDLPTVQ
VARKPVLEVQFEDVTLLNYDPHPFIKFPVAV
>AIA18399.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIILGPVAIAKNGVIGRNNDLPWDLPEDLQHFRDVTRGKTVLMGRKTYESIVKRRGGPLP
KRRNLVITSRDIGSAEGLEVFKSMDEALRSVPAEEDVYIIGGAGIFKEGVDKADMMDVTH
IFKEYEGDVRFPDIDWSKWEKVSEDPREEFSFAVYKKIR
>AIA18369.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTTLPATGARTYPSLRAAWIPLAALCLAFFVEMVDNTLLTVALPTIARNLHSDTTSLQWV
TSAYSLTFGGLLLTAGSIADRFGRKRVLLYGLAAFGTISLGVAMVSSSGELIALRAALGL
AAAAMAPITNSLVFRLFDSPTLRMRAMTVMIVVGMSGFVLGPVLGGTVLAHFQWQWLLLI
NAPVALIAWLGVRIGVPGDRPEDLTHDRLDLPGAVLSMATIGLACYSLTSGVQHGWAAPL
TIASMIGAGAALVGFILRERTADSPMLDLTLLSRGPVRGAAVAQAGTAIAMAGVMFALIL
HFQFAWGWSPMRAGLANLPLILTMIAATPISEGLTKRFGHRIACLVGAGFLVAGLIGLAW
GVEQNYLAIAASMVVMTIGLRTVMTICAVALVGAMPENRTSIGTALNDTAQEVGTSVGTA
IVGTMVALLITTTLPDGVWTSELVASFFHGERIIFVVLAVVVGVVAALGALTLTDSRNVE
EHDEPEDAAALAVAAR
>AIA18315.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIVSLIAAAAKNNIIGKNNDLPWRLPNDMKYFKNITWGMPVIMGRKTFESMKNEPLVGRQ
NIVITKQTTWKPEGAVVVHNWNDALFVAAETDCNEVFVIGGGEIFKDSIKKADRIYMTRV
HTIVDGDAFFPEIDAKKWKLVSKRDCSADEKHLYDYSFEIWEKR
>AIA18305.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAVFDGIYQGLLRDIMDKGIREVNQRTGHETAALPGVSFSIDVEKDGFPLLSLRKIPTKI
FIAEQIWFISGARKPEVFLRDFTRIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGMLVSML
EKDPSSRHGVVVTWDPANDGLGGASKANVPCPYTFTVNIMGGRLNMMNVVRSNDVILGLP
HDVAGFCLLQLILAQKLGVKPGVYTHTIANAHVYDIHYDAAKEMIGRKSDMPKVSVTLPV
DTFARAEAKDTQLVEDINGPLTEQYQPGEAIKGLRIVL
>AIA18278.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKTFIIAAITADGFIGRTSSHHADWTGKADKKLFVEKTKEAGVMVMGSRTFATIGRALPG
RRTIVYTSKPETITVDGVEATNEPPAQLISRLANEGASGVAICGGATIYSLFMEAGLVDE
LYLTVIPTVFGQGVPLFANPVEQHLELLENRDLGDGAILLHYKTA
>AIA18247.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLISIIVAMTPERLIGAAGRLPWYLPEDLRRFRARTMGHAMVMGRKTFSSLGRALPGRRN
LVVSRNPNPPVVEGVEWFTSLDDAIDFARRAGEAECFIAGGTEIYAEALSKADRMYVTYV
QRDFPFQGDTYFPIWDQTHWVAASHELVKDLDFVTYERKR
>AIA18241.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLSDIMTNGVKELSERTGLETSALPGVHFKIDPAKDGFPLLTLRKIPIKAIVAEQIWFLT
GSRKPEDFLRDYTKIWDPFTNPGDVVTVAYGYRWRKHFGRDQIKLLIELLQQEPSSRHGV
VIAWDPAQDGLSLVKKKNVPCPYTFTVNIFGGKLHLHNIVRSNDMILGNPFDVAGFCLLQ
FILAQKLGVEVGTYSHSISNAHIYSNHYEGAHELMKRKSDHPPIMLHLPENAFARAEERD
TTLLDEIVADISGQYNPQEAITGLKIAL
>AIA18229.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|0
MKVFIIAAVTADGLIGATSDHAADWTSKEDKQLFKSLTTEAGVMVMGSNTYKTIDRALPG
RQTIVYTHNADPEYPEGVTATTKPAAELIAELNEKGVTAVAICGGAQIYDLFLRSGVVTE
LYLTIEPVLFGQGIHLFKSATFQKLELMESRKLNDNVLLAHYKLLAE
>AIA18227.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
GHTVVMGRKTWDSLPRKPLPGRINVVVTRQKDWQAEGAVVANSLGQATAGTSGTVMVIGG
AEIYERALPLASRIELTEIHKDFDGDARFVLDRTGWHETLREEHVTPDGLRYSYVTLTR
>AIA18223.1|FEATURES|farme|beta_lactam|SMB-1|antibiotic inactivation|1
MFEAISLLAWLAAASGAPVPAVDPLTQPITTSGSAEWLAPAPPEKIYGNSYLVGFGGMSV
ALIDTGDGLVLVDGALPQAAPAILANVRQLVFDPKDIKFILSTEPHFDHAGGLAALARDT
GATVVASARGVEGLRTGRHAADDPQLAYGGSWPAVTTPMRVMADGEVLTLGKVGITAHAT
PGHTMGSMSWSWHACEGAACKAIVFASSLNPVSADDYKFSSAAGAPFVAAFAQSWRTMEA
LACDILISAHPDNAGEGRYNAKPGACRAYADRSRQALAKRLASEKAE
>AIA18219.1|FEATURES|farme|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|0
MKVSDVMSRQIDFVRPTDRVQRVAVLIFGRGVNGVPVCEGKKLVGFVSENDILQKFFPSL
RELDEDRVKESNFEMMEEKASTILSLPVSKIMSTQPLTVKADTPLLRAQSMMKVNEVGRL
PVVDSEKNLIGVISKGDVFKALIGQQISFTENEDYNDFLSKTYYSTVDWDDRIKKEIPDL
VKLLEKHKVKTILDVGTGTGDYAIELASRGYNVVGTDRSKAMIDEANIRKIALSSKNYGN
IHFWNKDTEDFLYEMDIKFDAILIMGNSLSHNPENYRRLIKKCADSLSENGIMIFQTTNF
EKILKVKKRMWSVNFVPVADEPVKEYSFIQFYDKPIKEKTILKTFAILSFDGKRWSWSGI
RNSIMAYTNEARIKSILKNEGFTKIETYGGSFDGRTWDHLFRKQFKPMESDWLNVVATNK
K
>AIA18206.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKTFIIAAITADGFIARDAEHTSTDWTSPEDSQLYRQTTKEAGVMVMGSTTFATIMRSLP
GRKTVVYTTKPERFAGIEDVETTREAPAALVARLEAEGYSQAAICGGSHIYRQFLAAGVV
DELYLTVEPVLFGTGIGLFNDKLDVRLELLSVENLNENTLQLKYKVIK
>AIA18198.1|FEATURES|farme|beta_lactam|TEM-207|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGGRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHL
>AIA18145.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MQISIIVAMTPDRLIGAAGRLPWYLPEDLKRFRRLTLDHAIVMGRKTFSSIGRALPRRRN
LVVSRNADPPKTENIEWFHSLQEALKAAEQGAETEVFIAGGTEIYKEALPIATRMYVTYV
QRDFPFQGDTYFPMWDQTQWTMISHERSQGADKDLEFVIYERSQNPPGQVLTEPGN
>AIA18146.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FYKVNLADGFPLLTTKKVNFNACLHELLWYLSGDDHIRNLRKVTKIWDAWADEKGDLETA
YGRYWRRFPHPVQKSHAPVAQTGEAAAPVQEIDQIQCVIDEIKRNPFSRRLVVVAWEPGN
AEVSKLPPCHYSFAFNVSPDETGKPRRLNCHLTQRSGDIALGIPFNLACYATLTQMLAQE
VGLEIGTVAHTIIDAHIYTADANSTMAAYDHAAGLREQLNRAPRPLPKLTIAKKPFNELT
FEDFKLENYDPHPAIQFKVAV
>AIA18050.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
GGTSAEREVSLWTAKSVANALTLLKEEFAEIDAADADWLDQVVGYNPKVVIIALHGPFGE
DGTVQKALEEKGIRYTGSNSATSKVAINKNRTKEIAQSLGINLATSRLFKKGEEVVWNRE
FPVVVKPNGDGSSFGVTIVKNSEDLQKAAENAFAYGEEILLEDFIPGVELSCGVVQKGTE
LTALPLVEIRPGEEFFNFEAKYNESKC
>AIA18048.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MPLIRVILIITVFGAFALTSCNKSSSNTTPNSTVTQVSPTPKNQTELEKALEQKLTSICS
RAQGSIGVTAVHVETGRAVSVNGNAVLPLYSVFKLPLAITVLKDVEANRLKVEQMVHVTP
DEIVPGTPENTALWAKPVDRTVAELIEFSISRSDNTSTDKLLQLVGGPTRVTEQMRSLGF
NNLDIHSTVMGYVKTRQSVNTGSADDLANLLTQLQQGKILQPAQSQLLVGYMRGTITGMR
RLRGDLPPGTVVADKTGSGERNTQTNVPKTTNDVGLITLPNGKGTIAMAVLVTDSRLVDT
AQEKIIAELARAAFDAYAKRE
>AIA17985.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIILGPVAIAKNGVIGRDNDLPWDLPEDLQHFRDVTRGKTVLMGRKTYESIVKRRGSPLP
KRKNIVITSRTDYQVPEGVEIYKSIDQALASLSPEEDVYVIGGAGIFKEAVNKADIMDVT
HIYKEYPGDVYFPDIDWTKWEKVSEDPREEFNFVTYKRK
>AIA17949.1|FEATURES|farme|tetracycline|tetC|antibiotic efflux|1
MQKKNTKAALSFIFITLLIDVMGWGLIIPVMADLIAELKQIPVNIASTYGAALLSAFAVT
QFLFAPVIGNLSDRFGRRPVLLCSLLGFGIDYIILALAPVYGLLFIGRVVAGITGASFTT
GTAYIADVSANETDRAKNFGLIGAAFGLGFVLGPALGGLLASWGIRAPFYAAAALCLLNC
LYGYFFLPESLSKENRRPFEWKRANPFGSLKFLTRHPEIGGLAMGFFLIYLGSQSVQGNW
NFFTIYRFHWSEKMVGISLAIVGVLVGGVQGGLTRVVNPKIGNEKSIYLGLSLYTLALVL
FALATQSWMMYVFLIPYCLGGICGPSLQSVISGHVQANQQGELQGALTSLMSLTTIIGPP
IMSFTFSYFTTDKAPFYFPGMHFLIGALCMFLSIVIIYKVLSKEKKEHPELRNVIEGSEG
EQKS
>AIA17930.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKHFKAIAAMSLNRVIGNGNKIPWHLPEDFKWFKQMTTGHVIVMGRKTFESIGKPLPNRE
TMVLSRSHFQYPGVKTISDLNQIDLQNETREVFICGGAQIYGQTLAVCSDLYLTLVKREV
EGDAFFPAFEDRFEPAEELRDTPEFKILHYRRKLP
>AIA17919.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DDQGELGPIYGKQWLSWSTPSGDTIDQISRAVDLIRRNPDSRRIIVNAWNVGELEQMSLT
PCHALFQFWVANGRLSCQLYQRSADIFLGVPFNIASYALLTHMFAQQCDLQVGDFVWTGG
DCHLYANHLTQADEQLRRAPYPLPRLVINRKPPSIFEYEFEDFTIADYQAHPSIKAPIAV
>AIA17897.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIALVAAVAKNGVIGAKNDLPWYLPEDLKRFKEITTGKTVLMGRKTFESIMARLKKPLPN
RINIVITRNLDYKVPEGVVVQADVASAMRSHGSSDIFIIGGGEIFAQTFDLADTLYITHV
DKDVEGDVYFPKIDLKKWHLENEEPHEGYSFRIYKKI
>AIA17894.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNDLPWSLPDDSKYFMVTTRGHHAIMGRKNYDSLPDAYKPLPN
RTNIVVTRQRAFSAPGCIVVHNIDDALNLARTRGESEAFVIGGAEIYTLALANANRLYLT
EIEADVDGDTYFPSFDKAQWKQVSRKHHDADQRHAYAFDFVVYERIA
>AIA17764.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DDDLFGGEPFDQIDGVFQQMRERPELRTHRITNWLTPYLLRQHQKVVVTPCHGDLHFRIH
VAEGSLSLFHTQHKMDMLVGGINNICQYAALLMAAAQVLDLRADKLIFSISDAHYYKMQK
EMLQEVLSREPRHFPTVYLTEKLTSVKDLRPHHFQIEDYHPHGDFRIPTPV
>AIA17755.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MKAETYLTPVLYLPVAERTVDTQFQDMLRDVRDNGYWDQSAQDDPARMKLGYQLHYNLRN
GFPLMTERDMTAPILRDGKEPWPSMAEQSIGEIAAFLNGARTHKEYQSYGCYWWGRWLTA
EKCEKRGLLKGDNGPGSYGAAWTHFPTL
>AIA17754.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
ASVPGEIVPSREFYDYQAKYVSDDSRLIIPASLNEAQVRNAQALAVQAFQALECSGLARV
DLFLEKPTGKFFVNEINTLPGFTSISMYPKLWEASGLSYADLLDRLIALAIERHAEKKKL
RTKV
>AIA17683.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEPLFFIVAVARNGIMGKDGKLPWHIPEDLKFFKETTMGHAIIMGRKTYDERKKPLPGRR
NIVVSRKPDFQANGCEVTTSVEQAIALARTTDSNPCVVGGNEIFRLALPYATRIYITEID
RDYEGDTVLDIDLTGFRETERRKGETPDVTFVTLDRV
>AIA17635.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSGMGFIRVKGARVHNLKNIDVSIPRDKLVVLTGLSGSGKSSLAFDTIYAEGQRRYVESL
SSYARQFLEMQDKPDVDLIEGLSPAISIEQKTTSKNPRSTVATVTEIYDYLRLFYARVGK
PFCYNCGDPIEG
>AIA17559.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMCHVLEQGVKKEDRTGTGTLSVFGYQMRFDLQQGFPLVTTKKLHLKSIIYELL
WFLRGETNVGYLREHGVTIWDEWAEANGELGEGIYGRQWRAWPNPDGTHIDQLSQVIEQI
KHKPNSRRLMVVAYNPSFADKTPLPPCHSFFQFYVAAGKLSCQMYQ
>AIA17529.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MGEQTKHMINSAIVAMSSDRVIGKDGGLPWHLPRDMKFFKKTTMGHHVIMGRESFASMDY
MPLKGRTNIVLTRDPFFITSSAIVMHSMEEAISYAYEAGETEAFIIGGGMIFKQFMHLIE
KIYLTEVISHVVGDIYFPELDMNEWHIASSEFYEADDKNEFPMRFEVLQRK
>AIA17530.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|0
MGIGQGELQLTTLQMAHAAAIIANEGTYTDPHILKARVSPGGQPRAEYYPRRRVHIDYRY
FEPVIEGMSGAVRAGTATMAAHPDIEMCGKTGTSENPQGKDHSVFFGFAPRHQPKIAITV
YIENAGWGGSFATPVAGLMMEKYLRGDIIESRKWIETKMLETDLIHDPKS
>AIA17513.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MISLIAAIGRNNELGKGNDLLWRLPSDQKFFRETTKGHTVIMGRKTFESIGGALPNRRNI
VITRDKNYKKDDAEVVNSLDEALDLSKTIHDDEIFIIGGAEIYRQALPFADKLYMTHIDA
ADKGADAFFPEIIPIVWNEISHEEHERDATHPFPYTFSVYERF
>AIA17490.1|FEATURES|farme|tetracycline|tap|antibiotic efflux|0
MKIDISPLTKNKNFRYLFLGQFVSYFGTLISVTVVPLQVYNLTHSSAMVGLISIVELVPM
LLAAFLGGALADHFDRKKLLVVCEFLMAVGIGILMINSTFSQPSLVVIFIVSALMQAING
FHRPSMDSLGQALLLRQEIPAAAALQSFKFGFVTLFGPSIGGILISTAGAHVAYAFDLAT
FVFSIIMLCSLKTQHLVREKNKLKLASSLIEGLKYAVKRQEILGTYIIDLVAMGLAFPVA
LFPALSHEWGQTKKIGLLYSALAVGSLAVPLFSGWAAKVQKQGQVIIVAAALWGIGIALF
GMVENFWLALVFLALAGFADTVSGLFRSMIWNQTIPNEIRGRMAGLEMMSYMTGPLIGNA
RAGWIASVTSNHFSLIFGGFMCVVFVSLTAVLLPHFWKYANREVRIDAISIAKDG
>AIA17483.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MARPSITIVLARAINGVIGKDNDLPWHIPGDLKRFKQLTMGSVMIMGRKTFDSLPGILPG
RRHIVMTRDSDWSVNGVEVVHDVESAIAAAGVEPISVIGGAAIFELFEPIADKIELTEVI
AEVDGDVSMPDLRSSERWREVAYEDHLPTADTPAWRTVTLVRA
>AIA17473.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|0
PSAFFLRKMGYPAVVGESFHSDEWRKEINSKKDWRKAFAYAKKLGYPVIAKPNSKSQGKG
VYLSHSSQELKKALMEIFTLDRIALVQRPVSGHDYRIVVLDGTIISAYERIPLSVTGDGS
TSIKKLLVQKQANFKKNGRDTRIKSDDPRIPIKLAKQKLTLSSVPGQGQKVFLLDNANLS
SGGDAVDVTQEMHPAWKKLAARIAKDMNLRFTGIDVIVPAGLSVAPKKYWLLEVNDSPGI
DNYAAIGPAQRKVVENLYRTVLKAMAR
>AIA17466.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISLIAAIGRNNELGKGNDLLWRLPSDQKFFRETTKGHTVIMGRKTFESIGRALPGRTSI
VITRQPNYRVDGVLTARNLFESLRLCGNADQAFVIGGGEIYSQALPLADRLYLTAVDAEV
EGDTYFPPWDEQQWRMVEETTHPCDAKNSFAMRFQIYDRKYPV
>AIA17459.1|FEATURES|farme|aminoglycoside|APH(4)-Ia|antibiotic inactivation|0
MPPEVIARILRAYNVPYSRVAAPQKGYRNTSYGINGIYNLILYKSEAGILARIKNANTVG
AFVAAAGMSARTPRNPRILKLASGGRVRYAALYNYLPGSTIPWEAYTMDHIKALGQAMSD
MHQTLSLYDTQSLPDVADENSALLKRMQRYFVDTHVAGALTSKLGIHSVRCHFFDVLAAS
KKLPGQHALHMDFVRGNILFEGSKITGILDFEKAAKGSPLYDVARTLAFLLVDCKYKQEN
KIRKYFLQSGYIKRGAAELRDYMVNGMSVLESLVDFFLLHDFYKFLRHNPYESLPQNEHF
VRTKAMLLKRGLIECD
>AIA17458.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKVFIIAATTVDGYIGQTAGQSATEWTNPEDKFLFTEYVRKANNMVMGLNTFLSTARRYP
TVFNKTMPGRRIFVYTHHPEAIAEYPNVEAVNESPEELIRRLEGEGITALAICGGSHVYT
MFMQANVVDDLYIDVQATVFGSGIGLFNAPIETKIKLEDTKRLGDNNLLMHYTVSK
>AIA17425.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
YAIDLRGIATTVAKKMGIYERVCELRTSIEFVRYVDANGNLLFEEHGEKGGFRQGEEVEL
VRGDLVEILMQTIQDIPCYFNQAVQQINQQPDSVEVIFKDGRKEYYDLVIGTDGLHSTTR
QLAFTKDEYKLHHLGSYICIFNVPNYLKLKRCEMLFEKDQKLTSVASDKDPSAAQAAFMF
RSNHLLKDIRDSKEQKQFLRDTFSNLGWQANHLLELMEHSENFYFDSVTQVKMPSWTKGR
VALLGDAGYCPSPLSGQGSSLAIVGAYILAGELKNAGENYTHAFDRYNELMHPFVEANQG
FGEWVSKTFLMPEDLSKEAAAARADVILEKMKTVTNALTLPEY
>AIA17412.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KCNKRGLEEGDLGPGSYGPAWRAFSTAEGKPFDQITHLVEQITEMPHLRTHLVVPWIPQY
LGRGTGKQQKVVVVPCHGFMHVIVNNGELSVHHFQRSADVPVGLVFNMVQYALFTMMLAQ
VTGYKAKELVYTLSDAHMFMQQKEAVEELLSREPRAFPTVTLDPSVKNIFDF
>AIA17396.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
FEMNIGIVAVSENYAIGKGGKLPWHYSADLKNFKETTTGGIVVMGSHTWRSIGRPLPDRT
NMVLSHSEQPDLPEGVILCHSKKQILERAERLEGDVFIIGGAGVFEAFQDEIERWIVTRI
PETIEDADVFMPVQFLDDFELTSQKTIDDGLVVETFDRRHER
>AIA17331.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKISLMCAITLDGKIARNEHHFVDWSSREDKRLFFATTKRAGVLIIGNNTYRTFSAPLPG
RLHIVLTSDTSDKINIPGQVEYTSASPEEIAADLKARGFEEAILAGGGQVNTLFLKANLI
DELLLTLEPVVFGSGIDLFRSGELDARWRLVHMEKLNDIGSLHLRYTLAPNS
>AIA17265.1|FEATURES|farme|bacitracin|uppP|antibiotic target alteration|0
MEIYKPFAERTPDSQYQDLLRRIWEEGTEVMPIHGEKAKMVVGAQLRYRLANGFPVITER
DLSGVFFKGALAEHIAFLNGARTQEQLEAFGCKWWDRWVTKERTAIFNLPEGDLGDGSYG
AAWAAFPTAEGKPFNQVEHLMQQIKERPYLRTH
>AIA17266.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|0
MKTFIIAALTADGYIGQDASHLATRWTSHADKVFFSQKTKEAGAAIFGRTTFETFNRALP
GRRTIVYTSRPESVTVEGVETIGGSPQEVIEKLEAESVERLAICGGAHVYAEFLQADLVD
EIFINIHPVVFGAGVPLFREPVQRTLELLEAKQIGDGTVMLHYAVKKD
>AIA17231.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
EREVSLSSGKACARALREQGYNVREIDVKRDLTDLITQLEPRPDVAFNALHGRGGEDGCI
QGVLEILAIPYTHSAPLASALAMNKQKAKEILKPMGVPCPDGQLVHIDDLRKGIAPFKPP
YVVKPNNEGSSVGVFIIRQGDNKPPLGLDKWSYGPYALVEKYIPGKELSVAVMGAHLHKA
RALTVTEIKANTEFYDYEAKYAAGGSTHVIPAPINQDVFNEAMRIAAFAHEKLGCTGVTR
SDF
>AIA17228.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|0
MKVILVVATTVDGFIARTKDQLVNWTDIEDKDFFHSITTQLGTVIMGLNTYKTLPAPLPG
RLNIVMSTNGGENIPGELEFFSGEPLELLDSLSKRGITEVALVGGAQVDGSFFVDNLVDE
IFITISPLLFGQGLNLSSGYDLETKLSLLEAKPIGTDSVLLHYQVIK
>AIA17211.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MVKIEGLTKAFAGHCIFKDLSVEFPRGELSAVMGPSGCGKSTLLRCINFLEMFDSGRITI
GDVSVSWNAGETARLSEDKKTALQQLRLKTGMVFQSFNLFPHLTVLDNVTLAPILVKRIP
AAQAEDMGRAILERVGLGDKTDRYPSTLSGGQQQRVAI
>AIA17194.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
DFKWFKKMTTGQVVVMGRKTFESIGRPLPNRETIILSRNQFQYPGIRTIADLSQIDLQNE
SREVFICGGAQIYEQALPQCSDLYLTLVKRTVEGDAFFPVFENRFNKVETLVDVAEYSIL
HFRNAGITTTDCTAK
>AIA17144.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MQLAVLLLCLLAVGCANGQGSVRKDARKDRPRDSERPARPDDVVRQKTGLEKQFEEIARK
SGGRVGVRAMLLATGETFSLNENERFPMQSVYKLPIAMAVFGRIEAGTIKLEQMLRIGGG
EVLKGSTALPAEKYPDGTERSVEELLGLMVSESDNTASDALLRLAGGPREVMNYLKKLGI
NDMVVANFEKEMHADWQAQYRNYATPSAAVELLRAIDEANGISPPNKTRLLKFLTESPTG
PRRLKGLLPEGAVVAHKTGTSATRNNLTPATNDIGILTLPDGRRFAIAVFVADSSADQAT
REETIARITRAAWTYWSEK
>AIA17142.1|FEATURES|farme|beta_lactam|PER-1|antibiotic inactivation|1
MDSGKSEAERRLGKAQVVAAQPNTTRLQERLDNLDLSSAQGDVGIGVLDLDTGESWFRNG
KQWFPMQSVFKLPVGIVVLKLVDEGKLSLNQTVTITREQFVPAWSPILKEITGDRGQFTV
QYLLQRAVGDSDNTAADALVRLVGGPEQVTDILGRMNLRDIRVDRLEQQLQPDTVGLTNF
RPELVDKQKYEEAVQQIPDAVKKAAMERYLTDPRDTATPEGMIDLLVKLQSRQLLSEDST
ALLLKIMTDSPTGQQRLKAGLPPGWSIAHKTGTGENVVGIGIATNDVGLISSPTGRRVAI
AVFIAGSKAPLEQRESVMSAVASAVVQAMQ
>AIA17094.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISAIAAMSSNRVIGRDGDLPWNLPRDMKFFMNTTKGHHVIMGRNNFASMNYIPLKNRV
NIVLTRDPFFITSTAIVLHSIEEAINFAYEAGEEEAFIIGGGEIYTQALHLTEKIYLTEV
ITELPGDTYFPELDMREWEVVSSEYVEPDAKNEFPMRFDVLLRKE
>AIA17062.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MLGNDAPIASLPGEIIPNHEFYSYEAKYTDDGATLKAPATLSPAVTKNIQALAIQAFQTL
CCDGMARVDFFLRNNEEIIINELNTIPGFTTTSMYPRMWQSSGIHYPDVIYKLIELALEK
FESEAVLKTDYVE
>AIA17051.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSLIAGLTRNRVIGKNNDLPWHLPDDMKFFMNTTLGHAVIMGRKNFDSLPPKFKPLRD
RYNIVISAQPGYKASGAVVVSSWNQALAEAKANTEREEIFVIGGAQIYLLAMQDANRLYL
TEIDATIDGDTYFPEIDKSEWIERSRTHHAVDNKHQYAFDFVVYDRRFKSLR
>AIA17044.1|FEATURES|farme|polymyxin|pmrF|antibiotic inactivation|0
MADVKPIPEGYHSLTPYLIIDGAAEAMEFYKKAFGAVELFRMEHGGKVGHAEMKIGDSPF
MLGDEMEQYKGPKALGGTPMMLMIYVDDVDTIYQQAIAAGGIEVKPLQDQFYGDRSGTLT
DPFGHVWTIATHKEDVSPEEIEKRVAALHGQGAGA
>AIA17041.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
AAVAKAGVVAPSTVELADAEAALAQYGKLVAKPVADGSSYGLIFVNGPAELDQLKAAAAR
EAYVIEPFVAGAEATCGVLEQGGKVFALPPVEIRPADGAFDYVGKYLAKTTEEICPATFA
PQINAAMQEAALKAHKTVGAGGYSRSDFIVTPKGPIFLEINTLPGMTAASLYPKSLKAQG
IAFRDFLDGQIALAVARAKEAVS
>AIA16981.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|1
MKKSIYIMALGAFGIITTEFGIIGIMPAIAKHFGISIDTAGWLLSGFALTIALTGPFSVL
LTSKINRKWMMSLVLFIFVLSNMLSAVAPSFTVLMIARILPAFLHPVFWAVATVAAAKQV
EPKDAPKAVSVVLAGLSVATVLGVPLTTYVSELINWKASFWVSGVINLIAFAALSAFVPS
MPVTEKQSVKSQLVILRKGQMWVNLIATMIMIAGIFATYSYLAEYLGKISNMNGKQISIM
LLLFGTTGIAGNWVTGLALSKNVLLTTRFFLLSLIAVHVMAYLFGGLFVPMASIVGIWGF
IHTGGFLIGQTRSTSEAPEAPELAASLMVSFGNAGVTLGTFLGGIIIASFGIHQV
>AIA16945.1|FEATURES|farme|beta_lactam|WS62_15880|antibiotic inactivation|1
GDPMNTKHLMALVLLAGAALPAASQDAIRCTLLVDAATGKTLVREGQCEQRVTPASTFKV
ALSLMGYDSGILLDEHTPLLPFRKGYVDWLPEWRTATDPAAWMKQSVVWYSQQVSTRLGA
KRFQSYLDRFDYGNRDASGNPGKNDGLTQAWLGSSLKISPDEQAVFLRKLVNRTLPVSGK
AVDMTASLMRYPRLRNGWELYAKTGTGSEPGALPHGWLVGWTGDGKRTVVFARLAQDAQR
EPGGRAGLRVRDAFIRELPTLLERI
>AIA16944.1|FEATURES|farme|beta_lactam|ASD05_04445|antibiotic inactivation|1
MRGFPARKKGNAEVSSLKLFALSLITSLLSSAVAAPTENTNPELRQFAELEARTGSQIGV
AAIDISTKRGVDYRANERFLMCSTFKAMAVAAVLQRVDQKKEKLDRFVTYGEAQLLEYAP
VTRAHVKEGGMTLEALCEAAIRQSDNTAANLLLNVLGGPKGFTEFARSLGDEFTRLDRME
PELNMGSAGDERDTTTPAAMAKDLQRLFTSDVLTVESRKRLEDWMAANETGTRMIRASVP
AGWRVGDKTGRSGKGATNDIAILRPPTGEPIFMAIYTNAPNESSEGREKLVAEVARIALE
ALAK
>AIA16940.1|FEATURES|farme|beta_lactam|OXA-50|antibiotic inactivation|1
MARLFAVLIFLVASLHPLAAQTYREVPELAKVFNEKGVAGTFVLFDVPTNTMLVSNEARA
KMRFVPASTFKIANSLIGLEVGAVKNVDEVLPYGGKPQPMKEWERDMSLRDAIKVSNVAI
YQELARRVGLERMREGLKKLGYGNMEIGNVVDRFWLDGPLAISAVEQTEFLYRLVKGSLP
ISPNALRAVKEITLLEKTETYELHGKTGWLSSRTPPQTGWWVGWIERESKVYPFALNIDM
MSDGDAAKRISIGRECLKVLGKL
>AIA16926.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MGSKTFATIGRALPGRRTIVYTSRPEAITAEGAEATSEAPAALIARLKKEGAAGLAVCGG
ASIYAQFMAAGVVDELYLTVVSKLFGTGVPLFGQELDVSLDLLACERLDEQTILLHYRVS
GR
>AIA16906.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MTEKTDHLATPTHLRAFYHLLTNTLITSVINFTLWFAITFYVYLETKSVFAVSLIAGLYL
VATASTGIWFGSLVDHHKKKTMMIVSNIASLFLYITSFAIYQSAEPGAFKDPASVSLWAL
VVTLMLGVIAGNIRGIAMPTLVTILIPESKRDKANGLVGTASGVSFLVTSVISGFLVAAG
GMLYALLLGLGILVVSLIHLFLVSVPEKGIAHLEGAPKKIDLKGTYKIVRGVPGLMALIL
FSTFNNFLGGVFMALMDAYGLSLVSVQVWGLLWGVLSTGFIIGGLVIAKVGLGKNPVRAL
LLSNIVLWAVSIIFPLQASIILLAGGMFIYMCLIPYIEASEQTILQKVVPFERQGRVFGF
AQSVEQAASPLTAFLIGPIAQFIFIPFMTTGFGVQAIGSWFGTGPDRGMALVFIIAAVIG
LIATVIAFRSKQYKQLSKRYTEGHGDDSSPPALDQPVQEGLVQ
>AIA16900.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MATMPQATSAESAIQIEHLVKRFGQLRAVDDLTFNIAAGETFGLIGPNGSGKTTLIRLLL
GLLAPNSGSVHILGRKIPNRRVAAQIGYMTQSSALYNELSIRENLAFFGKLYGLRGA
>AIA16892.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLLVAMDEKRGIGKEGKLPWHLSADLRNFRELTMGHHLIVGRKTFESIGKPLPGRHT
ILVTRNSNLKPEGCFVARSVEDAFSLARERGENEAFVIGGAEIYRQSLDAANRIYLTQVH
AVVDADTFFPEFDRRDWIETQHLDHPADEKNQYAFTLTMLERIPPARG
>AIA16882.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MSTKTASVRFIFATIFLDALGIGLLIPVLPDVIRRFNSDPQFVSDHFGYFVAVYALMQFL
ASPVLGSLSDRFGRRPILLISLLGAGLDYILMAFAPNLTILYLGRIISGLTGASMTVASS
YMADISDDKNRSANFGLIGAGWGLGFICGPLIGGLLGDMSPTMPFLGAAVLNLLNFFFGL
FVLPESLPATMRRNVEIKRLNPFKSLAKVLQPSPILVLVWIYVLLFLSGQSHPSIWTLYT
EYKFGWTPRQVGFSLAFVGAVIAAAQGGLTRVIIPKTGEIRALFLGIMMYVIGFALFGLA
PAGWMMYAIMLLFSISGIAMPSLQSMLAKRFPSQEQGELQGTLVSLASLTAIIGPLFYTK
VFSYFTDEKAPIHFPGAPYIGASLFAVVALVLYAVALHRSESEPPTNS
>AIA16878.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MAYTGEGVSSSQIAFDKIRTKEKFREHGVATPAWEVIHAGQRPTIPLPIVVKTPRQGSTV
GVVIVKSENELESAIAEAAKYDRELLIEKFVSGRELTIGILGDQALPIIEIIPKGGFYDF
NNKYPFLNPKAGGGAEHVCPANIAAEKTNEIQNLALRAFRAAGLQVYGRVDVILPDNGPG
TVLEINTIPGMTEASLLPEAAAVAGISYTDLCARIIALSQVRQRDARARTRTEDQR
>AIA16867.1|FEATURES|farme|beta_lactam|TEM-207|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLAPRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGGRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AIA16836.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKISAIVAMSKNRVIGRNNQLPWHLPEDLKRFKRITMGHPMIMGRKTFESIGRVLPGRES
IIITRQKDYQVPGAVVVPSLKDAIEYCRNKSQTDEAFVIGGGEVFRDAMPLLNRIHLTLI
DAEIEGDVFFPEISKELFREVSREDHLGQPTPYRFLILEKID
>AIA16770.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVGRREWSVWMITLVLAMAENGVIGNKGAIPWRIADDMKRFKALTVGKIVVMGRKTWDSL
PRKPLVDRTNIVVTRRTGWSADGAVTASSLDDALNKAANATDVMVIGGGEIYHAALPRAD
RIELTEVHGAFDGDAHFAFDRASWREDARETHTTPDGLAYSYVTLTRR
>AIA16747.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNESKPKISLIAALIEKTRAIGKGPDLLVRISDDLKRFKALTTGHPIIMGRKTFESIGRL
LPGRPNFIISRNPNYSIAGAVVCQTLEEAISKASEEEFKGQTRQKEIFLIGGGEIYKQGL
PFTDKLYLTLVETDLEGDVFFPDYSEFKKVISKEDRIDEKTGLKYSWVNLEK
>AIA16721.1|FEATURES|farme|multidrug|msbA|antibiotic efflux|1
AEAQEFIKHMPKGYDTLVGDRGVKLSGGERQRIAIARAILKNAPILVLDEATSSLDSVSE
VAIKKALDELMKGKTAIVIAHRLSTIQKMDRIVVLNKEGNIEEMGSHAELLANNGLYANL
WNHQVGGFIDEDAVE
>AIA16663.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|0
MKITLIILQSLDGIIARQQGDDLSWGTAEDKNFFRSKTREIGTMIMGSSTYKQMPPPAFS
DRCSLVFTSKPEEFPKQEQIHFFQGTPAEGVKYLESLGKTTAALIGGGTINNEFLEAGLV
DELYITIAPRIFGTGVKGLGEKQLAVKLELLDFEKISKDELLLHYRVRKD
>AIA16587.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTRPRIAFVVAVARNGVIGRKGDLPWRISSDLKRFKQITMGKPVIMGRKTWESLPRRPLA
GRLNIVITRHREYSAPGAVVVASVDAALAEARQERPEEICVIGGSEIFRAFLPMADRLYL
TEVDLEPEGDAVFPPLDFTQWTETSREVHPRAENDDAGFVLRVLDRKR
>AIA16575.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDKNGAIGKDGKLPWHYSADMKFFKETTIGNACVMGHKTWLTLKKPLPQRLNI
VLSRKSEIEPQESVIVLRDLESVLAKASSLDCDLYVIGGEQVYNAFLPHIDRWLVTEVPL
TINDADTFIPKEYLRDFECIESSEIGENLTVRLYQRK
>AIA16566.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
VSAAFSLIRQSLNGEQQDYTSGSIRKAVVLLAIPMMLEMCMESVFAVVDIYFVSHLGKHA
TSTVGLTESVTAIIYSLAIGISMAATAMVARRVGEKDQKAASRAGMQSIFISLAITIAIS
VPGFIYSADILRLMGAEEAAIIEGVGYTRIIMGGSLVIMLLFLINGIFRGAGDAMMAMKS
LWLANICNIILCPIFIRGLGPIPAFGVTGAAMATTAGRAIGVIYQVYHLFNGQRLIQFTL
RHLAPDWKIIRSIYTIAWPATLQFLIGSGSWIVLASLVVTTGHSDASAGYQIAIRIVMFF
ILPAWGMSNAAATLVGQNLGAIQPERAEESVLKTAKYNAVFMGLVSIVLFTFAPLIISFF
TREPSVAGYAILAARIISAGYLFYGVGMVMANAFNGAGDTRTPTIINLFGFWCFQIPLAW
VLSKPLEMGATGVFIAIPVAETAISIVAYIVFRQGRWKLKKV
>AIA16554.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMQQIKERPYLRTHILSPWIPQYTLQHSGLTRRVVVAPCHGYVHVLCFPETKELVIHHFQ
RSGDLPVGVPFNFMQYAAFGLMVGQLIGYTLKEVVYTFSDVHMYESQYDKVRELLKREPK
KLPTVVIADEAKGISDIMDFRPEHFVLSDYDPHPKMGIPTPV
>AIA16545.1|FEATURES|farme|aminoglycoside|AAC(6')-Ib3|antibiotic inactivation|1
MEKFTFKPLTISDLNLLCEWFDNPHVLEWWDDQLTPAEIKQKYGSRINDDVVHPHIAYLH
NKPIGFIQYYWVNKVGNGWWPNEDNGTVGLDQFIGDENFIGKGYGTTMIKEFIQFLFHNP
AITKIITEADPNNHRARRCYQKVGFHEEGEINTPDGKSLLMTMKRQK
>AIA16500.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MILSAIVAVSDNDVMAKDGKIPWFVRGEQLIFKRLTTGHPIIMGRKTFETPKTLKGKPML
LPDRLNIVVTRNRHYQVPEGGVVVNSLKQALELPAVKQADEAFVIGGAEIFELAMPHVTK
LYLTRVHTTIEDGDKFFRFNQKDWNQTHKEFYKKNDVPDRPYDFEFQVWERSSPASS
>AIA16471.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|0
TMSGTVVMGSSTWRSIGRVLPGRQSIVLSHSEMSELPDDVLLCHSVKQVLERTERFPGDV
FIIGGAGVFESFQDEIQRWVVTRIPETIEDADVFMPVQFLDDFELTDRKDIGEGLIVETF
DRRP
>AIA16466.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLGPVAVSENNVIGKNNDLPWHLPEDLKHFKELTLGKTVLMGRKTFESIVSRLGKPLPGR
KNVVITRQEEYKAPAEVLVFKSLDEAVQNLLADDVYIIGGAEIFKQALPVAQGYGIYTRA
WQF
>AIA16462.1|FEATURES|farme|multidrug|mdtL|antibiotic efflux|0
SLIMLVFSVSPILAPLSGSFVIQFGDWRTLFYVMTGTGILGLLLVAFVLKETRPKARAHG
LDSIRCARCLLAAAARLEVHGADADRHVRDVELHGVPGQFELRLHPALRADADAVFDRLF
GQCRELSFFAVSQATGFLVGRFGLNRVVRIAVGGFVAAMGSRH
>AIA16458.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|0
MKVFIIEAQSADGFIARDHSAPSTAWTSKEDKEFFREHTKRAGVMIMGATTYKTIGRPMK
DRVTIVYSRSETYEGVEMTQDDPKTLIDKLSARGFTEVAICGGSSIYSMFLEAGVVDTIY
LTVEPVLFGSGVSPFKDSTDTKLELVSESKTESGTLFLEYKVLSTIS
>AIA16427.1|FEATURES|farme|aminoglycoside|sat-4|antibiotic inactivation|0
MSTITIVKYQPEHQPYFEKFNRAWIEKWFTMEPLDEWVLTNPEEAILKDGGEILMALYDG
EVAGTVGLRKLQKAVYEFTKMAVDENFRRKGIAEALCYASFEKAKELGATKVILYSNTKN
AGAIKLYEKIGFKHLPVENDVYERANVKMEIDINSFTIKHNAQPATS
>AIA16413.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MSNTVAEIFNVRSHNPSFFSVKESTVYKGPLLDFCIPVNLHFPPAQMVQRIGEHLPEILR
YYPDYAEVHAKYIGEIAGVPPACIVPANGSTEIITRLCHLTRGPILTPIPTFSRWTDLPN
ELGIPLHTIEQDVRRNFRLEVAEIVSRATELGVRMLVISNPSNPTGTWFEFDEIKKLVLS
LPEVELIVIDESFLDFSDLESAVSLIPRAQNLVVVKSLGKSLGWHGVRLGYAAMNSRGAA
LLRSELPFWNVNGLAAYILKSLSEFKDEFLQSLALVAQDRTYMLNQLEGVSGLRVFPSKA
NFLYVELPSNVPGRKLRDRLLEEYGLMVRECSNKIGSSERYLRLAVQTREAVDLLAQALR
ESLGRIH
>AIA16382.1|FEATURES|farme|multidrug|Mdr|antibiotic target alteration|0
LNNEQFGWVLSAFSLAYALFEIPSGVLGDRIGQRAVLIRIVLWWSIFTALTGLASGLVTL
ILVRFLFGMGEAGAFPTSTAVISHWFPANETTRGLSALFLGQTIGAAIAPLIVVPIAESH
GWRSSFFVNGAFGLIWVLALFRWFRNNPAEMKGITAEERTYIEKNRRFQKHATSFLWRKV
LKNRSLRALVAAFFCAQWGQYFFVAWMPVYLQEGKHFSEDQMKITTFLVFITAIVGVLIS
GFVGDWLAQKKGVVFGRRVLGMCALGGLSLSLFATAFLSDTRSVSASLITGYAFFVATGA
>AIA16369.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
PFYISKKGEWRSGAPLLGPAESKEVLTFSSGDAAAAPASNALAPIFGAIQTKGDVAIAST
NTAGTKDTGLDVIFPLLHGTFGEDGTIQGLLEMANIPYVGAGVLASAVGMDKVMMKKVFA
QEGLPQCVFRHFTRTEWEKNRAYHLVELETAIGYPCFVKPANLGSSVGISKARNQQELIE
AVNFAFQYDRKVIVEENIDAREIEVAILGNDEPMASVAGEIVSSNEFYDYKAKYVDGNSA
MIIPADIPAETSEQIRQLAVQAFLAVDGSGLSRVDFFLGKTDQKIYINEINTMPGFTPFS
MYPLLWKESGKPYTELLDDLIRLAIERHTAKQNIQYSFDVE
>AIA16300.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
DRRGIGKSGTLAWRLSGDLKYFKELTSSTLDTNKKNAVIMGRKTWDSLPEKFRPLPGRIN
VVLSQNPKLQLPSGVLLFSNIDEAVKSLSFNNDVDEIFVIGGGQIYAQSLMHPACKTLFI
THVKGDYNCDTIFPSIPIIFKLIEESEPLNESSIQYRFAEYQK
>AIA16295.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
QDRFMIIGIVAVDRQGAIGKGGKLPWHYSADMKFFKETTIGNACVMGYKTWLTLKRPLPN
RLNIVLSRSAEIEPLESVVVLRDVESVLQKADALTRDLFVIGGAQVYHAFLPHIDKWIVT
EVPLTVEGADTFIPENYLEGFSLADTKDLGEGLRVSSYIRSPAA
>AIA16287.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MSVPVEKEKEQRRSTTSLIILIVGIIFLATNLRAPITAVGPVVALIRDSLGISNAGIGTL
TTIPLLAFAILSPFAPRLARRFGMEMVLFVVLAVLSIGLVLRPLGGFSTLYLGTILMGAG
IAIANVLMPAFIKMKFPNNIGMMTGVYSISMNLTGALAAGLSIPIATSSSFGWKGSIGIW
AILAIIALVIWIPQIRNRKNGALPGQNGGKGKSLWRSKLAWKITIFMGLQSLLFYCMVAW
LPVILQSRGMESTQAGWMLSAIQFSQLPFTFIVPIIAGRMKNQVPLVWITFVLMTAGLSG
ILFGGTFLVLPSVIVIGIAAAFAFSLAMMFFSLRTQNSYEAADLSAMAQSFGYLLAASGP
PIFGLLFDLTNGWTFPLLLLIAATCVILFVGLGAAKDEYVSEK
>AIA16271.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|1
MAHVFVIAAQTLDGFIAKDSNHPAFWTSKEDKERFVKLTKQAGVCIMGSSTFKTLPRPLK
ERHNVVYSRKEKFEGENVETTSEDPIALVQRLEAQGFNEIAICGGSAIYSLFLKAGVVDT
LYITIEPLLFGKGMTVFSDDMNLQLELKSFEKTEGGTLMLEYKVKNKII
>AIA16258.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MRVFIIAAQTADGLIGTDASQSALEWRSKADGKSFGELTRAAGVLVMGATTYRTFRLKRA
PPGRQLFVYTHHPETIFGEGVQTTNEEPQALVKRLAAEGNAGLAVCGGASINSLFLDAGL
VDELYLTIEPVLFGAGIPLLRHPIQRRLSLIECKQLTDHTLRLHYAVEK
>AIA16254.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MSRFIDLSIYRRNRNFAFLFTGQFISFAGTMITSVALPFQVYHETRSTLMVGLLSLVQLI
PILFTALLGGVFADRYHRRVLLFTAESVLAVGCLLLAWNATLTTPYIWLIFCVAALMSAF
NGLHRPALESIVQQIVDEKDFGTVGSLSTFKYSISMIGGPALGGLLIATHGIAITYFVDM
MTFLFSLFCLFMMSHIPKPDRTHDDTTLQSLKAGVRYAMSRQELIGTYVVDFIAMIFGMP
SALFPAIAHSYGGVKVLGLLYAAPAVGALVISFYGNWTRFRRHGLAISIAAVLWGLSIIA
FGLVSNLYAALFFLAAAGAFDGISGIYRSVMWNQTIPNHLRGRLAGIEMISYLSGPKLGD
TEAGLVAAAFGITASIVSGGALCVAGVGICCLFLPKFIQYRAK
>AIA16252.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MPTNKKAAITFIFFTLLIDVMGFGLIIPVMADLIAQLKHIPMNIASNYGAILLSVFAITQ
FLFSPVIGNLSDRFGRRPVLLCSLLGFGVDYIVLAIAPAYGWLFIGRVVAGITGASFTTA
TAYIADVSTNETDRAKNFGLIGAAFGIGFVLGPALGGFLAHWGIRAPFYAAAALCLLNCL
YGYFFLPESLDAQHRRPFDWKRANPFGSLRFLTRHPEIGGLAIGFFLIYLGAQSIQGNWN
FFTIYRFGWSEKMIGISLALVGVLVGGVQAGLTRVINPKIGNENSIYLGLSLYTFGLLLF
AFANQSWMMFAFLVPYCLGGICGPSLQSVISGHVPVNQQGELQGALTSLMSLTTIIGPPL
MSLTFSYFTTDKAPFYFPGMQFLIGAVCMLLSVIIIYKVLNKEKKEHPELRTVIDNENV
>AIA16251.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MNKALVVILAAVTLDSIGIGLIFPILPSLLRDVGHVSEVATLLGVMLALYSACQFLFSPV
LGVLSDRFGRRPVLLVSLAGAAIDYLIMAFAPELWMLVLGRAISGVTSANMAVATAYITD
ISTEEERARRFGLFHAMFGIGFIIGPVLGGVLGDYWVRAPFIAAALLNAVNFALALFVLP
ESRPGQPGARFDLDTLNPFKPLKWALTFSALIPLMAIFVIMNFVGTMYGTMWALFSEDAF
AWNGLMIGLSLGAFGVFHAGAQAFLTGPAVARLGERWALIVGMACELTALVIMGLATQGW
ILFALAPLFALGGIGMPALQSLVTTQVGADKQGQLQGVLASLVSLAAVFGPLFFSFAYFS
IRSTWPGLIWIIGAGIYLLALPLMLGIRRKSAAAPMPGE
>AIA16198.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRHVMQHGTDKSDRTGTGTKSVFGYQMRFDLSEGFPLLTTKKVHTKSIIHELL
WFLKGDTNIKYLKENGVSIWDEWADEDGNLGPVYGSQWRSWQAADGSTVDQITNVISQIR
KNPDSRRLIVSAWNAGEIEKMKLPPCHAFFQFYVANGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAQVCNLQPGEFVHTLGDAHIYSNHFEQVALQLSRQPGPLPHMKLNPGIKNIF
DFK
>AIA16182.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGAKTWRSIGKALPGRQSI
VLSRSEIVDLPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVDDADVYMPLQFLDDFELVDSKEIDKGLIVETFDRRT
>AIA16168.1|FEATURES|farme|bacitracin|uppP|antibiotic target alteration|0
MEPRYKPYDERSRDFQYRELLIKCLPREMHPGGKGEFVKNEFQPTGRYSNFAAAPLDFYF
DNGFPLITERRLGFWRKFLNEMWAFINGARTLDELRQYGDEKTWPNFWEKWVYPEKCAVF
GLVPGDLGNGSYSVLGKYPTV
>AIA16162.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKIMLLAAVTLDGKIARNEHHFVDWSSREDKKMFFATSKQAGVIIVGHNTYKTLPAPLPG
RLHVVLTTNTADKVAVPGQVEFTSDPPEKIVADLEARGYTEAVLTGGAQINALFLKAGLV
DEVWLTVEPLIFGVGIDLFRGTPFDVRARLIHMEQLNDGGTLHLRYSLHSP
>AIA16137.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTRKLNQRNEMMRTTILFGGTNKERLVSVASAQALHQALPEAELWFWDVADTVHEVASQM
LLGHARPFEDEFKPGNRGLPLEAALDKAKSEDRVLVLGLHGGRAENGELQAMCELRGIPF
TGSGSASSNLAFDKAAAKRFAAIAGVAAPAGVALENLDAAFAEYGRLIAKPARDGSSYGL
IFVNAKQDLVAVRNAAKTEEYLIEPFVAGVEATCGVLEQSDGTLMSLPPIEIVPGEGTFD
YAAKYLLKSTQEICPGRFSADISAQLMDQALRAHRALSCSGYSRTDFIVSAKGLVYLETN
TLPGLTAASLYPKALKAQGIEFSDFLRDQIALAERRSRERV
>AIA16076.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQSHLTIVVAIDAQRGIGINNTLPWRLREDLAHFKRTTMGHPVIMGRKTFDSIGKPLPNR
RNIVITRNPEWRHDGVEAVASLDAALKLTGDTPACVIGGAQIYAETLACAHRLIVTEIDK
TF
>AIA16067.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MDDFIIRAATPSDAAAIVSLLRELADYENLLDHFTLTEAEVAREMFGAACHCDLAFQDGE
PVGITTWYWTYKSFRARRGLFVEDLFVRASARGRGMGKALLVHLAAKARDAGGFLEWQVL
DWNAPSIAFYQSLGAKPWENWLIYRLEGEALERITA
>AIA16002.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISTIVAVAKNGVIGKADGLPWYLPAELARFKEVTMGHPIIMGRRTHESIGRALPGRTNI
VITRNKDFKAEGCIVTLSLEKALAKAKRAEGADEIFIIGGEQIYAEAIPLLDRIYLTKVD
ADVDGDKFFRFDESQWNQIRSDKHQKDDKNLYDFTFLLLERAR
>AIA15950.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
METQRLLAEEKQGRGDTNVAILGDPSRSGLVRLGSRASEPERLDVVFPVLHGTFGEDGTL
QGLLEMAAIPFVGCGTLASACGMDKVTMKALFKDAGLPICRHTWLLRSDWDHDQNKVIRK
IIREIGFPCFIKPANLGSSVGVSKATDKKSLAKGIDLAARYDRKIMIEEEVVGREIECAV
IGNEEPRASLPGEYVIHEESARFLDYTEKYSSTGHVEFLVPAKIPKATVKKIQAMAAVAY
KSIDASGLSRVDFFLKPDGELLINEINTLPGLTEVSGFPKMWEATGVPFKSVIDQLIQMA
IERHRERARNETSI
>AIA15926.1|FEATURES|farme|aminoglycoside|AAC(6')-34|antibiotic inactivation|0
MHLDCGPCVVRDWNPNDKGALVEIANNRNIWRNLTHRFPHPYIDADADGWFALLEKIPER
THWAIAVEQEVVGGIGFERGEGVHARAGHFGYWLGQPYWGRGIITAAVRATSDHIFEHFD
LERLEAAVFEWNPASMRVLEKCGFVREGVLRRSILKDGQLIDSVLYARVRGD
>AIA15879.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MTTRKELPKKIAVLMGGPGSEREVSLATGRGVAKALRSLGAEVVEIDVRNEDFQLPNEVD
LAFNTIHGTFGEDGHLQKILEGRGIAYTGEGVVASEIAFDKIRTKEKFQEHGVTTPPSEV
IHAGQRPTIPLPIVVKAPRQGSTVGVVIVKNESELESAIVEASKYGRELLIEKFVAGREL
TIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQAGGGAEHVCPANIDAGKTKEIQELAL
RAFRSAGLQVYARVDAILSDDGQPYILEINTIPGMTEASLLPEAAAAAGIGYPDLCARII
VLSRRRQGHGGQTRPGTEGKR
>AIA15850.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MKTGEASKDDPQFGDLSKFAPAAATRVVGDGEVVTVGPLSVTAHYTPGHTPGGVSWTWQS
AEGGRTANMVYGDSITAYGAPGYKFSAHPEVLASLRNTFARVAALKCDILVTAHPEAGGL
WPRVEKRAQLGNAALIDPDACRKYAAKGTARLETVLAEEKAKP
>AIA15827.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSMIVAASENGVIGKDGTMPWRLPTESAYFREVTLGHPVITGRKNYEAMGRPLPGRLN
IVITRQTDYEVPKGVIVVHSLAEALKLPQVQSEQEVFIIGGAEIYQQAMPLADILYLTTV
HAQIDGNTFFKYDPGQWQLEWSQHHPADAENKYSFTLQRFQRIQ
>AIA15815.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
CMKASIVAYDHNRTIGDHGEIPWQGKMRGDAHYFRDMTSGHPVIMGRGTYEAMGRLLPNR
QNIIVTSQDLDIDGAVTVHTLDEAYSIAQTLDEKVFVIGGGQIYDAAMNDVDIIYATEID
ASTDGDVHFPVIDPTIWRETAREHHEADEKNIYDYDFITYERI
>AIA15811.1|FEATURES|farme|trimethoprim|dfrA8|antibiotic target replacement|0
MTTDLTRHPHLPETPFVKAVWAESYDFTTDRIVMGDTSSESGMPWPKNDADLAAFREETR
DHVLVMGSTTYDHLPPHMKLPSSTKERPIIILTSRITEYIHKTTGLLAVQPLNPTGTIEH
GVMLQWLQKWPEFAGKKIAVIGGARVIDAFKPYYDEMVVTWHPGRHYPSADVGAPRTSIF
DGFIATDDTKELDTVQLPENNLPRSIRLTRFTRKENA
>AIA15750.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTIPLILVVAMAENGVIGRDNRLLWRIKTDMGRFRRLTMGKPMIMGRKTFESIGKPLPGR
ETIVLTRDGAFSAEGVHVAHTWEEAVAKGEELAGKAGADAVAVAGGAEIYALALPHVQTL
FLTQVHTALEGDAVFPSFDRSQFREVKREDHPQGPDDEHPFTFIDLERRR
>AIA15743.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKKERFMNAQLVRAAIVLGLLSVIGPLAIDMYLPALPAIGRDLGASSGAVQQSLMAFMIA
FAVGQLVYGPLSDMFGRKPPLYAGIGIFLVGTLGAAFAPSIEWLVFFRLIQGMGACAPMS
LPRAIVRDNYTGAPAAQLMSLIMLVFSVSPILAPLTGSFVIQFGDWRTLFYVMAGTGVMG
LLLVAFVLKETRPKSARTGSTLGSALGAYWQLLRDAKFIGLTLIGTFGMSSFMAFLGNSS
FIYIQHYGLTPTQYSVAFSVNAVSFFAVSQATGFLVGKFGLNRVVRIAVGGYVASMIGLL
VVYLSGIDSVWVLGGFMFVAFGFLGLVLPATSVLAMEEQGEIAGSASALLGTIQMVVAAV
VMGIVGAFGDGTARPMVIAFAACAIAAFVITRRTLSKGDGTRMVSVPAE
>AIA15734.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MAGGTSDSAIQLKETVMVCGAVRMDGPASKADGSAPRIEAAMREIRRRIAARSLPTGAKL
PSVRSFAKLMQVSTSTVVEAYERLVAEGAIRSRPGSGFYVASALAPLSLAEIGPKLDRAV
DPFWVSRLALNGGADVAKPGCGWMPADWMPQDVLRRAMRTLSRGEPEQLTDYATPLGLLP
MRQLLSRRFAEQGLHASTGQIILVDSGTQAIDLLCRFLLEPGQTVLVDDPCYFNFHALLR
AHRVKVIGVPYTPTGPDVALFEQALSEHKPRLYITTSGVHNPTGACLSPVTAHRVLMLAE
RANLTIIEDDIFADFEEQRAPRLATFDGLNRVVQIGSFSKTLSASVRCGYIAAPKDRIEP
LTDLKIAANFSGSQLSEALVYAALKDVQYRRH
>AIA15694.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MITFYLARADNGVIGLDNVIPWFIPGEQRRFKAMTMGKPMVMGRRTFESFKAPLPGRRHI
VLTRNPGWAAPGAEVAHDREAAIALAGDVPEIAVIGGAEIFRMFDNIAHAVELTEVHLSP
EGDAVLPPFDRAQWREVSREDFETHSFVRLERASR
>AIA15685.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MLLSAITAVGQNNVIGKDNTLPWRLPADMRFFKNTTMGHAVIMGRKTYESFGKALPGRTN
IVITRQSDYILTDAMVVHGLEEAILEARETEKEKASENEEIFILGGAEIYRQSMQLLNRI
YLSRVYGDFEGDAVFP
>AIA15676.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLAVTVVSLLYFGEIMILSAMVAASDNNVIGNRGVIPWHIKGEQAHAKQLSLGKPLIMGR
KTHESIGRSLPGRLNIVISRNPAFKVFDGAVLVGSLDEALQLPDVKDAPEAIIFGGEKIF
EEAMPKLDRIYLTRVHGNFDGDTFFRFNPAEWKIISEEKHPTDPTSGQPYDFDYLILERI
>AIA15675.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|0
MQISVEKIGKKFVKEWIVRNATFELAAGQQYTFVGPNGSGKSTLLQLLTGIVPVSEGTIR
YIDQSGKEIEVDHWYKHLVIAAPYLELIEEFTLRELIQFHSKFKAFKNGISFKDFEDFIQ
LPHASGKTLRHFSSGMKQRVKLGLAFMSDVPVIFLDEPTTNLDVPGINWYLDHVVHHTQN
QLVLLGSNVKQEYEFCENIISVSAFK
>AIA15655.1|FEATURES|farme|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MINFKGSLTGMLLMAATGCSVSAHAAFDQLTLKSQFETLENKSGGRLGVTVVDTSDGSEY
SWRGNERFPLCSTSKVMAVAAILKKNESDHSLLDKKIHINKSDMVNYNPITQKHIGSSMT
VAELSAAALQYSDNAAMNKLLAYLGGPQQATHFARTIGDKAFRLDRKEPELNTAIPDDVR
DTTTPSAMADTLNKLVLGTALKGEQRAKLSEWMKGNTTGANSIKAGLPADWIVADKTGSG
DYGTTNDIAVIWPKDQAPIILTTYFTQKDKDAVARKDVLASAAKLVVDAISK
>AIA15652.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
PPQGEQLSGLQASPQYRDGAFHNALPTPGYNGDKNMLVAMWEFLTKKTENARPAQPLPLV
NTDLASLPLAQDTLVWLGHSSWDLQLAGKRILIDPVLGNYAAPFSFLNKAFEGDYPWRAA
SMPEIDLLIISHDHYDHLDYATIKALLPKVKRVVTPLGVGSHLRYWGMDPTIIDERDWNQ
SVRISEALTVHVLPARHFSGRGIKRNQTLWGSFMFVTPEQKVYYSGDSGYGPHFRDIGEQ
FGAVDLAIMENGQYDQDWKYIHMLPDETAQAAADLNAKAVVPGHNGRFVLAKHTWNDPLI
QLAKASRDKGYRLLTPELGEPVRVNDTAQQFRPWWE
>AIA15622.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLISIIVAMTPDRLIGSAGRLPWYLPDDLKRFRQLTTGHAIVMGRRTFTSIGRALPGRRN
LVVSRNPDPPKRENVEWFAALDAALEAARQGGEKECFIAGGTEIYAEALKKADRMYVTFV
QRDFPFQGDTYFPMWDQTQWNVVSHGLVKDLEFVVYERTGATGGTQIQMEAGD
>AIA15615.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|1
MVKITERDMKDYWITIHPKKAEQKITKTDRKKVQDGKMTDEELYKRQLERISKKDLESFK
DELEVLAIKRQMEGGYSNTPKIIKSDVTNEQYAVISEHLDELPGVDTTTYWERSYPENST
LRTLLGNVSSANEGLPKEKIQYYLSRGYSRNDQVGTSYLEKQYEAQLRGQKEEVKYVTDK
KGSLLNTIQVSKGERGNDLVLTIDMKLQKAVEKQITDQLLAKKQMNGTEFLDRAFVIMMD
PHTGEILTMAGKKYTIDKTTGTPKIEDFSLGNISTSYEMGSVVKGATVLAGLDSGAITPN
TILVDNPIKIKGTPIKKSAEAVGLGPLNYSSALKYSSNVFMFKTVMAMAGLQYQPNMTLP
IKADTFTKLRFYYNQFGLGVSTGIDLDNESIGLQGGNTIAGTALDLGIGQYDTYTPLQIV
QYISTIANGGYRIKPQIVKEIRKPTIKTDEIGGTQYSFESEVLNRITMKEEYIKDIQNAF
KRVTQEKGGTGYVAFNTAKYNPAGKSGTAQAYQKNPNGGDPIEVNNSTFVAYAPADKPEI
AVAVAVPSAFLPNTPNTITKELARSALDTYFDLK
>AIA15584.1|FEATURES|farme|multidrug|mexY|antibiotic efflux|0
LAGLSSLLIGILIRSIPMAFFLFTGTLFIGVGIAIGNVLLPAIAKDKFPDQFGLMTSVYS
TSMGLVASLASGVSVPLAVGMNLGWKGALNVWGIPAVAAILVWIFLSKFNQGNQKEIKKV
TPSSNHIWRSPLAWQIAIFMGFQSFLFYVTISWLPEILHSHGLSMETAGWLLSFSQIVGL
PASFFIPVIAGRYRSQIWISFVLSMCSIIGYGGLLLGSS
>AIA15579.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MVQPRYKVIVDAFAADIRSGRLSPGARLPTHRQLARREGVALVTASRVYAELEAIGLVVG
ETGRGTFVRETSLPAGLGIEQQAALSGLTDLNFNSPSLPGQGEMLRSALRELASSGDLEA
LLRYQPHAGRQHERAVFARHLLARGMEVAAEQILIVNGATHGLAAVVLGLFRPGDVLAVD
ALTYPGFKLLAETMRLDLAPVPIRSDGLDLTALARICKDRHVRAVYTMPTLHNPLGCVMT
AERRQELVAIARKHELLIIEDAAYAFLVDDAPAPVAAIAPELTIYVSGLSKSVATGLRVG
FVAAPAHYVPMIERAIRATAWNTAGVMTAIACNWIVDGTVSQLEAQKRDDARVRQQIAAE
VLTGITRIAHPASYFIWLPFTEDVRADLVAMALIRENIAVSTAEPFATTEQVPHAIRLAL
GSVDLTSLRESLGTVRKAINAYTY
>AIA15573.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKKLNVAIVVAMDKNRLIGKSGDLPWNIPEDRKRFKDLTMGHAVIMGRKTFESILKYIHK
PLPGRTNIIVTRDQSYTADGCIVCHTLEDALKKATKIEEQNPNPEVHIGGGAELYKQVLP
FVDKLYLSIVEGDYQGDAYFPDYSMFKKVVRNEQKTSNGYLYTILDLER
>AIA15550.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MNMGAMNMFNDFKFTDDRPVYIQVKDYLKRLIIKGSLQADQKLPSTRELGLLLAVSRNTV
ISAYAELEGDGFVYAIQGKGSYVAAASAPPGAAAPSCEFDWQSRINGYARQAIELDRMKR
GIRADKSVISFTSIAPDEKLFDLDNVKRAFLERIAKEGGVLLNYGYAKGYKPLIDYLLKY
MEQRGVDLSGKDMLITNGFTEAFDIVMSALRRKDGGSVICENPTHYTAIKNLRLNGFDIT
GIPMERDGINLTELERALTERAYDCAYFIPSYHNPTGIVTSPEKRLAIMQLMARHRIPVI
EDGFNEELRYSGSHVSPLIATAGQGNGVIYIGSFSKVLFPGLRVGWVLADRRLIDSLESI
KRARSIHTSTLDQSVLFQYLYNGNLEKYLKKARAHYKRKYEWTKHCCEIHLPYKRLSGDG
GLHLFVEFDECFDTTALLNECSGQGVIFTPGDMFYTDGGGGHTMRLGFSRVPDDDIGKGL
EIIGQTAKQLMR
>AIA15538.1|FEATURES|farme|beta_lactam|AIM-1|antibiotic inactivation|1
MPPVALADAAPGQRAWTQACADSDGWDKPGPPFRVYGGTYYVGTCGITSLLVVGPEGHTL
IDSGTDAGAAVVLANIRALGFEPKDVRTILTSHEHFDHVGGMARLQAATGATIVTSAPAA
AVLRSGKPAADDPQAASGHPPFPAVTGQIVVLDGERPQLIADREFTPLFTPGHTPGAMSW
TWRECEGESCKSIVYVDSLNPISAPGYRFSDHPAMVVAFRAGIAKIAALDCDIVLAPHPG
AAKLRERLLGEAPLIDRGGCRTYAASVTERLDKRLAAEAQEDTSGG
>AIA15535.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MKRIAALLSCLLAVPALSVAAEWEGPQDPFKLYGNSYYVGTAGLSSVLITTPAGHILIDG
ATPKAAVQIAAHIRQLGFKPEDIRYILTSHEHFDHVGGVAELQRLSGATVLTSAAAKPVL
ETGKTDKGDPQFGNNMPDMTPVSPVRAVRDGESVELGPVSIKAHYTPGHTKGGISWTWMA
FENGRPMNMVYADSLNAITGPGFRYSGNTVYPDAKADIERSIARVAALPCDILVTAHPEA
NDLLERQAKGKLADANACQAYAETGRVRLAKTLAEEAAKR
>AIA15502.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
AILLGLRFVQGLGAAATRVIATSIVRDQFSGREMAEVMSLTFMVFMAIPIIAPGVGQIIL
LTGPWHYIFLFMAGLSALILIWAWFRLPETLHPEYRRPLRLGVIAEGFRLVFTNRVAFFY
GLAGTFLFAAMFGFIISTQQIFVGIYGLGPWFPLAFASMAGFMAVASFVNSRIVRRYGMR
RLSHTAMLVYVTCASILLILSVSGPVPFWLFFALLLVIQVAFGTAASNMNSLSMEPLGAV
AGTAASVFGFFQTVGGALLGTYIGQQFNGTLTPNATGYVVMGLLVLCCILIAEKGRLFGV
GQEYEPTGVVAHAD
>AIA15410.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSLVVAASENNVIGKDNKLLWRLPNDMAFFKNVTWGMPVIMGRKTFESLGSKPLKGRT
NIVITRKGEIDEEVVTVSSLEQAVKAAGDTDAKECYIIGGGEIYRQSMQIADKIYMTRVS
AVVEGDTWFPEIDEKVWRVTSSVSFDADEKHAYAYRFETWQRN
>AIA15407.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MSRNSPPLEKEPPMRIICMAVITLDGKLAHNSEQFVDWSSKEDKRLFMQTTRDAGVLIMG
HHTYKTMSRPLPGRLHIVLTSTPEAETPIPGVVEYPSAAPPAIAADLAARGYPTAILGGG
GQVNRLFLEHDLIDELWLTVEPLIFGGGIDLVGGGSFDRRGRLIHLE
>AIA15405.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MANFSIRRAQSGDEDLVLALLRDLAEYEKLLDKFHITADVIARDYFREQPLLNCDLAFEG
DTPVGCATWYWTYHSFAARRGIYLEDLFVRPQTRGKGYGKALLSHLARTAVENGGAQVEW
EVLPWNTPSIEFYELIGAKRLSDWYVYNLSGDALKKMGS
>AIA15401.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLTKMQRDRKLMILTAIAAMAENYTIGLENRLPWHLPADLQHFKSITSGHPVIMGRKTYA
SIGRPLPNRTNIVITRDRAFKAPGCVVTNTIGDAISIAEQHTDDEAFVIGGAEIYQQMWS
KIQRIYLTIIHHEFDGDAYFPTLMPGEWKETARERHAADVDNAFEYSFLTMERVHANMGK
RKINMDDLVTLK
>AIA15365.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MSKREPKEKKPAGLAFIFVTLLIDVIGFGLVIPVLPNLVGQLAGGTAQHQVLVYGWLLSL
YGLMQFICAPILGNLSDRYGRRPVLLISLLCTGIDYIIQATAGTIGLLFVGRIIAGIMGA
SFTPATAYIADVSKPEDRAKNFGMVGAAFGLGFMIGPALGGLLGQYGNRIPFYAAAVAAL
LNVLYGYFVLPESLSKDKRRKFTISNANPFKSIGILGRKKWVLLLSISTSILWLAQQVPP
STWILITEYKFHWDPHANGLSMGLLGACSMVVQLWLIRVLQEKWGDVGLVWISLIFNIIG
FVAMGLSPTGPFMLVSMVVWTVAFVGGPGLQSLISHQYDETEQGAVQGALTGIQSLTGVI
GPLIFTAVFGYFTARGHVNLPGAPFLLGAVFIVFATIIAYSALRHHKFSRGGEELAPAPD
PTT
>AIA15361.1|FEATURES|farme|bacitracin|bcrA|antibiotic efflux|1
MNVVNAVEIEGVSQRYGSMTVLHDLTLSLGEGEVLGLFGHNGAGKTTVMKLILGLLKTST
GQVRVLGCRPAQAEVRRQLGYLPENVTFYPQLSGRETLRYFARLKGTPLTQVDELLDQVG
LTAAADRRVKTYSKGMRQRLGLAQAVLGQPRLLLLDEPTVGLDPIATQDLYGLIDRLRQQ
GTSIILCSHVLAGVEAHINRAAILATGRLQAIGSLARLREDADLPARIRANGLARREHWL
QRWNAAGHTAIAVGGNGVEVMAVNGHKVDLLRQLFHEDQPQDIEILQPSLEDLYGYYMSR
APGGTEGIHP
>AIA15312.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MKVFIIAAVTADGFIGRSSEHLADWTGGEDKKVFVRLTKEAGVMVMGSRTFATIGRALPE
RRTIVYTHDAARITTDGVETTSEAPAGLLARLKAEGAFGVAICGGASIYELFMAAGVVDE
LYLTFVPIVFGKGLNLFTKERATKLTLLETSSLADGSVFAHYAVEK
>AIA15270.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKIAVALIALLPLGDVAQAQTVKDLLAALLVKWNTPTEPFKMIGNVYYVGTDGLASY
LITSPQGHILVDTVMPESTSQIKASIEKLGFKITDIKYLLNTHAHIDHTGGFAEIKQASG
GQLVAGEADKPLLEGGYYPGAQQDEALKFPPVNVDRTVREGDKVTVGDVTLTARETPGHS
PGCTSWEFSVKDGDATRTALIFCSGTVALNRLVGNPTYSGIVTDYKKTFARARDMKVDVL
LAPHPEMYKMAEKRAKLAEGGPNPFVNPGEFNAYAATLEKSFEDALAKQTAAAQEKKG
>AIA15265.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MKLSLKGVGKLYQGKVQALQDFTLDVSPGILGLLGPNGAGKSTLVRILATITKPTGGTVT
WNDVDIVRSPNRLRAVLGYLPQDFGVYPNLNAVEFLEYLAAAKGLDRKTARQRIQELLEV
VNLVEARKRPLGGYSGGMKQRVGIAQALLNDPELLIVDEPTAGLDPEERVRFRNLLSELS
GERIVILSTHIVSDVEACATNIALIARGRLITCAAPEELLQSVEGKVWERVVASAELPIL
RQQYLTSSTLHRSDGVHLRIVAEEAPGPGAIPQPPTLEDAYLYWISGRKGETE
>AIA15260.1|FEATURES|farme|beta_lactam|LRA-12|antibiotic inactivation|1
MFKRILKNTFVITLLLFCGTLSFAQQVKEPTGGNPEWSKPYDPFRIVGNLYYVGTYDLGC
YLITTTKGHILINTGLAGSFDMIKSNVASLGFNFSDIKILLTTQAHFDHTGALATIKKAT
GASMMADEKDVDLIEEGGVSDYAFGGSVMFAPVKVDRKLHDKDVVALGDMKLTHLHHPGH
TKGSCSYLFDIKDEKGSYRVLIANMPTIVTDKHLDAIPAYPDIARDYAYTLKELKSLTFD
IWVASHASQFDLHVKRKPGDAYNPEVFRDREGYDRSLADLQAAYDKKMAAK
>AIA15256.1|FEATURES|farme|beta_lactam|HMPREF1562_2717|antibiotic inactivation|0
MKLLSVAVTLLFLSCASKAQVQPEYIHQIDSLLQVKQPRAFNGVLLIAQEGAILYSKAYG
YSNFDKNTPLKIDDKFSTMSIAKQVTATLIMLEVEKGTIDLHVPIRRYLPDFKYTWADTV
TMHHLLNHTSGLESFDIKKPLKFATGKDFSYSNIGYSIAGQILEKQSGKTFEQLVTSLFR
HCGMSNSAYYTKQNQALLTKGHTLQNDGKHLVRNDISFNPADYFGCHLMVTAADLAKWNE
SLHNGMVLKPATNKLMINYSTKATHPLFGQDAIGYG
>AIA15245.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIKSIIVAESINHVIGNQGKLPWHMPADMKHFRNITMGHHVIMGRKTFESIPHGLPGRKV
IVLSQQAGYRAENAIVVSNWKAAFEVAQQVQETEVLIAGGATIYQEALEWVDKIYLTRIE
AEITGDAFFPELNERNWRTISSMYHPPDAQHAYGYDFVELKRRVSLA
>AIA15241.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MQPNSNHRKPKIIIIVAMTPSGVIGVRGKNELPWRAVGEKLIEDLPRFEKITTGNGNNAL
VFGRNTLESFRNKALPNRKNFVLSRKENYSPPDGVTRFFDLDSALSAAQDCDQIFII
>AIA15202.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIAAVAENSVIGNKGQLPWNLPDDMKFFQRTTLNHHVISGRKNYESIPERFRPLRDRVNI
VVTRGTDYEAPGAIVSHSLEDALDIARKAEVKEVFLIGGGQLYKEAFEADLVDRLYLTTV
HAKPEGDVFFPKIGKGWKEVWSEKHKADDRHKYAFTLAVLQR
>AIA15198.1|FEATURES|farme|tetracycline|tet(30)|antibiotic efflux|1
MNKALIVILATVAIDAIGAGLIFPILPELLTQLTEGGDIGFLYGAMLAVYAVMQFVFSPV
LGALSDRFGRRPVLLLSLAGTLIDYLVMALSPLGWILVVGRAMAGITSANMAVASAYITD
ITPPEQRAARFGLVGAVMSMGFIVGPVIGGVMGAWWLRSPFLIAALFNGLNLAVALFVLP
ESRKASDEPFDFKQLNPLAPLMWLWNFKPLLPMVIVSIVFGLIAAVPGTIWVLYGAERFG
WDSVHMGISLSVFGVSGALSQAFLVGPLTKRFGDLGTLMIGVAFDTLAYTLMAFAYQSWM
GYAVAPLFALGGVAMPALQSLLTSRVNDEQQGQLQGVLASLMSLAGIVGPVLTTAIFFST
KDIWIGTIWLVGAALYLLATPLFATVRQCKPAMA
>AIA15153.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MKRLLATLFVCLLLAPASGRAGSATQSASTPKDAASTPEAKIAELFGATPGAFVLYDRNA
DRFVRHNAARCAVRASPFSTFKVPNSLVGLESGVIKDADFVIPWDKKKYPADEAFLPEWN
RDHDLRSAIQYSVVWYYRELALRVGKAPMNRYVEAMNYGNRDTSGPLDGFWLNSSIKISP
DEQIAFLRALYDEKLPFSKRSMKIVKDILPSEKIGAATIRGKTGTGRIDGELWLGWYVGW
VETGDNVVFFALQMDSPDVQTLMPLRKTTTKKILSALGYLPGAAAS
>AIA15137.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
VDNTLLTIALPTIGRDLGSGTTALQWVTGAYSLTFGGLLLTAGSAADRLGRRRVLLVGLA
VFGLISLAVVAVDSAGELITLRAALGIAAAAMAPITNSLVFRLFEEQALRMRAMTVMIVV
GMSGFILGPLLGGTALAHVRWEWLLGVNAPIALIAWVGVRLGVPADRDEDLSGDRLDVPG
AVLSISTIGLACYTLTSGVEHGWLSLATFGSATGAVLALCAFVWHERRTPQPMLDLDVFD
NGTVRGASLAQIGTAIAMAGVMFGLILHFQYAYGWSPVKAGLANLPMILTMILATPLSEW
LAKRFGHRIACLIGAVLLSGSLAGLAWGVSHGYLAIAICMVVLTIGLRTVMTICAVALVD
AMPSNRTSIAAALNDTAQEVGTSVGTAVVGTLIAALVTATLPSGAWSNDLVASFFHGERV
TYAALAVIVGLVAGWGALTLSDSRSTEEPH
>AIA15133.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMG
IYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIP
CEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSY
VSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKH
FLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQ
GNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVS
KEIAEARSNKILAMIKSVSNSINLPQYE
>AIA15130.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTATTTPLSPHTYPSLRAAWIPLAALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTALQW
VTGAYSLTFGGLLLTAGSMADRLGRRRVLLVGLAVFGSLSLCVVAVTTAGELIALRAALG
LAAAAMAPITNSLVFRLFDSQALRMRAMTVMIVVGMSGFVLGPVLGGTALAHVRWEWLLV
VNAPIALIACIGVRLGVPADRREDLTDDALDLPGAVLSITAIGLACYSLTSGVEHGWLSA
ATLASIAGAIAAAVAFVQHERRSAAPMLDLGLFSNGTVRGAAIAQIGTSIAMASVMFGLI
LHFQYAYGWSPVRAGLANLPIIVTMIAATPVSEWLARRFGHRIACLVGAAFLAGSLAGLS
WGVEHGYVAIAACMVLMTVGLRTVMTICAVALVDAMPSNRTSIGAALNDTAQEVGTSVGT
AVVGTLIAALVTTQLPAGTWGSDLVASFFHGERITYALLAIVVGVVAAGGALTLTDSHAT
EEPV
>AIA15120.1|FEATURES|farme|fosfomycin|FosA4|antibiotic inactivation|1
MLSGLNHLTIGVLDVERSLQFYGSLLECRVRATWRSGAYLSIGSLWLCLSLDAKRSTEPA
PDYTHYAFSVAQDKFDVLVRRLREHGVVEWKENCSEGNSFYFLDPDAHKLEVHVGDLDTR
LAQCRLAPYDFMRFFD
>AIA15108.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MKKIAIVGYDRHRAIGAHGTLPWGGRMKTDMRRLREYTTGNAIIMGRKTYDSIGHALPNR
QNIVLTRTPFEADGVTVVSTLEEAYAVVEPGRDAYIFGGAQIYELALATTDEILATEIDM
DVEGADAFFPVLGPEWVETSREHFATDSDNAYPFAFVTYKKSV
>AIA15103.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTARIAMIAAVAENGVIGSAQTIPWRIPSDMAFFKQTTMGKPIVMGRKQFETVGRPLPSR
FNIVVTRQEDYRAEGVLVCATVREALDKAQEIARTDGAEEVMIIGGGEIYAQLMPLADRL
YISHVDLAPNGDVYFPAIRETDWAVVDLPEVQPHPKDEATYRVKVYERRRA
>AIA15073.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGQDLHAGTAAVQMSLLIFFLSMGFGQI
VVGPISDMVGRKLPLYGGLALFMVGGIGSATAMSPTIEWLIAFRFLQGLGASAGMAVPRA
IVRDLHTGTEAAKLMSLLMLVFSVSPILA
>AIA15036.1|FEATURES|farme|beta_lactam|pbp1b|antibiotic target alteration|0
MLRKRLRRKLTAKAKAKAAASASASKPRIEGNATTVSADSERVKAPKRNRRRFSKIAVWL
GGLMVVIAGIAFFVTAHWVRGLDISKLENPLPEPTLIMDRNGKPASQLSSSRIVPVSLDQ
IPLDLRNAVIAVEDRRFYEHSGIDLWSTARALLRDLKSGEMKEGGSTLTQQLAKNMFLAS
DKTLSRKLKEAGYALKINTVYSKDEILELYLNSIYFGEGRWGVEGAAQEYFAKPVQELKL
EEAALLAGLPKAPTTYSPAKNMQKALERRNLVLSLMKEQNFITEAAYEKAVAQPIVLKQH
NEESLKGKYPSYVDYVIQEAADVYGFTEEQVLTNGLRIYTDLDPQVQQAAQDVYASDALF
PESKPDQLIQSGAVIIDHKTGGIRALVGTRGPQVYRGFNHATQLKRQPGSSFKPLAVYGP
ALERGYTPSSSLYDGDLDIAGYRPKDWDGQTRGQVTLREAIMRSWNIPAVWLLNEIGIDA
GIDFARRAGIALGPADRSLSIALGGLSEGVSPLQMAQAFGAIANLGVRHQAHAIVKVTTK
EGYPLVEAQPQPAAVTKPAIAYSLTLLLQDAVKSGTGQAAALGRPTAGKTGTTQLPDTKE
FADIGANGIKDAWFVGFTPELTAAVWIGYDQTDKNHYLTTGGAVPAAVFKEIMSRALRDV
SASSFSVPDDYVPEPEPTSTWLQSIQEKLGIGKPAANAEQSKNKDNENGKTKGKGKPKEH
>AIA15031.1|FEATURES|farme|quinolone|DNA_gyraseA_C|antibiotic target alteration|0
MIAARLSSGKDYIFLGSHAGQSIRFSEDKVRPMGRPARGVRGMDLDDKDYIVGAEVIGEE
GLVLSISENGFGKRTAVGDYRLTNRGGKGVINMKTTSKTGKVVGILSVKEDSELMIVTRD
GKMIRIDSGEIRQVGRSTQGVRLVRMEENDQVAAACLIPEADDKNGDDGQTNLTLQ
>AIA15019.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
DLGEVLTLCKPAPAARPVQDETADRGLRALISRPAPPPGRAFDNLYFVGGDWSSAWAIDT
PEGIILLDALNNQAEAAALIEGGMRKLGLDPARIRYIVVSHGHGDHYGGAPYLAQKYGAR
VVMSDIDWTMMETRLEFATPIWGAPPKRDISVKDGDKLTLGGTSLTLYVTPGHTWGTLSP
VFDVSWQGRKHRVLLWGGTGFNFGADIPRMEAYGRSTQRMAQVARAEGIDVMLSNHSRVD
GSQGKLARLRDAGGTQNPFVIGESTVERTLTVMNECSLAQR
>AIA14960.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIVLVVAVADNGVIGKEGKIPWHISEDLKRFKALTLGHTVVMGRKTWDSLPRKPLPGR
VNVVVTRQKDWQADGAVTASSLGQATCGTSGTVMVIGGAEIYERALPLASRIELTEVHRA
FEGDARFDLDRSGWTETARERHVTPDGLRYSYVTLVRS
>AIA14879.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MMEIVLLVAVADNGVIGAHGTIPWRLKSDQQRFKTMTMGKPIVMGRKTFVSLRRPLPGRT
NIVITRDINYTAPGAVVTRSFADARAVATGDALRRLATEIAVIGGAEIYAQSLPFADRLE
ITEVHVSPDGDTRFPAIDPADWEEVARVRHPAGPDDSADYSYVTYRRRKPH
>AIA14822.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MDVRLIAAIGRQGQLGLNGDMPWGRGHPEDLKRFRELTTGGIVVTGHRTFETVKHLDNTH
GRRFIRDFASLSPVRYLADVVSEFGDDRVIWIAGGAKTYARFAPWVNEFVIRTVPYTGPA
DVFLPPLWSTK
>AIA14823.1|FEATURES|farme|trimethoprim|Thymidylat_synt|antibiotic target alteration|0
MKAYLDLLHDVMINGVVKNDRTGTGTRSVFGRQLRFKLADGFPLLTTKKLHTRSIFAELL
WMIAGDTNNNTLRDQGVTIWDEWAKDDGSLGPIYGEQWRAWKGGYAGYHDAVMGKRERID
QLSQALDLLR
>AIA14820.1|FEATURES|farme|beta_lactam|OXA-129|antibiotic inactivation|1
MRKSVFISLLFLPLVGQAATTPMLSEEPSWQRYYEEAGVKGVFLLCDADASHCYTNDKAR
AETPFIPASTYKIPNLLIALETGVIKDPDQIFRWNGEPRRLKQWENDFTLRGAVQNSVVP
IFQQFARDIGERRMSSYLHKFHYGNEAVEGGIDHFWLDGALRISATQQVQFLQRLNLGQL
PASKINQLRVKDILISDATPDYVIHGKTGYSLGAPGYGDRNAPGVAWWVGWIEKGTATWY
FAGNIDVARDTDVAARKSIPLKILQGRGILP
>AIA14801.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MMDRKVPGKIAVLMGGPGSERKVSLATARGVAKALRSLGAGVTEVDVKDENFEMPADAEL
GFITIHGTFGEDGQIQKILEKRGIAYTGENVLGSEVAFDKIRSKEKFREHGVTTPEWEVI
QPGQRPTIPLPIVVKPPREGSTVGVAIVKTEDHLDFAIAEAAKYGRDLLVEKFVPGRELT
IGILGDQALPILGNNSKGRFLRF
>AIA14776.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MPISAIVAMAENRVIGKNNQLPWRLPADLRHFKALTMGKPILMGRKTHESIGRVLPGRQN
IITTRNTAFQVPEALVVHSLEAALKTLPETEEVMLIGGAELYRELFPKVQRIYMTLVHAE
VEGDSYFPELKPSEWQQISCEDHEADQDNAYPYSFLVWERL
>AIA14758.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
YIDRQGKWWLLEMLGNVIDTHGAPQLAPVLGSGSFVTIPNNRVIKPDVILPILHGKNGED
GSVQGLAQLLHIPIVGCDMTASAICMDKIATKEILMTHHIPVVPYVTHRVNGPTLDFNHL
SMKLGSPMFVKPARAGSSVGVSKIYSEEELTKALEVAHQHDDVVLIERGIVARELEVAAL
GNPPHYKISGVGEIKPGEDFYSY
>AIA14749.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MISLRGASKSFGTTEVLRDLDLTVERGSVFALLGPNGAGKTTLINILSTLVSPDSGTATV
AGFDVVTQREQVKRVISVTGQSAAVDEVLTGEENLRMMGRLSGLSAAESARRATELLERF
DLVDAARKRVKTYSGGMRRRLDLGISLLLTPPVVFLDEPTNRPRHPQPTGPVGCHPLARR
ERDDDPAHHPVPRGGGPARRPHRGARARADRRGGHSRRAQGPRGR
>AIA14716.1|FEATURES|farme|beta_lactam|AS202_10895|antibiotic inactivation|1
MRPFLQCLLLCLLLPLLSAAAPADIFSGYSGTVILYDLQTKQYSGLNQAQWDVGALPAST
FKIPNSLIGLESGVIPNIDFVIPWDRVKRPIEAWNQDHTLKSAFAVSCVPYYQELARRVG
FARMQDLVGKLDYGSMDVRAGNL
>AIA14709.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSNKILVLQGGTSDEREVSLRSAANVIGWLEKDGYNVVVADPASADFNLADLSAHCDVVL
PLLHGEGGEDGYLQGQLQELQKPFLGSDSGACELTFNKALYREFVIKQKIQMPQGVVVDR
AQFDTAALRQAPYVLKPIDGGSSVDNVILPDLSKEPDSSYFDELFNRHREMLLEQLIGGQ
ELTVGILRNKALPVIHIVPPENEEFDYENKYNGRSQEIVNPPDIPHEKQREAQNLALKLH
VLTGCRHISRSDFILAEDGTLYTLETNTIPGMTEQSLFPKMAAADGVGMAALVRSFVEMA
EGL
>AIA14704.1|FEATURES|farme|beta_lactam|bla|antibiotic inactivation|1
MRPFLQCLLLCLLLPLLSAAAPADIFSGYSGTVILYDLQTKQYSGLNQAQWDVGALPAST
FKIPNSLIGLESGVIPNIDFVIPWDRVKRPIEAWNQDHTLKSAFAVSCVPYYQELARRVG
FARMQDLVGKLDYGSMDVRAGNLDEFWLRGYSRITPRQQLQFLTRLIERKLPFSQRSQDL
VESIMLRESKPAYQYFGKSGWAFEGKHETGWFVGFVRRGPKAWAFASRLEADSPDAAKSG
PASEAAAKSWLRGQGLID
>AIA14688.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
FEAAGVTTPRWQVIGANEKPTLPVPLVIKAPRQGSTVGVYIIKEAGKLETALAEARKFDR
QLLVEEFVPGRELTIGILGDQALPILEIIPKGGFYDFTNKYPFLNPQAGGGAEHVCPAKI
EAKLTRKIQDLALRAYRSIGLQVYARVDVLLPENAEPSVLEVNTIPGMTEASLLPEAAAA
AGIKYDELCLRIIELSCARWEGAK
>AIA14682.1|FEATURES|farme|beta_lactam|UB46_32240|antibiotic inactivation|1
GVVLLDTATGKRAGHRMDGRFPMCSTFKVLAASAILHNVDAGKESLERRVYFNETDLVTY
SPETKKHVGPSGDDTPVTKLDLAEYMEAVGDWLIGHIRGRPCSILRAPDGIGGETFFQRH
AMPGMSDLVEMAKVSGDKKPYLQIDRIEGLIAVAQIGGLELHPWNCAPGQYDVPGRLVFD
LDPAPDVEFSEVIATAREMKDRLEALGLETFCKTTGGKGLHVVTPLSTAKKDSVSWKEAK
AFAQVVCQQMAEDAPERYLVNMSKKLRDGKIFLDYLRNDTKSTAVAPLSPRARPGATVSM
PVTWPQVKAGLDPKRYTVRTAPALLKKSKAWAGYDKAAHSLKAAIGKLVG
>AIA14675.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVKLEFDQRPKAVLALNDSLIMIKRSGTHIIRNTDQLLGTFFQPIMFLVLFASVFGGAI
SKALPEGVSYLNFLMAGIIVQTAAFGSTTTALAVCNDLQKGIVDRFRSLPMSTLAVLNGH
VVSDLFRNSISTIVMILAGLVIGFRPHASVTEWLLLASILLLFTLAFSWMSAILGILAKS
VEGVQWLGFVLVFPLTFASTAFVPSEGMNSVLKAFAVNQPITHIVEALRALILGKPLGDH
GWLAIVWSVAILVIAVPLATIMFKRKTAN
>AIA14641.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MPDIKFIAAIDDKRGIAKAGKIPWDVPSDRKYFREHVKPGPVVMGWNTFESNGQKPYGDG
KNTVITRRDESAPGVAVVHDLEAFFKNLDEDIWVAGGGQVFTAALPYATTLYVTRVKGDY
NCDVFFPEFENDFVLSHEEPAQVENGVQYQYQVWQRKN
>AIA14634.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
EALLKHARPFEDAFKPGTPGIGPIEQALDQARAQDRVLVLGLHGGSAENGELQAMCEMRG
IPFTGSGSACSHLAFDKIAAKRFAEIAGVKGPPGVALHDIEGALAQHGRLIAKPIRDGSS
YGLLFVNSTQDLVAVRLAAKTEDYLIEPFIAGTEATCGVLEQLDGSLIALPPIEIIPAEG
PFDYVAKYLAKATQEICPGRFTPEISRQLMEQSLKAHRALSCGGYSRSDFIITDKGPVYL
ETNTLPGLTKASLYPKALKAQGIDFADFLKDQITLAARRARK
>AIA14633.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKIDPQAFGKVAVLLGGTSAEREVSLQSGALVLAALRARGVDAFAFDPAERSIFALKEE
RVERVFNVMHGGYGENGALQGALDLLGIRYPGAGVLGSALCMDKVRSKLIWQQIGIPTPA
FEVVMRVDDYAVRASEIMAKLGFPLFVKPASEGSSVATARVTSPTSLVAAIAEAARYDSA
VLVEQSIESGSEYTLALVDGLDLPTIRIVPAGEFYDYHAKYVADDTQYFIPCGLPAQVEQ
QIKVLAA
>AIA14628.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGILFLFQAFTLVIIDVFNYNHNEMASFDVTYRSLLKDIMDKGVREANSRTGHETASLPG
MSFSIDIESEGFPLLASRKIPLKLFIAEQIWFISGTRKPEIFLRNYTKIWDDFTNPGDVV
TVAYGYRWRKHFGRDQLGSLISMLEKDKSSRHGVVITWDPIGGRLNLMNVVRSNDMMLGF
PHDVAGFALLQAILAQRLNVKPGIYTHVIANAHIYDIHYEAARQIIKRPVGSAPIRLTLP
EGSFKRAEDKDDNLVDEIYQNLAAEYEPGEAIKGLKIVL
>AIA14539.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
ALVATLSLFAPAMAGQPAAWSQPTKPFQILDNIYYVGTKGLASYLIVSNGKAILLDGTLA
ENAGYIEANIKALGFRLEDVKIILNSHAHYDHAAGIAKLRQDTGAQVMAMEEDRSALEHG
KQEGDTN
>AIA14521.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
PEPFYANYNGFAIQADVVVKPISSTIQSGFALPPIEDFEKAITPKTKAIVVCNPNNPTGY
LYSAEEMETLKQIVLKHNLYLFADEAYREFCYEGKHTSAMHLKGAEQHVVLMDTISKRYS
ACGGRIGAFITKNKQVFDAAMKFAQARLSPPFYAQVLGEAAVDLPDNYFDTTKAEYKLRR
DTIVKRLNAMPGVFCPNPGGAFYAMAQLPVKDSDAFCQWLLEEFSYEGQTVMLAPATGFY
STPGLGRNEVRLAYVLNVESINSAMDCLERALEVYPDKIVKLAEAQAGG
>AIA14450.1|FEATURES|farme|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MDTLAIARNQAFNQLAEAAVRQYCKTVHEITYIEHGADNLIILVNHEFVFRFPRDDGASR
RLFFETALLQKLAGKVTTVTIPSVVQVHHQPLFVVAPYTEGVHLDGRQIQSLSQEEQTAV
GETIAQFVVELNQAISGAEVSQLRQQAGVVHADGAWEPYFERLFALQPLPNAKLQPLVNE
FYPLWKDYLKHQDRTLAIHDDLHPVNLLFMGPRLTGVLDFGDANTGGIEEELRWLYLMGD
VVLGSAIAKYQELTGKNINHDHVRVWAIMHELSSYVRGLARQETEQFPFKRAEANLKAWL
PNFPV
>AIA14429.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|0
MKVFIIAAATADGFIARNDHQHIDWTSQEDKKFFVNMTKESGVMVMGGNTYRTFRNPLPG
RRHIVYTRGEVKGEAFEKTTENPQDLIKRLKQEGYTSIAIIGGSSIYSMFLDAGAVTDIY
LTIEPLLFGEGVKLFDSTLDTKLELKSSKNLNDDTILFHYKVKDGNTD
>AIA14408.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|0
MFGAAALVLTAFVANQRRTERLTQSSLLPMHLFANRGFSAGIVTQAAFSAAMAGFVLALV
IYVQSGLGFSAIHSGLVLLPFSLGAFIGVGVSAPLGLKLGKVIPFAGAICQAAGIWWLAR
VVADQRSGFGAWDATPPMLLAGTGLGLLVVPLIDIALSTVSTDDAGAASGTYSTFQQLGS
ALGIAIIGAVFFHVVGDNFTEVGLRDGFTQASWWAVGGYLLSAAATLVPARPQRSAAARA
>AIA14369.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|1
AKTGEALHRNGECDKAFAPQSSFKLPLAIMGYDAGILTNETTPRWDYKAEWKRPKREQQP
TDPTIWERDSIVWYSQEITRRLGKEKFADYVRRFDYGNADVRGVKGQTDGLTESWLMSSL
KISPDGQVDFLRRFLSRKLWVSQVAYDKTMAIIPKFPAADGWQVQGKTGSGRMRTKAGKY
DGDSWLGWFVGWADKGDRRVVFATLNIQDWKNDEPISFATRDTLIADLPKLVK
>AIA14340.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
ATLSLFAPAMAGQPAAWSQPTKPFQILDNIYYVGTKGLASYLIVSNGKAILLDGTLAENA
GYIEANIKALGFRLEDVKIILNSHAHYDHAAGIAKLRQDTGAQVMAMEEDRSALEHGKQE
GDTNYGGARFPAVKVDRALHDGDVVALGDVRMTAVLTPGHTKGCTTWTVMSADNGAPRQV
VFPCSITVAGNILVGNKSYPGIVEDFRDSFERLGSMEADVVLTAHPEFADVFQRKARRDA
GDKDAFVDKDLLHRMVEKARTAFDRNLKAAQE
>AIA14339.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
TQAFLTGPITKQLGDRGAIIFGVVADSVAFVAIGLATAGWMPFVLAPLFALGSVGHPALQ
SLMSAQVGESRQGELQGVLASAASLTSIAGPLLATTVYFWTKPYFIGTVWLVAAALYLLA
IPVLIWVAARGRTAAAAA
>AIA14316.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MKVFMIAAMSADGYIGRDSNHLADWTGNEDKKVFVRLTKAAGVMVMGARTFGTIGRALPG
RRTIVYTRHPESIRAEGIEATAEPPAELLERLKREGANGVAICGGAATYDLFLQAGLIEE
IYLTVEPVLFGSGVRLFNNPIEVPLKLLETTALSDNVLLLHYHVASV
>AIA14309.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVFIIAAVTVDGFIGRSSDHLADWTGGEDKKIFVKLTKEAGVIVMGSRTFATIGRALPG
RRNIVYTNTPERITAEGVETTHESPGELIDRLAAEGHTAMAICGGTTVYNLFMDSGRVTE
LYLTFVPMAFGEGLRLFTTEQATHLTLVDSSVLADGGLLAHYELAR
>AIA14305.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MKAKVAFIFVTIMLDMIGIGLVIPTLPDIMRRFTSDPALVSTYFGYFISVYAAMQFIASP
LLGALSDRYGRRPILLVSLLAAAADYVLMAFAPTLPILFIGRIFSGITGANITVAMAYIA
DVSDDSNRSANFGLVGAAFGLGFIIGPAIGGLLGHYGPEVPFLVAAGINFLNFLFGVFVL
PESLAQSRRIDWKRTNPFLSLASAFKAKHIIALVAVHFFFQLAGQTHFSIWTLYTEHRYG
WNSQDVGLSLAYVGLLSALSQAVLTRILIPKIGEYRAVVWSCLGFTVEFLLLAFSNQGWM
MYAIFGAFCVFWISGPGLQSLITKEIPPEMQGELQGSLVSLTSLASIITPLVMTQTFAFF
SRPGADPYLPGAPYFLGALICFGAWVLMLFAPKPGEKKA
>AIA14264.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MESDVQIRIASPDESDTIAAVIREAFAGFESFYTPEAFAATTPNAEKIRERFDEEGTIWA
ALKDKEIVGTVSAIVKGEKVYIRSMAVSPTAQGLGIGRKLLETVEKFAIENGSESLFLYT
TPFLPGAIWLYEQSGFERGDIETDGFFGTFWFAMEKD
>AIA14263.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VAMGENRAIGRGGRLPWHLRSDMRYFREITMGKPVIMGRRTFRSLPRVLDGRLNIVLTRD
RGFVAPDAIMAHSLEEGLAAARASAKRTRAEEIMIIGGEDVFREVLPQAGRIYLTEVHAS
PDADTWFPALDMSTWREVSREAHAAGPKDDHPYSFIVLERKKEISS
>AIA14252.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MRHHASTRERLPILEGFYATTLASLGPVRSVLDLACGLNPLALPWMPLAPDARYYACDIY
ADMIAFLNSFFAQAGIRGQARVCDLVASAPDEQVDLALVLKALPPLDQQAKHAGRNLLRA
LNARHILVSFPAHSLGGRGKGMAENYEQRFRALADAEGWSIERFVFPTELAFLVRKD
>AIA14194.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSGFAIIVAADEQRGIGKDNTPPWRLPGDMAFYKRTTISAPENKQNALIMGRRTFESIPK
KFRPLPQRLNIVLTRDGSYVPEGGALRASSLDEALALVAARDDVGQTFVIGGGQLFDEAL
QRHDCERIIITRVHATFDCDTFLVPFEQAFELKHSDGPHQDEAASYTFETYERRS
>AIA14145.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTILFGGTNKERLVSVATAQALCEALPDADLWFWHVADTVHEVSRAQLVEHKRPFEDEFQ
PESRGLPLAQALDRAKADGRVLVLGLHGGRAENGELQIMCEVRGVPFTGSGSASSHLAFD
ETAAKRFAAFGGVASPAGIDLNNLDEAFAEYGKLIAKPVRDGSSYGLIYVVAKQDLVAVR
NAAKAEEYLIEPFISGTEATCGVLEQSNGKVFTLPPIEIVAAEGRFDYTAKYLLKSTQEI
CPGRFSPEVTAQLQDLAVKAHRALSCSGYSRSDFIISAKGPVYLETNTLPGLTKASLYPK
MLKAQGIEFTDFLHDQIALAIKHTQR
>AIA14107.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MSVELQFERKPKFILALRDSAIAIRRSSTHIIRNTDQLLGAFFQPIMFLLLFSAVFGGAI
SQTLGGTSYLNFLMAGIIVQTVAFGSTTTAIAICNDLQKGIVDRFRSLPMSNLAVLNGHV
VSDLLRNFISTLVMILAGLAIGFRSHASVTDWLMITGILALFTLAFSWLAAIVGVIAKSV
EGVQWLTFVFVFPLTFASSAFVQTSSMNKVLRAFAENQPITHVVEAVRALMLDKPIGNHG
WLAVIWSLGILIVAVPTATYLFRKKSS
>AIA14017.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLTIRQAVPGDEQVVLDYVCKLADYESLRHEVAATVGDIRESLFGATPRAYCDLAFWKG
EPAGFALWFYNYSTFRGRAGIYLEDLFVDDAMRGKGIGKALLKHLAQRCVKDGLPRLQWW
VLDWNAPSIEFYKSLGAVPQDEWTVFRVSGDALDKLAAQ
>AIA13984.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
SASGCSPSSSQTSDVGSQPAEASTPQAEGTTKTSALQNQIKEIAAEAKGKVGVTAVVLES
GETVASLNPQEHFPMQSVYKLPISMAVMKAVDAGKVKLTDKVTISKSEFVGRAAHSPIRD
QHPNGASLTVEELLRYALSESDGTASDVLMKLAGGPAAVQALTELSIKDLIVLDTEQTFT
QDKTAQYRNWATPEAAVALLRALHESRGVSESSQSLLLKFMTESTPGAKRLKGMLPAGTP
VAHKTGTSGTDKGVTAATNDIGIITLKNGKHVAIAVFVSDSPADQVTREGVIAKIAKAVY
DTVSGGR
>AIA13942.1|FEATURES|farme|trimethoprim|dfrA14|antibiotic target replacement|0
MKVFIIAAMTADGHIGQARDHLATTWTNPEDKYLFKHFVKEANNMVMGLKTFLTTANITP
TVFNKSMPGRRLLVYTHRPEAVAAYENVEVVTESPQELVARLEREGLGSVVVCGGSEVYT
MFMQSGVVTDLYIDMQATLFGEGVPLFNAPIDAVISLKEIKRLGDNNVLLHYQVAK
>AIA13907.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MAPIRVALVVAVSRNGVIGRDGTLPWRLKSDVRFFKTITMGKPLVMGRKTWESLPRKPLP
GRDNIVLTRHRGYEAAGATVVSDPEAALSKAQMFARRAKADEIAVIGGGEIYQLFLPMAD
RLYLTVVDLDVEGDTRFPAFDPAQWKDVGRESFGKSEGDDADFVIRTLDRRFK
>AIA13906.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
KGDFRWGDDLSYKPVKVDRVLRDNDEVELGGVTMTARLTPGHTKGSTTWMMKVNEAGKQF
DVIFAGSTSAPGYKLVDNPKYPGIVADYTYTFRLLKSLHCDVFLGPHGSFFSLLDKAGRL
KQGEQNNPFIDPKGYREFLEESEKDFLEQLEKQRQAGKTK
>AIA13897.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MIPAIKKAWFYTFCLLLLTLGCTSVNSSNREDTPNNETSAPSGITISNADRTNELRDRIE
QISQAARGRVGVTATVLETGESVTLNGDRQFPMQSVYKFPIAMAVLAQVDQGKLKLDRKV
RVETSDVLQGSRILDEKSQGMEFSLAELLKYMVSESDGTSCNVLLRQVGEPRIVTEYLRS
LGINDIVVANTEKELAQDPAVKYRNYATPDATVVLLRAFHEGKGLSKSSQALLLQLMTET
TTGPQRIKGLLPDGTVVAHKTGTSSTVNGVTAATNDVGLVTLPNGRHMAIAVFVSDSGAN
NATREGVIAKVTKAAWDEWSK
>AIA13890.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIVVGRKTFESIGRPLPGREMIVVTRNES
FAPEGCFIARSVEDAIQFAKERGESELFICGGAEIYAQTLDRADRIYLTLVHADCGADTF
FPAYNGDQWVERESEHHAADEKNQHAFTFKLLVKKAS
>AIA13848.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DTPDTNQSIGWAPGQLGPIYGKQWRHWRATMSRPDGTLDSPGFDQITNLVEGIKSAPHSK
RLFVSSYDPQDAKDCFVTTCHGTFFVSVFDDRLNLHQIQRSGDVPVGIPYNIASYSLLIY
MLAQVTGLQPGTLYHTISDAHVYGNQVPAMRSLLEREPLPYPSVRINPDVKDIFAFTVED
FELVGYEHQGPLDVPVAV
>AIA13826.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKIMLLAAVTLDGKIARNELHFVDWTSKEDKKLFFDTSKRAGVLILGNNTYKTLPVPLPG
RLHIVLTRTPQEKESMPGAVEYTDGSPGEIVADLEARGYTEAVLTGGAQINALFLKSGLV
DEVWLTVEPLLFGVGIDLFRGVE
>AIA13817.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
MKKHFLRFTWCLFCFILFSSCAPAQNTPPKEENKREADLLELVKLDKTIKLDIRYARTDN
FVGKVVYPEARAFLQRPAAEAVVRVNQKLKEKGLGLMIFDGYRPWAITKLFWEVTPDDKR
KFVANPANGSKHNRGCAVDLSIYDLQTGKLVEMPSDFDEFTERASPDYMGGTEKERANRD
LLRKSMEAEGFTVNANEWWHFDYKDWQSYAIYDIPFSAIGDLKTRFSEAKIEEHSDWKRF
FDAAKAKGGIVIYDLRENKYMVYDRERMNRGFVPASTSKIIHSLIFLDSGAVKDENEIIK
WDGVKRWVPEWNQDHSLKTALKASAAWFYVEASKRAGRETMQKYYDAAGYGNRSTEGFGE
DYWVKGKLRITPRQQIEFLVKFYENRLPFSPKVPALVKDLLVYEKTDKYIIRGKTGWSQD
FDPWVGWWIGYVERGSDIYFFATELDMKKNEDAQKRYEITKRVLRSLKVIE
>AIA13797.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISMIVAQSDNRVIGNGGDQPFYLPADLKRFRELTTGHTVVMGRRTFEAIMNRLGKPLPD
RTNIVISRTLEPGEGYTVVRSLKEAMDNLAMDSEAFIIGGATVYEQALPMTDRLYMTRVD
ANLPGDTFFPELDSKEWKLKSDERHESDDKNPYDYNYLTYERKR
>AIA13746.1|FEATURES|farme|beta_lactam|OCH-7|antibiotic inactivation|1
DVPASKQRDYAQGYAKDDTPIRMKGGVLSSEAYGVRSTAADMTRFLQINMKMVRIDPAFQ
RAVDATHTGYFQAGPMTQDLIWEQYPYPAALQSLLDGNASAMILNATPVTRIDPPQAPRD
DVWINKTGSTNGFGTYIAFVPKERIGVVMLANRNIPNEDRVKAAYAIITSLAGGQ
>AIA13665.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
RTAPAHQSRGGRVILSLLVAMDEKRGIGKAGGLPWRLSSDLKRFRTLTMGHHIIVGRKTF
DSIGKPLPGRQTIIVTRNADFHHEGCFIARSVDDAIQLARARGESEAFICGGAEIYAQAM
SAADRMYLTLVHADANADTFFPEWSREQWIERESQSHAADEKNQYPFTFKLLVKQPTD
>AIA13658.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
CLSEIRRLKTETRIHGQKPKPEDPKTSMIIGIAAVSQNNAIGKGGKLPWHYSADMKFFRE
TTTGHAVVMGRKTWLTLGKPLKNRLNIVLTRDSSIEPQESLLVLNDVDSVLSFSKSLTTD
LFVIGGAQVYREFLPFIERWLITEVPLIVKGADAFMPEGFLDDFEAKSKKKLDVDLKVVT
YDRA
>AIA13652.1|FEATURES|farme|chloramphenicol|catA15|antibiotic inactivation|1
MNFNPIDMDNWSRKPYFEHYLNNVRCSYSITANIDISRLLKELKRQGIKLYPALIHMITT
VVNRHSEFRTCFNSDGTLGYWDSLSPSFTIFHDDDKTFSSIWTLYGEDFIGFYSRYLDDM
KKYGSVKQFAAKTNEPPNTFPISSIPWVSFTGFNLNIFNEGTYLLPIFTMGKYFQQEEKI
LLPLSGQFHHAVCDGYHAGMLYNELQLLADACTEWLPN
>AIA13643.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MKHDDYSIVVQDLRKSFGKLDVLKGINLTVKRGTILAVLGPNGAGKTTTVRILTTLLEAD
SGIATIEGYDVAKQADEVRSVIGLTGQNAAVDEFLTARENLLMMGRLYHLSKKDSQMRAE
QLLEQFGLVEAADRVAKTYSGGMRRRLDLAASLIATPPVLFLDEPTTGLDPRSRLAMWDI
IQKLADHGSTILLTTQYMEEADQLANRIV
>AIA13625.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MVRRFVSLCIGLSVVQGMLPGLAVVLAAPLVWNESAAQGRSVPSNWTEKVKPYQVMGNIY
YVGTLDLSSFLITSPEGHVLIDTGVEENAVAVLDNIRTLGFSVKDIRVILTTQAHYDHVG
AHARLKNESGARVLVAAGDAPLVAGGGEGDYLFGPEYHFPPTEVDATVKDGEVVKVGPIA
LTAHLTPGHTKGTTTWTATVRDSAGQDRKVVFLGSTTVNTGTKLVKNEKYPAIEADYKHA
FEVEKALPCEVFLAAHASAFGGPEKTAAAAAKGDAVFVDPQGCRAAIERSEKAFLAELEK
QRTGG
>AIA13621.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MRLRTLHLIAVLCAFALASLGFAGESQTIVAQNKMTPTSAVRAQESPLERAIKRLAESSG
GIVGVSAIHIESGRRVSMNGGTRFPMASVYKLPIALQLLNKVDRGELRLQDSITLSAHDF
RPGHSPIVEFANNKPVTLTLERLFELMLGESDNSASDALLRLAGGPAAVTNRMQALGITG
INVSRPEGELILNHRGVRELPPESEWTIALLDALSAKVTPAQRDEAAAAYADDPRDTSTP
DAMADLLVRVHRRDVLLEPASMERLLQIMTATQTGPARLKGLLPTGTIVAHKTGTMGGTT
ADVGIVTLPDGAGHMAIAVFVKASTKEVPERERVIAEIARTIYDYLVLRSQ
>AIA13604.1|FEATURES|farme|bacitracin|uppP|antibiotic efflux|0
MALTPPRQKLAGRIGALLGIILMALSLRAAVVSVPPLLGSIGPELGFTSFSTGLLAMLAP
VVFAGFGLLTPRLIRWWGLEKVLVSAVLLAVAGQLLRSMVGEVTSFLLLSAITLAGYGMG
NVVLPPLVKKYFPDRLAIVTSSYVTMLAVGTWMAPQFSVPLAELAGNWRSSIAAWALLSA
VVLVPWGIQLYRDRKRGIQLYRDRKNPRPDTPLVNGLAAAPPARINPWKSPVAWGLAIFL
AGNSAQTYVYFTWLPPYLSQQGLDTHTAGSMLALFAILGLPVSLLVPLWVPRLRHPIVAV
LLFTACWITGHLGMYLSPTEHTALWVVFAGLGQGTFAIALLMMNLRSRTTYGSGVLAGFS
QGVGYAGAAVAPLLFGIVKDATGSWSASFAMLGICLAVMFTGAVMINGPRKIEDGRDGAE
RLGELEQVK
>AIA13550.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MGEKVRVGLVYGGRSGEHEVSLQTALAVMKAFDYTKYEIKPFYIAKDGEWRAGDTLLAPP
SALDQLRLAGVDAIIGTSALMPVFGGQSENQDASIAISSVPGAVTISSVGQQVDAVEASE
DGQIDVIFPLLHGTFGEDGTIQGLFEMANIPYVGAGVLASAVGMDKITMKKVFAQEGLPQ
CVYRYFNRTQWQKDSDFYIMEIETALGYPCFVKPANLGSSVGISKARNREELIAAVDYAL
RFDRKVIVEEFVDAREIEVSVLGNDEPRASVVGEITSSSEFYDYKAKYIDGKSMMHIPAN
IPAEVSDSVREMALRAFLAIDGSGLSRVDFFMRKEDGQVFINEVNTMPGFTPYSMYPLMW
KESGVPYTELLDTLIALAIERHAEKQ
>AIA13525.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MHTRNHLPNPTRALALATFLLVLAALASGQNGAPVSSCANCPEWNKPQKPFRVYGNTYYV
GPHGLSSILITSRAGHILIDGALPESVPQVVANIRSLGFRVEDVKLVVNSHVHFDHGGGI
AELQRLSGAEVAASPWSAEVLTKSGVGKGDPQFGSIPPVALVPRATTLGPSPPQAFGGVA
RKLVRPNPCRRSARQRGRA
>AIA13521.1|FEATURES|farme|multidrug|MexF|antibiotic inactivation|1
MSYINKILVIGAGIAGPAVCYWLKRFGFTPILIERSANLRKGGHALDVRGVAIDLVKRMG
IYEKICTMRTQVEFGRYVDAQGNIVHEEEGERFCFRQGEDVEIVRGDLVEILIDAIEGVP
C
>AIA13436.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MVISLIAAVAQNRVIGKNNDLPWHLPDDMKYFMQTTKGHHCIMGRKNYDSIPEKFKPLPN
RTNIVVTRQEEFKAPGCIVTHSVEEGIEIAVANGEPETFIIGGADIYRLGLIYGTRLYLT
EINSMIAGDIFFPEFDKSEWRESSRKHHEADDRHLYSFDFVVYDKIK
>AIA13398.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MIPAIKKAWFYTFCLLLLTLGCTSVNSSNREDTPNNETSAPSGITISNADRTNELRDRIE
QISQAARGRVGVTATVLETGESVTLNGDRQFPMQSVYKFPIGMAVLAQVDRGKLKLDQKI
RVEARDFVSDLQHSPIRDENPQGLELSLAELLKYMVSESDGTACDVLLKLVGGPEVVTQY
LRDLGVNGIVVANTEKEIGQDKAVQYRNYASPNAAVVLLQALHEGQGLSESSQALLRKLM
TQTPTGLQRIKGLLPDGTVVAHKTGTSRTVDGVTAATNDVGLVTLPNGRHMAIAVFVSDS
GANNATREGVIAKVTKAAWDEWSK
>AIA13380.1|FEATURES|farme|multidrug|AarF|antibiotic efflux|0
MKMHRITRWGRAVYVLWTLLTFALDVALEAKGWFGRKAKREARLRQQAIRLRGRLIKLGP
TFIKMGQMLATRADLLPLDYLKELSELQDRVPPFPDSQARAILEAELGQPVENVFAELSE
PPVASASLAQVYRGRLLTGEAVAVKVQRPLLEEQIRFDLDLLRGIGRWLDRHPNLL
>AIA13379.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
IDNEKYEVVPIGITKTGQWALVPGPQNLIDTEQPKPLEVNDDNDKPGVLVRGQAATLTEA
VDPLKVLSSVDVVFPVLHGPYGEDGTIQGMLKVANIPFVGPSVLGSAVAMDKDVMKRLFK
ASGVPTPKLLVFHKADEDSIQFSKISAELGTLVFVKPANLGSSVGVSKVTNEEQLKRAVD
EAFKYDTKILIEEGIDGREIECSVLGNENPIASVPGEIVVHADFYSYDAKYLNETSSSLI
IPAELSP
>AIA13374.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNKKNYAAIYAVSENDVIGHENSLPWDLQKADLSNFMTLTKSPDRNGNPPVLICGGRTLE
SLGYKPLKNRLNIVMTTNPDKDELNEFKEAGGLAFTNKQDLLAYLDTIPNEEIFIIGGRD
MWVMFWKEIGIVYKTEIRARVKGAILFPPTLSLESFTEILSKAKNWPVDEKNQFPSTFRV
YKRPGHYTLEQRLVMEKITLPAPVSSDDMGGYLGDVHESIAEEERLILAKLQPLELTYDD
LLQYKGVKKEETQSTT
>AIA13318.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
DVKLIVNSHVHFDHGGGIAELQRLSGAEVAASPWSVEVLTKTGVGKADPQFGSVLPVALI
QRATTLRDGQTLRIGDIKLTAHFTPGHTPGGTSWTWESCEGKRCLSLVYADSMTPVSSDG
FRFTDSREYPTAVQDFEKSFSFLRATPCDILLTSHPDASGLWQRLERRERGVRPDPMVSP
NACKILAGRASEQLRRRLAAEKGQ
>AIA13302.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTNEHTSQKEFIFLVALLTALVAMSIDTMLPAIGTMASEFGVSDPNKRQYIIGAFFAGMT
IGTLLSGPISDSTGRKPAIFAGLLIYVAGSLLCLFSTSFEMLLAGRALQGVGASSPRIVS
LAMVRDGQGGAAMARIMSFVM
>AIA13299.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MGRKTYESIGKPLPGRKNIVITRNEDWQNEAIEVVHSTDEAVAIAKESDIKEIFVIGGAE
IFKSVLPQANRIYLTRIHHQFEGDVFFPELAKDEWNLVNQKACAADEKNAYPHTFQVWER
K
>AIA13292.1|FEATURES|farme|aminoglycoside|PlsC|antibiotic inactivation|0
MICPNHQSYLDPFPVCSIYPRKVLQNIFHVGASMYFANFAMAHLAQLINVVPVDPDANLL
RAMRAGAAGLRAGKILNIYPEGERSFDGRLHEFKKGAAILATELSVPVVPVALDGVYRIW
PRKSWRVRLAKVKISFGEPIDVTTLADGMDKEALYEVITATLKERIQRMLDEMRRSR
>AIA13290.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MVLVTFLFLLAALASGQSGAPAPSCANCAEWNKRQEPFKIYGNTYYVGPHGLSSILITSK
AGHVLIDGALPESVPQVVANIRSLGFRVEDVKLVVNSHVHFDHGGGIAELQRLSGAEVAA
SPWSAEVLTKSGVGKGDPQFGSIPPVALVPRATTLRDGRTLRVGDIKLTAHFTPGHTPGG
TSWTWKTCEGKRCLNLVYSDSMTPVSSDGFRFSDSREYPTAVQDFEKSFAFLRSTPCDIL
LTSHPDASGLWERLEGRQKGVRPDPFVAPNACKDLAGRASEQLRRRLESEKGR
>AIA13258.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MDSSTTTSAARLRGMGKAEFIAMMAMLMAINALAIDIMLPGLQQIGASLGVASENHRQYV
ISAYLMGFAVSQLFYGPISDRFGRRVPMFVGLVVYIGSALACVFVPTFTSLLLFRLLQGI
GSAATRVITISIVRDVYGGRSMAEVMSLIMMVFMIVPVIAPGTGQTVMLFGNWHLIFIFM
AAIASAVLVWVYLRLPETLDP
>AIA13229.1|FEATURES|farme|beta_lactam|VEB-3|antibiotic inactivation|1
MNKQILLTLLLVSGSVLPGCVQSPDPSRESVAICLQQRFAIAASTHTMDSVKSEADGRLG
KAQVVAAQPNTTRLQERLNNLDLSSAQGDVGIGVLDLDTGERWFRNGKQRFPMQSVFKLP
VGIVVLKLVDEGKLSLNQTVTITREQFVPAWSPILKEIKGDRGQFTVQYLLQRAVGDSDN
TAADALVRLVGGTEQVTANLGRMNLRDIRVDRLEQQLQPDTVGLTNFRPELVDKQKYEEA
VQQIPDAVKKAAMERYLTDPRDTATPEGMIDLLVKLQSRQLLSENSTALLLKIMTDSPTG
QKRLKAGLPPGWSIAHKTGTGEDVVGIGIATNDVGLISSPTGKHIAIAVFIAGSKAPLEQ
RESVMSAVASAVVQAMQ
>AIA13222.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTKSLPLSLIAALGENRVIGVDNSMPWHLPGDFKYFKATTLGKPIIMGRKTWDSLGRPLP
GRLNIVVSRQTDLVLEGAEVYPSLEAAIVRAQAWANEQGVDEVMLIGGAQLYAQGMAQAD
RLYLTRVALSPEGDAWFPEVDLTQWTLVSNTPNPAEGDKPAYNFEVWEKA
>AIA13176.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSRIAFVVAVSRNGVIGRAGGLPWHISSDLKRFKAITMGKPLIMGRKTWESLPKKPLPGR
QNIVISRQKNYQAEGAIVVPDTASALTAAGEAEEIAVIGGGEVFTNFLAKADRIYLTEVD
LEVEGDTRFPVIDPGQWIETAREIHLRGPHDSAAFILRVLDRKM
>AIA13174.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MEKARISAIAAIGKNGELGTENQLSWRISDDLKRVKELTTGHPLIMGRKTHESIGKPLPN
RTNIVVTRDPAYVSEGCVIVHSLSEALEKAREIDGEEIFIFGGAQIFKEAMPFTERIYLT
KIDAEDPNADVFFPDYSEFTNVIEKEKRDQDGLAYEWITLEK
>AIA13160.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
NYDSLNAKFKPLPNRTNIVVTRQQNFQAPGCIIVNSVEKGIDIARENKEQEAFIIGGAEI
YKIALPVADRIYLTEIHAEVKGDTFFPSFSRAEWGEVSRQPHPSDDKHQFSFDFVVYDKI
H
>AIA13118.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MALDEQAPARGHTTGEQFVSARVNGVPPSGIRKFFDIVATMKDVISLGIGEPDFVSPEPI
LNAGIESLRAGHTAYTSNSGILQLRELLSKHLERLYNVNYDPETELLITVGVSEALLIAL
MSALEPGSEVIVPEPCFVAYQPTVIFAGGVPVPVPTYVTQDFQVTVDELEKARTPRTRAL
LLGYPNNPTGAVLERSRLEEIAAWAVKHDLLVISDEIYDRLVYGIEHTCVSSLPGMWDRT
ILLGGFSKSHAMTGWRIGYAAAPPALLAAMRKVHQYIIMSAPTTGQEAAIEALISGEPYV
ESMREEYDRRRRLIVDGFNRLGLKCFEPRGAFYAFPSIESTGLTDEEFSERLLMEEKVAV
VPGSAFGKSGTGHVRASYATSYERIAEALVRIERFIDKLK
>AIA13101.1|FEATURES|farme|beta_lactam|OXA-247|antibiotic inactivation|1
MKSMRAVLLLLMFMAGCAGVRAQDLSPFFKDTDGAFVLYDQKNDRYTRYNETRCRERFSP
KSTFKIPNSLIGLETGVIRDADFVIAWNRQKYPPQDNWDQYPFKHWGQDHNLRSAIKYSV
VWYYRELALRVGLQRMKRHVAAFAYGNEDISGGIDNFWLNGGLRISADEQVEFLKKFYAG
RLPVSKRSTEIVKDILILEKTPEYTLSAKTGGGSIAEGTYIGWFVGYVETKGNVYFFATN
IEGASYPAIREKRIDVTKLILAELGVLPK
>AIA13087.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
MKRIFPITACALFLTLFSVVFSAAQGTYLNKKEADLIELIKLDNTIKLDIRYAASNNFVG
KPVYPEARAFLQRPAAEALLKVHKLLKKQGLGLVIFDGYRPWTITRLFWDVVTLEQRKFV
ADPEKGSKHNRGCAVDLSIYDLKTGALLDMPSGYDEFTERASPDYRGGTELQTKNRELLR
GLMEAEGFTVNPNEWWHFDYQGWENYGVYDIPFSVIGALDQDIAKAEIKENKTWKKIFDA
TGVTGGIYIYDLKKNKFTVYDRARFDTGFVPASTSKIFHSLIFLESGAVKDENEIIKWDG
VKRWVPEWNQDHSLKTALKASAAWFYVEASKRAGRETMQKYYDAAGYGNRSTEGFGEDYW
VKGKLRITPRQQIEFLVKFYENRLPFSPKVPALVKDMLVYEKTDKYTIRGKTGWSQDFDP
WVGWWIGYVERGSDIYFFATELDMKKNEDAQKRYEITKRVLRSLKVIE
>AIA13062.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
QKNDRYTRYNETRCRERFSPKSTFKIPNSLIGLETGVIRDANFVIPWNRQKYPPQDDWAD
QYPFKHWGQDHTLRSAIKYSVVWYYRELALSVGPKRMKKYVMAFKYGNQDISGRIDNFWL
GGPLRISADEQVEFLKKFYAGRLPVSKRSTEIVKDILVLEQTPDYKLSAKTGGGSIREGT
YIGWFVGYLETHGNVYFFACNIEGKSYPEIRDKRIDVTKRILAELGLLPKQGAAQ
>AIA13061.1|FEATURES|farme|beta_lactam|OXA-129|antibiotic inactivation|1
MTLALRAFVLLIAFLSMSAAEAAAQNLDRVFGNTKGAFVLYDMKSNRYVRHNPGRARLRF
TPASTFKILNSLIGLETGVVRDADFRISWDRQRYPNEDRPNTAPFIHWWQDHTLRSAIKY
SVVWYYIEIARNVGAERMQKYVRQFRYGNGDTSGGIEQFWRNSSLQISAEEQVDFLRRFY
TGKLPVSSRSTGIVKDILLLEETPSYRLSGKTGAAPFEGGTLAWFVGYLEREGNVYFFAL
NMDGANYEAIRDERINLTKRILVELGYL
>AIA13060.1|FEATURES|farme|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MKKSLFYLALFSLSASCVAADLSSQQVTSLVKAAIEPLMEQQEIPGMSVAVLYKGRAQFV
NFGVADLESRRRVTENTLFELGSVSKTFTGTLAGVMIRNGEIRLNDPVQKYWPQLTGEQW
RPVRMLHLATYTAGGLPLQLPDDVTDQASLLRFYQEWQPEAAPGTLRQYSNASIGLFGSL
MVKGDYEQAMARNVFQPLRLTRTYITVPPSMMLDYAWGYKNGQPVRVSPGMLDAEAYGVK
STARDMLTFMQANVDPNRLSSGNAVLRNAIRTAQARYFKVGTLFQGLGWEIYDWPVTADT
LMGDSDNGVALQPRPATLLNPVGPSQSASWVHKTGATNGFGAYIAFIPERNSGIVILANK
NYPNPLRIKAAWQILQALQQERPE
>AIA13040.1|FEATURES|farme|beta_lactam|Sputcn32_3157|antibiotic inactivation|1
MRLRAALLTALLLLPTLACAKTTGDGAARAAASPQTADTRAEGPKAREASPADLEPFFKQ
FPNGAFVLYDLKRDRHLRYNEARCRERFSPFSTFKIPNSLIGLDTGVITDADFLIKWDEK
KYPAHDRDILPFSAWWQDQTLRTAFRRSVVWYYRELALKVGERRMKEYVQKLRYGNEDAS
GPVNNFWLGSSLRISADEQVDFLKRLYKEELPVSK
>AIA12956.1|FEATURES|farme|aminoglycoside|PKc_like|antibiotic inactivation|0
MLKDGTTVNVILYKSEPGILDKIKAANAVSAHLAAKGFPVRHTVDSRITKMTNGSHEKYA
AVYTYLDGHTIPWEEYNQDHIKALGMTMSNMHAALADCDYLLPDVADEYLAIVARMRAYF
ADAPVQRALADKLLLAIKPEVFDGFEQLLVGSKLLPGKQPLHMDLVRSNVLFEDVEDNED
LKVRRPGGG
>AIA12951.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|0
MKVFIIAAVTTDGFIGRDENQLSLDWTSNADKVLFMQLTKRAGVVVMGSRTFATMQRTLP
ERRLIVYTSQPEKITLEGVEKTSEDPHELIERLKNEGAKGVAISGGAAIYDMFMKADLVD
EMYLTIEPVLFGSGVRLFRDSTLDHRLTLLESRHRADGSIVLHYRINK
>AIA12935.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSLLMLVFSISPILAPLTGSLVISLADWRAIFWVVTVAAVLGLVMIATMLPETRPKTLRV
ESGIGSALAGYKLLLGDWNFLALSLIGGFGIASFFVYLANSPFVLIEHFGLTPTLFSVFF
SINAVSFFTVAQFTGKLAERFGLRRVVRIAVIGYFAAIAVLFALTASGVDRLDVLAACLF
VGYGFLGLVIPTTAVLAMEEHGEIAGTASALMGTLHFLTGALAVAAIGLFADGTVLPMVT
GIATCALVTFLLAQVTLRQRQAVEVPAE
>AIA12936.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MQTRFIRNAVILGLLSAIGPFAIDMYLPALPTIGKSLNADIGAVQLSLMLFFISFGTFQL
IFGPISDMYGRKWPLYIGLVLFAIGGIGCAFAPDITTLNIFRFLQGIGACAGMVIPRAVV
RDMHTGVEAARLMSLLMLVFSISPILAPLS
>AIA12919.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MLGRVSYPFFVSQSTTEDKAMAIDEQAPAQQRATGEQFVSDRVNNVPPSGIRKFFDIVAT
MKDVISLGIGEPDFVSPEPILNAGIDSLKAGHTAYTSNSGILELRELLSKHIERLYKVHY
DAEREILVTVGVSEALLLAFMATLEPGSEVIVPEPCFVAYQPTVVFAGGVPIPVPTYVSQ
DFQVTVEDLEKARTPRTRAILLGYPNNPTGAVLERSRLEEIAAWAVKHDLLVVSDEIYDR
LVSGIDHTCVSSLPGMWERTILLGGFSKSHAMTGWRIGYVAAPPALLAAMRKIHQYIIMS
APTTGQEAAIEALKSGEPFVESMRQEYDRRRRLIVDGFNRLGLKCFEPRGAFYAFPCIES
TGLSDEEFCDRLLMEEKVAVVPGSAFGMSGTGHVRASYATAYERIEEALVRIERFLNKLK
>AIA12896.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
GPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPKDIDLAFLAIHGTFGEDGQL
QQILENRGVPYTGDGVEQSRTAFDKIESKKRFEAAGITTPRWQVIDANEKPTLPVPLVIK
APRQGSTVGVYIIKEAGKLETVLAEARKFDRQLLVEEFVPGRELTIGILGDQALPILEII
PKGGFYDFTNKYPFLNPQA
>AIA12764.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSKHIKILVIGAGIAGPATCYWLKRFGFSPVLIEKSASIRKGGQALDIRGIATNIAKEMG
IYDQICDKRTQINIGRCVDIAGNILHEEQGEKFGFRQDDEVEILRGNLIDILMNKISDIP
CYFNQHIIGVQQNDNHVTVHFNNGSVENYDIVIAADGIHSETRSLIFDKNEYQLVNLGFY
ISTFTIENYLDLNHMELECEANHRLVSINSDNNPKIANIGIMFRSQHILADIRDEHEQKQ
FLCDTFRDFGWETQNILNRVP
>AIA12692.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELLQSILDNGYEHEDRTGVGTISHFGYQTRFDLRSGFPIVTTKKIPFRWIAEELF
WFLSGDTNELNLRAKGVDIWAEWADEAHTERFGRSAGDLGPVYGYLWRSFGGHYPKFDGV
DQIKNLIDQIESNPNSRRLIVTGWDPHQADNVDLPPCHTLFQFKVEQSGLLHLQLYQRSA
DAFLGVPFNISSYALLLHMVAHVTGLKAGEFVYTLGDYHIYKNHLQQVRELLRREPLHLP
RLEIVDEGKRFRGLAGLLAITYDNLKLVGYQSHGKIAAPVAV
>AIA12640.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MKIQKLAVIALGIICPCGLGYATERENDSTTSLAELISSIQVKSGGKVAVSVRHIETNQG
GSWRHGFEEMPLYSVFKLPLAVVVLKDVEAGKLQLDQRVSVKESDVAPGIAANTDRWRNV
PLEMTVRQLLELSLIESDNTSSDKLLQLTGGPGALTKRIESLGFDKIKINVSVKEMSQNK
KHLNVATAESIVRLLSGLQQGSVLKDEQRTVLFELMGKSRTGLKRLRGLLPAGTAVLDKT
GTGPDGSAINDVGIVTLPGSGGHLAVAVLISGSKLPVEEQEHMIAEIALASYKLFTPQP
>AIA12626.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
TFESIGKPLPGRQMIIVTRSESFAPEGCFIAHSISDAISFARERGESELFVCGGAEIYAQ
MLGAADRMYLTLVHADSQADTFFPEWDKDEWIEVESEHRTADEKNQYSFTFKVLARRSQV
>AIA12616.1|FEATURES|farme|tetracenomycin|tcmA|antibiotic efflux|1
GNPWAILITLSLGFFMTLLDLTIVNIAIPSMIDALGASLDEILWVVNAYVLVLAVLLITA
GRLGDLRGQRNLFIGGVVVFTLASLACGLAPNPTLLIAFRAVQGVGAAMLMPQTMAIIIA
TFPADRRGTALGIWGAVAGLATVAGPTLGGVLVTYASWRWIFIVNVPIGVVVLAMTFAFI
PDTRIEREHKLDLLGVAIATAGLFCLTFALIEGQRYSWNGAIIALLVAAAILTVVFIFQQ
RSQQDAEPLVPFSLFHNRNFTVINVVASLVSVAILGFFLPVTIYLQSVLGYSAIKAGLIL
APMSLIALLLAPIAGKMSDRIGGKFILMTGLTLFGLGAAILTVQTSVDSNWPEFMPAIAI
MGLGMGGIWAP
>AIA12601.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MPFQFISDKELISDKFSDDPMKKALTVIYATVILDAAGIGLTLPIFPRLLQDVGHTDNLG
WRFGAFLALYALMQFIFSPVLGSLSARFGRKPVLMLSLAGAAVDYVFMALAPSLWLLFIG
RAIAGITGASNAVAAACVTDITEDAERTRRFGQLSACFGIGFIAGPAIGGVLGEFSVRLP
FIAAAVLNAANLLTALFLLPETRKIGAEAEKQEFSPLAHFRWLLGYRLLLPLAGAYFVLA
LVGEVGGTIWVLYGQDKFSWSPMMVGISLAAFGFFHAVVQAFIAGPISERWGEHRTLLIG
IIADSAAYIIIALLTEGWMAFLLMPLFCLGGIGAPALQSLVTGRVDNDHQGRAQGMLASM
TSLASIIGPLAISTIYFASRDVFPGLVWVLGAAFYVLCLPVAFTRRPKNATA
>AIA12596.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MTTTTSAVRAQQQPPLERAIKRLAESSGGIVGVSAIHIESGRRVSVNGDLRFPMASVYKL
PIALRLLQRIDRGELRLDDPITLSTHDFRPGHSPIAEFANNKPVTLPLERLLELMLGESD
NSASDLLLRLAGGPAAVTNRMQALGIMGINVSRPEGQLILNHRGVRELPPESEWTMALLD
SLSAKITPAEREAAAAAYADDPRDTSTPDAMADLLVRIHRRDVLEPASMERLLQITTATQ
TGPARLKGLLPIGTVVAHKTGTMGGTTNDVGIVTLPDGAGHLAIAVFVKASTKDVPERER
AIAELARTVYDFFVLKSRDEG
>AIA12592.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MLRRIAALALALLLTPSLPWAQTRPVSSSWTARVKPYQVMGNIYYVGTEDLSSFLVTSSE
GHVLIDTGVEQNAAAVLDNIRALKFDLKDIRIILTTQAHYDHVGAHARVKQESGARVLVA
AADAPIVSSGGEGDYLFGPEYHYPPAKVDGLVKDGDVVRLGPIALTAHLTPGHTKGATTW
TMTVKDAAGREHSAVFLGSTSVNPGTKLVNNEKYPTIEADYKRAFAVERALRCEVFLAAH
ASLFNGAEKAAAAAAGKGDAAFIDPDGCRAAIDRSQKAFDEELVKQRAAAGK
>AIA12564.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MAGPIYYVGTRGLAVYLIKTKVGLILISGGPPKTENLIADSVKKLGFNLKDIRLLLSSHA
HFDHIGTLAALKNLTGASVAIMDADVELLKSGGKTDYLYANRPELHFDGVTPDRILRDGE
TVNLGGTQLIAHRTPGHTRGCTTWEMNIAVGGRHHKVVFADGTGINPGTRFVKNPSYPGI
REDYQSTFRVLESLRPDIFLSYHAEFFGFEAKRQGMAKEGFRAWLDAEGYRASILKKREA
FEKLVRDEELPNG
>AIA12560.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKIAVALAALMSLTTAVEAQTPKDLIEALKVKWNTPTEPFRMIGNVYYVGTDGLASY
LITSPQGHILVDTVMPEATSQIKASIEKLGFKITDIKYLLNTHAHNEHTGGLAEMKRASG
GRLVAGDADKSLLEGGYYPGAEDDTALAFPPVKVDRTVREGDTVTVGDVTLTARETPGHS
PGCTSWAFSVKDGDATRSVLIFCSGTVALNRLGADPTYSGIVTDYRKTFARAKDMKVDVL
LAPHPEMYRMQDKRAMLSDAAPNPFVNPGEFNAYAATLEKAFEDALAKQTADAQEKKG
>AIA12517.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MEIVLVVAVAENGVIGAGGTIPWRLKSDMQRLKAMTMGKPIVMGRKTFESLPRGALPGRT
NIVVTRDAAWRAAGAVVTHSFTDAKAIATGDALRRFATEIAVIGGAEIYVQWMDSAD
>AIA12518.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
KLLHEMEATEADIDTALFGANPRLFCEIAEWDGEPAGFAVWFINFSTFSGRSGIYLEDLF
VRPAQRGKGVGKALLVHLAKECVANGWSRLQWSVLDWNTPSIEFYKSLGAVLMDEWTICR
VGGSDLTALAQGAR
>AIA12463.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|0
MKQPKVIAVAAISLDGKIAYDHERQIETSVEDKRYFERVTREAGTIICGRRTLDAMKRPL
EGRRNVVYTTQADLLAQEPTDELWYTDEPPEQILEKLAAQGAETVAVIGGCDIFTMYADL
TDEWHLTVCPIWVGEDGVAMGKFSRVRYSLFKRVPFNSDEELLILKS
>AIA12393.1|FEATURES|farme|beta_lactam|Shewmr7_3328|antibiotic inactivation|1
MLYDQKNDRYTRYDEARCRERFSPKSTFKIPNSLIGLETGVIRDANFVIPWNRQKYPPDG
WDEYPFIHWKQDHTLRSAIKYSVVWYYRELALRVGQKRMKKYVTAFNYGNQDISGRIDDF
WLGGQLRISADEQVEFLKKFYAGRLPVSKRSTEIVKDILVLEKTPDYTLSAKTGGGSIRE
GTYIGWFVGYVEAKGNVYFFACNIEGTSYPEIRDKRIDVTKRILAELGLLPKQGATQ
>AIA12344.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MMLSHVVACSENGVIGKDGGLPWHLPEDLKRFKALTMGHILIMGRKTFDSIGRALPGRYT
IVVSRNTTMMPRIVTPAASIDEAIQHASTLTAAWKDEVFIVGGGEIYRQTLPRVQRIYLT
KVKMNIDGDTTYPLDSLSDFELKETIEVEDSHPPFTTSILERRS
>AIA12340.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
HIIYSDTLVKRKEMWARVKRSGEPSGAHYRFQHGGSTAFTAGASNMNARKFLVRVAQLSQ
QSLHNFESKLNAKPLKAIHIGELFCQHFLSMLYSEMRHYLDMVKYVLDNGVPKINRTGVA
ALSVFSYFYRVNLQEGFPLLTTKQMYWDSMVHELFWYLSGEEHIRTLREKTKIWDAWADP
EGRLETAYGRFWRRFPVPAQGLPGERWTERWTQVDPVTGERVFDQIQYIIDSLKEIRVNP
THPSLRRLIVSAWHPANAAESKLPPCHYTFCFNVMGDKLNCHLTQRSCDIALGVPFNLAC
YSLLTMMIAQETGFKPGEFAHTLIDAHIYENHIEGMKEQLTREPGPLPTVTIEKKPFDQL
SFEDIQLHNYVAAPKIKFPVAV
>AIA12297.1|FEATURES|farme|beta_lactam|K678_12262|antibiotic target alteration|0
MIIMLNGVSSSGKSSIARALQDAWSTPLLHVGVDTFIDMLPARFCGEGQEARYGLQFVPV
QTREGPVVEIRPGSYAKRLFAGMIGAIGALARARNAIIVDEVLFGDEMLREYIRELRGQT
VYFVAIHCTQEIVEQARA
>AIA12283.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MRVIINLVVALMLPGVAGCNRAPSAAQSTTPQQASAVRSDSADIELTKLLRSLCDAVAGD
IGVAVVHVESGKIVTVAGDKKLPLYSVYKLPLAITVLREIEAGKLRLDQKVKVNPADIAG
VQFNTDLWRGTQEKTVRELIEYAIVRSDNTSADKLLGLIGGPPIVTQQMRTIGLANIDVV
VTSREFTAHRDKPNTGTTTDLAQLLARLQKGELLQPAKVSLLRDYMERSKTGGERRLRAN
LPAGTQVADKTGTGDVATNDVGLITLPENKGHLAIAVLISGSKLPVDKQEKTIADIARAA
YDSFVSQPAPR
>AIA12235.1|FEATURES|farme|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MTYRIQQVTPADLDLMNELLSVFGQAFDDEETYNGKRPGAGYMRRLLESDNFIALAALND
QKVVGGLAAYELKKFERERSEIYIYDLAVAKNHRRKGIATALIMELKKIAAARGAYVIFV
QADTGAEDEPAIELYTKLGIREDVLHFDIPVENGDE
>AIA12223.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MNVFLIAAVTADGFIAETQDHLADWTSTEDKKLFTRLTKEAGYMVMGANTYRTIGRALPE
RHTIVYTNHPEKIDNPEIETTTEAPADLITRLEKAGANGIAVCGGAQIYSLFASAGLLDE
IYLTIEPVCFGKGITLFNQDLQLNLSLLDTQQLNENAIMLHYRVARPDKPE
>AIA12158.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MMKIILMAAVTIDGKIARDEHHFVDWSSKEDKKLFYSTSRRAGVIIVGNNTYKTFPSRLP
GRLHIVLTTNVSDKVNIPGEVEFTARPPAEIVADLERRGYTEAVLTGGAQINALFLKANL
VDEIWLTVEPHIFGVGLDLFRGVVFDDHPNLLEVRQLNEGGSVLLRYALKAEGGRRKAES
E
>AIA12111.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MQEIASVTKGPVGAAAMIVETGEPVSINGGDHFPMQSVYKLPIAMAVLSRIDNKTLTFDQ
KVRVDPKDFVSRREFSIATKYPNGADISIRELLDYMISESDGTACDALMRMLGGPEVVTK
YLRDLGVQDVVLATYEQDMFKTPSVSFQNWSTPEAMIQILKLLQVGKVLSEERRDILLSL
MIKSRPGPQRIKGLLPAGTTVAHKTGTSATIKGVTTATNDVGLITLPSGQHLAIAVFVSN
TTADQKTREAVIAKIARAATDCWVEPSRAELVRPQR
>AIA12087.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSHGPITMIVARATNGVIGRDGSLPWRISADLKRFKALTTGTAMIMGRRTFNSLPRVLPG
RRHIVLTRDRNWTADGAEVAHSIEEALSLAADEPVSVIGGAEIFELFLSRADRFELTEVV
GDIEGDTRMPDPRSTGDWREVAREEHQAEGDTPVFRFITLERV
>AIA12064.1|FEATURES|farme|macrolide-lincosamide-streptogramin|RlmA(II)|antibiotic target alteration|0
MSVSNETVTTVNEDKLHQLLGKFVSDFGAAFHAGMVVIGMELGLYKDMAGNGPTLPSELA
ERTGTNERYVREWLNSQAAGGYVEYEADTGRYSLSAEQAFTLADENSPAYMPGAFLLATS
ALKAVPKLIERFRTGEGFGWHEHDTGLFRGTELFFRPGYAANLVSSWIPSLEGIEVKLND
GAKVADVGCGLGASTILMAQAYPKSTFTGFDYHDGSIEMARERAKEAGVSDRVNFEVAKA
KD
>AIA12038.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MKKLIVALVALISLGGAVQAQTLKDLLATLTVKWNAPTEPFKMIGNVYYVGTAGLASYLI
TSPQGHILVDMAMPETAQQIKGNIEKLGFKVTDIKYLLNTHAHLDHAGGLAEIKQASGAQ
LVAGEADKPLLEGGYYPGQREETALAFPPVKVDRTVREGDMVTVGDVTLTARETPGHSPG
CTSWSFPVKDGDATRSALIFCSGTVALNKLVTNPTHPGIVSDYRKTFARAKDMKVDVLLA
PHPEMYKMPEKRAKIADGAPNPFVDPGEFNAYAATLEKAFEEGLAKQTAAAQEKKG
>AIA11999.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIINAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIASYALLTMM
IAQVCDLKPGDFVHTLGDAHLYSNHLEQARLQLTREPRALPQMKINPSVKSIFEFDYSDF
ELSGYEPHPHIKAEVAV
>AIA11946.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIAAMARNRVIGANNSIPWHLPDELKSFKAITMGHHIVMGRNTWESIGRLLPGRETVIVT
RQADYKVAGAIIAHTLDEALAASRGDSEVFVIGGAQIYAAALPRADRIYLTEIEADFDGD
TLMPELALNAWRVVSRAVHSADEKNRYAYTVTIYDRVS
>AIA11846.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MSTWKNLPIFLGIFIFYRMATNRKAAIGFIFITLLIDVMGWGLIIPVMPDLIAQLKGISI
NEASSYGAWLISVYAFVQFLFAPVVGNLSDRFGRRPVILLSLLGFGIDYLFLALAPSYGW
LFVGRVIAGLTGASFTTATAYIADISTNETRAKNFGIIGAAFGLGFIIGPALGGLLAGFG
TRAPFYAAAVLCLVNCLYGYFVLPESLSQENRREFQWKRANPFGSLQLFKRYPAIGGLAF
SFFLIYLASQAVQGNWNFFTIYRFSWSEKMVGISLAVVGLLVGVVQGMLTGVATKKLGNE
RSVYIGLLLYTLGLVLFAFATEGWMMFVFLVPYCLGGICGPALQSILAGHVPPNEQGELQ
GAMTSLMSLTTIIGPLVMNNLFYFFTKDSAPFHFPGVSFLLGAVFMLLSCLIAWRVLSKE
KKTHPELINVIEGTAEEELVLKK
>AIA11843.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
YLKDVFAWGPARIGVLLALIGLCDIVSRAILLPKLLIFSEKNIIFAGLILMIAGFASLAL
SGYLGIASLLWVSIVLITVGEGLFDPSYNNMLSQSVSENKQGQLQGVNQGLHSSYEIFGP
FAAGLIYLYNPLAIYILAALLMVATLLCFWKNSRVFVN
>AIA11842.1|FEATURES|farme|tetracycline|tetC|antibiotic efflux|1
LGERWALIVGMACELTALVIVGLATQGWILFALAPLFALGGIGMPALQSVTTQQVDGDKQ
GQLQGVLASLVSLASIFGPVFFSFMYFAVSDTWPGLIWIVGAGIYLLALPLMLGIRRGAT
PAAVAGE
>AIA11841.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLRSILANGNEHQDRTGVGTISHFGYQTRFDLRQGFPIVTTKKVPFRWIAEELF
WFLSGDTNEANLRARGVDIWAEWADEDHTRRFDREAGDLGPVYGYLWRSFGGNYPDRNGV
DQIANLISEIGSNPNSRRLIVTGWDPRQANRVDLPPCHTLFQFKVENGTVLHCQLYQRSA
DAFLGVPFNISSYALLMHMVAHVCGLEVGDFVYTLGDYHIYKNHLEQVEELLAREPFPLP
KLEIVDHDKRLRGLEGLLAMRYENLNLVGYQSHGKIAASVAV
>AIA11777.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MSSTRVTTPTAPTRTYPSLRAAAIPLFALCLAFFVEMVDNTLMGVALPTIGRDLGGGTLS
LQWVTSAYALTFGGLLLTAGSAADRLGRRRVLLVGLAVFGGVSLGVLAVDSTGQLIGLRA
TLGVAAAMMAPITNSLVFRLFDDDVLRRKAFTVMITVGMTGFILGPVLGGSALAHLDWQW
LLIANAPIALIAWIGVRIGVPADHPEDLTHEKLDLPGALLSIAAIGLGCFTFTSGVLYGW
TSWQTLGSAIGALLALAGFVIHERRTPQPMVDLSLFSRGTIRGASLAQLATAVAMAAVMF
GLILHFQYAYGWSPMKAGLANLPLIVTMLLASPLAENLVTRFGHRVACLIGSGFLAGSMA
GMAWAVEHGYLAIAVFMVTFTIGLRVVMTTCAVALVDAMPSNRTSLATSLNDTAQEVGTS
IGTAFIGTMIAVLVTKVLPDGVWSDDLASSYFHGEQVAFLALAVLVGTIAAWGSVTLTDS
HATDEH
>AIA11735.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MRQSRPAALGFIFVTLMIDVTGFGIIIPVVPDLITDLIHGDLSNASKYGGWLMTAYAIMQ
FVFAPVLGNLSDRYGRRPVLLFSLFGFGVDYLFTAFAPTIAWLFVGRIIAGITGASMTTA
MAYIADVSPPEKRAQNFGLVGAAFGLGFIIGPVIGGLLGTFGTRAPFFVAAGLSFINWIY
GYFILPESLPKENRRKFEWKRANPIGSLMQIKKYPALTGLIGSFVFIYLAAHAVQSTWTY
YNMEKFGWHKKEVGISLGVVGAMVAFVQGVLIKKTIPKLGQAKSVYIGLLLYSLGMLLFG
LATQGWMMYAFTIVYCLGGIAGPALQGIMSAQVPATEQGELQGTLNSLISITTIAGPLMM
TNLFYWFTNKNAPVRFPGAPFIAGAILTLMSAWIAYRYLHSKKVKPAV
>AIA11731.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKAKISLIVAMAENRVIGKENGMPWHIPGELPRFKRITTGHPIIMGRKTYESIGRPLPNR
VNIVITRDAGFKVDGVVVVHSLEEALEVAKKAELLTPHPSPLPINGAREQLGEVFIIGGG
EIFKQAMPIADKLYLTLIHKNIEGDTHFPKYEKIFSKEVFREDHETEEYRYSFLEFEK
>AIA11708.1|FEATURES|farme|beta_lactam|OCH-7|antibiotic inactivation|1
MSGAALAADRDTAKIRQTVDRTIRPLMALHGIAGMAVGVVVDGRPYVFDYGVASKATKQP
VTRDTLFELGSVSKTFTATLASYAQIEGDLSLNDAVSRHLPSLDGTAFGKVTLLNLGTHT
PGGLPLQVPDEVHNDAQLMQYFRTWRPAGPPGTIRTYANPGIGTLGLIAAKSMNENFDTL
MQTRLFPALGLKHSYIDVPASKQRDYAQGYAKDDTPIRMKGGVLSSEAYGVRSTAADMTR
FLQINMKMVRIDPAFQRAVDATHTGYFQAGPMTQDLIWEQYPYPAALQSLLDGNASAMIL
NATPVTRIDPPQAPRDDVWINKTGSTNGFGTYIAFVPKERIGVVMLANRNIPNEDRVKAA
YAIITSLAGGQ
>AIA11683.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKIMLLAAMTLDGKIARNELHFVDWTSKEDKKLFFDTSKRAGVLILGNNTYKTLPVPLPG
RLHVVLTRTPGEKESMPGAVEYTDRSPEEIVADLEARGYTEAVLTGGAQINALFLQSRLV
DEVWLTVEPLIFGVGIDLFRGVEFDERATLIYVERLNEGGTVHLRYSLR
>AIA11625.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MAVAENGVIGNDNGLPWRLSSDLKRFKAVTWGKPVVMGRKTYLSIGQPLPGRTLIVVTRD
ASFRADGVEVAHSLDDAIDRAEKAARAANAGEIMIAGGAEIYAQTLGDADRLYLTTVHDK
PEGDAAFPEWDKSEWQLIHAEKLRASERDSAPTTYEVYDRL
>AIA11604.1|FEATURES|farme|aminoglycoside|rmtD|antibiotic target alteration|0
MSVSKETLTTVNEDKLHQLLGKFVSDFGAAFHAGMVVIGMELGLYKDMANEGPTLPSELA
QRTGTNERYVREWLNSQAAGGYVEYDASTGRYSLSAEQAFTLADENSPAYMPGAFLLATS
ALKAVPELTKRFRTGEGFGWHEHDTGLFRGTELFFRPGYAANLVSSWIPSLEGVEAKLNN
GAKVADVGCGLGASTILMAQSFPNSTFTGFDYHDRSIELAKERATEAG
>AIA11581.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIAAVGANGVIGAEGEIPWRLPTDFAHFKRTTLGKPLIMGRKTFESIGKPLPGRTNIIVT
RQADYSAEGILVARSLAEALERAQQVAVADGSQEVFIGGGGEIYREAMSLAQRLYVTHVD
ASPAGDAFFPTIDPKIWEVEAVLDVQRTERDSHAFTVKLYHRR
>AIA11543.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAHPEYQYLKLLAEILRNGKSKPTRGVHGIKSIFGYQMKFDLRHGFPILTTKKMPFKLMA
HEMLWFVSGSSNIKYLQDHNIRYWDEFADKDLNLGPVYGVQWRHWQDPKGGEIDQLQWAI
DQIKNNPHSKAILVSAWNPADLEEMRLPPCHTMFQFDVTKGKLRLQLYQRSSDVFLGLPF
NISQYALLLYMVAHVTGLEARELVVSIGNAHLYTN
>AIA11522.1|FEATURES|farme|beta_lactam|TU73_12825|antibiotic target alteration|0
SDLPLEAEDSLTLLTVVPSDEGGEREGVLAPPYPVTTVGILAGARDLLCRTPASLRQEVH
RGHAAHEILDAAAMHRAELLVIGACGLSPVTRFLLGSVADRVVRHATCPVLVVRPGSTAV
RRVILGIDDSPSATRAAEWLRGFPLPAEAEVRLVTVLPLLESWLSSPAVLTPPLVDHTMT
LAERERDV
>AIA11445.1|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic target protection|0
MAKGMPDSASKFNSSRAEEYGQQSRIALAGYDACHELSACMLAAALGPQSAAKILVVGAG
GPAQEITIGGLLEPNWRFTAVDPSEPMLAIARARIAEAGMADRTEIVLGRVHDLPNEPLF
DAATLIGVLHHLPGDEAKQDILHAIASRVRPGAPLILAGNHYSYASEPLMLEAWGQRWRM
HGATPDEVKAKLGKILQGADPPHSEAAVFALLADGGFEAPKRLFASLFWGAWIAFRVGQS
S
>AIA11440.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MALAAFMLVVATFASGQDGARPSSCDDCPEWNRTQQPFRVYGNTYYVGPHGLSSILITSK
AGHVLIDGALPESAPQIVANIRSLGFRVEDLKLIVNSHVHFDHGGGIAELQRLSGARVAA
SPWSAEVLTKSGVGKGDPQFGSIRPVALVPRADTLRDGQTLRVGDIKLTAHFTPGHTPGG
TSWTWRSCEGGRCLSLVYSDSMTPVSADGFRFSDSREYPNAVKDFEKSFAFLTSTPCDIL
LTSHPDASGLWQRLEGRQKGVSPDPMLSPNACKELAGRASEQLRRRLESEKER
>AIA11430.1|FEATURES|farme|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|0
MIITIRPEQQADIDDIFELNKVAFGQENEARLVDLLRTAPGYVPGLSLVATAENTVVGHI
LFSKIFVVSGDARHETLALAPMSVLPGYQKQGVGARLITQGLESARELGFGSVVVLGHEH
YYTKFGFVPASRWGIRAPIDVPDDVFMAMELLPGSLKNISGVVQYPVEFSAI
>AIA11375.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|0
MNKAKYIAIAAITLDGKIAKDKNHMSDWTSKEDKVFMRALLDKCGVIIVGNNTYKTAIKP
LSKRNCLVLTKQVPSPGLGRARERSNAGNPQYVNPNKTNLKKLITKLKYRKVAILGGAQT
YAYCLKNNILDELYLTIEPLVFGKGINLFGDDSLNKNFKLISTKKLNNKGSLLLKYKKL
>AIA11318.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MGWVHHIDITVTDLAVSTAFYDQVLKLMGFRRIRDESGVPLWAGARTEVGLQQARADHNR
PHDRYSPGLHHLAFGAPDRAAVDRVYEALLKLNVKILDAPATYEQYSPGYFAVFFADPDG
IKLEYVYTPVWPTE
>AIA11307.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISFLAAMDRNLVIGDEKGIPWHLPADLKRFRKLTLGKPIVMGRTTFEHIGRPLDKRTN
IVMTRKTDYQPEGVLVAHSVEEAIRLAGDVEELVIVGGGEVYRAFLQLANRLYITFVVGE
FKGTAHFPCKFPTPCGFAWEVKHRESNAPDEKNPHAHQYIVVERREKSESTGGDFNIPNL
I
>AIA11266.1|FEATURES|farme|beta_lactam|blaOXA|antibiotic inactivation|1
MKQLLTIILFAIVVSTLATSKGVEQPDLSPFFKDTTGAFVLYDLKDNHYIRYNEKRCRER
FSPKSTFKIPNSLIGLETGVIRDADFVIPWNRQKYPPQDNWNQEPFSHWGQDHTLRSAIK
YSVVWYYRELALRVGESRMKKLVSAFSYGNENVSGAIADFWLNGTLKISADEQVEFLKAF
YAERLPVSKRSIDIVKDILVLEKTPTYTLRGKTGGGSIAEGKYIGWFVGYLEINSDVYFF
ATNIEGSSFQAIRDKRIEITKQILMQLGYLTR
>AIA11257.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MMTTSGAVRAQTPPLERAIKRLAESSGGIVGVSAIHIESGRRVSVNGSLRFPMASVYKLP
IALRVLQRVDRGELRLNAPVTLSTHDFRPGHSPIVEFANNKPVTLPLERLLELMLGESDN
SASDALLRLAGGPAAVTNRMQALGIMGINVSRPEGQLILNHRGVRELPPESEWTMALLDS
LSAKITQAEREAAAAYADDPRDTSTPDAMADLLVRIHRRDVLEPASMERLLQITTATQTG
PARLKGLLPIGTVVAHKTGTMGGTTNDVGIVTLPDDTGHLAIAVFVKASTKDVPERERAI
AEIARTVYDFFVLKGQ
>AIA11251.1|FEATURES|farme|beta_lactam|SHD_1818|antibiotic inactivation|1
MNTRNGFLLALLFIVGSNAAPAEAQDLTPYFKNTNGAFVLYDLNENHYIRYNEQRCRERF
SPKSTFKIPNSLIGLETGVIRDADFTIAWNRQKYPPQENWNQEPFVHWAQDHTLRSAIKY
SVVWYYRELALRVGKQKMNKYITAFNYGNETMSKDVDNFWLDGSLKISADEQVEFLKEFY
AGRLPVSKRATEIVKDILVLENTPAYKLSAKTGGGSIAEGKYIGWFVGYLETKGNVYFFA
TNIEGASFAEIREKRVELTKEILAALGYLPK
>AIA11204.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|0
MGRKTWEGLKNPPLPRRRNIVLSRTLADVPGGEILRSPEGLDRLTGIDRAYVIGGEQIYR
LLLPHTSEILLTVLDEEAEGDAVFPEFEAEFGEPEVLDRLEGVCEWRRYVRITPTDLNP
>AIA11140.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MVAETARASATKATGEGFVSARINAVPPSGIRRFFDIAATMKDVISLGIGEPDFVTPAPI
VEAGVESLRAGHTSYTSNSGILELREGISRQLDTLYSVNYDPETELLVTVGVSEALLLAL
MAVLETGDEVIVPEPCFVAYQPTVIFAGGTPVSVPTYVNQDFQVTVDDLEKARTPRTRAV
LLGYPNNPTGAVLERSRLAEIAEWAEKHDLLVVSDEIYDRLVYGIEHTCFSSLPGMWERT
ILLGGFSKSYAMTGWRIGYAAAPPAILSAMRKIHQYAIMSAPTTGQEAAIEALKSAEPYV
ESMRQEYDRRRRTIVDGFNRLGLDCFEPKGAFY
>AIA11135.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSGPRLALVVAMTENRVIGKGGTLPWRIPEDMKWFREITRGKPCIMGRKTWESLPKRPLP
GRTNIVVTRDAGYRAEGAIVVASLDEAIVAAARELPEEIAVLGGAQIYAEALPRADRIYL
TRVHATIEGDTFLPEIDMHAWRLTQRAPLTTSSTGLGFDIVQMDRL
>AIA11079.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKITLVVAASENNVIGDSHAPNHAIPWHLPNDMKFFRDITRGKPVIMGRKTLEFIGHALP
GRRNFVITRQVSVPFEGVEVVGSLGEALSKARESAPEEICVIGGGEIYRQALPLADRVYL
TRVHAEVQGDTTFPELDPGEWKEVSAERHESDDQHQHAYTFFVYERISK
>AIA10990.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MTTDQVVVMGRKTFESIGKPLPNRTTIILSRSNFQFPNVKTISDLEQLDADWPELAGKEI
YICGGAQIYEQALPLCSDLFLTLVKRKVEGDTFFPEFEQAFQQVGVMRDCPEFKILHYKN
SNLLR
>AIA10987.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYQQLLRHVLAHGSGHEDRTGVGTLSCFGYQTRYDLREGFPVITTKRVPFRWIAEELF
WFLSGDTNEANLRARGVDIWKEWADLEHTSRFGRDEGDLGPVYGYLWRSFGGGYPERDGV
DQIARLVREIEQNPNSRRLIVTGWDPRVADEVDLPPCHTLFQFKVERERVLHCQLYQRSA
DAFLGVPFNISS
>AIA10959.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|0
MSDDEDLKFTVQRPPAYGELTDVLPGLFWVRLPVPLRLNHVNCWLLDNGPGWTLIDCGMN
TDDIFEIWDKLWRGLLRSRPLQNLTFTHAHIDHIGFAGYFVKEMKCAVRLPFAEWLNGWM
MWHEREEGLSEQFASYMKRNGASDEDVAAVMGSQRPSKYLGSRPPREFSRIKDGDVVSMG
QRDWRVITAGGHSPEHASFYCEEDKILIAGDQVLSHITPSVIVPSAQPDANPMQEYLDSL
ARFEELPTDTLVLPSHGLPFRALHTRLRQLREHHQARLDDMASFVTEKTTAFAIVQEVFP
RVLHENPRQAFGEALAHLNALAAMGKLKREVDANGMITFAP
>AIA10935.1|FEATURES|farme|multidrug|hp1181|antibiotic efflux|0
MTFSALIVLSNAIVGAGVFPVMWMGGRVLYGFAICAMFIVAQSWLNDAVGNSIRGRVMAI
FYVCYIVGLGVGSFLLGFVDLATPAAPLVGIVFTALSMLPIGMTRLPQPPVPVGASIAFA
AAWRISPVGIAGMLAVGGLSMMIAGFAPIHATEKGFSQQEVATLMFAMPLGTLIFQIPLG
WISDRTDRRYVLIATSLLVALAGIAASRLDGGTFIILMMVYVVWSGASESIYSLSNAHAN
DRAGKTDLVTLSSTMLFAWSISGFVVPGFGTLLTAAYGTQSFMYVAIAIAIVFAAFVAWR
ILTARRVPPAATGHFAPMTAQAPVPVDAAAPVDAP
>AIA10914.1|FEATURES|farme|beta_lactam|OXA-50|antibiotic inactivation|1
SGYGNADVRDEAEQGSYWYDGSLRISANEQVRFLQRLHNGELGLSARTTDMIRQVALVEE
TPRWRLVAKTGACRGVGEQTTTHWYVGWVEKADNTYYFALRLAADSFEPALRDRVPIARD
LLARLHILD
>AIA10915.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MATLAAVSLVVSALAFVHVYAQDQPASWSEPQKPVRIFGNTWYVGTRGLSAILITSPTGA
VLIDAAVREAADGIASNITSVGVRLEDVKLIVNSHAHNDHAGAIAELQRRTGATVAALPW
SAEALKSGKKYAGDPQFESPTTPPERVAKVKTIRDGEVLRAGGVEITAHKTAGHTPGSTT
WTWRSCEEGRCVDIVYADSLTAVSADKFRFTDNKTYPHVIDDFTRGYAFLRSASCDILVT
PHPEASDFWPRIAKRDGGERDALIDRTQCARYADRADAQLQKRLATERAK
>AIA10871.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
ALPWRLPEDMKFFRTLTTGHPIVMGRKTWDSLGRPLPNRRNIVLSREIPPLEGAEVVRSV
EELNALGLTGDVYVIGGAEIYRALMPRCAAVYLTVLAAEAEGDAFFPPFEADFPRMSVIQ
ELEGIAQWRLYERE
>AIA10851.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MTILRPGATVAAAIVVLAPASFAMQNASADGPWTKAIEPSRIIQNVYYVGTEDLASYLVT
SSQGHVLIDSGVAANAATIAAGIQKLGFKLEDVKYLLTTQAHFDHVAAHAELQKRTGAQV
VASDGDAPLLETGGKADYHFGADYNFAAVKVDRRVKQGDTISIGDRAITAHMTPGHTQGT
TTWVMPVKQETGETLNVVFVGSTSVNPGVKLVANAKYPQIADDYAASFARLKALKVDVFL
TAHLSANEGLEKMAKLRAGATPNPFVDAAGFRAYLERSQANFEAELAKQRSGGQLLIW
>AIA10836.1|FEATURES|farme|beta_lactam|LRA-2|antibiotic inactivation|1
NVGNIKAILQSHAHPDHIGGIAELQKLSGAAVYARRPADEVMRTGKLPAEDPQFTTKGPK
IPTVPNVWVVHGDQLLGVGSNRLRVLATPGHTPGGTSWTWESCEEKLCLQMVYADSLAPV
SGDKYRFSDHPEVLEQFETSFKTLEAQRCEVIISPHPEASGFFERIKKAGGKGDALKDAE
GCKSYAKVFRERLAERLAQERAAGVKRKGK
>AIA10822.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLISLIVAMAHQRVIGYKNQLPWHLPADLRHFKAITLNKPIVMGRKTYESIGKPLPQRTN
IILTTDPAYEAAGCQVIHTPMEAMEIASEAEELIIIGGSRVYAAYLPFARRIYMTVIEAE
VKGDTFFPELDEAGWELVSREDHVADEKNSYGYRFLVWESLKV
>AIA10812.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MRQKLNLITLGVNDFDRSVAFFEKGLGWKKSSASVEELALFPLGGIVLALHPRKDLAADV
TVSSEGSGFSGITLSYNAKSEIEVDEVLEKVRRLGASIIKPAQKVHWGGYSGYFKDFDGH
LFEVAYNPFWDLDAQDNLKLP
>AIA10801.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAVGAVPVMEARSVSKYFGTVIALKDVSLAVHPGEVVCLLGDNGAGKSTLIKMLSGLEKP
DEGTIAVDGTPVVFGSPRDAFARGIATVYQDLAVLPQMSISRNFMLGMEPVKRFGPFRFF
DEAKAGEIARQELAKIGIQVNYLRQKVGTMSGGERQSLAIARAEYRGARPLILDEPTSAL
GVNEAAIVLRHVIRARARGLGVIFITHNVHHALPIGDRFVILNRGRVANTFARTEIDEES
LNKHMGGGAEFDELQRELLTLDAELKRSTAQKTALPG
>AIA10761.1|FEATURES|farme|beta_lactam|LRA-12|antibiotic inactivation|1
TVAAAIVVLAPASFAMQNASADGPWTKAIEPSRIIQNVYYVGTEDLASYLVTSSQGHVLI
DSGVAANAATIAAGIQKLGFKLEDVKYLLTTQAHFDHVAAHAELQKRTGAQVVASDGDAP
LLETGGKADYHFGADYNFAAVKVDRRVKQGDTISIGDRAITAHMTPGHTQGTTTWVMPVK
QETGE
>AIA10746.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MEIVLVVAVAENGVIGAGGTIPWRLKSDMQRLKAMTMGKPIVMGRKTFESLPRGALPGRT
NIVVTRDAAWRAAGAVVTHSFTDAKAIATGDALRRFATEIAVIGGAEIYVQWMDSADRLE
ITEVHARPDGDTHFPAVDPAAWEEVARVRNPAGSQDSVDFSYVTYRRRKPR
>AIA10721.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|0
MKVFIIAAMTADGHIGQAKDHLATTWTNPEDKYLFKHFVKEANNMVMGLKTFLTTAKVTP
TVFNKSMPGRRLFVYTHHPEAIAAYENIEVVTESPQELVARLEREGLDSVVICGGSQIYT
MFMQS
>AIA10715.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MVRARYKGVVDALAADIRAGRIPPGTRLPTHRELAAREGLALVTATRVYAELAEMGLVSG
EAGRGTFVRESSLSSRDDIVKRAFSDDVVDLNFNYPSVPGQADLLRNALRALASSGDLEA
LLRYQAHGGRTHERASVALHLEQRGLTVPADRVLIVSGAQHGLAVAALAMLQPGDVVAVD
ALTYPGFKVLAQVLHLELVPLPPATDGPDMDALAQLCSTRRIRAVYAMPTLHNPLGWVTS
QESRRQLVAIARKHGLLIIEDAAYAYLVERPPAPLAALAPESTLYVSGLSKNVATGLRFG
FVVAPSEYVDVLERVIRATTWNTPALMTAIAAGWLNDGTVTRLEAQKRAD
>AIA10650.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
MNTSTIKFFTGTLLLTLALGLFSFMFKSNPEVRDDLKPFYDKYGVDGSFVLYDQKKQKYI
IYNKDQVSKPFTPASTFKIFNSLVALETKVVADEYAVFKWDGQQRQVAAWNADTDMRNAF
KNSTVWYYQEIARRVGGKRMNSWLNKAKYGNADTSGGIDAFWLTGGLRITPMEQIGLLRK
LHDDKLPFSMRSMNIVKDIMIVKDTLGYVLRAKAGLGKQGNQYVGWYVGYITTRDNTYYF
SNCVQTDRRNAEFANARLNIVYDVLDRLAIVKK
>AIA10612.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLVIRRARPDDIGTVFSLIRELADYEKLSHEVAASEADIAAALFCEHPTLFCDLVEWNG
EVAGFAVWFVNFSTFAGRHGIYLEDLFVRPAFRRNGLGQALLGHLARTCVERGWTRLQWS
VLDWNLPSITFYKSLGAELMEEWTLCKVTGASLAALAEKAP
>AIA10584.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVSVVAAITADGFIGRDAHHLSDWTSKEDKQVFVRLTKEAGTIVMGSKTYATIGRPLPG
RRNIVYTTRPNEFQIEGVEATSEEPAMLVARLEQEGATGLAVCGGASIYGQFMRAGVVTD
LYLTIEPVLFGTGVPLCNAELDTRLALRETSKLNENTILLHYSVLQKA
>AIA10544.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
KVELGGVTMIARLTPGHTKGSTTWAMKVQEAGKQLDVIFMPKYPGIVADYTYTFRLLKSL
HCDVFLGPHGSFFSLLEKAARLKQGEKNNPFIDPKGYRAFLEDSEKGFLEQLEKQRQASK
TK
>AIA10535.1|FEATURES|farme|beta_lactam|blaOXA|antibiotic inactivation|1
MKQLLTIILFAIVVSTLATSKGVEQPDLSPFFKDTTGAFVLYDLKDNHYIRYNEKRCRER
FSPKSTFKIPNSLIGLETGVIRDADFVIPWNRQKYPPQDNWNQEPFSHWGQDHTLRSAIK
YSVVWYYRELALRVGESRMKKLVSAFSYGNENVSGAIDDFWLNGTLKISADEQVEFLKAF
YAERLPVSKRSIDIVKDILVLEKTPTYTLRGKTGGGSIAEGKYIGWFVGYLEINSDVYFF
ATNIEGSSFQAIRDKRIEITKQILMQLGYLTR
>AIA10514.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
MNRISRAIALILIVLGCILSVLVQTQQSVLTAPTPALESPPRPGGVAQTVNFGRHFQDLG
VEGSIAIYDLNSDRLYQHNPQRNATAFLPASTFKILNSLISLETGVISDEIAVLTWDGTQ
RQIPAWNRDLNMRGAMKLSAVWFYQVLARRVGHEQMQKWVAKVGYGNQKIGNKDDIDKFW
LEGELRITPKEQIQFLRRLYKNDLPFSERSLSLVKDIIIVEQTPDYTIRAKTGWANFGEQ
TKPQIGWYVGYLEKDKNVYFFATNIDIRNNNDASARIELTRRCFKDLALL
>AIA10501.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MATLAAVSLVVSALAFVHVYAQDQPASWSEPQKPVRIFGNTWYVGTRGLSAILITSPTGA
VLIDAAVREAADGIASNNTSVGVRLEDVKLIVNSHAHNDHAGAIAELQRRTGATVAALPW
SAEALKSGKKYAGDPQFESPTTPPERVAKVKTIRDGEVLRAGGVEITAHKTAGHTPGSTT
WTWRSCEEGRCVDIVYADSLTAVSADKFRFTDNKTYPHVIDDFTRGYAFLRSASCDILVT
PHPEASDFWPRIAKRDGGERDALIDRTQCARYADRADAQLQKRLATERAK
>AIA10473.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MRNHLPNPTRVLALAGFLLILAALAWGQTGAPPSSSCDNCPEWNKPQQPFRIYGNTYYVG
PHGLSSILITSRAGHILIDSALPESVPQVVANIRALGFRIEDVKLIVNSHVHFDHGGGIA
ELQRLSGAKVAASPWSVEVLTKSGVGKGDPQFGSIPPVALIPRATTLRDGQTLRVGGIKL
KAHFTPGHTPGGTSWTWNSCEGKRCLNLVYSDSMTPVSAEGFRFSDSREYPNAVKDFEKS
FAFLRSTPCDILLTSHPDASGLWQRLEGRERGVRPNPVISPNGCKSLAERAGEQLRRRLA
AEKGR
>AIA10463.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
TIGRDLGSGTTALQWVTGAYSLTFGGLLLTAGSMADRLGRRRVLLIGLAVFGSLSLCVVL
VTTAGQLIALRAALGIAAAAMAPITNSLVFRLFDDKDLRMRAMTVMIIVGMSGFVLGPLL
GGTALAHVRWGWLLVVNAPIAVIACIGVRLGVPADRPEDLTNDTLDIPGAVLSVAAIGLA
CYSLTSGVEHGWLSAI
>AIA10443.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MRQEHAEVFAMNTPMLRAALVLGLLSAIGPFAIDMYLPALPAIGVSLSASTAEVQMSLMA
FMAAIAVCQLFYGPISDMIGRKPPLYFGIALFSLGAIGCALAPSIEWLIAARFVQGVGAC
AAMAL
>AMJ38582.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MLSVKKDKNSSTGLVIILGLLAMLMPLSIDMYLPAMPQIAKEYGVSAGSVQMTLSAYILG
FALGQLFYGPLADSFGRKPVITVGTLIFALAAAACAMSQSVEQLINMRFLHGLSAAAASV
VINALMRDSFSKEEFSRMMSFVMLVTTIAPLLAPIIGGWLLVLWSWHAIFWTLSLAALAV
TLMVATQIKETLPKAQRQRFHLRTTLKNFLSLFRHKRAFSYMLASGFSFAGLFSFLNAGP
FVYIEVNHVSPQHFGYYFALNVVFLFIMTLINSRSVRRFGPLAMFRFGLVIQFAMGIWLL
IVSAFGLGFLPLVFGVAMFIGCVAMVSSNAMAVILDEFPHIAGTASSLAGTLRFGVGALV
GALLSMANFTSAWPMVWSIALCATCSLLLYFYASRTRKSSAAA
>AMJ38567.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MLASGFSFAGMFSFLSAGPFVYIELNHVSPQHFGYYFALNIVFLFVMTIINSRFVRRVGA
LNMFRAGLWIQFVMAIWLVLSALLGVGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHM
AGTASSLAGTFRFGIGAIVGALLSTATFNTAWPMLWAIALCATCSILFYLYASRPRKTAH
K
>AMJ38530.1|FEATURES|farme|beta_lactam|KS18_02580|antibiotic inactivation|1
MWMRNKSVWRGLLLAGLLNLSLGSTVALADNTALTQKLAALEKSTGGRLGVAWIDGDGLR
YGYRADERFPMTSTFKTLAAAAILHNSVSQPNLLEKKIRIREADRVAWTPVTGNYFGKEM
SIAALCAAAIEYSDNLAANYLLKELGGPQGVTAYARLLGDTLTRLDRQETELNSAAPGDE
RDTSTPAAMAENLSKLTLGDALPTAQRQRLISWLKQNTTGDQSIRAGVPAGWTVGDKTGA
GAYGTTNDLAILWPEKGAPKILAIYFTQPQPDAANNKAVLASATRLAIDALGR
>AMJ38523.1|FEATURES|farme|multidrug|farB|antibiotic efflux|0
MGIDRGNQLLHRIGPPTKIKSGLFIAIAVIILELIGGMQSYLNQLILPIMANDLHGQNYY
GVILGASSIATMTGLPIGAALMNRVRLVRLLVGATLVLVFGALVSAVAPSVIVFVIGSIL
RGLAGSILAMTSLGAVALGLSGRARQLTLAFASASWVVASVVGPAYAAWVTHLLSWRWAI
LLYLPFLLAARFVIAFNLKTESQKKDAPMSYQALFLIIIGVGVTIVPIAGIGKILLLLVG
IGLLTRVAILLMPSGTFSQRTQRRAALAGMFFLTGSYFAANELVSLTAHDLFDASAKSLG
YILTGGGLAWALLGVFCGIKPASSMLAYRIRSSIGLTLLLLSTAAISVVSLTDSSLSHPT
VFFVILWTLAGTGMGLTYLDTLNIFFEDPAVPDGITIEEMASSSVIVESLSSTMFIPLTS
SIVAMAFTNQQVTSTLPYGISWLIVVGLAFVAFYYLMGVQSSKNS
>AMJ38479.1|FEATURES|farme|beta_lactam|ACT-27|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGISCSALAAPVSEK
QLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSIS
KTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVT
DNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDH
TWINVPKAEEAHYAWGYRDGKAVRVSPGNAGCTSLWRENQRAGYGELGHGKHGAGEGCRC
LT
>AMJ38375.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
LSQVEQSPHYRDGQFHNQVPTPGYTGNKSMLAAWWEFLVAKRENARPAHPLPLVATDLAG
LSPEQDTLVWLGHSSWYLQLAGQRILIDPVFSNYAAPLSFLNKAFAGDYPWSAQTMPEID
LLIISHDHYDHLDLATIKALMPKIKRVITPLGVGSHLRYWGMRGEIIDEMDWNQSIRVTD
SLIVHALPARHFSGRGIKRNQTLWASFMFETPEQNVYYSGDSGYGPHFKAIGEQFGSVDL
AIMENGQYDHDWKFIHMMPEETAQAAVDLHAKAVLPGHAGRFVLAKHTWDDPYKRLALAS
RRYDYRLLTPMLGEPVILSAPDQLFTAWWQQVTQ
>AMJ38222.1|FEATURES|farme|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|0
MKLPLTTPRLLLRRFRTEDLPSFSHYRNLSEVARFQSWTHYGMTEATAFYEQQRSQAFAE
DESWFQLAVEIQANGALAGDVGIHFLDHGRQAELGMTFSPAYQHQGYAREAMRAVMALLF
EQLAHHRLTAVVDTRNTGAIKLLEGLGFRREAHYRQNIFFKGEWGDEYLYALLRSEYQ
>AMJ38158.1|FEATURES|farme|beta_lactam|SHV-11|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEKLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AMJ38085.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MVWLGHSSWYLQLAGKRILIDPVLSSYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHD
HYDHLDYATIKALLPKVKRVVTPLGVGSHLRYWGMNPEIIDERDWNQSVHISDTLTVHVL
PARHFSGRGIKRNQTLWGSFMFVTPERKVYYSGDSGYGSHFKAIGEQFGGVDLAIMENGQ
YDQDWKYIHMHPAETAQASADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRL
LTPELGEPVRVSDTTQQFREWWE
>AMJ38022.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ38013.1|FEATURES|farme|beta_lactam|TEM-163|antibiotic inactivation|1
DQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHY
SQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGD
HVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVA
GPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERN
>AMJ38000.1|FEATURES|farme|beta_lactam|ACT-32|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPQPGTR
>AMJ37933.1|FEATURES|farme|beta_lactam|SHV-11|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AMJ37895.1|FEATURES|farme|tetracycline|tetB(60)|antibiotic efflux|0
ESGSGKSTTGLALLRLINSHGSIVFDGQPLQNLNRRQLLPIRHR
>AMJ37878.1|FEATURES|farme|multidrug|efrA|antibiotic efflux|1
GFEREIAQGGDNVSGGQKQRLSIARALVKKPDVYIFDDSFSALDFKTDASLRSALKNYTE
EATVLIVAQRINTIMNAEQIIVLDEGRVVGKGTHEELLRSCGTYQEIASSQLSKEELGNV
>AMJ37860.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRHMLQKVM
>AMJ37837.1|FEATURES|farme|beta_lactam|EBR-1|antibiotic inactivation|0
KSLKDINVTMDSIRAVFITHDHADHIKAVGHLGEKLNIPVYTTARVHAGINKSYCMTEKL
HGSVRYLEKEEPMLLEDFRIESFEVPHDGTDNVGYCIEIDGKVFSFLTDLGEITPTAARY
ICKAHYLIIEANYDEEMLRMGPYPTYLKERISSKTGHMSNIDTANFLAENIMEHLRYIWL
CHLSKDNNHPELAYKTVEWKLKSKGIIVGKDVQLLALKRNTPSELYEFE
>AMJ37774.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLYPVYHGSAKSNIGIEQLIEVIT
NKFYSSTYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMY
TSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKP
QQREMLLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKK
PTVIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVNTQLKNNEVILSGEIPARCIQEYRNDLTF
FTNGRSVCLTELKGYYVTTGESVCQPRRPNSRIDKVRYMFNKIT
>AMJ37738.1|FEATURES|farme|beta_lactam|TEM-112|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIRRTEGANRFFAQHGGSCNSP
>AMJ37725.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
MPFVFSVIVIKVIVEIPLPPGKISVQPSALQDDLQTRLFTGDGPNFPEPDMSWIILVIAG
LLEVVWAVGLKYTHGFSRLTPSVITVTAMIVSLALLAWAMKSLPVGTAYAVWTGIGAVGA
AITGIVLLGESANPMRLASLALIVLGIIGLKLSTH
>AMJ37704.1|FEATURES|farme|multidrug|mexK|antibiotic efflux|0
MKLVKYFLQKRAVTILLLVLVLAGGLFSYFKMGKLEDAPFTIKQALVLTSYPGASPAEVQ
SQVTDILEEAIQSLGELYYLKTENRAGLSKITVYVKKEIRAEEMQQLWDKLRRKVNDVQD
KLPAGAGTSIVNDDFGDVLGVFYGLTGDGHTYRELEDQAKFIKNELLKVKDVAKIEIYGV
QTPTIDVLISPSVMAQSGVTTAD
>AMJ37636.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|0
NSPSYNPNNLSGTPKEAMRNRAITDVFEPGSTVKPMVGM
>AMJ37534.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKTYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWAHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ37424.1|FEATURES|farme|tetracycline|tetQ|antibiotic target protection|1
NLLFACGATEKRGSVDKGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDF
IAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLY
LDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPAD
YWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDP
KGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDM
EDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSIN
SYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNP
YWASIGLTLEPLPIGSGVQIESEISFGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVT
FTYALYYSPISTPADFRQLSPYVFRLALQQSGVDILEPMLYFELQIPQVASSKAITDLQK
MMSEIKGISCNKEWCLIEGKVPLNTSKDYASEVSSYTKGLGTFMVKPCGYQITKGGYSDN
TRMEEKDKLLFMFEKSVSSK
>AMJ37389.1|FEATURES|farme|beta_lactam|ACT-27|antibiotic inactivation|1
MLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKP
SGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKT
NVQDMANWVMANMAPENVADASLKQGVALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVE
GSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYP
NPARVEAAYHILEALQ
>AMJ37371.1|FEATURES|farme|beta_lactam|BL1_cmy2|antibiotic inactivation|1
AIIYEGKPYYFTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVT
HYWPELTGKQWQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFY
>AMJ37343.1|FEATURES|farme|beta_lactam|AYO01_11775|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>AMJ37336.1|FEATURES|farme|beta_lactam|CMY-26|antibiotic inactivation|1
SYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>AMJ37333.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
FLSGKNAISHISFAGRPANASFTGDGPIVLEPDMSWIVLLIAGLLEVVWAIGLKYTHGFT
RLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYAVWTGIGAVGAAITGILLLGESASPARL
LSLGLIVAGIIGLKLSTH
>AMJ37303.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ37256.1|FEATURES|farme|beta_lactam|mecR1|antibiotic target replacement|1
MLAGLIPFIPIKFSFIKFNNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSI
DNICTVIWIVLVIILSFKFLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIR
KAEAIQSPITFWYGKYIILIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSI
IMSYNPLVHIVKRKIIHDNEVEADRFVLNNINKNEFKTYAESIMDSVLKTPFSNKNILSH
SFNGKKSLLKSRLINIKEADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKP
LQSDYQILDESKNFGSNSGSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDR
HIISDKNSRMSWNHKHYLFESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLN
YGNENLGSYKSYWMEDSLKISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYE
LYGKTGTGIVNGKYNNGWFVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVL
NDQ
>AMJ37049.1|FEATURES|farme|quinolone|PLPDE_IV|antibiotic inactivation|0
MFLINGVVQDTLAANDRATQFGDGCFTTARIQQGQVALLDAHLQRLQTTCEKLHIPFNDW
LTLSEEMQRLARPHAQGVLKVTLTRGVGGRGYSTAGCVSPTRILSFSPYPAHYARWREEG
ITLTQSPVPLGRNSWLAGLKHLNRLEQVLIRSHLEQTDADEALVLDSDGWLTECCAANLF
WRQGRDVFTPRLDCGKAR
>AMJ37011.1|FEATURES|farme|beta_lactam|MIR-16|antibiotic inactivation|1
MMTKSLSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDV
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AMJ36904.1|FEATURES|farme|beta_lactam|CMY-85|antibiotic inactivation|1
MHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQLGIELAQSRYWRIGDMYQG
LGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAF
VPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>AMJ36903.1|FEATURES|farme|beta_lactam|CMY-51|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSGRGALRLGLSRREAFARFSGTT
>AMJ36898.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
YTHGFTRLTPSVITVTAMIVSIVLLSWAMRSLPVGTAYAVWTGIGAVGAAITGILLLGES
ASLARIASLALIVAGIVGLKLSTH
>AMJ36881.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
KRVGLQPEHAWRYPHAFSGGQRQRICIARALALNPKVVIADESSRRARRSVRGRATSFVR
AGLRPFVSIIATKL
>AMJ36869.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFGDYAAPFSFINKAFPGDYPWRAEGMPDIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALISEADWQQAIPVSDEFTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPMQGEPLWVADKTQS
FNAWWR
>AMJ36831.1|FEATURES|farme|multidrug|mexA|antibiotic efflux|0
IAYRLKNGQAEAAYLTVDRLNDGNRFIVKEGLSVGDTIVAEGVGLVREGMSITPKNETK
>AMJ36825.1|FEATURES|farme|beta_lactam|OXY-6-1|antibiotic inactivation|1
SAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTT
PLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGT
TNDIAVIWPENHAPLVLVTYFTQPQQGAKSRKEVLAAAAKIVTEGL
>AMJ36789.1|FEATURES|farme|beta_lactam|AE24_04439|antibiotic inactivation|1
MLDWPVNPDIIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEK
ELGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ36772.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ36752.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
MSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAMIVSLALLAWAMKSLPVGTAYA
VWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIGLKLSTH
>AMJ36730.1|FEATURES|farme|beta_lactam|CMY-118|antibiotic inactivation|1
WQPQWTPGAKRLYANSSIGLFGALAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQK
NYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQS
RYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTG
STGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>AMJ36613.1|FEATURES|farme|beta_lactam|OXY-6-1|antibiotic inactivation|1
SGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQTLYRGDERFAMCSTGKVMAAAA
VLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMTLAELSAAALQYSDNTAMNKMI
SYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTTPLAMAESLRKLTLGNAL
GEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGTTNDIAVIWPENHAPLVL
VTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AMJ36548.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
GLLKRRPRELSGGQRQRVAMGRAIVRDPAVFLFDEPLSNLDAKLRVQMRLELQQLHRRLK
TTSLYVTHDQVEAMTLAQRV
>AMJ36473.1|FEATURES|farme|beta_lactam|BL2_len|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLGQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>AMJ36463.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
PVFSDYAAPFSFINKAFPGDYPWRAEGMPDIDLLIISHDHYDHLDYATIRALLPKIKRVI
TPLGVGSHLRYWGMDGALISEADWQQAIPVSDEFTVHVLPARHFSGRGLKRNQTLWASFL
FVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQAADD
LRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPMQGEPLWVADKTQSFNAW
WR
>AMJ36450.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDVNEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ36428.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
TVPEKRLNDYPHQLSGGERQRIMIAMAILTRPKLLIADEPTTALDVSVQAQILELLAELK
QELNMGMLFITHNLNIVKRLADRVAVMRYGEIVETGECQALFSAPQHPYTQQLLDAIPSG
DPVALPQPTQTLLEVKDLSVRFPIRQGILRRTVGYSHIVDRLNFTLQRGESLGLVGESGS
GKSTTGLALLRLIPALGEIWFEGTALHLLNLKQLQPYRSQIQVVFQDPYSALNPRLNVLQ
IIAEGLQVHQKLNEQQREERVISAMNEVGLDPETRYRYPTEFSGGQRQRIAIARALILEP
RLLILDEPTSSLDRSVQAQILTLLKTLQQRHQLSYLFISHDLQVVRSLCHQVMVMRNGKV
IEHGNCAEVFANPTQDYTRQLLAFAD
>AMJ36422.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MSDYLLIIKLRASPSRSEALFMKILITCVVLMILAAAGGVISALVPSMGRSPDTEQRHKF
AKSPQYRDGKFHNEALTPMVSGSKGRMAVMWDFLFKKSRLAKPDHALPYVNTDLVSIDTD
KDVIVWLGHSSWYLQLDGKRILIDPVLSDHAAPFSFMNKSFIDDYPWQAQRMPKLDYVLI
SHDHYDHLDYETMQILQSRIGQIITPLGVGTHLLRWGFVPEQIVEADWNQQVVLDETLTL
HVLPARHFSGRGFEGNPTLWASFLLQSSQRRLYYSGDSGYGTHFKKIGDRFGPIDVAILE
NGQYDSDWQYIHMLPEETAQAALDLNAAAVLPSHAGRFVMAKHSWNEPFIRLALTSRDKP
YRLLTPKLGEVVWDDGKTQQFDVWWN
>AMJ36299.1|FEATURES|farme|multidrug|MFS_1|antibiotic efflux|0
MFLYFLGIVAHVGVDVGINAQAPRILTEHTGDTFTEIAATATMVYFIARMIGCFTGGIVL
SKISNHVVILVCGIIMTASAVCFTIFCSITSNLPAALFWVAVALVGFGNSNVFSLFLSHT
LMYRHEHQNEISGLMLMGLIGGAIFPPIMGALADAMNAQLGAIIVMAVGCLYVLVIGVGY
KAIIEG
>AMJ36204.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQKSLSAAGRLGRQALLFPLCLVLYEFTTYIGNDMIQPGMLTVVQEFNVGQEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVAYFVVTCLAILLAQTIEQFTLLRFLQGVSLC
FIGAVGYAAIQESFDEAVCIKITALMANVALIAPLLGPLAGAAWVHVLPWQMMFVMFAAL
AAFAFYGLWRAMPETATRRGEKLSLQALGSDYKQVLSNRHFLCGALATGFASLPLLAWIA
QSPVIIISGEGLSSYDYGLLQVPVFGALILGNFTLAKLTSKRSVRSLIKLGAWPMMFGLA
LAAIATVHASHAYLWMTAGLSIYAFGIGIANAGLYRLTLFSSDMSKGTVSAAMGMLSMLI
FTVGIELTKHAYLLGGNSWFSLFNLMSGIIWLTLLVLFLRNKQVGMPQAA
>AMJ36127.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
LAAWWEFLVAKRENARPAQPLPLVNTDLASLPLGQDAMVWLGHSSWYLQLAGQRILIDPV
FSRYAAPFSFINKAFAGDYPWHAEGMPEIDLLIISHDHYDHLDYATIKALMPKVKRVVTP
LGVGSHLRYWGMESAIISEADWNQAVPVSDELTVHVLPARHFSGRGLKRNQTLWASFMFV
TPQQKIYYSGDSGYGPHFKAIGEQFGAVDLAIMENGQYDQDWKYIHMMPEETAQAADDVR
ARAVLPGHAGRFVLAKHTWDDPYIRLAEASTGRPWRLLTPMLGEPVWVADKTQSFNAWWR
>AMJ36101.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKRLTVCVVVIMLIGAAASLPFLLNAGFGQAPKGAQLSQVEQSPHYRDGQFHNQVPTPGY
TGNKSMLAAWWEFLVAKRENARPAHPLPLVATDLAGLSPEQDTLVWLGHSSWYLQLAGQR
ILIDPVFSNYAAPLSFLNKAFAGDYPWSAQTMPEIDLLIISHDHYDHLDLATIKALMPKI
KRVITPLGVGSHLRYWGMRGEIIDEMDWNQSIRVTDSLIVHALPARHFSGRGIKRNQTLW
ASFMFETPEQNVYYSGDSGYGPHFKAIGEQFGSVDLAIMENGQYDHDWKFIHMMPEETAQ
AAVDLHAKAVLPGHAGRFVLAKHTWDDPYKRLALASRRYDYRLLTPMLGEPVILSAPDQL
FTAWWQQVTQ
>AMJ36091.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MLLTIGRGATLPFMTIYLSRQYQLSVDLIGYAMTVALTIGVVFSLGFGILADKFDKKRYM
LLAICGFASGFIAIPLVHNVVIVVLLFALINCAYSVFATVLKAWFADNLSATNKTKIFSL
NYTVLNIGWTVGPPLGTLLVMQSINLPFWLAAACSALPLVFIQTWVKRSPATAEGVNAAV
WSPSVLLRDRALFWFTLSAFLASFVGGAFASCISQYVMVVANGDFAEKVVAVVLPVNAAI
VVSLQYALGRRLTATNIRPLMTLGTVFFVVGLVGFAFSGNSLLLWGISAAFFTIGEVIYA
PGEYMLIDNIAPAGMKASYFSAQSLGWLGAAVNPLVSGVILTTLPPWSLFVALIVAIILA
WALMIKGMRAKPWGQTAVC
>AMJ36090.1|FEATURES|farme|bacitracin|bcrA|antibiotic efflux|1
MLQVKELNQYYGGSHILRGVNFEARIGEVTCLLGRNGVGKTTLLKCLMGLIPARSGSVLW
QEKNVTQWKPHQRVRAGVAYVPQGRDIFPRLTVEENLLLGLSRFSAPEARHVPDDIYALF
PVLQEMKHRRGGDLSGGQQQQLAIGRALASRPQLLILDEPTEGIQPSVIKEIGQVISQLA
HRGDMAILLVEQFYDFAEQLADKYLLMSRGSIIQSGDGKNMESEGVRGLVAI
>AMJ36088.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRFQLEVDVIGYALSLALV
VGVLFSMGFGILADRFDKKRYMVWSVLVFILGFSAIPLVNNALLVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFWLA
>AMJ36033.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
GQAPQGAQLSLVEQSPHYRDGQFHNQLPTPGFTGQKNMLAAWWEFLVAKRENARPAQPLP
LVNTDLASLPLGQDAMVWLGHSSWYLQLAGQRILIDPVFSRYAAPFSFINKAFAGDYPWH
AEGMPEIDLLIISHDHYDHLDYATIKALMPKVKRVVTPLGVGSHLRYWGMESAIISEADW
NQAVPVSDELTVHVLPARHFSGRGLKRNQTLWASFMFVTPQQKIYYSGDSGYGPHFKAIG
EQFGAVDLAIMENGQYDQDWKYIHMMPEETAQAADDVRARAVLPGHAGRFVLAKHTWDDP
YIRLAEASTGRPWRLLTPMLGEPVWVADKTQSFNAWWR
>AMJ36012.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
MSWIILFIAGLLEVVWAIGLKYTHGFTRLTPSVITVTAMIVSIVLLSWAMRSLPVGTAYA
VWTGIGAVGAAITGILLLGESASLARIASLALIVAGIVGLKLSTH
>AMJ35984.1|FEATURES|farme|beta_lactam|SHV-26|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AMJ35857.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
EFIRDVAKSSVDDPLNARYTPFDGKPAFLQAAANWYRNVHGVELDWRSQLFAVEGAVDGL
AGLFAILIDRGDAVAFADPYYPSYHCMSVMHGAEEILLPARAELGWLPDLDAVDESVWRR
LRMLILNYPNNPTGAQAPASFFEHAVELAKRYGFLIVHDFAYTGLGVSDQQVSLLTVPGA
SDVSVEVD
>AMJ35832.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
MQDDLQTRLFTGDGPNFPEPDMSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAM
IVSLALLAWAMKSLPVGTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIG
LKLSTH
>AMJ35817.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|0
MFRLEEEKNSRGTVMSGSAIRGRQGSERFFTLPAVTLIASSFVLGMSDFVVVGILPDIAH
GLRVLEVTVGNLVSRFATHLTLIGVFLAGNILCALAPNYAVLPHYRHMAKVGFLPQFRMR
AGNGRLSALRLRTIPGR
>AMJ35810.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ35739.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIRFEHVSKAYLGGRQALQGVTFHLQPGEMAFLTGHSGAGKSTLLKLICGIERPSAGKIW
FSGHEISRLKNREVPFLRRQIGMIFQDHHLLMDRTVFDNVAIPLIIAGASYDDIRRRVSA
ALDKVGLLDKAKNFPIQLSGGEQQRVGIARAVVNKPAVLLADEPTGNLDDALSEGILRLF
EEFNRVGVTVLMATHDMGLISRRSYRMLTLSDGHLHGGHGE
>AMJ35689.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAGFYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYERAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMADMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>AMJ35658.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
VAIMLLASATTLPFVLNAGFGQAPQGAQLSLVEQSPHYHDGQFHNQLLTPGFTGQKNMLA
AWWEFLVAKRENARPAQPLPLVNTDLAGLPSGQDVMVWLGHSSWYLQLAGKRILIDPVFS
NYAAPFSFINKAFAGDYPWHAEGMPDIDLLIISHDHYDHLDYATIKALMPKVKRVVTPLG
VGSHLRYWGMESAIISEADWNQSLQVSDELTVHVLPARHFSGRGLKRNQTLWASFMFVTP
QQKIYYSGDSGYGPHFKAIGEQFGEVDLAIMENGQYDQDWKYIHMMPEETAQAADDVHAR
AVLPGHAGRFVLAKHTWDDPYKRLAEASTGRPWRLLTPMLGEPVWVADKTQSFNAWWR
>AMJ35553.1|FEATURES|farme|beta_lactam|OXY-1-3|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPPSWGVGDKTGG
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AMJ35539.1|FEATURES|farme|beta_lactam|MIR-14|antibiotic inactivation|1
ELTAKQWNGITLLHLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPA
>AMJ35523.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MGYERAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNV
QDMANWVMANMAPEKVADASLKRGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGS
DSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNP
ARVEAAYHILDALQ
>AMJ35491.1|FEATURES|farme|beta_lactam|ACT-14|antibiotic inactivation|1
LTAKQWNGITLLHLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASI
GLFGALAVKPSGMGYERAMTTRVLKPLKLDHTWINVPKAEEAHY
>AMJ35461.1|FEATURES|farme|beta_lactam|ACT-32|antibiotic inactivation|1
VHRTITPLIEQQKIPGMAVAVIYQGKPHYYTFGKADIAAN
>AMJ35318.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ35256.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHILPWEMMFVLFAVL
AAISFVGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTSRRTVRSLIIMGGWPILFGLL
LSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQG
>AMJ35239.1|FEATURES|farme|quinolone|oqxB|antibiotic efflux|1
MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIA
ETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARL
PEDVRRLGITTQKQSPTLTLVVHLFSPNGKYDSLYMRNYATLKVKDELARLPGVGQIQIF
GSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQ
GRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGA
NAIDLSNAVRAKMAELATRFPEDMKWAAPYDPTVFVRDSIRAVVQTL
>AMJ35210.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MPEIDLLIISHDHYDHLDYATIHALLPKIKRVITPLGVGSHLRYWGMDGALITEADWQQA
IPVNDELTVHVLPARHFSGRGLKRNQTLWASFLFVTPQQKIYYSGDSGYGPHFKAIGDEF
GPVDLAIMENGQYDQDWKYIHMMPDETAQAADDLRARAVLPGHAGRFVLAKHSWDEPYQR
LAAASEGRAWRLLTPVQGEPVWVADKTQSFNAWWR
>AMJ35039.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
MQDDLQTRLFTGDGPNFPEPDMSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAM
IVSLALLAWAMESLPVGTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIG
LKLSTH
>AMJ35019.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
RYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVAFNKAESGTAVLVDVNTGEV
LAMANSPSYNPNNFAGTSKDTMRNRAITDVFEPGSTVKPMVVMTALQRGIVNENTVLNTI
PYRINGHEIKDVARYSE
>AMJ34819.1|FEATURES|farme|beta_lactam|lactamase_B_2|antibiotic inactivation|0
DWQQAIPVSDEFTVHVLPARHFSGRGLKRNQTLWASFLFVTPQQKIYYSGDSGYGPHFKA
IGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQAADDLRARAVLPGHAGRFVLAKHSWD
EPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQSFNAWWR
>AMJ34812.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPDIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALISEADWQQAIPVSDEFTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ34601.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
PKLTGKPAATIDPEIQNYVWEIEHKPLPENFINTLAETLVDLHNIPEENINVQHINIKTI
QEIKNDFQRRMNKVKETYGVSDELWNRWKQWLENDELWPRHATMIHGDLHPGHIMVDNQA
NVTGLIDWTEATHSDPSMDFIGHHRVFDDEGLEQLITAYGKAGGEIWPRMKEHIIELNAV
FPMFIAEFAMESGESAYETMALKELGMKE
>AMJ34557.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
IRIDPGFSDYAAPFSFINKAFPGDYPWRAEGMPDIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALISEADWQQAIPVSDEFTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ34541.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
GVSNHQLGLVISAALIGLALGAIFSGPLADWLGRKKIIINSVFFFGFWTIATAFSHNVEQ
MMFFRFMTGLGLGAAMPNIGTLVSEYA
>AMJ34496.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
KVKETYGVSDELWNRWKQWLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEAT
HSDPSMDFIGHHRVFDDEGLEQLITAYGKAGGEIWPRMKEHIIELN
>AMJ34478.1|FEATURES|farme|multidrug|hp1181|antibiotic efflux|0
MNLSLRRSTSALLASSLLLTIGRGATLPFMTIYLSRQYSLSVDLIGYAMTIALTIGVVFS
LGFGILADKFDKKRYMLLAITAFACGFIAIPLVNNVTLVVLFFALINCAYSVFATVLKAW
FADNLSSTSKTKIFSINYT
>AMJ34471.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
LGIVISFVWLKVIHDPNNHPGVNQKELDYIAEGGALINMDQKSSAQKVPFSVKMGQIKQL
IGSRMMIGIYIGQYCINALTYFFITWFPVYLVQARGMSILKAGFVASIPAVCGFVGGVLG
GVISDWLMRRTGSLNIARKTPIVLGMLLSMTMLMCNYVNVEWMVIGFMAMAFFGKGIGAL
GWAVMADTAPKEISGLSGGLFNMFGNISGIVTPIAIGYIVGTTGSFNGALIYVGIHALVA
VLSYLVLVGDIKR
>AMJ34409.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKMTLRALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVCASWVHKTGAAGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>AMJ34398.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MMKLLNKALLRMSDWSRTTWCLAILMTVAFVLIGRLAQLQVFDTFDLEKKNLLQVQVDRK
LQSPRGTIYDRNGKPLAMSVVTKSLYADPKMIKQSPQEIAELISPYVTMSKENIVKALQE
DTAFVWLNRMMDADKSKAVQQVIKDNNIAGLNFVEESKRYYPNGVLAAQVLGFVGTDDKG
LDGLEMVLDDELKGGVQQEIVATDNKGNAIFGSVLSKFLPDKGKSVTLTIDATIQFIAER
ALDKAMVDTGAKHASVIVMDPKNGEILAMANRPSYDPNNYNQSGEEAFKNIAVTNLYEPG
STFKPIIASAALAAGKWKLDTVYNDKGAFAANGHIIRNWNGEGYGPVRLLDILKYSINTG
MAEIGTLTGADILSKYIRDYGFGSETGIELPGEGAGILYNPEDMSKLDVATMSIGQGIAV
TPLQMVRAFGALSNGGAMMKPHIIKSYSNSQGDVTSTTETSVVGQPVPAETAKTIVDILE
KEVSEGGGTKAMVEGYHFGGKTGTAQKLDTKHGGYLDGQYIASFIGFGPVEDPKFVVLVV
IDDPQKGSYYGSQIVAPVFKDIVSQLVRYYQMSPYVKESTPVAVKAANTLPEPKPGSDGS
VTLPNFTGFTYGEVRDWLHKAGLAFKPDGTGTATSQDESSGTTVQAGTAITVHFRR
>AMJ34381.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MKAAPKTPKAKRQEEQANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVRQGDMR
SLRVQEVSTARGMITDRSGRPLAVSVPVKAIWADPKEVHDAGGISVGGRWKALANALNIP
LDQLSARINANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIG
FTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERL
QALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNLSGTPKEAMRNRTIT
DVFEPGSTVKPMVVMTALQRGVVRENSVLNTIPYRINGHEIKDVARYSELTLTGVLQKSS
NVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYG
LMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGG
GVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASQPRFALVVVINDPQAGKY
YGGAVSAPVFGAIMGGVLRTMNIEPDALTTGDKNEFVINQGEGTGGRS
>AMJ34204.1|FEATURES|farme|beta_lactam|SHV-11|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIPDKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AMJ34098.1|FEATURES|farme|beta_lactam|TEM-57|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYRAGE
RFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPE
AMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP
>AMJ34078.1|FEATURES|farme|beta_lactam|TEM-57|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYRAGE
RFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCA
AAITLSDNTAANLLLTPLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPE
AMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP
>AMJ33936.1|FEATURES|farme|beta_lactam|OXY-6-4|antibiotic inactivation|1
MLKSSWRKSALMAAAAVPLLLASGSLWASADAIQQKLANLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AMJ33862.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MVRAFGAIANGGSMMKPHIVKSYSNIKGEVTSTTDPEVVGQPIPEETAKTIADILEKEVS
EGGGTKAMVEGYHFGGKTGTAQKLDTKNGGYLAGRYIASFIGFGPVEDPKFVVLVAIDDS
KKGSIYGSQIAAPVFKNIVSQLVRYYQMSPSVKDGATVAAVPAAKLPAVKPNGDGSVVLP
DFRGYTFGEVRDWLHTAGLYFKPDGTGKAISQEQLPGTVVSPGTPIVVQFSH
>AMJ33793.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
IAIAIRAIPDGTGQNAAENAHHEEKGLPVWRDVQLLLIGVVVLAMAFAEGSANDWLPLLM
VDGHGFSPTSGSLIYAGFTLGMTIGRFTGGWFIDRYSRVTVVRASAVMGALGIGLIIFVD
NPWVAGVSVLLWGLGASLGFPLTISAASDTGPDAPKRVSVVAITGYLAFLVGPPLLGFLG
EHFGLRSAMMVVLGLVMVAALVARAVAKPQHEPVMENS
>AMJ33766.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLASATALPFVLNAGFGRAPQGAQLSLVEQSPHYRDGQFHNQLPTPGF
TGQKNMLAAWWEFLVTKRENARPAQPLPLVNTDLASLPIGQDTMVWLGHSSWYVQLAGKR
ILIDPVFSDYAAPFSFINKAFPGDYPWRAERMPEIDLLIISHDHYDHLDYATIKALMPKI
KRVVTPLGVGSHLRYWGMESAIISEADWHQAVQVSDELTVHVLPARHFSGRGLKRNQTLW
ASFMFVTPQQKIYYSGDSGYGPHFKAIGEQFGAVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRTRAVLPGHAGRFVLAKHSWDDPYKRLAAASQQRPWRLLTPMLGEPVWVADKTQS
FTTWLR
>AMJ33752.1|FEATURES|farme|beta_lactam|ampC|antibiotic target alteration|0
PSNLTEVINGCLAYIDDENISVEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKIYIR
ARAEVETDAKTGRETIIVHEIPYQVNKARLIEKIAELVKDKRVEGISALRDESDKDGMRI
VIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDILSAFVRHRREVVT
RRTIFELRKARDRAHILEALAIALGSSSLSAVRRRLRKRKLA
>AMJ33707.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRYQLEVDVIGYALSLALV
VGVLFSMGFGILADKFDKKRYMVWSVLVFILGFSAIPLVNNAILVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFW
>AMJ33478.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
NAGFGQPPQGAQLSEVEASPHYRDGQFHNTLPTPGFTGQQNMLVAWWQFLTRKTENARPA
QPLPLVKTDLASLSPEQDTLVWLGHSSWYMQLAGKRILIDPVLSSYAAPFSFLNKAFAGE
YPWRAESMPEIDLLIISHDHYDHLDYATIKALLPKVKRVVTPLGVGSHLRYWGMNPEIID
ERDWNQSVHISDTLTVHVLPARHFSGRGIKRNQTLWGSFMFVTPERKVYYSGDSGYGSHF
KAIGEQFGGVDLAIMENGQYDQDWKYIHMHPAETAQASADLNAKAVVPGHNGRFVLAKHT
WNDPLIQLAKASKDKNYRLLTPELGEPVRVSDTTQQFREWWE
>AMJ33417.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVIT
NKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMY
TSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTP
>AMJ33301.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MIPTLRRSTAALLASSLLLTIGRGATLPFMTIYLTRQYQLEVDKIGYALSSALIVGVLFS
MGFGILADKFDKKRYMTLAVLAFIGGFIAIPLVNSVALVVFFFALINCAYSVFSTVLKAW
FADVLSPEKKAQIFSLNYTFLNIGWTVGPPIGTLLVMYSINLPFWLAAGCAALPLVFIQL
FVQRTSAAIAEDNAVQWSPSVLLRDRALLWFTLSGLLASFVGGSFASCISQYVLVVADSD
FAEKVVAVVLPVNAAVVVALQYAVGLRLTARNIRPLMTFGTVCFVLGLGGFVISDNSLLL
WGLSAAVFTLGEVIYAPGEYMLIDNIAPPGMKASYFSAQSLGWLGAAFNPMLTGTILTHL
PHWSLFAILMLAIIAAWLMIFRGMNVRPWNGSAVARA
>AMJ33247.1|FEATURES|farme|beta_lactam|OXY-2-4|antibiotic inactivation|1
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQIL
YRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTL
AELSAATLQYSDNTAMNLIIGYLGGPEKGHRLRPQYRRCHLSSRSYGAHAEYRHPGR
>AMJ33242.1|FEATURES|farme|beta_lactam|SHV-33|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETEL
>AMJ33166.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
HVLPARHFSGRGLKRNQTLWASFLFVTRQQKIYYSGDSGYGPHFKAIGNEFGPVDLAIME
NGQYDQDWKYIHMMPDETAQAADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRA
WRLLTPVQGEPVWVADKTQSFNAWWR
>AMJ32985.1|FEATURES|farme|beta_lactam|AmpC|antibiotic inactivation|1
MGSHYYISQPTPLAALPLQVPDEVKSSSDLLRFYQNWQPQWKPGTTRLYANASIGLFGAL
AVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAY
GVKTNVQDMANWVMANMAPEKVADASLKQGIGYNWHNLATGVSGQCIRVWAGRCSTGPWR
PTRWSRAATVR
>AMJ32924.1|FEATURES|farme|quinolone|oqxB|antibiotic efflux|1
MGKTLGRRGAVFVVYLLLLCAAGVMFKAVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAV
IRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINA
KIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRAGLGYGALQNAVNTMSGAIMQTPGMH
FPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQ
ADGQFRDSVEDIANLRTRNNQGEMVPIGSMVKITTTYGPDPVIRYNGYPAADLIGDADPR
VLSSAQAMTQLDAMSKQIPPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALY
ESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFAREL
EIQGKGIMEAALEACRLRLRP
>AMJ32831.1|FEATURES|farme|beta_lactam|BL1_ampc|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGTALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>AMJ32823.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGSGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ32725.1|FEATURES|farme|multidrug|mdfA|antibiotic efflux|1
MAAYTPVSRLTFRHLMFPLSLVLFEFATYIAHDMIQPGMLLVTSEFHVGAEWVSTSLTAY
LIGGILLQWLLGPLSDKYGRRPV
>AMJ32724.1|FEATURES|farme|beta_lactam|ACT-23|antibiotic inactivation|1
GMAVAVIYQGKPHYYTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIALGEISLD
DPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAW
>AMJ32684.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
AQPLPLVATDLAGLSPQQDTLVWLGHSSWYLQLAGQRILIDPVFSNYAAPFSFLNKAFAG
DYPWTAQTMPEIDLLIISHDHYDHLDLATIKALMPKIKRVITPLGVGSHLRYWGMRSEII
EERDWNQSVRVTDSLIVHVLPARHFSGRGIKRNQTLWASFMFETLEQNVYYSGDSGYGPH
FKAIGEQFGSVDLAIMENGQYDQDWKFIHMMPEETAQAAADLHAKAVLPGHAGRFVLAKH
TWDDPYKRLALASRRQDYRLLTPMLGEPVILSEPDQPFTAWWQQATQ
>AMJ32642.1|FEATURES|farme|macrolide-lincosamide-streptogramin|msrE|antibiotic inactivation|0
ILIDPVLGNYAAPFSFLNKAFAGEYPWRAEIMPAIDLLIISHDHYDHLDLATIKALMPKI
KRVITPLGVGSHLRYWGMDGAL
>AMJ32578.1|FEATURES|farme|tetracycline|tetA(P)|antibiotic efflux|1
KTYLLFSAITAMCFSLVATVMIVYHIEIVHLNPLQLILVGTTLELACFIFEIPTGIVADV
YSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWIAEEEKNKD
LDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLYMPENNFKP
SAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTL
PKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIF
ALTRNFSLMLIAYLATNTFRIINEPIFSAWLNGHIDDNSRATVLSINGQMNSLGQILGGP
IIGIIATNISVSIGIVCTSLLVAPVLVLYIISMIMDKKIS
>AMJ32540.1|FEATURES|farme|tetracycline|tet39|antibiotic efflux|0
MTVNSSRNALKRRTWALFMFFFLPGLLMASWATRTPAIRDILSVSIAEMGGVLFGLSIGS
MSGILCSAWLVKRFGTRNVILVTMSCALIGMMILSLALWLTSPLLFAVGLGVFGASFGSA
EVAINVEGAAVEREMNKTVLPMMHGFYSLGTLAGAGVGMALTAFGVPATVHILLAALVGI
APIYIAIQAIPDGTGKNAADGTQHGEKGVPFYRDIQLLLIGVVVLAMAFAEGSANDWLPL
LMVDGHGFSPTSGSLIYAGFTLGMTVGRFIGGWFIDHYSRVAVVRASALMGALGIGLIIF
VDSAWVAGVSVVLWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLVGPPLLGY
LGEHYGLRSAMLVVLALVILAAIVAKAVAKPDTKTQTAMENS
>AMJ32496.1|FEATURES|farme|multidrug|cmeA|antibiotic efflux|0
YDSKQELYKQNVVSAFDLSTAKNSLLAAQAQLAQMKAQEVNARNNLSYTLVKSPADGVVG
TLPYRVGTLVSASLPEPLTTVSDNSDMYVYFSMTENQLLGLIRRYGSKEEALKQMPEIGL
QLND
>AMJ32470.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
PLVATDLAGLSPQQDTLVWLGHSSWYLQLAGQRILIDPVFSNYAAPFSFLNKAFAGDYPW
TAQTMPEIDLLIISHDHYDHLDLATIKALMPKIKRVITPLGVGSHLRYWGMRSEIIEERD
WNQSVRVTDSLIVHVLPARHFSGRGIKRNQTLWASFMFETPEQSVYYSGDSGYGPHFKAI
GEQFGSVDLAIMENGQYDQDWKFIHMMPEETAQAAADLHAKAVLPGHAGRFVLAKHTWDD
PYKRLALASRRQDYRLLTPMLGEPVILSEPDQPFTAWWQQATQ
>AMJ32436.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
NRSSSGSRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTAYL
AGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVT
>AMJ32328.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTELATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSDYPAPFSFINKAFPGDYPWRAEGMPDIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALISEADWQQAIPVSDEFTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPMQGEPLWVADKTQS
FNAWWR
>AMJ32321.1|FEATURES|farme|multidrug|mdtL|antibiotic efflux|1
MTRFLLCSFALVLLYPSGIDMYLVGLPRIAQDLGASEAQLHIAFSVYLAGMASAMLFAGR
IADRSGRKPVAIVGAVIFVVASLLCALAHASSHFLVGRFIQGIGAGSCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKYPWQSLFYTMTGMGVMVGLLSVFILRE
TRPTAPPQTATPQHGGSESLLNRFFLSRILITTLS
>AMJ32316.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
KIYYSGDSGYGPHFKAIGEQFGGVDLAIMENGQYDQDWKYIHMHPAETAQASADLNAKAV
VPGHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEPVRVSDTTQQFREWWE
>GU721005.1_1001|FEATURES|farme|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
MEAGLVDQDDLDEEHQGLAPAELFARLKASCPT
>GU720999.1_1015|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
MRNKLFLALFSFGFFSSSAQTTYYPDSIWQVKTAAEMMMDKTLLDSAVRFAVANENKFDR
DLRIATLKAYGNEPDFKIIGPTKDRGGPAGLIIMNGYIVAQWGDVNRVDMTNSVTKSFLS
TIAGLAIDEGLIRNVSDKVYNYVWDGTFAGEHNSKISWEHLLTQSSDWSGTLFDLADWAD
RPPKEGGIDDWKNRKLNEPGSFFKYNDVRVNVMAYSLLQVFRKPLPMVLKEKIMDPIGAS
TTWRWYGYDNSFINIDGLMMQSVSGGGHHGGGLFISTLDQARFGLLFLRKGKWRTQQLIS
EKWVRAVHQPSSAFKDYGYMWWMNNSKKWKDVSPDIYYANGAGGNYIVIDNEHGLVVVTR
WMDDSKMGELMKIIEQSIKNN
>JX009351.1_1034|FEATURES|farme|beta_lactam|AK972_2544|antibiotic inactivation|1
TYTAGGLPLQFPEESDNTGKMISYYQHWKPDFAPGTQRLYSNPSIGLFGHLAAQSLGQPF
DRLMEQTLLPKLGLKHTFINVRVPTGKSEQYAQGYDKDQKPVRVTPGALDSEAYGIKTST
QDLARYVIANLHPETLE
>JX009341.1_1043|FEATURES|farme|aminoglycoside|ANT(2'')-Ia|antibiotic inactivation|1
MDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAI
VEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPV
RCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA
>JX009327.1_1053|FEATURES|farme|beta_lactam|UCMB321_2366|antibiotic inactivation|1
MFKKNLAKLEVLVTSLLLVGASNSFAADTPQDKVKSIIDAAIEPIMQEQNIPGMAVAVLV
NGKPYHFNYGLASKANRQAVTDDTLFEIGSVSKTFAATLAGYAQAQGKLVPSERVSHYLP
ELKGSAFDNITVLQLGTYSAGGLPLQFPDAFDAQDKMLDYFKQWKPIYPAGSHRQYSNPS
LGLFGYVAAKSLGAPFDELIEKTLLPALGMKHTYLHVPPAQMPHYAEGYTQDDKSVRVGP
GALDAEAYGIKTTSTDLLRFVEANLQPETLEAPLHKAIDLTQSGYYQIDGTTQGLGWEFY
PYPVKLEPLLTGNSSEMAYEAHKITTQFNPAQPPQKNALFNKTGATRGFGAYVVYVPAKK
IGIVMLANKNYPNPVRVKAAYQILNALEAVK
>JX009321.1_1061|FEATURES|farme|beta_lactam|M992_2411|antibiotic inactivation|0
LLLDSSGGPQGLTDWLRLTGDQVTRLDRREPDLN
>JX009313.1_1065|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
TIIVLDGRTGGYQAYDSTRANQRMSPASTYKIFNSLLALESGALDNEREIIPWDGKPRSM
KRWERSNESARCVPGVVSAVLSGCVAQDCADLCAGQARCGG
>JX009305.1_1071|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MPQLSLSGVRNLGALALFLATGHCLAADDLRAVVDASVKPLMQQQSIPGLVVGVVKDGKA
QYFNYGVAS
>JX009301.1_1073|FEATURES|farme|beta_lactam|AV650_28380|antibiotic inactivation|1
MKKNFNKVLAITSLMVSMAPFAAQKSLTAEQISQIVNGTVKPLLEAQSIPGMAVAVIYQG
QPYYFTYGQADIKKNLPVTKKTIFELGSVSKTFTGVLGGDIITRGEMKLSDPVTKYWPQL
TGSQWKGINMLHLATYTAGGLPLQVPDSVTDDASLLNFYQNWQPQWKPGTMRLYANASIG
LFGHLAVKPSSMTFEQTISQRVFQPLQLTHTWINVPKSAEKEYAWGYSNGQPVRVSLGML
GAESYGVKSTIEDMTVWLKANMTPQHLNDSTLKQGILLAQSRYWRVGNMYQGLGWEMLNW
PVNADTLINGSDNQVALAPHPSIAIIPPDPAENASWVHKTGATEGFGAYVAFIPEKQIGI
VMLANKNYPNQERIKTSYAILEALQ
>JX009295.1_1079|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MPQLSLSGVRNLGALALFLATGHCLAADDLRAVVDASVKPLMQQQSIPGLVVGVVKDGKT
QYFNYGVASKDAKQPVSENTLFEIGSVSKTFTATLAGYAVASGKLTLTDPASQYLPALRG
GKFDHISLLNLGTYTAGGLPLQFPREADNTQHMISYFQQWKPDFAPGTQRLYSNPSLGLF
GYLAAQSLKQPFDALMERTLLPKLGLKHTFVNVPASQMNLYAQGYGKDGKPVRVGPGAMD
SEAYGIKTSAADLLHYVSVNMNPAGLEKSLQQAIATTHTGYYSVNGMTQGLGWELYPYPI
TLAALVEGNSSQMALEPHTVDWLTPPQAPHADTLVNKTGSTNGFGAYVAYVPSKGMGVVV
LANKNYPNGERVKVAHAILSALDH
>JX009269.1_1101|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
DAAVALAFSFDHKVLVESAIVGREIECAVLGNDDPQASLCGEIVLSDAFYSYDTKYINEQ
GAQVVVPAAITPEVSDKIREVALKAFRALECFGLARVDVFLTPDNNVVINEINTLPGFTN
ISMYPKLWAASGISYSQLITRLIELALERHQQDRALNSSVFDR
>JX009247.1_1122|FEATURES|farme|multidrug|floR|antibiotic efflux|1
MQKFLFLLLSLVLLGPLGIDLYLPTIPAIALGLNSSEALIQSTISLFILVLGLGQIIAGP
LVDNYGRKPVALAGIVIYMIGAAMAALATTPTVFVASRLLQGVAVCCTAVVAFSGVRDRM
NGDDAARAFGFLNGTLNIIPALAPLLGGLLAEALGWRAPFWFLVCYALAVLVLIALRLPE
TRPADTVRVKGLPVRQYARILKDRRFLSFAVVNSGAMGMALTYVSLAPNVLMGTAGLTPL
QFSLVFGANGFWIMLVSFFANRIIHKVGRPVCLATGGILMGIGCVGLLLGVTWLSGSAQT
HWLAYMLPVASACAGLAFVMGPATSYALEPYSNEAGVASALVGFVQMAGGAGLGLLAMAL
PLQPKLSLALVMLVGCLLALHARQRSKQIKGQLKKIA
>JX009237.1_1129|FEATURES|farme|beta_lactam|farB|antibiotic inactivation|0
MPTGASAPSSPLVIRLDAPQHVGDQPVRYQSLWLLMRLYYAARFETASVPLAALKSRFAQ
AGDLRMLVSRAFADFAEWGVSAGWGDDHQADARLLPTRGRG
>JX009219.1_1146|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MKRIHKLAVALLTALAIPAGHAADKVDIDAIVQPLMQKYGVPGMAIAVSVEGKQQFYHYG
VASKQTGKPITNQTLFEIGSLSKTFTATLAAYANDEGKLSFAEPASRYLPELRGSAFDHV
SLLNLATHTSGLPLFVPDEVTNDAQLMA
>JX009346.1_1180|FEATURES|farme|chloramphenicol|cmlv|antibiotic inactivation|1
ACTTSCLILGASFAAFSYFVPVLVDVSGFTMQTVPFILMLYGLANIVGNMITGRLAYRHS
LAIMVVGLSILSLSLFGMALFAEYPLIAICAVILIGLSGVPMNPAMMMARIVSVAHPGPM
VNAVHTSVINIGLGGGSYLGGMAIASGYGLRSALWIGMALAVLALLSILPYLRRGQQGWR
>JX009328.1_1195|FEATURES|farme|chloramphenicol|cmlv|antibiotic inactivation|1
WKACTTSCLILGASFAAFSYFVPVLVDVSGFTMQTVPFILMLYGLANIVGNMITGRLAYR
HSLAIMVVGLSILSLSLFGMALFAEYPLIAICAVILIGLSGVPMNPAMMARIVSVAHPGP
MVNAVHTSVINIGLGGGSYLGGMAIASGYGLRSALWIGMALAVLALLSILPYLRRGQQGW
R
>JX009248.1_1270|FEATURES|farme|beta_lactam|blaP1b|antibiotic inactivation|1
SPPRGPVLDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADL
VTYSPVIEKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRL
DRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLR
SVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGH
SIFDVYTSQSR
>JX009218.1_1292|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MDSEAYGIKTSASDLLHYVEVNMRPATLDPVLQQAITTTHTGYYTVEGMTQGLGWEMYPY
PIKLDALVEGNSTKMAVEPHPVNWLTPQQAPHADTLVNKTGSTNGFGAYVAYVPSKGMGV
VILANKNYPIADRVTAAHGILSAMDQ
>JX009208.1_1301|FEATURES|farme|beta_lactam|PMI39_02504|antibiotic inactivation|1
LFGWLATKPSGLTFEQAMQQRVFMPLQLKHTFITVPNTAKENYAWGYREGKPVRVSPGML
DAEAYGVKSSIKDMARWMQANMNPQQINDKTLQQALDFAQTRFYRTDALYQGLGWEMLDW
PAQAEMAVKGADNKVALGPQPVRDAKSHPRVTASWVHKTGATGGFGAYVAFIPAKQVGIV
ILANKNYPNTERVKAAMQILKALQ
>JX009202.1_1311|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MPQLSLSGVGKLTALALFMAAGQCLAAADLRTVVDASVKPLMQQQSIPGLVVGIVKDGKT
QYFNYGVASKDAQQAVSENTLFEVGSVSKTFTATLAGYAVATGKLSLTAPASDYLPALRG
GRFDHISVLNLGTYTAGGLPLQFPAEADNNQRMISYFQHWKPDFAPGTHRLYSNPSLGLF
GYLAAQSLKQPFDQLMEKTLIPKLGLKHTFVTVPKSQMNLYAQGYGKDGKPVRVGPGAMD
SEAYGIKTSASDLLHYVEVNMRPATLDPVLQQAITTTHTGYYTVEGMTQGLGWEMYPYPI
KLDALVEGNSTKMAVEPHPVNWLTPQQAPHADTLVNKTGSTNGFGAYVAYVPSKGMGVVI
LANKNYPNGERVKVAHAILSALDH
>KF630360.1_11318|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
QPLPLVKTDLASLPLEQDTLVWLGHSSWYLQLAGKRILIDPVLSNYAAPFSFLNKAFAGE
YPWRAESVPEIDLLIISHDHYDHLDYATIRALLPKVKRVVTPLGVGSHLRYWGMKPEIID
ERDWNQSVRISDELTVHVLPARHFSGRGIKRDRTLWGSFMFVTPEQKVYYSGDSGYGPHF
KAIGEQFDGVDVAIMENGQYDQDWKYIHMLPEETAQASVDLNAKAVVPGHNGRFVLAKHT
WNDPLIQLAKASKDKNYRLLTPALGEPVRVNDATQTFRAWWE
>KF630351.1_11341|FEATURES|farme|multidrug|ABC_transporter|antibiotic efflux|0
MISANNITLRVGKKALFEDVNIKFTEGNCYGLIGANGAGKSTFLKILSGQLE
>KF630334.1_11382|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
AIFALPLIGKFNRNARDYSCLRIVQWGFKAILKVTGVHTTVIGFENIPDEPVLFIGNHRS
FFDILLTYSRCPRLTGYVAKKEMEKIPLLSTWMRFVYCLFLDRENPKEGLKTILQAIDYV
KQGISICIFPEGTRNKGEELSMLPFKEGAFKIAAKTGCAIVPISMNNTAAIFENQFPRIK
KVNVVVEYGTPIYPKDLAPEDKKHIGAYVQNIIQETINKNAELI
>KF630334.1_11384|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICKTLLEKGHDAFLLDVFLGLENAPENLEDVFTLPGH
GLEIAKNISETEPDLAAVKASRPDQSDCFFGPNVIELCRLADMTFLGLHGGEGENGKLQA
SFDLLGIRYTGPDSLGCAVAMDKGLTKQIFMEAGVDTPSGVCLYKEDSDCSLESLGLSFP
VVVKPCSGGSSIGVYIVNTEEEYRQALKNSFRYENEVVVETYIKGREFACGVIDGKALPP
IEIIPKNGWFDYANKYQANATEEVCPADISEEIAERMKALTVRAFQALKLNVYSRADFIL
DADGNLYCLEMNTLPGMTSASLLPKEALADGIEYGDLCELIIQKSMEARYQ
>KF630331.1_11392|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
TCGEVVLNSDFYSYDTKYIDDKGAQVVVPADIDPAINDKIRAIAIRAYQTLGCCGMARVD
VFLTQENEVVINEINTLPGFTNISMYPKLWQASGLSYPELITRLIELALERHAADSALKS
SVNG
>KF630327.1_11398|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|0
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERFEPIPVGITKDGKWIINGEDPRGWN
LDGGRAADRKDHPGIAPGDA
>KF630322.1_11411|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVD
RNDFSFMNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFAC
NQYLKAFGVRIAESLLLRQGQSVSDEDVLEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAEEVLVEAFMEGTELTCGCYKTKEKSVVFPPTEVVTHNEFFDYDAKYNGQVD
EITPARISDELTDRVQMLTSAIYDILGCSGIIRVDYIVTAGEKINLLEVNNTPGMTATGF
IPQQVRAAGLEIKDVMTDIIENKF
>KF630318.1_11425|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
PNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFL
SEVHQTFEGTPSSQCSTKQNSSLSQPKPFKL
>KF630317.1_11430|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MGIIKAKDLVHEYIRRDEEGNVESIQTALDKVSLDVKKGDFIAVLGHNGSGKSTLAKHIN
AILEPTEGSLWVDGFDTTDEKNIWDIRQRAGMVFQNPDNQIIASVVEEDVGFGPENIGV
>KF630298.1_11476|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MVCKALREKNHQAVLVDVFCGVDVKGNLEDVFAEEAYDIDKAAEYMHSFDAGLNEMTASR
RRFFGPNVLELCEAADVVFLALHGANGEDGKVQATFDLLGIPYTGTGYLSSALAMDKSIT
KQFFRAHNVPTPNGVTLKKGQESEPLSGFGLELPVVVKPCCGGSSVGVYIAHTNEEYWQA
MKDAFSYEPEVVVEEYIEGREFSVGVVDGKGLPDHRDRTDRRLL
>KF630298.1_11477|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
VLTEEQTKEMQKHAEDGAAALGIENYCRLDFMMRKDGRMYCLEANTLPGMTPTSLLPQEA
QVLGISYPELCELLIQLSLRKRGKNA
>KF630285.1_11510|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWAEARDKEGRAGAIGLNGGM
PWHCAEDMKHFKELTVSHPVIMGRKTWESLGGKYRPLPNRDNIVVSHDPMYRAPGATVVT
SLDDALDMARQEAIPDDGLDRSEIWIIGGAQLFAKALPFADKAYVTDLAATVDADSYAPD
MASLVEAGMWREAEVGEWHTPAKEESGIDSYRFRILAKTK
>KF630273.1_11535|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLAQVCDMKVGEFVHVIADAHIYDRHVPMIEELISREPLPAPTFWLNPEITDFYDFTPDD
VRLDRYETHPQIKNIPIAV
>KF630273.1_11536|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MRAIVCADKNWGIGYKNRLLVSIPSDMKFFRETTTGKVIVMGRKTLESFPNGMPLKNRIN
IVLTRDRNYEAKGAVIVHDEEELMNELGKYDTEQIYIIGGESVYKMMLSHCDKIYVTKVD
RAFQADTYFPNLDEMSEWKMTQESEE
>KF630214.1_11658|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MNNIFAERLKKAMEQKNMKQIDLVKKAAEQGVKLGKSHVSQYLSGKTTPRSEILNFLATT
LGVETEWLKGTDVSVDTLKKETNEAGIQMENMKFDYNYNNMKENTRETVEEVQVREFKKS
SKLNNVLYDVRGPVVEEAARMENAGTQVLKLNIGNPAPFGFRTPDEVIYDMRQQLTECEG
YSPAKGLFSARKAIMQYAQLKKLPNVSIEDIYTGNGVSELINLCMSALLDNGDEILIPSP
DYPLWTACATLAGGKAVHYICDEQAEWYPDMDDIRKKITSRTKAIVIINPNNPTGALYPR
EILQQIVDIAREHHLIIFSDEIYDRLVMDGAEHISIASMAPDLFCVTFSGLSKSHMIAGF
RIGWMILSGNKAVAKDYIEGIKMLSNMRLCSNVPAQSIVQTALGGHQSVESYIVPGGRIY
EQREFIYNALTDIPGITAVKPKAAFYMFPKIDTKKFNIVNDEKFALDLLKEKKILLVHGG
GFNWHQPDPFRVVYLPRIEVLKEAAGKIRDFLEYYQQEI
>KF630193.1_11712|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
LQDDLQTRLFTGDGPNFPEPDMSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAM
IVSMALLAWAMKSLPVGTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIG
LKLSTH
>KF630179.1_11741|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICRTLIEKGHDAFLLDVFLGLEHAPEHLEDVFTLPGH
GLEIAKNISCEEPDLAAVKASRPDQSDCFLGPNVIELCRLADITFLGLHGGEGENGKLQA
TFDLLGIRYTGPDSLGCAVAMDKGLTKQVFLQAGIDTPAGVTIHKKSKDRSLALTGLSLP
VVIKPCSGGSSIGVYIVSTEEEYAEALEKSFFYEDEVVVEEYIKGREFACGVIDNEALPP
IEIIPKTGFFDYANKYQADATLEVCPADIPEETASRMMELTVKAFRALKLNVYSRADFLL
DEKGNLYCLEMNTLPGMTAASLLPKEAKAAGIEYGDLCELIIKKSLEARY
>KF630168.1_11771|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MRDFLSKRVVSLEPSGIRKFFDIVSEMPDAISLGVGEPDFDTPWRVREEGIYSLERGRTF
YTSNAGLKELRYEISEYLERKYELVYDPNHEITVTVGGSEGIDIAMRTILDPGDEVIVVQ
PCFVSYVACVVMAGGTPVIVSLKEEDKFKLKKEQLEAAVTDKTKAMIISFPNNPTGAIMT
REELEPIAEFAKEHDIVVISDEIYSELTYGRDHVSIASLPEMKDRSIVINGFSKAFAMTG
WRLGYVAAPRYMMKQMVKVHQFCIMAAPTTSQYAAIEAMRSCDDEVEEMRTAYNQRRRFL
VHEFQRMGIECFEPEGAFYIFPSIKKFGMTSEEFATKLLNEEKVAIVPGSAFGACGEGYL
RVSYAYSIEELKEALGRLERFINHLPKKQ
>KF630165.1_11780|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF630159.1_11796|FEATURES|farme|beta_lactam|ACT-2|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGCDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>KF630157.1_11803|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYSAFEVKTYFITQSGDFIKTQEFTETPG
DDEKLMTNDTVVASQAIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKHILEVAGVPQVAYTVFIEGEDLEAAVAETLEKLTFPVFVKPANMGSSV
GISKAENETELRAAIDLALKYDSRILIEQGVVAREIEVGILGNTNVKTTDPGEVVKDVAF
YDYQAKYIDNKITMDIPAHVPAEVMTQMRAYAAKAFRALGGCGLARCDFFLTEDGAIYLN
ELNTIPGFTQWSMYPLLWENMGLSYSDLIKELVALGQEMFDKRESHLI
>KF630156.1_11805|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
HYTKAQFRNPGGVSEMEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWAEAR
DKEGRAGAIGLNGGMPWHCAEDMKHFKELTVSHPVIMGRKTWESLGGKYRPLPNRDNIVV
SHDPMYRAPGATVVTSLDDALDMARQEAIPDDGLDRSEIWIIGGAQLFAKALPFADKAYV
TDLAATVDADSYAPDMASLVEAGMWREAEVGEWHTPAKEESGIDSYRFRILAKTK
>KF630148.1_11824|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLDLPFCTVKLATMALTPEQLADIRTRIPARPETDIPMPYEDLVRKILTEGTLKSDRTGT
GTVSLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQERNVHIWDEWA
DENGDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVENHPDSRRMVVSAWNPAEVEN
MALPPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQAGLQPGEFV
WTGGDCHVYDNHIDQVLEQLSRDPYPYPQIRINKADSLFDYDYSDFEIVGYQHHPTIKAP
VAV
>KF630145.1_11836|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLKNRRNIVLTRDESFAPEGVDVVH
SIDEALAAVADEPVAWVIGGGDVYRHFLPYCVEAEVTHDHCVHVVDTYFPDLEADPAWEI
AQRSGVATIAAGEGDEGVDYEFVTYRRIEA
>KF630142.1_11840|FEATURES|farme|aminoglycoside|LPLAT|antibiotic inactivation|0
MNIPAEFNEIRPYTPEELPQIYEELIADPAFRTVVESVMPGVPFEGLAMKMRQCKTNLEF
QKAFFYGLLWDLVKKTANGLTFDCSALSDLTRNYTFISNHRDIILDSAFLSILLIDNGMT
TVEIAIGDNLLIYPWIHKLVRVNKSFIVKRGLNMRQKLEASALMSRYMHFAMKEKHENLW
IAQRQGRAKDSNDRTQDSVLKMMAMAGEGDVTERLKGR
>KF630141.1_11843|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QMVPQVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIFSFKYE
DFELVNYDPWPHIAGKVSV
>KF630137.1_11852|FEATURES|farme|multidrug|MexF|antibiotic target protection|0
GGFTGLLLGSTSQGLLQHAVGPVYVVPRKYVEAAETRLDTVPSSPAEVKPKALDDIKGVE
EVPVSKAEPDVVEAIETKIDPDRQ
>KF630131.1_11878|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTAGHVIIMGRKTFESLPFLLPNREHW
VITRDKGFDAPEGVKIFHNLEAAAEEAHALDAAYVIGGAQVYEAFLPYVDTMYITEVDHE
FDGDAFFPEFSEDAFTIESVVDGIVDEKNQYPHRFVTYRRKAAK
>KF630127.1_11889|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNGLPLKNR
TNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVLGGESVYRMMLPYCSKVYVTK
IDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF630126.1_11891|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
GLDRSEIWIIGGGQLFREAMPFADKAYVTQISMHADADTYAPDVKSLVESGAWKVLEEGV
WQNTRKGSGDIAGFRFMTYAKNREE
>KF630119.1_11908|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVSKVEHEGDAAELAAAVFEASHHDWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHV
EVPASLPEETLNRVRETAKKAFIAVDGAGLSRVDTFVTADGEVMVNEINTMPGFTPISMY
PKAWEATGVSYTNLITMLIEGVLR
>KF630116.1_11915|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IERPHFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF630110.1_11928|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
KYTLYIVEMHGLDWHVQLPDGAKAPVDRNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQ
GYFDMLHIPYSCCGVLAASLTYDKFACNQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIG
LPCFIKPSLGGSSFGVTKVTAKEQIQPAIAKAFAEAQEVLVEAFMDGTEITCGCYKTKDK
SVVFPITEVVSHNEYFDYEAKYNGASDEITPARISDDLTRRVQTLTSAIYDILGAYGIIR
VDYIITEGEKINLLEVNTTPGMTATSFIPQQVRAAGMEMKDVMTDIIENKFKD
>KF630101.1_11947|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKMARRIALLCGGASGEREVSLLSAAAVEEALEKRYEVIKIDTGVEGWAHTLLDSSVEG
VFICLHGGAGENGSIQGFCESVGLPYTGPGVLSSAIAMDKFVAKLLVESFRIPTPGYIRV
LRGEECNIEDIRTKLGGKLVVKPSTEGSALGVSIVDNGDDLACAIDTALELAPSVLVEQF
ISGRELTVAVLGGEKPRVLPPIEIIPANEFYDYEAKYEQGMAQHICPANLTEEELRQCEE
MALGAHDALGCYGVSRTDCILDERNRLWYLETNTIPGMTGTSLLPDAAKAVGITFDELCW
NIMEDAWSRC
>KF630093.1_11966|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIAAVDRKRGIGYQNRLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSTQKDLICPDAEVFSSLKEALNSCQPDEHVYIIGGASVYRQALPFAGALCLTEVDAE
APQVDAYFPEVAPTVWQEKSRESHPADEKHPCPYAFVDYIRR
>KF630090.1_11972|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVAVDKNWAIGNGNKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVN
VVLTTDQNYKANGAVIVHTIEQMLAELKKYASEDIFVIGGESIYRQLLPYCSKAYVTRID
HAYDADTHFPDLDADPQWEMTKISDEQTYFDLEYVFTIYERIS
>KF630082.1_11988|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGREDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDALDLARQEAIPDDGLDRSEIWIIGGGQLFREAMPFADKAYVTQISMHADADTYAPDV
KSLVESGAWKVLEEGVWQNTRKGSGDIAGFRFMTYAKNREE
>KF630070.1_12017|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
VSGQACVKAGGRDESLLEKYGRYLRMNLIVAVDEKWGIGRDGGLLAHLPEDMKYFRETTR
GKTVVMGRKTLESFPGGKPLKNRVNIVLSRNEQYAPEGVRVHQRVEDVLEALKGCGEDDV
FVIGGGMIYREFLPYCTKAYVTYIRRTFDVDTDFENLDRNGDWELESVSDAKEHEGISFE
FRIYGRGRL
>KF630068.1_12023|FEATURES|farme|tetracycline|tetC|antibiotic inactivation|0
MTGGRYIMEKKNIDWGSIGFGYIPTDYRYVANFKDGKWDEGQLTTDPNVTLNECACVFQY
AQTVFEGMKAYTTEDGHIVTFRPDLNAERLANSARRLEMPVFPEDRFVEAVVQTIKANEA
YVPPYGSGATLYVRPYMFGSNPVIGVKPADEYQFRILTTPVGPYFKGGATGASRG
>KF630060.1_12041|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLKNMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDAAADDFMVTMAT
GGFDVAFIAVHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQACDSLIRMGLRRAGIAC
>KF630056.1_12052|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVAVDSNWAIGKENKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVN
VVLTTDKNYKVKDTVIVHSVEEMVEELKKYNSEDVYVIGGESIYRQLLPYCTKAYVTKID
HAYDADTYFPDLDADPEWEMTKISDEQTYFDLEYVFVIYERR
>KF630051.1_12064|FEATURES|farme|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|0
PETLGETIPDFHNMEFRLKQLRDAVAANAAGRVAEEQYYLDEIEKRADEMCKAERLFREG
KLPKRVCHRDTKVNNMMFDEDGKVLCVIDLDTVMPSFIFSDYGDFLRTGANTGDEDDKDL
DRVNFNMEIFKAFTKGYLKGAKSFLTPIEIENLPYAAALFPYMQCVRSLADYINGDTYYK
IKYPEHNLVRTKAQFKLLQSVEEHTPEMVAFINECLVNG
>KF630038.1_12099|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
LLEWIVNLKRKGNTLSKQLIAIWAEARNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMG
RVTFDGMNRRCLPGRETLILTRDKDFDCEEVTTVTSVEEALAWFEQQDKDLYIAGGAGVY
KAFDGHYDALIKTTIEADLEGDTYFPQLDMTAFKEVSHERVAKDDKNAYDFIISRYEKEG
D
>KF630029.1_12122|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSLTSGAGICRTLRENGHQAFLLDVFLGFPYDSDKLEEVFTLPNA
GLEIADGIKTTEPDLAAIKASREDQSDCFLGPNVIDICRLADIVFMGLHGDVGENGKLQA
TFDILGIKYTGPNYLGSALAMDKGVTKQIFTMAGVPTPLGTNLTKDRKDTALSDLGLTLP
VVVKPCSGGSSIGVYIVDTMDAYKEAVENSFRYEDEIVIEPYIKGREFAVGIIDGKALPV
IEIIPKTGFFDYANKYQDGCTEEICPANIDEEVTERMQRAAELAFKALKLDIYSRADFLL
DENNDIYCLEVNSLPGMTAASLLPKEARAAGITYGDLCELIIQKSLARYNA
>KF630028.1_12126|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGVEKSDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQDNGVRIWNEWADENGDLGHIYGYQWRSWPNYKGGFIDQISEAVETIK
HNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRDLPQMRINPDVKNIF
DFKFEDFELVNYNPHPHIAGKVSV
>KF630028.1_12127|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIAAVDRKRGIGYQNRLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSTQKDLICPGTEVFPSLEEALSSCQPDEHVYIIGGASVYRQALPFADTLCLTEVDAE
APQVDAYFPEVAPTVWQEKSRESHPADEKHPCPYAFVDYIHR
>KF630027.1_12131|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLSIIVAMAENNVIGKDNKLLWHVPEDLKRFKSITSGNIIIMGRKTFESLPGVLPNRKHI
IITR
>KF630023.1_12139|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMILNQRSQDILAANNWNVCQYA
>KF630021.1_12144|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VVSTTTEYQGDNLVSVKSLEDALLLAKGRDVYISGGYGLFKEALQIVDKMYITEVDLNIE
DGDTFFPEFDINDFEVLIGETLGEEVKYTRTFYVRKK
>KF630016.1_12160|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIINGE
DPRGWNLDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDP
EMHHVLTSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVV
LDAAGIPTAPGVTVDARNFTAADVLAEIEAAGLTYPLFVKPSRAGSSFGVTKVEKADDRE
TQQDRLAAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDD
QFYDFDSKYMDASASHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTV
MVNEINTMPGFTPISMYPKAWDATGVSYTELITRLIEGVLR
>KF630011.1_12170|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
VKEMNLIAAVDANWAIGYKNKLLVSIPDDMKFFRQTTTGKVVVMGRKTLESFPNGQPLKN
RVNIVLTSDKNYKVKDAIVVHDLDELHKELEQYNSEDVYVIGGESIYRQLLDECDVAHIT
KIDYAYDADAYFPNLDEKEEWQITEDSDEQTYFDLEYYFLKYERIR
>KF630010.1_12172|FEATURES|farme|beta_lactam|YBT1518_18690|antibiotic inactivation|0
VYRKTLSFRKTDISNSNVIIMEDKKTQLTNEAGIPVGDNQNSRTTGPRGPELLENVWLLE
KLAHFNRERIPERIVHAKGCGAFGTFTVTNDITRYTKAAMLA
>KF630009.1_12174|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
GGLSTERDVSFKTGDMVAKALRENGHQVILLDVFMGYSDKKEDLTGIFDRSEEVSVKVSG
IPEIAPDLAKVKASRKDQSDNFFGPNVIELCQMSDIVFMALHGENGENGKIQAAFDLFGI
RYTGTGYLSSALAMDKEMSKKLFLSAGIPAPKGASMKKADCSDDITKLGIQFPCVVKPCC
GGSSIGVSIAHNAEEYKAALDEAFRWEENLIVEEYVKGREFSVGVIEGKALPIIEIAPVQ
GFYDYKNKYKAGSAVETCPAELSEAVTEKMQHYAEQVAQVLGLDTYSRTDFLLDENENIY
CLEANTLPGMTPTSLLPQEAQVVGVNFNELCEKLIQISLDKYEK
>KF630008.1_12177|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MDAIVAVDARWGIGRDGGLLFRISADLRRFKALTMGHTVVMGRRTLQSLPGGRGLPGRRN
LVLSRQGDLVPKGAEVFHEVQPMLDAAGEDAFVIGGAQVYRLLLPACRRLYVTQIDADGG
ADVFFPEPAPELWRITEQSPWQEEQGLRYRYLTYERKDGTDGI
>KF630005.1_12184|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
DKDKYDIVPIGITKDGRWFRYDGNAENIKSDKWHEDKEHCIPAYIVPDTAIHGMIELRKE
GTAFTRLDGVFPVLHGKNGEDGTVQGLIEMAGIPVMGCGTLASALCMDKYRAHVVAEEAG
IAVPKACSIIGRVTDRQLFEAVSELTYPLFVKPVNAGSSYGISVAETPGELVSALELALQ
YDNEVIIEEKIDGFEVGCSVIGDGKGNEIVGRVDEIELFNGCFFDYTMKYTGVDSKIHSP
GRLDPETEEKVNQAGIKLFRALGCKGFARIDMFLTPDKEIVFSEANTIPGFTSVSRFPKM
MAGIGMEYKDVIDKIIEYSFR
>KF629990.1_12231|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNFIVAVDKNWAIGYKNDLLVSIPEDMKFFRETTTGKVVIMGKNTLESFPNKKPLKNRVN
IVIALEKDYKAEGATVVYSIEEALEEAKKYNTEDVFVIGGGSIYRQMLPYCDTAYITYIN
NEYAADTFIPNLDEMADEWYIAQESEEGTYFDIEYFFRTYKRKK
>KF629989.1_12233|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGTEKSDRTGTGTISVFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLQGDTNAKYLQEHGVRIWNEWADENGDLGHIYGYQWRSWPDYDGGFIDQISEAVETIK
HNPDSRRIIVSAWNVADLKNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGEFIHTLGDAHIYLNHLDQVKLQLSREPRALPQMKINPDVKSIY
DFQFEDFELVNYDPHPHIAGIVAV
>KF629986.1_12240|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELLNRVLTEGVRKEDRTGTGTISVFGHQMRFNLEEGFPLLTTKKLHLKSIIYELL
WFLNGDTNVKYLQDHGVRIWNEWADADGSLGHIYGYQWRSWPDYKGGSIDQITEAVETIK
HNPDSRRIIVSAWNVADLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQATGLKAGDFVHTLGDAHIYSNHLEQVKLQLTREPRALPRMEINPDVKSIF
DFKFEDFNLTGYDPHPHIKGEVAV
>KF629982.1_12250|FEATURES|farme|beta_lactam|PMI37_00545|antibiotic target alteration|0
PVYGVQWRSWPAPTPEDPNRTID
>KF629980.1_12258|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNKRLKEILKEYEKRKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQA
ADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKG
VSMLKENCTRNIHDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVE
EYIRGREFSVAVVDGKAYPIIEIAPKQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHY
AEAGAKALCIEGYARFDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEE
LIRISFKKYSK
>KF629978.1_12261|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
PPLKVNAERIAASAARLEMPVFPKERFIDAVEQVVKANAAWVPPYGSGATLYLRPYMFGS
NAVIGVKPADEYQFRILTTPVGPYFKGGAKPITIRVSDYDRAAPCGTGNIKAGLNYAMSL
HAIVDAHKQGFDENMYLDPKTRTKVEETGGANFIFVTKDGKVVTPKSDSILPSITRRSLI
YVAKEYLGLEAEEREVYFDEVKDFAECGLCGTAAVISPVGKINDHGKEICFPSGMEKMGP
VIQKLYDTLTGIQMGRIEAPKGWIHVIE
>KF629978.1_12263|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GTSAYTIKKFGVVNRYDLSKEFPALTLRRTGIKSCVDEMLWIWQKKSNNIHDLNSHIWDS
WADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVLFDLKNNPYSRRIMTNIYVHQDLHEMN
LYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQACDMEA
GELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNPEIKDFYKFTTDDLIVENYETWP
QIKNIPIAV
>KF629976.1_12270|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLQHVLDHGILKEDRTGTGTHSVFGYQMRFDLQNGFPLLTTKKLHLKSIIHELL
WFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYDGGHIDQIKEAIDTIQ
HNPDSRRIIVSAWNVADLPQMNLPPCHAFFQFYVANGKLSLQLYQRSADIFLGVPFNIAS
YALLLMMVAQVTGLEAGDFVHTLGDAHIYNNHIEQVREQLSREPRALPKMKLNPDVKSIF
DFKYEDFELTDYNPHPHIAGKVAV
>KF629971.1_12285|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGGDKVSKADKLFVNMCRDILRDGFSSEGQIVRARWEDGTPAHTIKKFGIVNRYDLQEEF
PALTLRPTAIKSAVDEMLWIWQKKSNNIKDLNSHIWDEWADEDGSIGKAYGYQLGVKYKF
PHGEMDQVDNVLWQLKNTPYSRRIMTNIYKFDDLMEMGLEPCAYSMTFNVTGNRLNGILN
QRSQDILAANNWNVVQYSVLIHMMAQVSGLKPGELVHVISDAHIYDRHVDIISEMIERPQ
YPAPKFILNPEVKNFYDFTTDDIRVEDYQKNPQIKNIPIAV
>KF629960.1_12313|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKTSLGGSSFGVTKVTAKEQIQP
AIAKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPITEVVSYNEYFDYEAKYNGASD
EITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAAGMEMKDVMTDIIENKFKD
>KF629956.1_12330|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRIVVLAGGLSTEREVSISSGTLVAEALRSKGHEVVLLDVFMGYEENICDIDALFKQNYS
FTDGNSIGDDVENTITNIKEAKENRLDKTSRYIGRNVIEICAEADITFLALHGGEGENGQ
LQATLDLFGIKYTGSGYLGSALAMNKGLTKSVFMQKNINTPSGELYKNEKDALAWNMFPC
IVKPCSGGSSVGVSKVENADQYKKAVKEALKYEDEIVVEQFVTGREFSVGLIGGKALPPI
EIAPKSGMYDYAAKYQAGATVETCPADIDEETDKKLRDAATEAYEALHLESYARIDFLLD
KGGFTYCLEANTLPGMTPTSLLPQEAAVEGISYPDLCEKIIEISLAKYPKEKSDF
>KF629950.1_12343|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
LSKLQIAVLFGGASSEHEVSRMSATTVLRAIDKSRYEVTPVGIKKDGSWWLYPGDIGLIL
DGRWESCPDNLPAFLVPDASVGGLLIRDSDHSDTVKKIDCVIPALHGKNGEDGTIQGLLQ
LAGIPFVGCDMTSSAACMDKVITNVMLEQAGIPQARFTWLYAYEFQSAPDEAVLKIEKDL
GSYPVFVKPANAGSSVGVSKAENREELRAAIAKAAKEDGKILIEENIVGQEVECAVLGNE
DDLLASTVGEIAPSNEVLRLRSQIPFRHLRALYSSPFGVRRH
>KF629944.1_12362|FEATURES|farme|beta_lactam|blaR1|antibiotic inactivation|1
MKKHIIGTLFALVLLASVARASETVERTDLADIFQGFDGTFIMYDEGADRYTVFNKALSE
TRLPPCSTFKVFHALIGLDSGVLDRDDARTLMKWNGKPSSIAAWNHDQTLASAMRHSVVW
YFQRVATGIGEERMQRGLDRIGYGNRDISGGLTRFWLQSSLKISPREQVGLLRALFNGSL
PFAAEDIAVVKRDITLSSGKGLRFMGKTGSGSDDADRGIIGWFVGGVETPHNRWSFAVNI
QGPDASGVRARGIAEAALERLSILP
>KF629940.1_12379|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADVLFVNMCEKILEEGFSSEGMQVRARWEDGTAAHTIKTFGVVNRYDLEEEFPALTL
RPTAIKTAVDEVLWIWQKKSNNIKDLKGHIWDEWADENGSIGKAYGYQMGLKYKSAQGEM
DQVDNVLWQLKNTPYSRRILTNIYKFDDLAEMNLEPCAYSMTFNVTGDRLNAVLNQRSQD
ILAANNWNVVQYSVLLHMFAQVSGLRAGELVHVIADAHIYDRHIPVIEELVSRPQYPAPK
FRLNPEIKDFYDFTVDDVMIEDYQKNPQILNIPIAI
>KF629937.1_12386|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MECECAVMGNDEPFASTVGEVCSANDEFYDFDAKYNDAASKTLIPARMSEESIEEIRKMA
VKAYRAMGCSGLSRVDFFLMKDGTVILNEINTLPGHTPISMYPQLMQYEGMTPAQQEDKL
IKLALDKAEVDYE
>KF629929.1_12413|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIAAVDANWAIGYKNKLLVSIPDDMKFFRQTTTGKVVVMGRKTLESFPNGQPLKNRVN
IVLTSDKNYKVKDAIVVHDLDELHKELEQYNSEDVYVIGGESIYRQLLDECDVAHITKID
YAYDADAYFPNLDEKEEWQITEDSDEQTYFDLEYYFLKYERIR
>KF629928.1_12415|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
ENGVIGDKNALLWHISEDLKYFKSVTSGHPVVMGRKTYESLGRPLPNRTNVVVTRQEMEI
PGCRVAHSLEEAVALFPAEEEVFVIGGAQIYAQALPLAGRFYLTRVFHAYEGDTHFPAWN
DAEWRLVSSESFASGANYPYPFAFETYERRRN
>KF629920.1_12436|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|0
VNSPAVFLPEKHFRSLKLFQKDGLFDYANKYQAGGASEICPPISLDAETQELIQRAGERA
FEALRMDVYSRADFIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEYSELCEAIIQ
ESMKARY
>KF629919.1_12439|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIVAVDKNWAIGLHNKLLVSIPADMKFFRETTMGKVVVMGRKTLESFPGGQPLKKRTN
IVLTSDKNYKVKDAVVVNSVEALLEELRQYNDEDIYVIGGESI
>KF629917.1_12444|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
WNEWADENGDLGHIYGYQWRSWPDYDGGFIDQISEAVETIKHNPDSRRIIVSAWNVADLK
NMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGEF
IHTLGDAHIYLNHLDQVKLQLSREPRALPQMKINPDVKSIYDFQFEDFELVNYDPHPHIA
GIVAV
>KF629915.1_12448|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MNLIVAVDKNWAIGNKGELLVRIPADHKMFRQETTGKVVVLGRKTMDTFPGGQPLKNRDN
IILSRNEAYQQKDAQVVHSVEELLEAVKGYDTKEVYVIGGSSVYEQLLPYCDTAHVTKID
HAYEADSWFPNLDEDPDWEITADSDEQYYFDLTYHFLKYERKKG
>KF629915.1_12449|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IYVHQDLHEMNLYPCAYSMTFNVTQKIGHDKLTLNAVLNQRSQDVLAANNWNVVQYSVLL
HMLAQVCDMEVGELGHVIADAHIYDRHVPIIKELISRTPYPAPKFWLNPEIRDFYQFTRN
DVRADDYVTGEQIKDIPIAI
>KF629889.1_12539|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
IALLCGGASGEREVSLLSAAAVEEALEKRYEVIKIDTGVEGWAHTLLDSSVEGVFICLHG
GAGENGSIQGFCESVGLPYTGPGVLSSAIAMDKFVAKLLVESFRIPTPGYIRVLRGEECN
IEDIRTKLGGKLVVKPSTEGSALGVSIVDNGDDLACAIDTALELAPSVLVEQFISGRELT
VAVLGGEKPRVLPPIEIIPANEFYDYEAKYEQDMAQHICPANLTEAELRQCEEMALGAHD
ALGCYGVSRTDCILDERNRLWYLETNTIPGMTGTSLLPDAAKAVGITFDELCWNIMEDAW
SRC
>KF629887.1_12544|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
PTSRSPTTLVSGISGQLYKQFALTIAASTVLSGFNSLTLTPALCALMLQPTRPSKNPLYR
GFNHLYDKTQGVYDRIVEYLLQRPVASIVSYAVFTLIAVLLFVKWPSTFVPEEDDGYFLA
VVQLPPASSLERTQAVGKQINKILDSYPEIKDYIGISGFSVMGGGEQSNAATYFIVLKNW
NERKGKEHTAEAVVQRFNMEVYGIQEAEIFAMVPPAIPGLGATGGLQLQLEDRHNLGATE
MQRAVETLMEHYRNYPALASVSSQYQANVPQYFLNIDRDKVQLMGIPLNSVFTALGYYMG
EAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGEMVPFSSFTRVEEQLGMDQ
INRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTT
VVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILL
VALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGA
GAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF629887.1_12545|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNCKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF629883.1_12557|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERFEPIPVGITKDGKWIINGEDPRGWN
LDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVL
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGI
PTAPGVTVDARNFTAADVLAEIEAAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRL
AAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFD
SKYMDASASHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTVMVNEIN
TMPGFTPISMYPKAWDATGVSYTELITRLIEGVLR
>KF629879.1_12568|FEATURES|farme|tetracycline|tet32|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAV
TSFYWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMD
IPTIIFINKIDQNGIDLQCVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIIS
GSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAIIETFIT
ETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPQKKASCTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEG
VRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYL
SFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGR
SVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM
>KF629874.1_12585|FEATURES|farme|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|0
MDLTEFNEIRPYNDEELPQIFEELIADPAFQKAATGAIPNVPFELLAQKMRACKTKLDFQ
EAFCYGILWKIAADHTAGLTLDHTAIPDKSKAYTYISNHRDIILDSGFLSILLIDQGMDT
VEIAIGDNLLIYPWIKKLVRVNKSFIVQRALTMRQMLESSARMSRYMHYTISEKKQSIWI
AQREGRAKDSNDRTQDSVLKMLAMGGEGDLIDR
>KF629872.1_12589|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWR
VL
>KF629867.1_12602|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKLIVAVDACWAIGKDGDQLCYIPPDLKRFQRLTTGHPVLLGRKTLATFPGGRPLKNRRN
LILSTDPAFAPAGGEVFATLKAALAAAPADTFVIGGASVYRQALAYCDTAYVTQIHRAFP
AADCYFPNLAADPAWEAVETEGPYRYEDLAYTYVTYRRR
>KF629857.1_12624|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|0
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKHNL
>KF629854.1_12631|FEATURES|farme|chloramphenicol|catQ|antibiotic inactivation|1
MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANLEITSLLREIKLKGLKLYPTLIYIITT
VVNRHKEFRTSFDQNGKLGYWDSMNPSYTIFHKDNETFSSIWTEYDENFPRFYYNYLEDI
RNYSDVMNFMPKAGQPANTINVSSIPWVNFTGFNLNIYNDATYLIPIFTMGKYFQQDNKI
LLPMSVQVHHAVCDGYHTSRFFNEVQELVSNFETWLGEK
>KF629851.1_12644|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLN
PEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF629849.1_12652|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VNNYVDIVEKFRDKGEIMRIVVLAGGTSTERDVSLVTGYRVCESLRRNGHEANMLDIFLG
VDDSEVKTFFTEKNDLGELSDNLKKKTADIPAEVKRRTEARESFFGRNVLELCKEADMVF
MGLHGSNGEDGKVQATFDLLGIRYTGTDYLSSAISMSKELAKKVLVPEGIPMPKGVTLHK
GHKIEYVPFPCVVKPCCGGSSVGVSIAHNEKEFEEALDEAFSYEDTVLVEEFVDGREFSV
AVLDGKALPVIEIEPLEGFYDYKNKYKAGSTKETCPANIPEDIASQMQFWAEKCCQAAGV
TTYARVDELLDKNNNIFCLEINTLPGMTDTSLIPQEAAAVGISYDELTEKII
>KF629846.1_12657|FEATURES|farme|beta_lactam|CblA-1|antibiotic target alteration|0
MKQYLDLLNRVLTEGVEKSDRTGTGTISVFGPQMRFNMDEGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQDNGVRIWN
>KF629840.1_12671|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGK
KKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQAEYSSTRDKLSWIF
SAMQWKPANGISPR
>KF629840.1_12672|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERY
KELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHSMPPFAGQGVNSGLVDALIL
SDNLADGKFNSIEEAVKNYEQQMFIYGKEAQEESTQNEIEMFKPDLYVSAIVKCIKWNKT
AHNKQIGNRAGEVLLLNFCAMLKISNSIQHLC
>KF629840.1_12673|FEATURES|farme|aminoglycoside|aadK|antibiotic inactivation|1
VLKVGSIANLPNVVRHSKTEPNKMKVREEKLRTIIEWSEKNEDVRVLLLTSSLVNPLALV
DEFSDLDIEFVFEDNTNYISDKSWTLKFGNPIAMIEEDESCFNHKHAMKMLLYEDGVKVD
FKLYSKSKFIKETQEKELPEDWDIGYKILIDKDGITKQMLKPTYQISIIKKPSEKEFQNL
INDFWWDTTYVAKCLVRDEIFYAKFMSETVIRTEYLIPLIEWHIASEHNWNITTNKYGRL
FKKYLNQEMWAKTEQTFSGSDIKENWTALFSMTDLVSEIGTELSKKLEYKYPDKLENDIR
KYLAGLKPKT
>KF629837.1_12680|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLSDSEHKMSVVVLFGGMSSEHEVSRVSAGTFVDQLDRQRYELLIIGITKEGRWLYTEAD
SAQMADGSWEELPGNMPCVLSPDRADHGLILFTPAGQVEKVHVDVVIPVLHGLWGEDGTV
QGLLELAGIPYVGCGVLASAVCMDKAVANAMFDASGIPHTKWLSATRWEIESDPDGVCDG
VIAKLGWPIFVKPANAGSSVGITKAHDRDELKQAIALALENDHKVVFEAFVDGHEVECAV
IGSDPAVSTRPGEILAGAEFYTYDDKYKNGVSQVVIPARLPEEKLDEVKTYA
>KF629836.1_12682|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKQNLAVIFGGQSSEHEISCMSASNIIQCIDAQRYNIILVGITKEGHWVEAADLNAVQD
GSWRQSKTSIVLSPDATRKGLYRMSEDEKAQFVHLDVIFPVLHGLYGEDGTVQGLFKLAG
IPFVGCGLFASAAGMDTLYTKIIVDTLGIRQAKYVPVYKEELPKMDEVVARVESALEYPV
FVKPSRAGSSKGVNKAANREQLKNALIEAADNDRKILVEETIIGREVECAVLGNLDVKAS
GVGEILSADEFYDFDAKYYNSESKTLVDPPMPENMREQIREDAVKIFMALDGRGLSRVDF
FLTESGVVFNEINTLPGFTAISMYPMLWEAQGIPKKELVQKLIDLAFER
>KF629834.1_12687|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
SISDEDVIEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQPAIVKAFDEAQEVLIEAYMEGT
EVTCGCYKTKEKSVVFPITEVVTENEFFDYDAKYNGQVSEITPARLSDDLTHRIQTLTSA
IYDILGASGIIRVDYIITAGDKVNLLEVNTTPGMTATSFIPQQVRAAGLDIKDVMTDIIE
NQF
>KF629829.1_12696|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQTEEYQTNLICMSKISIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTIVMGRKT
FESLPKGALPNRRNVVLSSNPAAECPGAEVFPSLETALQSCKEDEHVYIIGGASVYQQAL
PFADELCLTEIDSTAPEADAFFPEVSPAVWHEKNREAHPADEKHLCSYAFVDYVKA
>KF629826.1_12708|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKSSLGGSSFGVTKVTAKEQIQP
AITKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPITEVVSHNEYFDYEAKYNGASD
EITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAAGMEMKDVMTDIIENKFKD
>KF629826.1_12709|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNANVEFDEIRPYHDEELPQVYEELIADAAFRQAVDTVMPGVPFEVWSQKMRACKTKLEF
QKTFCYGLLWKLAKEATDGLTLDHTALPDKSAAYTYVSNHRDIILDSGFLSILLVDQGMD
TVEIAIGDNLLVYPWIKKFVRVNKSFIVQRALTMRQMLEASARMSRYMHYTISEKKQSIW
IAQREGRAKDSNDRTQDSVLKMLAIGGEGDVIDRLMEMNIAPLAISYEYDPCDFLKAQEF
QLKRDIEGYKKTTADDLLNMQTGLFGYKGRVHFQTGACMNDEL
>KF629822.1_12719|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
VNSSDYNREKIMNLIAAVDNNWAIGKNNQLLVRIPMDQKFFREMTTGKVVVMGRKTLESF
PNSRPLKNRTNIVLTHNPSYEVEGAVVVHSLDELHKELEKYNSEDIYIIGGQKIYEQLVD
ECDVA
>KF629817.1_12736|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTILN
RHEEFRTALDKNGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAY
GERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYYIP
LSIQVHHAVCDGFHVCRFLDELQDLLNK
>KF629814.1_12746|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAQVPGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF629807.1_12763|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|0
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEM
>KF629804.1_12774|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQQVNKIRVALLFGSCSSEHEVSCVSAAAWADALATMPDRYEVILVGITKQGRWLKYSG
STEGMRSGSWEQDASCVPCVLSPDRSDHGLLVHSANGYELLPVDVVAPILHGKNGEDGTI
QGLLELAAIPYVGCGVLASAACMDKAVANTIMDAYHVPHCHWCSAVRAEAETQRSTLLTR
VENRLPYPIFVKPANAGSSVGITKAHNREELNTAIDTALREDDKVVFEEFIDGQEVECAA
IGNPDNPQEVRTTRPGEILAGAEFYTYDDKYKNGISKTVIPAHLPDQKLDEVKTLAARAY
LALGCAGLARCDFFVEHGTGRVLCNELNTLPGFTPISMYPKLMENEGYSFAALVDKLIGL
ALSKKRGAY
>KF629794.1_12797|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
LTPRREQAREEILRPAHGRLFRPINHERKQQINMEKLNVVALFGGQSSEHVVSCMSVQNV
AANINKEKYNVILVGITEEGRWLKVDSLDEVKNDTWRTSGSRAVLSPDATEKVLWVIRHG
KAEKIPVDVVFPVLHGLYGEDGTVQGILELAQIPYVGCGVLASAVSMDKLSTKLIVKDLG
IRQAEYVPVMKEELEQMDQVAKRVEDAFPYPVFIKPSNAGSSRGVSRADDRKSLENGLKE
AALHDRRILVEEMIVGHEVECAVFGGGKEEVRASGVGEILAAADFYDFDAKYYNSDSRTV
VDPELPGNAAEEIRESAVRIFKAVDGYGLSRVDFFVKEDGEVVFNEINTMPGFTAISMYP
MLWEARGVGKEKLVDDLLEHALKRYER
>KF629782.1_12836|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QVDRVIYDLKNNPYSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTKEPGKDKLTLNAILN
QRSQDILAANNWNVCQYSLLLMMIAQCCDMESGELVHVIADCHIYDRHVPVIKELISRTP
YPAPTVKLNPNVKNFYDFTTDDLIVENYQTWPQIKNIPIAI
>KF629781.1_12838|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWSDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIIKELIKRPTYPAPK
VTLNPEVKDFYKFTVDDFMIEDYQAGPQIKNIPIAI
>KF629780.1_12842|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLLENGHQAYLLDLYFGLENAPANLEDVFTLPGA
GLEIAKNISTKEPDLEALKKSRPDQSDCMFGPNVIELCRMADITFVALHGSVGENGKLQA
AFDLLGIKYTGCNSFGCALSMNKLVTKQIYKMSGVPTPRGTHLTKETKDLPLSELGYYLP
LVVKPCENGSSIGVYICHTEEEYNNAVRESFEKNPDEELVIEPYIKGREFASAVIAGKAL
PLVEIIPKDGVFNYENKYQAGGAQEICPPVSIDEETQQRMMRAGEEAFAALRMDVYARAD
FIIDDEDGEFYSLEMNALPGMTAASLLPKAAKAAGIEYNELCERIIEESMNARYR
>KF629779.1_12844|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIAAVDKNWAIGRNNKLLVSIPDDMKFFRETTTGKVVVMGRKTLESFPGKKPLKNRVN
IVLTGDRSYQADGAVIVHDMEELHEELKKYPSEDIYVIGGESIYKQLLDECDVAHITKID
FAYEADAWFPNLDEKEAWVVTADSEEQTYFDLEYHFYKYEKKA
>KF629770.1_12868|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAP
LQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEELIRISFKKYSK
>KF629763.1_12887|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
IVTFRPDLNAERMAASAARLEMPVFPKERFIDAVEQVVKANAAWVPPYGSGATLYLRPYM
FGSNAVIGVKPADEYQFRILTTPVGPYFKGGAKPITIRVSDYDRAAPCGTGNIKAGLNYA
MSLHAIVDAHKQGFDENMYLDPKTRTKVEETGGANFIFVTKDGKVVTPKSDSILPSITRR
SLIYVAKEYLGLEAEEREVYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMNE
MGPITKKLYETLTGIQMGRIQAPEGWLKVIE
>KF629759.1_12896|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELLWFLQGDTNV
KYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIKHNPDSRRII
VSAWNVADLNNMNLPPCHAFFQFYVANGSLSLQLYQRSADTFLGVPFNIASYALLLQMVA
QVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIFSFKYEDFEL
VNYDPWPHIAGKVSV
>KF629755.1_12910|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKRLNIALMAGGDSSERGIALQSAAQIASALDPAKYDITLIDLHGRDWHYTSPDGRQWQV
DKNDFSITIDGEHKAFDYALILIHGTPGENGRLQGYLDMMGIPYSSCSMTSSVVTFDKIT
TKRTVAEFGIPLARGFFFGRDSRIDPKEIVRTLGLPVFVKPNASGSSFGVTKVKSEADIL
PAVAEAFTESDEILIEECIQGREMGCGMLIAKGREYIFPITEIVSKKEFFDYEAKYTAGC
SDEITPADIAPEIKAELNRLTALAYKACRCRGVVRVDFIVTPEGKPYLIEINSIPGMSGG
SIVPKQVREAGMTLGELYDLIIEDTYDRDRR
>KF629747.1_12937|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MIDYNKVLCPAIKEMKPSGIRKFFDIAQQLEGVISLGVGEPDFKTPWLIRQEAISTLEKG
KTCYTANAGLIALREEIAKYFQRTIHTSYDPNKEIIVTVGGSEAIDLTIRCLIQPGDEVL
IVEPSFVCYRPIVSLCGGVPVVIETKEENEFRLTADELREKITDKTKLLVLPYPNNPTGA
IMRREDLEAIAKVLKDTNIMIASDEIYSELTYSGKHCSIAEIEGMRERTIVINGFSKSFA
MTGWRLGFLGGPKEIVSQMLKLHQYAIMSSPTVSQYAAIVAMHSCQKDIDAMRNEYNIRR
RFAVDSFNKLGLKCFAPQGAFYVFPCIKSTGMTSTDFCEKLVYTKKVAVVPGDAFGECGE
GYVRVSYAYSLNHLREAIKRIGEFLEDIKNGNVQ
>KF629746.1_12940|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MRAIVCADKNWGIGYKNRLLVSIPSDMKFFRETTTGKVIVMGRKTLESFPNGMPLKNRIN
IVLTRDRNYEAKGAVIVHDEEELMNELGKYDTEQIYIIGGESVYKMMLSHCDKIYVTKVD
RAFQADTYFPNLDEMSEWKMTQESEEQTCFDLEFCFTTYERC
>KF629743.1_12951|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTKADTIFKENITKIMEEGVWSEQARPKYKDGTTANSKYITGAFAEYDLSKGEFPITTLR
PIAIKSAIKEVFWIYQDQTNSLDVLEDKYNVHYWNDWEVEGVPANNGDKRSIGQRYGAVV
KKHDIINRLLAQLEANPWNRRNVISLWDYEAFEETAGLQPCAFQTMFDVRRVGEDIYLDA
TLTQRSNDMLVAHHINAMQYVALQMMIAKHFGWKVGKFFYFINNLHIYDNQFEQAEELLN
RQPSDCQPRLVLNVPDGTNFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF629742.1_12953|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
KSAVKLALKLIKITKKTISNSDFLNSYDIVQKKKNRIENMTLSLIVAITKNNVIGKDNQM
PWHLPADLARFRKNTTGKPVIMGRKTFESIGRPLPKRTNIVLSRTPYEHEGVIWKNSFES
AVDFVKEFDEIMLLGGGELFKQYLPKADKLYLTQIQADIDGDTFFPEINWAEWNIEFEEY
RQADADNPYDCRFLILQRKV
>KF629738.1_12964|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADGFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEAGDEVDIDRIVEICGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGVAC
>KF629734.1_12974|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLQHVLDHGILKEDRTGTGTHSVFGYQMRFDLQDGFPLLTTKKLHLKSIIHELL
WFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYNGGHIDQIKEAIHTIQ
NNPDSRRIIVSAWNVADLPQMNLPPCHAFFQFYVANGKLSLQLYQRSADIFLGVPFNIAS
YALLLMMVAQVTGLEAGDFVHTLGDAHIYNNHIEQVREQLSREPRDLPKMKLNPDVKSIF
DFKYEDFELTDYNPHPHIAGKVAV
>KF629733.1_12978|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWAEARDKEGRAGAIGLNGGM
PWHCAEDMKHFKELTVSHPVIMGRKTWESLGGKYRPLPNRDNIVVSRDPMYRAPGATVVT
SLDDALDMARQEAIPDDGLDRSEIWIIGGAQLFAEALPFADKAYVTDLAATVDADSYAPD
MASLVEAGMWREAEVGEWHTPAKEESGIDSYRFRILAKTK
>KF629733.1_12979|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PNLEVPGEFVWTGGDCHVYDNHVDQFLEQLGRKPYPYPTIEIRKADSLFDYQYEDFKVVG
YQHHPTIKAPVAV
>KF629729.1_12988|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERFEPIPVGITKDGKWIINGEDPRGWN
LDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVL
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGC
>KF629728.1_12990|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
NWAIGHKGDQLVYLKEDLKRFRALTLGHPVILGRKTLATFPGGRPLKGRPNLILSSNPAY
TAEDAQVFQDLDSLLAQAPPDSMVIGGATVYDCLLPYCDTAYVTKIHSAFPADAWFPNLD
QLPDWQIAAEEPPLEQEGLFYHYVTYHRETTL
>KF629721.1_13007|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSKIALIAAVAEKGAIGRDQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTSLSWPNVTVVHTLDEIPIQDTTEDEIFIMGGATLYNETIKIADTLYITHIH
HTFDDADTFFPTINPSEWKIANSQEMPADEKHAYPYTFVTYTRRRIENRESSDK
>KF629706.1_13057|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic efflux|0
MFYDLLVHVDLPDESRFVMALGNINNYLAALNGEPCTVVLLANGGAARFLARKDNAQTEA
IEKLAQAGVSFRVCANAMKKVPITKEDLLPCVEVVPAGVVEIVRLQREDFAYIKP
>KF629704.1_13064|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISLIVAVAENGVIGDRNALLWHISEDLRHFKAVTTGHPVVMGRKTWESLGRPLPNRTNV
VITRQNIEIPGCTVVHSLEEAVALFPADEEVFVIGGAQIYAAALPLARKFYLTRVFRAYE
G
>KF629688.1_13109|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDL
HKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRA
ILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTE
VEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTP
DEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKR
PLPITMIGDAAHLVPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIYGK
EAQEESTQNEIEMFKPDFTFQQLLNV
>KF629683.1_13126|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIAIIVAVAENGVIGGDNRLLWHISEDLKHFKAVTTGHPVVMGRKTYESLGRPLPGRRNV
VVTRQNISIEGCDVVHSLDEALALFRPEEKVFVIGGAQIYAQALPLCDEFYLTRVFHAYQ
GDTCFPRWDEREWEIIDSESFASGKEFPYPFAFEHYR
>KF629672.1_13152|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MALQPCAYETLWDVGDGYLNCMLIQRSGDMGLGVPFNTAQYAALQCMIGQVTGLKPGKFT
HVINNAHIYENHVDALREQLARREQALPAPKIIVNPEVKDFYDFTPEDITLDGYEHLGKL
SMTVAV
>KF629658.1_13184|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VVSTTTEYQGDNLVSVKSLEDALLLAKGRDVYISGGYGLFKEALQIVDKMYITEVDLNIE
DGDTFFPEFDIND
>KF629642.1_13216|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LQLFAPVLNAILNQRSQDILAANNWNVCQYAVLMHMLAQVCDMQVGELVHVIADAHIYDR
HIPLVKELISREPLPAPTFWLNPEVKDFYRFTRDDVRLDNYQTGPQITNIPIAV
>KF629642.1_13217|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIAAVDKNWAIGRNNKLLVSIPDDMKFFRETTTGKVVVMGRKTLESFPGKKPLKNRVN
IVLTGDRSYQADGAVIVHDMEELHEELKKYPSEDIYVIGGESIYKQLLDECDVAHITKID
FAYEADAWFPNLDEKEAWMVTADSEEQTYFDLEYHFYKYEKKV
>KF629639.1_13224|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KRKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNAILVDIFCGLEPVD
WDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQAADIVFMGLHGSNG
EDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKGVSMLKENCTRNIH
DLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVEEYIRGREFSVAVV
DGKAYPIIEIAP
>KF629637.1_13229|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKGVSMLKENCTRNIHDLGMEFPVVVKT
CCGGSSVGVYIVNNQKEYEEALTDACQYGADIVVEEYIKGREFSVAVVDDKAYPIIEIAP
IQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVKAAKALGLTGYSRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIRISLKKYE
>KF629636.1_13231|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|0
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDVFTLPDH
GLEIVKNISTEEPDLEAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
SFDLLGIKYTGPDSL
>KF629618.1_13277|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICNTLLEKGHDAFLLDVFLGLENAPENLEDVFTLPGH
GLEIAKNISETEPDLAAVKASRPDQSDCFFGPNVIELCRLADMTFLGLHGGEGENGKLQA
SFDLLGIRYTGPDSLGCAVAMDKGLTKQIFMEAGVDTPFGVCLYKEDSDCSLESLGLSFP
VVVKPCSGGSSIGVYIVNTEDEYRQALKNSFRYENEVVIETYIKGREFACGVIDGKALPP
IEIIPKSGWFDYANKYQANATEEVCPADISEEIAERMKALTVRAFQALKLNVYSRADFIL
DADGNLYCLEMNTLPGMTSASLLPKEALADGIEYGDLCELIIQKSMEARYQ
>KF629616.1_13282|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PVWEDGTPAYTIKRFGVVNRYDLRKEFPALTLRKTALKSAMDEILWIWQQKSNNIHDLHS
HIWDSWADENGSIGKAYGYQLGVKHQYKEGMMDQVDRVLFDLKNNPYSRRIMTNIYVHQD
LHEMNLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQA
CDMEAGELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNPEIKDFYKFTTDDLIVEN
YETWPQIKNIPIAV
>KF629613.1_13291|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GGFIDQISEAIETIKQNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQ
RSADIFLGVPFNIASYALLLQMVAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPR
PLPQMKINPDVKSIFDFKFEDFELVNYDPHPHIAGVVAV
>KF629608.1_13302|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDKIAVLLGGTSAEREVSLNSGAAVLAGLREGGIDAYPVDPKEVDVTQLKSMGFQKVFI
ALHGRGGEDGTLQGMLELMGLPYTGSGVMASALSMDKLRSKLLWQGAGLPVAPWVALTRA
EFEKGLSDKQLAEISALGLPVIVKPSREGSSVGMSKVVAENALQDALRLAFQHDEEVLIE
KWLSGPEFTVAILGEEILPSIRIQPSGTFYDYEAKYLSDETQYFCPAGLEASQEANLQAL
VLKAWTTLGCKGWGRIDVMLDSDGQFYLLEANTSPGMTSHSLVPMAARQAGMSFSQLVVR
ILELAD
>KF629607.1_13306|FEATURES|farme|chloramphenicol|catQ|antibiotic inactivation|0
MTDKALWAFSDTSGNCSNTISLCEATKEDAPFIAAIYNQAILAGNCTCDTKTVTSEMREK
WICQHAADGYPVYLCLENGIPVGYGYLTAYRQGREAVNHVAEVSYYLDFSAHGRHIGTHL
LAALEQQAKKQGLKVLIAILVGSNRPSVGLLEKYGYVEWGRLPQIVHLGDRHTDHLIYGK
YL
>KF629607.1_13307|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MVERIYHVGLTVSDLDRSIAFYRDILGLEFQGEIFMAGEETDRLFRMKDTKARVAYLNGS
KAIEAPPIGPR
>KF629597.1_13329|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPYSYRVVNRYDLSKEFPALTLRRTGIKSCVDELLWIWQRKSNNVHDLKPHIWDSWADED
GSIGKAYGYQMSVKHQYKEGMMDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCA
YSMTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVH
VIADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYEFTPDDVRLDGYETHPQIKNI
PIAV
>KF629594.1_13341|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
LQDDLQTRLFTGDGPNFPEPDMSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAM
IVSLALLAWAMKSLPVGTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIG
LKLSTH
>KF629594.1_13343|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKAGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>KF629584.1_13367|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
NKMNVIVAADKNWGIGKDNKLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNR
TNIVITKNKDYDAKGAIVVHSIEEALEEVKKYPSEDVYCIGGDSVYTQMLPYCDVAHVTK
IDFVYEADSHFPDLDEDEEWEITAESDEQTYFDLEYQFVKYERKK
>KF629579.1_13375|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADNIFIDMCKDVIENGTSTEGEKVRPVWEDGTPAYTIKRFGVVNRYDLRKEFPALTL
RKTALKSAMDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQLGVKHLYKEGLF
DQVDRVIYDLKNNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKIGHDKLTLNAVL
NQRSQDVLAANNWNVVQYSVLLHMLAQVCDMEVGELVHVIADAHIYDRHVPIIKELISRT
PYPAPKFWLNPEIKDFYQFTRNDVRADDYVTGEQIKDIPIAI
>KF629575.1_13384|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALKSAMDEILWIWQKKSNNIHDLHSHIWDSWADESGSIGKAYGYQLGVKHQYKEGMM
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNDKLTLNAIL
NQRSQDILAANNWNVCQYALLLMMMAQVCDMEAGELLHVVADCHIYDRHIPLIKELIQRK
PYPAPVVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPVAI
>KF629568.1_13410|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLLENGHQAYLLDLYFGLENAPASLEDVFTLPGA
GLEIAKNISTKEPDLEALKKSRPDQSDCMFGPNVIELCRMADITFVALHGSVGENGKLQA
AFDLLGIKYTGCNSFGCALSMNKLVTKQIYKMSGVPTPRGTHLTKETKDLPLSELGYYLP
LVVKPCENGSSIGVYICHTEEEYNNAVRESFEKNPDEELVIEPYIKGREFASAVIAGKAL
PLVEIIPKDGVFNYENKYQAGGAQEICPPVSINEETQQRMMRAGEEAFAALRMDVYARAD
FIIDDEDGEFYSLEMNALPGMTAASLLPKAAKAAGIEYNELCERIIEESMNARYR
>KF629561.1_13425|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQQANKIRVALLFGSCSSEHEVSCVSAAAWADALATMPDRYEVILVGITKQGRWLKYSG
STEGMRSGSWEQDASCVPCVLSPDRSDHGLLVHSANGYELLPVDVVAPILHGKNGEDGTI
QGLLELAAIPYVGCGVLASAACMDKAVANTIMDAYHVPHCHWCSAVRAEAETQRSALLTR
VENRLPYPIFVKPANAGSSVGITKAHNREELNTAIDTALREDDKVVFEEFIDGQEVECAA
IGNPDNPQEVRTTRPGEILTGAEFYTYDDKYKNGISKTVIPARLPDQKLDEVKTLAARAY
LALGCAGLARCDFFVEHGTGRVLCNELNTLPGFTPISMYPKLMENEGYSFAALVDKLIGL
ALSKKRGAY
>KF629559.1_13431|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPCDSDKLEEVFDRPDG
GLEISKGISTSVPDLDALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTVKTKDTRLDELGYYLP
LVVKPCSNGSSIGVYICHTEEDYYDAIHKSFDVDNTDEVVIEPFIKGREFACGILAGKAL
PLVEIVPKDGLFDYANKYQAGGASEICPPISLDAETQELIQRAGERAFEALRMDVYSRAD
FIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEYSELCEAIIQESMKARY
>KF629555.1_13452|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
FNLFPQYTALENVMLAEKLLAEEREDYNKNKKEILAEIENHGKELLKKMGLEDRMDHYPH
QLSGGQQQRVAIARALALQPDILCFDEPTSALDPELTGEVLKVIKGLAEEKTTMVIVTHE
MAFARDVADTVVFMDKGVIVEQGDAKEVINNPKEERTKQFLLRYSQG
>KF629554.1_13453|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
HVKAGLNYAMSLHAIVDAHKNGFDENMYLDSKTRTKVEETGGANFLFVTKDGKVVTPKSD
SILPSITRRSLIYVAKEYLGLEAEEREVYFDEVKNFAECGLCGTAAVISPVGKIVDHGKE
IYFPSGMNEMGPITKKLYETLTGIQMGRIQAPEGWLKVIE
>KF629546.1_13476|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERFEPIPVGITKDGKWIINGEDPRGWN
LDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVL
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGI
PTAPGVTVDARNFTAADVLAKIEDAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRL
AAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFD
SKYMDASASHVEVPANLPEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEIN
TMPGFTSISMYPKAWEATGVRYTDLITTLIEGVLR
>KF629538.1_13495|FEATURES|farme|quinolone|patB|antibiotic efflux|0
SGIRKFFDIVSEMPDAISLGVGEPDFDTPWRVREEGIYSLERGRTFYTSNAGLKELRYEI
SEYLERKYELVYDPNHEITVTVGGSEGIDIAMRTILDPGDEVIVVQPCFVSYVACVVMAG
GTPVIVSLKEEDKFKLKKEQLEAAVTDKTKAMIISFPNNPTGAIMTKEELEPIAEFAKEH
DIVVISDEIYSELTYGRDHVSIASLPEMKDRSIVINGFSKAFAMTGWRLGYVAAPRYMMK
QMVKVHQFCIMAAPTTSQYAAIEAMRSCDDEVEEMRTAYNQRRRFLVHEFQRMGIECFEP
EGAFYIFPSIKKFGMTSEEFATKLLNEEKVAIVPGSAFGVCGEGYLRVSYAYSIEELKEA
LGRLERFINHLPKKQ
>KF629536.1_13499|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKVSIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTILMGRKTFESLPKGALPNR
RNIVLSSNPDTVCSGAEVFPSLETALKSCREDEHIYIIGGASIYQQALSFADELCLTEID
STAPEADAYFPEVSSKVWQEKSREAHPADEKHLCSYAFVDYVRK
>KF629532.1_13512|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MAKRVTVKELNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAIL
VDIFCGVENVDWENPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVLELCEKCDI
VFLGLHGANGEDGKVQATFDLLGIRYTGTGYLSSAMAMDKRITKEVFLMNHVPTPGGFTM
TRDNLEKDIAKHGLEFPVVVKTSCGGSSVGVYIVNDQKEYEEALTDACQYGADIVVEEYI
KGREFSVAVVDDKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVK
AAKALGLTGYSRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIR
ISLKKYE
>KF629531.1_13515|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGGKTLESFPNGLPLKNR
TNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESIYRMMLPYCSKVYVTK
IDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF629531.1_13516|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRPVWEDGTSAYTIKKFGIVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLN
PEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF629527.1_13526|FEATURES|farme|multidrug|hp1181|antibiotic efflux|0
MNLSLRRSTSALLASSLLLTIGRGATLPFMTIYLSRQYSLSVDLIGYAMTIALTIGVIFS
LGFGILADKFDKKRYMLLAITAFASGFIAIPLVNNVTLVVLFFALINC
>KF629519.1_13552|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMDQVDRVLFDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKLVLNA
VLNQRSQDILAANNWNVCQYSLLLMMIAQACDMEAGELVHVIADCHIYDRHIPVIKELIS
RKPYPAPTVKLNPEIKDFYKFTTDDLIVENYETWPQIKNIPIAV
>KF629499.1_13614|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LCLIKPKHDNSIKEKRTKMNIVVLAGGLSTERDVSFKTGSMVAKALKENGHKVILLDVFM
GYSDREEDLTGIFDRADEISVQVSDIPTEAPDLAKVKASRKDQSPCFFGPNVIKMCQMAD
IVFMALHGENGENGKIQAAFDLFGVKYTGSDYLSSAIAMNKETSKQFFLANGIPTPKGIS
MTRATRQDDITKLDLTLPCVVKPCCGGSSIGVTIVRDAAEFKAALDDAFKWENELVIEEF
VQGREFSVGVIEGKALPIIEIAPKEGFYDYKNKYKAGSTVETCPAELPEQVTKDMQHYAE
EVARVIGLDTYSRSDFLLNDKNEMFCLEANTLPGMTPTSLLPQEAAVIGMSFNQLCEHLI
NISLKKYEV
>KF629492.1_13631|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MDKSITKQFFRAHHVPTPNGVTLKKGQESEPLSGFGLELPVVVKPCCGGSSVGVYIAHTN
EEYWQAMKDAFSYEPEVVVEEYIEGREFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAGA
TVDTCPAVLTEEQTKEMQKHAEDGAAALGIENYCRLDFMMRKDGRMYCLEANTLPGMTPT
SLLPQEAQVLGISYPELCELLIQLSLRKRGNNA
>KF629474.1_13686|FEATURES|farme|multidrug|mdtG|antibiotic efflux|0
KDDLEVRIKPLEEAHPDLKINKQIVPGPAVGALTKASYDHDVVVVGSRGRGGFTGLLLGS
TSQGLLQHAVGPVYVVPRKYVEAAETRLDTVPSSPAEVKPKALDDIKGVEEVPVAKAEPE
VVEAIETKIDPERQ
>KF629470.1_13697|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKIVVLAGGTSTERDVSIVSGTGICGALRQKGHQAILVDVFCGQEEVDWEDPFPAEYDVE
KVAAYIRGFNLQMAELKKTRKNFFGPNVIDLCKKADFVFLGLHGANGEDGKLQGAFDLMG
IPYTGTGYLSSAMAMDKGVTKAMFQMRGVPTPAGKAMKKKDRVETPQELGMDFPVVVKTC
CGGSSIGVYIVDNQEDYTKALDGAFTYENEVVVEEFVEGVEYTVAVVDGKAYPVVQIVPV
QGFYDYENKYKPGAVKETCPAPISEELTKRLQEAAVDGYHALEMESYARLDFIVTKDEKI
YCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIKVSQKKYA
>KF629457.1_13726|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRINIVITSNKEYEVKGAIIVHSI
EEALEEIKKYPAEDVYCIGGDSIYAQMLPYCDVAHVTKIDFAYEADSHFPNLDEDDEWEI
TGESDEQTYFDLEYQFVKYERKK
>KF629455.1_13730|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKVGIPIA
PGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTLPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGIAC
>KF629451.1_13744|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKLAVLFGGISSEHDISCLSAASILRNLNKDKYEIYPVGITRDGEWFYCPDCDPDRVESG
AWERMAGKVKVVLAPDRGMHGMVLLREGEIEIVRLDCVFPVLHGVGGEDGTMQGLLELAG
IPYVGCGVAASANTMDKALTKKVVEGTGVRQARYYLALRYDFERNAEAVVAAAAETLGAF
PVFVKPCSQGSSVGVAKANNLLELAEGLTEAFKLDTKVLVEEFIDGHEVECAVLGNLEPQ
ASTVGEIAPTQEFYTFDAKYKDESSRLYIPAHITEEQIAAVRQDAVRVYTALGCRGLSRV
DFFVTHDSGEVVFNELNAIPGFTSISMYPKLFDYEGIGYAELLDRLISLALEEHHG
>KF629448.1_13751|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MQAIVAVSQSWGIGKDGHLLFRISADLQRFKALTTGHTVIMGRKTLESLPGGRGLPNRRN
LVLTRQKRFIPDRAEAVHSLEELLALAGSDAFVIGGQAVYEQLLPHCTRVYVTKVLSEAP
ADAFFPSLDDDPHWRIVAASEIQEENGLRFQYVEYAPA
>KF629448.1_13752|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KAYCYQLAVKHHYPEGDMDQVDRVLYDLKHNPASRRILTNIYNFQDLHEMALYPCAYSMT
FNVSGRTLNAILNQRSQDMLAANNWNVVQYAVLVHMMAQVSGLEAGELVHVIADAHIYDR
HVPIIEKMLEREPRPAPKFIMDPAVTDFYQFTRDSFSLEGYDPQPFEDKIPVAI
>KF629430.1_13796|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGIEKSDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIHELL
WFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYKGGTIDQISEAIETIK
HNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMVAQVTGLKAGDFVHTLGDAHIYLNHLEQVKLQLSREPKALPQMKINPDVKNIF
DFKFEDFELINYDPHPHIAGKVAV
>KF629428.1_13803|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDN
>KF629420.1_13827|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YGTPAYTIKRFGVVNRYDLRKEFPALTLRKTALKSAMDEILWIWQQKSNNIHDLHSHIWD
SWADEKGSIGKAYGYQLGVKHQYKEGMMDQVDRVLFDLKNNPYSRRIMTNIYVHQDLHEM
NLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQACDME
AGELVHVIADCHIYDRHIPVIKELISRKPYPAPTVKLNPEIKDFYKFTTDDLIVENYETW
PQIKNIPIAV
>KF629414.1_13840|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DGTSAYTIKKFGVVNRYDLSKEFPAITLRKTYIKSATDELLWIWQKKSNNIHDLKSHVWD
EWADEDGSIGKAYGYQLGVKHQYKEGMMDQVDRVIYDLKHTPFSRRILTNIYVHQDLHEM
NLYPCAYSMTFNVTQKKGDDRLTLNGILNQRSQDVLAANNWNVCQYAVLMHMLAQVCDMR
VGELVHVIADAHIYDRHVPIVKELIERQQYDAPKFWLNPDIKDFYQFTTDDIKITDYVTG
EQIKDIPIAV
>KF629406.1_13866|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLAQVCDMKVGELVHVIADAHIYDRHVPIIRELIEREQHPAPKFTLNPDVKDFYQFTTKD
ITIEDYVTGPQIKNIPIAV
>KF629405.1_13868|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKPSLGGSSFGVTKVTAKEQIQP
AIAKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPITEVVSHNEYFDYEAKYNGASD
EITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAAGMEMKDVMTDIIENKFKD
>KF629399.1_13887|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAGYGG
GSLWLRAGAVWMESDRL
>KF629394.1_13900|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DLSKEFPALTLRRTAVKSAIDEVLWIWQKKSNNIHDLKSHIWDEWADPDGSIGKAYGYQM
QVKHQYKEGMMDQVDRVLYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKRP
GEDKLLNNAQCHFKPALPGYSCGK
>KF629394.1_13903|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
VTAHAEGFDENMYLDAATRTKVEETGGANFIFITKDGKLVTPKSDSILPSITRRSIVYVA
KEYLGMDVEEREVFFDEVTDFAECGLCGTAAVISPVGKINDHGKEICFPSGMDDMGPVIK
KLYDTLTGIQMGHIKAPEGWIQVIE
>KF629391.1_13908|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KGEDRLTLNAILNQRSQDILTANNWNVCQYAVLVHMLAQVCDMNVGELVHVIADAHIYDR
HIPLVEELIQRPVHDAPKFALNPEIKDFYDFTPEDVTVTDYVTGPQIKNIPVAV
>KF629386.1_13922|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MESVEFRSMKKNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGKWLLVD
SVKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQG
LFELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEK
EIPYPIFVKPSCAGSSKGVSKAENREELEAALYEAVKHDRNILCEETIVGREVECAVLGD
RTQVKSTCVGEILAAEEAAFYDFDAKYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVD
GFGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRY
R
>KF629380.1_13937|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGTSTERDVSIVSGTGICSALRQKNHQAILVDVFCGLENVDWADPFPESYDVE
EAVSYIRSFNRHIEELKKSRKEFFGPNVLELCKKADFVFLGLHGSNGEDGRLQAVFDLMG
IPYTGTGYLSSAMAMDKGVTKAMFQMRGVPTPGGKAMKKKDRVETPQELGLDFPVVVKTC
CGGSSIGVYIVDNQADYTKALDGAFTYENEVVVEEFVEGTEYTVAVVDGKAYPVVQIVPV
QGFYDYENKYKPGAVKETCPAPISEELTRRLQEYAVEGYHALEMESYGRLDFIVTKDEKI
YCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIRVSMKKSTNEEN
>KF629369.1_13966|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPPRPLTLPRTALKSATDEILWLYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQK
SHYAEGDFDQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDD
KPTLNMILNQRSQDILAANNWNVCQYAILLMMVARSVDMIAGELLHVIADAHIYDRHVDI
IRELIERPQFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF629367.1_13976|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMNKNDVVAVIMGGPSAEREISLVTGAAIAGALREKGYNVAEIDLEPKKLALQLEECSAK
VVFNAVHGMYGEDGRLQTLLEMLEIPYTGSGMLASALGMDKAASKRIMQAAGIATPKSLI
FVKGETHDFCGEILSAFKKMPVVVKPATQGSSIGVEIVKNDTDINSAMEKAFTYSREVVV
EEFIQGKELTVAIMQDGGMAVALPVINIVPHSGVYDFHSKYTKGETEYLVPAPLDKETTR
HVQELAVATYKVLGCSGVARVDVMLDEAGKGYVLEANTVPGMTATSLVPKAAAAVGISFP
DLCEKILLSASLNDK
>KF629349.1_14031|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GHIYGYQWRSWPDYKGGTIDQISEAIETIKHNPDSRRIIVSAWNVGDLDNMNLPPCHAFF
QFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMVAQVTGLKAGDFVHTLGDAHIYL
NHLEQVKLQLSREPKALPQMKINPDVKNIFDFKFEDFELINYDPHPHIAGKVAV
>KF629348.1_14035|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIVNADKNWGIGKNNELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGMPLPKRTN
IVLTHDKDYDAKGAIVVGSKEELLDELEEYKDEDIFIIGGESIYRMMLPYCDTAYVTRTD
FAYDADTYFPDLDEMPEWKLVKESEEETYFDIEYQFVVYQK
>KF629333.1_14085|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RSADIFLGVPFNIASYALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPR
PLPQMKINPDVKSIFDFKFEDFELVNYDPHPHIAGAVAV
>KF629331.1_14092|FEATURES|farme|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MIDLDVEIYQHLNEQIKINKLCYLSSGDDSDTFLCNEQYVVKVPKRDSVRFAQKREFELY
RFLENCNLSYQTPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAV
LFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWLIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF
>KF629330.1_14096|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MMRNPLSKKITGIEPSGIRKFFDLVSEMPDAISLGVGEPDFDTPWRIREEGIYTLEQGKT
FYTSNAGLKDLKIEISKYLERKIHVEYDPDHEIMVTVGGSEGIDVALRAMLDLGDEVLIP
QPSYVSYVPCTILADGNPVVIPLQEKNEFKLTAEELEAAITPKTKMLVMPFPNNPTGSIM
TKEDLEPIAEVVKRHDLYVLSDEIYSELTYKTEHVSIASLPGMQERTLVINGFSKGFAMT
GWRLGYICGPSVIIEQMLKIHQFAIMCAPTNSQYAAIEGLRHCEDEVQQMRNAYNQRRRY
LVNEFAKMKLECFEPFGAFYIFPSIKEFGMTSEEFAMRFLEEEKVAVVPGSAFGESGEGF
LRVSYAYSLEDLKEAIGRLSRFVERLRSQK
>KF629329.1_14099|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVNADKNWAIGKNNSLLVRIPADMKYFRQMTEGNIVVMGRKTLESFPQGRPLANRVN
IVISHNPDYQVKDAIVVHSVEEAMQECKKHKGEVFVIGGESIYRAMLPYCNIAYVTRTDH
VYEADTWFPDLDKDPDWQKTAETDEQTYFDLEYVFAKYERIK
>KF629325.1_14113|FEATURES|farme|multidrug|ACR_trans|antibiotic efflux|1
AVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIR
DAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVY
IPNFYELMQKLQERFSKKQ
>KF629322.1_14121|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNMNIVVLAGGISTEREVSIVSGTGVCQALRKKGHRAILVDVFCGDARVASECIEDCFPK
EYDVASAADYMRSMSEEIEEIKKSGREFFGPNVLKLCKLADIVFLALHGADGEGGTVQAA
FDLLRIPYTGSGHLGSAMAMDKNISKRLFQAYGVPTASGIALKKENPRLAAAENGVGLPC
IVKPCCGGSSVGVTIAHTEEEYEEALSAAFSYENEVIVEAYIHGREFSAGVIDGKAYPII
EIAPVEGFYDYQNKYTAGATIETCPAELSKEQTEQMQSYAVKAYEALQLSGYGRMDFMMD
EQGRMYCLEANTLPGMTPTSLLPQEAAAVGIAFPELCELLIEVSMKARGQKR
>KF629309.1_14153|FEATURES|farme|multidrug|cpxA|antibiotic efflux|0
MVCNLAIDAYYGCMADFSHILMTRPDFGDDDREWLHQLVADWQVIADLSFADLLLILQNG
EGKYIIAEQCRPSTVMSLRAEDVVGNVVPESLCAELDAAMDSESVFRSSKLRTVGKAKVC
NVYAPVRHNGKTLGLVVRETNMATRESNGRYESESISAGKQLYEMIPRGQFPYRNPVMNQ
RHNARVADGFIVLTVDGIVRYASPNAISCFRRLGSVSTMQGEYLSEIGTKLLHENDPVLE
TLPLVLSGKAAVDSELDANKAAVSMRSLPLMDANGRVGGIVLCRDVSELRRREKELQTKD
ATISEIHHRVKNNLQAVSALLRLQARKTKSEEVKKELKEAQRRVQTIAMGHEGLSQTADE
IVDYDKVISNLLKMAVDLATMRDQHIDVDFVGKFGMMPAQDATPLSLVLTELITNSVEHG
FEGRKEGHITISVGRGGNNLNVVVEDDGTGLADEEHDGMARSSGSGLGTQIINTFVTNDF
GGTVHWEPRRGGGTRVVLDMKLRAAQDN
>KF629305.1_14167|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNISIIVAIARNHGIGFENKLLYWHPNDLKRLKALTTGHTIIMGRKTFESLPKGALPNRR
NIVLSRREGAVFAGAECFPALEIALSHCKEEEEIFILGGASLYKEAMHIAQQLYITFIDD
TSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFINYSRIK
>KF629299.1_14183|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EGIHKEDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIYELLWFLNGDTNAKYLQ
DHGVRIWNEWADENGELGHIYGYQWRSWPDYKGGSIDQISEAVETILHNPDSRRIIVSAW
NVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQITG
LKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIFDFQYEDFELVNYD
PHPHIAGKVSV
>KF629295.1_14194|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MNIINIGILAHVDAGKTTLTESLLYASGTISEPGSVEKGTTRTDTMFLERQRGITIQTAV
TSFQWHSCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVLSAKDGVQAQTRVLFHALRKLN
IPTIIFINKIDQVGIDLESVYQSVRDKLSADIIIKQTVSLSSKITLTENTSAEVWDSVIE
NNDELLAKYIAGESISQKELAQEEQRRVQDASLLPVYHGSAKNGLGIQQLMDAVIGLFQS
TKEQGSAALCGRVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQIADTDPLLHYEVDSTTHEIILSFLGRMQLEVVSALLTEKYKIETAVKEPTVIY
LERPLKVASHTIHIEVPPNPFWASIGLSVTPLPLGSGVKYESRVSLGYLNQSFQNAV
>KF629294.1_14195|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPAPK
VALNPEVKDFYKFTVDDFTIEDYEAGPQIKNIPIAI
>KF629292.1_14201|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLLENGHQAYLLDLYFGLENAPASLEDVFTLPGA
GLEIAKNISTKEPDLEVLKKSRPDQSDCMFGPNVIELCCMADITFVALHGSVGENGKLQA
AFDLLGIKYTGCNSFGCALSMNKLVTKQIYKMSGVPTPRGTHLTKETKDLPLSELGYYLP
LVVKPCENGSSIGVYICHTEEEYNNAVRESFEKNPDEELVIEPYIKGREFGQRCHCRKRH
SH
>KF629275.1_14244|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ERQENRMSYADKVFINMCRDIIENGTSTEGEKVRPKWEDGTAAYTIKKFGVVNRYDLSKE
FPALTLRRTAIKSCVDELLWIWQKKSNNVHELKSHIWDSWADENGSIGKAYGYQMQVKHQ
YKEGMMDQVDRVLYDLKENPYSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTKEEGSEQL
TLNGILNQRSQDVLTANNWNVCQYAVLLHMFAQVCGMKAGELVHVIADAHIYDRHIPLIE
ELISREPLPAPKFWLNPEVKDFYDFTPDDVRLEDYETHPQIKNIPVAI
>KF629270.1_14259|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIAAVDRKRGIGYQNRLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSTQKDLICPGTEVFPSLEEALSSCQPDEHVYIIGGASVYKQAMPLADMLCLTEIAAE
APQVDAYFPAMDFAIWHEKSRESHLVDEKHPCSYAFVDYIRK
>KF629263.1_14275|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEVVLMKVGVIMGGISSEREISLNSGNSIMENIDKNKYDVVPVVIDEKADIINKVKDLDF
ALLALHGKFGEDGTVQSVLQTLDIPYSGCGPLSSALCMDKDLTKVVLAANGIRTAKWLNV
KSVEEIDYEAIEKMGYPVFIKPTNGGSSVATFKVYDKEKVQEAVEEGLKWDTEVMIEEFV
DGDEITCPVFDNKLFPIIAIKPKSDFFDYTQKYSAGGADEVIVELEENLHKEVEAMALRT
YKALKCEVYSRIDMIVNKEGIPYILEVNTLPGMTAASLFPKSAKGQGYSYSEFLDLIIET
SLKVNRAV
>KF629259.1_14285|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
ESMNIVVLAGGTSTEREISIVTGTGVCKALRQKGHNAILVDIFCGLEPVDWDEPFGDKDY
EVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQAADIVFMGLHGSNGEDGKVQATFD
LLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKGVSMLKENCTRNIQDLGMEFPVVV
KTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVEEYIKGREFSVAVVDGKAYPIIEI
APKQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHYAEAGAKALCIEGYARFDFMMKEN
GDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEELIRISLKKYSK
>KF629251.1_14308|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SEAVETIKHNPDSRRIIVSAWNVADLKNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFL
GVPFNIASYALLLQMMAQVTGLKAGEFIHTLGDAHIYLNHLDQVKLQLSREPRALPQMKI
NPDVKSIYDFQFEDFELVNYDPHPHIAGIVAV
>KF629244.1_14326|FEATURES|farme|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MMALTNELYRVLAGAGFDIRDIRPLSCGDDSDAYLCDDVYVMKVPKRETVKKTQALEFQL
YRFLEPFSFPCEIPKVIYQGEAFNMMTYIKGERLAYENYHKLSEKEKDRLACDEAEFLKA
LHSVEIPDSHPLYSELKLEVKDRFLQDQKKLLTILKAEKLLTPGRQAWVERIYRDLLDMD
FLFAYRPCLTHNDYSADNMLYQKNRLTGVIDFGDAVIGDPDNDFLCLLDNSTDDFGKDFG
RRVLRYYGHPHPELAERKAEINDAYWPVQQILLGHSRKEAQLFEEGIRDLEMVRF
>KF629239.1_14336|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVSIIVAVAENGVIGDKNTLLWHISEDLKHFKAVTTGHPVIMGRKTYESLGRPLPNRTNV
VITRQQVEIPGCRVVHSLGEAVALFPGDDEVFVIGGAQIYAQALPLADRFYLTRVFRAYE
GDTHFPEWDEAQWRLLSSESFASGANYPYPFAFETYERRRN
>KF629238.1_14339|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICRTLIEKGHDAFLLDVFLGLEHAPEHLEDVFTLPGH
GLEIAKNISCEEPDLAAVKASRPDQSDCFLGPNVIELCRLADITFLGLHGGEGENGKLQA
TFDLLGIRYTGPDSLGCAVAMDKGLTKQVFLQAGIDTPAGVTIHKKSKDRSLALTGLSLP
VVIKPCSGGSSIGVYIVSTEEEYAEALEKSFFYEDEVVVEEYIKGREFACGVIDNEALPP
IEIIPKTGFFDYANKYQADATLEVCPADIPEETASRMMELTVKAFRALKLNVYSRADFLL
DEKGNLYCLEMKHSAGHDRSQPAAERSESGRNRIRRSV
>KF629236.1_14346|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
IGKEQDLLCHLPNDLKHFKTLTLGHTIIMGRKTFESLPKGALPNRENIVLSRRKDALFPG
AKVFHSLQDAISKYPDNEELFIIGGATLYKETIGMAENLYITHIHHIFDDADTFFPAIDT
DKWEETERTEMPADDRHPYSYCFTRYRRKML
>KF629234.1_14350|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQFDLEREFPILTTKKVAFKTAVRELLWIFKEQSNDVKRLQEQNVHIWDEWEMEDGTIGT
SYGWVVQKFHQMDTLLEQLKTNPQDRRMMLNLWQIPYLDTGALYPCCFLTMWDVTDGRLN
CMLVQRSGDWGLGVPFNTSQYAVLVHLLAQVSNLRPGMLTHVINNAHIYENQVEGIRLQL
TRRAEAFEAPALWINPEIQDFYAFQIQDIKLIGYKSHDKISMEVAV
>KF629231.1_14356|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
NLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQACDME
AGELVHVIADCHIYDRHIPVIDMFRLSRS
>KF629230.1_14360|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTAGHVIIMGRKTFESLPFLLPNREHW
VITRDKGFDAPEGVKIFHNLEAAAEAARALDAAYVLGGAQVYEAFLPYVDTMYITEVDHE
FEGDAFFPEFPEEAFTIESVVDGVVDEKNKYPHRFVTYR
>KF629227.1_14366|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLELCVIFGGQSPEHEISRKSVTSVLNNLNKDKYNISTIGITKNGAWYLYTGDYAKIESG
EWEQDTENKKKAILSPDAEDKAILVFDGDKVTKIHPDVIFPVLHGEFGEDGTIQGLFELS
GIPYVGMGVMASANGMEWIRPHQKSCLQVQIFRRLIGLL
>KF629227.1_14367|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VFASADIPQADWVVVNKTDNFEDKMDEIENKLGYPCFVKPARTGSSVGVGKAHDRKELKA
ALENAAQFDRKILVEENIDGHEVECAVLGNEDVKAATVGEIMPTVEFYDFDAKYNDNSTE
LQIPADLPKETIEQIREYAVRAFKALDGSGLSRVDFFVKHSDGSVVLNEINTLPGFTNIS
MYPKLWGAVGIEYSELLDKLIELAEKRVK
>KF629225.1_14371|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIVAVAENGVIGGDNRLLWHISEDLKHFKAVTTGHPVVMGRKTYESLGRPLPGRRNV
VVTRQNISIEGCDVVHSLDEALALFRPEEKVFVIGGAQIYAQALPLCDEFYLTRVFHAYQ
GDTCFPRWDEREWEIIDSESFASGKEFPYPFAFEHYRRRK
>KF629220.1_14385|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NRYYLSKEFPALTLRKTYIKSAIDELLWIWQKKSNNVHDLKSHVWDEWADEDGSIGKMGI
KHQYKEGMMDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKSGH
DKLTLNAILNQRSQDILAANNWNVVQYAALVYMMAQVCDMEAGELVHVIADAHIYDRHIP
IIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF629218.1_14389|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWIYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYVEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVNIVRVLIERP
QFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF629210.1_14411|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MYQRSADSFLGVPFNIASYALLLQMMAQVTGLKPGDFIHTLGDAHIYLNHLEQVDLQLSR
EPRPLPRMILNPDVKNIFDFKYEDFQLEGYDPWPHIAGKVSV
>KF629203.1_14431|FEATURES|farme|multidrug|mdtK|antibiotic efflux|0
FMLYSKKTDYLMESIRLGREMDRREKLNLIVGLSIPSMLAQISTVMMFFIDASMVGHLGA
EASASIGLIESTTWLIGSLLSAAATGFSVQVAHFIGANDFANARQVFRHALICGVAFSIF
VSLLCVGIHAYLPYWLGGGADIATNSSRYFLIYGLVLPFVFLYHISEMMLKSAGNMHTPS
VMAVLICICDVIFNYLFIYILKLGVVGAALGTAMAYVCISLPNLYLAGFKNKILNLRQDH
VRFRWVRSYVHNACKISIPIAIQNILMSGAQIVSTMIVAPLGNIAIASHSFAITAESLCY
MPGYGIGDAATTLVGQTHGAGRVGLCKNFAYMTVGLGMAVMAVMGVVMYVFAPEMIGVLS
PVESIREMGTICLRIEAFAEPFFAASIVTYCVCVGAGDTRKPAMINLGTMWLVRLTLAYA
LSKSYGLEGVWIAMAIELTFRGILFLIRLFRGSWMKSFHVG
>KF629202.1_14433|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
IVNADKNWGIGKNNELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGLPLKNRVNIVL
TKNQNYQVKGAIIVHSVEEVLEELKKYDSEDVYVIGGEQIYRQMLPYCDTAHMTKIDHAY
EADAYFPNLDEKEEWKITATSDEQTYFDLEYYFVKYEKQVQ
>KF629196.1_14448|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKQNLAVIFGGQSSEHEISCMSASNIIQCIDAQRYNIILVGITKEGHWVEAADLNAVQD
GSWRQSKTSIVLSPDATRKGLYRMSEDEKAQFVHLDVIFPVLHGLYGEDGTVQGLFKLAG
IPFVGCGLFASAAGMD
>KF629129.1_14628|FEATURES|farme|multidrug|mexK|antibiotic efflux|0
MKIEDFKYELILLRDLAHANGRERTRLIRALLRYSPGDYTRFCVWVAMVVIIGGIAAGVI
AGIRGENPFPILLCVGLAGVGSAAIGYRAAHKRRVDSLIALSEKLNARAEKLPVGEFERI
AEMLSVAPEKTGKTFNFVAIVGTLGLIGMIIKNGIVLMDEITLQISQGVEPVTALIDSSQ
SRLRPVMMASLTTILGMIPLLPDAMFGSLAASIMGGLLFGTLITLLFIPMTVALSG
>KF629105.1_14675|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MVCKALREKNHQAVLVDVFWGIDEKGNLEDVFAEEAYEIDKAAEYMHSFDAGLNEMIASR
RRFFGPNVLELCEAADVVFLALHGANGEDGKVQATFDLLGIPYTGTGYLSSALAMDKSIT
KQFFRAHHVPTPNGVTLKKGQESEPLSGFGLELPVVVKPCCGGSSVGVYIAHTNEEYWQA
MKDAFSYEPEVVVEEYIEGREFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAGSTVETCP
AVLTEEQTKEMQKHAEDGAAALGIENYCRLDFMMRKDGRMYCLEANTLPGMTPTSLLPQE
AQVLGISYPELCELLIQLSLRKRGKNE
>KF629104.1_14679|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNSKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELNDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF629092.1_14713|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELLDRVLREGVKKEDRTGTGTISVFGHQMRFNLDDGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHVYGYQWRSWPDYNGGFIDQISEVVETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIF
DFKFEDFELVNYDPHPHIAGAVAV
>KF629090.1_14722|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|0
MGGKSSEHDVSLISAKTVIESIDKERYSVIMVGITKDGQW
>KF629085.1_14738|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAVDSNWAIGKENKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVN
VVLTTDKNYKVKDTVIVHTIEEMVDELKKYDSEDIFVIGGESIYRQLLPYCTKAYITKID
HAYDADTYFPNLDEDPEWEMTKISDEQTYFDLEYVFTIYERR
>KF629082.1_14744|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYEGGFIDQISEAVETIRKNPDSRRI
IVNAWNVADLKNMNLPPCHMFFQFYVADGRLSLQMYQRSADSFLGVPFNIASYALLLQMM
AQVTGLKPGDFIHTLGDAHIYLNHLEQVDLQLSREPRPLPRMILNPDVKNIFDFKYEDFE
LVNYNPHPHIAGKVAV
>KF629082.1_14745|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIAAVDRHMAIGYENKLLFWLPNDLRRFKALTTGNTIIMGRKTFESLPKGALPNRRN
IVLSTRPDTLCPGAEIFPSLEEALKHCEQDEQIYIIGGASVYRQALPLADALCLTEIDAE
APQADAYFPEVSPEIWQEKSRESHPIDEKHPCPYAFVNYIRR
>KF629077.1_14759|FEATURES|farme|beta_lactam|A6804_08920|antibiotic inactivation|1
MFKMTLCALLITAPCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKSIDPATKYWPELTAKQWNGI
TLLHLATSTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFHPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>KF629075.1_14763|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KEGRWLYTEATAAQMADGSWEELAGNMPCILSPDRADHGMVLFTPEGHVEKLHVDVVIPV
LHGLWGEDGTVQGLLELAGIPYVGCGVLASAACMDKGVANALFEANDIPHTKWLAANRWQ
IESDLEGVCAGVEAKLGWPVFVKPANAGSSVGISKVSNREELKKAIALALENDRKVVFEA
FVDGQEVECAVIGSDPAVATRPGEILAGAEFYTYDDKYKNGVSQVVIPANLPEEKLDE
>KF629072.1_14769|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MDAIVAVYSDWGIGDGGTQPVVLKADRRHFRSLTDGSAVIVGRKTLADFPGGKPLANRFN
IVVSRQGINVDGALVVHSTGEALDAAEDFEQCFVIGGASVYMQFFNYLERVYVTKIDIEP
QSDSFFPNLDRNPEWECVSQEPWEEEDGIRYCFCTYEKKFSL
>KF629064.1_14788|FEATURES|farme|bacitracin|uppP_2|antibiotic target alteration|0
MKQYLDLLNRVLTEGIEKSDRTGTGTISVFGHQMRFNMDEGFTCL
>KF629060.1_14794|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
ELLHVIADAPIYDRHVDVIKELIGRETYPAPKVRLNPEVKDFYQFTTSDLLVEDYQAGPQ
VKNIPIAV
>KF629057.1_14806|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGISTERTVSLVSGTGVCQALRRKGHQAILVDMFMGLENQPADLNTLFDAPDG
LCPDVKIEVQAPDLDAVRRSRPDQSPSRIGPHVLDICRLADIVFLGLHGQDGEDGRIQAT
LDLLGVPYTGAGYLGSAIAMDKIAAKEMMDANGIPNPKWQKLTYTEAEIPQLAETLPMPC
VVKAPTGGSSLGVYLPKDRAELADALRQVRSFCHEVLVEQRIYGRELTDAVLGERYLPPV
ETFPSVENFDYEAKYQAGGAKEICPAELTEEQAKAVGEMALRVHKALGLAVYSRTDMILD
ENGQLWCLEANSLPGMTPTSFVPKEAAAVGISYDDLCEEIVRQSLKIKRR
>KF629056.1_14809|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LEDKKKRIGVIFGGKSGEYEVSLLSAASVIRVLNTQKYEPVYIGITKEGKWKRYDGDADS
IENGSWLAEAEDLNPGDLKQYIDFALPIVHGPYCEDGKLQGFLETMDIPYGGCGVLASAV
AMDKQVARQVFLRAGLPMCKHVFLTKAEWQDEQETVLARIEQQIGYPNFVKPANLGSSVG
ISKAKDRTSLIEALALALSYDSRVIVEEFVDCRELETGILGNDYPAAAEVGEILSSAEFY
DYEAKYSDGASRICIPAEISAEDREEIRMMAVKACKAIGGEGYCRVDFFKDRRTGKIYLN
EINTIPGFTKYSMFPLLWEAAGVKYPDTVERIIELGYERYYTKNHRETML
>KF629048.1_14828|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNRKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>KF629025.1_14888|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSQADKLFVAMCQEILDHGYSSQGQTVRAKWEDGTPAHTIKQFGIVNRYDLQEEFPALTL
RPTAIKSAVDEMLWIWQKKSNNIKDLSSHIWDEWADENGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPAPK
VALNPEVKDFYKFTVDDFTIEDYEAGPQIKNIPIAI
>KF629017.1_14910|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRYMFQKIM
>KF629016.1_14913|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRGGQSVTDEDVMEKIGLPCFIKPNLGGSSFGVTKVTAKEQIQP
AIAKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPITEVVSHNEYFDYEAKYNGASD
EITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAAGMEMKDVMTDIIENKFKD
>KF629014.1_14924|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKSRSLLSQAVVSGLLFFQLLSVSASDLTSDIQEVIKGKNAQVGVAVLYKDDAVTVNNED
QYPLMSVFKFHIALAVLKKMEQEGIPLTALVTLGPSDIDTKTWSPMYKKYKSKEITLSYG
DLINYMVSQSDNNACNWLINFVGGIQNVNAFIKDLGINQIQLIETEKSMEQDIRKSYNNW
STPLSVAQLLRKVYTEKVLSDEYFAFLEKAMLASASGKDKFRAGFPKEVEVGHKTGMSYR
TLEGIRMCDADVGVIYMPGGEKCYLAVLVKDSKESDAENAKIMADIAKKVYEHYTENSAK
DGSHKRE
>KF629011.1_14936|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELCSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRTFIENPLPMLQTTIAAKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGKVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF629008.1_14945|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MVGRIYHVGLTVSDLDRSIAFYRDILGLEFQGEILMEGEETDKMFRKENCKARVAYLNGS
KTLEAPPVELIQFVDSKIHKEQSDLFTTSISEVCFYTDDIDSVYKTLIENHVECLSEPQH
FDFRADGFGESRAFYFRDPDGIILEMMQPL
>KF629007.1_14947|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
VWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKP
YYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTA
KQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLF
GALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDA
EAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTG
>KF629001.1_14964|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|0
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDVFTLPDH
>KF628986.1_15008|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LQIFVDYDKIENEESSLLSVLPVLYTEFGGRSVLKSAVSGYIIVSGMTPVLAATGFGFAL
LLRSRLSQIIKEYRHMAKIRVAVLFGGVSSEHDVSLVSAENVIRSIPKEKYEVLCIGITK
KGRWLYFPGDVSEISTGAWEQNPDCTAAILSPDPLHGGIVTIENGETYIKKVDVVFPVLH
GRNGEDGRLQGIMEMARIPYVGCGVLSSAVCMDKGMTHTVLDYNGIQTAKWASVHQRDLN
KLNEKCVAIAETLGFPLFVKPANAGSSVGVSKATDLESLKDAVQIAFTHDEKVIIEEFID
GRELEVAVFGYDAPIASYVGEIEPAAEFYDYDDKYVNGSSKLYIPARITDQESDRIRETA
LRAYQALGCKGLSRVDFFLSKDGSIILNEINTLPGFTSISMYPKLMEHLGMKQEYLVDKL
IEQAMENAART
>KF628978.1_15026|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDKIAVLLGGTSAEREVSLNSGAAVLAGLREGGIDAYPVDPKEVDVTQLKSMGFQKVFI
ALHGRGGEDGTLQGMLELMGLPYTGSGVMASALSMDKLRSKLLWQGAGLPVAPWVALTRA
EFEKGLNDQQLAEISSLGLPVIVKPSREGSSVGMSKVVAENALQDALRLAFQHDEEVLIE
KWLSGPEFTVAILGEEILPSIRIQPAGTFYDYEAKYLSDETQYFCPAGLEALQEANLQAL
VLKAWTTLGCKGWGRIDVMLDSDGQFYLLEANTSPGMTSHSLVPMAARQAGMSFSQLVVR
ILELAD
>KF628976.1_15031|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDGLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRLIYLRLYSGTLCLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVGLNDVLGDQTRLPRERWRDAPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLAEKYKIETAVKEPTVIY
LERPLKAANHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRYMFQKIM
>KF628970.1_15044|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
SLGGSSFGVTKVTAKEQIQPAIAKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPIT
EVVSHNEYFDYEAKYNGASDEITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITE
GEKINLLEVNTTPGMTATSFIPQQVRAAGMEMKDVMTDIIENKFKD
>KF628962.1_15062|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
ADAHIYDRHIPLVEELISREPLPAPTFWLNPEVKNFYEFTPDDVRLDNYETGSQIKNIPI
AV
>KF628958.1_15078|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|0
MKIVVLAGGTSTERDVSIVSGTGICGALRQKGHQAILVDVFCGQEEVDWEDPVPGRI
>KF628945.1_15108|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MMRNPLSKKITGIEPSGIRKFFDLVSEMPDAISLGVGEPDFDTPWRIREEGIYTLEQGKT
FYTSNAGLKDLKIEISKYLERKIHVEYDPDHEIMVTVGGSEGIDVALRAMLDQGDEVLIP
QPSYVSYVPCTILADGNPVVIPLQQKNEFKLTAEELEAAITPKTKMLVMPFPNNPTGSIM
TKEDLEPIAEVVKRHDLYVLSDEIYSELTYKTEHVSISSLPGMKERTLVINGFSKGFAMT
GWRLGYICGPSVIIEQMLKIHQFAIMCAPTNSQYAAVQGLRNCGDEVEEMRKSYNQRRRF
LMHEFKKMGLECFEPFGAFYVFPSIKQFGMTSEEFATRLLNEEKVAVVPGTAFGECGEGF
LRISYAYSLEDLKEAIGRLERFIGRLRNERK
>KF628944.1_15111|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKAILSADRKWGLGYQGRLLVSIPSDLRFFRETTMGHVVVMGRKTLATLPAGQPLKGRTN
IILSRDPEWTVRGATVVHSIKELMEVLKPYEDDDIYVAGGGEIYRQLLPYCDTAYVTRID
MTYQADTFFEDLDESPDWEMVEEGDEQTCFDIEFYFTEYRRKNEKAERQR
>KF628936.1_15125|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQSANKMCVALLFGGMSSEHEVSCVSVGNFVRNIDRSKYEVLTVGITKEGRWLYTEATAE
QMADGSWEELPGNMPCVISPDRADHGMILFTPDGRVEKMHLDVVIPVLHGLWGEDGTVQG
LLELAGIPYVGCGVLASAVCMDKAVANALFDAAGIPHTKWLSACRWEIESDLDGVCDGAI
AKLGWPIFVKPANAGSSVGITKAHDRDELKQAIALALENDHKVVFEAFVDGHEVECAVIG
SDPAVATRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLPEAKLDEVKTYAAMAYTALNCE
GLARCDFFVEKNTGRVLINEINTFPGFTAISMYPKLMEHEGLPVPQLIDRLIELALERTE
KQHG
>KF628932.1_15134|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
VEKAAAYIRGFNLQMAELKKTRKNFFGPNVIDLCKKADFVFLGLHGANGEDGKLQGAFDL
MGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVPTPAGKAMKKKDRVETPQELGMELPVVVK
TCCGGSSVGVYITKTPGRIRRGTARCILLRG
>KF628927.1_15149|FEATURES|farme|glycopeptide|vanI|antibiotic target alteration|1
YDLDVKYVDPTDIHRIPAQISPENYARAQELACAAHKALGCLGISRSDFIVSEDGPVILE
TNTIPGMTDTSLYPDEIRHTDDMTFPQV
>KF628918.1_15177|FEATURES|farme|tetracycline|MFS|antibiotic efflux|0
MNLSLRRSTSALLASSLLLTIGRGATLPFMTIYLSRQYNLSVDLIGYAMTIALTIGVVFS
LGFGILADKFDKKRYMLLAITAFASGFIAIPLVNNVTLVVLFFALINCAYSVFATVLKAW
FADNLSSTSKTKIFSINYTMLNIGWTIGPPLGTLLVMQSINLPFWLAAICSAFPMLFIQI
DLEGG
>KF628914.1_15184|FEATURES|farme|multidrug|ABC_transporter|antibiotic efflux|0
MALITCENVSIGYEGQTVVKELNFSIERGDYLCIVGENGSGKSTLVKSLLGLKGADRGKI
IYGDGLKKNEMTVAWRW
>KF628909.1_15196|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NNWNVCQYAVLVHMLAQVCGMKAGEFVHVIADAHIYDRHVPMIEELISREPLPAPTFWLN
PEITDFYDFTPDDVRLDRYETHPQIKNIPIAV
>KF628902.1_15210|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
IAIVCGGDSSEHDVSLRSGQGLYSFFDMERYDIYLVDVKGTDWHVALDNGETIEIDKNDF
SFVKDGKHVYFDYAYITIHGQPGENGVMQGYFDLIHLPYSTSGVLVEALTFDKYVLNNYL
RGFGINVADSILLRRGEEYDEDAIAERIGMPCFVKPAADGSSFGVSKVKNADQLAPALRV
AFMESNEVMIEGFLDGTEISQGIYKTAEKTVVLPATEVVTSNEFFDYDAKYNGQVQEITP
ARLSPETAEEVAKTTSRIYDILHANGIIRIDYIISKDKDGKDKVNMLEINTTPGMTVTSF
IPQQVR
>KF628885.1_15254|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRIVVLAGGLSMERNVSLSSGNKICRALRSRGHQAILVDMFMGFEDYDGKLEDVFDTPDG
FCGDYSVAEAEPDLAAVRASRKDQSKSLFGPGVLDVCAKADIVFLALHGTCGEDGRVQAA
FDLLGIPYTGAGYLSSAIAMDKDLTKRLVSEYVITPQWRTVRYTEGDIARLASETKLPCV
VKPVANGSSVGVSIAHTGAELKKALEECLQFGAQVVLEQYISGREIQVGIIAGKALPSIE
IIPKTGFYDYANKYQAGAAEEICPSPIPEDWEMRVRTATETVYRLIGLSVYSRADFIVTP
DGTPYFLEINTLPGMTKTSLLPQEAAAVGIGYEELCEKIVEESLKQRRGL
>KF628869.1_15291|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKIIVAADKNWGIGKDNKLLVSIPADMKMFRQETTGKVCVMGRKNLESFPGGLPLKNRIN
IVLTRNENYKVKDAIIVHSIEELMEELKKYPAEDVYCIGGDTIYKQLLPYCDAAQVTKID
FAYIADSYFPNLDEDPQWHVAAESEEQT
>KF628862.1_15307|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
HLRAPKFWLNPEVKDFYDFTPDDVKLEGYETHPQIKNIPIAV
>KF628856.1_15324|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSHVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF628855.1_15327|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF628827.1_15401|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGCIARYRLEALMSKADELFVSMCQDILDNGTTTEGQKVRPHWEDGTPAYTIKNFGVTNR
YDLREEFPALTLRRTALKSAMDEILWIYQRKSNNINDLHSHIWDEWADETGSIGKAYGYQ
IAQKSHYVEGDFDQMDRVLYDLQHTPFSRRIMTNMYTFSDLSEMHLYPCAYSVTYNVTEQ
PGDEKPTLNMVLMQRSQDILAANNWNVCQYAILLMMVAQSCGMIAGELLHVIVDAHIYDR
HVDIVRELIARPQYSAPRVSLNPEVTNFYDFTTDDLIVEGYEHGPQIKNIPIAV
>KF628825.1_15406|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
TGTGYLSSAIAMDKCMTKEFFLANHVPTPKGATLTGENGFDTDLSVLGLEFPVVVKTSCG
GSSVGVYIVNDQKEYEEALKEVSIYGNEAVVEEYIKGREFSVSVVDGKAYPIIEIAPIQG
FYDYKNKYQAGSTVETCPAHIAQELTDKMQDLAVKAAKALKLEAYSRLDFLMKENGDMYC
LEANTLPGMTPTSL
>KF628818.1_15425|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKLRVGIVFGGKSAEHEVSLQSAKNIVNAIDKSRFDVVLLGIDKQGQWHVSDASNYLLN
ADDPAHIALRPSATSLAQVPGKHEHQLVDAQNGQPLPTVDVIFPIVHGTLGEDGSLQGML
RVANLPFVGSDVLASAACMDKDVTKRLLRDAGLNIAPFITLTRANRHNISFAEVESKLGL
PLFVKPANQGSSVGVSKVTSEEQYAIAVDLAFEFDHKVIVEQGIKGREIECAVLGNDNPQ
ASTCGEIVLTSDFYAYDTKYIDEDGAKVVVPAAIAPEINDKIRAIAVQAYQTLGCAGMAR
VDVFLTPENEVVINEINTLPGFTNISMYPKLWQASGLGCTDLITRLIELALERHAADNAL
KTTM
>KF628817.1_15426|FEATURES|farme|beta_lactam|BAMA_03925|antibiotic inactivation|1
DYDSLFQELEEKYDATLGIYALDTETNKEISYNADERFAYCSTYKALAAGAILEKYSIEE
LDNVIYFEEEDVLSYAPVAKDKVDTGMTIREICDAAVRQSDNTAGNLQFTLLDGPNGFKQ
SLSKIGDTVSEPSRIETELNDAVPGDIRDTSTPKQLAFNLKEYVTGDILSDDKKEIFIDW
MSNNATGDELIRAGVPSDWIVADKSGAGSYGTRNDIAIVTPPNKKPIFVAVLSKKAEQDA
EYDNKLIADATKIIFDLIS
>KF628814.1_15436|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELVVSLRSAQGLYSFIDKERYNLYIVEMEGHRWEVVLPDGSKTPID
RNDFSFMENGEKKQFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTC
NQYLKGFGIRVAESLILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQP
AIEKAFEESDEVMIEAFMKGTEITCGCYKTSDKEVVFPITEVVSANEFFDYGAKYNGESR
EITPARLPEDTAERVRLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF628803.1_15460|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQTIILLYGGRSAEREVSVLSAESVMRAVNYDRFTVKTFFISQSGDFIKTQEFSQTPGQ
EDRLMTNETIDWDKKVAPSAIYEEGAVVFPVLHGPMGEDGSVQGFLEVLKMPYVGCNILS
SSLAMDKITTKRVLESAGIAQVPYVAIVEGDDVTAKIAEVEEKLTYPVFTKPSNMGSSVG
ISKSENQEELRQALKLAFQYDSRVLVEQGVNAREI
>KF628790.1_15494|FEATURES|farme|beta_lactam|Lnau_0681|antibiotic inactivation|0
KAYTTEDGRIVTFRPDLNGERMENSARRLEMPVFSKERFIQAVKETVKANAAYVPPYGSG
ATLYIRPYMFGSNPVIGVKPADEYQFRVFTTPVGPYFKGGVKPLTIRVSDFDRAAPNGTG
HIKAGLNYAMSLHAIVDAHNQGFDENMYLDPGTRTKVEETGGANFL
>KF628783.1_15511|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MISLIVAFDRHQLIGSKNRLPWHYKEDLAYFKQTTMGHDILMGRQTFESILSYQNKPLPN
RHHYVLTTTTNYDYEEVTVLANWKTIIQNYPKEKELFIIGGRSVYEQILPYADRLYITHI
DQVFEGDTYFPTIDWNEWVCMKEYLSGELRFAVYERMS
>KF628777.1_15527|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DEILWIYQKKSNNIHDLNSHIWDAWADADGSIGTCYGDVVGRKFIYKGEETDQMDYVLRQ
LKENPYSRRIMTNLYQFEYLHSGALDPCCYSMTYNVTKDAAEDRLVLNGVLNQRSQDVLA
ANNWNVCQYSILLMMVAQVNDMIPGELVHVIADAHIYDRHVPAVRELISRTPYAAPKVTL
NPEIKDFYDFTTKDLIVEDYQAGPQIRNIPIAV
>KF628775.1_15535|FEATURES|farme|bacitracin|bcrA|antibiotic efflux|1
VNDMLALEQVTASYGGSRVLFGVDIKAKKGEVTCLVGRNGVGKTTTVKSIMGLVSTPSGS
ITLDGKSIFKMPVYARAKSGIGYVPQGREIFPQLTVRENILLGMEANKKVRDIPEHIYEI
FPILKEFLDRKGGDLSGGQQQQLAIARAIVSNPKVLILDEPTEGIQPSVIQEIGRTITKL
KEYMAVLMVEQYLEFVLEVSDKCYVMEKGRIQMSGKTEDLDKKKLQEMLAM
>KF628774.1_15539|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
LIYIAAVDSHWAIGQKGQLLVTIPQDQKRFRDMTLGKVIVMGRKTLDTLPGGQPLYGRRN
VILSRDPEYRVKGADVCHSVKECLELLKNYGPDDIYIIGGESIYRQFLPYCSRAEITWID
FAYSADAHFPNLEESGEWEMTEESDEQTYFDLCYTYRVYEKQR
>KF628772.1_15541|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLSALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>KF628770.1_15544|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
FSVAVVDSKAYPVIEIAPLQGFYDYKNKYEAGSTIETCPAELPETLTREMQKYAELGYKA
LALQAYARLDFILDKEGNMYCLEANTLPGMTPTSLIPQEAKVLGMDYPELCEKLIEVSLK
KYK
>KF628762.1_15559|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTTGHVIIMGRKTFESLPFLLPNREHW
VITRDKGFDAPEGVKIFHNPEAAAEGAGALDAAYVIGGAQVYEAFLPYVDTMYITEVDHE
FDGDAFFPEFSEEAFTIESVVDGIVDEKNQYPHRFVTYRRKAAK
>KF628756.1_15582|FEATURES|farme|aminoglycoside|1-acyl-sn-glycerol-3-phosphate_acyltransferase|antibiotic inactivation|0
LLKFLWIVLGILLVIIVLAIIVVLCVNARVQQLKDEKYSAQERFSFISWVVSWAIPVLFN
VKVNAKGLEKLDQVKHGVIYANHQSNIDIVAMLKAIKKPHGYVAKKELDNIFLLSDSMRL
IQCQFMDRTPRG
>KF628743.1_15618|FEATURES|farme|bacitracin|BcrA|antibiotic target protection|1
MDIALQINNLSKAYGKHQVLENISFTVVKGEIFALLGTNGAGKTTTLECLEGIRRYDTGK
ILINGKLGVQLQSSSLPADITAKEAIMLFAKWQDLEVTDDYFIYLGIKAFLKKQ
>KF628734.1_15648|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNGILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGKVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF628725.1_15666|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
LIYIAAVDSHWAIGQKGQLLVTIPQDQKRFRDMTLGKVIVMGRKTLDTLPGGQPLYGRRN
VILSRDPEYRVKGADVCHSVKECLELLKNYGPDDIYIIGGESIYRQFLPYCSRAEITWID
FAYSADAHFPNLEESGEWEMTEESDEQTYFDLCYTYRVYEKQRTGK
>KF628718.1_15685|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDMCKYVLENGENREDRTGTGTRSVFGYQTRYDLRDGFPLMTTKKMFLRPIAEELL
WFIKGDTNIKYLVDRNVKIWNEWPYEDFKKSPDFNGETIEEFVEKIKTDDEFAKKHGDLG
PVYGAQWRDFNYEGVDQLAKLVDSLTNNPFSRRHIICAWNPAQVDNMALPPCHAFLQFYV
SADKKYLSCQLYQRSADIFLGVPFNIASYALMTEMLARTCGYEAKEFIHTIGDAHIYKDH
FEVVKQQIAREPLPKCKLVLNPDVKSIFDYKIEDIKIEDYQSHGKLVGKVSV
>KF628704.1_15712|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKG
>KF628703.1_15714|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLKNRRNIVLTRDEDFAVEGVDVVH
SIDEALAAVADEPVAWVIGGGEVYRQFLPYCAEAEVTHNHCTHAVDTYFPDLDADPAWEI
AWRGGVATIASGEGDEGVDYEFVT
>KF628695.1_15736|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
SGGQQQQLAIARAIVSNPKVLILDEPTEGIQPSVIQEIGRTITKLKEYMAVLMVEQYLEF
VLEVSDKCYVMEKGRIQMSGKTEDLDKKKLQEMLAM
>KF628693.1_15749|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MLSIIVAVAENNVIGGDNKLLWHIPEDLKRFKAITSGNTIIMGRKTFESLPGVLPNRKHL
VITRDENYSVDNANVE
>KF628675.1_15803|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
YRKVYEHAKETLGLPIFIKPANAGSSFGIHRMESFDGFEEAMKDAFYHDGKGKVILETTI
KGFEIGVAVMGNKELFAGSVDEIETAAPFFDYEGKYEMVDSHIYCPARISPKLFEEAREI
AKKAYRAMNCKGMTRVDMFVTPEDTIVLNEVNTIPGFTDTSRYPTMMKEAGIPFPELIDK
LVALAME
>KF628663.1_15835|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKNIAVIFGGRSSEHEVSCVSAATVIRSLDEEKYNVILVGITKDGRWLLVDKLKDIEDG
SWRESRVNAIISPDTEDRALVLLAEGTYRLQPVDVIFPVLHGLNGEDGTIQGLFEMARIP
YVGCGVLASAVSMDKVYTKIIVEDLGIRQARFVHIRRSDLDQMEDALDRAEAKLSYPMFV
KPSRAGSSVGVSKAEDREGLSKALLKAAEHDRNILVEETIVGREVECAVLGGKEIKASGV
GEILAAADFYDYDAKYNNQESKTLIDPPMSEETREEIRKSAADIFKAVDGYGLSRVDFFI
AEDGEVVFNEINTLPGFTSISMYPMLWAAQGITTPALADELIRLAEERFE
>KF628650.1_15872|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PIIKEVIQRETFEAPKVWLNPDVKDFYAFTVDDLHVEDYVTGPQIKNIPIAI
>KF628639.1_15904|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTTGHVIIMGRKTFESLPFLLPNREHW
VITRDKGFDAPEGVKIFHNPEAAAEAARALEAAYVIGGAQVYEAFLPYVDTMYITEVDHE
FDGDAFFPEFSEEAFTIESVVDGIVDEKNQYPHRFVTYRRKAAK
>KF628635.1_15911|FEATURES|farme|tetracycline|tet32|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAV
TSFCWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFNALQKMN
IPTIIFVNKIDQNGIDLRRVYQSIKDKLTSDMIVMQEVALSPKITITDISDLDQWDIVIS
GSDELLERYVAEDPLDIQELQYEKCKRTRCCSLFPVYHGSTKDNLGTEKLIEAITETFIT
ETDDIQSELCGYVFKVEYTDRKKRLTYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNG
EIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALVEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVVTKEPSVIY
LERPQKKASCTIHIEVPPNPFWASIGLTVTPLPIGSGTQYKSEVSLGYLNQSFQNAVMEG
VRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPIVLEQALKKAGTQLLEPYL
SFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGR
SVCITELKGYQETSGEPVFQPRRPNSRLDKVRHMFQKIM
>KF628635.1_15912|FEATURES|farme|macrolide-lincosamide-streptogramin|vatD|antibiotic target alteration|0
MQAFIACYCAISLIKSVLERRNYFELETDGYYNRKAKVLQHYKNKSLYHFGKNRYIIVEA
TTIRNYGG
>KF628621.1_15954|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGISTEREISIVSGTKVCEALREKGHRAILLDVFFGNTGLQADCAFTEAYDVN
AAAAYMRSFDSKLEEAVKTQKEFFGPMVLELCKAADVVFLALHGENGENGKVQAAFDLLG
ITYTGSGYLGSALAMDKGISKQLFLENGVPTPKSVMLKKAEGMKQPETIGICLPCVVKTC
CGGSSVGVYIANTREEYEQAVKNAFHYEDEIIIETYVKGREFSIGVVDGEAYPTIEIAPI
QGFYDYKNKYEAGSTIETCPAELAADLTKKMQDYAVMAYHVLRLENYARVDFLMDESNNM
YCLEANTLPGMTPTSLLPQEAGALGMSFADLCEKLIEVSLKK
>KF628618.1_15959|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIVAKAQNNIIGGNNKLLWHISDDLKRFKEITSGNTIIMGRKTFESLPGVLPNRKHV
ILTRDKNFSVDNENVEVIHSVDEIINNYKDSSVEAFIIGGGEIYKEFLPHANNLYLTEVL
KDFEGDTSFPQVNLENWVVDYSSDILTNAKDGLQYKFINYIKKS
>KF628615.1_15968|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVKVEHEGDAAELAAAVFEASHHD
WRILVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAE
>KF628610.1_15980|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYSAFEVKTYFITQSGDFIKTQEFTEKPG
DNEKLMTNDTIVASQAIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFLETLQFPYVGTNVL
SSSVAMDKIMTKHILEVAGVPQVAYTVYIEGEDLEAAVAETLEKLTFPVFVKPANMGSSV
GISKAENEAELRAAIDLALKYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAF
YDYQAKYIDNKITMDIPAHVPTEVMTQMRAYAAKAFRALGGCGLARCDFFLTEDGAIYLN
ELNTMPGFTQWSMYPLLWENMGLSYSDLIKELVALGQEMFEKRESHLI
>KF628607.1_15988|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNIVVLAGGSSTEREVSIVSGQGICTALRRRNHKAVLVDAYFGKESWGEEMFPQTYDIDA
EIKYMQEKSGELEETMKNRKEFFGPNVLEICKAADMVFLALHGSNGEDGKVQSVFDLMGI
PYTGSGPLSSGMAMDKGITKMVFEAKGVPTPKGITLQKGKCSSELADYDMDFPVIVKPCC
GGSSVGVCIAKNQEEYEAALDESFSYENEAVVEQFIEGREFSVAVVDGKAYPVIEIAPLQ
GFYDYKNKYEAGSTIETCPAEISESLTREMQRYAEQGYKALGLQAYGRLDFIMDKDGNMY
CLEANTLPGMTPTSLIPQEAKVLGMDYPELCEKLIEVSLKKYK
>KF628595.1|FEATURES|farme|aminoglycoside|AGP_acyltrn|antibiotic inactivation|0
MKRIALIVIRVIWRLPYWWGYKVNKYKHIDKYSADERYGFIHQVVAIVTRKARVELECYG
VENLPKKSGYFVAPNHQGLFDPLAIFQTHSRPIRAIVKKELASVEYL
>KF628593.1_16023|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYSAFEVKTYFITQSGDFIKTQEFTEKPG
DNEKLMTNDTIVASQAIKPSDIYEEGAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKHILEVAGVPQVAYTVYIEGEDLEAAVAETLEKLTFPVFVKPANMGSSV
GISKAENEAELRAAIDLALKYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAF
YDYQAKYIDNKITMDIPAHVPAEVMTQMRAYAAKAFRALGGCGLARCDFFLTEDGAIYLN
ELNTMPGFTQWSMYPLLWENMGLSYSDLIKELVALGQEMFDKRESHLI
>KF628588.1_16040|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
PNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDS
FNLSETEDGMHSSFEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGA
NKLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDED
NANIIARISRMVYDAMR
>KF628583.1_16053|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKKKDSDKLVLNGILNQRSQDVLAAN
NWNVCQYAVLMHMLAQVCDMQVGEFVHVIADAHIYDRHIPLVEELISREPLPAPTFWLNP
EVKNFYEFTPDDVRLDNYETGSQIKNIPIAV
>KF628562.1_16094|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
ERGRDEQTLEENGRYSYMNLIVAVDEKWGIGKDGGLLAHLPEDMKYFRETTRGRTVVMGR
RTLESFPGGKPLKNRVNMVLSRDEAYAPEGVRVYHSVEDVLEALRDCREEDVFIIGGGMI
YREFLPYCSKAYVTYIHRAFDVDTAFENMDQDENWKLESVSDGKEHEGISFEFRVYRRVR
>KF628561.1_16095|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
METLGIPYTASGVLASACGADKEVSKLLYAKAGIPVAPGLALETGDEVDIDHIVEVCGER
CFVKPAVNGSSYGISLVHEPSELPAAIKKAFEYGDKVLVEKCIEGTEITVGVYGEDDVRA
LPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPENYARAQELACAAHKALGCL
>KF628554.1_16113|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MEENMTQVRVFLGAVVLALIICCWSPAKTAAQEIGESARVAEDLDVVRLSGRVYMHVSRY
EMPPFGLVPANGLILVDKGEAFLFDTPWTESQTEVLLDWIENVLHARVTACVPNHWHKDA
MGGLPAVHRRGIPTYAYDGTIAIARQKGLRPPEHGFASERTLKLHGLEVRNVYLGGGHST
DGIFVWIPAENLLFPGCMAKDAKAVNLGNTEDADVRAWPGTMEKALAAFPDARIVVPGHG
QPGGPELLRHTRDLALRAGGSR
>KF628548.1_16128|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MEENMTQVRVFLGAVVLALIVRCWSPAKTAAQEIGESARVAEDLDVVRLSGRVYMHVSRY
EMPPFGLVPANGLILVDKGEAFLFDTPWTESQTEVLLDWIENVLHARVTACVPNHWHKDA
MGGLPAVHRRGIPTYAYDGTIAIARQKGLRPPEHGFASERTLKLHGLEVRNVYLGGGHST
DGIFVWIPAENLLFPGCMAKDAKAVNLGNTEDADVRAWPGTMEKALAAFPDARIVVPGHG
QPGGPELLRHTRDLALRAGGSR
>KF628544.1_16139|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHIPIIKEMIKRETYPAPKVTLNP
EVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF628539.1_16152|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAVDKNWAIGCKNKLLVSIPADMKFFRETTTGKVVVMGRKTLESFPNGQPLKKRVN
IVLTRDKNFKAGDAIIVHSMEELREELKKYPSEDIYVIGGETIYKQLLDDCDVAHITKID
YAFEADAYFPNLDEMPEWKITQDSEEQTYFDLEYYFYKYDKIK
>KF628530.1_16173|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
RTNIVLTHDKDYDAKGAIVVGSKEELLDELEEYKDEDIFIIGGESIYRMMLPYCDTAYVT
RTDFAYDADTYFPDLDEMPEWKLVKESEEETYFDIEYQVLVYQK
>KF628527.1_16181|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MEIIVAVDENYGIGKDGDLLAHLSPDLKRLKAMTVGNIIVMGSKTYMSFPKRPLPDRENL
IITHHPENYPGIKCFTGVDEFLEYSKTADKPIFVLGGGSVYEQLLPYCEKAHITKILHSF
EADTFFPDLDNNPEWEKESEEDIVTGEKYPFRYVTYVRRKK
>KF628524.1_16189|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
PENLEDVFTLPDHGLEIVKNISTEEPDLEAVKASRPDQSDCFFGPNVIELCRLADITFLG
LHGGEGENGKLQASFDLLGIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTIYKNS
EDQSYQSLGLTLPVVVKPCSGGSSIGVYIVNTDEEYAEALKKSFRYEDELVVEPYIKGRE
FACGIIDGTALPPIEIIPKTGFFDYANKYQDGATSEVCPADIPEEVAERMKELTVKAFNA
LKLNVYSRADFLLDAEGNLFCLEMNTLPGMTSASLLPKEAKVYGIEYGDLCELIIKKSME
ARY
>KF628523.1_16191|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MAKRVTVKELNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAIL
VDIFCGVENVDWENPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVLELCEKCDI
VFLGLHGANGEDGKVQATFDLLGIRYTGTGYLSSAMAMDKRITKEVFLMNHVPTPGGFTM
TRDNLEKDIAKYNLQFPVVVKTSCGGSSVGVYIVNDQKEYEEALTDACQYGADIVVEEYI
KGREFSVAVVDEKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVK
AAKALGLTGYSRLDFMMKENGDMYCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIR
VSQKKYE
>KF628513.1_16220|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MMQSEDKLCVVVLFGGMSSEHEVSRVSAGTFVDNLDRARYEVLTVGITREGRWLCTEATS
AQMADGSWEELPGNMPCVISPDRADHGMILFTPSGQVEKLHVDVVIPALHGLWGEDGTVQ
GLLELAGIPYVGCGVLASAVCMDKAVANALFDAAGIPHTKWLSACRWEIESDLDGVCDGA
IAKLG
>KF628508.1_16238|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
VALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWRE
DPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVS
ALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQY
ESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLA
PIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGE
IPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKGRHMFQKVM
>KF628502.1_16254|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MGGKSSEHDVSLVSAKTVIENIDKDLYNVIMVGITKDGQWKLVDRLDHLEDGSWVNSKTS
AYICPDTGRKELLLERDGKVDRISIDVVFPVLHGMNGEDGTVQGLLELAAIPYVGCGVLA
SACSMDKFYTKIVVDSIGVRQAKFVGVRRHELTHMDEVVARVEAGVPYPVFVKPSKAGSS
QGVSKAENREELIDALNLAAKHDSKILVEETIVGREIECGVLGMNEPKASGVGEVLSAEE
FYSYDAKYNNEESRTVVDPELPEGKAEEIRKDAVAIFKALDCSGLSRVDFFLTKDTNEVV
FNEINTLPGFTAISMYPMLWEARGLSKKALVQKLIDLAMNRYDV
>KF628499.1_16263|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDL
HKGSGQEAMKKAGLLQTYHDLALLLGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRA
ILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTE
VEETGIFNKQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTP
DEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKR
PLPITMIGDAAHLVPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIYGK
EAQEESTQNEIEMFKPDFTFQQLLNV
>KF628497.1_16270|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
ANGIPNPKWQKLTYTEAEIPQLAETLPMPCVVKAPTGGSSLGVYLPKDRAELADALRQVR
SFCHEVLVEQRIYGRELTDAVLGERYLPPVETFPSVENFDYEAKYQAGGAKEICPAELTE
EQAKAVGEMALRVHKALGLAVYSRTDMIMDENGQLWCLEANSLPGMTPTSFVPKEAAAVG
ISYDDLCEEIVRQS
>KF628483.1_16308|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGRKTFESLPKGALPNRRNVVLSSNPAIQCPGAEVFPTLEAALQSCQPEEQVYIMGGASV
YKQAMPLADMLCLTEIDAEAPQVDAYFPAVESAIWHEKSRESHLVDEKHPCPYAFVDYIR
K
>KF628481.1_16316|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGDFVH
TFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIFDFKFEDFELVNYDPHPHIAGA
VAV
>KF628479.1_16319|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
PPSRSKKVAIIGGGPVGLTMANLLQQNGIDITVYERDENPKARVWGGTLDLHKNSGQEAM
KKVGLLQTYYDLALPMGVNFADEKGNIIATRNPTLENKFDNPEINRNALRKMLLGSLKND
TVVWDRKSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFII
QGDIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKGL
DFKDTKSVSEF
>KF628479.1_16321|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTL
DLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDL
RAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTD
TEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFK
TPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKS
KRPLPITMIGDAAHLLPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIY
GKEAQEESTQNEIEMFKPDFTFQQLLNV
>KF628478.1_16324|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GYSNERDVSLSSGGSICRALRERGHNAYLLDAFLGLEKAPENLVDVFTLPGGGLEIATGI
QTSEPDLDALWASRPGDSPSYLGPNVLELCSLADITFLALHGGLGENGKLQAAFDTLGIR
YTGPDSLGCALSMDKGVTKDLFHSAGVPTPYGTHISRKNKDISLESLQIPLPLVVKPCSG
GSSIGVHFVHTEEEFREAMRLSFEKEDEVVIEPFIDGREYACGIFDGQALPLVEIIPDGG
VFDYVHKYQSGGASEICPATSVDQETTEAIQKTGVLAAQALRLNVYCRADFIVDARTGQF
YCLEVNSLPGMTSASLLPKAAKAAGYEYGEFCERIIEKSLDARYR
>KF628473.1_16338|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
HVIADCHIYDRHVPVIKELISRTPYPAPIVRLNPEVKNFYDFTTDDLIVENYQTWPQIKN
IPIAI
>KF628471.1_16342|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
RRFFGPNVLELCEAADVVFLALHGANGEDGKVQATFDLLGIPYTGTGYLSSALAMDKSIT
KQFFRAHHVPTPNGVTLKKGQESEPLSGFGLELPVVVKPCCGGSSVGVYIAHTNEEYWQA
MKDAFSYEPEVVVEEYIEGREFSVGVVDGKAYPIIEIAPIEGFYDYTNKYKAGSTVETCP
AVLTEEQTKEMQKHAEDGAAALGIENYCRLDFMMRKDGRMYCLEANTLPGMTPTSLLPQE
AQVLGISYPELCELLIQLSLRKRGKNE
>KF628464.1_16358|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VLGEIPFVRRAGRIGRNDFKNAGEMEQYLDLLRRIKAEGVVRGDRTGTGTKGVFGHQMRF
DLSEGFPLLTTKKVFLKGVIHELLWFLAGDTNIKYLVDNGVHIWDNDAFRYYNELCVRHG
VLPVDRDTFLRAAQDGVESPVEGYRFGDLNHVYGYQWRSWPKPDGRFIDQIAQAVELIRH
NPESRRIIVSAWNVAEIGDMALPPCHVLFQFYVAGGRLSCQLYQRSADTFLGVPFNIASY
ALLTLMTAQVCGLEPGEFVHTLGDAHLYLNHMEQADEQLSREPRPLPVMRLNPDVKSLFD
FRYGDFTLEGYDPWPAIKAPMSF
>KF628448.1_16400|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
VIVEIPLPPGKISVQPSALQDDLQTPLFTGDGPNSPEPDMSWIILVIAGLLEVVWAVGLK
YTHGFSRLTPSVITVTAMIVSLALLAWAMKSLPVGTAYAVWTGIGAVGAAITGIVLLGES
ANPMRLASLALIVLGIIGLKLSTH
>KF628444.1_16411|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDIIVCIDKNNGIGKDGGLLFRIPEDMAYFRRMTVNKTVIMGRKTLESLPGGRPLENRRN
IVLTRNRDRVPDGADAVSSIDELKRAIGSDKAFVIGGESIYAMLLDYCERAYVTEVEAHG
NADCFFPDIRNMPAWSLEEQGEEREHGGLKYRFNVYKNHSIKEL
>KF628443.1_16413|FEATURES|farme|aminoglycoside|A464_1655|antibiotic inactivation|0
VEYKLLEKEDLELMKEIIEDDDIEFDLEKINEFYNDKNVIGFIAKAENKIVGFAYGYDII
HPNGKHAYFIYSIGMLPDYQDKGYGTKLLGFIKDYISSNGFFEMFVLTDKGNPRACHVYE
KLGGKNDFEDEICYVYDFEGDEK
>KF628442.1_16415|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGLSTERDVSFKTGDMVTKALRKNGHQVILLDVFMGYGEEEQDITGIFEHSEE
ASVKVTDIPETAPDLDKVRKSRKDQSACFFGPNVIAMCRMADIVFMALHGENGENGKIQA
AFDLFGIRYTGSDYLSSAIAMNKNMAKQFFEANGIPCPKGIYMKKKDRKDSLAEIGITLP
CVVKPCCGGSSIGVSIVKEESNFTKALDDAFFWEDEILIEEYVEGREFSVGVIKGRALPV
IEIAPKEGFYDYKNKYKAGSTVETCPADIKDSVAKEMQKHAVKVAEALGLDTYSRIDFLV
NAKDEVYCLEANTLPGMTATSLLPQEAKVEGVNFEELCQQLVDISMEKYGA
>KF628441.1_16418|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSASNIIQCIDAQRYNIILVGITKEGHWVEAADLNAVSDGSWRQSKTSIVLSPDATRKGL
YRMSEDEKAQFVHLDVIFPVLHGLYGEDGTVQGLFKLAGIPFVGCGLFASAAGMDKIYTK
IIVDTLGIRQAKYVPVYKEELPKMDEVVARVESALEYPVFVKPSRAGSSKGVNKAANREQ
LKSALVEAADNDRKILVEETIIGREVECAVLGNLDVKASGVGEILSADEFYDFDAKYYNS
ESKTLVDPPMPENMREQIREDAVKIFMALDGRGLSRVDFFLTESGVVFNEINTLPGFTAI
SMYPMLWEAQGIPKKELVQKLIDLAFER
>KF628436.1_16429|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSLTSGTMICNALRRIGHRAILVDLFFGTDVPKNIEEAFCAEGFL
QPRPVAAEAPDIDAIKKSRPDSGYGEIGKNVLALCQAADIVFMALHGEIGENGKLQAIFD
VMGIRYTGAGFLGSAIAMQKGIAKQIFLQNDIPTPFGKIYTKKTCDKIREDFQFPVIVKP
CSGGSSIGITRADTFDELVRSLDEAFRYEDEVLVEQFVSGREFTCGVLDKSALPVAEVIP
NEGFYDYKHKYQAGMITEVVPANIPEEISKRIQEASLKVTKALGLEVYSRMDFILDDAGK
IYCLEANTLPGMTPTSHFPQEAKSIGMSYEELCQNI
>KF628425.1_16451|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
VLSWSAPLLAQLIMLIVMCMQRHWLYAAMLAPSLLGSALMLITMIMRVRHEETNSNTITG
SDSPVPTHHNGNEIDHAQLFADMPSISFEHLHGLDNDPLIWRTIVRNWLVRSPTNGIGMS
EHGIFHIDLASSGPHAMVAGTTGSGKSELLISWCMALAIRHSPQTLHFVFLDFKGGSTFN
ALERLPHTVGNVCDLDLAHAVRALNAIEQELARREALVSAERVSRFDQLSHPPARLVVVI
DEFHALRDRLPDYMQRLNRLASLGRSLGMHLIVCTQNPMGQVHADMKANISLSICLRVTD
QMQSNELIGTKDAALIPPAFPGAAYCHDGQRTVPFRCSAVHDIDSLVHAINTASAFSGTT
NPSPLFSAPLAPHAGKDDLTAPQREAWHHVPFALSDDGVLISTAFLDVGHGNIAVIGACG
SGKTNLLLCCASRLYESGRCTIRFTRKTNSEWTTDDGRTSPQHERTIWFVDDADELLSPF
AAMPEADKLKTALADPSITVIAAVEKPQSTLLERCLTRVAFPCGERATDVMMGIPSAVLD
GFGVDDYAIAGRGVFIQQARACPVQCAEFQGF
>KF628391.1_16531|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSEKYRKKVKVAVIFGGYSSEYSVSLESSSAVIKNLDPEKYEVLPVGITKEGQWFSYTGP
VENIENDTWHQSEYCTPAMISPDRNTHGLVLLGEDGAKTMPIDVAFPVMHGKNGEDGTIQ
GLITMAGIPLAGCGILASALCMDKDRAHLVAEAAGVRVPKAMVLTQGDDRKMAVDFALKI
GYPVYVKPVKAGSSYGVTKVEKPVELQSAIIKAFQYDDEVIIEENIDGFEVGCAVLGNCN
LITGEVDEIQLSGGFFDFTEKYTLKTSEIHVPARIELRKMQEIKQTAKTIYRALGCRGFA
RVDMFLTPDGEIVFNEVNTIPGFTEHSRYPGMMKAAGLEFPEILERIIRLAME
>KF628378.1_16559|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSYIERKRPQNCGMRRKIMKIVVLAGGISTEREISIVSGTQVCKALRSRGHQAILVDVYF
GREDADPMQAFTDEYDVDAAAAYARSFDGQVEKSIQEGKAFFGTNVIALCQAADVVFLAL
HGENGENGKVQAAFDLLGIRYTGSGYLGSAIAMDKGLSKQLFWQNEVPTPAGFILRKGED
ISLEAHGMTLPCVVKPCCGGSSVGVTIPKTQEEYEAAVADAFSYEDVIVVEEYIKGREFS
VGVVDGIAYPIIEIAPIEGFYDYTNKYKAGSTVETCPAVLTKEQTEQMQAYAVKGFKALQ
LDNYGRLDFMMSEDGKMYCLEANTLPGMTPTSLLPQEAKVLGIEYEDLCQLLIDISMRDE
>KF628373.1_16575|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NEYPNMKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSI
IHELLWFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEA
IETIKHNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVP
FNIASYALLLQMVAQVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPD
IKNIFSFKYEDFELVNYDPWPHIAGKVSV
>KF628363.1_16602|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKSRSLLSKAVVSSLLLFQVLSVSASDLTSDIQEVIKGKKAQVGVAVLYKDDAFTANNDD
QYPLMSVFKFHIALAVLKKMEKEGIPLTAVVTLGPSDIDTKTWSPMYKKYKSKKITLSYG
DLINYMVSQSDNNACNWLINFVGGIQNVNDFIKNLGIDRIQLIETEKSMEQDIRKSYNNW
STPLSVTQLLRKVYTEKVLSDEHFAFLEKAMLASASGKDKFRAGLPKEVEVGHKTGMSYR
TPEGIRMCDADVGVIYMPGGEKCYLAVLVKDSKETDAANAKIMADIAKKVYSHYTENAGK
NSAPAK
>KF628362.1_16608|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIAAIVAVDENWGIGRNGDLLINIPEDKKFFKERTNGSIVIMGRKTWDSLPKKPLPNRKN
YVISKSQKHVNGVDFISMDSAIELIQNEDSDIFIIGGGQIYEKLLPYCEKVFVTKIYKSF
ESDTFFPNIEEDNTWKCVESGDIQYYQSIPYKFLIYKNRKKQEDF
>KF628361.1_16611|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVAVDNNWAIGSKNELLIRIPNDHKHFREETTGKVVVLGRKTLETFPQGMPLKNRIN
IILSKDPNYQVKDAIVVHSIEELLEELKKYDEENIYIIGGESIYRQMLPYCDVAHVTKID
HAYEADAYFPDLDSDPEWEITADSDEQVYFDITYQFLKYERKKA
>KF628354.1_16630|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
ANGIPNPKWQALTYTEEEIPHLAETLPMPCVVKAPTGGSSLGVYLPKDRAELADALHQVR
AYCDRVLVEQRVYGRELTDAVLGERYLPPVETFPSVENFDYEAKYQAGGAREVCPAELTD
AQAKAVGEMALRVHRALGLAVYSRTDMILDADGNLWCLEANSLPGMTPTSFVPKEAAAVG
IGYDELCEEIVRQSLKIK
>KF628343.1_16659|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRIIVLAGGLSPERDVSLISGAGICRTLREKGHKAYLLDVFFGLPYDPDKLEEVFDLPGG
GLEIADGIKTTTPDLEALKASRPDQSDCYLGPNVIDLCRIADITFMGLHGSVGENGKLQA
TFDILGIKYTGPNSFGCALSMDKLVAKQIFKRSGVPTPRGTSLNRDTKDTPLEKLGYYLP
LVIKPCSGGSSIGVYIVHTEEEYREAIRCSFDVNREDEVVIEPYIKGREYACSIVAGKAL
PLIEIIPKDGIFNYENKYQDGGAQELCPPVSLDDKTQAKIQRAGEKAFRVLHMDVYARAD
FIVDETDGKFYCLEMNGLPGMTPASLIPKSARAIGVDYGDLCELIIEESMKTRYQD
>KF628341.1_16663|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICKTLLEKGHDAFLLDVFLGLENAPENLEDVFTLPGH
GLEIAKNISETEPDLAAVKASRPDQSDCFFGPNVIELCRLADMTFLGLHGGEGENGKLQA
SFDLLGIRYTGPDSLGCAVAMDKGLTKQIFMEAGVDTPSGVCLYKEGSDCSLESLGLSFP
VVVKPCSGGSSIGVYIVNTEEEYRQALKNSFRYENEVVVETYIKGREFACGVIDGKALPP
IEIIPKNGWFDYANKYQANATEEVCPADISEEIAERMKSLTVRAFQALKLNVYSRADFIL
DADGNLYCLEMNTLPGMTSASLLPKEALADGIEYGDLCELIIQKSMEARYQ
>KF628340.1_16667|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKMFREETTGKVVVMGRKTLESFPNGLPLKNRTNIVITGNRDYQVKGAVIVHSIEEALKE
VEKYPAEDVYCIGGDSIYKQMLPYCDTAHVTKIDFAYEADAYFPNLDEDPDWEITAESEE
QTYFDLEYAFVKYERKDR
>KF628339.1_16672|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
PLWHRFVDAIVQTVKANAAYVPPYGSGATLYVRPYMMGTNPVIGVKPADEYMFRVFTTPV
GPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAAT
RTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEEREIYFDEV
KDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGVQMGRIQAPE
GWLKVIE
>KF628328.1_16695|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
QELLKREPLPAPKFWLNPEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF628317.1_16724|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
WHYLDAKQTDLAKNTWLDNSSMVEDVYGLLKNQDVAFPVLHGMYGEDGTIQGLFELAKLP
YVGCRVMGSSVAMDKIYTKKILDTVGVPQVKSVYVKKRYDEKLVVVTNTFDEIEEIEDYI
VRELGMPCFIKASRSGSSVGCYRCDNQTELIGKLSEAAKYDRHVVVEECIDCIELETAVL
GNDDVIVSRVGQIMPHGEFYTFESKYEDEESKTCIPALVDEQIQEQIR
>KF628314.1_16732|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLVREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLGKVRHMFQKVM
>KF628313.1_16737|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSYIERKRPQNCGMRRKIMKIVVLAGGISTEREISIVSGTQVCKALRSRGHQAILVDVYF
GREDADPMQAFTDEYDVDAAAAYARSFDGQVEKSIQEGKAFFGTNVIALCQAADVVFLAL
HGENGENGKVQAAFDLLGIRYTGSGYLGSAIAMDKGLSKQLFWQNEVPTPAGFILRKGED
ISLEAHGMTLPCVVKPCCGGSSVGVTIPKTQEEYEAAVADAFSYEDVIVVEEYIKGREFS
VGVVDGIAYPIIEIAPIEGFYDYTNKYKAGSTVETCPAVLTKEQTEQMQAYAVKGFKALQ
LDNYGRLDFMMSKDGKMYCLEANTLPGMTPTSLLPQEAQALGMDFADLCEKLIAVSAK
>KF628310.1_16743|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLELCVIFGGQSPEHEISRKSVTSVLNNLNKDKYNISTIGITKNGAWYLYTGEYAKIESG
EWEQDTENKKKAILSPDAEDKAILVFDGDKVTKIHPDVIFPVLHGEFGEDGTIQGLFELS
GIPYVGMGVMASANGMDKTSSKIVFASADIPQADWVVVNKTDNFEDKMDEIENKLGYPCF
VKPARTGSSVGVGKAHDRKELKAALENAAQFDRKILVEENIDGHEVECAVLGNEDVKAAT
VGEIMPTVEFYDFDAKYNDNSTELQIPADLPKETIEQIREYAVRAFKALDGSGLSRVDFF
VKHSDGSVVLNEINTLPGFTNISMYPKLWGAVGIEYSELLDKLIELAEKRVK
>KF628308.1_16749|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
LARNGEGSEQLQADNEPGKQKNKNVSDRRIIMNLIVAADKNWGIGKDNKLLVSIPSDMKF
FRQETMGKVVVMGRKTLESFPNGLPLKNRTNVVLTSDKNYQVKDAVIVHSIDEVLEELKK
YDDDEIYVIGGGKVYEELLPYCDVAHVTKIDFAFEADTHFPNLDENPEWEITASSDEQTY
FDLEYTFVKYERK
>KF628306.1_16752|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKKKDRVETPQELGMDFPVVVKTCCGGSSIGVYIVDNQEDYTKALDGAFTYENEVVVEEF
VEGVEYTVAVVDGKAYPVVQIVPVQGFYDYENKYKPGAVKEPCPAPISEELTKRLQEAAV
DGYHALEMESYARLDFIVTKDEKIYCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELI
KVSQKKYA
>KF628300.1_16770|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
LARNGEGSEQLQADNEPGKQKNKNVSDRRIIMNLIVAADKNWGIGKDNKLLVSIPSDMKF
FRQETMGKVVVMGRKTLESFPNGLPLKNRTNVVLTSDKNYQVKDAVIVHSIDEVLEELKK
YDDDEIYVIGGGKVYEELLPYCDVAHVTKIDFAFEADTHFPNLDEDPEWEITASSDEQTY
FDLEYTFVKYERK
>KF628298.1_16778|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLDLRFCAVKLASMALTPEQLADIRTRIPARPETGIPMPYEDLVRRILTEGTLKSDRTGT
GTISLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQEHNVHIWDEWA
DENGDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVKNHPDSRRMVVSAWNPAEVEN
MALPPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIARQAGLQPGEFV
WTGGDCHVYDNHIDQVLEQLSRDPYPYPHIRINKAASLFDYDYSDFEIVDYRHHPTIKAP
VAV
>KF628289.1_16802|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MKTKVLVLFGGQSSEHIVSCMSAVNVINHIDRNRYEVLIIGITEEGKWLYTESAEAIQNE
SWRQGTVQAVLSPDATEQCVLLLKEGGVEKRKVDVVFPVLHGLYGEDGTVQGLFELARIP
YVGCGVLASAVSMDKLYTKIIVDDLGVRQADYVPVMRRELSSMEEVVKRVEEKFSYPVFI
KPSNAGSSRGVSKASSREELEKGLKEAARHDRKILVEEMIVGHEIECAVFGGGNGEIIAS
GVGEILAAADFYDFEAKYYNEESRTVVNPVLPNGAAEKVREAAKKIFRAVDGYGLSRVDF
FVTEEGE
>KF628286.1_16811|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|0
MAKRVTVKELNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAIL
VDIFCGIENVDRENPFPSEYDVDAASEYMSSI
>KF628282.1_16823|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
LEKEIPYPVFVKPSNAGSSRGVTRADNREELITGLKEAADNDRRILVEEMIVGREIECGV
FGDGASTKASGVGEILAAAEFYDFDAKYYNAESKTVVDPELPDGATERVREAAVKIFNAV
DGYGLSRVDFFVKADGTVVFNEINTLPGFTAISMYPMLWEARGVDKRQLIDDLIDHAFRR
YER
>KF628281.1|FEATURES|farme|aminoglycoside|AGP_acyltrn|antibiotic inactivation|0
DVFVPMISIFHQGRRPRYMAKAEMASWPLIGKWFQLVGMQPVQRRSGKAKAIEETSIEIL
TSGRPLTVWPEGTVTRDPQKWPMSMKNGVGVIALESSRRLGYQIPLYCAVTWGAASINHW
WPWPRKNVVMCYDDALDYADLLADCDSWGEEVPEDLANELTRRIRVRMTEVMVEIRGEQA
PDGYWDYRTMSRVKD
>KF628276.1_16843|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VCAIRFVYSHILYGKRVKLLAYCSFILLKILFEHSKKCLRSDFLRGKEPFIMKKTVCVIF
GGASSEYEVSLMSSASIIRNLDTEKFDILTLGITKDGRWLLYSGAVENIENNTWMNSETA
RPAFISPDKATNGLVVLNADGSYTVLKVDVLFPVLHGKNGEDGTIQGLFKLSGIPYVGCG
TLASAVCMDKAVTHTLLSAANIEQAHYLWFYADRYFADGEKIRNKIAARLNFPVFVKPAN
AGSSVGVSKVTAPEKLDAAIRLAAENDTKVVVEEGIVGQEVECAVLGNRGKSVASPVGEI
GAGAEFYDYDDKYKNGVAQLFIPARLPEDVAEEVRKTAVRAYNLLGCDGLSRVDFFVTEK
EHRVILNEINTLPGFTSISMYPKLWENAGTPYSELLEKLIDCAFYA
>KF628272.1_16853|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
YTEQEVEDLAAATQVPCVVKPVASGSSIGVSIAHTRQELHGALMEGLRFGGQCVLEQYVA
GREIQVAILAGQALPSIEIIPKEGFYDYENKYQPGAAEEVCPAPIPPAWEQRVGQAALTV
YHALGLSVYSRADFIVDQEGTPWFLEINTLPGMTPTSLVPQEAAAVGIDYASLCQRIIEE
SLRVRKG
>KF628266.1_16865|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
PPRVPVELIQFVDSKIHKEQSDLFTTSISEVCFYTDDIDSVYKTLIENHVECLSEPQHFD
FRADGFGESRAFYFRDPDGIILEMMQPL
>KF628266.1_16866|FEATURES|farme|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQDGELGIYDEMIPSYTIFHE
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>KF628240.1_16922|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SMTFNVTKKEGHEKLSLNGMLNQRSNDVLTANNWNVCQYAVLLHMLAQVCDMEVGELVHV
IADAHIYDRHIPLVEELIKREPLPAPKFWLNPEVKNFYDFTPDDVKLIDYETHEQIKNIP
VAV
>KF628224.1_16964|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
VPFVFSAIVTKVIVEIPLPPGKISVQPSALQDDLQTRLFTGDGPNSPEPDMSWIILVIAG
LLEVVWAVGLKYTHGFSRLTPSVITVTAMIVSMALLAWAMKSLPVGTAYAVWTGIGAVGA
AITGIVLLGESANPMRLASLALIVLGIIGLKLSTH
>KF628221.1_16979|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MEHDSSRSGYHEPEPGHAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFKGGMP
WHLPEDMKRFKELTVSHPVIMGRKTWESLSLKYRPLPNRDNIVVSHDSSYTAPGATVVDS
LDDALDLARQEAIPDDGLDRSEIWIIGGGQLFHEAMPFADKAYVTQISMHVDADTYAPDI
KGLVESGAWKVAEEGVWQGARKGSDDIAGFRFITFERNHEE
>KF628220.1_16983|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVAVDKNWGIGYQNKLLNSIPEDMKYFRETTTGKVVVMGRKTLESFPNGLPLKNRTN
IVITGDHTYKAKDAIIVHSIEEALEELKKYDSNDIYVIGGESIYRQLLPYCDVAHVTCMD
YTYQADTWFPNLDEDKDWVVAADSEERTYFDLEYCFKMYVRKTKLKEIVDLLK
>KF628216.1_16995|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLCDTIGTAYGYITNKFKLTQNLIDTIKNNPTDRRMVMSLWQNDYLETAVLPSCVWSSEW
DVTDGKLNLWVHQRSCDVPLGLPFNVTQYAVLLSLIAHVTGLKPGTIDWSIKDAHIYVNQ
IDGIKEQIERSKTNNDIKAPTLWINPEVTDFFKFDNSKDLKDIKIEGYEHMGPIKFPIAQ
>KF628208.1_17021|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MAMSTISIVAAISDNNAIGKNLGLLWHMPADMKRFKDLTTGHAVIMGRKTFESLPKGGLP
NRKNVVLTTMPEAGFINCFACESMHDALDICEKEENIFIIGGSLVYRQGLGIADKMYLTR
IHGEFPDADAFFPVV
>KF628206.1_17025|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LYPCAYSMTFNVTKKPGHDKLTLNAILNQRSNDVLAANNWNVCQYAVLIHMLAQVCDMEV
GEFVHVIADAHIYDRHVPMIEELISRKPLPAPKFWLNPEVKDFYQFTRDDVKLIDYQTHD
QIKNIPVAV
>KF628203.1_17033|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
LVAAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPNRVNIV
LTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAYITRLDYA
YEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNETPALH
>KF628198.1_17046|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADQEYLSIVKNILDKGALGENRTGMPAYKLPHQIMQFDLEKEFPILTTKFVAFKTAV
KEILWIWQKQSNDVRELQKWNCHVWDEWMREDGTIGKAYGYQLGKYHQVDTLLDMLKKDP
ESRRMVVVLWNVKDLPDMALYPCAFLTMWDVSNDGRLNCMLVQRSGDMGLGVPFNMTQYA
ALICMIAQVSGLRPGLFTHVINNAHIYENHVEQLKLQLSRLPEAYAAPRLVLNPDVKDFY
DFKPEDIQLENYRHHDKIAMEVSV
>KF628195.1_17054|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EEFPALTLRRTALKSAMDEILWIYQRKSNNINDLHSHIWDEWADETGSIGKAYGYQIAQK
SHYVEGDFDQMDRVLYDLQHTPFSRRIMTNMYTFSDLSEMHLYPCAYSVTYNVTEQPGDE
KPTLNMVLMQRSQDILAANNWNVCQYAILLMMVAQSCGMIAGELLHVIVDAHIYDRHVDI
VRELIARPQYSAPRVSLNPEVTNFYDFTTDDLIVEEYEHGPQIKNIPIAV
>KF628192.1_17062|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDIIVCIDKNNGIGKDGGLLFRIPEDMAYFRRMTVNKTVIMGRKTLESLPGGRPLENRRN
IVLTRNRDRVPDGADAVSSIDELKRAIGSDKAFVIGGESIYAMLLDYCERAYVTEVEARG
NADCFFPDIRSMPAWSLEEQGEEREHGGLKYRFNVYKNHSIKEL
>KF628177.1_17102|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MYAIAAVDRHWGIGRDNALLFHIPADMRRFRALTEGKTVLMGRKTLQSLPGGRGLPHRRS
IVLTGDRSFTAENAEIVHFPVEAVFQAGEDAWIIGGESVYRRFLPLCDRVFITKIFADGH
ADAFFPDLDADPRWQVDSESELMEENGLKYQFVEYVPAPEEALLPSAAEDVQEPPLFAPP
ADFSAFSGF
>KF628172.1_17118|FEATURES|farme|chloramphenicol|KS18_02010|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEIL
>KF628169.1_17128|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVSGKTLNCILNQRSQDMLTANGWNVCQYAALMSMIARACGLEAGELLHVIADAHIY
DRHIPIVEKLLERENECMPAPKLVIEEGITDFYAFNTENVYLEDYQSLKGVGKIPVAI
>KF628161.1_17150|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LMHMLAQVCDMKVGELVHVIADAHIYDRHVELVKELITRQQHPAPKFWLNPEIKDFYQFT
PDDIKVTDYVTGPQIKNIPVAI
>KF628151.1_17178|FEATURES|farme|tetracycline|tet40|antibiotic efflux|1
MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFE
IPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAW
IASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPIILGGSLCLLLGLVMVR
IMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLST
AHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSA
GYILCLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLD
SFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD
>KF628146.1_17193|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HDLSSHIWDQWADESGSIGKAYGYQIGQKSHYAEGDFDQMDRVLYDLKHNPASRRILTNI
YTFEDLHEMALYPCAYSMTFNVSGNTLNAILNQRSQDMLAANNWNVVQYAVLVHMFAQVS
GLQAGELVHVIADAHIYDRHVPVIEQLIQNEPKPAPQFFIDPDVHDFYAFTRDSFRVEGY
EYSEFTGKIPIAV
>KF628143.1_17198|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LYPCAYSMTFNVTQTPGNDKLTLNAILNQRSQDILAANNWNVCQYALLLMMMAQVCDMEA
GELLHVVADCHIYDRHIPLIKELIQRKPYPAPIVKLNPEVKDFYQFTTDDLIVENYETWP
QIKNIPIAV
>KF628140.1_17204|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GSIGKAYGYQLGVKHHYPQGDMDQVDKVLWDLKHDPASRRIMTNIYTFADLSEMALYPCA
YSMTFNVTGDRLNAILNQRSQDMLTANNWNVVQYAALTMMFAQVSGLKPGEFIHVIADAH
IYDRHVPAVEEIIKNEPKPAPKFIIDPTVDDFYKFTRDSFSMEGYEYSDFKGTIPVAV
>KF628127.1_17240|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
EDGHIVIFRPDLNGARMEDSCRRLEMPVFPKERFVDAVVQTVKANAAYVPPFGSGATLYI
RPYMFGSSAVIGVKPAEEYQFRVFTTPVGPYFKGGAKPITIRVSDYDRAAPHGTGHIKAG
LNYAMSLYPIMEAHRQGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSDSILPS
ITRRSLVAVAKDYLGLEVEEREVCFDEVKDFAECGLCGTAAVISPVGKINDHGKEICFPS
GMEKMGPVTQKLYETITGIQMGRIQAPEGWIKVVE
>KF628108.1_17291|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRFKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDAL
>KF628101.1_17304|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNLIAAVDLNWAIGRGGDQLCYIPADLKRFQALTTGHPVILGRKTLATFPGGRPLKNRRN
LILSRDPAFAPEGAEVFRSLEALRAAAPADSFVIGGESVYAALLDWCDTAYITKIGRAWE
GADAFFPDLGAGPDWEMAEEGEPQEHAGIPFRYVTYRRRKPHVCG
>KF628096.1_17319|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWVYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRELNERP
QFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF628095.1_17320|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADDLFIAMCKDIIENGYDTKGEKVRPKWEDGTSAYTIKRFGVVNRYNLAEEFPAITL
RKTYIKSAIDELLWIWQKKSNNVHDLHSHIWDAWADEDGSIGKAYGYQLGVKHKYKEGMM
DQVDRVIYDLKNNPYSRRIMTNIYVHQDLSEMNLYPCAYRVRFY
>KF628089.1_17334|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KGLAYELLWFLKGSTNVRWLQERNVHIWDEWADENGDLGPVYGAQWRSWPAPTPDDPNRT
IDQISNVLDLVENHPDSRRMVVSAWNPAEVENMALPPCHALFQFYVADGKLSCQLYQRSC
DMFLGVPFNIASYSLLTLMIAQQAGLQPGEFVWTGGDCHVYDNHIDQVLEQLSRDPYPYP
QIRINKADSLFDYDYSDFEIVGYQHHPTIKAPVAV
>KF628083.1_17350|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALVYMMAQVTGFEPGELVHVIADAHIYDRHIPIVEELISRPTYPAPK
VTLNPDVKDFYDFTVDDFTIEDYQTGPQIKNIPIAV
>KF628070.1_17385|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
DAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAK
EYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKINDHGKEICFPSGMEKMGPVIQK
LYDTLTGIQMGRIEAPKGWIHVIE
>KF628063.1_17406|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALVYMMAQVSGFEPGELVHVIADAHIYDRHIPIIKEMIKRETYPAPK
VTLNPEVKDFYKFTVDDFTIEDYQAGPQIKDIPIAI
>KF628062.1_17408|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPLNIAS
FALLLQMVGQVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKDIF
SFKYEDFALVNYDPWPHIAGKVSV
>KF628059.1_17417|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ADCHIYDRHVPVIKELISRIPYPAPIVKLNPDVKNFYDFTTDDLIVENYQTWPQIKNIPI
AI
>KF628055.1_17425|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIAAVDRKRGIGYQNRLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSTQKDLICPGTEVFPSLEEALSSCQPDEHVYIIGGASVYRQALPFADTLCLTEVDAE
APQVDAYFPEVAPTVWQEKSRESHPADEKHPCPYAFVDYI
>KF628055.1_17426|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
LQLSREPRDLPQMRINPDVKNIFDFKFEDFELVNYNPHPHIAGKVSV
>KF628048.1_17444|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
SDKLEEVFDRPDGGLEISKGISTSVPDLDALRKSRPNQSPSEIGPNVIELCQMADITFMA
LHGSIGENGKLQATFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTSKT
KDTPLDELGYYLPLVVKPCSNGSSIGVYICHTEEEYYDAIHKSFDVDNTDEVVIEPFIKG
REFACGILAGKALPLVEIVPKDGLFDYANKYQAGGASEICPPVSLDEETQELIQRAGERA
FEALRMDVYSRADFIVSDADGE
>KF628043.1_17455|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MERSGIMNIIVAVDENWAIGCRGDLLVRIPADHKMFRNETLGKVVVLGRKTMDTFPGGLP
LQGRTNIVLTRNPEYQVKDAVAVHSVEELLEEVKKYDSRDVYVIGGDSVYRLLLPYCD
>KF628040.1_17460|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
AIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNGLPLKNRTNIV
LTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESIYRMMLPYCSKVYVTKIDHA
YQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF628028.1_17483|FEATURES|farme|aminoglycoside|AZ78_1791|antibiotic inactivation|0
MGRLVGDGAVICYIQDLMIHPDYQHYGIGSAIIEDLIEYVENLCEEGTEIMLDLDECPFC
RLV
>KF628011.1_17531|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PG
>KF628004.1_17549|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QKKSNNIHDLSSHIWDAWADESGSIGKAYGYQLGVKHRYPEGEFDQVDRVLYDLKHNPAS
RRILTSLYNHHDLSEMALYPCAWSVTFNVSGRTLNAVLNQRSQDMLTANGWNVMQYAVLV
HFLARASGLEAGELVHVIADAHIYDRHVPVVEELIARTPYEAPRLWLDPAVTDFYTFTKD
SFRLEGYQAHPLEEKIPVAV
>KF627997.1_17570|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
DRHPYDLSGGEQQRLALAKVLLLQPRLLLMDEPTKGLDAEYKQELGDILKKLKAHGITIF
MISHDVEFVAEYADRVGLFFQGNVVTCKSARDFFAGNSFYTTAANRMARHYFPDAVTGKE
VAACLKARL
>KF627995.1_17575|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNKRLKEILKQYEERKHKIIKGDESMNIVVLAGGTSTEREISIVTGTGVCKALRKKGHNA
ILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQA
ADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKG
VSMLKENCTRNIHDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAY
>KF627983.1_17610|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADTQYLGIIKNILDAGSLGDNRTGMPAYKLPHQIMQFDLEKEFPILTTKFVAFKTSV
KEILWIWQKQSNDVRLLQQWNCHVWDEWMREDGTIGKAYGYQLGKYHQVDTLLETLKKDP
QSRRMVVDLWNVKDLPDMALYPCAFLTMWDVSDDGRLNCMLVQRSGDMGLGVPFNMAQYA
ALVHMIAQVSGLRVGLFTHVINNAHVYKNHVDAMKTQLARLPKAYDAPVLKLNPDVHDFY
DFKPEDIVLENYKHYEKIAMEVSV
>KF627974.1_17635|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IYSRHFCNFASHQLIGKLFAMKQYLDLLNRVLTEGTEKSDRTGTGTISVFGHQMRFNLDE
GFPCLTTKKLHLKSIIYELLWFLQGDTNAKYLQEHGVRIWNEWADENGDLGHIYGYQWRS
WPNYKGGFIDQISEAVETIKHNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVANGRLS
LQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQL
SREPRDLPQMRINPDVKNIFDFKFEDFELVNYNPHPHIAGKVSV
>KF627973.1_17637|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
LEREEEVMKIVVLAGGTSTEREVSIVSGTEICRALRSRGHQAILVDVFFGRDGIVPTTAF
DGEYDVDREAEYIKECSEQVPARLAEGKDFFGPGVLELCKAADVVFMALHGANGEDGKVQ
AVFDLFHIRYTGTDYLSSAMAMDKGITKKLFAANQVPTPAGVEIHRESSSRELKDYGMEF
PVVVKTCCGGSSVGVYIVHDQKEYEEALQGAFSYEEQVVVEEYIQGREFSVGVVDGKAYP
VIEIAPVEGFYDYKNKYSAGAAVETCPAELTKEQTERMQKYAEMGCKVLGIKGYARLDFM
MKENGDMYCLEANTLPGMTPTSLLPQEAAVLGMDYPSLCEELIRISLKKYE
>KF627972.1_17642|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGVEKSDRTGTGTISVFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHIYGYQWRSWPDYNGGFIDQISEVVETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMRINPDVKSIF
DFKFEDFELVNYDPHPHIAGAVAV
>KF627969.1_17650|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MLEIKDLTVRYGKQEPTVESFQLSMKKGEIVSIVGESGSGKTTVIRAVLGALPGSGYISA
GEIYFQGEALTQKSGEEWRNLKGTRMSMIFQDCGGTLNPIRKIGKQYVEYICTHSRVTRP
QAWNKAAEMLKKMRLADAENIMKSYPHQLSGGMRQRVGIAMAMTFQPQLLLADEPTSALD
VTTQAQIVRQMMELRDRYETGIIIVTHNLGVAAYMADKLVVMQNGKVVDQGTRDEVMNHP
VSDYTKSLLQAVPEMEGERFVS
>KF627967.1_17656|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGTEKSDRTGTGTISVFGHQMRFNLDDGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHIYGYQWRSWPNYKGGFIDQISEAIETIK
QNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMVAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIF
DFKFEDFELVNYDPHPHIAGVVAV
>KF627943.1_17717|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
LTPFGLSFAAAKRLEMPVFPEDRFVDAIVQTVKANAAYVPPYGSGATLYVRPYMMGTNPV
IGVKPADEYMFRVFTTPVGPYFKGGPKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAI
VDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVA
KEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQ
KLYDTLTGMQMGRIQAPEGWLKVIE
>KF627937.1_17732|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MQSEKMCVVLLFGGMSSEHEVSRVSVGNFVNNIDREKYEVLTVGITKEGRWLYTEATAAQ
MADGSWEELAGNMACVISPDRADHGMILFTPEGHVEKVHVDVVIPVLHGLWGEDGTVQGL
LELAGIPYVGCGVLASAVCMDKAVANAMFDASGIPHTKWLSATRWEIESDPDGVCDGVIA
KLGWPIFVKPANAGSSVDINK
>KF627930.1_17755|FEATURES|farme|beta_lactam|BAMA_03925|antibiotic inactivation|1
QELEEKYDATLGIYALDTETNKEISYNADERFAYCSTYKALAAGAILEKYSIEELDNVIY
FEEEDVLSYAPVAKDKVDTGMTIREICDAAVRQSDNTAGNLQFTLLDGPNGFKQSLSKIG
DTVSEPSRIETELNDAVPGDIRDTSTPKQLAFNLKEYVTGDILSDDKKEIFIDWMSNNAT
GDELIRAGVPSDWIVADKSGAGSYGTRNDIAIVTPPNKKPIFVAVLSKKAEQDAEYDNKL
IADATKIIFDLIS
>KF627923.1_17770|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSLLNNKKVAIIGGGPVGLTMANLLQQNGIDITVYERDENPKARVWGGTLDLHKNSGQEA
MKKVGLLQTYYDLALPMGVNFADEKGNIIATRNPTLENKFDNPEINRNALRKMLLGSLKN
DTVVWDRKSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFI
IQGDIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKG
LDFKDTKSVSELLTNRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLI
GDTAHLMPPLAGQGVNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADST
KNEIEMRNPSFTFQQLMNV
>KF627914.1_17793|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGNSTEREVSISSGQGVCQALRERNHKAILVDAYFGKESMEGELFSDKYDTEQ
AAAWMRKQSNNLEEVMKTRKEFFGPHVLEICQKADIVFLALHGANGEDGKVQSVLDLMGI
KYTGCGPLSSGMAMDQRDYQNGI
>KF627913.1_17797|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALRSAMDEILWIWQKKSNNIHELHSHIWDSWADEDGSIGKAYGYQLGVKHQYKEGMI
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNEKLTLNAIL
NQRSQDILTANNWNVCQYAILLMMIAQVCDMEAGELLHVVADCHIYDRHIPVVKEMIKRK
PYPSPIVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPVAI
>KF627902.1_17828|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDL
HKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRA
ILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTE
VEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTP
DEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKR
PLPITMIGDAAHLMLPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFIYGK
EAQEESTQNEIEMFKPDFTFQQLLNV
>KF627895.1_17841|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
LEAAVVRTVQKLTFPVFVKPANMGSSVGISKAENEAELRSAIDLALKYDSRILIEQGVVA
REIEVGILGNTTVKTTDPGEVVKDVAFYDYQAKYIDNKITMDIPARVPVEVMTQMRAYAA
KAFRALGGCGLARCDFFLTEDGAIYLNELNTMPGFTQWSMYPLLWENMGPSYSDLIKELV
VLGQEMFDKRESHLI
>KF627894.1_17846|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFIQTCQDILSKGVWDTDRPVRPRWEDGTPAHTIRLFGVVNRYDLRKEFPIITV
RKQFLKSAVDELLWIWQKKSNDVHQLSSHIWDAWADENGTIGKAYGYQLGVKHHYPQGDM
DQVDKVLWDLKHDPGSRRILTNLYNHHDLSEMALYPCAYSMTFNVSGNTLNGILNQRSQD
MLTANGWNVMQYAVLLHMFAQVSGLEAGELVHVIADAHIYDRHVPIVEEIIARQPYDAPK
FIMDKSVTDFYAFTKDSFRLEGYQAHPLEEKIPVAV
>KF627893.1_17849|FEATURES|farme|tetracycline|tet40|antibiotic efflux|1
MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFE
IPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAW
IASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPVILGGSLCLLLGLVLVR
IMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLST
AHFLDDTVIPVIGPLNSVTWFGVISLIGSGLGILASQLLIARMEKKGTVSRTSVVMSTSA
GYILCLVLFAVGRSFW
>KF627889.1_17855|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YSMTFNVTKEPDSEKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVH
VIADAHIYDRHIPLIKELIEREPLPAPTFWLNPEVKDFYQFTTDDVRLENYETHPQIKNI
PIAV
>KF627887.1_17860|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVAHFTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKNIFSFKYED
FELVNYDPWPHIAGKVSV
>KF627882.1_17869|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKRIAAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAYITRLD
YAYEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNERPALH
>KF627879.1_17881|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ANGWNVMQYAVLLHMFAQVSGLEAGELVHVIADAHIYDRHVPIVEEIIARQPYDAPKFIM
DKSVTDFYAFTKDSFRLEGYQAHPLEEKIPVAV
>KF627874.1_17889|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IASYALLTMMMAQVCGLKPGEFVHTLGDTHIYLNHIEQVKLQLTREPRALPRMEINPDVK
SIFDFKYEDFTLCDYNPHPHIKGAISV
>KF627871.1_17896|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADALFLQNCRDILDHGVWDTDLPVRPHWEDGTPAHTVKKFGIVNRYDLQEEFPILTL
RRTYWKTAVDELLWIWQKKSNNIHDLNGHIWDEWADPDGSIGKAYGYQLSIKHQYPEGEM
DQVDRVLYDLKHNPASRRILTSLYNHQDLHEMNLYPCAWSMTFNVSGNVLNAILNQRSQD
MLAANNWNVVQYAVLVHMLAQVSGLVPGELVHVIADAHIYDRHVPIIEKMLAQTPSPAPV
FRMDPSVTDFYAFTRDSFSLEDYIPAPFEDQIPIAI
>KF627870.1_17901|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIAVLCGGRSSERDVSLSTGIQVARALRETGHDVVLVDACVDFPLDCRPEEVFEKALPI
ENHAIGAAAPCVKRFFDRASGFFGKNVLEICKSADIVFNALHGDEGENGKLQAVFDLLNI
CYTGSGAQGCMLAMNKSLSKQLFRTHGIPTPEAVILSESDKCRAAELCEKLGLPCVVKPA
SLGSSVGVSIVRTIDEFFTALDSAFSLENTVIVEKYIKGREFAVGIVGSRVLPAIEIIPK
HGFYDYKNKYQPG
>KF627867.1_17906|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
KNIAIIAGGNSSEYEVSMKSGKNIYDEVDETRYNKYLVVLKERDWHVEIGEEKFPVDKND
FSFTRNGEKILFDFAYITIHGVPGENGLLQGYLDMMGVPYGCCNVLASALTFDKHTCNTY
LKSYGVNVADSVMLIRGMAYDVNEIINEVGLPCFVKPNAEGSSFGVTKVKEAAQLEDALK
KAFALCREVLIETFIDGTELTCGVVKAGDMDITMPIAEVVPKNEFFDFEAKYDPTKSDEI
IPARISPELTNRIKILSSMIYDILRCEGIIRVDYIVREDEIFMLEVNTTPGMTSNSFVPK
MVRAMGGTLREVLTKIIDNKLNR
>KF627859.1_17924|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KEFIMKIVVLAGGTSTERDVSIVSGTMVCKALREKGHQAILMDVFFGLKQIPESLFPEEY
DVEGAAEEIRSHNDSLAEAVKARREFFGPHVIEICQKADVVFMALHGANGEDGKVQAAFD
LFGIPYTGTGYLSSAVAMDKGLTKQFFETHGVPVPKGISLMKNQAFVSLEKSGLEFPVVV
KPCCGGSSVGVFIAGNQEEYEAALQAAFAYEDELIVEEYVKGREFSVGVVDGKAYPIIEI
APIEGFYDYTNKYKAGSTIETCPAELTEEQTRQMQEYAVLGAESLGIEGYCRLDFMMRGD
GRMYCLEANTLPGMTPTSLLPQEAQAIGIDYPSLCEELIRLSLKKYQG
>KF627857.1_17930|FEATURES|farme|beta_lactam|BAMA_03925|antibiotic inactivation|1
MIFVILLSVGCSNNQENISDGNENVNADYDFLFQELEEKYDATLGIYALDTETNKEISYN
ADERFAYCSTYKALAAGAILEKYSIEELDNVIYFEEEDVLSYAPVAKDKVDTGMTIREIC
DAAVRQSDNTAGNLQFTLLDGPNGFKQSLSKIGDTVSEPSRIETELNDAVPGDIRDTSTP
KQLALNLKEYATGDILSMIKKRFL
>KF627845.1_17965|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ILNQRSQDILAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHIPIIKELIQ
RPTYDAPTFWLNPDVKDFYEFTRNDVRLDNYVTGPQIQDIPIAI
>KF627841.1_17975|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKQATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF627838.1_17981|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAADANWGIGKENKLLVSIPADMKFFRTTTTGNVVIMGRKTLESFPGGLPLKNRVN
IVLTRDKNYRVKDAIVVHSVEEALEEVKKYKEDVYVIGGDSIYKQMLPYCHKAHVTKIDF
AYEADTFFPNLDEDKEWKVTERSEEQTYFDIEYEFRTYERVKK
>KF627815.1_18039|FEATURES|farme|beta_lactam|mecR1|antibiotic target replacement|1
MKKHILTGTLFALVLLASVVRASETVEQTDLADMFQGFDGTFVMYDEGAGRYTVFNKARS
ETRFSPCSTFKVFHALIGLDSGVLDRDDARTLMKWNGKPSSIAAWNHDQTLASAMRHSVV
WYFQRVAAGIGEERMRRGLDRIGYGNRDISGGLTRFWLQSSLKISPREQVGLLRALFNGS
LPFAAEDIAVVKRDITLSSKDGVRFMGKTGSGSDGTGRGAIGWFVGGVETQHNRWSFAVN
IQGPDASGIRARGIAEAALRRLNILP
>KF627795.1_18092|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNLIVAADRNWAIGKDGDQLCYLPADLKRFQALTTGHTVIFGRKTLTTFPGARPLKGRRN
LVLSRQAGLEIEGAEVFQDLDALRRAAPADAFVIGGESVYRALLDACDTAYVTRIDAAWP
ADSFFPDLDRRADWYVAGAEAPLEHEGLVFRYVTYRRRP
>KF627793.1_18098|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSSAGICRTLLEKGHDAFLLDVFLGFPYDPEHLEEVFTLPDH
GLGIVKNIDTTEPDIEAVKASRPDQPDCFLGPNVIELCRMADITFLGLHGGEGENGKLQA
TFDLLGIRYTGPDSLGCAVAMDKGFTKQVFLQTGIDTPAGACIHKKASEKSLDALGLTLP
VVVKPCSGGSSIGVYIVNTESEYEEALSSSFRYEDEVVVEKYIKGREFACGIIDGKALPP
IEIIPKTGFFDYANKYQDGATEEVCPADIDKATANRMMELTVKAYRALKLNVYSRADFLL
DSSGNLYCLGVNPLPGMTAASLLPKEAAAA
>KF627786.1_18109|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDIIVCIDKNNGIGKDGGLLFRIPEDMAYFRRMTVNKTVIMGRKTLESLPGGRPLENRRN
IVLTRNRDRVPDGADAVSSIDELKRAIGSDKAFVIGGESIYAMLLDYCERAYVTEVEACG
NADCFFPDIRSMPNWRLAEQGEEREHGGLKYRFNVYKNHSIKEL
>KF627785.1_18113|FEATURES|farme|beta_lactam|PER-1|antibiotic target alteration|0
MKQYLDLLDRVLTEGIEKGDRTGTGTISVFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLKGDTNVKYLQDHGVRIWNEWADETGVSL
>KF627785.1_18119|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLQAGDFI
HTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIFDFQFEDFELVNYDPHPHIAG
KVAV
>KF627785.1_18120|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSRISIIAAVDSRMAIGFQNKLLFRLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSSNPAAECPGAEVFTSLEAALESCQAEEKVYIIGGASVYRQTISLADELCLTEVN
DTAPEADAFFPAVDTTIWHEKSREVHPADEKHLCSYAFVDYVRGID
>KF627782.1_18131|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMIKEFKSMKKNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGRWLLVD
GVKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQG
LFELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEK
EIPYPIFVKPSCAGSSKGVSKAENRKELEAALYEAVKHDRNILCEETIVGREVECAVLGD
RTQVKSTCVGEILAAEEAAFYDFDAKYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVD
GFGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRY
R
>KF627779.1_18143|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKGKIKMSYADQIFVQNCKDILAHGVWDTDCPVRPKWDDGSPAHTIKLFGVINRYDLRKE
FPILTVRRTYWKTAVDELLWIWQKKSNNIHDLNSKIWDQWADETGSIGKAYGYQLGVKHH
YPQGDMDQVDKVLWDLKHDPASRRIMTNLYNHHDLSEMALYPCAYSMTFNVSGNTLNAIL
NQRSQDMLTANGWNVTQYAILLHMIAQVSGLEAGELVHVIADAHIYDRHVPVVEKLLEAK
QSPAPKFIIDQSVTNFYAFTRDSFSMERYTPAEFHEQIPVAV
>KF627774.1_18159|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIIKELIKRP
TYPAPKVTLNPEVKDFYKFTVDDFMIEDYQAGPQIKNIPIAI
>KF627747.1_18216|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLYDEQYLTIAQNILDHGYYDTNRTGVSTYKLPHQSMQFDLEREFPILTTKKVAFKTAV
RELLWIFKEQSNDVKRLQEQNVHIWDEWEMEDGTIGTSYGWVVQKFHQMDTLLEQLKTNP
QDRRMMLNLWQIPYLDTGALYPCCFLTMWDVTDGRLNCMLVQRSGDWGLGVPFNTSQYAV
LVHLLAQVSNLRPGMLTHVINNAHIYENQVEGIRLQLTRRAEAFEAPALWINPEIQDFYA
FQIQDIKLIGYKSHDKISMEVAV
>KF627741.1_18234|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQKLMVVCGGQSSEHIVSRMSCTSVMNNLNKEHYDVTLVGIDQDGSWYLLDQGQDDLAQ
DTWLENSQVIQDIFGVLKQQDVVLPILHGAFGEDGTIQGLFELAGVPYVGCRVLASAVSM
DKIYTKKILETAGIPQVKSLYVKKRYDGKLVVVNKQFDEIEDIEKTVEKELGFPCFIKAS
RSGSSVGCYRCDHKEDLMTKLIEASKYDRHIVVEECVDCIELETAVLGNDDPIVSRVGQI
MPHGEFYTFESKYEDEESKTCIPALVDQEIQDKIREYALRVFKAVDGHGLSRVDFFLDKK
SNQIYLNEINTLPGFTKISMYPQLMN
>KF627733.1_18262|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MYSNNNSFIIERGISLNKLTVAVIFGGQSSEHEVSRVSASTIISNLDPEKYYVIPVGITK
DGKWMIYNGPVENIKNGEWEKFGTPAVLSPDASQKGLLKTVGGKVKLIPIDLAFPVLHGK
YGEDGTIQGLFELAQIPYVGNGVLSSSISMDKAFTKIIAKNAKIPQAKYVEVHSEDLKRI
KTTASKIEKKLGYPCFVKPANAGSSVGITKAHNKEELMEGLKVAAVHDSKIVVEEGIVGR
EIECAVLGNRGHVEASCVGEIFSAGEFYDYDAKYNNAESKTVVPAEISPEKQDEIRKMAV
KVFNAVDGSGLARVDFFVENETENVIFNELNTLPGFTPISMYSMLWAACGKSTAELLDNL
IELALERFSL
>KF627729.1_18277|FEATURES|farme|multidrug|ABC_transporter|antibiotic target protection|0
MALITCENVSIGYEGQTVVKELNFSIERGDYLCIVGENGSGKSTLVKSLLGLKGTSRG
>KF627726.1_18284|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
VIADAHIYDRHVPVVEELIRRPQYPAPKFRLNPDVKDFYDFTVDDIEITDYQKNPQVKNI
PVAI
>KF627725.1_18286|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|0
IQKVPEEQLCVIGGAAVYEMLLPYCTTAQVTKSYVTLKADTFFPDLDADSCWSLAEEGKI
EEENGVRFQYLKYVNRSPRQWR
>KF627722.1_18294|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
VNSNDYNREKIMNLIAAVDNNWAIGKNNQLLVRIPMDQKFFREMTTGKVVVMGRKTLESF
PNSRPLKNRTNIVLTHNPSYEVEGAIVVHSLDELHKELEKYNSEDIYIIGGQKIYEQLVD
ECRCSPQSQRWTSSMMRMHIFQILMRSLSGRLQETAKSRHTLIWSFISFDTRR
>KF627721.1_18300|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKCPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLNSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIIKELIKRPTYPAPK
VTLNPEVKDFYKFTVDDFMIEDYQAGPQIKNIPIAI
>KF627712.1_18324|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAADKNWGIGKDNKLLVSIPSDMKFFRQETMGKVVVMGRKTLESFPNGLPLKNRTN
VVLTSDKNYQVKDAVIVHSIDEVLEELKKYDDDEIYVIGGGKVYEELLPYCDVAHVTKID
FAFEADTHFPSLDEDPEWEITASSDEQTYFDLEYTFVKYERK
>KF627696.1_18364|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQSEKMCVVLLFGGMSSEHEVSRVSVGNFVNNIDREKYETLAVGITKEGRWLYTEATAAQ
MADGSWEELAGNMPCVISPDRADHGMILFTPEGHVEKVHVDVVIPVLHGLWGEDGTVQGL
LELAGIPYVGCGVLASAVCMDKAVANALFGANGVPHTKWVAANRWEIESDLEGVCDGVEQ
KLGWPVFVKPANAGSSVGISKVSSREELKKAIDLALENDRKVVFEAFVDGQEVECAVIGS
DPAVATRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLPEAKLDEVKTYAAMAYTALNCEG
LARCDFFVEHGTGRVLINEINTFPGFTSISMYPKLMEHEGLPVPALIDRLIALALERKEK
QHG
>KF627688.1_18388|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAVDKNWAIGCNNRLLVSIPSDMKFFRETTMGKVVVMGRKTLESFPGGQPLKNRTN
IVITSDSDYKVKDAIVVPSIEAAVEELKKYEEEDIFVIGGESIYRQMLPYCKMAYVTKID
HAYDADTFFPNLDEMEDWKLTGVTEEQTYFDLEYVFARYERIERSE
>KF627683.1_18400|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVAVDKNWAIGMDNKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVN
VVLTSDKKYNVKGTVVVHSIDEMVEELKKYNDEDIFVIGGESIYRQLLPYCKTAYITKID
HAYQADTFFPDLDQDPQWQMTKISDEQTYFDLEYVFTIYERVS
>KF627681.1_18405|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHMLAQVCDMKVGELVHVIADAHIYDRHVPIIRELIEREQHPAPKFTLNPDVKDFYQFTT
KDITIEDYVTGPQIKNIPIAV
>KF627679.1_18407|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TVGMSRADKIFIQNCKDILTNGVWDTDKEVRPKWDDGEPAHTVKKFGIVNRYNLDEEFPL
LTIRRTYWKTAVDEMLWIWQKKSNNIKDLNAHIWDSWADENGSIGKAYGYQLGIKHKYSE
GEFDQVDRVIYDLKNNPASRRIMTNIYNFADLHEMGLYPCAYSMTFNVSGNKLNAILNQR
SQDMLAANNWNVVQYSVLVHMMAQVAGLEVGELVHVIADALIYDRHVPIIEKMMNSEIHE
APRFIIDKSVDDFYKFTRDSFKVEDYKYSPFEDKIPVAI
>KF627676.1_18421|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GKAYGYQLSIKHQYPEGEMDQVDRVLYDLRHNPASRRILTNLYNFADLHEMHLYPCAYSM
TFNVSGNVLNAILNQRSQDMLTANNWNVVQYAVLVHMFAQVSGLVPGELVHVIADAHIYD
RHVPIVERMLEQSPASAPRFSVDPGVTDFYAFTRDSFRLEGYVPAAFEETIPIAI
>KF627674.1_18424|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKPHISLIVARSRNGIIGKEGKLPWRLSEDLKFFKQTTMGRPVIMGRRTWESIGRPLPGR
QNIVLTRDPSYKAEGATVVSSLEEALKHFGPDDIVFVIGGADLYRRALPLVDTAWVTEIE
ADVEGDASFDPLNKDEWMLVWSEDHPKTEAQPLGFKFQRFERVKHTVY
>KF627663.1_18448|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNIIVAVDKNWAIGKDNKLLVAIPADMKMFRQETTGKVIVLGRKTLETFPGGLPLKNRTN
IILTTNKDFKVKDATVVHSIEELLEEIKKYPSDQVYCVGGDSVYKQLLPYCDTAHVTKID
FGYEADRYFPNLDESPEWEITARSEEQ
>KF627662.1_18451|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGTAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>KF627655.1_18473|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVREPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGIAC
>KF627651.1_18484|FEATURES|farme|quinolone|oqxB|antibiotic inactivation|0
MKRIILVVLRCIFKLPYWWFYKLKQYQNKEKYPTIDEGYQFIHNVADEIVKKARVDLECY
GLENLPQENGYLITPNHQGLFDIVAVFKTHDKTAKFVLKKELASTILIKDVVKTLDYYAL
DRSSIRDGAKMVKNVSKEIEAGMNYVIYPEGTRSQQGNKIGEFKGGTFKIALKSHCPIVP
VAMIDCYQVFDNNTIKPVKAQIHYLKPIEYDEYKDLKTPEIAALVQSRIQACMDEYC
>KF627622.1_18569|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVPGPASEGERTVQLIAAVDRNWAIGRDGDQLAYLKADLKRFKALTTAHTVILGRRTLAT
FPGGRPLPGRRNLVLSGKPDFRPQGAEVFSSLETLLAVAPADAFVIGGGSVYWALLPWCD
RAYVTKIDAVFPGADTWFPDLDAREDWTVEAEEPPLEEGGLPFRYVTYRRIGSSS
>KF627617.1_18582|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNIIVAVDKNWAIGKDNKLLVAIPADMKMFRQETTGKVIVLGRKTLETFPGGLPLKNRTN
IILTTNKDFKVKDATVVHSIEELLEEIKKYPSDQVYCVGGDSVYKQLLPYCDTAHVTKID
FGYEADRYFPNLDKSPEWEITARSE
>KF627610.1_18604|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MMFRLGAIWAQTDAGIIGRDGDMPWYAPEDLAHFKKVTLGAPVIMGRRTWESFPPRFRPL
PGRTNIVISRSVTEAEERDGAVWVPSLDAALYAARDAAGAPVEATPADTAAVDAWIIGGG
SVYAEALSRTDLPAFGRVKTVERTLFYCQEGNEITGDTRAPELQLADSAGSYEGGSPNGC
WRVTSESAWENSEKGYLLDESGTKNPMYFSFQRLERI
>KF627605.1_18617|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQLFIKMCQDIIENGVSTEGEKVRPKWEDGSSAYTIKRFGVVNRYDLSKEFPALTL
RRTALKSAFDEILWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVLYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGVL
NQRSNDVLAANNWNVCQYALLLMMIAQVCDMEVGELVHVIADAHIYDRHIPLVKELISRE
THPAPKVWLNPEVKDFYAFTTADLIVEDYQAGPQVKNIPIAV
>KF627601.1_18629|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKPTLAVLFGGCSPEYSVSLQSSYAVLSNLNPDRYTVLPVGITQSGQWFHYTGAYDRIA
TDSWAEDPGCLTPVVVSQDRSVHGLLAFSAPRHQVIQVDYALPILHGKNGEDGTVQGLLE
LAGIPVVGCGTLASALCMDKDRAHKLASLAGVAVPASLVLKLGEDPQAAVDFARQTGYPL
FVKPVKAGSSYGISQIHQEEELLPALDLAFQYDNQVILEETIPGFEVGCAVIGTRELLVG
EIDEIELSGGFFDFTEKYTLKTSAIHVPARVDPQTAQAVKQTAKVLYRALGCAGFARVDL
FLTPQGKIVFNEINTIPGFTEHSRFPGMMQAAGMT
>KF627590.1_18659|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NNWNVVQYSVLVHMLAQVCDMQVGELVHVIADAHIYDRHIPIIQELIARQPYPAPKFSLN
PEVKDFYQFTRNDVSVEDYITGEQIKDIPIAI
>KF627586.1_18666|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
EKCIEGTEITVGVYGEDEVRALPIVEIRKPEDCEFYNLDVKYVDPTDIHRIPAQISPENY
ARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDMTF
PQVCDSLIRMGLRRAGIAC
>KF627575.1_18692|FEATURES|farme|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKRELELY
RFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAV
LFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWLIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF
>KF627549.1_18775|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
HVIADAHIYDRHVDAIKELISREPFPAPKFWLNPEIKDFYQFTPDDVKLEGYQTGEQIRD
IPIAI
>KF627545.1_18790|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
QHLTVLSWSAPLLAQLIMLIVMCMQRHWLYAAMLAPSLLGSALMLITMIMRVRHEETNSN
TITGSDSPVPTHHNGNEIDHAQLFADMPSISFEHLHGLDNDPLIWRTIVRNWLVRSPTNG
IGMSEHGIFHIDLASSGPHAMVAGTTGSGKSELLISWCMALAIRHSPQTLHFVFLDFKGG
STFNALERLPHTVGNVCDLDLAHAVRALNAIEQELARREALVSAERVSRFDQLSHPPARL
VVVIDEFHALRDRLPDYMQRLNRLASLGRSLGMHLIVCTQNPMGQVHADMKANISLSICL
RVTDQMQSNELIGTKDAALIPPAFPGAAYCHDGQRTVPFRCSAVHDIDSLVHAINTASAF
SGTTNPSPLFSAPLAPHAGKDDLTAPQREAWHHVPFALSDDGVLISTAFLDVGHGNIAVI
GACGSGKTNLLLCCASRLYESGRCTIRFTRKTNSEWTTDDGRISPQHERTIWFVDDADEL
LSPFAAMPEADKLKTALADPSVTVIAAVEKPQSTLLERCLTRVAFPCGERATDVMMGIPS
AVLDGFGVDDYAIAGRGVFIQQARACPVQCAEFQGF
>KF627539.1_18806|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|0
MEFKMNIVVLCGGNSTEREVSINSGSMVCEALRKKNHNAILMDVYFGLEDIDIFEKSASE
YDVESVKKNIQSLSDKVSEDRRSFFGNNVIEICQKADIVFMALHGKNW
>KF627538.1_18811|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSQADKLFAAMCQEILDHGYSSQGQTVRAKWEDGTPAHTIKQFGIVNRYDLQEEFPALTL
RPTAIKSAVDEMLWIWQKKSNNIKDLSSHIWDEWADENGSIGKAYGYQLGVKYKFPHGEM
DQVDNVLWQLKHTPYSRRIMTNIYKFDDLMEMGLEPCAYSMTFNVTGDRLNAILNQRSQD
ILTANNWNVVQYAVLVHMLAQVSGLKAGQLVHVIADAHIYDRHVDIVREMIQRPQYPAPK
FSLNPEITDFTTFTTDDILIEDYEKNPQIRNIPVAI
>KF627536.1_18816|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
VSIPADMKFFRETTTGKVVVMGRKTLESFPNGQPLKKRVNIVLTHDKNFKAGDAIIVHSM
EELREELKKYPSEDIYVIGGETIYKQLLDDCDVAHITKIDYAFEADAYFPNLDEMPEWKI
TQDSEEQTYFDLEYYFYKYEKIK
>KF627530.1_18829|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MELIVAVDQNWAIGRGGDQLIYISQDLKRFKTLTTGHPVILGRKTLDTFPGGRPLKGRRN
PILSRSPGFAPEGAEVYLDLDALLAAAPEDSFVIGGASVYRALLDQCSTAYVTKIEAAFP
AADCWFPDLDSRPEWRISEESESQEEDGVKFRYVTYRKEE
>KF627529.1_18831|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|0
GPNGTGKSTLGYAITGNPAYTVTEGDIVFGGESIVDMPVNERAKKGIFLSFQNPLEVPGV
TLSSFIRSALEQKTKTRLRLWDFKKKLAETMKLLNMDESYSDRDLNVGFSGGEKKKAEIL
QMLMLEPKLAILDETDSGLDVDAVRTVSQGVKLYRERV
>KF627525.1_18838|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLGGGISTERDVSLSSSRMIYEALKKKGHQAVLLDVYLGYEDDYAGIFEKDVDWAE
NIGGIKESNPDIAQIKALRKDGGRSFFGPNVIEICQMADVVFLGLHGEDGENGKVQAAFD
LLGIRYTGTDYVSSALSMDKSLAKELFAFHGIPTPAGIHVRKGQESAERVPYPCVVKACK
GGSSVGVCIVHEEKEYQAALEEAFRYDEEAVIEQYIEGREFSCAVIDGKALPVIEIAPLC
GFYDYKNKYQAGSTIETCPADLPEDKTREMQLISEKVFRALRLKKYARMDFMMDKEGKLY
CLEANTLPGMTPPSLIPQEARAIGISFEDLCQWILELAQKD
>KF627522.1_18854|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSSAGICKTLVEKGHEAYLLDVFLGLENPPANLEDVFSLPGH
GLEIAKGIRTTEPDIEAIKASRTDKSSCFLGPNVIELCRMADITFLGLHGGEGENGKLQA
TFDLLGIRYTGPDSLGCAVAMDKDFTKQVFLQAGVDTPAGGCLHKNDTDKSLARFSLTLP
VVVKPCSGGSSIGVYIVHTEKEYEEALNNSFRYEDEILVEPYIKGREFACGIIDGKALPP
IEIIPKTGFFDYANKYQDGASEEVCPADISPEIENKMKELTVKAYRALKLSVYSRADFLL
DEKGNLYCLEMNTLPGMTPASLLPKEAGAVGIDYGSLCELIIQKSMEARYQ
>KF627518.1_18863|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVAVDENWAIGYNNELLVSIPDDMKFFRETTTGKVVIMGRKTLESFPGGRPLKNRVN
IVITKKEDYEVDGAVVVHSVEEAVKEASKYDENDVFVIGGGSIYKAMLPYCNTAYVTYIN
QAYSADTFIPNLDKEVDWVLADESDENTYFDIEYFFRIYKRK
>KF627515.1_18877|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADVLFVNMCKGILDHGFSSEGQTVRARWEDGTPAHTIKNFGIVNRYDLSEEFPALTL
RPTAIRSAVDEMLWIWQKKSNNVGELGSHIWDQWADSAGSIGKAYGYQLGVKYRFAQGEM
DQVDNVIWQLKNTPYSRRIMTNIYNFGDLMEMGLEPCAYSMTFNVTGNKLNAILNQRSQD
ILTANNWNVVQYSVLVHMLAQVCGLVPGELVHVIADAHIYDRHVPVVEELIARTPYEAPR
LWLDPAVTDFYTFTKDSVRLEGYRFHPLEQPIPVAV
>KF627513.1_18882|FEATURES|farme|trimethoprim|dfrA|antibiotic target replacement|0
MSKVSIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTG
>KF627506.1_18899|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LPHRKEGIELNKKTVVVLFGGQSSEHEVSRVSASTIISNINQDKYYVIPVGITKEGQWLI
YNGPVENIKSGEWEKFGTPAVLSPDASHRGILKIVGNKVKTIPVDVVFPALHGLYGEDGT
IQGLLELAKIPYVGCGVLASAVSMDKAFTKIIAKNAKIRQADYLLATKEEIKKKSVLSKI
EKKIGYPCFVKPSNAGSSVGITKAHNYDELVKGLELAAENDRKIIIEKNITGREVECAVL
GWKKARASSVGEIFSAAEFYDYDAKYNNADSKTVIPADLDEETVKEIQKTAVKIFKAVDG
KGLARVDFFVESGTGRVIFNELNTLPGFTSISMYPKLWEDAGMPITLLIDELINTAFDA
>KF627501.1_18913|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IYLNHLEQVKLQLSREPRPLPQMKINPDVKNIFDFKFEDFELVNYDPHPHIAGAVAV
>KF627498.1_18920|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MFSKLFFCLIFLAALTPLYSQEPLAQQLKSIIENKKATVGIAVLYNGKILVTVNDKAGYP
MMSTFKFPLALAVLERLDKQGLPLETELFISKPDLHPDSYSPLREARPEGNFKITIGELL
KYSVALSDNNACDILIDYLGGTSALQKYVRRQGIKQMKITATEDRMHKSGDPYLNHTRPS
SAVRLLEKFIQQELLSPVYQKFLENTMIATSTGSDKLKGLLPAETIIGHKTGSSDRDSTG
MKAGDNDMGFVYLPHGGDHYTIAVFITDSMEDDKTNAAIIAKISKAVYDYINEISS
>KF627497.1_18924|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SNLLATVRIEWKKNGRNGMSLADKIFVDMCKDILENGTSTEGEKVRPHWEDGTSAYTIKK
FGVVNRYDLSKEFPAITLRKTAIKTCTEEMLWIWQRKSNNIHDLNSTVWDEWADADGSIG
KAYGYQLGVKHQYKEGMMDQVDRVIYDLKNNPFSRRIMTNIYVHADLHEMNLYPCAYSMT
FNVTHHPGDEKLTLNAILNQRSQDVLAANNWNVCQYAVLMHMLAQVCDMKVGELVHVIAD
AHIYDRHVPIIRELIEREQHPAPKFTLNPDVKDFYQFTTKDITIEDYVTGPQIKNIPIAV
>KF627489.1_18948|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|0
VPDGADAVSSIDELKRAIGSDKAFVIGGESIYAMLLDYCERAYVTEVEACGNADRFFPDI
RSMPNWRLAEQGEERKYGGLKYRFNVYKNHSIKEL
>KF627486.1_18956|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|1
MNLIVAADENWGIGREGQLLFHISPDLKNFKALTLHGTVIMGRKTLESLPGGR
>KF627483.1_18966|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
SPRGPGLEAGELVHVIADAHIYDRHVPVVEELIARTPYEAPRLWLDPAVTDFYTFTKDSV
RLEGYRFHSLEQPIPVAV
>KF627458.1_19038|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
HVIADAHIYDRHVPMIEELISREPLPAPKFWLNPEVKDFYDFIPDDVKLEGYETHPQIKN
IPIAV
>KF627433.1_19112|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
AKGVYKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTK
VEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVKDF
AECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIQAPEGWL
KVIE
>KF627423.1_19134|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLLENGHQAYLLDLYFGLGNAPANLEDVFTLPGA
GLEIAKNISTKEPDLEALKKSRPDQSDCMFGPNVIELCRMADITFVALHGSVGENGKLQA
AFDLLGIKYTGCNSFGCALSMNKLVTKQIYKMSGVPTPRGTHLTKETKDLPLSELGYYLP
LVVKPCENGSSIGVYICHTEEEYNNAVRESFEKNPDEELVIEPYIKGREFASAVIAGKAL
PLVEIIPKDGVFNYENKYQAGGAQEICPPVSINEETQQRMMRAGEEAFAALRMDVYARAD
FIIDDEDGEFYSLEMNALPGMTAASLLPKAARAAGIEYNELCERIIEESMNARYR
>KF627417.1_19146|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTKADTIFKENITKIMEEGVWSEQARPKYKDGTTANSKYITGSFAEYDLSKGEFPITTLR
PIAIKSAIKEGVWIDQDQTNSLDVLEDKYNVHYWNDWEVEGVPANNGDKRSIGQRYGAVV
KKHDIINRLLAQLEANPWNRRNVISLWDYEAFEETAGLQPCAFQTMFDVRRVGEDVYLDA
TLTQRSNDMLVAHHINAMQYVALQMMIAKHFGWKVGKFFYFINNLHIYDNQFEQAEELLK
RQPSDCQPRLVLNVPDETNFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF627398.1_19196|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MRLPYQKPWRIGWKFDFFCGKIKKTIIDVLYYKAILKMVSKKEATDKAVSKKGRNMSKET
LILLYGGRSAEREVSVLSAESVMRAVNYSRFIVKTYFITKGGEFIKTQEFTDRPAEEEKL
LTNDLAESYPKISPAAIYEKDAVVFPVLHGPMGEDGSIQGFLEILRLAYVGPNILSASST
MDKLLAKHVFEAVGVPQVPYVAAFADENQVEIAQEVVEKLDFPVFVKPANMGSSVGISKV
DDLADLQPALSEAYKYDNRVVIEQGVDAREIECAVLGNNSDVSATLPGEVVKDVGFYDYN
SKYIDNKIQMDIPAKVSADLAQKIQEYAKKAYKAVNGAGLSRCDFFVTKDGNVYLNEVNA
IPGFTQWSMYPLLWENMGLSYSDLIEKLVDLAKETFETRENHLL
>KF627394.1_19204|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MLARTCGYEAKEFIHTIGDAHIYKDHFEVVKQQIAR
>KF627384.1_19240|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLALPFCTVKLATMALTPEQLADIRTRIPARPETDIPMPYEDLVRKILTEGTLKSDRTGT
GTVSLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQERNVHIWDEWA
DENGDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVENHPDSRRMVVSAWNPAEVEN
MALPPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQAGLQPGEFV
WTGGDCHVYDNHIDQVLEQLSRDPYPYPQIRINKADSLFDYDYSDFEIVGYQHHPTIKAP
VAV
>KF627366.1_19289|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LSYADKVFIDMCRDIIENGTSTEGEKVRPRWEDGTPAYTIKKFGVVNRYDLSKEFPALTL
RRTGIKSCVDEMLWIWQKKSNNINDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMM
DQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGIL
NQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHVPMIEELISRE
PLPAPKFWLNPEVKDFYDFIPDDVKLEGYETHPQIKNIPIAV
>KF627348.1_19353|FEATURES|farme|macrolide-lincosamide-streptogramin|tsnr|antibiotic target alteration|0
MTDAVEVLRIDSLEDERLDAYVRLTERELRCVLEPQKGIFIAESAKVIERAVRAGYEPVS
FLLGERWLDQMMPLFERLVVREGAGPVPVFVASMELMEQLTGFNVTRGALAAFRRPRQIP
VDEFLGGVVEAAGDRPVRVCVLEGIVDHTNVGAIFRSAAALNVDGILVSPTCCDPLYRRS
ARVSMGTVFQVPWTRIGSEARVWPHDGLSALHDAGFSCAAMALTDDSVSLDDPVLQEIDR
LAIFMGTEGAGLGAKTIAGCDHAVRIPMAHGVDSLNVAAASAVAFWQLCPHGSNEYHYQP
GLYH
>KF627330.1_19401|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
NKYLKKGEHIMSKINVALIFGGKSGEHEVSLLSTASICKHINRDKYNVFTIGITKEGRWM
FYDGNEENIKDGSWVNLANPSVEINLIPSGNKEVGLKFEDGRVEKIDVLFPVLHGPYGED
GTIQGLFEISQIPYVGCGVLASSVGMDKLICKKVFSQIGLPQVDYTYTNKWEFNINKDQE
LDKIEEKLNYPIFVKPANLGSSVGISKAINREELLVGIEEALKYDSRIVLEKGINAREIE
VAVIGNGEVKASIAGEIKPAKDFYDYEDKYINGTSTYDIPANIKAEDMEDIRRMA
>KF627327.1_19407|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MLQISEKGKKIPASPIRKLVPYADRAKERGIKVYHLNIGQPDIATPEVALKAVRQMKLPV
IEYTASAGNHTLRTKLAGYYQKLGISLTEEDILITTGGSEAILFAFMSTLNEGDEIIIPE
PFYANYTAFALMVGAKIKTVTAKIEENFALPPMSEFEKQITPKTKGIVIVNPNNPTGYLY
SPKELEELAKIVKKHELYLYSDEVYRRYCYDGLKHFSVMNLKGIEQNTILFDSMSKRYSE
CGIRVGAIITKNKAILDAALKFGMARLCPPALGQIAAEASLDTTDEYFESVYHEYIKRRN
FMVEALNKMPGVVCPIPKGAFYSIVKLPVDDAEKFAQWLLEEFDYNGQTVMLAPASGFYY
TPGLGKNEVRIAYVLKISDLQKAMEILSVALKTYPGRTL
>KF627323.1_19422|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGVEKSDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIYELL
WFLRGDTNVKYLQNNGVRIWNEWANENGDLGHIYGYQWRSWPNYKGGSIDQISEAVETIK
HNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRDLPQMRINPDVKSIF
DFKFEDFELINYNPHPHIAGKVSV
>KF627314.1_19452|FEATURES|farme|beta_lactam|SHV-40|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGGRG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>KF627309.1_19466|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|0
MNIIVAADKNWGIGRNNELLVSIPADMKM
>KF627306.1_19474|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLSDSEHKMSVVVLFGGMSSEHEVSRVSAGTFVDQLDRQRYELLTIGITKEGRWLYTEAD
SAQMADGSWEDLPGNMPCVLSPDRADHGLILFTPAGQVEKVHVDVVIPVLHGLWGEDGTV
QGLLELAGIPYVGCGVLASAVCMDKAVANAMFDASGIPHTKWLSATRWEIESDPDGVCDG
VIAKLGWPIFVKPANAGSSVGITKAHDRDELKAAIRLALANDRKVVFEAFVDGHEVECAV
IGSDPAVSTRPGEILAGAEFYTYDDKYKNGVSQVVIPARLPEEKLDEVKTYAAMAYTALG
CEGLARCDFFVEKDTGRVLINEINTFPGFTPISMYPKLMEHEGIPVPALIDRLIALALER
TEKQHG
>KF627300.1_19494|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKISIIAALDRRRAIGFQNKLLFWLPNDLKRFKGLTTGNTIVMGRKTFESLPKGALPNR
RNVVISSNPALQCPGAEVFPSLTAALQSCKEDEHVYIIGGASIYQQALPFADELCLTEID
STAPEADVYFPEVSPAVWQEKSRETHPADEKHLCSYAFVDYTRK
>KF627294.1_19507|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKIKVGVIFGGQSTEHDVSVVSGSSVIKNLNKEKYEIYPIYISKDGEWFHYMKPVQDIE
IFEIGEQPKELEKISNEFETLKKQDIIFPVLHGLYGEDGTIQGLLELLKVPYVGCKVLAS
GICMDKVYAKMIFEKANINQAKAVVVNTKNGYTYVDEELNHISTTIEEICKIVNEKLKYP
VFVKPSNSGSSVGVSKAENDEELKNSIQEAAKYDKEILIEQGINGKEIECAVLGMDDVKA
SCVGQILSADEFYDYDSKYKNAESKTIIPADVSKEISEKIRKTAIKAFKAVKGSGLARVD
FFVDKETDEIYLNEINTMPGFTNISMYPKLWENCGLTYSKLLDRLIEQEL
>KF627293.1_19512|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MTCKLSAIVAVCDDWGIGCEGDMVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLK
NRRNIVLTRDEDFTPEGVDVVHSIGEALAAVADEPVAWVIGGGDVYRQFLPYCVEAEVTH
NHCVHPVDTYFPDLDADPAWEVARREGVATIAAGEGDEGLDYEFVTYRRVSA
>KF627289.1_19520|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMMAQVCDMEAGELLHVVADCHIYDRHIPLIKELIQRKPYPAPVVKLNPEVKDFYQFTTD
DLIVENYETWPQIKNIPIAV
>KF627286.1_19530|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MDYDKLIAPAAAAMRPSGIRKFFDLAAEMPECISLGVGEPDFKTPWAVREAGIESLEHGR
TRYTSNAGLKELRAEIARYLDRRMGLKYDPAKEVLVTVGGSEAIDMCIRALVQSGDEVII
PEPCFVCYEPITTLSGGVPVHVACRQEDEFRLRADALKAAITPKTKLLIMPFPNNPTGAV
MEREDLEAIAEVLRGTNIMVLSDEIYAELNYGLQNHVSIAALPGMAERTVVVNGFSKTYA
MTGWRLGYACGPAPIIKIMTKIHQSAIMSAPTTSQYAAITALKDCDGEIERMRNEYNMRR
RLVVKSFNDMGLSCFEPRGAFYAFPCIKSSGMSSEEFCTKLLEQKHVAIIPGNAFGASGE
GYARVSYAYSVEHLMEAIRRIREFLNENCK
>KF627262.1_19591|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNMIVAADKNWAIGKDNSLLVVIPSDQKTFRSMTLGHPVVMGRKTFESLPGGLPLDLRKN
IVLTTNPEFHPKGVTVVHSLKELFEELGEEKEEAFVIGGQSIYEQLLPYCDVVHVTRIDQ
AYEADTYFPDLDQKPEWVITAESEEQTYFDLE
>KF627259.1_19599|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
QMTKIHQFAIMCAPTNSQYAAVEALRHGDEDVAMMRTAYDQRRRYLLHAFKEMGLSCFEP
FGAFYVFPCIKEFGMSSDEFATRLLEEEHVAVVPGSAFGDCGEGFVRISYAYSLENLKIA
MERLSRFVSHLREWNR
>KF627254.1_19608|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MAKRVTVKKLNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAIL
VDIFCGVENVDWENPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVLELCEKCDI
VFLGLHGANGEDGKVQATCDLLGIRYTGTGYLSSAMAMDKRITKEVFLMNHVPTPGGFTM
TRDNLEKDIAKHGLEFPVVVKTSCGGSSVGVYIVNDQKEYEEALTDACQYGADIVVEEYI
KGREFSVAVVDDKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVK
AAK
>KF627244.1_19638|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MKTFDKSSKLDHVAYDIRGPVLDEANRMIANGEKILRLNTGNPAEFGFTAPDEVIRDLIM
NVRNSEGYSDSKGIFSARKAIMQYCQLKGFPNVDIDDIYIGNGVSEMISMSMQALLDDGD
EVLVPMPDYPLWTACVSLAGGNAVHYVCDEKSNWYPDIDDIKSKITSNTKAIVVINPNNP
TGSLYPKDVLEQIVDIARQNDLIIFADEIYDRLVMDGKKHTAIASLAPDVFCVSMNGLSK
SHRICGFRVGWMVLSGPKKNVKGYIEGLNMLANMRLCANVLSQHVIQTSLGGYQSVDELL
IPGGRIYEQREFITNTVNAIPGLSAVKPDAGLYIFPKIDRNMYDIEDDEEFCLRLLKKEK
VLLVPGKGFNWNEPDHFRIVYLPRVEELADLGNKIERVLSYYKR
>KF627244.1_19639|FEATURES|farme|aminoglycoside|ERS381432_03028|antibiotic inactivation|0
MSQQYERIMVAIDGSYESELAFIKGVHVAKRNNGPRGE
>KF627239.1_19653|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NIASYSLLTMMMAQQAGLKPGEFVWTGGDCHVYDNHVDQFLEQLGRKPYPYPTIEIRKAD
SLFDYQYEDFKVVGYQDHPTIKVPVAV
>KF627236.1_19663|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
KMSKVSIIAAVDRHMAIGFENKLLFWLPNDLKRFKALTTGNTILMGRKTFESLPKGALPN
RRNIVLSSNPDTVCPGAEVFPSLEAALKSCREDEHIYIIGGASIYQQALSLADELCLTEI
NSTASEADAYFPEVSQELWQEKSREAHLADEKHLCSYAFVDYVRK
>KF627235.1_19664|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MTCKLSAIVAVCDDWGIGCEGDMVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLK
NRRNIVLTRDEDFTPEGVDVVHSIGEALAAVADEPVAWVIGGGDVYRQFLPYCVEAEVTH
NHCVHPVDTYFPDLDADPAWEVARREGVATIAAGEGDEGLDYEFVTYRRVEA
>KF627230.1_19676|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLLLRDGQSVTDEDVMEKIGLPCFIKTSLGGSSFGVTKVTAKEQIQP
AIAKAFAEAQEVLVEAFMDGTEITCGCYKTKDKSVVFPITEVVSHNEYFDYEAKYNGASD
EITPARISDDLTRRVQTLTSAIYDILGAYGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAAGMEMKDVMTDIIENKFKD
>KF627207.1_19734|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
LIVAVDKNWAIGLHNKLLVSIPADMKFFRETTMGKVVVMGRKTLESFPGGQPLKRRTNIV
LTSDKNYKVKDAVVVNSVEALLEELRQYNDEDIYVIGGESIYRQLLPYCKVAHITKIDHA
YEADTYFPNLDEMPEWKITGVSEEQTYFNLEYEFVKYERIG
>KF627203.1_19743|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MGRATLESFPGGRPLPGRRNIVLSKTLNRDDVLIVRSVDELMNIAGIDDAFVIGGGQVYS
QLLPYCDTAYITQLEGDFGAEVFMPDISEAGFVKTGSSDLKEENGVRFTFDVYTIKNKSR
>KF627199.1_19754|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDIIVCIDKNNGIGKDGGLLFRIPEDMAYFRRMTVNKTVIMGRKTLESLPGGRPLENRRN
IVLTRNRDRVPDEADAVSSIDELKRAIGSDKAFVIGGESIYAMLLDYCERAYVTEVEACG
NADCFFPDIRSMPAWSLEEQGEERKYGGLKYRFNVYKNHSIKEL
>KF627197.1_19758|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLQRFRGEFLQQFLHSLRRWKNMKIVVLAGGTSTERDVSIVSGTGICQALRQKGHQAILV
DVFCGLEPVDWANPFPAEYDVEKAAEYIKSFNSQMKELKKTRRDFFGPNVIELCKKADFV
FLGLHGANGEDGKLQAAFDLMGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVSTPGGKSMK
KKDRQDSLAALGMEFPVVVKTCCGGSSIGVYIVDDQEAYQKALDAAFEYENEVVVEEFIK
GVEYTVAVVDGTAYPVVQIVPKEGFYDYENKYKPGAVQETCPAPISEELTKRLQEAAVDG
YHALEMESYARLDFIVTEDEKIYCLEANTLPGMTPTSLIPQEAKVLGMDYPTLCEELIRI
SLKKYE
>KF627196.1_19760|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
GRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQ
GKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPE
LTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSI
GLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGA
LDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTG
>KF627190.1_19773|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRKFHPYAVAAAAAGKKIYHLNIGQPDIHTPDALYDAIHNFRTPVLAYAASPGIPELIEA
IRKYYENIGVGLDESDILITTGGSEALQIAANCLLDEGDEVIAPEPFYPNYHTFITTAGG
VIHPLHTKPEEGYFYADRARIEACITPKTKAIMITNPGNPTGTCLTEAQMKMLLDVAVAH
DLYLVADEVYREFTYDGEPLHSFGKFDYGQENLILIDSVSKRFSACGARIGCLISRNREF
MANAL
>KF627184.1_19794|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF627183.1_19797|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MILENMIRKEVKDMPPSGIRKFFDIVNEMEDVISLGVGEPDFVTPWNIREAGIYSLEQGD
THYSSNAGFIELREEIAKYLKRRFDLSYNPSDEMLVTVGGSEGIDIALRALVGPGDEVLI
PEPSFVAYKGCTTFTGAKANVLELKAENDFKLTADELEEAITENTKVVIIPFPNNPTGAI
MTREELAPIVEVLKKKDVIIISDEIYAELTYNKEHVSIASFPEIKDRTLVINGFSKAYAM
TGWRLGYACGNKVLIDAMKKIHQYAIMCSPTTAQFAAIEALKNGDESVSEMVKEYNRRRR
VLVDGFRKLGFECFEPLGAFYVFPCIKSTGLSSEEFCEKLLLKEKILTVPGNAFGECGEG
FIRACYASSMENIYEALRRIERFVKEEL
>KF627179.1_19809|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIAAVDRKRGIGYQNRLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSTQKDLICPDAEVFSSLEEALNSCQPDEHVYIIGGASVYRQALPFADALCLTEVDAE
APQVDAYFPEVAPTVWQEKSRESHPADEKHPCPYAFVDYIRRQN
>KF627174.1_19826|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLQHVLDHGILKEDRTGTGTHSVFGYQMRFDLQNGFPLLTTKKLHLKSIIHELL
WFLKGDTNVKYLQANGVRIWNEWADENGDLGHIYGYQWRSWPDYDGGHIDQIKEAIDTIQ
NNPDSRRIIVSAWNVADLPQMNLPPCHAFFQFYVANGKLSLQLYQRSADIFLGVPFNIAS
YALLLMMVAQVTGLEAGDFVHTLGDAHIYNNHIEQVREQLSREPRALPKMKLNPNVKSIF
DFKYEDFELTDYNPHPHIAGKVAV
>KF627168.1_19844|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTHSVFGYQMRFDLQNGFPLLTTKKLHLKSIIHELL
WFLKGDTNVKYLQANGVRIWNEWADENGDLGHIYGYQWRSWPDYDGGHIDQIKEAIDTIQ
NNPDSRRIIVSAWNVADLPQMNLPPCHAFFQFYVANGKLSLQLYQRSADIFLGVPFNIAS
YALLLMMVAQVTGLEAGDFVHTLGDAHIYNNHIEQVREQLSREPRALPKMKLNPNVKSIF
DFKYEDFELTDYNPHPHIAGKVAV
>KF627166.1_19851|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAANNWNVCQYS
LLLMMIAQACDMEAGELVHVIADCHIYDRHIPLIKELIQRKPYPAPVVKLNPEVKDFYQF
TTDDLIVENYETWPQIKNIPIAV
>KF627165.1_19854|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MSKISIIAAVDRRMGIGYQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNIVLSTNPATNFPGAEVFPSLEAALQSCHEKEHVYIIGGETVYRQAIELADELCLTEID
NEAPQADAFFPAIDPQIWHKKSKEVHLADEKHLCSYSFVDYIKEL
>KF627165.1_19855|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TLGDAHIYLNHLDQVKLQLTREPRPLPQMKINPDVKSIFDFKYEDFELVNYDPHPHIAGK
VSV
>KF627149.1_19898|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TLSMSPSADNIFIDMCKDVIENGTSTEGEKVRPVWEDGTPAYTIKRFGVVNRYDLSKEFP
ALTLRRTALKSCVDEMLWIWQKKSNNIHDLNSHIWDSWADESGSIGKAYGYQMGVKHQYK
EGMMDQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNDKLTL
NAILNQRSQDILAANNWNVCQYAYDDGSGM
>KF627145.1_19910|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIEEFVDGDEITCSVFDNKLFPIIAIKPKSDLFDYTQKYSAGGADEVIVELEENLHKEVE
AMALRTYKALKCEVYSRIDMIVNKEGIPYILEVNTLPGMTAASLFPKSAKGQGYSYSEFL
DLIIETSLKVNRAV
>KF627143.1_19913|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGISTERDVSLCSGRNIYEALKGNGHDVVLVDLFLGLPEEKEPLDHLFTDDRD
WSASVGTIAEDAPDIAHVKALRPNYRSLLGPNVLKLCELSDMVFLALHGENGEDGKIQAL
FDLMGIHYTGTGYTSSALCMDKNITKQMFRGRNVPTPPGITVQKGKPFRLPESVGYPCMV
KTCCGGSSVGVYRVNDASELEKALDEAFTFEDQAIIERCIIGREFSIAVIEGEALPIIEI
APISGFYDYKNKYQPGSTIETCPAKLPEETAVRMQRHAEAACASVGIEGYARVDFMLDDR
TGEDYALEVNTLPGMTPTSLMPQEAQAIGYSFPQLCEWILNVSMKDGGLQRG
>KF627134.1_19937|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRNPLADKVVDIKPSGIRKFFDIVSEMQDAISLGVGEPDFDTPWHIRDEGIYSLERGRTF
YTSNAGLQDLRQEICNTIRRKQGVSYDWQHEVLVTVGGSEAIDIGLRAMCNPGDEVLIPQ
PSYVSYLPCTVMADGKPVVIPLQYENEFKLTVEDLEKYISPRTKVLIMPFPNNPTGSIMT
KEDLEPVAEFVKEH
>KF627130.1_19946|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRIN
IVITSNKEYEVKGAIIVHSIEEALKEVEKYPAEDVYCIGGDSIYKQMLPYCDTAHVTKID
FAYEADAYFPNLDEDPDWEITAESEEQTYFDLEYAFVKYERKDR
>KF627118.1_19977|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MPAYKLPHQIMQFDLEKEFPILTTKFVAFKTSVKEILWIWQKQSNDVRLLQQWNCHVWDE
WMREDGTIGKAYGYQLGKYHQVDTLLETLKKDPQSRRMVVDLWNVKDLPDMALYPCAFLT
MWDVSDDGRLNCMLVQRSGDMGLGVPFNMAQYAALVHMIAQVSGLRVGLFTHVINNAHVY
KNHVDAMKIQLARLPKAYDAPVLKLNPDVHNFYDFKPEDIVLENYKHHEKIAMEVSV
>KF627100.1_20026|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKAILSADRKWGLGYQGRLLVSIPADMKFFRETTMGKVVVMGRKTLESFPGGQPLKRRTN
IILSRDPEWTVRGATVVHSIKELMEVLKPYEDDDIYVAGGGEIYRQLLPYCDTAYVTRID
MTYQADTFFEDLDESPDWEMVEEGDEQTCFDIEFYFTEYRRKNEKAERPR
>KF627093.1_20043|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRIN
IVITSNKEYEVKGAIIVHSIEEALEEIKKYPAEDVYCIGGDSIYAQMLPYCDVAHVTKID
FAYEADSHFPNLDE
>KF627089.1_20056|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYDLYIVEMEGLRWEVQLPDGRKAPVD
RNDFSFMKGAEKVKFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAMTYDKFIC
NQYLKAFGIRISESLLLRQGQTVSDEDVIEKIGLPCFIKPSLGGSSFGVTKVKTREQIQP
AILKAFSEAQEVLVEAFMDGTEITCGCYKTKQKSVVFPITEVVTDNEFFDYDAKYNGQVD
EITPARISDELTRRVQTLTSAIYDILGCSGIIRVDYIITAGDKINLLEVNTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF627083.1_20070|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FYVADGRLSLQLYQRSADIFLGVPFNIASYALLLQMVAQVTGLKAGDFVHTFGDAHIYLN
HLEQVKLQLSREPRPLPQMKINPDVKSIFDFKFEDFELVNYDPHPHIAGVVAV
>KF627073.1_20099|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
VVVEQGVENPKEIEVAVLGNDNPVASCSGLIIPANEFYDYEAKYSNSESKLLIPSGTENE
DFIRSEAVKAYKACDCKGLSRVDFLVSESGDIYLNEINTIPGFTSISMYPKLFAASGIAY
SDLINKLLDLAVEFSAKK
>KF627070.1_20106|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKISIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTIVMGRKTFESLPKGALPNR
RNIVLSSNPDTVCSGAEVFPSLETALKSCREDEHIYIIGGASIYQQALSFADELCLTEID
STAPEADAYFPEVSSKVWQEKSREAHPADEKHLCSYAFVDYVRK
>KF627057.1_20137|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MPTYKLPHQIMQFNLQKEFPILTTKFVAFKTAVKEMLWIYQKQSNVVEDLRQMNVKIWNE
WEGEDGTIGKAYGYQVKKFHQIDNLIEALKNNPQDRRMMLNLWNWEDLPEMSLAPCCFLT
MWDVTDGHLNCMLIQRSGDMPLGVPFNSAQFSVLTHMLAQVTGLKPGLFTHVINNAHIYE
NQIEGMEVQITRANDAYSAPKLWLNPEIKDFYEFTIDDIKLIDYEYHPAIKMEVSV
>KF627051.1_20150|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PLLEVPFNIASYSLLTMMMAQQAGLEPGEFVWTGGDCHVYDNHVDQFLEQLSRDPYPYPT
IEIRKADSLFDYQYEDFTIVGYQHHPTIKAPVAV
>KF627044.1_20170|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWEWDHTITSRNLHRWRPAIAGAG
>KF627034.1_20200|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLCFIGAV
GYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAALAAISF
FGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIAQSPII
IITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAA
TVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLIFTVGI
EISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>KF627031.1_20205|FEATURES|farme|multidrug|mdtG|antibiotic efflux|0
EAHPDLKINRQIVPGPAVGALTKASYDHDVVVVGSRGRGGFTGLLLGSTSQGLLQHAVGP
VYVVPRKYVEAAETRLDTVPSSPAEVKPKALDDIKGVEEVPVAKAEPEVVEAIETKIDPE
RQ
>KF627019.1_20239|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MLAAIWAQDEQGVIGKEGKLPWHLPNDLKFFKEKTIHNTLVLGRATFEGMGCRPLPNRTT
IVLTSNPDYQAEGVLVMHSVEEILAYADKYEGVTVIGGGSVVFKELIPACDVLYRTMIHE
TFEGDTFFPEIDWSVWEKVATVPGVVDEKNLYAHDYETYHRNDK
>KF627015.1_20246|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
NWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNGLPLKNRTNIVLTGNPNY
HVKDAVIVHTTEELLEELKKYDEEEIFVLGGESVYRMMLPYCSKVYVTKIDHAYQADTYF
PNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF627009.1_20257|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|0
EAIPDDGLDRSEIWVIGGAQVFQEALPFASKAFVTKIQTSVDADTYAPDMDALVDAGLWE
VADPGHWKRTQKDDSRIKRYRFVTYRKIG
>KF626994.1_20284|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKIRVAVIFGGKSNEHDVSVVSATHVIKSIPKDKYDVICIGITKKGHWMKYIGDVDDIA
SNKWEQHPDNVPCVLSPDPLHKGFIALGENGEYQNVKVDVIFPVLHGKNGEDGTIQGLFQ
LAEIPFVGCDCISSANCMDKGLTHTVLDANGIKTAKWVGIITSELSHLDKKCDEMESKLG
YPMFVKPANCGSSVGVSKAKNRDELKSATKLAFAHDSKVIVEETIVGMECECAVMGNDEP
FASTVGEVCSANDEFYDFDAKYNDAASKTLIPARMSEESIEEIRKTAVKAYRAMGCSGLS
RVDFFLMKDGTVILNEINTLPGHTPISMYPQLMQYEGMTPAQQEDKLIKLALDKAEVDYE
>KF626993.1_20286|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSSQDL
DISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPQK
AYSNWSTPSEMVRLLKMADEKNLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGVVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEMK
>KF626971.1_20345|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MQFTMAHTEIHVLDLEASLVFYEKALGLVPVREKGPEDGSWKLVFLGDGASGHQLELTWN
EGRTEPYNQGGRDIHLAFAVDDMEAAHELHASMGCIAKENPSMGIYFITDPDGFYIEIIP
AR
>KF626970.1_20347|FEATURES|farme|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|0
MKVREEKLRTIIEWSEKNEDVRVLLLTSSLVNPLALVDEFSDLDIEFVFEDNRR
>KF626969.1_20350|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICKTLLEKGHDAFLLDVFLGLENAPENLEDVFTLPGH
GLEIAKNISETEPDLAAVKASRPDQSDCFFGPNVIELCRLADMTFLGLHGGEGENGKLQA
SFDLLGIRYTGPDSLGCAVAMDKGLTKQIFMEAGVDTPSGVCLYKEDSDCSLESLGLSFP
VVVKPCSGGSSIGVYIVNTEEEYRQALKNSFRYENEVVVETYIKGREFACGVIDGKALPP
IEIIPKNGWFDYANKYQANATEEVCPADISEEIAERMKALTVRAFQALKLNVYSRADFIL
DADGNLYCLEMNTLPGMTSASLLPKEALADGIEYGDLCELIIQKSMEARYSS
>KF626968.1_20355|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVHVI
ADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYDFTPDDVKLEGYETHPQIKNIPI
AV
>KF626965.1_20361|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
KESFILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTKNEIEMRNPSFTFQQLMNV
>KF626955.1_20389|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GFWISQDQTNSLDVLEDKYNVHYWNDWEVEGVPANNGDKRSIGQRYGAVVKKHDIINRLL
AQLEANPWNRRNVISLWDYEAFEETAGLQPCAFQTMFDVRRVGEDVYLDATLTQRSNDML
VAHHINAMQYVALQMMIAKHFGWKVGKFFYFINNLHIYDNQFEQAEELLKRQPSDCQPRL
VLNVPDETNFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF626951.1_20402|FEATURES|farme|trimethoprim|thymidylate_synthase|antibiotic target alteration|0
MSYADQVFRANCLDILQNGVRDDDLTVRPHWEDGTPAHTIKKFGLVNRYDLQKEFPILTL
RRTYLKSAVDELLWIWQKKSNNVHDLSSHIWDAWADETGSIGKAYGYQLGCQAPIQGGHV
RSGRPRAL
>KF626949.1_20405|FEATURES|farme|beta_lactam|CCC_03326|antibiotic target alteration|0
LMISLDVNIQEFAQQSALKVMEEKQAERVSILLMNPQNGEIYACVNVPEFDLNDPFTLTD
DLNMQLNESGITIPSEDHNEQSELAVQTASGKTNTERKQELLNQMWRNPCLNDTYEPGST
FKIITMAAGLEAGVVSPGDRFYCPGYKVVEDRRIHCAKRTGHGSQNFVEGAQNSCNPVFI
EVGLRLGVERYYKYFRQFGLLDKTGTDLPGEAGTIMHQKKNMGEVELATV
>KF626947.1_20409|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
QVTLGRDGIMGRATLESFPGGRPLPGRRNIVLSKTLNRDDVLIVRSVDELMNIAGIDDAF
VIGGGQIYSQLLPYCDTAYITQLEGDFGAEVFMPDISAAGFVKTSSSDLKEENGVRFTFD
VYTIKNECR
>KF626945.1_20412|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
GHIVTFRPDLNGERMEHSAARLEMPVFPKDRFVDAVVQTIKANAAYVPPYGSGATLYVRP
YMFGSDAVIGVKPASEYQFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLN
YAMSLHAIVDAHKNGFDENMYLDSKTRTKVEETGGANFLFVTKDGKVVTPKSDSILPSIT
RRSLIYVAKEYLGLEAEEREVYFDEVKNFAECGLCGTAAVISPVGKIVDHGKEICFPSGM
NEMGPITKKLYETLTGIQMGRIQAPEGWIKVVE
>KF626925.1_20465|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
KGLKPCAYETIWSVTGNKLNMFLNQRSGDLLAASGAGGINEVQYAALLMMVARHTGYEPG
IFTHFVANEQIYDRHVEQAKELLSRVESVKDAGIMPRLILNPDKKDFYNMDIDDFTIVDY
NPVSPQISLELGI
>KF626903.1_20519|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNIIVAVDKNWAIGKDNKLLVSIPADMKMFRQETTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTGNKDY
>KF626900.1_20525|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MLSIIACISKVHRAIGYKNRLLYAIPSDMTRFRMLTTGHTIIMGRKTFESLPNGALPNRR
NIVISKTREQITGCEVYTSLEEALAARKEEVGNKEASDECFIIGGASIYEQALPFADKLY
LTIVEKEPEHADTFFPEINPAEWEVTEKEMRNENGLPFTFLTLYRKQ
>KF626898.1_20531|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GQKSHYAEGDFDQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRP
QDDKPTLNMILNQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRH
VDIVRELTERPQFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF626892.1_20549|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKLIVAVDKNWAIGKNNRLMWSIPADMKFFRETTKGNIVIMGRKTLESFPQSQPLKNRVN
IVISKNPDYKVKDAVVVHSVEEALEEAKKYEGETFVIGGESIYRAMLKYCDTALVTKIDH
AYDADTYFPSLDEDPEWKMTKISEEQTCFDLEYYFTVYERIPLSITGIPPPPTVITIVPL
SANCLTVSNSTILIGCGDATTLLYPLPASSTNVNPFSF
>KF626881.1_20574|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVAVDENWGIGKDNELLCRISADMKNFRAVTMGHVLVLGRKTLESFPGKKPLPKRTH
IVLTANKAYEAEGVILCHSLEELPVVLADYEDDDIFVIGGGSIYEQLLPQCKKAYITKIY
DKFPADTYFPNLDEKPEWTLTEKGEVQEENGVKFSFDIYEQK
>KF626880.1_20577|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAVDKNWAIGCKNKLLVSIPADMKFFRETTTGKVVVMGRKTLESFPNGQPLKKRVN
IVLTHDKNFKAGDAIIVHSMEELREELKKYPSEDIYVIGGETIYKQLLDDCDVAHITKID
YAFEADAYFPNLDEDPEWEITASSDEQTYFDLEYTFVKYERK
>KF626878.1_20584|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AYSMTFNVTGNKLNAILNQRSQDTLAANNWNVVQYSALLMMFAQVSGLEPGELVHVISDM
HIYDRHVPIIKELIERETFPAPKVRLNPEIKNFYDFTVDDFIVEDYEHGKPIGKVPIAI
>KF626871.1_20598|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
ELIKREPLPAPKFWLNPEIKDFYQFTRNDVKLIGYETHEQIKDIPVAV
>KF626862.1_20625|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MPAYKLPHQIMQFDLEKEFPILTTKFVAFKTSVKEILWIWQKQSNDVRLLQQWNCHVWDE
WMREDGTIGKAYGYQLGKYHQVDTLLETLKKDPQSRRMVVDLWNVKDLPDMALYPCAFLT
MWDVSDDGRLNCMLVQRSGDMGLGVPFNMAQYAALVHMIAQVSGLRVGLFTHVINNAHVY
KNHVDAMKTQLARLPKAYDAPVLKLNPDVHDFYDFKPEDIVLENYKHHEKIAMEVSV
>KF626860.1_20631|FEATURES|farme|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|0
MKVREEKLRTIIEWSEKNEDVRVLLLTSSLVNPLALVDEFSDLDIEFVFEDNTNYISDKS
WTLKFGNPIAMIEEDESCFNHKHAMKMLLYEDGVKVDFKLYSKSKFN
>KF626860.1_20634|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
RPRGQSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFIIQG
DIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKGLDF
KDTKSVSELLTNRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLIGDT
AHLMPPFAGQGVDIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTKNE
IEMRNPSFTFQQLMNV
>KF626858.1_20641|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNAIVAVSENWGIGKDNALLFHIRADLQRFKALTTGHTVVMGRRTLESLPGGRGLPGRRN
LVLSTRPDFAAERAEVVRSLDEAVAAAEEDAFVIGGETVYRALLARCERVYVTKVFAAAD
ADAFFPDLDAAPGWAVEESGPVQEENGLRFQYVTYRQVGE
>KF626852.1_20655|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
RRNIVLSRREGAVFAGAECFPALEIALSHCKEEEEIFIIGGASLYKEAMHIAQQLYITFI
DDTSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFINYSRIK
>KF626844.1_20675|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
PAFPGAAYCHDGQRTVPFRCSAVHDIDSLVHAINTASAFSGTTNPSPLFSAPLAPHAGKD
DLTAPQREAWHHVPFALSDDGVLISTAFLDVGHGNIAVIGACGSGKTNLLLCCASRLYES
GRCTIRFTRKTNSEWTTDDGRTSPQHERTIWFVDDADELLSPFAAMPEADKLKTALADPS
VTVIAAVEKPQSTLLERCLTRVAFPCGERATDVMMGIPSAVLDGFGVDDYAIAGRGVFIQ
QARACPVQCAEFQGF
>KF626840.1_20687|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVC
DMKVGEFVHVIADAHIYDRHIPTIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDY
QAGEQIKDIPIAI
>KF626835.1_20702|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MKAILSADRKWGLGYQGRLLVSIPSDLRFFRETTMGHVVVMGRKTLATLPAGQPLKGRTN
IILSRDPEWTVRGATVVHSIKELMEVLKPYEDDDIYVAGGGEIYRQLLPY
>KF626807.1_20771|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSR
>KF626803.1_20782|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVNVVLTTDKNYKVKDTVIVHSVEEMVEE
LKKYNSEDVYVIGGESIYRQLLPYCTKAYVTKIDHAYDADTYFPDLDADPEWEMTKISDE
QTYFDLEYVFVIYERR
>KF626795.1_20800|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLQRFGGEFLQQFLHSLRRWKNMKIVVLAGGTSTERDVSIVSGTGICQALRQKGHQAILV
DVFCGLESVDWANPFPAEYDVEKAAEYIKSFNSQMKELKKTRRDFFGPNVIELCKKADFV
FLGLHGANGEDGKLQAAFDLMGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVSTPGGKSMK
KKDRQDSLAALGMEFPVVVKTCCGGSSIGVYIVDDQEAYQKALDEAFEYENEVVVEEFIK
GVEYTVAVVDGTAYPVVQIVPKEGFYDYENKYKPGAVQETCPAPISEELTKRLQEAAVDG
YHALEMESYARLDFIVTEDEKIYCLEANTLPGMTPTSLIPQEAAVLGMDYPTLCEELIRV
SQKKYE
>KF626793.1_20804|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
SRKKGSSSLNIIVAADKNWAIGENGKLLVSIPSDMKFFRQMTEHKVVVLGRKTLATFPNG
LPLVNRKNIILTRNPEMKVKGATIVHSVEEALEELAGYEDEDIFIIGGGHIYEEFLPYCK
VAHVTKIDHAYQADTFFPNLDETGEWEITADSDEQTYFDLEYAFLKYERKGEAKPRIRK
>KF626789.1_20813|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKIVVLAGGTSTERDVSIVSGTGICGALRQKGHQAILVDVFCGQEEVDWEDPFPAEYDVE
KAAAYIRGFNLQMAELKKTRKNFFGPNVIDLCKKADFVFLGLHGANGEDGKLQGAFDLTG
IPYTGTGYLSSAMAMDKGVTKAMFQMRGVPTPAGKAMKKKDRVETPQELGMDFPVVVKTC
CGGSSIGVYIVDNQEDYTKALDGAFTYENEVVVEEFVEGVEYTVAVVDGKAYPVVQIVPV
QGFYDYENKYKPGAVKETCPAPISEELTKRLQEEAVDGYHALEMESYARLDFIVTKDEKI
YCLEANTLPGMTPTSLIPQEAAVMGMDYPTLCEELIRVSMKKKYE
>KF626780.1_20837|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKLTEIAAIGKNRELGKDNQLIWHFPQDLKFFKEQTKGHTIVMGRKTFESLPGMLPKRHH
IVISKSGAKFPEEVEVFSSIDAFVDAYQTKEEEIFVIGGATIYKQMLNLCHRLILTEINQ
SYDADVFFPEFDKTLYHKQILNDIMENGVHYQHVEYRLKSETTRD
>KF626773.1_20856|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPL
>KF626772.1_20860|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MNKKAPHRISEQHLTVLSWSAPLLAQLIMLIVMCMQRHWLYAAMLAPSLLGSALMLITMI
MRVRHEETNSNTITGSDSPVPTHHNGNEIDHAQLFADMPSISFEHLHGLDNDPLIWRTIV
RNWLVRSPTNGIGMSEHGIFHIDLASSGPHAMVAGTTGSGKSELLISWCMALAIRHSPQT
LHFVFLDFKGGSTFNALERLPHTVGNVCDLDLAHAVRALNAIEQELARREALVSAERVSR
FDQLSHPPARLVVVIDEFHALRDRLPDYMQRLNRLASLGRSLGMHLIVCTQNPMGQVHAD
MKANISLSICLRVTDQMQSNGLIGTKDAALIPPAFPGAAYCHDGQRTVPFRCSAVHDIDS
LVHAINTASAFSGTTNPSPLFSAPLAPHAGKDDLTAPQREAWHHVPFALSDDGVLISTAF
LDVGHGNIAVIGACGSGKTNLLLCCASRLYESGRCTIRFTRKTNSEWTTDDGRTSPQHER
TIWFVDDADELLSPFAAMPEADKLKTALADPSVTVIAAVEKPQSTLLERCLTRVAFPCGE
RATDVMMGIPSAVLDGFGVDDYAIAGRGVFIQQARACPVQCAEFQGF
>KF626770.1_20866|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MAEVAMTEKTQEKTVDERPVVLKVDHVAKMFRLPTEQATGLKMAFLNWTKGIKGYTEQHV
LRDINFEVQQGDFFGIVGRNGSGKSTLLKIISQIYTPEQGSVTVKGKLVPFIELGVGFNP
ELTGRENVYLNGALLGFTRTEIDAMYDDIVEFAELEDFMDQKLKNYSSGMQVRLAFSVAI
KAQGDILVLDEVLAVGDEAFQRKCDDFFTKIKRDPTKTVILVTHSMDAVKRYCNKAILIK
DGNIIASGDKDSVADQYTLENIRSDQKHSRPKKNEHPEGLNDRVPTFRFIPVSPTVANCS
DTFKFDIEYEYNDDDGYIAIAMNDIKRGGIPYDSGQKNLKVQKGHHILHMDMPLALFNNG
EFRLVGSFRTENLEDDKRTDMIAYTNDDNSLLFAVRDKANTRDYALLNDRAMRMHLISYD
D
>KF626756.1_20895|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLKGKKDTVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF626701.1_20996|FEATURES|farme|macrolide-lincosamide-streptogramin|ybjZ|antibiotic efflux|1
MFMTTIECDNLTVRIAGRTIFEHVDLHISEGGMVALTGPSGCGKTTLLHTLGLLQEADGG
RLMIDRENVTHATARRRRRFWHDTASFILQDYGIMDEESVAFNVSMQLGPFGQRAGGDRK
QIREALRATGLAKRTQEPASHLSGGEKQRLGIARAIYKNASVIFADEPTASLDAHNRQIV
IDLLRHRADQGAIVVLATHDPILVSACDQNYQVGNHN
>KF626691.1_21018|FEATURES|farme|chloramphenicol|cmx|antibiotic efflux|0
MALDVGKALKSKTLVVGVLSMSLLMSASNAVSGTIPAMKEAFSDYSAANVELLTTVPTIG
SMVGTALTGLFANAIGRKKIAMAGFLISAVTGVIPAFFPYYWPILISRMFFGFGSALFVT
LSVSYITDLYDGDMQRKLLGWRQAVGNLGDVVLLFVASLLITINWQSTYLIFFLLFVPMV
LVGMFIPKEFDNFSIRSALVDDEGHVVDKSASQKQTTNWQVLWLAFIFLVVSMLYNVMSI
KLASYVVDEGIGSASLATLIFSFLVVATILSGVLFDKVAEVTKRLTVTISEVVIGICFIA
TALTKNVPLMFALVLIAGFAWGII
>KF626679.1_21033|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
SGGQRQRIGIARAMGLKPDFVVADEPVASLDVSVQAQIINLFSDLQERRGTTFMFISHDL
SVVEHLCSRLMIMYLGVIVEVGSREEIFSNPIHPYTKELLDAIPAANPKGRHALRKSDSE
PFAVRRSYAHDIREGQVPELRKVNEHHWAAWS
>KF626674.1_21043|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERFEPIPVGITKDGKWIINGEDPRGWN
LDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVL
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGI
PTAPGVTVDARNFTGADVLAEIEDAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRL
AAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFD
SKYMDASASHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTVMVNEIN
TMPGFTPISMYPKAWDATGVSYTELITRLIEGVLR
>KF626670.1_21050|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MGDLSEGAEMTREELKKLHVAVVSGGWSDEHEIAMESGKQCAAALKEAGFTSVDLLDVAE
KDFVVTLAQGGYDVVYVAMHGRFGEDGCIQGLLEILHIPYTFSGVLASAMGTEKELSKLM
YRQAGVPTPKGIDVAAGTVFTDEQVDKLIEDLGLPMFVKPSGNGSSYGVTRVTSREELPA
ALELAGEQGERILIEESIEGTEITVPVIGNEDPTALPIVEIVTGDEFYSIKTKYEPASLH
HVIPARLEPAVYARAQELAIKAHNALGCRGVSRSDFIVTKDGVPVVLETNTIPGMTARSL
LPDSARTGGIDFPELCTRFIEFALEDRQ
>CAA38525|FEATURES|argannot|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETRNGARLDDKTRRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHKLGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRRVTYEMPMLGSNGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPAHEVAECSCEPSG
>AAL82588|FEATURES|argannot|aminoglycoside|AAC(3)-Ib/AAC(6')-Ib''|antibiotic inactivation|1
MSIIATVKIGPDEISAMRAVLDLFGKEFEDIPTYSDRQPTNEYLANLLHSETFIALAAFD
RGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSHRRLGVATALISHLKRVAVELGAYVIY
VQADYGDDPAVALYTKLGVREDVMHFDIDPLTNSNDSVTLRLMTEHDLAMLYEWVNRSHI
VEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGGGDGWWEE
ETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYE
KAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>ABL71428|FEATURES|argannot|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MSVSIRCLGRSDVSVLRQMNALFGDAFDDPDTYLGEPPDDAYLSGLLAGDHLIALAAMDG
AVVVGGLIAYELEKFERARSEIYIYDLAVAETHRRQGIATALIGTLQRIAAERGAWVVYV
QADYGDEPAIALYTGLGKREDVLHFDIPVDAG
>ABR10839|FEATURES|argannot|aminoglycoside|AAC(6')-32|antibiotic inactivation|1
MSPSKTPVTLRLMTERDLPMLHAWLNRPHIVEWWGGEEERPTLHEVVKHYLPRVLAEEAV
TPYIAMLGDEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQFLSNHTQLNQGLGTKLVQA
LVELLFSDPTVTKIQTDPAPNNHRAIRCYEKAGFVQQNVITTPDGPAVYMVQTRQAFERV
RSAA
>AAA25680|FEATURES|argannot|aminoglycoside|AAC(6')-IIb|antibiotic inactivation|1
MHPGVVTLRPMTEDDIGMLHEWLNRPHIVEWWGGERPSLEEVKEDYRPSALAEEGVTPYI
GLLDGTPFAFAQSYVALGSGGGWWEEETDPGVRGIDQSIADSGLLGRGYGTRLVQALVDL
LFADPQVSKVQTDPSPNNMRAIRCYEKAGFRKVKVVSTPDGPAMYMLHERPLVNGLRSAA
>BAD12078|FEATURES|argannot|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRKATVQDPPLLARLAMNVWKESSLKELVAEFEQMTKSNDAVAFILFIEDQAVGFAQCQ
LRHDYVEGTNTSPVGYLEGIFVEKEFRHRGYASELLLKCEDWVKTKGCLQFASDCELDNI
DSLAFHLKVGFTEANRMICFTKQL
>BAD14386|FEATURES|argannot|aminoglycoside|AAC(6')-Iae|antibiotic inactivation|1
MKYNIVNIKDSEKYITQAAEILFDVFSHINFDSWPSLQKATETVIECISAENICIGILIN
DELCGWVGLREMYKKTWELHPMVIKKKHQNKGFGKILIFETEKKAKERNLEGIVLGTDDE
TFRTTLSMSELNNENIFHEIKNIKNLKNHPFEFYEKCGYSIIGVIPNANGKNKPDILMWK
NIM
>AAA69747.1|FEATURES|argannot|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MSIQHFQTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTL
ADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLL
ANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTP
DGPAVYMVQTRQAFERTRSVA
>AAC41391|FEATURES|argannot|aminoglycoside|AAC(6')-Ih|antibiotic inactivation|1
MNIMPISESQLSDWLALRCLLWPDHEDVHLQEMRQLITQAHRLQLLAYTDTQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIFVLPEYRRSGIATGLVQQVEIWAKQFACTEFASDAALDN
QISHAMHQALGFHETERVVYFKKNIG
>AAB63533|FEATURES|argannot|aminoglycoside|AAC(6')-Ii|antibiotic inactivation|1
MIISEFDRNNPVLKDQLSDLLRLTWPEEYGDSSAEEVEEMMNPERIAVAAVDQDELVGFI
GAIPQYGITGWELHPLVVESSRRKNQIGTRLVNYLEKEVASRGGITIYLGTDDLDHGTTL
SQTDLYVHTFDKVASIQNLREHPYEFYEKLGYKIVGVLPNANGWDKPDIWMAKTIIPRPD
SQ
>CAA91010|FEATURES|argannot|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MLKKSFLDAGNESWGDIKNAIEEVEECIEHPNICLGICLDDKLIGWTGLRPMYDKTWELH
PMVIKTEYQGKGFGKVLLRELETRAKSRGIIGIALGTDDEYQKTSLSMIDINERNIFDEI
GNIKNVNNHPYEFYKKCGYMIVGIIPNANGKRKPDIWMWQILARKNSPTIAST
>AAD03491|FEATURES|argannot|aminoglycoside|AAC(6')-Is|antibiotic inactivation|1
MNIMPISESQLSDWLALRSLLWPDHEDAHLLEMRHVLKQTDTLQLLVYSETQLAIAMLEA
SIRHEYVNGTQTSPVAFLEGIYVLPEYRRSGIATQLVQCVEEWAKQFACTEFASDAALEN
TISHAMHRALGFHETERVVYFKKNIG
>AAL10408|FEATURES|argannot|aminoglycoside|AAC(6')-Ib8|antibiotic inactivation|1
MYSIVTNSTDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLA
QESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTK
LVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQA
FERTRSDA
>ACK43806|FEATURES|argannot|aminoglycoside|aadA17|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>AAA16527.1|FEATURES|argannot|aminoglycoside|aad9|antibiotic inactivation|1
MRRIYLNTYEQINKVKKILRKHLKNNLIGTYMFGSGVESGLKPNSDLDFLVVVSEPLTDQ
SKEILIQKIRPISKKIGDKSNLRYIELTIIIQQEMVPWNHPPKQEFIYGEWLQELYEQGY
IPQKELNSDLTIMLYQAKRKNKRIYGNYDLEELLPDIPFSDVRRAIMDSSEELIDNYQDD
ETNSILTLCRMILTMDTGKIIPKDIAGNAVAESSPLEHRERILLAVRSYLGENIEWTNEN
VNLTINYLNNRLKKL
>AAK62560|FEATURES|argannot|aminoglycoside|aad(6)|antibiotic inactivation|1
MRSEKEMMDLVLSLAEQDERIRIVTLEGSRANINIPKDEFQDYDITYFVSDIEPFISNDD
WLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIK
VLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHF
NQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEA
LFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERR
EQ
>CAA62365|FEATURES|argannot|aminoglycoside|APH(3')-IIb|antibiotic inactivation|1
MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAE
LPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAMPGDTLSALAQRDELEPERLVRL
VAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLL
DRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAA
WAEAFLVEYGGDIDGERLAYFRLLDEFF
>AAG11411|FEATURES|argannot|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYPGCEWVVVEDGASGAGVYRLRGGGRELFVKVAALGAGVGLLGEAERLV
WLAEVGIPVPRVVEGGGDERVAWLVTEAVPGRPASARWPREQRLDVAVALAGLARSLHAL
DWERCPFDRSLAVTVPQAARAVAEGSVDLEDLDEERKGWSGERLLAELERTRPADEDLAV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALVLRELAHEEDPWFGPECSAAF
LREYGRGWDGAVSEEKLAFYRLLDEFF
>CAA24743.1|FEATURES|argannot|aminoglycoside|APH(4)-Ia|antibiotic inactivation|1
MKKPELTATSVEKFLIEKFDSVSDLMQLSEGEESRAFSFDVGGRGYVLRVNSCADGFYKD
RYVYRHFASAALPIPEVLDIGEFSESLTYCISRRAQGVTLQDLPETELPAVLQPVAEAMD
AIAAADLSQTSGFGPFGPQGIGQYTTWRDFICAIADPHVYHWQTVMDDTVSASVAQALDE
LMLWAEDCPEVRHLVHADFGSNNVLTDNGRITAVIDWSEAMFGDSQYEVANIFFWRPWLA
CMEQQTRYFERRHPELAGSPRLRAYMLRIGLDQLYQSLVDGNFDDAAWAQGRCDAIVRSG
AGTVGRTQIARRSAAVWTDGCVEVLADSGNRRPSTRPRAKE
>AAP50754|FEATURES|argannot|aminoglycoside|rmtB|antibiotic target alteration|1
MDKNDVVKKILESKKYENLDSDIVEKVVSISEKKYKLKEVENYSKKKLHQIWGSYYSAYP
NWDKLLKKYNQGQLSIEDLLKIHSSTNERVATLNDFYTYVFGNIKHVSSILDFGCGFNPL
ALYQWNENEKIIYHAYDIDRAEIAFLSSIIGKLKTTIKYRFLNKESDVYKGTYDVVFLLK
MLPVLKQQDVNILDFLQLFHTQNFVISFPIKSLSGKEKGMEENYQLWFESFTKGWIKILD
SKVIGNELVYITSGFQK
>BAU61743|FEATURES|argannot|aminoglycoside|npmA|antibiotic target alteration|1
LLILKGTKTVDLSKDELTEIIGQFDRVHIDLGTGDGRNIYKLAINDQNTFYIGIDPVKEN
LFDISKKIIKKPSKGGLSNVVFVIAAAESLPFELKNIADSISILFPWGTLLEYVIKPNRD
ILSNVADLAKKEAHFEFVTTYSDSYEEAEIKKRGLPLLSKAYFLSEQYKAELSNSGFRID
DVKELDNEYVKQFNSLWAKRLAFGRKRSFFRVSGHVSKH
>BAD12551|FEATURES|argannot|aminoglycoside|rmtA|antibiotic target alteration|1
MSFDDALASILSSKKYRSLCPDTVRRILDQEWGRHKSPKLAVEATRTRLHGICGAYVTPE
SLKAAAAALSVGDVQKALSLHASTKERLAELDCLYDFIFSGGVPHRVLDIACGLNPLALF
IRDITSVWACDIHQGLGDVITPFAHHQGLDFTFALQDVMCTPPTETGDLALVFKLLPLLE
REQAGAAMALLQALATPRIAVSFPTRSLGGRGKGMEANYSAWFEGALPDEFEIEDTKTIG
IELVYMIKRNK
>ADW66527|FEATURES|argannot|aminoglycoside|rmtD|antibiotic target alteration|1
MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDADKAAREALHGVTGAFMTEREY
KRAMELAATRDWEALLGMHASTRERLPVESMDRVFDQLFEAIGTPARILDLACGLNPVYL
AHRLPNAAIAGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEADAALMFKVLPLLERQR
TGAAMEALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENEL
FYVLKRK
>AFJ11385|FEATURES|argannot|aminoglycoside|rmtF|antibiotic target alteration|1
MDERAQAALDALLSAKNLRDVCPETVRRVFMELLPRYRKPKDAEKAARTHLHQITGAFMT
ADAQKKARALLARWNEGDESALAAALSLHASTRERLPGADEWMRRVSPFLGADARVLDLA
CGLNPILLGSMGVTNALGMDIHLGCVRLVNETARARGWHTRARACDLLSEIPAEEADAAL
LMKLLPVLEAQKTGRAAELLASLRAPRLVVTFPTRTLGGRGVGMEKHYADWFERILPDTL
SVRDRFTVSDELVYLVERT
>X57709|FEATURES|argannot|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDGAVFRLSAQGRPVLFVKTDLSGALNEL
QDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAM
RRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD
GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRF
LVLYGIAAPDSQRIAFYRLLDEFF
>AKP24022.1|FEATURES|argannot|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLV
WRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLP
SALLPIWDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMF
SSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLL
DQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY
>AFC91828|FEATURES|argannot|beta_lactam|pbp1a|antibiotic target alteration|0
MNKPTILHLIKYLSISFLSLVIAAIVLGGGVFFYYVSKAPSLSESKLVATTSSKIYDNKN
QLIADLGSERRVNAQANDIPTDLVKAIVSIEDHRFFDHRGIDTIRILGAFLRNLQSNSLQ
GGSTLTQQLIKLTYFSTSTSDQTISRKTQEAWLAIQLEQKATKQEILTYYINKVYMSNGN
YGMQTAAQNYYGKDLNNLSLPQLALLAGMPQAPNQYDPYSHPEAAQDRRNLVLSEMKNQG
YISAEQYEKAVNTPITDGLQSLKSASNYPAYMDNYLKEVINQVEKETGYNLLTTGMDVYT
NVDQEAQKHLWDIYNTDEYVAYPDDELQVASTIVDVSNGKVIAQLGARHQSSNVSFGINQ
AVETNRDWGSTMKPITDYAPALEYGVYDSTATIVHDEPYNYPGTNTPVYNWDRGYFGNIT
LQYALQQSRNVPAVETLNKVGLNRAKTFLNGLGIDYPSIHYSNAISSNTTESDKKYGASS
EKMAAAYAAFANGGTYYKPMYIHKVVFSDGSEKEFSNVGTRAMKETTAYMMTDMMKTVLS
YGTGRNAYLAWLPQAGKTGTSNYTDEEIENHIKTSQFVAPDELFAGYTRKYSMAVWTGYS
NRLTPLVGNGLTVAAKVYRSMMTYLSEGSNPEDWNIPEGLYRNGEFVFKNGARSTWTQPA
PQQPPSTESSSSSSDSSTSQSSSTTPSTNNSTTTDPNNNTQQSNTTPDQQNQNPQPAQP
>AFG41385|FEATURES|argannot|beta_lactam|mrdA|antibiotic target replacement|1
MKLQNSFRDYTAESALFVRRALVAFLGILLLTGVLIANLYNLQIVRFTDYQTRSNENRIK
LVPIAPSRGIIYDRNGIPLALNRTIYQIEMMPEKVDNVQQTLDALRSVVDLTDDDIAAFR
KERARSHRFTSIPVKTNLTEVQVARFAVNQYRFPGVEVKGYKRRYYPYGSALTHVIGYVS
KINDKDVERLNNDGKLANYAATHDIGKLGIERYYEDVLHGQTGYEEVEVNNRGRVIRQLK
EVPPQAGHDIYLTLDLKLQQYIETLLAGSRAAVVVTDPRTGGVLALVSTPSYDPNLFVDG
ISSKDYSALLNDPNTPLVNRATQGVYPPASTVKPYVAVSALSAGVITRNTTLFDPGWWQL
PGSEKRYRDWKKWGHGRLNVTRSLEESADTFFYQVAYDMGIDRLSEWMGKFGYGHYTGID
LAEERSGNMPTREWKQKRFKKPWYQGDTIPVGIGQGYWTATPIQMSKALMILINDGIVKV
PHLLMSTAEDGKQVPWVQPHEPPVGDIHSGYWELAKDGMYGVANRPNGTAHKYFASAPYK
IAAKSGTAQVFGLKANETYNAHKIAERLRDHKLMTAFAPYNNPQVAVAMILENGGAGPAV
GTLMRQILDHIMLGDNNTDLPAENPAVAAAEDH
>AFQ67211|FEATURES|argannot|beta_lactam|ampC|antibiotic inactivation|1
LKRSLLIFAALCAASWTSVQAAQPTVDPVFASDVVDRYANHIYYGSGATGMALVVIDGNQ
RVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLNDPLSKYAPPGA
RVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLSTATLKAAPGSQ
AAYSNLAFDLLADALATAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQRLMIPEKGAS
PCNNTLAAIGSGGVYSTPGDMMRWMQQFLSSDFYTRSQQADRMQTLIYQRNQLTRVIGMD
VPGRADALGLGWVYMKPKNGHPGIIQKTGGGGGFITYMAMNPQANVGAFVVVTRSPLTRF
NNMSDGINDLVSELSGAQPNMQTASQ
>AAC45086|FEATURES|argannot|beta_lactam|ACT-1|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVKDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>CAJ28994|FEATURES|argannot|beta_lactam|ACT-2|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>AEI70575|FEATURES|argannot|beta_lactam|ACT-9|antibiotic inactivation|1
MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVTANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNTSLLRFYQHWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMNFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAIHVSPGMLDAEA
YGVKTNIQDMASWLKANMNPDALSDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLLVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSAL
>AKS43590|FEATURES|argannot|beta_lactam|ACT-38|antibiotic inactivation|1
MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANNPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WLGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITMRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMANWVMVNMKPDSLQDSSLKEGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AAC09015|FEATURES|argannot|beta_lactam|AER-1|antibiotic inactivation|1
MYVLSVEKPTLRNKFAAGIGVVLVCVVASFIPTPVFALDTTKLIQAVQSEESALHARVGM
TVFDSNTGTTWNYRGDERFPLNSTHKTFSCAALLAKVDGKSLSLGQSVSISKEMLVTYSP
ITEKSLSPETVTFGKICQAAVSYSDNTAANVVFDAIGGATGFNAYMRSIGDEETQLDRKE
PELNEGTPGDVRDTTTPNAMVNSLRKILLGDALSASSRSQLTQWMLDDQVAGALLRASLP
SDWKIADKTGAGGYGSRSIVAVIWPPSKQPLVVGIYITQTKASMQASNQAIARIGVVLKD
TVAP
>CAJ19601|FEATURES|argannot|beta_lactam|OKP-A-4|antibiotic inactivation|1
MRYVRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAJ19602|FEATURES|argannot|beta_lactam|OKP-A-5|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDERLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAJ19608|FEATURES|argannot|beta_lactam|OKP-A-10|antibiotic inactivation|1
MRCVRLCLIPLIAALPLAVFASPPPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVMIYLRDTPATMAERNQQIAKIGAALIEHWQR
>ACL68095|FEATURES|argannot|beta_lactam|OKP-A-14|antibiotic inactivation|1
MRYIRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATIAERNQQIARIGAALIEHWQR
>ACN65418|FEATURES|argannot|beta_lactam|OKP-A-16|antibiotic inactivation|1
MRYVRLCLISLIAALPLVAFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAG25813|FEATURES|argannot|beta_lactam|OKP-B-1|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRMLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AAS13468|FEATURES|argannot|beta_lactam|OKP-B-5|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>CAJ19618|FEATURES|argannot|beta_lactam|OKP-B-9|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYIEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRRLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMVERNQQIAGIGAALIEHWQR
>AAV80715|FEATURES|argannot|beta_lactam|OKP-B-13|antibiotic inactivation|1
MRYIRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAVIGAALIEHWQR
>CAP12357|FEATURES|argannot|beta_lactam|OKP-B-17|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>CAP12358|FEATURES|argannot|beta_lactam|OKP-B-18|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AFD53816|FEATURES|argannot|beta_lactam|NDM-1|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AGU91756|FEATURES|argannot|beta_lactam|NDM-9|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQKGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AAO84036|FEATURES|argannot|beta_lactam|ampC|antibiotic inactivation|1
MTKSVSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>ACS44784|FEATURES|argannot|beta_lactam|MOX-6|antibiotic inactivation|1
MQQRQSILWGVLPTLMWAGLAHAGDRAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFAPWL
KGSVFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIG
LFGYLAASSMKQPFDRLMEQTILPGLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGM
LADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYP
VSEQTLLAGNSAAMIYNANPAAPAPAARGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVML
ANRNSPIEGTLKAGHAILTQLAR
>ADM26831|FEATURES|argannot|beta_lactam|TLA-1|antibiotic inactivation|1
MKKHLVVIAFCVLFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAVLGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLDKLDKENISIDKKLFVKKSELLPNTWSPLRDKYPDGNVDLS
ISEILKATVSRSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTPDATVQLLKKFYKNEILSKNSYDYLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLVKDG
K
>ABW05394|FEATURES|argannot|beta_lactam|ampC|antibiotic inactivation|1
MKQRIALSLLALGPLLLVPRVYAAADEPMANIVEKAVQPLLEEYRIPGMAVAVLKEGKPH
YFNYGVANRESGRRISERTLFEIGSVSKTFTATLGTYAVVKGGFRLDDKVSQHAPWLQNS
AFDRVTMAQLATYSAGGLPLQFPDAVDSNERMRQYYRQWSPLYAAGTHREYSNPSIGLFG
HLAASTLGQPFRQLMSQTLLPKLDLQHTYLEVPDAAMVDYAYGYSKEDKPVRVNPGVLAD
EAYGIKTSAADLIKFVGANMTGSGDKAVQQALAMTRTGFYSVGEMTQGLGWESYAYPVTE
QALLAGNSPAVSFKANPVKPFVAPRVMGNERLYNKTGSTNGFGAYVVFVPARGVGIVMLA
NRNYPIEARVKAAYAIMRHLAP
>BAA23130|FEATURES|argannot|beta_lactam|SRT-1|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIVMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAKSYGIK
SNARDLIRYLDANLQQVKVAHAWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>ADO51656|FEATURES|argannot|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MMKNTLRKTVLMAAAVVPMLAFSAVSWAQTATKMTSVQQQLTALEKESGGRLGVMLINTE
DNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLTRSDLVNYNPITEKHL
DTGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAI
PGDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKSRRDVLASAAKIVTPGY
>ADW20349|FEATURES|argannot|beta_lactam|LRA-1|antibiotic inactivation|1
MFLYFTQIRAWPLAALLLFMLAACAGAPRAPDDATDTASDALAALELRNGGRLGVFALDA
GSGRSLGWREDERFGMCSTFKLLLAATVLDAARQGRLDGTAPIHFSDDDLVPHSPVLREH
LALGSSTLTAPELARATQLTSDNAAANLLIRKLGGPEAVTALWRASGDEVSRLDRLEPDM
NLLPPGDLRDSTSPRAMAQHVARLFTSEMLVPEDRERLREWMVETGTGLARLRAATPPHW
QAGDKTGSAIAPLMPNKTHDVAVFWPPGRAPVIVAAYYESDAHHAGRIRAQDEAVLAQVG
RIAVAWAGD
>ACN22483|FEATURES|argannot|beta_lactam|PER-5|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKGQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>AFE02728.1|FEATURES|argannot|beta_lactam|PER-7|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELK
KLSALSPN
>AEN02506|FEATURES|argannot|beta_lactam|KPC-3|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>ACM91559|FEATURES|argannot|beta_lactam|KPC-9|antibiotic inactivation|1
RLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERF
PLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAA
VQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAV
TESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGAYGTAND
YAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLG
>AGJ01154|FEATURES|argannot|beta_lactam|KPC-17|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQLVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>BAF91108|FEATURES|argannot|beta_lactam|KHM-1|antibiotic inactivation|1
MKIALVISFGLLLFTNMVCADDSLPELDIQKIEDGVYLYTAYEKIEGWGLVGSNGLVVLD
NKNAYLIDTPISATDTEKLVKWIDAQGFTAKASISTHFHTDSTGGIAFLNSKSIPTYASK
LTNQLLKNKGEEQATHSFGKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFV
KPEGLGNLSHAVIAEWPASAEKLIARYSNATMVVPGHGKVGDASLLEKTRQRAVEALAAK
K
>CAP72547|FEATURES|argannot|beta_lactam|CARB-10|antibiotic inactivation|1
MTRSALLIPLTTAAIALNAISPVYASDTHSIDDTVKQVETTLGAKVGIAVLDTGSQRAWF
HRADDRFPMASTSKALTCAALLDKGQSFMNKEALIKKADLDEYAPVTSGIVGKKVSAADL
CSITMRTSDNTAVNKVLEILGGPQAVTAYLRKTGDNITRLDRNEPDLNEGTPGDVRDTTT
PRAILETLNKLVLGPTLGSDERKQLTTWLESNEVGDPLLRAGVPSDWRVADRTGAGGNGT
RGVIAVMWPPKHAPIIAAIYITQTKATMEERNAAIASIGKAIAAEVLE
>ABO21414|FEATURES|argannot|beta_lactam|IND-2|antibiotic inactivation|1
MKKSIQLLMMSMFFSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKTKYAQATLVIPGHDEWKGGGHVQHTLDLLDKNK
KPE
>ADK25051|FEATURES|argannot|beta_lactam|IND-12|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKTKYAQATLVIPGHDEWKGGGHVQHSLDLLDKNK
KPE
>ADK38716|FEATURES|argannot|beta_lactam|IND-14|antibiotic inactivation|1
MKKRIQFFMVSMMLSPLFSAQVKDFVIEPPIKKNLHIYKTFGVFGGKEYSANSVYLVTQK
GVVLFDVPWEKVQYQSLMDTIQKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATAK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSKAATDLGYIKEANVEQWPKTINKLKSKYSKASLVIPGHDEWKGGGHIEHTLELLNKK
>BAL45798|FEATURES|argannot|beta_lactam|IMP-6|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>AAT48071|FEATURES|argannot|beta_lactam|IMP-7|antibiotic inactivation|1
MKKLSVFFMFLFCSIAASGEALPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGHTPDNVVVWLPEHRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLVSKYGKAKLVVPSHSEVGDASLLKRTLEQAVKGLNESKK
LSKPSN
>ADI49236|FEATURES|argannot|beta_lactam|IMP-9|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNT
DAYLIDTPFTAKDTENLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKYSFSGVSYWLVKKKIEVFYPGPGHAPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLMSKYSKAKLVVPSHSDIGDSSLLKLTWEQTVKGFNESKK
STTAH
>BAB72072|FEATURES|argannot|beta_lactam|IMP-11|antibiotic inactivation|1
MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKP
YGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKK
SNTVH
>AAT49070|FEATURES|argannot|beta_lactam|IMP-15|antibiotic inactivation|1
MNKLSVFFMFMFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGGSYWLVNNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSETGNASLLKLTWEQAVKGLKESKK
PSLPSN
>BAD89802|FEATURES|argannot|beta_lactam|IMP-21|antibiotic inactivation|1
MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVASKHGLVVLVNT
DAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKP
YGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKK
SNTVH
>ABY60377|FEATURES|argannot|beta_lactam|IMP-45|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNT
DAYLIDTPFTAKDTENLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKYSFSGVSYWLVKKKIEVFYPGPGHAPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLMSKYSKAKLVVPGHSDIGDSSLLKLTWEQTVKGFNESKK
STTAH
>ADT63777|FEATURES|argannot|beta_lactam|IMP-29|antibiotic inactivation|1
MSKLFVFLIFLFCSITAAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKGGKVQAKNSFSGVSYWLVKKKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLDDANVEAWPHSAEILMSRYGNAKLVVPSHSDIGNASLLKLTWEQAVKGLKESKK
PSQPSN
>AFO59566|FEATURES|argannot|beta_lactam|IMP-35|antibiotic inactivation|1
MKKIFVLFVFLFCSITAAGESLPDIKIEKLDEDVYVHTSFEEDNGWGVITKHGLVVLVNT
DAYIIDTPFTAKDTEKLVRWFVGRGYKIKGSISSHFHSDSAGGIEWLNSQSIPTYASKLT
NELLKKNGNAQAENSFSGVSYWLVKHKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFIKP
DGLGYLGDANLEAWPKSAETLMSKYGNAKLVVSSHSEIGGASLLKRTWEQAVKGLKESKK
PSQPNN
>BAM98935|FEATURES|argannot|beta_lactam|IMP-43|antibiotic inactivation|1
MKKLSVFFMFLFCSIAASGEALPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGHTPDNVVVWLPEHRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLVSKYGKAKLVVPSHSEVGDASLLKRTLEQAVKGLNESKK
LSKPSN
>BAM98942|FEATURES|argannot|beta_lactam|IMP-44|antibiotic inactivation|1
MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVVLVNT
DAYLIDTPSTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKP
YGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKK
SNTVH
>AIS19858|FEATURES|argannot|beta_lactam|IMI-7|antibiotic inactivation|1
MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKDLEKDFNGRIGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>AAL26996|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRAVLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP
>CAD60968|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFVIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLAGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTSPPLISANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETTAEIGKQLFAGQP
>AAF89152|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPNEWNQAYEPFRIAGNLYYLGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
QKLGFNYKDIKILLLTQAHYDHTGALQDFKTETAAKFYADKADVDVLRTGGKSDYEMGKY
GVTFKPVTPDKTLKDQDKIKLGNITLTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMP
SVIVDKKFSEVTAYPNIQSDYAYTFGVMKKLDFDIWVASHASQFDLHEKRKEGDPYNPQL
FMDKQSYFQNLN
>AAF89148|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
QKLGFNYKDIKILLLTQAHYDHTGALQDLKTETAAKFYADKADADVLRTGGNSDYEMGKY
GVTFKPVTPDKTLKDQDKIKLGNITLTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMP
SVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDLWVASHASQFDLHEKRKEGDPYNPQL
FMDKQSYFQNLN
>AAF89153|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESFPIIKGNI
QKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKFYADKADADVLRTGGKSDYELGKY
GVTFKPVTPDKTLKDQDKITLGNTTLTLLHHPGHTKGSCSFIFETKDENRKYKILIANMP
SIIVDKKFSEVTAYPGIQSDYAYTFKAMKNLDFDIWVASHASQFDLHTKRKEGDSYNPQL
FMDKENYFKRLE
>ADC91899.1|FEATURES|argannot|beta_lactam|GES-14|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AEK78851|FEATURES|argannot|beta_lactam|FOX-9|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYASGEAPLTVTVDGIIQPMLKAYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPEEVDSNDKMRTYYRSWSPVYPAGTHRQYANTSIGLFG
YLAANSLGQSFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEEKPIRVTPGMLAA
EAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYDYPVTE
QVLLADNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAB61635|FEATURES|argannot|beta_lactam|fonA-1|antibiotic inactivation|1
MIKNTLRKTTLMVATVMPLLFGSAPLWAQTANAKANIQQQLSELEKSSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDERDTSSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWIVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>ADQ00385|FEATURES|argannot|beta_lactam|DHA-7|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGSGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>ALE30770|FEATURES|argannot|beta_lactam|bla(IMI-8)|antibiotic inactivation|1
MFFFKKGASTFIFLLCLPLNSFASQVINSVEEMRELETSFGGRIGVYILNPKNGKEFAYR
QDERFPLCSSFKAFLAASVLKRTQEKSVSLDDMVEYSGRVMEKHSPVSEKYRKTGASVQT
LAKAAIQYSDNGASNLLMERYIGGPEGLTAFMRSTGDTDFRLDRWELELNTAIPGDERDT
STPKAVAMSLKNIAFGSVLDAKNKSLLQEWLKGNTTGNARIRAAVPDKWVVGDKTGTCGF
YGTANDVAILWTDANSPAVMAVYTTRPNQNDKHDEAVIKNAAKIAIKAVYGSYK
>CAA90890|FEATURES|argannot|beta_lactam|BL2c_pse3|antibiotic inactivation|1
MMQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWE
NKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKE
SDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGA
DMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVAD
NLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLDFKNQKD
EIMAQIGKEIYPFL
>BAL40892|FEATURES|argannot|beta_lactam|TLA-3|antibiotic inactivation|1
MKKITFLLLMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDKKLPL
LSVFKFHLACAVLDMADKGKFSTDQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIIT
YTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTN
ATVSLLKKFYDGKLLTKKSTDFLMQIMLGTTTGTNKIVEQLPKSTPVAHKTGSSGKPDNI
LTVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK
>BAL40894|FEATURES|argannot|beta_lactam|TLA-3|antibiotic inactivation|1
MKKITFLLLMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDEKLPL
LSVFKFHLACAVLDMADKGKFSTYQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIIT
YTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTN
ATVSLLKKFYDGKLLTKKSTDFLMQIMLATTTGTNKIVEQLPKGTPVAHKTGSSGKPDNI
LTVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK
>AAR06587|FEATURES|argannot|beta_lactam|SME-2|antibiotic inactivation|1
MSRTGRLSVFFSAIFPLLTLTNMAEAASQPPQVTVDKLKRLENDFGGRIGVYAIDTGSNK
TFGYRANERFPLCSSFKGFLAAAVLSKSQQQEGLLNQRIRYDNRVMEPHSPVTEKQITTG
MTVAELSAATLQYSDNGAANLLLEKLIGGPEGMTSFMRSIGDNVFRLDRWELELNSAIPG
DDRDTSTPKAVAESMQKLAFGNVLGLTERHQLMDWFKGNTTGGARIRASVPANWVVGDKT
GTCGVYGTANDYAVIWPVGHAPIVLAVYTSKPDKNSKHSDAVIADASRIVLESFNIDALR
MATGKSIGF
>AAF23817|FEATURES|argannot|beta_lactam|vhh-1|antibiotic inactivation|1
MKKLFLLLGLLACSSATYAANLMKTSPRLKKHISGRIGVSVWDTQTDEHWDYRGDERFPM
MSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMASQTTRIEHACEAAML
MSDNTAANIVLRSIGGPRGVTTFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAM
IWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEYNTI
>BAA23131|FEATURES|argannot|beta_lactam|classC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFTQAMEQGMLPALGMRHTYVQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAHAWREALTATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYRIVQALDKR
>CAA79967|FEATURES|argannot|beta_lactam|NmcA|antibiotic inactivation|1
MSLNVKQSRIAILFSSCLISISFFSQANTKGIDEIKNLETDFNGRIGVYALDTGSGKSFS
YRANERFPLCSSFKGFLAAAVLKGSQDNRLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDEDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILSEHEKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>ABS29619|FEATURES|argannot|beta_lactam|CGB-1|antibiotic inactivation|1
MKKSIPFFIISMLLSPLANAQDTQVRDFVIEPQIQPNFYIYKTFGVFGGKEYSTNAVYLV
TKKGVVLFDVPWQKTQYQSLMDTIQKRHHLPVIAVFATHSHEDRAGDLSFYNKKGIKTYA
TAKTNEILKKEGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYKILDGG
CLVKSKAAADLGYTGEANVAQWPKTMEKLKSKYAQATLIIPGHDEWKGGGHVEHTLDLLN
KK
>AAA22904|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTEMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQRKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVN
QYIESTSKP
>AAO83986|FEATURES|argannot|beta_lactam|bcl1|antibiotic inactivation|1
MKRSFFMLKTKITSSILVGACLLIGCSNGNEQPVSNEPEPEESVETGEAVFKALEEEYAA
RLGVFALDTGTGQTVSYRSDERFTYASAHKPLAVAVLLQQKSIEELEQLITYSADDLVNY
NPITENHVETGMTLRELSDASIRYSDNTAANFIFDEIGGPEGFKEGLRAIGDTVTEPERI
EPELNHVEPGEIQDTSTPEALAKSLQEFALGEALPADKQELLIDWLIGNTTGDALIRAGV
PEGWEVGDKTGAGSYGTRNDIAILWPPEKEPIILAVLSSKDEKDAEYDDELIAKATEEVI
NLLAQTE
>ADB27941|FEATURES|argannot|beta_lactam|BEL-1|antibiotic inactivation|1
MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAM
CSTFKLPLAALVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSAL
QLSDNAAANLLLKEVGGPPLLTKYFRSLGDKVSRLDRIEPTLNTNTPGDERDTTTPMSMA
QTVSKLIFGDTLTYKSKGQLRRLLIGNQTGDKTIRAGLPDSWVTGDKTGSCANGGRNDVA
FFITTAGKKYVLSVYTNAPELQGEERALLIASVAKLARQYVVH
>AAG44836|FEATURES|argannot|beta_lactam|penP|antibiotic inactivation|1
VTFSALPFRRADRRRLLAAALAACALTLTAACDSGTVTVPVTDSVTTSAVADPRFAELET
TSGARLGVFAVDTGSGRTVAHRADERFPMASTFKGLACGALLREHPLSTGYFDQVIHYSA
AELVEYSPVTETRVETGMTVRELCDAAITVSDNTAGNQLLKLLGGPEGFTASLRSLGDAT
SRLDRWETDLNTAIPGDERDTTTPAALAADYRALVVGDVLGAPERDQLKAWLVANTTGAT
RIRAGLPADWTVGDKTGSPAYGSALDVAVAWPPGRAPIVIAVLSTKSEQDAEPDNALLAE
ATRVVVDALG
>AAL57765|FEATURES|argannot|beta_lactam|BL2e_fpm|antibiotic inactivation|1
MFKKTFRQTAAIAVSLISLLASATLWANTNNTIEAQLSELEKYNQGRLGVALINTEDNSQ
ITYRGEERFAMASTSKVMAVAAVLKESEKQAGLLDKNIAIKKSDLVAYSPITEKHLVTGM
SLAQLSAATLQYSDNTAMNKILDYLGGPSSVTQFARSINDVTYRLDRKEPELNTAIHGDP
RDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGNTTGDHSIKAGLPKHWIVGDKTGS
GDYGTTNDIAVIWPENHAPLILVVYFTQQEKDAKYRKDIIAKATEIVTKEFANSPQTK
>AAP69913|FEATURES|argannot|beta_lactam|cphA5|antibiotic inactivation|1
MMKGWIKCGLAGAVVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTIVGATWTPDTARELHKLIKRVNNKPVLEVINTNYHTGQAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFNLQEGKVRAFYAGPAHTPDGIF
VYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPEL
IDHYQALIKAATHS
>AAP69914|FEATURES|argannot|beta_lactam|cphA6|antibiotic inactivation|1
MMKSWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAAHS
>CAA71322|FEATURES|argannot|beta_lactam|TEM-47|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>CAA73933|FEATURES|argannot|beta_lactam|TEM-52|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD45935|FEATURES|argannot|beta_lactam|TEM-59|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMGDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAE
>CAB92324|FEATURES|argannot|beta_lactam|TEM-68|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDELNRQIAEIGASLIKHW
>AAL03985|FEATURES|argannot|beta_lactam|TEM-71|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAN05028|FEATURES|argannot|beta_lactam|TEM-75|antibiotic inactivation|1
FFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYMTGSQATMDERNR
>AAF05614|FEATURES|argannot|beta_lactam|TEM-73|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAL29433|FEATURES|argannot|beta_lactam|TEM-81|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAVTMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAC43230|FEATURES|argannot|beta_lactam|TEM-86|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>CAC85660|FEATURES|argannot|beta_lactam|TEM-93|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAC85661|FEATURES|argannot|beta_lactam|TEM-94|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>AAK33121|FEATURES|argannot|beta_lactam|TEM-85|antibiotic inactivation|1
MDPQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAE
>AAM61953|FEATURES|argannot|beta_lactam|TEM-105|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CNAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAN05027|FEATURES|argannot|beta_lactam|TEM-110|antibiotic inactivation|1
FFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYMTGSQATMDERNR
>AAL77062|FEATURES|argannot|beta_lactam|TEM-111|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGADERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>AAN05026|FEATURES|argannot|beta_lactam|BL2b_tem1|antibiotic inactivation|1
FFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYTTGSQA
>AAO85882|FEATURES|argannot|beta_lactam|TEM-120|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAQ75087|FEATURES|argannot|beta_lactam|TEM-121|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAR21068|FEATURES|argannot|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAIATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAW47922|FEATURES|argannot|beta_lactam|TEM-138|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPIDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABI74448|FEATURES|argannot|beta_lactam|TEM-151|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGGSLIKHW
>ABG77582|FEATURES|argannot|beta_lactam|TEM-155|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACP18864|FEATURES|argannot|beta_lactam|TEM-169|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRGEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADA79631|FEATURES|argannot|beta_lactam|TEM-171|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CBJ06718|FEATURES|argannot|beta_lactam|TEM-177|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AEL79515|FEATURES|argannot|beta_lactam|TEM-189|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AFC75524|FEATURES|argannot|beta_lactam|TEM-194|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSRNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANILLTTIGGPKELTAFLHNMRDHVTRLDRWEPELNEAIPHDERDTTM
PAPVATTLRTLLTVELLTLASRPRLIDWMEADKVAGPILRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BAL68178|FEATURES|argannot|beta_lactam|TEM-198|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQAIMDERNRQIAEIGASLIKHW
>AHA58207|FEATURES|argannot|beta_lactam|TEM-213|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEFSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AJO16044|FEATURES|argannot|beta_lactam|TEM-214|antibiotic inactivation|1
MSIQHFRVALFPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AJO16045|FEATURES|argannot|beta_lactam|TEM-215|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CDN33426|FEATURES|argannot|beta_lactam|TEM-217|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVMYTTGSQATMDERNRQIAEIGASLIKHW
>AIW68620|FEATURES|argannot|beta_lactam|SHV-186|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PATMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAB36900|FEATURES|argannot|beta_lactam|CMY-7|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAM90334|FEATURES|argannot|beta_lactam|CMY-10|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGAGVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAPLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLRFVKANIGGVDDKALQQAISLTHQGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIEARIKAAHAILAQLAG
>CAD88477|FEATURES|argannot|beta_lactam|CMY-15|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKNYPNPVRVEAAWRILEKLQ
>AAU95778|FEATURES|argannot|beta_lactam|CMY-18|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGNGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVM
LANKSYPNPVRVEAAWRILEKLQ
>AAX58682|FEATURES|argannot|beta_lactam|CMY-20|antibiotic inactivation|1
MKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYF
TWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQW
QGISLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGAL
AVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAY
GVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKAD
SIINGSDNKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLAN
KSYPNPVRVEAAWRILEKLQ
>AAZ66866|FEATURES|argannot|beta_lactam|CMY-21|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGKLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABB72431|FEATURES|argannot|beta_lactam|CMY-22|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAYWRILEKLQ
>ABN69070|FEATURES|argannot|beta_lactam|CMY-24|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVYVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACA30420|FEATURES|argannot|beta_lactam|CMY-25|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>BAF56185|FEATURES|argannot|beta_lactam|CMY-26|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKTYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQDISLLHLATYTAGGLPLQIPDDVTDKTALLHFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSNVTDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACA97847|FEATURES|argannot|beta_lactam|CMY-33|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANK
SYPNPVRVEAAWRILEKLQ
>ABY58049|FEATURES|argannot|beta_lactam|CMY-2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDCIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPENEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>BAF95726|FEATURES|argannot|beta_lactam|CMY-39|antibiotic inactivation|1
MMKKSLCCALLLTAPLSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWIKVPQSEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADH82410|FEATURES|argannot|beta_lactam|CMY-47|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>ADT91162|FEATURES|argannot|beta_lactam|CMY-56|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKT
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AEM97673|FEATURES|argannot|beta_lactam|CMY-61|antibiotic inactivation|1
MMNRYAAALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYF
TWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQW
QGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGAL
AVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAY
GVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKAD
SIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLAN
KSYPNPVRVEAAWRILEKLQ
>AEZ49852|FEATURES|argannot|beta_lactam|CMY-65|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AFK08538|FEATURES|argannot|beta_lactam|CMY-71|antibiotic inactivation|1
MMKKSLCCALLLTAPFSTFAAAKTEQQIADTVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKKLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73449|FEATURES|argannot|beta_lactam|CMY-80|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEPQIADIVNRTITPLMQEQAIPGMAVAVIYQGKSYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWIKVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73452|FEATURES|argannot|beta_lactam|CMY-81|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIVNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDYVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AFU25638|FEATURES|argannot|beta_lactam|CMY-83|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVNPSGMSYEEAMTKRVLRPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AGC54799|FEATURES|argannot|beta_lactam|CMY-95|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHASPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVASAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AGR82311|FEATURES|argannot|beta_lactam|CMY-104|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNHTITPLMQKQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPSTKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVDAAWRILEKLQ
>AHL39330|FEATURES|argannot|beta_lactam|CMY-105|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AIT76098|FEATURES|argannot|beta_lactam|CMY-119|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWIQVNMDASRVQEKMLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAAEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAA87176|FEATURES|argannot|beta_lactam|SHV-7|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACO07068|FEATURES|argannot|beta_lactam|SHV-27|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAK69828|FEATURES|argannot|beta_lactam|SHV-32|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AVITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAN04884|FEATURES|argannot|beta_lactam|SHV-42|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHSSPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAV66328|FEATURES|argannot|beta_lactam|SHV-59|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSVANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTLASMAERNQQIAGIGAALIEHWQR
>ABY56290|FEATURES|argannot|beta_lactam|SHV-63|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGENVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTNQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA06589|FEATURES|argannot|beta_lactam|SHV-67|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWCADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47129|FEATURES|argannot|beta_lactam|SHV-74|antibiotic inactivation|1
MRYIRLCIISLLATLPLTVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47134|FEATURES|argannot|beta_lactam|SHV-79|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEVLPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABC58727|FEATURES|argannot|beta_lactam|SHV-86|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASRRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABS72342|FEATURES|argannot|beta_lactam|SHV-102|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAAERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>BAI94487|FEATURES|argannot|beta_lactam|SHV-133|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDGVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ADR66517|FEATURES|argannot|beta_lactam|SHV-135|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLKQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AEI83430|FEATURES|argannot|beta_lactam|SHV-137|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAALTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPHNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFC60795|FEATURES|argannot|beta_lactam|SHV-141|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ32277|FEATURES|argannot|beta_lactam|SHV-143|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDLWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23967|FEATURES|argannot|beta_lactam|SHV-161|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFW16978|FEATURES|argannot|beta_lactam|SHV-168|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AHA80958|FEATURES|argannot|beta_lactam|SHV-172|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKADRIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AHA80963|FEATURES|argannot|beta_lactam|SHV-178|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWVVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AJO16040|FEATURES|argannot|beta_lactam|SHV-180|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGHVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AJO16047|FEATURES|argannot|beta_lactam|SHV-189|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AKK23732|FEATURES|argannot|beta_lactam|SHV-190|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALLEHWQR
>CAA82916|FEATURES|argannot|beta_lactam|OXY-1-1|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>CAB42615|FEATURES|argannot|beta_lactam|OXY-1-6|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVPVTYFTQPQQDAKSRKKVLAAAAKIVTEGL
>CAI43424|FEATURES|argannot|beta_lactam|OXY-6-3|antibiotic inactivation|1
MLKSSWRKSALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTTDDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AFJ92668.1|FEATURES|argannot|beta_lactam|OXA-1|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>CAA41211|FEATURES|argannot|beta_lactam|OXA-5|antibiotic inactivation|1
MKTIAAYLVLVFYASTALSESISENLAWNKEFSSESVHGVFVLCKSSSNSCTTNNAARAS
TAYIPASTFKIPNALIGLETGAIKDERQVFKWDGKPRAMKQWEKDLKLRGAIQVSAVPVF
QQIAREVGEIRMQKYLNLFSYGNANIGGGIDKFWLEGQLRISAFNQVKFLESLYLNNLPA
SKANQLIVKEAIVTEATPEYIVHSKTGYSGVGTESSPGVAWWVGWVEKGTEVYFFAFNMD
IDNESKLPSRKSISTKIMASEGIIIGG
>CAA53242|FEATURES|argannot|beta_lactam|OXA-7|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTFWNKEFSAEAVNGVFVLCKSSSKLACATNNLARA
SKEYLPASTFKIPNAIIGLETGVIKNEHQIFKWDGKPRAMKQWERDLSLRGAIQVSAVPV
FQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLS
ASKENQLIVKEALVTEAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGAEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>CAA80304|FEATURES|argannot|beta_lactam|OXA-11|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGSQNISGGIDKFWLEDQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AAB05874|FEATURES|argannot|beta_lactam|OXA-15|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNAGPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>ACJ05191|FEATURES|argannot|beta_lactam|OXA-18|antibiotic inactivation|1
MQRSLSMSGKRHFIFAVSFVISTVCLTFSPANAAQKLSCTLVIDEASGDLLHREGSCDKA
FAPMSTFKLPLAIMGYDADILLDATTPRWDYKPEFNGYKSQQKPTDPTIWLKDSIVWYSQ
ELTRRLGESRFSDYVQRFDYGNKDVSGDPGKHNGLTHAWLASSLKISPEEQVRFLRRFLR
GELPVSEDALEMTKAVVPHFEAGDWDVQGKTGTGSLSDAKGGKAPIGWFIGWATRDDRRV
VFARLTVGARKGEQPAGPAARDEFLNTLPALSENF
>AAD12233|FEATURES|argannot|beta_lactam|OXA-22|antibiotic inactivation|1
MKRRHAAIGALLAALATFAHAEHPICTIVADAATGKAVLHEGKCDERVTPASTFKLALAV
MGFDHGFLKDEHTPVEHFRHGDPDWGGEAWHQPIDPALWLKYSVVWYSQRITHAMGAQTF
QAYVRKLGYGNMDVSGDPGKNNGMDRSWITSSLKISPEEQVGLMRRIVNRQLPVSAHTYE
MLDRTVQTWQVPGGWAVQGKTGTAGPAPGNTSPDGTWDQAHAYGWFVGWARKGDKTYVFA
NLIQDDKVEPTSGGIRSRDALFARLSEVLAFAGH
>AAG35609|FEATURES|argannot|beta_lactam|OXA-27|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKADINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALKMEMRSEMPASIRNELLMKSLKQLNII
>ACJ12495|FEATURES|argannot|beta_lactam|OXA-28|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFGLEGQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>AAK58418|FEATURES|argannot|beta_lactam|OXA-32|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSIAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>AAG24866|FEATURES|argannot|beta_lactam|oxa-2-related|antibiotic inactivation|1
IFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFDPVRSKKRYSPA
STFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAKE
IGDDKARRYLKKIDYGNAYPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQR
LVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREA
IVRAIL
>CAJ40948|FEATURES|argannot|beta_lactam|OXA-50|antibiotic inactivation|1
MRPLLFSALLLLSGHTQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLREAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTHFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>AAP43641.1|FEATURES|argannot|beta_lactam|OXA-53|antibiotic inactivation|1
MAIQIFAILFSTFVLATFAHAQDGTLERSDWGKFFSDFQAKGTIVVADERQADHAILVFD
QARSMKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVKRSFAGHNKDQDLRSAMRNS
TVWVYELFAKEIGDGKARRYLKQIGYGNADPSTSHGDYWIEGSLAISAQEQIAFLRKLYQ
NDLPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGSMGWWVGWVEWPTGPVFFALNIDTP
NRMDDLFKREAIARAILLSIEALPPNPAVHSDAAR
>AAR03105|FEATURES|argannot|beta_lactam|OXA-55|antibiotic inactivation|1
MNKGLHRKRLSKRLLLPMLLCLLAQQTQAVAAEQTKVSDVCSEVTAEGWQEVRRWDKLFE
SAGVKGSLLLWDQKRSLGLSNNLSRAAEGFIPASTFKLPSSLIALETGAVRDETSRFSWD
GKVREIAVWNRDQSFRTAMKYSVVPVYQQLAREIGPKVMAAMVRQLEYGNQDIGGQADSF
WLDGQLRITAFQQVDFLRQLHDNKLPVSERSQRIVKQMMLTEASTDYIIRAKTGYGVRRT
PAIGWWVGWLELDDNTVYFAVNLDLASASQLPLRQQLVKQVLKQEQLLP
>AAW81337|FEATURES|argannot|beta_lactam|OXA-65|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAX51233|FEATURES|argannot|beta_lactam|OXA-77|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLPRRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACU00283|FEATURES|argannot|beta_lactam|OXA-82|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAJ77817|FEATURES|argannot|beta_lactam|OXA-100|antibiotic inactivation|1
MNIKALLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAP69660|FEATURES|argannot|beta_lactam|OXA-129|antibiotic inactivation|1
MKTIAAYLVLVFFAGTALSESISENLAWNKEFSSESVHGVFVLCKSSSNSCTTNNATRAS
TAYIPASTFKIPNALIGLETGAIKDARQVFKWDGKPRAMKQWEKDLTLRGAIQVSAVPVF
QQIARDIGKKRMQKYLNLFSYGNANIGGGIDKFWLEGQLRISAVNQVKFLESLYLNNLPA
SKANQLIVKEAIVTEATPEYIVHSKTGYSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNESKLPSRKSIPTKIMASEGIIIGG
>ABY79006|FEATURES|argannot|beta_lactam|OXA-142|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEDQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>ACI22666|FEATURES|argannot|beta_lactam|OXA-146|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAAMDIKPQVGWLTGWVEQPDG
KIVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ACX31140|FEATURES|argannot|beta_lactam|OXA-148|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKASTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVKSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACX31141|FEATURES|argannot|beta_lactam|OXA-149|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKHVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADK35872|FEATURES|argannot|beta_lactam|OXA-168|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLAGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ADK35875|FEATURES|argannot|beta_lactam|OXA-171|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASTRNELLMKSLKQLNII
>ADI58617|FEATURES|argannot|beta_lactam|OXA-173|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAVPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGLDVNLQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADV41666|FEATURES|argannot|beta_lactam|OXA-183|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGTDKFWLEDQLRISAVNQVEFLESLFLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNENKLPLRKSIPTKIMASEGIIGG
>AEB98923|FEATURES|argannot|beta_lactam|OXA-197|antibiotic inactivation|1
MNIKALFLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEIAYKSLEQLGIL
>ADX07747|FEATURES|argannot|beta_lactam|OXA-202|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAMPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AFU91598|FEATURES|argannot|beta_lactam|OXA-204|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGHRRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>AEE61368|FEATURES|argannot|beta_lactam|OXA-210|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDCWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>AEL88491|FEATURES|argannot|beta_lactam|OXA-223|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEYHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEQ73520|FEATURES|argannot|beta_lactam|OXA-224|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNTEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>AFM55001|FEATURES|argannot|beta_lactam|OXA-228|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERVTEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDSNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGNDPAERKQLTLSILDKLGLFFYLR
>AFO55201|FEATURES|argannot|beta_lactam|OXA-241|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVIANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLAHASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CCJ32598|FEATURES|argannot|beta_lactam|OXA-250|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGLDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AGR55864|FEATURES|argannot|beta_lactam|OXA-320|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKIAITILNTLNL
>AEL30570|FEATURES|argannot|beta_lactam|adc56|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYQQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AFH53180|FEATURES|argannot|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRANPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>CAC17623|FEATURES|argannot|beta_lactam|OCH-3|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFTLSDPATKWAP
ELADSSFDKITMLDLGTYTPGGLPLQFPDAVSDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYRVDANNQGLGWEFY
NYPTALKTLLEGNSSDMALKSHKIEKFDTPSQPSADVWLNKTGSTNGFGAYAAFIPAKKI
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>AAB19430|FEATURES|argannot|beta_lactam|CARB-3|antibiotic inactivation|1
MLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSV
LDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVI
EKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDL
NEGKLGDLRDTTTPKAIASTLNKLLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGW
NIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYT
SQSR
>AAF61417|FEATURES|argannot|beta_lactam|CARB-5|antibiotic inactivation|1
MNVRKHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAVHDLETGKRW
EHKSNERFPLSSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGM
SLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWETELNEAVPGDK
RDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGA
GGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKTVLMENSRN
>AAM74565|FEATURES|argannot|beta_lactam|CARB-7|antibiotic inactivation|1
MKSLLVFALLMPSVVFASSSKFQSVEQEIKGIESSLSARIGVAILDTQNGESWDYNGDQR
FPLTSTFKTIACAKLLYDAEHGKVNLNSTVEIKKADLVTYSPVLEKQVGKPITLSDACLA
TMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKLGDLRDTTTPNA
ITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVKWSIADRSGAGGFGARSI
TAIVWSEEKKPIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR
>YP_009077556|FEATURES|argannot|beta_lactam|CARB-12|antibiotic inactivation|1
MKFLLVFSLLIPSVVFASSSKFRQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTIEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGSKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNKKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGRSIFDVYTSQSR
>AAP22374|FEATURES|argannot|beta_lactam|CARB-9|antibiotic inactivation|1
MKSLLVFALLMPSVVFASSSKFQSVEQEIKGIESSLSARIGVAILDTQNGESWDYNGDQR
FPLTSTFKTIACAKLLYDAEHGKVNLNSTVEVKKADLVTYSPVLEKQVGKPITLSDACFA
TMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKLGDLRDTTTPNA
ITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVTWSIADRSGAGGFGARSI
TAIVWSEEKKPIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR
>AAF89159|FEATURES|argannot|beta_lactam|blaB-15|antibiotic inactivation|1
MLKRLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVT
DKGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYST
KMTDSILAKENKPRAKYTFDNNKSFKVGNTEFQVYYPGKGHTADNVVVWFPKDKVLVGGC
IVKSGDSKDLGYIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISD
YQQKQKASN
>AAS48620|FEATURES|argannot|beta_lactam|VEB-3|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTFKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ABN80430|FEATURES|argannot|beta_lactam|VEB-5|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ACO56763|FEATURES|argannot|beta_lactam|VEB-7|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGITAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AKO63209|FEATURES|argannot|beta_lactam|blaVEB-12|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTAGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ABC94518|FEATURES|argannot|beta_lactam|VIM-13|antibiotic inactivation|1
MLKVISSLLFYMTASLMAVASPLAHSGESRGEYPTVSEIPVGEVRLYQIDDGVWSHIATH
TFDGVVYPSNGLIVRDGDELLLIDTAWGTKNTVALLAEIEKQIGLPVTRSVSTHFHDDRV
GGVDALRAAGVATYASPSTRRLAEAEGNEVPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLELSRTSAGNVADADLAEWPGSVERIQQHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHTNRSVAE
>ABW90721|FEATURES|argannot|beta_lactam|VIM-17|antibiotic inactivation|1
MFKLLSKLLVYLTASMMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ACV13198|FEATURES|argannot|beta_lactam|VIM-20|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQRYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AEI25539|FEATURES|argannot|beta_lactam|VIM-28|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AEZ49857|FEATURES|argannot|beta_lactam|VIM-32|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAAGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AGC50805|FEATURES|argannot|beta_lactam|VIM-35|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVTDADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AGC50806|FEATURES|argannot|beta_lactam|VIM-36|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATR
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>BAC06841|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVN
QYIESTSKP
>BAC06845|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQTTSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGNYGGTELIEHTKQIVN
QYIESTSKP
>CAQ87576|FEATURES|argannot|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVN
QYIESTSKP
>CAA74573|FEATURES|argannot|beta_lactam|CTX-M-4|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVAQINTADNSQ
ILYVADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIRASDLVNYNPIAEKHVNGTM
TLAELGAGALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNSAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGMPKSWGVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>AEM36716|FEATURES|argannot|beta_lactam|CTX-M-5|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWGVGDKTGS
GDYGTTNDIAVIWPANHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>AAK71471|FEATURES|argannot|beta_lactam|CTX-M-17|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAKGL
>AAN38836|FEATURES|argannot|beta_lactam|CTX-M-24|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>AAM70498|FEATURES|argannot|beta_lactam|CTX-M-25|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAVAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>CAD70280|FEATURES|argannot|beta_lactam|CTX-M-28|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AAO88912|FEATURES|argannot|beta_lactam|CTX-M-33|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYSPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>BAD83775|FEATURES|argannot|beta_lactam|CTX-M-35|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTESTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>AAV97956|FEATURES|argannot|beta_lactam|CTX-M-46|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTNAVQQKLAALEKSSGGRLGVPLIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAV97954|FEATURES|argannot|beta_lactam|CTX-M-49|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGRRLGVPLIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ABC18328|FEATURES|argannot|beta_lactam|CTX-M-54|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEQTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ADL27910|FEATURES|argannot|beta_lactam|CTX-M-55|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AEL20760|FEATURES|argannot|beta_lactam|CTX-M-58|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYGDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTESTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>ADA62520|FEATURES|argannot|beta_lactam|CTX-M-62|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTESTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABN69105|FEATURES|argannot|beta_lactam|CTX-M-65|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>AAV97957|FEATURES|argannot|beta_lactam|CTX-M-72|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDGTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ACB41777|FEATURES|argannot|beta_lactam|CTX-M-87|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTELTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACI29345|FEATURES|argannot|beta_lactam|CTX-M-83|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTH
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACI29348|FEATURES|argannot|beta_lactam|CTX-M-86|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPFAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ADN26580|FEATURES|argannot|beta_lactam|CTX-M-93|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTQNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ADM08178|FEATURES|argannot|beta_lactam|CTX-M-2|antibiotic inactivation|1
MMTQSIGRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>ADR66516|FEATURES|argannot|beta_lactam|CTX-M-98|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AEM44651|FEATURES|argannot|beta_lactam|CTX-M-108|antibiotic inactivation|1
VKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQI
LYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRAEIKKSDLVNYNPIAEKHVNGTMS
LAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPR
DTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSG
GYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVT
>AEM44654|FEATURES|argannot|beta_lactam|CTX-M-109|antibiotic inactivation|1
VKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSRI
LYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMS
LAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPR
DTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSG
GYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTK
>AEM44653|FEATURES|argannot|beta_lactam|CTX-M-113|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKRSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ACU00153|FEATURES|argannot|beta_lactam|CTX-M-114|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKAMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AEI70324|FEATURES|argannot|beta_lactam|CTX-M-116|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AFA51700|FEATURES|argannot|beta_lactam|CTX-M-122|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARSIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>AFA51701|FEATURES|argannot|beta_lactam|CTX-M-123|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AFH88134|FEATURES|argannot|beta_lactam|CTX-M-124|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAIIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>AFO69261|FEATURES|argannot|beta_lactam|CTX-M-125|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAEHRRDVLASAARIIAEGL
>AEW46676|FEATURES|argannot|beta_lactam|blaCTX-M-131|antibiotic inactivation|1
MTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQI
LYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMT
LAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPR
DTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGSG
GYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>AAN05031|FEATURES|argannot|beta_lactam|LEN-4|antibiotic inactivation|1
VISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVST
FKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCAAAITLSD
NSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLR
KLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGP
DGKPERIVVIYLRDTPASMAERNQQIAGIGAALI
>AAU25807|FEATURES|argannot|beta_lactam|LEN-5|antibiotic inactivation|1
MRYIRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAG25830|FEATURES|argannot|beta_lactam|LEN-10|antibiotic inactivation|1
ATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVLYLRDTPASMAERNQHIAG
>CAG25828|FEATURES|argannot|beta_lactam|LEN-11|antibiotic inactivation|1
ATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVIYLRDTPASMAERNQHIAG
>CAP12348|FEATURES|argannot|beta_lactam|LEN-20|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPVSMAERNQHIAGIGAALIEHWQR
>CAP12349|FEATURES|argannot|beta_lactam|LEN-21|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLVRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>BAM76830|FEATURES|argannot|beta_lactam|AQU-1|antibiotic inactivation|1
MKQTSPLSSLALSALLLSPLTQAAPADPLVGVVDEVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTYTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGRYSVGEMTQGLGWESYPYPVSE
QTLLAGNSVQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHSILSKLAP
>AHF82023|FEATURES|argannot|beta_lactam|blaAQU-2|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVNPGMLAD
EAYGIKTSSADLLAFVQANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSE
QTLLAGNSAQVIMKANPTTAAPXEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHAILSKLAP
>AAZ78355|FEATURES|argannot|quinolone|QnrA6|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD
>CAO82104|FEATURES|argannot|quinolone|QnrB12|antibiotic target protection|1
MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRA
ILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNT
NLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNS
ELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG
>CAP45902|FEATURES|argannot|quinolone|QnrB17|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ADI46626|FEATURES|argannot|quinolone|QnrB24|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AEH59666|FEATURES|argannot|quinolone|QnrB26|antibiotic target protection|1
MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ADM52188|FEATURES|argannot|quinolone|QnrB28|antibiotic target protection|1
MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>AEL00451|FEATURES|argannot|quinolone|QnrB33|antibiotic target protection|1
MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>AEL00456|FEATURES|argannot|quinolone|QnrB35|antibiotic target protection|1
MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG
>ABW03156.3|FEATURES|argannot|quinolone|QnrB44|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>ABW03157|FEATURES|argannot|quinolone|QnrB8|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG
>AGN92479|FEATURES|argannot|quinolone|QnrB72|antibiotic target protection|1
MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>ABU52984|FEATURES|argannot|quinolone|QnrS3|antibiotic target protection|1
ETYNHTYRHRNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDV
ADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISG
CNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCH
AELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>YP_008047252|FEATURES|argannot|quinolone|QnrVC5|antibiotic target protection|1
MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFS
YSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYIT
GCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLS
HSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD
>BAA14147.1|FEATURES|argannot|multidrug|NorA|antibiotic efflux|1
MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADIS
PSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDP
KKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDI
SIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISF
VVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIY
MAIGVSLAGVVIVLIEKQHRAKLKEQNM
>AAP43109.1|FEATURES|argannot|quinolone|oqxA|antibiotic efflux|1
MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPTVSAAKVLVKSISQWDSFNG
RIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQAALARAKTQ
ASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTA
PIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQGAS
SDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVR
LPGSAEFKATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLADGLRIVQKGLNPGD
SVIVDGLQKVFMPGMPVNAKTVAMTSSATLN
>AFH89470|FEATURES|argannot|fosfomycin|FosA3|antibiotic inactivation|1
MLQGLNHLTLAVSDLASSLAFYQQLPGMRLHASWDSGAYLSCGALWLCLSLDEQRRKTPP
QESDYTHYAFSVAEEEFAGVVALLAQAGAEVWKDNRSEGASYYFLDPDGHKLELHVGNLA
QRLAACRERPYKGMVFFD
>BAH75037|FEATURES|argannot|fosfomycin|fosX|antibiotic inactivation|1
MITGLSHITFICRDLDRMEAVLTGVLGARRVYDSGEATFSLSRERFYLVGGEGDDGLWLA
VMEGEPLAEPTYNHVAFAVDEADFEACLARVQALGLTFRPPRLRVAGEGRSLYFYDHDNH
LFELHTGTLPERLARYRQGRAAAPAPTPDNPETP
>NP_932197|FEATURES|argannot|fusidic_acid|fusB|antibiotic inactivation|1
MKTMIYPHQYNYIRSVILRLKNVYKTVNDKETVKVIQSETYNDINEIFGHIDDDIEESLK
VLMNIRLSNKEIEAILNKFLEYVVPFELPSPQKLQKVFKKVKKIKIPQFEEYDLKVSSFV
GWNELASNRKYIIYYDEKKQLKGLYGEISNQVVKGFCTICNKESNVSLFMKKSKTNSDGQ
YVKKGDYICRDSIHCNKQLTDINQFYNFIDKLD
>ABB53370.1|FEATURES|argannot|glycopeptide|vanYB|antibiotic target alteration|1
MEKSNYHSNADHHKRHMKQSVEKRAFLCAFIISFTVCTLFLGWRLASVLEATQIPPIPAT
HTGSSTDVVENLEENALATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIR
ISPYLQDLFDAARTDGVYPIVASGYRTTEKQQEIMDEKIAEYKAKGYTSAQAKAEAETWV
AVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPW
HYRYVGIEAATEMYNQGVCLEEYLKPEK
>ABB53373.1|FEATURES|argannot|glycopeptide|vanXB|antibiotic target alteration|1
MENGFLFLDEMLHGVRWDAKYATWDNFTGKPVDGYEVNRIIGTKAVAFALREAQIHAAAL
GYGLLLWDGYRPRTAVDCFLRWAAQPEDNLTKEKFYPNIERAELITKGYVASQSSHSRGS
AIDLTLYHLDTGELVSMGSNFDFMDERSHHTAKGIGDAEAQNRRCLRKIMESSGFQSYRF
EWWHYKLIDEPYPDTYFNFAVS
>ABB53371.1|FEATURES|argannot|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVTNGKLT
TMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYAQVKRMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>AAK58491.1|FEATURES|argannot|glycopeptide|vanTC|antibiotic target alteration|0
MKKNQGIEQFRVILAMMVVAIHCLPLHHLWPDGDTLITLTLFRIAVPFFFMISGYYVFSD
LATQNSYPARHRVWQFIKKQLQVYLIATLLFLPLAWYSGMLGLNMPLGTFIQTLLVNGIL
YHLWYFPAIITGSLLVMGLLTRLSFKQVFFTAVGLYVVGLGGDSWSGLAAQTPITPLYSR
IFQLLDGTRNGIFFAPLFLILGVLARRFAKKPASPHRYSYLLISLICLLLESYLLHHFTT
PKHDSMYIFLPFVLLFLFPIIQQWQAPIIWKQAGRLSLWLYLLHPYTIAVTHFLSQKLPL
LQNNLINFFVVLGLTIGVVHGLFALQKLFPFPKKTPPHLQRATKEFSAPALLHNLQEIKR
LIPATTKVMAVVKADAYGCDAKTVASTLERAGVDFFAVATLEEAIELRRAGIKSRLLILG
YTSAQRAKELKHYSLIQTIVSEAHGHALAQTSIPIECHLAVDTGMHRLGVAPDLETVTGL
YALPSLKITRIFSHLGSSDQLDTASILRTQAQITCFDDLLAGLSARNIAYGLTHLQSSYG
ILNYPEKHYDYVRPGILLTGSLSVPNEPTKQKINVQPILTLKALLVDKKTVAAGEAIGYG
LGTVFDRPATIGIVSIGYCDGVPRALSNQGFQLSYQGALLPQIGLVCMDMLLIDLTDYPE
LAVESSLEVISDWTTTAYQAQTITNELISRLGSRITSSSK
>AEI58860.1|FEATURES|argannot|glycopeptide|vanO|antibiotic target alteration|1
MGRLKIGILFGGLSEEHPISIKSAREVQKHLDLEKYEPYYIGITQSGSWMLCDGPAEDWE
NGDVRPAVLSPDRGVHGLLVLDEGKYETIALDVVLPVLHGKFGEDGAMQGLLEISGIPYV
GCDLPSSVMCIDKSLTYSVVRGAGIATPTFHIVTPDNDVDPDALNYPVFVKPARSGSSFG
VSKVSSKEELPAALAEARQYDAKILIEEAVIGSEIGCSILGDGEDLFAGEVDRVALTHGF
FKIHQEKSPETGSENSSFIVPADIPDASRDLVQETAKVIYRALGCSGLARVDLFLKEDGS
VVLNEVNTLPGLTSYSRYPRMMNAAGLSLGDVIDRLVKLTLAGVTNEG
>AAQ16248|FEATURES|argannot|glycopeptide|vanG|antibiotic inactivation|0
MTLKGVTYTEKADAGEMLLAICKDYPMSAPTEIGSYRGFRMEIYYDTVNAHYCMNLCGKA
KHKVDLGADALGNLTRIENELSKLPARLEDAKTKKAETIAQLETAKEEIKKPFAFEDELK
EKTERLNALNIDMDLYHIGGNNEYLITVS
>AAF36803.1|FEATURES|argannot|glycopeptide|vanF|antibiotic target alteration|1
MNRLKIAILFGGCSEEHDVSVKSAKEIANNIDTEKYEPIYIGITRSGVWKMCEKPCMDWD
NENCRSAVLSPDKKMHGLLVMRNKGYQIQRIDAVFSVLHGKSGEDGAIQGLFELSSIPYV
GCDVQSSAVCMDKSLTYIVAQNAGFGTPEFLILNHGDIPDSNTLTYPVFVKPARSGSSFG
VNKVNNEDELDAAIETARQYDSKVLIEQAVPGLEVGCAVLGNGTDLIVGEVDQISLSHGI
FRIHQEDQPEKGSENAVVLVPANLSAEKRIKIQETAKAIYKALGCKGLSRVDMFLQENGR
IILNEVNTLPGFTAYSRYPRMMAAAGMTLSGLIDHCITLALKG
>AEI58859.1|FEATURES|argannot|glycopeptide|vanHO|antibiotic target alteration|1
MTYSEPARSAAPRTGSPASASSSAVLARGITIYGCGSDEAALFREMAPRFGVMPTIVDEP
VSEANIGLVSGNRCISIGHKTKVTNSILLALAEAGVEYISTRSIGFNHIDVEYAASVGIT
VGNVAYSPDSVADFTLMLMLMAVRDAKSIIRRTEVHDYRLNEVRGKELRDLTVGVVGTGR
IGVAVLDRLRGFGCRVLAYDTLLTASADYVPLDELLQQSDIVTLHVPLNNDTYHLLDRKN
IERMKDGAYIINTGRGPLIETEALISALEDGKLGGAALDVVEGEEGIFYADCRNKPLESE
TLLRLEKLPNVLISPHTAYYTDHALSDTVENSIINCLQFESGK
>AAF72362.1|FEATURES|argannot|glycopeptide|vanHB|antibiotic target alteration|1
MRKSMGITVFGCEQDEANAFRALSPDFHIIPTLISDAISADNAKLAAGNQCVSEGHKSEV
SEATILALRKVGVKYISTRSIGCDHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAI
RGAKPTMHAVAQQDFRLDRIRGKELGDMTVRVIGTGHIGQAVVKRLRGFGCHVLAYDNSR
KMDADYVQLDELLKNSGIVTLHVPLCADTRHLIGQKQIGEMKQGAFLINTGRGALVDTGA
LVEALESGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTER
VLQDTTEKTIRNCLNFERSLQHE
>AAA65957.1|FEATURES|argannot|glycopeptide|vanXA|antibiotic target alteration|1
MEIGFTFLDEIVHGVRWDAKYATWDNFTGKPVDGYEVNRIVGTYELAESLLKAKELAATQ
GYGLLLWDGYRPKRAVNCFMQWAAQPENNLTKESYYPNIDRTEMISKGYVASKSSHSRGS
AIDLTLYRLDTGELVPMGSRFDFMDERSHHAANGISCNEAQNRRRLRSIMENSGFEAYSL
EWWHYVLRDEPYPNSYFDFPVK
>AAA65958.1|FEATURES|argannot|glycopeptide|vanYA|antibiotic target alteration|1
MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITE
EQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMV
NDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMER
APEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMD
YLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTN
SRR
>AAY52015.1|FEATURES|argannot|glycopeptide|VanZ|antibiotic target alteration|0
MNGGSRLKNWVVRAFFASYMYALFKIIVLKFGPTDVEFLWVRLMRNSTNPECIAARLHAG
NLIPLKEISRASDSMSGHSLLNLLGNVGIFVPLGIFLGVLAKSGKLTLAGSFWSSLGVSL
VLECTQVLFSIGTFDVDDLILNSIGGSIGFVVYALCALG
>AAV74562.1|FEATURES|argannot|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQIIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTMPGFTSYSRYPRMVAAAGITLPALIDSLITLALKR
>AAC69328.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|Erm(30)|antibiotic target alteration|1
MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELV
RSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQIL
RSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRV
DGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGI
PDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRR
YGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR
>AAA20192|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALLLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>AAA22599|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmD|antibiotic target alteration|1
MKKKNHKYRGKKLNRGESPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTT
VLSQKAGKVLAVENDSKFVDILTRKTAQHSNTKIIHQDIMKIHLPKEKFVVVSNIPYAIT
TPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHF
SPPPKVDSAMVRITRKKDAPLSHKHYIAFRGLAEYALKEPNIPLCVALRGIFTPRQMKHL
RKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI
>AAC32026|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmH|antibiotic target alteration|1
MAALLKRILRRRMAEKRSGRGRMAAARTTGAQSRKTAQRSGRSEADRRRRVHGQNFLVDR
ETVQRFVRFADPDPGEVVLEVGAGNGAITRELARLCRRVVAYEIDRHFADRLREATAEDP
RIEVVAGDFLKTSQPKVPFSVVGNIPFGNTADIVDWCLNARRLRTTTLVTQLEYARKRTG
GYRRWSRLTVATWPEVEWRMGERISRRWFRPVPAVDSAVLRLERRPVPLIPPGLMHDFRD
LVETGFTGKGGSLDASLRRRFPARRVAAGFRRARLEQGVVVAYVTPGQWITLFEELHGR
>AAC36915|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmQ|antibiotic target alteration|1
MKAKSNNYRGKVDISVSQNFITSKNTIYKLIKKTNISKNDFVIEIGPGKGHITEALCEKS
YWVTAIELDRSLYGNLINKFKSKNNVTLINKDFLNWKLPKKREYKVFSNIPFYITTKIIK
KLLLEELNSPTDMWLVMEKGSAKRFMGIPRESKLSLLLKTKFDIKIVHYFNREDFHPMPS
VDCVLVYFKRKYKYDISKDEWNEYTSFISKSINNLRDVFTKNQIHAVIKYLGINLNNISE
VSYNDWIQLFRYKQKID
>AAA26742|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmS|antibiotic target alteration|1
VARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRAR
RELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLL
PALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSAT
FVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRER
PLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPE
QWLTVFRTLRPVRSRPAGR
>AAA98096|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmT|antibiotic target alteration|1
MNKKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFSFELAKRCNYVTAIEI
DPKLCRITKNKLIEYENFQVINKDILQFKFPKNKSYKIFGNIPYNISTDIIRKIVFESTA
TESYLIVEYGFAKRLLNTNRSLALFLMTEVDISILSKIPREYFHPKPRVNSSLIVLKRHP
SKISLKDRKQYENFVMKWVNKEYIKLFSKNQFYQALKYARIDDLNNISFEQFLSLFNSYK
LFNR
>BAA03402|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmW|antibiotic target alteration|1
MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAI
TRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSIT
TPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDP
VPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLR
RERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSG
PPRARRRGGGA
>AAG03357|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmX|antibiotic target alteration|1
MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAV
EVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAW
TDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRR
VGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYL
PDCTPTTGSISSR
>AAA26652|FEATURES|argannot|macrolide-lincosamide-streptogramin|linA|antibiotic inactivation|1
MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVI
QKLEDIGYKIEVHWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFS
ETNYKDRKIPCISKEAQLLFHSGYDLTETDHFDIKNLKSIT
>ABR14060|FEATURES|argannot|macrolide-lincosamide-streptogramin|lnuD|antibiotic inactivation|1
MVNKADAIEIILYAEENEIDIWLDGGWGVDALLGEETRSHNDIDLFVEEKNGKTFIEILK
EKGFTEVIEAYTTTDHTVWKDDKDRIIDLHVFEFNEQGDLVFEGESYPSNVFSGIGKIGN
KVVKCIDAENQVLFHLGYEHDENDVHDVRLLCERYNIPVPSEYK
>AEA37904|FEATURES|argannot|multidrug|lsaC|antibiotic target protection|1
MSTIKIENLTFSYYGYVKPVFENVSFSFDTNWKTGLIGRNGIGKSTLFKLLLNQEVYKGK
ISKSVDFIKFPPNLSDTSKLGIELYRELISDEEEWKLFRELHLLKVDESLIYRKFETLSK
GEQTKILLAILFTREDGFLLIDEPTNHLDMDGRKIVSEYLKNKKGFLLISHDRDFLDGCI
NHIISINRNSIDVQSGNFTSWYENKLMKDQFEISQNEKLRKDIKRLKEAARQSQIWSDKV
ENTKNGVKVSGVKPDKGHIGHQSAKMMKKSKNLENRQNKAIEEKQNLLKDIETKESLLLH
PLHHHKNPLISVCDLSSYYGKKQILSNISFDIKQGDIVAIYGGNGSGKSTLIKILLGLNH
EYSGDVKLASNLKISYVPQDTSNLTGSLNEYIHKQGVDETLCKTILRKLDFARELFEIDM
KNYSDGQKKKVLIAVSLSKSAHIFIWDEPLNYLDVISRIQIEEIIKEANPTLIFVEHDKS
FVEDIANKIIRL
>BAA12910|FEATURES|argannot|macrolide-lincosamide-streptogramin|mphB|antibiotic inactivation|1
MSKDIKQVIEIAKKHNLFLKEETIQFNESGLDFQAVFAQDNNGIDWVLRLPRREDVMPRT
KVEKQALDLVNKYAISFQAPNWIIYTEELIAYKKLDGVPAGTIDHNIGNYIWEIDINNVP
ELFHKSLGRVLAELHSIPSNKAAALDLVVHTPEEARMSMKQRMDAVRAKFGVGENLWNRW
QAWLNDDDMWPKKTGLIHGDVHAGHTMIDKDANVTGLIDWTEAKVTDVSHDFIFNYRAFG
EEGLEALILAYKEIGGYYWPKMKEHIIELNAAYPVSIAEFALVSGIEEYEQMAKEALEVQ
GS
>AAF99569|FEATURES|argannot|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTRHNEIIKCAEKYQLHIQPQTISLNESGLDFQVAFGKDKHGVEWVLRLPRRPDVYKRTK
PEKQTVDFLQKNVSFEIPKWKVHAKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPLPEN
FINTLAETLVDLHNIPEENINVQHINIKTIQEIKNDFQRRMNKVKETYGVSDELWNRWKQ
WLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFIGHHRVFDDE
GLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMESGESAYETMALKELGMKE
>WP_033591432.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|MphD|antibiotic efflux|0
MMTKTSKTKTENLITKKELNQVFWRSFQMEFSWNYERQMNMAYVYAMIPILKKLYPQKEE
MAAALKRHLAFFNTTPHIVTFILGINAAMEEENVLDENFEVGTIDSIKTSLMGPLAGLGD
SFFWGTLRLIATGVGTSLALQGNVLGPILFLLIFNVPHVIVRYLLNRWGYKLGTGFLKNI
QANGMMESLTLGASIIGLMVVGAMTASMIDLTIPITISGSGKNAVTVQSIFDDIMPKLLP
LASFGFVFYLLKKEVKPLAILGGMAIVGILGSLIGLF
>AAK69028|FEATURES|argannot|macrolide-lincosamide-streptogramin|mel|antibiotic target protection|1
MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCK
MNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHG
ILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGN
YSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGG
RLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGA
EINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYF
AQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLA
KMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRD
KKINLKH
>AAA26684|FEATURES|argannot|macrolide-lincosamide-streptogramin|vgaALC|antibiotic target protection|1
MKIMLEGLNIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGI
VKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQ
DLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYE
KYEKEKKRLEKAINIKEQKAQRATKKPKNLSLSEGKIKGAKPYFAGKQKKLRKTVKSLET
RLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDK
MAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQN
ETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAI
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
EDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>ACX92986|FEATURES|argannot|multidrug|vgaD|antibiotic target protection|1
MLILEANHIEKSINDRKLLDVTHLQIHYEDRIGVVGRNGSGKTTLLSILAGEIEADKGEV
KTSASRYFLPQLKETDTFRSGGEITKSYIDKALAMKAEILFADEPTTNLDTHNIKELEKH
FSRYRGAIILVSHNRYFLDQICTKIWEIEDGEVKEIHGNYTSYVKQKELLRRQQQEEYEK
YITKKKQLERAVTMKEQKAQKMIKPPSKQMGTSESRIWKMQHATKQKKMHQNIKALETRV
EKLERVKKPKDYPAVKMKLSNQDQIQGRNVLRVKDLSVSFGNHVLWTDASFTIKGGEKAA
IIGNNGVGKTTLLKQILERVPAVTISPAAKIGYFSQNLDTLDTHVSILENVMSTAIQDET
TVRTVLARLHFYREDVYKEVQVLSGGERVKVAFAKLFVSDYNTLILDEPTNYLDIDAIEA
LEELLINYEGAVLFVSHDCRFVQNIASKIIELSDQKVIEFLGSYKAFRERSQETERDYMK
EELLKIEIKLTQMISEMNDEASNELEKEFQMLIHERNQLRNQVNN
>CAA50578|FEATURES|argannot|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MFREMRRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPISYVYADGKIYFHSAMKG
HKVDAILQNDKVSFCVVEQDDIRPSEFTTYFRSVIVFGKAHILTDELEKRVALGLLADKY
SYGEAGMEAEIAKGFNHLLIVKIAIEHITGKEAIELTKNRNDRP
>CAA26367|FEATURES|argannot|chloramphenicol|IO48_10670|antibiotic inactivation|1
MTFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLL
EYKDKEEMFPKKPIPENTIPISMIPWIDFSSFNLNIGNNSNFLLPIITIGKFYSENNKIY
IPVALQLHHAVCDGYHASLFMNEFQDIIHKVDDWI
>AAA22289|FEATURES|argannot|chloramphenicol|cat86|antibiotic inactivation|1
LFKQIDENYLRKEHFHHYMTLTRCSYSLVINLDITKLHAILKEKKLKVYPVQIYLLARAV
QKIPEFRMDQVNDELGYWEILHPSYTILNKETKTFSSIWTPFDENFAQFYKSCVADIETF
SKSSNLFPKPHMPENMFNISSLPWIDFTSFNLNVSTDEAYLLPIFTIGKFKVEEGKIILP
VAIQVHHAVCDGYHAGQYVEYLRWLIEHCDEWLNDSLHIT
>AAA73865.1|FEATURES|argannot|chloramphenicol|catB|antibiotic inactivation|1
MNFNLIDINHWSRKPYFEHYLNNVKCTYSMTANIEITDLLYEIKLKNIKFYPTLIYMIAT
VVNNHKEFRICFDHKGSLGYWDSMNPSYTIFHKENETFSSIWTEYNKSFLRFYSDYLDDI
KNYGNIMKFTPKSNEPDNTFSVSSIPWVSFTGFNLNVYNEGTYLIPIFTAGKYFKQENKI
FIPISIQVHHAICDGYHASRFINEMQELAFSFQEWLENK
>CAA08841.1|FEATURES|argannot|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGSNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAAMPMLCSSNIVGLHKYWLEFAV
>CAA11474|FEATURES|argannot|glycopeptide|vanO|antibiotic efflux|0
MDVDLQSIGIQTVQEALEKGSLIFNEKTKTDDFNRACDHILVLLVDAFQCFDRGSWGTSV
FLSITAIEEVAKAEVGLYRREGKIGKAKRGKDKLFNHQEKHRMAILPTVFMSKRLEEALG
KEKCAELLKEAAHGEFRNLRESSLYFSNENGQFVTPANVVSQNRAKEFLLLALEAADDRL
VGYTNHTGILEAKINEIFSVVAHS
>CAI47810|FEATURES|argannot|chloramphenicol|catB10|antibiotic inactivation|1
MTNYFESPFKGKLLADQVKNPNIKVGRYSYYSGYYHGHSFDECARFLLPDRDDIDQLIVG
SFCSIGTGASFIMAGNQGHRYDWASSFPFFYMKEEPAFSGALDAFQKAGDTVIGSDVWIG
SEAMIMPGINVGHGAVIGSRALVTKDVEPYTIVGGNPAKPIKKRFSDEEIAMLLKMNWWD
WPTEKIEEAMPLLCSSNIVGLHRYWQGFAV
>AAB51421|FEATURES|argannot|chloramphenicol|catD|antibiotic inactivation|1
MVFEKIDKNSWNRKEYFDHYFASVPCTYSMTVKVDITQIKEKGMKLYPAMLYYIAMIVNR
HSEFRTAINQDGELGIYDEMIPSYTIFHNDTETFSSLWTECKSDFKSFLADYESDTQRYG
NNHRMEGKPNAPENIFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYKEDNKIILPL
AIQVHHAVCDGFHICRFVNELQELINS
>CAA42594|FEATURES|argannot|chloramphenicol|cml|antibiotic efflux|1
MPLPLYLLAVAVCAMGTSEFMLAGLVPDIASDLGVTVGTAGTLTSAFATGMIVGAPLVAA
LARTWPRRSSLLGFILAFAAAHAVGAGTTSFPVLVACRVVAALANAGFLAVALTTAAALV
PADKQGRALAVLLSGTTVATVAGVPGGSLLGTWLGWRATFWAVAVCCLPAAFGVLKAIPA
GRATAAATGGPPLRVELAALKTPRLLLAMLLGALVNAATFASFTFLAPVVTDTAGLGDLW
ISVALVLFGAGSFAGVTVAGRLSDRRPAQVLAVAGPLLLVGWPALAMLADRPVALLTLVF
VQGALSFALGSTLITRVLYEAAGAPTMAGSYATAALNVGAAAGPLVAATTLGHTTGNLGP
LWASGLLVAVALLVAFPFRTVITTAAPADATR
>AFE02723.1|FEATURES|argannot|rifampin|arr-2|antibiotic inactivation|1
MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPA
VWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKKFPGNPTQSYRTCEPLRIVGVVE
DWEGHPVELIRGMLDSLEDLKRRGLHVIED
>AAD12753|FEATURES|argannot|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLISLLGAALDYLLMACPTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTAPHSTTGFIKKSLFFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>AAF01499|FEATURES|argannot|tetracycline|tetT|antibiotic target protection|1
MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRAST
VSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLN
IPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQ
IIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFA
ITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIK
SLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPC
DLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARF
GELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSF
QNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGT
EILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSEL
LSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN
>AAB08924|FEATURES|argannot|glycopeptide|vanE|antibiotic target alteration|0
MQLRRGKATDWHAMVQESLDSFASPHFLPIDIKPIDKIVIEGLIAEPSNWSIIARHTKYK
YRNLLKQESQNDELTNHLRETFKESADELKKELDTWLLGLDVTEK
>AAD25063|FEATURES|argannot|tetracycline|tetZ|antibiotic efflux|1
VLITATLDAAGLGLVMPILPTLLDQVGAPDDMIPLHVGLLTALYAIMQFLCAPILGRLSD
RFGRRRVLVASLAGATIDYLVLALTDTLWVFYLARAVAGITGATNAVTATVIADITPPDQ
RAKRYGWLGACYGGGMIAGPAIGGLFGGVSPHLPFLVAAALAGITLVLSASLLRETRPPG
SNGSHAQQPGTAKRTAVPGMLILLAVFGIVQFIGQAPGSTWVLFTQQRLDWNPVEVGVSL
SIFGMVQVFVQAALTGRIVSRIGETRAILVGIAADAIGLIGLALIASTWAMLPILAALGL
GSITLPALQTLLSRRAPEQQQGRLQGTLASLNSLTSIIGPVTFTGIFALTRTNADGTLWI
CAAALYVLCALLMIRETCASRRSR
>AFL92279|FEATURES|argannot|trimethoprim|dfrA1|antibiotic target replacement|1
VKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>ADI46759.1|FEATURES|argannot|trimethoprim|dfrA14|antibiotic target replacement|1
LKVSLMAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYA
VVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLSTIDI
EPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>AEW67113|FEATURES|argannot|trimethoprim|dfrA15|antibiotic target replacement|1
MAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKVDTLHISTIDIEPEGD
VYFPEIPSSFRPVFSQDFVSNINYSYQIWQKG
>CAE53424|FEATURES|argannot|trimethoprim|dfrA20|antibiotic target replacement|1
MGIKYSLIVAIGKHREMGADNDLLWHLPRDMQFFKETTTGHAVVMGRKSWESIPQKYRPL
PNRLNFVLTRDKNYSAEGATVIYDLKEVAQHLEGKNLTCFIIGGAQIYQLALETGLLNEM
YVTQVHNTFEEADTFFPFVNWGEWEEEDILEQDKDEKHLYSFNIKKFTR
>CAG34233|FEATURES|argannot|trimethoprim|dfrA23|antibiotic target replacement|1
MPTVEIIVAVDPVGGFGRNGQIPWTCKEDMKRFTTISKEIRVCVMGKNTYKDMLDMQMKK
EGAEERIKEKGILPERESYVVSSTLKPEDVIGATVVPDLRAVLNQYHDSDQRIAVIGGEK
LYVQALASATKVHMTVMHKPYNCDRTLPMSYIDKKFVAGQGSITIQTAVDGETHPVKFIT
YERARP
>CAI99385|FEATURES|argannot|trimethoprim|dfrA24|antibiotic target replacement|1
MTYQLDVSKILSFDLEAIVAATENGGIGYKGDLPWRLQGDLKRFREITQGGIVIMGAGTY
KSLPSPLKDRINIVITKKSEISWTACYDVRVVNSPEDALRMVGRIIDEKEEQGRDRPRVF
VIGGASIYQALMPFVSTLHWTEVHVEQLPEEIGLDTYIEDFLSLRGTSTPKRKSNLVLPP
TPTTP
>ACD56152.1|FEATURES|argannot|trimethoprim|dfrA5|antibiotic target replacement|1
MKISLMAAKARNGVIGCGSDIPWNAKGEQLLFKAITYNQWLLVGRKTFEAMGALPNRKYA
VVSRSGSVATNDDVVVFPSIEAAMRELKTLTNHVVVSGGGEIYKSLIAHADTLHISTIDS
EPEGNVFFPEIPKEFNVVFEQEFHSNINYRYQIWQRG
>CAA31356|FEATURES|argannot|trimethoprim|dfrA5|antibiotic target replacement|1
VKVSLMAAKAKNGVIGCGPHIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYA
VVTRSAWTADNDNVIVFPSIEEAMYGLAELTDHVIVSGGGEIYRETLPMASTLHISTIDI
EPEGDVFFPNIPNTFEVVFEQHFSSNINYCYQIWQKG
>CAA41326.1|FEATURES|argannot|trimethoprim|dfrA7|antibiotic target replacement|1
LKISLISATSENGVIGNGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSRKGISSSNENVLVFPSIEIALQELSKITDHLYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDINFPKIPENFNLVFEQFFLSNINYTYQIWKKG
>CAA40897|FEATURES|argannot|trimethoprim|dfrC|antibiotic target replacement|1
MASLNMIVAVNKTGGIGFENQIPWHEPEDLKHFKAVTMNSVLIMGRKTFASLPKVLPGRL
HVVVSKTVPPTQNTDQVVYVSTYQIAVRTASLLVDKPEYSQIFVIGGKSAYENLAAYVDK
LYLTRVQLNTQQDTELDLSLFKSWKLVSEVPTITENKTKLIFQIWINPNPISEEPTC
>AAN41433|FEATURES|argannot|trimethoprim|dfrB1|antibiotic target replacement|1
MQRVVGPHRTPRSSQERSEMERSSNEVSNPVAGNFVFPSNATFGMGDRVRKKSGAAWQGQ
IVGWYCTNLTPEGYAVESEAHPGSVQIYPVAALERIN
>ACR57831|FEATURES|argannot|trimethoprim|dfrB3|antibiotic target replacement|1
MDQHNNGVSTLVAGQFALPSHATFGLGDRVRKKSGAAWQGQVVGWYCTKLTPEGYAVESE
SHPGSVQIYPVAALERVA
>ABB72057|FEATURES|argannot|trimethoprim|dfrB6|antibiotic target replacement|1
MDQGSNEVINPVAGQFASPSNATFGMGDRVRKKSGAAWQGQIVGWYSTKLTPEGYAVESE
AHPGSVQIYPVAALERVN
>CAA88269|FEATURES|argannot|trimethoprim|dfrC|antibiotic target replacement|1
MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRN
VVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQG
DTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK
>AGL43627.1|FEATURES|CARD|quinolone|QnrB66|antibiotic target protection|1
MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>YP_491919.1|FEATURES|CARD|multidrug|gadX|antibiotic efflux|0
MQSLHGNCLIAYARHKYILTMVNGEYRYFNGGDLVFADASQIRVDKCVENFVFVSRDTLS
LFLPMLKEEALNLHAHKKVSSLLVHHCSRDIPVFQEVAQLSQNKNLRYAEMLRKRALIFA
LLSVFLEDEHFIPLLLNVLQPNMRTRVCTVINNNIAHEWTLARIASELLMSPSLLKKKLR
EEETSYSQLLTECRMQRALQLIVIHGFSIKRVAVSCGYHSVSYFIYVFRNYYGMTPTEYQ
ERSAQRLSNRDSAASIVAQGNFYGTDRSAEGIRL
>CAG27800.1|FEATURES|CARD|beta_lactam|TLA-2|antibiotic inactivation|1
MNIKYFKFAEKFILLVLIMSFSSLAFCKSDDSLEQRINSIISGKKASVGVAVAGIEDNFS
LSINGKKNFPMMSVYKLHIVLAVLNKVDGGSLKLDEKIPLNKKDLHPGTWSPLRDKYPNG
GVSIPLSEIIEYTITQSDNNGCDILIALAGGTEAVKRYIISKGISDFDIRATEKECHESW
NVQYSNWSTPVSAVALLKKFNDRKILSSVSTEYLMNVMIHTSTGNKRIKGLIPPSADVAH
KTGTSGIRNGITPGTNDIGIVTLPNGKHFAIAVFVSDSRENNAANERIIAEISKAAWDYF
VKMN
>CAA40386.1|FEATURES|CARD|beta_lactam|cphA7|antibiotic inactivation|1
MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEALIKAAPQS
>NP_312864.1|FEATURES|CARD|multidrug|cpxA|antibiotic efflux|0
MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELAND
PPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQK
KKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLL
WLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQ
RLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQK
NALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRN
ALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLG
LAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS
>YP_001706894.1|FEATURES|CARD|multidrug|adeF|antibiotic efflux|1
MSFSRKQFALSAIFVAILATGGSFMLLHENADAKAAPTAAQQAATVDVAPVVSKTITDWQ
EYSGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLAS
AEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYT
RITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNS
SQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFDNPNGVLLPGLYARIRLGG
GQPRPAILISPTAVGVDQDKRFVVVVDAKNQTAYREVKLGAQQDGLQIVNSGLQAGDRIV
VNGLQRIRPGDPVTPHLVPMPNSQITANATPQPQPTDKTSTPAKG
>BAA32493.1|FEATURES|CARD|fosfomycin|FomA|antibiotic inactivation|1
MTPDFLAIKVGGSLFSRKDEPGSLDDDAVTPFARNFARLAETYRGRMVLISGGGAFGHGA
IRDHDSTHAFSLAGLTEATFEVKKRWAEKLRGIGVDAFPLQLAAMCTLRNGIPQLRSEVL
RDVLDHGALPVLAGDALFDEHGKLWAFSSDRVPEVLLPMVEGRLRVVTLTDVDGIVTDGA
GGDTILPEVDARSPEQAYAALWGSSEWDATGAMHTKLDALVTCARRGAECFIMRGDPGSD
LEFLTAPFSSWPAHVRSTRITTTASA
>BAD06399.1|FEATURES|CARD|beta_lactam|GES-3|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRTAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ABA71732.1|FEATURES|CARD|glycopeptide|vanXYG|antibiotic target alteration|1
MMKTIELEKEEIYCGNLLLVNKNYPLRDNNVKGLVPADIRFPNILMKRDVANVLQLIFEK
ISAGNSIVPVSGYRSLEEQTAIYDGSLKDNGEDFTRKYVALPNHSEHQTGLAIDLGLNKK
DIDFIRPDFPYDGICDEFRRAAPDYGFTQRYARDKEEITGISHEPWHFRYVGYPHSKIMQ
ENGFSLEEYTQFIKAYLEDNKYLFEQAHRAEIEIYYVPAKDDKTLIKIPENCVYQISGNN
IDGFVVTIWRKTDD
>ABX72042.1|FEATURES|CARD|quinolone|QnrB13|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>AAK84316.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|vatD|antibiotic inactivation|1
MKMYPIEGNKSVQFIKPILEKLENVEVGEYSYYDSKNGETFDKQILYHYPILNDKLKIGK
FCSIGPGVTIIMNGANHRMDGSTYPFNLFGNGWEKHMPKLDQLPIKGDTIIGNDVWIGKD
VVIMPGVKIGDGAIVAANSVVVKDIAPYMLAGGNPANEIKQRFDQDTINQLLDIKWWNWP
IDIINENIDKILDNSIIREVIWKK
>ABA71729.1|FEATURES|CARD|glycopeptide|vanYG1|antibiotic target alteration|1
MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQD
GMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLV
EVEGGERVDERIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGY
SDSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYGFIFRYPGSKTDI
TGTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN
>AAK26252.2|FEATURES|CARD|aminoglycoside|AAC(6')-29a|antibiotic inactivation|1
VSILPVKEQDAADWLALRNLLWLADDHASEIEQYFSGGLEGLVEVLIARDATGAAVGHVE
LSIRHDLEELQGIKTGYIEGLYVAPSHRSTDLVRRFLRESEKWALEQGCSAFASDRSDRV
ITHRKFAGSAV
>NP_251185.1|FEATURES|CARD|multidrug|OprN|antibiotic efflux|0
MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWW
KQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQ
PGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVD
AYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQL
QAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPDIRAAERRL
AASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAARAWSVGPSISWAAFDLGSVRA
RLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAI
RYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA
>CAA37699.1|FEATURES|CARD|beta_lactam|r39|antibiotic inactivation|1
MLFPTARRTGFAALAALALVPAAACSGSAAPAEAEPASAEVTAEDLSGEFERLESEFDAR
LGVYAVDTGTGEEVFHRADERFGYASTHKAFTAALVLGQNTPEELEEVVTYTEEDLVDYS
PITEQHVDTGMTLLEVADAAVRHSDNTAANLLFEELGGPEGFEEDMRELGDDVISADRIE
TELNEVPPGETRDTSTPRAMAGSLEAFVLGDVLEEGPRDVLTEMLLNNTTGDELIRAGVP
EDWRVGDKTGGGSHGSRNDIAVVWPPEDDPIVIAVMSTREQEDAEFDNALVSGATEVVVE
ALAP
>BAA34299.1|FEATURES|CARD|multidrug|mexX|antibiotic efflux|1
MDRLAARLLAALVALFLLGCEEAADAGKTAEAPAEVGVIVARPAPIGITSELPGRLEAYR
QAEVRARVAGIVTRRLYEEGQDVRAGTVLFQIDPAPLKAALDISRGALPGRGQPRAAADK
LKAYADLIKDRAISEREYTEAQTDARQALAQIASAKAELEQARLRLGYATVTAPIDGRAR
RALVTEGALVGEDSPTPLTRVEQIDPIYVNFSQPAAKSRHAAGDPRRPGEGCRRQGHRRA
PGPGRRQRVPLAGELLFIDLAVDPGTDTIAMRALFRNPHRELLPGGYVQVRLQRAVNPQA
ITVPDALIRTAQSAVVKVVNPKGLVEDVEVRADTLQGRDWIISRGLKGGEWVIVENAAQH
AAGSSVQAVVRQPASADAPSPLAASPAGQ
>CAA44667.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|ErmU|antibiotic target alteration|1
MPSRYGSRQDLGQNFLVDPDIIKLIRRAPNERKVPSLIWRRRGHVTLPLSRLGRPVTAVE
LDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWVS
AVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERRP
EPLVRERREYQAFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLTA
EQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG
>AHA80961.1|FEATURES|CARD|beta_lactam|CTX-M-147|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTESTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>BAN04737.1|FEATURES|CARD|quinolone|QnrB61|antibiotic target protection|1
MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AGL43632.1|FEATURES|CARD|quinolone|QnrB71|antibiotic target protection|1
MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AGZ83153.1|FEATURES|CARD|beta_lactam|OXA-357|antibiotic inactivation|1
MYKKALIAATSILFLSSCSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTDYVPASTFKMLNALIGLEHHKVTTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDNFWLVGPLKISPEQETQF
AYKLANKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGVL
>AHM76774.1|FEATURES|CARD|beta_lactam|ACT-22|antibiotic inactivation|1
MMKKSLCCALLLSTSCAALAAPMSETQLAKVVARTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLSDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDASLKQGMALAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKKLGIVMLA
NKSYPNPARVEAAYRILSALQ
>NP_459347.2|FEATURES|CARD|multidrug|mdsA|antibiotic efflux|1
MLIAGVIAAIGGVIYMAGEALWDKDNAVGPPASAPPPPSVPVAKALSRTLAPTAEFTGFL
AAPETVELRSRVGGTLDAISVPEGRLVSRGQLLFQIDPRPFEVALDTAVAQLRQAEVLAR
QAQADFDRIQRLVASGAVSRKNADDVTATRNARQAQMQSAKAAVAAARLELSWTRITAPI
AGRVDRILVTRGNLVSGGVAGNATLLTTIVSHNPMYVYFDIDEATWLKALRHTRSDKNPP
VVNMGLTTDNGLPYQGVLDFMGNQMNRSTGTIRARAVIPDPDGMLSPGLFARISLPIGEP
RETVLIDDLAVSADQGKNYVLIVGKENQVEYRPVELGQMVDGFRVVTQGVLPGEKIILKG
LVRPGMTVAPRLVPMRQNVTDKQTATLTKADGDSAPKAVRQ
>CAJ47138.2|FEATURES|CARD|beta_lactam|SHV-83|antibiotic inactivation|1
KRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ADM92605.1|FEATURES|CARD|multidrug|adeR|antibiotic efflux|0
MFDHSFSFDCQDKVILVVEDDYDIGDIIENYLKREGMSVIRAMNGKQAIELHASQPIDLI
LLDIKLPELNGWEVLNKIRQKAQTPVIMLTALDQDIDKVMALRIGADDFVVKPFNPNEVV
ARVQAVLRRTQFANKATNKNKLYKNIEIDTDTHSVYIHSENKKILLNLTLTEYKIISFMI
DQPHKVFTRGELMNHCMNDSDALERTVDSHVSKLRKKLEEQGIFQMLINVRGVGYRLDNP
LAVKDDA
>CCP44758.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAV
ELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>CCW43444.1|FEATURES|CARD|beta_lactam|CARB-16|antibiotic inactivation|1
MDVRKHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAVHDLETGKRW
EHKSNERFPLSSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGM
SLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWETELNEAVPGDK
RDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGA
GGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKTVLMENSRN
>YP_001713101.1|FEATURES|CARD|multidrug|adeH|antibiotic efflux|0
MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQ
QTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGP
TRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQS
ALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTE
LATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRP
DIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTI
LSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQA
LSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGG
WSS
>AGL43626.1|FEATURES|CARD|quinolone|QnrB65|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAN
LKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG
>AHL30272.1|FEATURES|CARD|beta_lactam|OXA-385|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALISLEHHKATATEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AGW83453.1|FEATURES|CARD|beta_lactam|OXA-355|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDRNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGDDPAERKQLTLSILDKLGLFFYLR
>ACQ82815.1|FEATURES|CARD|beta_lactam|PDC-10|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>CAA27276.1|FEATURES|CARD|aminoglycoside|APH(7'')-Ia|antibiotic inactivation|1
MTQESLLLLDRIDSDDSYASLRNDQEFWEPLARRALEELGLPVPPVLRVPGESTNPVLVG
EPDPVIKLFGEHWCGPESLASESEAYAVLADAPVPVPRLLGRGELRPGTGAWPWPYLVMS
RMTGTTWRSAMDGTTDRNALLALARELGRVLGRLHRVPLTGNTVLTPHSEVFPELLRERR
AATVEDHRGWGYLSPRLLDRLEDWLPDVDTLLAGREPRFVHGDLHGTNIFVDLAATEVTG
IVDFTDVYAGDSRYSLVQLHLNAFRGDREILAALLDGAQWKRTEDFARELLAFTFLHDFE
VFEETPLDLSGFTDPEELAQFLWGPPDTAPGA
>CAA29819.1|FEATURES|CARD|beta_lactam|BcI|antibiotic inactivation|1
MKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKEDLV
DYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITMSN
RFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRA
GIPTDWVVGDKSGAGSYGTRNDIAVVWPPNRAPIIIAILSSKDEKEAIYDNQLIAEATKV
IVKALR
>AEQ59620.1|FEATURES|CARD|beta_lactam|TEM-192|antibiotic inactivation|1
MPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPIMSTF
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
TAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRK
LLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPD
GKPSRIVVIYT
>BAO79432.1|FEATURES|CARD|multidrug|cmeC|antibiotic efflux|0
MNKIISISAIASFTLLISACSLSPNLNIPEANYSIDNKLGALSWEKENNSSITKNWWKDF
DDENLNKVVDLALKNNNDLKLAFIHMEQAAAQLGIDFSSLLPKFDGSASGSRAKTAINAP
SNRTGEVSYGNDFKMGLNLSYEIDLWGKYRDTYRASKSSFKASEYDYEAARLSVISNTVQ
TYFNLVNAYENENALKEAYESAKEIYRINDEKFQVGAVGEYELAQARANLESMALQYNEA
KLNKENYLKALKILTSNDLNDILYKNQSYQVFNLKEFDIPTGISSTILLQRPDIGSSLEK
LTQQNYLVGVARTAFLPSLSLTGLLGFESGDLDTLVKGGSKTWNIGGNFTLPIFHWGEIY
QNVNLAKLNKDEAFVNYQNTLITAFGEIRYALVARKTIRLQYDNAQASEQSYKRIYEIAK
ERYDIGEMSLQDYLEARQNWLNAAVAFNNTKYSYANSIIDVIKAFGGGFEQSEDTSKNIK
EESKNLDMSFRE
>CCP46182.1|FEATURES|CARD|quinolone|mfpA|antibiotic target protection|0
MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLW
HSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLR
KCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCL
AGG
>CAA63498.1|FEATURES|CARD|chloramphenicol|cat|antibiotic inactivation|1
MTFNIIELENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDKNFISFYNNYKNDLL
EYKDKEEMFPKKPIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSENNKIY
IPVALQLHHSVCDGYHASLFMNEFQDIIHRVDDWI
>CAC84275.1|FEATURES|CARD|chloramphenicol|cat|antibiotic inactivation|1
MNFNKIDLYNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQEGYKFYPAFISLVTRV
INSNTAFRTGYHNDGELGYWDKLEPLYTIFDGDSRTSSGIGTPVKNDSKEFYELYLSDVE
KYNGSGKLFPKTPIPENAFSLSIIPWTLFTGFNLNIHNNSNYLLPIITAGKFINIGNSIY
LPLSLQEHHSVGDGYHAGLFMNSIQELSDRPNDWLL
>ACN32294.1|FEATURES|CARD|multidrug|tolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDV
TYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEA
EKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDD
SNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINA
SISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLIN
QLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQT
SARTTTSNGHNPFRN
>AAA26412.1|FEATURES|CARD|aminoglycoside|APH(3')-Ib|antibiotic inactivation|1
MNDIDREEPCAAAAVPESMAAHVMGYKWARDKVGQSGCAVYRLHSKSGGSDLFLKHGKDA
FADDVTDEMVRLRWLAGHISVPSVVSFVRTPNQAWLLTTAIHGKTAYQVLKSDFGARLVV
VDALAAFMRRLHAIPVSECSVQQWTTHAGLPERGSIEAGVVDVDDFDKEREGWTAEQVWE
AMHRLLPLAPDPVVTHGDFSLDNLLIVEGKVVGCIDVGRAGIADRYQDLAVLWNCLEEFE
PSLQERLVAQYGIADPDRRKLQFHLLLDELF
>CDL68900.1|FEATURES|CARD|beta_lactam|DHA-12|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVEAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMSLNDPAAKYRPELTQPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSWKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTTRILSPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIVNGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>YP_001440920.1|FEATURES|CARD|tetracycline|mepR|antibiotic efflux|0
MEFTYSYLFRMISHEMKQKADQKLEQFDITNEQGHTLGYLYAHQQDGLTQNDIAKALQRT
GPTVSNLLRNLERKKLIYRYVDAQDTRRKNIGLTTSGIKLVEAFTSIFDEMEQTLVSQLS
EEENEQMKANLTKMLSSLQ
>CAC14595.1|FEATURES|CARD|multidrug|smeE|antibiotic efflux|1
MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDS
VTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQ
EVQRQGINVAKSSSGFLNAIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGG
KYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRL
QTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANAL
DTAAGVDAALEDMKGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIM
SEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMAL
SVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIH
RPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALEN
HFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQ
IKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRP
NGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQA
FRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASG
DAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVP
TAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGAS
LIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGV
FFVPLFFVVVQRVFKRRSTT
>ACV32634.1|FEATURES|CARD|beta_lactam|SHV-124|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLDQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQ
>AGQ93789.1|FEATURES|CARD|beta_lactam|CARB-21|antibiotic inactivation|1
MVRVFTRYSLLNIAKVRIKTKRTKNTRMKKLFLLVGLMVCSTVSYASKLNEDISLIEKQT
SGRIGVSVWDTQMDERWDYRGDERFPLMSTFKTLACATMLSDMDSGKLNKNATARIDERN
IVVWSPVMDKLAGQSTRIEHACEAAMLMSDNTAANLVLNEIGGPKAVTLFLRSIGDKATR
LDRLEPRLNEAKPGDKRDTTTPNAMVNTLHTLMEDNALSYESRTQLKIWMQDNKVSDSLM
RSVLPKGWSIADRSGAGNYGSRGISAMIWKDNYKPVYISIYVTDTDLSLQARDQLIAQIS
QLILEHYKES
>YP_008997281.1|FEATURES|CARD|aminoglycoside|ANT(6)-Ia|antibiotic inactivation|1
MRSEKEMMDLVLSLAEQDERIRIVTLEGSRANINIPKDEFQDYDITYFVSDIEPFISNDD
WLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIK
VLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHL
NQILRFELLRMMSWKVGIKTEFSLSVGKNYKYINKYIDEDLWNRLLSTYRMDSYENIWKS
LFICHQLFREVSKEVAELLGFDYPEYGKNITRYTEDMYKKYVENDYF
>AGW83454.1|FEATURES|CARD|beta_lactam|OXA-356|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEIFHWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDRNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGDDPAERKQLTLSILDKLGLFFYLR
>AAD04032.1|FEATURES|CARD|tetracycline|otr(B)|antibiotic efflux|1
MSSANPGPAGTADQAGGAFTHRQILTAMSGLLLAVFLAALDQTVIATAMRTIADDLHGQT
EQAWATTGYLIASVLAMPFYGKLSDIYGRKPMYLISIVVFIGGSVLCGTAGSMWELALFR
AVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFG
IDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALALFLVPLLIVAEQGR
TWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIGVGI
FGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGS
MAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGL
CRQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYERLLTDPAITGDPANHRFLDMAESGQ
GAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFLAGGVVLLAGFVMTWFLRELQEETA
PEEERPAESGAGAKNGPLPASDA
>AIA08936.1|FEATURES|CARD|rifampin|rphA|antibiotic inactivation|0
MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESG
ELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSA
TAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGV
VVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVART
IAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCL
DDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMY
EAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPP
AGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPL
NIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPE
VVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALV
PVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAF
AGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDE
RLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVV
LDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVE
RATRLIRDGQRIRVHGTEGYIELLS
>ABN09669.1|FEATURES|CARD|beta_lactam|CTX-M-61|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAX55643.1|FEATURES|CARD|beta_lactam|y56|antibiotic inactivation|1
MKHSSLRRALLLAGITLPLVNFSLPTWAAAIPGSLDKQLAALEHSANGRLGIAMINTGNG
TKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPN
DPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIILSQIS
>BAA15934.1|FEATURES|CARD|multidrug|baeS|antibiotic efflux|0
MKFWRPGITGKLFLAIFATCIVLLISMHWAVRISFERGFIDYIKHGNEQRLQLLSDALGE
QYAQHGNWRFLRNNDRFVFQILRSFEHDNSEDKPGPGMPPHGWRTQFWVVDQNNKVLVGP
RAPIPPDGTRRPILVNGAEVGAVIASPVERLTRNTDINFDKQQRQTSWLIVALATLLAAL
ATFLLARGLLAPVKRLVDGTHKLAAGDFTTRVTPTSEDELGKLAQDFNQLASTLEKNQQM
RRDFMADISHELRTPLAVLRGELEAIQDGVRKFTPETVASLQAEVGTLTKLVDDLHQLSM
SDEGALAYQKAPVDLIPLLEVAGGAFRERFASRGLKLQFSLPDSITVFGDRDRLMQLFNN
LLENSLRYTDSGGSLQISAGQRDKTVRLTFADSAPGVSDDQLQKLFERFYRTEGSRNRAS
GGSGLGLAICLNIVEAHNGRIIAAHSPFGGVSITVELPLERDLQREV
>AAC37034.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|ErmG|antibiotic target alteration|1
MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEI
DSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSA
TISYLIVEYGFAKMLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSTLIVLKRKP
AKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYK
IFNG
>NP_252894.1|FEATURES|CARD|multidrug|mexG|antibiotic efflux|0
MQRFIDNSLESNWLWLTARICLALMFVASGLAKLFDYQASLEEMRAAGLEPAWLFNIATA
VTLLAGSALVLLDRKLWLGAGALAVFLLLTILIVHTFWSKTGVEAKLAMFFALEHIAVIG
GLIATAIASAQRQRLRQDVSVAATYQKA
>ACL37342.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib-Hangzhou|antibiotic inactivation|1
MTEHDLVMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>AAA65959.1|FEATURES|CARD|glycopeptide|vanZA|antibiotic target alteration|0
MGKILSRGLLALYLVTLIWLVLFKLQYNILSVFNYHQRSLNLTPFTATGNFREMIDNVII
FIPFGLLLNVNFKEIGFLPKFAFVLVLSLTFEIIQFIFAIGATDITDVITNTVGGFLGLK
LYGLSNKHMNQKKLDRVIIFVGILLLVLLLVYRTHLRINYV
>AHL30282.1|FEATURES|CARD|beta_lactam|OXA-384|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNSEMKKGISSSVRKEITYRSLEQLGIL
>ACS44715.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib3|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSDA
>AJT57878.1|FEATURES|CARD|beta_lactam|OXA-435|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLSGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>AHL39327.1|FEATURES|CARD|beta_lactam|CMY-86|antibiotic inactivation|1
MMKKSLCCALLLTAPFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEVAWHILEKLQ
>CAA79727.1|FEATURES|CARD|tetracycline|tetQ|antibiotic target protection|1
MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITD
SMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEG
IQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVY
PICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAM
FNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRI
NDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQH
PALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLL
EERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESD
ISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYV
FRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPL
NTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK
>AAC77293.1|FEATURES|CARD|multidrug|mdtM|antibiotic efflux|1
MPRFFTRHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFMHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGSLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLSLLIV
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNKLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELVEEQ
>CAA26235.1|FEATURES|CARD|peptide|viomycin|antibiotic inactivation|0
MRIIETHRDLLSRLLPGDTVGGLAVHEGQFHHVVIGSHRVVCFARTRAAADRLPGRADVL
RALAGIDLGFRTPQPLSEGGAQGTDEPPYLVLSRIPGAPLEDDVLTSPEVAEAVARQYAT
LLSGLAAAGDEEKVRAALPEAPANEWQEFATGVRTELFPLMSDGGRERAERELAALDALP
HLTSAVVHGDLGGENVLWETVDGVPRMSGVVDWDEVGIGDPAEDLAAIGASYGEELLGRV
LALGGWADNGTAERISAIRGTFALQQALYAQRDGDEEELADGLSGYR
>YP_002343805.1|FEATURES|CARD|multidrug|cmeR|antibiotic efflux|0
MNSNRTPSQKVLARQEKIKAVALELFLTKGYQETSLSDIIKLSGGSYSNIYDGFKSKEGL
FFEILDDICKKHFHLIYSKTQEIENGTLKEILTSFGLAFIEIFNQPEAVAFGKIIYSQVY
DKDRHLANWIENNQQNFSYNILMGFFKQQNNSYMKKNAEKLAVLFCTMLKEPYHHLNVLI
NAPLKNKKEQKEHVEFVVNVFLNGINSSKA
>AAB58161.1|FEATURES|CARD|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVR
GVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALN
QKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLG
VTLFGLI
>ABN69112.2|FEATURES|CARD|beta_lactam|MIR-4|antibiotic inactivation|1
MMTKSLSCALLLSVASAAFAAPMFEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLHAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>CAA37806.1|FEATURES|CARD|chloramphenicol|catII|antibiotic inactivation|1
MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITAFRTALAETDYKFYPVMIYLISR
VVNQFPEFRMAMKDNALIYWDQTDPVFTVFHKETETFSALFCRYCPDISEFMAGYNAVMA
EYQHNTALFPQGALPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEDNRVL
LPVSVQVHHAVCDGFHAARFINTLQMMCDNILK
>AHA80105.1|FEATURES|CARD|beta_lactam|ACT-20|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
YTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEALQ
>YP_002325610.1|FEATURES|CARD|multidrug|adeA|antibiotic efflux|1
MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRT
AEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQ
LERYEQLLPSNAVSKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIG
QSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKTVRI
TNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIPQAL
LVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGHQYEQFYIANKGLKVGDKVVVEGIER
IKPNQKLALAVWKAPAVANHASSVETKTSIAEGAQP
>AAC25500.1|FEATURES|CARD|aminoglycoside|AAC(6')-Iq|antibiotic inactivation|1
MDYSICDIAESNELILEAAKILRKSFLDAGNESWVDIKKAIEEVEDCIEHPNLCLGICLD
DKLIGWTGLRPMYDKTWELHPMVIKTEYQCRGIGKVLIKELEKRAKGRGIIGIALGTDDE
YQKTSLSMIDINERNIFDEIGNIKNVTNHPYEFYKKCGYMIVGIIPNANGKRKPDIWMWK
DIS
>AJA32743.1|FEATURES|CARD|beta_lactam|OXA-425|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTLKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASALPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABA42119.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|oleD|antibiotic inactivation|0
MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLY
HSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVL
ARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPD
TFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLG
SAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQA
DLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRET
ALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG
>AGL43630.1|FEATURES|CARD|quinolone|QnrB69|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG
>AGU69251.1|FEATURES|CARD|beta_lactam|OXA-313|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIQVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAC76297.1|FEATURES|CARD|multidrug|acrE|antibiotic efflux|1
MTKHARFFLLPSFILISAALIAGCNDKGEEKAHVGEPQVTVHIVKTAPLEVKTELPGRTN
AYRIAEVRPQVSGIVLNRNFTEGSDVQAGQSLYQIDPATYQANYDSAKGELAKSEAAAAI
AHLTVKRYVPLVGTKYISQQEYDQAIADARQADAAVIAAKATVESARINLAYTKVTAPIS
GRIGKSTVTEGALVTNGQTTELATVQQLDPIYVDVTQSSNDFMRLKQSVEQGNLHKENAT
SNVELVMENGQTYPLKGTLQFSDVTVDESTGSITLRAVFPNPQHTLLPGMFVRARIDEGV
QPDAILIPQQGVSRTPRGDATVLIVNDKSQVEARPVVASQAIGDKWLISEGLKSGDQVIV
SGLQKARPGEQVKATTDTPADTASK
>AAF72531.1|FEATURES|CARD|beta_lactam|CTX-M-13|antibiotic inactivation|1
MVTKRMQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTKDNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFAREIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>BAD00739.1|FEATURES|CARD|aminoglycoside|aadA7|antibiotic inactivation|1
MSEKVPAEISVQLSQALNGIGRHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAPLND
AVRQALLVDLLEVSASPGQNKALRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAG
IFEPATTDSDLAILLTKAKQHSVVLAGSAAKDLFSSVPESDLFKALADTLKLWNSPPDWA
GDERNVVLTLSRIWYTAATGKIAPKDVAATWAMARLPAQHQPILLNAKRAYLGQEEDYLP
ARADQVAALIKFVKYEAVKLLGASQ
>AAB53259.1|FEATURES|CARD|chloramphenicol|cat-TC|antibiotic inactivation|1
MNFNKIDLDNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQEGYKFYPAFIFLVTRV
INSNTAFRTGYNSDGELGYWDKLEPLYTIFDGVSKTFSGIWTSVKNDFKEFYDLYLSDVE
KYNGSGKLFPKTPIPENAFSLSIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKGNSIY
LPLSLQVHHSVCDGYHAGLFMNSIRNCQIGLMTGFYNIDKPTVLFTVGFLMSLTCPLI
>AAA25293.1|FEATURES|CARD|tetracycline|tetS|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYSSGAIKELGSVDSGTTKTDTMFLERQRGITIQTAI
TSFQRENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHALRKMN
IPIIFFINKIDQNGINLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQWETVIV
GNDYLLEKYTIGKTLNIAELEKEENERIQSCSLYPVYHGSAKNNIGIKQLIEVITSKLFS
PTQLNSDKLCGNVFKVEYSDDGQRLVYVRLYSGTLHLRDSVNISEKEKIKVTEMYTSING
ELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPHREILENPLPMLQTTIEPCKSVQREK
LLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQEKYHIEIETRKPTVIY
MERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTELLEPYL
SFEIYVPQEYLSRAYNDASKYCANILNTKLKGNEVILIGEIPARCIQEYRNSLTFFTNGR
SVCLTELKGYQVTNIKSAFQPRRPNNRIDKVRHMFNKINLH
>CEA29750.1|FEATURES|CARD|beta_lactam|SHV-187|antibiotic inactivation|1
MVKRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRA
DERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEL
CAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTT
PASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGA
RGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACV32633.1|FEATURES|CARD|beta_lactam|SHV-123|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGGNIKAERIVVIYLRDTPASMAERNQ
>ABP88094.1|FEATURES|CARD|quinolone|QnrB9|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>AAK63040.1|FEATURES|CARD|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKRELELY
RFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAV
LFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKDVSELLQTQAEMFIF
>AIS67612.1|FEATURES|CARD|beta_lactam|CTX-M-156|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPNAESRRDVLASAAKIVTDGL
>AAN39364.1|FEATURES|CARD|beta_lactam|SHV-45|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA71730.1|FEATURES|CARD|glycopeptide|vanWG|antibiotic target alteration|1
MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETS
SLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLN
LVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINE
GWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIA
SVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV
>ABF66027.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|lmrD|antibiotic efflux|1
ENTKSTRKMSDTTRAIRFFYLYLKRYKLQFAVIMIFIILATWLQVVSPSLLGDAITNLTK
YVTDFFTHQHAGQSQDALQQIAQQLSQQMHQTVDWHNVPEVVKSLPQAAQDQITANLPKG
TTLETLKTVATSHAASTSTFMKGMWQLLAVYVATGVSMLIYTLLFSRIVAHSTNRMRKGL
FGKLERLTISYFDRHQDGDILARFTSDLDNIQNTLNQALVSVISNAAVFVGVIIQIFNKD
VTFAWLTVAASPVAILSAVIIIRQSKKATDKQQEEVSQLNAYMDEKISGQKAIIVEGLQE
DSINGFLEHNENVKKRTFAAQAWSGMIFPLMNGFQLLSIAIVIFGGTAYVLNDDSMSIAT
GLGLLVAFVQYVQSYYNPIMQISSNFGQLQLAITGATRLNVMFDEPEEVRPENGKKFDTI
KDGIQIENLDFEYLPGKPVLKKVNIDVKKGQMVALVGPTGSGKTTVMNLMNRFYDVNGGA
IKFDGTDIREFDLDSLRSNVGIVLQESVLFDGTIADNIKFGKPNATQEEIETVAKTTHIH
DFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQQIQ
WAMEAAIAGRTSFVIAHRLKTILNADKIVVLKDGEVIEEGNHHELVAQGGFYSELYHNQF
VF
>YP_174574.1|FEATURES|CARD|multidrug|clbC|antibiotic target alteration|1
MKVVNHATKYERLKHFLNALNEPTYRYKQITEAIFKHRIGAFNKMTTLPKALRESLINEF
GPSILTVEPVLETTSQQVTKVLLKVAGNNQVEAVRMHYEAGWESFCISSQCGCGLGCTFC
STGAIGLKQNLSADEMTDQLLYFYLKGHSLDSVSFMGMGEALANVRIFDALNVLVDRQLF
ALSPRRITVSTVGIIPNIQRMTSSFPQMNLTFSLHSPFHDQRSELMPINNKYPLDQVMNV
LDQHIHETGRKVYIAYVMLRGVNDSEKHAEALVKRILNNRYPHLYHVNLIRYNPTVGTPE
NYGQTIEEKLQTFYRVVKSARIPVTIRSQFGREIDAACGQLYGQYQAKKR
>NP_252244|FEATURES|CARD|polymyxin|arnA|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
PEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQ
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELG
LVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKA
DPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVR
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
QQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTD
VDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAG
FREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREA
QA
>AFK13828.1|FEATURES|CARD|multidrug|ramA|antibiotic efflux|0
MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGE
SLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENH
SRAH
>AAV85981.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|0
MAKMMKWSAVAAVAAAAVWGGWHYLKPEPQAAYITETVRRGGISRTVSATGEISPSNLVS
VGAQASGQIKKLYVKLGQQVKKGDLIAEINSTTQTNTLNMEKSKLETYQAKLVSAQIALG
SAEKKYKRQTALWKDDATSKEDLESAQDALAAAKANVAELKALIRQSKISINTAESDLGY
TRITATMDGTVVAIPVEEGQTVNAAQSTPTIVQLANLDMMLNKMQIAEGDITKVKAGQDI
SFTILSEPDTPIKAKLDSVDPGLTTMSSGGYNSSTDTASNAVYYYARSFVPNPDGKLATG
MTTQNTVEIDGVKNVLLIPSLTVKNRGGKAFVRVLGADGKAAEREIRTGMRDSMNTEVKS
GLKEGDKVVISEITAAEQQESGERALGGPPRR
>AHL39333.1|FEATURES|CARD|beta_lactam|ACT-28|antibiotic inactivation|1
MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGATRLYANASIGLFGA
LAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAIHVSPGMLDAEA
YGVKTNIQDMASWLKANMNPDALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>AGZ83155.1|FEATURES|CARD|beta_lactam|OXA-359|antibiotic inactivation|1
MYKKAFIVATSLLFLSACSSNTVEQHQIYSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTEYVPASIFKMLNALIGLEHHKATATEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQEAQF
AYQLAHKTLPFSKDVQEQVQSMVFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVIQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AFN21551.1|FEATURES|CARD|beta_lactam|TEM-19|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABK33456.1|FEATURES|CARD|aminoglycoside|APH(3'')-Ib|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLLVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>BAJ17544.1|FEATURES|CARD|beta_lactam|CMY-59|antibiotic inactivation|1
GPGHLFAFNYGTDFMMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIP
GMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLS
DPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGA
KRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREG
KPVHASPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMY
QGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYV
AFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>AGU69250.1|FEATURES|CARD|beta_lactam|OXA-312|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASALPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AJO16043.1|FEATURES|CARD|beta_lactam|DHA-10|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDEVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>CAP12352.2|FEATURES|CARD|beta_lactam|LEN-24|antibiotic inactivation|1
MRYVRLCVISLLANLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>CAE50926.1|FEATURES|CARD|aminoglycoside|AAC(6')-Iih|antibiotic inactivation|1
MIISEFDRDNLVLRDQLADLLRLTWPDEYGEQPMKEVERLLEDERIAVSAIEGDELIGFV
GAIPQYGQTGWELHPLVVESMYRKQQVGTRLVSYLEKEIASQGGIVVYLGTDDVEGQTSL
AIEEDLFEDTFDKLETIQNRKDHPYEFYEKLGYQIVGVIPDANGWNKPDIWMAKRIARKH
GSE
>BAE77781.1|FEATURES|CARD|multidrug|mdtE|antibiotic efflux|1
MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYE
VAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARI
TFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVS
GKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPV
QLNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQN
VLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGL
QRIRPGIKARAISSSQENASTESKQ
>NP_274718.1|FEATURES|CARD|multidrug|mtrD|antibiotic efflux|1
MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLRATYPGASAQVMEDS
VLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQVEVQNKLSEVLSTLPA
TVQQYGVTVSKARSNFLMIVMLSSDVQSTEEMNDYAQRNIVPELQRIEGVGQVRLFGAQR
AMRIWVDPKKLQNYNLSFADVGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGT
AEEFGNVILRANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMAT
AKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVFVVMYLFLQNI
RYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVIGIVVDDAIVVVENVERIMAG
EGLPPKEATKKAMGQISGAVIGITAVLISVFVPLAMFSGATGNIYKQFALTMASSIAFSA
FLALTLTPALCATMLKTIPKGHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMV
VYIGLAVVGVFLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPE
IENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMMMGTLKDGFGI
AVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQKMRASGLFDPSTVRAGGLED
SPQLKIDINRAAAAAQGISFADIRTALASALSSSYVSDFPNQGRLQRVMVQADEDARMQP
ADILNLTVPNKSGVAVPLSTIATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAA
VQKMVDELGGGYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVIL
VIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNAILIIEFAKDL
QAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAGGASSASQRAIGTTVFWGMLI
GTLLSVFLVPLFYVVVRKFFKETAHEHEMAVKHAAEAGITGSDDSQH
>AAD03496.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ix|antibiotic inactivation|1
MNIMPISESQLSDWLALRSLLWPDHDDAHLLEMHQLLKQTDTLQLLAYTDSQQAVAMLEA
SIRHEYVNGTQTSPVAFLEGIYILPEYRRSGIATQLVQYVEEWAKQFACTEFASDAAIDN
TISHAMHRALGFHETERVVYFKKNIG
>AAC05822.1|FEATURES|CARD|rifampin|arr-1|antibiotic inactivation|1
MVANPPKPFEVHESGAYLHGTKADLKVGDRLVPGRESNFEAGRIMKHVYITQTLDAAVWG
AELAVGEGRGRIYIVEPEGEIEDDPNVTDKKLPGNPTRSYRTREPVRIVGELTDWEGHSP
EQIAAMREGLEDLRRKGLAVIYD
>AAD51345.1|FEATURES|CARD|multidrug|smeB|antibiotic efflux|1
MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENA
VTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQ
AVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQ
EYAMRIWLDPEKMRQYALMPWDIETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRL
HTPEQFAQVVLKADANGSVVRLGDVAKIGLGPESYDSISTFNGKPSASLGIELNAGANAI
AVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIILVVLVMYLFLQ
NWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVM
TFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMIL
SVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVD
RFLGRRTLGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMD
RLSAVAVKDDGVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTRAMAS
VPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRY
ASLEDAPVYAVKVDDAKAQAMGVNPQDVNDTLNAALGGDFVNNFIYKGRIKKVFIQGTAE
ARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAAVQRYNGISAMEITGQPAPGVSSG
EAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVP
FAVMLAVPVGMFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGKS
TREAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGM
FFVPLFYLLVRRLFPGRAPADATVPETSP
>YP_008997285.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>AAD52985.1|FEATURES|CARD|aminoglycoside|AAC(6')-Iz|antibiotic inactivation|1
MIASAPTIRQATPADAAAWAQLRLGLWPDADDPLEELTQSLADAEGAVFLACAADGETVG
FAEVRLRHDYVNGTESSPVGFLEGWYVQPQWQGSGVGRALLAAVQAWTRDAGCRELASDS
RVEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>BAN04743.1|FEATURES|CARD|quinolone|QnrB60|antibiotic target protection|1
MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG
>AHB39758.1|FEATURES|CARD|trimethoprim|dfrA15|antibiotic target replacement|1
MKLSLMAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKVDTLHISTIDI
EPEGDVYFPEIPSSFRPVFSQDFVSNINYSYQIWQKG
>AAK01167.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|msrC|antibiotic target protection|1
MENLAVNITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQG
KIQTEITFNYLPQLTYLAEAKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSY
EQGMLLDEPTTHLDRKSMDRLIEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIREF
PENYSAYLTQRELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRP
DRLSSSKQKDSVQKAIQKNTKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHNRYPIMG
QNIQLERSGRTLLINSDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQV
YQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTI
ALLFTKPSNVLLLDEPTNFIDVATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIK
GQKIKKVLTRNF
>BAE78083.1|FEATURES|CARD|multidrug|mdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>BAA07072.1|FEATURES|CARD|multidrug|pp-flo|antibiotic efflux|1
MTTLHPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSVLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCGRVGWRCLFAAVLLGIGELY
GSLNSSPSSYRCGLSRSVLSSRCPLPRTALLAEFDDIAGSAVAFYFCVQSLIVSIVGTLA
VALLNGDTAWPVIC
>BAJ10053.1|FEATURES|CARD|fosfomycin|FosC2|antibiotic inactivation|1
MLRGLNHITIAVSDLERSVEFYTRLLGMKAHVRWDSGAYLSLEATWICLSCDEVHPSQDY
CHIAFDVSEENFEPVTKKLREAHVVEWKQNRSEGLSLYLLDPDGHKLEIHSGSLQSRLES
LKSKPYQGLVWL
>CAJ51085.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTQHNEIIKIAEKHQLHIKPQTISLNESGLDFQVAFGEDEHGIEWVLRLPRRPDVYKRTK
PEKQMVDFLQKNVSFEVPNWKVHTKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPVTKN
FINTLAETLVDLHNIPEENITAHHINIKTIQEIKNDFQRRMNKVRETYGVADGLWNRWKQ
WLENDELWPRRATMIHGDLHPGHIMVDNQANVTGLIDWTEATYSDPSMDFMGYHRVFDDE
GLEQLITAYDKAGGETWPRMKEHIIELNAVFPMFIAEFAMESGEPAYEKMALQELGMKE
>WP_063978071.1|FEATURES|CARD|aminoglycoside|sgm|antibiotic target alteration|1
MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEI
YGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELF
RHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNV
ADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGM
FQNYSQSFESQARERSCRIQRLEIGNELIYVIQK
>AMP35312.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|vgaC|antibiotic target protection|0
MRTVSIFKNGNNRAIRLPRDLDFDGVSELEIVREGDSIILRPVRPTWGSFAQLDRADPDF
MAEREDVVSDEGRFEP
>AGI04227.1|FEATURES|CARD|aminoglycoside|APH(3')-VI|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFELMITKAINAKPISALFLTDQELLAIYKEALNLLNSVA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDAELWGDHRTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYFLKLDELN
>BAE06005.1|FEATURES|CARD|chloramphenicol|mexM|antibiotic efflux|1
MQALRSGGGRVLVGVLAAGLVAFGGWAWLGGDAGAKAAPAPARVPVIVARVERRDVEQQV
SGIGTVTSLHNVVIRTQIDGQLTRLLVSEGQMVEAGELLATIDDRAVVAALEQAQASRAS
NQAQLKSAEQDLQRYRSLYAERAVSRQLLDQQQATVDQLRATLKANDATINAERVRLSYT
RITSPVSGKVGIRNVDVGNLVRVGDSLGLFSVTQIAPISVVFSLQQEQLLQLQALLGGEA
AVRAYSRDGGSALGEGRLLTIDNQIDSSTGTIRVRASFDNRQARLWPGQFVAVSLHTGVR
RDQLVLSSKAVRRGLEGNFVYRVADDRVEAVPVRVLQDIDGLSVVEGLASGDQVVVDGHS
RLMPGALVDIQEPRPSLAQATERRP
>AJP77085|FEATURES|CARD|beta_lactam|ESP-1|antibiotic inactivation|1
MKKLTLILSLIIAFFGYAQTVTEPTNHSAEWSQPYEPFRIVGNLYYVGTYDLASYLIVTE
KGNILINTGLADSYPQIKANIEKLGFKYKDTKILTLTQAHFDHMGAMADIKAETGAKLYV
DEADAAELKSGGKSDYELGKYGVTFKPLTPDFLLKNNGKIKLGNTTLTLLHHPGHTKGSC
SFIFETKDENRKYKVVIANMPSIIIDHKFSDVKTYPSIQKDYAYTLEAMKKLDFDVWVAS
HASQFDLHKKRKEGDAYNPKLFMDKENYFKRLKDLEDDYLEKVKEENKPE
>AJP77057|FEATURES|CARD|beta_lactam|MSI-1|antibiotic inactivation|1
MGARSCSRAWCCSRATRSAPPGRRSGRLSCARCRRPSTGCNPSSTPPITGDIMKHIRLAC
VAAGLVAAASSVSAIGADWNAPQEPFALFGNSYYVGPHGVASVLITSNQGHILIDGGSDK
SPPQIAARIRQLGFKPEDIRFILVSHEHIDHAGGVAELQRLSNAEVLAGAAAVPVLHSGE
AGRNDPQYGGLPKMAPVARVRAVRDGEVVKLGPLAVTMHATPGHTQGGASWTWQSNEGGR
TANMVYADSLTAFGSGGFRYSGDARYPSARADVERSIAKVAALPCDILVSAHPEVSELWT
RYERRAAQGNAAFIDAGACKAYAVKARVKLQEQLARETAKP
>NP_627787|FEATURES|CARD|glycopeptide|vanJ|antibiotic target alteration|0
MVLRSAARPELWKRAPVLTVSALLLGLVMMLHAEIPNRFGSVGSLVETFLPWFGLFVPVL
AAGALWRRSAAAVTALVLPVTVWLSLFGGLLGDKSGAGGEFTMASHNVGAENPDPAGTAR
DLAASGVDVLALEEITAQDREVYEKGLAREYPYHTVQGTVGLWSKLPLSGTRPVDIATDY
GPLADTKPADVTMAGNRALRTTVATERGPLVVYVAHLGSVRLNPRAGFWTDSRDRNAWAL
GEALAADRSERIALLGDLNGTVDDRALAGITSQLHSVQEAAGNGFGFTWPAKFPVARIDQ
ILVRGVEPTGSWTLPATGSDHLPVAAGVSW
>AEP96393.1|FEATURES|CARD|glycopeptide|vanI|antibiotic target alteration|1
PKFRTVTAKETIDAERLAYPVYVKPARSGSSFGVTKVCRQEELLSAVEIARQYDSKVLIE
EAVVGSEVGCAIFGNDLDLMAGEVDQICLSHGFFRIHQENEPEKGSENSTLIVPADISPE
ARSRVQETAKAIYRALGCRGLARVDMFLKEDGTVILNEVNTLPGMTSYSR
>NP_465220|FEATURES|CARD|peptide|mprF|antibiotic target alteration|0
MKEKLMQAYAWFQKNSTVVKIVFITFVMAFVIFEIINIATGIDYPSLKENLTSQSPEQIF
IMFIVGLIAVTPMLLYDYVIVKLLPGKFSPSHVIASGWITNTFTNIGGFGGVLGASLRAS
FYGKNASHKEILLAISKIALFLVSGLSIYCLVSLATLLIPGFADHFVNYWPWLLAGGLYF
PILFTITKWKSKSLFVDLPIKRELTLIIASLLEWGFAFGCFAIIGTLMGEPVDIFKVFPL
FVIASVIGIASMVPGGVGTFDVVMILGLSQLGVSQELALAWMLFYRIFYYIIPFVVGLLF
FVQKAGKKVNDFLEGLPLLFLQKVAHRFLVIFVYGSGLLLILSSAVPNAIYHVPFLYKIM
PFNFLFTSQITIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIF
LGIVLLCLFLARNEFYREKLVYTWSKVIIDSIIFIVCLAGYIVIGIYNSPNIKHSKEIPD
YLRIASEHLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWGGNEVS
HTMFLRDKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRP
VFYEVRGTMIPYLHDHGFDFIKLGEEGFVDVQNFTMSGKKKKGERALMNKLEREGYTFEI
IEPPFNHDTWTTLRAVSDEWLDGREEKGFSLGFFDTYYLEQAPIAIAKNGEGTIVGFASM
MPSYTDEMTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYA
FLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGK
KRPLANSQVVLDFPLEEETKKPDSE
>AAS13767.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|Mrx|antibiotic inactivation|0
MSERRYSPLATLFAATFLFRIGNAVAALALPWFVLSHTKSAAWAGATAASSVIATIIGAW
VGGGLVDRFGRAPVALISGVVGGVAMASIPLLDAVGALSNTGLIACVVLGAAFDAPGMAA
QDSELPKLGHVAGLSVERVSSLKAVIGNVAILGGPALGGAAIGLLGAAPTLGLTAFCSVL
AGLLGAWVLPARAARTMTTTATLSMRAGVAFLWSEPLLRPLFGIVMIFVGIVGANGSVIM
PALFVDAGRQVAELGLFSSMMGAGGLLGIAIHASVGARISAQNWLAVAFCGSAVGSLLLS
QLPGVPVLMLLGALVGLLTGSVSPILNAAIYNRTPPELLGRVLGTVSAVMLSASPMVMLA
AGAFVDLAGPLPGLVVSAVFAGLVALLSLRLQFATMAAAATASAPTHTEGEH
>WP_063857787.1|FEATURES|CARD|beta_lactam|ADC-12|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKSVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKEWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDTQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGSYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>XP_753111.1|FEATURES|CARD|multidrug|abcA|antibiotic efflux|1
MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNA
RAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAF
GQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGI
AKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVI
MAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEF
CKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFV
CPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAK
FALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLF
GNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSR
YALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMS
MFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESL
MINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASH
KWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGR
SATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVS
GAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEF
SALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAAR
PQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAG
GRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRR
SPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQ
IWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPH
FVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTD
AVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQ
LPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLG
GYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVR
VPRDKKPVAKAE
>CDO61513.1|FEATURES|CARD|multidrug|efrA|antibiotic efflux|1
NILLGYFGARITTNIVRDIRDDLFEKIQTFSHSEYESIGVSSLITRTTNDAYQIMLFMGN
ILRLGFMTPVMFIASLYMVMRTSPSLGMYVLGALPFLLLAVVGIARLSEPLSKKQQKNLD
GINGILRENLSGLRVIRAFVNEKFEESRFNKVNETYTKSSKSLFRLMAAAQPGFFFLFNI
VMVLIIWSGTVQISHGDLEVGNLIAFIEYIFHALFSFMLFASVLMMYPRAAVSASRIQEA
LDMEPAIREEEGVTETATKGYLEFKNVTFAYPGHAESPVIRNVSFKASPGETVAFIGSTG
SGKSTLIQLIPRFYDVSEGEILIDGVNVKEYKLSALRNKIGYIPQKALLFTGTIADNLRY
GKEDATLEEMERAIDIAQATEFVSQKPQGYDEPLSEGGTNFSGGQKQRLAIARAIIRNPE
IYIFDDSFSALDYQTDANLRARLKKETTESTVLIVAQRVGTIMHADRIVCFKRRRRGRKF
GHQPF
>NP_207975.1|FEATURES|CARD|multidrug|hp1184|antibiotic efflux|0
MLIKKIDLHKDPIRKLFFYYFIPLAFSMISLSTYSMIDGMFVGKKLGKEAIAAVNIAWPI
FPGLIAYELLFGFGAASIVGYFLGQNKTHRARLVFSSVFYFVAISAFILSMALLPFSETI
ARFFGSNDALLSMSKRYIEIILMGAVFMVLHPLADVFVVNDKRPILAMVAMLIGSLANIF
FNYLFIFVLKVGVQGSAIATVIGHAIGVLVLMQHFWRKKGQLYFIKRFSLSSVISSAKSG
VPQSTAEFSASVMILLFNTAIMHTAGERFVSMYGIVMYNAIIFFTTLFAISQGIQPIASF
SYGARNLERVKEVFVFGLKAAFCIGIVFYGAYYFLDEFLIKLYLQPSEQDPLFMQETKRA
MNIYYVGYIFLGMTLLCAVFFQSIQRTKSSFIITLSHTLGFIVILLPILSHFYGINGVWV
TYPIAQFLAFLVALGVTYYEIKKGVFTTYKEKNPIALKT
>APB03216.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|LlmA|antibiotic target alteration|0
MYVAQDWQDYEVIDTGGGEKLERWGDVILRRPDPQIIWPIEREDGQWRSVHGHYHRSSSG
GGQWDMKKQLPDRWTISYDQLKFHIRPTNFKHTGLFPEQAANWRWMMDKIASAGRPVSVL
NLFAYTGGATVAAASAGAQVVHVDAAKGMVQWAKENAALSGLADRPIRYITDDVFKFVQR
EQRRGNKYDAIIMDPPSYGRGPSGETWKLEQSLYPFLESCMSIVSDNPLFMLINSYTTGI
SPTVLNNMLTMTMKPKYGGTISAGEIGLPITRSGMNLPCGILGRWES
>APB03220.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
MTGPNPNERYPIPGDNNLQFIKNTITKPNIIAGDYSYYYALNGESFEDQVLYHYEFIGTK
LMIGKFCSIASEVRFMMDGGNHRMDGSTFPFNIFGNGWEKFTPSLDQLPIKGDTIIGNDV
WIGRRATIMSGVRIGDGAIIAAEAVVVKDVEPYTIVGGNPAKDIRKRYSTEVIQELLDIK
WWDCDIEVINQYIGAIVSGDMDLLRKMRQN
>WP_063857800.1|FEATURES|CARD|beta_lactam|ADC-39|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ANP63073.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIQDIQSLAEAHGLLLTDKMNFNEMGIDFKVVFALDTKGQQWLLRIPRRDGMREQIKKE
KRILELVKKHLSVEVPDWRISSTELVAYPILKDNPVLNLDAETYEIIWNMDKDSPKYITS
LAKTLFEIHSIPEKEVRENDLKIMKPSDLRPEIANNLQLVKSEIGISEQLETRYRKWLDN
DVLWADFTQFIHGDLYAGHVLASKDGAVSGVIDWSTAHIDDPAIDFAGHVTLFGEESLKT
LIIEYEKLGGKVWNKLYEQTLERAAASPLMYGLFALETQNESLIVGAKAQLGVI
>NP_414996.1|FEATURES|CARD|multidrug|acrA|antibiotic efflux|1
MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPI
SGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
LNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVV
ISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>YP_007652797.1|FEATURES|CARD|bleomycin|bleomycin|antibiotic inactivation|0
MADHVTPNLPSRDFDVTEAFYAKLGFATSWKDRGWMILQRGGLQLEFFPYPDLDPATSSF
GCCLRLDDLDAMVALVNAAGAEEKSTGWPRFKAPQLEASGLRIGYLIDPDCTLVRLIQNP
D
>NP_251184.1|FEATURES|CARD|multidrug|MexF|antibiotic efflux|1
MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVASPLEQAITGVENMLYMSSQSTSDGKLTLTITFALGTDLDNAQVQVQNRVTRTEPKL
PEEVTRLGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAVLNVKDELARLDGVGDVQLF
GLGDYSLRVWLDPNKVASRNLTATDVVNAIREQNRQVAAGTLGAPPAPSDTSFQLSINTQ
GRLVTEEEFENIIIRAGANGEITRLRDIARVELGSNQYALRSLLNNKPAVAIPIFQRPGS
NAIEISNLVREKMAELKHSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVIL
FLQTWRASIIPLAAVPVSLIGTFAVMHMLGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIGLGLKPVEATKRAMREVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAIST
VISAFNSLTLSPALAAVLLKGHHEPKDRFSVFLDKLLGSWLFRPFNRFFDRASHGYVGTV
NRVLRGSSIALLVYGGLMVLTYFGFSSTPTGFVPQQDKQYLVAFAQLPDAASLDRTEAVI
KQMSEIALAQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAGAIAAAL
NAKYADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNQGYEELFKQTQNIITKARALPE
LEPSSVFSSYQVNVPQIDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQ
VNVQAEQQFRLEPEQIGQLKVRNNLGEMVPLASFIKVSDTSGPDRVMHYNGFITAELNGA
PAAGYSSGQAQAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVLA
AQYESWSLPLAVILIVPMTLLSAITGVILAGSDNNIFTQIGLIVLVGLACKNAILIVEFA
KDKQEEGMDRVAAVLEACRLRLRPILMTSIAFIMGVVPLVISTGAGAEMRHAMGVAVFSG
MIGVTFFGLLLTPVFYVLIRRFVENREARRAANDKGLPEVHA
>NP_249118.1|FEATURES|CARD|multidrug|OprM|antibiotic efflux|0
MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREF
FRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDL
STTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVAT
AYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQY
TRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLM
AANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRAS
LDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKR
YRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKK
EDPQA
>NP_251216.1|FEATURES|CARD|multidrug|MuxC|antibiotic efflux|1
MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMA
SSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLP
SGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGS
SLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKARE
YEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATD
AIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRA
TLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGD
PPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVS
LTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACI
AMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVG
FIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGR
DSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAAT
LGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQR
VPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQ
TSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLAL
ILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIM
MTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWV
NQKRGVRTDGALETPL
>EGP45230|FEATURES|CARD|multidrug|OprZ|antibiotic efflux|0
MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAW
IAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNR
YRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQ
LRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHAL
GLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARA
AFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIA
VAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEM
LEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS
>EGP45232.2|FEATURES|CARD|multidrug|AxyX|antibiotic efflux|1
MTHRVPFRTLAFASVLVLVSACSKQEAPEAAKAPAEVGVIVARATPTAVASELPGRLEPY
REAEVRARVAGIVTRRLYEEGQEVTRGTPLFQIDPAPLQAAYDSEAAALARAQANLSAAA
DKLRRYADLVSDRAISERDHAESVAQERQARAEVALAKANLQSARLRLEYARVTSPIDGR
ARRALVTEGALVGEGQATPLTVVQQLDPIYVNFSQPAAEVMQLQKQIRAGALQGVAPDKM
RVRLLLPDGSEYGQGGTLSFADLAVDPGTDNVTMRALFANPGRELLPGMYVRVRLEQAVN
RDTFLVPRNALLRNADGAHVLVAGDDGELRSVAVTAHRLLGPNWVVTEGLAGGERVVVEN
AAQLAPGQKIKPVERTAPSAPVATAGNNEKR
>YP_001255356.1|FEATURES|CARD|multidrug|cfrC|antibiotic target alteration|1
MKQTKTKYGKMKQIASNLKLPDYRYEQLTKAIFHQRIDNFHDMHILPKALRIALVNEFGK
NVSSVTPIFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCSFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAIIGLLRNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCSTLKKASISATVRTQFGSEISAACGQLCYENEL
>BAD59497.1|FEATURES|CARD|rifampin|rpoB|antibiotic target alteration|0
MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDW
CARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAA
PWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAI
DKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAER
FGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARV
GRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHF
GNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGT
SQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPN
IGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGR
FLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQR
QAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMR
KFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYED
AIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIG
AEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVF
SREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPV
DIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPV
FDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHL
VDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDV
VGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHER
TAANLGINLSRAESITETELSG
>CAD31707.1|FEATURES|CARD|chloramphenicol|cmlA5|antibiotic efflux|1
MDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAN
VVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLA
MVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLP
VKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFM
GRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWALQSVLGFIAPMWLVGIGVATAVSVAP
NGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLS
CVSRVKGSRGQGEHDVVALQSAGSTSNPNR
>AAW34150.1|FEATURES|CARD|aminoglycoside|APH(2'')-If|antibiotic inactivation|1
MDIKKIIEEKCNIVVDSIKLIGEGYDSKAYIVNNEYVFKIKFSANKKKGYEKEKAIYDFL
NKKLNTNIKIPNIEYSYISEELSILGYKEIKGTFLTPEIYFALSKEKQELLKQDIAMFLR
QMHDLDYSEISSYTIDNKQNVLEEYQLLKETIYDSLTDIEKQYVEEFMQRLNSTTIFDGK
KCLCHNDFSCNHLLLDDENRLCGVIDFGDSGIIDEYCDFIYLLEDSEEEIGVSFGEDILR
LYGNIDISKAKEYQDVVEQYYPIETIVYGIKNNRPDFIEKGRKEIYIRTRKDEKLRK
>WP_029424536.1|FEATURES|CARD|beta_lactam|ADC-80|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYIVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>WP_059262723.1|FEATURES|CARD|beta_lactam|ADC-81|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGW
EEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENI
GLVMLTNKRIPNEERIKAAYAVLDAIKK
>AKR18015.1|FEATURES|CARD|beta_lactam|PDC-75|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPRPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18024.1|FEATURES|CARD|beta_lactam|PDC-84|antibiotic inactivation|1
GEAPADRLKALVDAAVQPAMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPIAERVKIAYAILSG
LEQQAKVPLKR
>NP_252264.1|FEATURES|CARD|multidrug|nalD|antibiotic efflux|0
MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTRGAVYWHFQNKAHLFNE
MLNQVRLPPEQLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTE
ELREAQERNNAFVQMFIELCEQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRD
PRLFDPDTDAEHLLEPMFRGLVRDWGQASSAP
>NP_216424.1|FEATURES|CARD|isoniazid|katG|antibiotic target alteration|0
MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQNPAVADPMGA
AFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAGTYRIHDGRG
GAGGGMQRFAPLNSWPDNASLDKARRLLWPVKKKYGKKLSWADLIVFAGNCALESMGFKT
FGFGFGRVDQWEPDEVYWGKEATWLGDERYSGKRDLENPLAAVQMGLIYVNPEGPNGNPD
PMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAGPADLVGPEPEAAPLEQMGLGW
KSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWELTKSPAGAWQYTAKDGAG
AGTIPDPFGGPGRSPTMLATDLSLRVDPIYERITRRWLEHPEELADEFAKAWYKLIHRDM
GPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASLKSQIRASGLTVSQLVSTAWAAA
SSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVIRTLEEIQESFNSAAPGNIKVSF
ADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQTDVESFAVLEPKADGFRNYLGK
GNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANYKRLPLGVFTEASESLTNDFFVN
LLDMGITWEPSPADDGTYQGKDGSGKVKWTGSRVDLVFGSNSELRALVEVYGADDAQPKF
VQDFVAAWDKVMNLDRFDVR
>YP_500802.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MIELLSIALKHSNIILNSIFIGAFILNLLFAFTIIFMERRSANSIWAWLLVLVFLPLFGF
ILYLLLGRQIQRDQIFKIDKEDKKGLELIVDEQLAALKNENFSNSNYQIVKFKEMIQMLL
YNNAAFLTTDNDLKIYTDGQEKFDDLIQDIRNATDYIHFQYYIIQNDELGRTILNELGKK
AEQGVEVKILYDDMGSRGLRKKGLRPFRNKGGHAEAFFPSKLPLINLRMNNRNHRKIVVI
DGQIGYVGGFNVGDEYLGKSKKFGYWRDTHLRIVGDAVNALQLRFILDWNSQATRDHISY
DDRYFPDVNSGGTIGVQIASSGPDEEWEQIKYGYLKMISSAKKSIYIQSPYFIPDQAFLD
SIKIAALGGVDVNIMIPNKPDHPFVFWATLKNAASLLDAGVKVFHYDNGFLHSKTLVIDD
EIASVGTANMDHRSFTLNFEVNAFIYDQQIAKKLKQAFIDDLAVSSELTKARYAKRSLWI
KFKEGISQLLSPIL
>YP_039482.1|FEATURES|CARD|bacitracin|uppP|antibiotic target alteration|0
MVTALSDVNNTDNYGAGQIQVLEGLEAVRKRPGMYIGSTSERGLHHLVWEIVDNSIDEAL
AGYANQIEVVIEKDNWIKVTDNGRGIPVDIQEKMGRPAVEVILTVLHAGGKFGGGGYKVS
GGLHGVGSSVVNALSQDLEVYVHRNETIYHQAYKKGVPQFDLKEVGTTDKTGTVIRFKAD
GEIFTETTVYNYETLQQRIRELAFLNKGIQITLRDERDEENVREDSYHYEGGIKSYVELL
NENKEPIHDEPIYIHQSKDDIEVEIAIQYNSGYATNLLTYANNIHTYEGGTHEDGFKRAL
TRVLNSYGLSSKIMKEDKDRLSGEDTREGMTAIISIKHGDPQFEGQTKTKLGNSEVRQVV
DKLFSEHFERFLYENPQVARTVVEKGIMAARARVAAKKAREVTRRKSALDVASLPGKLAD
CSSKSPEECEIFLVEGDSAGGSTKSGRDSRTQAILPLRGKILNVEKARLDRILNNNEIRQ
MITAFGTGIGGDFDLAKARYHKIVIMTDADVDGAHIRTLLLTFFYRFMRPLIEAGYVYIA
QPPLYKLTQGKQKYYVYNDRELDKLKSELNPTPKWSIARYKGLGEMNADQLWETTMNPEH
RALLQVKLEDAIEADQTFEMLMGDVVENRRQFIEDNAVYANLDF
>AAK46002.1|FEATURES|CARD|aminoglycoside|tlyA|antibiotic target alteration|0
MARRARVDAELVRRGLARSRQQAAELIGAGKVRIDGLPAVKPATAVSDTTALTVVTDSER
AWVSRGAHKLVGALEAFAIAVAGRRCLDAGASTGGFTEVLLDRGAAHVVAADVGYGQLAW
SLRNDPRVVVLERTNARGLTPEAIGGRVDLVVADLSFISLATVLPALVGCASRDADIVPL
VKPQFEVGKGQVGPGGVVHDPQLRARSVLAVARRAQELGWHSVGVKASPLPGPSGNVEYF
LWLRTQTDRALSAKGLEDAVHRAISEGP
>AAC75291.1|FEATURES|CARD|beta_lactam|ampC|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNV
AAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVV
VTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVY
SMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVL
TEFNRLRTAGKVAIKLVDGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTG
VRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERN
GLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTAEDENVVGLQRVA
EPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE
>YP_007503908.1|FEATURES|CARD|fosfomycin|fosB|antibiotic target alteration|0
MSNTYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGYCKDII
VTIHNDNSVSVQDDGRGIPTGIHEEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGV
SVVNALSEKLELVIRRDGKVHEQIYRHGEPQDRLTVVGETDKTGTRVRFWPSMDTFKGET
EFQYDILAKRLRELSFLNSGVSIRLIDKRDGKEDHFHYEGGIKAFVEYLSRAKTSIHNNV
FYFSTEKDDIGVEISMQWNDSFQENVYCFTNNIPQRDGGAHLAGFRAAMTRTLNSYIEKE
GLNKKSKVSTTGDDAREGLVAVISVKVPDPKFSSQTKDKLVSSEVKTAVETLMNEKLSEY
LDENPNDTKIIVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPAFSEL
YLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLASQEVATLITALGCGIGR
DEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIIERGYVYIAQPPLYKVKKG
KQEQYIKDDEAMEQYQVSIALDGAALYVNENAAPIQGEHLEKLLHEYNGAHKIIRRLERL
YPLALLNSLVYQPKLEESALLNKTEVEAWAQSLTERLTRHEEHGSTYSYRIAENKERQLF
EPVLTIRTHGVDTDYNLDFDFVHGSEYARISKLGELIRGLIEEGAYVVRGERRQNVSNFE
QALDWLMKESRRGLAVQRYKGLGEMNPEQLWETTMNPETRRMLQVTVKDAIATDQLFTTL
MGDDVEPRRAFIEENALKAANIDV
>CAC29732.1|FEATURES|CARD|sulfonamide|folp|antibiotic target alteration|1
MSLAPVQVIGVLNVTDNSFSDGGRYLDPDDAVQHGLAMVAEGAAIVDVGGESTRPGAIRT
DPRVELSRIVPVVKELAAQGITVSIDTTRADVARAALQSGARIVNDVSGGRADPAMAPLV
AEAGVAWVLMHWRLMSAERPYEAPNYRDVVAEVRADLLAGVDQAVAAGVDPGSLVIDPGL
GFAKTGQHNWALLNALPELVATGVPILLGASRKRFLGRLLAGADGAVRPPDGRETATAVI
SALAALHGAWGVRVHDVRASVDALKVVGAWLHAGPQIEKVRCDG
>CAC29514.1|FEATURES|CARD|quinolone|gyrA|antibiotic target alteration|0
MTDITLPPGDGSIQRVEPVDIQQEMQRSYIDYAMSVIVGRALPEVRDGLKPVHRRVLYAM
LDSGFRPDRSHAKSARSVAETMGNYHPHGDASIYDTLVRMAQPWSLRYPLVDGQGNFGSP
GNDPPAAMRYCVSGNSLVRLLFGKSIRIGDIVTGAQFNSDNPIDLKVLDRHGNPVVADYL
FHSGEHQTYTVRTTEGYEITGTSNHPLLCLVNVGGIPTLLWKLIGEIRSGDYVVLQRIPP
VEFGPADWYSTMEALLFGAFISGGFVFQDHAGFNSLDRDYFTMVVNAYDTVVGGLRCISS
RITVSGSTLLELDVYNLIEFKKTRLSGLCGQRSADKLVPDWLWHSPSTVKRAFLQALFEG
EGFSSILSRNIIEISYSTLSERLAADVQQMLLEFGVVSERYCHTVNEYKVVIANRAQVEM
FFTQVGFGVTKQAKLIRDVVSMSPCVGMDINCVPGLATFIRKHCDNRWVEEDSFNQHNVD
CVQHWHHHSAEIVGHIADPDIRAIVTDLTDGRFYYARVASVTDTGIQPVFSLHVDTEDHS
FLTNGFISHNTEARLTPLAMEMLREIDEETVDFISNYDGRVQEPMVLPSRFPNLLANGSG
GIAVGMATNIPPHNLYELADAVFWCLENHDADEETMLVAVMERVKGPDFPTAGLIVGSQG
IADAYKTGRGSIRIRGVVEVEEDSRGRTSLVITELPYQVNHDNFITSIAEQVRTGRLAGI
SNVEDQGSDRVGVRIVIEIKRDAVAKVVLNNLYKHTQLQTSFGANMLSIVDGVPRTLRLD
QMICYYVEHQLDVIVRRTTYRLRKANERAHILRGLVKALDALDEVITLIRASQTVDIARV
GVVELLDIDDIQAQAILDMQLRRLAALERQRIIDDLAKIEVEIADLGDILAKPERRRGII
RNELTEIAEKYGDDRRTRIIAVDGDVNDEDLIAREEVVVTITETGYAKRTKTDLYRSQKR
GGKGVQGAGLKQDDIVRHFFVCSTHDWILFFTTQGRVYRAKAYELPEASRTARGQHVANL
LAFQPEERIAQVIQIRSYEDAPYLVLATRAGLVKKSKLTDFDSNRSGGIVAINLRDNDEL
VGAVLCAADGDLLLVSANGQSIRFSATDEALRPMGRATSGVQGMRFNADDRLLSLNVVRE
DTYLLVATSGGYAKRTSIEEYPMQGRGGKGVLTVMYDRRRGSLVGAIVVDEDSELYAITS
GGGVIRTTARQVRQAGRQTKGVRLMNLGEGDTLLAIARNAEESADGGVG
>BAA11086.1|FEATURES|CARD|aminocoumarin|grlB|antibiotic target alteration|0
MNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGNEI
DVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGVGA
SVVNALSEWLEVEIHRDGNIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFKAS
TSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVSYVNEGKEVLH
DVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDYAR
RINELKTKDKNLDGNDIREGLTAVVSVRIPEELLQFEGQTKSKLGTSEARSAVDSVVADK
LPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQSKN
TEKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIHTI
GAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPPLY
KLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETRTL
IRVQVEDEVRSSKRVTTLMGDKVQPRREWIEKHVEFGMQEDQSILDNSEVQVLENDQFDE
EEI
>AJF83452.1|FEATURES|CARD|peptide|lpxC|antibiotic target alteration|0
MVKQRTLNRVVKASGIGLHSGQKVMINFIPHTVDGGIVFRRIDLDPPVDIPANALLIQEA
FMCSNLVTGDIKVGTIEHVMSAIAGLGIDNLIVEVSASEVPIMDGSAGPFIYLLMQGGLR
EQDAPKKFIKILKPVEALIDDKKAIFSPHNGFQLNFTIDFDHPAFAKEYQSATIDFSTET
FVYEVSEARTFGFMKDLDYLKANNLALGASLDNAIGVDDTGVVNEEGLRFADEFVRHKIL
DAVGDLYLLGHQIIAKFDGYKSGHALNNQLLRNVQSDPSNYEIVTFDDEKDCPIPYVSVT
>AAB39605.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|1
MAKAKFERTKPHMNIGTIGHIDHGKTTLTAAITKVLHDRYPELNKATPFDKIDKAPEEKA
RGITISIAHVEYQTEKRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATAGPMPQTKE
HVLLARQVGVPYIVVALNKADMVDDEEILELVELEVRELLSAQEFPGDDLPVVRVSALKA
LEGDEKWADSIIELMNAVDENIPEPPRDTDKPFLMPIEDVFSITGRGTVVTGRIERGVVK
VNEQVDIIGIKSEKTTTTVTSIEMFNKMLDEGHAGDNAALLLRGIKREQVERGQCIIKPG
TTTPHTEFEAQVYILSKDEGGRHTPFFNNYRPQFYFRTTDVTGVVNLPEGTEMVMPGDNT
EMTVQLIQPIAMEEGLKFAIREGGRTVGAGRVTKILK
>NP_249649.1|FEATURES|CARD|aminoglycoside|APH(3')-Ia|reduced permeability to antibiotic|0
MKVMKWSAIALAVSAGSTQFAVADAFVSDQAEAKGFIEDSSLDLLLRNYYFNRDGKSGSG
DRVDWTQGFLTTYESGFTQGTVGFGVDAFGYLGLKLDGTSDKTGTGNLPVMNDGKPRDDY
SRAGGAVKVRISKTMLKWGEMQPTAPVFAAGGSRLFPQTATGFQLQSSEFEGLDLEAGHF
TEGKEPTTVKSRGELYATYAGETAKSADFIGGRYAITDNLSASLYGAELEDIYRQYYLNS
NYTIPLASDQSLGFDFNIYRTNDEGKAKAGDISNTTWSLAAAYTLDAHTFTLAYQKVHGD
QPFDYIGFGRNGSGAGGDSIFLANSVQYSDFNGPGEKSWQARYDLNLASYGVPGLTFMVR
YINGKDIDGTKMSDNNVGYKNYGYGEDGKHHETNLEAKYVVQSGPAKDLSFRIRQAWHRA
NADQGEGDQNEFRLIVDYPLSIL
>CAA52296.1|FEATURES|CARD|mupirocin|ileS1|antibiotic target alteration|0
MDYKETLLMPKTDFPMRGGLPNKEPQIQEKWDAEDQYHKALEKNKGNETFILHDGPPYAN
GNLHMGHALNKILKDFIVRYKTMQGFYAPYVPGWDTHGLPIEQALTKKGVDRKKMSTAEF
REKCKEFALEQIELQKKDFRRLGVRGDFNDPYITLKPEYEAAQIRIFGEMADKGLIYKGK
KPVYWSPSSESSLAEAEIEYHDKRSASIYVAFNVKDDKGVVDADAKFIIWTTTPWTIPSN
VAITVHPELKYGQYNVNGEKYIIAEALSDAVAEALDWDKASIKLEKEYTGKELEYVVAQH
PFLDRESLVINGDHVTTDAGTGCVHTAPGHGEDDYIVGQKYELPVISPIDDKGVFTEEGG
QFEGMFYDKANKAVTDLLTEKGALLKLDFITHSYPHDWRTKKPVIFRATPQWFASISKVR
QDILDAIENTNFKVNWGKTRIYNMVRDRGEWVISRQRVWGVPLPVFYAENGEIIMTKETV
NHVADLFAEHGSNIWFEREAKDLLPEGFTHPGSPNGTFTKETDIMDVWFDSGSSHRGVLE
TRPELSFPADMYLEGSDQYRGWFNSSITTSVATRGVSPYKFLLSHGFVMDGEGKKMSKSL
GNVIVPDQVVKQKGADIARLWVSSTDYLADVRISDEILKQTSDVYRKIRNTLRFMLGNIN
DFNPDTDSIPESELLEVDRYLLNRLREFTASTINNYENFDYLNIYQEVQNFINVELSNFY
LDYGKDILYIEQRDSHIRRSMQTVLYQILVDMTKLLAPILVHTAEEVWSHTPHVKEESVH
LADMPKVVEVDQALLDKWRTFMNLRDDVNRALETARNEKVIGKSLEAKVTIASNDKFNAS
EFLTSFDALHQLFIVSQVKVVDKLDDQATAYEHGDIVIEHADGEKCERCWNYSEDLGAVD
ELTHLCPRCQQVVKSLV
>CCE36834|FEATURES|CARD|fosfomycin|murA|antibiotic target alteration|0
MAERFVVTGGNRLSGEVAVGGAKNSVLKLMAATLLAEGTSTITNCPDILDVPLMAEVLRG
LGATVELDGDVARITAPDEPKYDADFAAVRQFRASVCVLGPLVGRCKRARVALPGGDAIG
SRPLDMHQAGLRQLGAHCNIEHGCVVARAETLRGAEIQLEFPSVGATENILMAAVVAEGV
TTIHNAAREPDVVDLCTMLNQMGAQVEGAGSPTMTITGVPRLHPTEHRVIGDRIVAATWG
IAAAMTRGDISVAGVDPAHLQLVLHKLHDAGATVTQTDASFRVTQYERPKAVNVATLPFP
GFPTDLQPMAIALASIADGTSMITENVFEARFRFVEEMIRLGADARTDGHHAVVRGLPQL
SSAPVWCSDIRAGAGLVLAGLVADGDTEVHDVFHIDRGYPLFVENLVSLGAEIERVCC
>ADL24064|FEATURES|CARD|fusidic_acid|fusE|antibiotic target alteration|0
MSRVGKKIIDIPSDVTVTFDGNHVTVKGPKGELSRTLNERMTFKQEENTIEVVRPSDSKE
DRTNHGTTRALLNNMVQGVSQGYVKVLELVGVGYRAQMQGKDLILNVGYSHPVEIKAEEN
ITFSVEKNTVVKVEGISKEQVGALASNIRSVRPPEPYKGKGIRYQGEYVRRKEGKTGK
>AJK71171.1|FEATURES|CARD|quinolone|gyrA|antibiotic target alteration|0
MENIFSKDSDIELVDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAMQNDEA
KSRTDFVKSARIVGAVIGRYHPHGDIAVYDALVRMAQDFSMRYPSITGQGNFGSIDGDSA
AAMRYTEAKMSKLSHELLKDIDKDTVDFVPNYDGSESEPDVLPSRVPNLLLNGSSGIAVG
MATNIPPHSLNELIDGLLYLLDSKDASLEEIMQFIKGPDFPTGGIIYGKKGIIEAYRTGR
GRVKVRAKTHIEKKTNKDVIVIDELPYQTNKARLIEQIAELVKEKQIEGISEVRDESNKE
GIRVVIELKREAMSEIVLNNLFKSTTMESTFGVIMLAIYNKEPKIFSLLELLNLFLTHRK
TVIIRRTIFELQKARARAHILEGLKIALDNIDKVIALIKNSSDNNTARDSLVAKFGLSEL
QANAILDMKLGRLTGLEREKIENELAELMKEIARLEEILKSETLLENLIRDELKEIRSKF
DVPRITQIEDDYDDIDIEDLIPNENMVVTITHRGYIKRVPSKQYEKQKRGGKGKLAVTTY
DDDFIESFFTANTHDTLMFVTDRGQLYWLKVYKIPEGSRTAKGKAVVNLINLQAEEKIMA
IIPTTDFDESKSLCFFTKNGIVKRTNLSEYQNIRSVGVRAINLDENDELVTAIIVQRDED
EIFATGGEENLENQEIENLDDENLENEESVSTQGKMLFAVTKKGMCIKFPLAKVREIGRV
SRGVTAIKFKEKNDELVGAVVIENDEQEILSISAKGIGKRTNAGEYRLQSRGGKGVICMK
LTEKTKDLISVVIVDETMDLMALTSSGKMIRVDMQSIRKAGRNTSGVIVVNVENDEVVSI
AKCPKEENDEDELSDENFGLDLQ
>BAA85265|FEATURES|CARD|polymyxin|arnC|antibiotic target alteration|0
MKKELSFHEKLLKLTKQQKKKTNKHVFIAIPIVFVLMFAFMWAGKAETPKVKTYSDDVLS
ASFVGDIMMGRYVEKVTEQKGADSIFQYVEPIFRASDYVAGNFENPVTYQKNYKQADKEI
HLQTNKESVKVLKDMNFTVLNSANNHAMDYGVQGMKDTLGEFAKQNLDIVGAGYSLSDAK
KKISYQKVNGVTIATLGFTDVSGKGFAAKKNTPGVLPADPEIFIPMISEAKKHADIVVVQ
SHWGQEYDNDPNDRQRQLARAMSDAGADIIVGHHPHVLEPIEVYNGTVIFYSLGNFVFDQ
GWTRTRDSALVQYHLKKNGTGRFEVTPIDIHEATPAPVKKDSLKQKTIIRELTKDSNFAW
KVEDGKLTFDIDHSDKLKSK
>CAG39047|FEATURES|CARD|glycopeptide|VanSC|antibiotic target alteration|0
MKWLKQLQSLHTKLVIVYVLLIIIGMQIIGLYFTNNLEKELLDNFKKNITQYAKQLEISI
EKVYDEKGSVNAQKDIQNLLSEYANRQEIGEIRFIDKDQIIIATTKQSNRSLINQKANDS
SVQKALSLGQSNDHLILKDYGGGKDRVWVYNIPVKVDKKVIGNIYIESKINDVYNQLNNI
NQIFIVGTAISLLITVILGFFIARTITKPITDMRNQTVEMSRGNYTQRVKIYGNDEIGEL
ALAFNNLSKRVQEAQANTESEKRRLDSVITHMSDGIIATDRRGRIRIVNDMALKMLGMAK
EDIIGYYMLSVLSLEDEFKLEEIQENNDSFLLDLNEEEGLIARVNFSTIVQETGFVTGYI
AVLHDVTEQQQVERERREFVANVSHELRTPLTSMNSYIEALEEGAWKDEELAPQFLSVTR
EETERMIRLVNDLLQLSKMDNESDQINKEIIDFNMFINKIINRHEMSTKDTTFIRDIPKK
TIFTEFDPDKMTQVFDNVITNAMKYSRGDKRVEFHVKQNPLYNRMTIRIKDNGIGIPINK
VDKIFDRFYRVDKARTRKMGGTGLGLAISKEIVEAHNGRIWANSVEGQGTSIFITLPCEV
IEDGDWDE
>NP_816529|FEATURES|CARD|multidrug|evgA|antibiotic target alteration|0
MIKVMLVDDHEMVRLGVSSYLSIQEDIEVVGEAENGKIGYEKALELRPDVILMDLVMEEM
DGIDSTKAILKDWPEAKIIIVTSFIDDEKVYPAIEAGAAGYLLKTSTAHEIADAIRATYR
GERVLEPEVTHKMMERLTKKQEPVLHEDLTNREHEILMLIAQGKSNQEIADELFITLKTV
KTHVSNILAKLDVDDRTQAAIYAFQHGLAK
>AAK74984.1|FEATURES|CARD|aminoglycoside|MB84_23135|antibiotic target alteration|0
MSNIQNMSLEDIMGERFGRYSKYIIQDRALPDIRDGLKPVQRRILYSMNKDSNTFDKSYR
KSAKSVGNIMGNFHPHGDSSIYDAMVRMSQNWKNREILVEMHGNNGSMDGDPPAAMRYTE
ARLSEIAGYLLQDIEKKTVPFAWNFDDTEKEPTVLPAAFPNLLVNGSTGISAGYATDIPP
HNLAEVIDAAVYMIDHPTAKIDKLMEFLPGPDFPTGAIIQGRDEIKKAYETGKGRVVVRS
KTEIEKLKGGKEQIVIIEIPYEINKANLVKKIDDVRVNNKVAGIAEVRDESDRDGLRIAI
ELKKDANTELVLNYLFKYTDLQINYNFNMVAIDNFTPRQVGIVPILSSYIAHRREVILAR
SRFDKEKAEKRLHIVEGLIRVISILDEVIALIRASENKADAKENLKVSYDFTEEQAEAIV
TLQLYRLTNTDVVVLQEEEAELREKIAMLAAIIGDERTMYNLMKKELREVKKKFATPRLS
SLEDTAKAIEIDTASLIAEEDTYVSVTKAGYIKRTSPRSFAASTLEEIGKRDDDRLIFVQ
SAKTTQHLLMFTSLGNVIYRPIHELADIRWKDIGEHLSQTITNFETNEEILYVEVLDQFD
DATTYFAVTRLGQIKRVERKEFTPWRTYRSKSVKYAKLKDDTDQIVAVAPIKLDDVVLVS
QNGYALRFNIEEVPVVGAKAAGVKAMNLKEDDVLQSGFICNTSSFYLLTQRGSLKRVSIE
EILATSRAKRGLQVLRELKNKPHRVFLAGAVAEQGFVGDFFSTEVDVNDQTLLVQSNKGT
IYESRLQDLNLSERTSNGSFISDTISDEEVFDAYLQEVVTEDK
>NP_461214.1|FEATURES|CARD|multidrug|MexB|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLAYIDNEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEVEADAKTGRETIIVHEIPYQVNKARLIEKIAELVKDKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIISAFVRHRRE
VVTRRTIFELRKARDRAHILEALAIALANIDPIIELIRRAPTPAEAKAALISRPWDLGNV
AAMLERAGDDAARPEWLEPEFGVRDGQYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLEQIAELLHILGSADRLMEVIREEMELIRDQFGDERRTEITANSADINIEDLISQEDVV
VTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLY
WMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTAL
TEFSRPRSAGIIAVNLNDGDELIGVDLTSGSDEVMLFSAAGKVVRFKEDAVRAMGRTATG
VRGIKLAGDDKVVSLIIPRGEGAILTVTQNGYGKRTAADEYPTKSRATQGVISIKVTERN
GSVVGAVQVDDCDQIMMITDAGTLVRTRVSEISVVGRNTQGVILIRTAEDENVVGLQRVA
EPVDDEELDAIDGSVAEGDEDIAPEAESDDDVADDADE
>CAG39357|FEATURES|CARD|multidrug|mdtH|antibiotic target alteration|0
MNFLKPAKHIKPLPENQIDDTYKRLRLQVFLGIFIGYAGYYLLRKNFSLAMPALQEQGFT
KAELGFALSAVSIAYGFSKFFMGTVSDRSNARIFLVLGLVLTAIVNLLMGFVPFFTSGIG
IMFVLLFLNGWFQGMGWPPSGRVLVHWFSVSERGSKTALWNVAHNVGGGIMAPIAAWGIT
TTAFINFGYLKGFEGVFIYPALLALIIAAISYILIRDTPQSQGLPPIEIYKNDFATSDKK
TLETELTTKEILFKYVLNNKWVWAIAFANIFVYFVRYGVLDWAPVYLSEEKHFDLKASGW
AYFLYEWAGIPGTLLCGYISDKLFKGRRGPAGFFFMLGVTVFVLIYWLNPPGNAWLDNVS
LIAIGFLIYGPVMLIGLQALDYVPKKAAGTAAGLTGLFGYLFGAVMANIVLGAVVDKFGW
DVGFILLTAISVFAMLSFILTWNKVGQETVHH
>NP_415611.1|FEATURES|CARD|bacitracin|uppP|antibiotic target alteration|0
MNFEGKIALVTGASRGIGRAIAETLAARGAKVIGTATSENGAQAISDYLGANGKGLMLNV
TDPASIESVLEKIRAEFGEVDILVNNAGITRDNLLMRMKDEEWNDIIETNLSSVFRLSKA
VMRAMMKKRHGRIITIGSVVGTMGNGGQANYAAAKAGLIGFSKSLAREVASRGITVNVVA
PGFIETDMTRALSDDQRAGILAQVPAGRLGGAQEIANAVAFLASDEAAYITGETLHVNGG
MYMV
>AQA08261.1|FEATURES|CARD|multidrug|mexf|antibiotic target alteration|0
MTKDLQKRTLFAVLALAIFLPVLFAGGLLLQIGIGLLAMLGVHELLHMKGLKTMTIEGAL
TLFATFALTVPLENYLTFLPVDGNVVAYSVLITIMLGTTVFSKNYTIEDAAFPIAVSFYV
GFGFNALLDARVAGFDKVLLALFIVWATDSAAYLTGMNFGKHKLAPRVSPNKSIEGFVGG
ILGAVLITVIFMLVDSTVALPYGIYRMSLFAAFFSVAGQFGDLIESAMKRHFGVKDSGKF
IPGHGGVLDRFDSMLIVFPMMHLFGLF
>EGP45233.1|FEATURES|CARD|multidrug|AxyZ|antibiotic efflux|0
MARKTKEESQRTRDRILDAAEHVFLSKGVASTTMSDIADFAGVSRGAVYGHYKNKIDVCI
AMCDRALGEAVSLTRVSTDGEALEALYASMRQYVQIYAEEGSVQRVLEILYLKCERSDEN
APLLRRRDLWERHALRTSEKLLRAAVSREDLPPALDVRLSNVYLHSLVEGVFGTICWSDR
LKGDIWPRVERMLRAAIDTLRLSPQLRLPQAA
>A0A147H3Q5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSALQALILGIVEGITEFLPISSTGHQIIVADLIGFGGERAIAFNIIIQLAAILAVV
WEYRAKIFGIVTDLPRKSYAQRFTGNLIIAFLPAAVLGVILGDLIHEYLFNPITVAFALV
IGGVIMIWAEKRTHRIRVEEVDDMRWHDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGATVYSVYKYRHLFTANDVLVFGVGFITSFIFAMLAVKALLKF
IGKHSYEVFGWYRIVFGLLILATWQFGWIDWHAAKAAG
>A0A0S1YWC9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIMLVIILALVEGITEFLPVSSTGHMILVNQLIGGEYLSPTFINSFLIIIQLGAILSV
VVYFWKDISPFVGTKKEFGLRLQLWMKIIVGVLPAMVIGLLLDDIIDKYFMNNTLIIAIT
LIVYGVIFIGIEVVYKLKNIKPKVKKFSGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLLKNGLAFTQMEWSYLALGSAIAFVVAYMVI
KWFMDFIKKRSFASFGLYRIILGIIVIVLLY
>M1LVM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIVNEVINTDQFLVLIKACFLGIVEGFTEFIPVSSTAHLIFIGKLISFDSCNGMVFEVFI
QVGAIFSAIFLFRFYIVEILCGVIRLDARYLLFSAKIICSTLPSVIIGALLIRHIKKLFL
CPNIMALSLIIGGFIIIIVEYRKNINHEKTLSHYTEMYNISIKQSLYIGFAQCIAMIPGV
SRFGATVIGGMLSGLSRSIATRYSFIIAIPTMLGAALYDLWSNIDNLSYVDFSNIFIGSL
SAFVSAFFIVKYIVRFVETNTYIAFALYRIAVGFAVLFLN
>ZP_03730066|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG
ELCSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRTFIENPLPMLQTTIAAKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGKVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPATGKLICQPRRPNSRIDKVRHMFHKLA
>A0A0F5I097|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWWELFVALILGLVEGATEFAPVSSTGHMIIVDDILLKSKELFSEPVANTFKVVIQLGS
ILAVVVVFKERILQLLGLKKENSASGSSGTRLSLLHVLVGLIPAIILGFLFEDYIDEHLF
SVHTVLIGLVTGAFLMLAADWLAPSHVRTETVDDITFSQAFLVGLFQCIALWPGFSRSGS
TISGGVLLGMSHRAAADFTFIMAMPIMAGASALSLFKNWEYFTMEALPFFTVGFISAFIF
ALLSIRFFLALINRIQLTPFAIYRIVLAAVIYFFFL
>A0A0R1TIX9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFELFKAFLFGIVEGITEWLPISSTGHMILLDQFVKLGVSKDFYSMFEVVIQLGAILAVV
VIYWKRIWPFHYQTNQKGLWKIMDEDIFFMWVKVVIACLPAVVAAVFNDEFEELFYNPVC
VALALIVFGIGFIVIENMHKGSTPKITSISQMTYVLVFIIGIFQLLAAIFPGTSRSGATI
LGALLLGVSRTAAAEFTFFLAIPVMFGAGILKLVKFGLVFTNLEIWIMIVGLVTAFVTSI
IAIKFLMQYIKKHDFKVFGWYRIILGILVLAYFFLIK
>A0A0G1VXY3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFMIAIILSAIEGVTEFLPISSTGHLILASTLLKIQGMEFVKSFEIIIQLGAILAVLFL
YWKKLLTNKETFIRVVIAFVPTAIVGLVFYKYIKDVLLGNPWVVVWSLGLGGLLLIILEK
FHTEKQKHMSVLDAFIIGVAQSFSVIPGVSRAGATIAGALLLGVKRETAVEFSFLLAIPT
MAAATGLDLVKNGRQFTGSQYELLAIGFIGAFITALVTVKWFIAFVKTHTFLPFAIYRIG
AALAFYFFILR
>A0A085GW99|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|GHAL_1908|antibiotic efflux|1
MSAIAKMNPIIELRHVYREFVAGNQTHVVLNDITLTIAQGEMVAIIGASGSGKSTLMNII
GCLDKSTRGEVLINGISVNETDSDRLAELRSCYLGFIFQRYHLMPYLTAEENIAIPALYT
AMPESERKARIQMLGQKLGLKSRLGYRPAQLSGGQQQRVSICRALINGAQVILADEPTGA
LDSVSGKALMGVLHQLHADGHTVIIVTHDHGVAKQAQRIVEISDGRIIADEINQSCPEDR
LAQHIPVVRDNGRASLWRSIHESMRMAWRSLLGHRMRTFLSMLGIIIGISSVVSSMAVGE
GARQTIMNEIGKLGNTTLEIRPGTGWGSKRPDMERALSLNDVASLQKQPWAEGVSPQVSS
MATAVRKGYDSSMMLSGVSQDFFALQGIRFIQGNGFTARDVAEGEPVLVLDETSRDTLFQ
DGEDPLGQIVQIAGASWRVVGVAVKPGPKVVGGFMAGWLPYTSLQQRISGDKPLEAIVLR
FQESLTPQDAMQTVEHLLTREHGKKDFFSQTDDQLTKAMQKTSDSMSLLITAIAAISLLV
GGVGVMNIMLVSVTERTHEIGIRLSVGARPSDIMHQFLIEAVMICTLGGLVGVGGSWIAA
QIFALITDEFSMAFTWLPVAIACAFSALIGLTFGYFPARSAAKLNPTEALARE
>R6ZEI4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIELLKAFLFGVVQGITEWLPISSTGHMILVNEFVKLNVSEEFWQTFLIVIQFGSILAVV
VLFWDKIFPFGKRNNPDPVKKEGILSWCKKDIWIMWFKILVACIPAAVIGLLFDEVFERL
FYNPVCVATALIVFGIAFIVVENRNKKRKPKINSLSEITYQTALIIGVFQLIAGVFPGTS
RSGATIVGALLIGVSRTVAAEFTFFLAIPVMLGASLLKMVKFGFGFTGTELAILLVGMVT
AFVVSVLVIKFLMGYIKKHDFKVFGWYRIVLGLLVLLYFGVFA
>B2JEB9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWIITLKALILGVVEGLTEFLPVSSTGHLIVAGSLLDFDVPQEKTFDVVIQLGAIFAVC
WEYRQRIIDVVAGLATRIESRRFTLNVIIATIPAIVLGLLLEKSIKAVLFAPVPVAFALV
VGGVLILWVEAWQRNRPEVRARVHSIDDLSPLDALKVGLAQCFALIPGMSRSGSTIIGGM
LFGLDRRVATEFSFFLAIPIIFGATVYELHKGWHELSSDALGLFSIGFLAAFVSAFACVR
WLLRYIAAHDFSAFAWYRIGFGLLILLIGYSGGLSWAE
>A0A0A8H8M1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIRLENIQKKINNTTILENINLYIQKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGKYFL
DTYEVTNLSKDEKARIRREKIGFIFQRYNLLSLLNAKDNVALPAVYAGKNKHERSQKAKE
LLSFLELDHKELSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGKIVLEIL
NKLNEQGHTVVLVTHDREIAARAKRVIEIKDGKIISDNGAKKADEIKAKLMPKEKKSFNL
LKNQLFESLKMSVASIVAHKLRSLLTMLGIIIGIASVVCVVALGLGAQQNILASISSIGT
NTIEVVSGRGLGDIRSGKTRLNLSDLKTLSSLPYLEAVEADIGKIGVVTYKNNSLQARIY
GVGPNHLRLRGFVMVDGRFINNEDIKDNANICIIDENALRILFDNISARDVLGKSVIFNK
QPLTIVGVLKKERDNKGFRADENTIKIYTPYSSLMNKITGDKQIRAIVTKVKDEVNPALA
EEAMVKILEIKRGKKDFFTINSDAIKNAIEENTATLTLLISSIAVVSLIVGGIGVMNIML
VSVSERTREIGVRMAIGARKEDILMQFLIEAVLICSLGAIFGVIFSFIIIEVFNSLNFGF
TMILSLNSVFLGLLSSVLIGVVFGFFPAKNAANLNPISALSKE
>D2TVW5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MERTLAACQRLKQPYELILVDDGSADNSANLLIAAAENWANHVIAVILNRNYGQHSAIMA
GFKQATGDLVITLDADLQNPPEEIPNLVQVAEQGYDVVGTRRMNRQDSWFRKTASKIINV
MITKATGRTMGDYGCMLRAYRRNIINAMLQCHERSTFIPILANTFARRTIEIDVAHAERE
FGDSKYSFMKLINLMFDLLTCLTTTPLRLLSVVGSFIAASGFLLAVLLIILRLIFGAMWA
AEGVFTLFAILFIFIGAQFIAMGLLGEYIGRMYNDVRARPRYFIQKIVGIHQDTDENQEK
K
>N6XYX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFSLLLVALVLGIVEGLTEFLPVSSTGHLIIVGDLLGYNDDTSKVFKIVIQLAAILAVC
WDYRERLIKVAVGLPTQPSAQRFVWMLFIGFLPAAVLGLMFHSTIKGLLFNPITVATALV
VGGLIILYVEKRAYHPRINDVDDMRWTDALKVGFAQALAMIPGTSRSGATIMGGLIFGLS
RKTAAEFSFFLAIPTMFAATAYDLYKNWALLRLEDLPVFAVGFVASFVAAMWAVKSFIKF
ISNHTFVVFAWYRIAFGLFVLATWYFGWVEWSEP
>A0A136FRX3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSAFPRLSVLLGLTLPLLANAATSLDDEVRTAARAVMAEQDLPGLAIGVSAPGLRRLYYF
GVADRRSSQPVDAATLFEIGSLSKTYTATLGGYAAATGRLRLDETVAQVRPALAGSAIGQ
ASLLQLATYSAGGLPLQFPDSVTRDDQTTAFYRAFQPPFPAGSRRLYSNPSIGLFGALAA
QRLDEPFATALQRHVLTPLGLSHTYLQVPAAAQDHYAWGHGKKGEPLRVNPGIYAEEAYG
IKTTAGDLLGFIEANLNPGRLPAPLAKAITTTQQGYYRSGPMTQGLGWEAYPYPLAKTQL
LAGNTPAMALEPQPVDWQHPPLLASGARLLNKTGSTNGFGAYALFVPERRIGLVILANRN
YPNSARIETAWRILQQLDGGVQ
>C9LCI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILELLKVVFLGIVEGITEWLPISSTGHLILVEEFVKLDVSKAFWEMFMVVIQLGAILA
VVVLYWKDIWPFRNKKPKHENVTKVEKAAGTLCRFVKIDKMIMWLKIMVSCLPAILIGLP
FDDFIEKKFNNWFVVAVMLIVYGVLFLVVEDYNEKRTVKIHSIADITWKTALLIGIFQVL
ALIPGTSRSGATIIGGILLGASRTVAAEYTFFLAIPVMFGASLLKIVKFGFDFTSWELTI
LGVGTVVSFVVSILAIKFLMGYIKKHDFKAFGWYRIVLGIIVMLFFTIFR
>A0A0X7K1D4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAQPLLELKGITRSFMAGEREFIALKGIDLTIQAGEMVAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLEDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPQT
ARHSRARELLARLGLSGHISHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHS
GKEVMRILTELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIVSDQANERVGLDLPSEAP
IEPRRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVEALNQLYYVDSATPVVGRNL
LLRFGNIDVDAQVNGVSERYFKVKGLKLEAGIAFSENDARRQAQVVVIDHNTRQRLFGPN
IDPLGQVILVGKLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRVLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGISLSYAIGY
LFSLFVKEWEMVFSLGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>A0A0E8GZF5|FEATURES|UNIPROT_deepARG|polymyxin|pmrF_2|antibiotic target alteration|0
MSESEKIKKVSIVIPVYNEQESLPILIERTSAACKLLTQPYEIILVDDGSSDNSAELLTA
AANEPESHIIAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRAHRQDSVFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGAEQTENNQEVEK
>A0A0Q3WJ52|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLQPTGINHLLFSVSDLERSFRFYQEVLGAIPLVRGRKLAYFDLNGYWLALNEEQDIPRQ
EIHQSYTHLAFSIEEDTFDTWLAHLKQHDVHILPGRERDVRDKRSIYFTDPDGHKFELHT
GTLEDRLAYYRQDKHHVTFFE
>A0A0Q4QGN6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDPISALLLGILEGLTEFLPVSSTGHLLIAERWLGARSDFFNIVIQAGAIIAVVLVFRQ
RLWSLATGLGERENRDYVLKLGTAFLVTALVGLPVRLAGWQLPETVTPVAWALVIGGVWM
LLAERWAERMPERDTVTWKIAVGVGLAQVVAGVFPGTSRSAAAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYAFLELARHGQLGHQDWGDVGIAFAAAVITGFVVVKWLLGYIKHH
RFTWFAIYRLALGAALLLFLPAGN
>YP_232872|FEATURES|ARDB_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAIRAM
LALLNAGFRWHETRPLDQVKTRRSVLAIFASPAFWVYTVGFSAGMGTYFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>A0A0P0QJ28|FEATURES|UNIPROT_deepARG|aminoglycoside|AR325_24545|antibiotic inactivation|1
MIVICDHDNLDAWLALRTALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVECARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>A0A078LSL4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWLAFQALILGVVEGITEFLPISSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVV
WEYRSKIFSVVAGLATEKPAQKFTVNLLVAFMPAVVLGVAFADLIHEYLFNPITVATALV
IGGVVMLWAEKRPHRIQAETVDDMHWSHALKVGFAQCLALVPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDFPVFAIGFVVSFIFAMLAVRALLKF
IGNHSYAAFAWYRIAFGLFILATWQFSMIDWSTATG
>G9S554|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEELSWFQTIIIAIVEGLTEFLPVSSTGHMIITQNMLGVPSSDFVKAFTVIIQFGAILSV
VVLYWKRFFKLNPCKIFDSEAVSGKTGSARWVEYGRRFLYKYDFYWKLLVAFIPAAFFGL
LFSDKIDEMLESVAVVAVMLVIGGVVMLFVDKWFNKTTPDQTMTLKRAFNVGLFQCIAMI
PGVSRSMATIVGGMAQKMTRKNAAEFSFFLAVPTMFAATAYKLLKLLTSENGMQVLQDNL
LTLIVGNVVAFIVALLAIKFFISFVTKYGFKAFGYYRIIVGGIIIVLMLLGYNLEIS
>A0A0H4SHE7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
TVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLG
GDAIARGEITLGDPVTKYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRF
YQNWQPKWKPGTTRLYANTSIGLFGALAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKA
EEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMVNMMPDSLQDSPLKHGIAL
AQSRYWRVGAMYQGLGWEMLNWPVDAQTVVGGSDNKVALAPLPAREVNPPAPRVNASWVH
KTGSTGGFGSYVAFIP
>A0A0Q5D128|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVDQPIISALVLGIIEGLTEFLPVSSTAHVLLAGHFLGFNSPGNTFAVLIQLGAILAILL
VYAQRLISIAVSLPSSVQSRRFVLTILAGFLPAAVIGAIAHDFIKTVLFETPMLICVMLI
VGGFILLAVDRMKFEPKYHDVMDYPLSLAIKIGFCQCLAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMVGAFTLDLVKNRALLSFDDSAVIVVGFLAAFVTAVFVVRSLLNF
ISSRGYAPFAYWRIAVGAIGLVALLLGA
>ABY55284|FEATURES|ARDB_deepARG|trimethoprim|dfrA7|antibiotic target replacement|1
MKISLISATSENGVIGNGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFDYMGVLPNRKYA
VVSRKGISSSNENVLVFPSIEIALQELSKITDHLYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDINFPKIPENFNLVFEQFFLSNINYTYQIWKKG
>D8JF75|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNKISCLLLSPLFIFNTSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKVVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLGLQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFVNANLNPQKYPADIQRAINETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTCVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ABS58643|FEATURES|ARDB_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0N9XXU2|FEATURES|UNIPROT_deepARG|aminoglycoside|XA26_51950|antibiotic inactivation|1
MTEWLPVTRGESGAGVFRNADGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAVIDW
RVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLDDML
ARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRRQEAADWVVCHGDLCLPNI
LVDPDRHTVEGFIDLGRLGLADRHADLALLLANTADAVPGFAEKATAGLAAGYPAQVDPE
RLRFYLALDPLTWG
>A0A0J6HLR0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIETLLDSGYEIAAVFTHPDDPKENAFYGSVAQLCARKGIPVHA
PEDANHPLWIERISQLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQRVAIERSDTALILHGKLRVSATDLLRDTLP
ALLQGKVSETPQDESQATVFGRRTPADGKLLWNKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWSADVAKDNEGLAPGRVISVDPLRIACGEDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRGPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDGNFDEDSSNLVVGPINKQRWIYSTSKQLLDRVIWAY
GQRDLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNENDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRNNFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWIPTVQMSETIGNTLDFFLREAMLERA
EQSTEESC
>N8WVW4|FEATURES|UNIPROT_deepARG|beta_lactam|F969_01910|antibiotic inactivation|1
MVLSTVKGFKAGIIALAIGWSVQANADDTKGNYIKAAIDQSFKPLMQQYDVLGMAVGVIY
QGKNHEYYYGLQSHIDHKAVNRQTIFELGSVSKIFTGIAGGYAKSQSKLSFNDHPAKYWP
DLKNSEINKVSLLELATYTSGNLPLQFPDQVKTEQQVLEYFQDWQVKHPPGQYRQYSNPS
IGLFGELSARSMNVPFSVLLEQTIFPKLNLKNTYINVPKAQRVHYAFGYDQNNHPVRVTP
GALDAQAYGVKSTLPDMLKLLDANLNPKKNKTDIKQALLETHHGYFKLGKMTQALGWENF
SYPTTLDILLESNSEKVVMQANRVVKNTVQEKSQVFHKTGSTNGFGTYVLFIPEENFGLV
MMMNKKIPNAERIKAAYQVFQSIKNS
>J8DBE0|FEATURES|UNIPROT_deepARG|beta_lactam|II9_03025|antibiotic inactivation|1
MEQIYFGDCLLYVSKKSVKNLKGMMILKNKMLLKIGICVGILGLSLTSLEAFTGGPLQVE
AKEKTGKVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKAL
AAGVLLQQNSTKKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNI
LFHKIGGPKGYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGN
ALPAEKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRSPI
IIAILSSKDEKEATYDNQLIKEAAEVVIDAIK
>A0A0N1QZS5|FEATURES|UNIPROT_deepARG|aminoglycoside|SeSA_A1736|antibiotic inactivation|1
MDIRHMNKTHLEHWRGLRKQLWPDHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A0M4N2Y0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSTFEKINKVSVVIPVYNEEESLPQLLERTIKSCKQLEQEYELILVDDGSSDNSAKMLEE
AANIEDNHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVATAEEG
YDVVGTRRRNRQDSWFRKTASKMINAMITKATGRSMGDYGCMLRAYRRHIIDAMLQCHER
STFIPILANTFARRTIEIEVAHAEREYGDSKYSFLKLINLMYDLLTCLTTAPLRLLSVVG
SVIAVAGFLLAVLLIVLRLIFGAIWAADGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYN
DVRARPRYFIQKVVGVKKPNKNQEED
>D1NXA3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MMATLLELNKITRRYPAGEQEITVLKDVSLKINSGEMVAIIGASGSGKSTLMNILGCLDK
PSAGQYYVAGQNIAELDNDQLAQLRREHFGFIFQRYHLLSHLSAEQNVEIPAIYAGVGKS
SRHERAEQLLQRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGHVILADEPTGALDSHS
GEEVMKILKDLCAQGHTVIIVTHDPKVAQQAERIIEIKDGEIINDSGAKSVAATLLPVKS
TVRKSSIPQIYGRFSEALLMAWRAMVVNKMRTLLTMLGIVIGIASVVSIMVIGDAAKGMV
LNDIKSIGTNTISIYPGTDFGSDDPENRQALKDSDITAIAQQPYVQSVTGSIESSARLRN
GNIDATARVSGVGTDYFNVYAEKFAEGMGFTPEMQSRRAQVVVIDSNTKRRFFPNKLNVV
GEILLINNVPATVIGVLGEQKSIFSAGKNLQVFLPDTTVNGKLLNRPYYDTIVVRVKDGT
DAQVAEQQLVRLLTLRHGKKDIFTYNMDTFVKTAEKTTRTMQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAVLVCLIGGLMGIGLSYGISLIAQI
ALPGWTFTFDPIALVSAFACSTAIGIIFGFLPARSAARLNPIDALARE
>D4JNJ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIFDIIKSVIFGIVEGITEWLPISSTGHMILLNEILPLRIGKNPDDFYSMFEVVIQLGA
ILAVVVLFWSQIWPFGRKNNKAPLAKTGIGAWVKTDIFVLWFHILVSTIPAAIIGVLFDD
VFERLFYNFQTVAIMLILFGIAFIVIETRHNGKSAKINSLVDISYTTALMIGFFQLIAAV
FPGTSRSGATIVGALLIGVSRTVAAEYTFFLAIPVMFGASLLKLVKFGFHFTGEEAAILI
IGMIVAFVVSLIVIKFLMGYIKKHNFIVFGWYRIVLGAIVLLCGIAGLL
>A0A0M3ASY3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVIIQLGAILAVVV
LYWRTFWAVGMGLLRREPTSWRFLRNLVVAFIPAAVIGLALHKYIEELLGAPKVVAWALI
VGGVAILAIERMVKENRFHGIADIPFVRVVGIGFIQCLAMIPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGATTLELLKNGDKLTSATVGWSSIALGFIVAFIVAMLVIKWFV
GLVSRHGFTPFAWYRIIAGITALAWLSMR
>ZP_00156276|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVETLKTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDSRFYDHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTSEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKSLNELTLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVVGIAKG
GADILLASGEKMTLSTNAMRWTGRSNPVKVGEQIWIRQRANGEWQLGQIPAANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKPGQKMWQPKNSPDRYDGPMRLRVGLGQSKNMIAIRAIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIE
CNDIPVIYGETKDKINGFANIPLGESALKPTDDSTNGEELDQQPETVPELPELQSNFTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYM
KTALSDKPERKLPLPPKIVEKSIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYY
VPTELQQRLNNEGNTPATQPQELF
>YP_001478502|FEATURES|ARDB_deepARG|beta_lactam|BL1_sm|antibiotic inactivation|1
MTKINRLAAALLAAMILPAGHAADKAEIDAIIQPLMQKYGVPGMAIAVSVDGKQQFYDYG
VASKQTGKPITNQTLFEVGSLSKTFTATLAAYAQNEGKLSFAEPASHYLSELRGSAFDRV
SLLNLATHTSGLPLFVPDEVTNDAQLMAYYKNWQPPHAVGSYRVYSNLGIGMLGMITAKS
LNQPFAQAMEKQLLPALGMNHSYVNVPAAQMDNYAQGYNKKDQPVRVTPGPLDAESYGIK
SNAEDLIRYLEANMQVAKVGDKWRKALAATHTGYYRAGVFTQDLMWESYAYPEKLTTLTE
GNNAGMIMNGTPATAITPPKQEQGAAWYNKTGSTGGFSTYAVFIPSKKIAVVMLANKWFP
NDDRVAATYQLIQALDKR
>A0A0B0SBX6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGRMSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPVESDAFLKTFLIAIQLGAIL
AILLLYGRRFLVDRALWWRVGVAFLPTAAMGFLLYPFIKGVVLGRDDVVVFFLFFVGLVL
LFADRLAERARFQDATELPLGRVALIGVFQGLAALFPGTSRSGATILGGLLLGLARKGAA
EFSFLLALPTMLVAVGYDLFKSAQAVPEGGYGLLLLGFLSALLTALLTVRWALGFVERYG
FRPFALYRMALALVYAYFFLR
>A0A0S1RTT5|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQ
PTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLRKLVNRQLPVKAAAYELADNLFEV
>A0A0G0GEL0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESIKLLALAITQGLSELLPISSSAHLILLGQVINIPTSTLLLSSLHIGTTIAILAFFWK
KLFSNFFTKKKWTFYIKILLSVIPSAILGVLFESKIETVLHDNWIIAVSLVFWGILMILA
QNKKDDDCGVTDMENVTWQQSLIMGFAQAIALIPGTSRSGVTTLSGIALGLNKYTAFEYS
LILGLPILIGAPIWEILKMTQDTGIPTITTLTMANYIDLGIILLVPFIVGCISLIALKKI
SRDKWLSAFGIYRIILGVAILVFGYLL
>A0A0P7CMJ6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRLAALAAAITLTLGHANAQADDQLQAKVDRIIRPLMQAQGISGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGQLDLTAPAKRYHPALAGTP
IGDATVLELGAYSADCLPLQFPDAVQTPQQVVDFFQHWQPHAKPGTQRCYSNPSLGLFGD
LAARAQHQPFATLMTEGLLPKMGLENTYLHIPASAQGLYAQGYDAAEKPVRVRPGPYADE
AYGIKSSASDLLRYVRLHMQPEGLPATLVKAIDITQQGYFQVGAMTQGLGWERYPYPATL
ATLVDGNSPRLIREPQATTRLQPALPAQPAAWYNKTGSTNGFGAYAAFVPSEQLAIVLLA
NRNYPNEARVRAAFEILSGL
>A0A0F6BJC0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLIGGINHLTFSVSDLEKSICFYQHVFGAKLLVKGRNLAYFDLNGIWLALNVQQDIPRNE
IQHSYTHIAFSVKEEDFDSAVQKLKELGVNILPGRQRDERDKRSVYFTDPDGHKFEFHTG
SLNDRLSYYRSEKQHMQFFD
>K2NZ87|FEATURES|UNIPROT_deepARG|beta_lactam|NA8A_07729|antibiotic inactivation|1
MFVTCAYAGAPNQAHRERLRAVVEDVVRPIMDEHDIPGVAVAVTVGGSPYFFNFGVASRD
DGRGVSERTIFEIGSISKTFTATLASYAQEVGALSLSDPASDYLPGLRGSRFDGISLLEL
GTYTAGGLPLQFPDNVTAQGMTSYYRNWRPDFAPATHRRYSNPSIGLFGFLAAERLGKPF
DELMEAKLFPMLGLPDTYIRVPTARMKDYAFGYSKEGKPIRVGPGVLDSEAYGVKTSSAD
LLRFVELNMTSAGLDEALRRAIKATHTGYYRVGAMTQGLGWELYDDPDDLKQVLAGNSAE
IAYKPNKVEWFSPARHPREAGLINKTGSTNGFGAYAAFIPAKKIGVVILANRNYPIPARV
TAAHRILIGAGALPF
>ABS73653|FEATURES|ARDB_deepARG|multidrug|YkkC|antibiotic efflux|0
MKWGLVVIAAVFEVVWVTGLKHADSALAWSGTIVGIIVSFYLLIKATDSLPVGTVYAVFT
GLGTAGTVLSEILLFKEQADPVKIVLIGVLLIGVIGLKLVTQDKPETKEEKA
>A0A0M0N344|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLQTIIIAIVEGLTEFLPVSSTGHMIIAQGLLGVESTPFVKAFTVIIQFGAILSVICL
YWRRFFYPEAVQTGTSYWKAMYDFYARLVVGVLPAVVLGLAFNDFIESNLGNVTLVAVML
IVGGVFMLFCDKLFGNGSEDTKLTYRRAFIIGLIQCISMIPGVSRSMSTIVGGMSQKLTR
KAAAEFSFFLAVPTMFGATCLETYKLISHGDGSLLATGNNLEMLIVGSVVAFIVAILAIK
FFINYVTKYGFAAFGWYRIVVGIIILICMLCGVDMKMAD
>A0A0A2F1C0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILESIIIAIVEGLTEFLPVSSTGHMILAEGLMRMENTEYLRAFTVMIQFGAILSVVML
YLERFLPWRNQPIGGNYGLSGWSLYGLMIIGCIPAGVLGLLLEEYIDQLLGNLWVVIAML
FIGGLVMIYMDRRFTNKTPRTVTPRRAFTVGLFQCLAMIPGVSRSMATIFGGMQQGLTRR
QAAEFSFFLAIPTMFGATLLKAYKLYKSSGIDVFSENWQTLLIGNVVAFLIALAAIKLFI
GIVTKYGFRIFGYYRIVIAIVFAILMLMGVPIHLS
>YP_002383389|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILALAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRAGLWIQFMVAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIALCATCSILFCLYASRPKKR
>ZP_04003442|FEATURES|ARDB_deepARG|multidrug|EmrE|antibiotic efflux|0
MNRKEYAMNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAY
IPTGIAYAIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLVINLLSRSAPH
>J3DWR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIVKGLPTERNARRFTLNLLIAFLPAVVLGVLFADAIHEYLFNPITVAVALV
VGGIIMLWAEQRSHVISVEHVDDMRWSHALKVGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPNDLPVFALGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWLFGWVNWTAAAAA
>X8GYM7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFQILKAILFGIVEGVTEWLPVSSTGHMILLNEFVKLDVSNEFWKMFLVVIQFGAILAVI
LLYWKTIWPVRRSKKTGRHYVSRKTIALWIKVIAACIPAAVVGLVLDDWLDEHLYNWWVV
SIMLILVGLVFLLVEKRNADRQPLVTSLEELTMKDALIIGIFQLLAAVFPGTSRSGATIV
GALSIGVSRKIAAEFTFILAIPVMLGASLLKIVKYFVGGAYFSGMEAAILLTGMLVAFFV
SLVIIRFLMDYIRKHDFKPFGMYRIVLGFAVILYFALLH
>A0A156B9F3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTQPASLPHSISLQDIDMFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMDKAYE
ILLVDDGSSDNSALMMTEAAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDAD
LQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCM
LRAYRRHIVDAMLHCHERSTFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMY
DLITCLTTTPLRLLSVFGSIIAVAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIG
AQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQEHKASQEEIHP
>R6GGK4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLIEIIKSVIIGIVQGITEWLPISSTGHMILLDEFIKLNVTKSFLDMFLVVIQLGSILA
VIYLYFNRLNPFSKGKNEQEKKETFSLWLKVVVGCIPAAVVGFLFDDFIHEKLYSPTTVA
LTLILYGILFIIVENQKKNYPLNKLNKLNYKTAFLIGIFQVLALIPGTSRSGATIIGASI
LGASRSVAAEYSFFLAIPVMFGASGFKFLKYVLKVGMSFSITESLILVFGMLSAFFVSVW
AIKFLMNYIKKHDFKAFGYYRIILGIIVLLYFTMFN
>R8VS21|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKTILFGIVEGITEWLPISSTGHMILLDEFVKLDVSEAFWDLFLVIIQLGAILAVV
LIYWDKIFPFRVRGRWGVDRQKMNMWGKILVASIPAGVIGILFDDLFTAWFYNYQTVAIM
LILFGVLFIVIENRNRNSVPRVRSIASITYPTAFMIGVFQLIAAVFPGTSRSGATIVGAL
LLGVSRTVAAEFTFFLAIPAMFGGSAIKLLKAGFHFSASEVGLLVLGMVVAFIVSIFAIK
FLMSYIKKHDFKVFGWYRIVLGILVLLYFAISSM
>ZP_03045710|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQGLLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAETEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVIERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A8A6H2|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPASPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>AAD42185|FEATURES|ARDB_deepARG|glycopeptide|VanXD|antibiotic target alteration|1
MKKNFAFLDEMIPGIRWDAKYATWDNFTGKPVDGYMVNRVMGTKELGVALRKAQKMAEKL
GYGLLLWDGYRPQCAVNCFLNWASQPEDNLTKKRYYPNIKRNEMVAKGYVASQSSHSRGS
TVDLTIFHLNSGMLVPMGGDFDFMDERSHHAASGLSEEESKNRQCLRYIMESSGFEAYRY
EWWHYVLADEPYPDTYFDFCIA
>G1VFN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIIEGLTEFLPVSSTGHMIITQKLLGVPANDEFVHAFTFIIQFGAILSVVC
LYWKRFFQIDHTPVPADEKSKFKRFIHPIRFYWLLFVGVIPAFIIGLPAKKSGLLDWLLE
SVWAVAIMLVVGGIFMLYCDKIFNKGKEENQITEKRAIRIGLFQCLSLIPGTSRSMATIV
GGMASGLTRKRAAEYSFFLAVPTMAGATVLDMYDLLNSDSTWASAHNLTMLAVGCVVSFI
VALLAMKWFVSFLAKYGFKWFGWYRIIVGLIIIIMLLCDIPLNMVD
>A0A0G8BZB2|FEATURES|UNIPROT_deepARG|beta_lactam|B4147_2149|antibiotic inactivation|1
MIVLNKFFNILHYKKIVPVLFLSCATLIGCSISNTPSEPPKQTKQENTVNHSFAKLEKEF
DAKLGIYALNTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDAHDTSTPKALATSLQAFTLGEVLSTEKRDLLIDWMKRNTTGDNLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKATNK
>ZP_03304051|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MILDLLKVFILSIVEGVTEFLPVSSTGHLILVNEFVKLEPEKFANAFNVIIQLGAILSVV
VLYFRKLNPWDLEKTKKYFPKNYEKLNGQSKIYYRLSHPHKETMDLWKRVIIGVIPAGVL
GLLLDDIIDAYLFNPMVVALMLFVWGIGIILLEKKNKNENRQRVDNLSLISYKTAFFIGC
FQVLAMIPGTSRSAATIIGAMILGLSRSASAEFSFFLAIPTMLGATLLKVFKNVSGFNAY
EWILILIGMILSFIVAYIVIKKFISYVQKNDFIIFGKYRIILSIIVFLYFLIIK
>A0A0K2MC27|FEATURES|UNIPROT_deepARG|chloramphenicol|X276_10040|antibiotic inactivation|1
MNFNLIDINNWSRKPYFEHYLNNVKCTYSMTANIEITDLLYEIKLKNIKFYPTLIYMIAT
VVNNHKEFRICFDHNGSLGYWDSMNPSYTIFHKENETFSSIWTEYNESFLRFYSDYLDDI
KNYGNIMKFTPKSNRSDNTFPVSSIPWVSFTGFNLNVYNEGTYLIPIFTAGKYFKQGNKI
FIPISIQVHHAICDGYHASRFINEMQELAFSFREWLENK
>A0A105BXG9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKTLILGVVEGLTEFLPVSSTGHLIVAGSFLNFDDAHAKTFDVVIQFGAILAVC
WEYRRRIASVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAVILLAEARQRERGEAPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>A0A0G3S638|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARIAAEQGIPVWAPE
DVNHPLWIERIREIKPDVLFSFYYRNLLCDDILNIAPQGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGNIVAQKSVAIGADDAALALHRKLCSAASELLAQALPAI
RDGKTEERAQDESLATYVGRRTPEDGRLDWERSAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLAAAKAGTVISVAPLVVACQEGALEIVTGQTERGVYMQGTQLAQALGLVA
GAVLSSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDNNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWVPTVEMEETVEHTLDFFLRTVELTDSGK
S
>CAW28032|FEATURES|ARDB_deepARG|multidrug|amrB|antibiotic efflux|1
MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSASYPGASAKVVEEA
VTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNADLAAVEVQNRLKIVESRLPES
VRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAE
YAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLV
TPEQFGEIPLRIRADGGAIRLRDVARVEFGQSEYGFVSRVNRMTATGLAVKMAPGSNAVA
TAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQN
FRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMA
EEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFS
AFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWML
VYALVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEP
VAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYA
MNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQ
IRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADGAKRLGIDDI
GRLHVRNEQGEMVPLATFAKAAWTLGPPQLTRYNGYPSFNLEGQAAPGYSSGEAMQAMEQ
LMQGLPEGIAHEWSGQSFEERLSGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVP
LGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEA
ARLRLRPIVMTSLAFGFGVIPLALSSGAGSGAQVAIGTGVLGGIVTATVLAVFLVPLFFL
VVGRLFRLRKAPRTGNSPQIPTEQA
>J7VLK1|FEATURES|UNIPROT_deepARG|aminoglycoside|A1OC_02073|antibiotic inactivation|1
MEAPDPFADGMPLPWAWQETLADARIERQSIGVSRADVARVQRPGQADAFVKSEVIDAFS
ELGDEIARLRWLQEQGQPVPTVIATAEEAGRRWLLMSALPGRDLASSPELAPQQLVEMLA
DALRGLHALPLAACPFDQRLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELCST
RPDHEDLVVSHGDACLPNLMVVEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGMVADERRLAFYRLLDEFF
>U2Q4W4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDFIVILKAIVIAIVEGITEFIPISSTGHMILVGNLIDFKGEFADMFEVVIQLGAILA
VVVLYWKKIYTTVLEFFKFIFGGKKEAKRGFDFWISVLIGTIPAIVLGFAFHDIIKEKLF
STKTVAIGFIVGGILLILIENNFRKNLKYKKNVTRDIDKISFVQAIKVGIFQCLAMWPGM
SRSASTIMGGWISGLSTPVSAEFSFFLAIPAMIGASGLDLIKYKGYATMTSTEWLALAVG
FVVAFLVALLVIEGFIAFLKKKPMRIFAVYRIFAGIILVALIATGVIK
>YP_002148734|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATLIAMTTHSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMA
RWMPETRPAGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQT
GQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>E1J2P4|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9347_01147|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATSGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0D0Q709|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKQPKTLSLLTLGSLLISSFASAAQDVPLATIVDGTIQPVLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTYTSTLGAYAVVKGGFKIDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESVEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFARLMGQTLLPGLGMHHTYLEVPKQAMGDYAYGYSKEDKPIRVNPGMLAD
EAYGIKTSSADLLAFVKANISGVDDKALQQAISLTHQGRYSVGEMTQGLGWESYAYPVSE
QTLLAGNSSAVIYNANPVKPVAASQETGGARLYNKTGSTNGFGAYVAFVPAKGIGIVMLA
NRNYPNDARVKAAYAILSKLAD
>K6DNC2|FEATURES|UNIPROT_deepARG|beta_lactam|BABA_08541|antibiotic inactivation|1
MRKTHDIFSMNKFIYALLVLVVAIVPLAGWSMTTHNPSDKPEKAVKKTPAPQIHREFAEL
ENKYDARLGVYAIDTGTNRKVSYRPQERFAYASTYKALAAGALLQHYSIDQLDELVTYNS
EDIVSYSPVTQLHVDTGMTLREVAEAAVRYSDNTAGNLLLEKLGGTEEFETALRKIGDHK
TQVDRYETDLNSAVPGDTRDTSTPKALATSLKAFVVSDLLPTEKRTILTDWMRGNATGDA
LIRAGAPTGWKVDDKSGAGSYGTRNDIAIVWPPNRAPIVIAVLSSRDTQNATYDNTLIAE
AAKIALNALK
>YP_002400591|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEISGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQASDTLRRTEPLLREGFVSAEEVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>A0A029P701|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHS
>YP_002848373|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MGFKPLINLKSDTRGLHMNKNRGLTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPEVGVV
TLKTEPLQITTELPGRTSAFRIAEVRPQVSGIILKRNFTEGGDIEAGVSLYQIDPATYQA
AYESAKGDLAKAQAAANIAQLTVKRYQKLLGTKYISQQDYDSAQADAQQANAAVVAAKAA
VETARINLAYTKVTSPISGRIGKSSVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDF
LRLKQELANGTLKQENGKAKVELVTNDGIKFPQSGTLEFSDVTVDQTTGSITLRAIFPNP
DHTLLPGMFVRARLEEGINPTALLVPQQGVTRTPRGDASALVIGADNKVETRQIVAAQAI
GDKWLVTDGLKPGDRVIVTGLQKVRPGAQVKAQEITADNNQQGQSGSQPEQSKS
>L0R2E9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-89|antibiotic inactivation|1
MMKKSLCCALLLTASFPTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANKHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPVPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>X0PPE6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNIIKAIVLGIVEGITEFLPISSTGHLYLADAFIKLQESTAFINMFMVVIQLGAIMSVV
VLYFHKLNPFSPKKNSLEKRTTWQLWGKVVIAIIPSMIVGPLINDFMDAHLTTWPVIATT
LILYGILFIWIENYNKHREPKEKDLNQMSLKLAFGIGLFQLLSLIPGTSRSGATILGGMV
IGASRFVATEFSFFMAIPTMFGASLLKMYSFFHHGNVLSSSQLIVLLVGVVVSFVVAYLS
IKFLLNYIKHNDFKAFGWYRIIIGIVVIAYFGGRTFL
>A0A0J1A146|FEATURES|UNIPROT_deepARG|beta_lactam|T630_2822|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLDAIKK
>D1CSA2|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-100|antibiotic inactivation|1
MENDPMKKKTRNRLLLCTTLAVTPWFSVVAAPMTQQQLTGLVDNTIKPLLEKQHIPGMAV
AVLYKGQPQFFNYGVAETEHQRAVTQHTLFELGSVSKTFTGVAAGVAMQTGLINLNDRVA
QHCPELNGAQWQKITLLNLATYTAGGLPLQLPDEVTDTASLQHYFQQWQPQWPAGTMRHY
SNASIGLFGALAVKNSGLSFADYLNKSVFQPLKLTQTFITVPPSAQADYAWGYQDGQPVR
VTPGMLGAEAYGVKSSTGDMVKYMQANINPASLSSDNKGLAMAIASAQRRYYRVGNMYQG
LGWEMVNWPISPAGVIADSSNDIALKARPATALKAPQSAVASSWVHKTGSTNGFGAYIAF
IPEKQLGIVMLANKNYPNPQRIAAAWQILQALDESK
>D0X2Q9|FEATURES|UNIPROT_deepARG|beta_lactam|VMC_37090|antibiotic inactivation|1
MKLNNALLAILSLTSFVTFAKTELTVSSQLKSVVDECAKGLINEYDIPGLAVAVTIDGKR
YFYNYGLADVSKGSLVTNDTIFELGSISKTFAATLTGYAQEKGKLDMDDKVKDYIPELEN
SALGNTKLVNVATYTAGGLPLQFPSEVTNDAEMMQYYKTWKPEYEAGTKRKYSNPSIGLF
GYIGALSMKSDYSEMMETVILPELGMTNTFVDVPKDKLNNYAFGYSSEGKPVRVNPGILD
AQAYGIKSTSLDMLQYIEANMGQAQLNTDIENALERTHTKYFDTDTFTQAVGWEGYDYPV
SLSQLLKGNSSDVILKAKPVQASVSGTLGRDVWYNKTGSTGGFGAYVAYVPSEKIGIVIL
ANKNYPNAERVEAAYHIISSVVK
>A0A0A0Q8R6|FEATURES|UNIPROT_deepARG|beta_lactam|MIR-16|antibiotic inactivation|1
MMKKNLSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEITLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPKWKPGTTRLYANTSIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMMPDSLQDSPLKHGIALAQSRYWRVGSMYQGLGWEMLNWPVDA
QTVVGGSDNKVALAPLPAREVNPPAPPVKVSWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A099HVU8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELIEIFKAMILGIIEGITEWLPISSTGHMILLDEFLQLGMSDSFKEMFFVVIQLGAIMA
VVVLYWKKIFPFSFKENQVIKKDIITMWIKIVIACMPAAIIGILFDDKINLLFYNFQSVA
IALIAFGILFIVVENYNKGKSSIANNINQLTYKMAIVIGLFQLVAAIFPGTSRSGATILG
ALLIGVSRDVAAEFTFFLAIPVMFGASLLKLIKFGIVFTSFELTVLLVGMVVAFIVSLLT
IKFLVGYIKKHDFKIFGWYRIGLGCILLIYYFMIM
>M5PB60|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQFKINEYPLPDLESGPYGIVRGADGALWFTEQKGNRIGRITAGGRMTEYAVPTENAGVS
IITSGINGDLWFTEYKAGKIGRITVDGEITEYPLPSGAAPFGITEGPDGAVWYTDMAGHK
IGRMSGAGEVSEYELPKPGSFPSFITAGPDGALWFTENQSNAIGRITPGGDIREFSIPTK
DSGPVGIAAGPDGALWFAEINGNQIGRITVSGMFREYPIPSVNARPHAIAAGPDGAMWFT
EWGSNKIGRITAAGDIAEYSIPAADAEPHGIAAGGDQSVWFAEECGQIGQFMILSNE
>A0A0G4PZ11|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSTFDEIKKVSVVIPVYNEEESLPQLLERTIKSCKQLEQEYELILVDDGSSDNSAKMLEE
AAAIEENHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVATAEEG
YDVVGTRRRNRQDSWFRKTASKMINSMITKATGRSMGDYGCMLRAYRRHIVDAMLQCHER
STFIPILANTFARRTIEIDVAHAEREYGDSKYSFLKLINLMYDLLTCLTTAPLRLLSIVG
SVIAVSGFVLALLLIILRIIFGAMWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYN
DVRARPRYFIQKVVGVNKPNEDQEKD
>AAR37056|FEATURES|ARDB_deepARG|glycopeptide|vanRD|antibiotic target alteration|0
MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGKDALKCIESVELDLAILDIMLPDVD
GFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYM
RYKQPSLKQEAECTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVST
EELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK
>YP_002006347|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRARIGKVVRGLRDDPLSQRFAANVVIASVPAIVLAFIFGKWIKAHLFNPISVALAFI
VGGVVILLAEWRDARRGTVSHPQGNALLEAAKAGAPRIESVDDLNWRDALKVGLAQCFAL
VPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKARALLNADDLGIFA
VGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIVVLLTAYTGLVSWHA
>A0A127STF0|FEATURES|UNIPROT_deepARG|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKQMKLYPAMLYYLATIVNRHSEFRTAINQEGELGIYDEMIPSYTIFHE
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQKLINS
>J8Q2C5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKEEATTYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSADDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>Q9R2G5|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-2|antibiotic inactivation|1
HPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGVGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>R5ID83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYYMEELSLFQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVPSSDFVKAFTVIIQFGAI
LSVVVLYWKRFFKLNKCKIFDTNIVNNNRSARWIEYGKRFLYKYDFYWKLLIAFIPAAFF
GLLFSDKIDEMLESVTVVAIMLVIGGIVMLFVDKWFAKSSSNQEMTPKKAFCIGLFQCIA
MIPGVSRSMATIVGGMAQKLTRKNAAEFSFFLAVPTMFAATAYKLLKLVTSENGLQILQD
NIVTLIVGNVVAFIVALLAIKFFISFVTKYGFKAFGYYRIIVGGIIIIFMLLGYNLEID
>C2VTY7|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0021_23020|antibiotic inactivation|1
MKGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGPMQVEAKEKKGQIKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHQIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPRDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLI
AEAAEVIVNAFR
>G3ESU0|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-21|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDHPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0X7K8G2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNSKAVVFAYHDIGCAGIEALLAAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDFIFSFYYRNLLSEALLATAKKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVIIDRTDTGLTLHAKLRDAASNLLRDALP
QLAQGKLAETAQDESQATYFGRRTAADGKLDWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVEFGQRNADGLFLAGPALADVLG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEIYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNENGVCDGQIVNIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLKEAMLEIA
DKK
>A0A0Q8XBR6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTELLVAILLGIVEGVTEFLPVSSTGHLILASELMGYDAAQWAVFNIAIQPGAILAIVVL
YWRTFLAVFKGLLRWEAASVAFVRNLLIAFVPAVVLGLAFGDQIDALLENAVVVAWALIA
GGVAILVIEKLARTENVFGISGVSTMQSIKIGLVQCLAMIPGVSRSGATIMGAMALGIDR
RTAADFSFFLALPTLTGATVLQLYKHRDAITADSLGLIAVGFVVSFVVALAVVKAFLAIV
TKHGFAPFAWYRIVAGAAALVWLGMR
>A0A0L8ABW8|FEATURES|UNIPROT_deepARG|aminoglycoside|W7K_07820|antibiotic inactivation|1
MGAPDPFTDGLPLPRAWQEALADARIERQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGDEIARLRWLQAQGVPAPTVIATAEEAGRRWLLMSALPGRDLASSPELAPQQLVELLA
DALRRLHVLPVAACPFDQRLASRLQAAQARVEAGLVDADDFDDERLGQSAQQVFAELCST
RPDHEDLVVSHGDACLPNLMAVEGRFSGFIDCGWLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGALVDERRLAFYRLLDEFF
>A0A127SJI8|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-207|antibiotic inactivation|1
FAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVL
LCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAA
NLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLT
GELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGGRGSRGIIAALGPDGKP
SRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BAC67134|FEATURES|ARDB_deepARG|tetracycline|tetB|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHLGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLNNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>CAV31157|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKIG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELHPNMRVMNFTESEQWDMVIE
GNDYLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILHNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A066SYM2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLEWKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A104CLD8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSQPLLKLAAVTRRFPAGDKDVVVLNNVSLSIDAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
ERHARARALLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDKDVARHARRIIEISDGEIVADRPNRHYAEALAQSGV
GAAATAETAPDGRSAPASGDAPAASTDTAPAPRTRRFAAGTGRFGEACRMAWIALVSHRL
RTLLTMLGIIIGITSVVSIVAVGEGAKRYMLDEIGSIGTNTISLYPGTDWGDSRADAIQT
LVPDDVAALAEQPYVDSATPETSRTLLLRYRNINVNALVSGVGERYFQARGMRFALGVAF
DDDAVRRQAQVVVIDQNTRRKLFGAARNPVGEVILVDNVPCVVIGVTADKKSAFGSVKSL
NVWVPYTTASGRLFGQRYLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFFTYNMDSV
VKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDILQ
QFLVEAVLVCLLGGTIGIALSFGLGALFSMFVAQWKMVFSAGAIATAFVCSTLTGVIFGF
MPARNASRLDPIDALARD
>A0A109N1U7|FEATURES|UNIPROT_deepARG|beta_lactam|AS888_05355|antibiotic inactivation|1
MKSLNHIFCTSTFKKIVPVLVLSCAALAGCSNHNGNAELTEPKKQETAKIQNFAQLEEKF
DAKLGIFALDTGTNQTVTYHPDERFAYTSTHKALAVGALLQQKSLEDLKQRITYTQEDLV
NYNPITEKHVDAGMTLKELSDASLRYSDNTAGNLILKQLGGPAGFKKALEEMGDDVTSPE
RIEPALNEVNPGETHDTSTPRALAESLQAFTLGDALPKEKRELLIDWMKRNTTGDALIRA
GVPKGWEVADKTGAGSYGTRNDIAIIWPSKGDPIVLAVLSSRDEKDAEYNDKLIAEATKE
VIQALKVKNK
>D1AVT6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLDILKVFILSLIEAFTEFIPVSSTGHMIIADKYINLSSNKEFVTAFQVIIQLGAILAV
VVIFFKKLYPFIYKGDERKELLELWSKIIVAVLPAVILGLAFDDYIEKHFFNTSIVAIML
LIYGILLIVIENKGRKSKINDISKLTYTMAVGIGMFQCLAMIPGTSRSAATIIGAMFLGL
NRIIATEFSFFLAIPTMLGATTLKLIKIGSSLSTYELFLIFLGLVFTFIMSLMIINSFLK
YIKNHDFKIFGYYRIIIALIILLDIYVW
>ZP_03310712|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDNLWVAFILSIVEGLTEYLPVSSSGHLVLVGDLLNFSGEKAATFQVVIQLGAIMAVVVL
YWGRFWGLLRPQQGVPFAGLRGIWMLFLTCVPACVLGLLLHSQIKSLFTPSMVLIPFVIG
ALLMIFVERRQFHPRYETLDDMTPGLAFGIGCFQCLALFPGFSRSAATIMGGMILGARRP
LAAEYSFIAAVPIMVAATGFDLLKSLHLFTAADIPFFAVGMIGSFISALIAVKAFVRLVG
HMTLVPFAVYRLLLAPFIWYFMVH
>A0A0D7XN75|FEATURES|UNIPROT_deepARG|beta_lactam|UZ38_16325|antibiotic inactivation|1
MKNKAGIQVGICIGLLCLSFTGFNPLFGSAHAEAKSIENTKMTSCITNQKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTY
SPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTTDKRTILTDWMQGNATGDELIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDADYNNALIAEAAKVAL
NALK
>AAT70791|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MSIQHFQTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTL
ADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLL
ANAAQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTP
DGPAVYMVQTRQAFERTRSVA
>Q2QCK5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLMLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>D2TVW4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MGLKALKKAGFEIQAVFTHTDDPKENHFFSSVARLGAELGLPVFAPENVNHSLWIERIEK
MQPDVIFSFYYRHMLSQELLALAPKGAFNLHGSLLPKYRGRVPINWAILNGETETGVTLH
KMIAKADAGDIIAQKKVAIDATDTALVLHEKIRQASEQLLADTLPLIKMGDYSATPQDES
QATYFGRRRAEDGLIDWSKSATEVNNLIRAVTEPYPGAFTYLAESKMIVWRARVLEKSHD
KLPGTIISTEPLQIACGQGVLEILTGQCGSGLYVEGSRLAAEMGIVTGVRVGAKPTAQVK
RRKRVLILGVNGFIGNHLTERLLADGHYDIYGLDISSSAVSRFINDPRFGDDQRFHFVEG
DISIHTEWIEYHIKKCDIILPLVAIATPIEYTRNPLRVFELDFEENLKIVRYCVKYNKRI
IFPSTSEVYGMCDDKEFDEDNSRLIVGPINKQRWIYSVSKQLLDRVIWAYGAKEGLKFTL
FRPFNWMGPRLDSLHSARIGSSRAITQLILNLVEGSPIKLVDGGAQKRCFTDIKDGIEAL
FRIIENKDEKCDGQIINIGNPTNEASIAQLADMLLVSFEKHPLRKLFPPFAGLKKIESSS
YYGKGYQDVEHRRPRIENARRLLDWEPTIDMKQTIDETLDFFLQAAAEELGKK
>YP_789012|FEATURES|ARDB_deepARG|beta_lactam|PDC-9|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLTVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDRAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A009YPW4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQHLEAFKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRQKIVDLIKGFFSGDAEARHFCMSVLIAFFPAVIIGVMAVDFIKSVLFSPLVVAIAL
IVGGLIIFWAESIKFDHKTTEATQITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIRNANVLTADNMTNIALGFITAFLAALFVVKALVR
FVEKHTLRVFAWYRIALGLIIMFVML
>YP_001974112|FEATURES|ARDB_deepARG|multidrug|smeB|antibiotic efflux|1
MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENA
VTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQ
AVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQ
EYAMRIWLDPEKMRQYALMPSDIETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRL
HTPEQFAQVVLKADANGSVVRLGDVATIGLGPESYDSISTFNGKPSASLGIELNAGANAI
AVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIILVVLVMYLFLQ
NWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVM
TFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMIL
SVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVD
RFLGRRTLGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMD
RLSAVAVKDDGVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTRAMAS
VPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRY
ASLEDAPVYAVKVDDAKAQAMGVNPQDVNDTLNAALGGDFVNNFIYKGRIKKVFIQGTAE
ARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAALQRYNGISAMEITGQPAPGVSSG
EAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVP
FAVMLAVPVGVFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGRD
TRDAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGM
FFVPLFYLLVRRLFPGRAPADATVPETSP
>A0A0A0Q8S1|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKSVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPNEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>A0A014N2J7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTAEQPINKVSVVIPVYNEQESLPELLRRTDAACAQLPMDYEILLVDDGSSDNSAAMLTT
AAEEEGSHIVAVLLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVATAQEG
YDVVGTVRQNRQDSWFRKKASRLINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRAIEIPVLHAEREFGDSKYSLMRLINLMYDLVTCLTTTPLRMLSVVG
SMIALAGFAFSLLLIGLRLFLGPQWAADGVFMLFAVLFIFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVINSSHPVSTEDDK
>I0QM61|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFLNIFILAVIQGLAELLPVSSSAHVIMAEKLLGLDPSAPNMTLLLVMLHTGTMFAVIV
FFWKSWRDSYFSSFAAFKRIALHIVLATVMTGIVGLSLQKLIKKFYAGNASDFQIESLFS
NSKLIASGLLAAGILILISSRIKERQAPGMSILQSLSIGFVQGLCLPFRGFSRSGATIST
GLSMGVARKTAEEFSFALAVVLTPAVIVKEALRVYHPAAGAAPVAAFSGILLPSLMGMVF
SFIAGLVALRWLAGWLEHGKWHLFGGYCIFAACVVLWIG
>A0A0G1YWH6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELWQALVLGAVEGFTEFLPISSTAHLILAARVLRLPSSEFLKSFEVAIQFGAILSVVLI
YFRTFLRNWAANRKVAVAFLPTALIGALLYPLIKRYLLDNAAVSLAALFLGGILLIIFER
IHREKPEAHDDIPSLSYAKAAGVGFFQTLAVIPGVSRAAATILGGLLLGMKRKTIVEFSF
LLAVPTMAAATGLDLVRSASQFSIGDVHLLIAGFAAAFVVARWSILFLLRYIQNHDFTAF
GWYRIALAVVFWALM
>A0A0J6S6G7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVASIGKAVVLALVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAIVG
VYFRQLLDLLLRAPRDPGARRFILAILIAFLPAAIIGGLFSKYIKFYLFNPWIICSTLVA
GGLVLLVIDETDLEQKYDDVHEYSLPMALKIGFFQCLAMIPGVSRSGATIVGAMLMGSGK
RAATEFSFYLAMPTMAGAFAKDLLDNYKNLSKDDVGLIAIGFVVAFLSALFVVRKLLDYV
SRHGFALFAWWRIVVGAAGFAGLIVFG
>A0A0U1LC40|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRQSRAAAAKEALP
ASTGWGLFSSGFREALNMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTRVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0Q5GK50|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLQLFDAFVLGLIEGLTEFIPVSSTGHLILAGQLLGFHSTGNTFEVLIQLGAVLAVLS
VYFGKLWHLFVTLPSDPKSRRFVGGILLAFLPAAVIGAIAHDFIKGVLFETPMVICVALL
VGGFILLAIDRMPLNPRYRDIEEYPLSLCFKIGLIQCLAMIPGTSRSGATIAGALLLGTD
KRSAAEFSFFLAMPTMAGAFAYDLYKNWSLLSVDDAATIGIGFVMAFLSALVVVRSLLGF
VSKYGFAPFAWWRIAVGAIGIGVILAYR
>YP_002738300|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDRGTTKTDNTLLERQRGITIQTAI
TSFQWKNTKINIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKIG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELHPNMRVMNFTESEQWDMVIE
GNDYLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTSFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>D4DQV4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAALFGIVEGITEWLPVSSTGHMILLNEFVSLDMTPEFWKMFLVVIQLGSIMAVV
VLYFDKLWPFAGGLRLKPHAVPLWSKIMLACVPAAVIGLALNDWIDEHFYNPWTVALALI
TFGVAFIAVENRNQSHRPHTVELAAISYKQAFWVGMFQLIAAVFPGTSRSGATILGGIAV
GLSRAVAAEFTFFLAVPVMFGASLLKIAKHGLSFSGHELAVMGSGMLVSFTVSILAIKFL
MSYIKRHDFKVFGWYRIVLGLLVIAYFTLIK
>A0A0D1AWS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIELLKAIFFGVIEGVTEWLPISSTGHLILVQEFIRLHQDKAFMEMFNIVIQLGAIIA
VIVIYFERLNPFQPGKSPQQIRLTWQLWLKVAIACIPSIIIAVPLDDWFEAHFNHMLPIA
IALIVYGVAFLWIEKRHQTLEPRVVKLSRMSYKTAFFIGCFQVLSIIPGTSRSGATILGA
IILGASRTVAADFTFFLAIPTMFGYSGLKALKFFIDGNHLTLSQLLVLLVASLTAFAVSL
YVIKLLTDYVKKHDFTVFGRYRIVLGSLLIVYSVFKSLF
>I6ZG87|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-11|antibiotic inactivation|1
MRYIRLCIISLLAXLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIA
>A0A0B1Q1B6|FEATURES|UNIPROT_deepARG|aminoglycoside|LA66_17590|antibiotic inactivation|1
MRSGESGNFIYRRDDGLAYAKIASPARVADLADERDRLTWLHGRGIACPEVIDWRATGKG
ACLTMTAIPGVAAVDLSGADLLKAWPSMAQQLGVLHSLPVVQCPFERSLSRMFASAVDVV
SRNAVNPDFLPDEDKNIPQQELLARVERELPVRLDQERADMVVCHGDPCMPNFIVDPRSL
QCAGVIDLGRLGTADRYADLALMVANAGESWTTPHEAERAFAILFDILGINAPDRERLAF
YLRLDPLTWG
>E1PKH4|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MTLPEPEMRDIKPINMLSVVIPVYNEQESLPELLQRTSVACDAINLEYEILLVDDGSSDR
SAELIEQAATVPGSRITGVLLNRNYGQHSAIMAGFSQVRGDLIITLDADLQNPPEEIPRL
VEAARQGYDVVGTVRQQRQDTWFRRKASRTLNHLIQRVTGKAMGDYGCMLRAYRRHIVEA
MLNCHERSTFIPILANTFARHTIELPVIHAERAFGDSKYSFMRLINLMYDLVTCLTTTPL
RLLSVVGSLIALSGFAFSLVLIVLRLFFGAAWAGDGVFVLFAVLFMFIGAQFVGMGLLGE
YIGRIYNDVRARPRYFVQRIVQAPEEPSVQDTQS
>A0A158AMZ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMFKALILGIVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGSVVTGLPARADARRFTLNVIIATIPAIVLGLLFEKSIKTVLFSPVPVSVALI
VGGIVILWAESRQRDRAAAPRVQSVDDLSYSDAFKVGLAQCFALIPGTSRSGSTIIGGMI
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVNDLGLFTIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>N9NEZ6|FEATURES|UNIPROT_deepARG|beta_lactam|F892_03691|antibiotic inactivation|1
MPNSKRFSIPAKKLCVLAGLLSCSAPLWAQQLSEQQVKAIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGVASKQSQQPIRNNTLFELGSVSKTFNATLAGYAQAQGRLSLSDHPAK
YFPELKNSAVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMIKYFQAWQPKTTIGAARQYS
NPSIGLMGYVTALAMKKPYTELLEKTLFPQLGLKQSFIQVPEQQMPNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINPQQLKQPLRKGIENTHVGYFKVGAMTQGLGWE
QYAYPTKLETLLQGNSSKMALESHAVTPIAQPKIAPAATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYNVIQQLIQQNSAR
>D3R0N2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEQINIGLELLKTLLLAVVEGITEWLPVSSTAHLLLVDKLVQLHGSSAFKSLFLVFIQLG
AILAVVIYYFKKLVPWQNGREGFKWRPERFGLWLKIVVASVPAAVIGIAFDDFFEAYFYN
QYTIGIMLIVFGLLFLWVERSSRKLSAAGRYKTVEELTYKAAFIIGCWQVVAAAFPGTSR
SGATIVGALLIGVSRAAAAEFTFYLAIPAMAGASLLKLLRFKGAFTPAELLILAVGFLLA
LAVSLPVIHYFISYIKRHDFKPFAYYRLILGILVLCLSFL
>A0A009Z7E4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MGLLACSAPLDAKDLSEQQVKAVIDQQFKPLLAQYNIPGLAVGVSLNGQHYFVNYGVASK
QTQQAVSSHTLFELGSVSKIFNATLAGYAQATGKLSLDDHPAQYFPALKNTAVNNATLLN
LGTYTAGGFPLQFPDQVTEQQDMLKYFQTWQPKNTIGTQRQYSNPSIGLMGYVTALAMEK
PYTELLEKMLFPALGLNESFIDVPEQQMTQYAWGYKGQQAMRVSAGMFDAEAYGVKSSSA
DLLKFLDAQINPQQLKQPLRKAIENTHVGYFKVGAMTQGLGWEQYSYPIKLDTLLEGNSK
QMAFESHAVIPIKQPKLADPATFFNKTGATNGFGAYVAFIPQQKIGMVMLANTNFPNEER
IKVSYRVMQQLLQSNSAQ
>A0A0B5FEV7|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDYLQVLVLAIVQGVAELLPVSSSAHVIMAEKLMGLDPSAPEMTLLLVMLHTGTMLAVIV
YFWKSWRERYFSSKYDFIHNAKQVIIATAFTGVIGLALMFFIEKVLMRGTQHSEIEHLFG
NMYIISAGLAMAGILILISGMRRAPMGDRPMRGADSAWIGAVQGVCLPFRGFSRSGSTIS
TGMLRGLDKVRVEEFSFALAVVLTPPVIVKEAYRLYKSGGAQTFSGHYMTVLTPSLVGMV
FSFLAGLVALRWLSRWLEHGRWYLFGIYCLVASAVVLAASQYL
>A0A068SWG2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGVIEGITEFLPISSTGHLIIAEQWLGHRSDTFNIVIQAGAIIAVTIIY
WRRLLDLLLGWREPANRDYAAKLIVAFLITAVLGLIVKKLGFALPEDAAPIAWALIIGGI
WMIFAEWAAARRPASTQITWLVAILVGIAQVVAGVFPGTSRSGATIFIAMLAGTGSRAAA
TEFAFLVGIPTMYAASGYELLKTLKDGSAAHEDWTSLGVAFVVSTIVAFIAVKWLLTYIR
SNRFTVFAIYRIILGFLLLGLIALGSVPQRGDQSAVVSSAVAPAETALRPALLK
>A0A0P0CW61|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDWLAAIILGLVEGLTEFIPVSSTGHMLLLGHFMGFQSAGKTFEIVIQLGALLAIVSVY
FKRLWTLATRWPFDPEARRFLIGLLVAFAPAVVIGFLAYGFIKDVLFETPQVICIALIVG
GLILLALDRMDKRPQWLDASQYPMRVYFLIGLFQCLAMIPGVSRSGATIAGGLLLKTDKR
SAAEFSFFLALPTMGAAVAYDLLKNHKTLDFSDVGLIVVGFVVAFLTALVVVRFLLDFVS
KHGFGPFAWWRIVVGVVGLALLQAGF
>A0A070KF38|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTTKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSDLSFEQAMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDTII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0M6WKF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIFDIIKSVIFGIVEGITEWLPISSTGHMILLNEILPLRIGKNPDDFYSMFEVVIQLGA
ILAVVVLFWSQIWPFGRKNNKAPLAKTGVGAWVKTDIFVLWFHILVSTIPAAIIGVLFDD
VFERLFYNFQTVAIMLILFGIAFIVIETRHNGKSAKIDSLVDISYTTALMIGIFQLIAAV
FPGTSRSGATIVGALLIGVSRTVAAEYTFFLAIPVMFGASLLKLVKFGFHFTGEEAAILI
IGMIVAFVVSLIVIKFLMGYIKKHNFIVFGWYRIVLGAIVLLCGIAGLL
>A0A0J0V9K4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHWMELWKAIILGMVEGLTEFAPVSSTGHMIMVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGVRGRHPGGHPRLNLIHVIIGLAPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADQFAKKAARTQTVDQITYKQAFFVGLMQCLSLWPGFSRSGSTIS
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIAGFLSAFVFALL
AIRFFLELINRIRLVPFALYRIVLAVVIYFLYF
>A0A0Q4UNZ6|FEATURES|UNIPROT_deepARG|aminoglycoside|ASF14_19185|antibiotic inactivation|1
MMDMDREEACAAISVPESMSAPLVGYEWARDNVGESGGAVYRLHGKLDAPDLFLKHGRSS
VAADVIDEMVRLRWLARHIPVPAVEGFVAMQDEAWLLMTALPGQTAYQLLEAQPDAHVGI
VDALAAFLRRLHAIPVNECPFNSDHAYRLARARERIHAGLVEEDDFDDEREGWTAEQVWE
AMQRLLPMPSDPVVTHGDFSLDNILMVDGEVVGCIDAGRVGVADRYQDLAILWNCLGEFD
ALLQNRLLEQYGIADVDERKLQFHLMLDEMF
>A0A0R9NU30|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>L1MJQ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLIDLIIIAIVEGLTEFLPVSSTGHMMIAEGLLGVEMSTFVKSFTVIIQLGAILAVVVL
YWRKFFYPSADALGGKGSTQSASGHIQQGGASFAQWWSRIWPFYLKLIVGVLPAVAVGLT
LKDVIDKNLESVTMVAVMLIVGGVFMLFCDQLFAPKDKAAVEAQAKIPVTYRRAFMIGLY
QCIAAVLPGTSRSMATIVGGMQQKLTRKMAAEFSFFLAVPTMFGAAVKEVYDLMKHGADI
TLSDGTVQHLTGTQMLTADGNLTTLLLGSLIAFIVALMAVKYFIHYIARYGFRAFGWYRI
VVGAVILVLPTLGVELKVEHEASSSAPQTEITAQSRTDHHSQRAFPSQQNTKTATQRPA
>A0A0E8XES0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFILGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGAVPHEGKTGGHLTLGHILLAMIPAVILGLAFHDVIKALFDPKS
VMYALVAGGVLLLAAEWFKPKNPKAVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFIVAAVVYWVFM
>C6G4D2|FEATURES|UNIPROT_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MNYIQREKQCSALQLHTSLDADLKGYQWARDHVGQSGAAIYRLYSKAGAPELYLKQGRGT
VADDITDEMIRLNWLKAYLPLPAIKHFTRTGDEALLLTTAIPGKTAFQMLEEYPAAQNSI
VDALAVFLQRLHQIPVSHCPFNSDHLFRLALAQTRMNSGLVDADDFDDERKGWSVEQVWS
EMQSLLPFSPDYVVTHGDFSLDNLIISQGEVVGCIDVGRVGIADRYQDLAILWNCLGDFS
PSLQNRLFHTYGIATPDLKKLQFHLMLDEFF
>W6RMK2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRNIPQSTFGILAAVSLILGTGAHAAEQQGGFGRLVDAVAGPLMAKNDISGMAIAVTAKG
KRYVFNYGVASKANGQKVTDATLFEIGSVSKTFTATLAAYAEASGDLSFADSPTKYLPEL
AGSRLASVTMLDLGTYMAGGLPLQFPDEVTNHKEMVGYYKNWKPSYAPGTHRLYSNPSIG
LFGYAAAKAMGWPFDDLMQQKLFPALGLSHSFITVPKNEAANYAYGYSKSGKASRVSPGV
LDSEAYGVKMSASDMLGFIEANMDASGLDNPLQAAIAATHVGYYKIGGMTQGLGWEIYAY
PTDLDHLLAGNATEMTLHAHEIEKLSPPRQPVKDALFNKTGSTNGFGAYVAFVPSQGIGV
ALFANKNYPNSERVKAAYRILAALDDQLPAASAD
>U1WIX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDQYIIALILGIVEGLTEFLPVSSTGHLILTGELLGATEEKWKTFEIVIQLGSICAVLLL
FWRRILGLLGIGRKRTFGPQLNLLHIFIGILPAGVLGVLLHGFIKEKLFSSFTVLLSLII
GGILIIVAEKMRPRITAETIDDISYKQAFGIGLFQCLALWPGFSRSGATIAGGLLLGTSR
KAAAEFTFIMAIPVMMGASGLDLIKSWDMLAASDLGFFAVGFITAFIVAALAIVSFLKLV
ERISLTPFAIYRFLLAIVFYFFILK
>B2CD52|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
AMLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNT
AANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKL
LTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWYFA
>S0AJJ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTAGRLKLGHILLAMIPAVVLGLLLHDFIKSLFAP
KNVMYALVVGGFLLLAAEWLKPKKPSAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTI
AGGMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTMGDLPMFAVGFATAFVVAL
IAIKTFLSLIKRISFVPFAIYRFIVAAVVYMVFM
>W8PJ60|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERSMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQPSARRFTANLLIAFLPAVVLGVLFADLIHEYLFNPITVAAALV
VGGLVMLWAEKRQHQVHAETVDEITWKDSLKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAIGFVTAFIFAMIAVKGLLRF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKP
>A0A0Q9GD19|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIIVAVILGIVEGLTEFAPVSSTGHMIIVDDLWLNSKELFSSPVANTFKIVIQLGSIL
AVVVIFKDRFINLLGLGKKPAAPIGPTNRLNLMQVIVGLLPAGVLGLLFDDYIDEHLFSL
NTVLIGLVVGAVLMILADLFGPKRPRVETVDQMSYGQALGIGLFQCIALWPGFSRSGSTI
SGGVLLGMSHKAAADFTFIMAVPIMAGASGLSLVKNWQYFTSDALPFFIAGFISAFIFAL
VSIRFFLKLINRIKLVPFALYRIVLAAILYFVFL
>A0A0M0NA63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFNQRGNREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLEMAKAGQLGSENWTDVGVAFLAAAVTGFVVVKWLMGYIKSH
RFTAFAIYRIALGAALLLWLPSGS
>H1AFJ2|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
TQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDA
GDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVRELCAAAITMSDNSAANLLLATVGGPA
GLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQ
LLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYSAGN
TPGEHGRAKSANRRDRRGANRKGQTP
>A0A0G9MTY6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDDTTLTAILLGIVEGLTEFLPVSSTGHLILATEALGYDAERWAVFNIAIQPGAILAVVV
LYWRTFWDAFIGLFTWDPKAVAFVRNLLVAFTPAVVLGLAFGDEIEMLLENATVVAWALI
VGGFAILAVEHFANPGREHVGVAALSLKQSALVGAVQCLAMVPGVSRSGATIMGALCLGV
DRKTAAEFSFFLALPTLTGATVLQLWKHGDGIGANGVGWSEIALGFVVSFVVALAVIKAF
VAYVSRHGFKPFAWYRIVIGAAALAWLTLR
>A0A070SVZ4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIYSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0J6RGQ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLASIGKAVVLALVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAIVG
VYFRQLLDLLRRAPRDPSARRFILAILVAFLPAAIIGGLFSKYIKFYLFNPWIICSTLVA
GGLVLLVIDETEIEQKYDDVHQYSLPMALKIGFFQCLAMIPGVSRSGATIVGAMLMGSGK
RAATEFSFYLAMPTMAGAFAKDLLDNYKNLSKDDVGLIAIGFVVAFLSALFVVRKLLDYV
SRHGFALFAWWRILVGAAGFAGLIIFG
>A0A0J3VWY5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVKRIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMHETIDETLDFFLRTVDLTDKPS
>CAL11685|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MTSAPQSVNWKRNLFVTWLGCFLTGAAFSLIMPFLPLYVEELGVSGHQSLNMWSGLVFSI
TFLFSAIAAPFWGSLADRKGRKIMLLRSALGMGIVMVLMGMAQNIWQFLALRALLGLLGG
FIPNANALIATQVPRNKSGWALGTLSTGGVSGALIGPLIGGLLADNYGLRPVFFITAAVL
FACFVMTWFYVREQFAPVLKKDMLNGRQVFNSLKNPKLILSLFVTTMIIQIATGSIAPIL
TLYVRELAGDIHNLAFVSGMIASVPGVAALISAPRLGKLGDKIGPERILIAMLALSVLIL
IPMAFVQTPLQLGILRFLLGATDGALLPAVQTLLIYNCTNQVAGRIFSYNQSFRDVGNVS
GPLLGAAVSASYGFRAVFCVTAVVVLFNALYSYWCLQRQPLKAQQRAIQQRQDS
>A0A0Q8JCK6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFKVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKITEIVKGLPTQRNAQRFTLNLLIGFLPAVVLGVLFADQIHHYLFNPITVAVALV
VGGIVMLWAEQRDHVVHIDHVDDMRWSDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEYSFFLAMPTMVGAAVYSGYKYRELFQAGDLPVFALGFVTAFFFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLLILATWAFGWVNWTAAAAN
>D7ZCR3|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGFPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPTTSDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMLTSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>ACB17801|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLINGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFMHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLAGLALLIV
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVLAGVIVVFTLAGLLNRVRQHQAAELAEER
>AAS89471|FEATURES|ARDB_deepARG|chloramphenicol|catB8|antibiotic inactivation|1
MKNYFNSPFKGELLSEQVKNPNIRVGRYSYYSGYYHGHSFDECARYLLPDREDVDKLIIG
SFCSIGSGASFIMAGNQGHQHDWASSFPFFYMQEEPAFSRALDAFQRAGDTVIGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTKDVEPYAIIGGNPAKQIKKRFSDEEISLLMEMEWWN
WPLDKIKTAMPLLCSSNIFGLHKYWREFAV
>A0A0E9LHN5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSLLLLKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQRIRDTLVALPSQRQARRFALNVLIGFFPAVLLGLLLGKAIKAHLFTPVVVASTFI
VGGFIILWAERRQQGTVRIHSVDDMGPWDALKVGLAQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDYSFFLAIPTLIGAGAYSLYKERALLSMADVPLFVVGLVFSFISAWLCVRWLLR
YISTHSFVPFAYYRIVFGVVVLATAWMGVVTWAD
>A0A098YP46|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLLETIILAIVEGLTEFLPVSSTGHMIITRDLLGMQADDPFINAFIVIIQFGAILSVVT
LYWKRFFRLDNTPVPEGTPAVKAFIHRWNFYWKLLVAFIPAAVIGLLANHLIEKMLGSVI
VVAVMLVVGGIFMLFCDRIFNHGQESTSLTDKKAFMIGVFQCIAMIPGVSRSMATIVGGM
AQGLTRKRAAEFSFFLAVPTMFAATCLDVFKLIKNGGVDALSSHVPTLLLGSAVAFVVAL
LAMKWFVNFLTKYGFKVFGVYRIIVGGFILIWLMMGHSLAMVD
>ABS72055|FEATURES|ARDB_deepARG|glycopeptide|vanSD|antibiotic target alteration|0
MKNRNKTSHEDDYLLFKNRLSVKILLMMVYSILIIAGVYLFILKDNFANVVVAILDSFIY
HDRDEAVAVYLRTFKAYEIWLFLIAVMGVFFMIFRRYLDSISKYFKEINRGIDTLVNEDA
NDIGLPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLVHDLKTPLSSVIGYLN
LLRDENQISEELREKYLSISLDKAERLEELINEFFEITRFNLSNITLVYSKINLTMMLEQ
LGHEFKPMLAGKNLICEFDVQPDMMLSCDANKLQRVFDNVLRNAVSYCYENTTIRVKARQ
TEDHVLIQIINEGDTIPGERLERIFEQFYRLDVSRSSSTGGAGLGLAIAKEIVELHHGQI
TARSENGITSFEVALPVVGKS
>AAC76696|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQ
LFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMA
RWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVLGL
SSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQT
GQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>A0A060BIN2|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQGLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>ABO65577|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDWMELLKAVILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLELLGIRGRHPGGKPRLTLLHVIIGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIVADRFAKKAARAQTVDQITYKQAFLVGLVQCLSLWPGFSRSGSTIA
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTVADIPFFIAGFLSAFVFALL
AIRFFLHLINRIRLVPFAVYRIALAFIIYFLYF
>H3RCX3|FEATURES|UNIPROT_deepARG|beta_lactam|CKS_2901|antibiotic inactivation|1
MKSFLTALLIAFTASAQAADLSSQTIAERVKSVIDPLMAQQGIPGMSVGVLYKGRPQYIN
FGVADTASDRRVTENTLFELGSVSKTFTGVLAGVLIRNGALRLNDPVSRYWPALNGPQWQ
SRWMVHLATYSAGGLPLHLPDEVTSQDELLAYAQQWQPDAAPGTQRHYSHVSIGLLGYLM
VKGEFEEAMQKDVITPLRLTRTFYTVPPSMMFDYAWGYQDGKPVRVSPGMLSAETSGVKS
TARDMMAFMQANANPNGLSSGNTALRNGILTAQSRYLRAGELYQGLGWEIYPWPIDSQTI
VTASDTQAALSTQPATILSPAQPMDRASWVHKTGSTKGFGAYIAFVPQQNSGVILLANKN
YPNPERIKAAVAIMAMLASD
>W6WHR6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFLPVSSTAHVLLAGHFLGFQSPGNTFAVLIQLGAILAILL
VYARKLLQIAADLPTSPKARRFVATVLIAFLPAAVIGALAHDFIKAVLFETPMLICIMLI
LGGFVLLAVDRMKFQPKYHDVMDYPPSLAFKIGLCQCVAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRNALSFDDGALIAVGFIAAFVTAILVVRSLLDF
VSSRGYAPFAYWRIVVGALGLIALLLGA
>NP_745564|FEATURES|ARDB_deepARG|multidrug|mexf|antibiotic efflux|1
MNFSKFFITRPIFAAVLSLVLLIAGSISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVAAPLEQAITGVENMLYMSSQSTADGKLTLTITFALGTDLDNAQVQVQNRVTRTQPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAILNIKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTASDVVAAIREQNRQVAAGQLGAPPAPGSTSFQLSINTQ
GRLVNEEEFENIIIRAGADGEITRLKDIARVELGSSQYALRSLLNNQPAVAIPIFQRPGS
NAIEISDEVRAKMAELKKDFPEGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVIL
FLQTWRASIIPLLAVPVSLIGTFAVMHLFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIGLGLKPLEATQKAMSEVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLKDHHAPKDRFSRFLDKLLGSWLFSPFNRFFDRASHSYVGGV
RRVIRSSGIALFVYAGLMGLTYLGFSSTPTGFVPAQDKQYLVAFAQLPDAASLDRTEAVI
KRMSEIALKQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAAAIAAAL
NAQFADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNLGYEALYKETQNIIAKSHNVPE
LAGLFTSYQVNVPQVDAAIDREKAKTHGVAITDIFDTLQVYLGSLYTNDFNRFGRTYQVN
VQAEQQFRLDAEQIGQLKVRNNLGEMIPLATFLKVSDTSGPDRVMHYNGFITAEINGAAA
PGYSSGQAEAAIEKLLKEELPNGMTFEWTDLTYQQILSGNTALLVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAITGVIVSGGDNNIFTQIGLIVLVGLACKNAILIVEFAKD
EQAKGLDPLAAVLEACRLRLRPILMTSIAFIMGVVPLVFSSGAGSEMRHAMGVAVFSGMI
GVTVFGLFLTPVFFFLIRRFVERRQARKAEHAQVLENHA
>T1Z245|FEATURES|UNIPROT_deepARG|beta_lactam|bla(CTX-M)|antibiotic inactivation|1
QRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFA
RQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMEQTLRNLTLGKALGDSQRAQLVTWMK
GNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVT
>A0A149PAN1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKTRAFNLISTATFALFTLCATSAASHAAEPVAAQLQPTVDAAIRPLMAKYHIAGMAVGV
IEDGKPYVYNYGVASTQTGKPVNRDTLFELGSISKTFTATLASYAQVDGKLSLSDGTERY
LPSLRGRPFGKVSLLNLGTHTPGGLPLQVPDDIHNDAQLLQYFYDWQPAHAPGTFRTYSN
PGIGTLGLITAKSMGEDFTALMQQRVFPALGMKSTYLHVPAAKMADYAQGYTKDGAPIRL
TGGVISAEAYGVKSTAADMLRFVQANMNLIPLDSQFQRAITDTHTGYFQAGVLTQDLIWE
QYPYPVELRTLQAGNSPEMVLNGTPSTEIKPPLPPQQNVWINKTGSTNGFGAYVAFVPQK
RIGIVMLANRNFPNEARVSAAHQILSVLDGGGH
>A0A0Q4PNX1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGLTQPATFIVLIQLGAILAVVT
VYFAKLGMLIRDALTGKRYAWQFALSVILACFPAVIAGVLLRDFIQGDLWESAALICWSL
LIGGFVLLIVDRLNLKPKYDDIYTFPWHLAVIIGLFQMISLIPGVSRSGSTVVGGMLFGA
SKRAAAEFTFFVALPIMVGAFGYDLYKSRDLIDTSIALNVAIGFAAAFVVGAIVVRYLLN
FVSRYGFAPFAWWRIAVGVFGLVGIYFFGR
>NP_459095|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDRFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMNFGELSAQLGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKEYGRLSVMAQYYCQVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPYPVKDIRVLSRITTEAFNQRRKTIRNSLGNLFSVETLTE
MGIDPAMRAENISVAQYCQMANYLSENAPLKES
>A0A0N8GHD4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIKELNHFLFSVSDLNRSIRFYQQVFNATLLVKGKTTAYFDLQGHWLALNEENDIPRSE
ISQSYTHIAFSIEEENFEQAYKELTDLNVNILPGRKRDSRDKKSIYFTDPDGHKFEFYSG
TLQDRIDYYKEAKPYMEFYEEEAMPGKSSK
>W9H971|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDDTTLLSALILGVVEGLTEFLPVSSTGHLILIGDLLGFQGPPGRLFEVVIQLGAILAIC
VVYFQRLWHIAVTLPTSRESRRFVIAILLAFLPAAVIGVMAHGFIKSVLFSPYVVCVALI
VGGIAILLIERNLPTPRHFKVEQFSPRLALGIGFVQTLAMIPGVSRSGATILGALLMGVE
RKTAAEFSFFLAIPTMAGAVVYDTYKNFDTLTSDGSLVIAIGFVAAFLAALVVVKSLVAF
VSRFGFTPFGWYRIALGTLMLVILAMR
>U3HM49|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYISCGEATAIGDKMDLWIAFQALLLGVVEGITEFLPISSTGHQIIVADLIGFGGDRAQA
FNIIIQLGAILAVVWEYRSKIIDVVVGLPTKKPAQKFTGNLLVAFFPAVILGVAFADLIH
EYLFNPITVATALVIGGVVMLWAEKRQHRVQAETVDDMHWSQALKVGCAQCLALIPGTSR
SGATIIGGLLFGLSRKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTS
FIFAMLAVRALLKFIGNHSYAAFAWYRIIFGIIILATWQFSLIDWSTAAG
>A0A031GY62|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDLILALKAIIMGLVEGFTEFLPISSTGHLILAGSLLDFTKDVSKEVMDVFEIAIQAGAI
LAVCWEYRQRIGSVLTTFGSEAKSRKFVLNVAIAFLPLAVIGLAIGKMIKHALFKPVPVA
MAFIIGGIVILLVEHRARTNPVTVRVNSVDEMTPFDALKVGCAQAFALIPGTSRSGSTII
GGMLLGLSRKTATEFSFFLAIPTLLAATFYSLYKARDILSATDVPLFGLGTVSAFISAFL
CVRWLLRYISSHDFTFFAWYRIVFGLLVLASAHYGWVVWAE
>YP_002083353|FEATURES|ARDB_deepARG|multidrug|oprM|antibiotic efflux|0
MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREF
FRDPQLQQLIGLALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDL
STTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVAT
AYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQY
TRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLM
AANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRAS
LDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASNEYYQLADKR
YRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKK
EDPQA
>I2HPT2|FEATURES|UNIPROT_deepARG|beta_lactam|MY7_1065|antibiotic inactivation|1
MKNKAGIQVGLCIGLLCLSFTGFNPLFGSAHAEAKSIENTKMTSCITNQKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTY
SPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTTDKRTILTDWMRGNATGDEMIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDASYNNALIAETAKVAL
NALK
>A0A0N9FH84|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-139|antibiotic inactivation|1
MMKKSLCCALLLTASLSTFAAAKTEPQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNLVRVEAAWRILEKLQ
>C3XJR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIYAIILGIVEGLTEFLPISSTGHLILTSELLGIPQNTFHKTFEVVIQLGSILAVIFV
FSQKLFKNSLQLWIKLGIGFLPAGILGFLFYSYIKALFAPITVSIMLILGGIIFIILEIF
YKEREHHTTEVNTISYKQALLIGLFQALAMIPGTSRSGATIVGGLLLGCNRKVATEFSFL
LALPTMVLASAYSLYKNHEVLSVDNALILGTGFVVAFFSALLAIKLFLNFVSRFNFIPFG
IYRIVLGIIFLYYLDII
>A0A150KX24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVEIIKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYAANTFKVVIQLGS
ILAVVVVFKDRFIDLLGLRGRHRDEQPRLKLMQVIVGLIPAGVLGVLFDDYIDEHLFSTA
TVLIGLVLGALLMIAADWFAKKNTPKAQTVDQITYKQAIIVGLVQCLSLWPGFSRSGSTI
SGGVLAGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIAGFISAFLFAL
LAIRFFLHLINRVRLVPFAVYRIVLALVIYVLYF
>A0A0Q0AV48|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MRPYPIKFVSIVIPVYNERQSLPELLRRTEVACKHLNHRFEIVLVDDGSRDDSAEILQQA
AERSASPFVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVALAEQGY
DVVGTVRSNRQDSAWRRWPSKIINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEVLVDHAEREHGDSKYSPMRLVNLMFDLITCMTTTPLRLLSIIGF
SMALLGVLFAGLLIILRLIFGAPWAGDGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVVRSSSEVVSESVDSSVTPYMNKVAP
>ZP_04632979|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLVFHDVIKSLFNPHS
VMYALVAGGLLLLAAEWFKPKNPKAVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASALDLYKSLHFLTLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>D7PIL8|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-1|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVALKKSDLVNYNPITEKHLN
EGMTIGELAAAALQYSDNTAMNKLIEHLGGPHKVTDYARTLGDNTFRLDRTEPTLNTAIP
GDERDTTSPRAMALSLQHATLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWIVGDK
TGSGDYGTTNDIAVIWPENKAPLVLVTYFTQPEKDAKS
>A0A0D0HZ95|FEATURES|UNIPROT_deepARG|beta_lactam|BG10_6932|antibiotic inactivation|1
MVEKKFQKRVTDFIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQT
ITSLKFGNTKVETFHPGKGRTEDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEW
STSIENVLKRYGNINSVVPGHGEVGDRGLLLHTLDLLK
>YP_002338096|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVRGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREGKPHMTFY
>A0A0T7A583|FEATURES|UNIPROT_deepARG|aminoglycoside|N184_17645|antibiotic inactivation|1
MRVLLMDGETIGRWVEMRLALWPDTPEAEHRAEVESSLAEPDRYASFLCEDEAGVAAGFA
EASIRRDYVNGCETSPVAFLEGIYVLPRYRRRGVARALITAVERWATSQGCQELASDTVT
DNLRSQSLHMALGFEETERVVYFRKELSPAVADN
>ZP_02902679|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MLIFYSPGHRAPAHQQRIAMSPSDNDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYV
EQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLM
GLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMA
GGLLADNYGLRPVFFITASVLILCFFVTLFCIKEKFKPVSKKEMLHMREVVTSLKNPKLV
LSLFVTTLIIQVATGSIAPILTLYVRELAGSVSNIAFISGMIASVPGVAALLSAPRLGKL
GDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSS
NQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTASVVLFNAIYSWNSLRRR
RLPQVSN
>Q0PH33|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDPFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>R8D6P3|FEATURES|UNIPROT_deepARG|beta_lactam|IGA_01835|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALNTGTNQTVTYRSDERFAYASTHKALAVGALLQKNSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTHDTSTPKALATSLQTYALGDILSTEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNKS
>U2QWF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKGFFDMLTMIEVLKAILFGVVEGITEWLPISSTGHMILLDEFVKLNVSKEFLDLFLVVI
QLGAILAVVVIYWNKLIPLSTKHGLHISRRKCKMWVKIIVASIPAGVVGILWDDVFTKYF
YNYQTVAIMLILVGVVFIIIERSNKNKIAKIDSIDDISYGQAFLIGVFQMIAAIFPGTSR
SGSTIVGSLMLGISRTAAAEFTFFLAVPAMFGGSAIKILKYNGGFNSAEVALLAIGMIVA
FVLSIIAIKFLMSYIKKHDFKVFGWYRIILGIAVIGYFLAAR
>A0A0A0QAV2|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_pao|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPITLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>V2JBJ8|FEATURES|UNIPROT_deepARG|aminoglycoside|B551_0203615|antibiotic inactivation|1
MTLPAALADHGRLRWMPVSMGESGDLVYRRDDGRAFAKVVPESRSAELAGERDRLAWLEG
QGIACPKVLDWREAGNEVCLVMTAVPGVPAADLPGTDLLEAWPSMVRELGALHALSSGQC
PFERSLSAMFAHAVDVVNRDAVNPDFLPDEDKRTPAPELLARVERELPVRLAQEATSTVV
CHGDPCLPNFMVDPHTLRCTGIIDLGRLGRADRYADLALMVANAEESWQTPQQAEQAFAM
LFDTLGLTADRERLAFYLRLDPLTWG
>A0A0Q8QCZ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLALKALIMGLVEGFTEFLPISSTGHLVLAGSLLNFTGEKAKVFEIAIQGGAMVAVI
WEYHKKICEVLSGMLREARARRFALNVAVAFIPAAALGFLFEKKIKAVLFAPEPVALAFI
IGGLIILWVERRARNNPVAVRVQSVDDMTLLDALKVGFAQVFALIPGTSRSGATIIGGMM
FGLSRKVATEFSFFLAIPTLLAATFYSLWKDRALLSAADLPLFSIGAVVAFVSAFACIRW
LLRYISTHTFTVFAWYRIVFGIVVIATAYSGMISWAE
>A0A127SU42|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTILN
RHEEFRTALDENGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAF
GERTGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYHIP
LSIQVHHAVCDGFHVCRFLDELQDLLNK
>A0A062Y0B2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVM
YALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALIAIK
TFLQLIKRISFIPFAIYRFIVAAAGYVVFF
>H3NL13|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKVIILSIIEGITEFLPVSSTGHMILANEFVNLEPKAFSDTFMVIIQLGAILAVIA
IYFNRLSPFGKDKLDGGAYPQKVEQMSGWTKFVNKLYYWFNHNETVELWKKVIVAVIPAA
VLGVLFDDKIEGLLFFPIPVAIALIFYGIVIIFLEERNKSKANYKFTDVMQLSYKTALLI
GLFQVLAMWPGTSRSAATIIGGMILGLNRKTAADFSFFLAIPTMLGATLLKVVKAGAMTG
AQWGLIALGFVLSFIVAYVVIKKFLAYIQKNDFKVFGYYRIVLGILVLLYFLVF
>CAC35726|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLFPILIGLGLTGFSAMSQAENLLQVYQQARISNPDLRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYTSGFRDYKNQNSNVTSGSLQLTQTLFDMSKWRALTLQEKAAGIQDV
TYQTDQQTLILNTATAYFKVLAAIDTLSYTEAQKQAIYRQLDQTTQRFNVGLVAITDVQN
ARSQYDAVLANEVTARNDLDNAVEELRQVTGNYYPELASLNVNGFKTSKPQAVNALLKEA
ENRNLSLLQARLNQDLAREQIRQAQDGHLPTLDLNASTGVSNNRYSGSKNISQDADVGQN
KVGLSFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNVNASISSIN
AYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQQLSNARYNYLINELNIKS
ALGTLNEQDLIALNNTLGKAIPISPDSVAPENPQQDAAADGYANTASAQPAAARTTKTSG
SNPFSH
>A0A0S1RS41|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
TPASTFKLPIALMGADAGILQGAHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYS
QLTARALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLV
NRQLPLKPAAYDLAETLFDAGEAGGWRLYGKTGT
>B8ZHZ7|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFSLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKN
>A5KNX8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEALKVIIFGIVEGITEWLPISSTGHLILLEELLHLKQNQAFLDMFYVVIQLGAILAVV
VMYFHKLNPFSPKKTQKQKMLTIQLWVKVIIGSIPAMLIGLPFNDFIEEKFNNSYVVAAT
LIIYGILFIVIENYQKDKQPKVEKLSQLTIQTVLIIGVFQALALIPGTSRSGATIVGALL
IGVSRGVAAEFTFFLAIPAMFGASFLKLIKFGLNFTGMQVFLLLLGTVVSFAVSILAIKF
LMQYIRKHDFKVFGYYRIVLGVIVLLYFGIKTLLA
>ZP_03833009|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGEVPHEGKTSGRLKLTHILLAMIPAVVLGLIFHDFIKSLFYPQN
VMYALVIGGFLLLAAEWFKPKQPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFAVGFVTAFVVALIA
IKTFLKIIKRISFVPFAIYRFIVAGVVYMVFM
>A9N5B2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYDIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>A0A0S3NDH9|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMATAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMTIMGVAVLMLSLFILKE
TRPAAPATSNKPQENTESLLNRFFLSRVLITTLSVSVILTFVNTSPVLLMEIMGFKRGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMIASQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGVGAWNMLIGI
LIACSIVSLLLIILVAPGRTVAAHEEIHHHA
>G1WBT5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIQTIIIAIVEGLTEFLPVSSTGHMIITQNLLGVPKGDPFVHAFTFIIQFGAILSVVC
LYWKHFFQMRTKEEFQAKLRFYGLLIVGVFPAVVVGLLAKKSGLLDWLLDSVTVVAITLV
LGGVFMLFCDRLFNATDKTNEVNWKRAFKIGCFQCLSVIPGMSRSMSTIVGGMQQGLTRK
RAAEFSFFLAVPTMAGATLLDLLEMFKEGTNWATTTNIELLLLGCIVAFVVAIFAMKWFV
AFLTKYGFKAFGWYRIIVGLVILVLLATGHSLTMVD
>M6LLY5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSTGHLFLFSSFFPFSGESFGIEFDDLFDIFIQSGAILSVLFLYREKFESQIFSSFQYL
TKRNSNPEGFYFLVRIVIGAFPILVLGFLAKKFLDTIKTRSDLLDILAGAWVFGGVLILV
AEWLFRKRQGAEEKKPVGFRDAILIGIFQCVALIPGISRSAATIVTARFLGKDAKSSAEF
SFFLAVPVLFAAGIYKLVKHRSILNETTIPVLTFGFLISFLLCALVIRLFLRYLQKHSFG
VFGIYRILLGVGVLVFTKFIR
>N6WY46|FEATURES|UNIPROT_deepARG|aminoglycoside|J057_11761|antibiotic inactivation|0
MNLRSIFPRTGMALLALLVFTSGAVAQTDDWRPVLQKEIERIDQTFSGDLGVYIRHLGNG
REIAHNADQDWYLASTIKVPLAIVLMQRAEDEDLDLEQKLTLRASDYVDGTGDLLWVDPG
ARYSLEELNRRSIVDSDSTATDMLIRFLGEESFNEEVARLVPAGLGPITTILQVRYDAYS
EVHPSVSRLSNRDFIDLKTAHTYKARYDMLLEKLDISVSEAHAGSVREAFERYYQRGINS
GNLEVFGTLLEELVQGELLNEAHTDRLLGYLSEITTGDRRIAGGLPSGAPFAHKTGTQVA
RSCDIGLLNSQQPDEAVIVAACARNYAALSEAEKAYQAIGRALDEAGLVGNAD
>C3DV62|FEATURES|UNIPROT_deepARG|beta_lactam|bthur0004_59380|antibiotic inactivation|1
MVPVVFLSCATLIGCSDGNTQSESLKQTKQTNQIKQETTGNDSFAKLEKEFDAKLGIYAL
DTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNPITEKY
VDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEV
HPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVA
DKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKIALGVLKTKN
K
>YP_002939420|FEATURES|ARDB_deepARG|glycopeptide|VanUG|antibiotic target alteration|0
MGGGAEMKVRYNKLWKLLIDKGMKKSQLREAVGASKSTFAKLGKNENVTLPVLLNICEYL
ECDFGDIMEAVPENEV
>ACI02941|FEATURES|ARDB_deepARG|tetracycline|tetX|antibiotic inactivation|1
MRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDL
HKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRA
ILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQ
VEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTP
DEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNR
PLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAK
DTQDESTENETEMFSPNFSFQKLLNL
>P58411|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|1
MMQLSRGQRRWLAAIAVLLIGGFFIARHLMAPVPVNYQTVKVVHRDLQQNVLATGKLDAV
RKVDVGAQVSGQLEKLYVEIGDHVKRGQLLAMIDPQQAQNQIKEVEATLQDLNAQRIQAK
AELHLATVTLGRQQNLAKLQVVSRQDLDQAVTDLAVKNAKVGTIDAQINKAKASLDTAKI
NLDYTQISAPMDGDVVQITTLQGQTVIAAQQAPNILTLADMSTMLVQAQVSEADVINLKP
GMKASFTVLGDPGKRFSGVLKDILPTPEKVNDAIFYSARFEVPNPDRLLRLQMTAQVSIQ
LANVDQAVVIPLAALGDELGSNRYQVTVLKEGKEEKREVTIGIRNNVDAQVISGLSVGED
VIVSRGGTGDA
>B6FZD3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKAVLLGIVQGITEWLPVSSTGHMILVDEFVKLNFSPTFISTFLVVIQFGSILAVL
LIFFKKLNPFDSSKSKVEKKETLSLWAKVIVAVIPSGIIGVLFEEDIDRLFFNSTTVALA
LIIYGVIMIVIENRDKKPAVSDFSEVSYKLAIGIGLFQCLALIPGTSRSGSTIIGATLLG
ASRYVAAEFSFFLAIPTMLGASLLKLVKTGFAFTGFEWLVLGVGSVVAFVVSVIVIKFFM
DYIKKHDFKAFGYYRIVLGIIVLLYFGFIK
>A0A127T6Y6|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-71|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKYLADGMTVGELCA
AAITMSDNSAANLLLATVGGPIGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAP58293|FEATURES|ARDB_deepARG|tetracycline|tet40|antibiotic efflux|1
MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVQETSCFLFE
MPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAW
IASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPLILGGSLCLLLGLVMVR
IMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEGFDRLST
AHFLDDTVIPVIGPLNSVTWFGVISLIGNGLGILASQLLIARMEKKGTVSRTSVVMSTSA
GYILFLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFSTSGQLD
SFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD
>J3APA3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLASGFEIAAVFTHADDPKENAFYGSVAQLCARHGIAVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLSETLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQKVAIERSDTALSLHGKLRTAAADLLRDTLP
ALLQGKASETPQDESKATVFGRRTPADGKLVWAKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGLAPGRVISVEPLRIACGEDSLIINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDPNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A0M4FT79|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIKGINHLLFSVSNLDQSIAFYQSVFDAKLLVKGRTTAYFDLNGLWLALNLEEKIPRNEI
HQSYTHLAFSIDEQDFNSMLNKLKQLEVNILLGRERDVKDKKSIYFTDPDGHKFEFHTGT
LQNRMEYYKKDKPHMDFFV
>A0A060CVR9|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFG
ETVLNIKLLAEQNSEQVTKVLFEVSKNKRVETVNMKYKAGWESFCISSQCGCNFGCKFCA
TGNIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFA
LSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVMNIL
DEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTISAPE
MYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQLYGNYQNSQ
>A0A132TV41|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQVFLGKYAANTFKVVIQLGS
ILAVVVIFRNRFIDLLGLKRFSRKELTAVPEGQPAVETTGRLKLAQVIVGLIPAGVLGFL
FEDYIDEHLFSTSTVLIGLVVGAVLMICADLFAPKKIKTESVDQITYRQALSVGLIQCLS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLLKNWQYFTLDDLPFF
IAGFISAFLFALLSMRFFLKLINRIKLMPFAIYRIILAAVVYFVWF
>YP_002402255|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSSIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>A0A0E9BWD0|FEATURES|UNIPROT_deepARG|beta_lactam|BN1184_AW_00460|antibiotic inactivation|1
MTHLFRRRASTAVTLLALAMPLAAQAGFDEAALQRGIQQLEKNAGGRLGVAVTDTTDGTV
FTYRGDARFPLCSTSKVFAVAAILKKSESADGLMSEKIAIHKADLVNYNPITEKHVGATM
TVAELSAAALQYSDNTAMNALLTRLGGPQQVNAFARSIGDSTFRLDRKEPELNTAIPGDK
RDTTSPDAMMQSLKKLVLGKALAPAQRQQLTDWMKGNTTGANSIRAGLPASWTVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQPDKHAAARKDVLAGAAKIVASGYNK
>N9FNU2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLLLLLKAAMMGLVEGITEFLPISSTGHLILTGQLLDFWSIEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIIGGFIILWAERRQHQVVSHEVEDLTFKQATLIGLIQCFALIPGTSRSGSTIIGSLFLG
ISRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMVVLGVGIVVAFISALIVIRALI
RYVSKHDFTAFAYYRIGFGVFILATWWTGWVHW
>F3EYI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVG
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
VGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>I1V5A8|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLGEFSAATIQYSDNT
AMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPLAMAKSLQNL
TLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTRVV
>ZP_03105677|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNVTDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>A0A0A8H0Z1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MILLKNIYKKINDTVILDNISLNIQKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGKYFL
DNYEVNTASKEEKARLRREKIGFIFQRYNLLNLLNARDNVALPAVYAGKNKNERFIKSKE
LLSFLGLEHKELSKPNELSGGQQQRVSIARALINGGELILADEPTGALDSKSGEIVLDIL
KKLNEQGHTIVLVTHDPNIAAKAKRIIEIKDGQILSDSFPKEIRKITKKTITKEVKNLSL
LKNQLLESFSMSVASIVAHKLRSLLTMLGIIIGIASVVCVVALGLGAQKKILASINSIGT
NTIEIVSGKGLGDIRSGKTRLNLSDLKTLSSLPYLDAVEAETSKMGVVTYKNNSLQARIR
GVGPNHLKLDSSIMVSGRFINDEDIKDNTNICIVDENALKILFNNITSDRVLGKSIIFNK
QPLIVVGVSKKEEKNEIAVDDNTIKIYTPYTTLMNKITGDKQIRMIVTKVKDEVNPTLAE
EAIVKILKIKRGQKDFFTINLDKIKQKIEENTATLTLLISSIAIVSLIVGGIGVMNIMLV
SVSERTREIGVRMAIGARKEDILMQFLIEAVLICSFGAFLGVILSFVIIEIFNSLQLGFT
MILSLNSVLLGLLSSVFIGLIFGFFPAKNAANLNPINALSKE
>A0A0S3BZN3|FEATURES|UNIPROT_deepARG|beta_lactam|ATN06_17210|antibiotic inactivation|1
MKNTLLKLGVCVSLIGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYKILAGGCLVKSAQAKDLGNVADAYVNEWSVSIENVLKRYKNMNSVVPGHG
DVGDKGLLVHTIDLLK
>E8WP24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFEAIVLGIVEGLSEFLPISSTGHLILASALMKLQQSEAHKAFEVTIQLGAMLAVVEV
YRKQLFARPDLIKKVCFAFLPTGTIGFLVYKLVKSFFQPSLVSYMLIAGGIAFIVIELWM
RDRPATTHTLDEISYRQAFSIGLVQCLSMVPGVSRSGATIIGGLLFGLDRKDAAEFSFLL
ALPTMLAATCYDIYKNYEVFHMGDWQNIAVGFVTSFIFGVIGIKALLKFVTSHTFIPFGI
YRIVVGVLFLVFLF
>X0SDH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLIQAVIMGIVEGITEFLPISSTGYLILSADLMGFWTKEKVDLFVVVVQLGAILAV
IYDYWDRLWQALMGLLTGKAESMSNPRQLGLSLIVATIPVMIVGFTFADEIKSYLFNPIV
VAIMLIIGGLLIFYVENRPKTIIAQEAEDVSLKTALMIGLLQCLALIPGTSRSGATIIGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLLKHHDVLTNSEDWLVLGIGTVVSFIVALLC
IRLLVEWVSRRDFKIFAWLRIITGIIVLIAAWGFGYQMAG
>G8XDY1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRPVVPAITRFPVADAAAGPYAIAAGPDGALWFTLVHAGAIGRLTTDGRVDRFPLDSASC
GPSVITSGPDGALWFTRSRDHRVGRITVTGDVTSFAVPSADCGPFGIAAGADGALWFTQM
HTDRIGRVTTDGRVTEFPLPVRGAFPSAITAGPDGALWFTLNQAGAVGRIALDGTATVHP
LPTPGAGPVGITCGADGALWFVEIGAGQVGRITTDGEVTEFPLPDRAARPHAITAAPDGT
CWLTEWGANRVAAVSPDGGVREYDLPAPGSEPHGLAIGQDGALYVALETGEIVRLTGLS
>A0A090YU38|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLIA
GATLMIFAEAKKTKATAFSLDDLTYRQALAIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMVGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>F3Z2H7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSWISAALLGVVEGLTEFLPISSTGHLILANSLLGLSGQKIATFDVIIQLGAILAVVVL
YRRRFLGLVAPSLVQTDQDQSGLAEFAPPPSSQFAGIRGLFLLFLTSLPAALLGLASHDL
IKSNLFGPISVAWALGAGAVVILIIETVRPKPRYASLDDITPLLALGIGCFQCLALWPGF
SRSAATIMGGMVLGARRTMAAEYSFIAAVPIMIAASGLELVKNLGLFTSSDMMFLVTGFV
VSFFSAWAAIKFFIALLGKTTLRPFAYYRLALAPLVLLFWSTGVN
>R8YVX7|FEATURES|UNIPROT_deepARG|beta_lactam|F929_03476|antibiotic inactivation|1
MRFQKVSCLLLSPLFIFSTSIYAGNTPKEQEIKKLVDQNFKPLLEKYNVPGMAVGIIQNN
KKYETYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTLSFEDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNQSFDQVLEKTIFPDLGLKHSYVNVPKLQMQNYAFGYNQQNQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPTVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>N1NJA9|FEATURES|UNIPROT_deepARG|polymyxin|pbgP|antibiotic target alteration|0
MTFEKIKKVSVVIPVYNEEESLPQLLARTVTVCQKLEQEYEIILVDDGSRDSSADILTRA
AEIPENHVIAIFLNRNYGQHSAIMAGFHQADGDLVITLDADLQNPPEEIHRLVDAANEGY
DVVGTRRANRQDSWFRKSASRLINAMITRVTGRSMGDYGCMLRAYRRHIIRAMLQCHERS
TFIPILANTFARKTIEIDVTHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGS
IIAVTGFLLAVLLITLRLIFGSMWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGVKKTSENDNQEKS
>A0A0W0WTN9|FEATURES|UNIPROT_deepARG|beta_lactam|Lnau_0681|antibiotic inactivation|1
MKKISTILGITLFYCVNTWAQGSCFLVYEDQTLLLHEGKDCNQRYTPQSTFKIALSLMGF
DSGILKDALHPEWPYKKGYELYLNTWKYPHNPHSWIRDSCVWYSQVLTQQLGMKRFKDYV
EAFHYGNQDVSGDKGQNNGLTHAWLSSSLAISPKEQIRFLQEIINKKLPLSPKAFTMTKE
VLYIQELAGGWKLYGKTGNGRLSTQDRNQKLALQQGWFVGWIEKGNRVISFASHITDSKE
KATFASFRVKNDTLNKLFYLIEKLET
>AAL09826|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MNIINIGILAHVDAGKTTLTESLLYASGTISEPGSVEKGTTRTDTMFLERQRGITIQTAV
TSFQWHSCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVLSARDGVQAQTRVLFHALRKLN
IPTIIFINKIDQVDIDLEGVYQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDGLLEKYIAGEPISREELAREEQRRVQAASLFPVYHGSAKNGLGIQRLMDAVIGLFQP
TKEQGRTALCGSVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSDAPFSMLRTTITPKTAEQRDR
LLDALTQIADTDPLLCYEVDSITQEIILSFLGRVQLEVVSALLAEKYKIETAVKEPTVIY
LERPLKVASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVMDG
IRYGLEQGLCGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLELALKESGTQLLEPYL
SFTLYAPQEYLSRAYHDAPKYCATIETAQIKKDEVVFTGEIPARCIQAYRTDLASYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDRVRHMFQKVM
>A0A0Q4EJ26|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTELLTVILLGIVEGITEFLPVSSTGHLILATRLLGYDAGRWEVFNVVIQLGAILAIVVL
YWRTFWAVGMGLLKREPKSWLFLRNLVVAFIPAAVIGLALHKHIEALLGNAEVVAIALIV
GGFAILAVERFAPRSDISGVADIPLKTVIGIGFLQCLAMVPGVSRSGATILGALALGVER
RTAAEFSFFLAIPTMLGASALELLKNRDAIASGGGVGLGAIAIGAAVSFIVALLVVKWFV
GIVTKHGFVPFAWYRVAAGSAALVWLLSK
>A0A0F5BCV9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLVAAQAERIIEIHDGKIVHNPPAQEKKREQGVAAAA
VNTASGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQVLKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFSEGNTFNAVQQRDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKQSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
NSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>S1C5T2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGISVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLISDEILQLAPTGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCYAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSVLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHASTAQPGSVISAAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVE
GSRLNSQPVCTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCNDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALFRIIENTGNRCDGEIINIGNPDNEASIEELGQMLLASFEKHPLRHHFPPFAGF
RIVESSSYYGKGYQDVAHRKPGIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDK
>A0A0I9PNP7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGSVEVLKGITLSINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDIAQLNGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSERRA
RLARAHDLLVRLGLGDRADYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIVEIRDGEIVRNPPASRQGGGLRARPQA
EPSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
ETAEKQLLRLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAFILQLFL
PGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A089LJ92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDVMKAIILGIVEGLTEFLPVSSTGHLILAGDLLSFEGDAAITFKIVIQLGAVMAVLLL
YWKRYLEIGTNMVKMDFSKNKGLNVFHMILAMLPALILYLLFKDTIKSRLFGPTPVLIGL
VVGGLLMIIAARNRRTATADTMDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDLLSSDDLVLMLIGFAASFIVAMIAVVTFIK
LIKCLRLEWFALYRFILATLFFLIVIH
>A0A142GAB7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMIGATGLDLLKSWTYLSVDDLPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A089YVX2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MVIGCLLACTTAWTSTSVQAGVPSIEPLVKARAESLMSQYDIAGMAIAIIDGRQQMFFNY
GLASRETRTPVTEDTLFELGSISKTFTAALAAYAQANGKLSLTDHPGQYLPALRGTPLDQ
VSLADLGTHSAGGFPLQLPDDIQNDAQLMAYLRDWRPSYAPGTQRSYANPSIGLLGLIAA
KSMNVSFTQAMHDTLLPGLGLAHTYLDVPAAQLPLYAQGYDKKDQPVRLNPAVLADEAYG
FKSSAWDMLHYLQAQMDTVAVPAKLREALKATQQGYFRVGGMTQGLIWELYGYPVALDTL
VQGNSNAVALTTQPTSPLQPLDQVWINKTGSTNGFGGYVAFVPSKGIGVVVLANKNYPNE
ARVRFAHQLVQALDK
>A0A017S0Q7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILKAIILGIIEGLTEFLPVSSTGHLILFSQYVDFSGEFANTFNVVIQVGAILAVILYFW
NKLFPKFDNIRQAKEVYNLWLKVIIGVLPAVVLGVLFEDYIDKKLMGNSRAVAAALIVGA
ILLLISEKRQRRVKVKDTNDITVKQSFLIGVFQCLAMWPGMSRSASTIIGGLFLGLSREA
AAEFSFFLAVPTICGAALLKIVKLIKAGIVITSFQWIVLTVGTLVSFVVALLVIAGFMSY
IRKRKLAPFAYYRIILGVLVLLLV
>T0J7W7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMHILTVILLGIVEGLTEFLPVSSTGHLILASELLGYDAATWAMFNVVIQLGAILAVVV
LYWRTFWAVAMGLLRREPASWRFLRNLVIAFIPAAVIGLAVHDYVEMLLGAPMVVAVALV
VGGVAILLIERMAKDNRYHGIADIPLPQVIGIGLIQCIAMIPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGASTLELLKNGDRITSADVGWGSIALGFLVSFIVAVIVIRWFV
GLVSRRGFIPFAWYRIAAGIGAILWLSLR
>BAE98117|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVFSHGDLGDSNIFVKDGKVVALLILGRSGRADKWYDIAFCIRLIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>I6ZFS9|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-2|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAXXRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAG
>C3BEZ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDTIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAVL
YHKRLVSLCNIKPLLQKEKKFNALHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKPEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTMSGGLLAKVNY
NAASEFSFLIALPVMVGATGLDLLKSWEHLSIDDIPMFAVGFITSFVVAMLAVVTFLKLL
AKIGLKPFAYYRILLAIVFTLFVLL
>A0A0M9E142|FEATURES|UNIPROT_deepARG|beta_lactam|MHK_007990|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVYAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLI
>A0A0B4ZTP3|FEATURES|UNIPROT_deepARG|aminoglycoside|APH(3')-VI|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLSRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFELMITKAINAKPISALFLTDQELLAIYKEALNLLNSVA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDDFDAELWGDHRTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLKH
LKNDRPDKRNYF
>M4WJC6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDEKTLFEIGSLSKTFTATLASAAQQEGKLDFSAPASQYLPALKGSAFDHVTL
LNLATHTSGTPLFVPDAVKNTAQLMAWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALD
KPFSEAMEQGLLRDFGMTHTFINVPDAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEQEVAPRWRQAINATHNGYYRSGEFTQGMMWEYYPWPSPLSRLVEGN
SSQRIMKGLAATAIVPPQPAPEAAWYNKTGSTNGFSSYAVFIPEKRIALIMLANKWFPND
DRVKAAYAIIQQLDK
>F3BAY7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIFFEMLKTVFLGIVEGITEWLPISSTGHLILVNQIVQLDASKQFMEMFNVVIQLGAIM
AVVILYFHKLNPFSKRKSPKQKTQTLQLWIKVAIACLPAMIIGIPLDDWMDEHLHNSVVV
AAMLIIYGILFIVVENRNKNKTPSVTKFSQLSYQMALVIGVWQVLALVPGTSRSGATIVG
ALLLGTSRYIAAEFTFFLAIPVMVGASGLKILKFMLSGIGITGLEVAILIVGCLTAFIVS
VLAIKFLMGYIKKNDFKVFGVYRIVLGIIVLGTFFMM
>NP_934523|FEATURES|ARDB_deepARG|multidrug|norM|antibiotic efflux|0
MHRYKKEASSLIKLATPVLIASVAQTGMGFVDTVMAGGVSATDMAAVSVAASIWLPSILF
GIGLLMALVPVVAQLNGAGKREQVPFEIQQGAVMALLISIPIIGVLFQTQWILGYMNVDA
VMATKTIGYIHAVMFAVPAFLLFQTLRSLTDGLSLTKPAMVIGFIGLLLNIPLNWMFVYG
KLGAPALGGVGCGVATAIVYWIMFLLLLLYVTTSQRLRQVQLFTTFHPPQLNAQVKLFKL
GFPVAAALFFEVTLFAVVALLVAPLGSTVVAAHQVAINFSSLVFMLPMSIGAATSIRVGH
MLGEKSTEGARIASHVGILVGLSTAVFTALLTVILREQIALLYTDNRVVITLAMQLLIFA
AIYQCTDAIQVIAAGALRGYKDMRAIFNRTFIAYWLLGLPTGYVLGLTDWIVEPMGAQGF
WIGFIVGLSSAAAMLGVRLHWLHRQNDEIQLNYEAR
>A0A0M0W7B3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKALILGMVEGLTEFAPVSSTGHMIIVDDMWLKTEEFLGMYPANTFKIVVQLGS
ILAVVVVMWKRMLSLVGLYRIEGQSTSMKGRFNLMHVIVGMLPATVLGFAFKDFIDDHLF
KVEHVIYALVAGAILMIIADKFAPKKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLCGMSYRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFSFYVVGFISSFIF
ALLSIKFFVALVSKVKLMPFAIYRLVLAAVLAVIIFM
>I7C0T9|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFG
ETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCKFCA
TGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFA
LSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVMNIL
DEHIRLTSRKVYIDYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTISAPE
MYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQLYGNYQNSQ
>A0A0H3WVU6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLQVLVLAVVQGVAELLPVSSSAHVIMAEKLMGLDPSTPAMTLLLVMLHTGTMLAVIV
YFWKSWRERYFSSKHDFIHNAKQVVVATAFTGVIGLALMFFIEKVLMRGTGHAEIEHLFG
NLYIISAGLAMAGILILISGSRRAPMGDRPMRGADSAWIGAVQGICLPFRGFSRSGSTIS
TGMLRGLDKRRVEEFSFALAVVLTPPVIAKEAYRLYKSGGAQSLSGHFMSVLTPSLVGMG
FSFLAGLVALRWLSRWLEHGRWYLFGIYCLVASAVVLAASQYL
>A0A0Q5WMZ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPASIGKAVLLALVEGATEFIPVSSTGHQLLVGHFIGFHSPNNTFEVLIQLGAILAILL
VYFRRLLGIATALPSDPKARRFVLGILVAFLPAAIIGGLFSKLIKAYLFNPWIVCATLVA
GGLVLLVIDDTDLEVKKTDVYDFSLPMDLKIGIFQCLAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAMPTMAGAFAKDLLDNYKYLSSNDVGLIAIGFIVSFVSALFVVRLLLDYV
SRHGFWLFAWWRIIVGALGFAGLIILG
>YP_002931998|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLHTLLNAFILGIVEGLTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
VMFWRRLFGLIGIHFGRPVVHEGRGQGQLRLGHIVLAMIPAVVLGLLLHDFIKSLFTPLT
VAYALVVGGLLLLAAEWLKPAQTRAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGASALELYKSLPYLSLGDLPMFSVGFVTAFIVALIA
IKTFLNLIKRISFVPFAIYRFIVAAAVYLVFC
>A0A0Q8DCY5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKRNLQTLLVSALLLGSGSCMAAVDIRQVVDSNVKALMQQQAIPGLSVAIVNQGKVQYFN
YGVAAKDTQAPVTEDTLFEIGSVSKTFTATLGGYAQATGKLKLSDMASQHLPALAGSAFD
HISLLQLATYTPGGLPLQFPKTADSANTMLGYFQHWKPTYAPGEQRLYSNPSIGLFGYLT
AQSLGQPFNVAMEKTLLPKLGLTNTYVSVRSDKAGQYAQGYDKQQNPVRVSPGALDGEAY
GIKTSSQDLARYVIANMHPQALEQPLQQAIAATHAGYYTVNGMTQGLGWERYPYPITLQA
LIDGNSTPMAMEPHKVNWLSPAQAQPANVLYNKTGSTGGFGAYVAYVPSKDVGVVILANR
NYPNAERVKVAHAILSALDK
>A0A143HGB3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELIKSIILGFVEGMTEFAPVSSTGHMIIVDDMWLKTQEFLGESSANTFKIVIQLGS
ILAVVVVMWKRMLSLVGLYHIKGQRPHHHFNLLHVIVGIIPAGILGVLLEDFIDKHLFGI
KTVIFSLFFGALFMIAADKWGPKRPKVHSLDDLSYGQAFKVGLIQCLSLWPGFSRSGATI
SGGVMLGLDHRTASDFTFIMAVPIMAGASLVSLLKHWDEINFGDMNFYIVGFISAFVFAL
ISIKFFLKLISKVKLVPFAIYRIILAIILAIIVYM
>A0A089HP00|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MRRSAVDIIIGLILGIVEGLTEFAPVSSTGHLILVGHLLGFEGTVRASTFEIVIQLGSIM
AVAFLFWRRILSILGIHIGADKSEQKSKEKLTLIHIIIGAIPFGIGGVIFYDYIKEVLFS
AQTVVITLILGGVLMIAAEKFKPKHPAAETLDQVTYRQALIVGLFQCFALIPGFSRSGAT
LSGGLLSGMSHKTASEFTFIMALPIMFGASLKDLIESWEYLSAADIPLFITGFVTAFIVA
AIAVKFFLRLINRIKLIPFAIYRFVLAALFWVFLLN
>A0A0S9SI08|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAMGIAKAVVLGVVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAILA
VYFRRLLGITLALPNDPKARRFVLGILLAFLPAAIIGGLFSKYIKYYLFNPWIVCATLVA
GGIVLLVLDDTDLDVKKRDVFDFTLPMDFKIGLFQCIAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAIPTMAGAFAKDLLDNYKNLSRDDTGLIVIGFIVAFISAFIVVRTVLDYV
SSHGFRLFAWWRIIVGSLGFAGLIIFG
>A0A0J1L5M6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSHIRRSYPSGEGLVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPPQKPSGGRDIAEPT
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPNKAKVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSARAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASEVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGVLFGWLPARNAARLDPVDALARE
>E2IZV3|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-48|antibiotic inactivation|1
RRKKQSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLG
VVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDY
GNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYI
IRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAIT
>A0A0L7DA08|FEATURES|UNIPROT_deepARG|beta_lactam|AFL22_19085|antibiotic inactivation|1
MKKSLFYLALFSLSASCVAADLSSQQVTSLVKAAIEPLMEQQEIPGMSVAVLYKGRAQFV
NFGVADLESRRRVTENTLFELGSVSKTFTGTLAGVMIRNGEIRLNDPVQKYWPQLTGEQW
RPVRMLHLATYTAGGLPLQLPDDVTDQASLLRFYQEWQPEAAPGTLRQYSNASIGLFGSL
MVKGDYEQAMARNVFQPLRLTRTYITVPPSMMLDYAWGYKNGQPVRVSPGMLDAEAYGVK
STARDMLTFMQANVDPNRLSSGNAVLRNAIRTAQARYFKVGTLFQGLGWEIYDWPVTADT
LMGDSDNGVALQPRPATLLNPVGPSQSASWVHKTGATNGFGAYIAFIPERNSGVVILANK
NYPNPLRIKAAWQILQALQQEKPE
>A0A0V8JHY4|FEATURES|UNIPROT_deepARG|beta_lactam|AS180_17385|antibiotic inactivation|1
MMLKKWISNRLKFKAVAPVLIFSCVSLIGFSGANISSAEMKHETTIERKLAKLENKYDAK
LGVYALDTGTNKTIAYRPNERFAYTSTHKALAVGVLLQKNSIKDLDKRITYTRDDLVNYN
PVTEKYVDAGMTLKELSDASLRYSDNTAGNLILEEIGGPIGFKKALRELGDNVTNPVRME
PELNDVPPGEIADTSTAKALATSLQAFTLGDALPVEKRELLIDWMKRNTTGDALIRSGVP
KNWEVADKTGAGLYGTRNDIAVIWPKKGDPIVLAVLSSRNEKDASYDDKLIAEATKEVVK
ALKGKSH
>B1IES5|FEATURES|UNIPROT_deepARG|chloramphenicol|CLD_0021|antibiotic inactivation|1
MNFRIINKKDWDRKEYFEHYFSEVSCTYSMTVKLDITKIKNSNQKLYPTILYFITKVVNK
HNEFRTSFNMNGQLGVFEEMIPCYTVFHKDTETFSNIWTEYSENYDIFCKSYEKDMQMFS
SVKGLIAKPDIPANNFPVSMVPWTSFDGFNLNLQKGYEYLLPIFTIGKYYKENGRYLLPL
AIQVHHAVCDGFHVCRFVNELQELIKG
>S1LYB0|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDNDTSINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSELNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLLLCFFVTLLCIKEKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQIATGSIAP
ILTLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRFPQVSN
>A0A0M9BR51|FEATURES|UNIPROT_deepARG|aminoglycoside|AMS66_05610|antibiotic inactivation|1
MSDLSNEKIPKQAMQALKIVEELLGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNNSLPE
VTRKKLTDRLMLISGKIGNTDSMRPIEVTVINHSDVVPWRYPPRNEFTYGEWLRSVFEKG
QIQDPTYDPDLAIVLAQARKNSISLFGPDALDILDPVPMTDIRRAIKESLPGLIEGIKGD
ERNVILTLARMWQTVSIGEISPKDLAAKWALPRLPKEYSTLLDLARKAYRGEYVDKWEGL
DSEVTALVNHMKNSIESCLSKTQEKR
>A0A0F5VG52|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKPIHCNTRTLILSALCLFSAAAPVRSQTAADPIRQVVDQQAARLMAAYQIPGMAFGITI
RGEAYYYSYGLADVERDLPVTEHTIFELGSVSKTFAATLASDAQRQGKLSFDDQVSAYLP
ELKGSAIGDTALIQLATYTAGGLPLQFPDPVTDHAAMLDYYRHWQPAFPAGTRRQYSNPS
IGLFGHIAALSLGESYATLMESQILPALGMTQTFVKVPASKQADYAFGYNAASKAVRVTP
GVLDAEAYGIKSTAADMVRYIEANVGTAQVSQAMSQALANTRIGYYQAGPLTQGLGWEMY
PYPVSLDTLLAGNATEMILNPMPIQTIDSPKPLPAQIWVNKTGSTGGFGAYVAYIPAERT
GIVILANKNYPNAERIKAAYAILNAAVK
>A0A0U1YUI6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYITRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0G9LAZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLDFIYIIKAIVIAVVEGLTEFVPVSSTGHMILVGSLIGFRSGAVGAEEFAKMFEVVIQ
LGAILAVVVLYWNKLWKAVVEFFTYIFTLGKKGHSGFKFGINVIIGSIPALIVGVTLYDK
IKGLFKPSAVVVGFIVGGILLIIIENIYRNKASKRRSYQTMDVFDLTPIQALKVGLFQIL
AMWPGMSRSASTIMGGWIAGLSTPVAAEFSFFLAIPAMVGSSIMDLSNFDFSIMNSTYVV
ALIVGFIVAFIVALIVMDMFVSYLKKKPMRIFAIYRIIAGIVLLALSVAGIVTLTI
>A0A0E1NUM5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSLNEPIKKVSIVIPVYNEQESLPALIDRTTAACKLLTQAYEIILVDDGSSDNSTELLTA
AANDPDSHIIAILLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEETPRLVHVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGNSKYSLMRLINLMYDLITCLTTTPLRLLSLVG
SAIALLGFTFSVLLVALRLIFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGAEQTENNQDVEK
>D4LP14|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIFIELLKVILLGIVEGITEWLPISSTGHMILVDEFIKLNVSEAFMEFFLVVIQLGAILA
VVVLYWNKLWPFYIRKIPKKTQMALRKQPAVPRTVLTFVEKYCDKDKWILWFKILVACLP
TIIIALPFNDIIEKKFYNYVVVAIMLIVYGVLFIVIENYNKRRRPTCTRLDELSFKTALI
IGCFQVLSVIPGTSRSGSTIIGGILAGTSRTVAAEFTFFLAIPVMFGASLLKLVKFGFAF
SSTELIILIVGVVVSFVVSILAIKFLMGYIKKHDFKVFGWYRIILGILVLGYFVGKTFLA
>A0A0Q3S8L9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEIKGINHLLFSVSNLDLAINFYRNVFDATLLVKGRTTAYFDLNGIWLALNEEKAIPRNE
IHHSYTHMAFTIDEDHFEKMYDKLVQLNVNILNGRERDKRDKNSIYFTDPDGHKFEFHTG
TLRDRIEYYKQTKPHMDFYI
>A0A0R3JZW1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMIIKAIILGIIEGLTEFLPVSSTGHLIIANEYINFTGEFANVFDVVIQVGAILAVILYF
WDKIFPKFNNKRQAKRVYSLWIKVVVGFIPAAALGFLFEDTIDKYLFNPTAVAVALIVGA
VLLIISEARNKKVRVPDTDDMNIFEAFSVGVFQCLALWPGMSRSASTIIGGLFMGLSREA
AAEFSFFLAIPTIIGASVLKLFKADLAFNFIEWMTLLTGTFVSFIVALLVIKLFMGYIRK
KDLKPFAYYRIVLAVVVLLIELL
>F3DTU2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDIEALHETSINSDQPLLHLQQVSRSFMAGDREFQVLKHIDLAIHTGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAIYAGTAQAKRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIEVSDGEIIS
DRRTAQATQPVPEAQPAKQPGLTPRRLIASLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLLPTDVAALN
QLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSDQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNLWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>A0A0Q7RKB5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFRSPGNTFAVLIQLGAILAILL
VYFQRLLSIALALPTSVKARRFVVSVLLAFLPAAIIGAIAHDFIKTVLFETPILICVVLI
IGGFILLAIDRMPLTPRYTDVMDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDFTLIAVGFIAAFVAGIFVVRSLLDF
VSRRGFTPFAIWRIVVGTAGLIGLWMLG
>C1FV44|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYGKMKQIVSNLKLPDYRYEQLIKAIFHQRIDNFDDMHILPKALRMSLVNEFRK
NVSSVIPVFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISCQCGCGFGCRFCAT
GSVGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGL
SQRRITISTIGIIPGIQRLTQKFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVVGLLKNRGSWEHLYHIDLIPYNSTDKTTFK
FQSSSAIKQFCSTLKKAGISATVRTQFGSEISAACGQLCYENEL
>D2XSF3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-1|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAEXXXXXXXXXXXXXXXXXXXXXXXXXSVTAFALQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILV
>M9G7N1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVM
YALVVGGLLLIAAECLKPKEPRARGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIK
TFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0P9HW96|FEATURES|UNIPROT_deepARG|chloramphenicol|QJ48_02690|antibiotic inactivation|1
MNFTVIDMDKWERRAYFEHYLNVTRCTFSITANLNITRLLPVLRAKDLKLYPAFLYMVTK
TVNAHREFRVCFNKDGELGYWEKMLPSFTFFHKDDKTFSTMWTDFSNDFGVFYQNYLDDM
NRYGEVKGLSAKENEPPNTINVSCIPWVSFTGFNLNIYTDGRYLLPITTCGKYFEQAGEI
LLPVSLQVHHAVCDGYHAGIFINELQEMANNCEQWLL
>A0A0N8R3B8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRALLELKGVTRRFVAGEKDFIALNDINLTINAGELVAITGASGSGKSTLMNVLGCLDH
ANSGSYKVDGRETGTLTDDELAELRRDHFGFIFQRYHLLPHLAAIQNVEMPAIYAGTGKS
MRVERAQKLLERLGLSGHLEHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNTDRPIINEKATE
RLPSKPRQGNRLMANIGLFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIQAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVAALSSEYYIDSATPNIGRN
LLVRYRNIDVSATVSGVSPSYFQVRGTKLGLGVGFNKDDARRQAQVVVIDHNTRIRLFGP
KVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLLGQTYLDGITVR
VKDGQPSKVVEDNVNKLLQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSFVIG
YVFSLLVKEWQMVFSVGSIVTAFICSTLIGIVFGFVPARNAAQLDPIEALARD
>A0A0F5AGH4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MDRIGRWLADPVRVFTVSGPDAGPYALTGGSDGALWYTLVHQGAIGRRDADGRITVHSAG
TKPMMIAQGPDDALWFSEYGTHCIGRIAVDGTLSSFAPPTADGGPYGIAAGPDGALWFTL
SAAGRIGRITMDGHITEYPAPEGFPSAMAAGPDGAMWFTLNQGNAIGRITMDGRTTAHPL
PTEAAAPVGLAQGPDGALWFTEIGAGQIGRITVDGTVTEYPLPDRQARPHAITSGPDGAL
WFTEWGRGGVGRITTDGRITAYDLPRADCEPHGIAAHDGALWCALETGALARIDVPR
>R5QT50|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEIIKAIFFGIVEGITEWLPISSTGHMIILDEFVKLNVREEFWNLFLVVIQLGAILAVV
LLFWNQIFPLNLKDKKEPVWKKDILFLWVKILVACVPAGIVGVLFDDVFDKYLYNFPCVA
MALIVFGILFIIVEKKKKGTTFRITSIDQLDYKTVIWIGVFQLIAAVFPGTSRSGATIIG
ALLLGVSRVVAAEFTFYLAIPVMFGASLLKLVKFLMMGLSFTSMELAILAVGCIVSFVVS
IIVIKFLMGYIKKHDFIPFGIYRIVLGAVLLIYFALVR
>A0A0T7NPH0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_3|antibiotic efflux|1
MTALLELKGIRRSYQSGGETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGIYRVAGQDVATLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKHE
RRERANMLLTRLGLEERVNYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPNVAAQAERIIEIKDGRIMADSGSKTVPTVVASEAVS
LAPSAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQM
VLADIRAIGTNTIDIYPGKDYGDDDPSTRQALVYDDMVALKEQSYVSAVSPTISGSMRLR
YGNVDVAASVSGVSEQYFHVYGMKLEQGTPITREQVERQSQVVVIDRNTQRRLFPHIKDV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLIVE
MFLPNWQIAFPPVALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A0H1RXK4|FEATURES|UNIPROT_deepARG|chloramphenicol|XJ18_07905|antibiotic inactivation|1
MFKKIDENYPRKEHFHHYMKVTRCSYSLVIDLDITKLHSILKEKELKVYPVQIYLLARAV
QKIPEFRMDLVNDELGHWDLLHPSYTILNKETKTFSSIWTPYDENFARFYKSCVADIEAY
SESNKLFPKPHMPKNMFNISSLPWIDFTSFNLNVSTVETYLLPIFTLGKFKVEERKNILP
VSIQVHHAVCDGYHAGQYVEYLRWLIEHCEEGLDDSLGKS
>A0A069PVR3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILLCKALVLGVVEGLTEFLPVSSTGHLIVAGSLLNFSDAQAKTFDVVIQFGAILAIC
WEYRRKIGAVVTGLPANAGARRFATNVVIATIPAIVLALLFEKAIKSVLFSPVPVSVALI
VGGVVILWAEARHRDRGVAPSVTSVDDLTYSDALKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPVIFGATLYEMAKYWRTLSVHDVGLFLVGLVAAFVSAFVCVRW
LLRYVATHDFTAFAWYRIGFGLLILIVGYSGGLSWAE
>L0F2V8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKAIILGIVEGVTEWLPISSTGHMILVDEFIKLNMSDAFMEMFFVVIQLGAILAVV
LLYWHKLNPFSVQKGGAGNRITVKRETIEMWMKIIVSCIPAAVIGLLYDDEMNALFYNYQ
TVAIMLILFGILFIIIENKNKGKRSRINHLAQITYPIALMIGLFQLIAAVFPGTSRSGAT
IVGGLMLGVSRTVATEFTFFLAVPVMFGASALKLVKFGFNFTGQEIMILLIGMVVAFIVS
ILSIKFLMGYIKKNDFKAFGWYRIILGIIVIFYFSMQML
>A0A0M7ENE1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_2|antibiotic inactivation|1
MSFPAMRRTMLLALAVLSSMASVPPAMAAPSETDQKIDAAAQALMQEHGVPGLVIAITRD
GRHEFHQYGVASRQTKAKVSPDTLFEVGSISKTYTATLATYAEALGKLSLGDSPARFVPA
LQGSAFAKLNLIHLGTHTGGGSPLQVPDAVRNDAQLMDYLKAWTPQYAAGTYRTYANPSI
GMLGVVAAKSLDQPFTQAMEKTLFPLLGLSHTYIDVPAAKMGDYAQGYNKQDAPVRVNPG
VLAAEAYGVKTSARDLIRFVDANMNAAGNDAIHRAIRQTHVGYYRVGDMTQDLAWEQLAY
PATLDALLAANAGTLNSQSHPVTAMTPPSAPRDDVWINKTGSTNGFGGYVAFVPARKVGV
VILANKNYPNEARVRLAYQILEELSR
>I4B5M9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTPWQAATLGIIEGLTEFLPVSSTGHMILASALMEIKGDFVKTFEIAIQLGAIAAVFALY
VRRFLKEPRLYFILAVAFIPTGIAGLAVYKYIKALLFNPVSVSVALIAGGVVLLFFDRLI
ARRHALQPAHDHGSTKHQNRRPETGHTTGDVGITPKTAFVIGIFQTLSLVPGVSRAAATI
GGGLVMGLNRVRAVEFSFLLAVPTMVVATAYDLFKQRETLNAAHLDLLAIGAVVAFAFAL
LAVRFFVGFISKRGFFVFGVYRIIAGVIFLIYFWGRSF
>C5CR04|FEATURES|UNIPROT_deepARG|beta_lactam|Vapar_3231|antibiotic inactivation|1
MTSIADRRTFLLAASALPLASACTAWSAKAPQASALSSAEAQLAALERSVGGRLGLAAFD
TATGARVQHRATERFPMCSTFKMMASAAILARSSREPGLLEQRVSYARSDILPNSPITEK
NLGQGMAVSALCAATIQYSDNAAANLLMKILGGPSAVTEFARSIGDAVFRLDRWETELNS
AIPGDPRDTTSPEAMAASLQRLVLGDGLAAAQRSQLEAWLLGNTTGATRIRAGVPADWKV
GDKTGAGSYGTVNDIGVLWPPAGAPLVMAVYLTFPTPDAPGRNDVIASAARIASDALRG
>NP_044301|FEATURES|ARDB_deepARG|aminoglycoside|APH(3'')-Ib|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPLHDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>U5SE68|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIFIELLKAAFLGVIEGVTEWLPISSTGHMILVEEFINLDASAAFKEMFFVVIQLGAILA
VVLIFFHKLNPFSPKKTTQEKKDTMSIWYKVIVGVLPAAVLGFLFDDWLNDHLYNYWTVA
IMLIVYGILFIVIENRNKGKESSVNSFKDLTYKTAFLIGMFQVLSLIPGTSRSGATILGA
ILIGTSRFVATEYSFFLSIPIMFGASFLKLFKFGFNFTGIEIGILLTGMIVAFVVSVIAI
KFLMGYIKNNDFKAFGWYRIILGILVIGYFLLFS
>A0A009PJF4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIYANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKE
>A0A0D5C9G4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
AAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELIAAALQYSDNVAM
NKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTL
GKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIGGK
>I3ZJW3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDYILSVILGIVEGLTEFLPVSSTAHLRLTEALLHVSLTDPFWKMYTIVIQLGAILALL
LFFAIRIIAYMRSFPHGERGNKTWLTHPISLTLIAFICTAIPAKLLTKKIGENLENLTVI
ALALLIGGIIMWVVDVWANHREARITHVEQMGLGEAIWIGICQVLSAVIPGTSRSMSTIA
AGQIAGLDRSAALEFSFLISIPTMIAATGYSLLKAIHPSAKDLASQGAEALTPLVMGPER
WIVLIIGMAVSFIVAYLVVAWFLGWVRKRGFTIFAIYRIILGAGLLVWMHLHPSVLK
>A0A0A6W7K6|FEATURES|UNIPROT_deepARG|beta_lactam|OI73_12140|antibiotic inactivation|1
MKSFLTALLIAFTASAQAADLSSQTIAERVKSVIDPLMAQQGIPGMSVGVLYKGRPQYIN
FGVADTASERRVTENTLFELGSVSKTFTGVLAGVLIRNGALRLNDPVSRYWPALNGPQWQ
SRRMVHLATYSAGGLPLHLPDEVTSQDELLAYAQQWQPDAAPGTQRHYSHVSIGLLGYLM
VKGEFEEAMQKDVITPLRLTRTFYTVPPSMMFDYAWGYQDGKPVRVSPGMLSAETSGVKS
TARDMMAFMQANANPNGLSSGNTALRNGILTAQSRYLRAGELYQGLGWEIYPWPIDSQTI
VTASDTQAALSTQPATILSPAQPMDRASWVHKTGSTKGFGAYIAFVPQQNSGVILLANKN
YPNPERINAAVAIMAMLASD
>A0A0M0L3U5|FEATURES|UNIPROT_deepARG|beta_lactam|AMC98_05110|antibiotic inactivation|1
MKNKATLKLGICIGLLCLSLTGFKPFYGSTHAEAKGIGDTKMTSCITNKKFVQLEKKFDA
RLGVYAIDTGTNNTIAYRPNERFAYSSTYKVLAAAAVLEKNSIEKLNEVIYYSKDDLVTY
SPITEKHVDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKANRF
ETDLNSAIPGDIRDTSTAKALATDLKAFTVDNTLTTDKRTILTDWMRGNATGDELIRAGA
PIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSKRFTKDANYNNALIAEAAKVVL
NDLK
>A0A0M2PJ67|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSINGLNHLLFSVSNLEDSIKFYKNVFEAKLLVKGRSTAYFDLNGIWLALNEEKDIPRNE
ITESYTHTAFSIDEADFDQIYDKLKELNVNILSGRPRDKRDKKSIYFTDLDGHKFEFHTG
SLQDRLDYYKQEKTHMEFYD
>A0A0G1M041|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNFFDATILSLIEGFTEFLPISSTGHMILASSVLQLSDQEFVKTFEIAIQLGAILAIVCL
YANRFLSSIQLYKRLVVAFLPTAVIGFLFYQIIKTFLFSPLVVSITLILGGIALIIVDKN
KSLNKSEGIKIENISYKSAFIIGLVQSVSIIPGVSRAAATILGGMYTGFSKKQATEFSFL
LAVPTMFAATSFDLLKTSASLQSYEFLLLGIGGVISFISAWIAVKLFMNLIEKHGFTFFG
YYRIVLGLFFLLYFMKQG
>A0A0C4WP73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELWLAAQAFILGVVEGLTEFLPISSTGHQIIVADLLGFGGDRAKAFNIIIQLGAILAVV
WEFRQRIFGVIVGLPRERQAQRFTANLLVAFFPAVILGVAFADLIEHWLFNPITVASALV
IGGLVMLWAEKRQHAIEVHAVDDMGWKHALKIGCAQCLAMIPGTSRSASTIIGGLLFGLS
RQAATEFSFFLAMPTMVGAAVYSGYKHRALFENGGDLPVFALGFVVSFIFAMLAVRALLR
FIASHSYAVFAWYRIGFGLLILATWQMGMIDWSTAQG
>A0A0A1RXI9|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MIEMLKAVILGIVQGITEWLPVSSTGHLILVEQFVKFNLTDVFVSTFMVVIQLGSILAVL
TLYFRKLNPLDNSKTEKEKRATIDLWLKVIVAVIPSAILGFLFDDAIDALFFNPTTVSIT
LILYGVIMIILENRNKKPIVSDFSQLTYKLAIGIGIFQCLALIPGTSRSGATIIGAVFLG
ASRYIAAEFSFFLAIPTMFGASGLKLLKTGASFSGFEWGVIGVGFVTAFIVSVFAIKFLM
DYIKKHDFKAFGYYRIVLGIIVLAYFNFIL
>A0A060KQ68|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRKFTLMATATVTLLLGSAPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>YP_002800512|FEATURES|ARDB_deepARG|multidrug|MexF|antibiotic efflux|1
MNFSQFFIHRPIFAAVLSLLTLIGGAIALFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVASPLEQAIVGVEGMLYMSSQATSDGKLTLTITFALGTDLDNAQVQVQNRVTRTMPTL
PTEVQRLGVTVDKASPDLTMVVHLTSPDERYDMLYLSNYATLNVKDELARLDGVGDVQLF
GLGNYSLRVWLDPHRVASRGLTAMDVVDAIREQNRQVAAGSLGAPPAPGDTGFQLSINTQ
GRLVSEEEFENIIVRAGEDGEITRLKDIARIELGSSQYALRSQLNNRPAVAMPVFQRPGS
NAIDISDAVRARMAELKQSFPQGVDYSIVYDPTVFVRGSIEAVVHTLFEAIVLVVLVVIL
FLQTWRASIIPLAAVPVSLIGTFAVMHLFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIALGKPPLEATRQAMQEVTGPIVATALVLCAVFVPTAFISGLTGQFYQQFALTIAIST
VISAFNSLTLSPALAAVLLKDHHAPKDRFSRVLDRLLGGWLFGPFNRLFERASHGYVATV
RHVLRGSAIALLVYGGLMGLTWLGFSSTPTGFVPPQDKQYLVAFAQLPDAATLDRTDAVI
QRMSEIAGRHPGVADTVAFPGLSINGFTNSPNSGIVFTPLKSFEERQDPSLSADAIAAEL
NRRFAEIQDAYIAIFPPPPVQGLGTIGGFRVQVQDRGGLGYEELYRQVQNVIAKSRTVPE
LAGLFTSYQVNVPQVDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQVN
VQAEQRFRLEPAQIGQLKVRNNRGEMVPLSTFVRIEGSAGPDRVMHYNGFLTAEINGAAA
PGYSSGQAEAAMERLLREELPGGMTFEWTELTYQQILAGNTAIFVFPLCVLLAFLVLAAQ
YESWGLPLAVILIVPMTLLSAIVGVRIAGGDNNVFTQIGLIVLVGLACKNAILIVEFAKD
RQAEGLDRIAAVLEACRLRLRPILMTSIAFIMGVVPLVLSSGAGAEMRHAMGVAVFSGMI
GVTLFGLLLTPVFFVLVRAFVERREARRNRQALEAQG
>P08881|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MREAVIAKVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEDRLAS
RADQLEEFVHYVKGEITKVVGK
>Q2FC40|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIXLIXXALVLSACNSXSSHXKELNXLEKKYNAXIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
FK
>YP_002193132|FEATURES|ARDB_deepARG|tetracenomycin|tcmA|antibiotic efflux|1
MTDQTTISTAPKALDNAPPAPARGLRGHPWLTLFAVAIGVMMVALDGTIVAIANPAIAND
LDATFAEVQWITNGYFLALAVTLITAGKLGDRFGHRQTFLIGVAGFAVTSAAIGFSDSIA
MVITFRVGQGLFGALMMPAALGLLRATFPAAKLNMAIGIWGMVIGASTAGGPILGGLLVE
HVSWQSVFFINVPVGVLALGLGLVILKDHRADNAPRSFDLVGILLLSAAMFCLVWAFIKA
PEPHWGWGGGRTWGFIAAAVIGFVVFALWEKRVAEPLIPLKLFRSVALSAGVVLMVLMAI
AFMGGLFFVTFYLQNVHGLSPVDAGLHLLPLTGMMIVGSPLAGALITKAGPRIPLAGGMI
LTSIAMFGMSTLDKGTGSGLMSLWFALLGLGLAPVMVGATEVIVGNAPIELSGVAGGLQQ
SAMQIGGALGTAVLGAVMASRVDSELPGNWAGAGLPPMTPEQMDKAAEAVQVGLPPVTDS
TPPELAARMADVAHDTFLSGMGLASLVAAGVAAFAVLVALLTKRGQNAEAGAGVAHI
>A7ZTR5|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAMMGIAVLMLSLFILKE
TRPASPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0D4CI78|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFNLMIIELIKSFFFGLVEGITEWLPISSTGHMILLDQFVKLDVSKSFYSMFEVVIQLGA
IMAVVVIYWKRIWPFHHSQAVGIAAPKGIWRYVDKDIMIMWLKIFISCLPAGIIGVAFND
TFERLFYNPVSVAIALIVFGVAFIWIETAHKGKKAKVNSIAEISYNMAVMIGFFQLIAAV
FPGTSRSGATIVGALLLGVSRTVAAEYTFFLAIPVMFGAALFKLLKFGLAFTSMEFWIMM
VGLLTAFVSSIIVIKFLMRYIKKHDFKVFGWYRIALGLLVLLYFLVLK
>V9QXR7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNSKAVVFAYHDIGCAGIEALLTAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDFIFSFYYRNLLSEALLATASKGAFNLHGSLLPKYRGRAPAN
WVLVKGETETGVTLHRMVKRADAGAILAQQKVTIERTDTGLTLHAKLRDAATNLLRDALP
QLAAGKLTETAQDESQATYFGRRTAADGKLEWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCDSQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLKEAMLEIA
DKK
>A0A127T148|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>H0H8V9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAIVAILL
VYFQKLVSIAMAMPTSAKARRFVLAVAVAFLPAAVIGALAHDFIKTVLFETPVLICIVLV
IGGVILLAVDRMPLKPRYTDIMDYPPSLAFKIGLFQCLAMVPGTSRSGATIVGALLMGTD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRDALSFDDSALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGSLGLAALLLYR
>N9NKM3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDSEARHFAFSVLIAFFPAVVIGIFAVDFIKSVLFSPLVVAIAL
IVGGLIIFWVESKNFDHKTTEATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAATFDLIRNADVLTQDNMLNIGVGFIAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>Q5M1R0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIMQTAQYIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIV
MHLGAILAVMVIYFKRLNPFQPGKTAREVQLTWKLWLKVVIACIPSAFFGLLLDDWMEAH
LSNFFVVAIMLVVYGIAFIWIEDRNRRVDPKVTDLARMSYKTAFYIGLFQVLSIIPGTSR
SGATILGGIIVGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFIDGNTLTGGQAAILLVAS
VTAFLVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLFYGAVKLIFG
>A0A0M3ESK7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDITSLLHALILGVVEGLTEFLPVSSTGHMIIVAELLGFTGDKAKTFEVVIQLGSILAV
VFLFWRRMFALIGIHFGNVPHEGQTQGKLTLLHIIIAMLPAVVLGLLLRDQIKSLFNPVN
VMYALVAGGILLIVAEVFKPKKAQATGLDDISYRQAFAIGCFQCLALWPGFSRSGATISG
GMLMGINRYTASEFSFILAVPMMMGATALDLYKSWHFLGSSDIPMFAVGFLSAFIVALIA
MKTFLSLIKRISFIPFAIYRFIVAAAVYVVFVH
>H8ZPX9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKHLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEHKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>A0A103F716|FEATURES|UNIPROT_deepARG|beta_lactam|WS70_25295|antibiotic inactivation|1
MKIRHALSSAFVLLGCIAASVHAETICTAIADAGSGKFLQKDGDCSRRATPASTFKIAIS
LMGYDAGFLRNEHEPVLPYRDGYVDWGGAAWKQPTDPTRWLKYSVVWYSQRVTHNLGAQR
FARYAKAFDYGNADVSGDPGKNNGLDRAWIGSSLQISPLEQIGFLSKMLNRKLPVSAKAI
DMTEQIVDTTTLADGAVVHGKTGMAYPLLADGTRDEAHGFGWFVGWITRGKETLVFARLT
QDEGKQPVSTGIRTRDAFLRDLPQLLAAR
>ZP_03028124|FEATURES|ARDB_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
QQGSRPKTKLDIMRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDI
DLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQ
FGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRE
TLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAK
QAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK
>D4M338|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEVLKVIILGIVQGITEWLPISSTGHLILVEQLIQLKQSEAFTNMFNVVIQFGSILAVV
VIYFHKLNPFSPTKTEKQKKMTIQLWIKVVIGTIPALIGGLLLNDLIESKLSNAYVVALM
LIVYGILFIVIEKHNETREPKVKRISQLSVKTVLLIGVFQMMAMIPGTSRSGATIVGALA
LGVSRSVAAEFTFFLAIPVMFGASVLKLFKFGLAFTPMQVFLLLLGMIVSFAVSVIAIKF
LMKYIKNHDFKAFGYYRIVLGIIVFLFFGIQALFK
>A0A0E9MBL8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSVLLLKALILGIVEGLTEFLPVSSTGHLILVGDLLDFNDDKGKMFEIVIQFAAILAVC
WEFRSRLFDVASGLRKGTEEARRFVFNLAVAFMPAAILGLLFASKIKQFLFKPVPVALAF
IVGGLLILWAERRKHVISVERVDDMGWRDALKVGLAQSLALIPGTSRSGATIIGGLFFGL
SRQAATEFSFFLAIPTLFAATAYELIKYRHLLNVDDLGMFAVGGVASFISAFFAVKGLLR
YISRHDFSAFAWYRIGFGIIVLLTAYTGVVSWSVS
>A0A127SNS5|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTINEMPE
FRTALTEKGLGYFSEMHPAYTIFNQGQKTFSGIWTAYKSNYTAFLSSYEADVAKYSSSEK
YDPKPERPVNSFDVSMIPWFSFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKMLPLAIQV
HHAVCDGYHIGRFIELLQEKINDFDSSFNSTSYEISATAKERMYEMTDKAPWVFSDMSGN
CSNTISLCEATKEDAPFIASVYNQAILAGNCTCDTKTVTSEMREKWICQHAADGYPVYLC
LENGMPVGYGYLTAYRQGREAVNHVAEVSYYLDFSAHGRHIGTHLLTALEQQAKKQGIKV
LIAILVGSNRPSVGLLEKNGYVEWGRLPQIVHFGNRHTDHLIYGKYL
>C8NDK8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNLIEIIKTIILGIIEGVTEWLPISSTGHLILVNEIIQLDVSAKFLEMFNVVIQLGAIL
AVVLVYFNKLNPFAKNKKRKEFIETIDLWKKVIIGCIPAVILGFILNDFMDEYFNKPIII
ALALIVYGVAFIYIERQHKNIEPKIKSFKELDILTAIKIGLFQCLALVPGTSRSGSTILG
GLLVGTSRSIATEFSFFMGIPIMFGASGLKLLKFGFHYSFAEFIILVVGSVVSFVVSLFV
IKFLLKYIKQHDFQAFGWYRIALGIIVLGSLFFK
>A0A0K6LKL4|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKKMLKIGMCVGILGLSITSIEAFTGGPLQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLV
DYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIARNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIRA
GVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAEV
IVNAFR
>ABB80130|FEATURES|ARDB_deepARG|bacitracin|bcrC|antibiotic target alteration|0
MSFSELNIDAFRFINDLGKEYSMLNPVVYFLAEYMMYFLALGLVVYWLTRTTKNRLMVIY
AVIAFVIAEILGKIMGFLHSNYQPFATLPNVNKLIEHEIDNSFPSDHTILFFSIGFLIFL
FHKKTGWLWLVLAFAVGISRIWSGVHYPLDVAAGALLGVLSALFVFWTAPKLSFIHQMLS
LYEKVEHRIVPSKSKSNDKSKNF
>E8YWD4|FEATURES|UNIPROT_deepARG|beta_lactam|BC1001_5831|antibiotic inactivation|1
MKLKAMSLMASAVVALSVITPVSRAADDAANDATAAMKSLVDPAIEPLMERHHVPGMAVG
VIANGKTYVFDYGVASAETRQPVTQRTLFEIGSISKTFTATLAAYAQLNGQLNLTDDTQH
YLPSLRGSAFGKVSLLNLGTHTPGGLPLQVPDNIHDNAQLLQYFRAWKPAYAPGTYRTYA
NPGIGTLGLITAKSMGQDFASLIEQRMFPALGMTSSYIHVPAANISDYAQGYTKDGAPIR
MKGGVLADEAYGVRTTAADMVRFVQANMKLIGVDSQLQRAITATHTGYYKAGALTQDLIW
EQYPYPVTLSTLHEGNAPSMAVTPTPATAIEPPLPPQQNVWINKTGSTNGFGAYVAFIPG
KRVGVVLLANKNLPIEDRVSAAYRIMSALVAGGQ
>U2K396|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDISLIELLKVVILGIVEGLTEWLPVSSTGHMILVDEFIRLDVSTAFMDMFLVVIQLGAI
LAVVVLNMEKLNPFLKRKSQAERRETFDLWAKVIVACLPAAVIGLAFNKYMEEHFMNAPV
VAAMLILYGVLFIVVERWNKRRTPRVESLAKLDYRTAFIIGMFQVLSLVPGTSRSGATIL
GGIIFGASRYVATEFTFFLAIPVMFGASFLKIVKFGWNYTGTEIMILAVGMVTAFIVSIL
SIQFLLRYIKRNDFTAFGWYRIALGIIVLAYLFIVGDPTKE
>A0A068HIK7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARIAAEQGIPVWAPE
DANHPLWIERIREIKPDVLFSFYYRNLLCDDILNIAPQGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGNIVAQKSVAIGADDAALALHRKLCSAASELLAQALPAI
RDGKTEERAQDESQATYVGRRTPEDGRLDWERSAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLAAAKAGTVISVAPLVVACQEGALEIVTGQTERGVYMQGTQLAQALGLVA
GAVLSSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDNNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWVPTVEMEETVEHTLDFFLRTVELTDSGK
S
>ZP_04656349|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRRALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTAAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQSGQAP
>A0A085HAX1|FEATURES|UNIPROT_deepARG|beta_lactam|GLGR_3506|antibiotic inactivation|1
MKNTFRRTALMAAAVAPLLLGCAPLWASAASDAAGIQQKLANLEKSAGGRLGVALIDTED
NSRVLYRGDERFAMCSTSKVMAVAAVLKQSETDKGVLSKKIKIKKADLVNWNPITEKHVN
SSMTLEELSAATLQYSDNVAMNKIIAHLGGPNKVTAFARSIDDTTFRLDRTEPSLNTAIP
GDERDTTTPLAMAESLRNLTLGNALGETQRAQLVEWLKGNTTGGESIRAGLPKAWIVGDK
TGSGDYGTTNDIAVIWPENRAPLILVTYFTQPKQDAKSRRDVLAAAAKIVAEGL
>A0A0Y0MSI6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPQLSLPGVRNLTALAALLAAGNCLAANDLQAVVDASVKPLMQQQAIPGLAVAVVQNGKA
QYFNYGTASKETQQPVSENTLFEVGSVSKPFTATLGGYAQATGKLKLSDKASEHLSVLAG
SAFDQISLLQLATYTAGGLPLQFPDAADSAETMLGYFQHWKPTYGPGAQRLYSNPSIGLF
GYLSAQSLGQPFNVALQKTLLPKLGLNNTHVSVPADKRGLYAQGYDKNLKPTRVSPGALD
SEAYGIKTSTQDLAHYVMVNMHPETLDKPLQQAIAATHAGYYTVNGMTQGLGWERYPYPI
TLQALLEGNSTPMAMEPHKADWLTPAQPQPGQRAVQQKPVQPGGFGAYVVYVPSKDMGVV
ILANKNYPNAERVKVAYAILSALDH
>A0A0B4WZI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIFSALILGLIEGLTEFIPVSSTAHVLLAGHFLGFRSPGNTFVVLIQLGAILAILLVY
FKRLLSLALALPRSARARHFVLAVLFGFLPAAVIGAIAHDFIKNVLFETPMLICVVLILG
GLVLLAVDKIQFKPKYHDVTEFSLPMALKIGFFQCLAMIPGTSRSGATIVGALLMGADKR
SAAEFSFFLAMPTMVGAFALDLYENRNMLSFDDGMLIVIGFVAAFVSALLVVRALLDFVS
IRGYAPFAWWRIFIGAAGLIGLTLFG
>ZP_04284182|FEATURES|ARDB_deepARG|beta_lactam|BLA1|antibiotic inactivation|1
MEQIYFGDCLLYVSKKSVKNLKGMMILKNKRLLKIGICVGILGLSLTSLEAFTGGSLQVE
AKEKKGQIKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKAL
AAGVLLQQNSIDTLNEVIKFTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNI
LFHKIGGPKGYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKDLTVGN
ALPHQKRNILTDWMKGNATGDKLIRAGVPTDWVVADKSGAGSYGTRNDVAIVWPPNRSPI
IIAILSSKDEKEATYDNQLIAEAAEVVVNAFK
>A0A016XJP4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVLLLLKAALMGIVEGLTEFLPISSTGHLILAGSLLGFHDDKAKVFDIAIQTGAIFAVI
LVYWQKIRSTLVGLPSQPQARRFTLNVLIAFFPAVVLGLLAGKAIKAHLFTAEVVATAFI
LGGFIILWAERRQARLAALPADAGAAPRLVEDVDQMSWKDALKVGLVQCLAMVPGTSRSG
ATIIGGMLLGLSRKAATDFSFYLAMPTLIGAGAYSLYKERALLSLADLPMFGVGLLFSFI
SAWVCVRWLLRFIATHSFVGFAWYRIVFGLIVLGTAWSGVVDWRAA
>V6I5X9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSTGHLFLFSSFFPFSGENFGIEFDDLFDIFIQSGAILSVLYLYREKFRSQIVSSFQYV
TKQNADPHGFHFLIQIAIGAFPILAAGFIAKKFLDTIKARPDLLEILAGAWIFGGILILI
AEWFFHKKQGSGEREPIGFKDSILIGIFQCMALVPGMSRSAATIITARFLGKDTRSSAEF
SFFLAVPVLLAAGIYKLYKYRSILNGDTIPVLAFGFLVSFLLCTLVIRWFLRYLQRHSFS
VFGVYRILLGVGVLVFTKFIR
>C2NHX5|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0004_22910|antibiotic inactivation|1
MKGMMILKNKRMLKIGICVSILGLSFTSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFS
QLEKKFDARLGVYAINTGTKQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATG
DKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEAAEVIVNAFR
>ZP_04091278|FEATURES|ARDB_deepARG|glycopeptide|VanRB|antibiotic target alteration|0
MNEINLKTTGKIQIAVLSFFWRYTFMDIRILLVEDDEHICNAVKVFLSGAGYKVDACFNG
DEAHTKFYDNTYQLVILDILLPGMNGHELLREFRKLNNTPVLMMTALSDDENQIRAFDAE
ADDYVTKPFKIQLLLKRVEALLRRSGAVAKELHYGKLTILPEDFKVFYDDEELLLTLKEF
EILMLLVQNNGRTLSHEVILSRVWGYDFDGDGSTVHTHIKNLRAKLPDNIIKTVRGVGYR
LEETS
>A0A0K0QLK7|FEATURES|UNIPROT_deepARG|beta_lactam|AC241_12335|antibiotic inactivation|1
MVLKNKRMLKIGICVGILGLSLTSLEAFPGGSLQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRITM
SDRFETELNEAIPGDIRDTSTARAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
EVIVKALK
>A0A132F719|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIASVLTGLPSRPDARRFTLNVVIATIPAIVLGLLLEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVQSVDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDALGLFVLGLVAAFVSAFACVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>R6FQ84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILIFKAIILGIVEGITEWLPVSSTGHMILVDEFINLNVSPAFKEMFFVVIQLGAVMA
VVVLYWKKLFPFSTKEKFLIKEETFQMWFKIVVACIPAAVVGILFDDKIDELFYNYQTVA
LALIMVGIAFIIVEKRNKGRVFTKTELSDITYKDAIIIGLFQLIAAIFPGTSRSGATIIG
AIMFGVSRGLATEFTFFLAIPVMFGASLLKVLKFGLVFTGTEIAVLLIGMIVAFIVSMIS
IKFLTDYVKKHDFTVFGWYRIILGIIVILYFLGKTFIF
>A0A0L6Y0U6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPAAVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSRVHPHTSAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0A0CUD0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLFEQIKKVSVVIPVYNEEESLPLLLERTLAACKQLTQEYELILVDDGSSDRSAEILIQA
AEQYENHIVAILLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVKTAEQGY
DVVGTRRANRQDSLFRKTASKLINALITKATGRSMGDYGCMLRAYRRHIVEAMLQCHERS
TFIPILANTFARKTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGS
VIAVSGFLLAVLLVVLRLIFGAIWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGNKKTNNNQEEY
>S9UEU3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWWDMFVGFILGVVEGLTEFAPVSSTGHMILVDDFMLHSKEIFSPQMANMFKVVIQLGS
ILAVVVVFWDRFFQLLGLKRAPIDPELGRAGHSRLKLTQVLVGLIPAAVLGLLFEKYIDQ
YLFSIQTVLIGLVLGAVLMIAADWFRPAKPTAKTVDQVTYKQAFGIGLFQCLGLWPGFSR
SGSTISGGVLLGMSHRAAADFTFIMAVPVMAGASGLSLLKHWKDFSMDALPFFIVGFISA
FLFALISIRFFLKLINRVKLVPFAIYRIVLAAVIYFFFL
>E5YM68|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF0864_03634|antibiotic inactivation|1
MRKKMQNTLKLLSVITCLAATAQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVT
VNGKNYIYNYGLAAKQPQQSVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYV
PELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIG
TGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNM
EILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQDLMWE
QLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSSLEGNK
>A0A0B2YB91|FEATURES|UNIPROT_deepARG|aminoglycoside|QQ25_05210|antibiotic inactivation|1
MTEWLPVTRGESGAGVFRCADGSRYRKVVGPAAVADLAGERDRMSWAHDHGLSVPEVIDW
GATGDGGAFLVSSAVGGVGADRLTEAALRSAWPAVVDAVRTLHAIAVEDCPYRRDLDDML
ARARSVVTADAVNPEFLRDEDRDVPPGELLARVGREAGLRRRQEVADRVVCHGDLCLPNI
LIDPDRLTVEGFVDLGRLGLADRHADLALLSANTADTFPGFAEGAAAGLAAGYPAAIDDE
RLRFYLALDPLTWG
>E7SXH7|FEATURES|UNIPROT_deepARG|beta_lactam|SGB_02135|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVIYQGKPYYFTWGYA
DIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITL
LHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPS
GLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAETYGVKST
IEDMACWVRRNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIING
SGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPN
PARVAAAWQILNALQ
>I2GHB2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIHAIALAIIEGLTEFLPVSSTGHMIIYSSLAGIAGNEFTKLYTVDIQFGCILSVLVL
YYRRFLRDTRTSDSVAWYRSLPGGLQRLIGPYTSQVDFYLKLLVAFLPAAVIGFLLNDFI
DSLLENVVVVAVMLLLGGIVLVFIDRIFAEKPRDYDITFPEAIKVGFFQCIAMIPGVSRS
AATIIGGMTQGLTRQQAAEFSFFLAVPTMAAASGYKLLKTYKLLQPGDLQTLLLGNAIAF
VVGLLAIRGFVGFLNRYGFKVFGYYRIALGLLLLGLVAAGVKLDIV
>S4YHI3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLQLSGIRRSYQSGDQTVDVLKGVSLSIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLDGDALARLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAVALLQRLGLSERVSYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLCEQGHTVIIVTHDPAVARQAERIIEIRDGEIIADSRPAQQGNPNAKPLEL
AAPAPSWQQMAGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTFRQSLKYDDLDALREQPYISALSPTIASSMRLRL
GNVDVAANVTGVSEQFFRVYGMTFTQGAGIDPFQVQSQAQTVVIDANTQRRLFPHQKNVV
GEVMLVSNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNAYFDSITVRIRDDY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLLVQL
VLPGWQINFPPAALLSAFLCSTGIGVVFGYLPARSAARLNPIDALARE
>S9S5M4|FEATURES|UNIPROT_deepARG|beta_lactam|K678_12262|antibiotic target replacement|1
MYHDNDRAKLFSRRAMMLAGGKATLVVGLAARMYYLQVMEADKYAMQAEDNRITTRLLAP
PRGLILDRNGVAMAINQQNYRVMVVAEQTPSLDYTLDALAKIIPIGESERARIHKEARRR
RRFVPVSVRENLTWEEVARVEVNAPDLPGIIIDVGQSRYYPMESLGAHILGYVAAVSEND
LTDDPLEELPGFRIGKGGVEKVYDMALRGRAGTSSLEVNSVGRIHRELERKEGEPGIDLN
LTLDIRLQQYAAQRLGDESAAVVVMDILTGDVIVMASTPSFDPNSFNRGLSNDEWKDLTT
NPRSPLTNKVIAGQFAPGSTFKLLTALAALESRDITPDMRVLCTGHMQLGSIKFHCWKKE
GHGSQDLISGLKNSCDVYFYEVARRVGFEKIAEMARRFGLGTQTGIDLPSERPGLIPDRA
WKRKALKQPWHPGETLINAIGQGYVTATPIQLAVMTARIANGGYAVVPHVARDQIIEKSV
HPRPQPEWPSLEVSRQSLALVRKGMFAVSNEPGGTAYKARITQEGMWLSGKTGSAQVRRI
TMRERESGVKKNEQLPWKERDHALFVAYAPEENPRYSIAVVVEHGGGGSAVAAPIARDIM
LEVQKRDLARVSTEANGTPEPPPDFRRF
>YP_002152117|FEATURES|ARDB_deepARG|tetracycline|tetJ|antibiotic efflux|1
MNKLIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHSHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQETAPHSATGFIKKSLCFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>I3VNV9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTGIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>A0A0H5BP50|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEG
SHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGT
VRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPI
LANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALL
GFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARP
RYFIQRVVRQPETASKEEDRS
>A0A0F9ZRY9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLFQALLLSIVEGITEFLPISSTGHLILVSNLLKIPQTEFVKSFEIVIQLGAILAVVAI
YFRKIITNLDAKLWKNIIVAFLPSAIFGLIFYKYIKLYLIGNSTVVIWSLLIGGIVMLLF
EKSHIGSGLLLSPRDISFKKYFLIGLFQILSMIPGISRAFATIFGGMAVGMNRKEAVEFS
FLLAIPTMLGATVLDLAKSDMSVWSAVDGRLLAIGFVGSFITAYIVIKWLITFVQTHNFV
VFGWYRIILALLFFVFGL
>A0A0W1A141|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1|antibiotic inactivation|1
MSSPNEQLEKNPDAQQIKECLDLVTKILGDNILGVYLYGSALVGGLQKYSDIDLFVVINH
ATTLSEKNELTKHLLHISGLYMKSAKRPIEMTVVEKGAVNPWHYPPRFDFQYGEWLRASF
EMGEIESPNLEMPDLALIITQVLLKSQTLFGEQPEKILAPVPYADFIKAMLQDLDRLAAD
IKDDTRNVLLTLARIWCTLETNTICSKPDAADWVIERLPKTYQAVMNRAKSICIGDENEY
WEDIKASLVPCADWILQKINAIKLFINPNKIAYKVSE
>R3TRQ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLANIWKAIVLGIVEGITEWLPISSTGHLILVDEFIKMDVSADFTTMFNVVVQLGAIMA
VVVLYFDKLNPFSTKKTAIEKNDTWTLWYKVVVACVPAGILGILLDDFLDAHFHKFLPVS
IMLIVYGVAFIIVEKRNKNKTPKCTTLNDFTYKAALVVGFFQVLSLVPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASAIKIFKFIKAGNSFDFQQTFLLLLGMIVAFAVSI
IAIKFLLNYLKRNDFTVFGWYRIILGVILIGYWLITL
>A0A0J6ICQ1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSTLASVAHAEPFAPDIEDSVQKAAKALMQQYEVPGLVIAISDKGKQQFYSFGLASKETD
ARTTPDTLFEVGSISKLFTATLASYAQVEGKLSFTEPVSHYLPQLQGSAFGKVPLLHLAT
HTAGGFPLQVPDNVKNDEQLQDYLKHWQPTYQAGTHRTYANPSIGMLGVIAAKSLQMPFK
AAMQNMLYPALGLSSTYLSVPEDKMPLYAQGYDKQNQPRRLTPDVLADEAYGVRTSARDL
IHFAQLNLNTGKPASAIERAVQNTHTGYFQIGPMTQDLIWEQYPYPATQADLLEGNSNTM
AYETNKAVALNPPLAPQKAVWLNKTGSTSGFGGYIAVLPDKQQAVVILANKNYPNSARVE
LAYAIFKALN
>F4GVA4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENSWFMLKALFLGLIEGFTEFIPVSSTAHLLLIGDWINFSSSSDKVFEVVIQFGSILA
VMWIFRARLWQLIHGTLTGVRSEVMFTRNLLIAFLPAAVIGALAIKYIKMLFHSPAVFVF
TLVVGGIIMLWVERKPQYAKQADGEPEQQIEPGDSRASQLATAHSLEEITWKQALVVGFA
QCLAMVPGTSRSGATIISGMIAGIQRKTATEFSFFLAMPTMLAATVYDLYRNSGALDDTQ
LTAIVVGFVAAFVSALIVVRAVLRFVSRRTYRPFAWYRIGLGIVVFIWLAAR
>A0A0D7LWL8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRVAISPDDVALTLHHKLCQAARQLLEEALPAI
KTGDYAEHAQQEAEATCFGRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCKNDRAARPGTVISVSPLLIACADGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTAKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAISRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPENEASIQELAEMLLTCFEKHPLRNHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>C0EKF4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRFFGNGENRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAT
SGSYQIDGIETSQMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMDSKER
AERAKKLLGDLGLQNKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEDGHTVIMVTHDPGIAANANRVIEIRDGQIISDTSKNPDIPPSKVERIKE
KASWSFYYDQFMEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSQQKILED
INSMGTNTISIFPGRGFGDRRSGRIKTLTINDAKAISQQSYVASATPQTNSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLEEGRLFDDDDVKTDAQVVVIDQNTKTKLFGEGVNPLGKT
ILFKKRPLTVIGIMKKDDNSFGNSDSLMLWSPYTTVMHQITGESHTNSIVVKIKDDANTQ
VAEKSLTELLKARHGTEDFFMNNSDSIKEMVESTTGTMTLLISSIAVISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLSGVLLSASISLVFNYFVT
DFPMSISMTSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALAQD
>A0A009KVV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILSGQLLDFWTIEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTKEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHDLHSNDMLVLAVGIIVAFISALVVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>Q310A3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLTAAVLGLVEGLTEFLPVSSTGHLIITGYLLEYTGPKAESFQVAIQLGAILAVVFL
YKERFAALFRFGTGHGRFSGLRGWYLLALTSAPASVLGLLTHSFIKEHLFGPVTVAWALA
AGALYILAVEHKGEGTRYETLDDVSPALALGIGMFQCLALWPGFSRSAATIMGALLLGSR
RRLAAEYSFVAAVPIMFAATGYDMYKSYSLFSPADIPFWAVGLLVSFASAWAAVKGFIHL
VGRVTFRPFAWYRLALAPVVLLFWS
>A0A0E1QCB1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIMFILKAIIIAVVEGLTEFIPVSSTGHMILVGSAINFNGDFAKMFEVVIQLGAILA
VVVRYWEKIKESIVEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGITGLLFYHKIKSLFR
PEAVIIGFIVGGILLLIIENMFRKKEHAVQDIDSITFAQALKVGVLQILSVWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTPTLWSALILGFVVAFI
VSIIVMNKFVSYLKKKPMKVFAIYRVLAGLLLAALVFTKIIVLTV
>AAZ79402|FEATURES|ARDB_deepARG|beta_lactam|OKP-B-4|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>A0A098RX27|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLVSIALALPTSAKARRFVLAVALAFLPAAIIGALAHDFIKTVLFETPMLICVVLI
IGGVILLAVDRMPLNPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDGALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIAIGSLGLIALLVLG
>ABQ96629|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFLDESRRLDPSGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHASGDLRSAITFSETLAKFRSRDARDRGLDHA
>ZP_04234658|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEKMKKNTLLKVGVCVSLLGLTQFVSTISSVKAEQKLEQKVIKNETETISISQLNK
NVWVHTELGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYDEPLGDLQTITNMKFGNMKVETF
YPGKGHTEDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNM
NVVLPGHGEVGDKGLLLHTLDLLK
>B8ZHY7|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MLKSSWRKSALMAAAAVPLLLASGSLWASADAIQQKLTNLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTXKVMAAAAVLKQSESHPDVLNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKS
>ZP_04314903|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MIQSINHICFSVANLEKAIEFYQNILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEI
QYSYTHIAFTVTNNEFDSLKEILIQNQVNILPGRERDDRDKRSIYFTDPDGHKFEFHTGT
LQDRLQYYKEDKKHMTFY
>W6I0P5|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMTLTRCSYSLVINLDITKLHARLKEKKLKVYPVQIYLLARAV
QQIPEFRMDQVNDELGYWEILHPSYTILNKETKTFSSIWTPYDENFAQFYKSCVADIETF
SKSSKLFPKSHMPENMFNISSLPWIEFTSFNLNVSTDETYLLPIFTIGKFKVEEGKITLP
VAVQVHHAVCDGYHVGQYVEYLRWLIEHCDEWLNDSMPIT
>F7NMY8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNEIIIAIIIGIVEGLTEFLPISSTGHMILVGSLLGFEGEKAAVFSVFIQLGAILSVLIL
YWDKFLRLLDFRSPIGRRELTPWHVAAGIVPVLGIGFFLHKPIKAYLFSPFTVIIGLVAG
SILMLAAEKIAKRPQTRELDEITLRQAFFVGLFQILSLWPGFSRSGSTIAGGLLFSMSRK
AAAEFSFIIAVPIMAIACVYDLLKIWSQLNTNDLAMLAVGFVTAFIVAWLSIIWFLRFLN
RSTLTSFAYYRLAVAALSYYWFFGR
>A0A089UGH5|FEATURES|UNIPROT_deepARG|beta_lactam|LH23_07270|antibiotic inactivation|1
MKKSLCLTLLLTASCSSFAAQKELTALQIEKLVNRTVAPLMKEQAIPGMAVAVIYKGYPL
YFTWGKADLQRNLPVTQQTLFELGSVSKTFTGVLGGDALARGEINLNDPAQKYWPELNGK
QWKGITLLQLATYTAGGLPLQVPDEVTNSDALLKFYQNWQPQWAPGTQRLYANASIGLFG
ALMVKSSGMGFEQAMLKRVFEPLNLQHTWINVPATEESHYAWGYRDGKAVRVSPGMLDAE
AYGVKSSIEDMAHWVQANMAPNRLEDKTLAQGIQLAQSRYWRVGSMYQGLGWEMLNWPVK
GKTVIDGSDNKVALAPHPATLIDPPAPAVKASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNTERVKAAYAILEALQ
>L0HTV3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
NSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVN
GTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIA
GDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDK
TGSGGY
>C0B6S2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDVLIAVILGIVEGITEWLPISSTGHMILVEQFLHMSTSHEFNSMFRVVIQLGAIMAVV
VLYFNKLNPFSKRKSAKQKRNTINLWCKIVVACLPAAVIGLLFDDILDKYLYNYVVVALM
LIIYGIFFILIEKKNEHTRPQVTKLTELTYQMALIIGGFQVLALIPGTSRSGATILGALL
IGTSRYVATEFTFYLAIPVMFGASILKVIKFGFHYTAIEVVILLVGCLVAFFVSVFAIKF
F
>A4FF33|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MARERTVEIREHEVPDPAGGPYGITAGPDGALWFTLVHSGLIARLAPGGEATTHRLDADS
GPAIITAGADGALWFTEHRAHRIGRLTTEDGLTEFAPPTPQAGPYGLATGADGALWFTEA
SAGRIGRITAEGEIAEFGLPVPGAFPSMIAAGPDDAMWFTANQANAIGRMSFDGTAVLHE
LPTEAAAPVGLALGPDGALWFTEIGAGQIGRVTADGAISEFPLPDRTSRPHAIVARGDEL
WFTEWGANRVGRIDLDGRIDVHELPTPNSEPHGIAVGQDGALWVALENGALARVAPESHD
>A0A0D1A3G7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLILKAIIIGIVEGITEFLPVSSTGHMIIAGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIMSTLKNFLPSDRVPVKKCGLKFWINIGIASIPAAAIGMPFNDKIEEKLFY
PLPVTIALIVGAIWMIYAENRYRNNSKTTSIDDINAKQAIIIGLFQCLALWPGMSRSAST
IIGAWIVGLSTVAAAEFSFFLAIPAMIGASGMSLIKHNVFSTCSSIELIALAAGFIVSFI
VALVVIDKFIAFLKKKPMKVFAIYRIALGIVLMVLIYSNIIKWH
>I2NDF3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNVIEIEQLNKYFGEGENRAHILKDINVNIQQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGICRITGKETQQMTADELSDLRQRKFGFIFQRYNLLSALNANENVALPAIYAGMESSAR
KARANQLLDKLGLADKTENRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSHSGQ
TVLDILQDLHKEGHTIIMVTHDPKIAATASRVIEIKDGQIIRDKRQQLHAVEPQRMLPLH
KKPRFLDQLAESFKMAISAIFAHKLRALLTMLGIVIGITSVISVVALGRGSQEQILSNIN
NLGTNTMTIMNGTGFGDRRANLTKNLTISDAVMLGKQNFVNNTTPSSSLNTTLIYGNTNV
TGSVNGVGEQYAAVRGIKMRSGRFFSEEEVNEAAQVVVIDANTQKDLGFTSPVEGKIILV
GKKPLRIIGLAEESNNMNQTSLKLWTPYTTLMQRISGEKSIDSLTVKIKDNVESQTAEKS
ITELLTAKHGKKDFFIMNSDTIKQTITSTTNTMTLLISSIALISLVVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQSNILQQFLIEAILICLLGGVIGILFAIAIITTFNTLGSDFKMV
LSPESVVLAVFCSTLIGVIFGYMPAQNASKLNPITALAQE
>AAM11664|FEATURES|ARDB_deepARG|beta_lactam|CMY-34|antibiotic inactivation|1
MMKKSLCCVLLLTASFSTLAASKTEQQITDIVNRTITPLMKEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLNDPVTRYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDEVTDKAALLHFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMGYEEAMTNRILQPLKLKHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSIMDMARWVQVNMDASHVQEKTLQQGIELAQSRYWRIGEMYQGLGWEMLNWPVKA
DIVINGSDSKIALAALPAVEVNPPAPVVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVDAAWRILEKLQ
>A0A133HQV8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIVDVVTGLPAQREARRFTMNVVIATLPAIALALLFEKTIKSVLFAPVPVAVALV
VGGAAILWVEARQRERGAPARVQSIDELTPLDALKVGLAQCFALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPVIFGATLYETAKDWRAFSVDSIGLFSIGLVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIAFGLFVLLVGYSGWVEWS
>A0A0S8Z7I3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTGKIRLSTITRLAAGIALIGATQCFAEQPIETLVNDAVRPVMRDHGIAGMAVAVTLHGK
AHYFNYGVASRETGKPVTPDTLFEIGSVSKTFTATLAAYAQASGKLSLSDKASQVLPALR
GSAFDNISVLQLGTYSAGGLPLQFPQDADAPDKMFGYYKQWKPLYPAGSHRQYSNPSLGL
FGYLAAQSMGQPFDALMENTLLPKLGLQHTFLKVPQAQMALYAQGYNKDDKPVRVGPGAL
DAEAYGIKTSAADLIRYVEANMHPANLEIPMQRAIELTRSGYYTVGDMTQGLGWELYHYP
VTLDRLLAGNSTQMAMEAHKVQWLNPPQAQADNVLINKTGSTGGFGAYVAFVPSRDIGIV
ILANKNYPIAERIRIAHTLLTALGD
>A0A0S3JFD3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
VAVFWRRLFGLIGIHFGRPPVHEGEGNGRLSLIHVLLAMFPAVVLGLVLHDAIKSLFNPI
NVMYALVVGGVLLIAAEVLKPKVPRAKGLDDMTWGQAFLIGCFQCLALWPGFSRSGATIA
GGMLLGVSRYAAAEFSFLLAVPMMMGATALDLYKSMGFLTAADVPMFAVGFITAFIVALL
AIKTFLHIIKRITFIPFAIYRFIVAAAVYAVFM
>K0FSQ0|FEATURES|UNIPROT_deepARG|chloramphenicol|MC28_1628|antibiotic inactivation|1
MTANVDITMMLEKIHQKEIKFYPTFIYIISRMINKHTEFRTCFNDEGVLGYWEEMIPSYT
IFHKGDKSFSSIWTDYSSDFHIFYKNYEEDMKCFANVHGLFPKENIPPNVYPISGIPWTS
FTGFNLNINNDGDFLLPIITCGKYFNDGSKVMLPFSLQVHHAVCDGYHASRFIEDLQELV
NTCNEWL
>A0A0Q5NUL0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKLRAVRLFAAIVFSCTIPGVVHATGKDIRTEVDRAIQPLMKQYEIAGMAVGVISDGKPY
VFNYGLASAQPRKPVTDNTLFELGSISKTFTATLAAKARVDGYLSLSDRTSKYLPVLQNT
PFGNVSLLNLGTHTPGGLPLQVPDNVNNIGELMQYFRQWKPAYAPGTYRTYANPGIGTLG
LITAKSMNQDFDALMEKNLFPALGLRSSYINVPAARMKDYAEGYTKTDAPIRMKPGVLSS
EAYGIRTTAADMLRFLQANMGLIDLDSKLQRAITDTHTGYFNAGPMTQDLIWEQYPYPVA
LEKLLEGNAPAMILNATPVTELKPPQPPRDDVWINKTGSTNGFGAYVAFIPQKRLGIVML
ANKNIPNDARVTAAYQILESLAKEAQ
>A0A0M4G3K1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFLELLKAIILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGQYSANTFKIVVQLGS
ILAVVVVMWKRLFSLVGLYKIESENSSKRFNLLHVIVGIIPAGVLGVLLEDFIDENLFGV
ETVIYSLVAGSIFMIIADKFGPKKPSINSLDQITYAKAFKVGLVQCLSLWPGFSRSGATI
SGGVLFGMDHKTAADFTFIMAVPIMAGASLVSVVKNWEEINMGDMGFYAAGFISAFVFAL
ISIKFFLKLISRIKLMPFAIYRLVIAAILAVIVFM
>A0A0E3Y8T3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLALKAVILGVVEGLTEFLPISSTGHLILVGSLLDFNDEKGKIFDIVIQFGAILAVC
WEFRAKIAQVVFGLGSDAKARRFAVNVIVACVPAIVLGLLFGKHIKAVLFNPLVVATAFI
VGGVIILLVERHNRSNVEAGKLPRVNSIDELSTLDALKVGFAQCLALVPGTSRSGATIIG
GMMFGLERRVATEFSFFLAIPILFGATIYELYKSRSMLEVTDFGLFGIGFVFAFISAFIC
VRWLLRYIASHDFTAFAWYRIVFGIVVLASAYSGLVVWAD
>A0A0D6EEJ5|FEATURES|UNIPROT_deepARG|beta_lactam|HALO4343|antibiotic inactivation|1
MGKMLAANSGLIMTGSLLIGSFAWASDATENADIEALVNDTIAPLMAEHRIPGMAVAVSI
GGQQHYFNYGEADQEAGTPVTDETLFELGSISKIFTAALTGYAQSSGVLSLSDPASQYLP
ALEGSAFDEITLLELGTYTAGELPLQFPDAVQNEEQMLXYYRQWQPESPPGSHRLYSNPS
IGLMGYLTAQRLGQPFEMLMEEALFAPLGLEHSYYQVPESQQDHYAYGYSKEDKPIRVNP
GMMDAQAYGLKSTAADVLTFVEAHMEAPGLDDEPLRQALAATRTGYFEFGDMTQGLGWES
YAYPVTLEQLLAGNSLEMILEPNAANRLTPPLAPRQEAFYNKTGATNGFGGYVAFVPSEQ
IGIVLLANRNYPNQARIEAAHHILTALTETP
>A0A0D0HC08|FEATURES|UNIPROT_deepARG|beta_lactam|BG10_6439|antibiotic inactivation|1
MVLKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTGHVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRNILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPVIIAILSSKDEKEATYDNQLIAEAT
EVIVKALR
>ZP_03227726|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MIKGVNHFCFSVSDLDLSITFYERVLEARLLVKGRSTAYFDLNGIWLALNVEKDIPRNEI
NESYTHIAFTVEENDLNILHKRLIDWNVSILQGRDRDEKDRNSIYFADPDGHKFEFHSGT
LEERVEFYKNRKKHMEFY
>R6WEX2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLNLIAVIVGIVEGLTEFLPVSSTGHMIIVGHVLGFEGQLADVFDVFVQLGAILSVVFI
YKERFARFFTKDGWDINKGLSVWHVAAGIVPVMLVAFFLYHYIKEYLFSPFTVAIGLFLG
GLLLMFAEYRTKGREAELVDDVDKISIRQAVWVGIYQFLSLWPGFSRSGSTIAGGLLVGL
TRSAAANYTFVIAVPLMFVACIYDLLKNLQYLSAGDLQVLVIGFVVSFIVAYISVLWFLK
FLQNSKLTSFAVYRILLAGVTYWYFYM
>A0A0A7JJL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWSAFQAIILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRSKIFQVVQGLPTQPKARRFTANLLIAFMPAVVLGVLFADLIHEYLFNPITVAVALV
VGGVIMLWAEQRDHRIAVEHVDDMRWRHALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RQAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVVSFIFAMIAVRALLKF
IAHHSYAVFAWYRIAFGLLILATWQFGWVDWATAHAG
>A0A0R3CL20|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMLAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPQS
QRHSRAGELLARLGLSGHTSHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIISDKANDSVGLELPVEAP
VEPRRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIQTLMPSDVDALNQLYYVDSATPVVGRNL
MLRFGNIDVDAQVNGVSDRYFKVKGLKLEAGITFSESDARRQAQVVVIDHNTRQRLFGPN
IDPLGQVILIGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGIIGISLSYAIGY
LFSLFVKEWEMVFSVGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>A0A0U8PLN0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MAALLQLSGIRRSYRSGEQTVEVLKGISLSIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLSDDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAEALLRRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCAQGHTVILVTHDPAVACQAERIIEIRDGEIIADSRPAQQENAQAKPLAL
ATAAPSWRQVGGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTYRQSLKYGDLDALREQPYISALSPSISSSMRLRL
GNVDAAANVNGVSEQFFRVYGMSFTQGVGIDSMQVQSQAQTVVIDANTQRRLFPHQKNVV
GEVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNNYFDSITVRIRDGY
DSKEAEQQLSRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLAVQL
VLPGWQISFPPAALLSAFLCSTGIGVVFGYLPARNAARLNPIDALARE
>A0A127SIE4|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIDQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVDAAWQILNALQ
>N9RCB0|FEATURES|UNIPROT_deepARG|aminoglycoside|F889_00437|antibiotic inactivation|1
MNIMPVSESLMADWLGLRKLLWPDHDEAHLQEMQRLLQQTQSLQLLAYSDTQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPDYRRSGIATRLVQQVEAWAKPFGCTEFASDAALDN
RISHAMHQALGFHETERVVYFKKHIG
>BAA06252|FEATURES|ARDB_deepARG|beta_lactam|BL2e_fpm|antibiotic inactivation|1
MTMFKTTFRQTAAIAVSLISLLASPMLWADNNNTIEEQLNTLEKYSQGRLGVALINTEDN
SQITYRGEERFAMASTSKVMAVAAVLKASEKQAGLLDKNITIKKSDLVAYSPITEKHLTT
GMTLAELSAATLQYSDNTAMNKILDYLGGPAKVTQFARSINDVTYRLDRKEPELNTAIHG
DPRDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGNTTGDNSIKAGLPKHWVVGDKT
GSGDYGTTNDIAVIWPENHAPLILVVYFTQQEQNAKYRKDIIAKAAEIVTKEISNSPQTK
>A0A0E1EIF5|FEATURES|UNIPROT_deepARG|aminoglycoside|EY04_31830|antibiotic inactivation|1
MIRIEPCQSAHQPGWLALRQALWPDCPAEEHLEEIASLLDDPRRYINLLAYTADGQPVGL
AEASLRRDYVNGTEHSPVVFLEGLYVSAEQRRQGIAEQLIDAIAQWGRDQGCVEMASDTG
LENLLSQTVHKALGFEETERVVYFRKSL
>A0A0K0H8K5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ybjZ|antibiotic efflux|1
MTALLELCNISRSYPSGEAQVEVLKDISLQIRAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSMLDPDALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGIDRKK
RLARARELLQRLGLSDRVDYSPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILHQLRDRGHTVIIVTHDPQVASQAERVIEIHDGKIVRNPPAQEKGGGQSTAAAV
VNEASGWRQFVSSFREALAMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKHMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQVLKYDDLAAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFSEGNTFNVVQQRDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQIWLPYSTMSDRIMGQSWLNSITVRVKDGV
NSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLLVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVRQQFLIEAVLVCLVGGALGIGLSMLIAFMLQL
FLPGWEIGFSLTALLSAFLCSTFTGILFGWLPARNAARLDPVDALARE
>N9LUG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILTGQLLDFWTIEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMVVLAVGIIVAFVSALVVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>N8TFS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFHVLILAIIQGFAELLPVSSSAHVIVAEKLMGFDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWRTTYFSSWDRFKKQAWFVIVATGITGVLGLALQSMIKHVFFAGANHFEIEQLFS
NSKLMAAALASAGVLIILSSRLDRGQVGDVTMKSAAWIGAVQALCLPFRGFSRSGATIST
GLFLGVARQKAEEFSFALAVVLTPAVIVKELYRLLHAENFQSIHLAQLLLPSMFGMLFSF
IAGLVALKWLSSWLEHGRWHFFGIYCLIFSAVVLLIG
>A0A0C1ZHH9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFLKPSKAFFYSAFTLFFVSAASHAVTPSDAQLQALVSQAVTPVMQQNNIPGLTVAITL
NGQPHYFNYGVAAKDTGKKVSENTLFEVGSVSKTFTATLAGYAQATGKLDLSSKASQLWP
ELKGSAFDNISVLQLGTYSAGGLPLQFPAEADSSDKMLGYYQQWKPQFPAGSHRLYSNPS
LGLFGYLTAKSLGQPFEQAMTQTLLPKLGLQHTFLSVPAAQSKLYAQGYDSADQPVRVSP
GALDAEAYGIKTSAADLLRYVQAQLKPASLAPDLHQAIANTHIGYYRVGDMTQGLGWERY
TYPISLEKLQNGNSTPMAMEPHKVEWLTPPQTEPANVLFNKTGSTRGFGAYVAFVPSRDM
GIVILANKNYPNVERVKIAHAVFAALAD
>AAC98494|FEATURES|ARDB_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVVRWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCIQSLIVSIVGTL
AVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV
>A0A157ZXT3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMIKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEFRAKIASVVTGLPARSDARRFTVNVIIATIPAVVLGLLFEKHIKSVLFSPVPVSVALI
VGGIVILWAEARQRERGAAARVTSVDDLSLADAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATIYEMAKYWRALTADDIGLFAIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A085NX50|FEATURES|UNIPROT_deepARG|beta_lactam|JD73_27665|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0T9UKN1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKKSIINTLVFTAIAASPLYTSAQTILTEQQVAAIVNKTLKPLIEQQEIPGMAVAVFYD
GKPQFFNYGVADIKAGIPVTENTLFELGSVSKTFTGIAGEYAAQTGIMNLNDPVTKYAPE
LTGRQWQGVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPEWAPGVMRNYSNASI
GLFGALAVKNSPLTFENYMKESVFQPLKLTHTFITVPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTTKDMVRFMQANMEPNNLSVENDKLKKAIVAAQSRYFQAGDLFQGLGWEM
YNWPINPQTVIADSGNDIALKPRKAEELLPPQLATPASWVHKTGATNGFGAYIVFIPEEK
IGIVMLANKNYPNPVRVQAAYNILQALR
>U4DW10|FEATURES|UNIPROT_deepARG|aminoglycoside|VIBNIFTn2_1190029|antibiotic inactivation|1
MIVRRAERKDKEDWAKLRNALWPDELSAHKLDIESFFDLSSVHIVEVFVLDNENDEVVGF
IELNIRSHAEGIDARGVPYVEGWFIDSEYRGKGFGKLLLRQAESWAQRQGYQWLASDSDI
NNHASIACHKAVGFTEMARNVCFAKNLRLHQELKD
>A0A127SII9|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLNTASCSTFAAPQQINDILHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGPIPRQNTGLNLPLNNGMGSHYYI
LRPTPLAACHCRCRMTLNPQATCCASIKTGNLHGLQEHNVCMPTPVSVCSAHWL
>Q2LXE8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKKHHLRHALLVLSAAILLAVSCSFSAASASASPPASEKKIAVWEAAILGVVEGITEYLP
ISSTGHLILASHALGMTQFSETRGPLGTLMVKNDAMDSYNIVIQLGAILAVLGLYRKRVK
QMLKGLSGALAVLVSRRSVTALGDSERQGLKLLGLLLLAFLPAAVFGKLFHEVIETYLFG
PLPVVYALVAGGVLMIGVEYFFWLKDRNRLRISDVNSMFYRQALFIGMMQVVSMWPGTSR
SMITMIAGLIVGLDMIAAAEFSFLLALPTLGAATLYSGYKNWHALDDSAGMLALAVGLAV
SWLTAVIAVKALVRWLTHHGLIPFGVYRILLAGVLLIYFWQWR
>V5UD27|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLALKAVILGVVEGLTEFLPISSTGHLILAGSLLNFNDEKGKVFEIVIQFGAILAVC
WEFRAKIAQVVAGLGSDAKARRFAVNVIVACLPAIVLGLLFGKYIKAVLFNPIVVATAFI
VGGVIILLVERHNRSNTMAGKSPRVTSIDDLSFADALKVGFAQCFALVPGTSRSGATIIG
GMMFGLERRVATEFSFFLAIPILFGATVYELYKARSILSVDDVSLFGVGFIAAFVSAFIC
VRWLLRYIASHDFTAFAWYRIAFGIVVLATGYSGLVVWAD
>A0A077NPG6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKFVINTLVFATIGTSSFYASAQKTLTAQQVAEIVNNTLTLLLEKQDIPGMAVAVIYD
GKPQFFNYGVADIKTRRPITENTLFELGSVSKTFTGIAGGYAMQTDTLNLNDPVTAYSSE
LTGSQWRGVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPLWAPGIMRNYSNASI
GLFGALTANKSQLTFETYMTKYVFLPLKLTHTFITVPESMQSDYAWGYKNGQPVRVTPGM
LSSEAYGVKSTTQDMVKYMQANMAPDSLPADNDKLKKAILAAQSRYYRAGNMFQGLGWEM
HNWPINPQRVIADSGNDIALQPLKVEELIPPRSAVSASWVHKTGGTDGFGAYIAFIPEEK
IGIVMLANKNYPNPVRVEAAYHILKALR
>A0A0A2R780|FEATURES|UNIPROT_deepARG|beta_lactam|LR61_11945|antibiotic inactivation|1
MTKSVSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESVQSRYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>A0A0J6MBU6|FEATURES|UNIPROT_deepARG|beta_lactam|VK95_22555|antibiotic inactivation|1
MMKKTLSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVTRYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTNTASLLRFYQNWQPKWKPGTTRLYANTSIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMMPDSLQDSPLKHGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
QTVVGGSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>Q5MD18|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
RRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQILYRAD
ERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELG
AAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTP
LAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGSGDYGTT
NDIAIIWPENHAPLVLVTYFTQPEQKAESRRDVLAA
>A0A0A8H6I7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLDYYYALILGIIEGLTEFLPISSTGHMILGAEILGLNIDDFWRSFFIIIQLGSILAVI
FIFKDKLTQKLDIWLKLAVGFLPAGGVGFIAYKFLKEIFNGYTVATMLIIGGIVFIIIEL
KHRKKDYDIHSLDEVSYKQAFLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKVASEFSF
LLAIPTMIIATAYSIYKEPQVLSNMNNFIPLAIGFATAFVVAFVVIKIFLKLISKINFIP
FGIYRIILGFVFLYLFMSGALDISRTGV
>A0A0M3ELZ8|FEATURES|UNIPROT_deepARG|chloramphenicol|OA40_16080|antibiotic inactivation|1
MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAETDYKFYPVMIYLISR
VVNQFPEFRMAMKDNALIYWDQTDPVFTVFHKETETFSALFCRYCPDISEFMAGYNGIMA
EYQHDTALFPQGELPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEGDRVL
LPVSVQVHHAVCDGFHAARFINTLQMMCDNVLK
>Q1MEI0|FEATURES|UNIPROT_deepARG|beta_lactam|RL3159|antibiotic inactivation|1
MKRDWIGILSAALVSTCISTSSFAADELKLKASSDAAIKPIMDKYGIPGIAVAITADGQN
HIFNYGVESKDTGRPVTPATMFELGSISKTFTVTLTSYADVTGRLSLSDKASKYLPSMKG
RPFGDVVLMDLGTHTAGGFPLQVPDDVKTEKQLMEYLASWKPSYAAGTHRTYANPSIGAL
GYITAKSMGNDFTALMEEQLFPSLGLTSTYINVPKSKMADYAQGYKRSGEPARMTTATLS
SEVYGVKSTAGDMIRFTDANMGLVELDDKLQQAITNTHTGYFDVGAMTQDLIWEQYSYPA
TLTTLMDNNSSAMLKTIPVKQLMPVMKPRDDVWINKTGSTNGFGAYVAFVPKERVGIVIL
ANKNYPNEDRISAAYQILTDIISAR
>AAA25979|FEATURES|ARDB_deepARG|beta_lactam|CARB-3|antibiotic inactivation|1
MLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSV
LDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVI
EKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDL
NEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGW
NIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMEERNDAIVKIGHSIFDVYT
SQSR
>A0A0J6KVH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVIAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKAEATTFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVNDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTFFVLL
>A0A097SRR1|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
VFAHPETLVKVKDAEDQWGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLS
RIDAGQEQLGRRLHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTI
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLA
SRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIY
TTGSQATM
>A0A0Q5Z5V0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFVDAKAKVFDIAIQTGAILAVI
IVYWQKISSTVAALPTQRQAQRFALNVLIAFFPAVLLGLALGKAIKEHLFTPEVVATTFI
LGGLVILWAERRQQGSVRIEDVDQMSALDAIKVGLVQCLAMIPGTSRSGATIIGGMLLGL
SRKAATDFSFYLAIPTLIGAGAYSLYKDRGLLSMQDLPMFAVGLVFSFISAWACVRWLLR
YISSHSFTPFAWYRIAFGIVVLLTASMGWVDWTE
>A0A0R1Q763|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGVTEFLPISSTGHLVLVDQFIKLEQSSQFIDMFNVVIQLGAIMAVV
VIYFHKLNPWSPRKNALEKKSTWTLWKKVIVAVIPSAVIGLPLNDWMDEHLMNWFVVSMA
LIVYGILFILIENRNRDIEPKYADLNTLSYRTAIAIGLFQILSLVPGTSRSGSTILGGIT
IGASRYVATEFSFFLAIPTMFGASLLKLYKFFKHGGSLVGLPGVVLAVGVVVSFIVAYIS
IRFLLNYVKKNDFKAFGWYRIVLGIIVIGYFALIH
>YP_001465586|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYKANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASTMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>Q4TZR7|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLGFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0R2RF94|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDWIMTVVLGVVEGITEFLPISSTGHLLLMGHLFALQRSELFTIGIQSGALLAVLLIYA
PRLKAMVVGEEGQKGKAYLKKLGAAFMVTAVLGLTASEMGLKLPDSPRPIAWALLVGGVL
IWLAERRLLLHRGKEDPGWWVALVIGASQMLAAVFPGTSRSGATILAGMFCGLSRTAATD
FSFLLGIPTLLAACALSFYRQLKATGVPVQEEWMHLGLGLAVSAITAYFAVKWLLGYVRT
NTLIPFAWYRIGMGLVWLWMVK
>S1LQE6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRARQLLQRLGLEERAEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTVLHQLRDRGHTVIIVTHDPQVAAQAELVIEIHDGEIVRNPPAIEKNTAAANSEPG
VKTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAAKLDPVDALARE
>E3GGW8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLELLKAAFFGIVQGITEWLPISSTGHMILFEQFIHMNVSKDFWDMFLVVIQFGSILAV
VLLYFHKLNPFSPKKSPVQKRDTWSLWGKVLVAVIPAAVIGLLFDDFITDKLYGYVTVAI
TLIVYGIAFIVVENMDRTKHPTIRNFEQLDYKTALFIGVFQILALIPGTSRSGSTIIGAT
LLGCSRYVATEFSFFLAVPVMLGASLLKIVKFFVKTGIGFTGTEIGILLVGMIVAFVVSV
FAIKFLMGYIRKHDFKAFGYYRIALGIIVIIYAVMFA
>A0A060KTM0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAHTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRARLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>F1DI14|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
AVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTQTAWRADERFPMMSTFKVVLCGAVL
ARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLAT
VGGPAGSTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAAT
>A0A0J6NGH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVMLLAKALLLGIVEGVTEFFPISSTGHLIVVGDLIGFQNNADVFEVVIQLGAILAVVW
EYRQRFLGVAQGALQRDEQSLRFIGNLLVAFLPAAVIGFFAIKAIKHYLFNPVTVALALV
VGGVIILLVERRQRVPRVNSVDAMSWRDALKVGVAQVFAMVPGTSRSGSTIIGGMLFGLD
RKVATEFSFFLAVPTMFAATFYDVYKHWHQFTAADVPVIGVGFVAAFISAFFAVRGLIRY
VSSHNFNAFAWYRIVFGLVILATWQLGWVNWSA
>E0E147|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIFKAIFLGIVQGITEWLPVSSTGHMILVDQFLHLVGSKKFIDTFLVVIQFGSILAVL
ILYFNKLNPFSSRKSPKAKKATWNLWIKVLIAVLPSGIIGVLFEDQIDRIFFRPSVVAGA
LIIYGIIMIWIENRHRKPSITKFSQVSYKTALLIGLFQCLALVPGTSRSGSTIIGATLLG
TSRFIAAEFSFFLAIPTMLGASLLKLLKAGFAFTGFEWFIMFVGSLVAFIVSVIVIKFFI
SYIKKHDFKAFGAYRIVLGIIVFIYFAIAG
>H5V695|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPEFRMAMKDGELVIWDSIHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQRYCDEWQGRA
>A0A0K6J4T3|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MEQIYFGDCLLCVSKKSIKNLKGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGPLQVE
AKEKKGQIKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKAL
AAGVLLQQNSTEKLKEVITYTKEDLVTYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNI
LFNKIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKGFTAGN
ALPNHKRNILTEWMKGNATGDKLIRAGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPI
IIAILSSKDEKEATYDNQLIAEAAEVIVNAFR
>A0A0W0JRZ2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDADYEIAAVFTHADDPKEKTFFGSVAQLCAQHDIPVHA
PEDANHPLWVERIGKLAPDFIFSFYYRKLLSEPLLACATRGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHQMVKRADAGPVFAQQRVSISATDSALTLHGKLREAAIDLLSDTLP
LLAEGRLSGTPQDEARASCFGRRTPADGLIDWSLPATRLYNLVRAVTQPYPGAFCPVGDH
KLIIWAARVEPSNNGAAPGTVISHDPLRIACGDGSLIINAGQRGDEGLYLSGAQLAREFG
LVDGSQLLDTKKQRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
AKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPSIELSETIGKTLDFFLREAMAEKA
DQC
>A0A0A1FXK0|FEATURES|UNIPROT_deepARG|aminoglycoside|G155_25620|antibiotic inactivation|1
MTEWLPVPRGESGAGVFRNADGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAVIDW
RVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLDDML
ARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRRQEAADWVVCHGDLCLPNI
LVDPDRHTVEGFIDLGRLGLADRHADLALLLANTADAVPSFAEKATAGLAAGYPAQVDPE
RLRFYLALDPLTWG
>CAA54738|FEATURES|ARDB_deepARG|beta_lactam|BL2b_ula|antibiotic inactivation|1
MFKKRGRQTVLIAAVLAFFTASSPLLARTQGEPTQVQQKLAALEKQSGGRLGVALINTAD
RSQILYRGDERFAMCSTSKTMVAAAVLKQSETQHDILQQKMVIKKADLTNWNPVTEKYVD
KEMTLAELSAATLQYSDNTAMNKLLEHLGGTSNVTAFARSIGDTTFRLDRKEPELNTAIP
GDERDTTSPLAMAKSLHKLTLGDALAGAQRAQLVEWLKGNTTGGQSIRAGLPEGWVVGDK
TGAGDYGTTNDIAVIWPEDRAPLILVTYFTQPQQDAKGRKDILAAAAKIVTEGL
>Q7N6F9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNALLELKGIERSYPAGEQQIKVLDDVTLSIYAGEMVAIIGASGSGKSTLMNILGCLDQP
SNGEYRVAGQNVAELNNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAIYAGAAKAA
RRQRAIELLGRLGLEDRIYYQPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCEQGHTVIIVTHDPKIAAQAQRIIEIKDGHIMSDSGTQVSRKITQTPSLT
SKISSIRQIFGRFNEALFMAWRAMVVNKMRTLLTMLGIIIGIASVVTILVIGDAARASVL
SDIKEIATNTIDIYPGEDFGIDDPVSKQALKIADADAIKVQPYILAVSPEIEGQMRLRKG
NIDVSSKVTGVGDEYFQVYALRFAQGIGFSLDMIRRQGQVVVIDKNTQRKLFPHQKNVIG
EVILVGNMPATIVGVIANRESAFGNSKLLHIWLPYSTMTSRLMNRSYLDSITVRVKDDYN
SKDAEKMIVQLLTLRHGKKDIFTDNVDMLVKAAEKTAHTLQLFLTMVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVRQQFLIEAILVCLVGGVLGIGLSYTIAFIAQLA
LPGWHFVFQPIALLSAFACSTAIGVIFGFLPARNAARLDPIEALARE
>A0A0B0I3M5|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MDTITAIVLGIVEGITEFIPVSSTGHMILASKLLGYNDQDPTMKTFEVVIQLGAILAIAL
VYWRRILDLLGIKKIDSGGHRMASGKKLNLLHVIIGIAPALIVAFFARDFIKSLFSASTV
IWALVAGGVFMIFAEWFNKSKAKITAETIDDLSYKQVFLIGIYQILSVLWPGFSRSGSTI
AGGMLSGASYKASADFSFLIAIPIMVAASGYEMLDSYQNLTKDTLGLFAIGFILAFVVAY
VVVLAFMKLIQKIRLTHFAVYRFVLAVVFWLFIMR
>V6YZA3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFIELLKAIFYGIVEGLTEWLPVSSTGHLILVQEFITFNQSKDFIDMFNIVIQLGAILA
VIVIYFERLNPFQPGKTAKQVQSTWQLWLKVAIACIPSVAVALPFDDWFEAHFNKMVPVA
IALIVYGVAFIVSERRNHGLTPKVTDLSAMTYQTALFIGLFQVLAIVPGTSRSGATILGA
IILGMSRSVAADFTFFLAIPTMFGYSGLKAVKFFLDGNVLNWSQVLILLVASVTAFLVSL
YAIKFLTDYVKKHDFTVFGKYRIVLGLVLIVYVLVRTIL
>A0A0N9QP39|FEATURES|UNIPROT_deepARG|beta_lactam|imp|antibiotic inactivation|1
CGYGWGVVPKHGLVVLVNAEAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDST
GGIEWLNSRSIPTYASELTNELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDN
VVVWLPERKILFGGCFIKPYGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDA
SLEKTIN
>A0A0U1YUG6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDTSGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQVMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>K4Z7G8|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKPTREGRDLFETYQDTKNSAFRRNTIFVSYKCQLVYWGILTGRSKRKNDQILKPANQAH
QQFVQLEKKYDARLGVYAIDTGTNQTITYRSNERFAYTSTFKALAAGVLLQKNEIEQLDK
VITYTKDDLVEYSPITEKHVHTGMTLGELAEAAVRFSDNTAVNLFLKELDGPKGFEKALR
QIGDQVTHADRYETELNEATPGDIRDTSTPQALADDLKAFTVGNALPADKQNLLMNWMRG
NATGDKLIRAGVPIDWEVADKSGAGGYGTRNDIAIVWPPNRAPIIIAVLSSRDKKDAAYH
NELIAEAAKVTMKALQ
>A0A0C2M1Z3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTFIQVLILGAVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRPKIFDIVKGLPTQRNAQRFTLNLLIAFLPAVVLGVMFADKIHQYLFNPITVAMALV
VGGIVMLWAEQRSHVVSVDHVDDMRWSDALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQASDLPVFALGFVIAFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWVFGWVNWTEAAAG
>A0A0X8GJG9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRRKATKLLKILSVLSCVISPLSHAAENIDQAYIQKIVSTAITPIQKQFNIPGMAVAVSI
DGKNYFYNYGVASKEGKQAVSQDTLFEIGSISKTFTATLASYAQINGQLSFSDSVSQHLP
SLRGSAFDKVSLLNLATHTAGGLPLQVPDEITNNEQLMDYFKNWQPKHAAGTYRVYSNPS
IGLLGLITAKSMNTSFEDAIEKKLFPELGMTNSYVNVPAAQMKNYAQGYNKKDAPVRVTP
GVLASEAYGVKSSSADMIKYINANMQIGKINDKVQQALINTHSGYFKSGGIIQDLIWEQY
AYPVELNKLLTGNRDAMAYEANAASKITPVLAPQSMAWINKTGSTNGFAAYAAFIPSMKI
GIVILANKNYPIPPRVMAAYQILSQLDQQTALKN
>A0A0G3KB19|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPIAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMLTSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A143HZF2|FEATURES|UNIPROT_deepARG|beta_lactam|blaACT-34|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLAIPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIVRGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLLA
RWRSNLPA
>CAZ44321|FEATURES|ARDB_deepARG|trimethoprim|dfrA12|antibiotic target replacement|1
MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
PNRHTLVISRQANYRATGRVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFL
SEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG
>A0A0A0Q8K2|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGINLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>ACI76101|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MNRRRKLLIPLLFCGAMLTACDDKSAENTAAMTPEVGVVTLSPGSVNVLSELPGRTVPYE
VAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARI
TFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVS
GKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPV
QLNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQN
VLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGL
QRIRPGIKARAISSSQENASTESKQ
>I6Z9I8|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERLSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTATPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>Q83KF5|FEATURES|UNIPROT_deepARG|multidrug|mdtQ|antibiotic efflux|0
MNRDSFYPAIACFPLLLMLAGCAPMHETRQALSQQTPAAQVDTALPTALKNGWPDSQWWL
EYHDNQLTSLINNALQNAPDMQVAEQRIQLAEAQAKAVATQDGPQIDFSADMERQKMSAE
GLMGPFALNDPAAGTTGPWYTNGTFGLTAGWHLDIWGKNRAEVTARLGTVKARAAEREQT
RQLLAGSVARLYWEWQTQAALNTVLQQIEKEQNTIIATDRQLYQNGITSSVDGVETDINA
SKTRQQLNDVAGKMKIIEARLNALTNHQTKSLKLKPVALPKVASQLPDELGYSLLARRAD
LQAAHWYVESSLSTIDAAKAAFYPDINLMAFLQQDALHLSDLFRHSAQQMGVTAGLTLPI
FDSGRLNANLDIAKAESNLSIASYNKAVVEAVNDVARAASQVQTLAEKNQHQAQIERDAL
RVVGLAQARFNAGIIAGSRVSEARIPALRERANGLLLQGQWLDASIRLTGALGGGYKR
>K1JGL2|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1171_04302|antibiotic inactivation|1
MKGWIKCGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYIQENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSRQPVMEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTR
YLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELI
DHYEALIKAVPQS
>I2Q1R4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTETLAATVLGLVEGVTEFLPVSSTGHLILVGHLIGFTGDKADSFEVIIQLGAILAVVVL
YWKRFWWLLSPKPLHAFSGLRGIGLLFLTSLPAGLVGLVARKTIKAYLFGPITVAMALAV
GALMIFWVERRRMRDRYYTLDELTPALAFGIGCFQCLSLWPGFSRSAATIMGGMLLGAKR
SLAAEYSFIAAVPIMFAATAYDFYKSASLYSADDLGILAIGFVVSFLAALAAVKGFIVLV
KQVSLRPFAWYRLALAAAVFFLWPK
>ZP_03283366|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRPHSSFKIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAI
GQLLYGPLADSLGRKPVILGGTLIFAGAAVACALAQTIDHLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLVAPMVGGAVLVWFSWHAIFWILAIAALLASAM
IFFFIDETLPVERRQKFHIRTTLGNFASLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IELNHVSPQHFGYYFALNIVFLFVMTIINSRFVRRVGALNMFRAGLWIQFVMAIWLVVSA
FFGVGFWALVIGVAAFVGCVSMISSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNTAWPMLWAIAFCATSSVLFYLYASRSRKVAN
>A0A0I9QQ17|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHSLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>A0A0C1RT85|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDIWQTVLLGIIEGVSEFLPISSTGHLLIAEHWMGEKSETFNIFIQLGAVLAVCLIYKE
RVSSFLFLWKNKEKIPYFLKLTLAFFITALLGLWVKKMGWELPKDLGPVIIAIFGGAFWI
YFVEKVSCRNQSAVEDISWLTAIAVGASQVVAGVLPGFSRSAATILMAVLFGVSRPAATE
FAFLLGIPTMFAASLFSWIEQTNFLKVPPTDPPLTLLLGFFVSAAVAFIAVKWLLSFIQT
HTFIPFVWYRVGLGLVLLVIFAIEWKSH
>A0A109FSS9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFSVEQKDFERLLHRLEENNVHILQGRERNVRDCGSIYFVDPDGHKFEFHSGT
LQDRLNYYREEKPHMTFY
>A0A076NGZ5|FEATURES|UNIPROT_deepARG|aminoglycoside|CIMIT_00695|antibiotic inactivation|1
MPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQ
EGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVD
VVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPK
TLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERL
AFYLRLDPLTWG
>A0A0P9AEC2|FEATURES|UNIPROT_deepARG|beta_lactam|APR47_42920|antibiotic inactivation|1
MNTPIRRRTLLAAASAVPLASACAAWSAAGPDAEARLAALERDCGGRLGVHALDTASGAR
IAHRGNELFPMCSTFKLMLAAAILQRGTAQEPALLERRLSYTRAHLLPNSPITEKHLADG
MTVAELCAATLQYSDNAAANLLLHQLGGPAGVTAYARSIGDTVFRLDRWETELNSAIPGD
PRDTTSPAAMAASVQRLVLGDALAAPQRARLEAWLRGNTTSKERFLAGVPAGWAVGDKTG
AGDYGTNNDVGVLWPASGAPLVLAVYLTFPGDKGAKTRNDVVASAVRIVANAMRG
>A0A0B8P936|FEATURES|UNIPROT_deepARG|beta_lactam|JCM19231_3832|antibiotic inactivation|1
MFIFLNTFKYVSAHETITLINASIILKKEEYEYSTFPCRPYSLFCGILLPVFAHPETLVK
VKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLG
RRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFL
HNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWME
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
RNRQIAEIGASLIKHW
>A0A0K0X6V9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSRAFKVAIDGGPYALAAGPDGAMWVTLVHSGEIARVTETGEVTVYPVAPQARPSIIAAG
PDGAMWFTRAGDDRIGRITVDGELSEFALTENCAPFGIAAGPDDALWFTAMTSGEVCRIS
VDGEVTSAAVVGGMPSMITAGPDGAMWFTINQGNAIGRLETDGALVVRELPTPAAGPVGI
TAAHDDAVWFTEIGAEKLGRIPLDDAIAELELPGKPHAVIADPDDGVWVSLWGADQLARV
SGDGDIVTIDLPSGSEPHGLAIGPDGAAWVALEAGFVLRMPN
>A0A0J7D6Z2|FEATURES|UNIPROT_deepARG|beta_lactam|TU62_16300|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSVTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKED
LVEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQIGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNIFTEWMKGNATGDKLI
RAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
EVIVKSLK
>A0A059L870|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLSSGFEIAAVFTHADDPKENAFYGSVAQLCARKGIPVHA
PEDANHPLWIERIAKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQKTVAIERNDTALSLHGKLRLAATDLLRDTLP
ALLAGKVSETAQDESQATVFGRRTPADGKLVWQKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGQAPGRVISVDPLRIACGEDSLVITAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRNNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A126G806|FEATURES|UNIPROT_deepARG|beta_lactam|blaVEB|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTGSNRLKGQLPKNTIVAHKTGTS
GINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>A0A098T989|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDTTLVGALLGLIEGLTEFVPVSSTAHLLLAGHFLGFKSPGNSFEVLVQLGAILAILSV
YFARLWKLAMDLPSSAKARRFVGAVVLAFLPAAVIGALAHGFIKSVLFESPALICWVLIG
GGIILLLIDRMKLTPKYTNVMDYPLSLAFKIGLCQCLAMIPGTSRSGATIAGALLMGADK
RSAAEFSFFLAMPTMVGAFTLDLYKNHDKLAYDDVVTIVVGFIMAFIAGVIVVRSLLDFV
SRHGFALFAWWRILVGGLGLVGLWLMS
>K9DXJ0|FEATURES|UNIPROT_deepARG|aminoglycoside|HMPREF9710_02755|antibiotic inactivation|1
MNREEACRVVTVPESMSAALAGYAWARDRVGESGGAVYRLHGKPGAPDLYLKHGRHAVAD
AIGDEMTRLRWLAGRMPVPAVVHFDRSADEAWLLMTAVPGRTAYQLLQADPAQHDIVVDA
LARFLQRLHAIPTSACPFNSDHDYRLGLARSRIEAGLVDEDDFDEERAGWTARQVWDAMQ
ALLPLAPDPVVTHGDYSLDNLLIVDGQVAGCIDAGRVGIADRYQDLAIAWNCLGEFGGSL
QERFLRQYGIAAPDRRKLQFHLMLDELF
>AAD42184|FEATURES|ARDB_deepARG|glycopeptide|VanD|antibiotic target alteration|1
MFRIKVAVLFGGCSEEHNVSIKSAMEIAANIDTKKYQPYYIGITKSGVWKMCEKPCLEWE
QYAGDPVVFSPDRSTHGLLIQKDKGYEIQPVDVVFPMIHGKFGEDGSIQGLLELSGIPYV
GCDIQSSVICMDKALAYTVVKNAGITVPGFRILQEGDRLETEDFVYPVFVKPARSGSSFG
VNKVCKAEELQAAIEEARKYDSKILIEEAVTGSEVGCAILGNGNDLMAGEVDQIELRHGF
FKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAMKIYRILGCRGLARIDLFLREDGC
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIELSLRR
>A0A0Q8QID7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEMSLLSIVLLGIVEGLTEFIPVSSTGHLILAGEVMRVPQGTETFDIVIQLGAILAVVVL
YRQRFLDVIAGLFRRDPQAIRFTRNVLIGFLPSAVIGAVAYGAIKAMLNTPIIVAVALIL
GGVAILVIERSVRNPSCDSVEGMSVKTTLGIGLIQCLSMIPGVSRSGATIMGALTLGVER
RTAAEYSFFLAIPTMMGATTLALWKARHDLGDAQATAIAIGFVISFIVAMLVIRWFLNVV
TRHGFAPFAWYRIVVGTIALICLTL
>N9HXN3|FEATURES|UNIPROT_deepARG|beta_lactam|F918_01058|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTGTAGGYAKNKGKISFDDKPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYSADIQRAINETHQGRYQINTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>YP_001461101|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGATTISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLALLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGIIVVFTLAGLLNRVRQHQAAELAEER
>A0A143I1B6|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MQDIDMFSAPPVQKVSVIIPVYNEQESLPELIRRTTAACDTMGKAYEILLVDDGSSDHSA
LMLTEAAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVA
KADEGYDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAML
HCHERSTFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRL
LSVFGSIIAVAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYI
GRIYNDVRARPRYFIQRVVRQEHKASQEEIHP
>A0A0Q7S9Y7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLAAIILGLVEGLTEFIPVSSTGHMLLLGHFLGFESNGKTFEIVIQLGALLAIISVY
FKRLWMLATRWPFDPDARRFLIGLLVAFAPAVVIGLLAYDFIKTVLFETPLVICIALIVG
GLLLLWLDRMKKVPTFLEADRYPLRVYFLIGLFQCLAMVPGVSRSGATIAGGLLLGTDKR
SAAEFSFFLALPTMGSAVAYDLLKSWDRLDFSDTGLIAIGFVTAFLTALAVVRFLLDFVS
RHGFAPFAWWRIAVGVAGIVGLALTGGL
>YP_001882916|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAIQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVFRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGSLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLALLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEER
>A0A060KZ70|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAVKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESCLDVLASAAKIVTDGL
>YP_002852100|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGLDFIYILKAIVIAIVEGLTEFVPVSSTGHMILVGSLIGFRSGAVGAEEFAKMFEVVIQ
LGAILAVVVLYWNKLWGAVVDFFTYIFTLGKKGQSGFRFGINVIIASIPALIVGLTLYDD
IKSLFKPSAVVVGFIVGGILLLVIENRFRNRASKRGKTTTVDVFDLTPMQSLKVGLFQVL
SMWPGMSRSASTIMGGWIAGLATPVAAEFSFFLAVPAMIGSSAMDLFKFDYSIMNSTYIV
ALIIGFIVAFIVSIIVMDMFVSYLKKKPMRIFAIYRIIAGIVLLALSLAGIVTLTM
>A0A0U1YWR9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVGSFWLDGGIRISATEQTSFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>B2CD75|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
GLTSFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQ
LLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIIII
>J7II96|FEATURES|UNIPROT_deepARG|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKKSLRQFALLAATVFPLLASSVSLQAQTLSVEQKLAALEQRSGGRLGVALIDTADGSQ
ILYRGDERFAMCSTSKVMAAAAVLKQSESQHDLLNQRIEIKKGDLTNYNPIAEKHVGGSM
SLSELSAAALQYSDNVAMNKLIAQLGGPQGVTAFARKIGDETFRLDLTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDAQRAQLVTWMKGNTTGTASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLVLVTYFTQPQPEAESRRDVLASAAKIVTEGL
>A0A0E1S996|FEATURES|UNIPROT_deepARG|aminoglycoside|BURPS305_3406|antibiotic inactivation|1
MTHPAALFKIRAAQASDAAAWRQLRRALWPHADDIEHARDIARQLDAPARHACFIASPPG
ILAPVGFAEVAVRHDDVNGCGASPVLFLEGVFVEPAARRRGVARALCAAAAAWGTARGCA
AFASDAPLENAASHALHRALGFDETERVVFFRKPLAR
>A0A140J4L2|FEATURES|UNIPROT_deepARG|beta_lactam|AXF37_08125|antibiotic inactivation|1
MKKIIVFLCMGLLFCVSTWAQGTCFLATEKQTVLKREGNDCNQRYSPASTFKIALSLMGF
DSGILKDELHPEWPYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQALTRQLGMKRFKGYI
DAFHYGNQDVSGDKGQNNGLTHAWLSSSLAISPIEQIQFLQKIIHKKLPVSQKAYTMTKN
IIYIQELPGGWKLYGKTGTGRQLTKDKSQKLPLQHGWFVGWIEKDGRVITFAKHISDSKE
NNTFASFRAKNDALIQLFNLINELEK
>A0A0V8SJC6|FEATURES|UNIPROT_deepARG|chloramphenicol|ATM99_15730|antibiotic inactivation|1
MDAPALIDLDTWPRRQHFAHYLRAVPCTYAMTVEVDVTAFVDAVRAAGRRTYLTQVWAIA
SVVNRHDEFRMTLTTDGAPAVWPVVHPSFTVMHPGSETFASLWVPFDPDYAAFHDAAAAV
VAAHAASGELFPQGLRPAATFDVSSIPWTSFTGFTITATPGTHLAPIVTLGRYVERDGRV
LLPLAVQVHHAAADGFHTARLVEELRALLADPSWVAG
>D7AWL2|FEATURES|UNIPROT_deepARG|beta_lactam|Ndas_2388|antibiotic inactivation|1
MVFSSHRRTGLAALAAVVLVPATGCAAANGAATPEAEQSASPAASGGPAREFERLEEEFD
ARLGVYAVDTGSGEEVEHRPDERFAYASTHKALTAALVLQQNTPEEMEEVVTFTEEDLVD
YSPVTEQHVDTGMTLMEVADAAVRYSDNTAANLLFEELGGPDAFEDELEAIGDDVTDPER
IETELNDWTPGDTSDTSTPRAMAGNLREFTLGDALPEDRREVLNDLLVNNTTGDALIRAG
VPEDWRVGDKTGAGSHGTRNDIAVIWPPEGDPIVLAVMSSREAEDAEYDDALIARAAEIV
AEELG
>A0A0M8Y1A5|FEATURES|UNIPROT_deepARG|chloramphenicol|ADL06_32520|antibiotic inactivation|1
MDAPAPIDLDTWPRRQHFEHYRRTVPCTYSMTVELDVTAFAAALRGSSRKTYLAQVWALS
TVVNRHEEFRMCLTAAGGPAVWPVVHPAFTVFHPERETFACAWAPHDPDFGAFHDVAAPL
LAEHGRATDFFPQGDLPPNAFDVSSLPWTSFTGFNLNIGGGWDHLAPIFTLGRYGEREGR
VLLPLAVQVHHAAADGFHTARLVNELQALLADPSWVEEGPAS
>A0A0M1RAS9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGLLALLEAGYDIAAIFTHPDAAGENNFFGSVARIAAERGIPVYAPD
DINHPLWVDRIRAVAPDVIFSFYYRNLICDDILRLATKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVHRADAGAIIAQQRVAIGADETALQLHQKLCSVAQSLLRDALPTI
LNGTFSETAQDESKASCFGRRTPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSNVRDDVPAAKPGTIASVSPLIVSCGEQALEIVTGQTDNGVYVQGAQLAQSLGLVP
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>A0A0J6G7K0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIIDVVVGLPTKPEARRFTTNLIIAVMPAVVLGVIFADVIHEYLFNPITVATALV
IGGIIMLWAERRQHVIRAETVDDMTWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVRALLKF
ISNHSYAVFAWYRIAFGLLILATWQFGWIDWSAASA
>A0A085P7T7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPREPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0U5JTX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLVEVLKIIVLGIVEGFTEWLPISSTGHMILVDEIIRLNQPDAFKDVFLVVIQLGAILA
VVVMYFHKLNPFSPTKTSRQKDATWALWIKIIIACVPAAILGLLLDDWMEAHLFNAYVVA
AALIVYGVLFIVLENSSVCTNPRFNKAGQISAKTAFLIGMVQLLALIPGTSRSGSTILGA
MVLGCSRAAAAEFSFFLGIPVMFGASLLKIVKYFLAGNAFTGPQIFYTILGMLIAFVVSI
YSIRFLMSYVRKHDFKFFGYYRIILGVIVLAYFGITALAS
>A0A109W5N8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTSFLNAILLGIVEGLTEFLPVSSTGHLIIAGHLLDFTGPKAETFEIFIQLGAILAVVVL
YWPTFLGLIRPSDRRFSGLYGLWLLFLTSLPAALLGFVAHSFIKERLFSPMAVALALAAG
AAAIIVVERLPARNACRSLDTLTPALALGVGCFQCLALWPGFSRSASTIMGGMILGVERR
TAAEYSFVAAVPLMFAATSYDMLKSWHLFTPQDLPVLATGFAVSFASAWLAVKTFIALLG
RLTLRPFAWYRLVVAAMVVWVFWP
>A0A0W0IE45|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRALLELKGITRRFVAGEKDFIALNDINLTINAGELVAITGASGSGKSTLMNVLGCLDH
ANSGSYKVDGRETGTLTDDELAELRRDHFGFIFQRYHLLPHLPAIQNVEMPAIYAGTGKG
VRVERAQKLLERLGLPGHLEHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNPDRPIINEKTTE
RLPTKPRQGNRLMANLGLFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIEAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVAALSSEYYIDSATPNIGRN
LLVRYRNIDVSATVSGVSPSYFQVRGTKMGLGVGFNKDDARRQAQVVVIDYNTRIRLFGP
KVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLLGQTYLDGITVR
VKEGQPSKVVEDNVNKLLQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSFVIG
YVFSLLVKEWQMVFSVSSIVTAFICSTLIGIVFGFVPARNAAQLDPIEALARD
>R5UFD3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEALKVIILGIVEGITEWLPISSTGHLILVEEFVKLNFSQSYLDMFNVVIQLGAIMAVV
VIYFHRLNPFSPKKTEKQKKMTLQLWVKVVIASIPAGVVGILFNDFIEEKFNNSYVVATM
LIVVGVLFIVIENRHKGGKPQITKISQMGVPVLIWIGVFQMLAMIPGTSRSGATIIGALA
LGVSRTAAADFTFFLAIPAMAGASLVKLRHFGFDFTGTELGLLLLGCVVSFVVSILAIKF
LLKYIQNHDFKAFGYYRIVLGIIVFLYFGIHALLA
>N2A3N4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAIILGIIEGITEFLPISSTGHLYLADYFIKLDQPTSFINMFMVVIQLGAILSVI
LIYFNKLNPFAPSKSHREQQQTWQLWFKVIIAVIPSVIIGLPLNDWLDEHMTTWQVIATT
LIVYGILFIILEDYYEKKKPSLVDLNKLSYKMAFFIGCFQVLSLIPGTSRSGATIMGAML
LGASRYVSTEFSFFLAIPTMFGASLLKLGKYVMGGHAFVGNQLAVLLVGMLVSFVVAYIS
IKFLLKYVQTHNFKPFGWYRIILGIVVIIVGTIFAR
>ABO43851|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVKKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLASYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRYMFQKIM
>A0A0M1IZQ5|FEATURES|UNIPROT_deepARG|chloramphenicol|ND00_04320|antibiotic inactivation|1
MKFNLIDEENWNRKPYFDYYMKDIKCTYSMTANIEFTNLLMRVKRNNIKLYPILIYMTSK
IVNKHKELRTSFDEEGNLGYWERMSPSFTIFHKDDESFSNIWTEYSEDFKTFYNNCLLDI
EKHSDVKRLFAKENEPKNTFPVSCVPWISFTGANLNVYSDGEYPYLLPIVTYGKYFAQNA
KSLIPISIQIHHAVCDGYHVTRFLNELQDMAHNFNEWLIIK
>S0L321|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIENFIKAIIFGIIEGITEWLPISSTGHLILADEFLKIKESTEFMTMFNVVIQLGAILA
VVVLYFTKLNPFAPSKTLEEKRDTWSLWFKVIFAIIPSAIIGLFLDDWLDATFYNFISVA
IVLIVYGIAFIVVERRNRTVTPKVSTLNQISYRFAFLVGMFQVLALIPGTSRSGSTILGG
IILGGSRFVSAEFSFFLGIPTMFGASLLKMYKFFHAGNTFSTESLIILLTGTVVSFIVSV
LAIKFLMSYIKKHDFTVFGWYRIVLGIILIGYWWMSK
>A0A0V9EAY0|FEATURES|UNIPROT_deepARG|beta_lactam|APT89_02570|antibiotic inactivation|1
MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKNLETDFNGRIGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSVKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHDDKVIAEASRIAIDNLK
>C6M3G5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPSYRSSFPIPIPLHPEIQTGKRRLKTKKESNMDILTLLKALLMGIVEGLTEFLPISSTG
HLIVLGDLLNFHSNGKVFEIAIQLGAVLAVIFEYRQRFTSILSGLGKDRAANRFVLNLAI
AFVPAALMGFLFRKQIKLYLFNPKTVAIMLVLGGLFILWVERRQSKVKPKVKSVDEMRPI
DALVVGCAQVCALVPGTSRSGSTIMGGMLWGIERKAATEFSFFLAVPMMIAATGYDVFKH
YELFTLQDIGLIAVGFIAAFLAGFLAIKSLLKFVSSKNYVPFAYYRIVFGGLILLTSHMG
WVKWTA
>A2T8L6|FEATURES|UNIPROT_deepARG|beta_lactam|OKP-B-6|antibiotic inactivation|1
CLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASERFPLMS
TFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMS
DNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTL
RKLLTTPSLSARSQQLLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLG
PDGKAERIVVIYLRDTAATMAERNQQIAGIGAALI
>AAY52010|FEATURES|ARDB_deepARG|glycopeptide|VanSA|antibiotic target alteration|0
MAIKLKNKNKNKKTDYSKLKRKLYQYIVVIVMAAAVFVLFLRLFIKGTLGEWIVRFLENS
YHLERQDAMIIYQYTIRNNIEIFIYVAIAISILILCRVMLSKFAKYFDEINTGIDILIQN
EDKQIELSAEMEFMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSVIGY
LSLLDEAPDMPVEQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKKHIDLYYML
VQMADEFYPQLAANGKQAVIHASEDLTVTGDSDKLARVFNNILKNAAAYSEDNSVIDITA
GLSGDVVSIVFKNAGSIPKDKLAAIFEKFYRLDDARSSDTGGAGLGLAIAKGIIVQHGGQ
IYAESNDNYTTFTVELPALPDLVDKRSS
>A0A125QR75|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIFVAVVLGLVEGLTEFAPVSSTGHMIIVDDLWLKSTDIFGSEVANAFKVVIQLGSIL
AVVVLFWGRFMDLLGLKKLKDTSAVKGPRLNLLQIFVGLLPAGIFGLLFEDYIDDKLFRI
ETVIIGLFLGAFLMIAADKFRPKLTAETVDQITYKQALGVGLIQCLSLWPGFSRSGSTIS
GGVLLGMSYRAASDFTFIMAVPIMAGASLLKVVKYWDSFTPEVLPFFIAGFISAFIFALF
CIRFFLILINKVKLTPFAIYRIVLAVILLFIIW
>YP_002332257|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|vgaALC|antibiotic target protection|1
MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGI
VKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQ
DLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYE
KYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGKIKGTKPYFASKQKKLRKTVKSLET
RLEKLERVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDK
MAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQN
ETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAI
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
EDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>AAM77886|FEATURES|ARDB_deepARG|glycopeptide|vanXA|antibiotic target alteration|1
MEIGFTFLDEIVHGVRWDAKYATWDNFTGKPVDGYEVNRIVGTYELAESLLKAKELAATQ
GYGLLLWDGYRPNRAVNCFMQWAAQPENNLTKESYYPNIDRTEMISKGYVASKSSHSRGS
AIDLTLYRLDTGELVPMGSRFDFMDERSHHAANGISCNEAQNRRRLRSIMENSGFEAYSL
EWWHYVLRDEPYPNSYFDFPVK
>A0A0H4QM63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFVKLNESQAFIHMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNKVEKNNTWKIWLKVLVAILPSVIIGLPLNDWMDAHLTSWQVISA
TLLIYGILFIVVENYFKNKTPQYTDLDSLSYKTALGIGLFQVLSLVPGTSRSGATILGGI
SIGTSRFVATEFSFFLAIPTMFGASLLKIGKYFAKGNTFTGDQTIILLVGTFVSFLVAYA
SIKFLLNYIKKNDFKAFGWYRIILAIIVIIYFGFMKQA
>J3BBL0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWNIFVAFVLGLVEGLTEFAPVSSTGHMIIVDDTLLHSKELFSSEVANTFKVVIQLGS
ILAAVIVFKDRFLSLLGLKKMSPDGNGPGHKLRLSQVIVGLLPAAVLGLIFEDYIDEYLF
SIHTVLIGLVAGALLMIAADWFRPGRPKVTTVDQMTYKQALLIGLFQCIALWPGFSRSGS
TISGGVLLGLSHRAASDFTFIMAVPVMAGASFLSLLKHWQYITADSLPFFIVGFISAFLF
ALLAIRFFLKLINRIKLVPFALYRIALAAVIYFFIL
>A0A0A0Q8K7|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-30|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMIAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYARGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQVGIVMLA
NKSYPNPARVEAAYHILEALQ
>B2TY28|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQMPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQIGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>Q5WWP7|FEATURES|UNIPROT_deepARG|beta_lactam|lpl1405|antibiotic inactivation|1
MKKIIIFLCTGLLFCVSTWAQGTCFLAKENQTVLKREGNDCDQRYSPASTFKIALSLMGF
DSGILKDELHPEWPYKKEYELYLNVWKYPQNPHTWIRDSCVWYSQALTRQLGMKRFKGYV
DAFHYGNQDVSGDRGQNNGLTNAWLSSSLSISPAEQIQFLQKIIYKKLPVSQKAYTITKN
IMYIQELPGGWKLYGKTGTGRQLTKDKSQKLPLQHGWFVGWIEKDERVITFAKHIADSKE
NNTFASFRAKNDALIQLFNLINELEK
>A0A127SK65|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>G9A680|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLLSIALALPTSVKARHFVLSVLLAFLPAALIGAAAHDFIKSVLFETPMLICVVLI
VGGVILYAIDRLPLQPRYTDVFDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMVGAFTLDLYKNRDALSFDDVGVIAIGFIAAFVAGIFVVRSLLDF
VSHRGFTPFAIWRIIVGTAGLVGLWMVG
>A0A0K9JDM5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDLIKAIIIGIIEGLTEFLPVSSTGHIILAEALMKIPSGNVWTKAFSSVFDYSIQLGAI
FAVIQLYFDKLNPFSSKKTDHEKFQTWRLWIRVIVGVLPAIVFGFALNDFMDAHLMNFWV
VSATLIIYGIAFIVIENRQKSIVPVITNVNQITFKLALYIGLFQVLSIVPGTSRSGATIL
GAIILGASRFVAAEFSFFLSIPVMFGVTFLKMGSFFRDGGSFTGMQSIVMLVGFIVSWIV
AWFAIKFMMNYIKNNDFKVFGYYRIIIGAIFLVFGILGIVG
>A0A126PPA7|FEATURES|UNIPROT_deepARG|chloramphenicol|AW879_13615|antibiotic inactivation|1
MKKILPEYTSVDLSRWARKEHFEIFQGFAQSTFNQTVLIDITALLKHIKAVGWKFYPTII
FLISKIVNSRPEFRMAMKDNELIIWNEVHPNYTIFHNETETFSSLWSHYDGNIQHFQKTY
AEDIARYGNNLAYWPKDESRENIFFISGIPWVSFTSFNVNVAHMKNFFAPMFTLGKYYEH
DGKVLLPLAVQVHHSVCDGFHVARLYNELQEMIDALPQSGA
>CAK55563.1|FEATURES|CARD_deepARG|aminoglycoside|AAC(6')-31|antibiotic inactivation|1
MTTTISFVTLRLMTEHDLPMLHDWLNRPHIVEWWGGEETRPTLAEVLEQYLPSALAKESV
TPYIAMLDEEPIGYAQSYIALGSGDGWWEDETDPGVRGIDQSLANPSQLGKGLGTKLVCA
LVEMLFKDAEVTKIQTDPSPNNLRAIRCYEKAGFVAQRTINTPDGPAVYMVQTRQAFEQA
RSAV
>A0A0H7BTF7|FEATURES|UNIPROT_deepARG|beta_lactam|bla_1|antibiotic inactivation|1
MVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTR
LDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLL
RSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIG
ASLIKHW
>A0A0W0M2S5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSIKAVVFAYHDIGCVGLQALLESGYHIAAVFTHADDPSEKTFFGSVAQLCAQHDIPVHA
PEDPNHPLWIERVGKLDPDFIFSFYYRRLLSEPLLACASKGAFNLHGSLLPRYRGRAPAN
WVLVNGERETGVTLHQMVKRADAGPIMAQQRVPISALDTALTLHGKLRKAAANLLSDALP
LLARGRLPGMPQDESQATCFGRRTPADGLIDWARPAAQLNNLIRAVTQPYPGAFCPVGEH
KLIVWSARVEESDHGLAPGTVIDCDPLRIACGEGALVIGAGQRGADGLYLSGVQLAREFG
LVQGSRLQGQNQSRPTRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFSEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVVDGIEALARIIENRGERCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFA
GFREVESQSFYGKGYQDVSHRKPCVDNAKRLLDWTPTIELSETIGKTLDFFLREAMAEKA
DQR
>G2MSC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGSFINFTGKFATMFEIVIQLGAILAVVYY
YKGKIFASLKNLKPGDWGFNLWFKIFIAFIPAAVIGLFTHKYIEEHLFSPFTVAIALIVG
AIMMIVIEDTFGKRYKIDNMDKVDTKKSFWIGIAQVMSLFPGMSRSASTIMGGMLVGLSV
KAAAEFSFFLAIPTMLAATGFELIKSFTAMSLLEWEALTVGFIMSFITALFVVDKFLSYL
AKHPLKPFAYYRLIVGLLMLLLISEKIVK
>A0A0K8MRR4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFRAIIIGIVEGITEFLPISSTGHIDLVSQFVQISQGKAFEDMFEYVIQFGAIMAVV
ILYFSKLNPFSFRKSSQEKKDTWTLWFKVIVACIPSIVIGLPLNNFMDEHLHKPVVVASA
LIIYGIFFIIIENIYKNKTPKVTSLASIGYNTALYIGLFQALSIVPGTSRSGATILGAII
LGASRYVATEFSFFLAIPTMFGVTILKVGSYLLKGHTFTGEQWAVLATGTFVSFIIAVVA
IKWLLKFVQTHDFKPFGWYRIVVGIIVLIAMVWL
>U1ASI7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAANDGGGADLGKAVEATIPPLMKANDIPGMAVAVLANGEARYFNYGVASRESGQAVTQD
TLFELGSISKTFTGILGAYALAQGKLSLGDKASRYQPELKGSAFDRISLLQLATYSAGGL
PLQFPDAVVDPSSMLAYYRGWKPDYAPGARRLYSNPSIGLFGHLAARSLGQPFDEAMEKG
LLPKLGLSHTFIHVPAAEQSRYAWGYSKAGKPVRVGPGALDAEAYGIKSSAADMLKYLAI
NMSGQTEPALRRAMDASHAAYYRVGDLHQGLGWEGYRYPLSLERLLAGNSNEIAFQPQQV
AWLNPPRPAGADVLLNKTGSTNGFGGYVLFVPSRKIGIVMLANRNYPNAERVRAAYRILS
ALDPSLAHAGRP
>J8CHT3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKAEATAFLLDDLTYLQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIAIPVMVGATGLDLLKSWKYLRVDDIPMFAVGFITSFLVAMLAVVAFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A073KCI4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQGINHLCFSVSNLEKSIHFYEEILEGKLLVKGRKLAYFDVCGIWLALNEEEHIARNEI
HESYTHIAFSVRCEDLHRLLERLQENEVNILSGRKRDVRDCESIYFTDPDGHKFEFHCGT
LQDRLQYYKEEKLHMEFYEREGR
>C8C0S9|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-34|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMKEQAIPGMAVAVIYQGKPYY
FTWGKADIANNRPITQNTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTRYWPELTGKQ
WQNISLLHLATYTAGGLPLQIPDEVTNKTALLRFYQNWQPQWAPGAKRLYANSSIGLFGV
LAVKPSGMSYEGAMIRRVLQPLKLTHTWITVPQNEQRDYAWGYRDGKPVHVSPGQLDAEA
YGVKSSIMDMARWVQANMDASHVQEKTLQQGIGLAQSRYWRIGEMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPVVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>A0A0A0EUW9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGIIEGITEFLPISSTGHLLIAQHWLGHRSDLFNIAIQAGAILAVVLIYWK
RLWGMLVAFVGYDAPAPYDPLGVTATPAQSRDYAFKLLAAFAVTAIGGLLVKKLGWELPD
TVRPIAWALIIGAAWMVLAEHLAAKRAEREGERVAIAWTTALLVGVAQVVAGVFPGTSRS
AATIFVALLAGTTSRAAATEFAFVVGIPTMFAATGYELLSMMRDGGFGAENWTALGVAFV
ASAVTAFVAVKWLLHYIQSNRFTAFAVYRVLLGVALLAFIPEGG
>A0A091BVX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLTALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDLFNISIQAGAILAITLVYRQ
RLWQLATGLGVKAQRDYLLKIALAFAVTAVIGLPVRLLGWELPETVTPVAWALVIGGVWM
LVAERLGERGPPSDAVTWKIAVAVGLAQVLAGVFPGTSRSAAAIFIALLLGLNRKPAAAE
FVFLVGIPTMFAASGYALLETVLEGTAGDEDWLGLAVAFAAATATGFATVRWLLGYIATH
RFTPFAWYRIGLGAALLLGLPAGG
>YP_002389553|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATMLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRAMGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAAQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>D7NIY9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-107|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDCAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>C6D280|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLFNAIIMGIIEGLTEFLPVSSTGHLILTADLLNFQDDRAKVFEVVIQFGAVLAVLVL
YWRKFLGLLKFDFRKGSGVNAIHFVLAMIPAGVVGVLFHGFIKDYLFSPETVLIGLVAGG
ILMIVADRIKRKVTAEELDDITYKQAFAIGMFQVLALWPGFSRSGSTISGGMFFGASQKA
AAEFTFMVSVPIMAGASGIDLIKSREFLTASDAPLFIIGFVAAFIVAMIAIVTFLNLIKR
LSLSWFAYYRFALAIVFAFIIL
>A0A0B5ZH41|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKRMLKIGICVSILGLSFTSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFSQLEKKF
DARLGVYAINTGTKQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITYTKEDLV
DYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIRA
GVPTDWIVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEV
IVNAFR
>AAA22275|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVEQIVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTSKGLVLVDSSWDNKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGITALKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKNLGNVADAYVNEWSTSIENMLKRYRNINLVVPGH
GKVGDKGLLLHTLDLLK
>A0A060KQD7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVPDGL
>A0A095WJ63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNALILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFTNSFLIIIQLGAILSV
VVYFWKDLTPFVGTKEKFVLRFRLWVKIIVGVIPAMVIGLFLDDIIDKYFMDNVTTIAIT
LIVYGIIFIAIEVIYKIKNVKARVRKFSELKYSTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLLKNGLVFTEREWAYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIIVLVLLR
>YP_001700011|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MSDLEKSIAFYENVFGAKLLVKGNSTAYFDVNGLWLALNVEKDIPRNDIQYSYTHIAFTI
SEDEFDKMYDKLVQLKVLILDGRQRDERDKKSIYFTDPDGHKFEFHTGTLQDRLDYYKKE
KLHMEFFNH
>A0A0R3M827|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSDAVKAVILGIIEGITEFLPVSSTGHMLLAQRFFGLGEGAFWQSFVILIQLGAILAIV
MLYFTKLWRVALGMFTNPDDRRFVIGVLLAFLPAVVIGLAVGKYIKELLFNPWVVCFTLI
VGGAILLWVDQLELKPTEDDATRYPVMMYLWIGIAQCVAMIPGVSRSGASIVAAMLLGGD
KRSAAEFSFFLAIPTMIGAFAYDFYKNRAEMTTDHIGVLAIGFVVSFITAAIVVKTFLTY
VTRHGFTFFAWWRVVAGTAGLIALALGK
>A0A0M4STE8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MISLKNITKSFKLGDNEIEILHGINLEIRKGEFIAIIGQSGSGKSTLMNILGCLDSPSGG
QYLLDGKDISKFDSDALAKLRRDKFGFIFQRYNLLSTMNALENVALPSIYAGANKSDREK
RGMEILDSLGLSEKAKNLPNKLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGLRV
MEILVDLYKKGHTIIIVTHDPKIAEYASRVIEIKDGNIVNDNVKNSEIFEAKKQSQPEKS
KFTYYKDQLIESFKMSVNAMLAHKLRSLLTMLGIIIGITAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMLSGRVKTLSISDANMLSKQSFLDSVTPNTSTSGILTYENISL
TATLKGGGVGSFDVNGLKLEKGRIYDEDEVLNSDSVTLIDQNTKNSIFKNEDPIGKIILF
NKKPLRIIGVLQKDEFKVGDASSLKIYAPYTTVINKITGDKFISSITVKVNESVNAQIAE
KSLTDLLTIKHGKKDFFTRNSDSIKQTIEETISTMRLLISSIAVVSLVVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIAFSYAIGYIFNNFLDGFS
MIFSNGSIVLALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>ZP_02900740|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQALILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPKLAALNVENFKTDKPQPVNTLLKEAEK
RNLTLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTRGANSAQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYTPDSPAPVVQPASV
RTNTSTGKNPFRN
>AFK13827.1|FEATURES|CARD_deepARG|multidrug|robA|antibiotic efflux|0
MDQAGIIRDLLTWLEGHLDQPLSLDNVAAKAGYSKWHLQRMFKDVTGHAIGAYIRARRLS
KSAVALRLTARPILDIALQYRFDSQQTFTRAFKKQFSLTPALYRRSPDWSSFGMRPPLRL
GEFAMPKYEIISLPETHLVGTTQSYSCSLEQISEFRHQMRVQFWREFLSHAPAIPPILYG
LNETHPSQEKDDEQEVFYTTALTPDMANGYIHGSKPVVLEGGEYVMFSYEGLGTGVQEFI
LTVYGTCMPMLNLNRRKGQDIERYYPAQDAKPEEGPINLRMEFLIPVRR
>AAY43143|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDDENVLIFPSIKDALTHLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>L2TL31|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRIQEFTVSDETSGPYAITAGPDQALWVTLVHAGRIARLTVDGEVATYPLDTAECGPTII
TSGPDDALWFRRFRDHRIGRLTSDGAIDSFPTPTADSGPFGIVAGPDGALWFTETNADRI
GRITTDGKITEFPLPTDGGFPSAITSGRDDALWFTLNQANAIGRIDVDDNVATHSLPTPA
AGPVGITRGTDDALWFVEIGAGQIGRISAHGRIDEFALPDRSARPHAVVADPDGGCWFTE
WGANRIGHIGPGGDITEYDLPTPSSEPHGIAVGPDGAVWVALEIGRVVCFAPVSTC
>T9S0M9|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQMLFLAAGITLAVSPSHAISLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>AAB31949|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADIS
PSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDP
KKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDI
SIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANDYWSIMLISF
VVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIY
MAIGVSLAGVVIVLIEKQHRAKLKEQNM
>J7X5R0|FEATURES|UNIPROT_deepARG|beta_lactam|IC3_00832|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLVEYSPITEKHVDTGMKLGE
IAAAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKVLTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLIAEATEVIVKALK
>I6ZM37|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTATPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>A0A0N8LVX6|FEATURES|UNIPROT_deepARG|beta_lactam|AN672_11615|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>A0A0G0NHK3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQSIIFGIVEGVTEFLPISSTGHMILTAKLLGLTQTNFMKSFEIAIQLGAILSVVVL
YWRSLFVNRAIMKRIAVAFIPTGILGLLLHGLVKEYLLGSNMTVVLALLIGGILLIAFEW
THNEKEDALEDVAHLSYWRAALIGVAQSVAMIPGVSRSAATIVGGMLAGLKRKTIVEFSF
LLAVPTMLAATILDLSKSYKDFSADQFDVLAVGFIVSFFVALASIKFLLRFVKTNTFVSF
GVYRIAVAVLFLLFVL
>CAB61225|FEATURES|ARDB_deepARG|glycopeptide|VanZ|antibiotic target alteration|0
MEKILSRGLLALYLVTLIWLVLFKLQYNILSVFHYHQRSLNLIPFAAHGSLREMIDNIII
FIPFGLLLNVNFKKVGFLLKFAFILVLSLTFELIQFIFAIGATDMTDVITNTVGGFLGLK
LYGLSNKHINNKKLDRIIIFVGILLLVLLLYYRTHLKIKYS
>YP_001569068|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MsrA|antibiotic target protection|1
MEQYTIKFNQINHKLTDLRSLNIGHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESG
TVETVGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNY
SPILLLDEPTNHLDKIGKDYLKNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRV
FKGNYTQYQNQYEQEQLEQQRQYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIA
PDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPII
AQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMA
YYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALDRSCNVLSGGERTKLSL
AVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELT
GQSLHDIT
>G5JVB1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIIEIIKAIIFGVVEGITEWLPISSTGHLILVEEFIKFKNANAAFTNMFNVVIQLGAIL
AVVVTYFDRLNPFKRGKTARQVQITWQLWAKVIIAAFPAAVIGLKLNDWLDAHFQYFVPV
AIMLIVYGIAFIYVEKRHKNIEPQITSLERMPYKTAFYIGLFQVLSLIPGTSRSGATILG
GILVGTSREVATEFTFFLGIPIMFGASLYKIYKFVKSGTILMGSQFLILLVAMVTAFAVS
LYVIRFLTDYVKNHDFTFFGKYRIGLGLLLIAYWLVTFIF
>C3G2Z8|FEATURES|UNIPROT_deepARG|chloramphenicol|bthur0009_21620|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEENKIM
LPVSLQVHHSICDGYHASRFIEDLQELSNSCNEWLK
>V4P0Y2|FEATURES|UNIPROT_deepARG|aminoglycoside|AEAC466_20400|antibiotic inactivation|1
MGGDEREKACAAPQIPIVMSAQVNGYGWARDTIGESGAAVYRLDGKGRAPDFFLKHGKDA
VADDVTDEMVRLGWLSGFMPVSTVVQFVRTPNEAWLLMAAIQGKTAYQILAADPDARAAV
VDALAAFLRRLHAIPVNQCPFNSDHAFRLARARARIDAGLVETDDFDEEREGWTAEQVWE
ALQALLPFTPDPVVTHGDFSLDNLLIVDGEVIGCIDLGRVGIADRYQDLAILWNCLGEFD
PSLQDRLFQQYGIPDPDPGKLQFHLILDELF
>R8QDG0|FEATURES|UNIPROT_deepARG|beta_lactam|IIQ_01478|antibiotic inactivation|1
MIVSKKFFHISHYKKMLPAVLLSFVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALVTSLKAYALGDILSIEKRNFLIDLMKKNTTGDNLIRS
GVPEEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHAKEDAKYDDKLIADATKI
VLDSLKVTNK
>A0A0R2DJE1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDILKAIILGIIEGITEFLPISSTGHLYLADEFVKLHESTAFINMFMVVIQLGAILAVL
VLYFNKLNPWAPSKGIRERQQTWTLWLKVVIAVLPSVIVGIPLNDWMDAHLTSWQVIAAT
LIIYGILFIWIENYNQDRTPIFTDLNQLPIKLAILIGLFQVLALVPGTSRSGATILGAIL
LGTSRYVATEFSFFLAIPTMFGASLLKVLKYFLHGNSFTGMQLIVLLTGVVVSYVVAYLA
IKFLLRYIRNNDFKSFGWYRIGLGIIVISYFGLIRG
>CAJ43426|FEATURES|ARDB_deepARG|fusidic_acid|fusB|antibiotic inactivation|1
MIYPHQYNYIRSVILRLKNVYKTVNDKETVKVIQSETYNDINEIFGHIDDDIEESLKVLM
NIRLSNKEIEAILNKFLEYVVPFELPSPQKLQKVFKKVKKIKIPQFEEYDLKVSSFVGWN
ELASNRKYIIYYDEKKQLKGLYGEISNQVVKGFCTICNKESNVSLFMKKSKTNSDGQYVK
KGDYICRDSIHCNKQLTDINQFYNFIDKLD
>R8DTE4|FEATURES|UNIPROT_deepARG|beta_lactam|IIU_05946|antibiotic inactivation|1
MGLLKMNFSNKYKVLGTAVVLGQLVGGPIISHADTFVPNKQIQKQDFNKVTQTSQETAIH
DAFSQLEKKFDARLGVFAIDTGTNQTITYNADKRFAYASTHKALAVGALLQKKSLRDLDQ
VIPYTQDDLVNYNPITKDHVNTGMTLKDLCDASIRYSDNTANNLILKQIGGPKGMEQALR
GIGDTVTNSERFEPELNVVNLEKGEIQDTSTPRAIATSLQAFTLGNALPKEKRTILINFL
KGNTVGDTLIRAGVPKGWEVADKTGAGSYGTRNDIAVIWPPNGKPIVLAIMSDRNTKDAT
YNDKLIAQATKEIMDTLKGNHKKTNSFPI
>NP_709857|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMTTVRAPFDGRIISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>Q1LMH1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKIFASYRLRTVTAALALCTASAHAAGDGVPVGEDRLARLVADTVRPVMAQYEVPGMAVA
VTVRGKSQVFNFGLASKADATPVTEHTLFEIGSVSKTFTATLASYAAQRGAISFSDKASQ
YLPGLAGSSLDAISLLELGTYTAGGLPLQFPDAVTTSDRMLAYFKEWKPTYAAGTHRQYS
NPSIGLFGYLAARSLGEPFDNLMEHRIFPGLGLKHSFIRVPQSRMGDYAYGYKDGKPIRV
NPGMFDSEAYGVKTTAADMIRFVEANMDGARLEPTLQRAVTGTHTGYFRVGPMTQGLGWE
MYTWPTSLEDLLTGNAAGMLEPKEVARLAPPQPPRADVLINKTGSTNGFGAYVVFVPARQ
IGVVMLANRNLPIPERVRAAYQILKALDAQ
>E0TZ31|FEATURES|UNIPROT_deepARG|bacitracin|yubB|antibiotic target alteration|0
MTLWELFVAAILGIVEGLTEYAPVSSTGHMIIVDDIWLKSSNLMSEEAANSFKVVIQLGS
ILAVVIVFKDRILNLLGLKKNITSDQKQGHKLSIAQIAVGLVPAAVLGFLFEDYIDEYLF
SVKTVAIGLIAGAVLMLFADWVNKRKAATDTLDRISYKQAIGVGLFQCLALWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAMPIMMGASFLSLVKHWDSLSSDLMPFFIVGFICAFVV
ALFVVRFFLKLINKIKLVPFAIYRIILGVILLLIMM
>R8KPR0|FEATURES|UNIPROT_deepARG|beta_lactam|ICS_02171|antibiotic inactivation|1
MKNTLLKLGVCVSLLGTTQFVSAISSVKAEQKLEQNVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADR
IGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHTE
DNIVVWLPQYKILAGGCIVKSAEAKDLGNVADAYVNEWSTSIENVLQRYRNINSVVPGHG
EVGDRGLLLHTVDLLK
>A0A0Q6HEU8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRIKIEEFELPQIDSGPYGITRGKDGALWFTQHKANQIGRMTVDGKVTHIDLPTVNAGVL
SITSTDQGDIWFTENRANKIGKLTVTGEITEYTLPNSDSGPFGITQGHNGDIWFTEMNGN
RIGRILSSGEIIEYSLPVPDSYPSFIVAGPDYALWFTQNQSNQIGRITIGGEVTTYKLPT
KQAGPVGITNGPDGALWFVEINGNKIGRITTSGTISEFTIPTPNARPHAIVTGPDRALWF
TEWGSNQIGRITINGEIMEYPIPTKNAEPHGMVVGPDKALWFAEECNKLGRLSFV
>P29806|FEATURES|UNIPROT_deepARG|aminoglycoside|aadB|antibiotic inactivation|1
MDTTQVTLIHQILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAM
VEMLGGRVTEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPV
RCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA
>A0A101E4V3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGSFIKFTGKFATMFKIVIQLGAILAVVYY
FKDKILSSLKALKPGEWGFNLWYKTFIAFLPAAIIGILTHHYIEEHLFSPFTVAIALIVG
AIMMIVIEDIFGKKYKIDNMDKVSTSKAFWIGVAQVMSLFPGMSRSASTIMGGMLVGLSV
RAAAEFSFFLAIPTMLAATGFELVKNITSMSLLEWEALAVGFIMSFITALIVVDKFLAYL
KRHVLKPFAYYRLLVGVLMLFLIAQKIVK
>R6VFJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIIAQNVLGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHAPVPENTPAIKRFLHKFDFYWKLLVAFIPAAVLGFFFSDKIDEMLES
VVIVAVMLVIGGIFMLFCDKIFSQGKEDTVLTERKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKLTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEILFNNMPALIIGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILIMLLLGYNLEIG
>A0A097EJU2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLTVILLGIVEGVTEFLPVSSTGHLILAGTLLGVQDQATATFDIVIQLGAILAVIVLY
WRRFWDVAVGLVGGQPKSWAFVRNIALGFLPAAAIGVVVYKAVKALLESPTVVAVALIVG
GIAILVIERLVKQARIESVEAMPWSTALGVGVVQCLAMIPGVSRSGATIMGALSLGVDRR
AAAEFSFFLAIPTMLAASGYDLLKSGATLGQGEWLSIAIGFVVSFVVALVVIRWFVGIVS
RHGFAPFAWYRIVIGAVALVALQLR
>A0A094WDW9|FEATURES|UNIPROT_deepARG|chloramphenicol|BALCAV_0219240|antibiotic inactivation|1
MKFTIIDRKNWHRKEYFEHYLHQQTTFSITTEMDISVLMKTLKKKNYKLYPAFIFMVTRI
VNSYREFRTNFNSEGELGFWTELFPTYTVFDKETSTFSSIWSPNLRSFADFYVQYEKDIK
CYNGKGVLFPKTPVPENGIPISMIPWTTFTGFNLNINNGGDFLLPIITGGKYYQTETGLF
LPVSLQVHHAVCDGYHASLFMNELQELADHCAEWI
>ACI71754|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGIDPAMRAENISVAQYCQMANYLAENAPFQES
>A0A0B4R7I2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY2-15|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPNTAIPGDERDT
STPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGDY
GTTNDIAVIWPEDHAPLILVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>I7G423|FEATURES|UNIPROT_deepARG|beta_lactam|MSMEI_3884|antibiotic inactivation|1
MAVAVTVDGRQHFYEFGVVSKQTQAPVTRDTLFEIGSVSKTFTATLAGYAATRGVLNLDD
HPGRYLPALAGTPIDRAELRNLGTYTAGGLPLQFPESVTDDEQMIAYFQQFQPVTAPGKI
RQYSNPSVGLLGHISARALGGQFTDLMQSQILTGLGLRRSFVDVTDEAMDFYAWGYDKKN
HPVRVNPGVFDAEAYGVKSTTADMIRFIEHNIDPGALEPTLREAVKSTQVGYYKVGPMVQ
DLGWEQYPYPVALDQLLAGNSGEMAMSPQAATAIAPPSVGSALFNKTGSTDGFGAYAAFV
PERRIGIVMLANKNFPIPARVTAAHTVLDALDA
>YP_405005|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MNRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYEV
AEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARIT
FNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGASG
KSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPVQ
LNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQNV
LLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGLQ
RIRPGIKARAISSSQENASTESKQ
>YP_001176513|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYMLEARQLLALAIPVIIAQVAQTSMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSILIMVVLWNAGYIIRSMDNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFFSMISYVKRARSMRDIRNEQRFSKPDMDVLKRLAQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLGVGVCMAFCTALFTVTLREQIALLYNDNPEVITLASQLMLL
AAIYQLSDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPTGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAILMMLRMRFLQRQPSSVILQRAAR
>YP_002847905|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLIFHDTIKSLFNPIN
VMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLSASDIPMFAVGFVTAFIVALVA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>G1VUG7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLFDMIKAVLLGIIQGITEWLPVSSTGHMILFNSFFPMSSSLAKPDTPEFAFWGLFLVV
IQLGSILAVCVLYFHKLNPFSPRKSISEKRNTWDLWFHVLVASIPGIIGIFLNDYVEKYM
NNAIVVAIALIVFGIGFIVLESTKHHPKYRRVGEITYQTAFLIGLFQLIAALVPGTSRSG
ATILGASILGCSRFAASEFSFFMAIPAMAGASGLKFLKYFMHYGFSMSGGNIALLVVASI
IAFVISMFAIRFLMNYIRNHDFKIFGYYRIVVGVAVLICYFLGVLNLSAI
>ABY44328|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSSGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNMNLVVPGH
GEVGDRGLFLHTLDLLK
>C4U1J4|FEATURES|UNIPROT_deepARG|beta_lactam|ykris0001_260|antibiotic inactivation|1
MEDVLTMKTSIISSLIFATLATSPLYASEQKILTQQQIATIVNNTLAPLIEKQDIPGMAV
AVFYDGKPLFFNYGVADIKNRRPVTENTLFELGSVSKTFTGVVGGYAEQTGILNLSDSVT
KYSPELTGRQWKDISMLNLATYTAGGLPLQIPDSVTSMKLLWQYYQQWQPQWAPGVMRNY
SNASIGLFGALAVTKSNLSFEDYMVKHVFQPLKLTHTFITVPDSMQSDYAWGYKDGQPVR
VTPGVLAAEAYGVKSTAQDMVKFMQANIEPETLLADNDKLKKAIISAQSRYYRSGNMFQG
LGWEMYDWPINPQEVIDSSSNEIALQPHKINALMPPYSAVPASWVHKTGSTNGFGAYIAF
IPEKKIGIVMLANKNYPNPVRIEAANYILQSLY
>K7QCV4|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRA
FYVGPAHTPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTV
VGGHDSPLHGPE
>A4G8J0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTILALKVIIMGIVEGLTEFLPISSTGHLILAGSLLEFTGPKVKVFEIAIQTGAMLAVV
WEYRVKIAAVLGGLFTERRAQKFAVNIVVAFLPAALLGLVFAGAIKEKLFAPVPVAIAFI
VGGFVILWVERRNKQQVHAERVQSVDEMTLLDAFKVGCAQAFALIPGTSRSGASIIGGMM
FGLSRKAATEFSFFLAIPTLMGATVYSVYKDRALLSMADIPLFGLGGLAAFFSAFLCVRW
LLRYISTHDFTFFAYYRIGFGLFVLLSAHYGWVVWAE
>B8ZHY4|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LADLSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPXVLVTYFTQPQQDAKN
>G8LIH0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEMSLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTMRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>A0A0G0QXG7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLITASILGIVEGITEFLPISSTAHMVLISNLMHLAQSEFVKSFEIIIQLGAILAVVVL
YGKKYIRDWACIKKIIIAFIPTGILGFIFYRTIKSMIGNQNIILWALFLGGLGIIFFELI
YRKKEVYEGDISVITNRQAFVIGLCQSISMIPGISRSAITVVSGLAMGIHRKAIVEFSFL
LAVVTMVAATVYDFSKNFNSFSVDQFDYLAIGFIVSFITAILAIKFMVRYIKNHSFMAFG
VYRIVIAALFYLLIIR
>A0A0G3EU14|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFLQILILAIVQGVCELLPVSSSAHVILAEKMMGLNPSAPQMTLFLVMLHTGTMFAVIV
YFWKSWRERYFSSWPAFWRIVKQVVVATAFTGVIGLALMLLIERVILRGAQHSDVEQLFG
NVYIIASGLAAAGIMIILSGKRQSYAPPQPLDSRASAWIGAIQGLCLPFRGFSRSGSTIS
MGLFLGIDKARLEEFSFALAVVLTPPVILREVYRLVKHSGSSLALNGTFYTLAWPSLVGM
VFSFLAGLVALKWLSQWLEHGRWHLFGYYCLFASVAVLAINQVLH
>G8LS12|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MNYIQSILLGIIEGITEFFPISSTGHMILLASLMGILEKKITKLFLISVQLGAVFSLVFL
YRKKFFFQKFDFYLKIFIASLPILIVGFLLKNKINFFFSKNPLMVAIFLFIGGIIILIVE
NLYEKKNYKNKDYRITYFKAFIIGLGQCFSIIPGVSRSATTIVSGMLQNIERRKAIEFSF
FLSFPVIFIATCKKLFDHYFQFQYFIFSLNVRRFFIFPIIDKKFFLQENIKLLLVGNIVS
FITGILSIKCFMSYLKKNNFKIFGYYRIIFGIIFIIIHYFIKPIENF
>J8NNE4|FEATURES|UNIPROT_deepARG|beta_lactam|IKM_04476|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTVNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYNDKLI
ADATKVVLNTLKATE
>D7PIK5|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-1|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVGLKKSDLVNYNPITEKHLK
EGMTIGELAAAALQYSDNTAMNKLIEHLGGPHKVTDYARTLGDNTFRLDRTEPTLNTAIP
GDERDTTSPRAMALSLQHATLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWIVGDK
TGSGDYGTTNDIAVIWPENKAPLVLVTYFTQPEKDAKS
>A0A0A0C1I1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFDVAALLGLVQGVFMFVPVSSSSHLALTQHWLEGRGVPVPPPDSPEAIFVNLVLHVGT
LVSIGIVMRARLANLATGIVSELRTPAGQDRPAVRFALMIILGTAVTGVLGLGIREIAPF
ALGSPTVIAIMLVLTGVILWWTDKARPGTIENPGAKAAIGVGIAQALALLPGLSRSGLTI
AAGLALGMKRAQAAEFTFILAIPTILAATLVQALDILAVREPYQIPWGALGVGFLVSAAS
GTVALLLVLRLLYAARFRVFSLYVWALAAVVLALQVA
>D7BWG8|FEATURES|UNIPROT_deepARG|aminoglycoside|SBI_00203|antibiotic inactivation|1
MAASWDAELVRVAAMSDHSGPQVVSPVLFGVGGGDWLSVTAGESGASVFRSADTTRYAKC
VPAADATDLEAERDRIAWLSGQGVPGPRVLDWYSGDSGACLVTSAVSGIPADQVSAEDLR
MSWERIADAVRRLHELPVSECPFRRGLDAMVAVAGDVVARDAVNPEFLPVEQQHTPAVEL
LTRVIRQVPRRREQEVADTVVCHGDLCLPNIILDPQTLDVSGFIDLGRLGLADRYADLAL
VLANARETWTDEERARAADVAFAERYGIALDHDRLRFYLHLDPLTWG
>C3HUT0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLFNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKEANAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWEYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>U2PS90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNLIFLLKSAIIGIVEGITEFLPISSTGHIIIFQNLLGFQGDNETYVNMYAYVIQLGAI
LAVIVLYWRKIKETLLNFFPGKVGYEKSGFKFWFMIVIACIPGAVVQLTLDDLADKYLFN
TVSVAITLVLGAVWMLYAENRFRNVSGAKEINISPKQAIIIGLFQCLAIIPGMSRSASTI
IGGWIAGLSTVAAAEFSFFLAIPVMMGMSLLKFIKIGGVSTLTSIEIISLGVGFLVSFIV
ALIVIKKFIEYLKKKPMKVFVIYRMVFGIIILIAGFSGLFSIN
>A0A073H608|FEATURES|UNIPROT_deepARG|aminoglycoside|AC88_5564|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>A0A070DHW8|FEATURES|UNIPROT_deepARG|beta_lactam|BU55_14045|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>I0KDE7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLRVLRVPFAPLRLNLLVALRLTFAASMSLFHAIMLAIIEGLTEFLPVSSTGHMIIYSS
LAGISGDEFTKLYTVDIQFGCILSVLVLYYRRFLRDTRTREDMAWYNALPDGIRRLLGPI
SGQLDFYLKLFVAFLPAAVIGFLLNDFIDSLLENVVVVAISLVLGGIVLIFIDRLIEKNV
TRDYDITFPEALKVGFFQCIAMIPGVSRSAATIIGGMTQGLTRQQAAEFSFFLAVPTMAA
ASGYKLLKTYKLLQPADFQTLAIGNAIAFVVGLLAIRGFVGFLNKYGFKVFGYYRIIVGL
AILGLVAAGVKIDIL
>A0A0S3NN43|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHADNPGEKAFYASVARLAAETGIPVYAPD
NVNHPLWVERIAQMSPDVIFSFYYRHLISDDILQLAPVGAFNLHGSLLPKYRGRAPLNWV
LVNGENETGVTLHRMVKKADAGAIIAQQRVVISPDDIAITLHHKLCHTARLLLEQTLPAI
KHGHFQEIAQRENEATCFGRRTPDDSFLDWHKSADVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSRVHPDTSTAQPGSVISVAPLRVACGHGALEIITGQAGDGITMQGSQLAQTLGLVE
GSRLNNQPLCAAQRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALFRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RMVESSSYYGKGYQDVEHRKPSIRNARRCLGWEPKIDMQETIDETLDFFLRTVDLTDKSS
>A0A060KT53|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRVDERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0D0RFE3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFVTGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>CAR59752|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPR
SALVVKLIRPEQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFILCALF
NAWLLPAWKLSTVRTPVREGMRRVMSDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
SPAAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMLPIGMVGNLQQL
FTLICAFYIGSVIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDMG
KALAQPELPWMMLGIIGFITFLALGWQFSHKRTPRRMLEPGA
>YP_001880923|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A143GGN7|FEATURES|UNIPROT_deepARG|beta_lactam|AK972_2544|antibiotic inactivation|1
MYTSIFPTVRKTTIFALLLGAGNCMAATDIRQVVDSNVEPLMQQQDIAGLSVAVIQNGKA
QYFNYGVANKESKQPVTENTLFEIGSVSKTFTATLAGYALANGKLKLSDPASQYLPALRG
DKFDHISLLNLGTYTAGGLPLQFPEESDNTGKMISYYQHWKPDFAPGTQRLYSNPSIGLF
GHLAAQSLGQPFDRLMEQTLLPKLGLKHTFITVPKAQMNLYAQGYDKAGKPVRVGPGALD
AEAYGIKTSTSDLIQYVEVNMHPAKLEKPLQQAIAATHTGYYTVDAMTQGLGWEMYPYPI
TLDALTEGNSAQMAFQPHKVSWLTPPQAPYADTLVNKTGATGGFGAYVAYVPSKGLGVVI
LANKNYPNAERVKVAHAILSAMDK
>T8K5Z5|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAQEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPVREGMARVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKRFRLEHRLMAGLLVMSLSMMPVGMVSSLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAQQPELPWMMLGIIGIITFLALGWQFSQKRAARRLLERDA
>A0A0R3BS05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMTDMLRAVILGIIEGVTEFLPVSSTGHLLLAERFFNLGEGNFWKSFAILIQLGAILAIL
ALYFVKLWRVALGMFTNPDDRRFVIGVLVAFLPAVVIGLIAGKYIKEFLFNPWVVCFTLI
VGGAVLLWVDQLDLKVYEDDATRFPLLMYFWIGVAQCLAMIPGVSRSGASIVAAMLLGAD
KRSAAEFSFFLAIPTMVGAFAYDFYKNRADFTSDNLSVIAVGFVVSFITAMIVVRAFLNF
VTRRGFTFFAWWRVIVGTLGLIALAMGR
>AAV74569|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQIIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISVCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTMPGFTSYSRYPRMVAAAGITLPALIDSLITLALKR
>NP_457578|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDVTY
QTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEAEN
RNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNSAQYDDSNMGQ
NKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSI
NAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLNIK
YALGTLNEQDLLALNSTLGKPIPTSPESVAPETPEQDAAADGYNAHSAAPAVQPTAARAN
SNNGNPFRH
>E6L364|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MEYKKFDINSWNRKEHFEHYRNLQCSFSLTSEIEITTFLQYLKENKYKFYSSIIYLISKL
VNLTFEFKISIKNNEIVTWNVLHPSYTIFHKKEETFSSIWSEYSDDKTIFFNEFEKDCIN
YENNKSLFPKFNIPENHFNISCLPWIKYSGFNLNLPHLNDYFQPIITIGKYNKNENKIVL
PVTIQIHHAVCDGFHVAKFINKLQEWCNEPEKHL
>A0A011QPT4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPLLLLKALILGIVEGLTEFLPVSSTGHLILAGALLDFNDERGKLFEIVIQSGAMLAVC
WEFRAKIMEVLRGLPSDRAAQRFALNVLVAFLPLAIIGLLFGKTIKAYLFNAPVVATAFI
VGGLIILWAERREHRIRVESIDDLSLADAAKLGFAQALALIPGTSRSGATIIGGLLFGLS
RRAATEFSFFLAMPTLIGASIYQLYKERALLSADDLGMWVVGFVAAFISAFWAVRGLLRY
ISTHDFSIFAWYRIAFGILILVTWQYDLIAWGEH
>H0H7U7|FEATURES|UNIPROT_deepARG|aminoglycoside|AT5A_08635|antibiotic inactivation|1
MSLQFSIRDAAASLDDWSLLRHRLWPDASVADHRAELQNLSDNDAGFIAYDLVGMAIGFA
DVSLRRDYVNGCNTSPVAFLEGVYVEEEFRGQGVGAALIAEVTRWAISKGVSELASDANI
ANVDSHRMHAALGFEETERVVYFRKLLPSHS
>Q8VN22|FEATURES|UNIPROT_deepARG|beta_lactam|kluA-11|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGS
VDYGPTTHIAIIWPENHAPLVLVTYFTQPDQKAESRRDVLAAAAKIVTHGF
>A0A0F4SP31|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAIAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQPSARRFTANLLIAFMPAVVLGVIFSDLIHHYLFNPITVATALV
VGGIIMLWAEKRRHEVHAETVDEITWQDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGFKYRHLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLIILATWQFGWVDWSAAKP
>A0A060KTC7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWDVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>R4RRV8|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-1|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRCVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A0Q7J1V8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHTIFEAIIIGIVEGLTEFLPVSSTGHMILAQSLLNTQNDEVMKTFDFVIQLGAIMAVVL
IYWKRILSLFGLVKRKSESKSGKKLNLLHILIGIIPAGIIGVLFNDFVDEKLFNSTTVLI
GLVLGGILLIIAEKKKEQPSAVVLDDLTYRQAFFIGLWQLVSIWPGFSRSGSTIAGGMLS
GVSRAASADFTFIMAIPIMFGASGVYFLKNYEALSSNDLGFFIVGFVVAFIVALLAVVTF
IKLVQNMKLTYFAYYRFAVAIIFALYMYLK
>A0A0G1H9K9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQSIIFGVVEGVTEFLPISSTGHMILTAKLLGLTQTNFMKSFEIAIQLGAILSVVVL
YWKSLFVNRAIMKRIAIAFIPTGILGLIFHGLVKEYLLGSNMTVVLALLIGGILLIAFEW
THNEKEDALEDVAHLSYWRAALIGVAQSVAMIPGVSRSAATIVGGMLAGLKRKTIVEFSF
LLAVPTMLAATILDLSKSYKDFSADQFDVLAVGFIASFFVALASIKFLLRFVKTNTFVSF
GVYRIAVAVLFLLFVL
>A0A0N8NVN0|FEATURES|UNIPROT_deepARG|beta_lactam|blm|antibiotic inactivation|1
MKKDTLLKLGVCVSLLGTTQFVSTFSSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITKLKFENMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKNLGNVADAYVNEWSTSIENVLKRYGNINAVVPGH
GEVGDRGLLLHTLDLLK
>A0A066ZZN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTGLQAVILGIVEGLTEFLPISSTGHQIVVADLINFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVVGLPRQREAQRFTVNLLIAFMPAVVLGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERRQHVIRVDQVDDMRWTDALKIGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPDDFPVFAIGFVVSFIFAMIAVRGLLKF
IANHSYAAFAWYRIGFGLIILGTWLFGWVDWTTAHG
>ZP_04623896|FEATURES|ARDB_deepARG|fosmidomycin|RosA|antibiotic efflux|0
MGAISVSHLLNDMIQSLILAIYPLLQAEFSLSFAQIGLITLTYQLTASLLQPLIGLYTDK
HPKPYSLPIGMGFTLSGILLLAVATTFPVVLLAAALVGTGSSVFHPESSRVARMASGGRH
GMAQSIFQVGGNFGSALGPLLAAILIAPYGKGNVGWFSLAALLAIVVLLQVSKWYQQQQR
STHGKVLKASSVKVLPKKTVIKALVILMVLIFSKYFYLTSISSYYTFYLMHRFGVSIQNA
QIHLFVFLFAVAAGTIIGGPLGDRIGRKYVIWGSILGVAPFTLLLPHASLYWTGVLTVII
GIILASAFSAILVYAQELIPGKVGMVSGLFFGFAFGMGGLGAAVLGYVADLTSIELVYQI
CAFLPLLGIITVFLPNIEDK
>A0A0Q8MV45|FEATURES|UNIPROT_deepARG|beta_lactam|ASE04_11055|antibiotic inactivation|1
MRNIPQSTFAILAAASVFIGSGAQATDRQNELARVVDAVAVPLMAKNNIPGMAIAVTVGG
KRYIYNYGVASKAGRRSVTDATLFEIGSVSKTFTATLAGYAHASGDLSFADSPAKYLPEL
AGSRLTETTMLDLGTYTAGGLPLQFPDDVTDHKAMVGYYRNWKPAYAPGTRRVYSNPSIG
LFGYAAAKAMGWPFDDLMQQKLFPALGLSHTFISVPKIEDGNYAYGYSKTGKAIRVSPGV
LDSEAYGVKMSANDMLRFVEANMDGADLDKTMQAAIAATHTGYYKVGGMTQGLGWEMYDY
PTTLDQLLAGNSADMTLKANELEKLSPPRPPRKDVLLNKTGSTNGFGAYVAFVPSKSIGI
VLLANKNYPNSERVKAAYKILATLDGDFPAVSSD
>K8CTB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPPHEGVGKGRLSLIHILLGMVPAVVLGLVFHDFIKSLFNPIN
VMYALVVGGVLLIAAEVLKPKEPKAPGLDDMTYRQAFFIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSMGFLTMADLPMFAVGFVTAFVVALVA
IKTFLHIIKRISFIPFAIYRFIVAAAVYAVFM
>A0A0R1RZB2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIYEGKSVVFTLNVIKTIILGIVEGFTEWLPISSTGHLVLVGSVLKMDETKAFMDMFNYV
IQFGAILAVVVLFFHKLNPFSPRKTGLEQKQTWTLWSKVVIAVIPSVVIGFPLNDWMDAH
LMNNWVVASMLILYGILFIVIENRNKSVTPKFTDLNTLPYLTAFWIGCFQALSIIPGTSR
SGATILGAIIIGTSRFVGAEFSFFMAIPTMVGVSVLKVGKFFYEGNTFTGDQTIILLIGM
VVSFIISIVSIKFLMDYIKKHDFKVFGWYRIILGLSVLGAMLFA
>C3F1K4|FEATURES|UNIPROT_deepARG|chloramphenicol|bthur0007_21640|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEENKIM
LPVSLQVHHSVCDGYHVSRFIEDLQELSNSCNEWLK
>U2J8P5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKQIDFQKTGDIMLVIELIKAVFLGIVEGITEWLPISSTGHLILVQEFVKLNQGHAFNEL
FNIVIQLGAILAVMVIYFERLNPFQKGKTAREVRLTWQLWMKVIIACIPSAIIGLLLDDW
MDAHFSNFTSVATMLIVYGIAFIWIERRNRDVEPQVTDLARMHYKTALYIGLFQVLSIIP
GTSRSGATILGAILVGTSRSVAADFTFFLGIPTMFGYSGLKFVKFLLDGNHLNFAQWLVL
LVASLVAFAVSMVVIKFLTNFVKKHDFTVFGWYRIVLGIILLIYAAAKVLMA
>NP_052154|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIDRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWMTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLVQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFTLMLDEFF
>A0A0X4EP37|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYEILLVDDGSSDNSALMLTE
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIAVAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEEIHP
>A0A100YVH3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLELLKAAIYGVVEGITEWLPISSTGHMLLLEQFMPLSVSKDFWDMFLVVIQLGAIIA
VLVAFFHELNPFSRSKSADERRSTWTLWGKTIVACIPAAVVGLPLDNWIEDHLGTPFVIA
AALIVYGIVFIVIETVRERRAQRLMAAPAPTAAQASGPYRPRHLAAATPQPQQELTISQV
ADADARIQDIDDLDWKTALGIGLFQVLSIVPGTSRSGSTIIGGLILGCSRTVVAQFTFYL
AIPVMVGASGLRLVKYFLKGNTFSGTEAAILLTGCAVAFLVSLAAIRFLMGFVKKHDFKP
FGWYRIVLGVAVIAYFALVAA
>B2CD74|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
PEGRFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRE
LCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTT
MPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVQDHYLYY
>A0A0K6JPE9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MKLEQQEINILHSDSGPYGIAISPEGKVWFTQHKANKISCLDKTGQIQEYIVPTPDAGVM
CLTVSSEGDIWFTENRANKIGKLTAKRQFIEYPLPHQHSAPYGITEGPDGDIWFTEMNGN
RIGKLTSEGKIHEYELPNEGSYPSFITLGSDHSLWFTENQNNAIGKITESGELTEFPIPT
PAAGPVGITKGHDDALWFVEIVGNKIGKITVSGDITEYDIPTPNARPHAIAAGVRSDLWF
TEWGGNKIGRLTSDQTIEEYTINTPHAEPHGIGCDNDGTVWFALECNKIGKLKLTK
>A0A085HG35|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGLHDLVVAFILGVVEGLTEFLPVSSTGHMIIVGEYLGFSGDTASTFEVVIQLGSILAV
VVVFWRRMFGLIGIYFGKKEVPHEGRGTGRLTLIHIILGMLPAVVAGFALHDSIKEHLFG
AKTVMYALIAGGLLLIAAELLKPKKPRAEGLDDVSYRQAFIIGCFQCLALWPGFSRSGAT
ISGGMLIGVSRYAASEFSFILAVPMMLGATILVMYKSIGHLAWSDLPMFAVGFVTAFLVA
LAAIKTFLSLIKRFSFIPFAIYRFFVAGVIYFVFF
>K6DNQ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDHIIAFILGIVEGLTEFLPISSTGHMILVGNLLGFEGEKASTFEVIIQLGSMLAILVL
FWKRFLSLLNFSSIGKPEKRLDAIHIILGVLPAAVVGLVLHDFIKSLFSPNVVVISLIAG
AILMIFAEKKHRAFTSTTVDELSYKQAFTIGLFQCLAVIPGFSRAGSTISGGLLVGANHK
TSAEFSFLVALPIMVGATGLDLVKSLHFLHTSDIPMFAIGFITAFVVAMVVAVLFLKILG
KIGLTVFAYYRIVLAALFIVFVIL
>K7QSJ9|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY2-13|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGHLGGPEKVTAFAHSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>A0A0Q2M178|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFELFTALMLGILEGITEFLPVSSTGHLLIAEHWLGSRSDFFNIVIQAGAILAITFVFRK
RVWSLATGLDKYSNRDYVMKLATAFLITAVVGLAVRKANWQLPETIQPIAWALIIGGIWI
LIAESVAKHLPERENVTWSVAIAVGLAQVVAGVFPGTSRSASTIFLAMLLGLSKRSAAAE
FSFLVGIPTMFSASSYACFELFKRGELLHENWLEVSVAFVAAMLTGFAVVKWLLGYIKNH
SFAPFAYYRIALGLVLLTWLT
>YP_312992|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPMVRLLAFFHEELSERRPGRVPQIVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGRMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRIS
ESEAVAARECNLENICQTLLQLGQMNPNTPPTPAAKPPSMVADAFTNPDYIRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVSNPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>ACA23195|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASPTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>C5EN89|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLVEVLKIIVLGIVEGFTEWLPISSTGHMILVDEIIKLNQPDAFKDVFLVVIQLGAILA
VVVMYFHKLNPFSPSKSSRQKDATWSLWIKIVIACIPAAVLGLLLDDWMEAHLFNAYVVS
AALIIYGVLFIVLENSSVCANPSINKVGQISAKTAFFIGMVQLLALIPGTSRSGSTILGA
MVLGCSRGAAAEFSFFLGIPVMFGASLLKLVKYFMAGNVFSGPQVFYTILGMLIAFVVSI
YSIQFLMSYVRKHDFKFFGYYRIILGVIVLAYFGITALAS
>N9PTL3|FEATURES|UNIPROT_deepARG|beta_lactam|F895_00180|antibiotic inactivation|1
MMMSKKLKCLALLTPCILILQLTACQSVSQQKQQLSTQTNEQQQISSLFQSAQTKGVLVI
YDGKKIQSYGNDLNRAEQRYIPASTFKILNALIGIQYHKTTPNEVFKWDGKKRTFSSWEK
DLSLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLQITPV
EEVRFVYALAKQKLPFDQSTQQQVKGMLLADERQGTKIYAKSGWGMDVSPQVGWWTGWIE
QPNGKTIAFSLNMQMSQPEHANARKVIVYQALQELGLLAN
>A0KGY7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNNTDIKLVSVVIPVYNEEASLPALLSRVTAACDQLSQNYEVILIDDGSHDGSTELIRDA
AAVEGSKLVGVLLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVEAAMQGY
DVVGTMRRNRQDSWFRKTASKLINKSVQKATGVHMSDYGCMLRAYRRHIIDAMLCCQERS
TFIPILANSFARRTIELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTTPLRLLSIVGS
VVAGIGFTFSILLILMRLILGADWAADGVFTLFAILFTFVGVQLLGMGLLGEYIGRMYTD
VRARPRYFIHQIVRSATTPSQQEAEQ
>Q5HVG3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DEYEVTKLNNDEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKK
LLNDLELAHKLDSKPNELSGGQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEIL
QKLNEQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDTKKEKAQEKLILKTMPKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAHSNTSGVATYTNISLSARA
EGVGVNNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSENILGRVVLFN
SQSFKIIGVLQKDTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPM
ILNAYSVLLGLLSSMFIGVVFGFFPARNAANLNPISALSKE
>A0A0A0R1G2|FEATURES|UNIPROT_deepARG|beta_lactam|BL2a_pc|antibiotic inactivation|1
MHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKE
LGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNN
KSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKP
NDKLISETAKSVMKEF
>AAG07985|FEATURES|ARDB_deepARG|multidrug|oprJ|antibiotic efflux|0
MRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSFIVD
AELRRLVDMALDNNRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADLSAG
NRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQAYL
SYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERNLRQ
KQQAFNALVLLLGSDDAAQAIPRSPGQRPKLLQDIAPGTPSELIERRPDILAAEHRLRAR
NADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSWSFLPTLTLPIFDGGRNRANLS
LAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKARYE
SGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGGRS
>AAB19684|FEATURES|ARDB_deepARG|beta_lactam|OXY-2-8|antibiotic inactivation|1
STDAIHQKLTDLEKRSGGRLGVALINTADNSQILYRGDERFAMCSTSKVMAAAAVLKQSE
SNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQYSDNTAMNLIIGYLGGP
EKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGNALGEQQRA
QLVTWLKGNTTGGQSIRVGLPESWVVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQ
PQQDAKNRKEVLAAAAKIVTEGL
>A0A094JP71|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIFVGIILGMVEGLTEFAPVSSTGHMILVDDILFKTKEIFSEPVANTFKVCIQLGSIL
AVVIVFKDRILDLLGLKRKGSEEGEKKDRLTLGQIFVGLLPAAVLGFLFEDLIDEHLFGM
STVLVGLVAGAILMIVADWFRPTRPRVETLDQISYKDAFLVGLFQCIALWPGFSRSGSTI
SGGVLIGLSHRTASDFTFIMAVPIMAGASSLSLIKNWEYFTADALPFFIAGFISAFLFAL
LSIRYFLKLINKVKLVPFAVYRIVLAVIIYFLVF
>A0A061P352|FEATURES|UNIPROT_deepARG|chloramphenicol|JCM19038_2988|antibiotic inactivation|1
MTFNPITLENWERKEYFNHYLNQQTTFSMTTDIEISSFKAAIKRKGYKFYPTFIYMVTEV
INANESFRISFNEEGKLGYWEKLIPLYTVFDDQKQSFSNLWTDSTGNVLTFQEDYDRDVA
EYNHIGGLFPKTPIPANTFPISMIPWNSFSGFNLNVGNGGNFLLPIITAGKYYSKGTATY
LPVSLQVHHAVCDGYHAASFMNQLQELANTTNEWL
>J2VCT2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVVWEFRRK
IFDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALVVGGIIM
LWAEKRQHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKTATE
FSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFVTAFIFAMIAVRGLLKFIASHSY
AAFAWYRIVFGLLILATWQFGWVDWAAARP
>A0A0D7DF44|FEATURES|UNIPROT_deepARG|aminoglycoside|PZ61_34665|antibiotic inactivation|1
MSDHRGPAAVSPALLGVGGDWLPVTAGESGASVFRAADATRYAKCVPAADAAGLEAERDR
IAWLSGQGVPGPRVLDWYAGDAGACLVTAAVSGVPADRLRAEDLRASWAHIADAVRRLHE
VPVASCPFRRGLDSVVEVARDVVARGAVNPEFLPEEQRLVPPAELLARLTGEIPRRRDQE
AAGAVVCHGDLCLPNIILDPEALEVSGFIDLGRLGTADRHADLALLLANARETWVDEERA
RVADVAFAERYGMPLDQERLRFYLYLDPLTWG
>ZP_02632674|FEATURES|ARDB_deepARG|tetracycline|tetB(P)|antibiotic target protection|1
MIELEVLIMKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERK
RGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRI
LFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKL
FDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIG
LGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVP
NKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKP
ALKTTISAIDKEKNPELFKALTLLAEEDPLLELEMNDIDKEIYVNLFGEVQMEILSSMLD
DLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNV
SVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVF
MEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVE
NSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD
>A0A0L6KBW6|FEATURES|UNIPROT_deepARG|aminoglycoside|AKG12_05750|antibiotic inactivation|1
MSRQFVIETAGETSLDDWSLLRHRLWSDASPAEHRAELQDFSDNEVGFIAHDPAGAAIGF
AEASLRQDYVNGCDTSPVAFLEGVYVEEAFRKLGVAAALIAEVTRWAISRGVSELASDAD
ISNVDSHRMHAALGFEETQRVVYFRKSLPLGS
>A0A0W2HDZ8|FEATURES|UNIPROT_deepARG|beta_lactam|ASV07_20330|antibiotic inactivation|1
MMTKSLSCALLLSVTSAAFAAPMSETQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A094VTN4|FEATURES|UNIPROT_deepARG|beta_lactam|blaB|antibiotic inactivation|1
MFKTTYRQTAVIVVSLISLLVSPMLWAKTNSTIEEQLSTLEKNSQGRLGVALINTKDNSQ
ITYRGDERFAMASTSKVMAVAAVLKESEKQAGLLDKHMTIKKTDLVTYSPITEKHLATGM
TLAQLSAATLQYSDNTAMNKILDYLGGPSKVTQFARSINDVTYRLDRKEPELNTAIHGDP
RDTTSPLAMATSLQLLTLGDALGQYQRQQLITWLKGNTTGDQSIKAGLPNNWVVGDKTGS
GDYGTTNDIAIIWPENQAPLILVVYFTQQKQNAKPRKDIIVKATEIVTKEYINTSKIK
>N1LLK2|FEATURES|UNIPROT_deepARG|beta_lactam|EBGED10_21460|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQETYKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDNGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPVEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>R9PFH3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MRHKQDINFVSIVIPVYNEADSLQELITRTCAAADTMGKDYELLLVDDGSKDNSADQIEA
AAAQEGSHVVGIILNRNYGQHNAIMAGFEHVRGDLIVTLDADLQNPPEEIPNLVAKAEEG
YDSVGTVRKNRQDSRLRRYPSMLINKIVKRSTGVEMNDYGCMLRAYRRHVVDAMLQCHER
STFIPILANGFARHTVEIDVEHSERQQGESKYNIMGLINLMFDLLTSMTTAPLRMLSIMG
GAIAALGGLFGLVLLFMRLIYGAEWGVDGVFPLFALLFIFIGAQFVGLGLLGEYIGRIYS
DVRARPRYYVQDVLVGEATKQARDNDVNADNNDN
>E0XCV1|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
STSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSD
NTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLN
KLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKS
>J5PQI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLDLIKAAFLGFVEGLTEYLPVSSTGHLLLIEHFFGFQDEDFGKSFAVLIQLGAILALL
SIYFRKLWLLATHMVTDAYSRRFVIGVLIAFLPAAVVGALAHGFIKDVLFNPWIVCFSLI
AGGAVLLYVDQLPLKPKYDEATGFPLPMYFKIGVVQCAAMIPGVSRAGATIVGAMLLGAD
RRAAAEFSFWLAMPTMVGAFAYDLLKSHAQMTGEHLVVVAVGFVASFIFGWVVVKTFLGY
VSRHGFGLFVWWRVIVGTLGLIGLAIFG
>A0A0M3DJ16|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIFKAIILGIVQGITEWLPVSSTGHLILVEQFVKFDLSQVFVSTFMVVIQLGSILAVL
TLYFKKLNPLDSSKTEKEKKDTINLWIKVIIAVIPSGILGVLFDDAIDSLFFNPTTVSIT
LIVYGVIMILIENRNKKPKVNDFSQLTYKLALGIGLFQCLALIPGTSRSGSTIIGAALLG
ASRYVAAEFSFFLAIPTMFGASALKLYKTGAAFSGFEWLVLGAGFVTAFIVSVFAIKFLM
DYIKKHDFKAFGYYRIVLGVIVFAYFTFLI
>YP_788911|FEATURES|ARDB_deepARG|multidrug|opmD|antibiotic efflux|0
MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLDEFSGERREAPWWSF
FDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLD
YDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTAR
AYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPL
TTALESARYRLDVLRGEAPGSGAPILDGGGAAPLAKNLPLGDVDRLILQRPDVVSAERQL
AASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRAR
LRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANER
YRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAG
ETAGASR
>A0A0B5EWR1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTPREGEEAEEYVEIEGEGAEEAVGVEEFAQGEGFTGVEELTVCDPGGGPYAIAAGPDGA
LWFTLVHSGRIGRLVPGEEPRSHRLDPDSGPTVLCAGPDGALWFTQYKAHRIGRITVAGE
VTGFAPPTAECGPFGIAAGPDGALWFTETAADRIGRLGTDGTFTEYPLPVTGAFPSAIAA
AGDAMWFTLNQADALGRIGMDGAVTVHELPTEGAAPVGIAVGPDGGVWWTEIGAGQIGRL
APGGRITAYPLPDRSARPHAITTDAAGAAWFTEWGGNRLGRITPEGAVTHYALPTPAAEP
HGIAIGPDGAVWAALEIGALARLGRAGTGA
>Q7NYE7|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MLFHSLIMGLVEGITEFLPISSTGHLILTGDLLGFLDKEKRDVYEIFIQLGAMLAVVWEY
RRKIGHTVAGAVRPGGERNLLLGIVIAFIPAAVAGLLFSKQIKAVLFNPVCVAIAFIVGG
LIILWAEKREHKVAVETVDDLSLKDALKVGLCQCLALIPGTSRSGATIIGGLFLGLSRKA
ATEFSFFLGIPTLGAASLYSLIKHRDALSADDIGVFAVGFIASFVFAFLAIRALLRFIST
HSFAVFAWYRIAFGLIVLGTWWSGLVNWSA
>V0W3N6|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MLIFYFPGGEMSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGI
ALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSG
LGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATG
AVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLM
LPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMP
VGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGY
IGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRTARRLLERDA
>A0A0R3MAS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSDAVKAVILGIIEGITEFLPVSSTGHMLLAQRFFGLGEGAFWQSFVILIQLGAILAIV
MLYFGKLWRVALGMFTNPDDRRFVIGVLVAFLPAVVIGLIGGKYIKELLFNPWVVCFTLI
VGGAILLWVDQLELKPTEDDATRYPLMMYLWIGVAQCVAMIPGVSRSGASIVAAMLLGGD
KRSAAEFSFFLAIPTMIGAFAYDFYKNRAEMTIDHVGVLAIGFVVSFITAAIVVKSFLTY
VTRHGFTFFAWWRVVAGTAGLIALALGR
>A0A150DSV3|FEATURES|UNIPROT_deepARG|beta_lactam|AT258_08370|antibiotic inactivation|1
MIVSKKFFHIAHYKKVLPVVLLSCVTLIGCFNSNIQSEPPKQAKQENTSRHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQKIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDSVTNPE
RFEPELNEVQPGDTRDTSTPMALATSLQTYTLSDILPIEKRNFLIDLMKRNTTGDNLIRA
GVPEEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAVLSNHAKEDAKYEDKLIADATKI
VLDSLKVKNKSK
>A0A0N6ZVK5|FEATURES|UNIPROT_deepARG|aminoglycoside|NI25_18235|antibiotic inactivation|1
MSDRRGTQAMSPVLPGLDDGDWVPVTAGESGAAVFRSADATRYAKCVPAANAADLKAECD
RTAWLSGQGVPGPRVLDWQSGDAGACLVTSAVSGTPADQVPAEELRVAWERIADAVRRLH
EAPVVRCPFRRDLDAMVALARDVVTRDAVNPEFLPVEQQQTPTAELLDRLTRQVPSRREQ
EAADTVVCHGDLCLPNIILDPQTLDVSGFIDLGRLGLADRHADLALLLANARETWTDEEQ
ARAADMAFAERYGIALDHDRLRFYLHLDPLTWG
>ZP_04288431|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFIVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>J8AIS8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFSVEQEDFERLLQRLEENKVHILQGRERDMRDCESIYFQDPDGHKFEFHSGT
LQDRLNYYREEKPHMTFY
>A0A0P9P093|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGEPLLACASKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDESLATCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCLVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGYTGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKCLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>A0A0U3I0N3|FEATURES|UNIPROT_deepARG|beta_lactam|AS188_14525|antibiotic target replacement|1
MRTSSRSRAAAAGLGLTVLLLAAGCGALPDGARDAAEGVAAGLDAGDLTGTALPAQAQEE
LERITAHLGGADPAVALAGVEEAGEDGREAVLSWTWDLPGEQDWSYDARLPLEQDADGQW
RARWSPAVVEPSLGPDEGLRLRTLPADRGDVTGAGGEVLVTERPVHRIGIDRGRLGEADP
ARAARQLVAALEDVVELDPAAYAASVEQAGPEAFVEAVTLREDDFRALPAGRTSAVPGVR
AVDDEQPLAPSRGFAPALLGAVGPATAEDLERSGGELAAGDVVGRGGVQEAFDDRLRGRA
GAVVERIGLRADGGPAPGAAAPLHEVAPVDGQPVALTLDRGLQEAALEQLEGVASPAAVV
ALRPSTGEVLAAADGPGSEGYPTALQGRYAPGSTFKVATALAMLREGDDPSTEHPCPPSL
AVEGAEFRNAPSYDPAATGSIPLTEAMAQSCNTFFAGQHERVTQEELAEAAAALGTGMEA
RLGVEAFLGSIPDEEPPVQHAAALFGQGRTLVSPLSMAVLAASAADGGLVTPRLVATDGL
VDDAPARPATDAPLTAEEAAQLRTTMRAVVTEGHLDGLRALSPDTAIGKTGTAEYGTEDP
PRTHSWVIAAHEDLAVAVFVEDGDLGSVTGGPIALEVLRAARP
>A0A0B4UAY9|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERSRQIAEIGASLIKHW
>A0A089IF40|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFAEQDSIMKTYEIVIQLGAILAIAL
VYRKRVLNLLGIGRSSSGRGGVMPASRLNLIHVILGIAPALAVAFFARDFIKSLFGASTV
LWALVAGGILMIVAEWVNRRKIRITAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKNFTSETIGYFVIGFLISFVVAY
LVVILFMKWIQKIRLTHFAIYRFILAAVFWLFIMR
>A0A0Q7XE17|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQVRDDFLRGLKVRAAVEGVIPSLMAEQQLPGMAVAVTLDGKPYYFNYGIASRETNAPVS
ENTLFEIGSVSKTLTATLGTWALVQGKLSLDAHPSRYLPQLKGSAIDKATMLHLATYTAG
GLKLQFPDEVREGQEIGFFRAWRPDAAPGTMRRYSNPSIGLFGHAAAAALGIDFATAMAS
KIFPRLGMKNTYGNVPAHAMPDYAWGYDDGRQVRVNPGPFDAEAYGVKTSSTDLLRFVQA
NIDPSHLEPFMRRAVAATHVPYFEAGPLWQGLGWEQFPYPATLERLQSGSASAVTRELVA
ARRLTAGDTPGGATLFHKTGSTNGFGAYAAFVPQKKIGIVMLANSTYPNADRIKAAYAIL
QQLAP
>A0A0T2YND3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFVLLIKAAIMGVVEGLTEFIPVSSTGHLILAASLLNMPGEKIKLFEVVIQTGAMMAIV
SLYAGKLWETLVHLPREQQAQRFTLNVLVGFFPAALLGFLFIGVIKSVLFNPLVVALGFI
VGGVVILWAERRQERGVAPRIESVDDVRWTDALKVGLVQCAALVPGVSRSGATIIGAMLL
GFSRKAATEFSFFLAIPVLFGAAAYDLYKSRDLLSTADIPLFAVGLFFSWLSAWICVRWL
LRFVASHTFAPFAWYRIAFGALILLTAAMGWVDWVA
>A0A0E9C576|FEATURES|UNIPROT_deepARG|multidrug|BN1184_CB_00500|antibiotic target alteration|0
MLCDQILNSAKQGAFNLHGSLLPKYRGRAPLNWALVNGETETGVTLHRMVKKADAGDIIA
QQRVAIADEDNALTLHRKLVDCASALLESALPAMKQGNIVGTPQNEADATVVGRRTPEDG
RINWALPASQINNLVRAVTDPWPGAFAFAGTTKFVVWKAKVLSTPHNVRPGTVLSAEPFV
VACGEGALEIQTGQTANSVYMNGVQLAQHLGMVNGALLYSQAVAAVKRRTRVLILGVNGF
IGNHLTERLLQDDNFEVFGLDIGSDAISRFVGHPRFQFVEGDISIHSEWIEYHIKKCDVI
LPLVAIATPIEYTRNPLRVFELDFEENLKIVRDCVKYGKRIIFPSTSEVYGMCTDANFDE
DHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEKEGLRFTLFRPFNWMGPRLDNLNAARI
GSSRAITQLILNLVEGSPIKLFDGGRQKRCFTDISDGVEALFKIIENKNNNCDGQIINIG
NPDNEASIKELAERLLESFERHPLRASFPPFAGFREVESSSYYGKGYQDVEHRKPSIRNA
KRLLGWTPTVEMNTTIDNTLDFFLRTVELQDDKE
>YP_001668745|FEATURES|ARDB_deepARG|multidrug|MexF|antibiotic efflux|1
MNFSKFFITRPIFAAVLSLVLLIAGSISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVAAPLEQAITGVENMLYMSSQSTADGKLTLTITFALGTDLDNAQVQVQNRVTRTQPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAILNIKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTASDVVAAIREQNRQVAAGQLGAPPAPGSTSFQLSINTQ
GRLVNEEEFENIIIRAGADGEITRLKDIARVELGSSQYALRSLLNNQPAVAIPIFQRPGS
NAIEISDEVRAKMAELKKDFPEGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVIL
FLQTWRASIIPLLAVPVSLIGTFAVMHLFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIGLGLKPLEATQKAMSEVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLKDHHAPKDRFSRFLDKLLGSWLFAPFNRFFDRASHRYVGGV
RRVIRSSGIALFVYAGLMGLTYLGFSSTPTGFVPAQDKQYLVAFAQLPDAASLDRTEAVI
KRMSEIALKQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAAAIAAAL
NAQFADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNLGYEALYKETQNIIAKSHNVPE
LAGLFTSYQVNVPQVDAAIDREKAKTHGVAITDIFDTLQVYLGSLYTNDFNRFGRTYQVN
VQAEQQFRLDAEQIGQLKVRNNLGEMIPLATFLKVSDTSGPDRVMHYNGFITAEINGAAA
PGYSSGQAEAAIEKLLKEELPNGMTFEWTDLTYQQILSGNTALLVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAITGVIVSGGDNNIFTQIGLIVLVGLACKNAILIVEFAKD
EQAKGLDPLAAVLEACRLRLRPILMTSIAFIMGVVPLVFSSGAGSEMRHAMGVAVFSGMI
GVTVFGLFLTPVFFFLIRRFVERRQARKAERVQVLENHA
>A0A090NCB0|FEATURES|UNIPROT_deepARG|beta_lactam|WRSd3_03658|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHISP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLHQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIVNGSDNKIALAARSVKAITPPTPAVRASWVHKTGSTGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>R7ALA3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILEALKALFIGIVEGITEWLPISSTGHMILVDEFVKLDVSDQFLALFLVVIQLGAIMAV
ILLYFHKLNPFSPKKTHAEKRGTWRLWGMVAIGCIPAAIVGLLLDDWVNEHFYNAYTVAI
MLILYGVVFIVMERRNRKKALRLMEVGATPAGREMLEAPVRGRHARVEREHTEVSAEEAL
FKIRNVDDIDWKAALKIGCFQVLAIIPGTSRSGATIIGGMLCGCSRTAAAEYTFFLAIPI
MFGWGVVKAAKFMMEGLVMTQTEIMVLAVGIISAFIMSVVAIRFLMGYIKKNDFTAFGVY
RIIVGIIVVAFFTIQGTGFIMQ
>D8MPI6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTADQPINKVSVVIPVYNEQDSLPELIRRTSEACSQLSMAWEILLVDDGSSDRSPEMLTA
AAEEPGSHVVAVLLNRNYGQHSAIMAGFNHVSGDLIITLDADLQNPPEEIPRLVAKAQEG
YDVVGTVRQNRQDSWFRKRASRLINNLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAIEIPVLHAEREFGDSKYSLMKLINLMYDLVTCLTTTPLRMLSVFG
SLIALAGFALSLLLIVLRLFFGPEWSGDGVFMLFAVLFIFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVNSSAPVRSEEDQ
>ZP_03054084|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MKEACLYADIDGCLFKRSELKGKKIMNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDD
LWLKSKEIITPEAANTFKVVIQLGSILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTI
AQIAVGLVPAVILGFLFEDYIDKYLFDVRTVAVGLILGAVLMLVADWINKRKTETSSVDN
MTYKQALYIGLFQCLALWPGFSRSGSTIAGGVILGLNHRAAADFTFIMAMPIMAGASLLT
LVKNAEYLTTDMLPFFIVGFVSAFIVALFVVRFFLKLINKIKLVPFAIYRIILGVILFIL
FM
>YP_001749316|FEATURES|ARDB_deepARG|multidrug|MexF|antibiotic efflux|1
MNFSKFFITRPIFAAVLSLVLLIAGSISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVAAPLEQAITGVENMLYMSSQSTADGKLTLTITFALGTDLDNAQVQVQNRVTRTQPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAILNIKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTAGDVVAAIREQNRQVAAGQLGAPPAPGSTSFQLSINTQ
GRLVNEEEFENIIIRAGADGEITRLKDIARVELGSSQYALRSLLNNQPAVAIPIFQRPGS
NAIEISDEVRAKMAELKKDFPEGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVIL
FLQTWRASIIPLLAVPVSLIGTFAVMHLFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIGLGLKPLEATQKAMGEVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLKDHHAPKDRFSRLLEKLLGSWLFAPFNRFFDRASHSYVGGV
RRVIRSSGIALFVYAGLMGLTYLGFSSTPTGFVPAQDKQYLVAFAQLPDAASLDRTEAVI
KRMSEIALKQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAAAIAAAL
NAQFADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNLGYEALYKETQNIIAKSHNVPE
LAGLFTSYQVNVPQVDAAIDREKAKTHGVAITDIFDTLQVYLGSLYTNDFNRFGRTYQVN
VQAEQQFRLDAEQIGQLKVRNNLGEMIPLATFLKVSDTSGPDRVMHYNGFITAEINGAAA
PGYSSGQAEAAIEKLLNEELPNGMTFEWTDLTYQQILSGNTALLVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAITGVIVSGGDNNIFTQIGLIVLVGLACKNAILIVEFAKD
EQAKGLDPLAAVLEACRLRLRPILMTSIAFIMGVVPLVFSSGAGSEMRHAMGVAVFSGMI
GVTVFGLFLTPVFFFLIRRFVERRQARKAERVQSLENHA
>A0A0B5E9G0|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
PATERASGTEVSYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGR
RIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLH
NMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEA
D
>A0A0E2GAY8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFCKSWKKTYFSSWESFKKQAFYIILATLITGVLGLALQSIIKHVFFGGASSFEIEHLFS
NSKLMAAALISAGVLIILSSRLDRGQSGEISLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQKAEEFSFALAVVLTPAVILKELYRLVHAQGLQTVAHGQVFHSIVPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCIGFAIVVLCVN
>A0A087L7G1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDTAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGGKPVEHDGKTAGHLKLGHILLAMFPAVVIGLIFHDLIKSLFEP
KNVMYALIVGGVLLLVAEWLKPKNPSAVGLDDITYRQAFAIGCFQCLALWPGFSRSGSTI
SGGMLVGVNRYAASEFSFILAVPMMMGASALDLYKSLHFLTLGDLPMFAVGFITAFIVAL
IAIKTFLQLIKRISFVPFAIYRFIVAGVVYMVFM
>YP_251227|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmX|antibiotic target alteration|1
MSTYGYGRHEHGQNFLTDHKIINSIVDLVKQSSGPIIEIGPGSGALTHPLSRLGRPITAV
EVDAKLAAKLTKKTASASVEVVHGDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAW
TDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRR
VGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLP
PRLRTSDWIDLFQVTGFSPPRHRPISQSGSSQRPPQRKKRGRRR
>I5CK32|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILTLKALILGVVEGLTEFLPVSSTGHLIVAGSVLNFDVPQEKTFDVVIQLGAILAVC
WEFRQRIVDVVSGLGTRPEARRFTLNVIIATIPAIVLGLLFEKSIKAVLFSPVPVALALV
VGGVLILWVESRQRNRPDVQARVHSMDDLSPLDALKVGLAQCFALIPGMSRSGSTIIGGM
LFGLDRRVATEFSFFLAIPIIFGATVYELHKGWHELSTDALGLFSIGFLAAFVSAFACVR
WLLRYIAAHDFSAFAWYRIGFGLLILLIGYSGGLSWAD
>A0A0B2UC35|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIVNLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTDDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFTGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTADNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIALGVIILIAAMFFNLSA
>K0WFL3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGIEALLNSGFDIAAVFTHADDPKENAFYASVAQLCANKGIPVHA
PEDANHPLWIERIAKLDPEYIFSFYYRNLLSEPLLALAKKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQRVAIERSDTGLTLHAKLRTAASDLLRDTLP
NMLQGKITETPQDESKATVFGRRTPADGKLVWAKPAEELFNLVRAVTRPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISVDPLRIACGQDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDSSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLNWEPTVEMRETIGNTLDFFLREAMLEIA
DKK
>N2JKQ4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEDEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A127MMX3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTLVFAYHDIGCAGIEALLAAGYQIDAVFTHADDARENRFFGSVAQLCAQRGIPVHA
PEDVNHPLWIARIRELQPQFIFSFYYRHLLGEELLACARRGAFNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHRMVKRPDAGAIIAQQRVAIDAEDTALSLHGKLREAAGELLERLLP
AMLEGDFVEREQDESQASYFGRRTPADGQLDWRRPASELHNLVRAVTQPYPGAFAPVGER
KLIVWQSKVVPGNQGRPAGAVLSVEPLRIACGEDSLEIVAGQQGDAGLFLAGAQLAREMG
LVTGSRLHAVGKPRRKTRVLILGVNGFIGNHLSERLLRDGNYEVYGLDIGSDAIERLKSN
QDFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLVRY
CVKYGKRVIFPSTSEVYGMCSDASFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQ
KGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDV
DDGIEALARIVDNDGGRCDGQIVNIGNPDNEASIRELGEELLRQFETHPLRAHFPPFAGF
REVESRSFYGDGYQDVAHRKPSIDNARRLLDWEPKVHMRETIAKTLDFFLREAIAEQQQA
GKLRVAS
>W5W959|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPFQQFTVSDADSGPYSVTTGPDGALWFTLVHSGRIGRLTVDGELSTYPVAEGSGPTVIT
TGPDGALWFSQYQGHRIGRITVQGEATEFELTTPQAGPFGIATGPDGALWFTETASDRIG
RITVEGQVTEYPLPVRGAFPSAIAAGPDQALWFTLNQANAIGRIDTEGQVVVHALPTEAA
APVGICAGDDGALWFVEIGAGQIGRMTVDGKVTEYPLPDRAARPHAIIAGGTGHCWFTEW
GGNRLGRISVDGEIELHELPVAKSEPHGLAVGPDGAVWTALEIGVLARWPVGP
>A0A0M2SGK9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKLGDINHLLFSVSDLDRSIEFYENVFDAKLKVKGRKTAYFDLDGYWLALNEEKEIPRNE
IQYSYTHIAFSIEENEFENMCAKLEHLAVNILSGRKRDARDGRSIYFTDPDGHKFEFHTG
TMKDRLDYYKDEKEHMVFYD
>A0A0U0EBF1|FEATURES|UNIPROT_deepARG|beta_lactam|ERS020515_01168|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIDMAEKKFKNRVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKWKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINLVVPGHG
EVGDKGLLLHTLDLLK
>A0A0N0FT24|FEATURES|UNIPROT_deepARG|beta_lactam|AC505_1001|antibiotic inactivation|1
MQRNGTLLCTGLLLVSSVAFAEDNSAALDTLVQTEARKVMQENNITGLSIAITHHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFIATLATWAQANGRLSLTQSIDSYMPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPEKVQNTRQLMDYFKAWQPEYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYVNVPDDKQALYAQGYNTLDEPVRVNPGVLAAE
AYGVKSSSRDLIRFVEANIGLGQYDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPIHL
DVLLAGNASAMLNTQKADAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAQKQLGIVILAN
KNYPNEERVKLAYRILQHAEPLN
>A0A0B1G6H2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVLFAYHDMGCLGIETLLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWG
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>R5V0T1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFWELLKALFLGIVEGVTEWLPISSTGHLILVDAFLKLDASDAFKEMFDVVIQLGAILAV
VVIYWKNLWPFHKKETNPNPLTKTGFGACVQKNILQMWCKVLVACVPAAVVGLLFDDVFH
ALFYNPITVAIMLILFGVAFIVIERWQKTKQPRIHSIGGLDYKTVLLIGVFQLIAAVFPG
TSRSGATIVGALLLGVSRTAAAEFTFYLAVPVMAGASLLKLVKFGFHFTGMEFAVLLVGM
VSAFVVSIFIIRFLMDYIRKHDFTVFGWYRIVLGILVLIFAAVGVI
>A0A0B5QYV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKEATAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWEYLSVDDIPMFAVGFITSFTVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A127SFE1|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-101|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTFWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAM
>A0A0Q2BB10|FEATURES|UNIPROT_deepARG|beta_lactam|APB94_11310|antibiotic inactivation|1
MRFQKISCLLLSPLFIFSTSIYAGNTPKEQEIKKLVDQNFKPLLEKYNVPGMAVGIIQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTLSFEDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNQSFDQVLEKTIFPDLGLKHSYVNVPKLQMQNYAFGYNQQNQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKHNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0C2Z048|FEATURES|UNIPROT_deepARG|beta_lactam|CCC_03326|antibiotic target replacement|1
MYHDNDRSKLFSRRAMMLAGGKATLMGALAARMYYLQVMEADKYAVQAEDNRISTRLLAP
PRGLILDRNGIAMAVNQHNYRVMVVPEQTPSLDYTLDALTKIIAIGDGDRARIHKEVRRR
RSFVPLSVRENLTWEEVARVEVNAADLPGVIIDVGQSRYYPLESLGAHILGYVSAVSENE
LSGDPLEELPGFRIGKGGVERIYDMALRGRHGTSSLEVNSVGRVIRELERKEGEPGLDLN
LTLDMKLQEYAAQRLGDESAAVVVMDIHTGDVLVMASTPSFDPNSFNRGLSNEEWKDLST
NPRSPLTNKAIGGTFAPGSTFKLVTALAALEARDITPEMRVFCSGHTQLGSIKFHCWKKE
GHGAQDLVNGIKNSCDVYFYEVARRVGFEKIAEMAKKFGMGAPTGIDLPGEKSGIIPNKA
WKKAALKQPWHPGETLINAIGQGYVTATAMQLATMTARLANGGFAVIPHVARDQISEKSA
KSRSNPTWPSLDVSRQSLALVRKGMFAVSNEPGGTAYRARITQDGMWLSGKTGSAQVRRI
TMRERETGVKKNDQLPWKERDHALFVAYAPEENPRYSIAVIVEHGGGGSAVAAPIARDIM
IEVQKRDMARVAADSAGAPASPDLRRF
>YP_001455939|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKQPHEGTGKGRLTLGHIVLGMIPAVVLGLVFHDTIKSLFNPVN
VMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLTVEDIPMFAVGFVTAFIVALIA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>D2WSB0|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-5|antibiotic inactivation|1
SEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETE
LNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAG
WFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRE
>CAS11956|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALVQQTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGIRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AAPVVEKK
>W0AYV7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHADNPGEKAFYASVARLAAETGIPVYAPD
NVNHPLWVERIAQMSPDVIFSFYYRHLISDDILQLAPVGAFNLHGSLLPKYRGRAPLNWV
LVNGENETGVTLHRMVKKADAGAIIAQQRVVISPDDIAITLHHKLCHTARLLLEQTLPAI
KHGHFQEIAQRENEATCFGRRTPDDSFLDWHKPADVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSRVHPDTSTAQPGSVISVAPLRVACGHGALEIITGQAGDGITMQGSQLAQTLGLVE
GSRLNNQPLCAAQRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALFRIIENAGNRCDGEIINIGNPDNEASIKELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLGWEPKIDMQETIDETLDFFLRTVDLTDKSS
>BAH62779|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MKTATYHFLRHLLFSMNRLNRSCFLIKKYCRKGAGKSSRLPAEYPRLSLFFPGGEMSRVS
QARSLGKYFLLVDNMLVVLGFFVVFPLISIRFVDQMGWAALMVGIALGLRQLVQQGLGIF
GGAIADRFGAKPMIVTGMLMRAGGFAAMAVAHEPWVLWFSCILSGLGGTLFDPPRAALVV
KLVRPHQRGRFFSILMMQDSAGAVIGALLGSWLLQYDFRLVCSAGAALFIACAAFNAWYL
PAWKLSTVKTPIREGLGRVLRDKRFVTYVLTLTGYYMLAVQVMLMLPIMVNDIAGSPAAV
KWMYAIEATISLTLLYPIARWSEKRFRLEHRLMAGLLVMTLAMLPIGMTSSLQQLFTLIC
LFYIGSIIAEPARETLGASLADARARGSYMGFSRLGLAFGGALGYAGGGWLFDAGKAVGQ
PELPWLMLGAIGVITFLALWWQFSPKRSASGMLEPRT
>N9RIK2|FEATURES|UNIPROT_deepARG|beta_lactam|F887_03629|antibiotic inactivation|1
MNQPNTFSMTLKKLCLLTGLVSSSSALWAGTLTEQQVQKIVDQQFKPLLAQYKIPGMAVA
VTLNGKHYFVNYGVASKQSQQPISNHTLFELGSVSKTFNATLAGYAQAQGQLSFADHPAK
YFPELKNTAVNRATLLNLGTYSAGGFPLQFPDQVTQPQDMVKYFQTWQPKTKVGAARQYS
NPSIGLMGYVTALAMKKPYAELLEQTLFPQLGLTHSFIQVPEQQMQHYAWGYKADQAMRV
SPGMLDAEAYGVKSSSADMLKFLDAQINPQQLKQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPVKLETLLEGNSSKMALESHTALAVKQPKIASAATFFNKTGSSNGFGAYAAFIPQQ
KIGIVMLANTNFPNQERIKASYGVMQQLIQVNSAQ
>ZP_04285110|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MEKMKKNILLKLGVCVSLLGTTQFVSTISSVQASQKVEQKVMKNEAGTISISQLNKNVWV
HTELGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHA
HADRIGGMKTLKERGIKAHSTALTAALAKKNGYEEPLGDLQTVTNLKFGNMKIETFYPGK
GHTEDNIVVWLPQYQILAGGCLVKSAGAKDLGNVADAYVNEWSTSIENVLKRYRNIISVV
PGHGEVGDRGLLLHTLDLLK
>B5CST5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEALKVIILGIVQGITEWLPISSTGHLILVEELIKLQQNDAFKNMFNVVIQFGSIMAVV
VIYFHKLNPFSPTKTQKQKMMTIQLWIKVIIGTLPAMIVGLLLNDWIEAKMSNAYVVAFM
LILYGILFIVIENINAKREPRVTKLSQLSVPTVLLIGVFQMMAMIPGTSRSGATIVGALA
LGVSRGVAAEFTFFLAIPVMFGASALKLFKFGLAFTPMQVFLLLLGMLVSFGVSIIAIKF
LMKYIRNNDFKVFGYYRIVLGIIVFLYFGISALL
>K9AMH2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAILELIKAIVLGMVEGLTEFAPVSSTGHMILIDDMWLKSKEFLGPQSAFTFKVVIQLGS
VFAAAWVFRHRYFEMLHLEKAPKNAKEKRGGRLKLTHILVGMIPAGILGLIFDDFIEEHL
FSVPTVLIGLFLGAIYMIIADIYSKKVKNPKTVDEITYFQALIIGLSQAIAMWPGFSRSG
STISTGVLMKMNHKAASDFTFMMAVPIMLGASAKSLISNLEYITADQIPFYLLGFLGAFI
FGLIAIKLFLSLISKVKLIPFAIYRIILVIIIAIVYYGFGIGKGL
>A0A127SCW0|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-10|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYANKNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>L2VMJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTMIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFFTAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0G3G8H9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVWVAALLGVVQGIFMFLPVSSTAHLVLTQHWLIRQGEPLPAPESPEMILFDLVVHVGT
LVSIVVVFRKSLTRLTGGIARESLQWASARGSAGREMLFLRLGLLVVLSVFATAVVGFTL
KAGFEQVFAHPTLIAGTLSLTGVLLWWTDRLQRRPLGLRQLSPKIATIIGVAQGFALIPG
LSRSGMTITFALFTGLKRRWAAEYSFFLAIPTILAATAVQSLDVLNGDGLGNLNWTALAV
GFVVSALVGIVSLKMVLFFLYRANLKVFSFYLWALALLVLFGFLDVDIMYGK
>A0A0U5MY60|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFFNLLEAAFLGLIEGLTEFIPVSSTGHLLLIGHFLGFESTGKTFEVLIQLGAILAILS
VYSAKLAKIATDFPRDARTRRFVLGVLVAFLPAAVIGALAHGFIKGVLFETPMLVCIMLI
VGGFILLWVDQLNLRPRYHNVMDYPLPICLAIGFIQCLAMIPGVSRSGSTIVGSLLLGAD
KRSAAEFSFFLAMPTMAGAFAYDLFKSRNILSFNDGALIVVGFIMAFISGVFVVRHLLDY
VSRHGFALFGWWRLIVGSAGMAALIIWG
>C2QBY2|FEATURES|UNIPROT_deepARG|chloramphenicol|bcere0009_21450|antibiotic inactivation|1
MKFHVIDRENWDREQYFEHYLKLKCTFSMTANVDITLLTEKVSQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTVFHKDDKSFSSIWTDYYSDFHIFYKNYEEDMR
CYANVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADFLVPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFIEGLQELSHTCNEWLK
>A0A0P0MA96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLMLLLKAAVMGVVEGLTEFLPISSTGHLILAGALLGFDDDKAKVFDIAIQTGAILAVI
IVYWQKISSTVRALPSSADAQRFALNVFIAFVPAVILGLLFGKAIKANLFTPEVVATSFI
IGGFIILWAERRQASAVRIGEVEDMRWQDALKVGLVQCLAMIPGTSRSGATIIGGMLLGM
SRKAATDFSFYLAIPTLIGAGAYSLYKDRALLSMADAPMFAVGLVFSFLSAWVCVRWLLK
FISTNSFEVFAWYRIVFGLVVLGTSYFGLVSWAA
>A0A0S8BUZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALYLKALLLGIVEGLTEFLPISSTGHLIIAGQLIGFNGEKAKLFDIVIQLAAILAVC
WEYRGRLRAALAGITTERIQQRFVANLAIAFIPAAALGLLFHGDIKEHLFHPLPVATAFV
VGGFLILWAEGRDHRVTVETVDDMRWQDALKVGCAQTLALIPGTSRSGATIIGGLFFGLS
RRAATEFSFFLAIPTMFAAVIYDVYKNRAILQTDDLAMFAIGFAASFVSAFFAVRGLLRY
ISHHDFSAFAYYRIAFGGLVLVTSYTGIVNWSH
>A0A0Q8BM20|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD74_10480|antibiotic inactivation|1
MKIVRGTIDNVDPWARLRAALWSDGSVEQHREDIIVTFLQGADRAVAFLSGSEEGEIVGF
AEGSLRNDYVNGCKTSPVAFLEGIYVLPSHRQQGIARLLCNAVGDWGKSQGCLEFASDAP
LENEVSRKFHAALGFAETQRVVFFRKDIEA
>CAR56416|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVR
GVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALN
QKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GFSSGQAQAAVERIAHETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAGKDSAGYGVSPSGASASDA
>ZP_03002663|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLEFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHSIAEGQCWQSDWRIS
ESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>A0A0Q4IF04|FEATURES|UNIPROT_deepARG|aminoglycoside|ASE85_08680|antibiotic inactivation|1
MSGAAARIVRAAAVHADCWARMRTALWPDASHTDHRTEIADILATGDGLVAFVAINATGV
AMAFVEAALRHDYVNGCDTSPVLFVEGLYVMPDRRRAGLGRALIHAVAEWGAEQGCTEMA
SDAEMANLSSHAFHQAAGFAETERVIYFRKMIG
>S6J300|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSNKAVVFAYHDIGCAGIEALLAAGYEIAAVFTHADDPKENTFYGSVAQLCSLKGIPVHA
PEDANHPLWIERIAKLNPDYLFSFYYRNLLSEALLATPGKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQERVAIDRTDTALTLHAKLRNAASSLLHDTLP
LLAQGKISETAQDESKATTFGRRTPADGKLLWKNSAEQLFNLVRAVTKPYPGAFCAVGEH
KLIVWSADVVKGNEGLAPGRVISVDPLRIACGQDSLVINAGQRNENGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIANAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKR
>C0EC30|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILEILKAILFGIIQGITEWLPISSTGHMLLADELIHLNVSKAFMDLFIVVIQFGSILA
VVTLYFHKLNPFSPKKSPAEKKGTWSLWGKVAVASIPLVIIGLPLDDFITEKLYGPITIA
ATLIIYGILFIMLENRHKKPTVNSFGELSLKMAFCIGLFQVLATIPGTSRSGATILGAVF
LGASRVVSAEFSFFLAIPAMFGASGYKLLKFFLANDTGFSGGEWAVLIVGTVVAYLVSVV
AIKFLMSFIQKHDFKPFGWYRIALGVVVLIVFLFVLR
>YP_001764894|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPIFAWVIAIFIMLGGLFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLLYTSATSSAGAASLYLTFKQGVNADLAAVEVQNRLKTVDARLPEP
VRRDGIQVEKAADNIQLVVSLTSDDGRMTDVQLGEYASANVVQALRRVEGVGKVQFWGAE
YAMRIWPDPVKLAGHGLTASDIASAVRAHNARVTIGDIGRSAVPDSAPIAATVFADAPLK
TPADFGAIALRAQPDGSALFLRDVARIEFGGNDYNYPSYVNGKVATGMGIKLAPGSNAVS
TEKRVRATMDDLSRYFPPGVKYQIPYETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGVMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEGLAPYDATVKAMRQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALSLAVSIGFS
AFLALSLTPALCATLLKPVSGDHHEKRGFFGGFNRFVARATQRYATRVGTMLKKPVRWLV
VYGALTAAAALMLTQLPTAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRAVESAIRRDEP
TAYTYALGGFNLYGEGPNGGMIFVTLKNWKERKAERDHVQSIVARINERFAGTPNTTVFA
MNSPALPDLGSSSGFDFRLQNRGGLDYATFSAAREQLLAAGGKDRALTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVMVQADGRHRLDPDDV
KKLRVRNARGEMVPLAAFTTLHWTLGPPQLTRYNGYPSFTINGSAAAGHSSGEAMSAIER
IAATLPAGIGYAWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVLGVTLRAMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLVDAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQMAIGTGVLGGVITATVLAVFLVPLFFV
IVGRLFDVGPRRRGGAQPTTMEGSQP
>A0A087L6C2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELSGIRRSYLSGDQTVDVLKDVSLSIEAGEMVAIMGASGSGKSTLMNILGCLDQP
SAGTYRVAGRDVATLNGDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERATALLQRLGLGERVAYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLCEQGHTVIIVTHDPAVARQAERIIEIRDGAIIADSGAAKHGNAQAKTLEL
ATPAPSWQQMLGRFREALVMAWRAMAANKMRTVLTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDVFPGKDFGDDDPVYRQALKYGDLGALHEQPYVNALSPKIGSSMRLRF
GNIDVAANVTGVSEQFFLVYGMAFTQGAGIDPLQVQSQAQVVVIDANTQRRLFPHQKNVV
GEVILVGNMPATVVGVAKEKQSMFGSSQALSVWVPYTTMANRLVGKDSFDSITVRIREDY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTHTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLLVQA
VLPGWQISFPPAALLSAFLCSTAIGVIFGYLPARSAARLNPIDALARE
>A0A0F7KBP8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWPILIKALILGIVEGLTEFLPISSTGHLILMGDLLDFNDDKAKVFTVAIQLGAILAVC
WEYRARLTAIVTSIGSKESNRFLLNLLIAFLPAAILGFLFIKTIKSYLFHPLPVAMALII
GGILILWAERRDHIVDVKQVEDMDWKHALKIGCAQCLALIPGTSRSGATIIGGLFFGLSR
KAAAEFSFFLAIPIMFAATFYDVYKSRDLLQMEDLSMFAVGFMASFVSAWLAIRGLLRYI
SHHDFALFAWYRIGFGIMILVTAYTGLIAWSTG
>YP_002368151|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGAISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTAKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAEPAKKSGYEEPLGDLQTVTNLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGH
GEVGGKGLLLHTLDLLK
>A0A094K6B6|FEATURES|UNIPROT_deepARG|chloramphenicol|JS81_09190|antibiotic inactivation|1
MNFHKVNWNEWERKETFHHFLNQQTTFSMTTEIDITALYARIKQKGFKFYPAFLYVVTRV
VNSHTAFRMGYNHKREFGCWDQLHPLYTIFDRESEMFSGIWTMAEGDFKAFYRLYLTDVE
RYGGSGKLFPKTPIPENAFSVSMIPWTSFTGFNLNIHNQRDYLLPIVTAGKWIRHGRSIR
LPVALQVHHAVCDGYHAGMFMNAVQEWADHPEEWL
>A0A0Q7WKQ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIQTLIEALLLGLLEGLTEFLPVSSTGHILLAGHFLGFESTGKVFEVLIQLGAILAILS
VYAGRFFTFLRRPGAFRLIGEAIVGVIAALVWLCGCAFEIVAATVRRRKVNLFLPPELPN
DPAVRLMVGVGLGFLPAAVIGALAHDFIKTVLFETPILICVMLILGGIVLLWIDRQDLKP
KYHDAASLPLSTYLKIGLFQCLAMIPGTSRSGATIVGSLLLGVDKRAAAEFSFFLAIPTM
MGAFALDLFKNRDLLSASDFPVIAVGFIAAFVTAILVVRSLLAYVSRHGYSLFGWWRLAV
GGVGLIALLIWG
>A0A0D8KHA1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLVSIATAMPTSAKARRFVLAVAVAFLPAAVIGALAHDFIKTVLFETPMLICVVLI
VGGVILLAVDRMPLKPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGALLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDGALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGSLGLVALLVFG
>G2SR92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAHSFQTLVSHIFIDYNKEVNQSRYIQKGLLIIMIIELIKAFLFGIVEGITEWLPISSTG
HMILLDQFVKLDVSKSFYSMFEVVIQLGAIMAVVVIYWNKIWPFHKSRQTGPLAPTGIWR
YVDKDIIIMWIKIVIACLPAGIIGVAFNDTFEKLFYNPVSVAIALIVFGIAFIWVETVHK
NKRAKISSLAELSYYTVILIGFFQLIAAVFPGTSRSGATIVGALILGVSRTVATEFTFFL
AIPVMFGASLFKLLKFGFVFSSAELLILIVGLITAFVSSIIVIKFLMQYIKKHDFKVFGW
YRIVLGLLVLLYFLVIK
>A0A127SNS6|FEATURES|UNIPROT_deepARG|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHPEFRTAINQAGELGIYDEMIPSYTIFHE
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>A0A0B5QZS2|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSEPPKQTKQIKQIKQENTGHDSFAKLE
KEYNAKLGIYALDTGTNQTVAYHPNDRFAFASTSKSLAAGALLRQNSIEALDERITYTRE
DLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNKVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYNDKLIADA
TKVVLDTLKVTNKN
>A0A101D7S5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGNFIHFTGNFATMFEIVIQLGAILAVVFY
YRKKIFASLKNLKPGSWGFNLWFKIFIAFIPAAVIGLLTHKYIEEHLFSPFTVAIALIVG
AIMMIVIEDAFGKRYKIDNMDKVDTKKSLLIGIAQIMSLFPGMSRSASTIMGGMLAGLSV
KAAAEFSFFLAIPTMFAATIFSLLKGFSAMSLLEWEALTVGFIMSFLTALFVVDKFLSYL
TRHSLKPFAYYRLVVGVLMILLVAQKIVK
>D6B5U5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MHLPDPPSVEEIPVGDEKDGPYGIASGAGGALWLTFAGSGRIARLAPGGGLRTYALDASG
CRPTVITPGPDGALWFTRHGDHRIGRVTVDGDSTSFPLPTPDSGPFGITAGPDGALWFTE
TRTDRVGRITVAGEVTEFGLPGTAPGALPSAITAGPDGALWCTLNQADAIGRVTVDGEVT
TYPLPTSGAAPVGITSDGTALWFVEIGAGRIGRISVDGVIEEFPLPDPAARPHAVVAPAP
GECWFTEWGANRVGRLTGDGEITEYDLPTPASEPHGITSGPDGALWAALETGGVARIVP
>D4C2Y9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSHADEFDEIKKVSVVIPVYNEEQSLPQLLERTIKSCKQLTQSYELILVDDGSSDRSAQM
LTEAAENPENHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVQTA
MQGYDVVGTRRANRQDSWFRKTASKMINAMITKATGRSMGDYGCMLRAYRRHIIQAMLQC
HERSTFIPILANTFARRTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLS
VVGSIIAAGGFLLAVLLIALRLIFGAEWAADGVFTLFAVLFMFIGAQFVAMGLLGEYIGR
IYNDVRARPRYFIQKVVGADAKSDKNQEED
>A0A0H3WBB3|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-438|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYGYDTKIGWWVGWVELDDNVWFFAMNMDMP
TSDGLGLRQAITKEVLKQEKIIP
>A0A0F2SY90|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MELIDAAPEGAGPYGITVAPGGDVWFTLVHSGEVGRLTADGSVRRYGLGAPDCGPAVITA
GPDGALWFSRMRDHRIGRITAAGEASSFPVRTEGAGPYGIAAGPDGALWFTELGAGRVGR
IGVDGEVEEYPLPLAGAFPSMITAGPDGALWCTLNQADAVARIGVDGEVAVHRLPTEGTA
PVGITAGADGALWYVGIGGGLVGRITVDGQVTEHPLADRAAKPHAIAAGPDGALWFSEWG
AGRIGVLHPDGRLDGYPIPGPGAEPHGIAVGADGVVYASLERGQILRLGA
>J8IM46|FEATURES|UNIPROT_deepARG|beta_lactam|III_02965|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGVQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNKLIADAAEVIVKALK
>S1J323|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLNADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>I6Z9I3|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVAAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAACIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>A0A0M1NUC3|FEATURES|UNIPROT_deepARG|chloramphenicol|AM233_18735|antibiotic inactivation|1
MKFNIIDRENWVRKEYFEHYLQQQTTFSITNEMNITVLMENLRKKNYKLYPAFIFMVTKI
VNSHRELRTSFNQEGNLGYWSEILPSYTIFDKKTYTFSSIWSPNASRFSEFHSQYEKDVE
EYNGTGSLFPKTPIPDNHIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQIKDEWF
LPVSLQIHHAVCDGYHASVFMNDLQRFADESADWL
>W0HQH8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCVGVTALIKAGFTIEAIITHPDAPTEKPFFGSVARIAAEHGIPVFAPD
DVNHPLWVARITAMAPDVIFSFYYRQLLCQEILSLPTVGAFNLHGSLLPRYRGRSPLNWV
LVNGEEETGVTLHRMTARADAGNILAQRGVAITPQDDAPSLHRKLCEAAAAVLESILPAI
REQRFSETPQDESAASYVGRRTPEDGRLDWCQPAATLANLVRAVTDPWPGAFSYAGGEKF
IVWKAQVRPNSDAAQPGTVLSVDPLVIACGSDALEIQTGQSQQGVYMQGGQLAQALGLVN
GALLNPRPLVSHKRRTRVLILGVNGFIGNHLTERLLRDGNYEIYGLDIGTDAISRFMVNP
LFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRHC
VKYQKRIIFPSTSEVYGMCTDPVFDEDDSSLIVGPINKQRWIYSVSKQLLDRVLWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGAQKRCFTDI
SDGIEALFRIIENKDQNCDGQIINIGNPDNEASIRQLAELLLASFERHPLRQHFPPFAGF
RDVESSSYYGKGYQDVEHRKPSIRNAKRLLDWAPTVPMAQTIDETLDFFLQTVDLPDAPQ
>BAG31347|FEATURES|ARDB_deepARG|beta_lactam|CMY-59|antibiotic inactivation|1
MSTRCKSNTLIASDGPGHLFAFNYGTDFMMKKSLCCALLLTASFSTFAAAKTEQQIADIV
NRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGV
LGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALL
HFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVP
QNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGI
ALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASW
VHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>NP_289615|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEAEK
RNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASSGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>F1DI08|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
LVEYSPVTEKHVTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTR
LDRWEPVLNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVQ
>H5X5M7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPDLSTVSIVEFPVDAEGPYGIAVGADGAVWFTYVHDGRIGRLAGNGQHTSYRLETPSGR
PSIITAGPDGALWFTESHADRIGRISTDGAITGFAVPTADAGPFGITEGPDGALWFTEPH
ADRIGRISTDGAITEFPLPGSGTFPTMITAGCDGALWFTLNQADAIGRITTDGRVDIHPL
PTSGAGPVGITAGGDGALWFVEIVAGQLGRITVDGAITELPLPDREGRPHAITSAADGSC
WFTEWGTNRVGRVGADGHITEYALPDRFSEPHGIAAGRDGALWVALESGAIARVDDPPV
>Q63B80|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MMILKNKKMLKIGMCVGILGLSFTSLEAFTGGPLQVEAKEKKGQIKHKKQATHKEFSQLE
KKFDAQLGVYAIDTGSNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKE
DLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRKMGDRIT
MSDRLETELNEAIPGDIRDTSTAKAVAMNLKAFTAGNALPNHKRNILTEWMKGNATGDKL
IRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEA
AEVVVNAFK
>F3G691|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEVRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
IGGVIMLWAERREHTVRTETVDDMSWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A0F5F2B4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MGENKPINRLSVVIPVYNEQESLPELLQRTAAACDTLQMDYEILLVDDGSSDRSAGLIEQ
AASAPGSRVIGVLLNRNYGQHSAIMAGFSQVRGDLIITLDADLQNPPEEIPRLVEAARQG
YDVVGTVRQQRQDTWFRRKASRTLNRLIQRVTGKAMGDYGCMLRAYRRHIVEAMLNCHER
STFIPILANTFARHTIELPVIHAERAFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVIG
SLIALAGFAFSLVLIVLRLFFGAAWAGDGVFVLFAVLFMFTGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQRIVQAPEEPSVQDTQS
>A0A037Z829|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLIIKSIVIAIIEGLTEFVPVSSTGHMILVGHLIEFKGDFANLFEIVIQLGAILAVVVL
YWDKLYRSVKDIFVPGRRGLKFWINIVVAAFPAALLGFLLDDFIDAKLFNPITVAAALLV
GGILMIVIENKYRRGNKIKSMDNIRLRQSFLVGLFQCLALWPGMSRSASTIMGGWIAGFS
NVIAAEFSFFLAIPMMVGASGLKLIKSNIIMTNVEIIALVIGFVVAFIVSLIVIEKFIKF
LQKKPMRIFAVYRIIVGAVLLIMAAFGKIS
>ACO92337|FEATURES|ARDB_deepARG|aminoglycoside|ANT(2'')-Ia|antibiotic inactivation|1
MLRSSNDVTQQGSRPKTKLGRMDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVT
RKHDDIDLTFPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEI
AEAPQGSCPEAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSL
GAEKVEVLRAAFRSRYAA
>Q60B18|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLPDWLNALILGLVEGLTEFLPVSSTGHLILVGELLKFNDDRGKLFEVVIQSGAILAVC
WEYRRKLVELLFGLGHSRQARRFVLNLIIAFLPAGIVGFLAGKAIKAHLFNSTTVTTTFI
LGGLIILWVERRQRPPRVESIDDVDWRLALKLGLFQTLAMIPGTSRSGATIIGGLLLGLS
RRAATEFSFFLAIPTLFIATAYDLYKTGGILHAEDLSAFGIGFAAAFVSAFLAVRGLLRY
IGGHDFTAFAWYRIAFGLVVLSTAHYGLVAWTG
>C6X4Q0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLFKAILIAIIEGLTEFLPVSSTAHMIFTSSLFGIQEDEFVKMFQVSIQFGAILAVVFL
YWKKFFDFKNLSFYLKLAVAVIPALVLGKLLDDKIEAVLGDPVPIAIVLILGGVVMLFID
KLFKTQVIDDEKDVSYKSAIIIGFWQCLAMMPGTSRSAASIIGGMQQKLTRKAAAEFSFF
LAVPTMLAVTVYSIFVKDWNYKGIEQKGFEMLLQGDNLMLFLVGNIVAFVVAVLAIKFFI
GVLTKYGFKPWGWYRIIVGIVLLIYFTQFA
>A0A063XWG4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGTQALLDAGFEIAAIFTHPDNANENHFFGSVARIAAERGIPVYAPE
DVNHPLWVDRIRDLNADVIFSFYYRNLLCENILNTARFGAFNLHGSLLPAYRGRAPLNWV
LVNGEKETGVTLHRMVTRADAGAIIAQQRVAIEENDEALSLHRKLSEAAKAMLSSVLPDI
KAQRFSETAQDESKASYVGRRTPEDGRLDWEKPAQTLQNLVRAVSDPWPGAYSFAGTHKF
IVWKSRVRTDLSPARAGTLLSVAPLVVACGEGALEILTGQADNGVYMQGAQLAQSLGLVA
GALLTSKPVVAVKRRTRVLILGVNGFIGNHLTERLLRDDNYEIYGLDIGSDAISRFLGSP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
HGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGEIINIGNPDNEASIKELAEMLLASFEKHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLHWEPTVDMRQTIDETLDFFLRTVELTDEK
>A0A150U309|FEATURES|UNIPROT_deepARG|bacitracin|BE21_07815|antibiotic target alteration|0
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHESEAAKTLDIVIQLGAVLAVVVYF
RQRLAVTVRGIFRRDPDSLRLALALAFAFFPAALVGLLFHKAIKAHLFGPGPVAVALIAG
GFLMIGVESARRRRPDQGAPRVEDVTLQRALAIGVAQCFSLWPGASRSMATIVGGQLSGL
STAAAAEFSFLLAIPTLGAATVFDLAKNGRALLDAPGGAAALAVGLAVSFAVALLVIAVF
LRYLKRYGLAPFGWYRIALGAVVLWLWLASRTAPVDAGAAAEPAPGYWVRHVREA
>ABS73480|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLNEVGKINIKGINHLLFSVSNLEKSIEFYEKVFHAQLLVKGQKTAYFDLNGLWLALNLE
ADIPRNEIHKSYTHMAFTIDPKDFDAIHHRLKNLNVNILNGRPRDKQDQKSIYFTDPDGH
KFEFHTGTLQDRLSYYKKDKPHMKFYI
>F8FPV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDILNAIIMGIVEGLTEFLPVSSTGHMILTAHLLGFEGDRAKTFEVVVQLGAVLAVLVL
YWRRFLGFLDVRPGFMKRPGINAVHVALAMIPAVVIGLLFRDQIKEFLFGPNPVLYSLVA
GGVLMIVAEKARVRVTSETMDDITYKQALGIGLFQCLALWPGFSRSGSTMSGGMLLGTSQ
KAAAEFTFIVSVPMMFAASGYDLYKSREFLTMADLPLFLIGLAASFIVGMLAIVTFLNAI
KKLKLSYFAYYRFALAAIFFVILYL
>ZP_04261748|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MSEFSLIFYLFREERGVLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICG
VWIALNEEAHIPRKEIHQSYTHLAFSVEQEDFERLLQRLEENKVHILQGRERDVRDCESI
YFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY
>A0A0X8PQS4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFTNFIKAILFGIIEGITEWLPISSTGHLILADEFIGLNVTPEFMTMFNVVIQLGAILA
VVYLYFHKLNPFSPQKNEIEKKDTWTLWFKVIVAVLPSVIIGLPLDDWLDAHFYNFFSVS
IVLIVYGIGFIVVEKRNKNKAPKCTDLNKFTYKAALIVGMFQVLALIPGTSRSGATILGA
IMIGASRYVAAEFSFFLGIPTMFGASALKIFKFLKDGNAFDFQGTVILLTGTIVSFIVSI
IAIRFLMNYIKRNDFTVFGWYRIVLGIILIGYWLIQL
>A0A014L7T1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MDRIGRWLADPVRVFTVSAPDAGPYALTGGPDGALWFTLVHQGAIGRRDADGRITVHSVG
AKPTVIAQGPDGALWFSEYGTHRIGRIAVDGTVSSFAPPTADGGPYGIAAGPDGAIWFTL
STADRIGRITVDGDITEYPAPGAFPSAMAAGPDGAMWFTLNQGNAIGRITMDGRTTAHPL
PTEAAAPVGLAQGPDGALWFTEIGAGQIGRITVDGTVTEYPLPDRQARPHAVTSGPDGAL
WFTEWGRGGVGRITTDGRITAYDLPRADCEPHGIAAHDGALWCALETGALARIDVPR
>A0A0Q9XZ61|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIRDWIVALILGFVEGMTEFAPVSSTGHMIIVDDMLFKSAQLLGSQEVANTFKVVIQLG
SIMAVVIVFWSRLWSLVGINIGGTSTSTPTNHSRLKLSHVIVGLIPAAVLGLAFEDVIDK
YLFRIETVLLALVAGAILMLIADRQSKKERDFRGNSLDEITYRQALLIGLFQCIALWPGF
SRSGATISGGVLMGLKHRAAADFTFIMAVPIMFGASAVSLLKKWDVMTLDVLPFFIVGFI
SAFVFAWVSIRFFLALISRVKLRPFAIYRIILAVVLAIVYYSIG
>U1XGL6|FEATURES|UNIPROT_deepARG|aminoglycoside|O206_06725|antibiotic inactivation|1
MGTLVARREHAEAWAQLRHALWPDTSLEQHLQEIYETLDQDDPDAVTFIAESAGGQIAGF
AEAALRRDYVNGCETSPVLFLEGIYVSPEYRQRGIARLLCEAIANWGREKGCTEFASDVL
LENRDSQSFHTALGFDETERVIFYRKLL
>A0A0A7JNF6|FEATURES|UNIPROT_deepARG|polymyxin|NJ69_08675|antibiotic target alteration|0
MNVKTVVFAYHDIGCTGIESLLEAGYDICAVFTHIDQPQERIFFGSVARLCAERGIPVYA
PEDVNHPLWVQRIRELEPDFLFSFYYRQLLGECILACAKRGAFNLHGSLLPRYRGRAPAN
WAIINGETQTGVTLHRMVGRADAGPILAQVPVAIAETDTGLRLQQKLRAATIGLLREKLP
LLAAGGLSEVRQDEAQASYYGRRTAADGLIDWQHPAKRLYDLIRALTHPYPSAYCQTSEH
KLLIWDADVILGNLGQPPGTVLCADPLRIACGEDSLVVRHAQRGDHGLYLCGAGLARELG
LVEGASLNAAHPPAKRPTRVLILGVNGFIGNHLSERLLSDGNYEIHGMDIGSDAIERLKD
NPQFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIR
YCVKYGKRVIFPSTSEVYGMCQDPEFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
KQGLRFTLFRPFNWVGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGEQKRCFTD
VADGIEALARIIDNEGSCCDGQIINIGNPENEASIRELGEALLRQFDAHPLRGEFPPFAG
FQLVENRTFYGDGYQDVSHRKPRIANARRLLHWQPTVDLEQTIAKTLDFFLNEALRERGR
GQ
>A0A037UUK7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIYLQAAVLGVIEGLTEFLPVSSTGHLIVFGELLGFKGPPGKTFEVMIQLGAIVALIFL
YFRKLFGTLFGLPTDPAARRFALSILVAFLPALVLGATLHGFIKSVLFSPVVVAVALIVG
GIVILIAEETQKRVLYTHADNVPLKTSFLVGCGQALALVPGVSRSGATIIAGLLLGLERR
AAAEFSFFLSIPTMTGAFAYDAIKNRHELSSGDAGVIAVGFFAAFIAAMLVVKPFLAIVT
RIGFAPFAYYRIAFGTFILAVIYVFNAWPSNGAG
>A0A0M2KJK4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADLHQLWVAAILGIVEGLTEFLPVSSTGHMILVGHLLGFEGDKADTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKVPHEGTGKGYLTLIHLLLGMVPAVVLGLVLHDKIKSLFNPVN
VMYALVVGGILLLVAEFLKPKKPKAVGIDDISYRQAFVIGCFQCLALWPGFSRSGATISG
GMLIGVSRYAASEFSFILAVPMMLGATILDLYKSRDFLRLADFPMFAVGFITAFIVALIA
IKVFLKLIQNISFVPFAIYRFIVAIAVWFLFVQV
>V7ZIU8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPQCTILTLPPSLPHPSPSPMSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSD
FFNIVIQAGAILAICLALRQKLWTLATGLGQRDNRDYVLKIGVAFLVTAVVGLIVRKAGW
QLPETVHPVAWALLIGGLWMLVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRS
ASAIFLAMLLGLSKRSAAADFVFMVGIPTMFAASGYALLEMYKEGGFGSENWADVAVAFV
AATITGFVVVKWLLGYIKKHRFTVFAVYRIVLGAALLLWLPAAA
>A0A060L060|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLVSHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A0D0MKC5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTEPLLKLRGIGRSFPSGEQEVQVLKDVDLDIGNGEMLAIVGASGSGKSTLMNILGCLDR
PSSGTYTVSGHDVGTLDSDALAQLRREHFGFIFQRYHLMQHLTAAGNVEVPAVYAGTEGV
ARDARARQLLARLGLADRTEHRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSKS
GQEVIGILRELHAQGHTIIIVTHDMQVASCTERIIEIADGVIVGDRPNVPTIAAPAQAVG
TDASTPPPMTRPKLGIASLSTGWARFAEAFRMAWRSMMAHRMRTALTMLGIVIGITSVVS
IVAIGEGAKRFVLADIRAIGTNTLDVYPGRDFGDDKAASIRTLTPADLEAIAAQPYVHSV
TPTVVRSLRLRYRSADVNGNVSGVSDAFFRVRDIQMTSGTAFTAADVRHQAQVVVIDANT
RRKLFPDGTDPVGKVILVGNLPCTVIGVSQEKKAMFGENKTLNIWLPYSTGASRLFGQQH
FDGITVRIRDDQPTKAAEDSIVRLLTLRHGAKDFFTFNMDSIVKTAERTSQSLTLLLSLI
AVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDVLQQFLTEAVLVCLVGGFIGV
LLSYGISFLFSLFVTQWQMIFSMGAVVSAFLCASLIGVLFGYLPARNAARLDPIEALARE
>A0A0D1CS79|FEATURES|UNIPROT_deepARG|aminoglycoside|TQ38_01765|antibiotic inactivation|1
MIVRITLGSDADLSEWSALRTQLWPDGSEVEHHEDLVQLRANAQSFIAFLARDQRSRLVG
FAEAALRVDYVNGCESSPVAFLEGLYVVEECRRQGIGRALVDAVEAWARSMGCAELASDA
MLDNTVAQAMHAALDFEETERVVYFRRVLPPMPPLS
>A0A0Q5GNT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
KLWSLATGLGERDNRDYVLKIGVAFLVTAVVGLIVRKAGWQLPETVHPVAWALLIGGLWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGSENWADVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRIVLGAALLLWLPAAA
>A0A127SBL7|FEATURES|UNIPROT_deepARG|chloramphenicol|catB|antibiotic inactivation|1
NWSRKEWFEHYLNEVRCTFSITANIDITRLQIVRKEEKIKLYPVLIYLISVVVNKYEEFR
IDYDEYTEQGRLGYWDNVHPVYTVFHKDSGTFSSLWTEHDNCFSVFYDRYQKDIAKYGSV
ERFSPKENVPKNIFSVSSIPWTTFTGFNLNVYTDGSYLRPIFTFGKYFEQDGKTLLPLSV
QVHHAVCDGFHASRFIDDFQKLVNDDTLWRDLDEGKQI
>A0A0U2WU16|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAHPMLELTGITRRFPAGDRDVVVLRNVNLTIEAGEIVAIMGASGSGKSTLMNILGCLDH
PSEGSYRVAGRETRDLDADALAQLRREHFGFIFQRYHLLPHLEAAGNVEMPAVYTGAPHA
ARRARAEQLLSRLGLADRTHHRPSQLSGGQQQRVSIARALMNGGDVILADEPTGALDTRS
GKEVIRILRELNALGHTVIIVTHDEHVAAHARRIIEIRDGEVVADRQNTPVTDDDAVAPE
ASDEDGDEAANAANAAKATVDANAATAAATGDALANTSPMPERRWTGGVGRFAEAFRMAW
IALVSHRLRTFLTMLGIIIGITSVVSIVAIGEGAKRYMLAEIGSIGTNTINIYPGKDWGD
SRAGTIQTLVPEDVYALTEQNYVDSVTPETARNLLLRYRNVDANATVTGVGESFFQVRGM
KIAQGIAFGPDEVRRQAQVAVIDQNTRRKLFPTNPNPLGEVIFVDNLPCVVIGVTEEKKS
AFGDMKSLNIWVPYTTASGRLFGQRNVDSITVRVRDGQPSKIAEKSLETLMTQRHGRKDF
FTYNMDSVVKTVEKTSQSLTLLLSLIAVISLVVGGIGVMNIMIVSVTERTREIGIRMAVG
ARQSDIMQQFLVEAVMVCLMGGAIGIALSFGASFVFSLFVAKWKMVFSMGSIVTAFLCST
LIGVVFGFMPARNAARLDPVEALARD
>N9DGW4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLFHVFILAVIQGLAELLPVSSSAHVILAEKIMGFDPSAPQMTFLLVMLHTGTMFAVIV
YFWRSWKKTYFSNRDDFKQRFFYVLIATAITGVLGLLLQALIKHVFFGGASNFEIEHLFS
NSKLMAAALAAAGVLIILSSRFDRGQQGDIGLSSAIVIGAVQALCLPFRGFSRSGATIST
ALFLGISRQKAEEFSFALAVVLTPAVIAKELLRLVHAQQATVGASHLALGSLLLPSLFGM
VFSFLTGLLALKWLSAWLEHGRWYLFGIYCLVFSGVVLSSA
>A0A089JAW2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYDYIIAVIQGIVEGVTEFLPVSSTGHLILSGSLLGFTGDKADTFEIIIQLGAILAVAVI
YWRRILGLLGLVKAESGSMNTNGGWKLNLIHIILACLPAMVLGLVLHSFIKTYLFSPYTV
LAGLVFGGLFMLYGQKRQIAVLAENIDQLTYKQAIKIGLFQCLALWPGFSRSGATIAGGL
LGGAGYKAATDFSFLIAIPMMVAASGYELLKSYQTLTAADAGFFITGFLVAFVVALLAVI
TFLKLLQRLKLAPFAYYRFVLAAVFLIYLLVR
>A0A0T9QUV7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEDVLTMKTSIISSLIFATLAASPLYASEQKILTQQQIAAIVNNTLTPLIEKQDIPGMAV
AVFYDGKPLFFNYGFADIKNRRPVTENTLFELGSVSKTFTGVVGGYAEQTGILNLSDSAT
KYSPELTGRQWKDISMLNLATYTAGGLPLQIPDTVTNMKLLWQYYQQWQPQWAPGVMRNY
SNASIGLFGTLAVKKSNLSFEDYMAQHVFQPLKLTHTFITIPDSMQSDYAWGYKDGQPVR
VTPGVLAAEAYGVKSTAQDMVKFMQANIEPEKLLADNDKLKKAIIAAQSRYYRSGNMFQG
LGWEMYNWPINSQEVIAFSSNEIALQPHKINALMPPYSAVPASWVHKTGSTNGFGAYIAF
IPEKKIGIVMLANKNYPNPVRVEAANHILQSLY
>V5Z5E3|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVVFAYHDIGCTGIRALAEAGYEIAAIFTHADNAAENHFFASVARTAAELGVPVYAPE
DANHPLWIERIREMNPDAIFSFHYRHMLNDDIINSANLGAFNLHASLLPKYRGRAPLNWV
LVNGEQETGVTLHRMVKRADAGAIIAQKKVKIAEHDDALTLHRKVCAAAGELLAEALPGI
QKGDFSEHPQDESQASYVGRRTPEDGRIDWHLPAQRIYNLVRAVTDPWPGAFSYVGTGKF
IVWQAKVHHDRPAAKPGTILSVAPFVVACAEGALEIVTGQSDSGVYMQGSQLAQTLGLVA
GGLLHNHPAAVAKRRTRVLILGVNGFIGNHLTERLLVDDNFEVFGLDIGSDAIGRFIGHE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDATFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGRQKRCFTDI
HDGIEALFLIIENKQQNCDGQIINIGNPENEASIKQLAEQLLESFERHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLNWQPKVVMDKTIDDTLDFFLQSVESGDAEA
>A0A0J6H343|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEGKTIQGLNHLLFSVSDLSASISFYEKVFDAKWLVKAEKTAYFDLNGIWLALNEEKDIK
RTEIHDSYTHIAFSIKQEDLPYWEMKLHGLGVNVLKGRKRHEGDKDSIYFSDPDGHKFEL
HTGTLLDRLAYYQKEKPHLSFHEANIRELYEKNK
>V0UY29|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACGARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFMNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLNWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A085H1T2|FEATURES|UNIPROT_deepARG|beta_lactam|GHAL_0542|antibiotic inactivation|1
MRKKMQSTLKLLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVT
LNGKNYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYV
PELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIG
TGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNM
EVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWE
QLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSELEGK
>A0A0D8IZ87|FEATURES|UNIPROT_deepARG|chloramphenicol|TQ39_15890|antibiotic inactivation|1
MTFHKIDMQAWERKKRYEHYAEAVPCTYSMTVALDVTKLLCGVREKGLPFFPVVLYGLAR
EVNRHAEFRMAQDEMGNVGYYSHCDPCYTVFHKETESFTEVWTAYDASPAVFLARYREDM
ARYRNAPELSKPPAGKNLFNVSCIPWSSFTGFNLNLQNGYDYFLPIFTIGKYFSDGGKMR
LPLAVQVHHAVCDGYHLSRFINGLQTWMDAFPQELEQEIEQQPGKPPR
>F2L9C8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLDFNAEQEKTFDVVIQFGAILAVC
WEYRRRIGTVVAGLPTRPEARRFALNVVIATLPAIVLALMFEKAIKRLLFSPVPVAFALV
AGGLVILWAEARQRDRREPARVMSIDALSPLDALKVGIAQCCALIPGVSRSGSTIIGGML
AGLDRRVATEFSFFLAIPIIFGATFYETVKDWHAFSVDSVGLFAVGMVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLLVLLVGYSGWLDWS
>ZP_04633037|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MTSAPQPINWKRNLFVTWLGCFLTGAAFSLIMPFLPLYVEELGVSGHQSLNMWSGLVFSI
TFLFSAIAAPFWGSLADRKGRKIMLLRSALGMGIVMVLMGMAQNIWQFLALRALLGLLGG
FIPNANALIATQVPRNRSGWALGTLSTGGVSGALIGPLIGGLLADNYGLRPVFFITAGVL
FACFAMTWLSVKEQFSPVLKKDMLNGRQVFNSLKNPKLILSLFVTTMIIQIATGSIAPIL
TLYVRELAGDIHNLAFVSGLIASVPGVAALMSAPRLGRLGDKIGPERILIAMLALSILIL
IPMAFVQTPLQLGILRFLLGATDGALLPAVQTLLIYNCTNQVAGRIFSYNQSFRDVGNVS
GPLLGAAVSASYGFRAVFCVTAVVVLFNAIYSYWCLQRQPLKARQREVQQPQDS
>A0A0G4BWL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLVGFHSNHKVFEIAIQLGAVLAVVF
EYRQRFSNVLHGLGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIADVDALRPIDALMIGIAQVFALIPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFIAAFVSGLVAVKALLK
FVSKKNYIPFAYYRIVFGIVIIILWLSGWISWE
>N9RLH4|FEATURES|UNIPROT_deepARG|aminoglycoside|F902_01455|antibiotic inactivation|1
MNIMPISESQLSDWLALRSLLWPDHDDAHLLEMRQLLKQTDTLQLLAYTDTQQAIGMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGIATQLVQFVEEWAKQFACTEFASDAALDN
HISHAMHRALGFHETERVVYFKKNIG
>A0A0A8BDK7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLALKAVILGVVEGLTEFLPISSTGHLILVGSLLDFNDEKGKIFDIVIQFGAILAVC
WEFRAKIAQVVFGLGSDAKARRFAVNVIVACVPAIVLGLLFGKHIKAVLFNPLVVATAFI
VGGVIILLVERHNRRNVEAGKLPRVNSIDELSTLDALKVGFAQCLALVPGTSRSGATIIG
GMMFGLERRVATEFSFFLAIPILFGATIYELYKSRSMLDVADFGLFGIGFVFAFISAFIC
VRWLLRYIASHDFTAFAWYRIVFGIVVLVSAYSGLVVWAD
>W8XU38|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDTACATLGRQYEILLIDDGSSDDSARMLTE
AAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFG
SVIALLGFAFGLMLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQPETASKEEDRS
>YP_002408235|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A077N5Z1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKFVINTLVFATIGTSSFYASAQKTLTAQQVAEIVNNTLTPLLEKQDIPGMAVAVIYD
GKPQFFNYGVADIKTRRPITENTLFELGSVSKTFTGIAGGYAMQTDTLNLNDPVTAYSSE
LTGSQWRGVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPLWAPGMMRNYSNASI
GLFGALTANKSQLTFETYMTKYVFLPLKLTHTFITVPESMQSDYAWGYKNGQPVRVTPGM
LSSEAYGVKSTTQDMVKYMQANMAPDSLPADNDKLKKAILAAQSRYYRAGNMFQGLGWEM
HNWPINPQRVIADSGNDIALQPLKVEELIPPRSAVSASWVHKTGGTDGFGAYIAFIPEEK
IGIVMLANKNYPNPVRVEAAYHILKALR
>R6GJR2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKVIFLGIVEGITEWLPVSSTGHMILVDQFMKLKVSEEFWQMFLVVIQLGAVLA
VVVLDFKKLWPFHKNDPSRESNWNYISTNERIGKLQKFADKYINMNKIVLWLKILVSCVP
AIIVALPFNKWIEKTFMNYWVVSVMLIVYGVLFIVIENYNKSRKPSRTKLSDISFKDALF
IGIFQLLALIPGTSRSGATIIGGILLGMSRKLAAEYTFFLAIPVMFGASFLKLIKFGLHF
TGTEVVYLLLGMVVAFGVSIAAIKFLMGYIKKHDFKVFGWYRIALGVVVLAYFLLA
>A0A0U1I0C3|FEATURES|UNIPROT_deepARG|aminoglycoside|ERS008437_00710|antibiotic inactivation|1
MEIKKLSSANINLWIALREQLWPHHPENANRSDGKNIILSDELASFIAVDEDGLGIGFAD
ASIRNDYVNGCIHSPVAFLEGIFIVPPSRRGGVAKQLVDAVQAWGLEKGCQELASDTALD
NVLSQQVHEALGFKETERVVYYRKVSLR
>M7S984|FEATURES|UNIPROT_deepARG|aminoglycoside|A670_03335|antibiotic inactivation|1
MDIRQMNKTHLELWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A0M1NVD8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGLNHFLFSVSDLDSSMEFYQKVFDAKLLVKGRTTAYFDLNGMWIALNAEKDIPRNE
ISQSYTHIAFSIEEADFMNMYEKLIGLNVNILSGRPRDEKDKKSIYFTDPDGHKFEFHTG
TLQDRIDYYKQEKAHMEFFID
>A0A0F6IVF0|FEATURES|UNIPROT_deepARG|beta_lactam|BTCBT_007483|antibiotic inactivation|1
MHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWM
EADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMD
ERNRQIAEIGASLIKHW
>Q3S676|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNRLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKREPQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>ZP_04192734|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKERVDNMKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNK
NVWVHTELGYFNGEAVPSNGLVLNTAKGLVLVDSSWDNKLTKELIEMVEKKFQKRITDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKNSGYEEPLGDLQIITSLKFGNTKVETF
YPGKGHTEDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNI
NSVVPGHGEVGDKGLLLHTLDLLK
>W0BQW3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGITLRVEAGEMVAIVGASGSGKSTLMNILGCLDRP
TSGTYRVAGMDVSTLDGDALAKLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIRDGELVSNPPARHARAAAPKEVLP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTNVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
AQAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGLSPVAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>B2M1S5|FEATURES|UNIPROT_deepARG|beta_lactam|adc-29|antibiotic inactivation|1
MQFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNRFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>N9R6P0|FEATURES|UNIPROT_deepARG|beta_lactam|F901_01005|antibiotic inactivation|1
MNQPKAFSMTLKKLCLLTGLLSCSSALWAGNLTEQQVQTIIDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQAVSNSTLFELGSVSKTFNATLAAYAQAQGQLSLSDHPAK
YFPELKNTAVNRATLLNLGTYSAGGFPLQFPDEVVQQQDMVKYFQTWQAKTKIGAARQYS
NPSIGLMGYITALAMKKPYNELIEKTLLPQLGMTQSFIRVPEQHMPQYAWGYKADQAMRV
SPGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPVSLETLLQGNSSKMALESHAITAIKQPKLATPATYFNKTGSSNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQSNSAQ
>A0A0F7HD22|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSDIRRSYLSGDQTIDVLKNVSLRIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGTYRVAGQDVATLDGDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLSKAA
RRERAAALLQRLGLGERITYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLREQGHTVIIVTHDPAVAQQAERIIEIRDGEIIADSRPQAQGNPQAKMLDM
ATPAPSWQQVAGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMI
LADIKSIGTNTVDIYPGKDFGDDDPSFRQALKYGDLSALREQPYVSALSPNISSSMRLRF
GNIDVAANVAGVSEQYFRVYGMTLSQGVGIDTLQVQSQAQVVVIDANTQRRLFPHKKNVV
GEVILIGNMPATVVGVAQEKQSMFGSSKALSVWVPYSTMANRLMGNDYFDSITVRIREGY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGIALSFAIGLLVQL
AMPGWQISFPPVALLSAFLCSTGIGVVFGYLPARSAARLNPIDALARE
>Q8KT58|FEATURES|UNIPROT_deepARG|beta_lactam|cfxa2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNGFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNDASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMFMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>D5CQC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLLIKAAILGVVEGLTEFLPISSTGHLILAGDLLNFNDEKGKVFEIVIQFAAILAVC
WEYRAKIFTVVGGLSSEQAAQRFATNLVIAFLPAAVLGVLFASKIKQYLFAPVPVALAFI
IGGVIILWAEKRKHKIAFETVGDMTWQEALKVGCAQTLALIPGTSRSGATIIGGLFFGLS
RKAATEFSFFLAIPTLFGATVYEVVKYRHLFHSDDLGMFVMGSVFSFISAFLCVRWLLRY
ISRHDFTVFAWYRIAFGLIVIATHYSGMVNWSAA
>YP_002849839|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFRDFEAEEKLFQRRVLVAFGLVVICFGILIYNLYNLQICQHQYYTTRSNANDIKMLPV
APTRGMIYDRNGIPLVRNVTWYDISVTPYKISDMNALLQQLTPIVDLTPDDIDQFRHELK
ASSRYRPVVLKNALTDVEIARFSVNQFHFSGVNINSYEDRQYPYGAALAHVLGYVSKIND
NDLKALDQKGLVENYAADHNIGKQGIERYYENELHGKTGYQEVEVDNHGRIVRLIKDVPP
VAGKDIHLTLDLHLQQYIESLLAGQRAAVLVEDPHDGSVLAMVSNPSYDPNPFVKGISYQ
DYNKLLQDKDLPLINRVTQGLYPPASTVKPYMAMSALLNGVITPQTSFFGAPTWTLPGTE
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRINSMLSQFGYGKPTGIDLDEE
YNGLLPSREWKQKVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIVPHLL
LDEESGKTITPYQAPEAPSQIASASSPYWGLVRQAMFGMANEPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPVRLRDHVFYTAFAPYKNPKVAVALILENGGSDGVTAAP
VMRQIMDHLFAPQDNTVQTVTTEQSGPIAVSPSNTDIKNTFASIR
>F9H1B7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKDLNRYFGEDENRVHILKNVSLNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
NGSYKINGKETIELSKDQLSDLRSQKFGFIFQRYNLLSSLTAAENVVLPAIYAGMSQEKR
LSRAKQLLEKLGLGDKWQNKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGQ
NVMEILRQLHAEGHTIIMVTHDREIAASANRVIEIKDGEIIGDTQKEAVKSAVENPTKSK
PHFGFSKDQFVEAFRMSVSAIIAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
KGIGTSTMTIFNGTSFGDRRAEQMQNLTINDATALNQQSYVQSVTPNSSSSGTLIYGNQT
FSSTSLKGVGEQYFDVDGLKLKSGNLFSAQDVADNNQVALIDESAKKSIFPDENPIGKIV
MFNKRPLRIIGVVSDKQMGGASSSLNLYAPYTTVMNRISGSKKIGSITVKVDDSVNTTVA
EKGITELLTMRHGKKDFFIMNSDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIML
VSVTERTKEIGVRMAIGARQFNILQQFLIEAVLICLIGGVTGILLSGLIGLLFNVFMTNF
TMAFSTGSIVAAVVFSTLIGVIFGYMPAKRAAQLDPITALARE
>ZP_04612558|FEATURES|ARDB_deepARG|fosmidomycin|RosA|antibiotic efflux|0
MTDRSETGFQPSANTAVKRTSFSILGAISVSHLLNDMIQSLILAIYPLLQAEFSLSFAQI
GLITLTYQLTASLLQPLIGLYTDKHPQPYSLPIGMGFTLSGILLLAVATTFPVVLLAAAL
VGTGSSVFHPESSRVARMASGGRHGMAQSIFQVGGNLGSALGPLLAAILIAPYGKGNVGW
FSLAALLAIVVLLQVSKWYQQQQKASHGKAIKISSVKMLPKKTVIKTLAILMVLIFSKYF
YLTSISSYYTFYLMHKFGVSVQNAQIHLFAFLFAVAAGTIIGGPLGDRIGRKYVIWGSIL
GVAPFTLILPYASLYWIGILTVIIGVILASAFSAILVYAQELIPGKVGMVSGLFFGFAFG
MGGIGAAVLGYVADLTSIELVYQICAFLPLLGIFTALLPNIEDK
>T8K5Y5|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSLCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADNYGLRPVFFITAS
VLMLCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQIATGSIAP
ILTLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISAHYGFRAVFLVTAGVVLFNAVYSWNSLRRRRLPQVSN
>A0A0R1MG02|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKSIILGIVEGITEFLPISSTGHLVLVDEFIKMEQSKAFVDMFNVVIQLGAIMAVV
VIYFNKLNPWASQKNSLEKKQTWTLWKKVIIAVIPSIIIGLPLNDWMDSHLMNWLVVSIA
LIFYGILFIVIENHNAHIQPKFSDLNTLSYKTAIIIGLFQVLSLIPGTSRSGSTILGGIM
VGTSRYVAAEFSFFLAIPTMFGASLLKLYKYFSHGGSLAGLQGIILAVGVIVSFVVAYVS
IRFLLNYIKTKDFKIFGWYRIVLGIIVIGYFLIFH
>A0A0K6KSK5|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKNKATLKLGICIGLLCLSLTGFKPFYGSTHAEAKGIGDTKMTSCITNKKFVQLEKKFDA
RLGVYAIDTGTNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYTKDDLVTY
SPITEKHVDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKANRF
ETDLNSAIPGDIRDTSTAKALATDLKAFTVDNTLTTDKRTILTDWMRGNATGDELIRAGA
PIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSKRFTKDANYDNALIAEAAKVVL
NDLK
>A0A069FWI1|FEATURES|UNIPROT_deepARG|beta_lactam|CO98_2386|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIALNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>ZP_03232999|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEQEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>A0A009ZJN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLFHVFILAVIQGLAELLPVSSSAHVILAEKIMGFDPSAPQMTFLLVMLHTGTMFAVIV
YFWRSWKKTYFSNWNDFKQRFFYVLIATAITGVLGLLLQALIKHVFFGGASNFEIEHLFS
NSKLMAAALAAAGVLIILSSRFDRGQQGDIGLSSAVVIGAVQALCLPFRGFSRSGATIST
ALFLGISRQKAEEFSFALAVVLTPAVIAKELLRLVHAQQASVGASHLAIGSLLLPSLFGM
VFSFLTGLLALKWLSAWLEHGRWYLFGIYCLVFSGVVLSLA
>A0A0G8F286|FEATURES|UNIPROT_deepARG|beta_lactam|B4077_3831|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTTQFVSTVSSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHSD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITKLKFENMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKNLGNVADAYVNEWSTSIENVLKRYGNINAVVPGH
GEVGDRGLLLHTLDLLK
>A0A087M2D0|FEATURES|UNIPROT_deepARG|aminoglycoside|JP75_11845|antibiotic inactivation|1
MDCADHLGQPVKIALATAADAADWVAMRTALWPSGGDGAHAADIAELLDDAGETINLIAR
DADGAALGFVEAALRHDYVNGCKTSPVAFLEGIFVKPEARGRGVARAMVGAVEAWAREQG
CTEFASDAALENFVSHDMHRALGFAETQRVAFFRKVLG
>J7IB33|FEATURES|UNIPROT_deepARG|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKKSLRQFALLAATVFPLLASSVSLQAQTLSVEQKLAALEQRSGGRLGVALIDTADGSQ
ILYRGDERFAMCSTSKVMAAAAVLKQSESQHDLLNQRIEIKKGDLTNYNPIAEKHVGGSM
SLSELSAAALQYSDNVAMNKLIAQLGGPQGVTAFARKIGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDAQRAQLVTWMKGNTTGTASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLVLVTYFTQPQPEAESRRDVLASAAKIVTEGL
>A0A0C2EDF6|FEATURES|UNIPROT_deepARG|beta_lactam|UCMB321_2366|antibiotic inactivation|1
MFKKNLAKLEVLVTSLLLIGASHSFAADNTQDNIKAIVDAAIGPVMQKQNIPGMAVAVLV
NEKPYYFNYGVASKTNQQPVTDDTLFEIGSVSKTFTATLAGYAQAQGKLNPSERVSHYLP
ELQGSAFDRITVLQLGTYSAGGLPLQFPDAFDTQDKMLDYFKQWKPTYAAGTHRQYSNPS
LGLFGYVAAKSLGAPFDELMEKTLFPKLGLKNSYIHVPEARMSHYAQGYTQDDEPVRVGP
GALDAEAYGVKTTSTDLLRYVEANIRPEPLEAPLHKAIDLTQSGYYQVAGTTTQGLGWEF
YPYPVKLDRLLTGNSSEMALEAYKVSPFNPAHPPQKNALFNKTGSTRGFGAYVVYVPAKK
VGIVMLANKNYPNPVRVKAAYQILNALEGVQ
>K8B9W5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPHEGLGKGRLSLIHILLGMVPAVVLGLVFHDFIKSLFNPIN
VTYALVVGGVLLIIAEVFKPKEPKAPGLDDMTYRHAFFIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSMGFLTMADLPMFAVGFVTAFVVALVA
IKTFLHIIKRISFIPFAIYRFIVAAAVYAVFM
>J7KSL8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACQKIGKPWEIILVDDGSSDRSADLLTEAA
SDPEKHIIAVLLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYAAQGYD
VVGTVRANRKDSLFRKLASKTINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVLHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFFGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLATTLRDEEE
>A0A0B1Q016|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQFNDIFDATLLGLIEGLTEFIPVSSTAHLLLIGQAIGWRSTGHSFEVLIQLGAVLAVLS
VYFGKLWHLARTLPTEARSRRFVLGILVAFLPAAIIGALAHGFIKGVLFDSPAIICIALI
VGGIVLLYIDRMPRRIRYKDAMEFPPSVCLAIGFFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMAGAFTYDLIKNRDILSTDDMTLIVIGFVAAFLSALFVVKFLLDF
VSRHGFAPFAWWRIVFGTAGLIALYAFA
>A0A0P9MU21|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPKQRQAQRFTVNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
VGGVIMLWAERRQHTVRTETVDDMTWSDALKVGMVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDVAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A097SRS0|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
MPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTF
KVLLCGAVLXRIDAGQEQLGRRLHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
TAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRK
LLTSELLTLASRQQLIDWIEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPD
GKPSRIV
>A0A104JBI2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLDFNAEQEKTFDVVIQFGAILAVC
WEYRRRIGTVVAGLPTRPEARRFALNVVIATLPAIVLALMFEKAIKRLLFSPVPVAFALV
AGGLVILWAEARQRDRSEPARVMSIDALSPLDALKVGIAQCCALIPGVSRSGSTIIGGML
AGLDRRVATEFSFFLAIPIIFGATFYETVKDWHAFSVDSVGLFAVGMVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLLVLLVGYSGWLDWS
>A0A0L6FR80|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKRPPHLLLAATLTLAAPPLLANDLQATVDGVIPPLMREQGIAGMAVAVYANGQSHYFNY
GLADKASRQAVSRDTLFEVGSVSKTYTATLAALASAEGKLDLQAPANRYQPALAKASIGK
ASVLELGAYSGDCLPLQFPDEVQTPAQTLAWFQHWQPRFAPGTHRCYSNPSLGLFGDLAA
RAQQRPFAELMIQQVLPRLGLKHTYLEVPASARGLYAQGYDANDKPVRVNPGPYAEQAYG
IKTSASDLLRYVQLQLQPDTLDPAMRKAIAITQSGYFQVGAMTQGLGWERYPYPVSLDTL
LEYNGAKIIRGENPIQALNPALPADPAAWYNKTGATGGFGAYVAFVPSRQMGIVLLANRN
YPNEERVRAAQRILSSLEP
>YP_002398630|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWMERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFMNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLNWEPKIDMQETIDETLDFFLRTVDLTDKPS
>C6KGW8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKSVGK
>A0A0A0Q7Y1|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-5|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>YP_001785754|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLILKAIIIGIVEGITEFLPVSSTGHMIIAGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIMSTLKNFFPSDRVPVKKCGLKFWINIVIASIPAAVIGIPFNDKIEEKLFY
PLPVTIALIVGAIWMIYAENRYRNNSKVISIDDVNAKQAIIIGVFQCLALWPGMSRSAST
IIGAWIVGLSTVAAAEFSFFLAIPAMIGASGMSLIKHNVFSTCSSIELIALAAGFIVSFI
VALVVIDKFIAFLKKKPMKVFAIYRIVLGIVLIILIYANIITWH
>R4WAM1|FEATURES|UNIPROT_deepARG|beta_lactam|AQU-1|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVLKGGQAH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGMHHSYINVPKQAMANYAYGYSKEDKPIRVNPGMLAD
EAYGIKTSSADLLAFVKANVNGVDDKGLQQAIALTHQGRYSVGGMTQGLGWESYPYPVSE
QTLLAGNSAQVIMKANPTKAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHAILSKLAP
>AAQ16270|FEATURES|ARDB_deepARG|glycopeptide|vanYG1|antibiotic target alteration|0
MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASSFLWYGFGNAAKKDSVIEEMPFTITQD
GMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYEVNLA
K
>B2CD54|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
GLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQ
LLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIIYARH
SP
>A0A0K3ZVD3|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRSLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPTAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGISAWNMLIGI
LIACSIVSLLLIMFVAPGRPVTAHEEIHHHA
>A0A0U7SXC8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MPRVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLSQPYEIILVDDGSSDNSADMLTA
AAEKPDSHVIAVLLNRNYGQHSAIMAGFNQVTGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEIDVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SIVALSGFVLALVLIALRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGAQQGHNTQEEE
>W1INC0|FEATURES|UNIPROT_deepARG|polymyxin|pbgP|antibiotic target alteration|0
MVFEKIKKVSVVIPVYNEEESLPQLLERTISACQQLEQKYELILVDDGSRDSSADILTQV
AEDPKNHVIAILLNRNYGQHSAIMAGFHQADGDLIITLDADLQNPPEEIPRLVKTAEEGY
DVVGTRRANRQDPWFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIVRAMLQCHERS
TFIPILANTFARKTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGS
IIAVTGFLLAILLIALRLIFGSMWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGAKKTDDNQEKRE
>A0A076W689|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYRSEITSDTIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAI
LAIAVLYHKRLVSLCNIKPLLQKEKKFNVLHVFLGVFPAVVAGLLLHDVIKTYLFQPYTV
VIGLVAGAILMIFAEVKKPEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTMSGGL
LAKVNYNAASEFSFLIALPVMVGATGLDLLKSWEHLSIDDIPMFAVGFITSFVVAMLAVV
TFLKLLAKIGLKPFAYYRILLAIVFTLFVLL
>ZP_03832747|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVLAIMVMLTGLLAIVKLPIAQYPTIAPPAIEVTANYPGADASTLQDS
VTQVIEQNMNGIDNLMYMSSSSDSSGTVQITLTFDAGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVNVQKSSSSFLMVAAFISEDGKMSQEDIADYVAANVKDPISRTSGVGDAQLFGA
QYAMRIWLDPNKLNNYQLTAGDVTAAIRVQNNQIAAGQLGGAPPVPGQQLNASIIAQTRL
NSAEEFSKILLKVNADGSQVRLKDVARVELGAESYDTIARFNGQPAAGIGIKLATGANAL
DTATAVKNSLTKLEEFFPSGLKVVYPYDTTPFVKISINEVVKTLVEAIVLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSAFGYSINTLTMFAMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATKRSMEQIQGALVGIALVLSAVFVPMAFTGGSTGAIYRQFSITIVSAMVL
SVLVALILTPALCATLLKPIAKGDHGEKKGFFGWFNRLFEKSTHHYTDSVANILRSTGRY
LVIYLLIVVGLALLFLRLPTSFLPDEDQGVLLNIVQLPSGATQENTQKIMDRMTQYYLEN
EKGNVKSVFTVTGFGFSGRGQNAGLAFASLNDWSERSGAENKVQAIAGRANAVFSQYKEA
IVIAANVPAIIELGTATGFDFQLIDQANLGHAKLTEARNQLLGMAAQRPDTLVQVRPNGM
EDTPQFRLDIDQEKAQALGVSLSDISSTLATTLGGSYVNDFIDRGRVKKVYVQADAPFRM
LPDDIKNWYIRGSNGQMVPFSAFTQSHWEYGSPRLERYNGQPSMQIQGEAAPGKSTGEAM
ALMESFVTQLPQGIGYEWTGMSYQERLSGNQAPAIYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGIIGALIAANMTGLENDVYFKVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLDAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPVFFVVVRRRFGKKVDDTTAH
>A0A0F0DUF2|FEATURES|UNIPROT_deepARG|aminoglycoside|UB43_11210|antibiotic inactivation|1
MRHCEEPDLPDWIELRLQLWPGDHADAFVAEARDILAQPQRYGAWLARDEKGRALGLAEA
SVRSDYVNGTDGSPVLFLEGIYVREDARRQGVARALVGAVQVWGCARGCVDFASDAALDN
TDSHALHLALGFVETERVVYFRKPLDD
>A0A0J6NMN1|FEATURES|UNIPROT_deepARG|beta_lactam|VK98_00160|antibiotic inactivation|1
MFKHLILFASLAAPLTQAVAADPLAVAADKLAKLERDFGGSIGVYAIDTGSGATVANRPN
ERFPLCSSFKGFLAAGVLAQSQQQPGLLDKRIRYSKTALPNWSPITTKQQANGMTVAELN
AASVQYSDNGAANLLLKEINGPAALTAFMRSIGDASFRLDRLEPELNSAIPGDPRDTSTP
KAVAESMQKLALGKALPEAQRQQLADWLKGNTTGNARIRAAVPAGWEVGDKTGTCGVYGT
ANDFAVIWPPKRAPIVLAVYTKHAKKEAKHSNEVIAAAARAALEAFKVKK
>A1JPP5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSESEKIKKVSIVIPVYNEQESLPILIERTSAACKLLTQPYEIILVDDGSSDNSAELLTA
AANEPESHIIAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRAHRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGAEQTENNQEVEK
>A0A0D7E8S0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWVAIQALILGVVEGVTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRRKILDVVIGLPKESQAQKFTLNLLIAFMPAVVLGVAFADLIHEYLFNPITVATALV
IGGVVMLWAERRDHIIRAETVDDMNWALALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDFAVFAVGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIGFGLLILATWQFGLIDWASAQG
>D1LFI2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
QLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRRLTLGHALGETQRAQLV
TWLKGNTTGAASIRAGLPTSWT
>A7Y410|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVSGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A061NCH9|FEATURES|UNIPROT_deepARG|chloramphenicol|JCM19055_3274|antibiotic inactivation|1
MTFNPIILENWERKEYFNYYLNQQTTFSMTTDIEISSFKAAIKRKGYKFYPTFIYIVTEV
INANESFRISFNEEGKLGYWEKLIPLYTVFDDQKQSFSNLWTESTSNVLTFQEDYDRDVV
EYNHMGGLFPKTPIPANTFPISMIPWNSFSGFNLNVGDGGNFLLPIITAGKYYSKATATY
LPVSLQVHHAVCDGYHAASFLNQLQELANTTNEWL
>ZP_02707994|FEATURES|ARDB_deepARG|quinolone|PmrA|antibiotic efflux|1
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISA
ALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNA
TALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAI
LTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVR
DLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANA
SSPLQLGLYRFLFGLGTGALIPGVNALLSKMAPKAGISRVFAFNQVFFYLGGVVGPMAGS
AVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>NP_347599|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MYTNLIFIFKIILEGIIEGVTEFLPVSSTGHMIILGSIIGFKEGAKPVSLYGAEYIHMFE
IIIQLGAILAIVVLYWDKIFSALKPSNLFPSMKEHEKSGIGVVGEFFVKGYNTMPGFKFW
TNIVVACIPAIVIGLPFQKKIDKLLFFPAPVAAALMVGAVWMIFAENKYRKRAKIKSVDE
ITIKQAIVIGCFQCLALWPGMSRSASTIIGAWIVGVATVAGAEFSFFLAIPMMLGASLLF
LIKNSVVLSSVQILGLAVGFIVAFIVALVVVDRFISFLKKKPMRIFAVYRLAIGIIVLVL
GFTKVIS
>U7QXZ7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNALLELRGIERSYSAGEQQIKVLDDVTLSIHSGEMVAIIGASGSGKSTLMNILGCLDKP
SRGEYRVAGQNVAELNNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAIYAGAAKTV
RRQRAIELLGRLGLDKRVNYRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCEQGHTVIIVTHDPKIAVQAQRIIEIKDGHIMNDSGSQLSKTVTEAPPIT
AKISSIRQIFGRFNEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVTILVIGDAAKALVL
SDIKEIATNTISVYPGEDFGSDDPASKQALKIADVNAIRAQPYILAVSPDIEGGARLRKG
NIDVAARVSGIGDEYFQVYALRFAQGMGFTSDMVRRQGQVVVIDKNTQHKLFPHQKNVIG
EVILMGNMPATIVGVIAERKSALGSDSSLHVWLPYSTMTSRLLNRNYLDSITVRIKDGHN
SKEAEQKIVRLLTLLHGKKDIFTYNTDMLIKTVEKTTRTLQLFLTMVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAILVCLVGGILGIALSYTIAFIAQLA
LPGWSFVFQPVALLSAFACSTAIGVIFGFLPARNAARLDPIDALARE
>A0A127SUG6|FEATURES|UNIPROT_deepARG|chloramphenicol|catA16|antibiotic inactivation|1
MTVNIDITDLLKLTKERNYKLYPVILYAITKVVNNHIEFRMSLDENDNLGYYINVNPSYT
IFHKDNNTFSNIWTKYDSSFEKFYNNYEKDIQEYGNEKGFITKKCEENNLINISSIPWVT
FTEFNLNLPRGEKYLLPIFTVGKFYEQSNKILLPLAVQVHHAVCDGFHTSRFINDLQEFV
NNFENIV
>A0A0U0X9I2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>A0A0M2SZS9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSVKGLNHLLFSVSNLEDSIKFYKNVFDAKLLVKGRSTAYFDLNGIWLAHNEEKDIPRNE
INQSYTHIAFSIEETEFDHMYLKLKELNVTILPGRTRDERDKRSIYFTDPDGHKFEFHTG
TLQDRMDYYKKEKTHMEFYN
>ABC38359|FEATURES|ARDB_deepARG|multidrug|AmrA|antibiotic efflux|1
MKYEWARMRRRWAALAVAAFVAAGCGKRESAHEAAASREASVVTVKKTSVPLSVELPGRL
DAYRQAEVRARVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKAQAAHL
AALDKRRRYDELVRDRAVSERDHTEALADERQAKAAVASARAELARAQLQLDYATVTSPI
DGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQ
QDVEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDR
AVARDAILVPRDALLRTADSATVKVVGENGKIRDVTVEATQMKGRDWIVTRGLAGGERVV
VVDAAQFDAGATVKAVERGAAAQPASGAAAAAAPDKRQT
>K0X1K5|FEATURES|UNIPROT_deepARG|beta_lactam|I1A_001895|antibiotic inactivation|1
MSFINPSKVISRSAFGLFFGAAACMAATPSDEQLQALVNKAVTPVMQQQNIPGLAVAITV
NGQPHYFNYGVAAKDTGQKVSESTLFEIGSVSKTFAATLAGYAQATGKLDLSTKASQIWP
ELKGSAFDGISVLQLGTYSAGGLPLQFPDEWDSADKMLGYYKQWQPSFPAGSQRLYSNPS
LGLFGYLAAKTLGQPYDQVMSETLLPKLGLKHTFIQVPASEAKLYAQGYDKKDQPVRVSP
GALDSEAYGIKTSAADLLRYVEANLKPASLEAPLQKAIASTHTGYYTVGDMTQGLGWERY
AYPISLDKLQNGNSTPMAMEAHKVKWLASPQPEPANVLYNKTGATGGFGAYVAFVPSKDL
GIVILANKNYPNAERVKIAHEIFSALTD
>A0A089ZG21|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMDIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKIHHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFKAFLG
>A8DF57|FEATURES|UNIPROT_deepARG|beta_lactam|ampC-EC68|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPLNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A097SRR9|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
CLPVFADGETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGA
VLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLL
TTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDQRDTTMPAAMATTLRKLLTAELL
TLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAAVGPNGKPSRIV
VISNTGGLATM
>Q6FBS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP3|antibiotic target alteration|0
MGNIEAFKALFLGFIEGLTEFLPISSTGHLILFGHLIDFHSDSGRAFEVVIQLGAILAVC
WLYRKKIIDLVQGFFSGDQEARHFTFSVLMAFFPAVIIGVLAVDFIKSVLFSPLVVAIAL
IIGGLIIFWVESRDFKPSTTEATKITFKQAIAVGFIQCLAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLLRNADVLTSDNMLNIGLGFITAFISALFVVKALVR
FVEKHTLRVFAWYRIVLGIIIMFVML
>R4S362|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-33|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLSACWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A068R1Q2|FEATURES|UNIPROT_deepARG|polymyxin|pbgP|antibiotic target alteration|0
MIFEKIKKVSIVIPVYNEEESLPQLLERTLAVCQKLEQKYELILVDDGSRDSSSDILTQV
AESPENHVIAILLNRNYGQHSAIMAGFHQADGDLIITLDADLQNPPEEIPRLIKTAEEGY
DVVGTRRANRQDSWFRKTASKIINAMITKATGRVMGDYGCMLRAYRRHIVLAMLQCHERS
TFIPILANTFARKTTEIDVAHAEREFGDSKYSLMNLINLMYDLLTCLTTAPLRLLSVVGS
VIAITGFLLAMLLIALRLIFGSIWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGVKKTNNNQEEN
>CAR59503|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYTSEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLVMIVLWNAGYIIRSMHNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFLGLLVNIPVNYIFIY
GHFGMPELGGIGCGVATAAVYWVMFIAMLSYIKHARSMRDIRNEKGFGKPDSVVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLGVGICMAVVTAIFTVTLRKHIALLYNDNPEVVALAAQLMLL
AAVYQISDSIQIIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAVLMMLRMRYLQRQPSAIILQRAAR
>F6B6X8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNLLTPIILGIVEGLTEFIPVSSTGHLILSGELLHFTGERAATFEIFIQLGAILAVVML
YRERFLRLFSRRNLMEGLRFKQRELNLAHIAIAILPAFIFGFLLHDIIKKYLFSAHTVLV
GLVVGGIVMILAERLPIPAFATNLDKINFRQCLVIGLAQCLSLWPGFSRSGATIAGGLVA
GLDHKTAAEFSFIIAVPVMFAATGYDLLKSWQLITPDFMVTLAIGFVVSFIVSVLAIVGF
LKLLNRTKLTPFAIYRFILALAYYMVILR
>A0A127ST56|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSKFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNHPNPARVAAAWQILNALQ
>A0A0A6QHA5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWIVACKALVLGIVEGLTEFLPISSTGHLIVAGSLLGFDGEFEKTFDVVIQLGAILAVC
WEFRRKIGTVVMGLPTRPEARRFALNIVIATIPAVVLGLLFEKAIKSVLFSPVPVAFALV
AGGLIILWVEGRRRAGRGPGADKAPPPARVNSLDDISLLDAFKVGLAQCCALIPGMSRSG
STIIGAMLFGVERRVATEFSFFLAIPIIFGATVYEMHKAWQTLSVDWLGLFGVGFVAAFV
SAFACVRWLLRYIASHDFTAFAWYRIAFGLVILLFGYGDWLDWQ
>H5SEZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLISIIAFFVWGEPKMEHTAIALLLGLLEGATEFLPISSTGHLIVAQAWLARTSEADKTF
AIAIQLGAILAVCWHYRGRIAAVLFGLMQRDAPAVRLVVNLIVAFLPAAVVGLLAGKAIK
AHLFSPAVVATTLALGGVAILLVERFRSTPRIARVEEMTWRDALKVGCAQCLALIPGTSR
SGATILGGLLFGLSRTAATEFSFFLAVPTMFAATLYTLTKDWQSLTISNVHEIAVGFVAA
FVAGLVAVRWLLAYISRHSFALFAWYRIALAAVVWWVLVR
>C9Y4A5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTRAKSNALYAAAWRLVLSPETLIMTFFCASMRRGEPMKRKVSVLLMMIVLGSAAQAAPV
SRPDDVVEPLMARYQIPGMAVAVSVNGETHFWHYGVASKATRKPVDEKTLFEIGSLSKTF
TATLASAAQQEGKLDFSAPASRYLPALNGSAFDRVTLRHLATHTSGMPLFVPDDVKNTTQ
LMAWYRAWQPAQPVGTERVYSNLGIGMLGMITAKALDKPFSEAMEQGLLADFGMTHSFIN
VPDAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSSSADLLRYLQIQLGERDVAPRWRQ
AINATHNGYYRSGEFTQGMMWEYYPWPSPLSRLVEGNSSQRIMKGLTATAIVPPEPAPQA
AWYNKTGSTNGFSAYAVFIPEKRIALIMLANKWFPNDDRVRAAYDIIQELDK
>A0A0U0X1M3|FEATURES|UNIPROT_deepARG|beta_lactam|MAB_2875|antibiotic inactivation|1
MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPDELASLEKDFGGRIGVYALDTGSGDTVG
HRADERFLMCSTVKTFIVSAILRRRLSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTV
SELCDATLRYSDNTGANLLITQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTS
TPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKG
ETNDIAVIWPPGRAPIVMAVLTVPEDPTSTKGKPTIAAATRIVLRAFGA
>A0A133LLA9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSIAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRVAISPDDVALTLHHKLCQAARQLLEEALPAI
KTGDYAEHPQQEAEATCFGRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCKNDRTAQPGTVISVSPLLIACADGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTAKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAISRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPENEASIQELAEMLLTCFEKHPLRNHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>A0A0C1WI12|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSSINLNKLKSYSAFGLFFSAAACLAAPPTDDQLQALVKAAVTPVMQQQDIAGLAVAVTV
DGKAHYFNYGVADKSTGQAVSENTLFEIGSVSKTFTATLAAYAQASGKLQFSDKASQHWP
ELKGSAFDHVSLLQLGTYTAGGLPLQFPDAADSADKMLGYYQQWKPTFAAGSQRLYSNPS
IGLFGYLAAKSLGQPFNQVMTETLLPKLGLKHTFLSVPASEQKLYAQGYDKNNKPVRVSP
GALDSEAYGVKTSAADLLQYVEANLDTAKLETPLQKAIALTHTGYYTVGDMTQGLGWERY
TYPISLDRLLDGNSTPMAMEAHKVKWLNPPQPEPANVLLNKTGSTAGYGAYVAFVPSKKV
GIVILANRNYPNGERVKIAHRILGELTR
>F1ZCC6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSLNITAILLGIVEGLTEFLPVSSTGHLVLATELFGYNPKAWEVFNVVIQLPAILAVVV
LYRNTFTQVAIGVLRKDRESLHFVRNVLAAFIPSAVLGVLLKKKIDAMLETPVIVAVALI
VGGFAIIAIEKFAREGKFEPVSALSLRKSFTIGLMQCLAMIPGVSRSGATIMGSLAMGEN
RRTAAEFSFFLAVPTMFGATAKQLWDNRHELTAQAGPVGWTQIAIGSVVSFVVALVVIRL
FLDYVTKRGFIPFAVYRIIAGGLALVWLMKI
>A0A0F4BNW3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYEILLVDDGSSDNSALMLTE
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIALAGFAISVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEEIHP
>J2YH51|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHNKNLALSGFFTISLLLSGASACLAASQPDSALKPLVDAAIRPLMQQQDIAGMAVAITL
KGQPHYFNYGLASKEGKKAVDADTLFEVGSVSKLFTATLGAYAQASGKLSLNDPASRYLP
ALKGSAFEHISLLQLGTYSAGGLPLQFPAQWDSQDKMLGYYQGWKPAFAPGAQRLYSNPS
IGLFGYLAAQSLGQPFEQLMEQRLFPQLGLQHSYVQVPKSQMGNYAQGYDKDGKPVRVGP
GALDAEAYGVKTSATDLLRFVQANLKPESLAQPWPQAIALTHTGYYQVEGMTQGLGWELY
PYPLSLDALLAGNSSQMAFEPHPTRWLTPPKAPRADTLLNKTGSTGGFGAYVLFVPGKDI
GLVLLANKNYPNAERVKVAHALLKALDDAQP
>A0A0T9UJU3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_6|antibiotic efflux|1
MTALLELKGIRRSYQSGGETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKHE
RRERANMLLTRLGLEERVNYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKTVPTVAASEVMS
LTAPAPSWQQLTGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQM
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMVALKEQSYVSAVSPTISGSMRLR
YGNVDVAASVSGVSEQYFRVFGMKLEQGTPITREQVERQSQVVVIDRNTQRRLFPHIKDV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMANRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLIVE
MFLPNWQIAFPPAALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A150DXL6|FEATURES|UNIPROT_deepARG|beta_lactam|AT270_14340|antibiotic inactivation|1
MEKNILLKLGVCVSLLGTTQFVSTISSVQAERTVEQKIIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKMLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKNLGNVADAYVNEWSTSIENVLKRYRNIISVVPGH
GEVGDRGLLLHTLDLLK
>A0A117UZ58|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTTITAILLGIVEGLTEFIPVSSTGHLILASELFGYDAKSWEVFNVVIQLPAVMAVVVL
YWRTFMDVAVGALRGSRESIAFVRNVLAAFIPAAIVGVLFKSRIDLLLENPVVVCAALIL
GGFAIIAVERLVSHQNYRPVGQMPLGQAIRIGFMQCIAVIPGVSRSGATIMGALVMGENR
RTAAEFSFFLAVPTMLGATVKQLWDHRHELSAGAGPVGMKEIAIGSVVSFVVSLIVVKFF
IGYVSKRGFTPFAVYRIVLGAAGLVWLLWV
>L8PUR1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWELFVAAILGIVEGLTEYAPVSSTGHMIIVDDIWLKSSDLMSEEAANSFKVVIQLGS
ILAVAIVFKDRILNLLGLKKNITSDQEQGHKLSIAQIAVGLVPAAVLGFLFEDYIDEYLF
SVKTVAIGLIAGAVLMLFADWVNKRKTATDTLDRISYKQAIGVGLFQCLALWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAMPIMMGASFLSLVKHWDSLSSDLMPFFIVGFICAFVV
ALFVVRFFLKLINKIKLVPFAIYRIILGVILLLIMM
>D4JFD6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKSILYGIVEGITEWLPISSTGHMILLEEYMPMNVSKDFWDMFLVVIQLGAIMAVV
LLYWNKIFPFRIRKNEKIKVKQDILILWLKIIVACVPAAIVGLLFDDWLNEHLYNGFVVA
VMLIVVGVAFIIIENKNVNKPSRVNTLSQITYKDAIIIGVFQLIAAIFPGTSRSGATIVG
GLMIGVSRTVAAEFTFFLAIPVMFGASLLKIVRFGLSFSLMEFLILIVGMLVAFVVSILV
IRFLMGYIKKHDFKIFGYYRIILGAIVLLTFIF
>BAA31456|FEATURES|ARDB_deepARG|multidrug|norM|antibiotic efflux|0
MHRYKEEASSLIKLATPVLIASVAQTGMGFVDTVMAGGVTQTDMAAVSVASSIWLPSILF
GIGLLMALVPVVAQLNGSARREKIPFEIQQGVVLALLISIPIIGVLLQTQFILQLMDVEA
VMADKTVGYIHAVIFAVPAFLLFQTLRSFTDGMSLTKPAMVIGFIGLLLNIPLNWIFVYG
KFGAPELGGVGCGVATTIVYWVMFALLLAYVMTSSRLKSINVFGEYHKPQWKAQVRLFKL
GFPVAAALFFEVTLFAVVALLVSPLGPIIVAAHQVAINFSSLVFMLPMSVGAAVSIRVGH
RLGEENVDGARVASRVGIMVGLALATITAIITVLSRELIAELYTNNPEVITLAMQLLLFA
AVYQCTDAVQVIAAGALRGYKDMRAIFNRTFIAYWILGLPTGYILGRTDWIVEPMGAQGF
WLGFIIGLTAAALMLGVRLRWMHRQEPDVQLNFSLQ
>A0A0E3KEI5|FEATURES|UNIPROT_deepARG|beta_lactam|VO64_0581|antibiotic inactivation|1
MKRNLQTLLVSALLLGSGSCMAAVDIRQVVDSNVKALMQQQAIPGLSVAIVNQGKVQYFN
YGVAAKDTQAPVTEDTLFEIGSVSKTFTATLGGYAQATGKLKLSDMASQHLPALAGSAFD
HISLLQLATYTPGGLPLQFPKTADSAKTMLGYFQHWKPTYAPGEQRLYSNPSIGLFGYLT
AQSLGQPFNVAMEKTLLPKLGLTNTYVSVRSDKAGQYAQGYDKQQNPVRVSPGALGGEAY
GIKTSSQDLARYVIANMHPQALEQPLQQAIAATHAGYYTVNGMTQGLGWERYPYPITLQA
LIDGNSTPMAMEPHKVNWLSPAQAQPANVLYNKTGSTGGFGAYVAYVPSKDVGVVILANR
NYPNAERVKVAHAILSALDK
>A7HS58|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDPNFLHAIILGIVEGVSEFLPISSTGHLIIVGELLGFSSVPGKVFEVVIQLGAILAIC
VLYSGRLTRVLRDAPRDAGARNFIGAIFVALIPAGLLGVLYHDFILEVLFTPYVVCAALI
TGGIAIVVVERLHLEPRITSVEAFSMRTALKIGLFQCIALVPGVSRSGATILGALLVGVE
RKTAAEFSFFLAIPVMLGASVVSLRDTWQLISMDDLHLIAAGFIAAFISALLVVKWLVSF
VSSHGFTVFGWYRILFGSLLLIYFSLSS
>ABM94007|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDILLLVKAAIMGIVEGLTEFLPISSTGHLILTASLLNFTGEIVKVFDIAIQTGAMFAVI
WEYRVRLRATVAGITHEAVAQRFVRNLLIAFVPAVISGLALGGLIKEHLFHPVPVATAFV
VGGLIILWVERRHRALFGDRDLEGGRVARVETIDDMSALDALKVGLVQCAALIPGTSRSG
ATIIGAMLFGFSRKAATEFSFFLGIPTLMGAGAYSLIKQRDLLSWGDLPVFAVGVVFAFL
SALVCIRWLIRYVSTHDFTVFAWYRIAFGGLVLLSAWGGWVDWKD
>Q93FX9|FEATURES|UNIPROT_deepARG|aminoglycoside|APH(3'')-Ib|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSYRLINV
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>Q38VP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLTLNVIKAIILGIVEGFTEWLPISSTGHLVLVGSVLKMGESKAFMDMFNYVIQFGAILA
VVVLYFHKLNPFSPQKNQLEQKQTWTLWFKVILAVIPSVIIGFPLNDWMDEHLMQNWVVA
SMLILYGILFIVIENRNKQRTPKFADLNTLPWLTAFWIGCFQALSIIPGTSRSGATILGA
ILIGTSRFVGAEFSFFMAIPTMIGVSILKIGKFFYQGNTFTGDQSIILLVGMVVSFIISI
ISIKFLMGYIKKNDFKVFGWYRIILGVLVLGAMFL
>A0A0L6TZX8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGFIEVLKAIILGVVEGVTEWLPISSTGHMILVDDFIKLNMSDPFIEMFLYVIQLGAILA
VVYIYWHKLVPFSFTNGKIMIRKNTVILWSKIVVACIPGIVAYILLDSLFDTYFMNSITV
SAMLILYGILFIIIENYNKKRKPEIVKLSQLTYKKALQIGAFQALSIVPGTSRSGVTILG
GMILGTSRTVAAEFTFFMAVPVMFGISLLKMIKFGFAFTPWEALILLVGMVSAFITSVLA
IKFLMTYIKKHDFKIFGWYRIVLGVIILGYFLIRG
>A0A0J7EFX0|FEATURES|UNIPROT_deepARG|beta_lactam|TU65_26010|antibiotic inactivation|1
MIVSKKVFHIAQYKKMLPVVLLSCVMLISCSNSNIQSEPSKQTKQENISRHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKVLAVGALLQKKSIEDLDQKIKYTSKDLV
NYNPITEKYVGTGMNLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDSVTNPE
RFEPELNEVQPDDTRDTSTAMALATSLQTYALSDILPIEKRSFLIDLMKRNTTGDNLIRA
GVPAGWEVADKTGSGSYGTRNDIAIIWPPNKNPIVLAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNKL
>ZP_03302371|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWGLNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKLEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDAK
>EAS48788|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDFAAVGDAVILGITEGLTEFLPVSSTGHILLLGHFLGFQSTARSFEVLIQLGAILAILI
LYFGRLWRIFVTLPTEPRSRRFAAGILLAFLPAAFVGVLAHDFIKTILFETPMVICVALI
VGGILLLVIDRMPRAVRYDDIMDYPLSLCLKIGIFQCLALIPGTSRSGATIAGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTYDLIKNRDVLSLDDAGLIVIGFVMAFVSALIVVRYLLDF
VSRHGFAVFAWWRIGVGLVGMVLLLALPADEGGEAATPVPASASQPLATDGAQPAR
>A0A0S2SBK4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIEGLTEFLPVSSTGHMILTADLLGLNTENDTVKTFEVIVQLGAVLAVVVLYWRRFLS
LFDFRRKISSQPRLNLLHIILAMIPAGLIGVLFRDVIKQYLFGPETVLYSLVIGGLLMIA
AEKFHPPIRSHTLDEITYKQAFTIGMFQVLALWPGFSRSGSTMSGGLFARVSHTAAAEFT
FLVSVPVMLGASGIDMIKSMDHLSMSDFPVFAAGFITAFIVGMLAIKTFLGLLKRLSLTT
FAIYRFVLAAVFFFIIL
>A0A071M3A1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFTMTRFAATLLVAACATTAAGRAAATVQDDIRDTVTRHVAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSKQTGKPVTGGTLFEIGSVSKTLTATLASDAQEGGELSLADPVAKYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDSIRDDAGLIRYLDAWRPEYAPGTHRKYSNVAI
GMLGWLTAKAMHKDFAALMEQRLFPALGMTHTYINVPDARMADYAQGYTKDGRPVRMTQG
MLWQPAYGVRTTAADLLRFVQANMGMIQTAPRLQRAIDRTHAGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNAPKMLYDVVPASAIKPPLAPNPDTWINKTGSTGGFSTYVAFVPSKRIA
IVMLANGSVPIEDRVKAAYGILGSLGAGR
>A0A0M4FFL9|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M15|antibiotic inactivation|1
RFAMCSTKKVKAAAAVLMKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSA
AALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPR
AMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGD
>A0A0U4G4S9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGHPPHEGVGKGRLSLIHILLGMVPAVVLGLVFHDFIKSLFNPIN
VMYALVVGGVLLIIAELLKPKEPKALGLDDMTYRQAFFIGCFQCLALWPGFSRSGATISG
GMLVGVSRYAASEFSFLLAVPMMMGATALDLYKSMSFLTMADLPMFAVGFVTAFVVALVA
IKTFLHLIKRISFIPFAIYRFIVAAAVFAVFM
>ABQ41442|FEATURES|ARDB_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGVLIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTYFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRPRGAATEKSPVV
>A0A117JCY0|FEATURES|UNIPROT_deepARG|beta_lactam|AU186_01365|antibiotic inactivation|1
MIRLSRRHVLIGGLTLAAVAACTEKQAVADPRAVPPIDARIGEFERQHNALIGVFAVNLD
TGRAIAHRAQEPFAMCSTFKGYAAARILQKAERGELALSDRVAVEQSDIVPNSPVTQTRV
GQTMTLAELCEAALQRSDNAAGNLLLRAIGGPPAITDFARSIGDQRSRLDRWEVELNAAV
PGDPRDTTTPEAIGGGYRSMLTGAVLAEPQRRLLEDWMRANQTSSVRPALAPGWTTADKT
GSGDYGSTNDVGVAFGPDGRRLLLAVMTRSAGNDPNAPNMRPLIGELAALLVAALLA
>A0QVQ7|FEATURES|UNIPROT_deepARG|beta_lactam|MSMEG_2658|antibiotic inactivation|1
MTNLSRRSVLIGSLAVMAAAGVRMPTASAAPVDDRIADLERRNNASIGIYAVDLDSNRTV
AHRADDSFAMCSTFKAYLAARILRGAERGELSLDDRVFVDPAALLSNSPITETHAGGEMT
LAELCQAALQRSDNAAANLLLKQIGGPAEITAFARSIGDQRTRLDRWETELNSAVPGDPR
DTSTPAALAGGFRAVLTGDVLAPPQRQLLDEWMRANETSSLRAGLPDGWTSADKTGSGDY
GSTNDVGIAYGPQGQRILLALMVRTRGDDPNADGFRPLIGELTALVLPELGVH
>A0A0A2TLI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDFLSALILGIVEGITEFLPISSTGHLIIVNQFVGFTEQFANMFDVVIQLGAILSVVVY
FWKRLIPLGFNKSSDNQGIFDLWKKTLVGVIPALGIGFLVGKYIEELLFNTTVVAIALIV
GGLILLYIENKRPSVRISSIQHLSYKTAFLIGLIQCLAMIPGTSRSAATIIGAMLLGATR
VVAAEFSFFLAIPTMFAASAYSFFKNSMFLTAHELIVVACGFFVSFIVAWMVIAGFMNYI
SKRDFKPFAYYRIVLGIFVLIYFGFLQS
>E3G224|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTTLLELKDIRRSYPSGDGSVEVLKGITLSVNAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVEGVDIATLDGDALARLRRDHFGFIFQRYHLLPHLTAAQNVEVPAVYAGRGRQQ
RLARARELLGRLGLHERVDYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSASG
EEVMAILHQLREQGHTVIVVTHDPEVAAQAERIVEIRDGELISNPPAKPAAAARVGAEKT
LPASGWRQFSGGFREALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVIVGDAAKQRVL
ADIRAMGTNTIDVYPGKDFGDDDPQYQQALKYDDLLAIQKQPWVSSATPAVSKNLRLRMN
NTDVAASANGVGPQYFNVYGMTFSEGSTFNDVQLRGRAQVVVLDGNTRRQLFPHKASVVG
EIILVGNMPATVVGVADEKQSMFGSSKILRVWLPYTTMAGRVIGQSWLNSITVRVKEGYD
STLAEQQLARLLNLRHGKKDIFTWNMDSILKTAERTTHTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARAADVLQQFLIEAVLVCLVGGALGVGLSLMIAFTLQLL
LPGWEIGFSPLALLMAFVCSTLTGVLFGWLPARNAARLDPVDALARE
>G4HC67|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDVVKAIILGIIEGLTEFLPVSSTGHLILAGSLLNFEGDAATTFKIVIQLGAVMAVLIL
YWKRYLAIGTNLIRMDFSRSRGLNVIHMILAMLPALIVYLLLKDTIKSHLFGPTPVLIGL
VAGAVLMIIAARSRRTETADTMDRINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGATLLDLYDSRDLLSSDDLVLMLIGFVTSFLVAMIAVVTFIK
LIKRLRLEWFALYRFVLAALFYFIIIL
>A0A0G9K8E7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFDSILLGIIEGFTEFLPISSTGHLIVLSEILGLEQNNVNKAFEIIIQFAAIMALVFV
YPSKFTFSHIELWKKIVIAFLPIGIVGFLFSSQIKNLFSIEIIAWMFIIGGIVFLIIEKF
YDENKTHTLDVENVSYKQAIFIGVMQIFALIPGTSRAGASIIGAMMAGLNRKTSAEFSFL
LAVPVMCATTGYDLVKHHEELLVGANLLNLAIGFVVSFFVALIVIKLFLKFLERFTFVAF
GIYRIIFGILILLIF
>ABG36700|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSGQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMDRRL
VHGETADLAPTGFGQQVREAMDQRREHHIEQRDATRNRDGRIFYRRNLLATLREREVARA
GAEMAEGKALPFRAAKDGESVSGKFTGTVHLSSGKFAVVEESHEFTLVPWRPIIDRQLGR
EVMGIVQGGSVSWQLGRQRGLER
>A0A127SD47|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLDKIDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTPDATVHLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHNTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLIKGG
K
>I2B7L4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGIRALLAAGYHIAAIFTHTDNPAENHFFGSVARLAAEQGIPVFAPD
DVNHPLWVARIRALHADAIFSFYYRHLLSDEILSTARIGAWNLHGSLLPRYRGRAPLNWV
LVNGEKETGVTLHRMVSRADAGDISGQLPVSIDDNDTALSLHKKLCAAATTLLGDVLPAI
RDGKDRAWPQDEHQATVVRGRTPEDGALHWENPARALYNLVRAVSDPWPGAFSYAGNSKF
IVWSSRVRSDLPPAVPGTVLSVSPLVIACGEGALEILTGQSEGGVYMQGAQLAQALGLVA
GARIAAQPPVAARRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGTDAIGRFLGNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCTDGQFDEDTSNLVVGPISKQRWIYSVSKQLLDRVIWAYGDK
AGLRFTLFRPFNWMGPRLDSLDAARIGSSRAITQLILNLVEGTPVKLIEGGSQKRCFTDI
SDGIEALFRIIENKDGQCDGQIINIGNPDNEASIKELAEMLLACFERHPLRQRFPPFAGF
REVESSNYYGKGYQDVEHRKPSIRNARRLLNWSPGVPMDQTVAQTLDFFLRSIYPDEPQP
>AAA24784|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNVCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0Q9H4Y5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MIINIEEYELSHIDSGPYGITTGKDGALWFTQHKANQIGRMTVDGKITHIDLPTANAGVL
SITSTAHGDIWFTENRVNKIGKLTITGEIMEYVLPNPDSAPFGITEGHNGDIWFTEMYGN
RIAQILPSGEIIEHDLPRPGSYPSFIVAGSDNALWFTLNQSNQIGRITLEGDVTTYNLPT
ERAGPVGITNGPDGALWFVEINGNKVGRITTSGVISEYPIPTPNGRPHAIVTGPDDALWF
TEWGSNQIGRITVNGKITEYPIPTKNAEPHGIVVGSDKALWFAEECNKLGRLSFGQKP
>Q32ES6|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLVSIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLMPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFN
AWLLPAWKLSTIRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGA
PSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLF
TLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGTIGYIGGGWLFDLGK
SAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>A0A127SLW9|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MTVKLDISKLKKDGKKLYPTLLYGVTTIINRHEEFRTALDENGQVGVFSEMLPCYTIGFN
LNLKKGYDYLLPIFTFGKYYEDGEKYYIPLSIQVHHAVCDGFHICRFVNEL
>Q104Z0|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampc-EC10)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARIAAAWQILNALQ
>D7PII5|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKHSETQTELLNRRVSLKKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKS
>BAG24378|FEATURES|ARDB_deepARG|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVDTMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>I6FQN8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYRQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGDFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>D5DFK2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQGINHMCFSVSNLEQSIIFYQKVLGAELLVKGKSTAYFSLNGLWLALNEEKNIPRSDI
QYSYTHLAFSISIENFDEARELLKQHNVTILPGRNRDERDRKSIYFTDLDGHKFEFHTGT
LQDRLAYYQETKPHMTFYSPEE
>F1T7N0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLFVLKSIVLGIVEGVTEFLPISSTGHLIIFEKLMKFESVSPNYVEMYTYVIQLGAI
LAVVLLYWKKIRETIVNFFPQKVGYEKSGFKFWFMIFIACIPGAAVKLLLDKPVEKYLMS
TVPVAIVLILGGFWMIYAEKKFRNNNLGKQKLSVTPKQALIIGAFQCLAIIPGMSRSAST
IIGGWVAGLSTVIAAEFSFFLAIPVMFGYSLLEIIKIGGLTSLPAAELISLAVGFVVAFL
VSVAVISQFISYLKRKPLKSFAIYRMIFAVIVLIAGFMGFF
>F8FE36|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQARIQEYLLTEQDTAPYGITAGPDGALWFTEQKGNRIGRITPDGEMRFHPVPTPESGLS
CITAGEDGALWFTAYKAGRIGRITVEGVITEFALPGDGSAPFGITPGPDGALWVTLTMTG
RIGRVSLTGEITEHALPQAGCFPSFIACGPDGALWFTENQGNAIGRITTDGEVREYPLPR
EKSGPVGLACGPDGALWFTELLGNRIGRISTSGELREYELPAENARPHAITPGLDGDLWF
TEWGSGRIGRITAGGEITEYSIPTEGAEPHGIALGSDGAVWFAEECGRIGRLIPEGPGVP
QA
>A0A088UB18|FEATURES|UNIPROT_deepARG|beta_lactam|DM41_7074|antibiotic inactivation|1
MRFNATRFAATLLVAACVTATAGRAAAATPDDLHDTVTRHIAPLMKQYAIPGMAVGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVGKYLPA
LQGKPFGVVTLLDLGTHTSGGMPVQVPDSIRDDAGLIRYLDAWRPAHASGTYRTYSNVSV
GMLGWLTAKAMHKDFAVLMEQRLFPALGMTHTYINVPEARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLIETAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNSMKMLRDGLPASAIKPPLAPSADTWINKTGSTNGFSTYVAFVPSKRIA
IVMLANRSFPNEDRVKAAYGILGALDGRR
>B4AF44|FEATURES|UNIPROT_deepARG|chloramphenicol|BAT_2929|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMTLTRCSYSLVINLDITTLHAILKEKKLKVYPVQIYLLARAV
QKIPEFRMDQVNDELGYWEILHPSYTILNKETKTFSSIWTPYDENFAQFYKSCVTDIETF
SKSSNLFPKPHMPENMFNISSLPWIDFTSFNLNVSTDETYLLPIFTLGQFKAKEEKIILP
VAIQVHHAVCDGYHAGQYVEYLRWLIEHCEEWLNDSLQIT
>A0A0W0MYP1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHTLKKYAVSALLLGAGSCMAATDMRQVVDSHVTPLMKQQGIPGLTVAVVQHGKVQYFN
YGVAAKDTQAPVTENTLFEIGSVSKTFNATLGGYAQAIGKLKLSDMTSQHLPVLAGSAFD
RISLLQLATYTAGGLTLQFPDAADSATTMMDYFRQWKPTYAPGEQRLYSNPSIGLFGYVT
AKSLGQPFTVAMEKTLLPKLGLTNTYTRVPADKAGQYAQGYDSQQKPVRVNPGALDFEAY
GLKSSSQDLARYVIANMHPQTLEQPVQQALATTHAGYYTVNGMTQGLGWERYPYPIALQA
LLDGNSTPMAMEPHKVNWLKPAQPQPANVLYNKTGSTGGFGAYVAYVPSKDMGVVILANK
NYPNAERVKVAYAILSAMDN
>F0Q7E5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFILLAKAAVMGVVEGLTEFLPISSTGHLILAGALLGFDDDKAKVFDIAIQTGAIFAVV
LVYWQKIRETLVALPTQPRARRFALNVLIGFLPAVVLALIFGKAIKEHLFTPVVVASTFI
LGGFVILWAERRAPGAVRVDSVDDMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERHLLSMSDLPLFAVGLLFSFVSAWLCVRWLLR
YISTHSFVPFAYYRIVFGIVVLATAWTGWVHWAE
>A0A075MBC8|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-33|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIEMDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0K9HW09|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWIELLKAVILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGFRGRHPGGHPRLTLLHVIVGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADKFAKRAARAQTVDEITYKQAFLVGLVQCLSLWPGFSRSGSTIA
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIAGFLSAFVFALL
AIRFLLQLINRIRLVPFAVYRIVLAVVISLLYF
>J7WUA1|FEATURES|UNIPROT_deepARG|beta_lactam|IC3_00736|antibiotic inactivation|1
MIVLKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDRKIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKLLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKNPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNKS
>A0A0G0BIZ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSEIKALILGIIQGITEFLPVSSSGHLVIFEDFLNLDVEALKSFDVVVHMGTFLAIIIYF
FPIFKKLFTAAVSYLPFLKSKKNNADRKLIKLLLIGTIPAVIAGFLLEDTIDYYFRDPKI
IMILMFILGLVFLLVERKSNQKQKDVNKYSQSLIIGLSQAIALLPGISRSGSTIATGLML
GIKREKAAEFSFLLGSIAIFGAGLLTALKTIKSGEMILPWSIYLIGFISSFISGYFSIKF
LMKYLQNHTLKIFAYYLILFSIINFFLNITS
>A0A0G0UM92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQVITYTSAAILGIVEGATEYLPISSTFHLIWASKILGLGQSDFQKAFEVIIQGGAILAV
VFLYLPLWRKKAVLFPKIICSFIPTAVIGLLLYKIIKGFFFENFALQLAVFALIGAGFIF
FENFHKPKLTRQSSELSFREALLVGLIQALAVVPGVSRAGAVILGLMFLKVKRDDAAEYS
FLLAVPTLLAASGLDLVKSAPYLLQNTSEIGILAVGFIAAFASALVAVKWLISYLKNHNL
TSFGFYRIIIAFFLLAIFSSSI
>A0A144PZC3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLLQAVIMGIVEGITEFLPISSTGYLILSADVMGFWTKEKVDLFVVVVQLGAILAV
IYDYWGRLWQALMGLLTGKAEGMANPRQLGLSLIVATIPVMIVGFTFADEIKTYLFNPIV
VAIMLILGGLLIFYVEKRPKKIIAQEAEDVSLKTALLIGLFQCIALIPGTSRSGSTIIGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLLKHGDVLSSSEDWTVLAIGTIVSFVVALLC
IRLLVAWVSRRDFTVFAWLRIITGVIVLIAAWGFGYQMTG
>S5HVM6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTAACESLGKAWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVDHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEESHQ
>ZP_00989608|FEATURES|ARDB_deepARG|quinolone|QnrS|antibiotic target protection|1
MDTNNSTYHHHSFAQQDLSELTFTACTFIRCDFRRSNLRDATFINCKFIEQGDIEGCHFD
IADLRDASFQNCQLAMANFSNANCYGIELRDCDLKGANFTRANFANQVSNRMYFCSAYIT
GCNLSYANFEQACLEKCELFENRWIGTYLGGASLKESDLSRGVFSEDVWGQFSMQGANLC
HAELEGLDPRKVDTSGIKIVAWQQEQLLETMGIVVMPD
>A0A0V1YTV2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQHESDATYYGRRKPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLDWEPSIAMRDTVEETLDFFLRSVDIAERAS
>A0A077VH77|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVILIFRLIKLSYESGYIMFIIELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSSE
FLGSQSAFTFKIVIQLGSVFAAAWVFRERFLEILHIGKHKHVDVENNQQRRSKPRRLNLL
HVLVGMIPAGILGLLFDNFIEEHLFSVPTVMIGLFVGAIYMIIADKYSAKVKTQQTVDQI
NYFQAFVIGISQAVAMWPGFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSL
LKHYQDIQIADIPFYILGFLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIILVIFIAILY
FGFGIGKGI
>A0A098CZF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLNFIELLKIIFLGIVEGITEWLPVSSTGHMLLVDAFIHTDMTQSFKDMFFVVIQLGAI
IAVIVEFWSQMNPFVNVEGKGVRIKRSVFNMWVKVVVAFLPSAVFGLFLNDFLEENFGTP
LTIAIMLIVYGIAFIVIERWNKTRVPKINTMKEITYQTALIIGMFQVLSMIPGTSRSGAT
IIGALLIGVSRVVAAEFTFFLAVPTMLGASAFKLLKFGLHFSLSEVIALIVGMVVAYVVS
IFVIKFLMNYIKRRDFQIFGWYRIALGIIVILFILVGVI
>CAC35724|FEATURES|ARDB_deepARG|multidrug|AcrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQQMPEVGIVTLKSAPLQITTELPGRT
NAYRVAEVRPQVSGIILKRNFTEGSDIQAGVSLYQIDPATYQASYESAKGDLAKAQAAAN
IAQLTVKRYQKLVGTKYISQQEYDSAVADAQQSNAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSAVTEGALVQNGQSTALATVQQLDPIYVDVTQSSNDFLRLKQELANGKLKQENG
KAKVELVTNDGLKYPQEGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
INPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTATQAIGDKWLVTEGLKSGDRVI
VAGLQKVKPGVQVKAQEVASDNQQQTAGNANAQSEQTKS
>ZP_03948381|FEATURES|ARDB_deepARG|multidrug|EmeA|antibiotic efflux|1
MSVFLWRRQIMTKKNSMMYLAISNLFLVFLGVGLVIPVIPQLKEEMHFSGTTMGMMISIF
AIAQLITSPIAGVLSDKIGRKKMIATGMLVFSISELLFGLAQAKSGFYISRGLGGIAAAL
LMPSVTAFVADMTTISERPKAMGLVSAAISGGFIIGPGVGGFIAYLGIRAPFFAAAFLAF
IGFILTLTVLKEPEKRILAAVEAKKGSFMDILRNPMFTLLFVIILISSFGLQAFESIYSI
MATINFGFTTSEIAIVITVSGILALICQLFFFDAIVQKIGEMGLIQLTFFASAIFIAVIA
FTKNNLVVVFSTFIVFLSFDLFRPAVTTYLSKHAGDQQGTINGLNSTFTSFGNILGPMAA
GALFDINHFFPYYVSAVILLGTGFLSLFLNRNKM
>A0A0Q4N8S8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLNRLAALAAAITLCLGHAAAQADDPLHAKVDRIIRPLMQEQGIAGMAVAIYARDHAHY
FNYGVASKADNVPVSQDTLFEIGSLSKTYTATLVALASAEGKLDLNAPAKRYHPALAGAP
LGDATVLELGTYSAACLPLQFPDTVQTQQQVVAFFRHWQPRAKPGSQRCYSNPSLGLFGD
LGARAQQQPFATLMTYGLLAKMGLKDTYLTVPDSAQGRYAQGYDAADQPVRVGPGPYADE
AYGIKTSASDLLHYVRLHMQPAGLPPALVQATAITQRGYFQVSAMTQGLGWERYPYPVTL
STLIEGNSPRLIREPQATTRLQPALPALPAAWYNKTGATNGFGAYAAFVPAEQLAVVLLA
NRNYPNEARVRAAFEILSGL
>A0A124VTS7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKTLILGVVEGLTEFLPVSSTGHLIVAGSFLTFDDAHAKTFDVVIQFGAILAVC
WEYRRRIASVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILLAEARQRERGEAPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>A0A0G3LGP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMFSALLLGILEGLTEFLPVSSTGHLLIAEQWLGRRSDFFNIVIQAGAILATTLVFRQ
RLWTLATGLGDRANRDYVLKLGTAFLVTAVVGLAVRKAGWQLPESVQPVAWALVIGGVWM
LVAEHFAARMPERERVTWKVAIAVGLAQVVAGVFPGTSRSAATIFLAMLLGLSKRSAAAD
FAFLVGIPTMFAASGYSFLELYKNGVVGSEDWGDVAIAFAAAVVTGFIVVKWLLGYIKSH
RFTAFAVYRIVLGAALLLWLPAA
>A0A0F7VH92|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-166|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLVELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A0S3MW77|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGVERKR
RLARAQELLQRLGLEERVDYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPATENMNVVAGTESI
VKMSSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQRQPWVASATPAVSQNLRLRY
SNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNSRRQLFPHKANVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRIMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFALQL
FLPGWEIGFSPLALLLAFLCSTVTGVLFGWLPARNAARLDPVDALARE
>B9KUW5|FEATURES|UNIPROT_deepARG|beta_lactam|RSKD131_3983|antibiotic inactivation|1
MCSPTLCRLPRAVGAVYPGSDDRIGQDMKHLSPLSILLMAGALTPALAQDSTPSFESAAA
AAFESVIKEHDIPGLVVGVTHGGRHSFYQTGLASREDQQSATPDTLFELGSISKIFNVTL
AALAEERGALSLDAPVADYLPSLRGSPAGELTLIDLATHHTGGFPLQVPDDVADVDRLVD
WLQNWRPPEPGARSYSNISIGLLGHITAGVMGMSYTDASQTVLFPALGLKSTWIDVPTDA
MGRYAFGYDRKTNAPIRVTPGVLDDEAYGVKSSARDMLTLLDLELGIGTTSPEVQRAVAT
TQEGRFRTRLYTQAMIWEAYPWPVDPERLVEGNGYDFILQPQPVDEVDAVSDPRVILNKT
GSTNGFGGYIAVVPSEDLGVVVLANRNYPNEARVRATLDLITHILAE
>A0A0M0KTT3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWELFVAAILGIVEGLTEYAPVSSTGHMIIVDDIWLKSSNLMSEEAANSFKVVIQLGS
ILAVVIVFKDRILNLLGLKKNITSDQKQGHKLSIAQIAVGLVPAAVLGFLFEDYIDEYLF
SVKTVAFGLIAGAVLMLFADWVNKRKAATDTLDRISYKQAIGVGLFQCLALWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAMPIMMGASFLSLVKHWDSLSSDLMPFFIVGFICAFVV
ALFVVRFFLKLINKIKLVPFAIYRIILGVILLLIMM
>A0A0S3JHE9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFESPKIEKVSIVIPVFNEQDSLPELIRRTDAACATLNRDYEILLVDDGSSDESARMLCD
AAEEPGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSVFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVEAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVVG
SVIAVLGFAFSIMLVVLRLAFGPQWAGDGVFMLFAILFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQESLASEEENRS
>K6TVX6|FEATURES|UNIPROT_deepARG|chloramphenicol|A370_04634|antibiotic inactivation|1
MGFNIINMSTWERKDCFNHFFNNAKCTYSITVNIEITNLYNYIKANKLRFYPTFTWIVSR
AINNYQEFKMGFDAEGRLGFFDEIGPSYSVLNEKTKNMSDLYTPFKNVFLSFYNDMVKSL
NSYKKDTSFTTQFQNNFFIASCLPWFNYTSFNVNNEGDRPFLFPMVTWGKFFEESSKIII
PLTIQVHHAVADGYHCSLFFSDIKGICINPEQYLN
>A0A127T1Z5|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLIIASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPEWASGTQRLYANA
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLTPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDTIINGSDNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>A0A029NNF8|FEATURES|UNIPROT_deepARG|beta_lactam|AB26_5377|antibiotic inactivation|1
MHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLID
>YP_001334578|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGSVEVLKGITLSIHAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGSDIAQLDGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERRA
RLARAHELLVRLGLGERADYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIVEIRDGEIVRNPPASRQGGGLRARPQA
EPSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
ETAEKQLLRLLELRHGKKDVFTWNMDSVLKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVALSLMIAFILQLFL
PGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>G4C4R8|FEATURES|UNIPROT_deepARG|aminoglycoside|SEENIN0B_01578|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPDHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKHC
>A0A0A1YKB3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAVQALILGIVEGITEFLPISSTGHQIIVADLIDFGGERAIAFNIIIQLGAILAVV
WQYRRKILDVLMGLPTERPAQRFTGNLLIAVIPAVILGVTFADLIHEYLFNPITVAGALV
VGGVIMLWAERRDHVVSAEIVDEMSWKQALKIGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPEDLPVFALGFVISFIFAMIAVRALLKF
IGNHSYAAFAWYRIGFGLLILLTWQLQLIDWSTAQG
>ZP_04405450|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MGLMFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGAD
YLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEE
PLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHEN
IMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPR
RLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQCDRRHTRYQATSPIPWEHINLTGEY
RWPKP
>A0A0A0Q8L5|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-20|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGKTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEALQ
>A0A060DSY6|FEATURES|UNIPROT_deepARG|aminoglycoside|ABAZ39_28550|antibiotic inactivation|1
MRVERCTHETLDDLATLRWELWPEAPIATHHTEAAEDLSAPDRAIAFIVRDEDGVAVGFA
EASLRRDYVNGCETSPVAFLEGIYVRAEQRKRGVARLLIQAVEGWGKEKGCSEFASDADI
GNDVSRRMHAALGFEETERVVFFRKSL
>R7H2G6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIFIELLKVILLGIVEGITEWLPISSTGHMILVDEFIKLNVSEAFMEFFLVVIQLGAILA
VVVLYWNKLWPFYIRKIPKKTQMALRKQPAVSRTVLTFVEKYCDKDKWILWFKILVACLP
TIIIALPFNDIIEKKFYNYVVVAIMLIVYGVLFIVIENYNKRRRPTCTRLDELSFKTALI
IGCFQVLSVIPGTSRSGSTIIGGILAGTSRTVAAEFTFFLAIPVMFGASLLKLVKFGFAF
SSTELIILIVGVVVSFVVSVLAIKFLMGYIKKHDFKVFGWYRIILGILVLGYFVGKTFLA
>AAW30456|FEATURES|ARDB_deepARG|multidrug|lsaA|antibiotic target protection|1
MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGE
ILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWELERELTLLNVDPEVLWRPFSSLSGG
EKTKVLLGLLFIEEKAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVV
DHILAIEKSQLTLYQGNFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNR
EGDKYGNAKEKGSGAIFDTGAIGARATRVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPL
SMDYQPTHHKTLLTVEELRLGYEKNWLFAPISFSINAGEIVGITGKNGSGKSSLIQYLLG
DFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVF
TNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVKPAMLVIE
HDAHFMKKITDKKIVLKS
>YP_001438577|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQTHANRTGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGVEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVAWFIVTCLATLLARDIEQFTVLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHAAPWEMMFVLFAVL
AAISFFGLWRAMPETATRLGEKLSLRELGRDYKAVLKNLRFVSGALAIGFVSLPLLAWIA
QSPVIIISGEQMSTYEYGLLQVPIFGALIIGNLVLAKLTARRSVRSLIVMGGWPMMFGLA
LAALATVISSHAYLWMTAGLSIYAFGIGIANAGLVRLTLFASDISKGTVSAAMGMLQMTI
FTVGIEISKHAWLGGGNALFNLFNFVSGLLWLGLMVIFLKDKTVGTRPEA
>AAR37061|FEATURES|ARDB_deepARG|glycopeptide|VanXD|antibiotic target alteration|1
MKKNFAFLDEMIPGIRWDAKYATWDNFTGKPVDGYMVNRVMGTKELGVALRKAQKMAEKL
GYGLLLWDGYRPQCAVDCFLNWTSQPEDNLTKKRYYPNIKRNEMVAKGYVASKSSHSRGS
TVDLTIFHLNSGMLVPMGGDFDYMDERSHHTASGLSEEESKNRQCLRYIMESSGFEAYRY
EWWHYVLVDEPYPDTYFDFWMA
>ABN79417|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILLHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIY
TERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNEQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>J8SVS4|FEATURES|UNIPROT_deepARG|beta_lactam|ICY_02429|antibiotic inactivation|1
MMVLKNKKMLKLGMCVGILGLSITSLATFTGGALQVEAKKKPGQVKHKNHATYQEFSQLE
KKFDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKD
DLVEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVT
MSDRLETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPDHKRKVLTEWMKGNATGDKL
IRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEA
AEVVIDAIR
>M7YA47|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLTSIGKAVLLALVEGATEFIPVSSTGHQLLVGHFIGFHSPNNTFEVLIQLGAILAILL
VYFRRLLGIATALPSDPKARRFVLGILVAFLPAAIIGGISSKMIKAYLFNPWIVCATLVA
GGLVLLVIDDTDLEAKKTDVYDFSLPMDLKIGIFQCLAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAMPTMAGAFAKDLLDNYKYLSSNDVGLIVIGFIVSFISALFVVRVLLDYV
SRHGFWLFAWWRIIVGALGFAGLIIFG
>A0A0U3NQA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVFIELLKAIFLGIVEGITEWLPISSTGHMILVEEFIQLDASPAFKEMFFVVIQLGAILA
VVLLFFHKLNPFSPKKTTQEKKDTMSIWYKVIVGVLPAAVLGLLFDDWLNEHLYNYLTVA
IMLIVYGVLFIVIENRNAGREGSIKTFKDLTYKTAFLIGMFQVLSLIPGTSRSGATILGA
ILLGSSRYIAAEYSFFLSIPVMFGASALKLVKFGFNFTGMEIGILVTGMVVAFLVSVLAI
KFLLGYIKNNDFKAFGWYRIVLGILVIGYFALFG
>CAW25151|FEATURES|ARDB_deepARG|multidrug|mexB|antibiotic efflux|1
MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDT
VVQVIEQQMNGIDNLRYISSESNSDGSMTITVTFEQGTDPDIAQVQVQNKLQLATPLLPQ
EVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGS
QYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRL
QTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANAL
DTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMAL
SVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAP
YLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLE
KESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKD
AMVFAFAPPSVRELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGM
SDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARM
NPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAM
AAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVE
AAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWV
PLFYVAVSTLFKDEASKQQASVEKGQ
>R0F196|FEATURES|UNIPROT_deepARG|aminoglycoside|D088_840008|antibiotic inactivation|1
MDIRQMNKTNLERWRGLRRQLWPTHPDDAHLADGEEILQADHLASFVAMEDGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>D2TR78|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLDLSNIRRSYPSGEEQVEVLKGINLQINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDRDALAQLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKQ
RLARAQALLQRLGLGERVEYHPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPSRPVPQGKGIQEPT
VTTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDYGDDDPQYQQALKYDDLIAIQKQPWVTSATPAVSQNLRLRY
GNIDVAASANGVNGDYFNVYGMTFREGNTFNREQLNGRAQVVVLDSNARRQLFPHKASVT
GEVILVGNMPATVIGVTEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDEVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGIGLSMLIAFTLQL
FLPGWEIGFSPMALLTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0U1YWK1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAAEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0K0N4E8|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-14|antibiotic inactivation|1
VXGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTA
IPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVG
DKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAXR
>Q4V093|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
KLWTLATGLGERANRDYVLKIGVAFLVTAVVGLIVRKAGWQLPETIQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGSENWTDVSVAFIAATLTGFVVVKWLLGYIKKH
RFTVFAVYRILLGAALLLWLPAA
>D0W254|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECRNINRYFGSGENRVHVLKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAS
SGSYRIGGLETAEMKPDELAALRRERFGFIFQRYNLLSSLTARDNVGLPAVYMGVGGKER
SVRAEKLLQDLGLEGKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEGGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKQTDIPAGSVESIKE
KASWSFYYGQFVEAFRMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSMGTNTISIFPGRGFGDRRSGRIKTLTVDDAKIIAKQSYVASVTPQTTSGGTLTYRNT
DLTASLYGVGEQYFDVLGLKLETGRLFDENDVKEDAQVVVIDQNVKNKLFADSNPLGQTV
LFRKRPLTVIGVMKKDEDSFGNSEALMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTELLKVRHGTEDFFMNNSDSIMKMVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGVRMAIGARRGNILQQFLIEAVLICIIGGLAGIGLSAAISLVFNHFVTD
FPMDISIMSVVGAVACSTAIGVVFGFMPANKAAKLNPIDALAQD
>BAC58936|FEATURES|ARDB_deepARG|tetracycline|tet34|antibiotic target alteration|1
MSKKFIITWDAMQTYCRELAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRYVDTICI
SSYDHDHQRDMTVLKAPEGDGEGYLIVEDLVDSGDTARKLREMYPKAKMIAVCAKPSGKE
LLDDYVVDIAQDTWIEQPWDMSIQYAEPVNRKQK
>A0A154TTT8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRFFGSGENRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAT
SGSYQIDGIETSQMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGSKER
AERAEKLLGDLGLQNKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEDGHTVIMVTHDPGIAANANRVIEIRDGQIISDTSKNPDIPPSKVERIKE
KASWSFYYDQFMEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSQQKILED
INSMGTNTISIFPGRGFGDRRSGRIKTLTINDAKAISQQSYVASATPQTNSNGTLTYRNT
DLTASLYGVGEQYFDVRGLKLEEGRLFDDDDVKTDAQVVVIDQNTKTKLFGEGVNPLGKT
ILFKKRPLTVIGIMKKDDNSFGNSDSLMLWSPYTTVMHQITGESHTNSIVVKIKDDANTQ
VAEKSLTELLKARHGTEDFFMNNSDSIKEMVESTTGTMTLLISSIAVISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLSGVLLSASISLVFNYFVT
DFPMSISMTSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALAQD
>A0A0B4U9Z7|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRGEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>A0A083ZZG4|FEATURES|UNIPROT_deepARG|polymyxin|arnC_1|antibiotic target alteration|0
MSRFEPIKKVSVVIPVFNEQESLPALLERTTTACKQLSQPYEIILVDDGSSDNSAEMLTA
AAEQPDSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKTASRVINMMIQRATGKSMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARCTTEIEVSHAEREFGESKYSLMKLINLMYDLVTSLTTTPLRLLSVVG
SVIALSGFVLAILLLVLRLILGPDWAVGGVFTLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQKVVGAKQAQNTQEEER
>U2VFZ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMIELLKAVLFGLVEGITEWLPISSTGHMLLLDQFVKLNVSKDFWDMFLVVIQLGAILA
VCVLFFHALNPFSGKKSPDERRDTWRLWAQIIVACIPAAAIGIPLDDWMEAHLGSPFVIA
AALIVYGVAFIVIESRRDSRAQQLVARGSSARHMAVPVTDNPSELADADARVTDVRHMPW
LTAIGIGIFQILSIVPGTSRSGSTIIGGLLLGCSRTVAAEFTFFLAVPVMVGASALRLVK
FFLKGNSFVLHELTLLLVGCVVAFVVSLLAIRFLMSFVKKHNFKPFGWYRIILGAAVVTY
FLLVH
>A0A0G2ZI97|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNVGIEEHVIPESGTGPYSITHGPDGALWFTEIAAGRIGRVSVGGEFAFFPLPARDSRPA
VITTGPDGALWFTLNQGHQLGRLTPLGELKRFPLPTPGAGPFGLAAGPDGALWFTALGTH
QLGRMTTAGEVREYPLPTPGAFPSMIAPGPDGALWFTQNQANSIGRITVEGALTQYPLPS
AGAGPVGIAPGPDGALWFVEILGGRIGRIALDGKITEHAIREGARPHAIVTGADGALWFT
QWGNNHIGRLTPAGDYEEFALPTPNSEPHGIAAGPDGALWFALERGSIGRLFVK
>A0A0D0LNV3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIILAIIEGITEFLPVSSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDRLLENPVTVAVSLLIGGLILLKVDEW
FNNPNTAETSQEITYLQALKIGLFQCIAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATVKKCYDYYKDGFELSHDQVNLLIIGNVVAFIVALLAIKTFIGFLTKNGFKV
FGYYRIIAGIILLLIHFFIHPLTII
>YP_002847888|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDSNGVNSNATSASLQLTQTLFDMSKWRALTLQEKSAGIQDV
TYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKDAVYRQLDQTTQRFNVGLVAITDVQN
ARSQYDTVLANEVTARNNLDNAVEQLRQVTGNYYPELASLNVDGFKTNKPQAVNALLKEA
ENRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGVSDTSYSGSKTRASDAGTRYD
DSNEGQNKIGLSFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNIN
ASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQQLANARYTYLI
NQLNVKSALGTLNEQDLVALNNTLGKPVSTTPDTIAPENAQQDAAADGYTSNSATPAAQP
TAARSTSSTGNNPFRN
>R4K4Z3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSMNFLLIIKVIILGIVEGVTEFLPISSTGHLIMFNDLLNFKGEFSNLFDIVIQLGAILA
VVVLFWDKLLKSLKTVVDPSFKSFGSKLWRNLIIAFIPSGVVGVLFHHFVDKHLMKVFPV
ALALLVGGILMILVENKFRNNNKTNDISDVTVKQAFIIGCFQCLSVIWPGFSRSASTIMG
GWIVGLSTVAAAEFSFFLAIPTMIIATGYTLLGNLSVLTGMEVIEIAIGFIVSFIVALLV
VDKFMNFLKKRSMRIFAIYRIIFSIIFLILVFTKVVSI
>T2NAR8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQAIVLAIVEGLTEFLPVSSTGHMIIAEGIMGVKSTSFVRAFTVMIQFGAILSVLVL
YRKRFFCFPVAPRALGQGKRKEFMSRFDLYWKLLIALGPAVILGFLFEDWVDRMLGSVWV
VAVVLFLGGIFMLFVDKLFASSDRGEITYPKAFVIGLFQCLAIFLPGLSRSMATIVGGQQ
QKLSRKAAAEFSFFLAVPTMLGATLLKAYKLYKEGGIEIFREHMTVLLVGNIVAFIVALA
AIKFFIGFLTRYGFKAFGYYRILVGGLLIVLMLSGVSLAV
>I9KWP8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAFKAIILGIVEGLTEFLPISSTGHLILAADLLDFNDNQGHIFEVVIQFGAILAVC
WEYRERILHVVRGLASERLSQRFAINVIVATLPAITLALLLGSFIKHTLFNPIVVASAFI
VGGLVILWAEHLESRRGTTRDPRGNALLEAAKAAAPRIESIDDLRWSDALKVGLAQCAAL
IPGTSRSGATIIGGMLFGLSRKVATEFSFFLAIPVIFGATVYELVKARSVLSLTDLGTFG
IGFVAAFISAFFCVRWLLRFVASHDFRPFAWYRIVFGLIVLITAYTGVIEWHG
>A0A011A6K3|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYKIMKQIVSDMKLPDYRYEQIINAVFHQRIDDFDNMQILPKALRMALVNEFGN
RVSSVKPVFIQDSIQAEKLLFELSDGEKIEAVGLKYKQGWESFCISTQCGCGFGCRFCAT
GSAGFKRNLTVDEITDQLLYFLFNSHKLNSVSFMGMGEALANPELFDAVKILTDQSLFGL
GQRRITVSTIGIIPGIQRFTREFPQVNLTFSLHSPFDKQRSDLMPINKKFPLNEVMKALD
EHIIHTGRRVFIAYIMLEGINDTKDHAEAVVSLLKNRGSWGHLYHIDLIPYNTTDKTAFK
FQSSGAIRQFGGTLKKAGISVTIRTQFGSEISAACGQLHYDNEL
>E8R3H2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTWLEATILGMVQGLAEFLPISSKGHLALTQQFFDRYAYQRPSRGEDNLFFAVILHVGTT
LAILFHYRAALKVGLKGLAGSPLVAPEYRRPALVRLAFLAGVATLPAAVAGVLFKSQVEQ
AFTSPTATALGFLFTAFVLLMIEWIGTIRKEEGWGPSRTTTLMALGVGTAQALALMPGVS
RSGMTIAAALLVGMSRSWAVGFSLLISVPVIAGATAKELIDHPDKLDSSNLGPTLLGGLV
ALVVGYLAIIWLVRIVRARKLWWCSIYLMGLAAVVLAFQAVGLAPDSRGAPLPDEPRVES
PSSFPEAPPVQG
>Q2EHL8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKQLNRYFGEGENRVHVLKDISLSIERGDFVAIMGQSGSGKSTLMNIIGCLDTAT
GGSSKIDGKETIELTNDQLSDLRSQKFGFIFQRYNLLSSLTAAENVALPAIYAGMPQSQR
LERAKQLLEKLGLGDKWQNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSHSGE
NVMEILRQLHEEGHTIIMVTHDKHIAASANRIIEIKDGEIISDTQKRQVKSAVKNPSVFK
GRFGFSKDQLMEAFRMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
RGIGTNTMTIFNGNGFGDRRSRHIQNLKISDANTLSKQSYIQSVTPNTSSSGILVVGNKS
FTSANLYGIGEQYFDVEGLKLKQGRLLTEDDVDQSNQVVVLDESAKKAIFANENPLGKTV
IFNKRPFRVIGVVSDQQLGGFPGNSLNLYSPYSTVLNKITGGSRIGSITVKISDDVNSTV
AEKSLTELLKSLHGKKDFFIMNSDTIKQTIENTTGTMKLLISSIAFISLIVGGIGVMNIM
LVSVTERTKEIGVRMAIGARQINILQQFLIEAVLICLIGGVAGILLSVLIGVLFNSFITD
FSMDFSTASIVTAVLFSTLIGVLFGYMPAKKAAELNPITALAQE
>S6ABG2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPILLLKALTLGIVEGLTEFLPVSSTGHLILVGDLLDFNDDKGKMFEIVIQFAAILAVC
WEFRARLGSVVTGLRAGREDAQRFVLNLAVAFMPAAILGLLFASKIKQYLFKPVPVALAF
IVGGVLILWAERRKHVIRVERVDNMGWRDALKVGLAQSLALIPGTSRSGATIIGGLFFGM
SRQAATEFSFFLAIPTLFAATAYELIKYRYLLNTDDLGMFAVGGAASFVSAFFAVRGLLR
YISHHDFSAFAWYRIGFGIIVLLTAYTGAVSWSVS
>A0A125SIY0|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
CGAMLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAAN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTS
QRLSARSQRQLLQWMVDDRV
>A0A0E2LG13|FEATURES|UNIPROT_deepARG|aminoglycoside|M001_13480|antibiotic inactivation|1
MTNIGWQIVPLDETLLAQWATLRQQLWPHHALSAHLQEGVEMLANAHLNAFLALDEQSQA
VGFVDAALRHDYVNGCNSSPVMYLEGVYVQPALRQRGVAQALIAQVAQWGRKLGCRELAS
DAAIDNLASQQMHQQLGFAETERVVFFKKALG
>A0A0Q6KXZ7|FEATURES|UNIPROT_deepARG|aminoglycoside|ASG66_11460|antibiotic inactivation|1
MEEYATSLAKRISGLFGNKLTGVYLHGSLAMDCFNPRISDVDLLIIVEDGISNDEKKALD
DLFLNEYIGDHLPAKGLEASVLRRRNVRPLLYPTPFEYHFSDMHIDAIKRGAATFPATDP
DIAAHIAVILTRGKALIGEPIEAVFAPVPYNYYMKSIYNDIHDAEADILKQPTYMILNLC
RVYQFCINQSVASKKEGGEWGLQSLPVRFHPIIQKALKVYETGEMWQTAVEKEASLTDFA
VYMTSSIREKSINFLDHDDNLKI
>A0A0A0Q8L4|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTNYPNPARVEAAYHILEALQ
>BAA36484|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADVS
PSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSVVLIHDP
KKSTTSGFQKLEPQLLTKINWKVFITPAILTLVLAFGLSAFETLYSLYTSYKVNYSPKDI
SIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLIYSVIVLVLLVIADGYWTIMVISF
VVFIGFDMIRPAITNYFSNIAGDRQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIY
MAIGVSLAGVVIVLIEKQHRAKLKQQDL
>J1IRD3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGIVRSFMAGDREFIALKGIDLTIHAGEMVAITGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRTLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPET
ARHSRAGELLARLGLSGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIIEVRDGEIVSDRANQSVGLDLPTEAP
IEPKRSGARKLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFPGKSFGDSRASAIETLLPSDVDALNQLYYVDSATPVVGRNL
LLRYGNIDLDAQVNGVSDRYFQVKGLKLEAGITFSESDARRQAQVVVIDHNARHRLFAPG
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEENVTKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGMIGISLSFAIGY
LFSLFVKEWEMVFSLGSVVTAFACSTLIGIVFGFVPARNAARLDPIEALARD
>C7N6W9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFEILKAFLIGVVEGVTEWLPISSTGHMILVDEFVKLNVSDDFLKLFLVVIQIGAILAV
IILYFNKLNPFSGKKAAQERRATWRLWGMVVIGCLPAAVVGLLLDDWVGDHFYNAAVVAS
MLILYGVVFIVLERRNREKLANYEALVEQGGAIGAQAPRLEDGSVDPDGMFAIQTVDDID
WKAALKIGLFQCLAIIPGTSRSGATIIGGMLTGCSRTAAAEFTFFLAIPIMFGWGLVKIV
KYMAAMASATGPIMTSVEAVVLLVGIVTAFVVSVISIKFLMGYIKKNDFALFGVYRIVVG
ILVLAYFGVKALLF
>G0UEF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVILGIVEGITEFLPISSTGHLILADEFIQMRQSTQFTDMFNVVIQLGAILAVV
VIYFNKLNPLSTKKNAIEKHDTWLLWLKVLVAVIPSVIIGLLLNDWMDAHLMNWQVVAAT
LLIYGVLFIVIENRNEKRTPHFTSLNNLPYQTAFIIGAFQVLSLIPGTSRSGATILGAIL
IGTSRFVATEFSFFLAIPTMFGASFLKIFKYFSHGGAFTGTQTMVLITGTVVSFIVAYLS
IRFLLNYIKNNDFKAFGWYRIVLSIFVIAYFGFLAK
>J2L2H2|FEATURES|UNIPROT_deepARG|beta_lactam|PMI11_04530|antibiotic inactivation|1
MNMRHCLIALAVSASPLHAADMTDKAFQEIADRIFQPVIREYDIPGLAVGVTINSSEFYY
TYGEASRETKAPVTSDTIFELGSVSKIFNVTLAALAEQRGLLSMEQRVSTYLPELEGSAF
DKITLVNLATHTSGGLPLQVPDSVTDDADLMTYLKSWKPAYKAGTMRSYSNVSIGLLGRI
SGERLGGTYRQAAEGELFPALGLKSTFIAVPPDVMDRYAFGYSKANKPVRVGPGVLDDEA
YGIKTTARDMVHLLELNLKPDTLVPEFKAAIEKTHTGYFDTAYYTQDIVWEQYAWPVALK
KLLDGNSAKMSLESQPVKQRAKPLAPQSAVLMNKTGSTNGFGAYVVLVPKVHIGLTVLAN
RNYPNTVRAEVGLKLVQALEAYAAK
>G8PXM8|FEATURES|UNIPROT_deepARG|beta_lactam|cft11|antibiotic inactivation|1
MQIARSILAGTFFLVCGTPAGFAQERIEDTVNAVIQPLMKQQDIAGMAVAVTYNGQRHYF
NYGVASKDTRKPVTDQTLFEIGSVSKTFTATLGAYAQAQGKLSLADPASRFAPELRGSAF
EGISLLNLATYTAGGLPLQFPDEADHPDRMFGYYTTWKPLYPVGTQRLYSNPSIGLYGYL
AARSLGRPFDEVMERTLMPGLGLKHSYVRVPQDQLGRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSSSDLMRFLEANLRPEKLDADLKQAIATTHTGFYKVGGMNQGLGWEFYPAPFTLD
DLLAGNTPQMALTPQKVEALNPPRPAPDGAWINKTGSTNGFGAYAAFVPGKDMGIVMLAN
RNYPIEERVKAAHRILAALDVK
>B7JPL5|FEATURES|UNIPROT_deepARG|beta_lactam|bla1|antibiotic inactivation|1
MKNKKMLKIGMCVGILGLSITSIEAFTGGPLQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLV
DYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSD
RFETELNEAIPGDIRDTSTAXAIARNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIRA
GVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAEV
IVNAFR
>A0A0W0B493|FEATURES|UNIPROT_deepARG|beta_lactam|VO69_08595|antibiotic inactivation|1
MKGWIKCGLAGALVLMASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFV
YFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPELI
DHYQALIKAAPQA
>A0A126S5N0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWSALQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVLGLPTQVPARRFTANLLIAFFPAVVLGVLFADLIHEYLFNPVTVAAALV
VGGVIMLWAERRQHRVEVDHVDEMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFALGFVVSFIFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWEFGWVDWSTAHG
>J8CH63|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEQEDFEYLIQRLEENDVHILKGRERDVRDCESIYFVDPDGNKFEFHSGT
LQDRLNYYRDEKPHMTFY
>L1NFM9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIIQIIIIAIVEGLTEFLPVSSTGHMIIVQSLLGIESDEFVKAFDVIIQFGAILAVVVL
YWKRFFRLEHSLPPESYTPLQRFLHKWDFYYKLLIAFIPAMLIGGLCNKLIDKLLGSVTV
VAVMLVAGGIFMLFCDKLFGNGSPDTHLTKKRAFVIGLFQCLAMIPGVSRSMATIVGGMA
QKLTRKDAAEFSFFLAVPTMFAATCLDLLKMFLHMHETGSYDMLMSHLGALLLGSVVAFL
VALFAIKAFIAYLTKYGFRAFGIYRIIIGGIIIVWLLSGNTLAMVD
>F9ZK64|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFILLLKALILGVVEGLTEFLPISSTGHLILFGDLLDFNDEKSKVFTIAIQLGAILAVC
WEYRKKIAGIVRGIGSDASSNRFVLNLFIAFMPAAVMGLLFIDVIKQYLFNPLSVATALV
IGGVVILWAERRDHVIDVEQIDDMDWKHALKVGVAQCLALIPGTSRSGATIIGGLLFGLS
RKAAAEFSFFLAIPIMFAATFYDVYKNRAILEWGDVSMFAVGFLGAFFSALVAIRGLIRF
ISNHDFTVFAWYRIVFGIVILVTAYTGVIGWSEM
>R5KCJ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLETVIIAIVEGLTEFLPVSSTGHMIIAQSLLGVESTPFVKAFTVIIQFGAILSVICL
YWKRFFYPNAESRGESYWRSMFNFYARLVVGVLPAVVLGLAFNDFIESNLGNVQLVAWML
IIGGIFMLFCDRIFNKGSEDTKLTYKRAFIIGLIQCISMIPGVSRSMSTIVGGMSQRLTR
KAAAEFSFFLAVPTMLGATCLEMYKMLTHGSGSLLTQGNNLETLIIGSVVAFVVAILAIK
FFINYVTKYGFAAFGWYRIIVGLIIIACGLMGVEMKMVD
>A0A0Q6FA22|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRSCIAAALVTAAAGAVPAKALTPAEFQDMAARIFLPVVEAHDIPGLAVGLTIDGEEYYF
THGEAVRATHAPVMAETIFELGSVSKLFNVTLAALAERRGLLSLGDSVSRHRPALKGSAF
DRITLVNLATHTTGGLPLQVPETVADDGDGLTAYLRAFTPNGDPNATRSYSNVSIGLLGQ
ITAERFAMPYAQAAQSVLFEGLGLSSTFVFVPDDAADRYAFGYAKDGDRPVRVNPGVLDA
EAYGVKSTVRDMTRFLEANLGTIDLPEDVSAALAETRTGRFRTQYYVQDLVWEQYPWPVD
LQRLKDGNSSAMALKPQPVERLEPPLSPASDGVFLNKTGGTGGFGSYVALVPGRRIGVTV
LANRNYPNEARAEATRRLIEAVEAASRP
>YP_001779894|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|VatB|antibiotic inactivation|1
MNKFGPNPNSIYPNENINSICYIKNVIKNPNIQVGDYTYYDDINGAEKFEEHVTHHYEFI
GDKLIIGKFCAIAKGIEFVMNGANHRMKSITTYPFNIMGGGWEKAMPTLEDLPLKGDTVV
DNDVWIGQNVTVMPGVHIGDGSIIAANSVVTKDVPPYHIAGGNPCKIIKKRFDDELIDYL
LNLKWWDWSEEKIFKNLEVLCSPDLDKIKSIK
>A0A139SSJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALLLGMVEGLTEFLPISSTGHQIIVADLMDFTGERANAFNIIIQLAAILAVV
FEFRRKILSTVMDLPGERSAQRFTFNLFIAFLPAALLGVLFADLIHQYLFNPITVASALV
IGGIIMLWAERRKHQVHCQQVDNMSWQDALKIGFAQCLAMIPGTSRSAATIIGGLLFGLS
RQAATEFSFFLAMPTMLGAAVYSGYKYRELFTLDDLPVFILGFITSFIFAMIAVRSLLKF
IANHSYAAFAWYRIAFGGFILLTWQLSLIDWSTAQ
>YP_405004|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLTIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKRNV
>K0G5H1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIENLNKYFGSGENKAHVLKNVNLAIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGICRIDGKETQQMNSDELSDLRQRKFGFIFQRYNLLSALTANENVALPAIYAGMDSGSR
KARADQLLDKLGLSDKTLNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLQILQDLHKEGHTIIMVTHDPNIAATASRVIEIKDGQIIRDERQQPYSEELKLVKREH
RPPRFFDQLIESFKMATSAIMAHKLRALLTMLGIVIGITSVISVVALGQGSQERILSNIN
SFGTNTMTIMNGTGFGDRRANLTKNLTISDATMLNKQAYIDSTTPSSSLSATVISGNTNV
TATVNGVGEQYLNVRGLKMVSGRFFNTEDVVLSAQVVVIDANTKKDLGLVEPVEGKVILV
GKKPLKIIGLAAESNNMNQTSLKMWMPYTTLMQRISGEKHIDSLTVKVKDNIESQTAEKS
ITELLIAKHGKKDFFVMNSDTIKQTITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQSNILQQFLIEAILICLLGGVIGILFAIAIIVTFNTLGSNFQMV
LSPASVVLAVFCSTLIGVVFGYMPAKNASKLNPITALAQE
>Q5R1L7|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0D0NPG2|FEATURES|UNIPROT_deepARG|polymyxin|arna|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFTYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0T9TZ28|FEATURES|UNIPROT_deepARG|polymyxin|pmrF_2|antibiotic target alteration|0
MSQNEQIKKVSIVIPVYNEQESLPALIERTSAACKLLTQPYEIILVDDGSSDNSAELLTA
AANEPGSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRMINLMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTFAVLLVVLRLIFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGVEQTENNQEVEK
>I4EN33|FEATURES|UNIPROT_deepARG|chloramphenicol|NITHO_7290001|antibiotic inactivation|1
MACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKV
LMPLAIQVHHAVCDGFHVGRMLNELQRYCDEWQGGA
>A0A142DYL1|FEATURES|UNIPROT_deepARG|beta_lactam|AMS64_00580|antibiotic inactivation|1
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAQLKKQ
>V9THF1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-58|antibiotic inactivation|1
ISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLD
RAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVP
VYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQL
PFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEKADGQVVAFALNMQ
MKAGDDIALRKQLSLDVLDKLGFYI
>B1KBS9|FEATURES|UNIPROT_deepARG|beta_lactam|Bcenmc03_6561|antibiotic inactivation|1
MRFNATRVAATLFVAACATATAGRAAAVTQDDLHDTVTRHIAPLMKQYAIPGMAIGIVAD
GKPQVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVARYLPG
LQGKPFGVVTLLQLGTHTPGGTPLQVPDSIRDDADLIRYLDAWRPEYAPGTHRKYSNVAI
GMLGWLTAKAMHEDFATLMEQRLFPALGMTHTYIDVPAARMADYAQGYTKDGKPVRMSEG
MLWQPAYGVRTTAADLLRFVQANLGMIQTVPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLAGNAPKMLFEAVPASAIQPPLAPNPATWINKTGSTGGFSTYVAFVPAKRIG
IVMLANGNVPIEDRVKVAYRILGSLGDGR
>A0A0F1BDI3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDISTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLDRAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPGASRAAATKEALP
PSTGWGQFSSGFREALAMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQSLKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0F2PZA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEQYLVPVILGIVEGLTEFIPVSSTGHLILSGELLNFTGERAATFEVFIQLGAILAVVML
YRERFRHFLTFENIVSGFKMKQRELNWMHIAVAILPAMVLGYLVHDIIKKYLFSVQTVLI
GLVIGGIVMIVAERMPSRTFATDLDKINFRQCLLIGLAQCLSLWPGFSRSGATISGGLLA
GLNHKTAAEFSFIIAVPVMIAATGYDLLKSWSLITPDFIVTLLIGFVVSFVVAVLAIVGF
LKLLERVKLTPFAVYRFVLSVGYYIMILR
>ZP_02784870|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRHRNINLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQ
LFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMA
RWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVLGL
SSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQT
GQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>G7F1K5|FEATURES|UNIPROT_deepARG|bacitracin|uppP2|antibiotic target alteration|0
MDIINAIILGIIEGITEFLPISSTGHLIVASKWLGIESTDANLAFEVIIQLAAILAVLAN
YKDKFSPKHFNLWVKVAIAFIPLGIIGFIFSDVIKTLFSVPVVGVMFIVGGVIFLLLERS
YKETHCTTTDVTQVTYKQALWIGVAQVFALIPGTSRAGSSIVGAMLCGLNRKASAEFSFL
LGLPVLAAASGYDLLKHYQQFSLDDLTALAVGFLTSFIVAYFTIKLFIRFLENFTFVSFG
LYRIVFGVILLTNLNSG
>V0SIA6|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1590_01078|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0K0TQH5|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-165|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQASSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>E5Y3V3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFSTGLIMGAVQGLTEFLPVSSSGHLVIAGDLLGFTGPKASTFEVAIQLGSIFAVLMV
YWDRFMGLLLPGRVQTSAPKPFAGLRGIWLLFLTTLPPSVLGLLLHSYIKQLFTPFSVSL
SLAVGGLLMLFVESYCAKRPPKYSSIDEVTPKLALGIGLCQCMALWPGFSRSGSTIMGGM
LLGEKRALAAEYSFVAAVPIMFAATGYDLLKTWSLFTVDDIPLFATGLFFAFLFGWLAIK
TFIALVGRITLRPFAVYRLLLAPIVYFFMVNMG
>A0A0Q5YVM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVG
LYFRKLWDVAIGLFTGDAYARRFVIGVLVAFLPAVIVGLVAGKYIKSLLFNPWVICFTLI
VGGAVLLWVDKLDLKPREHDATKFPLLTYLYIGIAQCVAMIPGVSRSGASIVAAMLLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKSRAEMTMDHINIVAIGFVVSFITAIIVVKTFLTY
VTRHGFVVFAWWRVIVGTLGLIALALGR
>A0A127T1R7|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLIIASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPEWASGTQRLYANA
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLTPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDTIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>A0A0E2CLS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGESLEFDDLFDIFIQSGAILSV
LFLYREKFRSQIVSSFRYVLKQNSDSEGFNFLIQICIGAFPILIAGFMAKKFLDTIKARP
DLLEILSGAWIFGGVLILIAEWYFHQKGTEEKKPIHFKDSILIGIFQCMALVPGMSRSAA
TIITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGNTIPVLMFGFLVSFLL
CTLVIRWFLRYLQKHSFSVFGVYRILLGVGVLVLTKLI
>B6BHN0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFDSIILGVIEGFTEFLPISSTGHLIVASEFLGINQTSVTKAYEVIIQFAAILAVIFN
YKDKFTIKKIDLWSKVFLAFLPIGVVGFIFSSQIKALFSIEIVAIMFIIGGVIFLIVEKF
FIPNETKLINDVEEVTLKQSLIIGFAQIFALIPGTSRAGSTIIGALLVGLSRKASAEFSF
LLAFPVMSAVTAYDLLKHYHEFSDANLMTLAVGFVVSFFVAYLTIKLFLVFLEKFTFVAF
GIYRIIFGVLLLILFN
>J8JHA4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLLGFEDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASALDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFLM
>A0A0J1IBW7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIMIAIILGIVEGLTEFAPVSSTGHLILVAHLLEFTGEKAKTFEIIIQLGSILAVVFVF
WRRILSILGIKKWQAEEDVGTLSIFHIAIGIIPFGVGGILFYDFIKEVLFRSGTVVITLI
IGGLLMLAAEKWKPRSPTAETLDQVTYQQAFTVGMFQCFALVPGFSRSGATLSGGILAGM
SHKAASEFTFIMAIPIMAAATGKDLFESWNYLSPQDLPLFLTGFITAFVVALLAIKFFLK
LINKIKLAPFAYYRFVLAFLFWIFIL
>R5QFZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MRFIEILKSVFLGIVEGITEWLPISSTGHMLLVDEFLTLDMSESFKEMYFYVVQLGAILA
VVLLFWNKMFPFQFKDKSQPVFRKDVFSAWLKVVVACIPGAVVTLLFDDYIEAHLHTPLV
IAIALIFYGIAFIIIEAWNKKRTPKVETLGDISYYTALLIGLFQVLSIIPGTSRSGATII
GALLIGVSRVAAAEFTFFLAVPVMFGMSAIKIAKFGLHFSAEEAIILAVGTIVAFFVSVA
VIKFLMGYIKKHDFTVFGWYRIALGILVILLMCIK
>Q8EEJ3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTISPLNSHTLGSTSLGLILLVAPLMVHATPQNALTASQDTKTIKSIVDSAVNPLMAEYG
IPGAVLGISMNGQQYFFPYGVSSKNTAEKVSKNTLFEIGSISKTFTATLATYAQFEGKLT
LTDKVSQYLPELAGSHFDQINLINLATHTAGDLPMQVPDNVTNNTELISYFKAWQPAYPA
GTHRNYANPSIGLLGVIAAKQLGQGFPEAVEQTLFRQLGMTNSYLMVPTNKMADYAQGYN
KQDQPVRLNPGVLADEAYGIKTTAVDLLRFVETNMQQHSVPARLQRAIDATHTGYFDVGP
MTQEMIWEHYPYPISLDNLLAGHTQDVVFGSMPVKAITPPQSPQQNVWINKTGSTGGFAA
YVAYIPAKKLAMVLLSNKNYPVPPRVTVGYQILTGLEKLPN
>A0A0M0Y3X9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLLHILLGMIPAVVLGLVFHDTIKSLFNPV
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLTAADIPMFAVGFVTAFVVALV
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0R1M299|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEIIQAIILGVIEGITEFLPISSTGHLYLANEFIHLHESTAFINMFMVVIQLGAILAVV
VLYFHKLNPWSPSKARIERRQTWQLWGKVIIAVLPSVVIGLPANDWMDAHLTSWQVIATT
LIVYGVLFIVIEHFNQGRRARFTDLNQMPIKIAIAIGLFQILSLVPGTSRSGATILGAIL
IGTSRYVATEFSFFLAIPTMFGASLLKITKYFLHGNTFSYTQVVVLITGVVISFLIAYLA
IKFLLDYIKRNDFKLFGWYRIVLGIVVVLYFGFAQK
>CAL18627|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLTGFSAMSQAENLLQVYQQARLGNPDLRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYTNGFRDNNGIDSNATSASLQLTQTLFDMSKWRELSLQEKSAGIQDV
TYQTDQQTLILNTATAYFQVLSAIDALSYTEAQKQAIYRQLDQTTQRFNVGLVAITDVQN
ARSQYDTVLANEVTARNNLDNALEALRQVTGNYYPELASLNVDSFKTDKPQAVNALLKEA
ENRNLTLLQARLSQDLAREQIRLAQDGHLPTLSLSASTGVSDTSYSGSKTTSQAYDDSNV
GQNKVGLSFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRNVVQTVRSSFNNVNASIS
SINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQQLSSARYQYLINQLN
IKQALGTLNEQDLQMLNSTLGKPVSTSPDSVAPENPQQDAAVDNFTANSSAPVAQPAAAR
STAPASSGTNPFRH
>S6ES99|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDLIYILKAIFIAIIEGLTEFVPVSSTGHMILFGSLIGFNSGNHVEFAKMFEVVIQLG
AILAVVVLYWGKLWYSIVEFFTYIFTLGKKGEKGFKFGINVIVASLPAGVIGLLFHDKIK
ELFKPSAVVVAFIIGGVLLLVIENKFRNKMSKKGKVPTTDVFDLTPMQALKVGVFQVLSM
WPGMSRSASTIMGGWIAGLSTPVAAEFSFFLAIPAMVGSTGVDLLKFDFSIMNKTYIIAL
VVGFIVAFIVSLVVMEMFVSYLKKKPMRVFAIYRIIAGVILLILSTLGIVSLVI
>Q8D342|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLNFKKLSIIIPVYNEQDSLIELIKRTVNTCSKLKIKYEIIIIDDGSNDKSINILEKEAL
KQNSKIVAIFLKKNYGQHSAIMAGFKHSSGDLVITMDADLQNPPEEIPKLILNAEKGYDV
IGTFRQNRKDNWFRKISSRLINIIIQIVIGKSMKDYGCMLRAYNRNIINSILEYNKKNIF
IPILANTLSKNIIEIPVLHYEREFGCSKYNLIKLIKLIYDLFFCISFNLIKKNKMFNIFI
ILIFLAVLMSIVFFFIFFLKIKLNIFYKILFIPIIITLFLIKSFIIIILKILIDIFFVKA
KKNSIYYINKIIKNNFSKKKDVT
>A0A0T9TQQ9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_2|antibiotic efflux|1
MTALLELKGIRRSYQSGGETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKHE
RRERANMLLTRLGLEERVNYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKTVATVAASDVMS
LTPPAPSWQQLTGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQM
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMAALKEQSYVSAVSPTISGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITHEQVERQSQVVVIDRNTQRRLFPHLKEV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTLRHGKKDIFTYNMDSLLQTAEQTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLMVE
MILPSWQIAFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A023PGL4|FEATURES|UNIPROT_deepARG|beta_lactam|CY96_28755|antibiotic inactivation|1
MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNQTHQVKQENIGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRKMGD
TVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
NKLIRAGVPKEWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLI
ADATKIVLETLKVTNK
>A0A0U0YPQ3|FEATURES|UNIPROT_deepARG|chloramphenicol|cmlA|antibiotic inactivation|1
MPAEHALLVVMATFEPLDLQQWPRREWFEHYLDRCPTYYSMTVDLDITNLRAAVDASGRK
TYPTQIWALATVVNRHPEFRMALDDQGNPGVWDVVDPAFTVFNPDRETFAGISARYTPDF
DAFHSEAAELLSEYRNASTLFPQGAPRPRNVFDISSIPWTRFTGFTLTIAPGWAHLAPIF
TIGKFYEQEGRTMMPLALQIHHAAADGYHSTRLVEELRQIIADPDWVRD
>A0A0P0G279|FEATURES|UNIPROT_deepARG|beta_lactam|blaIMI-3|antibiotic inactivation|1
MFISCLFSISFFSQANTKGIDEIKNLETDFNGRVGVYALDTGSGKSFSYKANERFPLCSS
FKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSLGDMAAAALQYSD
NGATNIILERYIGGPEGMTKFMRSIGDEDFRLDRWELDLNTAIPGDERDTSTPAAVAKSL
KTLALGNILSEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSCGAYGTANDYAVV
WPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>E2ZBT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDYMIAVILGIVEGFTEFLPVSSTGHMILVGDWLGFDGPRASVFEVFIQLGAILSVLFI
YKEKFIYMLQQYKCVHLLKRENWFRRDTGLTLAHVAVGIVPVMLVGFFAHHAIKTYLFSP
FTVIIGLIVGGLFMLAAERARIPVVCDDVEKLTIVQAFLVGAFQMLALWPGFSRSGSTLG
GGLLLGISRKAAADYSFIIAVPVMIVACFYDLLKSLSYLGGSDLAMIAIGFVTAFVVAYI
SVLWFLKFLNKSTLASFAYYRFVVAVVAFIHFIL
>J3GRF3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLSSGFEIAAVFTHADDPKENAFYGSVAQLCARHGIAVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQKVAIERSDTALSLHGKLRSAASDLLRDTLP
ALLQGKVSETPQDESKATVFGRRTPADGKLVWAKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGQAPGRVISVDPLRIACGEDSLIINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDNNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A0Q4KKK8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVTAIILGIVEGITEFLPVSSTGHLILATELLGYDAARWSVFNIAIQPGAILAIVVLY
WRTFLAVAKGLLSWEANSVAFVRNLLLAFFPAVVLGLAFGDQIDALLENAVVVAWALIAG
GFAILVVERLAKTDNVLGISGVSIAQSVKIGLVQCLAMVPGVSRSGATIMGAMSFGIDRR
TAADFSFFLALPTLTGATVLQLYKHRDMVTPGDFQLIAVGALVSFVVALIVVKAFMAVVT
RYGFGPFAWYRIAAGTAALVWLKTR
>D3HRN0|FEATURES|UNIPROT_deepARG|beta_lactam|LLO_1201|antibiotic inactivation|1
MKKLSLLLSMTLLFCANAWAQKNCFLARENQTVLKHEGNDCDQRYTPQSTFKIALSLMGF
DSGILKDALHPEWPYKKEYELYLNVWKYPHNPHTWMRDSCVWYSQVLTQQLGMKRFKQYV
DAFHYGNEDVSGDKGKNNGLTHAWLSSSLAISPTEQMQFLQKMVTKKLPVSKRAFEMTKD
ILYIQELAGGWKLYGKTGTGEQRPKGKNHKSPLRQGWFVGWIEKDNRKVTFVSHITDCKE
SFAGLKARNEALIQLFYLINELEK
>A0A0H4IV32|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-124|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVTPGQLDAEA
YGVKSNVTDMARWIQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALHTVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A096XHF6|FEATURES|UNIPROT_deepARG|aminoglycoside|K531_00085|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAIHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>YP_001571902|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDRFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMNFGELSAQLGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLGVPPSA
FTPPPKVDSAVVRLVPHATMPYPVKDIRVLSRITTEAFNQRRKTIRNSLGNLFSVETLTE
MGIDPAMRAENISVAQYCQMANYLSENAPLKES
>G2H086|FEATURES|UNIPROT_deepARG|beta_lactam|Rin_00014660|antibiotic inactivation|1
MHQKSPFKKMFKVKFMSVLLCLFISTTTGSNYAASNLDQSRIQSSVDEIIKPLIQKYSIP
GIAIGITVEGKNYFYNYGVASKETKQAVTNTTNFEIGSLSKTLTATLTSYAQINGQLSLS
DSVSKYLPVLRGSSFDNISLLNLATHTAGDFPLQIPDNVTNYDELMTYYKNWKPTYAADT
HRNYSNPGIGLLGIVTAKRMNMSFEDAMEKILFPKLGMKNSYINVPEEQMNNYAQGYNKT
DEPVRVSPAVLASEAYGVKTNTTDLIRFIDVNMKLIKLDEKLQRAVTNTHTGYFTAREIT
QDLIWEQYPNTTLLQQLLAGNSYDMIYKGVTVTKMVPPLPPQENVWLNKTGSTSGFGAYA
LYNPANKVGIVILANKNYPIDERVTAAYNILTQLKRSAGIEKIM
>ZP_04191906|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>F7L1L2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DKATSGKYYIDGEDISDFTADELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVD
HDNRMERAKKLLEKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDS
KSGIMVMKILNQLHEEGHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQREIKKELQED
KKSINNLKKNKFQVAKDQFFESFNMSVSAIIAHKMRSLLTMLGIIIGIASIVCVVAIGNG
SQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTDVDILEKQSYVDSVTPNSTSS
GTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALIDENTQKSLFGE
NENPIGKVILFNKKPLKIIGTVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
VKNDIDSQVAQKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVV
GGIGVMNIMLVSVTERTKEIGIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIG
WGFNSISKSFSMIFSVFSIVMAVLFSTLVGIVFGYMPAKNAAKLDPIEALSRE
>A0A0Q7S8V8|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD24_10300|antibiotic inactivation|1
MIKERCLDMNTQALLDKIVTLFREELKGNLIGVYLHGSLAMGCFNPTKSDIDFLVVVKEK
LTPVNNSRIAKIALSLHDEMSVMFNERGIEFTIILEIYLKPFVYPTPFEFHYSDYHREKY
RTDENYLCGGLEDKDLAAQLVVAYERGRTLYGTPLSELYEPINSQYYLDSILNDVEGCAD
EIIDNPPTNLTSMYLTLNFCRVLYYVTEGKISSKREGGEWGITNLPQHFQPLVKYYLAIY
TDESSDRENDNSNFDLQSLLAFVEYMTNEIKQNTSHH
>C0VMP3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMDFWTTEKSAVFVVAIQIGAIAAV
IYEYWSRLWNAATGMVTGEEKGRRLGLSLIFASIPIVLVGLTFGQFIKEVLFNDVIVALG
LIIGGLIIIWVEKNPPKINAVEVENITFKQAVWIGLIQVLALIPGTSRSGATIIGAMYLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYHVFDGLEDWTVIAVGLVVSFISALLLIRAL
VAYVAKRDFMIFAWYRIASGLLILLLFFTGWKLW
>A0A117USQ5|FEATURES|UNIPROT_deepARG|aminoglycoside|AQZ52_14750|antibiotic inactivation|1
MTLIVLAGPEHLDGWAKLRHALWDEEPVVAHREEAEEQLTVPERFLNLVALHDGAVVGFA
EASIRHEYVNGCEDSPVLFLEGIFVAPEVRRQGLARRLVAAVADWGRARGCREFASDAWH
DDRDSHAFHLAAGFAETERVVYFRQEL
>A0A0W0AJW6|FEATURES|UNIPROT_deepARG|beta_lactam|VO68_17070|antibiotic inactivation|1
MSRILLPGLLAAGLIFSLPASAASGCMLFADGTGKPISSQGDCSSQLPPASTFKIPLALM
GYDSGFLVDENLPALPFKPGDDDWLPAWRETTTPSRWLTYSVVWYSQRLTEWLGMERFQQ
YVDRFDYGNRDLAGNPGKHDGLTQAWLSSSLAISPQEQARFLGKMVSGKLPVSAQTLQHT
ANILRQPDIDGWQIHGKTGMGYPKLLDGTLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVFAALPDQLKKL
>A0A127SJF7|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLINASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PCLV
>A0A0B8ZB41|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTIVTAILLGIVEGLTEFLPVSSTGHLILATELFGYDAHQWAMFNVVIQLGAILAVVVQ
YWRTFWAVGMGLLKLNPMSLRFLRNLLAAFVPSAILGLALKDYIDVLLGSPSVVCWALIV
GGVAILLIERSAKTGELTGIGELPLRQALGVGAAQCLAMVPGVSRSGATIMGALAMGIER
RTAAEFSFFLAIPTMLGATTLELLDNRDALMNGTMGVGWTEIAIGFAVSFVVALAVIRMF
VAYVSKSGFRPFAWYRIVAGAVALVWLGMR
>ZP_02913367|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIVEIIKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYAANTFKVVIQLGS
ILAVVVVFKDRFIDLLGLRGRHRDGKPRLKLMQVIVGLIPAGVLGVLFEDYIDEHLFSTA
TVLIGLVLGALLMIAADVFAKKAPKAQTVDQITYKQALIVGLVQCLSLWPGFSRSGSTIS
GGVLVGMSHRAAADFTFIMAVPIMMGASVLSLLKNWQYFTIDALPFFTAGFISAFLFALI
SIRFFLKLINQIRLVPFAVYRIVLALVIYIVYF
>A0A0Q8ZV29|FEATURES|UNIPROT_deepARG|beta_lactam|ASE48_07805|antibiotic inactivation|1
MLLSRRRVLFGGMALAAAGALAGCADESALAAPALTLEEQIRELEARYNAFVGLYAVNLQ
SGFAVENRADEAFALCSTFKTYAAARVLRGVADGELTLEQQVFVKPEGLLPNSPVTGERL
GQEMTLAELSQAALQRSDNLAANLLLETIGGPQEITAFARSVGDDRTRLDRWEIELNSAI
PGDPRDTTTPRALAAGFRNLLAGDALPPAQREILDGWMRANQTSSMRAGLPPGWTTADKT
GSGDYATTNDSGVAYGPDGARVLLTIMTRTQSADPEAEGLRPLVGEVTALVLPHLLGRR
>A0A150E3V1|FEATURES|UNIPROT_deepARG|chloramphenicol|AT270_12175|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCTFSMTVNVDITLLIEKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNEEGVLGYWEKMIPSYTIFHKDDKSFSSIWTNYSSDFCIFYKNYEEDMR
YYASVHGLFTKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>A0A0W1DWJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWLIAVILGIVEGLTEFLPVSSTGHLILATELLGYDASKWAVFNIAIQPGAILAIVVL
YRKLFWDMFTGFFRRDPVAIAFVRNLLLAFVPAVVLGLAFGDYIEALLENAVVVAWALII
GGVGILLVERFAKPKESGGVAALSTRQSIIVGLVQCIAMIPGVSRSGATIMGAMALGIDR
KTAAEFSFFLALPTLTGATVLQLAKHQDAITKNDIGLIALGAFVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIIVGIAALLWLGMR
>I3WA16|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLDPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALITDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0A0Q9I8|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-10|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQPKVPLKR
>A0A0G8BZG2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRELVYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEQEDFKCLIQRLEENDVHILQGRERDIRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMTFY
>W1I967|FEATURES|UNIPROT_deepARG|beta_lactam|CfxA6|antibiotic inactivation|1
MKKNKIILSVSIVILLCLTIISLKQFSHKSIANKSKSELNSQVISDSISKIASEYPGEIG
VAVIINNQDTVTVNNKSIYPMMSVFKVHQALALCNDFDKKGISLDTLVKINREKLDPKTW
SPMMKDYSTSVISLTVRDLLRYTLIQSDNNASNIMFKNILNTAQTDSFIAKLIPRSSFQI
AYTEEEMSADHDKAYSNYTSPLGAAILMNRLFTESLISNEKQNFIKNTLTECKTGVDRIV
APLLDKDGVVIAHKTGSGYVNENGILAAHNDVAFIRLPNNKYYTLAVFVKDFKGNEKQAA
KIIARISGTVYSLLIQF
>L8F6K9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSKALKVGLDGGPYALAAGPDGAMWVTLAHSGEIARVTETGEVTVYPVALQARPSIIAAG
PDGAMWFTRAGDDRIGRITVDGELTEFELAEGSAPFGIAAGPDDALWFTAMTSGEVCRIG
TDGEVTSVAVVGGMPSMITAGPDGAMWFTINQGNAIGRLETDRTLTVRELPTPAAGPVGI
TATHDDAVWFTEIGADQLGRIPLDEAIQELELPGKPHAVVADPDDGVWVSLWGADQLARV
SGDGEVVTIDLPSGSEPHGLAIGPDGAAWVALECGFVLRMPN
>L0M4R4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLQLTDIRRSYPSGDGSVEVLKGITLEINAGEMVAIVGASGSGKSTLMNIIGCLDKP
SSGTYRVAGVDVATLDSDALAQLRREHFGFIFQRYHLLSHLTAVQNVEVPAVYAGMERKA
RLTRAAELLKRLGLEERVDYAPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVMAILHQLKEQGHTIIIVTHDPQVAAQAERVIEIHDGEILRNPPAKAATGEARRLSGE
HVSGWRQFSNSFREALSMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRSIGTNTIDVYPGKDFGDDDPQYQQSLKYDDLLAIEKQSWVSSATPAVSKNLRLRAGN
IDVAASVQGIGQQYFNVYGMTFSEGNTFNAIQAAERAQVVVLDNNTRRQLFPNKTNVVGE
IILVGNMPATVIGVADEKQSMFGSSTILRVWLPYSTMAGRVMGQSWLNSITVRVKEGYDS
SFAEQQLTRLLNLRHGKKDFFVWNMDSVLKTAERTTHTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASNVLQQFLIEAVLVCLVGGALGVTLSLMIALALQLIL
PGWEIGFSPVALLTAFICSTLTGVLFGWLPARNAARLDPVDALARE
>I3TM79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLGDAVDALVLGIVEGLTEFVPVSSTGHQIVVADLLNFRGDFAIAFNVIIQLGAILAVV
WEYRGKIVHVVAGLPSDREAQRFTRNLLIAFFPAVILGLLFADIIQEYLFNPITVATALV
IGGLIILWAEKRDHRVRANSTEEMRWSDALKIGLCQCLALIPGTSRSGSTIMGGLIFGMS
RKAATEFSFFLAIPTMIGATVYMFLKHGSTLLAGDLGVLAIGFVTSFIFAMIAVRGLLKF
IGQHSYAVFAWYRIAFGLFILATWVFGWIDWTSVTDL
>ZP_04097279|FEATURES|ARDB_deepARG|glycopeptide|VanRB|antibiotic target alteration|0
MNEINLKTTGKIQIAVLSFFWRYTFMDIRILLVEDDEHICNAVKVFLSGAGYKVDACFNG
DEAHTKFYDSTYQLVILDILLPGMNGHELLREFRKLNNTPVLMMTALSDDENQIRAFDAE
ADDYVTKPFKIQLLLKRVEALLRRSGAVAKELHYGKLTILPEDFKVFYDDEELLLTLKEF
EILMLLVQNNGRTLSHEVILSRVWGYDFDGDGSTVHTHIKNLRAKLPDNIIKTVRGVGYR
LEETS
>A0A0J1HJN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTHLFQPYTVVIGLVA
GAILMIFAEVKKQEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWTYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTVFVLL
>B4RP40|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRCFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRV
AEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>N8QIB0|FEATURES|UNIPROT_deepARG|beta_lactam|F994_00492|antibiotic inactivation|1
MQQRLFYFGCLLLLTQLSACHMNRAQTSNQSVQKAVLQAPSERPEEIKQLFNSAHTSAVF
ITYDGRQFNRYGNALARAQNAYIPASTFKILNALIGLQHHKVSTSEVFKWKGEKRSFPAW
EKDMNLAQAMQLSAVPVYQQLARRIGLELMQKEISRLGFGNQKIGQQVDNFWLVGPLKIT
PEQEAQFVYQLATEQLPFDVKVQKQVKEMLYIERRGDTKLYAKSGWGMDVKPQVGWYTGW
VEQANGQITAFVLNLEMHDGDDVGERKQLTLDALDKLGLFFYLH
>A0A076V5H0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
CESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAALQYSDNVAMNKLISHVG
GPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQ
RAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVT
>U6ZY50|FEATURES|UNIPROT_deepARG|aminoglycoside|P308_30500|antibiotic inactivation|1
MIRILPGQAADPGHWLQLRLGLWPHCPPEEHREEIRQMLAEPARYGCWLAQAADGETLGL
AEASLRHDYVNGTDSSPVVFLEGIYVAPEHRRQGTAQRLIEQVSQWGRQQGCVEIASDAS
LDNLVSHALHRALGFEETERVVYFKKAL
>E7SFM3|FEATURES|UNIPROT_deepARG|beta_lactam|SDB_00851|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQMPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAACQILNALQ
>ZP_04626871|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAVVVV
FWRRLFGLIGIHFGAVPHEGKTSGHLTLGHILLAMLPAVGLGLVFHNVIKSLFNPHSVMY
ALVAGGLLLLTAEWFKPKNAKAVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISGGML
VGVNRYAASEFSFILAVPMMMGASGLDLYKSLHFLTLGDLPMFAVGFITAFIVALIAIKT
FLSLIKRISFVPFAIYRFVVAAAVYWVFM
>G2GXU0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MMPLLELKSIHRSYPSGEQSVEVLKDISLKINAGEMVAIMGASGSGKSTLMNILGCLDQP
TTGTYLVNGQDVASLDNDGLAILRREHFGFIFQRYHLLPHLNAAHNVEIPAIYAGWSNNK
RHERASMLLTRLGLSTRTDYRPNQLSGGQQQRVSIARALINGGQIILADEPTGALDRHST
VEVITILKQLQQQGHTVIIVTHDAQVAAQAERIIEISDGSIIADSGFKPSPNKLPTKSLS
PKADIPSWQQTVFRLREALLMAWCAMMTSKMRTGLTMLGIIIGIASVVFILVIGEAAQKK
VLADIRAIGTNTIHIYPGEDYGDDEPSHLRSLTANDLEALTAQPYIDVISPLIASSMRLR
SGNVDVAGHVFGVNGQYFHVFGMTMAQGSVISQYQVDQQSQVVMIDNNTQRLLFPHLENV
VGQVILIGNMPATVIGVVQKKPSMFNNSEALQVWVPYRTMSKRLNGKFYFDSITVRIKDG
YDSKDVEQKLVRLLTLRHGKKDIYTYNMDTLLQTAEKTTRTMQLFLTLVAVISLIVGGIG
VMNIMLVSVTERTREIGIRMAVGARPGDIMQQFLIEAVLLCLVGGTLGVMLSLSVGIVMS
ILLPSWPIVFSPMAMLSAFLCSTVIGIVFGYLPARNAARLSPIDALARE
>S0ADI3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLTQPYEIILVDDGSSDNSADMLTA
AAEQPGSCVIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVRVAEEG
YDVVGTVRANRQDSWFRKSASRIINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLNCHER
STFIPILANTFARRTTEIDVLHAEREFGDSKYSLMKLINLMYDLLTCLTTTPLRLLSVVG
SVVALSGFVLAVVLIALRLIMGPEWSGGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGEQPVHNTQEEE
>A0A0A8TNM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFHVLILAIIQGLAELLPVSSSAHVILAEKLMGFDPSAPDMTFLLVMLHTGTMFAVIV
YFWASWRKTYFSSITNFKKQAGFIILATAITGILGLTLQALIKHVFFAGANHFEIEQLFS
NSKLMAAALVSAGILIILSARLDRGQTGEISLKSAAWIGAIQALCLPFRGFSRSGATIST
GLFLGVARQKAEEFSFALAVVLTPAVIVKEFYRLMHAENFQHMHLTQLLFPSVLGMVFSF
IAGLAALKWLSSWLEHGRWQLFGFYCIGFAGVVLALG
>P10424|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLV
DYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTEWMKGNATGDKLIRA
GVPTDWVDADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAEV
VIDAIK
>U3NE26|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA243e|antibiotic inactivation|1
MTVRLSSCALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPDYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
LKAAAYDLAENLFEVGEASGWRMHGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDAQATKPNAGLRARDDLMRDWPAMADAPRK
>ACQ66105|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFELSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR
>A0A011DRP8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTLDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMVNIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLST
>Q52360|FEATURES|ARDB_deepARG|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFSTLQKLQ
IPTIIFINKIDRAGVNLERLYMDIKTNLSQDVLFMQTVVDGSVYPVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAITSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQHPALKCSVRPNKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQVASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSMSLK
>A0A0K6HPC8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTSDTIISAFILGIVEGLTEFIPVSSTGHILLLGHFLGFESTGKTFEVLIQLGAILAILS
VYFGRLWSIATALPNDRRAQRFVAGILLAFLPAAVIGVLAHGFIKSVLFESPALICTTLL
LGGVALLVIDRLPLKPRYHNAMDFPLHLCLAIGFVQCLAMIPGVSRSGSTIAGSLLMGTD
KRSAAEFSFFLAMPTMAGAFAYDLYKNRDVLSMDDATIIAIGFVMSFVAAVFVVRKLLDF
VSRHGFAPFAWWRIAVGLAGFAGLYFFG
>V7IDQ0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MHMNLIECRNINRYFGEDANRVHVLKDISLTIQKGDFIAIIGQSGSGKSTLMNIIGCLDS
ATSGSYQIDGVETSQMSGDELAALRRRKFGFIFQRYNLLGALSARDNVALPAVYAGMDQK
ERNERATQLLADLGLEGKEDNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSGS
GEMVMEIIRGLHAKGHTIILVTHDPKIAAFANRVIEIKDGEIIADTSKNADIPPSSVESR
AEKASWLFYKDQFVEAFKMSVQAIMSHKMRSLLTMLGIIIGIASVVSVVALGRGTQEKIL
SDISSIGTNTIGVYPGKSFGDRHRGRIRTLTIADAEAIGKQSYVDSVTPLTTSNATVTYR
NTNVTAQLYGAGEQYFNVRGIKLDQGRLFNQDDVDAAAQVVVIDPNTRKQLFPEGTNPIG
QTILFGKRPLRVIGISAEDQNGWGGGDSLQMWAPYTTVMNRISGERYISAVTVKIRDDVS
TSVAEQGIKELLLARHGQEDFFTSNSDSIKQTIEKTTGAMTLLISCIALISLVVGGIGVM
NIMLVSVTERTKEIGVRMAIGARQGNILQQFLIEAVLICLIGGAAGILLSYLIGLGFNAM
ASEFAMSFSTWSIVSAVCCSTFIGVLFGFMPAKNASKLNPIAALSRD
>D3H336|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMLTSQVLFLAAGITLAVSPSHVVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0B1ZA20|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHIAKTTLAGIFFLFCGTSVGFAQERIEETVNAVIQPLMKQQDIAGMAVAITHNGQRQFF
NYGVASKDTRKTVTDQTLFEVGSVSKTFTATLGAYAQAQGKLQLSDSVGGHAPELRGSAL
ENVRLLDLATYSAGGLPLQFPDDADHPDRMFSYYQAWKPLYPASTQRLYSNPSIGLFGYL
AARSLGQPFDDVMQQTLMPGLGLKRSYVRVPQDQLGRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSSADLIRFVEANLRPQTLDEPLKQAIATTHTGFYRVGQMNQGLGWEFYPAPFTLE
DLLAGNTPQMALTPQKVEALSPPRPAPDGSWINKTGSTNGFGAYAAFVSGKDLGIVILAN
KNYPIEERIKAAHKILAALEQQ
>R7HWE7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLTLNLIEILKTLFLGIVEGITEWLPISSTGHLILVDEFLKMKQNDEFMNVFNVVIQLG
AILAVVVLYWSKLWPFHLKKNAPKKSWFVNEAKEGFLKSFQTFCNNYCYMDKIVMWIKIV
CACIPAIIMGPLFDDWMEKHLMNGFVVACMLILYGILFIVIENYNKTRTPKVNTLKEIDF
KTAFGIGLFQVLSLVPGTSRSGSTIIGGILLGVSREMAAEFTFFLGIPVMFGASFLKLFK
FGLAFTSAELIILLIGMVTAFLVSIVVIKWLMGYIKKHDFKVFGWYRIVLGILVLAYFIF
IK
>F4QL13|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLIAVLLGVVEGLTEFLPVSSTGHLLLLTHFLKFETTGKTFEVLIQLGAVLALLTLYF
QRLWGVVVTLPTEPRSRGFVISVLVAFLPAMVLGVLLHDFIKTVLFESPQLICISLIVGG
VLLWAVDKWAPKPVHDDAMVLDWKTSLIIGLFQCLAMIPGMSRSGSTLIGAMLCKVDKKA
AAEFSFFLAMPTMAGAFAYDVFKTYKQMDFSDMWLIVVGFTAAFVTAVLVVKALLAYVSR
HGYGVFAVWRICVGVVGLVLLQMGF
>B9DTK9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MLFFEILKAIFFGVVEGITEWLPISSTGHLILVQEFIKMNQDKDFMDMFNIVIQLGAIIA
VMVIYFERLNPFQPGKSARQVQLTWQLWLKVVIACVPSAIFGLLLDNWMEAHFYNFVVVA
LMLILYGYAFLWIEKRNEKVEPKVTELSRMSYKTAFLIGCFQVLSIVPGTSRSGATILGA
IILGTSRPVAADFTFFLAIPTMFGYSGLKAVKFFLDGNHLAFSQILILLVASLTAFVVSM
YAIKFLTDYVKKHDFTVFGKYRIALGSVLILYFFVSLFM
>B7N7S6|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGIDPAMRAENISVAQYCQMANYLAENALLQES
>A0A0J6K1Z7|FEATURES|UNIPROT_deepARG|aminoglycoside|VI26_20275|antibiotic inactivation|1
MPIQKLDHAALPDWVALRQQLWPHHASAAHYRDGEAILASGHLATFLARDATGQAVGFAD
AAIRHDYVNGCADSPVAFLEGIFVLPACRRHGIARQLVAAVQAWGLEHDCAELASDAPLS
NVDSQRMHACLGFEETERVVFFRKALV
>J2QLH4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLSSGFEIAAVFTHADDPKENAFYGSVAQLCARHGIAVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLSEPLLATARNGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQKVAIERSDTALSLHGKLRTAAADLLRDTLP
ALLQGKVSETPQDESKATVFGRRTPADGKLVWAKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGQAPGRVISVDPLRIACGQDSLIINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDPNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKH
>D8GV60|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVRGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFTVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQERLNYYREDKPHMTFY
>ABK86187|FEATURES|ARDB_deepARG|glycopeptide|VanSA|antibiotic target alteration|0
MKNKNKNKKIDYSKLKRKLYQYILTIVMAAVVFVLFLRLFIQGTLGEWIVRFLENSYHLE
RWDAMIIYQYTIRNNIEIFIYVAVAISILILCRVMLLKFVKYFEEINTGIDILIQNVDKQ
IELSAEMEFMEQKLNTLKRTLEKREHDAKLAEQRKNEVVMYLAHDIKTPLTSVIGYLILL
DEAPDMPREQKAKYVRITLEKAYRLEQLIDEFFEITRYNLQTITLTKKHIDLYYMLVQMT
DEFYPQLAAKGKQVVLHASEDLTVFGDPDKLARVFNNILKNATAYSKDDSVIDIKADLSE
DVVSIVFENAGYIPKDKLATIFEKFYRLDDARSSDTGGAGLGLAIAKEIIVQHGGQIYAE
SNDNSTTFTVELPAFQDLVDKEGS
>ACB20240|FEATURES|ARDB_deepARG|chloramphenicol|catII|antibiotic inactivation|1
MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAKTGYKFYPLMIYLISR
AVNQFPEFRMAMKDNELIYWEQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTA
EYQHDTRLFPQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFSPVFTMAKFQQEGDRVL
LPVSVQVHHAVCDGFHAARFINTLQLMCDNILK
>A0A149QP65|FEATURES|UNIPROT_deepARG|aminoglycoside|AB839_00285|antibiotic inactivation|1
MDEHNATPDGMPLPLAWQKALADARIERQSMGVSRADVARVLRQGRPDAFLKSELIDAFS
ELGDEIARLRWLQAQGQPAPTVIATAEEAGRRWLLMSALPGRDLASSPELAPQQRVEILA
DALRGLHALPVAACPFDQRLASRLPAAQARVEAGRVDADDFDDERLGQSPQQVFAQLCST
RPDHEDLVVSHGDACLPNLMVAEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFDDTRW
VTPLFQRYGAVADERRLAFYRLLDEFF
>A0A0T9TRY4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKKSIINSLVFTTIATAPLYTSAQSILTQQQVATIVNNTVTPLLEQQNIPGMAVAVFYD
GKPLFFNYGVANVKTGIPVTENTLFELGSVSKTFTGIAGEYAVQTGIINLNNPVTKYAPE
LAGEQWHGVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGEMRNYSNASI
GLFGALMAKESQLTFENYMKKYVFQPLKLTHTFITVPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTTKDMVRYMQANMAPDNLPAENDKLKKAIIAAQSRYFQVGDMFQGLGWEM
YNWPINPQRVVADSGNDIALKPRKVEGGLPPQPAMRASWVHKTGATNGFGAYIVFIPEEG
IGIVMLANKNYPNPARVQAAYNILQALR
>A0A0B8ZNT3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHLLINAFILGVVEGVTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
VMFWRRLFGLIGIHFGQPPLHEGKTQGHLTLGHIILAMIPAVVMGLVFHDAIKTLFAPRT
VVYALVVGGFLLLAAEWLKPKQPRAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRFAASEFSFILAVPMMMGATALELYKSLPFLSVADLPMFAVGFVTAFIVALIA
IKTFLSVIKRISFVPFAIYRFIVAAVVYMVFL
>A0A127SHD0|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-207|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGGRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0F6UAR3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
PEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQ
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELG
LVEGARLRGAASGPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKA
DPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVR
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
QQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTD
VDDGIEALARVIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAG
FREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREA
QA
>A0A0F7H8J8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGGKPVPHEGHTAGRLKLGHILLAMIPAVVLGLIFHDVIKSLFEP
KNVMYALVVGGLLLLAAEWLKPKKPRAVGLDDITYRQAFLIGCFQCLALWPGFSRSGSTI
SGGMLVGVSRYAASEFSFILAVPMMLGASGLDLYKSLHFLTLNDLPMFAVGFATAFVVAL
IAIKTFLQLIKRISFVPFAIYRFIVAAAVYMVFIN
>A0A0K8PXP2|FEATURES|UNIPROT_deepARG|beta_lactam|SAZU_7360|antibiotic inactivation|1
MPADAPASSRRAFLAAAALLPLAGCGPADRDTDRAGPAATTTRPTPEPSRRTPAPPVHRP
RLADLEREYGARVGVYALATGTGATAVHRSDERFAFCSVFKALAAAAVLHHRSLDGLDRR
VTYTRADLKSTTPITGRHVATGMTLRQLCDAAVRYSDGAAGNLLMRDLGGPAKLTAYLRG
LGDTVSRMDHYEPELHDVPPEDPSDTTTPRAIATDFHKLLLGTALPAGERALLTDWLSRN
ATTVGARRIRAGLPKGWQVADKTGTGNYGRANDIAIVRPTRTEPLVLAVMTDRRGYDAAP
SDALIAEATARTITALGL
>A0A0M0Y5M1|FEATURES|UNIPROT_deepARG|beta_lactam|AL012_16990|antibiotic inactivation|1
MFKKRGRQTVLIAAVLAFFTASSPLLARTQGEPTQVQQKLAALEKQSGGRLGVALINTAD
RSQILYRGDERFAMCSTSKTMVAAAVLKQSETQHDILQQKMVIKKADLTNWNPVTEKYVD
KEMTLAELSAATLQYSDNTAMNKLLEHLGGTSNVTAFARSIGDTTFRLDRKEPELNTAIP
GDERDTTSPLAMAKSLHKLTLGDALAGAQRAQLVEWLKGNTTGGQSIRAGLPEGWVVGDK
TGGGDYGTTNDIAVIWPEDRAPLILVTYFTQPQQDAKGRKDILAAAAKIVTEGL
>C6S5H0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A0Q0TFF5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIRATLVALPTQRQAQRFVLNVLIGFLPAVVLGLLFGKAIKAHLFTPVVVASTFI
IGGFIILWAERRSPAATRIQSVDDMTPLDALKVGLVQCLAMVPGTSRSGSTIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGGYSLYKERALLSVADLPMFITGLVFSFLSAWLCVRWLLR
YISTHSFVPFAYYRIVFGIVVLVTAWTGWVQWAD
>A0A0A8HSV2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFLELLKALVLGIVEGLTEFAPVSSTGHMILVDDMWLKSTQFLGSESAFTFKVVIQLGS
VFAAAWVFRHKYFEMLHIGKYAPEVQKGRRSKPRRLKITHILVGMIPAGILGVLFDDFIE
KHLFSVPTVLIGLFLGAIYMIIADKFSRGVRNPKNVDEINYFQAFVIGLSQAIAMWPGFS
RSGSTISTGVLMKMDHKSASDFTFMMAVPIMMAASGLSLLKNFSYIHLSHIPFYIIGFLA
AFIFGLLSIKLFLSLIQRVKLLPFAIYRIVLVVVIAVVYYGIIK
>B3SRA9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
INGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKN
YPNPARVAAAWQILNALQ
>A0A0S2FHI0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGIIEGITEFLPISSTGHLLIAQHWLGHRSDLFNISIQAGAILAVVVIYWR
RLWTLATGFGQRDNRDYLFKLALAFGVTAVLGIAVKKAGFSLPDHVLPIAWALVLGGVWM
IAAEHFAAKRAAALGERSEITWTVATLVGIAQVVAGVFPGTSRSGATIFIALLAGTTSRA
AATEFTFLIGIPTMFAASGYELLGVLGTPAAANEDWNALAVAFVASAVTAFIAVKWLLRY
IQTHRFTAFAIYRFVFGAALLLLMPSGS
>D5Q8G7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLDVIFILKSVIIAIVEGLTEFIPVSSTGHMILVGNLIDFKGQFAEMFEVVIQLGAILA
VVVLYWKKIKDSVREFLKFIFTGGKEGKIGFRFGMNVIIGCIPFAIIGVLFYDNIKSLFN
LQSVIIGFIVGGILLLVVETLFRKKNHSTDNIDKITPIQALKVGTLQVLSAWPGMSRSAS
TIMGGWIAGLNSPTAAEFSFFLAVPAMVASSGKDLFEFDYSVMTPTLWIALVVGFIVAFI
VSIIVMEKFVNFLKKKPMRVFAIYRIIMGAVLAVLALTNIISI
>ZP_02889083|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLSAEDVVQSIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEDEFGDIVVKTTPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGIDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASLIPLIAVPVSIIGTFSLLLGFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIESGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFKRFNKVFHRGAENYGRGVR
GVLSRKTLMLGVYLVLVGATVLVSKIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFSERHGKALSAGAIAGALN
QQYGAIKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GFSSGQAQAAVERIAHETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGIAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAGKDSAGYGVSPSGASGSGVPATDA
>T9CX84|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAILHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>B4EV80|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALLELNNVSRLYTNGEEDTVVLDQISLTINAGEMVAIIGASGSGKSTLMNILGCLDKP
SSGEYKVAGQCVADMESDQLAALRREHFGFIFQRYHLMAHLTAEQNVEIPAIYAGKSTEQ
RKERARALLTRLGLAERIHYRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSQSG
KEVMAILKQLNQQGHTVIIVTHDPLIAQQADRIIEIKDGQIISDNNNHHSAPVKKAPPAI
QTASYFHQVIGRFTQALNMAWRAMVVNKIRTLLTMLGIIIGIASVVTIIVIGDAAKDRVL
ADIKAIGANTIDIYPGKELGSDSPEDKQSLTIQDVDALKQQSYIQSVTPQIYFSSRLRRG
NQDAPATVSGVNEDYFSVYALKFAQGSTFTPDMIHRQAQVVVIDENTRHRFFPNKQAVIG
EQIIIRNIPSTIIGVVAEQKSTFGDNKSLRVWVPYSTLSSRIYNRSYLDNITVKVKEGYD
ASVAEQQILRLLTIRHGKKDIFTYNIDSFIKAAEKTTQTMQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVMQQFLIESVLVCLVGGLLGISLSFAIAMFASMM
LPNWHFVFQPTALISAFACSTAIGVIFGFLPARNAAKMNPIDALARE
>A0A0E3K232|FEATURES|UNIPROT_deepARG|chloramphenicol|CSCA_3312|antibiotic inactivation|1
MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANIEITGLLREIKLKGLKLYPTLIYIITA
VINRHKEFRTCFDENRKLGYWDSMSPSYTVFHKEDETFSSIWTEYDESFPRFYDNYLDDI
KSYGDVLKFMPKPDEPGNTFNVSSIPWVNFTGFNLNIYNDATYLIPIFTMGKFFHQDNKI
FIPMSIQVHHAVCDGYHTSRFFNEVQELSSNFETWLGEK
>D4RWT0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLTELVKIVVLGIVEGITEWLPVSSTGHLILFGQFLNLKSGQEFINMFNVVIQLGAILA
VVVIYFKKLWPVSKNNGTAKLCWDKDKLWLWLKIIVACIPSAVIGLLFEDKIDAIMTSPY
IVAATLIIYGIVFIVVENINKNKEFKITSLKEITFRTALIIGLFQVLALIPGTSRSGVTI
IGAMLIGTARTEAAEFTFFLGIPTMFGASLLKIFSFLKDGGGFSGPEAIYLFVGMVVSFA
VSIIVIRFLMSFIKKHDFKPFGIYRIVLGLAVIAFLVFA
>S2ZN07|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYRQNERGVVDVWNLIVSALYGVVEGITEWLPISSTGHILLLNKFVPLAVTTDFWDMFLV
VIQLGAILAVCVMFFHKLNPFSLKKTKEERKSTWILWAKVVVCCIPAAAVGIPLDNFIEE
HLGGPYVIASTLIVYGLIFIALETHREKIARTAPVVQPQGKHMRLPTDATPLRRSADELS
RVTDIDKLDWKTAFGIGLFQVLAIVPGTSRSGATIIGGLVLGCSRAVAAEFTFFLAIPTM
VGASGLRLVKFFLKGNSFTSSEAAILAVGCIVAFAVSLVMVRALMGYVRKHDFKPFGIYR
IVLGIAVIVYFALFA
>A0A0E1E965|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELWTAVQALILGIVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTINLLIAFMPAVVLGVIFADLIHEYLFNPITVATALV
VGGLVMLWAERRQHEIHANSVDEISWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRNLFQPDDLPVFAVGFITSFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLVILATWQFGWVDWTAVHS
>A0A0C5JWA2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MLELTGITRRFPAGERDVTVLRDVHLTIEGGEIVAIMGASGSGKSTLMNILGCLDHPSEG
SYRVLGRETHDLDADALAQLRREHFGFIFQRYHLLPHLDAASNVEMPSVYTGTPHAARRT
RAIMLLERLGLAERTAHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTRSGKEV
IRILKELNALGHTVIIVTHDESVAAHARRIIEIRDGEVVDDRENTPIDIAPDLTPAHETS
QEGGEGETSAGATASTPAATATGAATAGTGDPASVNASHGGAIPPRRWTGGIDRFAEAFR
MAWIALISHRLRTFLTMLGIIIGITSVVSIVAIGEGAKRYMLAEIGSIGTNTINIYPGKD
WGDNRATAIQTLVPEDALALSEQIYVDSATPETARSLLLRYRNVDASAMVTGVGEHFFQV
RGLKIAQGIAFGADEVRRQAQVAVIDQNTRRKLFGANPNPLGEVIFVGNLPCVVIGVTVE
KKSAFGETKSLNIWVPYTTAAGRLFGQRNVDSITVRVRDGQPSKAAEKSLETLMTQRHGR
KDFFTYNMDSVVKTVEKTSQSLTLLLSLIAVISLVVGGIGVMNIMIVSVTERTREIGIRM
AVGARQSDIMQQFLVEAVMVCLMGGAIGIALSFGASFLFSLFVEKWKMVFSMGSVVTAFL
CSTLIGVVFGFMPARNAARLDPVEALARD
>AAA60851|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNNGPDNQTIASFEIRD
QYITALNHLVLSLELPEVKGMGRFGYVPYVGYKCINHVSVSSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHSINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>ZP_03281411|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKQAEQGAQQMPEVGVVTLKSEPLQMTTELPGRT
SAYRIAEVRPQVSGIILKRNFTEGGDVKAGESLYQIDPATYQASYESAKGDLAKAEAAAK
ISQLTLNRYKKLLGTQYISQQDYDTALADAQQTNAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQTNALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVELVSNDGIKFPQAGTLEFSDVTVDQTTGSITLRAIFPNPDKNLLPGMFVRARLEEG
TNPNALLVPQQGVTRTPRGDASALVVGADDKVETRNITATQAIGDKWLVTDGLKAGDRVI
ITGLQKVRPGAQVKAQEVKSDDKQQAAAGGQSEQTKS
>A0A0E0VCV2|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIIALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFIAPGRPVAAHEEIHHHA
>Q9RER5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVPA
EVVINGSDNKVALAATPVTAVNPPAPSVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHILEALQ
>CAW29737|FEATURES|ARDB_deepARG|multidrug|mexD|antibiotic efflux|1
MSEFFIKRPNFAWVVALFISLAGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDS
VTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQ
AVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFF
SSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKG
TLDDPQEFGQVVLRANQDGSLVRLADVARLELGKESYNISSRLNGTPTVGGAIQLSPGAN
AIQTATLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLF
LQNVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSI
LFSGFLALTFTPALCATLLKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGR
FMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKS
REAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSAAAEIAALNEHFALPDDGTV
MAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEA
PQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPE
SVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEM
ERLAAQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLI
VPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAI
EAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPIC
FVWLLSLLRSKPAPIEQAASAGE
>A0A0Q5GQI2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MYATPTLRSLVAGLALTACLACSSLSAEAADPAAVERQVRSVIEPVMREAAIPGMAVVVI
ENGRRHHFNFGVDAPSGGKPVTADTLFELGSLSKTFTATLGAAAEAEGRLSLADPAERYE
PALAGHPLGRATLLDLATYTAAGLPLQFPDDVSGADGILRYFQAFRPEVEPGAVRRYSNP
SIGLFGELAGRAMGPGFETAMTRDILPALGLRSTFLTVPESEMARYAYGTAPSGEAIRVS
PGALDGPAYGLKSSAADMARFLEVEIDPSSLAAPLRAGVEATHLGHFRVGPMVQGLGWEQ
YPYPVDVETLVSGNSADMALKPQAATRLDPPQEPQGAVLFNKTGSTRGFGAYAAFVPERR
IGVVFLANRNWPNEARVRAGHAILSTLD
>D5HHY2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MALSFIEILKVVFLGIVEGVTEWLPISSTGHMLLVDEFISLNASTDFKEMFFVVIQLGAI
LAVVTIFWNKMWPFQLKDKTQPVMKKDTWSMWFKTVVACIPGAIVTILFDNYIEAHLHTA
VVIAIALIFYGIAFIVIENWNKTRTPKVETLNDITYKTAFLIGMFQVLSIIPGTSRSGAT
IIGALLIGVSRVAAAEFTFFLAVPVMFGLSALKMIKFGLSFTSAEFAILIIGCVVAYLVS
IVVIKFLMSYIKKHDFKIFGWYRIVLGVIVLAYFALFA
>A0A0Q8EN57|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGILEGLTEFLPVSSTGHLLIAQHWLGPRSDFFNIVIQAGAILATTLVFRR
RIWELATGWRDAATRDYAMKLAVAFLVTAFVGLPVRLAGWELPETVAPIAWALILGGVWM
LVAEHFAEKRGDVAAITWKVAVLVGLAQVVAGVFPGTSRSAAAIFMAMLAGTSRRSSAAE
FVFLVGIPTMFAASGYAFLELVKDNALGSENWGEVALAFAAATATGFVVVKWLLGFIKAH
RFTGFAIYRIVLGALLLLLMPVGS
>M8KY97|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDYFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWFPARNAARLDPVDALARE
>A4WWA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDSTTLVALVLGLLEGLTEFIPVSSTGHLLLAGHFLGFESAGRSFEVVIQLGAVLAVLT
VYASKLISVIRAAPRDPQAARFLAAVLLAFLPAVVVGVMAHGFIKTVLFETPILIAIMLI
LGGIILLFVDRMAPAPRYNDVTEVPLGVALKIGFFQCLAMVPGVSRSGATIVGALLLGTG
KRAAAEFSFFLSMPTMAGAFAFDLYKNRDVLDAGALGEIAVGFVAAFLAAVLVVRWLLGY
VSRHGYSLFGWWRIIVGSIALAALLKGF
>N9BTM8|FEATURES|UNIPROT_deepARG|beta_lactam|F950_00947|antibiotic inactivation|1
MKSTYLHRIASFTFTGCMVGLISCTAVAQPLSAQQVQHQIDQHFQPLIDQYQIPGMSVAV
TMHGRHYYRHYGVVSVETQQAVSEQTLFELGSVSKLFTATLTGYAQAQGNLKLSDHPAQY
FPELKQSAVNQATLLNLGTYTAGGFPLQFPEQVTTQSDMVKYFQQWQPKAAPDRIREYSN
PSIGLMGELTARAMKAPYTTLMERNLLVALGMRHTYIQVPTAQMPHYAWGYKAKQAIRVS
PGMFDAQAYGLKSTTADMLKFLDAELNPQRLKPALQQAVESTQIAYFKVGPMQQGLGWEQ
YAYPVALDTLLAGNSTQMALNAQPAQPIAHPVKAPAQTWLNKTGATNGFAAYVVFIPSEQ
IGLVMLANRNFPNEARIRAAYATLTQLIQSNHNK
>U2YJT3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPTLTAILLGIVEGLTEFIPVSSTGHLILATELFGYDANQWAMFNVVIQLGAILAVVVQ
YWGTFWRAGIGVLRLEARGLAFLRNILLAFLPSAVLGLALKDYIDIMLGSPSVVAWALIV
GGIAILGIEKVAKSGPYQEVADLPARQALGVGFAQCCAMIPGVSRSGATIMGALAMGINR
KTAAEFSFFLAVPTMIGASTLEFIDKGDQLTGGGHVGWSELGIGFVVSFFVALAVIRMFV
AYVSRSGFAPFAWYRIVIGIFAVAWLALR
>A0A127SRP8|FEATURES|UNIPROT_deepARG|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINREGELGIYDEMIPSYTIFHE
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRNDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>K0NM97|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPASFINMFMVVIQLGAILSVI
VIYFNKLNPFAPSKSRREKGQTWQIWFKVIVACLPSIIIGLPLNDWLEANMTTWQVIATT
LIVYGILFIILENYYAKRNPSLTDLNKMTYKTAFLIGCFQVLSMIPGTSRSGATILGAML
IGSSRFVATEFSFFLAIPTMFGASLLKIVKFFKNGHVFVGNQLAVLLVGMLVSFIVAYLA
IKFLLKYVQSHDFKPFGWYRIILGVIVIICGLVFA
>U3NE22|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-114r|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGAQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>A0A0G4AZP9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIVEIIVLGLIQGLTEFIPISSSGHLVIAQNFFSGSADHLFLEFINIGTMLALFVYFRN
RIWSIIVDVFVKRNIRLALNIVITAVPAGIVGLLLADFIGSSAFFGSMYVVVVTLFVVGV
LMVVLERLPKASKVRSMEELPKRRAFVIGLAQMVALIPGVSRSGSTIIAGRLAGFSAAEA
AEYSFLASLPIMMGVTLKVFVSDYAYLSDHLGMLIVGNIVAFASGLLAVGFLMKYLSRHG
LAVFGWYRIALAFVLGLILLLQ
>I1W1X4|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDE
TTRLALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>C8PHL4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIFDAVILGIVEGLTEFLPVSSTGHMILAAKLMGLQQTDTLKCFEVVIQLGSILAVVAM
FYKRLLVDFKLWCKLVVGFIPTAAIGFLLYKSIKSLFAPQTVAYALIGWGIIFIAVELFR
KARPRENELEHLDQISYVQAFIIGLSQCFAMVPGTSRSGATIIAGLLCGLSRNLAARFSF
LLAIPTMFAATFYDTYKNLDTFAQNSDNITTFLIGGAVAFVVALAAIKLFLSFVSKFDFI
PFGIYRILIGVVFFIFVF
>A0A0E9H0B5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLIQKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKEAAAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0N7I8Q0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIDQYLDAALLGLIEGLTEFLPVSSTGHLIIFDTLLGFEGPPGKVFEVVIQLGAILAIC
TVYFARLWKVVTGLKDDPGARHFAMAVILAFLPAMVLGAALHGVIKAVLFNPTVVSIALI
LGGVAILMAERLVPAPRYHQIERFPAPLALKIGLCQCLALVPGVSRSGATILGSLLMGVD
RRTAAEFSFFLAIPTMAGATVYDLYKNWSLMNVDSALLIGVGFVTAFIAAALVVKVLVDF
VGRYGFAPFAWYRIAIGSGMLAFLYL
>C2TGR5|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0016_23450|antibiotic inactivation|1
MLKIGMCVGILGLSITSIEAFTGGPLQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLG
VYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLVDYSPV
TEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSDRFETE
LNEAIPGDIRDTSTAKAIARNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIRAGVPTD
WVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAEVIVNAF
R
>A0A061YX86|FEATURES|UNIPROT_deepARG|aminoglycoside|DK27_19345|antibiotic inactivation|1
MSAQAGWRVRAAVGADAQALLALRLALWPDADDGVAELQAALAQADASHLLVVDDADAAL
GFAEASVRHDYVNGTESTPVGFLEGWYVSPAWRGRGLGRALVAAAVEWTREQGCTELASD
ARLDDSGAQAAHAACGFEPTERVVYYRLQLA
>A0A0F7HJL1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKIGSINHLLFSVSDLEKSIQFYQDVFDAELKVKGRTTAYFELNGYWLALNEEADIPRNE
ISHSYTHIAFSLEDDDFGEMYEKLERLGVNILKGRKRDTRDGQSIYFTDPDGHKFEFHTA
TLADRLAYYKEEKGHMEFYE
>A0A0V9JIY2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|APU02_14045|antibiotic efflux|1
MEPIIVLRQVCRAFNAGTQVLPVLSDISLTLHAGEMVAIVGASGSGKSTLMNIIGCLDKP
TSGEVLINGTPVHEADELRLADLRSRYLGFIFQRYHLMPYLTAEENIAIPALYTAMPEPE
RKARIQRLARQLGLENRLQHRPAQLSGGQQQRVSVCRALINGAHIILADEPTGALDSVSG
KALMDVLHQLHTAGHTVIIVTHDRDVARQAQRIIEISDGRIISDEQHVAVRQASALPDQD
NGRASLGRSLHESVRMAWRSLLGHRMRAFLSMLGIIIGIASVVSSMAVGEGARQAIMSEI
GKLGSTTLEIRPGTGWGSKRPDMERALSLDDVRSLQALPWIMGVSPVVSSTTLAVRKGLD
SSLMLSGVSQDFFSLQGLRFVEGNGFTARDVAEGEPVLILDETGRDTLFPGGENALGEIV
QIAGAPWRVIGVATRPGPKVVGGFMAAWAPHTALQQRLTGEKPLESLIARFQPTLEPHDA
AQRAERHLLREHGRKDFFIQTDDQLANALQKTSDSMSLLITAIAAISLLVGGVGVMNIML
VSVTERTHEIGIRLSVGARPSDIMNQFLIEAVMICALGGLLGVMGSWVAGHIFAVATDAF
TMVFTAFPVLMACGFSALIGLTFGYFPARRAARLNPTEALARE
>A0A0T9URP1|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSSLRRSLLLAGITLPLVNFALPSWAAGVSGSLDKQLAELEQSANGRLGIAMINTANG
SKILYRGAQRFPFCSTFKFMLVAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLIKQLGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPN
DPRDTTTPAAMAASMNKLVLGDALLPAQRSQLATWLKGNTTGDATIRAGAPADWMVGDKT
GSGDYGTTNDIAVLWPTKSAPIVLVVYFTQREKNAKSRHDVLASATKIILSQIS
>C5ISB8|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKTAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>ZP_04081918|FEATURES|ARDB_deepARG|bacitracin|BcrA|antibiotic efflux|1
MSAIIKTTNLTKIYGNQKSVDNLNITVNQGEIYGFLGRNGAGKTTTIRMLLGLIKPTHGK
IEIFGEDLFKNQKEILKRIGSIVEVPGFYENLTARENLLINAKIIGIHKKNAIDEALEIV
GLQHETKKLVGKYSLGMKQRLGIARSLLHYPELLILDEPTNGLDPIGIKEIRRLIKNLAK
ERKITLLISSHILSEIEQLVDHMGIIHEGKLLEEIDFNSLRKKNRKYIEFQVSNDNKATT
ILEKNFDIFDYEVHDEGIIRVYSKLGQQGDINKIFVQNDIQVLKILMSEDRLEDYFTKLV
GGGTIG
>A0A0D1NFX3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFVTGFVTAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>H3N9L9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGEGNVEVLKGITLSIAAGEMVAIVGASGSGKSTLMNILGCLDKP
TGGTYRVAGTDVARLNGDELARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGAERKA
RLARAHELLIRLGLGDRAEYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSRSG
EEVMGILHQLKAQGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPALGSAHGGVLRQRT
AAEPSAWRQFSSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAIGTNTIDVYPGKDFGDDDPRYQQSLKYDDLLAIQKQPWVSSATPAVSKSLRLRA
DNIDVAASAEGVGSQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNARRQLFPHKAKVV
GEIILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVNEGY
DSSIAEQQLLRLLELRHGKKDVFTWNMDSVLKTAERTTHTLQLFLTLVAVIALVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLLIAFVLQL
FLPGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A069F5L1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFELLKALVLGIVEGLTEFAPVSSTGHMILVDDMWLKSTQFLGSESAFTFKVVIQLGS
VFAAAWVFRHKYFEMLHIGKYAPEVQSGRRSKPRRLKITHILVGMIPAGILGVLFDDFIE
KHLFSVPTVLIGLFLGAIYMIIADKFSRNVRNPIQVDEINYFQAFVIGLSQAIAMWPGFS
RSGSTISTGVLMKMDHKSASDFTFMMAVPIMLAASGLSLVKNIGFIHLSHIPFYIIGFLA
AFIFGLLSIKLFLTLIQRVKLLPFAIYRIVLVVVIAVVYYGIIK
>A0A155SSJ9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTQALLEAGYDIAAIFTHPDAAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVERIRALAPDVIFSFYYRNLISDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQKVAIDADDTALQLHQKLNATAQTLLRDALPGI
LNGTFSETAQDESKASCFGRRAPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQVS
>A0A0D0JWL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTVNLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALV
IGGIVMLWAEQRQHEVHAETVDEIRWTDALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IGSHSYAAFAWYRIAFGLFILATWQFGWVDWSAAKP
>CAA33123|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITISETLAKFRSRDARDRGLDHA
>D4F3Y2|FEATURES|UNIPROT_deepARG|polymyxin|EDWATA_01448|antibiotic target alteration|0
DTALTLHHKLCQCAKTLLAEALPQIRSGNYSEYPQDESAATYVGRRTPADGRIEWNKPAR
TLYNLVRAVSEPWPGAFSYAGNRQFTLWQARVRHDLPAARPGTVLSTAPLVVACGQDALE
IVAGQPQDGLYMQGSQLAESLGLVEGAILNSSLNFGARRATRVLILGVNGFIGNHLTERL
LAEENYEVYGLDIGSDAISRFIGHPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATP
IEYTRNPLRVFELDFEENLKIVRDCVKYQKRIIFPSTSEVYGMCSDPQFDEDHSNLIVGP
INKQRWIYSVSKQLLDRIIWAYGAKDGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQL
ILNLVEGSPIKLVDGGRQKRCFTDIKEGVEALFRIIENKDNRCDGQIINIGNPDNEASIR
ELAEQLLVCFEQHPLRDRFPPFAGFREVESSTYYGKGYQDVEHRKPSIRNAQRLLGWQPV
IPMEQTIEDTLDFFLRTFDGTEQE
>C0Q3Z0|FEATURES|UNIPROT_deepARG|aminoglycoside|SPC_2116|antibiotic inactivation|1
MNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFVAMADGVAIGFADASIRHD
YVNGCDSSPVVFLEGIFVLPSFRQRGLAKQLIAAVQRWGTNKGCREMASDTTPENTISQK
VHQALGFEETERVIFYRKRC
>AAD41882|FEATURES|ARDB_deepARG|glycopeptide|VanD|antibiotic target alteration|1
MFKIKVAVLFGGCSEEHNVSIKSAMEIAANIDTKKYQPYYIGITKSGVWKMCEKPCLGWE
QYAGDPVVFSPDRSTHGLLIQKDTGYEIQPVDVVFPMIHGKFGEDGSIQGLLELSGIPYV
GCDIQSSVICMDKALAYTVVKNAGIAVPGFRILQEGDRLETEDLVYPVFVKPARSGSSFG
VNKVCKAEELQAAIREARKYDSKILIEEAVTGSEVGCAILGNENDLMAGEVDQIELRHGF
FKIHQEAQPEKGSENAVIRVPAALPDEVRERIRKTAMKIYRILGCRGLARIDLFLREDGC
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIEFSLRR
>T8ZPN3|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAALAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRTGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A060KQB4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFMLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0E1L2H1|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MKFNLIDIEHWNRKPYFEYYLHSVRCTYSMTANIEITNLLHEIKLKKLKLYPTLIYIIAT
VVNNHKEFRTCFDENGNLGYWDSMSPSYTIFHKDNETFSSIWTDYDESFSCFYNDYLDDI
KNYGAIMKFTPKLNEPANTFPVSSIPWVNFTGFNLNVYNNGTYLVPIFTMGKYFEQNNKI
FIPMSIQVHHAVCDGYHISRFINEVQELALNSQTWLKHK
>ZP_03063399|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMATAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPASPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQMLFLAAGITLAVSPSHAISLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVATHEEIHHHA
>T2F8F6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMDIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLNLEQFGVLLVACLVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIVLLIYAAFKAFLG
>A0A0U1DZJ1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSKALKVQLDGGPYALAAGSDGAMWVTLVHGGAVARVSVTGDVRTYPVGEGSRPSIISAG
PDGALWFTRAGDDRIGRITTAGELTSFELPSGSAPFGIATGPDGALWFTMMSSGEIGRID
TDGEITAAATVGGMPSMITRGPDDALWFTLNEAGAVGRLAVDGTLNLRELPTAAAGPVGI
AATHDDAVWFTEIRADKIGRIPVDDAIQELDLPGKPHAVVADPTDGVWVSLWGSDQIARI
SGDGDVVTIDLPSGSEPHGLAIGPDGACWVALECGFVLKMPT
>D9STX1|FEATURES|UNIPROT_deepARG|chloramphenicol|Clocel_1050|antibiotic inactivation|1
MGFNIIDMNTWARKECFNHFFNNAKCTYSITVNIDITNLYNYTKTNKLRFYPTFTWVVSK
VINSYQEFKMAFDEEGSLGFFDEIGPSYSVLNDKTKVMSDLYTSFNSIFENFYKDMENAL
NRYKEDNTFTTKFQNNFFIVSCLPWFNYTSFNVNNEGSTPFLFPMVTWGKFFEEDDKIIM
PVTIQVHHAVADGYHCSLFFSDLKEISLNPEQYLK
>G5KI80|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVIIELIKAIIFGIIEGITEWLPISSTGHLILIQEFIPLNQSKAFLDMFDVVIQLGAIMA
VVVIYFKRLNPFQPGKTANEVRLTWQLWAKVVIAILPVVVIGLKLDDWFNAHFYNFITVA
IMLIVYGIAFIWIEKRQKSVDPNVTSLARMSYKTAFFIGLFQILSIIPGTSRSGATILGG
ILMGTGRTVATEFTFFLGIPVMFGASLLKVFKFFYAGNAITLSQSMILLVASLTAFLVSL
YAIKFLTDYVKKHDFTVFGKYRIILGSILICFAILKLFI
>H3NBV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLWNIIKAIILGIVQGITEWLPISSTGHMILVDELIQMQASAAFMEMFFVVIQLASVLAV
VLLYWNELNPVIRTHSGFSIDQDILSIWPKVIVGVIPAGVIGFLFDDWFTENFFNWYTVA
LALIIYGVLFIIIEHYNKKRTFDIKTWDDLSYQVALMIGLFQVLALVPGTSRSGATIIGA
LLIGTARPIAAKFSFFLSIPIMFGASFLKLVRFGFNFTGDELVLLLAGCLFSFVVSVFAI
KFLMNYIRKNDFSAFGWYRIVIGLLVIGYFGILAA
>A0A059L3Q3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDRLKTLAVCVALLATGQCVAQDQIETVVNAAVRPVMQAQAVPGIAVAVTVNGKPYYFNY
GVASKESAQPVTENTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASSVLPELAGSAFDN
ISVLQLGTYSAGGLPLQFPDEADAPDKMLGYFQQWKPTYAAGTHRLYSNPSLGLFGYLAA
QSMGAPFDDVMEKTLLPKLGLKHTYLTVPQAQMGLYAQGYNKDDKPVRVGPGALDSEAYG
VKTSAADMIRYVEANMKPASLKDPMQRAIATTHTGYYKVGDMTQGLGWEFYRYPVTLDTL
LAGNSTQMAMEAHEVQWLTPPQPQPESVLINKTGSTSGFGAYVAYVPSKDIGIVILANKN
YPNPERIKIAHTILSALAK
>ZP_03476117|FEATURES|ARDB_deepARG|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAITSFI
LPPASVSNRLSSYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIN
QGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGLSHQHPALKSSVRPDRPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQVASSKAITDLQKLMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSIYELIQNKKKI
>D7PIH9|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKS
>A0A0K9N7U8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDVIKVIILGIVEGITEWLPVSSTGHLILVGDVLKPGMSAGFMEMFNVVIQLGAIMAVV
VLYFHKLNPFSPRKSRKQKMLTWQMWIKVVIASVPAGIIGILFNDILDELFYKPLPVAVM
LILYGVLFIIIENRNAHRKPSINRISDLTVPMLLWIGFFQMLALIPGTSRSGATIVGALI
IGVSREIAAEFTFFLAIPAMFGASLIKLIKFGFHFTGAEFGLLMLGCIVSFGLSIVAIRF
LMGYIKKHDFKVFGWYRIVLGGIIVITAAVQLVLK
>S3YHW0|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1181_02941|antibiotic inactivation|1
MKKQILIFTAVVCGMTCTTTAYAQFKIGGKKINVGKVVQAGTDAAKAITLSDADIAAMTL
EGKIAGFLKGKKATVGVAVLTDKDETILHNNEVHYPLLSVFKFHVALAVLDKMNREEIPL
KHIVHVKASQLQPNTYSPLRQKHSSQDLDISLGELLQYSISLSDNNACDILIEYAGGIGH
IHQYIRKLGINDFNLSETEDSMHRNPPKAYSNWSTPSEMVRLLKMADEKNLFAPVYRDFL
WKTMTETATGSNKLKGLLPSNTVVGHKTGSSDRNLKGVKMADNDAGIVIMPGGKKYYIAV
FVTDSSETDEENAAIIAHISRMVYDEMK
>R6AUC2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILDVIKTIILGIIEGITEWLPISSTGHMILANEFLKLNVSAEFWEMFEVVIQFGAIFAV
VVICFKDLFPWGFNKDKTDTKETFNLWGKIVVSSIPAAVIGLLFDDYINAHFFNAWTVAI
MLIVYGLLFIIIEKKHKGKRARVTDVKDVSYKDAFMVGVFQALAIIPGTSRSGSTILGGL
LLGLDRSVATSYTFYLAIPAMGGASLLKLLKFGFAFTSSELIILITGMITAFIVSIFAIK
FLLKYIRKNDFTVFGYYRIVLGIIVILYFLFK
>A0A0R1V3X0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKEKIFMLDIIKAIILGIVEGVTEFLPISSTGHLVLVDEFIKLQQSKQFVDMFNVVIQLG
AIMAVVVIYFHKLNPLSPRKSVIERKKTWTLWKKVIIAIIPSVIVGFPLNDWMDEHLMNW
FVVSMALIIYGVLFIVIENRNKNIAPKYDNLDTLTYKTAIAIGLFQVLALIPGTSRSGST
ILGGIMIGTSRFVATEFSFFLAIPTMFGASLLKLYKYFNHGGSLAGLQGVVLAVGVLVSF
VIAYLSIRFLLNYVKKNDFKAFGWYRIVLGVVVIGYFAFFH
>A0A089I1T8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGYNEQEPIMKTYEIVIQLGAILAIAL
VYRQRVLNLLGIGRSRQGRGGVMPASRLNLVHIILGIAPALAVAFFARDFIKGLFGATTV
LWALVAGGILMIVAEWVNKRKIRVTAHELDDLSYGQALAIGMYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKYFTSDTIWDFAIGFVISFIVAY
VVVILFMKLIQKIRPTHFAIYRFILAAVFWLFIMR
>A0A0A2Y8A5|FEATURES|UNIPROT_deepARG|chloramphenicol|JP30_06285|antibiotic inactivation|1
MNFNKIDLDNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQEGYKFYPAFIFLVTRV
INSNTAFRTGYNSDGELGYWDKLEPLYTIFDSVSKTFSGIWTPVKNDFKEFYDLYLSDVE
KYNGSGKLFPKTPIPENAFSLSIIPWTSFTGFNLNVNNNSNYLLPIITAGKFINKGNSIY
LPLSLQVHHSVCDGYHAGLFMNSIQELSDRPNDWLL
>A0A0L6T7L5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLGFHDEKSKVFDIAIQTGAIVAVM
IVYWERLRETMLGIGNDAKAQRFATNVGIAFFPAVILGLLFGKAIQANLFTPQVVATTFI
VGGFIILWAERRTSTARIQSVDEMTRLDALKVGLVQCFAMIPGTSRSGATIIGGMLLGMS
RKAATDFSFFLAIPTLIGAGAYSLFKQRALLSAADIPLFGVGLLFSFLSAWLCVRWLLRY
ITTHNFVPFAWYRIAFGIVVLVTWHFGWVTWAG
>A0A0T9U4K8|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGATPHEGKTSGHLTLGHILLAMLPAVGLGLVFHNAIKSLFNPHS
VMYALVAGGLLLLAAEWFKPKNPKAVGLDDITYRQAFAIGCFQCLALWPGFSRAGATISG
GMLVGVNRYAASEFSFILAVPMMMGASALDLYKSLHFLTLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>S9S2W4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MALGEGATALLLGVIEGLTEFIPVSSTGHLLLASEALGFHSTGRVFEVAIQLGAVLALVT
VYAGRLALVFGTAHRDPLQRRFMASVLLAFLPAAALGVALHDVIKTVFFETPALIAWMLI
LGGLVLLAVDRLSLTVRHAEADRLPLRTSLAIGLCQCAALVPGVSRSGATIVGALLMGVS
KRAAAEFSFFLSLPTMAGAVAYDLWQNRELLGSGDLGLIAIGLAAAFVTAALVVRTLLGF
VSRHGYGLFGWWRILLGAIVLWTF
>N9DCF4|FEATURES|UNIPROT_deepARG|beta_lactam|F942_03152|antibiotic inactivation|1
MLSLLQRSRYSHKPLWSKKSLCLMGLLACSPPLYAKDLTEQQVKAVIDQQFKPLLAQYNI
PGLAVGVSLNGQHYFVNYGVASKQTQQAVSSHTLFELGSVSKIFNATLVGYAQATGKLSL
ADHPAQYFPALKNTAVNQATLLNLGTYTAGGFPLQFQDQVTEQQDMLKYFQTWQPKNTIG
TQRQYSNPSIGLMGYVTALAMEKPYTELLEKMLFPALGLNESFIDVPEQQMTQYAWGYKG
QQAMRVSAGMFDAEAYGVKSSSADLLKFLDAQINPQQLKQPLRKAIENTHVGYFKVGEMT
QDLGWEQYSYPIKLDTLLEGNSKKMAFESHAVIPIKQPKLAAPATFFNKTGATNGFGAYV
AFIPQQKIGMVMLANTNFPNEERIKASYRVMQQLLQSNSAQ
>F4KP41|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLESIILAIVEGLTEFLPVSSTGHMILTQGILGMESTPFLRAFTVMIQFGAILSVVVL
YYKRFFTFRVEEGARPLPQRWQWVGRFSFYIKLLVGLIPAAVIGLLLEEQIDKLLDNVYV
VATMLFLGGIFMLFIDRIWPAKKQTVERPSYRNAFVIGCFQTIAMIPGVSRSMATIVGGL
QQRLTRRAATEFSFFLAVPTMLGATLLKGYKLLADPVSSQMLQENWTALLVGNVVAFVVA
LLAIKFFINYVTRYGFKLFGYYRIVVGLLVLILLLCGVPLAMH
>AAT59669|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYIVDPDGHKFEFHSGT
LQERLNYYREDKPHMTFY
>Q83ZX4|FEATURES|UNIPROT_deepARG|beta_lactam|blaP1|antibiotic inactivation|1
MKFLLVFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGRSIFDVYTSQSR
>A0A142I9J9|FEATURES|UNIPROT_deepARG|beta_lactam|blaPDC|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFSDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A127T3T2|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-226|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNVKDLMIVEAGRNWILRAKTGWEGRM
GWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>A0A0Q5GLI7|FEATURES|UNIPROT_deepARG|beta_lactam|ASF86_08960|antibiotic inactivation|1
MRFKKISYLILPSLFIFNTSIYAGNISKEQDIKKVVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKSVNGNTIFELGSVSKLFTATAGGYAKTKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQYSNPSIG
LFGKVVGLSMNQPFSQVLEKTIFPSLHLKHSYVNVPKTQMQNYAFGYNQENQPIRVTPGP
LDAPAYGVKSTLPDMLSFIDANLNPQKYPADIQRAIEETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISQEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>E6MP18|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIQTLIISIVEGLTEFLPVSSTGHMIITQNLLGVPQGDPFVHAFTFIIQFGAILSVVC
LYWKHFFQMRTMEEFLSKMKFYGLLIVGVIPAVVIGLLAKKSGLLDKLLDSVEVVAVTLV
IGGVFMLFCDRIFNQGKEENKVDWKRAFKIGCFQCLSVIPGMSRSMSTIVGGMQQKLTRK
RAAEFSFFLAVPTMAGATLLDLLDMFKEGTTWATPDNIKMLILGCVVAFVVAIFAMKWFV
SFLTKYGFKAFGWYRIIVGTVILILLFTGHSLVMVD
>YP_002791405|FEATURES|ARDB_deepARG|trimethoprim|dfrA19|antibiotic target replacement|1
MSHPQLELIVAVDSKLGFGKGGKIPWKCKEDMARFTRISKEIRVCVMGKHTYTDMRDMQL
EKDGAEERIKEKGILPERESFVISSTLKQEDVIGATVVPDLRAVINLYENTDQRIAVIGG
EKLYIQALSSATKLHMTIIPREFDCDRFIPVDPIQNNFHIDSSASETVEATVDETQERIH
FATYVRNNQ
>N8S2P8|FEATURES|UNIPROT_deepARG|beta_lactam|F981_03472|antibiotic inactivation|1
MVVLNKTKTIFCVLIGSMSLTTYVNANEIPATSIKVETAMNTAFQPLMKTYAVPGMAIGV
LYNGKSYEKYYGVQSLANAKAVNKNTLFELGSVSKIFTATAGTYAQNLGKISLQDHPEKY
LPALKNSDINQVTLLELATYTSGNLPLQFPDQIKTDAQTLKYFQDWKVKNPIGQFRQYSN
PSIGLFGEATAKAMNMPFSALLEQVIFPKLELQHTYVQVPKAQQGNYAFGYDQNNHPLRV
TAGAFDAQAYGVKSSLPDMLHFLNLNLNPDQAKAAIKPAILATHTGYFKMGGMTQALGWE
SFSYPATLNTLLESNSDRVVMQSNPVEKTLVKTGSRIFHKTGSTNGFGTYVIYIPQENFG
LVMLMNKKIPNAERIKAAYEVLNSLKQKSNP
>F3ZQS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDELSTLQTILIAIVEGLTEFLPVSSTGHMIITQSLLGIESTEFVKAFTVIIQFGAILSV
VCLYWKRFFHLNSCKIFDSEAVKGLSGSKKGLTYLKRFLYKYDFYWKLLVAFIPAAFFGL
LFSDIIDDLLESVTVVATMLVLGGVFMIFSDKIFKNQSQSTEMTDRKAFKIGIYQCIAMI
PGVSRSMATIMGGMAQKLSRKHAAEFSFFLAVPTMFAATCYKILKLYLSGGTQVLSDNLF
TLILGNVVAFIVALLAIKFFISFITKYGFKAFGYYRIIVGVAILAMILMGHNLEIA
>ZP_04635798|FEATURES|ARDB_deepARG|beta_lactam|BL2e_y56|antibiotic inactivation|1
MKHSPLRRSLLLAGITVPLLNFALPSWAVGAKMSLDNQLAELEKSSNGRLGLALINTGKG
TKIHYRGGQRFPFCSTFKLMLAAAVLGRSQSQPNLLSKHITYHESDLLAYAPITRKHLAQ
GMTVAELCAATIQYSDNTAANLLIKQLGGLAMVNQFARSIGDQTFRLDRWEPELNTALPN
DPRDTTTPAAMAASVNKLVLGDALAAPQREQLALWLKGNTTGAATIRAGAPTDWVIGDKT
GSGDYGTTNDVAVLWPAKGAPLVLVVYFTQLKKEAEPRRDVLAAATKIVLAHLS
>A0A086AU97|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAISLLLGGLILLKVDEW
FNKPNTAETSQEITYLQAFKIGMFQCLAMIPGVSRSGASIVGGMSQKLTRTTAAEFSFFL
AVPTMFGATAKKCYDYYKAGFELSHDQVNLLIIGNIVAFIVALLAIKTFIGFLTKNGFKV
FGYYRIIAGIVLLLIHFFIHPLTII
>A0A127SPY7|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-65|antibiotic inactivation|1
NTQVLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLFNQPVEIKPADLVNYNPIAEKHVN
GTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIP
GDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDK
TGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>W5X0D2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLLHAIILGIIEGVTEFLPISSTGHMIIASAMMGIEDNDFTKAFEVIIQFGAILSVLVL
YWRRFLPNWVFYKKLFVAFLPTAIIGFIVKDFVDQLLGSVDVVAASLIIGGIILIWSDKI
FAHLTENGRKTSDLTYLDSIKLGLFQSIAMIPGVSRSAATIMGGMTLGMNKKEAAEFSFF
LAVPTMAAATAYKLLKIYKTIEPNEIGLLAVGCFVGFIVAMVAIKFFIGVVSKYGFKFFG
YYRILVGAIILFYTNFR
>A0A088U2Y4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIASVVTGLPSRPDARRFTLNVVIATIPAIVLGLLLEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVQSVDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDALGLFVLGLVAAFVSAFACVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>L4JJI2|FEATURES|UNIPROT_deepARG|beta_lactam|A311_00288|antibiotic inactivation|1
MLKTTLCTLLITVSCSTLATPHSEQQINDIVHHTIIPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGAL
AVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMAHWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPARVTAAWQILNALQ
>A0A0M1M6Y6|FEATURES|UNIPROT_deepARG|chloramphenicol|ADT22_00070|antibiotic inactivation|1
MNFTIINKETWDRKEYFEHYFSEIPCTYSMTTKLDITKIKKENQHIYPTMLYLISKVVNN
HSEFRISFDMNGELGVFDRMHPSYTVFHKDTETFSNIWTEYSDDYETFCKLYEIDICTFG
SVKKINAKPNVPENSFPVSMLPWTTFDGFNLNLQKGYNYLIPIFTIGKYYEENGRYMIPL
AIQVHHAVCDGFHVCRFVNELQGLMED
>A0A0M0MEB7|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMMLEKIHQKEIKFYPTFIYIISRM
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKGDKSFSSIWTDYSSDFHIFYKNYEEDMK
CFANVHGLFPKENIPPNVYPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNDGSKVM
LPFSLQVHHAVCDGYHASRFIEDLQELVNTCNEWL
>A9VH74|FEATURES|UNIPROT_deepARG|beta_lactam|BcerKBAB4_0809|antibiotic inactivation|1
MFVLNKFLNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>N9S2N2|FEATURES|UNIPROT_deepARG|beta_lactam|F943_03244|antibiotic inactivation|1
MLSLLQRSRYSHKPLWSKKSLYLMGLLACSPPLYAKDLSEQQVKAVIDQQFKPLLAQYNI
PGLAVGVSLNGQHYFVNYGVASKQTQQAVSSHTLFELGSVSKIFNATLAGYAQATGKLSL
DDHPAQYFPALKNTAVNQATLLNLGTYTAGGFPLQFPDQVTEQQDMLKYFQTWQPKNTIG
TQRQYSNPSIGLMGYVTALAMEKPYTELLEKMLFPALGLNESFIDVPEQQMTQYAWGYKG
QQAMRVSAGMFDAEAYGVKSSSADLLKFLDAQINPQQLKQPLRKAIENTHVGYFKVGAMT
QGLGWEQYSYPIKLDTLLEGNSKKMAFESHAVIPIKQPKLAAPATFFNKTGATNGFGAYV
AFIPQQNIGMVMLANTNFPNEERIKASYRVMQQLLQSNSAQ
>A0A0U1YUF0|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVALWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQITFLRKLYQNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>H1YFX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIIQVIILAIIEGITEFLPVSSTGHMVIASAFMGIGKEDFVKLFEVVIQLGAILSVVVL
YYKRFFKSLDFYFKLVVGVIPAVIVGVLLKKRIDMLLESPLVVACSLLVGGIILLFVDQW
FKQSTVKEEEDISYATALKVGFFQCLAVIPGVSRSAATIVGGMSQKLSRTAAAEFSFFLA
VPTMFGATLKEIWDYHKEHEHLFNSEQIKFLVVGNIIAFIVAMLAIKTFITFLEKKGFKL
FGFYRILAGIVLIVMYYTGHLTA
>ACB17398|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVEKPDPEMFRIGASAVANLEPQ
>A0A084YXU7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTTGHLKLGHILLAMIPAVVLGLLLHDFIKSLFAP
KNVMYALVVGGFLLLAAEWFKPKKPSAEGIDDITYRQAFMIGCFQCLALWPGFSRSGSTI
AGGMLVGVNRYAAAEFSFILAVPMMIGASALDLYKSLHFLTMGDLPMFAVGFATAFVVAL
IAIKTFLSLIKRISFVPFAIYRFIVAGVVYMVFM
>A0A124EQB4|FEATURES|UNIPROT_deepARG|beta_lactam|AU192_24225|antibiotic inactivation|1
MTGLSRRHVLIGGLTLAALAASPHKAVMADPNRPLPPIEDRLGEMERRQNALIGVFATNL
GTGHTIAHRAQDPFAMCSTFKTYAAARVLQKAERGELALTDRVTIEPGDIVPNSPVTEAR
VGQTMTWAELCQAALQRSDNAAGNWLLRVIGGPSGVTDFARSIGDERSRLDRWEIELNAA
VPGDPRDTTTPEAIGTGYRAILTGNVLADPQRRQLEDWMRANQTSSVRPVLPPGWATADK
TGSGDYASTNDVGIAFGPAGERLLLAIMTRTAANDPDIPNDRQLVGEVASVLVAGLLA
>A0A0K6GL79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHIIELMKAIILGLVEGVTEFAPVSSTGHMIIVDDMWLKSGEFLGKYGANTFKVVIQLGS
VLAAVVVFKDKFFELLYLRKRDKKTGPHLTLMHIFIGLVPAGVLGVLFEDYIDEHLFSTE
TVLIGLVLGALLMIAADRFGKRTIAQTVDDITYKQAFIVGLVQCLSLWPGFSRSGSTISG
GVLVGMSHRAAADFTFIMAVPIMAGASGISLLKNWQYITIDALPFFVVGFISAFIFALLA
IRFFLHLINRVRLVPFAIYRIVLAAVIYIVYFA
>YP_002226908|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLIGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIHENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLPGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>V3PWW6|FEATURES|UNIPROT_deepARG|beta_lactam|L370_01734|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPH
YFTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDSASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMASWVMVNMKPDSLQDTSLRQGITLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSGNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYHILDALQ
>P52664|FEATURES|ARDB_deepARG|beta_lactam|BL2e_fpm|antibiotic inactivation|1
MTMFKTTFRQTATIAVSLISLLVSPMLWANTNNTIEEQLSTLEKYSQGRLGVALINTEDN
SQITYRGEERFAMASTSKVMAVAAVLKESEKQAGLLDKNITIKKSDLVAYSPITEKHLVT
GMSLAQLSAATLQYSDNTAMNKILDYLGGPAKVTQFARSINDVTYRLDRKEPELNTAIHG
DPRDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGNTTGDHSIKAGLPKHWIVGDKT
GSGDYGTTNDIAVIWPKNHAPLILVVYFTQQEQDAKYRKDIIVKATEIVTKEISNSPQTK
>ABB18304|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTEPEQWDVVIE
GNDDLLEKYMSGKSLEALELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYS
STYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKKPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVNTQLKNNEVILSGEIPARCIQEYRNDLTFFTNGR
SVCLTELKGYYVTTGESVCQPRRPNSRIDKVRYMFNKIT
>A0A089I7V6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDVIKAIILGIIEGLTEFLPVSSTGHLILAGNLLSFEGDAAITFKIVIQLGAVMAVLIL
YWRRYLKIGANMIRMDFSKSKGLNVIHMILAMLPALILYLLFKDTIKSKLFGPTPVLIGL
VVGGVLMIIAARSRRTETADTIDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDLLNSDDFFLMLIGFMTSFIVAMIAVVTFIK
LIKRLRLEWFALYRFVLAALFYFIVIL
>J7ZVL2|FEATURES|UNIPROT_deepARG|beta_lactam|IG7_00746|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQIKQENTGNQSFAKLE
KEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITYTHE
DLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGDTVT
TSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIADA
TKVVLNTLKATE
>A0A0C1GZZ3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGANRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDSAT
SGSYQIDGIETAKMEPDELAALRRERFGFIFQRYNLLGSLTARDNVALPAVYMGMGGKER
SNRAEKLLQDLGLEGKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVIEIIQKLHKEGHTVIMVTHDPGIAAIANRIIEIRDGEIISDSSKNPEIPESKIERIKE
KSSWLFYYDQFVEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSEKKILAD
ISAMGTNTISIFPGRGFGDRRSGRIKTLTIDDAKVIAKQSYVASATPQTTSGGTLTYRNT
DLSASLYGVGEQYFDVLGLKLESGRLFDESDVKEDAQVVVIDQNTKEKLFGADVNPLGKT
VLFNKRPLTVIGVMQKEENSFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQ
VAEKGLTELLKTRHGTEDFFMNNSDSIKQMVETTTGTMKLLISSIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLVGVGLSTLISLVFNHFVT
EFPMEISIGSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALSKD
>B7KUB6|FEATURES|UNIPROT_deepARG|beta_lactam|Mchl_1758|antibiotic inactivation|1
MRKRVLAAIVLSGLPHVTAPALAADPSARVAAAVEQAYRPLMKAYDVPGIAVAVTRAGHS
AVFAFGLADRERQRPVTRDTLFEIGSVSKTFTATLVSYAQGLGRLSLDDAPSRFLPSLRG
SALDRISLLDLGTYSAGGLPLQFPDAVTDEAAMIAYFRRWQPSAPPGTQRLYSNPSLGLF
GAAAAAAMGGDFVEMMETRLFPGLGLKHSFIRVPASESERYAWGYGKDGAPIRVNPGVLD
GEAYGVKSSAADMIRFVEAHLDPTRLDPPIRQAVQGTQIGYFRVGAMVQGLGWEQFPYPI
SLGRLQAGNAEPMRFEAQPAKRLDPPQRPTGVTLFDKTGSTNGFGAYVAFVPAKRIGLVM
LANRAFPMPARIAAAHAVLEVLAAEEP
>A0A069QK45|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIQTIIVAIVEGLTEFLPVSSTGHMIITQALLGIESDEFVKAFDVIIQFGAILAVVVL
YWKRFFRLNHSTPPEGLTPFQRTLRKWDFYYKLLIAFIPAMVIGGLCNKFIDALLGNVMV
VAVMLVVGGVFMLFCDKLFGNGSPETKLTPRRAFAIGLFQCMAMIPGVSRSMATIVGGMA
QKLTRKDAAEFSFFLAVPTMFAATCLDLLKLFLHMHKIGDYSMLASHAGTLLLGSAVAFV
VALIAIKAFIAYLTKYGFRAFGVYRIIVGGAILAWMLAGNSLAMVD
>V7EQ92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENTLVAALLGLIEGLTEFIPVSSTGHLLLAGHFLGFDSPGRTFEVVIQLGAVLAILTVY
AAKLWRVASTIHTDPASARFVASVLLAFFPAALIGVLAHDFIKTVLFETPALIAIMLILG
GLVLLVIDRLAPPPQHEDAMQLPFRKALAIGAVQCLAMIPGVSRSGATIVGARLMGVGKR
ASAEFSFFLSMPTMAGAFTYDLWKSRHILDFSALTDIAVGFALAFISAVLVVRWTLDFVS
RNGFAIFGWWRIIVGSAALALLSLGL
>D4HVK9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEDHPMKKKTRTTLLLCTALAVTPWFSAVAAPMTQQQVTRLVDDTIKPLLEKQHIPGMAV
AVLYQGQPQFFNYGVAETEHQRAVTQHTLFELGSVSKTFTGVAAGVAIQTGLINLNDRVA
LHCPELNGAQWQKITLLNLATYTAGGLPLQLPDEVTDTASLQHYFQQWQPQWPAGTMRNY
SNASIGLFGALAVKNSGLSFADYLNTSVFQPLKLTRTFITVPPSAQADYAWGYKDGQPVR
VTPGMLAAEAYGVKSSTGDLVKYMQANINPASLSSDNKELAKAIVSAQTRYYRVGNMYQG
LGWEMVNWPISPDEVIAGSGNDIALHAWPATALKAPQSAVASSWVHKTGSTNGFGAYIAF
IPEKQLGIVMLANKNYPNPQRVAAAWQILQALDESKQEDAGDKTAFCHPH
>B2ZTR2|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
TSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAV
NSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTS
GNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVL
EKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSF
IHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMK
PNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVMLTNKR
>A0A0M0X4B3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQNINHLLFSVSNLEKSIAFYEKVFDAKLLVKGRTTAYLDVNGLWLALNVEKDIPRND
IHQSYTHIAFSIQEDDFDKMYEKLVHHNVNILEGRQRDVRDRKSIYFTDPDGHKFEFHTG
TLQDRLDYYKKEKTHMEFFNV
>C9LWH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLKTVVLGIVEGLTEWLPISSTGHMILVDEFIKLDVSKSFMDMFLVVIQLGAILAVVV
LNFEKLNPFSSWKSSWEKRATWQLWYKVILACVPAAVIGLLFNKFMEEHFMTAPVVAATL
IFYGVMFLVVESYNKRRTPRVREIERLDYKTAFIIGLFQVLSLVPGTSRSGATILGGILF
GTSRYVAAEFTFFLAIPVMFGASLLKMVKFGWHYTGSEILILVVGMATAFVVSILSIKFL
LRYIKNNDFKAFGWYRIVLGIIVVLYLYFVGDPVQG
>A0A0T9TSC4|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLVFHDVIKSLFNPHS
VMYALVAGGILLLAAEWFKPKNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASGLDLYKSLHFLTWGDLPMFAVGFITAFVVALIA
IKTFLSLIKRISFVPFAIYRFVVAAAVYWVFIS
>BAF77214|FEATURES|ARDB_deepARG|multidrug|mepA|antibiotic efflux|0
MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLP
VFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQ
IAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMISMIGMLASVGLNI
ILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEI
FKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPL
IAYNFMANKGRMKDVIKAVIMSIGVIFVVCMIAVFTIGHHMVGLFTTDQAIVEMATFILK
VTMASLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALFGLTGVIWSLL
IAESLCALAAMLIVYLLRDRLTVDTSELIEG
>U2GXT7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MISLKNITKSFKLGDNEIEILHGINLEIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSGG
QYLLDSKDISKFDNDALAKLRRDKFGFIFQRYNLLSTMNALENVALPSIYAGANKSEREK
RANELLGSLGLSEKAKNLPNKLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGLRV
MEILVDLYKKGHTIIIVTHDPKIAEYASRVIEIKDGNIVSDNVKNSEIFEASKQTQPEKS
KFTYYKDQLIESFKMSVNAMLAHKLRSLLTMLGIIIGITAVISVVALGKGSQEQILAGIR
KIGTNTIDIMPGKGFGDMLSGKVKTLSISDANMLAKQSFLDSVTPNTSTSGVLTYENISL
SASLKGGGVGSFDVNGLKLEEGRIYDDDEVLNSASVALIDQNTKNSIFKNDDPIGKIILF
NKMPLRIIGVLQKDDFKMGDSSTLKIYAPYTTVLNKVTGDKFISSVTAKVNEGVNAQIAE
KTLTELLEIKRGKKDFFTRNSDSIKQTIEETISTMRLLISSIAVVSLVVGGIGVMNIMLV
SVTERTKEIGIKMAIGARQSNILQQFLIEAVLLCLIGGAIGIVLSYAIGYIFNNFLNGFS
MIFSNGSIVLALVTSMAIGIIFGYMPAKNASKLNPIDALSRE
>G2S4Y6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNNIHRSYPSGDGPVDVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TRGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAQALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPLVAAQAERIIEIHDGELVSNPPPNPSKAAAPKEVLP
ASGGWGQFASGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLMAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVNGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPDKTNVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTHTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMIIAFTLKLFL
PGWEIGFSPVAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A031LLG3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILAAELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWSRLWGAATGMVTGEAQGRRLGFGLILASIPIVAIGLTFGQTVKELLFNNYAIAIG
LIVGGLIIIWVEKNPPRIRVKEVEELSYKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYDVFQTAEDWAVLTTGLIVSFVSALLLIRAL
VAYVAKRDFMIFAWYRIASGLVILLFAFTGWKLW
>A0A0K3T2T5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKTTLCTLLITVSCSTLATPHSEQQINDIVHHTIIPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGAL
AVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPARVTAAWQILNALQ
>A0A0R2BBL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MINTTIITIIQAIILGVIEGITEFLPVSSTGHLYLANAFIHLQEPDAFINLFMVVIQLGA
IMAVVVLYFHKLNPFAPSKTLAARRATWVLWGKVVVAMLPSLIVGPLVNDFMDAHLTTWP
VITTTLIVYGVLFIVIENWNSHRRPTATDLTRLPLKMAFAIGVLQLLSLVPGTSRSGATI
LGAMLLGTSRFVAAEFSFFLAIPTMFGASCLKVLKFVLHGNQLTTSEAAVLGIGVFVSFV
VAYLAIKFLMRFIQHHDFKIFGWYRIVLGLVVLAYFGAQQLL
>E1VGY8|FEATURES|UNIPROT_deepARG|beta_lactam|oxa9|antibiotic inactivation|1
MVKPRSQLAFLLVVISVLFSANAVASEQAALLKCTLVVDAATGSTLYRNGDCTRRASPCS
SFKIPLAIMGFESGILHSPESPTWELKPEYNPSKRDQMYPKVNPVLWERDSVVWFSQHLT
TRLGEAAFSDYIKKFQYGNQDGSGDSGKNNGLTRSWLMSSLAISPEEQVQFLHRFIARQL
PISRNTYEMVRATIPQYQAKDGWVVHGKSGSGWLLDRDGKEDESRPQGWFVGWAEKAGRQ
VIFARLEIGNVKSDVPGGTRAREEILSEIHALVSAK
>A0A142BN04|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREVVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVDADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>Q06316|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MADRRRVHAWARARPAAPEPAPPTPSAAAPSVAPGPAATPPDPAVEQEFTRLQTQYDARL
GLYAVDTGSGESVAFRADERFAFASTFKALAAAAVLDSTTPQQLDQVVRYSKDELLENSP
ITKDHVATGMTLRELCDAAVRFSDNTAGNLLLKHVGGPQGLDAALTAVGDEVTSADRWEP
ELNSAVPGDVRDTSTPRALAHDLRQFVLGDALAEDDRALLTDWLRRNTTGGTVIRAGVPA
DWVVGDKTGSGYYGGRNDIAVLWPPNRAPIVMAVMTSREEPRAKRADALLADAARVAVTA
LG
>A0A0A3AE14|FEATURES|UNIPROT_deepARG|chloramphenicol|IO48_10670|antibiotic inactivation|1
MTFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYKIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLL
EYKDKEEMFPKKPIPENTIPISMIPWIDFSSFNLNIGNNSNFLLPIITIGKFYSENNKIY
IPVALQLHHAVCDGYHASLFMNEFQDIIHKVDDWI
>R8E3N2|FEATURES|UNIPROT_deepARG|beta_lactam|IIU_05053|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINVVVPGH
GEVGNKGLLLHTLDLLK
>AAG21695|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYPNPAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQKYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDVEWITVNVPKLMQTTPTVELINSLMEK
>AAQ10697|FEATURES|ARDB_deepARG|quinolone|qacB|antibiotic efflux|1
MISFFTKTTDMMTSKKRWAALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIV
DIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIA
GALIMPTTLSMIRVIFENPKERATALAVWSSVSSIGAVFGPIIGGALLERFSWHSAFLIN
VPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIP
WVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMTSVLLLASQW
LQVVEELSPFKAGLYLLPMAIGAMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFF
GHPLSYSTMALALILVEAGTASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAV
LGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFND
AFVATALVGGIIMIIISIVVYLLIPKSLDITKQK
>J2R5M1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLGFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPGARRFTANLLIAFLPAVVLGVIFADLIHHYLFNPITVATALV
VGGIIMLWAERRQHEVHAESVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRQLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLIILATWQFGWVDWSAAKP
>YP_310046|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRCRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSALLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRATRRLLERDA
>K0FMD0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENSILFYERVLEGKLLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFSVEQKDFERLLHRLEENNVHILQGRERNVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREEKPHMTFY
>O67939|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTEWQAVVLGIVEGISEFLPISSTGHLILTAHILGIKHTDFVKSFEISIQLGSILAVVVL
YFNRLIRDYEIWKRIIAAFIPTGIIGFLLYKLIKGFLIGNDLVVVVSLILGGIILIFADT
YCEKFCYLGDVRELPLRKAFMIGVFQSIAVIPGVSRSGSTIIGGMLMGLNRKVAAEFSFL
LAIPTMFAATTYDLIKSGGSFNAQEWNILIIGFITSFITALIVVKWFLNFLKSHSLKIFG
FYRILIGLVYAAFFLF
>G5GLU0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELVKVVILGIVEGLTEWLPVSSTGHMILVDEFIRLDVSTAFMDMFLVVIQLGAILAVVV
LNLEKLNPFLKSKSEAERRATFDLWGKVIIACLPAAVIGLAFNKYMEEHFMNAPVVAAML
ILYGVLFIVVERFNKRRTPRVESLAKLDYRTAFIIGMFQVLSLVPGTSRSGATILGGIIF
GASRYVATEFTFFLAIPVMFGASFLKLVKFGWNYTGTELVILAVGMVTAFIVSILSIRFL
LRYIKRNDFTAFGWYRIALGIVVLAYLFVIGDPTKE
>Q9AMA1|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-12|antibiotic inactivation|1
PRFMSIQRRNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPRDARDTTTPASM
AATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIV
ALLGPNNKAERIVVIYIGX
>YP_002145859|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRCEHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQIWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0N1AHE6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSHTITAVILGIVEGLTEFLPVSSTGHLILATELLGFNAKEWEVFNVVIQLPAILAVVV
LYWRTFVDVAKGALRADPDSLHFVRNVLVAFIPSAILGVLLKKKIDMLMETPAVVAAALV
VGGVLILVIERLARQGEYQPVSKLPLPKALAVGVMQCLAMIPGMSRSASTIMGALSMGIN
RKTAAEFSFFLAVPTMFGATAKQLWDNRHELTSGAASVGWGDIAVGGVVSFLVSLVVIKF
FVTYIGRHGFAPFAWYRIVIGAGALVWLLGV
>A0A0K4JJC3|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MSEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLDKEYEILLIDDGSSDNSAQMLVD
ASQAEGSHVVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKEMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKEIK
>A0A0K2Z127|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGLNQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLELARDGQLGSENWTEVGVAFLAAAITGFVVVKWLMGYIKSH
RFTAFALYRIALGAALLLWLPSGS
>D0WEZ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIALEALKALLIGVVEGLTEWLPVSSTGHMILVDEFVKLDVTPEFLALFLVVIQIGAIMA
VIILYFSKLNPFARTKTPDERRSTWRLWGMVVIGCVPAAVVGILLDDWVNAHFYHAYVVA
AMLIAYGVVFIALERRNARRFAAYARGVESGVVKGDVPRLADGSLDPDGLFAVRTVDDID
WRTALKIGCFQVLAIIPGTSRSGATIIGGMLTGCSRTAAAEFTFFLAIPIMFGWGLVKIV
KYIAHAGLAMDSTEIAVLVVGIVTAFLVSVVSIKFLMGYIKRNDFAPFGVYRIVVGVIVL
GYFLAKGLAA
>A0A0A2TV94|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIQGINHLCFSVSNLDRSITFYEQALGARIQVKGRKLAYFELAGLWIALNQEDDVIRNY
TERTYTHIAFTVKEEEFDESVQQLRAAGADILPGRPRDPKDALSVYFTDPDGHLFELHTG
NMKQRLDYYREDKPHMTFYS
>R7ZI60|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVIVVMWKRMLSLVGLYNIDGQSRSMKGRFNLMHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVIYALVAGAILMIVADKFAPRKPKVDSLDDISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGISHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYAVGFISSFIF
ALLSIKFFLALISKVKLMPFAIYRLVLAAILSIIIFM
>A0A104M6X2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIVDVVTGLPAQREARRFTMNVVIATIPAVVLALLFEKTIKSVLFAPVPVAVALV
VGGAVILWVEGRQRERGEPARVQSIDALTPLDALKVGLAQCFALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPVIFGATLYETAKDWRAFNVDSVGLFAIGLVAAFVSAFACVRW
LLRYVASHDFTVFAWYRIVFGLFVLLVGYSGWIEWT
>H9BJT2|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKSSHIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A135HQZ9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKSFLLKSGVLAAATLFIGADVNAAGSDVRDRLQQVVSEAVLPVMKEYAVPGLAVAVTA
GGRQYFFNYGVASKENDREVTENTLFEIGSISKTFNATLAGYAEAVGKLSFTDKASKYWP
ALNGSSFDRISLLELGAYTAGGLPLQFPKDVTTDEKMLAYYRNWRPDYAPGTHRQYSNPS
IGLFGYLTARSMNAPYDELMSKKLLAMLDLRNTYVKVPENRMGDYAYGYLKDGKPVRVSP
GVLDSEAYGVRTTSADLIKFVEKNIDPSKLNPALRKAIAATHTGYYWIRPMTQSLGWELY
PYPVALDRLLEGNSAGMARKANKAEKLDPPLPPQEDILLNKTGSTRGFGAYAAFVPTKRI
GVVILANKAYPIPERVKAGYRILQALDRETGSASAR
>Q65KV0|FEATURES|UNIPROT_deepARG|multidrug|ykkD|antibiotic efflux|0
MEWICLIAAGILEMLGVTMMNQFHKDKRVRWIFLLIIGFAASFFLLSLAMETLPMGTAYA
VWTGIGTVGGALVGILFYGEPKDGKRIFFIALILGSAVGLKLIS
>A0A0R2B4D0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFELLKAFLFGVVEGITEWLPISSTGHMILLDQFVQLDVSKDFYSMFEVVIQLGAILAV
VVIYWHKIWPFHQADKNTQAQGIWRYVDKDIMIMWLKIFIACLPAGIIGVAFNDTFERLF
YNPTCVAIALIVFGIAFILIEDIHKNKQPKITSIAELSYYTVVLIGFFQLIAAVFPGTSR
SGATIVGALILGVSRTVATEFTFFLAIPVMFGAALFKLVKFGFSFTPLEIWILVVGLVTA
FITSIIAIKFLMQYIKKHTFKAFGWYRIILGLLVIAYFWFVK
>A0A091BE33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDLLSALLLGIIEGLTEFLPISSTGHLLIAQHWLGARSDLFNISIQAGAILAITLVYRQ
RLWQLATGLGEAATRLYALKIAVAFAVTAVVGLPVRLLGWELPDTVTPIAWALVLGGVWM
LIAERISEGKPPSDALTWKVVVAVGLAQVLAGVFPGTSRSAAAIFMALLLGMNRKPAAAE
FVFLVGIPTMFAASGWALMETVLDGGAGDEDWASLGVAFVAATLTGFAAVRWLLGYIATH
SFRPFAWYRIGLGVALLLGLPAGS
>A0A126NSM6|FEATURES|UNIPROT_deepARG|aminoglycoside|AXG53_04165|antibiotic inactivation|1
MRRALASDWSAWAQLRRGLWADCETDLAELQQLLEEDGGTVLLAFAQGQPVGLAEASLRH
DYVNGTSSSPVGFLEGWYVIESQRGLGIGRALVAEVARWARAQGCSELASDTALDNTHAQ
AAHKASGFVETERVVYYCMSLDAPAE
>A0A0G0MPN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIQTILLSVVQGITELLPISSSGHLILVTKLLNIENLSNFTLTTFHLGTTLAIVLFNW
KFLFTNISSKFKLYIYIALASIPAGLIGILWGDAIEAQLHETYVVAISLIVVGVLMVIAD
LRFKERKVESEIENTTFRQTFISGLSQALALIPGVSRSGITTLGGMLSGLDQYTAIRLSF
ILGLPVLFGSFVYEMIKNVNSINIFSDSRVLIGILITFVVGYLSLYLLEKISKSRFLRYF
GVYRIVLGLIIFLFIL
>S5PCJ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMTIFDSILLGIIEGFTEFLPISSTGHLIVLSEILGLEQNNVNKAFEIIIQFAAIMALVF
VYPSKFTFSHIELWKKIVIAFLPIGIVGFLFSSQIKNLFSIEIIAWMFIIGGIVFLIIEK
FYDENKTHTLDVENVSYKQAIFIGVMQIFALIPGTSRAGASIIGAMMAGLNRKTSAEFSF
LLAVPVMCTTTGYDLVKHHEELLVGANLLNLAIGFVVSFIVALIVIKLFLKFLERFTFVA
FGIYRIIFGILILLIF
>A0A0B2TPC6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSDMEAINKVSVVIPVFNEQESLPELIRRTTAACDQMNRDYEILLVDDGSSDNSAALLTE
AAQAPGSHVVAVILNRNYGQHSAIMAGFSHVSGDLVITLDADLQNPPEEIPRLVDTADQG
YDVVGTIRENRQDSVFRKTASRMINHLIQRTTGKAMNDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRTTEIMVRHSEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSVVG
SVIALSGFTLALLLILLRLFFGAAWAADGVFTLFAVLFSFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRIVGNDPRFSEQDNEE
>A0A011PPV4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPLLLLKALILGIVEGLTEFLPVSSTGHLILAGALLDFNDERGKLFEIVIQSGAMLAVC
WEFRAKIMQVLRGLPSDPGAQRFALNIVVAFLPLATIGLLFGKTIKAYLFNAPVVATAFI
VGGLIILWAERREHRIRVESIDELSLRDAVKLGFAQALALIPGTSRSGATIIGGLLFGLS
RRAATEFSFFLAMPTLIGASLYQLYKERALLSVDDLGMWVVGFVAAFISAFWAVRGLLRY
ISTHDFSIFAWYRIAFGILILVTWQYDFIAWGDH
>A0A0J6YMU3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSTWRPFGLLEFVAGILFSHHGRLNASTRLNAALACLVIVAAGCSGAVQEVRDVDPVGSV
VDPTIRQLMAEHAIPGMAVAVIVDGKPHFFDYGVASKSEDAPVDDHTLFEVGSLSKTFTA
TLAGYAQARGTFSLSEPASTHWPALHGTAFDRISMLQLGTYSAGGLPLQFPAEADTAGSM
LDYFRHWDPSYPPGSRRLYSNPSLGLFGYLAARSLGGTFADLMQNTLLPQLGLDDTYLQI
PSNEMGHYAQGYTKTDAPTRVTPGALDAETYGIKTTTHDLVQFVTAAMQPEGRDDPWRRA
IATTQTGYYRVNGMTQGLGWEIYPRPVTETALIAGNSDAMASQPQPIEWLDTPSPPDPTA
LFNKTGSTNGFGSYVAYIPQKQLAVILLANKNYPNSARVDAAYRILDSVGHVAQ
>D2J8J7|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGNKKVKQRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A0S1YEZ5|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-167|antibiotic inactivation|1
GLTAFLRRIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQ
LLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDT
PASMAERNQQ
>I6Z9J1|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDGQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>J8RRP4|FEATURES|UNIPROT_deepARG|beta_lactam|ICU_02593|antibiotic inactivation|1
MNIILVFSIENLKGMMVLKNKKMLKLGMCVGILGLSITSLATFTGGALQVEAKKNPGQVK
HKNHATYQEFSQLEKKFDARLGVYAIDTGTNRTIAYRSNERFAFASTYKALAAGVLLQQN
SIDKLNEVITYTKEDLVEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPK
GYEKALRQMGDRVTMSDRLETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPADKRKI
LTEWMKGNTTGDKLIRAGVPTDWEVGDKSGAGSYGTRNDITIVWPPNRAPIVIAILSSKD
EKEATYDNQLIAEAAEVVIDAIR
>J3HNL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGQTAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGTGRLTLIHILLGMVPAVVIGLLLHDQIKTLFNPIN
VMYALVVGGVLLLVAEYFKPKQPKAVGVDDITYLQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMIGATGLDLYKSLGFLTMQDFPMFAVGFVTAFVVALLA
IKVFLELIKRISFVSFAIYRFIVAAVVYAIFM
>AAA98228.1|FEATURES|CARD_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPRVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>Q9RM43|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLAKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A090GLM5|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFGKLWQMLIKLPSDPQTRHFVIGILIAFLPAAVIGAVGHDFIKNYLFESPKLICSMLI
IGGVVLLVVDRINFKPVHHDVERFPLSVYLKIGLFQCLSLIPGTSRSGSTIVGALLMGVD
KRAAAEFSFFLAMPTMVGAFAFDLFKNRNVLTSADLPIISVGFIAAFVAALIVVRFLLDY
VSRKGYSLFGWWRLVVGIVGLAGLMVWG
>CAC17149|FEATURES|ARDB_deepARG|beta_lactam|OCH-6|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGNSHFFGYGVASKESGQKVTEHTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFKNWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVWLNKTGSTNGFGAYAAFIPAKKT
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>A0A0M0X4Y8|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MQLRQMNKYRRIEEFLREHKCPNFRMKQILNAIFKERIDKYNEMNVLPKSLRGILVKEFG
ESILDVIPLKEQHSEQVTKVLFEISGNEKVETVNMKYKAGWESFCISSQCGCSFGCKFCA
TGDIGLKRNLTSDEITDQILYFHLQGHSIDSISFMGMGEALANVQVFDAIDVLTDPTLFA
LSPRRLTISTIGIIPSIKKMTQNYPQVNLTFSLHSPFNEQRSKLMPINNRYPLLDVLDIL
DEHIRVTSRKVYIAYIMLPGVNDSIDHAKGVVSLLKGRYKAGSLYHVNLIRYNHTVRSPL
WFDEVDESRVVNFYKELKSSGLNVTIRSQFGIDIDAACGQLYANYQKSDKQ
>NP_709488|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPASPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTFSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0U4V5I4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWTLATGLGERDNRDYVLKVSVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHVAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSRRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTEHWADVAVAFVAATITGFVVVKWLLSYIKKH
RFTVFAVYRIVLGAALLLWLPAAAG
>ZP_04638974|FEATURES|ARDB_deepARG|polymyxin|rosB|antibiotic efflux|0
MHHSTPLITTIVGGLVLAFLLGTLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPEL
AEIGVILLMFGVGLHFSLKDLLAVKSIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVF
GLCLSTASTVVLLRALEERQLIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETT
SLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAY
GAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLH
EPLAVLASLAIIIFGKSVIAFALVRLFGHSKRTALTISVSLAQIGEFAFILAGLGISLGL
MSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPVDLCNHA
LLVGYGRVGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLD
CARWLLLTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIA
NSMLNMLKIDTLTEEDKRPVCPI
>A0A0Q4NKR4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVALILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVAHEGTGTGHLTLIHILLGMVPAVVIGLLLHDHIKALFNP
VNVMYALVVGGVLLIAAELLKPKQPKAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATI
SGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSMGFLSMADLPMFAVGFVTAFIVAL
IAIKSFLHIIKRISFIPFAIYRFVIAAAVYAVFVL
>ZP_04223576|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEKMKNTLLKLGVCVSLLGITPFVSTISSVQAEQTVEHKVIKNETGTISISQLNKN
VWVHTELGYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVII
THAHADRIGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFY
PGKGHTEDNIVVWLPQYNMLVGGCLVKSASAKDLGNVTDAYVNEWSTSIENVLKRYENIN
FVVPGHGEVGDKGLLLHTLDLLK
>A0A0A3YXR3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTVEQPINKVSVVIPVYNEQDSLPELIRRTSEACAQLSMAWEILLVDDGSSDRSAEMLTA
AAEAPGSQIVAVLLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAVAAEG
YDVVGTVRQNRQDSWFRKRASRLINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRATEIPVLHAEREFGDSKYSLMRLINLMYDLVTCLTTTPLRLLSVVG
TLIALAGFAFSLLLIGLRLFLGPHWAADGVFMLFAVLFIFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVNSTVPVRSEEDE
>A0A0P6ZTF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTIVTAILLGILEGLTEFLPVSSTGHLILAQAWFGYDPALWRQYNIIIQLGAILAVVVT
YFKTFWTMGTGLLRGERKAILFVRNILLAFLPAAVIGLLILDVIDAMLESPAVVAIALIV
GGIAILVLEKAIPTREEQGVEALSWKTAIGIGFVQCLAMIPGTSRSGATIMGALAMGVGR
KTAAEFSFFLAVPTMLGASVVKIVQEPELLAGTATIGWTHIALGFVASFLVALVVVRAFV
AYVSKRGFAPFAWYRILIGSVTLIWLFAF
>N9BGS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHNLELLKALFLGLIEGLTEFLPISSTGHLILFGHLIDFQSDAGRAFEVVIQLGAILAVC
WLYRHKIIELVRGFFSGDQHARRFAINVILAFIPAVVIGVLAVDFIKQVLFSPLVVACAL
IIGGLIIFAVEARKIEPKTIEATDITIKQAIIVGFAQCVAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLIRNASVLTSDNLLNISVGFVAAFIAALIVVKTLVK
FVEKHTLRVFAWYRVVLGVILLIVFL
>X2L7V5|FEATURES|UNIPROT_deepARG|beta_lactam|cmy-48|antibiotic inactivation|1
CALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYYFTWGKAD
IANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLL
HLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSG
MSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSV
IDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGS
DSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNP
ARVEAA
>A0A0W0P1E6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSNKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKENTFYGSVAQLCARKGIAVHA
PEDANHPLWIERIAKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPHYRGRAPAN
WVLVKGESETGVTLHRMVKRADAGAIIAQERVAIERSDTALTLHHKLRDAAASLLRDTLP
ALAQGKITETAQDESKASYFGRRTAADGKLDWKRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGQAPGRVISVDPLRIACGQDSLVITSGQRNANGLFLGGPQLANELG
LVDGSLLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDKYDVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDSSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNDNDSCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIDNAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DRAKQEAR
>A0A0K2JDV6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILDIVKVVLLSLVEGLTEFIPVSSTGHMIIVEQFLKLSENKQFVNAFEIIIQLGAILSV
VVYYWNKIWPFSSKISSQKRKEITLMWIKIIAAVLPAVVLGLLFDDVIDEHLFNPMTVSV
MLVVYGILLIWLESGKKRKEKFKTIAELPVITALEIGIFQCLAMIPGTSRSAATIIGGVL
LGLNRVLATEFSFFLAIPTMLGATLLKIIKIGSGLGSYEWFLIALGFVLSFIFAYGVIKV
FMNYIKKHDFKIFGYYRIIVGIIILILFLTGVVK
>A0A0U9H5G1|FEATURES|UNIPROT_deepARG|beta_lactam|OPHB3_1536|antibiotic inactivation|1
MKKLSMEKFILFTSLLALISLVACAEADSSTNSSPKEENENGQSAKLDEEFASLEDDFDA
QLSVYALDTGADQTIAYRAEERFAFSSTYKALAAALLLEQNEMEELNEVITYTEDDLVPY
SPVTEKHVDSGMTLLEIGEAAVRTSDNTAGNLLFEALGGPAKFEEALREIGDDVTQSDRY
ETELNEFNPEDTRDTSTPKALATNLKKFAVGDLLTDEKRELFTDWLQGNATGDTLIRAGA
PKGWVVSDKSGAGTYGTRNDIAVVWPPDREPIVMAIMSRHDTEDADYDDALISEAAEVVF
DALK
>ACH85966|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>I0F4S7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEIKGINHLLFSVSHLDTSIDFYQKVFGAKLLVKGKTTAYFDMNGIWLALNEESDVPRNE
IKLSYTHIAFTIEDHEFEEVSAKLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLRYYKQEKTHMSFYDDTAF
>C0Z7D8|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKVYTSRLFGFTAKTIFLTLLTLAGCSSAETPVAKTETPASAMDIKFAALEKQFGARLGV
YAIDTETDLAVAYREDERFAFASTYKALAAGAVLHQKPLEELDKVITYTKDDLVTYSPIT
EKHVATGMTLREVADAAVRYSDNTAGNLLFKELGGPKGFESALRQIGDGVTKSERYETEL
NEAKPEDTRDTSTPKALATSLRAYTVGNALSSDKQKILIEWLQGNTTGAKLIRAGVPKDW
KVGDKTGAASYGTRNDIGIIWPPNKKPIVIAVLSSRDKQDATYDDALIAEATKIVVDALT
AAKP
>A0A0R1SV86|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIVLTLNVIKAIILGIVEGFTEWLPISSTGHLVLVGSVLKMGESKAFMDMFNYVIQFGA
ILAVVVLYFHKLNPFSPQKNQLEQKQTWTLWFKVILAVIPSVIIGFPLNDWMDEHLMQNW
VVASMLILYGILFIVIENRNKQRTPKFADLNTLPWLTAFWIGCFQALSIIPGTSRSGATI
LGAILIGTSRFVGAEFSFFMAIPTMIGVSILKIGKFFYQGNTFTGDQSIILLVGMVVSLI
ISIISIKFLMGYIKKNDFKVFGWYRIILGVLVLGAMFL
>R7G0I0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVISDVVKIILIAIIEGITEWLPVSSTGHIIIFERFFTLSDDFTDEFKKLFDYVIQLGAI
TSVPILFRDKLFSFKKQRKQTVELWAKVVIASIPAVAAIALDNLFESFGEKVQSYIIASA
LIFYGIVFVVIEKIYENVTDKKPYVRDVTYCDSLKIGGFQALAAIPGTSRSGITIIGGRI
CGLSRQAATELSFYLAIPAIVGASGYKTLKFALSGVMLTFRQANALLLGFAVSFAVSMFV
IKLLTNFVKTRGFTGFGVYRILLGVALFIIL
>A4ZVU6|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHHVKGEITKVVGK
>A0A0F6VW45|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELRAIRRSYPSGETDVEVLKGVTLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVATLNDDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAIYAGTGRAA
RQARARELLARLGLEARVGYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVIATLKQLRDRGHTVIIVTHDPDVAAQAERIIEIRDGEIISNPPPVGKRDAARLPAQP
QDAPALGQFINSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
EDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQAIQRQLWVSSATPTVSQNLRLRYG
NVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRAQVVVIDSNARRQLFPNKANVVG
EVVLVGNMPATVIGVAEEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSITVRVKEGYD
SSEAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARKSDVLQQFLIEAVLVCLVGGALGIGLSLLIAFALQLI
LPGWEIGFSPVALLTAFLCSSATGVLFGWLPARNAARLNPVDALARE
>BAC73509|FEATURES|ARDB_deepARG|tetracenomycin|tcmA|antibiotic efflux|1
MTSQTTIDTTGPGDKAPLAPSDKAPAKGLRGHPWYTLITVAVGVMMVALDGTIVAIANPT
IKADLGASFADVQWITNGYFLALAVTLITAGKIGDRFGHRQTFLIGVVGFAAASGAIGLS
DSIALVITFRVFQGLFGALLMPAALGLLRATFPAEKLNMAIGIWGMVIGASTAGGPILGG
VLVQHVSWQSVFFINVPVGALALVLGLLILLDHRAENAPRSFDILGIALLSGAMFCLVWA
LIKAPTWGWGDGKTWAFLIASLVGFALFGFWETRVREPLIPLALFRSVPLSAGVVLMVLM
AIAFMGGLFFVTFYLQNVHGMSPVDAGLHLLPLTGMMIVGSPVAGMLITKTGPRIPLAGG
MALTAIAMYGMSTLETDTSGAVMSLWFALLGLGLAPVMVGATEVIVGNAPMELSGVAGGL
QQAAMQIGGSLGTAVLGAVMASKVDNDLAGNWADAKLPPLTGAQLDQASEAVQVGVAPVP
KGTPAAIAEQITGVAHDTFISGMSLASLVASGVAAVAILVAMLTKRGENADAAGAGAGHI
>N8YAG9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGVTEFLPISSTGHLILASELMNFWTKEKSDLFVVAIQMGAIAAV
IYEYWSKLWGAATGLFSGEPKGRHLGVSLILASIPIVLVGLTFGEKVKELLFNDVTVAIG
LIIGGIIIWWVEKHPPKVNAEEVENISLKEAIYIGLIQVLSLIPGTSRSGATIIGAMCLG
VSRKAATEFSFFLGIPVIIGAGLLDLAKSYHVYQTGEDWTVFFVGLIVSFVSALILIRVL
VAYVAKRDFMVFAWYRIVSGLIILLFALTGWKLW
>E3EXX2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVDNNLFLSAFLGVIEGLTEFLPVSSTGHLLIAGHFLGFESPARVFEVAIQLGAILALVV
YYFARLYGVARRIPHDPLARRFVLSVLIAFLPAVFIGVLAHDLIKRVLFESTATIAVALI
VGGVILLVVDRMKITPRYRDPMDLPLPMALKIGLVQCIAMIPGVSRSGATIVGSLLMGVE
KRAAAEFSFFLSIPTMFGAVAYDLFKNRDALSGAAWVDIAVGFVATFIVALIVVRWLLDY
ISRHGYALFGWWRITLGTVTLIALALGFGAN
>F7L4L3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIITQNILGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPAPAGASALKCFLHKFDFYWKLLVAFIPAAILGFLFSDKIDEMLES
VAIVAVMLVIGGIFMLFCDKIFSKGSEDTVLTERKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKLTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEILVNNMPALIIGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILVMLLLGYNLEIG
>0910185A|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-IVa|antibiotic inactivation|1
MNESTRNWPEELLELLGQTELTVNKIGYSGDHVYHVKEYRGTPAFLKIAPSVWWRTLRPE
IEALAWLDGKLPVPKILYTAEHGGMDYLLMEALGGKDGSHETIQANRKLFVKLYAEGLRS
VHGLDIRECPLSNGLEKKLRDAKRIVDESLVDPADIKEEYDCTPEELYGLLLESKPVTED
LVFAHGDYCAPNLIIDGEKLSGFIDLGRAGVADRYQDISLAIRSLRHDYGDDRYKALFLE
LYGLDGLDEDKVRYYIRLDEFF
>A0A0Q7ELZ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLAAIILGLVEGLTEFIPVSSTGHLLLAKQLLGLADEPWNTFIVMIQLGAILAVVVV
YFQRLWKVLLGLPGKDPAARRFALSVLLAFFPSAVLGLLFHDFIKDVLFDPMIVCVTLIV
GGFALIALERWAPPARIDDSMGFSWKTALGVGIAQCLSIIPGVSRSGATIVGGLLLGVDK
RAAAEFSFFLAIPTMVGAFALDFWESRELLTGDVVSLIAIGFVVSFFSGLFVVKTLVDFV
GRYGFAPFAAWRILVGTIGLLVMWAYA
>A0A023SF60|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-10|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEDQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>YP_001571041|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRNIRRSYPSGEEQVEVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSMLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGIERKK
RQARARELLQRLGLSDRVDYHPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLVAAQAGRVIEIHDGKIVHNPPAQENGREQGVAAAA
VNTASGWRQFASSFREALAMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQVLKYDDLAAIQKQPWVNSATPTVSKSLRLRY
GNMDIAVNANGVSGDYFNVYGMSFSEGNTFNVVQQRDRAQVVVLDANTRRQLFPNQANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNRNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
NSDQAEQQLTRLLTLRHGQKDFFTWNMDSILKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFMLQL
FLPGWEISFSLIALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>R8NMN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEAKKAEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIAIPVMAGATGLDLLKSWKYLSVDDIPMFAVGFITSFLVAMLAVVTFLKLL
EKIGLKPFAYYRILLAIVFTLFILL
>A0A0Q7L4K4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLLSIALALPTSIKARRFVVSVLLAFLPAAVIGAIAHDFIKTVLFETPVLICVVLI
VGGVILYAIDHLPLKPRYTDVMDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMVGAFTLDLYKNRDALSFDDFTLIAVGFIAAFVAGIFVVRSLLDF
VSRRGFTPFAIWRIIVGIAGLIGLWLLG
>A0KQI1|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFDGPKAATFEVVIQMGSILAV
VAVFWRRLFGLIGIHFGQKPAQGHATLSLVHIILGMLPAVIIGLAIHSWIKAHLFGPQTV
MYALVAGGILLIIAEKFRPAVRSETLDDISYKQALGIGLFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMVAASGLDLYKSRDLLSMADFPMFAVGFITAFVVAMIAIK
TFLALIRRLDFIPFAIYRFVVAFAVYLVFVA
>D0BNJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MITIIEIIKTIILGVIEGVTEWLPISSTGHLILANEILQLDVSSKFQDMFNVVIQLGAIF
AVVILYFNKLNPFEGKKTRKEFLATIELWKKVIIGCIPAIVGGLLLNDFMDEYFNKAIVI
ATTLIVYGIAFIVIERRHKTVEPRIHSFEELDYVTAIKIGLFQTLALIPGTSRSGSTILG
GLLVGTNRFVATEFSFFMSIPIMFGASGLKLLKFGFHYTSAELIILLVGSVVSFFVSLIV
IKFLLSYLKRNDFQAFGWYRIILGIIVLASSFFLK
>J2SQI1|FEATURES|UNIPROT_deepARG|beta_lactam|PMI30_03884|antibiotic inactivation|1
MTNNRSTARLKILAACVAVFGASHCVAAAQTDQPIETIVNDAIRPVMQAQGIPGMAVAIT
LNGKQHYFNYGVASKETGRPVAKDTLFEVGSVSKTFTATLAAYAQATGKLPLSDKASQVL
PTLRGSAFDSISVLQLGTYTAGGLPLQFPGDADHQDKMLGYFKQWKPTYAAGTHRQYSNP
SIGLFGYLAAHSMGAPFDKLMEKTLLPKLGLKHSYLKVPQDQMGLYAQGYNKDNKPVRVE
PGALDSEAYGVKTSASDLLRYVEANINPTSLEKPLQQAIALTHTGYYQVGEMTQGLGWEF
YNYPVTLDTLLAGNSSQMALEAHEVQWLNPPRPQHNTALINKTGSTGGFGAYVAFIPAKD
IGIVILANKNYPNPERVKIAYEIMNALAE
>C3QRC0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIITQNILGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPAPAGASALKCFLHKFDFYWKLLVAFIPAAILGFLFGDKIDEMLES
VVIVAVMLVIGGIFMLFCDKIFSKGSEDTMLTERKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKLTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEILLNNMPALIIGNVVAFIV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILVMLLLGYNLEIG
>YP_002411827|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAVEKVNVAGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>J2XR21|FEATURES|UNIPROT_deepARG|beta_lactam|PMI24_01017|antibiotic inactivation|1
MSSINLNKLKRFSAFGLFFSAATCLAAPQTDDQLQALVKATVTPVMQQQDIAGLAVAVTV
DGKAHYFNYGVADKSTGQAVSENTLFEIGSVSKTFTATLAAYAQASGKLEFSDKASQHWP
ELKGSAFDHISLLQLGTYSPGGLPLQFPDAADSSDKMLGYYQQWKPTFPAGSHRLYSNPS
IGLFGYLAAKSLGQPFNQVMTETLLPKLGLKHTFLSVPASEEKLYAQGYDKNNKPVRVSP
GALDSEAYGVKTSAADLLQYAQANLDTAKLEAPLQKAIALTHTGYYTVGDMTQGLGWERY
TYPISLDRLLDGNSTPMAMEPHKVKWLTPPQPEPANVLLNKTGSTAGYGAYVAFVPSKKV
GIVILANRNYPNGERVKIAHRILSELTR
>A0A059WGX5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA8|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRICYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADQLEEFVHYVKGEITKVVGK
>A0A017T4H7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSWFDAILLGILEGLTEFLPVSSTGHLILLGSWLGHESEAAKTLEVVIQLGAVLAVVMYY
RARLVDLGRGVLARDPGSLKVVLALGIAFVPAAALGLLFHKIIKEVLFGPMPVALALIVG
GVVMIGVERLQRKRGQEGLTRLEDVTPRRALIIGLAQSFALWPGASRSMSSILGGQLVGL
STAAAAEFSFLLAIPTLGAATVFDLIKNGRALLEAPGGLLALGVGLVVSFVVALLVISGF
LRYLKRFGLSPFGWYRIVLGALVIVFASRG
>A0A0M6YZR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGQTIVNALILGIVEGLTEFIPVSSTGHILLLGHFLGFDSTGKTFEVLIQLGAILAILS
VYFGRLWKLTVTLPSDPTSRRFVFGILLAFLPAAVIGVLLHSFIKEVLFQTPALICTTLL
IGGIILLWIDRLPLKPRYTNVMDYPLSLCLKIGFAQCLAMVPGVSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMAGAFTYDLYKNRNILSSDDVMLITIGFVASFFAGVFVVRGLLDF
VSRHGFAPFAWWRIFVGLAGFAGLYFLG
>BAB33938|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSIEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHNHTVDHH
>ACP31588|FEATURES|ARDB_deepARG|quinolone|QnrB10|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>T0R394|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNNTDIKLVSVIIPVYNEEASLPVLLSRVTAACELLPQDYEVILIDDGSHDGSTELISEA
AGNNDSKLVGVLLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVEAAMQGY
DVVGTVRRNRQDSWFRKTASRLINKSVQKATGVHMSDYGCMLRAYRRHIIDAMLCCQERS
TFIPILANSFARRTIELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTTPLRLLSIVGS
LVAGLGFTFSILLILMRLVMGADWAADGVFTLFAILFTFVGVQLLGMGLLGEYIGRMYTD
VRARPRYFIHQIVRTATPSQQETEQ
>V5SM11|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_pse|antibiotic inactivation|1
MYKFHLPRLASFSAFALLLGASHCMAATKSDDQLDALVKAAIGPVMQQQNIPGVAVAITL
NGQQHYFNYGVASKEDGKPVSQDTLFEIGSVSKTFATTLAAYAQASGKLSLSDRASQVWP
DLRGSAFDTISVLQLATYTAGGLPLQFPDEADRPDKMLAYFKQWKPVYAAGTHRQYSNPS
LGLSGYLAAKSMGQPFDELMEKTLLPKLGLKHTYLKVPQDQMGLYAQGYGKDGSPVRVSP
GALDSEAYGVKTSAADLLRYVEANLKPATLEKPLQQAIALTHSGYYTVGKMTQGLGWEHY
HYPASLDTLLNGNSTEMAMAAHKVQWLNPPQPAQDAAWFNKTGSTGGFGAYVAFVPSEDI
GIVILANKNYPNSERIKLAHNILSALTE
>M4KYP5|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKLKNKASIKFGICVGLLCLSITGFTPFFNSTHAEAKSIEDTNMASCITNKKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAK
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSNRFTKNANYDNALIAEAAKV
VLNDLK
>A0A0L1NRL4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MESHSIMPKKNQRKLASYSAFALLLGVSHSFADERIEAIVKATIEPVMQQQHIPGVAVAI
TVNGKAHYFNYGVASKENGKAVTENTLFEIGSVSKTFTATLAAYAQATGKLTLSDNASQV
LPTLRGSAFDRISVLQLGTYTAGGLPLQFPSDADHQDKMLGYFKQWKPTYTAGTHRQYSN
PSIGLFGYLAAQSMGAPFDELMEKTLLPKLGLKHSYLKVPQDQMGLYAWGYNKDNKPVRV
EPGALDSEAYGVKTSASDLLRYVEANMNPTSLEKPLQQAIAITHTGYYTVGEMTQGLGWE
FYNYPVTLDTLLVGNSSQMAMEAHAVQPLNPPQPPHDNVLINKTGSTGGFGAYVAYIPAK
DIGIVILANKNYPNAERIKIAHEILSALDK
>B2TW38|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENE
ATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPSAFSYVGNQKFTVWSSRVHPHASKA
QPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQGSRLNSQPACTARR
RTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHPHFHFVEGDISIHSE
WIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYCVKYRKRIIFPSTSE
VYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEKEGLQFTLFRPFNWM
GPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRIIENA
GNRCDGEIINIGNPENEASIEELGKMLLASFEKHPLRHHFPPFAGFRVVESSSYYGKGYQ
DVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>EDK66453|FEATURES|ARDB_deepARG|quinolone|PmrA|antibiotic efflux|1
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISA
ALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNA
TALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAI
LTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVR
DLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANA
SSPLQLGLYRFLFGLGTGALIPGVNAILSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGS
AVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>A0A0W2H805|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPQHEGMSKGRLTLIHILLGMLPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>H3SDM0|FEATURES|UNIPROT_deepARG|beta_lactam|PDENDC454_07895|antibiotic inactivation|1
MFSGFLFNKKYNNGFNIGSHLKRDKLLRKGMIILKNIRILKIGMCVGILSLSVANVNLFT
GESLQIEANEKTEQLKHANHAAHREFAQLEKKFDARLGVYAIDTGTNQTVAYRPNERFAY
ASTYKALAAGALLQQNSNDQLDEVITYTKDDLVEYSPVTEKHVAAGMTLGEIAEAAVRYS
DNTAGNLLFKELDGPKGFEKALRQIGDRVTQADRFETELNEAIPGDIRDTSTAKALATDL
KAFTVGNALPADKRKILTDWMRGNATGDKLIRGGVPTDWEVGDKSGAGSYGTRNDIAIVW
PPNSAPIIIAILSSRDKKDATYNNELIAQAAKVTMNAFTSTASYSL
>A0A0S4TW84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFALNVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
IGGLVILWAEWRERHRGQTHDPRGNALLEAAKAGAPRVETLDDLRMSDAIKVGLAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSTDDLSIFG
IGFVAAFISAFFCVRWLLRFIASHDFRGFAWYRIVFGVIVLVTAYTHLIAWQA
>A0A0D0QNY6|FEATURES|UNIPROT_deepARG|beta_lactam|RW25_27295|antibiotic inactivation|1
MFILRKFFNITHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNRTNQVKQENIGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREMGD
TVTNSERFEPELNEVNPGETHDTSTPKATAKTLESFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLI
ADATKIVLETLKVTNK
>U2LGX1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MERTLVHMVWELIKSLIFGIVEGITEWLPISSTGHLILLDEFLKLDATDNFKEMFDVVIQ
LGAILAVVVIYWKKLWPFGKQDNPHPMAQTGFGACLKKDILQMWCKVIVATVPAAVIGLL
LDDWSQAHLYNAWTVVIMLILFGIAFIWIEKWHKNRTPKMSNIASLRYNTVLMIGIFQLI
AAIFPGTSRSGATIVGALLLGVSRTAAAEFTFFLAIPAMFGASLLKLVKCGLPSTGMETA
MLLIGMISAFVVSIVVIRFLMSYIKKHDFTVFGWYRIVLGVLVLIGGITGFIG
>T5HKP3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRDAWGKIACRKKEGRVSMQIRMTEYQVPDPESGPYGITVCANGRIWFTEQKGNRIGMLT
ESGDITEYTIPTESAGASIITSGIDGELWFTEYKAGKIGKITLQGKITEYALPPGAAPFG
IAAGCDDAMWYTDMAGHQIGRLSSSGEITEYKLPKPGAFPSFITRGADGALWFTQNQSGS
IGRITADGDISEYPLPQEHSGPVGITAGPDGALWFTEINANQIGRITVSGKISEYPLPTA
HARPHAIAAGGDGALWFTEWGAGQIGRITVDGDITEYPIPTADSEPHGIAAGSAHSIWFA
EECGRIGKISIQN
>U2Z108|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTGETILLPLLLGLLEGLTEFIPVSSTGHLLLAGHFLGFESNGKTFEVVIQLGAVLALLT
LYFGQLWRVLRDAPHDPQARRFIAAVLIAFLPAAVIGVLAHDIIKTVLFETPALIAVMLV
LGGIVLLFVDRMALNPRHDDAMKLPVRTALAIGFFQVLAMVPGVSRSGATIVGGLLMGVN
KRAAAEFSFFLSMPTMAGAVAYDLFKNRDVLDWSALNEIAIGFAMAFVSGAIVVKWLLGY
VSRHGYALFGWWRIIVGVAALIGLFLVG
>A0A0B4ZTY1|FEATURES|UNIPROT_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MREVVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEDRLAS
RADQLEEFVHYVKGEITKVVGK
>Q2RTE2|FEATURES|UNIPROT_deepARG|bacitracin|uppP2|antibiotic target alteration|0
MDLVMLIKAAILGLVEGITEFLPISSTGHLIIAGSLLDFLDEQKRDVFVIVIQLGAILAV
CWEYRRRLTDVVAGLGSDPQSWKFVTNLLIAFLPAVVLGLTFGKAIKAHLFSPVPVATAF
IVGGLVILWAERRRHPIRVREVDEMTWVDALKIGLAQCFALIPGTSRSGATIIGGLFFGL
SRKAATEFSFFLAIPTLTAASLYDLYKNRALLDGDMSGLMAVGFVVSFLSALVAVRGLIR
YISRHDFTVFAWYRIAFGLVVLATAWSGLVSWSA
>A0A0U1YV06|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFAEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHALDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>AAL30847|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRYMFQKIM
>A0A0J7A2N2|FEATURES|UNIPROT_deepARG|beta_lactam|TU52_24550|antibiotic inactivation|1
MIVLNKFFNMLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQAKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSMEDLNQRILYTREDLV
NYNPITEKYVDKGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLIEIGDTVTNPE
RFEPELNEVHPGEIHDTSTPKALATSLQAFALGDILSTEKRNLLIDWMKRNTTGDKLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKTPNKQ
>A0A132EGI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIASIVTGLPSRPDARRFTLNVVIATIPAIVLGLLLEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVQSVDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDALGLFVLGLVAAFVSAFACVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>YP_002229045|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MQRIIQFFSQRATTLFFPMALILYDFAAYLTTDLIQPGIINVVRDFNADVSLAPASVSLY
LAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLLTTSMTQFLVARFVQGTSICF
IATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKVLFGIIAVMG
LLALCGLLLAMPETVQRGAVPFSAVSVLRDFRNVFRNPIFLTGAATLSLSYIPMMSWVAV
SPVILIDAGGMSTSQFAWAQVPVFGAVIVANMIVVRLVKDPTRPRFIWRAVPIQLSGLAT
LLLGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMVILTVM
AVSVEVGRWLWFHGGRLLFHLLAAVAGVIVVFTLATLLQRVRQHEAAELAAEK
>A0A0C5ENU3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHNKNLALPGFIAASLLAFGAGDCLAAAPRDSALKPLVDAVIRPLMQQQGIAGMAVAITV
KGQPHYFNYGLASREEQKAVDQDTLFEIGSVSKTFTATLAAYAQASGKLAFDAPASRYLP
ALQGSAFERISVLQLGTYSAGGLPLQFPQQWDSQAKMLGYYQQWQPSYAPGAQRLYSNPS
LGLFGYLAAQSLGQPFAQAMEQRLFPALGLTHTYLQVPAAQQGHYAQGYDKDGKPVRVGP
GAMDAEAYGVKTSAADLLRFVQANLQPQALPQPWQQAIALTHTGYYQVEGMTQGLGWELY
PYPSSLDALLAGNSAQMAFEPHPTRWLNPPQAPQADTLLNKTGGTGGFGTYVLFVPGKDI
GLVLLANKNYPNAERVKVAHALLEALDKSTAVAGQP
>A0A0F5FQT7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNIIARVALPLGLATASSCLLAIAAEAADPESIAAAVDATFEPLLGAHDVPGIAVAVTVD
GERHFFNYGVASKDGGAPVTQDTLFEIGSVSKTFAATLGAYAQVLGRMSIEDHPSAYMPE
LEGSPIDEASLLNLATYTAGGLPLQFPDGVTTNAGAPAYFAQWRPDAAPGEMRRYSNPSI
GLFGHLAARAMDADFAELMEGEIFPRLGVENSYVRVPEAAMDAYAWGYNRNDLPTRASPG
VFNAEAYGVKATAADMIRFVEANITPERLEPEMRSAVEATHVGYFEVGEMVQGLGWEQYP
YPVTLERLLAGNSATMAMEPNAATQLTPPRAPEGPTLFNKTGSTNGFGAYVAFVPGEGIG
VVMLANRNFPIPARITAVHAVLEALAE
>A0A0J1MZC3|FEATURES|UNIPROT_deepARG|chloramphenicol|SK32_02286|antibiotic inactivation|1
MKKTTPEYTAVDLSRWPRKEHFEVFQSFAQSTINQTVLLDITAVLKHIKEIGWKFYPTMI
SLLAKVVNKHTEFRMAIKNNELVIWNEIHPSYTIFHNETETFSSLWSRYDGNIHHFQNTY
SEDVARYCNNLSYWPKGESPENVFFVSAIPWVSFTSFNINIANMQNFFAPMFTLGKYYEQ
DGKVVLPLAVQVHHSVCDGFHLARLINELQEMSHDLRHHSEERNV
>U9Y0K0|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1589_03333|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQINLKPLDINEKTLQQGIQLAQSRYWQISDMYQGLGWEM
LDWPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>W0UZP5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLVEGFTEFLPISSTGHLILAGSLLDLNRQVSKDVMDVFEIAIQAGAIFAVCWEYRARI
AEVLSGLVAGQARSRLFTLKLIVAFLPAVVLGLLFSKSIKQHLFNPITVATAFIVGGIII
LLVERHARRNPKAVRIETVDDMSLLDALKVGCAQCFALIPGTSRSGSTIIGGMMLGLSRK
AATEFSFFLAIPTLLGATVYSLYKARAILSVADVPFFGIGTLAAFISAFLCVRWLLRYIS
SHDFTFFAWYRIVFGLVVIASAYSGLVVWAE
>A0A0H3YFT0|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MSAAKFNRLSTRCKSNTLIASDGHGHLFAFNYGTDFMMKKSLCCALLLTASFSTFAAAKT
EQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGS
VSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDD
VRDKAALLHFYQNWQPQWTPGAKRLYSNSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKL
AHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQ
EKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPP
APAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>H0TUQ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSDTLRAVILGIVEGVTEFLPVSSTGHLLLAERFFGLGEDGFWKSFAILIQLGAILAIV
ALYFFKLSRVAIGALSNADDRRFIIGVLVAFLPAVIIGLIAGKYIKALLFDPWVVCFSLI
VGGAILLWVDQIDLKPREHDATRYPLMMYLWIGVAQCLAMIPGVSRSGATIVAAMLLGAD
KRSAAEFSFFLAIPTMIGAFVYDFYKSRAEMTADHLGIVAIGFVVSFITAMIVVKAFLGY
VTRHGFVLFAWWRVIVGTLGLIALALGM
>A0A0E2LKA6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNHNDIKRVSVIIPVYNEEESLPELLRRVTESCEQLSQDYEVILIDDGSRDRSAAIISEA
AARAGSKLVAVQLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVTTVMEGY
DVVGTIRRNRQDSWFRKTASRFINKSVQRATGVQMSDYGCMLRAYRRHIIDAMLRCQERS
TFIPILANSFARRTTELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTAPLRLLSIVGS
VVAGIGFTFSILLILLRLLMGADWAADGVFTLFAILFTFVGVQLIGMGLLGEYIGRMYTD
VRARPRYFIHQIVRSTPDASQQETQS
>A0A0F5R145|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDYIKAIILGIIEGLTEFIPVSSTGHMILAAKLLDFVGERATVFEVVVQLGAVLAVFVL
YFKRFVGFLKFDFSKNSGLNLIHIILGMIPAGILGVLLHGFIKDYLFNYKSVLVALIVGG
ILMIFAERYQKGRLPSAETVDDITYKQAFGIGIFQILALWSGFSRSGSTISGGIFMGTSQ
KAAADFTFILSVPMMIGATGVDLIKSRDLLVPEDYGLFAVGLVVSFIVGLIAVTTFINLI
KKLKLSWFAYYRFALAAVFFLFVVL
>X0SA63|FEATURES|UNIPROT_deepARG|beta_lactam|JCM18903_723|antibiotic inactivation|1
MKKSVQILLNQVGLTALLTAALLSGTVHAADSDDLLKNAVDQQARSLMNEHDISGMAFGI
IIDGKSHFYHYGLADKKAGKPVSEDTIFELGSISKTFAATLASYSELKGTLTLEDTADKY
IPYLKNSTIGNTKLINLATYSAGGLPLQVPDDVKNNKQLLRYYKSWQPVFPVNSKRLYSN
ASIGLFGYISALSMDTDYTQLMEEKILPSLNMPNTFINVPNDKMADYAFGYNTAGDAIRV
NPGMLDAEAYGIKSTIKDMTQFMAANMGLVPLDKDIQQALDNNRKGYYQASTFTQGLGWE
MYPYPTKLNTLLEGNSMDVVLKPQAITTDNHPTPILNNVWVNKTGATNGFGGYIAYIPAE
KSGIVILANKNYPNADRVKAAYTILESAITH
>A0A150BS83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNVFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKEATAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKINY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVNDIPMFVVGFITSFIVAMLAVVTFLKLL
GKIGLKPFAYYRILLAILFTLFVLL
>CAC16665|FEATURES|ARDB_deepARG|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMAY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A0B2F8T7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDIIKAIILGIIEGLTEFLPVSSTGHLILAGDLLSFEGEAAITFKIVIQLGAVMAVLIL
YWKRYLEIGSNMIRMDFSKSKGLNIIHMILAMLPALILYLLFKDTIKSRLFGPTPVVIGL
VVGGLLMIIAARNRRTETADTMDGISYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDLLSSDDLLLMLIGFAASFIVAMIAVVTFIK
LIKRLRLEWFALYRFVLAALFYLIVIH
>YP_002399550|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNTLLKEAEK
RNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTATSNGHNPFRN
>ACJ64205|FEATURES|ARDB_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGVLIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTYFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>S6AT90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAMQAIILGIVEGLTEFLPISSTGHQIVVADLLDFTGERAIAFNIIIQLAAILAVV
WEYRRKILDVVVGLPTQRNAQRFTINLLVAFFPAVILGVAFSDLIHHYLFNPITVASALV
VGGVVILWAERRAHLVQADSVDEMTWKHALKVGCCQCLALVPGTSRSGATIIGGLVFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFALGSVVSFLFAMIAVRSLLKF
IGSHSYAAFAWYRIGFGLLILATWQLGVIDWSTAQG
>ZP_04210257|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLQKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMLFAEVKKKEAAAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>R8PHP6|FEATURES|UNIPROT_deepARG|beta_lactam|IKQ_00440|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQATQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGNALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>YP_002479998|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDNLLTALILSIVEGLTEFLPVSSSGHLILAGDLLGFVGEKAATFDVVIQLGAIMAVVVL
YWKRFWGLVRPQPYARFAGRRGIVLLMLTSLPACILGLLLHAYIKEYLFRPATVLIALVV
GAICMILVEKRKFKPTCISLDDMTPRLALGIGCFQCLALWPGFSRSAATIMGGMLLGAKR
PLAAEYSFIAAVPIMVAATGYDLLKNLSMFTAADIPFFLVGMIGSFVSALLAVKVFVALV
GRMTLIPFACYRLLIAPFVYYFMVN
>A0A0R2F9N0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAIILGIIEGITEFLPISSTGHLYLADDFIHLSQPTAFINMFMVVIQLGAILAVV
VLYFNKLNPWAPSKNRIERHQTWTLWAKVILAVLPSVVIGLPLNDWMDAHLTTWQVIAST
LIGYGILFIIIENFNRNRTARFTDLNSLPIKLALAIGLFQILSLVPGTSRSGATILGAIL
IGASRYVATEFSFFLAIPTMFGASLLKLVKYFVHGNSFTYSQIVILITGTLVSFIVAYIA
IRFLLNYIKQNDFKLFGWYRIVLGLVVVGYFSLFAH
>A0A0Q5HD46|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLAIKAIIMGLVEGFTEFLPISSTGHLILAGSLLNFTGEKVKVFEIAIQAGAMLAVI
WEYRERIARVLSGLFTERRQQKFVINLIVAFVPAALLGLIFANAIKAELFKPVPVALAFI
IGGLIILWVERRPKHAQQQGLPHASRVETVDEMTVLDALKIGCAQSFALIPGTSRSGATI
IGGMLFGLSRKAATEFSFFLAIPTLLGATVYSVYKERALLSLADLPMFGLGGLSAFISAF
LCVRWLLRYISSHDFTIFAWYRIVFGIIVLVTAHYDLVHWAE
>E3EAE3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIEGLTEFLPVSSTGHMILTADLLGLNTENDTVKTFEVIVQLGAVMAVVVLYWRRFLS
LFDFRRKISSQPRLNLLHIILAMIPAGLIGVLFRDVIKQYLFGPETVLYSLVIGGLLMIA
AEKFHPPIRSHTLDEITYKQAFTIGVFQVLALWPGFSRSGSTMSGGLFARVSHTAAAEFT
FLVSVPVMLGASGIDMIKSMDHLSMSDFPVFAAGFITAFIVGMLAIKTFLGLLKRLSLTT
FAIYRFVLAAVFFFIIL
>W3V601|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFEQIKKVSVVIPVYNEEESLPLLLERTLAACKQLTQEYELILIDDGSSDKSAEILIQA
AEQPENHIIAILLNRNYGQHSAIMAGFNQVNGDLVITLDADLQNPPEEIPRLVKTAEQGY
DVVGTRRANRQDSLFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIIEAMLQCHERS
TFIPILANTFARKTIEIDVAHAEREFGDSKYNFMKLINLMYDLLTCLTTAPLRLLSVVGS
VIAVSGFLLAVLLVTLRLIFGSIWAAEGVFTLFAILFMFIGAQFIAMGLLGEYIGRIYND
VRARPRYFIQKVVGNKKTNDNPENQEEY
>Q2QCK1|FEATURES|UNIPROT_deepARG|beta_lactam|pse1|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHPAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>A0A0U1YUJ2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>V5MB54|FEATURES|UNIPROT_deepARG|beta_lactam|YBT1518_13965|antibiotic inactivation|1
MKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIATLNEVITFTKEDLV
DYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITMSD
RFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNTTGDKLIRA
GVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLIAEATEV
IVKALR
>AAP97131|FEATURES|ARDB_deepARG|beta_lactam|cphA6|antibiotic inactivation|1
MMKSWMKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMIYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRRAGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPSL
IDHYEALIKASPHS
>AAV74570|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAVCMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTLPGFTSYSRYPRMVAAAGITLPALIDSLITLALKRG
>A0A085ESQ9|FEATURES|UNIPROT_deepARG|aminoglycoside|FG94_04780|antibiotic inactivation|1
MSSIKPCTSPEQAGWLQLRMALWPADRAVHLQEMQELCAQPDRYAQFVAYSSLGEPQGLV
EVALRSDYVNGTDSSPVGFLEGLYVAPGFRQQGIAAMLVNIAQRWVKEQGCTEMASDALL
DNTSSHAMHRALGFEETERVVYFRKLLS
>ZP_04635523|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MASAPQPVNWKRNLFVTWLGCFLTGAAFSLIMPFLPLYVEELGVSGHQSLNMWSGLVFSI
TFLFSAIAAPFWGSLADRKGRKIMLLRSALGMGIVMVLMGMAQNIWQFLALRALLGLLGG
FIPNANALIATQVPRNKSGWALGTLSTGGVSGALIGPLIGGLLADNYGLRPVFFITAAVL
LLCFALTWLYVREQFAPVLKKDMLNGRQVFNSLKNPKLILSLFVTTMIIQIATGSIAPIL
TLYVRELAGDIHNLAFVSGMIASVPGVAALMSAPRLGKLGDRIGPERILIAMLALSVLIL
IPMAFVQTPLQLGILRFLLGATDGALLPAVQTLLIYNCTNQVAGRIFSYNQSFRDVGNVS
GPLLGAAVSASYGFRAVFCVTALVVLFNAIYSYWCLQRQPLKARQREVQQQQDS
>A0A0C2YB81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWELFVAFILGLVEGATEFAPVSSTGHMIIVDDILLKSKELFSAPVANTFKVVIQLGS
ILAVVVVFKDRILNLLGLQKNRGTMSQIGPRLTLVHIFIGLIPAIVLGFAFEDYIDEHLF
NVYTVLIGLVAGALLMLAADWLAPKSVKTKTVDEITYKQAFLVGLFQCIALWPGFSRSGS
TISGGVLLGMSHRAAADFTFIMAMPIMAGASAISLIKNWEYFSIDVLPFFIVGFISAFLF
ALLSIRFFLALINKIKLTPFAIYRIVLAAVIYFVFL
>A0A022PMV0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLFEQIKKVSVVIPVYNEEESLPLLLERTLAACKQLTQEYELILVDDGSSDRSAEILIQA
AEQYENHIVAILLNRNYGQHSAIMAGFNQVNGDLIITLDADLQNPPEEIPRLVKTAEQGY
DVVGTRRANRQDSLFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIVEAMLQCHERS
TFIPILANTFARKTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGS
VIAVSGFLLAVLLVVLRLIFGAIWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGNKKTNNNQEEY
>AAF24171|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYHNSAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSLASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>A0A0S1RSA6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQ
PTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLRKVVNRQLPVKAAAYELADNLFEVGQADGWRL
>A0A0E0V8G1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTKACESLGKEYEILLIDDGSSDNSAHMLVD
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>M9TJA7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
ADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGIT
LLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVKP
SGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKS
TIE
>A0A127SBU7|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLDKLDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLIKGW
KIIIPK
>I6D8H3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTECLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>YP_001338814|FEATURES|ARDB_deepARG|aminoglycoside|ANT(2'')-Ia|antibiotic inactivation|1
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
QQGSRPKTRLGRMDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLT
FPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCP
EAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLR
AAFRSRYAA
>D8E3D9|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MLIFYFPGGEMSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGI
ALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSG
LGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATG
AVLFVLCAAFNAWLLPAWKLSTVHTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLM
LPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMP
VGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARVRGSYMGFSRLGLAIGGAIGY
IGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>A0A0B4S3S8|FEATURES|UNIPROT_deepARG|aminoglycoside|2|antibiotic inactivation|1
MRDSVTAEISTQLSKVLSVIEHHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVTARLDD
TTRRALFNDLLEVSAFPGESEILRAIEVTIVVHEDIMPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0D7PAW6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMTDMVRAVILGIVEGVTEFLPVSSTGHLLLAERFFDLGEGNFWKSFAILIQLGAILAIV
VLYFAKLWRVALGMFSNPDDRRFVIGVLVAFLPAVVIGLIAGKYIKEYLFNPWVVCFSLI
VGGAVLMWVDQLDLHPHEDEATRFPLLMYFWIGLAQCLAMIPGVSRSGASIVAAMLLGAE
KRAAAEFSFFLAIPTMIGAFAYDFYKNRGDFTTDNLSLIAVGFVVSFITALVVVRAFLNF
VTRRGFTFFAWWRVIVGTLGLIALAMGK
>A0A106NVJ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIVSVVAGLPSRPDARRFVLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERGETPRVQSVDALTPLDALKVGLAQCFALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWS
>YP_002239469|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGSVEVLKGITLSINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDIAQLNGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGRERRA
RLARAHDLLVRLGLGDRADYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIIEIRDGEIVRNPPGSRQGGGLRARQQA
EPSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
ETAEKQLLRLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAFILQLFL
PGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0L7ANA7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASLVEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>ZP_02698269|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDRFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRALAARLQTHPFLGPKLTIYQQDAMTMNFGELSAQLGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPYPVKDIRVLSRITTEAFNQRRKTIRNSLGNLFSVETLTE
MGIDPAMRAENISVAQYCQMANYLSENAPLKES
>J4J340|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALVELVKVVILGIVEGLTEWLPVSSTGHMILVDEFIRLDVSTAFMDMFLVVIQLGAI
LAVVVLNAEKLNPFLKSKSQAERRATLDLWGKVIVACLPAAVIGLAFNKYMEEHFMNAPV
VASMLILYGVLFIVVERWNKRRTPRVDDLSALDYRTAFIIGMFQVLSLVPGTSRSGATIL
GGIIFGASRYVATEFTFFLAIPVMFGASFLKLVKFGWNYSGTELVILGVGMVTAFIVSIL
SIQFLLRYIKRNDFTAFGWYRIALGIIVLAYLFLIGDPTKE
>A0A0H3MZI5|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MKFTVIDKENWDRKEYFEHYFSGVPCTYSMSVKLDITEIKNRKKKLYPTMLYFITTIVNR
HDEFRTSFNAEGQLGVYDEMIPFYTIFHKNTETFSNLWTEYFNKYDDFCAAYEKDMEEFG
ELKGMMVKPNIPENNFPVSMIPWTTFEGFNLNLQKGYEYLLPIFTMGKYYEERGRYILPL
AIQVHHAVCDGFHVCRFVNELQDLING
>A0A0R2NTR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAVILGIVEGITEFLPISSTGHLVLVDEFIKMSQSTQFTDMFNVVIQLGAIMAVV
VIYFHKLNPLSPRKSSNEKRDTWVLWSKVILAVIPSVIIGLPLNDWMDAHLMNWAVVSAT
LIIYGILFIVIENHNKQLTPKFSNLATLPYTTALFIGCFQLLSLIPGTSRSGATILGAIL
IGTSRYVATEFSFFMAIPTMFGASLLKLYKYFDHGNSLAGMQGAVLAVGVIVSFVVAYLS
IRFLLDYIKKNDFKVFGWYRIALGAVVIAYFTLFNH
>G3KE68|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
FCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCG
AVLSRXDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLL
LTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPXAMATTLRKLLTGEL
LTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRI
VVIYTTGSQATMDERNRQIAEIGASLIK
>A0A0E9FSA0|FEATURES|UNIPROT_deepARG|beta_lactam|ERS133249_01683|antibiotic inactivation|1
MRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAAL
GPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>YP_001879173|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MTNLKSDTRGLHMNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTE
PLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSA
KGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETAR
INLAYTKVTAPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQ
ELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLL
PGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWL
VTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>A0A0C2N861|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWIALQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHQYLFNPITVATALV
VGGVIMLWAERRQHEVHAESVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAIGFITAFIFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLVILATWQFGWVDWSAAKP
>A0A0J1F083|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIEGLTEFLPVSSTGHMILTAHLLGLSEDNESVKTFEVVVQLGAVLAVVVLYWNKFID
MFRFTGGSRPYSRRLNLGHIFLAMVPAVVIGLVFRDWIKAHLFGPETVLYSLVIGGILMI
VAERWSRKSGRITTHDVDDISYKQAFAVGIFQILALWPGFSRSGSTISGGLFAGVSRVAA
AEFTFLVSVPIMIGATGYDLYKSIDHLNGSDFPIFAIGFIAAFIVAMLAIKTFLSILKKL
SLTVFAVYRFVLAAVFFIILM
>A0A0S4I079|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_2|antibiotic inactivation|1
MYTNKLPRLASYGAFALILGAASCIAAPPSDQQLESVVNAAVGPVIQQQNIAGLAVAITQ
NGQQHYFNYGVASKENRKPVSQDTLFEIGSVSKTFAATLAGYAQANGKLSLSDTASTVLP
ALRGSAFDRISVLQLGTYTAGGLPLQFPDDADHADTMLDYFKRWTPVYPAGTHRLYSNPS
IGLFGYLAAHSMGQPFDDLMEKTLLPKLGLKHTYLKVPPAQMGLYAQGYNKDDKPVRVEP
GALDSEAYGVKTSASDLIRYVEANMKPAGLEKPLQQAIATTHTGYYTVGQMTQGLGWEFY
PYPVTLDRLLAGNSTEMAMEAHEVKWLNPPQQPPQNVLLNKTGSTGGFGAYVAFVPSKGI
GIVILANKNYPNPERIKIAHTILNALSE
>J1IGV2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MYTSLFPTVRNTAIFALLLGAGNCMAATDMRQVVDSTVQPLMQQQDIAGLSVAIVQNGKA
QYFNYGVASKESKQPVTENTLFEIGSVSKTFTATLAGYALANGKLKLSDPASQYLPALRG
DTFDHISLLNLGTYTAGGLPLQFPDESDNAGKMISYYQHWKPDFAPGTQRLYSNPSIGLF
GHLAAQSLGQPFDRLMAQTLLPKLGLKHTFISVPKSQMNLYAQGYDKAGKPVRVGPGALD
AEAYGIKTSTSDLIQYVEVNMHPAKLEKPLQQAIAATHTGYYTVDGMTQGLGWEMYPYPI
TLDALTEGNSAQMAFQPHKVNWLTPPQAPHADTLVNKTGATGGFGAYVAYVPSKGLGVVI
LANKNYPNAERVKVAHAILSAMDK
>A0A127SEP1|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDNARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAARNWIQRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>A0A0F5PXL4|FEATURES|UNIPROT_deepARG|aminoglycoside|WH91_09680|antibiotic inactivation|1
MAIVDVDDFAALRHALWPNDSVAEHREELVKALAAPARCINLIARWQGGTAAGFAEASIR
HDYVNGCHTSPVGFLEGIYVDPHYRRAGVASQLVLAVEDWVRRNNCTELASDAALDNDQS
HGMHDALGFIETQRVVYFRKALL
>A0A0R0C338|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGTRSDFFNIVIQAGAIFAVTLALRQ
RLWSLATGLGERENRDYVMKLGVAFLVTALVGLPVRLAGWELPETVTPVAWALVIGGAWM
LVAEHFASRMPDRDTVTWKVAIAVGLAQVIAGVFPGTSRSAAAIFLAMLLGLTRRSAAAE
FVFLVGIPTMFAASGYAFLELAKDGKLGSENWTDVGVAFAAAVVTGFVVVKWLLGYIKRR
PFTGFALYRIALGIGLLLFLPAGN
>A0A0M3TW19|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLACKALILGIVEGLTEFLPVSSTGHLIVAGSLLNFTDEHAKTFDVVIQLGAILAVC
WEFRRRIASVVTGLPSRPEARRFTLNVIIATIPAIVLGLLLEKSIKAALFSPVPVAFALV
VGGVVILWAEARQRGQGGEGKAARVHDVDDMTPMDALKVGLAQCFALIPGTSRSGSTIIG
GMLFGLDRRVATEFSFFLAIPIMFGATAYELYKDWHLLSVDALGIFALGFVAAFVSAFLC
VRWLLRYIAGHDFTAFAWYRIGFGLLILLVGYSGALSWTD
>YP_002400590|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTMQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIASLFLIYKWSYGEPLIRLIIAGPILMSCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEAVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAIMQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHSITEGQCWQSDWRIS
ESEAMTARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLH
IRIGLHAAFNACEEMCQRVVLERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGVATALSHSPQITLEETSASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>A0A0P9XNS6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSIKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPREKTFFGSVAQMCARHGITVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGENETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAEGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGE
NKLIVWAANAEAGNNGEAPGTVISHDPLRIACGEGSLVITAGQRGDSGLYLSGAQLAREF
GLVAGSQLLDKAQRRSIRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDERCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>A0A0X8EX84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIIDVVVGLPTQPQARRFTVNLIIAVMPAVVLGVIFADVIHEYLFNPITVATALV
VGGVIMLWAERRQHVIRAETVDDMTWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVRALLKF
ISNHSYAAFAWYRIAFGLLILATWQFGWINWSAASA
>ZP_01438526|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDSGSIFDAVILGITEGLTEFIPVSSTGHILLLGHFLGFESTGFVFEIVIQLGAILAILA
VYLGKLWQLFVTLPSSGKSRRFVAGIILAFLPAALIGVLAHDFIKTVLFETPLVVCVALI
VGGIVLLVIDKMPLRVRYTEIMDYPLSLCLKIGFFQCLAMIPGTSRSGATIAGSLLMGTD
KRSAAEFSFFLAMPTMLGAVTYDLFKNRDILSTEDIGLIAIGFICAFLAALLVVRILLDF
VSRHGFAPFAYWRIAVGIIGVVLILAFDPHEAAAPQAGSAGDDYGIEETPVAVPDDQPRD
GYGVSE
>A0A0Q8ZCP1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSQPLLELKGITRSFMAGEREFIALKGIDLSIHAGEMLAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPQS
QRHSRAGELLARLGLSGHTSHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIISDKANDSVGLELPAEAP
VEPRRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVEALNQLYYVDSATPVVGRNL
LLRYGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRQRLFGPT
IDPLGQVILIGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGIIGISLSYAIGY
LFSLFVKEWEMVFSVGSIVTAFACSTLIGIVFGFVPARNAARLDPIEALARD
>A0A0N1U755|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGINALLKAGFTISAIYTHADTASENHFFGSVARIAAENSIPVYAPE
EVNHPLWIDRIKSAEPDVIFSFYYRNLLCDQILNSAKQGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVKKADAGEIIAQQRVAIADEDNALTLHRKLVDCASALLESALPAM
KQGNIVGTPQNEADATVVGRRTPEDGRINWALPASQINNLVRAVTDPWPGAFAFAGTTKF
VVWKAKVLSTPHNVRPGTVLSAEPFVVACGEGALEIQTGQTANSVYMNGVQLAQHLGMVN
GALLYSQAVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVFGLDIGSDAISRFVGHP
RFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYGKRIIFPSTSEVYGMCTDANFDEDHSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLFDGGRQKRCFTDI
SDGVEALFKIIENKNNNCDGQIINIGNPDNEASIKELAERLLESFERHPLRASFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLGWTPTVEMNTTIDNTLDFFLRTVELQDDKE
>R4WAW1|FEATURES|UNIPROT_deepARG|beta_lactam|AQU-1|antibiotic inactivation|1
SPLSLLALSALLLSPLTQAAPADPLVGVVDEVIRPLVKEHRIPGMAVAVFKEGQPHYFNY
GVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGGIGLDDKVSRHAPWLKGSAFDG
ITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAA
SSLQQPFAQFMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLADEAYG
IKTSSADLLAFVKANINGVDDKGLQQAISLTHQGHYSVGGMTQGLGWESYPYPVSEQTLL
TGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANRNYPI
QE
>A0A127SDB2|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MGIKEKLMAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQAD
RAMLVFDPVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDL
RSAMRNSTVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIA
FLRKLYRNELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRFGWWVGWVEWPTGSVFF
ALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>Q44674|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MNVKRKATLKFGICIGLLCVSFTGFNSLFGSTHAEAKSIENTKMTSCITNQKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKQKPIEKLNDVIRYTKEDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAD
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLGNTLTTDKRTILTDWMRGNATGDELIRA
GAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILTKRFTKDAEYDNALIAEAAKV
ALDDLK
>AAV58816|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTMPGFTSYSRYPRMVAAAGITLPALIDSLITLALKR
>M8AMZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGVIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLVSIALALPTSAKARRFVLAVALAFLPAAIIGALAHDFIKTVLFETPMLICVVLI
IGGVILLGVDRMPLKPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDGALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIAIGSLGLIALLVLG
>BAF77563|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFIIELIKGIILGVVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVEGENDQQRRSKPRRLNLLHVLVGMVPAGILGLLFDD
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSVKVKNPQTVDQINYFQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILG
FLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIVLVIFIAILYFGFGIGKGI
>A0A068HJQ2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSYPPVKKVSVVIPVYNEQESLPELIRRTDTACATLGRQYEILLVDDGSSDDSARMLTE
AAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDTFFRKSASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLFG
SVIALLGFAFGLMLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQPETASQEEDRS
>D0S912|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWARLWGAATGIFSGEPQGRRLGIGLILASIPIVLIGLTFGQTVKELLFNDIAIAIG
LIVGGLIIIWIEKHPPQERVHEVEDLSIKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSAHVFDGQQDWIVLATGIIVSFISALLLIRAL
VAYVAKRDFMIFAWYRIASGLVILLFAFTGWKLW
>A0A060KQA5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKPDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILITYFTQPRPKAESRRDVLASAAKIVTDGS
>C2XUY2|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0026_25030|antibiotic inactivation|1
MLPVVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEYDAKLGIYALNTGTNQ
TVTYRSDERFAYASTHKALAVGALLQKNSIEDLDQRIKYTSKDLVNYNPITEKYVDTGMT
LKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVQPGDTH
DTSTPKALATSLQTYALGDILSTEKRNFLIDLMKRNTTGDNLIRAGVPGEWEVADKTGSG
SYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKIVLDALKVTNKS
>R0FTZ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGHRSDFFNIVIQAGAILAICLALRQ
KLWTLATGLGERENRDYVLKIGVAFMVTAVVGLIVRKAGWQLPETVHPVAWALLIGGLWM
LVAEHFADKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGAENWADVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAIYRIVLGVALLLWLPAVA
>ZP_03790349|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLAGMIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPNDSYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GAGDYAMRVWLDPQKVAQRNLTADDVVRAIREQNVQVAAGVIGASPTLPGTPLQLSVNAR
GRLQNEDEFGDIVVKTAPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLAISDEVRKTMAELKQDFPAGVDYRIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASIIPLIAVPVSIVGTFSLLLLFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGLTARAATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVR
GVLSRKAVMLGLYLVLVGATLMVSKIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGAIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFDQRHGKALSAGAIAGALN
QKYAALKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYARLADATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVNVTDVFDTMQIYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNAAGEMVPLSSLVTVSPTFGPEMVVRYNAYTAADVNGGPAP
GYSSGQAQAAVERIAAQTLPRGVKFEWTDLTYQQILAGDSAFWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGKTPFEAAVEASRLRLRPILMTSIAFIMGVVPLVLSTGAGAEMRHAMGVAVFFGMLG
RDAVRADAHAGVLRGAAHARGRQDSRRAEGFGGATACRLRTLEDRKMNKTNINERIARVA
KIAAASGLLVALLAACAVGPDYRRPDVATPAAFKEAPALAPGEQAGTWKAAEPADAAHRG
EWWRAFGDPVLDALETQALAANQNLKAAAARVEQARAATRAARSQWFPQVGVGFGPTREG
LSSASQFQPQGSGPTNATLWRAQGTVSYEADLFGRVGRNVEASRADEAQSQALFRSVQLA
LQADVAQNYFELRRLDSDQDLYRRTVGLREEALKLVQRRFAEGDISELDVSRAKNELATA
QADAVGVARRRAASEHALAILLGKAPADFSFSETPIAPVAVRVPAGLPSALLERRPDIAA
AERAMMAANARIGLAKSAYFPKLDITGAFGYEAATLGNLFLWSSRTFLLGPFAGTALTLP
IFDGGRRSAGVAQARAKYDEEVANYRQQVLVAFREVEDNLADLRLLDDQIRAQSDAVNAS
RRAAKLSRTQYQEGAVSYLDVIDSERSVLESQLQSNQLTGTQAVSTVNLIRALGGGWGSD
AALGSREPGKQDVAAR
>A0A077NUE4|FEATURES|UNIPROT_deepARG|beta_lactam|XBFM1_2480032|antibiotic inactivation|1
MPFSSLRLTRISATIFPLLGALIPFPTHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
HSIITYRGHERFPLCSTSKMMTVSALLKKSETDKDLLNQRIHYQQSDIVEYSPITEKHLK
DGMTLAELSAATIQYSDNTAMNLLLDQLGGAHSVTRFARSIGDNAFRLDRKEPELNMVTP
GDERDTTTPQAMADSLYKLALGNTLAATQRTQLVEWLKGNTTGGTSISAGVPDNWIVGDK
TGRCDYGSTNDIAVIWPDKDKAPLILVTYFTQPSDKDAKAHNDVLAAAARIMTQEK
>A0A0A1A8Z0|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLAVGWQFSQKRTARRLLERDA
>NP_815950|FEATURES|ARDB_deepARG|glycopeptide|vanXB|antibiotic target alteration|1
MENGFLFLDEMLHGVRWDAKYATWDNFTGKPVDGYEVNRIIGTKAVALALREAQIHAAAL
GYGLLLWDGYRPKSAVDCFLRWAAQPEDNLTKEKYYPNIERAELITKGYVASQSSHSRGS
TIDLTLYHLDTGELVSMGSNFDFMDERSHHTAKGIGNAEAQNRRCLRKIMESSGFQSYRF
EWWHYKLIDEPYPDTYFNFAVS
>C3VJU6|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
SNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVP
YNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGGIKK
VKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKKFL
LDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYAS
>A0A090V302|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEEQVEVLKGITLQINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDRDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLVRAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVMAILHQLRDRGHTVIIVTHDPLVASQAERVIEIHDGEIVRNPPAKRVAQGQGIQEPT
VKAASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLAAIQKQPWVTSATPAVSQNLRLRY
GNTDVAASANGVSGDYFNVYGMTFSEGTTFNREQLNGRAQVVVLDSNTRRQLFPHKANVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0P7KIW8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MVNAAPQRGVSFPPNAQAIEALIDSTVNPLMNEYGIPGIAIGVSINGQQYFFSYGVSSKK
TGEKVNENTLFEIGSISKTFTATLATYAQLEGKLTLTDKVSQYLPELTGSHFDQINLIHL
ATHTAGNLPMQVPDNITNNAELISYLKAWQPAYAAGTHRNYANPSIGLLGVIAAKQLGQG
FPEAVEQTLFRQLGMTNSYFMVPTNKMTDYAQGYNKQDQPVRLNPGVLADEAYGIKTTVV
DLLRFVETNMQQHSVPARLQRAIDATHTGYFDVGMMTQAMIWEQYPYPIALDKLLTGHTQ
DVVFGSMPVKAITPPQAPQQNVWINKTGSTGGFAVYVAYIPAKKLALVLLNNKNYPVPPR
VTAGYQILTGLETLQN
>ACB16010|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVM
YALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALIAIK
TFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>ZP_03486481|FEATURES|ARDB_deepARG|tetracycline|tet40|antibiotic efflux|1
MMKCNFMFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVQET
SCFLFEMPTGVVADLYSRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFIT
GALEAWIASEEEDKPIDKVFLRGSQMGQIGGVLGVVLGTLLGNINLQMPLILGGSLCLLL
GLVMVRIMPETNFSPAIEERQGLLKDFVCLFKLNLGFVKGAPVLLALLAITLCGGLASEG
FDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGSGLGILASQLLIARMEKKGTVSRTSV
VMSTSAGYILFLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWMNDHVDEKMRATVFS
TSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD
>YP_309843|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGNEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>S3J0J4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGEEQIEVLKGVSLTIEAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVAGLDSDALATLRREHFGFIFQRYHLLSHLNASQNVEVPAVYAGTTRVQ
RQQRAHDLLERLGLKERVEYLPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDTHSG
EEVMATLKQLRERGHTVIIVTHDPYVAAQAQRIIEIRDGEIISNPPPTDQPAALKVENPA
LRNGSSVQQAISSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LEDIRSIGTNTIDVYPGKDFGDDDPQFQQALKYDDLAAIRQQPWVSSATPSISSNLRLRY
GNVDAAASVNGVSGDYFNVYGMVMSQGASFNDEQMAGRAQVVVLDANSKRQLFPNKSNVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKVLRVWLPYNTMAGRVMGQSWLNSVTVRVKEGY
SSHEAEQQLNRLLLLRHGKKDFFTYNMDGLLKTAEKTTRTLQMFLTLVAVISLLVGGIGV
MNIMLVSVTERTKEIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLLIAFTLQM
VLPGWQIGFSPVALLTAFGCSTATGVLFGWLPARNAARLNPIDALARE
>A0A0T9RTT3|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MVFNVAVFLVSIIWHWVSLMTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFT
GDKAKTFEVIIQLGSILAVVVVFWRRLFGLIGIHFGAVPHEGKTSGHLTLGHILLAMLPA
VGLGLVFHNVIKSLFNPHSVMYALVAGGLLLLAAEWFKPKNAKAVGLDDITYRQAFAIGC
FQCLALWPGFSRSGATISGGMLVGVNRYAASEFSFILAVPMMMGASGLDLYKSLHFLTLG
DLPMFAVGFITAFIVALIAIKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>A0A127SKI4|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MPPLIEFPDFIQFQYSVFRQGLQVPAKRGIIIRDLQLGICEDAKMFFEKIDKNSWKRNEY
FEHYFMNIPCTYSMTVKVDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQEGELGI
YDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVF
NVSMIPWSTFNGFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICR
FVNELQELINS
>A0A0E3CDI2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLMGFVGGKAKVFEIAIQTGAIFAVM
LVYWQKIRDTLVELPSSRQAQKFALNVIIGFLPAVVLALLLGKYVQEHLFTPVIVATTFI
LGGFVILWAENRPAAATRVQSVDDMTALDALKVGLVQCFALVPGTSRSGSTIIGGMLMGL
SRKAATDFSFFLAMPTLIGAGVYSLYKERALLSMADVPLFAVGLIFSFISAWLCVRWLLR
FISTNSFVPFAWYRIVFGIIVLVTAYTGIVDWHH
>I2EZI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNFIEAIILAIIEGITEYLPISSTGHMIIGSSLMGISELDFTKAFEVNIQFGAILSVVVL
YWKRFFQSFEFYKKLLAAFIPAAIIGFILNDFIDQLLESVAVVAIMLVLGGVILLFIDKF
FEKRASKENITYIEAVQIGLFQCIAMIPGVSRSAATIIGGMFQGLSRKDSAEFSFFLAVP
TMFAASAYKLLKGFKTGTLSFSENEIQLLLVGNIVAFIVAMIAIRFFISYLQKYGFKVFG
YYRIIVGLIILGLLAAGYDLHVI
>A0A0U1YX18|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAVLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELGDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0U0ZFH5|FEATURES|UNIPROT_deepARG|chloramphenicol|cmlA|antibiotic inactivation|1
MPAEHALLVVMATFEPLDLQQWPRREWFEHYLDRCPTYYSMTVDLDITNLRAAVDASGRK
TYPTQIWALATVVNRHPEFRMALDDQGNPGVWDVVDPAFTVFNPDRETFAGISARYTPDF
DAFHSEAAELLSEYRNASTLFPQGAPRPRNVFDISSIPWTRFTGFTLTIAPGWAHLAPIF
TIGKFYEQEGRTMMPLALQIHHAAADGYHSTRLVEELRQIIADPDWVNC
>AAD41881|FEATURES|ARDB_deepARG|glycopeptide|VanHD|antibiotic target alteration|1
MEKIIDITVFGCEPDEMEVFQKITYELGVTATLIKDSISESNAKLADGCRCVSVSHKAEL
SEPILLALKNAGVKYISTRSIGFNHIDIQAAGLLGMVVGTVEYSPGSVADYTVMLMLMLM
RGTKSILRETQRQNYCLNDLRGKELRDMTVGVLGTGRIGQAVMERLKGFGCKVLAYDRNQ
KAGADYVSFHELLKKSDIVTLHIPLAEDTRHMIGCEELEMMKQEALLINTGRGALVDTAA
LVEALKGQKIGGAALDVLEGEEGIFYHDCTQRTIEHPFLSVLQGMPNVIVTPHTAYHTER
VLVDTVRNTIRNCLNFERSLGNV
>A0A0P7N6T6|FEATURES|UNIPROT_deepARG|beta_lactam|ACU81_15235|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>J8R4H6|FEATURES|UNIPROT_deepARG|beta_lactam|ICE_02490|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPKLNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>A0A0R2LMQ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIVLGIIEGFTEFLPISSTGHLYLADEFIKLNESKAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNHREKSQTWSIWFKVIVAILPSVIIGLPLNDWMDAHLTSWQVISA
TLFIYGVLFIIVENWLKNKRPQTDSLEDLSYKTALQIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIGKYFMHGNSFTGSQLLILFIGTFVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIILAIIVVAYFGLKTVLA
>A0A0P9GID4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIKFVSIVIPVYNERQSLPELLRRTEAACEQLDHRFEIVLVDDGSRDDSADILQRA
AERADSPFVAVILNRNYGQHAAIMAGFEQCQGDVVITLDADLQNPPEEIPRLVKLAEQGY
DVVGTVRGNRQDSAWRRWPSKLINLAVQRSTGVAMNDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEVLVDHAEREHGDSKYSPMRLINLMFDLITCMTTTPLRLLSIIGF
SMALLGVSFAALLIVLRLIFGASWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVVRSSSPVATDSIDSSVTPYMNKVAP
>A0A0P9QDX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAGVVRAGLLAFRALQGLADEFRPAAGSSYVQACRGIVATIFYTTTLNSEPAASLHGGMM
DLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVVW
EFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALVV
GGVIILWAERRVHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLSR
KAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFVFAMIAVRALLKFI
ATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>E0HB56|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYFAFISERNGDMLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLDLSKDFMEM
FNVVIQLGAIMAVVILYFHKLNPFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDY
LDAHFYNFLTVSIMLIVYGIAFIIIEKRNKNVAPKCTNLKDFTYKAALIVGAFQVLALIP
GTSRSGATILGAILIGASRFVATEFSFFLGIPVMFGASFLKIFKFLAKGNTFGSEEIIIL
LIGSIVAFVVSIIAIKFLLNYLKKNDFTVFGWYRVILGAILIGYWLFS
>A3QRX6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPRALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGNGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Q8KQN7|FEATURES|UNIPROT_deepARG|beta_lactam|oxaSH|antibiotic inactivation|1
MNKGLHRKRLSKRLLLPMLLCLLAQQTQAVAAEQTKVSDVGSEVTAEGWQEVRRWDKLFE
SAGVKGSLLLWDQKRSLGLSNNLSRAAEGFIPASTFKIPSSLIALETGAVRDETSRFSWD
GKVREIAAWNRDQSFRTAMKYSVVPVYQQLAREIGPKVMAAMVRQLKYGNQDIGGQADSF
WLDGQLRITAFQQVDFLRQLHDNKLPVSERSQRIVKQMMLTEASTDYIIRAKTGYGVRRT
PAIGWWVGWLELDDNTVYFAVNLDLASASQLPLRQQLVKQVLKQEQLLP
>A0A0M0M3W5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIILLKALLLGIVEGLTEFLPVSSTGHLIVVGDLINFYNEGKVFEVAIQLGAILAIVF
EYRQRFINVATGITHDKKAQNFVLNLFIAFLPAAVVGLLFIKYIKLYLFNPITVATMLVL
GGLVILYAERRTHQVKIHDVDHIGWKDALKVGCAQIISMIPGTSRSGATIIGGLFFGFDR
KVAAEFSFFLAVPTMFAATFYDIYKHRDVLNFDQMPMFVVGFVAAFISALIAVRTFVRFV
SNHSYEIFAWYRIAFGAFILASWQFGWVSWS
>D7DP68|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLILKALILGVVEGATEFLPISSTGHLIIAGDLLDFLTKDKRDVFEIIIQLGAILAV
IWEYRVKFIHVATNLNESKSRQLVINLFIAFLPLAILGLAFHHQIKDLLFNPKSVAIALI
VGGFVILFIEKKLPAVKIHSVDDMDWKLALKVGFAQAIALIPGASRAGSTIIGGMCFGLS
RTAATEFSFFLAVPVMFAATFYDLYKSRDLLSAHDLTLFLAGFITAFIAALIVIKVLIRY
VANHDFTAFAWYRIVFGAIVLAYFWH
>C5TIU0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRFFGSGENRVHVLKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAT
SGSYQIDGIETSQMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGSKER
AERAEKLLGDLGLQNKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEDGHTVIMVTHDPGIAANANRVIEIRDGQIISDTSKNPDIPPSKVERIKE
KASWSFYYDQFMEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSQQKILED
INSMGTNTISIFPGRGFGDRRSGRIKTLTINDAKAISQQSYVASATPQTNSSGTLTYRNT
DLTASLYGVGEQYFDVRGLKLEEGRLFDDDDVKTDAQVVVIDQNTKTKLFGEGVDPLGKT
ILFKKRPLTVIGIMKKDDNSFGNSDSLMLWSPYTTVMHQITGESHTNSIVVKIKDDANTQ
VAEKSLTELLKARHGTEDFFMNNSDSIKEMVESTTGTMTLLISSIAVISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLSGVLLSACISLVFNYFVT
DFPMSISMTSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALAQD
>D3S972|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVWVATLLGVVQGIFMFLPVSSTAHLVLTQHWLILSGEPLPPPESPEMILFDLVVHVGT
LVSIVYVFRQSLWRLSGGIARESWQWASAGGSAGREMLFLRLALLCGLSVFATAVIGFTL
KASFEHVFANPTLIAGTLTLTGILLWWTDRLSRRPLGLRKLGPKIATIIGVAQGFALVPG
LSRSGMTITFALFSGLKRRWAAEYSFFLAIPTILAATAVQSLDVWINGNGLGDLTWTPLI
VGFVVSAVVGVVSLKMVLFFLYRARLKVFSFYVWALAALVLFGFLDVDIMYGH
>V5SCD0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPIWQAILLGFLEGLTEFLPVSSTGHLLLAGHFLGFESPAKTFEVQIQLGAILAVVVVYF
GRLWQMLLALPSDPWVRRFVISLFVAFLPAAVFGALLHGFIKDVLFENPVLVCAMLIAGG
FVLLAVDRWLAPTPRFADAMDIPPARALAIGFFQCLALMPGVSRSGATIVGGLLMGAERR
AAAEFSFLLALPTMSGAFAYDLYVNWNKIEQTDVLPLGVGFVMAFLTAVVVVKLALAFIA
RHGFTPFAWWRIVVGSIGLAALTIYG
>R6A640|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILYLKAVILGIVEGLTEFLPVSSTGHLIVAGSLLDYTGQEADTFYIAIQAGAIFAVC
WHYRQRLIDVCLGLFSDKVQQRLAVNTVVAFLPAAVIGVLVASYIKKWLFNPIAVATALV
VGGVIILIVEYYQDKKTYKPRVETMDDMSWKDALKVGFLQCLAMIPGTSRSGATIIGGLC
IGLSRKAATEFSFFLAIPTIFGATVYDLWKSRDVLTATALPMISVGFIVSFFSALVVVRW
LLHYVSKHDFSPFGWYRIFFGGVILLTWWTGLVQW
>V4QBV8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWVAIQALILGVVEGVTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRRKILDVVIGLPKESQAQKFTLNLLIAFMPAVVLGVAFADLIHEYLFNPITVATALV
IGGVVMLWAERRDHTIRAETVDDMNWALALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDFAVFAVGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIGFGLLILATWQFGLIDWASAQG
>D7XSC4|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9536_03967|antibiotic inactivation|1
GGRPRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAV
IYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKY
WPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYAN
SSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVS
PGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWE
MLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATSGFGSYVAFIPEK
ELGIVMLANKNYPNPARVAAAWQILNALQ
>M4NA43|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLHVILLGIIEGITEFLPISSTGHLLIAEKFGLGARSDLFNIGIQAGAILAVTLIYR
RRIWLLLTQWREPGNRDYLLKLTVAFLITAALGLVAVKLGFKLPETVTPVAWALVIGGLW
MIAAERLAARQPDRREVTWKVAILVGIAQMIAGIFPGTSRSAATIFAAMLFGTSNRAAAT
EFAFLVGIPTMYAATGYELLKVVRGGGAAHEDWTALVVGFVISAIMAFVAVKWLLGYIRA
HAFTPFALYRIAFGVALLWLVPAGG
>A0A0U2XY24|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQKRHFTFLTPIAAIATLAAIGWMAMSAGSYAAQPGADPQRAAIKKLVDQTAASLMKDNA
VPGMAVGVIVDGKSYVFNYGVADKTANKPVTADTLFEIGSVSKTFTATLTAYAQTTGALS
LTDKTSRFLPSLAGTPFGELTLLNLGTHTAGSLPLQLPDGIRDDDQLLAYLKTWKPAKPP
GTVRTYSNVSIGTLGWITSRSMGSDFTTLMTQHVFTPLGLSHTYLHVPADQMTNYAWGYS
KTDKPVRIRPDILESEAYGVRTTAGDLLRFVSVQLGKPVGDAKLQQAIHDTRIGYYFDSP
MTQDLIWEQYPYPVTLDSLLAGNGPKMAYETTSARELSPSIAPTPAVWVNKTGSTNGFGA
YVAFVPAKQMGIVILANKAFPIAERVRAAHQILSTLDGNAR
>A0A142GHK2|FEATURES|UNIPROT_deepARG|beta_lactam|AXW78_15340|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSESLKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>A0A142K3H5|FEATURES|UNIPROT_deepARG|beta_lactam|shv5|antibiotic inactivation|1
RRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIAEKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEH
>A0A0R1SK73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIELIKTIILGIIEGFTEFLPISSTGHLYLADEFIKLNESTSFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKDQVQKRQTWNIWFKVILAIIPSVVIGLPLNDWMDAHLTSWQVISA
TLLIYGILFIVVENWLKNKQPQVSDLDSLSYKTAFTIGLFQVLSLIPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIGKYFAHGNTFTGSQTIILLVGTFVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIILAIIVILYFVLVK
>A0A0M7KLU3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTTLYLIKAFILGIVEGLTEFIPVSSTGHLILIGDWLNFESSQGKVFEVVIQLGSILA
VMWIFRARLLRLIRGTLTGVASEVAFTRNLLIAFLPAAVIGAIFIKSIKQVFYHPGVVVV
TLVLGGLIMLYVERRTRHTPGDAPGAADDTASDERATAHTLEQITWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYKNMDLLTQHDLSGIA
VGFVAAFLSAIVVVRAVLRFVANHTYRVFAWYRIVFGAIVAAWIFTR
>H0DJ82|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIIELIKGIILGIVEGLTEFAPVSSTGHMILVDDILLKSKEFLGPESAFTFKVVIQLGS
VFAAAWVFRERYFEMLHIGKYKNEPVDGFRSKPKRLNLFHILIGMIPAGILGVLFDDLIE
EYLFSVPTVMIGLLIGAFYMIGADIVSRRIKNPQTVDQISYFQAFVIGLSQAVAMWPGFS
RSGSTISTGVYMKMTHKSASDFTFIMSVPIMLAASCLSLVKHIGSIHATDIAFYFLGFVA
AFIVGLIAIKTFLHLINKVKLIPFAIYRIILVVIIAILYFGFGLGTGISGE
>E8SDQ5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIKAINHITYSVSDLRNSIKFYKDILKATLLVEGKHTAYFTLGGVWLALNEEKNISRNEI
KQSYTHIAFSISESDFDSWYYWLKCNQVNILKGRERNIKDKQSIYFTDHDGHKIELHTGT
LQERLDYYQQEKTHMKFFKH
>A0A081M0N3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARLAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLGDEILNLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGDIVAQQAVAIGADDAALTLHRKLCAAATELLSRALPAI
LAGTTDERPQDHSQATYVGRRTPEDGRLDWELPAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLPAAKPGTVLSIAPLIVACQDGALEIVTGQTERGVYMQGAQLAQALGLVS
GAVISSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWEPKVEMEETVEHTLDFFLRTVELVDDKN
P
>A0A0C1FPD0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAISLLLGGIILLKVDEW
FSTPKGAETSQEITYLQAFKIGMFQCLAMIPGVSRSGASIVGGMSQKLTRTTAAEFSFFL
AVPTMLGATVKKCYDYYKAGFELSHDQVNLLIIGNIVAFIVALLAIKTFIGFLTKNGFKV
FGYYRIIAGIVLLLIHFFIHPLTII
>W0H4P8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSEPLAALYGGMMDLWTATQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFN
IIIQLGAILAVVWEFRRKIIDVVVGLPKQQQAQRFTINLLIAFLPAVVLGVIFADLIHHY
LFNPITVATALVIGGVIMLWAERRQHVIRAETVDDMTWRDALKVGCAQCLAMIPGTSRSG
STIIGGLLFGLSRKAATEFSFFLAMPTMVGAAVYSGYKYRELFRPEDFAVFAVGFVVSFI
FAMIAVRGLLKFIATHSYAVFAWYRIVFGLLILATWQFGWIDWAAAKA
>ZP_04121322|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKERVDDMKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNK
NVWVHTELGYFNGEAVPSNGLVLNTAKGLVLVDSSWDDKLTKELIEMVEKKFQKRITEVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKNSGYEEPLGDLQTVTNLKFGNTKVETF
YPGKGHTEDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNI
NSVVPGHGEVGDKGLLLHTLDLLK
>L7QJB7|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
MSISHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERMSQIVDMGGSLIKHW
>A0A0Q6UG73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLSAIILGLVEGLTEFIPVSSTGHLLLTKELMGLKDPSWDTFIVLIQLGAILAVVAL
YFQKLWKVLIGLPTRPEARRFALSVIVAVIPAFVAGLLLHDVIKKFLFESPLIICWSLLI
GGIILLAIDKKAPPAVDHDAMDLPLHKALIVGLFQCLSLVPGVSRSGSTIVGSMLFGIER
RAAAEFSFFMAIPIMVGAFALDVYKNRDALDAGHVGIVAIGFVVSFLSGLVVVKYMLDFV
GKRGFAPFAWWRIAVGIGGLAVLYLRH
>A0A109Y9V7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCVGINALLNAGYEITAIFTHNDVATENNFFGSVARLAAEHGIPVYAPD
EANHPIWLDRIRTMAPEMIFSFYYRHLLGDEILECAQKGAFNLHGSLLPKYRGRAPLNWA
LVNGERETGVTLHRMVKRADAGNILAQQKVAIDDQDNALTLHRKLTQAAEQLLSDVLPRL
RQGEVSEWPQDESQATRVGGRTAEDGRIDWNQPATTIHNLVRAVTDPWPGAFAFAGSVKF
IVWKSRVHPQQQQTKPGTVISKQPFLIACGGGALEIQTGQSEHGVYMNGSQLAQSLGMVP
GALLYSQPQSVLQRRTRVLILGVNGFIGNHLTERLLQDEHFEVYGLDISSDAISRFLEHP
RFHFVEGDIAIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCTDASFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEN
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
QDGVEALFRIIENKQQNCDGQIINIGNPDNEASIKELAEQLLESFERHPLRSQFPPFAGF
REVESSSYYGKGYQDVEHRKPAIRHARRLLGWTPTVTMDVTIDNTLDFFLRTVEQQADK
>A0A0K9GDG0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIRGINHLLFSVSGLNRSILFYQQVFDAKLLVKGRTTAYFDLNGMWLALNEEGGIPRKE
INESYTHIAFSIDEADFQPMLGKLKKLNVNILEGRERDRRDRRSIYFTDLDGHKFEFHTG
TLKERLDYYREEKGHMTFYLDDD
>C6XFB3|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MLRYSIIIALILGVVEGVTEFIPVSSTAHLLLVSRLLGADLGSSFIVLVQLGAVSALLYV
YFGRILSIFVSFPFSAAARHFTITLFLGFFPTVVCGFFAYNFIKSILFKEMIIIHITLII
GGFILLLVDRLKFESKYFHIENYPIPLAIKIGLFQCIAMIPGTSRSGATITGALILGADK
RSAAEFSFFIAIPTIIGACVLDFYKNYNVIVNNIGKEIIIGFMASFITSLLVIRSLFQVI
AKRGYTPFALWRILIGFVGLFLEIFP
>BAC98411|FEATURES|ARDB_deepARG|aminoglycoside|AadD|antibiotic inactivation|1
MKGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVLSTE
GVEFSYEWTTGEWKAEVNFYSEEILLDYASRVEPDWPLTHGRFFSILPIYDPGGYFEKVY
QTAKSVEAQKFHDAICALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLIGLH
HRICYTTSASVLTEAVKQPDLPPGYVQLCQLVMSGQLSDPEKLLESLENFWNGVQEWAER
HGYIVDVSKRIPF
>S5HIU3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIGNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>A0A031WFH7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METFSLLEIFKAVILGIVQGITEWLPVSSTGHMILVDEFIKLNFSNTFISTFLVVIQFGS
ILAVLVIFFRKLNPFDSAKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDIDRLFFNST
VVAIALIVYGIIMIGLEKRNKKPKYKDFSQVTYKLALCIGLFQCLALIPGTSRSGSTIIG
AVLLGTSRYVAAEFSFFLAIPTMLGASALKLLKAGFGFTGFEWLILGVGSVVAFVVSIVV
IKFFMDYIKKHDFKVFGYYRIVLGIVVLAYFFLL
>C2WMK8|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0023_23150|antibiotic inactivation|1
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSGPPKQTKQIKQIKQENTGHDSFAKLE
KEYNAKLGIYALDTGTNQTIAYHSNDRFAFASTSKSLAAGALLRQNSIEALDEGITYTRE
DLSNYNPITEKHVYTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLIADT
TKVVLDTLKVTNKN
>A0A0P9MVK0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAV
VWEFRRKILDVVTGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATAL
VVGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLK
FIATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>S6JQ29|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIIDVVVGLPTKPEARRFTTNLIIAVMPAVVLGVIFADVIHEYLFNPITVATALV
VGGVIMLWAERRQHVIRVETVDDMNWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVRALLKF
ISNHSYAVFAWYRIAFGLLILATWQFGWIDWSAASA
>A0A0W2D824|FEATURES|UNIPROT_deepARG|beta_lactam|ASV18_09260|antibiotic inactivation|1
MKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYYF
TWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQW
QGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGAL
AVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEAY
GVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVPAE
VVINGSDNKVALAATPVTAVNPPAPSVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLAN
KSYPNPERVKAAYHILEALQ
>YP_586061|FEATURES|ARDB_deepARG|multidrug|MexB|antibiotic efflux|1
MSNFFIERPIFAWVIALVIMLAGVLSIRTLPINQYPAIAPPTIAISVTYPGASAQTVQDT
VVQVIEQQLNGLDRLRYISSESNSDGSMTITVTFEQGTNPDIAQVQVQNKLALATPLLPQ
EVQQQGIRVTKSVRNFLLIVGLISTDPNMTREDLSNYIVSNIQDPLSRTAGVGDFQVFGS
QYAMRIWLDPAKLNSYQLAPLDVSNAIKAQNVQVASGQLGGLPAVRGQQLNATVIGKTRL
QTAEQFGDILLKVNPDGSQVRLKDVADVALGGQDYTINAQYNGRPASGIAIRLASGANAL
ETVKNIHNTLAQLEPTFPPGIKVVFPYDTTPVISDSIHEVIKTLLEAIVLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEDGLGPKEAARKSMGQIQGALVGIALVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMVL
SVLVALVLTPALCATMLQPIEKGDHGEHKQGFFGWFNRSFIRSTQSYERGVSGILKRRAP
FLLIYLAIVVVMGFLFTRIPTSFLPEEDQGVLYAQVQTPAGSSAERTQAVLDQMRNYLLN
DEGKIVESLFTVNGFNFAGRGQSSGLAFILLKPFKDREGDATSVFDLTKRAQAKFSTFRD
SLAFAFAPPAVQELGNATGFDFYMQDQAGLGHDALMNARNKFLSLAAKNPALQRVRPNGL
NDEPQYVLEIDDERARALGLSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPNSRM
SPEDLNKWFVRNDKGDMVPFSSFATGKWGFGSPKLQRYNGVPAVEILGEPAAGKSSGEAM
AAVEEIMKQMPAGISYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLATLARGLSNDVFFQVGLLTTVGLSAKNAILIVEFAKELHDHGKGLVE
AAVEACRMRLRPIIMTSMAFMLGVFPLAVSQGAGAGSQHAIGTGVIGGMITATVLAIFWV
PLFFVVVSALKERRGKSDSSSLEKGAQA
>K9DY82|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKAIIMGLVEGFTEFLPISSTGHLILAGELLNFTGVRETVFKIVIQLGAVLAVV
WEYRERVMRLFSGLGSDPLQQRFARNVAIAFLPAAVAGVLFSATITELLFHPVPVAIALV
VGGVIILWVERRQRLRNAPARVESVDDMTALDALKVGFAQSFALIPGTSRSGSTIIGGML
FGLSRKAATEFSFFLAMPTMLGATVYSVVKEREALSMADFPLFGLGFVSAFIAAFLCVRW
LLRYISTHDFTIFAWYRIVFGILVLVTAHFGLVNWSE
>CAJ93947|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MPGNAHDHVSPFRMEIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIF
EIVIQFGAILAVCWEFRARIGNVVRGLRAEPLAQRFAANVVIASVPAIVLAFIFGKWIKA
HLFNPISVALAFIVGGVVILLAEWRDARRGTVSHPQGNALLEAAKAGAPRIESVDDLNWR
DALKVGLAQCFALVPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKA
RALLNGDDLGIFAVGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIVVLLTAYSG
LVSWHA
>A0A0Q3TJ10|FEATURES|UNIPROT_deepARG|chloramphenicol|AN964_10735|antibiotic inactivation|1
MNFIKIDLDNWKRKEIFNHFLNQQTTFSITAEIDISVLYRTMKQKGYKFYPVFIFLVTNV
VNSNTAFRTGYNSEGVLGYWDKLDPLYTIFDSQSETFSGIWTKVINDFKGFYDLYLSDIE
KYSATGNLFPKTPIPENTFSISIIPWTSFTGFNLNINNNSNYLLPIITAGKFVKKGDSIY
LPLSLQVHHSVCDGYHAGMFMNSIQELADNPFDWLL
>A0A090UJ22|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPV
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLTVADIPMFAVGFVTAFVVALV
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A060UY22|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGSVEVLKGITLSIHAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDIAQLDGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSERRA
RLARAHELLARLGLGDRADYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIVEIRDGEIVRNPSASRQGGGLRARQQE
EPSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
DTAEKQLLRLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAFILQLFL
PGWEIGFSPLALVTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>F6KQM7|FEATURES|UNIPROT_deepARG|beta_lactam|amph|antibiotic inactivation|1
MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNREQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAKLKTL
>YP_002081505|FEATURES|ARDB_deepARG|multidrug|mexF|antibiotic efflux|1
MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVASPLEQAITGVENMLYMSSQSTSDGKLTLTITFALGTDLDNAQVQVQNRVTRTEPKL
PEEVTRLGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAVLNVKDELARLDGVGDVQLF
GLGDYSLRVWLDPNKVASRNLTATDVVNAIREQNRQVAAGTLGAPPAPSDTSFQLSINTQ
GRLVTEEEFENIIIRAGANGEITRLRDIARVELGSNQYALRSLLNNKPAVAIPIFQRPGS
NAIEISNLVREKMAELKHSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVIL
FLQTWRASIIPLAAVPVSLIGTFAVMHMLGFSLNALSLFGLVLAIGIVVDDAIVVVGERR
AQHRPRPQAGWEATKRAMREVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAIS
TVISAFNSLTLSPALAAVLLKGHHEPKDRFSVFLDKLLGSWLFRPFNRFFDRASHGYVGT
VNRVLRGSSIALLVYGGLMVLTYFGFSSTPTGFVPQQDKQYLVAFAQLPDAASLDRTEAV
IKQMSEIALAQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAGAIAAA
LNAKYADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNQGYEELFKQTQNIITKARALP
ELEPSSVFSSYQVNVPQIDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTY
QVNVQAEQQFRLEPEQIGQLKVRNNLGEMVPLASFIKVSDTSGPDRVMHYNGFITAELNG
APAAGYSSGQAQAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVL
AAQYESWSLPLAVILIVPMTLLSAITGVILAGSDNNIFTQIGLIVLVGLACKNAILIVEF
AKDKQEEGMDRVAAVLEACRLRLRPILMTSIAFIMGVVPLVISTGAGAEMRHAMGVAVFS
GMIGVTFFGLLLTPVFYVLIRRFVENREARRAANDKGLPEVHA
>A0A0M2DRZ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLMGFVGGKAKVFEIAIQTGAIFAVM
LVYWQKIRDTLVELPSSRQAQKFALNVIIGFLPAVVLALLFGKYVQEHLFTPVIVATTFI
LGGFVILWAEKRPTAATRVQSVDDMTALDALKVGLVQCFALVPGTSRSGSTIIGGMLMGL
SRKAATDFSFFLAMPTLIGAGVYSLYKERALLSMADVPLFAVGLIFSFISAWLCVRWLLR
FISTNSFVPFAWYRIVFGIIVLVTAYTGIVDWHH
>G9AAR1|FEATURES|UNIPROT_deepARG|aminoglycoside|SFHH103_00187|antibiotic inactivation|1
MESIIEIGTIKDVESWAQLRVALWPHHSLEDHRAELGRAFLSESGEAVAFIARNAANEAV
GFAEATLRHDYVNGCSSSPVLFLEGIYVRPVDRRKGIARLLCNTVADWGKSLGCVEFGSD
ALLENSASHALHTALGFEETQRVVFFRKPL
>YP_001454232|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMDPTKLNNFQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSQVRLRDVARIELGGENYDIIAKFNGQPASGLGIKLATGANAL
DTANAIRAELKKMEPFFPSGMKIVYPYDTTPFVTISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLSAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
SEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPVAKGSHGSTKGFFGWFNNMFEKSTHHYTDSVGNILRSTGRY
LLLYLIIVVGMAYLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTDYYLTK
EKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGDENKVDAITGRAMGAFSQIKDA
MVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNGL
EDTPQFKVDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRM
LPEDIGNWYVRGSDGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
AMMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATVLAIFF
VPVFFVVVRRRFSRKSEDIEHSHSVEHH
>A0A089PX97|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGVRALVEAGYDIAAIYTHPDNAAENNFFGSVARTAAEFGIPVFAPE
DVNHPLWVDRIKDAQPDVIFSFYYRNLLSEEVLNCASVGAFNLHGSLLPKFRGRAPLNWV
LVKGETETGVTLHRMVKRADAGDIVAQERVAIAAEDTALTLHHKLCETAKSLLAKSLPVI
KTGHFPQAAQDEAKATYFGGRSPKDGAISWEATAAEANNLVRAVTEPWPGAFSYVGGSKF
IIWKSRVLESNNGAKAGTILSVNPLVIACGTGALEVVTGQAENGVYMQGSQLAQSLGLVS
GAILNSKPVSAIKRRTRVLILGVNGFIGNHLTERLLRDDNFEIFGLDIGSDAISRFIGNE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDASFDEDNSPLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
GDGIEALFRIIENKNNNCDGQIINIGSPDNEASIKQLAEMLLESFERHPLRSQFPPFAGF
REVESSAYYGKGYQDVEHRKPSIRNAQRLLDWTPEVHMEKTIDETLDFFLKTVELTDPAS
>YP_002400009|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMMPEVGVVTLSPGSVNVLSELPGRTVPYE
VAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARI
TFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVS
GKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPV
QLNLENGKRYGQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQN
VLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGL
QRIRPGIKARAISSSQENASTESKQ
>U5NIR9|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-119|antibiotic inactivation|1
MVIRFFTILLSTFFLTSFVYAQEHVVVRSDWKKFFSDLRAEGAIVIADERQPKHTLSVFG
QERAAKRYSPASTFKIPHTLFALDADAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEVGEDKARRYLKQIDYGNADPSTIKGDYWIDGNLEISAHEQISFLRKLYR
NQLPFKVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>A0A0S4LKP6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNEWGPILAVILGVVEGLTEFLPVSSTGHLILVGHALGFTGDVAANAEISIQLGAILAVI
VFEREKIGRLLSGAWRERQTLWSSLGNSPTTTWGNRLKASMQTHPNLWFILGLGIAFLPA
AVLGLLAHGWIKSYLFTPLTVAWTSILGGIIILLVEARTRTVSATSLEQVSPQHAFWVGL
AQCASLIPGMSRSGSTIIGGLLVGLDRKVATEYSFFLALPTIIAATLYETWKARGAFNDQ
DFLALGLGMAISFLVAWAVIAVFLTYVQRHTLRVFAYYRIILGIVVMLVVR
>H1BWC3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPA
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>N9PW73|FEATURES|UNIPROT_deepARG|beta_lactam|F895_00055|antibiotic inactivation|1
MKLNNISRTSKQLLFMTGLVCASPMLWAQPLNEPQVKAIVDQQFKPLLAQYKIPGMAVAV
TLNGQHYFINYGLASKQSQQAVSNNTLFELGSVSKTFNATLASYAQVQGQLSLSDHPAKY
FPELKNTAVDRATLLNLGTYTAGGFPLQFPDQVVQQQDMIQYFQSWKPKTGIGAARQYSN
PSIGLMGYVTARAMKKPYAELLEKTLFPQLGLTQSFIQVPEQQMPQYAWGYKADQALRVS
PGMLDAEAYGVKSSSADMLRFLDVQINPQHLKQPLRKAIENTHVGYFKVGAMTQGLGWEQ
YAYPVKLETLLQGNSSKMALESHPAIAIKRPKIAPAATYFNKTGSSNGFGAYAAFIPEQK
IGIVMLANTNFPNEARIQASYTVVQQLLQANTAQ
>ZP_03067876|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLLLAAQSPNQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>A0A0W0ZNI2|FEATURES|UNIPROT_deepARG|beta_lactam|Lstg_3325|antibiotic inactivation|1
MKKNILFLCMGLLFCTTIWAQGTCFLAYENQTVLKHEGNECNLRYAPESTFKIALSLMGF
DAGILKDALHPEWPYKKEYELYLNVWKYPHNPHTWIRDSCVWYSQVLTQQLGMNRFKSYV
DAFHYGNQDVSGDKGQNNGLTHAWLSSSLAISPAEQIKFLQKIVHKKLPVSQKAFTMTKD
ILYIQELAGGWKLYGKTGTGRQLTKDKSHKLPLQHGWFVGWIEKDGRVITFVNHIADSKE
KTTFASFRAKNEVLIKLHYLINELEAPI
>A0A0R2JJE2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEIIKAIVIGIVEGLTEFLPVSSTGHIIIAESLMGIPGGKVWTKSFMNVFDYVIQLGAI
MAVIQLYFHKLNPFSPSKTRFEQKQTWSLWMKVIVACIPAAVIGLLLNDYMDQHFMTTTV
VAGALMFYGILFILLENYNARGDVQPWMTDLNKMSYKLALAIGLIQVLSIVPGTSRSGAT
ILGAMFLGVSRVAAAEFSFFLSIPVMVGVSILKLGSFFAKGGTFTGMQGLVLILSFLISW
LVAFFAIKFMMDYIKNNNFKAFGWYRIVLGIVVVILGVFGVLHM
>A0A0G3B129|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GNERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>H0KCV1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKQLNRYFGEGENRIHVLKDISLSIEKGDFVAIMGQSGSGKSTLMNIIGCLDTAT
GGSYKIDGKETIELTNDQLSDLRSQKFGFIFQRYNLLSSLTTAENVALPAIYAGMPQSQR
LERAKQLLEKLGLGDKWQNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSHSGE
NVMEILRQLHEEGHTIIMVTHDKHIAASANRIIEIKDGEIISDTQKHQVKSAVKNPSVFK
GRFGFSKDQLMEAFRMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
RGIGTNTMTIFNGNGFGDRRSRHIQNLKISDANTLSKQSYIQSVTPNTSSGGILVVGNKS
FTSANLYGIGEQYFDVEGLKLKQGRLLTEDDVDQSNQVVVLDESAKKAIFANENPLGKTV
IFNKRPFRVIGVVSDQQLGGFPGNSLNLYSPYSTVLNKITGGSRISSITVKISDDVNSTV
AEKSLTELLKSLHGKKDFFIMNSDTIKQTIENTTGTMKLLISSIAFISLIVGGIGVMNIM
LVSVTERTKEIGVRMAIGARQINILQQFLIEAVLICLIGGVAGILLSVLIGVLFNSFITD
FSMDFSTASIVTAVVFSTLIGVLFGYMPAKKAAELNPITALAQE
>M1WNM0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPPLYIAIILGIIEGMTEFLPVSSTGHLIIAGHVLGFVGAKAETFDIVIQLGAILAVVVV
YWDRFWGLLTPKQNIKFSGKYGIYLLFLTSIPASLLGLLTHKYIKLYLFSPTTVAWALGA
GAVMIIVVESVPKRERISSVDEISPWLAFGIGCFQCLALWPGFSRSAATIMGGMLLGVKR
SVAAEYSFLAAVPIMFAATGYDFLKNYQLFNSNDLFFLSVGFSVSFLSAWCAIKGFIYLL
GKLSLRPFAIYRLMLVPIILLFL
>A0A117DVF1|FEATURES|UNIPROT_deepARG|beta_lactam|MPS_2321|antibiotic inactivation|1
MPGKGIRAGEGTPLGIITRAATPLILAIASLCALVATPAVAAPDALSAAVDSAFRPLLVQ
YDIPGMAVAVTVNGQQRYFNYGVAAKQSGAPVTADTIFEIGSVSKTFTATLACYAQELGR
ISLAGHPSAYMPQLAGSAIDKATLLNLGTYTAGGLPLQFPPEITDDAQMQAYFQQWTPDD
APGQQRRYSNPSIGLLGHLTALAMNSDFADLVQTQVFRKLGLSHSFIRVPQAQMDDYAWG
YNASNEPVRVNPGVFAAEAYGVKSSAPDMLRFVEANISPEGLPASMRRAVQATHLDDFNV
ADMVQGLGWEQYSYPVTLDQLLAGNSNTIAMQPNPVTLVAGVPPSGPRLFNKTGSTDGFG
AYAAFVPDKRIGIVMLANKNFPNAARITAAHAVLEKLAAESR
>A0A0P9LXN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
VGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFMAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>R8XN18|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSNDNSAQMLVD
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPHLVEKADEG
YDVVGTVRQNRQDSWFRKSASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A120EJC0|FEATURES|UNIPROT_deepARG|beta_lactam|AWX17_11465|antibiotic inactivation|1
MKTWKEIFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEDKY
DANLGIYALDTGTNKTVTYHPDERFAYTSTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALEKIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALASSLQTYVLGQALPEDKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKDAEYNDKLIAEAAKQ
AVKALKVTRK
>A0A0C2R8Z8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNHNEVSYLDLWSILVGIILGIVEGLTEFAPVSSTGHMIIVDDLWLNTKEIFSPGVANT
FKIVVQLGSILAVIVVFWDRLWSLIGVGKAGAEKGPSLRLPMVIVGLIPAAVLGFMFEDF
IDKHLFSIETVLIGLIAGSVLMIAADIIHKKRKNVTQTVDQLTYRQALIVGLFQCIALWP
GFSRSGSTISGGVILGISHRASADFTFIMAVPIMLGASAVSLVKNWSYMTPEVIPFFVAG
FISAFLFALISIRFFLTLISRIQLVPFAIYRLVLAFVLIVLVYM
>YP_001140148|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQMGSILAV
VAVFWRRLFGLIGIHFGQKPPQDHATLSLVHIILGMLPAVIIGLGIHSWIKANLFGPETV
MYALVAGGILLIIAEKFRPTVRSETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMVAASGLDLYKSRDLLSMADFPMFAVGFITAFVVAMIAIK
TFLALIRRLDFIPFAIYRFIVAFAVYLVFVA
>BAA34539|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MsrA|antibiotic target protection|1
MEKYTIKFNQINHKLTDFRSLNIENLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESG
TVETDGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNY
SPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRV
FKGNYTQYQNQYEQEQLEQQRQYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIA
PDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPII
AQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMA
YYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSL
AVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELT
GQSIHDIT
>U1TMT5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPQLPLSGVRNLGAAALFLAAGHCLAADDLRAVVDSSIKPLMQQQSIPGLVVGIVKDGKT
QYFNYGVASKDARQPVSENTLFEIGSVSKTFTATLAGYAVASGKLTLSDPASQYLPALRN
SKFDHISVLNLGTYTPGGLPLQFPREADNNQHMISYFQQWKPDFAPGTQRLYSNPSLGLF
GYLAAQSLKQPFDQVMEKTLLPKLGLKHTFVKVPDSQMNLYAQGYGKDGKPVRVGPGAMD
SEAYGIKTSAADLLHYVSVNINPASLEKPLQQAIATTHTGYYNVNGMTQGLGWEMYPYPI
KLDALLDGNSTKMAMEPNPVNWLTPPQAPHADTLLNKTGSTSGFGTYVAYVPSKAMGVVI
LANKNYPIAERVKVAHAILSAMDH
>A0A091ABM4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKQNTAVSLLALSALLLSPLSHGEGADPLTTVVDGAIQPLLKQHRIPGMAVAVLKDGKAH
YFNYGVANRESGSRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFQLEDKASQHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVDSSDKMHAYYRQWTPAYPAGTHRQYSNPSIGLFG
HLAASSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPVRVNPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAAVTSAIALTHTGFHSVGDMTQGLGWESYAYPVTE
QTLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPAKGIGIVMLA
NRNYPIEARVKAAHAILSQLAL
>A0A010RKY6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPINCVSIVIPVYNEEESLPELLRRTEAACQLLKHEYEIVLVDDGSRDNSAQILEEA
AEREGSQVVAVILNRNYGQHAAIMAGFEHCKGDVVITLDADLQNPPEEIPRLVEQAELGY
DVVATVRNNRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVQHAEREHGESKYSPMRLISLMFDLLTCMTTTPLRLLSIIGF
SLAALGMLFAFLLIFLRLIFGASWAGGGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKILRNKPASPAPVVTVDGLPSTTTDQVSP
>D3A8F5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILILFKALILGIIEGLTEFLPISSTGHLIVFGDLMNFQSNGKVFEIAIQLGAVLAVVF
EYRQRFTHIIKGLGKERTANRFVLNLFIAFIPAAIVGLLFSKQIKLHLFNPITVATMLVL
GGFFILWVEKRQTTAKPKVNHVDDMRPIDAFVVGCAQICALIPGTSRSGSTIMGGMLWGL
ERKTATEFSFFLAVPMMIAATGYDILKKLQTLYLTRCRTNCHRFYRSIYRRSIGSKSFAE
IYLQ
>A0A0V7FY01|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
PEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQ
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELG
LVEGARLRGAASGPKRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKA
DPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVR
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
QQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTD
VDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAG
FREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREA
QA
>L8FDA3|FEATURES|UNIPROT_deepARG|beta_lactam|blaF|antibiotic inactivation|1
MTNLSRRSVLIGSLAVMAVAGVRMPTASAAPVDDRIADLERRNNASIGIYAVDLDSNRTV
AHRADDSFAMCSTFKAYLAARILRGAERGELSLDDRVFVDPAALLSNSPITETHAGGEMT
LAELCQAALQRSDNAAANLLLKQIGGPAEITAFARSIGDQRTRLDRWEIELNSAVPGDPR
DTSTPAALAGGFRAMLTGDVLGPPQRQLLDEWMRANETSSLRAGLPDGWTSADKTGSGDY
GSTNDVGIAYGPQGQRILLALMVRTRGDDPNADGFRPLIGELTALVLPELGVH
>A0A0R1XRH2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAIILGIIEGITEFLPISSTGHLYLADYFIKLDQPTSFINMFMVVIQLGAILSVI
LIYFNKLNPFAPSKSHKEQQQTWQLWFKVIIAVIPSVIIGLPLNDWLDEHMTTWQVIATT
LIVYGILFIILEDYYEKKKPSLVDLNKLSYKMAFFIGCFQVLSLIPGTSRSGATIMGAML
LGASRYVSTEFSFFLAIPTMFGASLLKLGKYVMGGHAFVGNQLAVLLVGMLVSFVVAYIS
IKFLLKYVQTHNFKPFGWYRIILGIVVIIVGTIFAR
>A0A0D0N0Z4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAAQQPLLQLENVSRSFMAGDREVTVLKQINLSIHAGELVAIIGASGSGKSTLMNILGCL
DNASSGIYRVAGQQTRDLDDDALAALRRDHFGFIFQRYHLLPHLDAVRNTEIPAVYAGTS
QAGRHQRAQELLTRLGLGGHLEHRPSQMSGGQQQRVSIARALMNGGEVILADEPTGALDT
TSGKEVMRILLELHAMGHTVILVTHDPKVAANAERVIEVSDGEIISDRRTSPRVQPVAEP
KPELQPTATARRRMIASFGLFREAFNMAWIALISHRMRTLLTMLGIIIGITSVVSISAIG
EGAKRYVLKDIQSIGSNTIDIYAGSNFGDSRAKSIETLLPSDVTALNQMYYIDSATPVVG
RSMLVRYRNIDVDAQLNGVSSRYFQVRNIQLAAGITFDDQDARRQAQVVVLDHNTAQRLF
GPGVDPLGKVILIGKLPCTVIGVTSDHKNLFIAGNTLNIWMPYETAAGRVLGQRHLDSIS
VRVKDGMPSKVVEEEIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRSLTLLLSLIAVISL
VVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSYG
IGYLFTLFVKQWEMVFSMASVVTAFACSTLIGVLFGFVPARNAARLDPIEALARD
>W9BX22|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEMYLIPILLGIVEGLTEFLPVSSTGHLILATELLGFDAEAWAVFNIAIQPGAILAIVV
LYWRTFMDVLAGLMRWEPSAVAFTRNLLIAFFPAVILGLAFGDQIDKLLENAVVVAWALI
IGGVAILVVEKLAKTSDAGGVAGVPFKTAIGIGLVQCIAMIPGVSRSGATILGAMAMGVD
RKTAAEFSFFLALPTLTGATVLQLYKNRDLLTPDEFGAIAIGFVVSFIVALVVVKAFLKI
VTRYGFAPFAWYRIVAGAAALVWLANR
>A0A0A0Q9J2|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTSGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A099N1A8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRLAALAAAITLTLGYSAAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARNHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGDASVLELGAYSADCLPLQFPDAVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLKQMGLRNTYLQVPASAQGLYAQGYDSADKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPEGLPPALAQATAITQRGYFQVGAMTQGLGWERYPYPVTL
ATLVDGNGPQLIREPQATTRLQPALPPLPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNYPNEARVRAAFDILSGL
>N9A3G5|FEATURES|UNIPROT_deepARG|beta_lactam|F959_01064|antibiotic inactivation|1
MTKPKHLSMNLKKLLIVAGVFSVSSTLWAKDLTEQQVKAVIDQQFKPLLAQYNIPGLAVA
VTLNGQHYFVNYGVASKQSQQPVRNDTLFELGSVSKTFNATLAGYAQAQGKLSFSDHPAK
YFPELNNTAVNRATILNLGTYTAGGFPLQFPDEVVTQQDMVKYFQKWQPKTKISVARQYS
NPSIGLMGYVTALAMKKPYSELIEKTLFPELGLKQSFIHVPESQMKNYAWGYKNDQAMRV
SAGMFDAEAYGVKSSSADMLKFIDAQLNPQQLKQPMRKTIENTHVGYFKVGAMTQGLGWE
QYTYPVSLATLLQGNSSKMALESHTVTPIKQPKLASAATLFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEARITASYQTIQQLLKQQ
>A0A0E9E5T0|FEATURES|UNIPROT_deepARG|bacitracin|uppP_3|antibiotic target alteration|0
MDIFQSIVIAIVEGLTEFLPISSTGHMIIAENMLGVDTSDPFVNAYTVIIQFGAILSVVC
LYWKRFFVLKPVEQGSTGMKALLQKYDFYWKLLVAFFPAAVIGLLLDDVIESLLGNVWVV
ASMLLGVGVLLLFVDKWFNNKQDAPLNEKRAFTIGLYQCLAMIPGTSRSFATIAGGMQQG
LTRKTAAEFSFFLAVPTMAAASGYSVLKMFIKPEFAAAREAMMSNIMVLVVGCVVAFIVA
LIAIKFFIAFLTKYGFKAFGWYRIVVGGIILLMLMSGISLQMVN
>A0A073K4X8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDTIIAFILGIIEGLAEFLPISSTGHLILAGHLLGFEGERAKTFEIVIQLGAILAIAVL
YHKRLVSLFNIKPLLQKEKKFNALHVILGVFPAVIAGLLLHDIIKTYLFQAHTVVIGLVA
GAILMIYAEIKKPKATAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKTNY
KVASEFSFLIALPVMVGATGLDLLKSWKYLSVDDLPMFAIGFITSFIVAMLAVVTFLKLL
AKIGLKPFAYYRILLAIVFTTFVLL
>D7PIH7|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLTKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPRKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKS
>AAN41648|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVLIFPSIKDALTNLKKITVHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>W1UFD3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFLEIIKAIILGIVEGITEWLPISSTGHMILVDQFLKLNVSKDFMDMFLVVIQLGAILA
VIVLYWEKIFPFKFSNGIKIEKDTVIMWVKIVIACIPAAVIGLLFDDQLNELFYNPTTVA
VMLILFGILFIVIENYNKGKRSKINSLSEITYNVAIMIGLFQLIAAVFPGTSRSGATIVG
ALLIGVSRTVAAEFTFFLAIPVMFGASALKLLKFGLATGFTMTGNELSILLVGMIVAFIV
SILAIKFLMSYIKNNNFKAFGWYRIILGIIVIGYFYLIK
>ZP_03823622|FEATURES|ARDB_deepARG|multidrug|adeB|antibiotic efflux|1
MMSQFFIRRPIFAWVIAIFIILFGLLSIPKLPIARFPSVAPPQVNISAVYPGATPKTIND
SVVTLIERELSGVKNLLYYSSTTDTSGTAEISATFKPGTDVDMAQVDVQNKIKAIEARLP
QIVRQQGLQVESSSSGFLMLVGIKSPNGQYSEIDLSDYLVRNVVEELKRVEGVGKVQSFG
AEKAMRIWVDPNKLVSYGLSISDVNAAIRENNVEIAPGRLGDMPAEQGQLITIPLSAQGQ
LDSIEQFKNISLKSKTSGSVIRLSDVANVEIGSQAYNFAILEDGKPSTAAAIQLSPGANA
VKTADAVREKIEELNINLPEGMQFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFL
HNVRYTLIPAIVAPIALLGTFAVMLVAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERI
MATEGLPPKEATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGIIYQQFTLTMSVSIL
FSALLALVLTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYERILLKVIKHSIPMM
VIFVVITGLTFAGMKYWPTAFMPEEDQGWFLTSFQLPSDATTERTKNIVNQFEDSLKDNP
NVKNNTTILGWGFSGSGQNVAVSFTTLKDFKDRTSSASEMTNAVNAEMANSKEGATMAVL
PPAIDELGTFSGFSLRLQDRANLGMPALLAAQDQLMAMAAKNKKFYMVWNEGLPQGDNIS
LKIDREKLNALGVRFADVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMHLKDILN
LKVAGASGQLVSLSEVVTPEWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGDAMREMENLI
AQLPKGIGYEWTGISLQEKQSESQMAFLLVLSMLVVFLVLAALYESWAIPLSVMLVVPLG
IFGAIVAIMTRGMMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVQAAK
LRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFVFI
LGGVEKLFKSKRTSTKQETTS
>D9R9E8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIIEILKVIVLGIVEGFTEWLPISSTGHMILVDEIIHLNQPTAFKNMFLVVIQLGAILA
VLVLYFDKLNPFSVRKKPVQKQATLILWSKIVLACIPAAVIGFLVDDILDEYLMNGYVVA
ATLILYGVLFIVIENRNQYRSFEVQKVGDISYQTALWIGLFQLLSLIPGTSRSGSTILGA
MILGCSRPASAEFSFFLGIPIMFGASFLKIVKYGLSFTGPQVFYLVLGMVIAFVVSVYSI
KFLMGYIRQHDFKFFGYYRIVLGAVVLLYFIITALLG
>B9KEB0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLDYYYALILGIIEGLTEFLPVSSTGHMILGAEILGLDINEFWRSFFIIIQLGSILAVI
FIFKDKLTQKLDIWLKLAVGFLPAGGFGFIMYKFLKEIFNGYTVATMLIIGGIIFIIIEL
KHRKKDYDIHSLDEVSYKQAFLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKVASEFSF
LLAIPTMIVATAYSIYKEPQVLSNMNNFIPLAIGFITAFIVAFVVIKIFLKLISKINFIP
FGIYRIILGFVFLYLFMSGALDISRTGV
>A0A104J3T6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHGIKCIMAAALFSTCATATIGYAANDRQDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPN
LQGSPFGNVTLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWRPTYSPGAYRTYSNVSI
GTLGLITATSMGQQDFAVPLSRHLLSPLGMKSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSMALNAMPVEEIKPPRAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>AAZ03413|FEATURES|ARDB_deepARG|beta_lactam|CMY-8|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>YP_001066168|FEATURES|ARDB_deepARG|multidrug|AmrA|antibiotic efflux|1
MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRL
DAYRQAEVRARVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHL
AALDKRRRYDELVRDRAVSERDHTEALADERQAKAAVASASAELARAQLQLDYATVTAPI
DGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQ
QDVEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDR
AVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVV
VVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST
>ZP_04616832|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGHLLGFTGEKAETFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGGKKVANDGQTGGHLTLGHVLLAMIPAVILGLVFHDAIKSLFQP
QSVMYALVIGGLLLLAAEWLKPKNPKAVGLDDISYRQAFMIGCFQCLALWPGFSRSGATI
SGGMLTGVSRYAASEFSFILAVPMMLGASGLDLYKSLHFLTWGDFPMFAVGFATAFVVAL
VAIKTFLSVIKRISFVPFAIYRFVVAAAVYWVFM
>V5MYM2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-138|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKSVTNGL
>AAN40998|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIKDIADELRGADYLV
WRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLP
SALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMF
SSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLL
DQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY
>D8GN80|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLFIIKAAAIGVVEGITEFLPISSTGHMIIVGNLINFKAPTYNGAYIDMFEVVIQLGA
ILAIVVLYWDKIFNSLKNLKPGKWGFKLWLTILVAFIPAAVLGLRFNDLIKSKLFNPVTV
ACALVFGGFLMIYMENKYRKGNSTNTIENVNLVQAFKIGCFQCLSLWPGMSRSASTIMGG
WVSGLTNVAAAEFSFFLAIPTMIAASGWSLIKVNVSMNISQIIALAVGFIVSFIVALVVV
EKFINFLKRKPMRVFAVYRIFIGAIILILYFAKVINI
>ACI87546|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHNHTVDHH
>A0A142JT89|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHAIAAAAALLGGASAHAAERVDAAALKRVVDAAIQPVMQAHDVPGMAVTVTAGGKQYDF
HYGVAAKREGRKVDADTLFEIGSVSKTFTATLAAYAQARGDLSLTDNAAKYLPQLAGSSV
GATSLLDLGTYAAGGLPLQFPEGVTDTGKMVDYFRDWRPRYAPGTHRQYSNPSIGLFGYL
AARSMGQPFEVLMEKTLFPALGLRSTYITVPQARMKDYAYGYTKDGKAVRVTPGVLDAEA
YGVKTTSADMMCFVMANIDGSGLDQTLQRALATTRTGYFKVGDMVQGLAWEMYAWPAQRD
SVLAGSSQQVVFEANPVARLEPPQAARSAMLVNKTGSTNGFGAYVAYVPSQRIGIVMLAN
KNYPVAERVKAGFKVLQYLDGRPVGEGKQP
>G5PB53|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADSPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>A0A011NK83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLECRFFRKFGVDLLLLLKALILGIVEGVTEFLPVSSTGHLILAGALLDFNDERGKLFEI
VIQSGAMLAVCWEYRAKIGSVVRGLPSEPAAQRFALNILVAFLPLAVIGLLFGKTIKTHL
FNAPVVATAFIVGGLVILWAERRQHRVRIESIDDLSLGDALKLGLAQALALIPGTSRSGA
TIIGGLFFGLSRRAATEFSFFLAMPTLIGASIYQLYKERALLSFDDLGMWVVGFLTSFIS
AFWAVRGLLRYISTHDFSIFAWYRIAFGIVVLLTWHYDLISWAGG
>A0A0R1JK73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIVLTLNVIKAIILGIVEGFTEWLPISSTGHLVLVGSVLKMGESKAFMDMFNYVIQFGA
ILAVVVLYFHKLNPFSPQKNQLEQKQTWTLWFKVILAVIPSVIIGFPLNDWMDEHLMQNW
VVASMLILYGILFIVIENRNKQRTPKFADLNTLPWLTAFWIGCFQALSIIPGTSRSGATI
LGAILIGTSRFVGAEFSFFMAIPTMIGVSILKIGKFFYQGNTFTGDQSIILLVGMVVSFI
ISIISIKFLMGYIKKNDFKVFGWYRIILGVLVLGAMFL
>W8XTT2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELRDIRRSYPSGDGSVEVLKGITLSIHAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDIAQLDGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSERRA
RLARAHELLLRLGLGERADYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIVEIRDGEIVRNPPASRQGGGLRARPQA
EPSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
ETAEKQLLRLLELRHGKKDVFTWNMDSVLKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAFILQLFL
PGWEIGFSPLALVTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0U2LY95|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLSNLWKAIILGIIEGVTEWLPISSTGHLILVDEFIKMNLSKDFMEMFNVVIQLGAIMA
VVVLYFHKLNPFSPQKNETEKKDTWILWSKVIVACAPAAIIGIPLDDWLEAKFHNFFTVA
LMLIVYGIAFVVIEKRNRDRKPKCTDLRDFTYKAAAIVGFFQVLSLIPGTSRSGATILGA
IIIGASRFVATEFSFFLGIPVMFGASFLKIAKFVMKGNSFGFTETFILLVGSIVAFVVSI
IVIKFLLNYLKRNDFTAFGWYRIVLGVLLISYWLFS
>D8MX27|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKGLFPVVCLSAVLTLTSADAFSAPPLSSEQIKSVVDGQIAPLLKAQQIPGMAVAVIYQ
GHPWFFNYGVAEVKSGRPVSANTIFELGSVSKTFTGVLGGYAVQSGLIKLDDPVAKYSAE
LSGKQWRDITLLNLATYTAGGLPLQVPDAVTDQKSLWNYYQQWQPQWKAGTMRNYSNASI
GLFGLLAVAKSNSSFASLMQQQVFNPLSLTHTYLRVPESAQADYAWGYKNGQPLRVTPGP
LDEQAYGVKSSAQDMAKFLQANIDPDSLPSEDAVLKKSLLTAQKGYYQVGNFRQGLGWEM
YDWPTNPQTIIADSANDVALKPREVHALVPARAATPASWIHKTGSTNGFGTYIAFIPAEK
LGIVMLANKNYPNPTRVEAAANILQALR
>NP_977823|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>A0A136GEC8|FEATURES|UNIPROT_deepARG|beta_lactam|AX282_13510|antibiotic inactivation|1
MKNKATLKLGICIGLLCLSLTGFKPFYGSTHAEAKGIGDTKMTSCITNKKFVQLEKKFDA
RLGVYAIDTGTNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLVTY
SPITEKHVDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKANRF
ETDLNSAIPGDIRDTSTAKALATDLKAFTVDNTLTTDKRTILTDWMRGNATGDELIRAGA
PIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSKRFTKDANYNNALIAEAAKVVL
NDLK
>E0NWG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIWSKEDLNTVEISLAEMLKVVILGIVEGLTEWLPVSSTGHMILVDEFIRLNVSTAFMD
MFLVVIQLGAILAVVVLNAKKLNPFLGSKTRSERRDTLDLWGKVIVACLPAAVIGLAFNK
YMEEHFMNAPVVASMLILYGILFIVVERWNKRRTPRVDSLAALDYRTAFIIGVFQVLSLV
PGTSRSGATILGGIIFGASRYVATEFTFFLAIPVMFGASFLKLVKFGWHYTGAELLILAV
GMVTAFAVSILSIQFLLRYIKRNDFTAFGWYRIALGILVLAYLFMIGDPTKEQ
>A0A085K8X7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASVWAMFNVMIQLGAILAVVV
LYWRTFWAVAMGLLRLDPVSIRFVRNLLVAFIPAVVIGLALHDYIDTLLGSPRVVACALV
VGGVAILVIERLIREQRFHGIADIPLVRVIGIGFIQCLAMVPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGASTLELLKKGDQLTSAQVGWDSIALGFIVSFIVALLVIKWFV
GLVSRHGFAPFAWYRIIAGIGALVWLSLR
>F9EUF8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGANRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDSAT
SGSYQIDGIETAKMEPDELAALRRERFGFIFQRYNLLGSLTARDNVALPAVYMGMGGKER
STRAEKLLQDLGLEGKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVIEIIQKLHKEGHTVIMVTHDPGIAAIANRIIEIRDGEIISDSSKNPEIPESKIERIKE
KSSWLFYYDQFVEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSEKKILAD
ISAMGTNTISIFPGRGFGDRRSGRIKTLTIDDAKVIAKQSYVASATPQTTSGGTLTYRNT
DLSASLYGVGEQYFDVLGLKLESGRLFDETDVKEDAQVVVIDQNTKEKLFGADVNPLGKT
VLFNKRPLTVIGVMKKEENSFGNADVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQ
VAEKGLTELLKTRHGTEDFFMNNSDSIKQMVETTTGTMKLLISSIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLVGVGLSTAISLVFNQFVT
EFPMEISIGSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALSKD
>A0A0T7NTW9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MVFNIAVFLVSIIWHWVSLMTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFT
GDKAKTFEVIIQLGSILAVVVVFWRRLFGLIGIHFGAVPHEGKTSGHLTLGHILLAMLPA
VGLGLVFHNVIKSLFNPHSVMYALVAGGLLLLAAEWFKPKNAKAVGLDDITYRQAFAIGC
FQCLALWPGFSRSGATISGGMLVGVNRYAASEFSFILAVPMMMGASGLDLYKSLHFLTLG
DLPMFAVGFITAFIVALIAIKTFLSLIKRISFVPFAIYRFVVAAAVYWVFM
>A0A144CB82|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPSRQSRAAAAKEALP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTRVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0B5E4A9|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
RPVGGMGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRR
IHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHN
MGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEAD
>A0A0J1LMI4|FEATURES|UNIPROT_deepARG|beta_lactam|SK36_03808|antibiotic inactivation|1
MMKKSLCCVLLLTASFSTLAASKTEQQITDIVNRTITPLMKEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLNDPVTRYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDEVTDKAALLHFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMGYEEAMINRILQPLKLKHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSIMDMARWVQVNMDASHVQEKTLQQGIELAQSRYWRIGEMYQGLGWEMLNWPVKA
DIVINGSDSKVALAALPAVEVNPPAPVVKASWVHKTGSTGGFGSYVAFIPKKNLGIVMLA
NKSYPNPARVDAAWRILEKLQ
>A0A0L8BKF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFRSPGNTFAVLIQLGAILAILL
VYFQKLLSIALALPTSVKARRFVVAVLLAFLPAAVIGAIAHDFIKTVLFETPMLICVVLI
IGGFILLAIDRLPLTPRYTDVMDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDFTVIAVGFIAAFVAGIFVVRSLLDF
VSRRGFTPFAIWRIVVGTAGLVGLWMLG
>A0A0L8F134|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYINLIFIFKTILEGIIEGITEFLPISSTGHMIILGSIIGFKGGANPAKLYTKGYIDMFT
VIIQLGAILAIVVLYWDKIISTLKPSNIFPSLEKANGDSRSYFSRMYDMPGFNFWFKIVI
ACIPAGILGVLFNEKIEGLLFKPAPVALALIFGAVWMIYAEKKYRKNLKVKRVDDITLRQ
ALIIGCFQCLAVLWPGMSRSASTIIGAWIIGVSTVAGAEFSFFLAIPIMVGASAVSLIKS
KIILSSMQIIGLGVGFIVAFIVALYVVEGFIGFLKKKPMRVFAIYRLFLGIAVLILGFAK
LI
>A0A0K2DB86|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLTDALEALVLGLVEGLTEFIPVSSTGHLLLLGHFIGFESNGKTFEVLIQLGAILAILS
VYFSKLLLIARGLPTDPGMRRFVLGVLIGFLPAAIIGALLHGFIKEVLFDPTIVCISLIV
GGVVLLAVDGLTLKVEHRDAMHYPLPMYLKIGICQCLAMIPGVSRSGATIVSAMLMGADK
RSAAEFSFFLAMPTMAGAFAYDLLKNYKNLSFNDGALIVVGFISAFVAGLFVVRSLLNFV
SRHGFAVFGWWRIVVGAAGLAGLLVYG
>D3ABR2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGETLTIIEVVEILKAIIFGFIQGVTEWLPVSSTGHMILLNEFLPLRQSNEFMELFFVVI
QFGSILAVPLLYWKRMVPWALKGGFRLKPDILLLWGKIVVACIPAGVAALLWNDEINNLF
YHPYVVVIMLIVVGILFLVVEARKREPVVHTAVELTWRAALWIGFFQMIAAVLPGTSRSG
ATIIGALMIGVSRIAAAEFTFIMAVPVMVGASLFKILQFGWELTWVEAVILLTGMIVAFL
VSLLVIQGLMNFIKKHSFKIFGWYRIGLGIVMAMYLLT
>A0A0M7M084|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENALYLIKAFILGIVEGLTEFIPVSSTGHLILIGDWINFESSQGKVFEVVIQLGSILA
VMWIFRARLLQLIRGTLTGVPSEVAFTRNLLIAFLPAAVIGAIFIKSIKQVFYHPAVVVV
TLVLGGLIMLYVERRTRHTPGDQPGAADDTASDERATAMTLEQISWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYKNMDLLTQHDLSGIA
VGFVAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGGIVAAWIFTR
>A0A031INQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTINLLIAFLPAVVLGVIFADLIHHYLFNPITVATALV
VGGVIMLWAERREHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFITSFIFAMIAVKGLLKF
IASHSYAAFAWYRIGFGLLILATWQFGWIDWAAATA
>A0A127SLQ7|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
DISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPPK
AYSNWSTPSEMVRLLKMADEKNLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGIVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEVK
>ZP_04107441|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MKNYIFVIKEALLVADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDDRAKVFEV
VIQLGSILAVVVIFWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVL
FGPGPVVISLVAGGILMIVAEKFSKSSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGS
TISGGLLARVSHTAAAEYTFILAVPMMVAASGLDLIKSWDILSTADIPLFATGFITAFVV
AMLAIVSFLKLLSRVKLTPFAYYRFILAAVFYFFIM
>J8BBN2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSDLKKSIMFYEKVLEGKLLAKGRKLAYFNICGIWIALNEEAHIPRNEI
HQSYTHIAFTVEQEDFNYLLKRLEENGVHILKGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYKDEKPHMTFY
>J0UPU4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTEQTLYLLKALFLGIVEGITEFIPVSSTAHLLILGSWIDFSSGDAKVFEVVIQFGSILA
VIWIFRARLIQLIMGTLRGDRTELMFTRNLLIAFLPAAVIGALTIQYVKALFHHQIVFVF
TLVLGGLLMLWVERKPQYAKNTSELDQGETATSQKATAFALEEITWKQALVVGFAQCIAM
VPGTSRSGATIIGGMLAGIQRKTATEFSFFLAMPTMLAATVYDLYRNGASLSSDQSTAII
VGFVAAFFSALFLVKAVLRFVSSRTYRPFAWYRIALGGVLFVWLMT
>YP_002256705|FEATURES|ARDB_deepARG|multidrug|MexC|antibiotic efflux|1
MKIERLRRHGGVHALLAAMLAGCGPSEPQSAPPAPQVATTSVAPTHLELTEDLPGRVAAV
RVAEIRPQVSGIVLRRLFEQGTEVRAGQPLFQINPAPFRADADTAAAALRRAEAALARAR
VQTTRLQPLVEADAVSRQVYDDAVSQRDQAAADVEQARATLARRQLDLKFATVEAPIPGR
IDQALVTEGALVNSGDSNPMARIQQIDQVYVDVRRPASSLEALRRTLATQTAGAGNGLPV
AVLRGNGEPYEAKGRILFSGINVDAGTGDVLLRVLVNNPQRQLLPGMFVRARVPHVRYTD
ALTVPQQAVVRVGGQPQVWALDANGHARLKPVELGELVDRRYRIRTGLSAGQKIVVEGME
RLSDGAAVTAHDWKSPEPVPAGPAH
>YP_002088900|FEATURES|ARDB_deepARG|multidrug|opmD|antibiotic efflux|0
MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSF
FDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLD
YDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTAR
AYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPL
TTALESARYRLDVLRGEAPGSGAPILDGAAAAPLAKNLPLGDVDRLILQRPDVVSAERQL
AASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRAR
LRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANER
YRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAG
ESAGANR
>K1VRF3|FEATURES|UNIPROT_deepARG|chloramphenicol|SM8_04379|antibiotic inactivation|1
MDAPIPTPAPIDLDTWPRRQHFDHYRRRVPCTYAMTVEVDVTAFAAALRRSPRKSYLAQV
WALATVVNRHEEFRMCLTSSGDPAVWPVVHPAFTVFNPERETFACVWAPYDPDFGTFHDT
AAPLLAVHSRATAFFPQGNPPPNAFDVSSLPWASFTGFTLDIRDGWDHLAPIFTLGRYTE
RDDRLLLPLSVQIHHAAADGFHTARLTDELQTLLADPAWL
>N9VNM2|FEATURES|UNIPROT_deepARG|beta_lactam|G114_05220|antibiotic inactivation|1
MSALLLRGLLAAALLHAIPASAAGCFLFADASGKPLEREGECSQRLPPASTFKIPLALMG
FDSGFLVDAGHPALPFKQGDEDWLPAWRETTTPSRWMTYSVVWYSQRLTEWLGAERFQQY
VDRFDYGNRDLSGTPGQHDGLTQAWLSTSLAISPEEQARFLGKMVSGKLPVSATTLARTA
EILKVTEIDGWQVYGKTGMGYPKRLDGTPNREQQIGWFVGWASKGGERRIFVHTVIQPPG
QQFASLKAKEEVLATLPARLAAH
>A7ZZ23|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FNLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>X5PLP6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVLGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLVVDRMKLQPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFVAAFVTALIVVRFLLDY
VSRNGYSLFGWWRLVVGGVGLVALMIWG
>ZP_03063547|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKETTHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPDQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEEKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>C3FBD2|FEATURES|UNIPROT_deepARG|beta_lactam|bthur0007_56400|antibiotic inactivation|1
MLKIGMCVGILGLSITSIEAFTGGPLQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLG
VYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLVDYSPV
TEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSDRFETE
LNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTEWMKGNATGDKLIRAGVPTD
WVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIAEAAEVVVNAF
K
>A0A142BVP1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>A0A086C2H0|FEATURES|UNIPROT_deepARG|aminoglycoside|G039_0303925|antibiotic inactivation|1
MHDAAASLPPQAPAAWADYLSGYRWQAQREGCSAAAVHRLDAARRPTLFVKHEALSEQAE
LPDEIARLRWLHGAGIDCPQVLNETQGGGRQWLLMSAVAGDTLSALAQRGELEPERLVRL
VAAALRRLHDLDPAACPFDHRLERRLESVRRRVEAGLVEETDFDDEHRGRSAVELYRLLL
DRRPAVEDLVVTHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIETDLGAP
WAEAFLEAYGGDIDGERLAYFRLLDEFF
>A0A127SLF1|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNCKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKGLLVADHDRY
>F7UB62|FEATURES|UNIPROT_deepARG|aminoglycoside|Agau_C200043|antibiotic inactivation|1
MSGQFVIKAADAASLDDWSLLRHRLWPDASPAEHSEELQDLSDNEAGFIAYNLAGVAIGF
ADVSLRQDYVNGCDTSPVAFLEGVYVEGDFRGQGVAAALIAAVTRWAVGKGVSELASDAD
IANVDSHRMHAALGFEETERVVYFRKLVSVPEN
>A0A132BNP3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWELFVAAILGIVEGLTEYAPVSSTGHMIIVDDIWLKSGSLMSEEAANSFKVVIQLGS
ILAVAIVFKDRILNLLGLKKNITSDQEHGHKLSIAQIAVGLVPAAVLGFLFEDYIDEYLF
SVRTVAIGLIAGAVLMLAADWINKRKETTDTLDRISYKQAIGVGLFQCLALWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAMPIMMGASTLSLVKHWDSLSSDLMPFFIVGFICAFVV
ALFVVRFFLRLINKIKLVPFAIYRIILGVILLLFMM
>YP_002847165|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MQRILAFFSQRATTLFFPVALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLY
LAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLFTTSMTQFLVARFVQGTSICF
IATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKILFAIIAVMG
LIALIGLMLAMPETVQRGAVPFSARGVVRDFRDVFRNRVFLFGAATLSLSYIPMMSWVAV
SPVILIDAGGMTTSEFAWAQAPVFGAVIVANMVVVRFVKDPTRPRFIWRAAPIQLSGLAV
LIVGNLLWPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMVILTVM
AVSVEIGRWLWFNGGRISFHLLAVAAGIAVVFTLAGLLKRVRQHEATTLATEN
>U2Q591|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFLKALILGIIQGITEWLPISSTGHMILVDEILKLNVSSNFMELFLIIIQFGSILAVIV
IYFKDLVPFEVKGGFKLDMEKINLWVKIVIASIPAGIVGVLWADELNAAFFNSKVVAIML
ILVGAAFLVIEKWNKNKSPKVNTIADITYKSAFIIGVFQLVAAVFPGTSRSGSTIIGALL
LGIARPVAAQFTFFLAVPIMAGASLLKLIKFEGSFTSTELGILIVGMVSAFIVSIVCIKF
LMSYIRKHNFNVFGWYRIALGILVLFLLR
>J9V7T2|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-107|antibiotic inactivation|1
LPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAV
LKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIA
HVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGLAMG
DSQRAQLVTWLKGHTNGAA
>A0A0M1KQV8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWTLATGLGERDNRDYVLKVSVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSRRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWADVAVAFVAATITGFVVVKWLLSYIKKH
RFTVFAVYRIVLGAALLLWLPAAAG
>AAC21590|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRFTLLAFALAVALPAAHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFDAQLARETAGTR
>A0A060LTJ3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MPINHLTFSVSNLEKSITFYEQVLGATLLVKGEKLAYFDLDGTWLALNVEEAIPRNEIAQ
SYTHIAFSIEEEAFESTVHRLNALEVSILKGRTRDEQDKQSIYFTDPDGHKFEYHTGTLQ
DRLDYYRKDKSHLTFY
>A0A089HTP3|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MRLISKYETIRRMLSDFKQPEYRYAQIMDAIFKQNVCEYERMTILPKFLRDELTRMLGPN
VCSIVPVKELTSKQISKVLFAIAGDERVEAVRLTYERGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFRLNGHALDSVSFMGMGEALANPHIFDAMTILTDPHLFGLG
HRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLKALDR
HIRHTGRKVYIAYILLRGVNDSTEHAEAVAELLRGRGPGEHLYHVNLIPFNSTEVTPDSY
RQSDPNQIKAFVRILNSKGISVTVRTQFGSDINAACGQLYRSE
>AAB59094.1|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLEFIADSSAFAFLAFISEGWL
DFPVLILLAGGGIALPALQGVMSIQTKSHEQGALQGLLVSLTNATGVIGPLLFTVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>A0A0U1YUD4|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIALLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>U3XTH1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METFSLLEIFKAVILGIVQGITEWLPVSSTGHMILINEFIKLNFSNTFINTFLVVIQFGS
ILAVLVIFFRKLNPFDSAKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDIDRVFFNST
VVAIALIVYGIIMIGLEKRNKRPKYKDFSQVTYKLALCIGLFQCLALIPGTSRSGSTIIG
AVLLGTSRYVAAEFSFFLAIPTMLGASALKLLKAGFGFTRFEWLILGVGSVVAFVVSIVV
IKFFMDYIKKHDFKVFGYYRIVLGIVVLAYFFLL
>NP_630216|FEATURES|ARDB_deepARG|fusidic_acid|fusH|antibiotic inactivation|0
MATLIPKKGSTLLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPAAATDHAF
TARLHIGEGDTLRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGI
VEVVPRDDRDVAMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWVPDQLHTGE
FRVDSVTGTTVELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRT
GAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRV
MSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWG
RFIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWK
DLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLE
FGDATGDGKADLLVRTKDGKVALRTNHGTYWDQGKFMITL
>D2XSF5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-1|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILV
>D7PIJ7|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLTKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPRKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKS
>H6NFY8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQARIQEYLLTEQDTAPYGITAGPDGALWFTEQKGNRIGRITPDGEMSFHPVPTPESGLS
CITAGEDGALWFTAYKAGRIGRITVEGVITEFALPGDGSAPFGITPGPDGALWVTLTAAG
RIGRVSLTGEITEHALPQAGCFPSFIACGPDGALWFTENQGNAIGRITTDGEVREYPLPR
EKSGPVGLACGSDGALWFTELLGNRIGRISTSGELREYELPAENARPHAITPGLDGDLWF
TEWGSGRIGRITAGGELTEYSIPTEGAEPHGIALGSDGAVWFAEECGRIGRLIPEGPGVP
QA
>F5RF79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDHLLLIKAVILGILEGLTEFLPISSTGHLIIAGSLLGYTDDTSRVFKIVIQLAAILAIC
WEYRRKIIDVASGLGRVPAANRFALHVFIAFLPAAVLGLMFHRIIKTYLFNPLTVAGALI
VGGVIILLIERRTHVPRYETADDLDWRAALKVGFAQSLAMFPGVSRSGATIMGGLMFGLS
RRAATEFSFFLAIPTMFAATVYDVYKNWALLRVEDLPVFTAGFVASFLAAFFSVRWLLRY
IASHTFELFAWYRIAFGLFVLATAGFGWVDWADH
>A0A0C5CCE2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHLWNLFVAAILGLVEGLTEFAPVSSTGHMIIVDDLILKSNHLYGTEAANVFKVVIQLGS
IMAMVVVFWDRFLNLLGLKKNITREQMYGERLRLTHVITGLVPAAVLGFLFEDYIDAHLF
SVNTVLVALVVGAILMIVADLTRPRRPKTETVDQITYRQAFVVGLFQCLALWPGFSRSGS
TISGGVLLGMSHRAAADFTFIMAVPIMFGASFLSLVKHWGAVTPETIPFFITGFISAFIF
ALIAIKFFLALINKVKLVPFAIYRILLAIVLLLLIWNR
>A0A0H2QAX3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAGLLELKGITRCYPAGDSTITVLKDISLSINAGEMIAIIGQSGSGKSTLMNILGCLDKP
TTGEYWVNGQNTAALDSDQLAALRREHFGFIFQRYHLLSHLSAEQNVEIPAIYAGTAKEQ
RRQRAISLLNKLGLESRIAYRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSQSG
EEVMKILKDLCTQGYTVIIVTHDPKIAAQTQRIIEIKDGEIINDPGRAPIDHHVILPTPI
QNKTTISQIFGRFNEALLMAWRAMVVNKMRSLLTMLGIIIGIASVVSIMVIGDAAKGMVL
NDIKAIGTNTISVFPGEDFGSDDPENIQALKPADVLALEQQPYVQAVSGVTEGAARLRHG
NLDASGRIQGISRNFFAVYAEKFSEGMNFTPDMMERQAQVVIIDANVKRRFFAHQKNVVG
ETLLIGNMPATIIGVLAEKKTMFGPTNSLEVWLPDTTFRSRITNRPYIDNIVVRVKDGYD
VKSAEQQLIRILTLRHGKKDIFTYNIDTFIKTAEKTTRTMQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVMQQFLIEAVLVCLIGGVLGIGLSYGIALLAQLA
LPSWQLTFDPMALITAFICSTAIGIIFGFLPARNAAKLNPIDALARE
>N1VSZ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNTLNAFLRGIIEAATEFLPVSSTGHLFLFSYFFPFENLKVDHESFEDLFDIFIQTGAI
LSVVVLYFQLLWKHTKSAVLFITKKADDQSGFSFYRNLLVGILPILILGFVFKNSLDQIK
MRTDLLLILGSSWLVGGLVMVFVEMKHYDESEGKLIGMKESIFVGFFQCFALIPGVSRSA
ATIITARILGVSKKDSAEFSFFLAIPVLTLAGIYKLYKHRSILNSETIGLLLFGSIVSFV
ICYFIIRLFMAFIRRRSFLSFGIYRILLGILVILYFVRG
>J8JI24|FEATURES|UNIPROT_deepARG|beta_lactam|IIK_01494|antibiotic inactivation|1
MKKNILLKLGVCVSLLGTTQFVSTISSVQASQKVEQKVMKNEAGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSRGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGMKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQSVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSASSKDLGNVADAYVNEWSTSIENVLKRYGNINLVVPGH
GEVGDRGLLLHTLDLLK
>A0A081PDC0|FEATURES|UNIPROT_deepARG|chloramphenicol|N180_04680|antibiotic inactivation|1
MNTTYQAINIEDWKRKEHFNAYRNAVKCGFSLTFKLDISRVIPFIKEQGYKFYPVMIYLL
SKAANKHPEFKMAMKEGELIVWDRVDPVYTVLHPETETFSALSCRYTEELTKFVKAYDQT
AEQHHNDYRFFSEKAPENHFNISAIPWINFDSFNLNIADFTDYFAPSFTMGKYQKDGNNI
LMPMAIQVHHAVCDGFHVAKFIETLQEYCLNIENFK
>A0A0R2MXZ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDIFKAVILGIIEGLSEFLPISSTGHLYLADYVIKLGQPTSFVNMFMVVIQLGAIMSVV
VLYFNKLNPFARSKSGPEKRATWLLWFKVILAVLPAVVIGLPLNDWLDKNMTSWQVISAT
LIIYGMLFIILENFYAKRQPTVTKLSDLSWHFAFLIGCFQVLSLIPGTSRSGATILGAML
LGASRYVATEFSFFLAIPTMFGASLLKLVKFFKAGNALAGSQLAILLTGMIVSFIVAYLA
IKFLLKYVLTHDFKPFGWYRINLGLVVILCGFFM
>YP_002256547|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFAVNVIVATIPAITLALIFGKTIKAHLFNPIVVASAFI
IGGLVILLVEWRERRRGQTHDPRGNALLEAAKAGAPRIETLDDLRLSDAIKVGLAQCFAL
IPGTSRSGATIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSADDLSIFG
IGFVAAFISAFFCVRWLLRFIASHDFRGFAWYRIVFGVIVLVTAYTHLIAWQA
>A0A120EVR3|FEATURES|UNIPROT_deepARG|aminoglycoside|ATB53_18915|antibiotic inactivation|1
MTEGFSIRAAAAADLRAWAALRMALWPDERDAFGGVAEALQREDAANFLAFAGAGYAIGF
ADVTLRQDYVNGTDSSPVGFLEGWYVVPEWRGRGVGRALLRQVQDWTCAQGCSELASDAL
LDDAAAQAAHRACGFEESERVVYFRMSVAD
>A0A0M0GJM4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIIKGLNHLLFSVSNLEKSISFYQKVFDAKLLVKGRNTAYFDLNGMWLALNVERDIPRNE
INQSYTHIAFSIDAAEFDKMHEKLNELNVNILSGRLRDERDKKSIYFTDPDGHKFEFHTG
TLKDRLEYYKQEKTHMEFFD
>A0A0K0HEQ2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MNDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLIFHDTIKSLFNPI
NVMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFIIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTVADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>G5JQW6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLVIELIKAIFLGIIEGITEWLPISSTGHLILVQEFVKLNQGHAFNELFNIVIQLGAILA
VMVIYFERLNPFQKGKTPKEVRLTWQLWMKVVIACIPSAIFGLLLDDWMDAHFSNFTSVA
TMLIVYGIAFIWIERRNRNVEPQVTDLARMHYKTALYIGLFQVLSIIPGTSRSGATILGA
ILVGTSRSVAADFTFFLGIPTMFGYSGLKFVKFLLDGNHLNVAQWLVLLVASIVAFAVSM
AVIKFLTNFVKKHDFTVFGWYRIVLGIILLIYAAVKVLMV
>A0A0F7Y587|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSALQAIILGVIEGLTEFLPISSTGHQIIVADLINFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQVPARRFTANLLIAFIPAVILGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERRQHRVEVDHVDDMRWTHALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFAIGFVVSFIFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWEFGWVDWSTAHG
>R7RPA9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILKAIILGIIEGLTEFLPVSSTGHLIIANKYISFTGNFANVFDVVIQVGAILAVMLYFK
DKIFPKFEDKRQARRVFRLWYKVVVGFLPAAVLGFLLDDYIEEHFFNPRTVAYALIFGAL
LLLFAEARLKRVKVDDVDEMTYKDALGVGLFQCLALWPGMSRSASTIIGGLFLGLSREVS
AEFSFFLALPTIIGASVLKLFKSGLMFTPYEWLVLFVGTFVSFVVALIVIAAFMSYIKKR
KLAPFAYYRIILGIIVLLLL
>A0A087MH53|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLTALLLGIIEGLTEFLPISSTGHLLIAQHWLGARSDLFNICIQAGAILAITLVYRE
RIWSLATGWRQPAERDYLLKILGAFAVTAAVGLPVRLLGWELPETVTPIAWALVIGGVWM
LVAERLSERGPPSSQVTWAIVVAVGLAQVLAGVFPGTSRSAAAIFMAMLLGLNRKPAAAE
FVFLVGIPTMFAASGYALLETVLEGEAGTEDWAGLAVAFVAATITGFATVRWLLTYISSH
RFTPFAWYRIGLGALLLLGLPAGG
>ZP_03281873|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDSDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRASRAAAPKEALP
VSTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQNQQALKYDDLAALQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRKQLFPDKASVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVNEGYDS
ALAEQQIERLLTLRHGKKDFFTWNMDGILKTAEKTTRTLQMFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPLAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>ZP_04630103|FEATURES|ARDB_deepARG|polymyxin|RosB|antibiotic efflux|0
MGTLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKD
LLAVKSIAIPGAIAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQ
LIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFI
TLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMV
LNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLHEPLAVLASLAIIIFGKSLIA
FALVRMFGHSKRTALTISVSLAQIGEFAFILAGLGISLGLMSDHGRNLVLAGAILSIMLN
PLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPVDLCNHALLVGYGRVGSLLGAKLHAEG
VPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCARWLLLTIPNGYEAGEIVA
SARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREVANSMLNMLKIDRLTEEDKRPV
CPI
>Q3SWA8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MISDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFDLGSGNFWDTFTVLIQPGAILAIV
VIYFAKLWRVALGMFSNPADRRFVIGVLAAFLPAVIVGLIAGKYIKELLFNPWVVCFSLI
VGGAVLMWVDQLDHRPREHDATAFPLPMYVWIGIAQCVAMIPGVSRSGATIVSAMLLGAD
KRAAAEFSFFLAIPTMTGAFAYDFYKNHADMTTDDLGTVAIGFVVSFVTAIIVVKAFLSY
VTRNGFTFFAWWRVIVGTLGLIALALGR
>ZP_03050421|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLRQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>A0A0G8BEB0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MAALLQLNGIRRSYRSGEQTVEVLKGISLSIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLSDDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAEALLRRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCAQGHTVILVTHDPAVARQAERIIEIRDGEIIADSRPAPSEDAQAKPLTL
AAAAPSWRQMGGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTYRQSLKYGDLDALREQPYISALSPSISSSMRLRL
GNVDAAANVNGVSEQFFRVYGMSFTQGVGIDPMQVQSQAQTVVIDANTQRRLFPHQKNVV
GEVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNSYFDSITVRIRDGY
DSKEAEQQLSRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLAVQL
VLPGWQISFPPAALLSAFLCSTGIGVVFGYLPARNAARLNPIDALARE
>CAD04961|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKQDQQGGQQMPEVGVVTLKTEPLQITTELPGRT
VAYRIAEVRPQVSGIILKRNFVEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAELTVKRYQKLLGTQYISKQEYDQALADAQQATAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQASALATVQQLDPIYVDVTQSSNDFLRLKQELANGSLKQENG
KAKVDLVTSDGIKFPQSGTLEFSDVTVDQSTGSITLRAIFPNPDHTLLPGMFVRARLQEG
TKPTALLVPQQGVTRTPRGDATVLVVGADNKVETRQIVASQAIGDKWLVTDGLKAGDRVV
VSGLQKVRPGAQVKVQEITADNKQQAASGDQPAQPRS
>A0A0F4BHI0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPQHEGAGKGRLSLIHILLGMIPAVVLGLVFHDAIKSLFNPI
NVMYALVVGGFLLIAAEVLKPKTPRAEGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDVYKSYHFLTAGDIPMFAVGFITAFIVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A085A2L1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSYPPVQKVSVVIPVFNEQESLPELIRRTDAACASLGREYEILLVDDGSSDDSAQMLCD
AADSAGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSFFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRAVEIPVLHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SVIALLGFAFSLLLIVLRLALGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRKGETVSQEEDQS
>A0A0C1RMJ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MALWQAIILGIVEGLTEFLPISSTGHLLATKEILDLGQTQTTEKAIDSYIISIQIGAIFA
VAVLYRNRLKQMFQGLRGNNSDGRRILNALIVAFIPTALIGYIAADFVKDELYGLTPVAA
AWIVGGASILFVQRKRLFQEEGIVLENLSLNQALIIGFVQSLALWPGVSRSLVTIVAGVL
IGMSLKAAVEFSFLLGFVTLTAATIYEIGNDGQEIINNFGYLSPTIGLVVAFSSAILSVR
WMVGWLEKRSFAVFGYYRILAGLVAFLLISIGFF
>E1P0U6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKNISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKER
SARAEKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASKVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSMGTNTISIFPGRGFGDRRSGKIRTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTRV
AEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>CAG27784|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALVQFACA
PVLGALSDRFGRRPILLVSLAGATVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFL
LPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDR
FHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRG
WMAFPIMVLLASGGIGMPALQTMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGLWSGAGQRADR
>A0A0E9BJQ1|FEATURES|UNIPROT_deepARG|beta_lactam|BN1183_AV_01670|antibiotic inactivation|1
MTHLFRRRASTAVTLLALAMPLAAQAGFDEDALQRGIQQLEKNAGGRLGVAVTDTADGTV
FTYRGDARFPLCSTSKVFAVAAILKKSESADGLMSEKIAIHKADLVNYNPITEKHVGATM
TVAELSAAALQYSDNTAMNALLTRLGGPQQVNAFARSIGDSTFRLDRKEPELNTAIPGDK
RDTTSPDAMMQSLKKLVLGKALSPAQRQQLTDWMKGNTTGANSIRAGLPASWTVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQPDKHAAARKDVLAGAAKIVASGYNK
>Q2LA82|FEATURES|UNIPROT_deepARG|beta_lactam|PER-1|antibiotic inactivation|1
VVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPCEKF
PMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQL
LQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTS
MKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKA
GKTAATNDLGIILLPDGRPLLV
>YP_001174764|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKKQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAKDLSVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMLATVIAMTTHSLPLLIAASALQGMGTGVGGVMARTL
PRDMYQGTQLRHANSLLNMGILVSPLLAPLIGGVLDSIWSWRACYAFLLILCIIVTFSMA
RWMPETRPTGAPRTKLIANYKTLFGNGAFSCYLLMLIGGLAGIAVFEACSGVLLGAGLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVISCLLAGVMMWIPGLFGVMTVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGALAWLSAMMPQT
GQASLGLLMTLMGLLILLCWLPLASREPHHEQMV
>A0A060KZD6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLCQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>YP_668774|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGVRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>A0A089UES9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTPEPIKKVSVVIPVYNEQDSLPELLRRTTEACQKLNRDYEILLIDDGSSDESAAMLTR
AAEAPDSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIVTLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSWFRKRASKMINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRAIEIPVHHDERQFGDSKYSFMRLINLMYDLITCLTTTPLRLLSVVG
SIIALSGFALAVLLVVLRLALGPQWAADGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVSSETALSSEENQ
>NP_309470|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSVHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>D4CHX2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFFEILKVLVLGIVEGFTEWLPISSTGHMILVDEIIHLDVSQAFREVFMVVIQLGAILA
VVVLYFHRLNPFSPRKTENQKRATIRLWMKIVVACIPAAIIGIPFDNLLDKLMNGYVVSA
MLILYGVFFILLENRNRGVQFRIQRVTQISFRTAACIGLFQVLAMVPGTSRSGATILGAM
LLGCSRGAAAEFSFFLGIPVMFGASFLKIIKFIFVDGMTFQAYEVFYLLFGMAVAFGVSV
YSIKFLMEYVKQHDFKFFGYYRIVLGIIVLSYFGISALVAA
>A0A0P0YP48|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQAVNHVTYSVSDIKKSVEFYKNILKAKILLESDKTAYFTIGGLWLGLNEESEIPRNEI
HYSYTHMAFSIKENDFDEWYDWLKQNHVNILEGRPRDVRDKKSIYFTDPDGHKLELHTGS
LQDRMNYYKDEKPHIKFYE
>N9GPH0|FEATURES|UNIPROT_deepARG|aminoglycoside|F926_02644|antibiotic inactivation|1
MNIKPASEASLKDWLELRNKLWSDSESSHLQEMHQLLTEKYALQLLAYSEHQAIAMLEAS
IRFEYVNGTETSPVGFLEGIYVLPEQRRSGVATMLIRQAEVWAKQFSCTEFASDAALDNV
ISHAMHRSLGFQETEKIVYFSKKID
>I6YE79|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEMHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>A0A0Q4LNP6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLTVILLGIVEGITEFLPVSSTGHLILATRLLGYDAGRWEVFNVVIQLGAILAIVVL
YWRTFWAVGMGLIKREPKSWLFLRNLVVAFIPAAVIGLAFHKYIEALLGNAEVVAIALVV
GGFAILAVERFAPRSDISGVADIPLKTVVGIGFLQCLAMVPGVSRSGATILGALALGVER
RTAAEFSFFLAIPTMLGASALEILKNRDAIASGGGVGLGAIAIGAAVSFIVALLVVKWFV
GIVTKHGFVPFALYRVVAGSAALIWLLTR
>A0A0T6DRJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLFVQAVIMGIVEGITEFLPISSTGYLILSADVMGFWTKEKVDLFVVVVQLGAILAV
IYDYWGRLWQALMGLLTGKAEGMTNPRQLGLSLIVSTIPVMIVGFTFADEIKAYLFNPIV
VAIMLIIGGLLIFYVEKRPKTVIAEEAEDVSIKTALMIGLFQCLALIPGTSRSGATIIGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLVKHGDVLTNSEDWLVLGIGTIVSFIVALLC
IRLLVAWVSRRDFTIFAWLRIITGVIVLIASWGFGYQMAG
>YP_688009|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSTPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHTVDHH
>W4SBL4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVHAAMHYPDVSPHPLSSPMSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDF
FNIVIQAGAILAICLALRQKLWTLATGLGQRDNRDYVLKIGVAFLVTAVVGLIVRKAGWQ
LPETVQPVAWALLIGGLWMLVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSA
SAIFLAMLLGLSKRSAAADFVFMVGIPTMFAASGYALLEMYKEGGFGSENWADVAVAFVA
ATITGFVVVKWLLGYIKKHRFTVFAVYRIVLGAALLLWLPALA
>A0A026RVS4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPTI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCNDKYFDEDHSNLTVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A085U849|FEATURES|UNIPROT_deepARG|beta_lactam|nADLYRO1b_1549|antibiotic inactivation|1
MMHKTLSCALLLVASGSTFATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYY
FTWGMADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSKYWPALSGKQ
WEGISLLNLATYTAGGLPLQVPDNITDETSLQNYYETWQPQWAPGTKRFYSNASIGMFGK
LAVKPSGMSFEQAMNKRVFQPLNLTHTWIHVPEREEKHYAWGYRDGKAVHVSPGMLDAEA
YGVKSSIKDMASWVRANMTPSEVKDASLQKGILLAQSRYLQVGDMYQGLGWEMLNWPMKA
TVAVGGSDNKVALAPLSAVEINPPAPALNSSWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVEAAYRILEALQ
>A0A0S2FZZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLLAALLLGIIEGITEFLPISSTGHLLIAQHWLGARSDLFNISIQAGAILAVVVIYWK
RLWGLATGFTRRDNLDYLLKLGLAFGITAVLGVAVKKAGFQLPDHVTPIAWALVLGGVWM
IAAEHFAAKRAAALGERSEITWTVAALVGVAQVVAGVFPGTSRSAATIFIALLAGTTSRA
AATEFAFLVGIPTMFAATGYELMHVAGTPAAAGEDWSALAVAFIASAVTAFIAVKWLLRY
IQSHRFTAFAIYRLAFGAALLLLMPSGS
>A0A119M6D0|FEATURES|UNIPROT_deepARG|beta_lactam|WL73_29435|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLALTLSACASPLANASSVGAATSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALLTQRVTYRQADLPEWSPVTEKH
VDTGMTVDELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDETFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQFAQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTTNDIGVLWPPARGPIVLTVYYTQAHADAKRKDDVIAAATRIAIAALG
>A0A0A6W3V0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDDKKIEKVSVVIPVYNEQESLPALIQRTDDACKSLNLDYEILLVDDGSQDASATMIAD
AASLPGSHIVAVLLNRNYGQHSAIMAGFSNVSGDLIITLDADLQNPPEEIPRLVAAAQEG
YDVVGTVRQNRQDSWFRRQASRTINQMIQRVTGKSMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRTIELPVTHAEREHGSSKYSFMRLINLMYDLVTCLTTTPLRMLSVLG
SLIAIAGFAFSVILILLRLFLGAAWAGDGVFMLFAVLFIFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVINPQKDRSVQETE
>A0A083Z6C0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEALPITKVSVVIPVYNEQESLPELFRRTTAACESLGKDYEILLIDDGSSDHSARLLID
ASEAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKTASKMINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAVTGFTLSILLVILRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIRPESPHSTKENQ
>ABG71110|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNTLLKEAEK
RNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>S9SMF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWWDMFVGFILGVVEGLTEFAPVSSTGHMILVDDFMLHSKEIFSPQMANMFKVVIQLGS
ILAVVVVFWDRFFQLLGLKRAPIDPELGRAGHSRLKLTQVLVGLIPAAVLGLLFEKYIDQ
YLFSIQTVLIGLVVGAVLMIAADWFRPAKPTAKTVDQVTYKQALGIGLFQCLGLWPGFSR
SGSTISGGVLLGMSHRAAADFTFIMAVPVMAGASGLSLLKHWKDFSMDALPFFIVGFISA
FLFALISIRFFLKLINRVKLVPFAIYRIVLAAVIYFVFL
>E2PHD7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASKVGRIQE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSMGTNTISIFPGRGFGDRRSGKIRTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQV
AEKGLTELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A0Q7R1Y4|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD52_30785|antibiotic inactivation|1
MRVLLMDGEMVGRWLEMRLALWSDTPAAVHRDEIDSSLAAAERQAAFLCEDDAGVAVGFA
EVSLRTDYVNGCETSPVAFLEGIYVLPGYRRHVVARALITAAERWAISRGCRELASDTDI
DNLESHGLHMALGFEETERVVYFRKELSVAADN
>A0A0W0T139|FEATURES|UNIPROT_deepARG|beta_lactam|Ldum_0387|antibiotic inactivation|1
MKKIAVFLSAGFLLCGSAWTQESCFLAQEEQTVLHQEGNDCNQRYSPNSTFKIPLSLMGF
DAGILKDATHPEWPYKKEYELFLNVWKYPHNPHSWMRDSCVWYSQVLTQKLGMKRFKGYV
GAFHYGNEDVAGDKGKNNGLTHAWLSSSLAISPVEQIQFLQKMIHKKLPVHPKAFAMTKD
ILYLQELAGGWKLYGKTGTGQQLTRDKSRKLPLQHGWFVGWIEKEGRMITFASHIADSKE
KTSIASFRAKNEALNKLFYLINDLEK
>A0A090KNK1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLMFLKTIILGMVEGLTEFAPVSSTGHMIIVDDLWLQSKEFLGGQYVANTFKVVIQLG
SILAVVVVMKDRFLDLLGLKKRSFKIGQKSTGHLRLTHIIVGILPAGILGVLFEDIIDEV
LFGYQYVVYALIAGAILMIFADKFRAKRPAAETVDQITYKQALLIGLFQCLSLWPGFSRS
GATISGGVLMGLSHRAAADFTFIMAVPIMAGASLISLVKNWQYFSIDALPFFIAGFISAF
IFALISIRFFLKLIDRIKLVPFAIYRIILAVLLLFLV
>A0A0J8IRZ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTINLLIAFLPAVVLGVIFADMIHHYLFNPITVATALV
VGGIIMLWAERRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWIDWAVAKA
>A0A117MWQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPISSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAIFSV
VVYFWKDISPFVKTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNVLIVAIT
LIAYGVIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIIVIVLLY
>A0A0B1R237|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLEEQAIRKVSVVIPVFNEEESLPELVRRTDAACAELNLEYEILLVDDGSSDRSGEMIAD
AADMPGSHVVGVLLNRNYGQHSAIMAGFNHVSGDLIITLDADLQNPPEEIPNLVRAAQQG
YDVVGTVRQNRQDSWFRRRASRTINQLIQKVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARRTIELPVAHAEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSIVG
SLIALAGFAFSLVLIVLRLFLGADWAGDGVFMLFAVLFIFVGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVINSQKDASSVQEIEQ
>Q6KB06|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYKGKPYY
FTWGKADIANNHPVTQHTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMAHWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>A0A0Q3W026|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLPDWLIGLIMGMVEGLTEFLPVSSTGHMILVADLLNFTGEKASFFEVIVQLGSILAVVV
VFWKRLWSVLGVKSDGYRKTNLNLIHIIIGAIPAGIVGLIFHDFIKDVLFSPKTVVIGLV
AGGILLIVAEKVSKQPKSSDLDHISYKQAFIIGCFQMLALWPGFSRSGSTIAGGLLFGLD
RKTSAEFTFILAVPMMIAASGLDLIKNIDILSASDLPLFATGFITAFVVALLAIVSFLKL
LEKVKLTGFAVYRFIVAIVFTIVFIF
>A0A0Q5IK31|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
KLWSLATGLGERANRDYVLKIGVAFMVTAVVGLIVRKAGWQLPETVHPVAWALLIGGLWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGSENWTDVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRIVLGAALLLWLPAAA
>A0A0L8M979|FEATURES|UNIPROT_deepARG|aminoglycoside|ADK74_11615|antibiotic inactivation|1
MSDHPGPRTVSPVQLGAGDGGGWLSVTAGESGAAVFRSADAARYAKCVPATDSAGLKDER
DRVAWLSERGVAGPRVLDWHSGDAGACLVTSAVPGVPADQVSVADLRDSWGRIADAVREL
HEVPVWQCPFRRDLDAMVAVARDVVTRAAVNPEFLPVEQQHTPATELLARLTPQVARRRD
QEAADTVVCHGDLCLPNIVLDPQTLNVSGFIDLGRLGLADRHADLALLLANARETWPDEE
RARAADVAFAERYGIALDHDRLRFYLHLDPLTWG
>J8MWY2|FEATURES|UNIPROT_deepARG|beta_lactam|IKG_05810|antibiotic inactivation|1
MVQKNKKELDWLKPVNVVTTAAILATTLFTPIVDVLPGKYNIVHAAETQSPAKYGVIDTS
NNWKGIYSDHIWPHVTENMGTYNRYRLGTPTNGMTTNMVNFKIDYPLVAVEAKLRSNADR
YIEFHWARYDFVKGTWGLQDSTAFISPDAPKPKVGEWGIWKVTYDQTTKKNTYYLNGKMV
GYRNYQDGTLGNANYLFRAEGFEKSYVDVESIYTSNSATNFVLAPKVNGVTDVQTKLTGS
GSPGAAVTIESNVMPGKYTGTVDGNGNFSIDIPKQKAGTELTVTQALDGSTSEKTVVTVK
DGTAPDAPKVNPVTSQDTKITGTGEKGAKATVKIGNGEYEGTVDEKGNYAIDIPEQPVGT
ELSVTLTDAAGNTSQPTKINVGEKDTTAPDAPKVNKVTDQDTKVTGTGEKGSKVSVVVDG
KEIGMGKVDDQGNYTVDIPKQAGGKEIVVTLTDAAGNTSQPTKTKVETKDVTAPDAPKVN
PVTDQDTKVTGMGEKGATVKVVVDGKEIGTGKVDDQGNYTVDIPKQPVGKEVVVTLIDTA
GNTSQPTVTKVKIDSATQEKAVKEAKYAIDHLFTNSSRSKFNHDFTTVKKGAIQIHVTEQ
HIAEAMEKLRKIPDDYKEKPAFQKEIERAQSLVEDREKMQEGNLVQNGLFDSGLNKWKPW
LGTGATTPTVKTDDDKSKNVIKLDPNSSVEQVLTGLEPNTTYELTAYARAEDNEKFSVGT
KKTGTANVTVPIYSKEYSQAHLTFKTGPNSTTATIYLYKNGGTKSGYADFVITKKVMGET
EQTHQKFSQLEKEFDAKLGIYALDTSTNQTVIYNPNERFAYASTHKALAVGVLLQKKSIE
DLDQRIMYTDKDLVNYNPITEKHIDRGMTLKELADASLRYSDNTAQNLIFKQIGGPDGFK
KALQEIGDTVTNPQRIEPELNDVNPGETPDTSTPKALAASLQTFILGDVLPTEKRNLLID
WMKRNTTGDKLIRAGVPKGWEVADKTGAASYGTRNDIAVIWPPNKKPIVLAILSNRDKKE
AKYNDQLIAEATKIALDSLKINNK
>R2RBB4|FEATURES|UNIPROT_deepARG|chloramphenicol|UAK_02230|antibiotic inactivation|1
MFNIINVEKWNRAEVFHHYLAQQTTFSLTKEIDITLLHVYLKKKEHSFYVGFIYLMTAIA
NQEIHFRMSFNSQGQLGYWDKLSPLYTIFDKETHQFSTLATEYSPDFGTFKQRYLADLAA
FSNTGKLFPQKSIPENVINLSMIPWTSFTGFNLNVNNGGNYLLPIVTAGKFIPRENKLFL
PVSLQVHHAVCDGYHAAQFLNRFEEMAALPQKYFEE
>A0A133KFD5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFLHLWNLFVAAILGLVEGLTEFAPVSSTGHMIIVDDLILKSNHLYGTEAANVFKVVIQ
LGSIMAMVVVFWDRFLNLLGLKKNITREQMYGERLRLTHVITGLVPAAVLGFLFEDYIDA
HLFSVNTVLVALVVGAILMIVADLTRPRRPKTETVDQITYRQAFVVGLFQCLALWPGFSR
SGSTISGGVLLGMSHRAAADFTFIMAVPIMFGASFLSLVKHWGAVTPETIPFFITGFISA
FIFALIAIKFFLALINKVKLVPFAIYRILLAIVLLLLIWNR
>A0A074HTR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAGYVVFF
>A0A0L8LT56|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPRRAASFEQIPVSDAGAGPYALAVGPDDALWCTLVHAGQIARLTPDGHLDRYPLDSASC
GPSLVTPGPDGALWFTRSRDHRIGRITVTGEATSFPLPTPDSGPFGMVSASDGALWFTQL
HTDRIGRITTDGRVTEFPLPLSGAFPSALTTGPDDALWFTLNQAHAIGRLSLAGDFTLHP
LPTANAAPVGITCGADGALWFVEIGAGRIGRITTDGQIAEFPLPDPASRPHAIVAGPAGD
CWFTEWGANRIGSITPDGRIEEYDLPTPSSEPHGLAFGSDGALYVALEIGAIARLALQGP
LS
>G8A3U3|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGGQATMDERNRQIAEIGASLIKHW
>A0A0Q0AES3|FEATURES|UNIPROT_deepARG|polymyxin|ALO63_02771|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTRADDAKEKTFFGPVAQLCARHGIPAHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDPLLACAKKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAAGLLSETLP
LLALGQLSGTPQDETLASCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGVQLAREFG
LVEGSQLLDKEKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYYIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKLVIFPSTSEVYGMCQDASFKEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDISHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>A0A061P0M7|FEATURES|UNIPROT_deepARG|aminoglycoside|JCM19038_3715|antibiotic inactivation|1
MSRFSNVEIPKEAYDAFTVVKEVIGHGIIAVSLYGSAASGGLRKNSDVDVLVVVREALSE
KTRQVLTEQLVRISGEIGNEEGKRYLELNVIQKTQGTQFQYPPRSEFMYGEWLRQEFEAG
LIPEPMYDPDLAIVLAQAREDGVSLFGPELSTILEPIPKEDIKKAILDSLPSLVEKPEGD
ERNVLLTLARMWRTLEDGTILSKDIAAQWAIPRLSKEHGAILDLARRAYLDQLNDHWDDK
QTEVKSLIHQLVRIIEGYR
>M9G1G0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A031J1T4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLNTGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVTIERSDTGLTLHAKLREAASNLLRDVLP
QLAEGKLTETAQDESQATYFGRRTAADGKLDWKHPAETLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKR
>W4BFS8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDVMKAIILGIIEGLTEFLPVSSTGHLILAGHLLSFEGQTAITFKIVIQLGAVMAVLLL
YWKRYLAIGANLIRMDFSPSKGLNVIHMMLAMLPALILYLLFKDTIKSQLFGPIPVLIGL
VAGGLLMIIAARSRRTETAETMDRIHYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASVLDLYDSRELLDSDDLFLMAIGFMTSFLVAMIAVVTFIK
LIKRLRLEWFALYRFVLAGLFYLIVLQ
>A0A0R2JSV4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIELLKSFIVGIVEGITEFLPISSTGHIIIADALMGIPGGNVWTPAFTHMYEYVIQLGAI
MAVLQLYFTKLNPFAPSKTALEKQQTWSLWSKVIVGVLPSAVIGLALNDYMQDNVWVVAT
MLIVYGILFIVIENYLSDKQPRFTDLNAMSYKLALFIGFFQVLAIIPGTSRSGATILGAL
LLGTSRFVATEFSFFMSIPMMFGIAFLKLTDYFLKGGSFTAIQSGVLVVGFIVSWIVAYI
AIKFLLDYVKKNDFKAFGYYRIVVGILVIALILMGVINA
>A0A0R3A829|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLDAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWVERIAKLNPDFIFSFYYRNLLSEPLLATARHGAFNLHGSLLPKYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAILAQQKVSIERNDTGLSLHAKLREAAGNLLRDALP
QLAQGKLSETAQDESQATCFGRRTAADGKIDWKKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLVVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNDNGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNENGVCDGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKK
>A0A0K9M5C9|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIAIKVGDILPQLQGLNHLLFSVSDLEKSFCFYRDVLHAKPLVRGRKLAYFDLNGYWLAL
NEEPDIPRNEIAHSYTHMAFTITEESFDEWYAHLEKHGVTILHGRDRSERDKRSIYFTDP
DGHKFELHTGTLQDRLAYYRDEKHHMTFFE
>A0A127SEV3|FEATURES|UNIPROT_deepARG|beta_lactam|BL2c_pse3|antibiotic inactivation|1
MDTGILTREVAQEESTLQARIGVAVIDTGSGLIWQHRGEERFPLNSTHKAFACAAVLAQA
DNNKVSMDMPIPINRDALVTYSPVTGKVPSGGSQSLRELCRAAVSVSDNTAANLALNAIG
GPPSFTTFMRSMGDNETHLDRLEPELNEANPGDARDSTTPLAAARSLQKLLLGDVLSTTA
RTELTQWMLDDQVADTLLRAGIPKDWRIADKSGAGGHGSRSIIAVIWPPERSAVVIAIYI
TQTTASMSASNQAVSRIGSALAKAMP
>A0A0R1J0J7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFIKLNESTAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNHREKNQTWSIWFKVLVAIIPSVVIGLPLNDWMDAHLTSWQVISA
TLLIYGILFIVVENWLKNKRPQVEDLDQLSYKTAFTIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIGKYFMKGNTFTGDQTIILLVGTLVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIVLAIIVIAYFGIKSFV
>H5XNJ8|FEATURES|UNIPROT_deepARG|aminoglycoside|SaccyDRAFT_2173|antibiotic inactivation|1
MSEPPETLTVSPVLLGVGGGDWLPVTTGESGAAVFRSADATRYAKCVPAADAASLKAERD
RITWLNGQDVPGPQVLDWHSGDVGACLVTSSVSGVPADQVSAEDLRAAWERIADTVRRLH
EVPVSQCPFRRDLDAMVAVARDVVARDAVNPDFLPVEQQNTPTAELLEHLTRQVPRRREQ
EGADTVVCHGDLCLPNIILDPQTLNVSGFIDLGRLGLADRYADLALLLTNARETWMDEER
ARAADLIFAERYGIALDHDRLRFYLHLDPLTWG
>ZP_03915077|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MEENHMKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGIT
IQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHA
LRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQW
DTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVIT
NKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMY
TSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKP
EQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTEL
LEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTF
FTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0Z8J355|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGAILLVYAFITFLF
>A0A0R5RPZ5|FEATURES|UNIPROT_deepARG|beta_lactam|ROB-1|antibiotic inactivation|1
MLNKLKIGTLLLLTLTACLPNSVLSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQAR
IGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYS
PETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLE
PDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATP
TSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFH
TLQLN
>A0A0W0B2L5|FEATURES|UNIPROT_deepARG|beta_lactam|VO70_16610|antibiotic inactivation|1
MKGWIKCGLAGALVLVASIWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVHAFYTGPAHTPDGIFV
YFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPELI
DHYQSLIKAAPQA
>C4GHK3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGTGENRVHVLKDINLTIEKGDFVAIIGQSGSGKSTLMNILGLLDTPT
SGTYRIAGTETSKMSADELAAMRRKRFGFIFQRYNLLSSLTARDNVALPSVYAGIGYAER
SQRADMLLDKLGLQGKEKNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDSHSGE
NVMEIIHQLYNDGHTIIMVTHDPKIAAQANRVIEIRDGEIIADSSKSEEIHPSNVQAIQE
KRGLAFYKDQFNEACKMSVQAIVAHKMRSLLTMLGIIIGIAAVVSVVALGNGTQEKILKD
ISSMGTNMISIFPGKGFGDRRSGKVKTLTVADSQAIAGLSYVESTTPGSYSSGTLTYKNI
DLTASVAGVGEQYFDVRGEKIGLGRLFNAEDVKDNAQVVVIDENTQKKLFPNGENPLGKV
VLLKKRPLTVIGVLKKDDNQFEAPSDSLQIYTPYTTLMSQISGNKYISNITVKVKPDVDT
QTAEKGITELLRARHGTEDFFTQNSDSIKKMVEKTTGTMALLISSIAVISLVVGGIGVMN
IMLVSVTERTKEIGVRMAIGARQNSILQQFLIEAILLCLIGGLAGVLISFGLASLFNSVV
TDFAMSFSTASIIGAVLCSSAIGVLFGYMPAKNASKLNPIDALAHD
>CAI43343|FEATURES|ARDB_deepARG|chloramphenicol|cmlA4|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTVQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLAFTSLAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVTGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLI
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFIAPMWLVGIGVATAVSVAPNGALQGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRAEGSRGQGEHDVVALQSAESTSNPNR
>YP_002886367|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEWYELFVGFLLGVVEGLTEFAPVSSTGHMILVDGLWLNSSQFLGQEVANTFKIVIQLGS
ILAVVVVFRDRFKTLLNPKSLLTLRQSGTARQFNLVHILIGLLPAGVLGVLFEDYIDTHL
FSVKTVLIGLVVGAFFMIAADLSGVKRQTTATLDDITYKQALGVGLIQCFSLWPGFSRSG
STISGGVLLGMSHRAAADFTFIMAVPIMFGASALSLYSKWTYFTLDTLPVFVVGFISAFL
FALLSIKFFLKLINKVKLMPFAIYRIVLAVVIYVLYF
>C8C0J9|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-85|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPPMDSGR
>A0A0T9T7L7|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MSQNERIKKVSIVIPVYNEQESLQVLIERTSAACKLLTQPYEIILVDDGSSDNSAELLTA
AANEPGSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVNVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLVTCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGAEPTEDNQETEK
>ZP_03072121|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALAEKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSAIILQRASR
>A0A0E1LM19|FEATURES|UNIPROT_deepARG|beta_lactam|OY17_09145|antibiotic inactivation|1
MKNKAGIQVGICIGLLCLSFTGFNPLFGSAHAEAKSIEDTKMTSCITNQKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTY
SPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTTDKRTILTDWMQGNATGDELIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAEAAKVAL
NALK
>NP_815952|FEATURES|ARDB_deepARG|glycopeptide|vanHB|antibiotic target alteration|1
MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEV
SEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAI
RGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSR
KIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQRQIGEMKQGAFLINTGRGALVDTGS
LVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTER
VLRDTTEKTIRNCLNFERSLQHE
>A0A0C6FQP8|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDVASIGKAVVLALVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAIVG
VYFRQLLDLLRRAPRDPSARRFILAILIAFLPAAIIGGLFSKYIKFYLFNPWIICSTLVA
GGLVLLVIDETEIEQKYDDVHQYSLPMALKIGFFQCLAMIPGVSRSGATIVGAMLMGSGK
RAATEFSFYLAMPTMAGAFAKDLLDNYKNLSKDDVGLIAIGFVVAFLSALFVVRKLLDYV
SRHGFALFAWWRILVGAAGFAGLIIFG
>A0A0A3XTH8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVV
LYFKKLWDVAIGMFTGDAYARRFVIGVLVAFLPAVIVGLVAGKYIKSLLFNPWVVCFSLI
VGGAILLWVDRLNLKAREHDATRFPLLMYLYIGIAQCIAMIPGVSRSGASIVAAMFLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKNRSEMTMDHMGVVAIGFVVSFITAIIVVKTFLSY
VTRHGFVLFAWWRVIVGTLGLIALALGH
>A0A0I9QQ02|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMESGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>P13249|FEATURES|ARDB_deepARG|puromycin|pac|antibiotic inactivation|0
MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRHIERVTELQELFLTRVGLD
IGKVWVADDGAAVAVWTTPESVEAGAVFAEIGPRMAELSGSRLAAQQQMEGLLAPHRPKE
PAWFLATVGVSPDHQGKGLGSAVVLPGVEAAERAGVPAFLETSAPRNLPFYERLGFTVTA
DVEVPEGPRTWCMTRKPGA
>YP_371055|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVNANAPEKSAAPLPEVDVATVVPQTVTDW
QSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGTLVKKGDVLFVIDPRPYQAETDRAAAQLA
AAQARNGYAQTDWQRAQRLIGDNAIAKRDYDEKQNAAREATANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYINGARN
GRKVPVELGLANETGYSRSGEIDSVDNRLDTSSGTIRVRARFDNADGALVPGLYARVKVG
GSAPHEALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQQGMQHGNRRVIVSGLSAGDRV
VVNGTQRVRPGEQVKPHMVPMTGGDAPSAPLADNAKPAAPAKADS
>ZP_02865688|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGIDFLFILKALIIAIVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
ILAVVVLYWRKISSSVVEFLCYIFSFIGLKASNDKRKYEKRLAESKTGFRFGINVIIATI
PAAILGFLFDDEINKYLFSTKTVAVGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYG
QSLLVGCFQCLSLWPGMSRSASTIMGGWISGLSTTVATEFTFFLGIPVMVGASGLKLFKF
DYSQMDGTYLIALILGFIVAFIVSLVVIDKFINYLKKKPMRVFAIYRVFAGIVLAILIFT
KVIS
>CAS11958|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQASDTLRRTEPLLREGFVSAEEVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETELKNIRSGTPATIRLMSNSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVEKPDPEMFRIGASAVANLEPQ
>G0EL70|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MFNKIDLNNYNRKEHYEMYMNNIPCTYSITVPLNITKFKKAVKDKNIKFYASVIYLISKV
VNKYKEFKMVLNDNKELGYYDIINPSYTIFHNDTKTFSSIHTEYNEKFDLFYKNYISDME
TYGENKTFLAKPCDIKNIFNISSLPLSTFTSFNLNLPNSFEYLAPIFTIGKYYTDDKNNI
IMPLALQIHHSVCDGYHVGIFFEDLQHEFDEFDLLY
>ACN65732|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRHKNFNLLLMLVLLVAVGQMAQTIYIPAIADMAVALNVREGAVQSVMAAYLLTYGISQ
LFYGPLSDRVGRRPVILVGMSIFMLATLVAITTHSLPVLIASSAMQGMGTGVGGVMARTL
PRDLYEGAQLRHANSLLNMGILVSPLIAPLLGGILDTLWSWRACYAFLLVLCAGVTFSMA
KWMPETRPEGAPRTKLPASYKTLFGTGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMAVSILFILPIPAAFFGAWFAGRPNKRFPTLMWQSVICCLLAGLMMWIPGLLGIMTVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMMPQT
GQGSLGLLMMLMGLLILLCWLPLASRFTHHQQPV
>L7HM65|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSAGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEALLATAKNGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVTIDRSDTGLTLHAKLRDAATSLLRDALP
QLVQGKLTETAQDESQATCFGRRTAADGKLDWKKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVIQGNEGLAPGRVISVNPLRIACGQDSLVIKFGQRNATGLYLAGPSLADELG
LVDGSVLRGAESGSKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGNGYQDVAHRKPSIDNAKRLLNWTPTVEMSETIGNTLDFFLREAMLEIA
QSNEAAK
>A7Y409|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSTNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A121QEP7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIGFHSNHKVFEIAIQLGAILAVVF
EYRQRFSNVLHGLGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEHLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIADVDALRPIDALMIGVAQVFALVPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFIAAFVSGLVAVKALLK
FVSKKNYIPFAYYRIVFGIVIIILWLSGWISWE
>F2ZCT2|FEATURES|UNIPROT_deepARG|polymyxin|POR16_00582|antibiotic target alteration|0
MGCAGLQALLDAGYEIAAVYTHADDPDENTFFGSVARLCARHGITVHAPEDPNHPLWVER
VAKLAPDFIFSFYYRQLLGEPLLACAKKGAFNLHGSLLPHYRGRAPANWVLVNGETETGV
TLHQMVKRADAGPVFAQQRVPISATDTALTLHGKLREAATDLLSETLPLLAQDRLSGTPQ
DESRATCFGKRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCAVGDNKLIIWAADLELR
NDGEAPGTVISHDPLRIACGEGSLVIRAGQRGDAGLYLSGAQLAREFGLVEGSQLLDTQK
RRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLRTQPNFHFIEGDI
SIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRYCVKYNKRVIF
PSTSEVYGMCQDESFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQKGLQFTLFRP
FNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVADGIEALARI
IENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFAGFRDVESQSFYG
KGYQDVSHRKPSIANARQLIGWTPGIELSTTIGKTLDFFLREAMIEKADQR
>G8A3R7|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATTEERNRQIAEIGASLIKHW
>S6IHQ1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQIARSILAGTFFLVCGTPAGFAQERIEDTVNAVIQPLMKQQDIAGMAVAVTYNGQRHYF
NYGVASKDTKKPVTDQTLFEIGSVSKTFTATLGAYAQALGKLSLADPASRFAPELRGSAF
DGISLLNLATYTAGGLPLQFPDEADHPDRMFGYYTTWKPLYPVGTQRLYSNPSIGLYGYL
AARSLGRPFDEVMERTLMPGLGLKHSYVRVPQDQLGRYAQGYAKDGKPVRVGPGALDSEA
YGVKTSSSDLMRFLEANLRPEKLDADLKQAIATTHTGFYKVGGMNQGLGWEFYPAPFTLD
DLLAGNTPQMALTPQKAEALNPPRPAPDGAWINKTGSTNGFGAYAAFVPGKDLGIVMLAN
RNYPIEERVKAAHRILMALDAQ
>A0A0K2ZRZ8|FEATURES|UNIPROT_deepARG|aminoglycoside|XTALMG727_1576|antibiotic inactivation|1
MSDGYSIRAAVAADLRAWAALRVALWPDESDAFGGVVEALQREDAANFLAFAGDGHAIGF
ADVTLRQDYVNGTDSSPVGFLEGWYVMPEWRGRGVGRALLRQVQDWTRAQGCSELASDAL
LDDAAAQAAHRACGFEESERVVYFRMPVAD
>D7BBZ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTAFEALVLGVIEGLTEFLPVSSTGHLTLAAHLLKIPVESDNFAKSFLIVIQLGAILAVL
SLYLKRFLRDFEVWKRIVVAFIPTGIIGFGLYRVIKDHILGNDLIVVVALVGVGVVLLLV
DRWLQGHQRYDNVDQMPLGRALLIGTFQGLAAIFPGTSRSAATIVGGMLSGLSRRAAAEF
SFILAVPTMLAASGYDLYKSANTFPHEGYGLMAIGFVAAFITALLTVRWLLEFVSRNTFV
PFAIYRILIGVVYAMFFLR
>YP_001478290|FEATURES|ARDB_deepARG|quinolone|QnrB|antibiotic target protection|1
MTLKLDGEKIARNRFTGEKIENGSFINCDFSGTDLTGTEFIDCQFYDRESQQGGNFSRAL
LKDASFKNCDLSMADFRNASALGIEIRECRAQGADFRGTSFMNMITPRTWFCSAYITKSN
LSYANFSKVVLEKCELWENRWNSAQILGATFSGSDLSGGEFASFDWRAANFTHCDLTNSE
LGELDLRSTDLQGVKLDSYQVFQMMERLGIAVIG
>M1LVR0|FEATURES|UNIPROT_deepARG|chloramphenicol|catB|antibiotic inactivation|1
MNFNLIDINHWSRKPYFEHYLNTVKCTYSMTANIEITDLLYEIKLKNIKFYPTLIYMIAT
VVNNHKEFRICFDHKGSLGYWDSMNPSYTIFYKENETFSSIWTEYNESFLRFYSDYIDDI
KNYGNIMKFTPKSNEPDNIFPVSSIPWVSFTGFNLNVYNEGTYLIPIFTAGKYFKQENKI
FIPISIQVHHAVCDGYHASRFINEMQELAFSFQEWLENK
>A0A0R3DB13|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFGLGEGAFWDSFTVLIQLGAILAIVG
LYFKKLWDVAIGMFTGDAYARRFVIGVLVAFLPAVVVGLVAGKYIKSVLFNPWVVCFTLI
VGGAILLWVDRLDLKPREHDATKFPLLMYLYIGIAQCVAMIPGVSRSGASIVAAMLLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKNRSEMTMDHMGIVAIGFVVSFITAIIVVKSFLEY
VTRHGFVVFAWWRVIVGTLGLIALALGR
>A0A0S1SDM6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLQAIILAIIEGITEYLPVSSTGHMIIASSFFGIAQDDFTKLFTIVIQLGTILSVVVL
YFKRFFQTLDFYYKLLVAFIPAVVFGLLLSDVIDSLLENPLTVAVSLVLGGFILLKVDDW
FGDAENTEISYRTAFRIGLFQCLAMIPGVSRSGASIVGGMTQKLSRTAAAEFSFFLALPT
MLGATLKKSYDYYDAGFTLTSDQVNYLIIGNVVGFLVALFAIKTFIGYLSKHGFKMFGYY
RIIVGFAILIIHFFIRPLTVI
>E5WQ45|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1013_04536|antibiotic inactivation|1
MRKQYHSVFSKNRLKAVRLVSLVLLLALTGCANGSYQSDVSAAENSKETSVNTKQKFKKL
EKEFDARLGVYAYDTGTKKTITYRSNERFAYASTFKPLAAAILLQRKSLEEMNEIITYTS
DDLVTYSPVTEKHVKTGMTLRELCEAAIRFSDNTAGNLILEELGGPEGFEAALKEMGDTV
TKPERFETDLNEAEPGDIRDTSTPEALAASLQKVLIGHFLSEEKRNILTEWMRGNVTGDP
LIRAGVPSGWEVADKSGAAGFGTRNDIAIVWPPNREPIIMTILSSRDSKDAEYDNALIAE
AAEMAIKALDDEA
>V8CI70|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVEQGNPFVHAFTFIIQFGAILSVVC
LYWKKFFSFTSDMWRLYKLLVIGVLPAVVVGLTAKKSGLLDWLLDSIWVVAITLVLGGIF
MLFCDNIFNKGREENEVTPKRAFLIGLFQCLSVIPGMSRSMSTIVGGMANKLTRKKAAEF
SFFLAVPTMAGATILDVYDMMKGDVKWATSDNLFLLGVGCVVSFAVAIFAMKWFVSFLTK
YGFKAFGWYRIIVGVILLAMLLSGMSLNMVD
>A0A0A2TZ80|FEATURES|UNIPROT_deepARG|chloramphenicol|P364_0117545|antibiotic inactivation|1
MNFNKIDIDNWNRKEIFNHYLNQQTTFSITTEIDISVLYQNIKQIGYKFYPSLIFLVTSV
INSNTAFRTGYNSEGDLGYWDKLDPLYTIFDSVSETFSGIWTTGKNDFKEFYDLYLSDVE
KYQGSGKLFPKTPIPEYTFSISILPWTSFTGFNLNINNNSNYLLPIITAGKYNKEGNSIY
LPLSLQVHHSVCDGYHTGLFMSSIQEFADRSNDWLL
>A0A098GA78|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKKIIALLCMGLLPCATTWAGDSCFLVKENQTVLKQEGENCNQRYTPQSTFKIALSLMGF
DSGILKDALHPEWPYKKEYELYLNVWKDPHNPRTWIRDSCVWYSQVLTQQLGMKRFKNYV
DVFHYGNQDVSGDKGKNNGLTHAWLSSSLAISPIEQIEFLQKIIDKKLPVSPKAFAMTKD
ILYIQELAGGWKLYGKTGSGRQPTKDKSKQSPLQHGWFVGWIEKDGRVITFASHLTDSKE
EATAASFRVRNDMLIKLFYLINDLEK
>A0A0S4I2Y9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLASGFEIAAVFTHADDPKENAFYGSVAQLCAQKGIPVHA
PEDANHPLWIERIAKLNPDYLFSFYYRNLLTEPLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQKVAIERSDTALTLHGKLRVAAADLLRDTLP
ALLQGKVTETAQDESKATVFGRRTAADGKLFWKKSAEELFNLVRAVTQPYPGAFCDVGEH
KLIVWSAEVAKGNEGQAPGRVISVDPLRIACGEDSLVITAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDQYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDNNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNENDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>E9TDS8|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9542_01934|antibiotic inactivation|1
APRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIY
QGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWP
ELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSS
IGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPG
ALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEML
DWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKEL
GIVMLANKNYPNPARVAAAWQILNALQ
>H4JAG8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQTGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGGISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLIDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0J7D281|FEATURES|UNIPROT_deepARG|beta_lactam|TU62_23900|antibiotic inactivation|1
MFVLNKFFTISHYKKIVPVVLLSCVTLIGCSNSNTSSESPKQTKQTNQIKQENTGNNSFA
KLEKEYDAKLGIYALDTGTNQTVAYHANDRFAFASTSKSLAAGALLLQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAIAKTLQSFTLGNALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADTTKVVLDTLKATNKK
>G0K147|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MADALLELHGVSRAYRSAAGEVVVLKEVSLRIDAGEFIAIIGPSGSGKSTLMNILGCLDR
PTEGSYRVNGEATEQMAPDALARLRREHFGFIFQRYNLMENLSATENVALPAVYAGVDAE
TRNARARTLLETLGLGERTGNRPSQLSGGQQQRVSIARSLMNGGAIVLADEPTGALDHAS
GQQVMAELKRLHAQGHTVILVTHDAAIAANAARVIEIADGRVVADRDEPGLRAATSGRAT
ERGASPVTERRARIDAVREAARMAVRSMLAHRLRTLLIMLGIIIGVAAVVTVVALGKGAQ
AQVESQINELGASTLEIFPGADFGDPRSAEIETLVVGDADHLAALSYVDSVSPNLSGAVA
ALQGNRRANTQVLGVGADMPRVRGLRLKAGRFFTDAEVDAHRAVAVVDQKAAKTLFSGNP
IGSTVLLGGMPVEVIGVVGANAFAGGATPTVYVPYTSAASRLLGSQRLESITVRVRDNVP
TNAAEASLGAELERLHGRRDFFIYNADQIRKAVMKSSQTMAALVSAIAAVALVVGGVGVM
NIMLVSVKERVREIGVRLAVGARQGDILRQFLIEAVLICLFGGVLGVLFAFGVAALSSLL
SLGVPFLFTAGPVLAALACSSAIGLGFGYFPARSAAQLDPIQALAAE
>J3H6M3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLCSGFEIAAVFTHADDPKENAFYGSVAQLCARHGIAVHA
PEDANHPLWIERIAKLDPDYIFSFYYRNLLGEPLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIVAQQKVAIERSDTALSLHAKLRTAASDLLRDTLP
ALLQGKASETPQDESRATVFGRRTPADGKLVWAKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGLAPGCVISVDPLRIACGQDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLSDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDPNFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A0A2YK73|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
SSGSYQIAGKETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKAQ
RLQRAAQLLEKLGLGNKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMQILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDQRQSLQITAHKMTQTA
TNQGWQFYRDQFFEALNMSINAIIAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
NAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIDNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
AAEKNVTALLLSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGIRMAIGAKQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMS
EFTMLFSTFSIVVAVLCSTLIGIIFGYVPAKNAAKLNPITALSQE
>BAA08269|FEATURES|ARDB_deepARG|tetracycline|tetC|antibiotic efflux|1
MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCA
PVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYI
ADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFL
MQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDR
FRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRG
WMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSITGPLIVTAIYA
ASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST
>A0A150KZD5|FEATURES|UNIPROT_deepARG|chloramphenicol|B4144_1796|antibiotic inactivation|1
MNFHQIDIDRWNRKPYFEHYIKEGKCSYSVTANLNVTALLNGLRKKNMKLYPAFIYMISR
VVNSHIEFRTAFNDKGQLGYWEQMVPTYTIFHKEDKTFSAMWTEYSSDFSLFYKNYLQDI
DRYGDKKGLWVKENVPAHTFSISALPWVSFTGFQLNLYNGEYLLPIITLGKYFSDGEAVC
LPISLQVHHAVCDGYHVSMFINELQKLADSFEEWL
>R2Q0T9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLINIFKAIILGIVEGITEWLPISSTGHLILVDEFIKMDVSPAFTEMFNVVIQLGAILAV
VVLYFDKLNPFSGKKNQVEKSETWTLWSKVVVACIPAAVLGLLLDDFLDAHFHKFLPVAI
MLIVYGIAFIVVERHNKTKTPKCTSLNDFTYKAALIVGFFQVLSLVPGTSRSGATILGAI
LIGSSRFVATEFSFFLGIPVMFGASGLKIVKFLMNGNSFDFAQITILLVGMATAFVVSIV
AIKFLLDYIKRNDFTVFGWYRIILGIILIGYWLIAM
>A0A142GNM6|FEATURES|UNIPROT_deepARG|beta_lactam|AXW78_12100|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFSQLEK
KFNARLGVYVIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
KVIVKALR
>Q87K03|FEATURES|UNIPROT_deepARG|quinolone|VPA0095|antibiotic target protection|1
MLKTDLIFERENFSHHDFQNATFKNCHFYMCSFDHADLRDAKFIDCRFIESKALEGCSFR
FANLKDASFTNCMLAMSLFNGANCMGLELRKCDLKGANFQGANFANRVSNTMFFCSAFIT
GCNLTYCNFERVLLEKCDLFENRWNGANLAGATLKGSDLSRCEFSPEQWGTFNVEQCDLT
HVELDGLDIRRVSLFGVKICDWQQEQLLAPFGLIIL
>A0A0K9MCT4|FEATURES|UNIPROT_deepARG|beta_lactam|AC624_15330|antibiotic inactivation|1
MKVHTSRLFGFTVKTIFLTLLTLAGCSSAETPVEKTETSASAMDIKFAALENQFGARLGV
YAIDTETDLAVAYREDERFAFASTYKALAAGAVLHQKPLEELDKVITYTKDDLVTYSPIT
EKHVATGMNLREVADAAVRYSDNTAGNLLFKELGGPKGFESALRQMGDSVTTSERYETEL
NEAKPEDTRDTSTPKALATSLRAYTVGNALSSDKQKILIEWLQGNTTGAKLIRAGVPKDW
IVGDKTGAASYGTRNDIGIIWPPNKKPIVIAVLSSRDKQDATYDDALIAEATKIAVDALT
AAKP
>R8K5M8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVIAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVDDIPMFAAGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0Q8K7E0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTFVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVILLVVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLTSADLPIIAIGFVAAFVTALFVVRFLLDY
VSRNGYSLFGWWRLVVGIVGLLALMVWG
>A0A127I262|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLNTGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVVIDRTDTGLTLHAKLREAASNLLRDALP
QLAQGKLAETAQDESQATYFGRRTAADGKLEWKKPAEELFDLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKK
>A0A0X8CCS2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVG
LYFRKLWDVVIGFFSGDADARRFVIGVLVAFLPAVIVGLAAGKYIKLLLFNPWVICFTLI
VGGAILLWVDKLELKPREHDATKFPLLMYLYIGIAQCVAMIPGVSRSGASIVAAMLLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKSRAEMTMDNMNIVAIGFVVSFITAIIVVKTFLTY
VTRHGFLLFAWWRVIVGTLGLIALALGH
>ZP_03066488|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVILAQFGVSAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAASVVINAL
MRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAMIF
FLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVYIE
INHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWMAAWMVISALLGLGF
WSLVVGVAAFVGCVSMVSSNAMAGILDEFPHMAGTASSLAGTFRFGIGAIVGALLSLATF
NSAWPMIWSIAFCATSSILFCLYASRPKKR
>A0A070UX71|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTFPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>YP_080399|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MNIWDIIVAIILGIVEGLTEYAPVSSTGHMIIVDDVWLKSKELLTPEAANTFKVVIQLGS
ILAVAFVFKDRILNLLGMKKNITEEQKSGNRLSIAQIAVGLVPAAVLGFLFEDYIDQYLF
SVRTVAVGLIAGAVLMLAADWINRRKDTTDSVDRMTYKQALGMGLFQCLALWPGFSRSGS
TISGGVILGLSHRAAADFTFIMAIPIMMGASLLSLIKNWAYLSADLLPFFIAGFISAFIV
ALFVVRFFLRLINKIKLVPFAIYRIVLGLLLFILFL
>A0A0R2ZBP2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSQPLLELKGITRSFMAGEREFIALKGIDLTIQAGEMVAIIGASGSGKSTLMNILGGLDY
ATAGSYTINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPET
QRHSRARELLTRLGLAGHTSHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIVSDKANASVGLELPVETS
IESRRSGARRLVASLGLFKEAFNMAWVALVSHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDLDAQVNGVSERYFKVKGLKLEAGIAFSENDARRQAQVVVIDHNTRQRLFGAH
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKSLNVWVPYETAAGRVLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQNTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGIIGISLSYAIGY
LFSLFVKEWEMVFSVGSVVTAFACSTLIGIVFGFVPARNAARLDPIEALARD
>A0A060AES7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLIGFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQRNAQRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVHAETVDEITWKDALKVGVAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWTAVKP
>R1H049|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTEYYTLFVAFVLGVVEGLTEFLPVSSTGHLIIVGHLLGFEGPKAATFEVVIQLGSILAV
VVVFWRRLFGLIGIHFGQKPSQDHATLSLVHIILGMLPAVVIGLAIHSWIKANLFGPQTV
MYALVAGGILLLIAEWKRPAVRSETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMIAASGLDLYKSRDFLSMADFPMFAVGFVTAFVVAMFAIR
TFLALIRRLDFVPFAIYRFVIAFAVYMVFVH
>A0A0M1P4W0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDVVKAIILGIIEGLTEFLPVSSTGHLILAGDLLNFDGEAAITFKIVIQLGAVMAVLIL
YWKRYMEIGANLVRMDFAQSKGLNVIHMILAMLPALILYLLLKDTIKSQLFGPAPVLIGL
IAGGLLMILAARSKRTKTADTMDDMNYRQALGIGLFQCLALWPGFSRSGTTISAGLLLGA
SQKAAADFTFLISVPVMFGASLLDLYDSRNLLNADDLILMVIGFITSFLVALIAVATFIK
LIKRLRLEWFALYRFALAAIFYFIVIR
>CAD55935|FEATURES|ARDB_deepARG|beta_lactam|IMP-13|antibiotic inactivation|1
MKKLFVLCVCFFCSITAAGAALPDLKIEKLEEGVFVHTSFEEVNGWGVVTKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYEIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKSGKVQAKYSFSGVSYWLVKNKIEVFYPGPGHTQDNLVVWLPESEILFGGCFIKP
HGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEKGDASLMKRTWEQALKGLKESKK
TSSPSN
>V7FXG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLVVDRMKLQPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFVAAFVTALIVVRFLLDY
VSRNGYSLFGWWRLVVGTVGLVALMIWG
>CAL12097|FEATURES|ARDB_deepARG|beta_lactam|y56|antibiotic inactivation|1
MKHSSLRRSLLLAGITLPLVNFALPTWAAAIPGSLDKQLAALEHSANGRLGIAMINSGAG
TKILYRGAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITRKNLAC
GMTVSELCAATIQYSDNTAANLLIKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPN
DPRDTTTPAAMAASMNKLVLGDALRPAQRSQLAAWLKGNTTGDATIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATQIILSQIS
>A0A0K0HVY8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSNSEVNKSTDNTIKKVSVVIPVFNEQESLPILIKRTHAACELLNKPYEIILIDDGSHDA
SAEILTQAAEIPENHIVAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRL
VETAEQGYDVVGTVRAKRKDTWFRKTASKMINMMIQKATGKSMGDYGCMLRAYRRPIIEA
MLHCHERSTFIPILANTFARRTIEIDVRHDEREFGESKYSFLKLINLMYDLVTCLTTTPL
RLLSIVGSVIALSGFTLAVLLIAMRLIFGPTWAAEGVFTLFAVLFTFIGAQFVGLGLLGE
YIGRIYNDVRARPRYFVQKIVSADALKTHESVEQQEEE
>R6Q334|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALIEFDEVCKYYQMGDTTVKAADHISMKIEKGEFVAIVGQSGSGKSTCMNIIGCLDVP
TQGTYLLNGRDVGKMNRNELAAIRNEMLGFIFQQYNLLPKLNLMENVEVPLVYAGVSRAE
RHKRAKEVLEKVGLGDKLKNKPNQLSGGQQQRVSIARALVRNPPVILADEPTGALDSHTG
REVLGMLQELHNEGHTVVLITHDNSIAVQAERIIRLEDGRVVYDGDSHAPEAVVQPTLLP
EQESQTEEAQA
>YP_001908403|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIIMLAGALSILKLPIEQYPNVAPPAIEITAAYPGADAKTLQDS
VTQVIEQNMNGIDGLMYMSSSSDSSGALQLTLTFESGTNADIAQVQVQNKLQLATPLLPQ
EVQQQGIKVQKSSSSFLMVAGFINDNDTMTQNDIADYVGSNIKDPISRVTGVGDTQLFGA
QYAMRIWMDPHKLNNYQLTPVDVISAINTQNAQVAAGQLGGSPPVKGQQLNASIIAQTRL
TSPEEFGKILLKVNTDGSRVRLSDVAHIELGGENYEIIARFNGKPASGLGIKLATGANAL
DTASAVKAELSKLEPFFPSGLKVVYPYDTTPFVKISINEVVKTLVEAIVLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAIINTFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMDQIQGALVGIALVLSAVFIPMAFFGGSTGVIYRQFSITIVSAMVL
SVIVALVLTPALCATMLKPIAKGEHGKTTGFFGWFNRMFDKSTHHYTDSVGHIVRSTGRY
LLIYLLIVVGMAFLFLRLPSSFLPEEDQGVFLTMAQLPAGATQERTEKVLDQVTDYYLNN
EKANVNSVFTVNGFGFAGRGQNTGIAFISLKPWDERPGAENKVPAIAGRAMTALSAIKDA
MVIPFNLPAIVELGTATGFDFQLVDQGGLGHEKLTAARNQLLGMIAQHPDTLVGVRPNGL
EDTPQFKLSIDQEKAQALGVSLSNINTTLAAAWGGSYVNDFIDRGRVKKVYVMAAAPYRM
LPDDIGNWYVRATNGEMVSFNAFSSAQWVYGSPRLERYNGLPSMELLGQPAAGKSSGEAM
NLMQELAGKLPTGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVIGALIFTTLRGLSNDVYFVVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVLPLAISSGAGSGAQNAVGTGVMGGMVTATVLAIFF
VPVFFVVVRRRFGKNKEDGERSHAVDNH
>A0A0K4JLB7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHADNPGEKAFYASVARLAAETGIPVYAPD
NVNHPLWVERIAQMSPDVIFSFYYRHLISDDILQLAPVGAFNLHGSLLPKYRGRAPLNWV
LVNGENETGVTLHRMVKKADAGAIIAQQRVVISPDDIAITLHHKLCHTARLLLEQTLPAI
KHGHFQEIAQRENEATCFGRRTPDDSFLDWHKPADVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSRVHPDTSTAQPGSVISVAPLRVACGHGALEIITGQAGDGITMQGSQLAQTLGLVE
GSHLNNQPLCAAQRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALFRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLGWEPKIDMQETIDETLDFFLRTVDLTDKSS
>ZP_03102911|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKENGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>A0A0W1AWR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFAEQDSIMKTYEIVIQLGAILAIAL
VYRKRVLNLLGIGRSSSVRGGVMPASRLNLIHVILGIAPALAVAFFARDFIKSLFGASTV
LWALVAGGILMIVAEWVNRRKIRITAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKNFTSETIGYFVIGFLISFVVAY
LVVILFMKWIQKIRLTHFAIYRFILAAVFWLFIMR
>A0A127SUB7|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENQIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>YP_002240037|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISITAMYPGADAETVQNT
VTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLALATPLLPQ
EVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANAL
DTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRY
LVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTK
EKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITGRAMGYFSQIKDA
MVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGL
EDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRM
LPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSLEILGQAAPGKSTGEAM
SLMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFF
VPVFFVVVRRRFSKKSEDIEHSHQVEHH
>A0A0J2ETB0|FEATURES|UNIPROT_deepARG|beta_lactam|A6804_08920|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFHPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAN80811|FEATURES|ARDB_deepARG|multidrug|EmrE|antibiotic efflux|0
MLPGRVNSFVSLGFLLIIIVPAFISCHARAPWIHIHQDENGELCSNCSTILSSMNRKEYA
MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAY
AIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLVINLLSRSAPH
>A0A0S9NHG3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDWLAAIILGLVEGLTEFIPVSSTGHMLLLGHFMGFESAGKTFEIVIQLGALLAIVSVY
FKKLWTLATRWPFDAEARRFLIGLLVAFAPAVVIGFLAYDFIKTVLFETPQVVCIALIVG
GVILLLLDRMDKKPKWLDAEAYPMRIYFLIGLFQCLAMIPGVSRSGATIAGGLLLKTDKR
SAAEFSFFLALPTMGAAVAYDLLKNHKTLDFSDIGLIVVGFVVAFISALAVVRFLLDFVS
KRGFGVFAWWRIVVGVVGLVLLQAGF
>CAE46076|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGNVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEREKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAQLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0L6XM31|FEATURES|UNIPROT_deepARG|beta_lactam|OA40_05925|antibiotic inactivation|1
MTKSLSATLVSALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETSLNDPAVKYQPELTQPQW
KGITLLDLATYTAGGLPLQVPEAVKSSEDLLHFYQQWQPSWQPGKMRLYANSSIGLFGAL
TATAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNNQPVRVTGGPLDAESY
GVKSASKDMLRWAEINMSPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>A0A089NTK5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPASIGKAVLLALVEGATEFIPVSSTGHQLLVGHFIGFHSPNNTFEVLIQLGAILAILL
VYFRRLLAIATAVPSDPRARRFVLGILVAFLPAAIIGGLFSKLIKAYLFNPWIVCATLVA
GGLVLLVIDDTDLEVKKKDVYDFTLPMDLKIGIFQCLAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAMPTMAGAFAKDLLDNYKYLSSNDVGLIVIGFVVSFISALFVVRVLLDYV
SRHGFWLFAWWRIIVGALGFAGLIILG
>A0A024QNI4|FEATURES|UNIPROT_deepARG|beta_lactam|BN1047_01714|antibiotic inactivation|1
MGYSRVMRLSRRELLIGGLTLVAVGSVAGCADDTALAAPTTALPERIRDLEARHNAFIGV
FGMNLDSGMSVRHRAEEPFAMCSTFKTYAAAAVLRRVAEGELSLDKPVFVDPAGILPNSP
VTEERAGGQMTLAELCQAALQRSDNLAANLLLATLGGPRAITDFARSIGDDKTRLDRWET
DLNSAIPGDPRDTSTPEALGTGYRNLLAGDALPPAQRDLLDGWMRANQTSSMRAGLPPDW
TTADKTGSGDYATTNDVGIAYGPGGSRVLLSIMTRTQSADPDAEGLRPVIGEIAALVLPD
LLA
>J2XK16|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVVGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHHYLFNPITVATALV
VGGIVMLWAEKRQHEVHAESVDDITWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPSDFPVFALGFVTAFIFAMIAVRGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWVDWTAVKP
>A0A071I134|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRNLVLPTFGMIAVASLFHGSSACAADGGEQARLERAVNEAIRPVMKENDIPGMAVAVTV
NGKRYVFNYGVASRENGQKVTEDTIFELGSISKTFTATLASYAQLRGTLSFSDKASKYLP
ALAGSSFDTISLLDLGTYTAGGLPLQFPDDVTGQDKMIAYYKNWRPDHAPGTRRLYSNPS
IGLFGYLAAASMGEPFDALMEQKIFPGLGLTHTYIRVPQDQMGNYAYGYSKSNKPIRVGP
GALDSEAYGVKTTAADMIHFLEANMDSSKLDETLQSAIATTHTGYYRIGDMTQGLGWEMY
AYPTSLERLQAGNSNEMSRNPNKANKLVPPQPPRRDVLINKTGSTNGFGAYVAFAPAKGI
GIVMLANRNYPIPARIKAAYRILTALDKESGMR
>A0A150MEC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLLKAVILGLVEGVTEFAPISSTGHMIIVDDMWLKSEKFLTPYVANTFKVVIQLGS
ILAVVILFKDRFLELLSLKRDSYRIGEFPSRRLKLSHVLVGLLPAGVLGVLFEDIIDQYL
FKTEYVLISLVAGALLMMAADWRSKRNPGRQSVDEISYRQAFIIGLFQCLSLWPGFSRSG
ATISGGVFLGLSHRAAADFAFIMAVPIMAGASFLSLLKNWQYFRPEVWPFFAAGFVSAFV
FAFLSIRFFLRLIDKIKLFPFAIYRILLAALILCFLWLNR
>A0A060KTS9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGGKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>D1NY83|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSLADEFEEIKKVSIVIPVYNEEQSLPQLLERTIKSCKQLTQSYELILVDDGSSDRSAKM
LVEAAENPENHVIAIILNRNYGQHSAIMAGFNQADGDLIITLDADLQNPPEEIPRLVQTA
SQGYDVVGTRRANRQDSWFRKTASKMINAMITKATGRSMGDYGCMLRAYRRHIIEAMLQC
HERSTFIPILANTFARRTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLS
VVGSVIAAGGFVLAVLLIVLRLLFGSDWAADGVFTLFAILFIFIGAQFVAMGLLGEYIGR
IYNDVRARPRYFIQKVVGADLKTDKNQEEN
>A0A068HCF8|FEATURES|UNIPROT_deepARG|aminoglycoside|KONIH1_14625|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSAENI
VDALAAFLRRLHSIPASNCPFNSDHVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLISCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFYKYGIDNPDMNKLQFHLMLDEFF
>G8UTM1|FEATURES|UNIPROT_deepARG|beta_lactam|lp12_1556|antibiotic inactivation|1
MGLHIHIFKNVEVVMKKIIIFLCTGLLFCVSTWAQGTCFLAKENQTVLKREGNDCDQRYS
PASTFKIALSLMGFDSGILKDELHPEWPYKKEYELYLNVWKYPQNPHTWIRDSCVWYSQA
LTRQLGMKRFKGYVDAFHYGNQDVSGDRGQNNGLTHAWLSSSLSISPTEQIQFLQKIIYK
KLPVSQKAYIMTKNIMYIQELPGGWKLYGKTGTGRQLTKDKSQKLPLQHGWFVGWIEKDE
RVITFAKHIADSKENNTFASFRAKNDALIQLFNLINELEK
>A0A101K994|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPILLLHSLIMGLVEGITEFLPISSTGHLILAGDLLDFLDKDKRDVYEIFIQLGAMLAV
VWEYRAKIGRTVAGAARPGGERNLLLGIVIAFIPAAIAGLLFSKQIKAALFNPVCVAIAF
IVGGLIILWAERREHKIAVETVDDLSLKDALKVGLCQCLALIPGTSRSGATIIGGLFLGL
SRKAATEFSFFLGIPTLGAASLYSLFKHRDALSADDIGVFAVGFAASFVFAFLAIRALLR
FISTHSFAVFAWYRIAFGLIVLASWQTGWVNWSA
>YP_561834|FEATURES|ARDB_deepARG|beta_lactam|BL3_shw|antibiotic inactivation|1
MEFSRMMLNLVRKVFTTGPRVLSVVSLLSVNVLGINLAQAVTSEESVPKFSIEPLANNVY
LHQSFQQTESFGLVGANGLVVINEGKAFIVDTPWSESDTAVLVDWIKEQGYQLVGSVSTH
SHEDRTAGIGWLNAHSIPTFASELTNQILKESEKPLASHPFALPQASLFDGQLEAFYPGG
GHALDNLVVWLPKSNILFGGCLVRSLDSTSLGYTGEAVLEQWPTSAMKVLAKFPDVELVV
PGHGEPGDKQLLIHTKALAESGAKQASAK
>W1DTX2|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-193|antibiotic inactivation|1
MKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFSNDEHF
>D3I9F5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLETLILAIVEGLTEFLPISSTGHMIIAQNLLGIESTSFVKAFTIIIQFGAILSVLCL
YFQRFFKLNNAPVDPNLSLFKRLLHKFDFYVKLLVAFVPAAVIGLLGKKSGIIDRFLEHV
EVVAIMLVVGGVFMLFCDKLFEKKSSEETPLTNKRAFVIGCFQCLAMIPGVSRSMATIVG
GMSQRLTRRAAAEFSFFLAIPTMAGATVLDVYEVLFKDPNSVSWATGDNIKMLLIGCVVA
FVVALLAMKWFVNFLAKYGFKAFGYYRIVVGLFILVWLMLGYNLSMVD
>F5NXK5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERDIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRYLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>EDK34631|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAMI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFIADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDLKQNS
>D1BEB9|FEATURES|UNIPROT_deepARG|chloramphenicol|Sked_12550|antibiotic inactivation|1
MTSPSATPIDLSTWPRRQHFEHYRSAVPCTYALTVDLDATAFVEALRDSTRKTYIAQIWA
LATAVNQHDEFRMCLTPDGAPATWPVVHPSFTVFNAARETFASVWAPYDPSFAAFHDTAA
ALLTEHRTATEMFPQGPPPANSFDVSSLPWTSFTGFSLAVQPGFDHLAPIFTLGRYVERE
GSLRLPVALQVHHAAADGFHAARLLETVQGLLLEPGWVA
>A0A127W3C5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELFDLIKALILGFVEGMTEFAPVSSTGHLIIVDDMWLKTEEFLGKYPAITFKIVIQLGS
ILAVVVVFWKRLFSLVGLYKIDGKKMNSRFNLGHVIIGMLPAVILGFAFKDLIDDYLFGV
ETVIFALVAGAILMIVADKFGPKKPKVQTLDQITYKQAFSVGLVQCLSLWPGFSRSGATI
SGGVLFGMNHRTAADFTFIMAVPIMMGASLVSVLKNWEYLSMDNLSFYIVGFISAFIFAL
ISIRFFLKLISRVKLVPFAIYRLILAAVLAVIVFL
>E2I6F2|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYIVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>1BZA|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-44|antibiotic inactivation|1
ANSVQQQLEALEKSSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKQSES
DKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAALQYSDNTAMNKLIAHLGGPD
KVTAFARSLGDETFRLDRTAPTLNTAIPGDPRDTTTPLAMAQTLKNLTLGKALAETQRAQ
LVTWLKGNTTGSASIRAGLPKSWVVGDKTGSGDYGTTNDIAVIWPENHAPLVLVTYFTQP
EQKAERRRDILAAAAKIVTHGF
>R8VQ29|FEATURES|UNIPROT_deepARG|beta_lactam|KQ1_00834|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKNPIVLAILSNHDKEDAEYDDKLI
ADATKVVLNTLKATE
>A0A0C5DX24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELWTAVQALILGIVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVTGLPTQRNAQRFTVNLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALV
VGGVIMLWAERRQHEVHASSVDEINWKDALKVGFAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAVGFITSFIFAMIAVKGLLKF
IANHSYAAFAWYRIVFGLLILATWQFGWVDWTSVHS
>A0A0D9A6Q3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLHFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTVNLLIAFMPAVVLGVIFADLIHHYLFNAVTVASALV
IGGIIMLWAERREHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAVGFVTAFIFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKP
>B2DFV5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA22|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVIGK
>A0A127T6M8|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-2|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLGIKEKLMAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFF
SEFQAKGTIVVADERQADRAMLVFDPVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIF
RWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSN
GDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDFMIVEAGRNWILRAKTGWEG
RMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>A0A125Y0K9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGGFELDDKASLFAPWL
KGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIG
LFGYLAASSMKQPFDRLMEQTILPGLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGM
LADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYP
VSEQTLLAGNSPAMIYNTNPAAPAPAAAGHPVLFNKTGSTNGFGAYVAFVPAKGIGVVML
ANRNYPNEARIKAAHAILTKLAR
>A0A0Q9QLC8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHTIFEAIIIGIVEGLTEFLPVSSTGHMILAQSLLNTENDEVMKTFDFVIQLGAIMAVVI
IYWKRILSLFGLVNRKSESKTGKKLNLIHILIGIVPAGVIGVLFNDVVDAKLFNTTTVLV
GLVVGGILLIIAEKKKEPPKTTVLDDLTYRQAFAIGLWQLVSIWPGFSRSGSTIAGGMLS
GVSRAASADFTFIMAIPIMFGASGVYFLKNYEALSSDDLAFFVVGFLVAFVVALLAVVSF
IKFVQKMKLTYFAYYRFAVAIIFALYMFLK
>YP_002638807|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYTLVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>A0A127SZ45|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSI
VSIKASQMPPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHIND
YIHRLSIDSFNLSETEDGMHSSFEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQ
TMIDTETGANKLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFV
MDSYETDEDNANIIARISRMVYDAMR
>A0A0P9QHE5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGEPLLACASKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDETLASCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQEDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNLDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>A0A0U1I036|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MSQNEKIKKVSVVIPVYNEQESLPALIERTSAACKLLTQPYEIILIDDGSSDNSADILTA
AANEPDSDIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVAVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGGEQTENNQEIEK
>M9EBT6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSCVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>V5BYI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDTHLLISALILGVVEGLTEFLPVSSTGHLILVGQLLGFNDDKGKVFEIVIQFAAILAV
VWEYRARLFHALFSLSKEPASKRLAINLVVAFLPSAVLGFLFLKQIKAYLFNPFVVASAF
IVGGLLILWAERREHKIKAETIDDMTWQDALKVGFAQALAMIPGTSRSGATIIGGLFFGL
SRLAAAEFSFFLAIPTMFAATLYDVYKHRDLFSADDINLFAVGSTVSFISAFFAVRGLIR
FISRHDFTVFAWYRIAFGILVLGSAQFGWVNWSDH
>YP_001590162|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPINVM
YALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALIAIK
TFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>Q1HBB0|FEATURES|UNIPROT_deepARG|beta_lactam|MIR-14|antibiotic inactivation|1
YRIPHMPVFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIHMLELAT
YTAGGLPLQVPDEVTDNASLLRFYQNWQR
>J2VN18|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVV
LYFKKLWDVAIGMFTGDAYARRFVIGVLVAFLPAVIVGLVAGKYIKSLLFNPWVVCFSLI
VGGAILLWVDRLDLKAREHDATRFPLLMYLYIGIAQCIAMIPGVSRSGASIVAAMFLGAD
KRAAAEFSFFLAIPTMIGAFAYDFYKNRSEMTMDHMGVVAIGFIVSFITAIIVVKTFLSY
VTRHGFVVFAWWRVIVGTLGLIALALGR
>A0REB0|FEATURES|UNIPROT_deepARG|beta_lactam|BALH_2254|antibiotic inactivation|1
MVKNLKGMMILKNKRMLKIGICVSILGLSFTSLEAFTGGPLQVEAKEKKGQIKHKNQATH
KEFSQLEKKFDARLGVYAINTGTKQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDE
VITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALR
QMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKG
NATGDKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYD
NQLIAEAAEVIVNAFR
>A0A0J1NRE4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLVFHDTIKSLFNPIN
VMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLSASDLPMFAVGFVTAFIVALVA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0F0Y9B4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACETLGKAYEILLVDDGSSDDSAMMLTD
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIALAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEEIHP
>A0A154U6X7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILILFKALILGIIEGLTEFLPISSTGHLIVFGDLMNFQSNGKVFEIAIQLGAVLAVVF
EYRQRFTHIIKGLGKERTANRFVLNLFIAFIPAAVVGLLFSKQIKLHLFNPITVATMLVL
GGFFILWVEKRQTTAKPKVNHVDDMRPIDAFVVGCAQICALIPGTSRSGSTIMGGMLWGL
ERKTATEFSFFLAVPMMIAATGYDILKNYKLFTLQDVGQIAIGFIAAFIAGLLAVKALLK
FVSSKNYVPFAYYRIVFGGLILLTWMLGIVSWSE
>H9ZP90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGRVSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPVEEDPFLKTFLVAIQLGAIL
AVLLLYGRRLAADRALWLRIAVAFVPTGVIGFLFYPLIKGVILGNDAVVAFFLFFVGAVL
LFADRLAERAQYQDVKALPLARVAWIGVFQGLAALFPGTSRSGATILGGLLLGLNRQAAA
EFSFLLALPTMFAAVGYDLWKSAPEVPEGGWSLLLLGFLAALATALVTVRWMLAFVARYG
FRPFALYRMALAAVYAFFFLR
>Q671Q4|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGQIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0C5BRL7|FEATURES|UNIPROT_deepARG|aminoglycoside|aacA7|antibiotic inactivation|1
MDSSPLVRPVETTDSASWLSMRCELWPDGTCQEHQSEIAEFLSGKVARPAAVLIAVAPDG
EALGFAELSIRPYAEECYSGNVAFLEGWYVVPSARRQGVGVALVKAAEHWARGRGCTEFA
SDTQLTNSASTSAHLAAGFTEVAQVRCFRKPL
>S3FES4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWYELFIGFLLGVVEGLTEFAPVSSTGHMILVDDIWLNSSRFLGQEVANTFKIVIQLGS
ILAVIVVFRSRFKALLNPKELLAIRHEGPTKKLNLLHILIGLLPAAVLGLMFEDYIDTHL
FSIKTVLIGLVIGAFFMIAADLSGVKRQTTPTLDDITYKQALGVGLIQCFSLWPGFSRSG
STISGGVLLGMSHRAAADFTFIMAVPIMFGASALSLYSKWGYFTVDTLPIFLIGFVSAFL
FALLSIKFFLKLINKVKLTPFAIYRLVLAAVIYVLYF
>A0A0T6STK3|FEATURES|UNIPROT_deepARG|beta_lactam|AO734_03905|antibiotic inactivation|1
MKGWIKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELI
DHYEELIKAVPQS
>E6K371|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSILETLIIAIVEGLTEFLPVSSTGHMIIAQGLLGVESTPFVKAFTIIIQFGAILSVVCL
YWNRFFRLDHSPAPQGSSAWARLIHKWDFYWKLLVAFMPAVVIGLIGKKTGLIDRFLESV
GVVAIMLVVGGVFMLFCDSIFNKGSEDTKITEKRAFRIGLFQCIAMIPGVSRSMATIVGG
MAQKLTRRRAAEFSFFLAVPTMAAATVLDVWEVFFSDSADTNWATADNLAMLALGSVVAF
VVALLAMKWFVDFLAKYGFKAFGIYRIIVGGFILIWLMTGHTLSMVG
>A0A0L9EMH4|FEATURES|UNIPROT_deepARG|aminoglycoside|AEX30_06460|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPDHPDDAHLADGEEILQADHLASFVAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>YP_002349827|FEATURES|ARDB_deepARG|fosfomycin|FosX|antibiotic inactivation|1
MISGLSHITLIVKDLNKTTTFLKEIFNAEEIYSSGDKIFSLSKEKFFLIAGLWICIMEGE
SLQERTYNHIAFQIQSEEVDEYIERIKALGVEMKPERPRVEGEGHSIYFYDFDNHLFELH
AGTLEERLKRYHE
>V1AJQ5|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1616_02804|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
SELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>L0WDT7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILQAIILGIVEGLTEFLPVSSTGHLIVVGDWLGLANTDANKAFDVIIQLAAILAVLAN
YRDKISLRHLELWKKLVLAFIPIGIIGLLFHHQIKELFSVTVVAVMFIVGGVVFLVLEHF
YKEEQSHTVNVEDVTYRQAFWIGIAQIFAVIPGTSRAGSTIVGGLLCGLSRRACAEFSFL
LALPVMAAASGFDLLRHYQDFSDANLISLAVGFVTAFVVAYFTMKWFIHFLQRFTFVSFG
IYRIVFGVMLLVFYHSSVVTG
>A0A095EZ28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLDFNAEQEKTFDVVIQFGAILAVC
WEYRRRIGTVVAGLPTRPEARRFALNVVIATLPAIALALMFEKAIKRLLFSPVPVAFALV
AGGLVILWAEARQRDRREPARVMSIDALSPLDALKVGIAQCCALIPGVSRSGSTIIGGML
AGLDRRVATEFSFFLAIPIIFGATFYETVKDWHAFSVDSVGLFAVGMVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLLVLLVGYSGWLDWS
>N8PDT5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDAEARHFAFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVAFAL
IIGGFIIFWVESKNFDHKTTEATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIAVGFVAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>A0A0T9L5U8|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLAFHDVIKSLFNPQS
VMYALVAGGLLLLAAEWFKPKNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASALDLYKSLHFLSWGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFVVAGAVYWVFM
>A0A0M6Y6G4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGQTIVNALILGIVEGLTEFIPVSSTGHILLLGHFLGFDSTGKTFEVLIQLGAILAILS
VYFGRLWTLLVTLPSDPSSRRFVAGILIAFLPAAVIGVLLHGFIKEVLFETPALICTTLL
LGGIVLLWIDRLPLKPRYTNVMDYPLSLCLKIGFCQCLAMVPGVSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMAGAFAYDLYKNRNVLSMDDAMLIGIGFVASFIAGVFVVKGLLDF
VSKHGFAPFAWWRIFVGIAGFAGLYFLG
>F3IBF7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDIEALHETSINSDQPLLRLQQVSRSFMAGDREFQALKHIDLAIHTGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAIYAGTAQTTRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIEVSDGEIIS
DRRTAQATQPAPEAQPATPPGPAPRRLLASLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLLPSDVAALN
QLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSDQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGQVILVGKLPSTVIGVTSDHKNLFIAGNTLNLWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>G0PUI2|FEATURES|UNIPROT_deepARG|aminoglycoside|SACT1_0352|antibiotic inactivation|1
MSDHPGPGAVTPELFGVGGDWMAVTAGESGASVFRAADATRYAKCVPAADAAGLEAERDR
IAWLSGQGVPGPRVLDWYAGDAGACLVTRAVPGVPADRVGADDLRTAWGAVADAVRRLHE
VPVASCPFRRGLDSVVDAARDVVARGAVHPEFLPVEQRLVPPAELLSRLTGELARRRDQE
AADTVVCHGDLCLPNIVLHPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERA
RFADAAFAERYGIAPDPERLRFYLHLDPLTWG
>A0A0B0Q5F0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFQSIIMGVVEGFTEFLPVSSTGHMIVTADFLGIRQDSVTKAYEIIIQFAAIMAVVFA
YKDKFTFKKVELWKKIIIAFLPIGIIAFLFAKQIKALFSVEVVATMFIIGGVVFLIAEKY
YKPKAHFVDDVENVSYKQALLIGCAQLAGLIPGTSRSGSTILGAMFVGLTRKASAEFSFL
LAFPVMSAATGYSIVKNFHEFNGENLTVLGVGFIVAFITAYLSIKWFLKFLQRYTFVAFG
IYRILFGAVLLAIY
>A0A0S1RS31|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQ
PTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLRKVVNRQLPVKAAAYELADNLFEVGQADGWRLYGKTGT
>A0A070DBL0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPHVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>R7JXZ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKSLLFGIVEGITEWLPVSSTGHMILLDEFVQLSMSEAFKEMYLVVIQLGAILAVV
LLFWKQIWPFQRKSDGTNKVLPGWIKEDIFVMWLKIVVACIPAMIIELAAGDYLEALFYN
YRTVSIMLIVVGILFILVEDWNKKRTAKITSIRDITYQTAFLIGVFQLVAAVFPGTSRSG
ATIIGGLILGLSRQIAAEFTFYLAIPVMFGASLIKLLKFGVHYIALEAGVLAVGMISAFL
VSVLVIRFLMGYIKKHDFKIFGWYRIVLGIVVLASFALFL
>A0A0G0TSY7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYWQSIILGIVEGLTEFLPISSTAHLILGGKILNIVQTEFVKSFEIVIQLGAILAVIWL
YWKRIVSSKEIIKRIIVAFLPTAIFGFLLYKIFKGYLMENLAVIVWALILGGILLIVFEY
WHKEKADAAENIEDISYKNCFLIGTCQAIAMVPGVSRAGATILGGLFLGIKRKTIVEFSF
LLAVPTMLAATGYDLLKTGFTFSADQFGQLSVGLIVSFLVAILAIKFLLRYIQQHDFKLF
GLYRIIIGLIFLLIIL
>A0A0U2WED1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLALKAIILGVVEGLTEFLPISSTGHLILAGSLLNFNDDKGKVFEIMIQFGAILAVC
WEFRAKIARVMAGLGSDATSRRFAINVIVACLPAIVLGLLLGKHIKAMLFNPTVVATAFI
VGGVIILLVERHNRRNVEAGQLPRVNSIDDLSVADALKVGFAQCLALVPGTSRSGATIIG
GMMFGLERKVATEFSFFLAIPILFGATIYELYKARATLSVDDFSLFGVGFVAAFISAFIC
VRWLLRYIASHDFTAFAWYRIVFGLVVLATGYSGLVVWAD
>N8SAF5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWRKTYFSSWESFKKQAFYIILATLITGVLGLALQSMIKHVFFGGASSFEIEHLFS
NSKLMGAALISAGVLIILSSRLDRGQQGEISLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQKAEEFSFALAVVLTPAVILKELYRLVHAQGLQTVAHGQVFHSMVPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCIGFAVVVLCVN
>AAG08983|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|VgaA|antibiotic target protection|1
MKILLEALRIKPYVQDRLLLNIDQLQIYQNDRIGLVGGNGSGKTTLLHILDEKLFPEEGT
VTQYSRCELIPQLKHMETTKSGGEVTRKYIQQALDKNPELLLADEPTTNLDTNYIENLER
KLKDWHGAFIIVSHDRAFLDTLCTSIWEIKDGGITEYKGNYSDYIEQKELENRQEQLAHE
KYEKEKKQLEEAIKLKEEKAQRATKKPKNISSSEARLKGAKPYFANKQKKLRKTAKALET
RLDKLEKVEKTKELPPLKMDLLNSETFKNRIILRVEDVSGVIEERVLWKAASFYVRGGDK
LAIIGSNGTGKTTFIKKIVQDKPGISFSPSVKIGYFSQNLDILELDKTILENVQSSSRQN
ETLIRTILARMHFFRDDVHKPVNVLSGGERVKVALTKVFLSDVNTLVLDEPTNFLDMEAI
EAFESLLEEYEGSVIFVSHDRRFIEKIATRIMMIDNKEIKIFEGTYDQFKAKQAREETRD
IKEDKKLLLETRITEILSRLSIEPSEELEKEFQNLINEKRNLDN
>YP_040163|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFIIELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVEGDNNQQRRSKPRRLNLLHVLVGMVPAGILGLLFDD
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSAKVKNPQTVDQISYFQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILG
FLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIVLVIFIAILYFGFGIGKGI
>AAS49820|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVLSLELPEVKGMGRFGYVPYVGYKCINYVSVSSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTIFAHISHSINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>C5QNY2|FEATURES|UNIPROT_deepARG|fosfomycin|fosA|antibiotic inactivation|1
MEIKGINHVCFSVSNLVVSIEFYKNVLKGDLLVSGKSTAYFNIGGLWVALNEEVNVPRTE
IKYSYTHMAFSINDNEFEEWYKWLQKHNVNILEGRERHIKDKKSIYFTDPDGHKLELHTG
NLNDRLTYYKDEKPHMTFYNDVLIN
>J2XCF8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIETLLNSGYEIAAVFTHPDDPKENAFYGSVAQLCARKGIPVHA
PEDANHPLWIERISKLNPDYLFSFYYRNLLSEPLLATASKDALNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQRVAIERTDTALTLHGKLRLAATDLLRDTLP
ALLQGKVSETPQDESQATVFGRRTPADGKLLWNKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSADVVKGNEGLAPGRVISVDPLRIACGEDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDGNFDEDSSNLVVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNENDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRANFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWIPTVEMSETIGNTLDFFLREAMLEVA
ERSTEESC
>U3U1X2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MEGLTEFLPVSSTGHMIIVGHLLGFEGEKAETFEVVIQLGSILAVVVMFWRRLFGLIGIH
FSQERHEGVGSGKLTLIHILLGMVPAVVIGLVLHDQIKTLFNPINVMYALVVGGVLLLAA
EYLKPKQPKAVGIDDITYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFS
FILAVPMMIGATGLDLYKSMGFLTMQDFPMFAVGFVTAFIVALLAIKVFLELIKRISFVS
FAIYRFIVAAAVYAIFM
>F7L323|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVFPAMVIGLLLDDIIDKYFLDNVLIVAIT
LITYGVIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGLFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIIVIILLN
>A0A105YNW7|FEATURES|UNIPROT_deepARG|beta_lactam|WK95_28265|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLALTLSACASPLANASSVGAATSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALFTQRVTYRHADLLEWSPVTEKH
VDTGMTVGELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQFAQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTTNDIGVLWPPARGPIVLTVYYTQARADAKRKDDVIAAATRIAIAALG
>A0A0B6AIL9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWEIIVAIILGIVEGLTEFAPVSSTGHMIIVDDLWLNSKELFSSPVANTFKIVIQLGSIL
AVVVIFKDRFINLLGLGKKPAAPIGPTNRLNLMQVIVGLLPAGVLGLLFDDYIDEHLFSL
NTVLIGLVVGAVLMILADLFGPKRPRVETVDQMSYGQALGIGLFQCIALWPGFSRSGSTI
SGGVLLGMSHKAAADFTFIMAVPIMAGASGLSLVKNWQYFTSDALPFFIAGFISAFIFAL
VSIRFFLKLINRIKLVPFALYRIVLAAILYFVFL
>A0A0U9H4P4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKLGKINHLLFSVSNLERSISFYEKVFDATLLVKGRSTAYFDLDGLWVALNVEEDIPRSE
IQQSYTHIAFTIEDEEYEVLYNRLRELKVNILSGRQRDERDKKSIYFADPDGHKFEFHTG
TLEDRMDYYREEKSHMEFF
>YP_216904|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLPPIVDLSPDDIADFRHALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQSGQAP
>AAQ12900|FEATURES|ARDB_deepARG|glycopeptide|vanRB|antibiotic target alteration|0
MSIRILLVEDDDHICNTVRAFLAEAGYQVDACTDGNEAYTKFYENTYQLVILDIMLPGMN
GHELLREFRAKNDTPILMMTALSDDENQIRAFDAEADDYVTKPFKMQILLKRVEALLRRS
GALAKEIRVGRLTLLPEDFTVLCDGTELPLTRKEFEILLLLVQNKGRTLTHEIILSRIWG
YDFEGDGSTVHTHIKNLRAKLPENIIKTIRGVGYRLEESL
>I0WK39|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIKAIVLAIIEGLTEYLPVSSTGHMIIASSFMGIASDDFTKLFTIVIQLGAILSVLVL
YWKRFFQSVDFYLKLLVAFIPAVILGSLFSGLIDQLLESPLIVAIFLVIGGFLLLKIDTL
FTPSENQEIGYKTAFKIGCFQCLAMIPGVSRSAASIIGGMSQKLNRTTAAEFSFFLAIPT
MLGATAKKSFDYYQNGLTITPEQVNALIIGNAIAFIVGMIAIKSFITYLGKHGFKIFGYY
RIFIGVVLLIIHYFVQPLTTF
>A0A0J5VV22|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRPDARRFTLNVVIATIPAIALGLLLEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVVSVDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0K9H6S3|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIVKGLNHFLFSVSDLERSIQFYESVFEAKLLVKGKGTAYFDLNGIWLALNVEKNIPREE
IRQSYTHIAFSIEEEDYDRIYEKLENLQVNILIGRTRDERDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYKQDKKHMEFYL
>ZP_03541894|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDTLLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLMGFVGGKAKVFEIAIQTGAIFAVM
LVYWQKIRDTLVELPSSRQAQKFALNVLIGFLPAVVLALLFGKYVQEHLFTPVIVATTFI
LGGFVILWAENRPAAATRVQSVDDMTALDALKVGLVQCFALVPGTSRSGSTIIGGMLMGL
SRKAATDFSFFLAMPTLIGAGVYSLYKERALLSMADVPLFAVGLIFSFISAWLCVRWLLR
FISTNSFVPFAWYRIVFGIIVLVTAYTGIVDWHH
>A0A124PIG6|FEATURES|UNIPROT_deepARG|beta_lactam|WS71_01720|antibiotic inactivation|1
MKIKHALSSALVLLGCIAASAHAETICTAIADAGSGKFLLKDGDCSRRATPASTFKIAIS
LMGYDAGFLRNEHEPVLPYRDGYVDWGGAAWKQPTDPMRWLKYSVVWYSQRVTHNLGAQR
FARYAKAFDYGNADVSGDPGKNNGLDRAWIGSSLQISPLEQIGFLSKMLNRKLPVSATAI
AMTEQIVDTATLADGAVVHGKTGMAYPLLADGTRDRAHGFGWFVGWITRGKETLVFARLT
QDEGKQPVSAGIRTRDAFLRDLPTLLATR
>A0A0B4W880|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLILKAIIIGIVEGITEFLPVSSTGHMIIAGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIMSTLKNFLPSDRVPVKKCGLKFWINIGIASIPAAAIGIPFNDKIEEKLFY
PWPVTIALIVGAIWMIYAENRYRNNSKTTSIDNINAKQAIIIGLFQCLALWPGMSRSAST
IIGAWIVGLSTVAAAEFSFFLAIPAMIGASGMSLIKHNVFSTCSSIELIALAAGFIVSFI
VALVVIDKFIAFLKKKPMKVFAIYRIALGIILIILLYSNIIKWH
>D4M0K5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEFLKSFLFGIVEGITEWLPISSTGHLILLNQFVKLNVSEEFYSMFEVVIQLGAILAVV
ILFWNQIFPFGAPEGSHTVRRRQAKHAHRRKKSGNGILSYVKMDIIILWLKVLVACIPAI
VIGMPFNDLFEKWFYNYPCVAIALIVFGIAFIIVENNHKGKPAKINSMDELTYKTAFLIG
LFQLIAAIFPGTSRSGATIVGALILGVSRTVAAEFTFVLAIPVMFGASLLKLVKFGLNFT
GTEAIILLIGMVTAFVSSIIVIQFLMGYIKKHDFKVFGYYRIVLGILVILYALFLA
>C6XB81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAILGILEGATEFLPISSTGHLIVAGDLLNFNDDKGKVFEIVIQLGAILAVC
WEYRTRLTGIAQGLTSNPKSQRFVLNVFIGFLPAAVLGLVFHSFIKTHLFSPINVAVALI
VGGFLILWIERHFDGKDVVHKAATLDDITPLQALKVGFAQSLAMIPGTSRSGATILGGML
FGLSRKAATEFSFFLAIPVMLAASGYDVFKNRALFSADDIPMFAVGFIMAFIAALIAVKT
LIRYVANHDFRAFAYYRIVFGTLVLIYFLKFA
>X0RP32|FEATURES|UNIPROT_deepARG|chloramphenicol|BTS2_2475|antibiotic inactivation|1
MNFNKIDIHNWDRKEIFNHYLNQQTSFSITSEINISTLYRTLKHNGYKFYPTLIFIFTKV
VNSNTVFRTSFNHKGDLGYWDHLVPLYTIFDQKSETFSAITTDINNGDFKNFHKMYLSDV
DEYIGTGLLFPKKPIPENTVSISMIPWTSFTAFNLMIDSNKNHLLPIITAGKFVHKDDSI
LLPISLQVHHAVCDGYHASSFFETVQQLANSLNNWL
>P14551|FEATURES|UNIPROT_deepARG|tetracycline|tetB|antibiotic efflux|1
MDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAIL
PLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIAS
QMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQT
VITSPMQNSAPKSQLGVANGASACAGQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYER
LLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFL
PGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA
>B2CD57|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
GLISFLRQIGDNVTRLDRWETELNEALPGDARDTTNPASMAATLRKLLTSQRLSARSQRQ
LLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVV
>S1CWT2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRARQLLQRLGLEERAEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTVLHQLRDRGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPAIEKNTAAANSEPG
VKTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAAKLDPVDALARE
>A0A0A0QAW5|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTAVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTRINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>YP_001477358|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIVMLAGVLSIMKLPIAQYPTIAPPAVSISANYPGADAKTVQDT
VTQIIEQNMNGIDNLMYMSSTSDSSGSVTITLTFNSGTDPDIAQVQVQNKLSLATPLLPQ
EVQQQGLKVEKSSSSFLMVAGFISDDPSMTQDDIADYVASNIKDPISRSSGVGEVQLFGA
QYAMRVWLDPNKLNNFQLTTTDVTSAITEQNNQIAAGQLGGMPPVPGQQLNASIIAQTRL
TSPEEFGKILLKVNADGSQVRLSDVAHIERGAESYAVTARYNGKPAAGLGIKLATGANAL
NTAQGVKDALTKMQPFFPQGMKVVYPYDTTPFVKISINEVVKTLIEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
SEEGLPPKEATKKSMEQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATLLKPVAKGDHGVKTGFFGWFNRMFEKSTHHYTDSVANILRSTGRY
LVIYLLIVVGMALLFLRLPSSFLPDEDQGILLTMVQLPAGATEARTSKVLEEVTDYFMTK
EKDNVVSVFTVAGFGFNGNGQNNGLSFVSLKDWSERKGEENKVPAIAGRAMGAFSQIKDG
LVFPFNLPAIIELGTATGFDFQLIDQGGLGHEKLTEARNQLLGMAAKHPDMLVGMRPNGL
EDTPQFKLIIDQEKAKALGVSITTINSTLSTALGGSYVNDFIDRGRVKKVYVQADAPFRM
LPEDINKWFVRGTSGQMVPFSAFSSAKWEYGSPRLERYNGLPSMEILGQATPGKSTGEAM
NLMEELASKLPSGIGYDWTGMSYQERLSGNQAPALYAISILVVFLCLAALYESWSIPFSV
MLVLPLGVIGALLAATMRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPVFFVVVRRRFSKKSEDVEHSHPVDHH
>P59291|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEITSVNHICFSVSDLNTSIQFYKDILHGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNE
ISHSYTHIAFSIDEEDFQQWIQWLKENQVNILKGRPRDIKDKKSIYFTDPDGHKIELHTG
TLKDRMEYYKCENTHMQFYDEF
>A0A0Q0D598|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPKEKTFFGSVAQMCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGD
NKLIVWAASVDTSSNGEAPGTVISHEPLRIACGDGSLVITAGQRGDNGLYLSGAQLAREF
GLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>L1N519|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALVELVKVVILGIVEGLTEWLPVSSTGHMILVDEFIRLDVSTAFMDMFLVVIQLGAI
LAVVVLNAEKLNPFLSSKSQAERRATLDLWGKVIVACLPAAVIGLAFNKYMEEHFMNAPV
VASMLILYGVLFIVVERWNKRRTPRVDALSALDYRTAFIIGMFQVLSLVPGTSRSGATIL
GGIIFGASRYVATEFTFFLAIPVMFGASFLKLVKFGWNYSGTELVILGVGMVTAFIVSIL
SIQFLLRYIKRNDFTAFGWYRIALGIIVLAYLFLIGDPTKE
>K0B2R7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MIFIELLKAVFLGVVEGITEWLPISSTGHMILVEKFIQLNASAAFKEMFFVVIQLGAILA
VVLLYFHKLNPFSPSKSSKEKQDTMSIWYKVIVGIIPAGVFGFLFDDWLNEHLYNYKTVS
IMLIVYGILFIIIENRNKGRGGNIRSFSDLSYRTAFLIGMFQVLALIPGTSRSGATILGA
ILLGTSRYIAAEYSFFLSIPIMFGASGVKLLKFGLSFTSMEIAILVTGMVVAFIVSVVAI
KFLMSYIKNNDFKAFGWYRIILGILVIAYFAFWGN
>A0A0Q9Y5A6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIKGINHLLFSVSDLEKSVDFYQKVFGAKLLVKGRGTAYFDLNGIWLALNLEKDIPRDE
INLSYTHIAFSIEEEEYDKIYDTLQELKINILPGRQRDERDKKSIYFTDPDGHKFEFHTG
TLQDRLKYYKQEKSHMEFFD
>A0A0M1F1M4|FEATURES|UNIPROT_deepARG|aminoglycoside|ABW45_07695|antibiotic inactivation|1
MTGSAATIRPATAADAAAWAQLRLGLWPDADDPLETLVAALAEDAGAVFLACAAGGQAIG
FAEVRLRHDYVNGTDSSPVGFLEGWYVQPQWQGRGVGRALLAAVRAWTRDAGCRELASDS
RVEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>E9DPG6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQTAQYIIELLKAVFLGVVEGVTEWLPISSTGHLILVNEFLNLRQSKAFIDMFNIVIQLG
AILAVMVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFIGLFLDDWMEAHLSNF
LVVAIMLVVYGIAFIWIEDRNRRVEPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGAT
ILGGIIVGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFIDGNTLTGGQVAILLVASVTAF
VVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLLYGAIKLIFG
>A0A0U1KWT6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSENIITVIIGVVEGLTEFLPISSTGHMILVGSLLGFEGEKASVFEVFIQLGAILSVLIL
YRDKFLAMIRPRAINIYGNGLTAMHILVGIVPVMGIAFFLHKPIKTYLFSPYTVIIGLII
GAIFMLVAEKMANRPVTHSVDNMTIKQAFWVGLFQVLSLWPGFSRSGSTIAGGLFFGMSR
KAAAEFSFIIAVPLMLVACVYDLMKIWDKLSMAEFKLFIIGFIVAFITAYISIVWFLRFL
NNSTLASFAYYRFIVAGISYYYFFLR
>ABG69059|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQISN
>J2GE42|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLTFTAILLGIVEGLTEFLPVSSTGHLILATRLFGYDSSQWATFNIVIQLGAILAVIVQ
FWRTFWAVGMGLLKLNPTSIRFVRNVLLAFIPSAILGLLLNNWIEGLLGEPSVVAWALIV
GGIAILGIEKISKPGPLTGVAELPAKQCVGVGLAQCLAMVPGVSRSGATIMGALAMGIER
RTAAEFSFFLAVPTMVGATTLELIKHGSELSGGTGPVGWNEIAIGFFVSFVVALVVIKAF
MAFVSKSGFAPFAWYRIVAGIVALVLLARV
>ABB76658|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSDNEDVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGD
VYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>A0A0L0GZ63|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGIQALLDAGYDIEAIFTHPDNANENHFFGSVARIAAEQGIQVYAPD
DVNHPLWIERIRAMNPDVMFSFYYRNLLCNEILSAARLGAFNLHGSLLPKYRGRAPLNWV
LVNGEKETGVTLHRMIARADAGTILAQHRVAIDDADVALTLHHKLREAATTLLREVLPAI
REGYFTETAQDESQATYVGRRTPEDGRLDWDKPAAELHNLVRAVSDPWPGAFGYAGANKF
IVWKSRLHTDMRNAKPGTVLSVAPLIVACRDGALEIVTGQADHGVYMQGGQLAQALGLVA
GALLSSKPVVAIKRRTRVLILGVNGFIGNHLTERLLADDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKHFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
HGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKEGRCDGQIINIGNPDNEASIKELAEMLLESFERHPLRDRFPPFAGF
REVESSNYYGKGYQDVEHRKPSIRNAKRCLNWEPVVGMEKTVDETLDFFLRTVELTDEKA
S
>Q8GGL9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MHHRPSGSETRTSARTNSQGVTHASVQRRVQAGVRRGPSVPSGPYDVTTGPDDALWFTLI
HSGGIARLTPDGALDRHALDSPACGPSIITPGPDGALWFTRCQDHRIGRMTVTGHATSFA
VATPDSGPYGIAAGGDGALWFTQLHTDRIGRITVDGRVTEFPLPFRGAFPSAITAGPDQA
LWFTLNRADAVGRMDLGGEVTVHPLPTEHAAPVGITVGTDGALWFVEIGAGQVGRVGTDG
VVREFPLPDRACRPHAITADPARGVCWFTEWAADRIGSITPDGHIEEYELPDRGAEPHGL
TVAPDGALYVALETGRILRMEL
>A0A0F3LZV0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYFDVSILAVIQGLAELLPVSSSAHVIMTEKLLGLDPAAPDMTLLLVMLHTGTMFAVIV
YFWNNWRETYFSSGRTFKKNVFLIILATAVTGVVGLTLMKLIKYFFAANADTFEIESLFS
NSKIIASGLAAAGLLIILSSRLKEKDRGELSPLSAAGIGFVQGLCLPFRGFSRSGATIST
GLSLGVARQRAEEFSFALAVVLTPAVIVKEGLRAFSSGSAGTVAVSSGVLLPSLVGMLLS
FVAGLLALRWLSRWLEHDRWHLFGGYCLCAAALIGWLG
>A0A084J6V7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFSVEQKDFERLLHRLEENNVHILQGRERNVRDCRSIYFVDPDGHKFEFHSGT
LQDRLNYYREEKPHMTFY
>YP_001438874|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIIMLAGGLSIMKLPVAQYPSIAPPAVTINATYPGADAKTVQDT
VTQVIEQNMNGIDGLMYMSSTSDSSGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVLGLINTDGSMKQEDIADYAGANIKDPISRTTGVGDVQLFGS
QYAMRIWLDPNKLNNFQLTPVDVISAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSADEFSKILLKVNQDGSRVLLRDVAKVELGGENYDIIARYNGQPAAGLGIKLATGANAL
DTAEAVRKTIAGLEPFFPSGLKVVYPYDTTPFVKISIFEVVKTLVEAIVLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIALVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMVL
SVIVALILTPALCATMLKPVAKGDHGEGKKGFFGWFNRMFDKSTHHYTDSVGNILRSTGR
YLLLYLLIVVAMAFLFIRLPSSFLPDEDQGVFLTMAQLPAGATQERTQKVLDEVTDYYLT
QEKDNVNSVFTVNGFGFSGRGQNTGLAFVSLKNWDERPGAENKVPAITGRAMGRFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQGNLGHDKLTQARNQLLGEAAQHPDLLSQVRPNG
LEDTPQFKIDIDQEKAQALGVSISDINTTLASAWGGSYVNDFIDRGRVKKVYVMSQAQYR
MLPGDINNWYVRGTNGQMVPFSAFSTSHWEYGSPRLERYNGLPSMQIQGQAVQGKSTGEA
MAMMEQLASKLPTGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAASLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGL
IEATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIF
FVPVFFVVVRRRFSRKSEDIEHSHPVEHH
>A0A0A0D061|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLSAIILGVIEGITEFLPISSTGHLIIAEHWLGERSDTFNIVIQAGAILAVTIIYWRR
IFDLVVGWRRPENRRYGIRLLLAFVITGVLGLAAKKAGFTLPETILPIAIALVVGGIWMI
WAEQQAAKLPDSHKITWLVAIVVGLAQFVAGIFPGTSRSAATIFAAMLAGASNRAAATEF
AFLVGIPTMYAASAYELYGQFKQGGAHEDWGALGVAFVVSTITAFVAVKWLLGYIQTHRF
TAFAIYRIIFGALLLGAAALGWIA
>AAR37057|FEATURES|ARDB_deepARG|glycopeptide|vanSD|antibiotic target alteration|0
MKNRDKTSHEDDYLLFKNRLSLKILLIMACSILIIAAVYLFVLKDNFANVVVAILDSFIY
HDRDEAVAVYLRTFKAYEIWLFLIAVMGVFFMIFRRYLDSISKYFKEINRGIDTLVHEDT
NDIALPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLAHDLKTPLSSVIGYLN
LLRDENQISEELREKYLSISLDKAERLEELINEFFEITRFNLSNITLVYSKINLTMMLEQ
LGHEFKPMLAGKNLKCEFDVQPDMMLSCDANKLQRVFDNVLRNAVSYCYENTTIQVNARQ
AEDYVLIQVINEGDTIPGERLERIFEQFYRLDVSQSSSTGGAGLGLAIAREIVELHHGQI
TARSENGITSFEVTLPTVGKS
>A0A0K1QVR8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDSGTHMQNFRLSKVLSYSAFSLFLGASYCVAATPTDPQIETAVKNAVVPVMQQQHIAGM
AIAITVNGRPHYFNYGVASKETGTVVTQDTLFEIGSVSKTFTATLAAYAQASGKLSLSDK
ASHLLPALRGSAFDNISVLQLGTYTAGGLPLQFPSDADAPDKMLGYFKQWKPVYAAGSHR
QYSNPSLGLFGYLAAHSMGQPFEALMEKTLLPKLGLQHTFLKVPPTQMALYAQGYSKDDK
PVRVEPGALDSEAYGVKTSASDLLRYVEANMKPTGLEAPMQQAIAATHTGYYTVGDMTQG
LGWERYTYPIALDKLLAGNSSQMAMEAHKVQWLNPPQPQPANALFNKTGSTGGFGAYVAY
VPSKDIGIVILANKNYPNPERIKIAHSILSTLSQ
>A0A0V9R874|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFMNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLNWEPKIDMQETIDETLDFFLRTVDLTDKPS
>R7R4J9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKAILFGIVEGITEWLPISSTGHMIILDEFVKLDCTPEFKEMFLVVIQLGAILAVV
LLFWNKIFPFQFKDKSKPVIEMDKIMLWCKIVVACIPAAVIGLLFDDVFEALFYHAFSVA
IALIVFGVAFIVIERRNKGKKAKITRLEDITFQTALMIGVFQLIAAIFPGTSRSGATIVG
ALLIGVSRTVASEFTFFLAIPVMFGASLLKILKFGFAFSGMEIAILVVGTLVAFIVSVVV
IRFLMDYIKKHDFQVFGWYRIVLGVLVIILSQCGVIQV
>W2D687|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLNTGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVVIDRTDTGLTLHAKLREAASNLLRDALP
QLAQGKLAETAQDESQATYFGRRTAADGKLEWKKPAEELFDLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
QSTEVQK
>A0A0G4D265|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHISRNEI
HQSYTHIAFSVEQEDFKCLIQRLEENDVHILQGRERDVRDYESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>A0A0P9VNF1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAV
VWEFRRKIIDVVTGLPKQRQAQRFTVNLLIAFMPAVVLGVIFADMIHHYLFNAITVATAL
VVGGVIMLWAERRQHTVRTETVDDMTWSDALKVGMVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDVAVFAIGFITSFIFAMIAVRALLK
FIATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>E4PXX3|FEATURES|UNIPROT_deepARG|beta_lactam|SUH_0014p2|antibiotic inactivation|1
MIYKNYNCNIGGFILKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALNTK
SGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGK
DITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPK
SKKDTSTPAAFGKTLNKLIANGKLSKKIKISYLI
>A7Y416|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKGVALSMNKPFDQVLEKTIFPALGLKYSYVNVPKTQIQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>V9WWK7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAIAFNIIIQLAAILAVV
WEFRGKILEVVFGLTSQPAARRFTGNLLLAFLPAVVLGVLFADLIHHYLFNPITVATALV
VGGVIMLWAERRTHRVAVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYATFAWYRIAFGLLILATWQFGWIDWSTAQG
>M4QHK6|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
TLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQ
EQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKEL
TAFLHNMGDHVTRLDRWEPELNEAISNDERDTTMPVAMATTLRKLLTGELLTLASRQQLI
DWMEGIKLQDHFCARPFRLAGFIADKSGAGERGSRGIIAALGPDGKPSRIVV
>1QCA|FEATURES|ARDB_deepARG|chloramphenicol|catIII|antibiotic inactivation|1
MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLDDSAYKFYPVMIYLIAQ
AVNQFDELRMAIKDDELIVWDSVDPCFTVFHQETETFSALSCPYSSDIDQFMVNYLSVME
RYKSDTKLFPQGVTPENHLFISALPWVNFDSFNLNVANFTDFFAPVITMAKYQQEGDRLL
LPLSVQVHHAVCDGFHVARFINRLQELCNSKLK
>D1LFH1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
NLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASV
TAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLV
TWMKGNTTGAASIQAVLPASWV
>A0A0B5IS57|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYLSGDGSVDVLKGVTLSINAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGTYRVAGTDVSRLNGDELARLRREHFGFIFQRYHLLSHLTAVQNVEVPAVYAGTERRA
RLERASELLVRLGLGDRAEYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMTILHQLKSQGHTVIIVTHDPLVAAQAERIIEIHDGEIVRNPPPKGAGSAGVIRQSA
AAEPSAWRQFSSGFREALVMAWRAMTANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVSSATPAVSKNLRLRA
DNIDVAASAEGVGAQYFNVYGMTFSEGNTFNELQLSSRAQVVVLDSNTRRQLFPHKARVV
GEVVLVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGY
DSSTAEQQLLRLFELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAFVLQL
FLPGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A060KZ44|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPAGVTALARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVTDGL
>Q5WLE8|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MLKTKIASSFLIGACLLFGCSNDNEQPVSNEPKPESSVHTGEDVFKQLEKEYDARLGIFA
LDTGTGETVSYRADARFTYASAHKPLAVAVLLQQKSIDELEQLITYSADDLVNYNPITEN
HVESGMTLRELSDASIRYSDNTAANLIFHEIGGPEGFKEGLRAIGDTVTEPERIEPELNS
VEPGEIQDTSTPEALAKSLQEFALGESLPADKQELLIDWLIGNTTGDALIRAGVPEGWEV
GDKTGAGSYGTRNDIAILWPPEKEPIILAVLSSKDEKDAEYDDELIAKATEEVINLFVQA
E
>C2VTN4|FEATURES|UNIPROT_deepARG|chloramphenicol|bcere0021_21960|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKSKCTFSMTVNVDITMLLDEVYQKGIKFYPVFIYLISRV
VNNHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEKDMR
CYASVHGLFTKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEENKIM
LPVSLQVHHSICDGYHASRFIEDLQELSNSCNEWLK
>V6MFY8|FEATURES|UNIPROT_deepARG|aminoglycoside|T458_13365|antibiotic inactivation|1
MSDLNNEKIPKQAIQACEVVKELLGGAIVGVYLFGSAVTSGLRMNSDVDVLVVVNQSLSE
EIRRKLTDRLMHISGKIGNTDSVRPFEVTVINHGDVVPWRFPPKNEYLYGEWLRDEFENG
KIPEPTYDPDLAIVLAQVIKNSVPLFGSDASDVLDPVPMADIRRAIMESLPGLMEGIKGD
ERNVLLTLARMWLTVAVGEIASKDTAAQWAIPQLPTEHATLLNLARKAYRGEYVDKWEGL
DREVIALVNHMKNSIESYLRI
>A0A127SYN2|FEATURES|UNIPROT_deepARG|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLFYLATIVNRHSEFRTAINQEGELGIYDEMIPSYTIFHE
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>A0A0P9R2B4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIDKLAPDFIFSFYYRQLLGDPLLACAKKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDETRASCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>A0A0A8GZU4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIEYYYALILGIIEGLTEFLPVSSTGHMILGAEILRLEINDFWRSFFIVIQLGSILAVV
FIFKDKLTRKIDIWLKLAVGFLPAGGVGFIAYKFLKELFNGYTVATMLILGGIVFIIVEL
KHRKKDYNIHSLDEVSYKQAFLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKVASEFSF
LLAIPTMIVATCYSIYKEPEILSNINNFIPIAIGFITAFIVAFVVIKIFLKLISKIDFIP
FGIYRIILGFIFLWLFTSGMLDITKTSI
>A0A0Q4TAR0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAMSIVKAVVLAVVEGATEFIPVSSTGHQLLVGHFIGFQSPNNTFEVLIQLGAILAILA
VYFRRLLGIAVAFPSDPNARRFVLGILLAFLPAAIIGGLFSKYIKFYLFNPWIVCATLVA
GGLVLLVLDETDLEVKKRDVFDFTLPMDFRIGLFQCIAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAIPTMAGAFAKDLLDNYKNLSQDDFGLIAIGFVVAFLSAFVVVRTVLDYV
SSHGFRLFAWWRIIVGSLGFAGLILFG
>A0A0N8VXB2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFLEIIKAIILGIVEGITEWLPISSTGHMILVDQFLKLNVSKDFMDMFLVVIQLGAILA
VIVLYWGKIFPFKFSNGIKIEKDTMIMWVKIVIACIPAAVIGLLFDDQLNELFYNPTTVA
VMLILFGILFIVIENYNKGKRSKINSLSEITYNVAIMIGLFQLIAAVFPGTSRSGATIVG
ALLIGVSRTVAAEFTFFLAIPVMFGASALKLLKFGLATGFTMTGNELSILLVGMIVAFIV
SILAIKFLMSYIKNNDFKAFGWYRIILGIIVIAYFYLIK
>A8FC48|FEATURES|UNIPROT_deepARG|chloramphenicol|BPUM_1131|antibiotic inactivation|1
MFKQIDENYLRKEHFHHYMKVTRCSYSLVIDLDITKLHSIIKEKKLKVYPVQIYLLARAV
QKIPEFRMDLVNDELGHWELLHPSYTILNKETKTFLSIWTPYDENFAQFYKSCVADIETF
SKSSKLFPKSHMPENMFNISSLPWIDFTSFNLNVSTDEAYLLPIFTIGKFKVEEGKIILP
VAIQVHHAVCDGYHVGQYVEYLRWLIEHCDEWLNDSMPIT
>A0A127T2F4|FEATURES|UNIPROT_deepARG|beta_lactam|OXY-1-1|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRTQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>A0A059WJK3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
MNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLT
LGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDR
APLILVTYFTQPQPRQKC
>ZP_03949893|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MYFAFISERNGDMLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLDLSKDFMEM
FNVVIQLGAIMAVVILYFHKLNPFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDY
LDAHFYNFLTVSIMLIVYGIAFIIIEKRNKNVTPKCTNLKDFTYKAALIVGAFQVLALIP
GTSRSGATILGAILIGASRFVATEFSFFLGIPVMFGASFLKIFKFLAKGNTFGSEEIIIL
LTGSIVAFVVSIIAIKFLLNYLKKNDFTVFGWYRVILGAILIGYWLFS
>A0A080JV51|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLLEIKGVNRWFGHGESRVHVLKDINLSIEKGDFVAIIGQSGSGKSTLMNIIGCLDVPS
SGSYKIDSVETAAMSGDQQAALRRKSFGFIFQRYNLLGSLTARENVALPAVYAGMDLSER
QQRAQELLDQLGLSGKENNKPSELSGGQQQRVSIARALMNGGEIILADEPTGALDTASGK
NVMEILHGLHEAGHTIVMVTHDPGIAANANRVIEIRDGRIIADHSKSLDIAPSNITSIEE
KNSWLFYKDQLFESFKMSVQAIKAHKMRSFLTMLGIIIGIASVISVVALGRGSQEKILKD
INAIGTNTISVYPGKGYGDRRSSRIKTLTVADANSLKEQPYVDSVTPGVGMKGTLTFANQ
SLSAQLNGVGDQYFDVRGIKLAYGRLFDEDDVTQNSQIVVIDDNTKNKLFSDGTNPIGQV
ILFNKRPLQVIGVAQPNNTGFGDTDSLQMYTPYTTLMNRISGTKYITSVTVKIKDNVNSQ
TAEKGIIELLKARHGTEDFFTRNSDTIKQTIESTTGTMTLLISCIALISLVVGGIGVMNI
MLVSVTERVKEIGIRMAIGARQHNILEQFLIEAVLICLIGGLVGVLFSFGISVLFNLFAK
DFAMSFSTISIIMAVLCSTIIGVVFGFMPAKRASQLNPIDALSRD
>A0A0K0I004|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFGVFKRSELKGKKIMNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKEIIT
PEAANTFKVVIQLGSILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPA
VILGFLFEDYIDKYLFDVRTVAVGLILGAVLMLVADWINKRKTETSSVDNMTYRQALYIG
LFQCLALWPGFSRSGSTIAGGVILGLNHRAAADFTFIMAMPIMAGASLLTLVKNAEYLTP
DMLPFFIVGFVSAFVVALFVVRFFLKLINKIKLVPFAIYRIILGVILFFLFM
>A0A0A1W7A6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDLIAAIILGIVEGVTEFLPVSSTGHLILAGALLGYDDARWQMFNIVIQLGAILAVVVL
YWRTFWTVMVGLAKRDPGSIRFVCNLLIAFMPAAVIGVLAKKHIEALLLQPKVVAVALIV
GGVAILVIERVVKPGTTRGIAAVPAKTALGVGFLQCLAMIPGVSRSGATILGALTLGVER
RTAAEFSFFLAIPTMLGASVVETAGHLDAMRAGNSVGPLEIAIGFVVAFIVALLVVRWFV
GIVGRHGFGPFAWYRIVAGSIALALLTMH
>A0A0G3QIQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMILVGHLLGFEGETAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPHEGTGTGRLTLIHILLGMLPAVVLGLVFHDAIKSLFTPIN
VMYALVVGGVLLIAAECLKPKVPRAEGVDDITLRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSLKFLTVGDIPMFAVGFVMAFIVALIA
IKTFLELIKRISFIPFAIYRFIVAAAVYFIFI
>BAC67152|FEATURES|ARDB_deepARG|tetracycline|tetY|antibiotic efflux|1
MSKSLITALIVVALDAIGLGLIMPVVPALLNEFVPAEQTAFHYGVFLSLYAFMQVFCAPV
LGRLSDRYGRRIILLVSFLGATIDYSIMAAAPVLWVLYIGRIISGVTGATGAIAASIIAD
TTKQEERARWFGFMGACFGAGMIAGPAIGGVLGDISVHAPFVAGALLNAIAFCLVAFLLP
KASSQPPEGQPAKINLFEGFRFNFAVQGLTSFFALFFLMQLIGQAPAALWVIYGEQRLNW
DIGTAGVSLAIFGAAHTFVQAVLTGTLSKRLGDRGVLLLGMGADICGFLLLAFITQSWMV
LPAIFMLATGGIGMPALQAIISGLVRDEKQGALQGTLTGLTNITSIIGPVGFTTLYGLTA
GRWDGWVWLVAASLYFIAIPLLRQSASLLRS
>A0A0P6RR71|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRCVSIVIPVYNEQDSLPQLLRRTEAACRMLRYDYEIVLIDDGSRDDSANLLEEA
ATREDSPFVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLIAEAEKGY
DVVGTVRGNRQDSALRRYPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIIDAMLACRERS
TFIPILANSFARHTTEIVVAHAEREHGDSKYSPMRLINLMFDLITCMTTTPLRLLSIVGF
AMAGLGVLFAAALIVLRLVFGAGWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFVEKVLRGQPAMPPRAITVDGLSSSNDQVLS
>A0A0F5LS10|FEATURES|UNIPROT_deepARG|aminoglycoside|SAMN02745223_02496|antibiotic inactivation|1
MIVAPATAADLADWADLRQALWPDDGLDGHRAEIAGMLAAPDLANFIARTEDGLAAGLAE
ASLRRDYVNGCETSPVAFLEGIYVMPEYRRSGIASQLVAAVEDWARTRGCSEFASDASLD
NLRSHAMHAALGFEETQRVVYFRKVLD
>YP_002366749|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHISRNEI
HQSYTHIAFSVEQEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>A0A0F2NVH1|FEATURES|UNIPROT_deepARG|aminoglycoside|VR73_12885|antibiotic inactivation|1
MVIRAAHRHDLPAWSVMRTALWPNTGDGHLAELRAYFAGASTDIVEAFVVEIGQGRLAGV
LEMNIRNFAEGSRSPQRLYVEGWFICEAYRGMGLGKALIARAKQWAIERGYHELASDTEV
DNTHSIALHKALGFRETERIVCFLKNLAPSS
>D2JEK2|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSTHAKKLNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQIPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>G5LBR7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYDIAAIFTHADNPAENTFFGSVSQLAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLDWEPSIAMRDTVEETLDFFLRSVDIAERAS
>E0M3E7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDLGCVGINALLSAGYEITAIFTHNDVATENHFFGSVARLAAEHGIPVYAPD
EANHPIWLDRIRTMAPEMIFSFYYRHLLSDEILQCAEKGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVKRADAGNILAQQKVAIEDADNALTLHRKLTQAAEQLLNDVLPRL
RTGEVSETPQDESQATCVGRRTAEDGRIDWNQPAEKIHNLVRAVTDPWPGAFAFAGSVKF
IVWKSRVHTHPHQAKPGTVISKQPFLIACGEGALEILTGQSEHGVYMNGSQLAQSLGMVP
GALLYSKPQSALQRRTRVLILGVNGFIGNHLTERLLQDEHFEVYGLDISSDAISRFLEHP
RFHFVEGDIAIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCTDASFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
QDGVEALFRIIENKQQNCDGQIINIGNPDNEASIKELAEQLLASFERHPLRSQFPPFAGF
REVESSSYYGKGYQDVEHRKPAIRNARRLLGWTPTVTMDVTIDNTLDFFLRTVEQQADK
>A0A0N9WKV1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPIARSILAGIFFLVCGTSVSFAQERIEDTVNAVIQPLMKQQDIAGMAVAITYNGQRHYF
NYGVASKDTKKPVTDQTLFEIGSVSKTFTATLGAYAQAQGKLSLADPASRFAPELRGSAM
EGTRLLDLATYTAGGLPLQFPDEADHPDRMFSYYKNWKPLYPAGTQRLYSNPSIGLFGYL
AARSLGQPFDEVMERTLMPGLGLKHSYVRVPQDQMGRYAQGYAKDGKPVRVGTGALDSEA
YGVKTSSTDLIRFVEANLRPEKLDADLKQAIATTHTGFYKVGGMNQGLGWEFYLAPFTLD
DLLAGNTPQMALAPQKVESLDPPRPAPDGAWINKTGSTNGFGAYAAFVPGKDMGIVLLAN
RNYPIEERVKAAHRILMALDGQ
>YP_857635|FEATURES|ARDB_deepARG|beta_lactam|CepS|antibiotic inactivation|1
MDNPLNLYDLVGDFTQTSPCFMLGTRWPVRLAAPEHTEILAMKQTRALPLLALGTLLLAP
LSLAAPVDPLKAVVDDAIRPVLKQHRIPGMAVAVLKGGQAHYFNYGLADVATGAKVNEQT
LFEIGSVSKTYTATLGAYAVVKGGFKLDDQVSGHAPWLKGSAFDGITMAELATYSAGGLP
LQFPDEVDSSDTMRAYYRHWTPPYQAGTQRQYSNPSIGLFGHLAASSLQQPFSTLMEQTL
LPALGLEHTYLQVPEAAMARYAFGYSKEDKPIRVNPGMLADEAYGIKTGSADLLAFVKAN
ISGVDDKALQQAIALTHTGFYRIGEMSQGLGWESYAYPVSEQTLLAGNSPAVSLKANPVT
KFETPAAPGAMRLYNKTGSTGGFGAYVAFVPAKGIGIVMLANRNYPIEARVSAAHAILSQ
LAP
>Q1I6P8|FEATURES|UNIPROT_deepARG|aminoglycoside|PSEEN3982|antibiotic inactivation|1
MIHPCTNPTTPAWLHLRSALWPDSAAAEHLAEMADIARRPDTFVALLAYDEQGGALGLAE
ASVRHDYVNGSTTSPVAYLEGIFVEPARRGQGIARQLIAAVERWAAGKGCRELASDAALD
NLGSQHMHAALGFAETERVVYFLKPVTPLD
>A0A0F6C6V8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHILVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREYGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A023ZU08|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A096AF70|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLIQTIIIAIVEGLTEFLPVSSTGHMIITQNLLGVKQGDPFVHAFTFIIQFGAILSVVC
LYWKKFFSFKHVPSYEEDDGKTPFMRFINFYWLLFIGCLPAGIVGLVAKKSGLLDWLLDS
VSVVAITLVLGGFFMLFCDKIFNKGREENKVTVRRALSIGLFQCLSVIPGMSRSMSTIVG
GMANGLTRKRAAEFSFFVAVPLMAAATVLDLFDLMKEGTGWVTTHNLTVLGLGCVVAFVV
ALLAMKWFVSFLTKYGFRMFGWYRIIVGGIILALLAMGVDLNMVG
>A0A0A0Q8Q4|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-7|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGKPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>YP_002095805|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MLEDQKMNNLHNTNGLMRFAKVAAARHPARDAARRVRGRPPTTSVRTRRRPPRSEEAPTL
AAGEQAGTWKTAEPADGEHRGEWWKVFGDPVLDSLETQALAANQNLKAAAARVEEARAAT
RSARSQWFPQVGAGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVGRN
VEASRADQAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELREQALKLVQRR
FNEGDISELDVSRAKNELASAQADAVGVARRRAASEHALAILLGKAPADFAFKETPIVPV
AVKIPPGLPSALLERRPDVSAAERAMAAANARIGLAKSAYFPKLDITGSFGYEASTLGNL
FLWSSRTFLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDN
LADLRLLDDQIRAQEAAVNASRRAATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLT
GAQAVSTVNLIRALGGGWGNAPAPTAVGDAASGKADVAAR
>D0J984|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MNYIQSILLGIIEGLTEFFPISSTGHMILTASIMGILEKKITKLFLISVQLGAVFSVVFF
YRKKIFFQKADFYLKIFLASFPIGIFGFFLNRRTNFFLGNPLIVAFFLIIGGIILLKVEN
VYEKNFDKSNQINYFQAFIIGLCQCMALIPGVSRSAATIVACLLQNVHRRKAIEFSFFLS
VPVIVIATCKKLFDYYFQLTSFSFPWNFRIIIPMSKEFFLQEIQFLIIGNIVAFITGILS
IKCFMAYLKRNNLKLFGYYRIILGLVFIVIHYFFQPIEKFKF
>A7FE74|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDMYSLFVAFILGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGAVPHEGKTNGHLTLGHILLAMIPAVILGLAFHDVIKALFDPKS
VMYALVAGGVLLLAAEWLKPKNPKAVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTLGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFIVAAVVYWVFM
>A0A0D7KSL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWWDMFVGFILGVVEGLTEFAPVSSTGHMILVDDFMLHSKEIFSPQMANMFKVVIQLGS
ILAVVVVFWDRFFQLLGLKRAPIDPELGRAGHSRLKLTQVLVGLIPAAVLGLLFEKYIDQ
YLFSIQTVLIGLVLGAVLMIAADWFRPAKPTAKTVDQVTYKQAFGIGLFQCLGLWPGFSR
SGSTISGGVLLGMSHRAAADFTFIMAVPVMAGASGLSLLKHWKDFSMDALPFFIVGFISA
FLFALISIRFFLKLINRVKLVPFAIYRIVLAAVIYFVFL
>YP_002413233|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALANTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>A5KGJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLYALILGIIEGLTEFVPISSTGHMILGTTILGIDIDEFWKSFLIIIQLGSILAVIFV
FWRKLFQGLDIWLKLAVGFFPTGVIGLFVAKYLNALFNGCVVVGMLIFGGVVFILIELAH
KNKQYRINSLEEISFKQAFCIGIFQSLAMIPGTSRSGASIIGGLLLGFNRKVAAEFSFLL
AIPTMIIATAYSIYKEPELLGNANSLIPLGIGFITAFIVAVLVIKFFLKFISKFDFIPFG
IYRIILGFVFFYLYYSGILNAGSEFKL
>V7GZ39|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
VGGVVLLVVDRMKLQPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFIAAFVTALIVVRFLLDY
VSRNGYSLFGWWRLVVGAVGLVALFIWG
>A0A071M9H4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MRQPLLKLAAVTRRFPAGDKDVVVLNNVNLSIDAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDGLAQLRREHFGFVFQRYHLLPHADAVANLEMPAIYAGTPRA
ARHARARELLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQEVLRILHELNALGHTIVIVTHDKTVARHARRIIEISDGEIVADRPNRHYAEALAEAGI
DTAEAAATATAAGSSPAVDRHDTATPADANANADTDPAPRAPRFAAGTGRFAEACRMAWI
ALVSHRLRTLLTMLGIIIGITSVVSIVAIGEGAKRYMLDEIGSIGTNTINIYPGTDWGDS
RADTIQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNVDVNALVSGVGDRYFQARGMR
FALGAAFDDDAVRRQAQVAVIDQNTRRKLFGATRNPVGDVILVDNVPCVVIGVTADKKSA
FGSVKSLNVWVPYTTASGHLFGQRYLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFF
TYNMDSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGA
RQSDILQQFLVEAVLVCLLGGTIGIALSFGLGALFSMFVVQWKMVFSAGAIVTAFVCSTL
TGVIFGFMPARNASRLDPIDALARD
>CAJ65586|FEATURES|ARDB_deepARG|beta_lactam|VIM-1|antibiotic inactivation|1
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIQHSLEGLSSSGDAVRFGPVELFYPGAAHST
DNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGHG
LPGGLDLLQHTANVVKAHKNRSVAE
>M2VLF5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWVAIQALILGVVEGVTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRRKILDVVIGLPRESQAQKFTLNLLIAFMPAVVLGVAFADLIHEYLFNPITVATALV
IGGVVMLWAERRDHTIRAETVDDMNWALALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDFAVFAVGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIGFGLLILATWQFGLIDWASAQG
>A0A0U2TZA9|FEATURES|UNIPROT_deepARG|beta_lactam|blaKPC|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELELNSAIPGDARD
TSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCG
VYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>A0A0S1LLA5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-169|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A142NBA4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALV
IGGIIMLWAEQRQHEVHAETVDEIRWTDALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IGSHSYAAFAWYRIAFGLFILATWQFGWVDWSAAKA
>A0A0B5ILQ2|FEATURES|UNIPROT_deepARG|beta_lactam|TE10_15580|antibiotic inactivation|1
MRHSLFAPILLLALFALPAWAHEATVNQVKAAERQLEARVGYAELDLASGRLLASYRPDE
RFPMMSTFKVPLCAAVLARVDAGEEKLDRRVRYRQQDLVEYSPVTEKHLADGMTVAGLCA
AAITLSDNTAANLLLASVGGPQGLTAFLRRSGDQTSRLDRWETELNEALPGDARDTTTPL
AMAKTLRNLLTGSVLSAASRQQLRSWMVDDKVAGPLLRSALPHGWFIADKTGAGNRGSRG
IIAALGPDGQPARIVIIYLTGTEASMDERNRQIAEIGETLVKHW
>X6EF20|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFQSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVVGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLVVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLTSADLPIIAIGFVAAFVTALVVVRYLLDY
VSRNGYSLFGWWRLVVGIAGLVALMIWG
>ZP_03003660|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALGFVSLPLLAWIAQS
PIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVA
AAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLIFT
VGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>J8I825|FEATURES|UNIPROT_deepARG|beta_lactam|IIG_02323|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSESPKQTTQEHISNQSFVKLEKDY
DAKLGIYALDTGTNQIVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDTKYDDKLIANATKI
VLDALKVTNKS
>A0A0E0TS48|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIDFHSNHKVFEIAIQLGAVLAVVF
EYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEHLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIADVDALRPIDALMIGVAQVFALVPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFIAAFVSGLVAVKALLK
FVSKKNYIPFAYYRIVFGIVIIILWLSGWISWE
>A0A066T0N6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKALPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0P7ILA3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MGFIECKGINRYFGSGDSRVHVLKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAS
SGSYTIDGVETAQMTADQLAGLRRKRFGFIFQRYNLLSALNARDNVALPSVYAGLEKADR
SRRADKLLHDLGLEGKENNKPSELSGGQQQRVSIARALMNGGEIILADEPTGALDTQSGD
NVMEIIHSLHARGHTVILVTHDPKIAANANRVIEIRDGEIISDISKNAEVPPSNVGSIRE
NTSWLFFKDQFIESFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGKGSQEKILKD
ISAIGTNTISIRPGRGFGDRQSFRIRTLTIADADAISKQSYVDSVTPMVASSGTVTYRNI
DVTAQLFGAGEQYFDVRGIKLAEGRLYDADDVTNNNQVAVIDDNTKNKLFSDGTSPIGKV
ILFKKRPLRIIGVTEKDTSSFGSDDNLQIWAPYTTVINQISGQRYINSITVKVKDDVNSQ
AAEKGLDELLLSRHGVKDFFMQNSDSIKQTVESATGTMTLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGVRMAIGARQSNILQQFLIEAVLICLLGGLSGVLLSFAISLVFNHFVT
DFAMTFSTLSIVAAVTCSTIIGVVFGFMPAKRASQLNPIDALAHD
>A0A080IUY5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAGRGIPVYAPD
DVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVTRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTFPAI
KHGNILEVAQRENEATCFGRRTPDDSFLEWYKPASVLHNMVRAVADPWPGAFSYAGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0Q7G8Z8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFVPAVVLGLLLSDFIDGLLENPVTVAISLLIGGLILLKVDEW
FNNPNTTETSQEITYLQAFKIGLFQCIAMIPGVSRSGATIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATVKKCYDYYKAGFELSHDQINLLVIGNVVAFIVALLAIKTFIGFLTKNGFKV
FGYYRIIAGIILLIIHFFIHPLTIL
>A0A0E1LV27|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDLGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVTGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>1405331A|FEATURES|ARDB_deepARG|aminoglycoside|str|antibiotic inactivation|1
LEGSRTNENIKKDKFQDYDFAFFVSDIEYFTHEESWLSLFGELLFIQKPEDMELFPPDLD
TGYSYIMYFKDGIKMDITLINLKDLNRYFSDSDGLVKILVDKDNLVTQEIVPDDSNYWLK
KPTEREFYDCCNEFWSVSTYVAKGVFRREILFALDHFNNILRPELLRMISWYIGFNRGFD
FSLGKNYKFINKYLTDKEFNMLLATFEMNGYRKTYQSFKLCCELFKYYSNKVSCLGNYNY
PNYEKNIENFIRNNYEN
>A0A124EMB2|FEATURES|UNIPROT_deepARG|beta_lactam|AU188_10735|antibiotic inactivation|1
MIRLSRRHVLIGGLTLAAVAACTEKQAVADPRPVPLIDARIGELERQHNALIGVFAVNLD
TGRTIAHRAQEPFAMCSTFKGYAAARILQKAERGELALSDRVAVEQSDIVPNSPVTQTRV
GQTMTLAELCEAALQRSDNAAGNLLLGVIGGPPAITDFARSIGDQRSRLDRWEVELNSAV
PGDPRDTTTPEAIGGGYRSMLTGAALAEPQRRLLEDWMRANQTSSVRPALPPGWTTADKT
GSGDYGSTNDVGVAHGPDGRRLLLAVMTRSAGNDSNAPNMRPLIGELAALLVAALLA
>A0A124DWG9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSEEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIIAQQSVAISSDDVALTLHHKLCQAARHLLEQALPAI
KAGDYAERPQQEAEATCFGRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCTNDLAAQPGTVISVSPLLIACADGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTSKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPENEASIQELAEMLLTCFEKHPLRQHFPPFAGF
RDVESSTYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>YP_001437965|FEATURES|ARDB_deepARG|beta_lactam|BL1_sm|antibiotic inactivation|1
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDENTLFEIGSLSKTFTATLASKAQQDGKLDFSAPASQYLPALKGSAFDHVTL
LNLATHTAGTPLFVPDAVKNTTQLMDWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALD
KPFSEAMEQGLLRDFGMTHTFINVPVAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEQEVAPGWRQAINATHNGYYRSGEFTQGLMWEYYPWPSPLSRLVEGN
SSQRIMKGLAATAIVPPQPAPQAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRIKAAYAIIQELDK
>A0A0B4W9I9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIIFILKAIIIAVVEGLTEFIPVSSTGHMILVGSAINFNGEFAKMFEVIIQLGAILA
VVVLYWEKIKKSVVEFFKFIFTKGKEGKTGFKFGINVIVGSIPIGITGLLFYHKIKALFR
PEAVIIGFIVGGILLLIIENMFRKKEHAVQDIDSITFIQALKVGLLQILSVWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTPTLWSALILGFAVAFI
VSIIVMNKFVSYLKKKPMKVFAIYRVLAGLLLAVLVFTKIIVLTA
>A0A0G0NDZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFFSATILGAIEGLTEFLPISSTGHMILAGRLMHLPATAFQSTFEIAIQVGAIMAVAWL
YWRKLLLNRETLQKVLVAFLPTMIIGFGLYKIFKSFLAGNTAVTIGALFFGGVFLIIFEK
FYQHSSQSESASNQISYRQAVILGLCQSLAIVPGVSRSASTIVGGLALKIKREAIVEFSF
LLAIPTMLAATAYDLYKNASSFSGQQFELLIVGLIVAFLVALLAIKFLISYIQKNDFTAF
GWYRIIIAIVAYLILF
>A0A0W0HVG5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNSKAVVFAYHDIGCAGIEALLTAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDFIFSFYYRNLLSEALLATAKKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVIIDRTDTGLTLHAKLRDAATHLLRDALP
QLAQGKLAETAQNESQATYFGRRTAADGKLDWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEIYGLDIGSDAIERLR
SHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLKEAMLEIA
DKK
>A0A0D8WDX8|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMATMGIAVLMLSLFILKE
TRPAAPTTSDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMLTSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>D2BFP8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSPDLTVSIEELPVSGRDAGPYGITTGPDGALWFTMVHHGRIGRMTPGGELTSHQLDPAS
CGPTVIASGPDGALWFTEYQSHRIGRITTAGEIGSFALPSPDAGPFGIAAGADGAMWFTE
TNAGRIGRITTGGEVTEFPLPVPGAFPSAIAAGPDGAMWFTMNQADAIGRIGLDGDVTVH
PLPTAGAAPVGITAGADGAMWFVEIGAGRIGRITTGGRIDEFPLPDRGARPHAIAVDGHG
DCWFTEWGANRVGRITPDGRIDGYGLPTPASEPHGIAAGPDGTIWVALEIGALARLTPSG
PR
>A0A0A3IM63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLELLKALILGFVEGMTEFAPVSSTGHMIIVDDLWLKTTEFLGQGSANTFKIVIQLGS
ILAVVVVMWKRILSLVGLYKIEGQEKTKFNLGHVIVGIIPAGLFGVLFEDYIDENLFGIK
TVIIGLFIGAFLMIIADKFGPKRPKITSLDQISYAKALKIGLIQCLSLWPGFSRSGATIS
GGVLLGLDHKTAADFTFIMAVPIMAGASGLSLFKNWDQINMDHLGFYAIGFISAFVFALI
SIKFFLKLISKVKLTPFAIYRIVLALILMAVIYL
>J8K676|FEATURES|UNIPROT_deepARG|beta_lactam|IIO_01657|antibiotic inactivation|1
MKKNTLLKVGVCVSLLGLTQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIRTLKERGIKAHSTALTAELAKKNGYDEPLGDLQTITNMKFGNMKIETFYPGKGHT
EDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNMNVVLPGH
GEVGDKGLLLHTLDLLK
>M4YZY4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSDTLRAVLLGIVEGVTEFLPVSSTGHLLLAERFFGLGEDGFWKSFAILIQLGAILAIV
ALYFFKLYRVAIGALTNPDDRRFIIGVLIAFLPAVVIGLIAGKYIKALLFDPWIVCFSLI
VGGAILLWVDQIDLKPREHDATRYPLMMYLWIGVAQCLAMIPGVSRSGSTIVAAMLLGGD
KRSAAEFSFFLAIPTMVGAFVYDFYKSRAEMTSDHLGLIAIGFVVSFITAMIVVKAFLGY
VTRHGFVLFAWWRVIVGTLGLIALALGK
>B1G8F0|FEATURES|UNIPROT_deepARG|beta_lactam|BgramDRAFT_5618|antibiotic inactivation|1
MKLKAVSLMVTLLFALGAPAQASRAASEGEAERQVKSVVDSAIEPLIAKHHVPGMAVGIV
ANGKTYVFDYGMASAETGKPVTQRTLFEIGSVSKTFTATLAEYAQLNGHLRLSDPTQTYL
PSLRGSAFGKVSLLNLATHTPGGLPLQVPDEIHDNAQLLQYFSTWKPAYAPGTYRTYANP
GIGTLGLITAKSMNQDFASLMEQRLFPALGMTSSYIHVPPTKMSDYAQGYTKDGAPIRMK
GGVLADEAYGVRTTAADMLRFVQANMNLIDVDSQLQRAITATHTGYFKAGVLTQDLIWEQ
YAYPVTLTTLHEGNAPAMATTATPVIAIEPPLLPQQNVWINKTGSTNGFGTYVAFIPQKH
VGVVLLANRNFPIEDRVSAAYRIVSALVASKQ
>A0A085FM26|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFITNRIAAPFALAAVTTCFSSIVAFAAEPPAAIAAAVDAAFRPLLEQHGVPGIAVGVTM
DGQQYFFNYGVAAKDTGALVTENTLFELGSVSKTFTATLGAYAEALDRLELDDHPSKYLP
ALEGAAVDEASLLHLATYTAGGLPLQFPNGAGGMESYFQQWRADAAPGEQRRYSNPSIGL
FGHLTALALNDDFGHLMETEMFPRLGLEDSHITVPEAAMARYAWGYNKDGKPTRVNPGWL
AAEAYGVKSSTADMLRFVEANIAPDSLVPLVQRAVEGTHIGYFRVGEMVQGLGWEQYPFP
VSLERLLAGNSQTMAMEPNPAEALAPPAAPEGPALFNKTGSTNGFGAYVAFVPDKKIGVV
MLANKNFPIPARITATHAVLEQLAEAAD
>A0A0B6FP66|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDIYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLAFHDVIKSLFNPQS
VMYALVAGGLLLLAAEWFKPKNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASALDLYKSLHFLSWGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFIVAGAVYWVFM
>A0A0A7XPA3|FEATURES|UNIPROT_deepARG|beta_lactam|RR32_05590|antibiotic inactivation|1
MQFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLIDQNFKPLLEKYNVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFNDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETHQGRYQVNSMYQALGWEEFAY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYAVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>Q84GI1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQEISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGE
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNRETVQDKNLRQGIQLAQSRYWRVGEMYQGLGWEMLNWPVSA
EVLINGSDNKVALAATPVTAVNPPAPPVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHILEALQ
>G8GMB6|FEATURES|UNIPROT_deepARG|beta_lactam|IMP|antibiotic inactivation|1
TAAESLPDLKIERLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNTEAYLIDTPFTAKDTEK
LVTWFVGRGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSF
GGVSYWLVKNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPK
SAKLLMSKYGKAKL
>H2B2N8|FEATURES|UNIPROT_deepARG|beta_lactam|oxa1|antibiotic inactivation|1
MLAVKIKPFTKPILIMIFTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFL
LYDASTNAEIAQFNKAKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIW
NSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLE
SSLEISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRT
LQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>N1WQW5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFSGENFGIAFDDLFDIFIQSGAIL
SVLFLYREKFGSQIVSSFRYVTKQNSDPQGYYFLLQIAIGAFPILAAGFVAKKFLDTIKM
RPDLLDILASAWIFGGVLILVAEWFFHKKQNGSERKPVGFQDAILIGVFQCVALIPGISR
SAATIITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLVKYRSILNGTTIPVLVFGFLIS
FFLCTLVIRWFLHYLQKHSFGSFGVYRILLGVGVLVFTKFIR
>A0A0Q7K2T7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGLNHLLFSVSNLENSISFYQQVFDAKLLVKGRSTAYFDLNGMWLALNVERDIPRNE
INHSYTHIAFSIEEADFEELYEKLKKLHVNILPGRLRDEKDKRSIYFTDPDGHKFEFHTG
TLQDRLDYYKQEKTHMVFNDE
>B2I576|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLSLLWLSTIPPMFELFTALMLGILEGITEFLPVSSTGHLLIAEHWLGSRSDFFNIVIQA
GAILAITFVFRKKVWSLATGLDKYSNRDYVMKLATAFLITAVVGLAVRKANWQLPETIQP
IAWALIIGGIWILIAESVAKHLPERENVTWSVAIAVGLAQVVAGVFPGTSRSASTIFLAM
LLGLSKRSAAAEFSFLVGIPTMFSASSYACFELFKRGELLHENWLEVSVAFVAAMLTGFA
VVKWLLGYIKNHSFAPFAYYRIALGLVLLTWLT
>I7AK71|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-11|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVXLCGAVLARVDAGDEQLERKIHYXXXXLVXYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAG
>A0A0U0CSS9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGSLMNLEAANSFKVVIQLGS
ILAVAIVFKDRILHLLGLKKNVTRDQQKGYRLTIAQIAVGLVPAAVLGFLFEDFIDRYLF
SVRTVAYGLIAGAVLMLIADWINKRKETIDTVDRITYKQAFCVGLFQCLALWPGFSRSGS
TIAGGVIVGLNHRAAADFTFIMAIPIMAGASLLKLVKYWSSLSYDMIPFFLVGFICAFVV
ALLVVKFFLRLINRIKLVPFAIYRVILGIILIMLVR
>A0A0E1AMS5|FEATURES|UNIPROT_deepARG|aminoglycoside|U769_04250|antibiotic inactivation|1
MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAE
LPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAVPGDTLSALAQRGELEPERLVRL
VAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLL
DRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAA
WAEDFLVEYGGDIDGERLAYFRLLDEFF
>W4CI98|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTSKLLGFDEQDSIMKTYEIVIQLGAILAIAL
VYRERVLNLLGIGRKNSGRGGVMPASRLNLIHVILGIAPALAVAFFARDFIKSLFGATTV
LWALVAGGILMIIAEWVNRRKIRVTAHELDDLSYGQALAIGMYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKNFTSETIGYFVIGFLISFVVAY
VVVILFMKLIQKIRLTHFAIYRFILAAIFWLFIMR
>A0A155W1R0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIATIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWVERISQLAPDVIFSFYYRHLLSDEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRVAISPDDVALTLHHKLCQAARHLLEEALPAI
KTGDYAELPQQEAEATCFSRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCTNDIAAQPGTVISVSPLLIACVDGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTSKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPQNEASIQELAEMLLSCFEKHPLRNHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>A0A075P912|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIETLLSSGFDIAAVFTHADDPKENAFYGSVAQQCARNGIPVHA
PEDVNHPLWIERIAKLNPDYLFSFYYRHLLSEPLLATAGKGAFNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAILAQKKVAIECSDTALSLHDKLRVAATDLLRDTLP
ALLAGKVSEIPQDESKATTFGRRTPADGKLIWQKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISVDPLRLACGEDSLVISAGQRNDNGLYLSGPQLAGELG
LVDGSLLRGAESGRTPRHTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVILQLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDDKFDEDTSNLVVGPINKQRWIYSTSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A0S3BX12|FEATURES|UNIPROT_deepARG|chloramphenicol|ATN06_11665|antibiotic inactivation|1
MKFHVIDRENWNREKYFEHYLELKCTFSMTVNVDITLLIKEVHQKGITFYPTFIYIISRI
INKHKEFRTCFNEEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSRDFRIFYKNYEEDMR
CYANVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>A0A0Q6PZW3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACQQLHHDYEIVLVDDGSRDNSAQILEEA
AHRECSSVVAVILNRNYGQHAAIMAGFEQCKGDVIITLDADLQNPPEEIPRLVAQAELGY
DVVATVRNNRQDSALRRWPSKLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVPHAEREHGESKYSPMRLINLMFDLITCMTTTPLRLLSIVGF
GMAALGVLFAITLIVLRLAFGAHWAGDGTFVLFAVLFIFTGGQFIGMGLLGEYLGRMYGD
VRARPRFFIEKVLRNQPAAPAPVVTVDGLTSISSDQVHS
>A0A106DT67|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIASVVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
AGGAIILWAEARQRERSEPPRVQSIDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPIIFGATLYETVKDWQAFSVDSLGLFALGLVAAFVSAFVCVRW
LLRFVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A078BLD5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAHSAIVVVILGLVEGITEFLPISSTGHLILAASLLGWVSDKAKVFEIAIQSGAILAVM
WHYRVRIGEVLTGLAAAEPARRSTAWRFAINVLIGFIPAAILGLLFASAIKRWLFAPVPV
ALAFIVGALVIFWAEAWQKRSTQHVRIHHVDDMRASDALKVGIAQAFALIPGTSRSGASI
IGGMLFGLSRAAATEFSFFLAIPTLLAATVYELYKNRALLSLSDVPTFGLGMAVAFVSAL
MVVRWLLRYVGGHSFVPFAWYRVVFGALVLVTAWGGWVNWSG
>A0A098FLS8|FEATURES|UNIPROT_deepARG|chloramphenicol|BN1180_04911|antibiotic inactivation|1
MKIGFEKSTLNTIYNNKQHSDITNEMNITVLMENLKKQNYKLYPAFIFMVTKIVNSLREF
RTSFNEEGNLGYWSEVLPSYTIFDKKTSTFSSIWSPNGSRFSEFHSQYEKDVEEYNGTGS
LFPKTPIPDNHIPISMIPWSSFTAFNLNINNGGDFFLPIITGGKYSQIKDEWFLPVSLQI
HHAVCDGYHASVFMNDFQRFADESADWL
>BAG76424|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIQQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>A0A0N1UZ90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTSGQLKLGHILLAMIPAVVLGLAFHDFIKSLFAP
KNVMYALVVGGLLLLAAEWLKPKKPSAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTI
AGGMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTWGDLPMFAVGFVTAFVVAL
IAIKTFLSLIKRISFVPFAIYRFIVAAVVYMVFL
>CAC41009|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISISAMYPGADPQTVQNT
VTQVIEQNMNGIDHLMYMSSNGDSTGTVNITLTFESGTDPDIAHVQVQNKLALATPLLPQ
EVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANAL
DTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRY
LVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTK
EKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITARAMGYFSQIKDA
MVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGL
EDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRM
LPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSLEILGQAAPGKSTGEAM
ALMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFF
VPVFFVVVRRRFSKKSEDIEHSHQVEHH
>A0L0U4|FEATURES|UNIPROT_deepARG|beta_lactam|Shewana3_3440|antibiotic inactivation|1
MRALALSAVLLVTTMIGMPAVAKEWQENKSWNAHFSEHKTQGVVVLWNENTQQGFTNDLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNLDSFWLDGGIRISATQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANADYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFATNMD
MPSAEGLGLRQSITKTVLKQEKIIP
>W8FSF5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPCRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>A0A0S1Z1Z9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTTFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>B0S9E8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNTLNAFLRGIIEAATEFLPVSSTGHLFLFSYFFPFQNLSVPHEAFEDLFDIFIQTGAI
LSVVVLYYKTLWSHLVEAVRFGLGKSTDRSGFQFYLNLIVGILPILILGFLLKSQLDQIK
MRSDLLLILGMSWFVGGIIMVFVEKRHLDESSGKTIGFKESIIVGFLQCFALIPGVSRSA
ATIISARTMGVSKKDSAEFSFFLAIPVLTLAGIYKLYKHRQILNSETIGLLLFGSIISFI
ICYFIIRLFMAFIRRRSFISFGVYRILLGLLVILYFVRY
>A0A0M1EV72|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFNQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLEMARAGQLGSENWADVGVAFLAAAVTGFVVVKWLMGYIKSH
TFTAFALYRIVLGAALLLWLPSGS
>YP_001096238|FEATURES|ARDB_deepARG|tetracycline|tet33|antibiotic efflux|1
MHFIIDNFIVDKVSFLTSARGSLATVLITASLDAAGMGLVMPILPALLHEAGVTADAVPL
NVGVLIALYAVMQFIFAPVLGTLSDRFGRRRVLLVSLAGATVDYLVLATTSALSVFYIAR
AVAGITGATNAVTATVIADITPPHQRAKRFGLLSACYGGGMIAGPAMGGLFGAISPHLPF
LLAALLSASNLALTFILLRETRPDSPARSASLAQHRGRPGLSAVPGITFLLVAFGLVQFI
GQAPGATWVLFTEHRLDWSPVEVGISLSVFGIVQVLVQALLTGRIVEWIGEAKTVIIGCV
TDALGLVGLAIVTDAFSMAPILAALGIGGIGLPALQTLLSQRVDEQHQGRLQGVLARINS
ITSIFGPVAFTTIFALTYINADGFLWLCAAALYVPCVILIMRGTAASPKFGSWASGDSM
>NP_562102|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGIDFLFILKALIIAIVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
ILAVVVLYWRKISSSVVEFLSYIFSFIGLKTSGDKRKYEKRLAESETGFRFGINVIIGTI
PAAILGLLFHDEIKEYLFSTKTVAIGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYG
QSLLVGCFQCLSLWPGMSRSASTIMGGWISGLSTTVATEFTFFLAIPAMVGASGLDLFKF
DYSQMNATNWISLILGFIVAFIVSLVVIDKFINYLKKKPMRVFAIYRVFAGIVLAILIFT
KVIS
>A0A0S3BHD7|FEATURES|UNIPROT_deepARG|aminoglycoside|AS145_08555|antibiotic inactivation|1
MTNADWRIVPLDETLLAQWATLRQQLWPHHEMAAHLQEGAELLAAAHLNAFLVLDAQNQA
VAFADTALRHDYVNGCESSPVVYLEGVYVQPASRRRGLAQALIARVAQWGRELGCRELAS
DAAIDNLASQQLHQRLGFTETERVVFFKKALG
>Q8RKU1|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1a|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSVIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWHSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0Q4DJT4|FEATURES|UNIPROT_deepARG|chloramphenicol|ASE56_11865|antibiotic inactivation|1
MDQLTPIDLETWPRRQHFEHYLRSSPCTYAMTVEIDVTDFVAVRRASGCRTSIAQIWAIA
SIVNRHPEFRMRVDEAGAPAVWNVVHPAFTVFHPERETFACLWVPYDSDFAAFHASAEQT
IAAHANSLDFFPQGEPPRNTFDVSSVPWTSFTGFTLNIENGASHLAPIVTIGKYVERGER
LFMPLSLQLHHAVADGFHAARLVTELEDLMGAPTWLTASR
>A0A061Q3B1|FEATURES|UNIPROT_deepARG|beta_lactam|JCM19052_2163|antibiotic inactivation|1
MKKLFLLLGLLACSSATYAAKLNEDLSAIEDHITGRIGVSVWDTQTDEKWDYRGDERFPM
MSTFKTLACATMLKDMDSEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRIEHACEAAML
MSDNTAANIVLRSIGGPHGVTRFLRSIGDKATRLDRFEPRLNEAKPSDKQDTTTPNAMVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAM
IWKENHKPVYISIYITETDLSLQARDQVIAQISQLVLDEYKNI
>J7UNL3|FEATURES|UNIPROT_deepARG|beta_lactam|IE3_04466|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQATQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQIVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>YP_002666586|FEATURES|ARDB_deepARG|tetracycline|tet34|antibiotic target alteration|1
MAKKFIITWDQMHTFCRELAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRHVDTICI
SSYDHDHQRDMTVVKAPEGDGEGFLIVEDLVDSGDTARKLREMYPKAKLIAVCAKPAGVE
LLDDYVVDIAQDTWIEQPWDMSIQYVEPINRKQK
>A0A0C5RSL0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRPAALAAVIALALGHTGAQANDQLQAKVDQIIRPLMQEQGISGMAVAIYARDHAHY
FSYGVASKADKVPVSRDTLFEIGSLSKTYTATLVALASAEGKLDLEAPAKRYHPALAGAP
IGDATVMELGAYSADCLPLQFPDAVQTPQQVVDFFRHWQPRAKPGTRRCYSNPSLGLFGD
LAARAQHQPFSTLMTEGLLAKMGLKNTYLHVPASAQGLYAQGYDAADKPVRVSPGPYADE
AYGIKTSASDLLQYVRLHMQPQGLPPAVATATAITQQGYFQVGAMTQGLGWERYPYPVTL
GTLVDGNSARLIREPQVTTRLQPALPPLPAAWYNKTGATNGFGAYAAFVPSEQLAVVLLA
NRNYPNEARVRAAFEILSGL
>AAG34691|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGL
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR
>C8PLD9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MLELKDINKKFILGDNEIHVLKDVSLNIEAGEFISIIGQSGSGKSTLMNIIGCIDTPSSG
SYKIEGRETANLIGDELAALRSKKFGFVFQKYNLIATMDAIANVSLPAVYAGVGASERTK
RAVELLNKLELGDRTKNLPSKLSGGQQQRVSIARALINGGEVILADEPTGALDSKSGETV
MQILTALHKEGHTIIIVTHDAHIAEFADRIIEIKDGKILSDKRKAERVFERKKEQIKTKN
SFIFCKDQLIESFKMSISAIFSHKLRSILTMLGIIIGIASVICVVALGNGSQERIISQIR
AIGTNTINIYPGKNFGDVRAGFVSTLTISDSKVLARQPYVDYATPNSYASGTITYANLSS
KAQLRGGGVNSLAVNGIDIEEGRNFSDDDIKNSASVVIIDPNTKKTFFKNTDPIGKTILF
LGRPLKIIGVSGKDKNAFGSSENLRIYAPYSTVMNKISGDRKIGSITIKIKDDVDTHVAE
ESLTQLLIQRHGSRDFHTMNADTIKQTIESTVGTMTILISSIAVISLVVGGIGVMNIMLV
SVTERTREIGIRMAIGAKQSNILQQFLIEAILLCSLGGALGILIALALGFAFNTISPDFA
MKFTTAPFVIAFAASSAIGIVFGYLPARNASRLNPIDALAQE
>A0A0K9XNI0|FEATURES|UNIPROT_deepARG|aminoglycoside|AC230_04535|antibiotic inactivation|1
MKSSLHRKYPHHEWNAVTDGDSGAFVHRLTGPQPELYAKIAPRALDNSAFDLAGEADRLD
WLARHGIPVPRIVERGGDDTSVWIVTEAVPGVSAAEEWPEHQRPAVAEAMARIARTLHDL
PVAECPFDRSLAVAMDEARHNVRAGLVDLEDLDEARRGWSGAQLLAELDRTRPETEDIVV
CHGDLCPDNVVLDPETCEVTGVIDVGRLGLADRHADLALATRELEIEEDPWFGPEYARGF
LTEYGGPGVDKDKLAFYRLLDEFF
>A0A084GI31|FEATURES|UNIPROT_deepARG|beta_lactam|AZ46_0221210|antibiotic inactivation|1
MKSLSFSTFTFRKIVPVLFLSCAALAGCSNNDIHTSLTKTKEKENAHHHDFAELEERYDA
KLGVFALDTGTNQTVSYHPDERFAYASTHKALAVGVLLQQKSLEDLNQRIAYTSEDLVNY
NPITEKYIDTGMTLKELADASLRYSDNTAGNLILKQLDGPAGFKKALEDIGDNTTSPERF
EPDLNEVNPGETHDTSTPRALAASLQAFILGDALPPEKRELLIDWMKRNTTGDALIRAGV
PEGWEVADKTGAASYGTRNDIAIIWPSKGDPIVLAVLSSRDKKDAEYNDKLIAEATEKAI
KALKDKNK
>A0A0J5L0K0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGIRALIAAGYDITAIYTHPDNAAENTFFGSVARTAAEFGIPVFAPE
DVNHPLWVDRIKDARPDVIFSFYYRSLLSDAILNCARAGGFNLHGSLLPKYRGRAPLNWV
LVHGETETGVTLHRMVKRADAGDIVAQARVAIAADDTALTLHHKLCATASSLLADSLPAI
KTGNFAQIAQDEAEATYFGGRSPKDGAINWQGSAVAANNLVRAVSEPWPGAFSYAGGSQF
IIWKSRVLANNSGAKAGTVIAVNPLTIACGTGALEVIAGQVDNGVYMQGSQLAQSLGLVT
GAILSSKPVSAVKSRTRVLILGVNGFIGNHLTERLLREDDFEIFGLDIGSDAISRFIGHE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYKKRIIFPSTSEVYGMCSDASFDEDRSPLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNSARIGSSRAITQLILNLVEGSPIKLIDGGRQKRCFTDI
GDGIEALFRIVENKKNNCDGQIINIGNPDNEASIKQLAESLLESFERHPLRGQFPPFAGF
REVESSTYYGKGYQDVEHRRPSISNARRLLNWTPTVPMEKTIDETLDFFLKTVELRERAS
>A0A060KTQ2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRTMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A009KNS7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLNSKRLSGPVKQLLVLAGLLSGSTPLWAQQLSEQQVQAIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGVASKHSQQPIRNSTLFELGSVSKTFNATLAGYAQAQGKLSWSDHPAK
YFPELKNSAVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMIKYFQAWQPKTTVGAARQYS
NPSIGLMGYVTALAMKKPYTELLEKTLFPQLGLKQSFVQVPEQQMSNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQISPQQLQQPLRKAIENTHVGYFKVDAMTQGLGWE
QYAYPAKLETLLQGNSSKMALESHAVTPIAQPKMAPAATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYHVIQQLLQHNSAQ
>A0A0G0B4U7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLKVIILGIEQGVTELLPISSSAHLILTSQILDIQMDTYLLSVLHLGTTIALVIHFWS
ILFKDIFKKENISFYTKILISTIPAGIVGLLFESVIEEKLRGNLIIAISLIAWGIVMVLI
ERKVENKEQDLKSITWKQSLLMGIGQTFALIPGGSRSGISTLVGMLSGLNKYTAIQYSFL
LGLPLLLAVPIYEIYKEYPERVLNISDILGILIAGIFTFISLSLLKKFSKEKWLTFFGIY
RILLGIFVLIFLLF
>S7TYQ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSTILSASILGVVEGLTEFLPVSSTGHLILTSSLLGLSGAKIDAFEVIIQLGAILAVVVI
YWQRFRGLVLPERGQAFSGVRGLWLLFLTSLPASVIGLLTHKFIETKLFNPHSVAISLAV
GAVLILLVEGRKHKPRLFRIDNMTSGFALAVGMFQCLALWPGFSRSAATIMGGMICGADR
MVAAEYSFVAAVPIMIAATGYKLYKTWALYTSSDLVFLAVGFVVAFFAAWAAVKCFIGLL
QRWTLRPFAVYRLILAPLVILFWPS
>W1MF81|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
ILMRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAI
SLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQH
WPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYS
NPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLR
VGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGW
EAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPG
RDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A0E2UNA0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIKFVSIVIPVYNERQSLPELLRRTEMACHQLNQPFEIVLVDDGSRDDSAEILQQA
AERNGSPFVAVILNRNYGQHAAIMAGFEQCKGDVVVTLDADLQNPPEEIPRLVALAEQGY
DVVGTVRSNRQDSAWRRWPSKIINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEMLVEHAEREHGDSKYSPMRLVNLMFDLITCMTTTPLRLLSIIGF
SMAFLGVLFAALLIVLRLIFGATWAGDGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEQVVRSSSEIATDSVDSSVTPYMNKVAP
>G0AAQ2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSILKVLSFSACFLVAGSCAGAGLDQSGIKTAVDSAIQPLMQSYAIPGMAVAVTIDGKNY
FFNYGVASKETRQPVTNRTLFEIGSLSKTFTATLASYAQVDGKLSLSDSASKYLPSLGGS
SFDNISLLNLGTHTAGGLPLQVPDDLGNTGQLMDYFKHWQPAHAAGTYRKYSNPSIGLLG
MIAAKSMDMSFDDAIEKKLFPELGMTHSYINVPAGQMKDYAQGYTTKDVPVRVNPGVLAS
EAYGVKSGSADLIRFIGANMQAIKLEAKLQRAITDTHTGYFVSGEFTQDLIWEQYPYPLE
LKRLLAGNATTALYDELPAARLNPALPPQADVLINKTGSTNGFSSYAAFVPAKKIGIVIL
ANKSYPIDQRVTAAYRILTRLDSEAASKN
>ZP_03841721|FEATURES|ARDB_deepARG|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTAPHSATGFIKKSLCFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>A0A059VI85|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>D6JCF5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPANEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>E3HAG2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNSLLIVIILGIVEGLTEFIPVSSTGHMILVEQFVNNPQLSKEFMDTFLIVVQLGAILAV
VIIFWKDISPFVKDRKKVEEKLTLWSKIAVGVLPAAVLGLLLDDYISEYFFGNVIIVSVM
LILYGFIFMKEKNFEKENCIEDIKQLTYKTAFLVGWFQCLAMIPGTSRSGVTIIGGILLG
LSRGVAAEYSFFLAIPIMAGATLLKVLKNGLDFSPEEWKLTLVGTAVSFFVAYIVIKWFM
SYIKSRDFKVFGVYRIVLGILVLISIF
>A0A0F2NPX3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTGKNQLKYTILIILLLTACWAGAAPGDENDPPGKSEMTTGQAIILGVVEGLTEYLPVSS
TGHLLLAQRIMGIGEGASLSESDREREKEAADAYAICIQAGAIIAVLGLYFRRVRQMLFG
LFGRDPVGLRLLIGVAAGFLPAAVIGLLFNSHIKEYLFGPWPVVAAWLVGGVAILAVSSR
IRSKHEMVRSGCSLAGLTWKMALIIGFAQCIAMWPGVSRSLVTIVGGMMVGLSLPAAVEF
SFLLGVVTLGAATAYDGLKHGQVMLQTYDPQSLAIGLVFAFISAVLSIKWMVAYLNRHGL
AIFGYYRVILALVTTALLVTHTI
>C2PFA6|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0006_22950|antibiotic inactivation|1
MKGMMILKNKRMLKIGVCVGILGLSLTSLEAFKGGTLQVEAKEKTGPVKHNNHAMYKDFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNILTGWMKGNATG
DKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVCPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALR
>M4QLD9|FEATURES|UNIPROT_deepARG|aminoglycoside|aacA7|antibiotic inactivation|1
MDSSPLVRPVETTDSASWLSMRCELWPDGTCQEHQSEIAEFLSGKVARPAAVLIAVAPDG
EALGFAELSIRPYAEECYSGNVAFLEGWYVVPSARRQGVGVALVKAAEHWARGRGCTEFA
SDTRLTNSASTSAHLAAGFTDVDQVRCFRKPL
>A0A150DTP2|FEATURES|UNIPROT_deepARG|beta_lactam|AT258_18265|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSISSLQAFTGGASQVEAKEKTEPVKHNNHATYKDFSQLEK
KFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQKNSTEKLNEVVTYTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQIGDRVTM
SDRLETELNEAIPGDNRDTSTAKAIATNLKDFTVGNALPDKKRNILTDWMRGNATGDKLI
RAGVPKDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAT
EVIVNAIR
>BAB82500|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0W8JX65|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIWDIFVAIILGIVEGLTEYAPVSSTGHMIIVDDVWLKSKELLTPEAANTFKVVIQLGS
ILAVAIVFKDRILNLLGVKKNMTEEQKSGNRLSIAQIAVGLVPAAVLGFLFEDYIDQYLF
SVHTVAVGLIAGAVLMLAADWINRRTETTDSVDRMTYKQALGMGLFQCLALWPGFSRSGS
TISGGVILGLNHRAAADFTFIMAIPIMMGASLLSLIKNWAYLSADLFPFFITGFISAFIV
ALFVVRFFLRLINKIKLVPFAIYRIILGLLLFILFL
>J9UVY5|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-125|antibiotic inactivation|1
QIKLSESQLSGRVGLIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQL
ERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAF
LRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWM
VDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIV
>A0A0D0MS60|FEATURES|UNIPROT_deepARG|beta_lactam|RT97_13450|antibiotic inactivation|1
MNLLVHRRTLLLAASVLPLASACTAWSAKGGQQDASAQLAALEAASGGRLGVVGFNTATG
ARVQHRADERFAFCSTFKLMLAAAVLERSAKEGGLLARRVNYSKGDIIANSPITEKNVAT
GMTVADLCAATIQYSDNAAANLLMKVIGGPPAVTAFARSSGDDAFRLDRWETELNTAIPG
DLRDTTTPAAMAASVERLVLGNALGTSQREQLKTWLLGNTTSKERFVAGVPAGWKVGDKT
GAGSYGTNNDVGVLWPPAGAPLVLAVYLTFPEKDAKVRNDVVASATRIAVGALA
>CAR60299|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKQDQQGGQQMPEVGVVTLKTEPLQITTELPGRT
VAYRIAEVRPQVSGIILKRNFVEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAELTVKRYQKLLGTQYISKQEYDQALADAQQATAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQASALATVQQLDPIYVDVTQSSNDFLRLKQELANGSLKQENG
KAKVDLVTSDGIKFPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLQEG
TKPTALLVPQQGVTRTPRGDATVLVVGADNKVETRQIVASQAIGNKWLVTDGLKAGDRVV
VSGLQKVRPGAQVKVQEITADNKQQAASGDQPAQPRS
>A0A0B5E9G5|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
KYGVLVERRDITAKLDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRR
IHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHN
MGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEAD
>A0A0X3X9P6|FEATURES|UNIPROT_deepARG|chloramphenicol|ADL32_06955|antibiotic inactivation|1
MDAPIPTPAPIDLDTWPRRQHFDHYRRRVPCTYAMTVEVDVTAFAAALRRSPRKSYLAQV
WALATVVNRHEEFRMCLTASGDPAVWPVVHPAFTVFNPERETFACVWAPYDPDFGTFHDT
AAPLLAEHSRATDFFPQGNPPPNAFDVSSLPWASFTGFTLDIRDGWDHLAPIFTLGRYTE
RDARLLLPLSVQIHHAAADGFHTARLTDELQTLLADPAWL
>YP_001811890|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLSAEDVVQSIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEDEFGDIVVKTTPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGIDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASLIPLIAVPVSIIGTFSLLLGFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIESGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFKRFNKVFHRGAENYGRGVR
GVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFSERHGKALSAGAIAGALN
QQYGAIKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GFSSGQAQAAVERIAHETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGIAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAGKDSAGYGVSPSGASATDA
>A0A0J8DF19|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSINIIMIFKAILLGIVEGLTEFLPVSSTGHLILVGDSLSFTGKFANAFNVVIQVGAIFA
VVLYFWNKLFPKLNDKRQSKRVFTLWGKVIIGAIPAAVLGLMLDDYIEAHFFNSRVVAYA
LIIGAILLLISDKSNKRVRCETVEELTIVDSFMVGVFQCMALCPGMSRSASTIIGGRFMG
LSREVAAEFSFFLALPTLGGAALLKLVKIGLDFTGFEWVLIGVGTFVSFIVALLVIALFM
EYVKKKSLAPFAYYRIILGAIVLFMVFSGKLI
>V6MFI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWEIFVAFVLGLVEGLTEFAPVSSTGHMIIVDDTLLHSSALFSPHVANTFKVVIQLGS
IIAAVIIFKDRFLSLLGLKRLPSDNGNPREKLRLSQVLVGLIPAGILGVLFNDYIDEYLF
SVHTVLIGLVAGALLMIAADWFRPAKPKVVSVDQITHKQALIIGLFQCIALWPGFSRSGS
TISGGVLLGLNHRSASDFTFIMAVPIMAGASFLSLLKNWQYITIEALPFFVVGFISAFLF
AWLAIRFFLRLINRIKLVPFALYRIVLAAVIFFWIL
>A0A017I971|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSALSAPQQLNDIVHRTMTPLIEQHKIPGMAVAVIYQGKPYYFTWG
YADVAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSGDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWAQSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVDPDSII
NGSDSKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYIAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ZP_03359886|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKQDQQGGQQMPEVGVVTLKTEPLQITTELPGRT
VAYRIAEVRPQVSGIILKRNFVEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAELTVKRYQKLLGTQYISKQEYDQALADAQQATAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQASALATVQQLDPIYVDVTQSSNDFLRLKQELANGSLKQENG
KAKVDLVTSDGIKFPQSGTLEFSDVTVDQSTGSITLRAIFPNPDHTLLPGMFVRARLQEG
TKPTALLVPQQGVTRTPRGDATVLVVGADNKVETRQIVASQAIGDKWLVTDGLKAGDRVV
VSGLQKVVLAHRLKCRKLPRITNSKPQAVINLLSPGLNLNRSR
>T2LKN9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLNNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGSYIF
DDYEVTQLNNDEKARLRREKIGFIFQRYNLLNLLSANDNVALPAVYAGKKVQERNSRAQE
LLGNLELEHKIESKPNQLSGGQQQRVSIARALMNGGELILADEPTGALDSKSGIMVLEIL
KKLNAQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDSKKDKIAYQGQVKSMPKEKKTLT
LLKNQAFECLKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLDYLEAVDAHSSTSGVATYTNISLSARA
EGVGVNNFAIEGLKLQVGRILNNEDVENNANVVVLDFNAKRNLFPRQKSEDVLGRVVIFN
SQPFKIVGVLQKDTEKPIEDNVVRLYMPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQRDFFTFNSDTFKQAITANKRTTTILTASVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICSMGAILGVLLSVFVIFGFNTLSTDFPM
ILNAYSVLLGLLSSVLIGVVFGFFPARNAANLNPISALSKE
>A0A0E1EGD7|FEATURES|UNIPROT_deepARG|beta_lactam|EY04_27815|antibiotic inactivation|1
MKLMYVLMVSLTLIALNSVAHEGAITLTHFKGPLYIVEDKAYVQENSMVYIGADDITIIG
ATWTPETAEALEKEIRKVSALPIKEVINTNYHTDRAGGNAHWKKLGASIVSTQMTYDLEK
SQWKSIVDFTRQGFDKYPRLKESLPDKVYSGDFELQSGRVRALYLGPAHTEDGIFVYFPS
ERVLYGNCILKEKLGNLSFANRTEYPKTLKKLKELIDQGELQVESIIAGHDTPIHGVELI
DHYLALLEDAKK
>A0A0H0SMP9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLWEAFVAIVLGLVEGLTEFAPVSSTGHMIIVDDFLFQTKDLFSPEVANTFKIVIQLGS
ILAVVVLMWDRFMSLLGLNRLAGKREIPAGPRLNLATVIVGLIPAGILGVLFDDYIDEYL
FSTKTVVIGLVLGALLMLAADWFRPGRPKIESVDQITYKQAFLVGLIQCFSLWPGFSRSG
STISGGVLLGMSHRAAADFTFIMAVPIMAGASFLSLLKRWDAITMDSIPFFVVGFISAFV
FALLSIRFFLKLINRIKLTPFAIYRLVLAAVIYFVFM
>A0A094TL30|FEATURES|UNIPROT_deepARG|chloramphenicol|cat3|antibiotic inactivation|1
MNYKKIDLEQWNRKEHFLHYRHNLQCGFSLTTKIDITVLKTVLTKHNLKLYPVLIYLIAK
TVNYYPGSRMAIKNDELVIWDYINPAYTIFHPETETFSELWSEYFEDFCSFLEGYNQDYQ
QYKDNLNLSAKPNFPENHFCISMIPWISFDGFNLNIANVRDYFPPIFTMGKYTQQNNKVL
LPLSVQVHHATCDGFHVARMVNKLQELCDRFSS
>Q5QWM3|FEATURES|UNIPROT_deepARG|beta_lactam|IL1808|antibiotic inactivation|1
MKISLLVLFILSFAVPVCAETQERSDWGSVFEKYEAEGTIVVVDGRDSEQTTLVFDKERA
AKRFSPASTFKIPHTLFALDAGVVQDEFEVFKWDGVERSFAGHNSDQNLRSAIRNSTVWV
YQQFAEDIGAEKAKSYLKRIDYGNADPSDDVRNYWLDGQLAISANEQIAFLQRLYRNELP
FAVEHQRLIKDLMIVEAERNWILRAKTGWEGRFGWWVGWVEWPEGSVFFALNIDTPNRMA
DLAKREKITREILTSIDALPSRTAEKNEVDSETTVAVVDTNLYLLGTFDGNTADKVISTL
EAHPGVQRIVFTANGGSVNDRDTLRLGRYIRQKGLHTHLISNGVAASGGVSLFLAGVKRS
VGQGAHVGVHSWAQCSDSAEASHCKPATDFPRHDTAHDLHRIYTDEMLGADDFYWFSIKS
ASHNSIHWLSRDELLEFQVVNNELEDTLEIPFADKFRKEYESTCHNCPRASD
>S3TSP6|FEATURES|UNIPROT_deepARG|beta_lactam|F907_00108|antibiotic inactivation|1
MNLNDISKTSKQLLFMTGLVCASSMLWAHPLNEQQVKAIVDQQFKPLLAQYNIPGMAVAV
TLNGQHYFINYGLASKQSQQAVSNNTLFELGSVSKTFNATLASYAQAQGQLSLSDHPAKY
FPELKNTAVDRATLLNLGTYTAGGFPLQFPDQVVQQQDMIQYFQSWKPKTGIGAARQYSN
PSIGLMGYVTARAMKKPYAELLEKTLFPQLGLTQSFIQVPEQQMPQYAWGYKADQALRVS
PGMLDAEAYGVKSSSADMLRFLDVQINPQHLKQPLRKAIENTHVGYFKVGAMTQGLGWEQ
YAYPVKLETLLQGNSSKMALASHPAIAIKRPKIAPAATYFNKTGSSNGFGAYAAFIPEQK
IGIVMLANTNFPNEARIQASYTVVQQLLQTNTAQ
>A0A0G1GUF0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIVHALILSLIEGLTEFLPISSTGHMILVGKLLGIPQTEFLKSFEISIQLGAILAVLVL
YAKTLLQRISLWPKILAAFIPTAILGFIFYKIVKQYLLGNSMVTVLALGIGGVCFLFLEK
MMREKTFTAKTLDEISYKQSIIIGLSQSVSMIPGVSRSAASIFGAMAGGVNRQTAVEFSF
LLAIPTMVAATGLDLVKSGFSFSSNDYQLLGIGFIGAFITALVAVKAFLQFIKSNTFIPF
AWYRIVLAILFFIFVIR
>A0A085GK03|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLHSLAIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPQHEGEGKGRLTLIHILLGMVPAVVLGLIFHDTIKSLFNPVN
VMYALVVGGVLLIAAELLKPKEPRAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGISRYAASEFSFLLAVPMMMGATVLDVYKSIGFLSMADLPMFAVGFITAFIVALIA
IKTFLQLIKRISFIPFAIYRFVVAAVVYFVFF
>I6ZI86|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATITLLLGSVPLYAQTADVQQKLAELEWQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>NP_978424|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLNGINHLCFSVSNLEDSIEFYEKVLEGELLVRGRKLAYFNICGVWVALNEEIHIPRNEI
YQSYTHIAFSVEQKDFESLLQRLEENDVHILKGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMTFY
>T4VDL1|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MSFKIINKETWARKEYFEHYFSEVPCTYSMTVKLDITKIKNSNKKIYPTMLYFITKVVNN
HSEFRTAFNMDGELGVFDEMLPCYTVFNQDTETFTNIWTDYSDDYDAFCKSYEKDIELFS
SVKGMIAKPNIPPNHFPVSMIPWTTFEGFNLNLQKGYNYLLPIFTMGKYSEINGQYLIPL
AIQVHHAVCDGFHISRFVNELQKLIEE
>W6V9Y6|FEATURES|UNIPROT_deepARG|beta_lactam|PMI27_002094|antibiotic inactivation|1
MHNKLALYSAFALFLSAGHCVADDRIEAIVKAAIEPVMQQQQIPGVAVAITVNGQPHYFN
YGVASKENGKAVTEDTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASSVLPELRGSAFD
NISVLQLGTYSAGGLPLQFPDDADAPDKMLGYFKQWKPTYAAGTHRLYSNPSLGLFGYLA
AQSMGAPFDDVMEKTLLPKLGLKHTYLKVPQAQMGLYAQGYNKEDKPVRVGPGALDSEAY
GVKTSAADLIRYVEANMKPSGLETPMQRAVAITHTGYYKVGEMTQGLGWEFYHYPVTLDK
LLAGNSTQMAMEAHEVQWLTPPQPQPENVLINKTGSTGGFGAYVAYVPSKDIGIVILANK
NYPNPERIKIAHTILSALAK
>A0A0P6WTD1|FEATURES|UNIPROT_deepARG|beta_lactam|AM506_04660|antibiotic inactivation|1
MKSVSVLKIWMSVGLLSLSLFGDGLKQTEAKENVDQTQRTSHRTVNKFMQLEKKFDARLG
IYAIDTGTNRTVVYRPDERFAYTSTYKALAAGAVLQQNSIGELDEVITYTKDDLVTYSPI
TEQHVDTGMTLKEIGDAAIRYSDNTAGNLLLQELGGPNGFENALRQNGDHVTEADRYETD
LNSAIPGDIRDTSTARALATSLKAFTVDGILPNGKRTLLTDWMRGNTTGDELIRAAAPKG
WEVGDKSGAGDYGTRNDIAIIWPPNRDPIIIAILSSRDTKDATYNNELIAKAAKVALSSF
K
>A0A085F9E2|FEATURES|UNIPROT_deepARG|aminoglycoside|FF80_02028|antibiotic inactivation|1
MDCQDHLGQPMKIAAAKAADKADWAELRQALWPSNEAGAHEADIAALLAAPGNNINLIAR
LPDDRAVGLAEASLRHDYVEGCKTSPVAFLEGIYVAPDCRRLGIARGLVAAVEDWGRAQG
CSEFASDAALDNLESHQMHGALGFSETRRVVYFRKVLGP
>A0A0D8WC61|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTKACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMCDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>B7NAS9|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKKPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>V1HXM0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENAFFGSVSRLAAGLGIPVYAPD
DVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMTKRADAGEIVARQRVAIAQDDVALTLHHKLCQAARQLLDSILPAM
KCGDIPSVPQRESDATYYGRRRPEDGIIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQVGDGITVQGSQLAQTLGLVA
GARLNHPSAASGKRRIRVLILGVNGFIGNHLTERLLNEENYDVYGMDVGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QIVESRSYYGKGYQDVAHRKPNINNARRCLDWEPSIAMRDTVEETLDFFLRSVDIAERAS
>A0A0R2YI02|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPKARRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVAAALV
VGGVIMLWAERRQHAVRAETVDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGLVDWTAVKP
>A0A0A1RWP4|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-100|antibiotic inactivation|1
MMKKSLCCALLLAAPFSTFAAPKTEQHIADIVNRTITPLMKEQAIPGMAVAVIYQGKPYY
FTWGKADITNNRPITQNTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTRYWPELTGKQ
WQNISLLHLATYTAGGLPLQIPDEVTDKTALLHFYQNWQPQWAPGAKRLYANSSIGLFGA
LAAKPSGMSYEEALTRRVLQPLKLTHTWITVPQREQKDYAWGYHEGKPVHVFPGQLDAEA
YGVKSSIIDMTRWVQANMDANQVKEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>A0A0S1LJ16|FEATURES|UNIPROT_deepARG|beta_lactam|SHV111|antibiotic inactivation|1
ERFPMMSTFKVVLCGAVLARVDAGDEQLQRKIHYRQQDLVDYSPVSEKHLADGMTVGELC
AAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTP
ASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGAR
GIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALI
>G1UN39|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPIIEVSAVSKFFGSGENRVQVLHELSFSIEDGEFVAIVGPSGSGKSTLMNILGCLDKAG
SGICRINGQDTADLDPDALSVLRCAHLGFVFQRYNLLSRLSALENVALPAVYAGEGKAER
LQRARALLADLDLNDKLRNLPAELSGGQQQRVSIARALMNGGRIILADEPTGALDSASGD
NVMKILKELHARGHTVIVVTHDLKVAAHAARVIRISDGRIVSDERTRPHAPAAPPGATVR
PVLRMTGRLDQLREAVKMSLQAIWAHKLRSCLTMLGIIIGIASVVSVVALGRGSQEKIIA
DISAMGTNTIDIFPGRGFGDQRAAQITTLTVADADILAQQPYIASSTPNASSSGTLRYRN
ISVTAQLNGVGAGYFDVKGLEPASGGFFDENAVRRNESVVVIDENTRRRLFPIGQAEGRI
LLFNSRPLRVVGVVKKKDMGFGPSDTLNIWAPYTTVMYRITGSHSIASITVKVADGVMPL
MAERNITRLLTARHGSKDFSTFNTDSIRQTIESATGTMTLLITGIALIALVVGGIGVMNI
MLVSVTERTREIGLRMAVGARRVNIMEQFLLEAVLICLVGSVAGIALAGLISVAASMLSL
GFSLRFSMDSILLAVACSSLIGTCFGFVPARNASRLNPIEALSRE
>A0A0W3DNS4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWKKTYFSSWESFKKQAFYIILATLITGVLGLALQSIIKHVFFGGASSFEIEHLFS
NSKLMAAALISAGVLIILSSRLDRGQSGEISLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQKAEEFSFALAVVLTPAVILKELYRLVHAQGLQTVAHGQVFHSIVPSLVGMC
FSFGAGLLALKWLSSWLEHGRWHLFGLYCIGFAIVVLCVN
>F4EZB0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLSIMELLKTVVLGIVEGLTEWLPISSTGHMILVDEFIKLDVSKSFMDMFLVVIQLGAI
LAVVVLNFEKLNPFSSWKSSWEKRATWQLWYKVILACVPAAVIGLLFNKFMEEHFMTAPV
VAATLIFYGVMFLVVESYNKRRTPRVREIERLDYKTAFIIGLFQVLSLVPGTSRSGATIL
GGILFGTSRYVAAEFTFFLAIPVMFGASLLKMVKFGWHYTGSEILILVVGMATAFVVSIL
SIKFLLRYIKNNDFKAFGWYRIVLGIIVVLYLYFVGDPVQG
>A0A109R7T2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPVPRKLSGLTLVLVGLCAFSTAALAQDLVPGLDAAVTEGATQLMQTYGVPGLSIAVSVN
GKQHFYNFGVASRDTRVRISSDTLFEVGSISKTLTATLATYAQINGQLSLDAPVSRYVPE
LQGTAFGKVQLIHLATHTAGGFPLQVPDAVQNEQQLMDYLKAWKPVYPAGTQRSYANPSI
GMLGLITARSMNQPFVQAMENTLFPALGLHSTYIDVPKSKMALYAQGYDKQDQPVRLNSG
MLGNEAYGVKTSSRDLIHFAQLNALPGKPSTKIQQAIGDTHTGYFRIGPMTQDLIWEQYP
YPVTLKNLLLGNSDKMAYENNDAIALHPPLAPQEAVWINKTGSTGGFGGYVALIPVKKQA
VVILANKNYPNSARIELAYKILNALD
>A0A0T6RMW7|FEATURES|UNIPROT_deepARG|beta_lactam|AO734_18570|antibiotic inactivation|1
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRAQQIGWFIGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAQLKKQ
>A0A0W0HIW4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDNSAQLLEDA
ASEDGSNVVAVILNRNYGQHAAIMAGFEQCRGEVVITLDADLQNPPEEIPRLIEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGILFALALIVMRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSADQV
>Q9L8H5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGEREILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVHTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>Z2ERG0|FEATURES|UNIPROT_deepARG|beta_lactam|D046_1762A|antibiotic inactivation|1
MSVWDTQTDKRWDYRGDERFPLMSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWS
PVMDKLAGQSTRIEHACEAAMLMSDNSAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLE
PR
>A0A0L6NKX3|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPTTSDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPIAAHEEIHHHA
>A0A0A2XL60|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAAHFLGFEGQKAATFEVIIQLGSILAVIFV
YWRKMFGLIGIHFGEKMDQNKAHLNLIHIILGMIPAVVLGLLFHSTIKSWFNIHNVIGAL
VAGGILLILAEKFRPQPAYAEELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMG
VGKKAAAEYSFILAVPMMIGATALDLYKSLPFLSWDDLPLFAVGFVTAFIVAMIAIRTFL
HLIGKISFVSFAIYRFILAILLAWIVLA
>ZP_03564086|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFIIELIKGIILGVVEGLTEFAPVSSTGHMILVDDIWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVEGDNDQQRRSKPRRLNLLHVLVGMVPAGILGLLFDD
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSAKVKNPQTVDQISYFQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILG
FLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIVLVIFIAILYFGFGIGKGI
>A0A0F0YE78|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAKTLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRASRAAAPKEALP
ASTGWGQFSSGFREALNMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKASVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0L0RJN0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPTSFINMFMVVIQLGAILSVI
VIYFNKLNPFAPSKSKREKGQTWQIWFKVIAAVLPSIIIGLPLNDWLEENMTSWQVISAT
LIIYGILFIILENYYAKRQQSLTDLNKMSYKTALLIGCFQVLSMIPGTSRSGATILGAML
IGSSRYVATEFSFFLAIPTMFGASLLKLVKFFKAGHAFVGNQLAILLVGMVVSFIVAYLS
IKFLLKYVQTHDFKPFGWYRIVLGIIVIICGLVFA
>ACI75466|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MIMKRHRNINLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMAR
TLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFS
MARWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMN
VWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>YP_853293|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFALGQLIYGPMADSFGRKPVVL
GGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVINALMRDIYPKEEFSRMMSFV
MLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAMIFFLIKETLPPERRQPFHI
RTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVYIEINHVAPENFGYYFALNI
LFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISALLGLGFWSLVVGVAAFVGC
VSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGALLSLATFNSAWPMIWSIAFC
ATSSILFCLYASRPKKR
>A0A0A2DYP3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSILESIILAIVEGLTEFLPVSSTGHMILTEGLMGMQSSAYLSAFTVMIQFGAILSVLVI
YLPRFLRFGKDQETQYYGLSGFNLYWLMFIGCIPAAVMGLMLEEYIDALLGRVEVVIAML
FLGGIVMLFMDKLLAKDKPQRVTPLKAVIIGCFQCLAMIPGVSRSMATILGGMQQGLTRQ
QAAEFSFFLAIPTMFGATALKAYKLHKEFGMAIFADNWQTLLVGNVVAFVVALLAIKFFI
GVVTRYGFKAFGYYRIVIAIVFALMLLLGVPIELQ
>A0A0K1FJW8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLKVVILGIVEGLTEWLPVSSTGHMILVDEFIRLNVSTAFMDMFLVVIQLGAILAVVVLN
AKKLNPFLGSKSRAERRETLDLWGKVIVACLPAAVIGLAFNKYMEEHFMNAPVVASMLIL
YGILFIVVERWNKRRTPRVESLAALDYRTAFIIGVFQVLSLVPGTSRSGATILGGIIFGA
SRYVATEFTFFLAIPVMFGASFLKLVKFGWHYTGAELLILAVGMVTAFVVSILSIQFLLR
YIKRNDFTAFGWYRIALGILVLAYLFMVGDPTKE
>A0A100V1K6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEATPIKKVSVVIPVFNEQESLPELIKRTSAACEKLGKDYEILLIDDGSSDRSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>A0A0M2NMT0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLLELIKGLILGIVEGLTEFAPVSSTGHMILVDDMWLKSTKFLGEQSAFTFKVVIQLGS
VFAAAWVFRERFFEILHIGKHQPEQQATTGRRSKPKRLNLMHVLVGMIPAGILGFLFDDV
IEKYLFSVPTVMIGLFLGAIYMIIADKYSEKVTHPQTVDQINYFQAFVIGISQAIAMWPG
FSRSGSTISTGVLMKMNHKAASDFTFIMSVPIMLAASGLSLLKHYEYIHLAHIPFYLLGF
LAAFIVGLIAIKTFLHLINKIKLVPFAIYRIILVVVIAILYFGFGIGKGI
>S2SZP4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVIIGIVEGLTEFLPISSTGHIDLVNHVIKLSQSQDFINMFEYVIQFGAILAVI
LLYFNKLNPFSKPTAKARNATWQLWAKVIIAVLPSVVVGLPLNNWMDEHLHTPLVVATTL
IIYGVLFIILENYLKNKNAHITTLADITYQTALLIGLFQVLSIVPGTSRSGATILGALLI
GTSRYVATEFSFFLAIPTMVGVSIIKIGKYLWQGNGFSGEQWAVLMTGSIVSFLVAIVAI
KWLLKFVQTHDFKPFGWYRIALGAIVLLVMFI
>A0A0S3EUW4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVVIQLGAIMAVVV
LYWRTFWAVAMGLLRREPVSWRFLRNLLIAFMPSAVIGLALHNYIEVLLGAPQVVAWALI
VGGIAILLIERMVKKAEYHGIADIPLLQVAGIGFIQCISMIPGVSRSGATIMGALMLGVE
RRTAAEFSFFLAIPTMLGASTLELLKKGDQITSASVGWGSIALGFIVSFIVALLVIKWFV
GLVSRRGFTPFAWYRIVAGAAALIWLAAR
>J3IF36|FEATURES|UNIPROT_deepARG|beta_lactam|PMI36_02414|antibiotic inactivation|1
MRIKNQRKLASYSAFALLLGVSHSFADDRIEAIVKAAVEPVMQQQQIPGVAVAITVNGKP
HYFNYGVASKENGKAVTEDTLFEIGSVSKTFTATLAAYAHATGKLALSDNASQVLPTLRG
SAFDNISVLQLGTYTAGGLPLQFPGDADHQDKMLGYFKQWKPAYAAGTHRLYSNPSIGLF
GYLAAHSMGAPFDELMEKTLLPKFDLKHSYLKVPQDQMALYAQGYNKDDKPVRVEPGALD
SEAYGVKTSASDLLRYVEANMNPTSLEKPLQQAIATTHTGYYTVGEMTQGLGWEFYNYPV
TLDTLLAGNSSQMAFEAHEVKWLNPPQPQHNTALINKTGSTGGFGAYVAFIPAKDIGIVI
LANKNYPNPERVKIAYKILSALTE
>A0A0A2NF60|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTEQTLYLLKALFLGIVEGITEFIPVSSTAHLLILGSWIDFSSGDAKVFEVVIQFGSILA
VIWIFRARLIQLITGVLRGDRTELMFTRNLLIAFLPAAVIGALTIQYVKALFHHQIVFVF
TLVLGGLLMLWVERKPQYAKNTSELDQGETATSQKATAFALEEITWKQALVVGFAQCIAM
VPGTSRSGATIIGGMLAGIQRKTATEFSFFLAMPTMLAATVYDLYRNGASLSADQSTAII
VGFVAAFFSALFLVKAVLRFVSSRTYRPFAWYRIALGGVLFVWLMT
>ZP_04312848|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVEKMRKNTLLKLGVCVSLLGTTQFVSTISSVKAEHKLEHKVIKNETGTISISHLNK
NVWIHTELGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPIGDLQTVTNLKFGNMKVETF
YPGKGHTEDNIVVWLSQYNILAGGCLVKSASAKDLGNVADAYVNEWSTSIENVLTRYRNI
NAVVPGHGEVGDRGLLLHTLELLK
>ACL81266|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNKKNIKDSQNFITSKRNVDKIMTNISLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVNHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKVVFESIA
DEIYLIVEYGFAKRLLNTKRSLALLLMAEVDISILSMVPREYFHPKPKVNSALIRLKRKK
SRISYKDKQKYNYFVMKWVNKEYKKIFTKNQFNKSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>W0DY80|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFHAIVLGIIEGLTEFLPISSTGHLIVAAELMGLHQDDHNTAFKIIIQLAAILAVFAT
YAERFHPSQYQLWIKVFIAFLPIASIGFLFADSIEALFNVATVAWMFIIGGIIFLVVEHF
YKESQHTVRNLDQLTYKQTLWVGFAQIFALIPGTSRAGATIIGGMLTGLDRKTSAEFSFL
LALPVLTATSGYSLLKHYDAFAQTSFTPLIVGFVVSFLVAWLSIKLFLKFLQHFTFRAFG
IYRILLGSALLIWFV
>A0A0J1B6E8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIQLHGLRKDYRVGDHDLPVLKGITLNIEAGEYVALMGSSGSGKTTLMNLLGSLDHPTDG
DYHLAGIDVSSLTPLELAAFRSQHIGFVFQNFNLLPRATALDNVMLPTIYASDGRSRREC
IEDATKLLESVGLGGRLDHMPNQLSGGERQRIAIARALMNRPKLLLADEPTGNLDTVTEQ
EILALFRQLNQEHGITLVVVTHDAEVAHEADRVVRMKDGLVAEDVRQRASTVDRSRLANS
RSEPLREPATAWPMAATWNAVIVAVLALRRNALRTVLTMLGVIIGVASVISTMELSAGAS
TAIEETVASMGASMLTISPGKASSTGGRQRPIQIVPDDVLAVAEQCSAVKVAAPLVYSQV
QLVRQNRRWSPNLALGTTPQYLAARNWDQLEMGTPFTQEQVLDAAKVCILGKTVAHELFD
SEYPIGEEIRVNGVPLRVVGVLTEKGGDVIGNDQDDIIIGPWTTFKLRVNSSTGATAQFS
TFADQMPPMQLASTRRSTQREEIHQIYVEAESPDHVELARQQITQLLSRRHNVEPAGAYR
INDITEVSKVVGQVVGGVSALGLVIAGVSLMVGGVGIMNIMLVSVTERTREIGLRMAVGA
NRSAILRQFLIEATVLCVVGGFLGIFAGHMWSMLVGRVIGWPTAMSIWAPIVAVTVAASV
GIVFGYYPARTASRLNPIDALRYE
>A0A0A1FB60|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLVEGFTEFLPISSTGHLILAGSLLDFTADIGREKAEVFEIAIQAGAIFAVCWEYRVRI
GAVLRGLPSDYKARKLVLNLIIAFMPAAILGLLFSKMIKEKLFAPLPVAIALIIGGFVIL
WVERRNNARSKTGDSVARVESVDDMTAMDALKIGFAQAFALIPGTSRSGATIIGGMMFGL
SRKAATEFSFFLAIPTLFAATIYSLYKDRALLSAADIPLFSIGTVAAFISAFLCVRWLLR
YISSHDFTAFAWYRIVFGLVVIVTGYTGWVSWVH
>A0A0Q7D923|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLVKAAIMGIVEGLTEFLPISSTGHLILTASLLNFTGEMVKVFDIAIQTGAMFAVI
WEYRVRLGATVAGITHQAVAQRLVRNLLIAFVPAVVFGLALGGLIKEHLFHPVPVATAFV
VGGLIILWVERRHRALFGGRDLEGGRVARVETIDDMSALDALKVGLVQCAALIPGTSRSG
ATIIGAMLFGFSRKAATEFSFFLGIPTLMGAGAYSLIKQRDLLSWDDLPVFAVGVVFAFL
SALVCIRWLIRYVSTHDFTVFAWYRIAFGGLVLLSAWGGWVDWKD
>V5YUM6|FEATURES|UNIPROT_deepARG|aminoglycoside|aac(6')-Ial|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTVECARRQGWAAHLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>A0A0F4TD74|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDRLKTIAACMAIFAAGQCVAQDQIETVVNAAVQPVMQAEGIHGMAVAVTVNGQAHYFNY
GVASKETGNPVTQDTLFEIGSVSKTFTATLAAYAQTTGKLSLSDKASQVLPALRGSAFDH
ISVLQLGTYSAGGLPLQFPAEYDSADKMLGYYKQWKPLYAPGSHRLYSNPSLGLFGYLAA
QSMGQPFDNLMEKTLLPKLGLKHTYVHVPQDQMALYAQGYDKDGKPVRVTPGALDSEAYG
VKTSAADLLAYVGANMKPASLEKPLQQAIALTHSGYYTVGDMTQGLGWELYRYPITLDRL
LDGNSTPMAMQAHEVQWLNPPQAQPENVLINKTGSTGGFGAYVAYVPSKGIGIVMLANKN
YPNAERVRIAHQILSALSQ
>A0A090YAH1|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MLKIGMCVGILSLSLASVKLFTGEPLQVEAKEKAEKTKHVNHATHREFAQLEKKFNARLG
VYAIDTGTNQAVTYRPNERFAYASTYKALAAGAVLQQNSIDKLDEVITYTKDDLVEYSPI
TEKHVDTGMTLGEIAEAAIRYSDNTAGNLLFKKLDGPKGFEKALRQIGDKVTMADRFETD
LNEAIPGDIRDTSTAKTLATDLKAFTVGNALPTDKRKILTDWMRGNATGDKLIRAGVPKD
WEVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSRDKEDATYDNELIAQAAKVIVNVL
K
>H9UZW9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MGFLRSGCYPDSCHADWCRYNLTHRQCKSGPPMAGRFVWKPDPMFKTTLCALLITASCST
FAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQP
LKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQINLKPL
DINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIVNGSDNKIALAARPVKAI
TPQTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>S0KNE7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLLNILKAIILGIIEGITEWLPISSTGHLILANEFIKLQESEAFMTMFNVVIQLGAILA
VIYLYFNKLNPFSPSKSDIEKKDTWNLWFKVVVAVIPSVIIGLPLDDWLDAHFHNFFSVA
LMLIIYGIAFIIVEKRNKNVTPKCTDLNKFTYKAALIVGMFQVLSLVPGTSRSGATILGG
ILIGASRFVATEFSFFMGIPTMIGASGLKIVKFIMHGNSFSFQSTIVLLVGTVVSFIVSV
LAIKFLMNYLKKNDFTVFGWYRIILGAILIGYWLIAM
>ZP_03667925|FEATURES|ARDB_deepARG|fosfomycin|FosX|antibiotic inactivation|1
MISGLSHITLIVKDLNKTTTFLREIFNAEEIYSSGDQTFSLSKEKFFLIAGLWICIMEGD
SLQERTYNHIAFQIQSEEVDEYIERIKALGVEIKPERPRVEGEGRWIYFYDFDNHLFELH
AGTLEERLKRYHE
>A0A0N1KKY1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNLRTISLIAATFFACAVTTVGHAADDQQNRIKRTVDRAIQPIMVNDGIPGMAVGIIDGD
RHYVFNYGLASTKTRTPVTSDTSFELGSVSKTLTATLASYAQVSGYLSLSDETSKYLPSL
RNSEFGKVSLLNLGTHTPGGLPLQVPDSIRNDDQLMQYFKQWQPTYAPGTYRTYANPGIG
ALGLITAKSMGQDFSALMENRLFPALDMKHSYINVPAGKLNDYAQGYTKDGAPIRVAPGV
LSAEAYGVKATAADMVRFVEANMNLIQLDPKLQRAITDTHSGYFKAAGMTQDLIWEQYPY
PVKLQTLLDGNSSAMIFNATPATEIVPPQPPREDVWINKTGSTNGFGAYVAFIPQKRLGI
VILANKNFPIDERVSAAYRILTR
>ACN65403|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSTDSFQPETQRYALRRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>A0A0M3EWT8|FEATURES|UNIPROT_deepARG|chloramphenicol|OA46_22035|antibiotic inactivation|1
MKKITPGYTPVDLSRWPRKEHFEVFQSFAQSTINQTVELDITALHKHIKNVGWKFYPTII
FLISKIVNSHAEFRMAIKDNELVIWDEIHPQYTIFHNETETFSSLWSHYDGNIHHFQQVY
SEDVARYGDNLAYWPKEQSLENVFFISAIPWVTFTSFNVNVANMQNFFSPMFTLGKYHQK
EEKMVLPLAVQVHHSVCDGFHLARLYNELQALCNDIESLADAQQA
>A0A0F5RXC1|FEATURES|UNIPROT_deepARG|beta_lactam|OA45_00590|antibiotic inactivation|1
MKNKRLLKIGICVGILGLSLTSLEAFTGGSLQVEAKEKNGQIKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDLV
DYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKVGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIATNLKELTVGNALPHQKRNILTDWMKGNATGDKLIRA
GVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAEV
VIDAIK
>B4YF43|FEATURES|UNIPROT_deepARG|beta_lactam|LEN-16|antibiotic inactivation|1
TLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLLC
GAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGNL
LLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTAQ
HLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPER
IVVIYLRDTPASMAERNQHIAGIGAAL
>D3A484|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRFFGSGENRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDSAT
SGSYQIDGIETSQMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMDSKER
AERAEKLLGDLGLQNKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEDGHTVIMVTHDPGIAANANRVIEIRDGQIISDTSKNPDIPPSKVERIKE
KASWSFYYDQFMEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSQQKILED
INSMGTNTISIFPGRGFGDRRSGRIKTLTINDAKAISQQSYVASATPQTNSSGTLTYRNT
DLTASLYGVGEQYFDVRGLKLEEGRLFDDDDVKTDAQVVVIDQNTKTKLFGEGVNPLGKT
ILFKKRPLTVIGIMKKDDNSFGNSDSLMLWSPYTTVMHQITGESYTNSIVVKIKDDANTQ
VAEKSLTELLKARHGTEDFFMNNSDSIKEMVESTTGTMTLLISSIAVISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLSGVLLSASISLVFNYFVT
DFPMSISMTSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALAQD
>A0A0F6LFD7|FEATURES|UNIPROT_deepARG|aminoglycoside|X980_4941|antibiotic inactivation|1
MTHPAALFKIRAVQASDAAAWRQLRRALWPHADDIEHARDIARQLDAPARHACFIASPPG
ILAPVGFAEVAVRHDDVNGCGASPVLFLEGVFVEPAARRRGVARALCAAAAAWGTARGCA
AFASDAPLENAASHALHRALGFDETERVVFFRKPLAR
>J3H5R3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIETLLASGYEIAAVFTHADDPQENAFYGSVAQLCARKGIPVHA
PEDVNHPLWIERIAKLNPDYLFSFYYRHLLSEPLLATATKGAFNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAILAQKKVAIERNDTALSLHGKLRVAATDLLRDTLP
ALLAGKVSETPQDESKATVFGRRTPADGKLMWQKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAQGNEGQAPGRVISVDPLRIACGEDSLVITAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPHFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPINKQRWIYSTSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIDNAKRLLDWAPTVQMSETIGNTLDFFLREAMLEIA
DKL
>D1LFC0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
QLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLV
TWLKGNTTGAASIRAGLPTSWTVGE
>A0A0B4VT91|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMARLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>T2PZF5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTAACESLGKAWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIVMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEESHQ
>A0A060KQ89|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLVATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A101CP85|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVIL
YFKRFFQTFDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAISLLIGGLILLKVDEW
FNNPNTAETSQEITYLQALKIGLFQCLAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATAKKCYDYYKDGFELSHDQINLLVIGNVVAFIVALLAIKTFIGFLTKNGFKV
FGYYRIIAGIVLLLIHFFIHPLTII
>M5DFR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLFIKALILGIVEGLTEFLPISSTGHLILVSDLLDFNDEKGKVFAIVIQLGAILAVC
WEYRVKIGGVVMNIGSSEDANRFVLNLFIAFLPAAILGLLFIKTIKQYLFHPVPVAMAFI
IGGFLILWAERRKHVVDVDRVEDMDWKHALKVGLMQCLALIPGTSRSGATIIGGLFFGLS
RKAATEFSFFLAIPIMFAATFYDVYKHRDILHFTDIGVFIVGFVASFISALLAVRGLLRF
ISHHDFTVFAWYRIGFGIIVLATAYSGLVKWSAA
>E1URP0|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MKRKATLKFGICIGLLCVSFTGFNSLFGSTHAEAKSIENTKMTSCITNQKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKQKPIEKLNDVIRYTKEDLVTY
SPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDIRDTSTAKALATDLKAFTLGNTLTTDKRTILTDWMRGNATGDELIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILTKRFTKDAEYDNALIAEAAKVAL
DDLK
>A0A0V2DCQ0|FEATURES|UNIPROT_deepARG|aminoglycoside|LFZ48_07285|antibiotic inactivation|1
MDIRQMNKTNLEHWRGLRKQLWPGHPDNGHLADGEEILQADHLVSFVAIEDGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQQWGMNKGCREIASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A0A0Q8J8|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPVPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0G9GUR7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFKAVILGIVEGITEFLPISSTGHLVLVDEFIKMQQSTQFTDMFNVVIQLGAIMAVVVLY
FHKLNPLSPRKDTTEKRNTWVLWSKVLLAVIPSVIVGLPLNDWMDEHLMNWAVVSATLII
YGVLFIVIENHNKRLTPRFANLQTLPYTTALFIGCFQLLSLIPGTSRSGATILGAILIGT
SRYVATEFSFFMAIPTMFGASLLKLVKFFAHGGSLAGLQGAVLAVGVIVSFIVAYLSIRF
LLDYIKKSDNHCQQERNPLC
>YP_001571460|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKQDQQGGQQMPEVGVVTLKTEPLQITTELPGRT
VAYRIAEVRPQVSGIILKRNFVEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAELTVKRYQKLLGTQYISKQEYDQALADAQQANAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQASALATVQQLDPIYVDVTQSSNDFLRLKQELANGSLKQENG
KAKVDLVTSDGIKFPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLQEG
TKPAALLVPQQGVTRTPRGDATVLVVGADNKVEIRQIVASQAIGDKWLVTDGLKAGDRVV
VSGLQKVRPGAQVKVQEITADNKQQAASGDQPAQPRS
>A0A0G3QDR0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTVLLELKDIRRSYPSGDGQVDVLKGITLDIHAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGSYRVAGIDISTLNGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGVERKA
RLARAKELLARLGLGERMAYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDAEIAAQAERVIEIRDGEIITNPPSAKHGDAPKTMRTG
AEPGNWRQFSGRFQEALMMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVL
ADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDMVAIQKQPWVRSATPSVSQNLRLRSG
NIDVAASANGVSGQYFNVYGMTFSEGNTFNGEQEKGRAQVVVLDSNTRRQLFPNKAQVTG
EVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTLSARVLGQSWLNSITVRVNEGYS
SEQAEQQLTRLLSLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLLVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVLAQFLIEAVLVCLVGGGLGVALSMAIAFTLQLF
LPGWEIGFSPVALLTAFICSTFTGVLFGWLPARNAARLDPVDALARE
>A0A127SN23|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFICIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>A0A127JPX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFLLLAKAAVMGVVEGLTEFLPISSTGHLILAGSLLGFDDEKAKVFDIAIQTGAILAVI
IVYWQKIRDTLVALPTQAKARRFVINVLIAFLPAVVLGLLFGKAIKANLFTPAVVATTFI
LGGFVILWAERRPPSAVRIADVDEMRWQDALKVGLAQCFAMIPGTSRSGATIIGAMLFGL
SRKAATDFSFYLAIPTLIGAGAYSLYKERALLSMADLPLFSVGLVFSFLSAWLCVRWLLR
YISTHSFTPFAWYRIAFGIVVLATAWSGVVQWAE
>N9GY02|FEATURES|UNIPROT_deepARG|beta_lactam|F926_00636|antibiotic inactivation|1
MKLSKLYTLTVLIGFGLSGVACQHIHTPVSFNQIENDQTKQIASLFENVQTTGVLITFDG
QAYKAYGNDLNRAKAAYIPASTFKILNALIGIEHDKTSPNEVFKWDGQKRAFESWEKDLT
LAEAMQASAVPVYQALAQRIGLDLMAKEVKRVGFGNTRIGTQVDNFWLIGPLKITPIEEA
QFAYRLAKQELPFTPKTQQQVIDMLLVDEIRGTKVYAKSGWGMDITPQVGWWTGWIEDPN
GKVIAFSLNMEMNQPAHAAARKEIVYQALTQLKLL
>YP_001749617|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRRKILDVVFGLKSQPAARRFTANLLLAFMPAVVLGVLFADLIHEYLFNPITVATALV
IGGVIMLWAERRTHSVAVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFVTSFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWQFGWVDWSTAHG
>E6WYS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYFQSIIIGIIEGFTEFLPISSTGHMIVAEKFLGVAQSDLTKAFDVIIQFAAILAVMLV
YREKLSLRHLELWKKLILAFLPLGIVGFIFRHQIKALFSVEVVAWMFIIGGVIFLIVEYF
YDEEYPHRVRDVEKVSYRQALAIGIAQVFALIPGTSRAGATIIGGLLAGLDRKASAEFSF
LLAIPVMAAVSGFDLLKHYHEFAQADWGVYLAGFVTAFAVAWITIKLFLAFLSRFTFVPF
GIYRILFGAFLLWYF
>A7ZHE4|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGIDPAMRAENISVAQYCQMANYLAENAPLQES
>ZP_02900713|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMVPAVVLGLLFHDTIKSLFNPVNVM
YALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALIAIK
TFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>NP_862543|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmT|antibiotic target alteration|1
MNKKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFTLELAKRCNYVTAIEI
DPKLCRITKNKLIEYENFQVINKDILQFKFPKNKSYKIYGNIPYNISTDIIRKIVFESTA
TESYLIVEYGFAKRLLNTNRSLALFLMTEVDISILSKIPREYFHPKPRVNSSLIVLKRHP
SKISLKDRKQYENFVMKWVNKEYRKLFSKNQFYQALKYARIDDLNNISFEQFLSLFNSYK
LFNR
>V5W480|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-15|antibiotic inactivation|1
TMVLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPG
DPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKT
GSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAA
>A0A0A0Q8J9|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPIAERVKIAYAILSGLEQQGKVPLKR
>A0A127SD09|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MELSFSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWN
VQYTDWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHK
TGSSDTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYL
IKGGK
>ZP_04203285|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGIRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALK
>A0A0D1IPB2|FEATURES|UNIPROT_deepARG|beta_lactam|SC09_Contig24orf00024|antibiotic inactivation|1
MKLKNKASIKFGICVGLLCLSITGFTPFYSSTHAEAKSIEDTNMASCITNKKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNEQFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGVPKGFEKSLKQIGDHVTKAK
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGRRNDIAIVWPPNRAPIVLAILSNRFTKDANYDNALIAEAAKV
VLNDLK
>G6YHX3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAILGALAHDFIKTILFESPRLICIMLI
IGGVVLLTVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAVGFIAAFVTALLVVRFLLGY
VSRNGYSLFGWWRLVVGGVGLVALFIWG
>Q6HIK9|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKGMIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATG
DKLIRAGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLI
AEAAEVIVNAFR
>A0A0D5ZYH1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-444|antibiotic inactivation|1
MFSRWSKPLVLAATVCAMAMSAATAHAELIVRNDLKRVFDEAGVSGTFVLMDISADRTYV
VDPARAARRIHPASTFKIPNSLIAFDTGAVRDDHEVLPYGGKPQPYKQWEHDMALPEAIR
LSAVPIYQEVARRVGLERMQAYVDAFDYGNRQLGSVIDQFWLRGPLEISALEEARFTSRM
ALKQLPVKPRTWDMVHRMLLIEQQGDAALYAKTGVATEYQPEIGWWVGWVERAGRVYAFA
LNIDMPREGDMAKRIPLGKQLMQALDVWPVL
>F1DI09|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
EQLGRRIHYFQNDLVEYSPVTEKHLTDGMTVRELCSPAITMSDNTAANLLLTTIGGPKDL
TAFLHNMGDHVTRLDRWEPELNEAIPNDERDTMMPAAMATTLRKLL
>A0A0A0Q9J5|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKVRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>E7FXT1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIELLKVIILGIVEGITEWLPISSTGHMILVDEFLKLNARPEFKSMFFVVIQLGAILAVV
VIYWHKLFPFKKNKNGKITVEKDIINMWLKIVVACIPAGIVGILFDDWIDAHLYNPTVVA
IMLILFGVIFIVVENRNKNAKPKITKISEITYQTALIIGLFQLIAAVFPGTSRSGATIVG
ALIFGVSRIVATEFTFFLAVPVMFGASILKLAKFFVKGNGFMFSEFGLLVVGMVVSFIVS
VFAIRFLLNYLKKNDFKAFGVYRIVLGIIVLLFFYVVKPLLF
>BAA07084|FEATURES|ARDB_deepARG|beta_lactam|BL2e_fpm|antibiotic inactivation|1
MTMFKTTFRQTAAIAVSLISLLASPMLWADNNNTIEEQLNTLEKYSQGRLGVALINTKDN
SQITYRGEERFAMASTSKVMAVAAVLKASEKQAGLLDKNITIKKSDLVAYSPITEKHLTT
GMTLAELSAATLQYSDNTAMNKILDYLGGPAKVTQFARSINDVTYRLDRKEPELNTAIHG
DPRDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGNTTGDNSIKAGLPKHWVVGDKT
GSGDYGTTNDIAVIWPENHAPLILVVYFTQQEQDAKYRKDIIAKAAEIVTKEISNSPQTK
>A0A084Y6Y8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKALILGFVEGFTEFLPVSSTGHLILAGDLLDFNDERGKLFEIVIQSGAILAVC
WEYRAKISQVLLGLTSERAAQRFALNLLVAFLPLAIIGLLFGKTIKAHLFNAPVVALAFI
VGGFFILWAERREHRIRIESVDDLSLTDAFKLGCAQALALIPGTSRSGATIIGGLFFGLS
RRAATEFSFFLAIPTLIIATLYQLYKERALLSFDDLGMWVIGFLAAFISAFWAVRGLLRY
ISTHDFSIFAWYRIAFGLIVLLTWQYNWVSWTSG
>A0A0N9WY13|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQPGARRFTANLLIAFLPAVVLGVLFADWIHHYLFNPITVAAALV
VGGVVMLWAEKRQHQVHAETVDEISWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAIGFVTAFIFAMIAVKGLLRF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKP
>J2LA85|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLEEKAIRKVSVVIPVFNEQESLPELLRRTDAACAGLGLDYEILLVDDGSSDRSGEMIAD
AADMPGSHVVGVLLNRNYGQHSAIMAGFSNVSGDVIITLDADLQNPPEEIPHLVHAALQG
YDVVGTVRQNRQDSWFRRRASRTINQLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHER
STFIPILANTFARRTIELPVAHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIVG
SLIALTGFAFSLVLIVLRLFLGAAWSGDGVFLLFAVLFIFVGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVIHPQQDTASVQEIKQ
>A0A089PY88|FEATURES|UNIPROT_deepARG|beta_lactam|JT31_10470|antibiotic inactivation|1
MKKSLCLTLLLAASCSSFAAQKELTAQQIEKLVNRTVAPLMKEQAIPGMAVAVIYKGYPL
YFTWGKADVQRNQPVTRETLFELGSVSKTFTGVLGGDALARGEISLSDPAQKYWPELTGD
RWREITLLQLATYTAGGLPLQVPDEVTNNDALLKFYQTWQPQWAPGTQRLYANASIGLFG
ALMVKPSGMSFDKAMSKRVFEPLNLTHTWINVPATEESRYAWGYRDGKAVRVSPGMLDAE
AYGVKSSIEDMAHWVQANMAPDRLEDKTLQQGIRLAQSRYWRVGSMYQGLGWEMLNWPVK
GKTIIDGSDNKVALAPHPATLIDPPVPAVKASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNTERVKAAYAILEALQ
>K7Q9U9|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVSTRQTQDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRA
FYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTV
IGGHDSPLHGPE
>A0A117SZH3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
ILAVVIIFYKRFIDLLGLKRFSRKEMTSVPDGVPQVETEGRLKLGQVLVGLIPAGVFGLL
FEDYIDEHLFSTSTVLIGLVVGAIFMIIADRFAPKKPKTETVDQITYRQALSVGLIQCVS
LWPGFSRSGSTISGGVLIGMSHRAAADFTFIMAVPIMAGASLISLIKNWQYFTLDALPFF
IAGFISAFLFALLSMRFFLKLINRIKLLPFAIYRIVLAAVVYLVWF
>ACP19238|FEATURES|ARDB_deepARG|glycopeptide|vanYA|antibiotic target alteration|1
MLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGN
LLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGG
VSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWI
EENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKT
ISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR
>A0A0T9L3L6|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSPLRRSLLLAGITLPLANLAFPSWAKSAGQSLSEQLAALEEKAQGRLGVSLINTQSG
KELQYRGNEAFPFCSTFKLVLAAAILRQSMSQPALLEKHITYSEADLLSYAPIARENLGK
GMTVAALCAAALQYSDNTAANLLIQQLGGLEGVNKFTQSLGDTAFRLDRWEPELNSAIPG
DPRDTTTPSSMAALVKKIQFGDGLAPAQQQQLAQWLKGNTTGNASIRAGVPAGWVVGDKT
GSGDYGTTNDVAILWPPTGAPLILAVYFTQHKKDAESRRDVLAEATRIILAEYKS
>A0A0F2QXT7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYDWIAVVILGIIEGITEFLPISSTAHLLIAQHWLPRQSDLFNIVIQSGAVIAVLPLFPQ
RLHQFVFEWREPATQQYALKIVLAVVITGIGGLLLDHFGFVLPEALAPIAWAILLGGIGF
VMVERWLRDRPFDLSVTWTIAVIVGVGQLIAAVFPGISRSGATILLMLAVGLSRPAATEF
SFLVGIPTMLAAGGLKIYRALSHPFADALPERWDMVLLGFIVSAAVSFVVVKWLLRYVQT
HTFSIFGWYRIGLSGLLFAMLLME
>A0A031I3H2|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDLLTVILLGIVEGVTEFLPVSSTGHLILAGTLLGVQDQATATFDIVIQLGAILAVIVLY
WRRFWDVATGLAGGQPKAIAFVRNIALGFLPAAAIGVLVYKAVKSLLESPTVVAVALIVG
GVAILVIERLVKQARIESVEAMPWTTALGVGVVQCLAMIPGVSRSGATIMGALSLGVDRR
AAAEFSFFLAIPTMLAASGYDLLKSGATLGQGEWLSIAIGFVVSFVVALVVIRWFVGIVS
RHGFAPFAWYRIVIGAVALVALQLR
>BAD46890|FEATURES|ARDB_deepARG|tetracycline|tetQ|antibiotic target protection|1
MRFDNASTVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITD
SMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEG
IQAQTKLLFSTLQKLQIPTIIFINKIDRAGVNLERLYMDIKTNLSQDVLFMQTVVDGSVY
PVCSQTYIKEEYKEFVCNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAM
FNIGINELLDAISSFILPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRI
NDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDIEDFRIGDYLGAKPCLIQGLSHQH
PALKSSVRPNKPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLL
EERFSVKVHFDEIKTIYKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESD
ISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYV
FRLALQQSGVDILEPMLCFELQIPQVASSKAITDLQKLMSEIEDISCNNEWCHIKGKVPL
NTSKDYASEVSSYTKGLGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSMSLK
>D9HP85|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDTDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>A8UZH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGVLEAFVLGVLEGLTEFLPISSTGHLILASWIMNIKQTEAHKAFEVAIQLGSILAVVFL
YKNKLFSSRKLWERLIIAFIPTGALGFLLYKIIKSLFSPYVVATMLIVGGIIFIIVELLY
KEKEHHISNVEEIPYIKAFFIGVFQSFAMVPGTSRSGATIIGGLLLGLNRKTAAEFSFLL
AVPTMFVATAYDILKHHNEFQVDNWINLGIGFFTAFVFAVISIKLFLAFISRYNFIPFGV
YRIVVGIIFLLFFL
>S6IRH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVVGLPRQRSAQRFTVNLLIAFFPAVVLGVIFADLIHQYLFNPITVATALV
VGGVIMLWAERREHEVHAHSVDDITWQDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDMPVFAIGFVTAFIFAMIAVKGLLKF
IASHSYAAFAWYRIVFGLLILATWQFGWVDWAAAKS
>T9T6L7|FEATURES|UNIPROT_deepARG|beta_lactam|G994_04412|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>P0A3Y6|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLGENENLYLKMTDSRYKGTTYDVEREK
DMMLWLEGKLPVPKVVHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRL
FHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPE
EELVFSHGDLGDSKIFVKDGKVSGFIDLGRSGRADKWYDIPFCVRSIREDIGEEQYVELF
FDLLGIKPDWEKIKYYILLDELF
>K2PTA7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLNFIELLKVIFLGIVEGITEWLPVSSTGHMLLVDAFLHTDMTQAFKDMFFVVIQLGAI
IAVIVEFWSQMNPFVKVENKGVRIKRSVFNMWVKVVVAFLPSAVFGLFLNDFLEENFGTP
FTIAIMLIVYGIAFIVIERWNKTRQPKINSMKEITYQTALIIGLFQVLSMIPGTSRSGAT
IVGALLIGVSRVVAAEFTFFLAVPTMLGASAFKLLKFGLNFSLSEVIALIVGMVVAYVVS
IFVIKFLMSYIKRRDFQIFGWYRIALGIIVIAFILFGVI
>A0A0G1D9C9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNSIQVLILSALEGLTEFLPISSTGHLILASKLMGIAETDFVKTFEIVIQLGAILAIVVL
YFKKLLMSRDLVKKIFVAFIPTAVVGATLYPLIKEVLLGSSSITLNALFWGGVALIAVEW
FLKRKKSEVKKSSEITYKQAFIIGTFQSISVIPGVSRAAATIVGGLLTGLKREAAVEFSF
ILAVPTMFAATVFDIYKSRDMITQGGVLTLFIGSVLSFFFAVAAVKFLVNYVKKHDFTSF
GIYRIALSILFWIFVK
>A0A0U1HZ39|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_2|antibiotic efflux|1
MTALLELKGIRRSYQSGGETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKHE
RRERANMLLTRLGLEERVNYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKTVSTVAVSDVMS
LTPPAPSWQQLTGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQM
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMAALKEQSYVSAVSPTISGSMRLR
YGNIDVAASVSGVSEQYFRVYGMKLEQGTAITHEQVERQSQVVVIDRNTQRRLFPHLKEV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTLRHGKKDIFTYNMDSLLQTAEQTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLMVE
MILPSWQIAFPPMALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A0A8BTF4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLQVLVLAIVQGIAELLPVSSSAHVIMAEKLMGLDPSAPAMTLLLVMLHTGTMLAVIV
YFWKSWRERYFSSKQDFVHNAKQVIIATAFTGVIGLALMLFIEKVLMRGSEHAEIEHLFG
NLYIISAGLAMAGILILISGRKRAPMGDRPMRGADSAWIGAVQGLCLPFRGFSRSGSTIS
TGMLRGLDKVRVEEFSFALAVVLTPPVIVKEAYRLYKSGGAQTLSGHFATVITPSLAGMV
FSFLAGLIALRWLSRWLEHGRWYLFGIYCLVASAVVLAASQVM
>Q84GI5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGKQ
WQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMSFEQAMTQRVLQPLTLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNHEAVQDKNLRQGIHLAQSRYWRAGEMYQGLGWEMLNWPVSA
EVLINGSDNKVALAATPVTAVNPPAPPVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHILEALQ
>J8IL03|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MAIKIDEYELLEIDSGPYGITTGKDGVLWFTQHKANQIGRMTVNGEVTHFVVPTSNAGVL
SIISTTQGDVWFTENRANKIGKLTVTGEIIEYVLPCPDSAPFGITEGHNGDIWFTEMNGN
RIGRILPSGEMIEYDLPSPGSYPSFIVAGPDDAIWFTENQSNQIGRITILGEVTNYLLPT
EHAGPVGITNGPDNALWFVEINGNKIGRITPSGTISEYIIPTANARPHAIVTGPDCALWF
TEWGSNQIGRITMKGEITEYPIPTQSAEPHGIVLGPDGAIWFTEECNKIGRLSLL
>A0A0Q6KCC5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDYLVAILLGIVEGVTEFLPVSSTGHLVLATDLMGYDASRWAVFNIAIQPGAILAIVVL
YWRTFMAVLTGLLKREPNSIAFVRNLLIAFVPAVVLGLAFNNQIEALLENAIVVAWALIV
GGVAILIVERLAKTHAVGGIAGVSAVQSAKIGVVQCLAMIPGVSRSGATIMGAMSLGIDR
RTAAEFSFFLALPTLTGATVLQMVKHRDAITSGSLGLIAIGFVVSFIVALAVVKGFMAVV
TRHGFAPFAWYRIVAGTAALFFLYTH
>A0A0M0UXQ5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGLQALLDAGYEIAAVYTHADDPDENTFFGSVARLCARHGITVHA
PEDPNHPLWVERVAKLAPDFIFSFYYRQLLGEPLLACAKKGAFNLHGSLLPHYRGRAPAN
WVLVNGETETGVTLHQMVKRADAGPVFAQQRVPISATDTALTLHGKLREAATDLLSETLP
LLAQDRLSGTPQDESRATCFGKRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCTVGDN
KLIIWAADLELRNDGEAPGTVISHDPLRIACGEGSLVILAGQRGDAGLYLSGAQLAREFG
LVEGSQLLDTQKRRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
IQPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDESFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGKGYQDVSHRKPSIANARQLIGWTPGIELSTTIGKTLDFFLREAMIEKA
DQR
>A0A0K2BL80|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MCDINDINLLFIALILGVVEGLTEFVPISSTGHMILVSQLLGFHYYNIKTFEIIIQLGPV
VAVICILWRRVLGIIGLNLDKISNHNININSNKKLNINHITLGIIPSMVLGLICHKQIKN
FFEPKYVISALLLGSIWLLAGQLLLNYRKNSSSVTVFIDDISYLQAFLIGCFQCFALWPG
FSRSGATISGGILVGVSRTVAFEFSFILSVPIKLGATILDLYKNLPFIFLHDLPIFTIGI
STSFFISFVIIKYLFKIIQCISLVPFIIYRFVLVIILYYFIY
>A0A101NVZ5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTVRYLQYLQGLAVHRSAAPAITEIPVSDKQAGPYGIAAGPDGALWLTYVHSGRIARLTV
GGELTDYPLDSAACRPTVITAGPDGALWFTRSQDHRIGRITPEGAAASYPLPTPGSGPFG
ITAGPDDAMWFTQMNTDRIGRITGTGDITEFSLPTPGGFPSAITAGPDGALWFTLNQANA
IGRITVDGHIAIHSLPTPDAAPVGITSDGTALWFVEIAVGQIGRIDVNGRIAEFPLPDRA
ARPHAIVAASTADCWFTEWGANRIGHITVSGEIAEYDLPSPSCEPHGITLGPDGALWAAL
ETGCVARLVP
>A0A127SXU8|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQVGELGIYDEMIPSYTIFHE
DTETFSNLWTEYMPNIEEFSRAYENDIQRYGSNHGMTGKPDAPENVFTVSMIPWSTFESF
NLNLQKGYRYLIPIFTLGKYYMEDGRIMLPLAIQVHHAVCDGFHICRFVNELQELINS
>A0A075US73|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSRIGIEEFPVPGEGPYAIALGPDDALWYTLVRSGHIGRLVPGGTPENWPLAPDSGPTVI
AAGPDGALWFTEYQAHRIGRITTAGVISEFPLPTPECGPYGLAAGPDGALWFTEIAADRI
GRITMSGDVTEFALPGTGTFPSAIVAGPDGALWFTMNQADAIGRITTGGEITVHRLPAQA
AGPVGIAAGPDGALWFTEITAGQIGRITVHGDVTEFPLPDRSARPHAIAGGDNELWFTEW
GGNRVGSITPDGVIETHDLPTPGSEPHGLAFGPDRAVWTALELGALARIDNEGEVR
>Q9F491|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVEASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>R8HMG0|FEATURES|UNIPROT_deepARG|chloramphenicol|IIC_03218|antibiotic inactivation|1
MKFHVIDRENWNREQYFGHYLKLKCSFSMTANVDITMMLEEIHQKEIKFYPTFIYVISRV
INKHTEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTGYSSDFHIFYKNYEEDMR
CYANVHGFFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDGSRVM
LPVSLQVHHAVCDGYHASRFIEDLQELANTCNEWLK
>ZP_00235180|FEATURES|ARDB_deepARG|fosfomycin|FosX|antibiotic inactivation|1
MKDLNKTTTFLREIFNAEEIYSSGDQTFSLSKEKFFLIAGLWICIMEGDSLQERTYNHIA
FQIQSEEVDEYIERIKALGVEIKPERPRVEGEGRSIYFYDFDNHLFELHAGTLEERLKRY
HE
>YP_002705655|FEATURES|ARDB_deepARG|multidrug|smeA|antibiotic efflux|1
MSLLRPLSRFSHSLLLPPLLLALAACSAGRTEAPATPEVGIITASAQPLALQQTLPGRAV
PFEVSEVRPQIGGLIRQRLFTEGQQVKAGQLLYQVDPAPYQAALDTARGQLAQAEATVLS
AQPKAERTRALVSMDAASKQDADDATSALKQAQANVIAARAALQAARINLDYTRVTAPID
GRIGTSSVTAGALVAAGQDAALTTIQRLDPVYLDVTQSSTQMLALRKQLDAGLVKAIDGK
AQVKVVLEDGSTYAHEGTLEFVGSAVDPGTGNVVLRAIIPNPDGLLLPGMYLKAVLPMAT
DARALLVPQKAVVRNERGEPLLRLLDAKDHVIERRVSTGQVVGNQWQITQGLKAGERVIV
SNGSAVALGQQVKAVAATTAQLAAMPAIDPNGNTDEKSH
>A0A0K8WZE2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQLLGRRTDFFNIVIQAGAILAICLALRQ
RLWTLATGLGERDNRDYVLKVSVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSRRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWADVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRIVLGAALLLWLPAATG
>A0A0C4YB31|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTQAPLLLLQHVERTFRAGNQDIPVLRQVSLAICAGEMVAIVGASGSGKSTLMNILGCLD
QANAGRYLVAGQDVAALDDDALARLRRERFGFIFQRYHLLAQLCAADNVEMPAIYAATDR
AARRARALQLLERLGLGERAGHRPSQLSGGQQQRVSIARALINGGQVILADEPTGALDSH
SGKEVLAILRELHALGHTVIIVTHDMGLARNAERIIEIADGRIVADRANRPPQAEDEPGS
GLVQAKPATQAPGAGGNAEAPLRRARAWQGFTEAFSMAWGALMAHRMRTALTMLGIIIGI
ASVVSIVAIGEGAKRYVMADIRAIGANTLEIFPGKDFGDDRAAGIRTLVAADIEALHALP
YVDSATAITSKVQRLRYRSVDVNATVHGVGASFFRVRGLGLTQGAAFLPDELRRHAQVAV
IDEKTRRKLFGNALSALGQVILVGNLPCVVIGVAREKKTMFDDNGSSLNIWLPYTTAGSR
IFGQSHFDELSVRIRDGQPSAAAQQAIERLLTLRHGKKDFFTYNMDSIVKTMERTGQALT
LFLSAVAVISLLVGGIGVMNIMLVSVTERTREIGIRMAVGARQRDVLMQFLTEAVLVCLL
GGVIGTTVAYLVGLALALLIPQWQMVFSAGAVAGAFLCSTLIGVVFGYMPARNAARLQPI
EALGHE
>H0UEI1|FEATURES|UNIPROT_deepARG|multidrug|RBAM_005660|antibiotic target alteration|1
MQLKLNNKYSRIKEFLREHNYPSFRMKQILNAIFKERINKFNEIHVLPKSLREILGKEFG
ESILDVVPLKEQHSEQVTKVLFEIPGNEKIETVNMKYKAGWESFCISSQCGCNFGCKFCA
TGDIGLKRNLTSDEITDQILHFYLQGHSIDSISFMGMGEALANVQVFDALDVLTDPTMFA
LSPRRISISTIGMIPSIKKMTLNYPQVNLTFSLHSPFNEQRSKLMPINDRYPLLDVMDTL
DEHIRITSRKVYIAYIMLPGVNDSIDHAKEVVSLLKGRYKEGRLYHVNLIRYNPTVSSPL
RFAEVDDGHVVHFYKKLKSSGINVTIRSQFGIDIDAACGQLYGNYQKSNKQ
>S3BQS2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTAQQPFAECAAGPSTAVTTVAAFGADAGPYDVVTGPDGALWVTLVAAGAVARVSPDGEV
RMHGLDVSGCGPTVITPGPDGALWFARTHDHRIGRMTTDGVAESFALPTPECAPFGIAAG
ADGALWFTETTGNRIGRLTTDGEITEFPLPVSGAFPSALVAGPDDALWCTLNQADALCRI
ALDGEITVHRLPTEGAAPVGLVRGPGEDGRDELWFVEIGAGQLGRISTEGRVVEYPLPDR
AARPHAVAVTPDGTCWVTEWAAGRVTARAPSGRFTAYPLPHAEAEPHGLTVGPDGAVYVA
LEAGEVVRVSPSPSEN
>A0A0C1U434|FEATURES|UNIPROT_deepARG|beta_lactam|QP59_08460|antibiotic inactivation|1
MNYRFRLLVSLVIGSAGILLTSPISAKLIHRLHTPQISQQSIVSNLITLDDGSLNLLERQ
ERSDWASLFDRAEARGTIVVLDQRGGTQQLWVYDQERADRAYSPASTFKIPHSLFALDAG
VVRDEFQVFEWDGVERDFAPHNQDQTLRSAMRNSAVWVYEIFAAEIGEAQAREYLTQIDY
GNADPSTSEGTYWIDGALAISAQEQIYFLQKLYQNELPFRVEHQRLVKDIMIVEAERDWI
LRAKTGWEGRWGWWVGWVEWPTGPVFFALNIDTPNRLDDLYKREEITRAILQSIDALPAE
EDRQ
>A0A0N8QTB5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPREKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDALLACAKKSALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPILAQQRVSISATDTALTLHGKLREAAADLLGETLP
LLAHGQLSGTPQDEALATCFGRRTPADGLIDWALPATQLYNLIRAVTQPYPGAFYPVGEN
RLIVWAARVEARSAGDRPGTVISQDPLRIACGEGSLVIDAGQRGGNGLYLSGAQLAREFG
LVQGSQLMDTEKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSVDNARHLIGWTPGIELGETIGKTLDFFLREAMAEKA
GQR
>AAX35723|FEATURES|ARDB_deepARG|beta_lactam|mecA|antibiotic target replacement|1
MKKLIIAIVVVIIVVASSIFFYASKNSQINDTLDAIEDKNVKQVFKDSTYQSKNDNGEVE
MTDRPIKIYDSLGVKAINIKDRDIKKVSKNKKQVTAKYELQTNYGKINRDVKLNFIKEDK
DWKLDWNQSVIIPGMQKNQSINIEPLKSERGKILDRNNVELATTGTAHEVGIVPNNVSTS
DYKAIAEKLDLSESYIKQQAEQDWVKDDTFVPLKTVQNMNQDTKRFVEKYHLTTQETESR
QYPLEEATTHLLGYVGPINSEELKQKAFKGYKKDAIVGKKGIEKLYDKDLQNKDGYRVTI
IDNNKVIDTLIKKKKKDGKDIKLTIDSRVQKSIYNNMKDDYGSGTAIHPQTGELLALVST
PSYDVYPFMNGMSDEDYKKLTEDDKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKT
SYKINGKGWQKDKSWGDYNVTRYEVVNGDIDLKQAIESSDNIFFARVALELGSKKFEEGM
KRLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENKGN
VNAPHVLKDTKNKVWKKNIISQENIKLLTDGMQQVVNKTHREDIYRSYANLVGKSGTAEL
KMKQGETGQQIGWFISYNKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDDLYDNGKKT
YNIDK
>A0A0P8WR09|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A143J2U6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGIIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKTKGTISFDDAPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQLLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVIPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A117DNC6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFYAIVYGIVEGITEFLPISSTGHLILTGNLMGVPWSKEVKDTFEVVIQGGAILAVLA
YYWKDFLQIRHIGRDKTQQNLWLGVVVACIPAVILGVLFGDTIKAYLFRPSVVAWALIVG
GILMWLIESRRVTPNVDAIEKIGVRRSLMIGTLQCLALLWPGFSRSASSILGGMVLGLDR
PTATKFSFYLGVPTLGGAALRDFIKNRDILAEIGVLNVLLGAAVSFVVAYLSIGWLLRFV
STNNFKPFAIYRVVVGVLILVLIAAGVLNNGNLA
>A0A094UAP4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPALLELNEVSRVYSNGEEETIVLNKVSLTINAGEMVAIMGASGSGKSTLMNILGCLDKP
SRGEYKVAGQSVAQMEGDQLAALRREHFGFIFQRYHLMAHLSAEQNVEIPAIYADKNATQ
RKERARELLTRLGLGERVDYRPNQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
KEVMAILKQLNEQGHTVIIVTHDPLIAEQADRIIEIKDGKIISDRCHQTTTHKIKKETTT
VLTSSYLGQIVGRFTQALEMAWRAMVVNKVRTLLTMLGIIIGIASVVTIIVIGDAAKSMV
LSDIKAIGSNTIDIYPGKDFGSDSPEDRQSLTLQDVFALKQQSYVQAVTPQVQFSTRLRR
GNQDSPASVAGVSDDYFTVYAMKFSQGRSFTHDMIQRQAQVVVIDENTRHRFFPNKKNVI
GEQIIIRNIPSTIIGVIADKKSVFGNGQSLRVWVPYSTLNSRILNRSYLDSITVRAIEGY
DANVAEQQIIRLLTIRHGKKDIFTYNLDSFIKAAESTTQTMQLFLTFVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVMQQFLIESVLVCLVGGVLGIGLSFSIAIIASV
MLPEWHFVFQPIALVSAFICSTAIGVIFGFLPARRAAKMNPIDALARE
>C6G9T8|FEATURES|UNIPROT_deepARG|aminoglycoside|pRAx_0051|antibiotic inactivation|1
MKDQITHLPDNADRPCTRDNVGQSGATIYRLYGKPDAPELFLKHGKGSVANDVTDEMVRL
NWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLH
SIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDS
VVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYG
IDNPDMNKLQFHLMLDEFF
>A0A0E9M9F1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLLKAAILGVVEGFTEFLPISSTGHLILVGDLLNFNDERGKVFEIIIQFAAILAVC
WEYRTRISAVIIDLPHDRHAQRFATNVMVAFLPAAILGFLFAKSIKAHLFAPVPVALAFI
VGGFIILWAEKRDHQTTIHSIEDMSWQDALKVGLAQSLALIPGTSRSGATIIGGLFFGLS
RKAATEFSFFLAIPTLFAATLYEVVKYRDLFHISDLPMFAVGGVASFISAFLCVRWLLRY
ISNHDFTLFAWYRIAFGLVVLATAWSGAVSWSA
>A0A0S1RVX3|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILVQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQ
PTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLRKLVNRQLPVKAAAYELADNLFEAGQADGWRLYGKTGT
>B1FBJ4|FEATURES|UNIPROT_deepARG|beta_lactam|BamIOP4010DRAFT_1403|antibiotic inactivation|1
MRFNAIRIAATLFAAACVAVTAGRAAAATPDEIHDTVTRNVAPLMKQFAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLASDAQEGGELSLSDPAAKYLPA
LQGKPFGGVTLLELGTHTPGGMPLQVPDSIRDEAALMRYLDAWRPAYAPGTRRTYSNVAI
GMLGQLTAKAMNRDFAALMEQRLFPALGMTHTYINVPAARQADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLVDTAPRLQRALERTHTGYFRAGPFTQDLIWEQYP
YPVALPTLLEGNGPPMLHDATPTTELKPPLAPRPDTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRSFPIEDRVKAAYRIVESLDGKP
>A0A0E9BKU8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKIYFTALLVALSASSSATDLSSQEIASRVKDVITPLMAEQGIPGMSVAVLYKGRPQYLN
FGVADTATDRRVTENTLFELGSVSKTFTGVLAGVMIRNSELRLNDPVQKYWPALKGPQWQ
AIRMVHLATYSAGGMPLQLPASVVDQDSLLRYAQQWQPGVAPGIQRQYSNVSLGLLGYLM
VKGEFEEAMQKNVFTPLRLTRTFYTVPASMMFDYAWGYKDGQPVRVSPGMLSAETYGVKS
TARDMMTFMQANANPNGLSSGNTVLRNGILTAQSHYLTAGQLSQGLGWEIYPWPVKAQTL
IDASDTKTALEAQPATLVNPVKPADRASWIHKTGSTNGFGAYIAFVPQLNSGIVMLANKN
YPNPERIKAAVAILDALQ
>A0A0U1CG05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVLEAIILAIVEGITEFLPISSTGHMVIAQALMGMEPTPYVKAFTVMIQLGAILSVVVL
YFRRFFRFELPRDMWHEERKWRRTLGRFRFYFLLIVGVVPAAVLGLLFNDWVDEALGKVW
IIALNLVIGGVVMLFIDRLIRHNHKGEVTYGKALVIGLFQTIAMFFPGMSRSMSTIVGGM
SVGLRREVAAEFSFFLAVPTMLGAFLLEIIKFWKSDSLYILEEHWLTLLVGNVVSFVVAM
VAIQTFIRYLKRHGFAAFGIYRILVGGVILALMGLGVELAIV
>AAM19211|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0P8WN19|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHKYLFNPITVATALV
VGGVIMLWAERRQHEVHAQTVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAVGFVTAFVFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLFILATWQFGWVDWSAAKP
>E0F3D3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIEKLNKYFGSGENTAHVLKDINLTIEQSDFVAIIGASGSGKSTLMNIIGCLDTAS
SGVCKIDGKETLNMTSDELSDLRQRKFGFIFQRYNLLPALTANENVALPAIYAGMDNTSR
KARANQLLEKLGLADKTGNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILKDLHKEGHTIIMVTHDANIAANASRIIEIKDGYIIRDERQQPYSEDLKLTKREY
KKPRFFDQLIESFKMAINAITAHKLRALLTMLGIVIGITSVISVVALGQGSQQQILSNIN
SLGTNTMTIMNGTGFGDRRANLTKNLTISDAMMLNKQQFVDSTTPSSNLNGTVIYGNTNV
TASINGVGEQFVNVKGLKMISGRFFDADEVKLSSQVVVIDGNTKKDLGLTAPVEGKVILV
DKKPLTVIGMAQESNNLNQTSLKMWMPYTTLMQRISGEKFIDSLTVKVKDNVESQTAEKS
INELLTAKHGKKDFFVMNSDTIKQTITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQNNILQQFLIEAVLICLLGGIIGILFAMAIIFSFNTLGTNFKMI
LSPASVVLAVFCSTLIGVVFGYMPAKNASKLNPITALAQE
>NP_837350|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRYMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPEPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRMPSAIILQRASR
>A0ESJ4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGTLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILKALQ
>A0A0E3BCV9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMGVVEGITEFLPVSSTGHLILAGNALSFLAKEKRDVFEVFIQFGAMLAVIWEYRARLAN
VVVSARADQGARRFLVNLAIAFMPAAVLGLLIGSHVQRLLFSPGPVAVALVIGGIAILWA
ERRPVHVKAERAEEISRIDALKIGFVQCLALWPGTSRSGATIIGGLWFGASRQAATEFSF
FLGIPVLGAASGYNLFKHWNALSSDDIGVFVMGLLASFVFALLAIRLLMRYLTGHGFGVF
AWYRIALGTLILAVLVT
>A0A097SRQ4|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
AHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRI
DAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGG
PKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASR
QQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVFIYTT
GSRVTMG
>W0MVH1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDADYEIAAVFTHADDPKEKTFFGSVAQLCAQHDIPVHA
PEDANHPLWVERIGKLAPDFIFSFYYRNLLSEPLLACANRGAFNLHGSLLPHYRGRAPAN
WVLVNGETETGVTLHQMVKRADAGPVFAQQRVSISVTDTALTLHGKLREAAIDLLSDTLP
LLAEGRLSGTPQDESQATCFGRRTTADGLIDWSLPATRLYDLIRAVTQPYPGAFCPVGDH
KLIIWTASVEPSNNGAAPGTVISHDPLRIACGQGSLIINAGQRGDEGLYLSGAQLAREFG
LVDGSQLLDTKKQRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
AKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRNNFPPFA
GFRDVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPNIELSETIGKTLDFFLREAMAEKA
DQC
>Q03680|FEATURES|ARDB_deepARG|beta_lactam|BL2d_moxa|antibiotic inactivation|1
MRIRPTRRLLLGAVAPLALVPLVACGQASGSESGQQPGLGGCGTSAHGSADAHEKEFRAL
EKKFDAHPGVYAIDTRDGQEITHRADERFAYGSTFKALQAGAILAQVLRDGREVRRGAEA
DGMDKVVHYGQDAILPNSPVTEKHVADGMSLRELCDAVVAYSDNTAANLLFDQLGGRRGS
TRVLKQLGDHTTSMDRYEQELGSAVPGDPRDTSTPRAFAEDLRAFAVEDGEKAALAPNDR
EQLNDWMSGSRTGDALIRAGVPKDWKVEDKSGQVKYGTRNDIAVVRPPGRAPIVVSVMSH
GDTQDAEPHDELVAEAGLVVADGLK
>K7QYG9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGPMSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPVEEDAFLKTFLIAIQLGAIL
AILLLYGRRFLKDQALWLRVGVAFLPTGAMGFFLYPLIKGEILGDDGVVVLALFGVGLVL
LLADRLAQRARYQDALEVPLGGLLLIGFFQGLAALIPGTSRSGATILGGLLVGLSRKGAA
EFSFLLALPTMLIAVGYDLLKSAPQVPEGGWGLLGLGFFSALITALFTVRALLALVERVG
FTPFALYRMALALVYGHFFLRQG
>A0A0R2EDX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILGIVEGITEFLPISSTGHLVLVDEFIKLNEPKKFIDMFNVVIQLGAIMAVVVLYFHKL
NPWSPKKSRLERSQTWTLWKKVIIAVIPSVIIGLPLNDWMDAHLMNWLVVSIALIVYGAL
FIVIENHNQNLRPRFDSLNTLPYKVAILIGCFQILSLIPGTSRSGATILGAILIGTSRYV
AAEFSFFLAIPTMFGASLLKLYKFFAHGGTLAGNQGLILAVGVIVSFVVAYASIRFLLNY
IKTKDFKAFGWYRIILGVIVIAYFALLAH
>A0A127SBA9|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLYKLDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
NWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLIIGG
K
>A0A109LDR8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_4|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMLAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPQS
QRHSRAGELLARLGLSGHTSHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIISDKANDSVGLELPVEAP
VEPRRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIQTLMPSDVDALNQLYYVDSATPVVGRNL
MLRFGNIDVDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRQRLFGPN
IDPLGQVILIGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGIIGISLSYAIGY
LFSLFVKEWEMVFSVGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>R5SS55|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDVIEIIKVIFLGIVEGITEWLPISSTGHMILVDEFINLNVSTTFKDMFFVVIQLGAIL
AVVTLYFKKLNPFSPAKSKVEKKDTWTIWIKILIACVPAGVIGILFDDFLDEYLHTPIVI
AATLIIYGILFIIIEIWNKNRNAKITHIKDISYMTAFIIGVAQVLSLIPGTSRSGATILA
AILLGTSREVAAEFTFYLAIPVMFGASLLKLVKFGFAFTSQELIVLIVGMVVAYVVSIIA
IKFLMQYIKKNDFKAFGVYRIALGIIVLLYFLVIK
>W6VPQ1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAIVFAYHDIGCAGIETLLSSGFEIAAVFTHADDPKENAFYGSVAQLCARNGIPVHA
PEDANHPLWIERISKLNPDYLFSFYYRHLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQKVAIDRSDTALTLHGKLRVAATDLLRDTLP
ALLAGKISETPQDESKATVFGRRTPADGKLVWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAQGNEGQAPGRVISVNPLRIACGEDSLVITAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>A0A0K3QXW0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0C1ZX29|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVVFADLIHHYLFNPITVAAALV
VGGIVMLWAEQRQHEVHAETVDEIRWTDALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IGSHSYAAFAWYRIVFGLVILATWQFGWVDWTAAKP
>A0A0R3B6Y4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDKSAQLLEDA
AAEDGSNVVAVILNRNYGQHAAIMAGFEQCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAGLGVLFAVALIVLRLAFGAQWAGGGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGMVSSHTTTTSPSDQVSS
>A0A029PR94|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTDMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRTARRLLERDA
>ZP_03829223|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGEVPHEGHTAGRLKLTHILLAMIPAVVLGLIFHDVIKSLFYPQN
VMYALVVGGFLLLAAEWLKPKKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADLPMFAVGFVTAFIVALIA
IKTFLKVIKRISFVPFAIYRFIVAGVVYMVFM
>R5H8M1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLSFIEILKAILFGIVEGITEWLPVSSTGHMILLNEFVHMNVSEEFWDMFLVVIQLGAIL
AVVLLFWKQIWPFNFTGRSKTNGIVKKDIMKMWFKIIVACIPAAVVGLLFDDILEKYLYN
PITVAVMLILFGIGFILVENGHKGKRARVRSLAQLTYKDAIIIGLFQLIAAIFPGTSRSG
ATILGGLMIGVSRTVAAEFTFFLAIPVMLGASLLKVIRFGFAFSMAEAVILLVGMAIAFI
VSVLVIRFLMGYIKKHDFKVFGWYRIVLGILVLLYFFVIK
>A0A084JQ83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIIEILKVIVLGIVEGFTEWLPISSTGHMILVDEIIHLNQPSAFKNMFLVVIQLGAILT
VLVLYFDKLNPFSVRKKPAQKQATLVLWSKIILACIPAAVIGFLVDDILDEYLMNGYVVA
ATLILYGVLFIFIENRNQYRSFEVQKVGDISYQTALWIGLFQLLALIPGTSRSGATILGA
MILGCSRAASAEFSFFLGIPVMFGASLLKVVKYGMNFTGSQIFYLILGMVVAFVVSIYSI
KFLMGYIRQHDFKFFGYYRIVLGAVVLLYFIITAFIG
>A0A0H0DBH8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACETLGKAYEILLVDDGSSDDSAMMLTD
AAQAKGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIALAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEEIHP
>YP_098534|FEATURES|ARDB_deepARG|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQGRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHVYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>Q7WTR3|FEATURES|UNIPROT_deepARG|multidrug|mdtK|antibiotic efflux|0
MQKYLSEARQLLALAIPVILAQVAQTSMSFVDTVMAGAVSATDMAAVAVGTSIWLPAILF
GHGLLLALTPVVAQLNGSGRRDLIAHQVRQAYWLAGMVSVLVMIVLYNAGYLIGSLHNVD
PLLSQKAIGYLHALLWGAPGYLFFQVARDRCEGLSKTKPAMVVGFLGLLVNIPLNYVFIH
GHLGMPALGGVGCGVATASVYWVMFIVIRAWTNRAKSMRDIQLPQRFSAPDWKAIGRLTG
LGLPVALALFFEVTLFAVVALLVSPLGIVNVAGHQIALNFSSLMFVVPLSLGVATTIRVG
HRLGQGSAEQAKVAAWTAQGIGICMACITALFTIAFRERIAQLYADDPEVITMAAQLMLL
AAVYQLSDSVQVIGSGVLRGYKDTRAIFFITFIAYWILGLPIGYLLGMTNLLLPAMGPAG
FWIGFIIGLTSSAIMMIWRMRRLQRQPNATVLARAAR
>Q9CM47|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MMNQPLIELKNIVRRYGHGDTETTVLKSINLKIYAGEMVAIVGASGSGKSTLMNLLGVLD
QADDGEYLFRGRQISTLSSDELADLRCYHFGFVFQRYHLLPHLTAVENVEIPAIYSAMEK
EKRIERAQKLLCRLGLENQLKHKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQ
SSQEVLSVLKTLNHQGHTVVLITHDMQIASHADRIITMKDGEIIADSGVTQNLMKSSAQE
VTPQLSSMHYLATLRRYHAAFLMAMHMMFAHKIRTLLTMLGIIIGIAAVVCVIALGEGAK
NKVLAEFSALGNNTIDIYPGKNWGDPDAIKIQTLNQVDLALLRQQPYLKGATPQISVDLP
LRFLNRTVNASVYGVSDAFFQLRKHRLLSGRWFNAHDMATHQAVSVIDKKSQQVIFGTES
AVGKTVFIGQIPILIVGVVETPPQNIEGQRATIWLPYNTVVSRLYNQSYFQQITVQVKEH
IAPDLAEKAIIDLLTIQHGRKDFFTFSSRKFLQSLQRTTQTLTMMISSIAFISLVVGGIG
VMNIMLVSVIERTREIGIRVAVGAKEKDILHQFLIESASVSLLGGMLGVLLSLLLGGLFS
AFTDSIKMQFTFSSFLIAFVCSSMIGMIFGYFPARNAARLKPVVALSQE
>R8EI38|FEATURES|UNIPROT_deepARG|beta_lactam|IIU_01966|antibiotic inactivation|1
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSEPPKQTKQTKQIKQIKQENTGHDSFA
KLEKEYNAKLGIYALDTGTNQTIAYHSNDRFAFASTSKSLAAGALLRQNSIEALDEGITY
TREDLSNYNPITEKHVYTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGD
TVTKSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKKDAEYDDKLI
ADTTKVVLDTLKVTNKN
>J2Q1S6|FEATURES|UNIPROT_deepARG|beta_lactam|PMI23_04873|antibiotic inactivation|1
MSSIQSSKVISCAAFGLLFGATSCLAAAPDAVQLQALVNDAVTPVMQQQNIPGLTVALTI
NGKAHYFNYGDASKDTGQKVSENTLFEIGSVSKTFTATLASYAQATGKLDLSTKASQLWP
DLKGSAFDNISVLQLGTYSAGGLPLQFPDNADSSDKMLGYFQQWKPVYPAGSHRQYSNPS
LGLFGYLAAKSLGQPFDQAMTQTLLPKLGLQHTYLSVPAAQMELYAQGYDKNGKPVRVTP
GALDAQAYGVKTSAVDMLRYVQVNLKPETLEAVLQKTIANTHTGYYTVGDMTQGLGWEMY
RYPLSLERLLAGNSTEMAMEPHKVQWLNPPRPQPDDVLINKTGSTGGFGTYVAFVPSKNV
GIVIMANKNFPIPERVKIAHKILSAVTD
>A0A0C5FZ84|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MAVSEMSVADKGAGPYGIAAGPDSALWLTFAHSGRIARLTLDGELNEYPLESPECRPTVI
TPGPDGALWFTRSQDHRIGRITADGETESFPVPTPDSGPFGITAGPDDAMWFTEMNTDRI
GRITSTGDITEFVLPCTGAYPSAITAGPDGALWFTLNQANAIGRITVHGDIVIHRLPTPS
AAPVGITSDGAALWFVEIAAGQIGRISVDGAIKEFPLPDPTAKPHAIVAASTGDCWFTEW
GANSIGHITGSGKITEYSLPSPSSEPHGITLGPDGALWAALETGGVARLEP
>A0A0P9S855|FEATURES|UNIPROT_deepARG|beta_lactam|ALO72_03788|antibiotic inactivation|1
MQWNGTLFCTGLLLVSSVAFAEDNAAALDTLVQTEARKVMQENNIAGLSIAITRHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTQSIDTYLPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPENVQNTRQLMDYFKAWQPDYLPGTHRTYANPSIGLLGV
IAARSMKMPFQEAMQQLLFPALGLNSTYVSVPNDKQVLYAQGYNKLDEPVRVSPGILAAE
AYGVKSSSRDLIRFVEANIGLGQHDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTQMRL
DVLLAGNASAMLNTQKAEAIEPPLAEQPTAWVNKTGSTNGFGGYVAFIAERQIGIVILAN
KNYPNEERVKLAYRILQHAAPFN
>R8YDI3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIVNLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTLDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLVKNADVLTADNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIALGVIILIAAMFFNLSA
>J7K6F1|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRLSSTALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
VKAAAYDLAENLFEVGEASGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>Q2T5A3|FEATURES|UNIPROT_deepARG|beta_lactam|BTH_II1450|antibiotic inactivation|1
MRTAISGARAPRPDARPFNLLAILAFRSMNHSPLRRSLLIAAVSAPLVGACAPLRDNARN
VAAEQQLRELESTFDGRLGFVALDTATGARIAHRADERFPFCSTFKTMLSAAVLARSAGD
AALLQRRIPYAKRDLVRYSPITEKHVGAGMTVAELCAATLQYSDNTAANLLIALLGGPQA
VTAYARSIGDATFRLDRRETELNTAIPGDERDTTTPAAMAASVRRLLVGDALGTAQRAQL
NAWMLGNKTGDARIRAGVPAGWRVADKTGTGDYGTGNDIGVAYPPDRAPIVFVVYTTMRS
RNAQARDDVIASAARIAARAFV
>A0A076V4Y4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
LKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIA
QLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALG
ETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLILV
T
>W7RJA4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWDIFVAVILGIVEGLTEYAPVSSTGHMIIVDDLWLKSKELLTPEAANTFKVVIQLGSIL
AVAIVFKDRILNLLGVKKNITEEQKTGNRLSIAQIAVGLVPAAVLGFLFEDYIDQYLFSV
RTVAVGLIAGAVLMLAADWINRRKDTTDSVDRMTYKQALGMGLFQCLALWPGFSRSGSTI
SGGVMLGLSHRAAADFTFIMAIPIMMGASLLSLIKNWAYLSADLFPFFIAGFISAFIVAL
FVVRFFLRLINKIKLVPFAIYRIVLGLLLFILFL
>J8YJW9|FEATURES|UNIPROT_deepARG|beta_lactam|IG3_02951|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSSGLVLTTSNGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLNRYGNMNLVVPGH
GEVGDRGLLLHTLDLLK
>NP_843860|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDDRAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSTADIPLFATGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>F8WVZ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIFEAIIIAIVEGLTEFLPVSSTGHMIIAQSLLGIESSEFVKAFTVIIQFGAILSVIVL
YWNRFFRFRNDRLRADFKNIFSYLFYKLEFYWKLLIGFVPAAFLGLIFSDKIDELLESVT
VVAIMLVLGGIVMLFVDKWFNKPKEDSQEITYKNAFIIGFFQCIAMIPGVSRSMATIVGG
MSQGLSRKNAAEFSFFLAVPTMAAATGWKVYKLIKAPNGGAFDFDFSILLDNMTVLIIGN
VVAFIVALLAIKFFIGFVTKYGFKLFGWYRIVVGGIILILMLAGHELTV
>A0A077F745|FEATURES|UNIPROT_deepARG|beta_lactam|PSAKL28_20770|antibiotic inactivation|1
MMHYKTRLKPGILLAVTLCIAAGQSIASPLCEAQLESTVSTAIQPLMQQQAIPGMAVAIS
VNGKQHYFNYGEASKHSGQPVSAETLFEIGSVSKTFTATLAAYAEASGKLSLSDPASKHW
PELKGSAFDGITLLNLGTYSAGGLPLQFPEQVKDQASLLGYYRHWKADYAPGTHRLYSNP
SLGLFGYLAAKSMDTPFAELMQKQLLPQLGLLHTYVQVPATQMGHYAQGYDKDNQAVRVG
PGPLDAEAYGLKTTSADLLRFVEANLQPQSLSAPLQRAIATTQTGYYRVGEMTQGLGWEQ
YRYPVSLDQLLAGNSTAMTLEPQRVTWLKPARPLQDDMLLNKTGSTNGFGAYVLFVPSKH
IGIVLLANKNYPNAERVKVAHAILTALDH
>ZP_04640456|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAVVVV
FWRRLFGLIGIHFGATPHEGKTSGHLTLGHILLAMLPAVGLGLVFHNAIKSLFNPHSVMY
ALVAGGLLLLAAEWFKPKNPKAVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISGGML
VGVNRYAASEFSFILAVPMMMGASGLDLYKSLHFLTLGDLPMFAVGFTTAFIVALIAIKT
FLSLIKRISFVPFAIYRFVVAAAVYWVFM
>J8JBN9|FEATURES|UNIPROT_deepARG|beta_lactam|IKA_02882|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTKQTKQTKQTNQTKQ
ETTGNDSFAKLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSI
EDLNQRVLYTREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEF
KKSLREIGDTVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLI
DWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKE
DAKYDDKLIAEATKIALGVLKAKNK
>D8A5L2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLIHDKILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0G3XMR0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLALTAVLLGIVEGLTEFIPVSSTGHLILASALFGYDAEEWKVFNVVIQLGAILAVVV
QYWRTFWAAGTGIFQRHPESIRFVVNLLVAFMPAAIIGLLMKDYIDIMLGSPSIVAWALI
AGGIAILVIEKVAKEGPPSGIGQLPVKQALGVGFIQCLAMIPGVSRSGATIMGALAMGIE
RRTAAEFSFFLAIPTMLGASTLEIWQYRDELAGGHMTVGWGEIAIGFVVSFIVALIVIRA
FVAYVSRAGFAPFAWYRIVAGTAALIWLGFAANS
>YP_298289|FEATURES|ARDB_deepARG|multidrug|MexB|antibiotic efflux|1
MSNFFIDRPIFAWVIALVIMLAGVLSIRSLPISQYPAIAPPTIAISVNYPGASAETVQDT
VVQVIEQQLNGLDRLRYISSESNADGSMTITVTFEQGTNPDIAQVQVQNKLALAQPLLPQ
EVQQQGIRVTKSVRNFLLIVGLISTDPKVTREDLSNYIVSNIQDPLSRTYGVGDFQVFGS
QYAMRVWIDPAKLNSYQLTPLDVSNAIKAQNVQVASGQLGGLPAVQGQQLNASVIGKTRL
QTSEQFGNILLKVNPDGSQVRLKDVAEVGLGGQDYNINAQYNGQPASGIAVRLAAGANAL
ETVRAIRKTLDTLEPFFPAGMKVVYPYDTSPVISGSIHEVVKTLMEAIVLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAAFGYTINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEAARRSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSSMVL
SVLVALILTPALCATMLQPIEKGDHGENKGGFFGWFNRKFISTTQGYERGVSTILKRRLP
FVLIYVAILVAMGFLFTRIPTSFLPEEDQGVLYAQVQTPAGATAERTQKVLVQMREYLLK
EEGGVVDSLFTVNGFNFAGRGQNSGLAFILLKPWEERTGDNTSVFDLAARAQRKFASFRD
SMSFAFAPPAVQELGNATGFDLYLQDQAGIGHQALMNARDKFLALASKSPVLQRVRPNGL
NDQPQYQLVIDDEKARALGLSLADINSTVTIAWGSSYVNDFIDRGRVKRVYVQGRPDSRM
NPDDVDKWFVRNDKGDMVPFSAFAEGKWGFGSPKLQRYNGVPAVEVLGEPAAGRSSGEAM
KAIEEIMKQMPAGVGYAWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLATMARGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKSQYEHGKGLVD
AAIEACRMRLRPIVMTSLAFMLGVFPLAISTGAGAGSQHAIGTGVIGGMITATVLAIFWV
PLFFVAVNSLFARKRKPSQPDTPAEKGALQ
>CAA45230|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFALGQLIYGPMADSFGRKPVVL
GGTLVFAAAAVACALANTIVQLIVMRFFHGLAAAAASVVINALMRDIYPKEEFSRMMSFV
MLVTTIAPLMAPIVGGWVLVWLSWHYIFWILALAAILASAMIFFLIKETLPPERRQPFHI
RTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVYIEINHIAPENFGYYFALNI
VFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISALLGLGFWSLVVGVAAFVGC
VSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGALLSLATFNSAWPMIWSIAFC
ATSSILFCLYASRPKKR
>ZP_04083542|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFNDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSTIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFVTGFVTAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>V1H9E1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTAACESLDKTWEILLIDDGSSDSSAELMVK
ASQEAGSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLCCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSVMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPYTEESHQ
>G9Z0X8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGVQSLLEAGYDITAIFTHPDNANENHFFGSVARLAAEQGIPVYAPD
DVNHPLWIERIREMAPDVIFSFYYRNLLCNDIISIARAGAFNLHGSLLPKYRGRAPLNWV
LVNGEKETGVTLHRMVDRADAGNIIAQRTVAIDDADAAMSLHYKLRDTAQALLRDALPAI
SKGDFKETAQDESKATYVGRRTPEDGRLDWDRPAAELHNLVRAVSDPWPGAFGYVGANKF
IVWKSRLHNDNQGAKPGTVLSVTPLTIACQQGALEVVTGQSEQGVYMQGTQLAQALGLVP
RAIISSKPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNFEIFGLDIGSDAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDANFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NNLKFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGSQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
RDVESSNYYGKGYQDVEHRKPSIRNAKRCLNWEPTVDMEKTVEETLDFFLRTVELSDDSA
S
>A0A0K0XBN6|FEATURES|UNIPROT_deepARG|beta_lactam|AFA91_26250|antibiotic inactivation|1
MTDLSRRSVLIGSLAAVAAAGVRMPIASAAPVEGGIVDLEQRHNAVIGAYAVNLDSNRTV
AHRADDSFAMCSTFKAYLAARVLQGAQRGELSLDDRVFVDPSVLLPNSPITEEHAGGELT
LAELCQAALQRSDNAAANLLLNQIGGPPAVTEFARSIGDQRTRLDRWEVELNSAVPADPR
DTSTPAALAGGFRAFLTGDVLNPPQRQLLDEWMRANQTSSMRAGLPDGWTSADKTGSGDY
GSTNDVGIAYGPQGQRILLALMVRSGGDDPKAAGFRPLIGELTAMVLPGLL
>ABC33904|FEATURES|ARDB_deepARG|beta_lactam|SRT-2|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAVQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALEKR
>AAB20441|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MLRSSNDVTQQGSRPKTKLGGSSMGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQH
QPDSDYLGNLLRSKTFIALAAFDQEAVVGALAAYVLPKFEQPRSEIYIYDLAVSGEHRRQ
GIATALINLLKHEANALGAYVIYVQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>F0V6U3|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASLHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0N1CB51|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLADIIRAVILGIVEGVTEFLPVSSTGHLLLVGRFFNLGEGDFWKTFDVLIQLGAILAIL
ALYFSKLWRIALGIFSDPAAQRFVIGVLVAFLPAAVIGAAAGSYIKAYLFNPWVVCFSLI
VGGAILLWVDQLDLNPQHHDATAFPLKMYFYIGCAQCMAMIPGVSRSGASIVAAMLFGAD
KRSAAEFSFFLAIPTMVGAFVYDLYKNRGDLSSDHLTIVAVGFVVSFITAIIVVKTFLGY
VTRHGFELFAWWRVVVGTLGLIALALGK
>CAW28031|FEATURES|ARDB_deepARG|multidrug|amrA|antibiotic efflux|1
MHIQWTGSLRGLLAALVALFLLGCEEAADAGKTAEAPAEVGVIVARPAPIGITSELPGRL
EAYRQAEVRARVAGIVTRRLYEEGQDVRAGTVLFQIDPAPLKAALDISRGALARAEASHA
AAADKLKRYADLIKDRAISEREYTEAQTDARQALAQIASAKAELEQARLRLGYATVTAPI
DGRARRALVTEGALVGEDSPTPLTRVEQIDPIYVNFSQPAGEVAAMQRAIREGQVKGVAD
KDIAVRLVLADGSEYPLAGELLFSDLAVDPGTDTIAMRALFRNPHRELLPGGYVQVRLQR
AVNPQAITVPRDALIRTAQSAVVKVVNPQGVVEDVEVRADTLQGRDWIISRGLKGGERVI
VENAAQHAAGSSVQAVVRQPASADAPSPLAASPAGQ
>E0M3E6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MRDIKPINMLSVVIPVYNEQESLPELLQRTSAACDAIEIEYEILLVDDGSSDRSAELIEQ
AAIIPGSRITGVLLNRNYGQHSAIMAGFSQVRGDLIVTLDADLQNPPEEIPRLVEAARQG
YDVVGTVRQQRQDTWFRRKASRTLNHLIQRVTGKAMGDYGCMLRAYRRHIVEAMLNCHER
STFIPILANTFARNTIELPVLHAERAFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVVG
SLIALSGFAFSLVLIVLRLFFGAAWAGDGVFVLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQRIVQAPEEPSVQDTQS
>R7N6J4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKAILFGIVEGITEWLPISSTGHMILLNEIVSLNVSEEFYSMFEVVIQLGAILAVV
ILFWNQIWPFGKKDNKEPLAKDGVGAFVKWDIFKLWFHILVSCVPAAIVGLLFDEQLEAL
FYNYQTVAIMLILFGIAFIVIENYHKGKKAKVTALDGIDYKLAFWIGMFQLIAAIFPGTS
RSGATIVGALLLGVSRTVAAEYTFFLAIPVMFGASLLKGVKFLAGASMTSMEGAILAVGM
VVAFVVSFFVIKFLLGYIKKHDFKVFGYYRIALGIIVILFFLIRG
>I4B6G9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|Turpa_2231|antibiotic efflux|1
MIEIHNLCKSYSHGGGTVHALSNVSLEIAPDEFVAIMGRSGSGKSTLLQILGLLDVPTSG
SYRLFGKEVAHLAEDELAILRRQTLGFIFQQFHLLPRLKAIDNVGMPLLYSGRTGLAHSP
ERLMQDVGLADRAQHRPSEMSGGQQQRVAIARSLVNAPRILLADEPTGNLDTASQHDILE
LLTQMHQQGLGVIVVTHDEEVAERTHRIIRMQDGEIISDKRQARRGAVPVSPRINSGANR
GDEQASPSRGRYALELFKEGYRAVLANKLRSALSMLGITIGVASVIAMLALGRGAQESIE
SQLKSLGANVIVLRPNVARVGGVAQETGSPARIAFEDIAWVRERIPGVRAVAGNVTGRGQ
VSYANRNWNTQIQGVTTDYATIRSATPFIGRMFTAKEAQQRARVALAGLTVVRELFGSEN
PVGQFIKINKVNFQIIGVMPEKGGTGYRDQDDVIVIPLQTAMYRLLGKQFVDSLDIESDG
VVNLDDLGSAVQRGMSTRHRVPVSLQEDGYQIMNLADIRSAVSATSETMSALLAAIAAVS
LLVGGIGIMNIMLVSVTERTREIGLRKAVGARSKDILFQFLVETLAVSVSGGILGLMLGV
AISVGMSTLAGWSTSISGFSVLLSVVFSVFVGLVFGIYPARKAALLNPIQALRHE
>A0A0G1MPD2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFIFSLILGVVEGFTEFLPISSTAHLMIVSRFLAIPATDYLKTFEVAIQLGAISAVMVV
FFKKIISDLSLVKYMVIGFIPTGLIGFAAYPLVRSWLGSVWVALGALFLGGVFILLFEKL
FKEKNGGLDYKKAFLIGCFQCASFVPGVSRALATIVGGMVMGLPRRSAVEFSFLLAIPTM
MAATAFDLYKNFSVFTPEYWRFFAVGFFAAFISAFIGIRFFVDLVERKNLEVFGWYRICL
VIIVILASFLFSKPFTG
>YP_010878|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MSDMITAAILGLVEGLTEFLPVSSTGHLIITGELLGFTGPKATTFEVAIQLGAILAVVVL
YWDRFWGLLRPQPYVRFAGLRGIMLLLLTSLPASVLGLAAHSTIKAHLFTPSTVAIALAV
GAIFMLLVERRTERPRYMTLDEMSPALALGIGCFQCLALWPGFSRSAATIMGGMLLGARR
GLAAEYSFIAAVPIMFAATGYDLLKSWTLFTPADLPFFATGFVVSFLSAWAAVKLFIALV
GRMTFRPFAWYRLAIAPLVYYFMAY
>A0A0M5M6H8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DKATSGKYYIDGEDISDFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVD
HDNRMERAKKLLEKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDS
KSGIMVMEILNQLHEEDHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQKEIKKELQED
KKSINNLKKNKFQVAKDQFFESFNMSVSAIIAHKMRSLLTMLGIIIGIASIVCVVAIGNG
SQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTDVDILEKQSYVDSVTPNSTSS
GTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALIDENTQKSLFGE
NENPIGKVILFNKKPLKIIGAVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
VKNDIDSQVAQKSITDLLKAKHGKKYFFIMNTDTLKKTIESTTGTMKILISSIAVISLVV
GGIGVMNIMLVSVTERTKEIGIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIG
WGFNSISKSFSMIFSVFSIVMAVLFSTLVGVIFGYMPAKNAAKLDPIEALSRE
>A0A0A8UAZ8|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWMERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>U2V4B0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLSIAELLKTIVLGVVEGLTEWLPVSSTGHMILVDEFIRLNVSKAFMDMFLVVIQLGAI
LAVVVLSFDKLNPFSPWKSRQEKRDTVSLWGKVLVACVPAAAIGLLFNKYMEEHFMTAPV
VASTLILYGVLFILVENYNRNRRPRVGDLAALDYKTAFIIGMFQVLALVPGTSRSGATIL
GGILFGTSRYVAAEFTFFLAIPVMFGASLLKIVKFGLNFTGTEIVIMVVGMVTAFLVSIL
SIQFLLSYIKTNDFKAFGWYRIALGILVIAYLFLVGDPTANN
>A0A0W7YGE7|FEATURES|UNIPROT_deepARG|beta_lactam|AMR94_02915|antibiotic inactivation|1
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSEPPKQTKQIKQIKQENTSHDSFAKLE
KEYNAKLGIYALDTGTNQTIAYHSNDRFAFASTSKSLAAGALLRQNSIEALDEGITYTRE
DLSNYNPITEKHVYTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKKDAEYDDKLIADT
TKVVLDTLKVTNKN
>B1Z3I9|FEATURES|UNIPROT_deepARG|beta_lactam|BamMC406_5864|antibiotic inactivation|1
MRFNAIRIAATLFVAACAAVTAGRAAAATPDEIHDTVTRNVAPLMKQFAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTGTLASDAQEGGELSLSDPVAKYLPA
LQGKPFGGVTLLELGTYTPGGMPLQVPDSIRDDAALMRYLDAWRPAYVPGTRRTYSNVAL
GMLGQLTAKAMNGDFAALMEQRLFPALGMTHTYINVPAARRGDYAQGYTQDGKPIRMTGG
MLWQPAYGVKTTATDLLRFVQANMGLVDTAPRMQRALERTHTGYFRAGPFTQDLIWEQYP
YPVALPTLLEGNGPAMLHGATPATELKPPLAPRPDTWINKTGSTNGFSTYVAFVPAKRMA
IVMLANRSFPIENRVKAAYRIVESLNGKP
>N8QAN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILTGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGAFTGQEQGRRLSLNLIIASIPIVIIGLSFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAVLAVGIVVAFISALIVIRALI
RYVSKHDFTAFAYYRIVFGLLILATWWTGWVHW
>I7ANY8|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIXLDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAXXXXSLIKHW
>R6NL35|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLDFVEMLKVIFLGIVEGITEWLPISSTGHMLLVDEFIRLDMTDSFKEMFFVVIQLGAI
LAVVLLFWKKMFPFQFKDKTQPVVRKDIFSLWFKVVAACIPGAVVTLLFDDYVDAHFHTP
LVIAAALIFYGFAFILIENWNKKRKVRVESLNDITYQTAFLIGLFQVLAIIPGTSRSGAT
IIGALLIGVSRVAAAEFTFFLAVPVMFGWSLIKLIKFGIAFSAQELCVLGLGCVVAFAVS
VVVIRFLMGYIKKHDFKVFGWYRIILGAIVLGYFAL
>A8TG75|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-85|antibiotic inactivation|1
PLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGD
EQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGL
TAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLL
QWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLSPNNKAERIVVIYLRDTPA
SMAERNQQIAGIGAALI
>ABB97394|FEATURES|ARDB_deepARG|tetracycline|tetS|antibiotic target protection|1
MEEIKLKIINIGILAHVDAGKTTLTESLLYSSGAIKELGSVDSGTTKTDTMFLERQRGIT
IQTAITSFQRENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHA
LRKMNIPIIFFINKIDQNGINLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQW
ETVIVGNDYLLEKYTIGKTLNIAELEKEENERIQSCSLYPVYHGSAKNNIGIKQLIEVIT
SKLFSPTQLNSDKLCGNVFKVEYSDDGQRLVYVRLYSGTLHLRDSVNISEKEKIKVTEMY
TSINGELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPHREILENPLPMLQTTIEPCKS
VQREKLLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQEKYHIEIETRK
PTVIYMERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQN
AVMEGIRYGCEQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTEL
LEPYLSFEIYVPQEYLSRAYNDASKYCANILNTKLKGNEVILIGEIPARCIQEYRNSLTF
FTNGRSVCLTELKGYQVTNIKSAFQPRRPNNRIDKVRHMFNKINLH
>P18644|FEATURES|ARDB_deepARG|thiostrepton|tsnr|antibiotic target alteration|0
MTELDTIANPSDPAVQRIIDVTKPSRSNIKTTLIEDVEPLMHSIAAGVEFIEVYGSDSSP
FPSELLDLCGRQNIPVRLIDSSIVNQLFKGERKAKTFGIARVPRPARFGDIASRRGDVVV
LDGVKIVGNIGAIVRTSLALGASGIILVDSDITSIADRRLQRASRGYVFSLPVVLSGREE
AIAFIRDSGMQLMTLKADGDISVKELGDNPDRLALLFGSEKGGPSDLFEEASSASVSIPM
MSQTESLNVSVSLGIALHERIDRNLAANR
>CAG27847|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGD
VYFPEIPSNLGQFYQDFASNINYSYKSGKGLQVAATDRNLSRLCTKAAPGCDPLCSVRLH
EIVHYEANAPWIGRMNAQTQSVGRKLLPGNRAA
>A0A151XYZ3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MIVNQKIIFQTLFISLAMGFGMHLHASELSQNEKNIETVVTQSFKPLMDQYGVAGMAIGV
IYNGKTYENYYGIQSKLDHKSVNNQTLFELGSVSKVFTAISGTYANNQGKISFDDHPSKY
LPSLKHSDIDKANLLELLTFTSGNLPLQFPDNVKTEKQILEYFKNWKAKNPSGTYREYSN
PSIGLFGYLTAKSMNVPFSSLLEETIFPQLNLKHTYVNVPEAQKINYAFGYDENNMPVRV
NPGPLSDEAYGVKSTLPDMLDFVNANLNADKNSPAMKKAILDTHKGYFKVADSGMTQALG
WEMFSYPTTSEILQASNSQQILLGSNPVVKELSQPESKVFHKTGSTNGFGTYVLFIPEKG
FGLVMLMNKKIPNVDRIKAAYHVYESLKDH
>A8GCD5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELSGISRSYQSGDQTVAVLKDVSLSINAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLDGDALARLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAIALLQRLGLGERVGYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLREQGHTVIIVTHDPAVAQQAERIIEIRDGEIIADSRPERQSNPNAKLLEM
VAPAPSWQQTTGRFREALVMAWRAMAASKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTFRQALKYDDLEALREQPYVNALSPTIASSMRLRL
GNVDVAANVTGVSEQFFRVYGMTFTQGVGIDQLQVQSQSQTVVIDANTQRRLFPNIKDVV
GQVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNAYFDSITVRIREGY
NSQEAEQKLTRLLTLRHGKKDIFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLLVQL
VLPGWQISFPPAALLSAFVCSTAIGVVFGYLPARSAARLNPIDALARE
>N2IRH3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSAIQALILGIVEGLTEFLPISSTGHQIIVADLLGFGGDRAMAFNIIIQLGAILAVV
WEFRRKIIDVVVGLPRQREAQRFTVNLMVAFFPAVILGVAFADAIHEYLFNPITVAMALV
IGGVIMLWAERRQHNTNIDHVDDMTWVDALKIGCIQCLAMIPGTSRSGSTIIGGLLIGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFITSFIFAMIAVRGLLKF
IGNHSYAMFAWYRIVFGLLILATWKFGWVDWTSAVA
>R9LQ13|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHLIFDWIHSILLGILTGITECLPISSKAHLLIVQGLWQLSPNRFYQFFKVAIEIGTICA
IFYVFRKVLFSSHGAEKKKMFHLWKNIFFGSLPIGVGIFLIGSWIQKYLDATFVIVVSLI
SIGIIFLLIPDRSSKEKITSLEKLDPLHAFVIGLVQCVALIPGASYYAFSILGGLYVGCS
KETASRFGYLLMGPALLFSGLFEVYVYFWMGNTISLSQVIMIILGSCFSFVCAVATIRIF
LNFIKNHSWKGIGWYRIALGVLIFMTFCV
>B8ZHX8|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MLKSSWRKSALMAAAAVPLLLASGSLWASADAIQQKLTNLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESHPDVLNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKS
>A0A0A0CR52|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLSTLFHAAILGVVEGLTEFLPVSSTGHMIIVGHMLGFTGDKAETFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGDVPHEGKTNGKLKLSHIILAMLPAVTLGLLFHDVIKSLFNPQS
VMYALVIGGVLLITAEILKPKTPRAEGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVNRYTASEFSFILAVPMMMGASGLDLYKSLHFLSASDIPMFAVGFITAFVVALVA
IKTFLALIKRISFIPFAIYRFIVAAAVYWVFM
>ABS73654|FEATURES|ARDB_deepARG|multidrug|YkkD|antibiotic efflux|0
MHWISLIAAGLCEMLGVILMNQFQKEKKVKWILFIIAGFAASFSLLSYAMETIAMGTAYA
IWTGIGTAGGALAGILFYGEQKDAKRIFFIALILCAAVGLKILS
>W4CD90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFNEQDSIMKTYEIVIQLGAILAIAL
VYRQRIVNLLGFGRRDRGGVMPAARLNLIHVLLGIVPALAVAFFARDFIKSLFGASTVLW
ALVAGGILMIIAEWVNKRKIRVTAHDLDDLSYGQALSIGLFQIISVLWPGFSRSGSTISG
GMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKNFTSETIGYFVIGFIISFIVAYVV
VVLFMRMIQKIRPTHFAIYRFILAAAFWLFIMR
>A0A140SM50|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
PEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQ
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELG
LVEGARLRGAASGPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKA
DPHFHFVEGDIGIHSEWLEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIVR
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
QQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLIDGGAQKRCFTD
VDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAG
FREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREA
QA
>AAA98259|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|VgbA|antibiotic inactivation|1
MEFKLQELNLTNQDTGPYGITVSDKGKVWITQHKANMISCINLDGKITEYPLPTPDAKVM
CLTISSDGEVWFTENAANKIGRITKKGIIKEYTLPNPDSAPYGITEGPNGDIWFTEMNGN
RIGRITDDGKIREYELPNKGSYPSFITLGSDNALWFTENQNNAIGRITESGDITEFKIPT
PASGPVGITKGNDDALWFVEIIGNKIGRITPLGEITEFKIPTPNARPHAITAGAGIDLWF
TEWGANKIGRLTSNNIIEEYPIQIKSGEPHGICFDGETIWFAMECDKIGKLTLIKDNME
>G5PMX6|FEATURES|UNIPROT_deepARG|aminoglycoside|LTSEMIS_2197|antibiotic inactivation|1
MDIRQMNKTNLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHLALGFEETERVIFYRKRC
>C2PVV9|FEATURES|UNIPROT_deepARG|chloramphenicol|bcere0007_21950|antibiotic inactivation|1
MTANVDITMMLEEIHQKEIKFYPTFIYVISRVINKHTEFRTCFNDEGVLGYWEEMIPSYT
IFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMRCYANVHGFFTKENIPPNIFPISGIPWTS
FTGFNLNINNDGDSLLPIITCGKYFNDGSRVMLPVSLQVHHAVCDGYHASRFIEDLQELA
NTCNEWLK
>A0A0F5F1I8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTLVFAYHDMGCVGINALLKAGYEITAIFTHNDVATENPFFGSVARLAAEHGIPVYAPD
EANHPIWLDRIRSMAPEMIFSFYYRHLLSDEILQCAQKGAFNLHGSLLPKYRGRAPLNWA
LVNGERETGVTLHRMVKRADAGHILAQQAVAIDDQDNALTLHRKLISVAEQLLGDVLPRL
RQGEVSEWPQDESQATRVGRRTAEDGRIDWNQPAQTIHNLVRAVTDPWPGAFAFAGSVRF
IVWKSRVHHEPHQARPGTVISRQPFLIACGEGALEIQTGQSEHGVYMNGSQLAQSLGMVP
GALLYSQPQSALQRRTRVLILGVNGFIGNHLTERLLEDAHFEVYGLDISSDAISRFLDHP
RFHFVEGDIAIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCTDDSFDEDCSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
KDGVEALFRIIENKQQNCDGQIINIGNPDNEASIKELAEQLLESFERHPLRSQFPPFAGF
REVESSSYYGKGYQDVEHRKPAIRNARRLLGWTPTVTMDVTIDNTLDFFLRTIEQQADK
>A0A0A0Q7Z8|FEATURES|UNIPROT_deepARG|beta_lactam|MIR-10|antibiotic inactivation|1
MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQ
WQGIRLLDLATYTAGGLPLQVPDNVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGS
LAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEESHYAWGYREGKAVHVSPGMLDAEA
YGVKSNVKDMASWVMANMAPETLPPSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDV
KTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPVRVETAYRILETLQ
>ZP_02685546|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELCNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAEEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLAGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A104U0T9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKLGIKRIMAAALFSTCATATIGYAANDRQDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPN
LQGSPFGNVSLVELGTHTPGGMPLQVPGNIRNEDQLMRYLKDWRPTYSPGAYRTYSNVSI
GTLGLITATSMGQQDFAVPLSRHLLSPLGMKSSYVEVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSTALNAMPVNEIKPPRAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>Q8RMZ4|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MREAVTIEISNQLSGVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFEEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0I9QQR1|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISIIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>NP_756187|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIKISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KNNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVIGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPVE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>G2DKI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLFKALILGIVEGLTEFLPISSTGHLIVIGDLLNFHSNGKVFEIAIQLGAVLAVIF
EYRKRFTHVVSHIGRDQKVNRFVLNLAVAFIPAAVVGLLFSKQIKTFLFNPITVAAALIL
GGFFILWVERRQTTRKPKVTNVDDMRIRDALVVGCAQIFALVPGTSRSGSTIMGGMLWGL
ERKVATEFSFFLAVPVMIAATTYDVLKHYKLFSAQDIGLIVVGFVAAFVAGLLAVKALLK
FVSAKNYVPFAYYRIVFGGLILLTWAMGWVEWNS
>A0A0W0HIH3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIVVADLIGFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADKIHHYLFNAITVATALV
IGGVIMLWAERREHTVRTETVDDMTWTDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>E0RE90|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILSSIIMGIIEGLTEFLPVSSTGHMILTADLLGLNTENDTVKTFEVIVQLGAVLAVVV
LYWRRFLSLFDFRRKISSQPRLNLLHIILAMIPAGLIGVLFRDVIKQYLFGPETVLYSLV
IGGLLMIAAEKFHPPIRSHTLDEITYKQAFTIGLFQVLALWPGFSRSGSTMSGGLFARVS
HTAAAEFTFLVSVPVMLGASGIDMIKSMDHLSMSDFPVFAAGFITAFIVGMLAIKTFLGL
LKRLSLTTFAIYRFVLAAVFFFIIL
>AAY54279|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNLQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>YP_002043045|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMA
RWMPETRPAGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQT
GQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>NP_706765|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLNIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDIATLDADALAQLRREHFGFIFQRYHLLPHLTVEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>ZP_03958019|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MAHAFQTLVSHIFIDYNKEVNQSRYIQKGFLIIMIIELIKAFLFGIVEGITEWLPISSTG
HMILLDQFVKLDVSKSFYSMFEVVIQVGAIMAVVVIYWNKIWPFHKSKQTGPLAPTGIWR
YVDKDIIIMWIKIVIACLPAGIIGVAFNDTFEKLFYNPVSVAIALIVFGIAFIWIETVHK
NRRAKINSLAELSYYTVILIGFFQLIAAVFPGTSRSGATIVGALILGVSRTVAAEFTFFL
AIPVMFGASLFKLLKFGFVFSSAELLILIVGLITAFVSSIIIIKFLMQYIKKHDFKVFGW
YRIVLGLLVLLYFLVIK
>ZP_01363330|FEATURES|ARDB_deepARG|multidrug|mexB|antibiotic efflux|1
MIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGID
NLRYISSESNSDGSMTITVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAV
KNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKL
NSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKV
NPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANL
EPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVP
VVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARK
SMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALC
ATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMI
WMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVT
GFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLE
LGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDE
KASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRND
KGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKG
VGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALL
ATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPI
VMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKD
EASKQQASVEKGQ
>D6CPG9|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDAHSAIVVVILGLVEGLTEFLPISSTGHLILAASLLGWVSDKAKVFEIAIQSGAILAVM
WHYRMRIGEVLTGLTAAEPARRSTAWRFAINVIIGFIPAAILGLLFASAIKRWLFAPAPV
ALAFIVGALVIFWAEAWQKRSAQHVRIHHVDDMRASDALKVGIAQAFALIPGTSRSGASI
IGGMLFGLSRAAATEFSFFLAIPTLLAATVYELYKNRALLSLSDVPTFGLGMAVAFVSAL
MVVRWLLRYVGGHSFVPFAWYRVVFGALVLVTAWGGWVNWSG
>AAF72358.1|FEATURES|ARDB_deepARG|glycopeptide|vanRB|antibiotic target alteration|0
MSIRILLVEDDDHICNTVRGFLAEAGYQVDACTDGNEAYTKFYENTYQLVILDIMLPGMN
GHELLREFRAKNDTPILMMTALSDDENQIRAFDAEADDYVTKPFKMQILLKRVEALLRRS
GALAKEIRVGRLTLLPEDFTVLCDGTELPLTRKEFEILLLLVQNKGRTLTHEIILSRIWG
YDFEGDGSTVHTHIKNLRAKLPENIIKTIRGVGYRLEESL
>F5JFR2|FEATURES|UNIPROT_deepARG|aminoglycoside|AGRO_4010|antibiotic inactivation|1
MSGQFVIGNAADYPDAWCLLRHRLWPDTTPAEHREELQDVGETGAGFIVHDPAGVAVGFA
EVSLRRDYVNGCDTSPVAFLEGIYVEQAFRKRGVAALMVEEVTRWAISQGVSELASDADI
SNTDSHRMHAALGFEETERVVYFRKMLRLNDEPEQ
>A0A0N0EWA9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGEPLLACASKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDETLASCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQEDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>ZP_03223548|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A0R1L633|FEATURES|UNIPROT_deepARG|chloramphenicol|FC88_GL001386|antibiotic inactivation|1
MANLFLQFAKDNNYDFYPLFIYSIVRVINSNYLYRMDFNEAGELGYYESSVPFYSIFDSR
TELFSNIDTPDAYTFAEFDRDYLSDVKKYRGTGKLFPKQPVPKNVVNISMIPWVNYTGFN
LNINNNDNYLLPIVTAGRFERAGDEIKLPVTFQIHHAVCDGYHTSQFFIKLQDILNNVDE
L
>Q104Z1|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampc-EC9)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKAYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0R1VSD8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGITEFLPISSTGHLVLVDEFIKLQQSKQFIDMFNVVIQLGAIMAVV
IIYFHKLNPWSPKKSRLEKKNTWTLWKKVIIAVIPSVIVGLPLNDWMDEHLMNWQVVSAA
LIIYGVLFIIIENHNKNTAPHYADLNTLPYSTAIAIGICQVLSLVPGTSRSGSTILGAIT
IGTSRYVATEFSFFLAIPTMFGASILKLLKYFMHGGSLAGLPGVVLLVGVVVSFVVAYIA
IRFLLNYIKKNDFKVFGWYRIILGIIVIGYFTLVH
>ZP_03027239|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAATVACALANTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILALAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>B3H155|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTACFYSITFLYIFKYIIYYAKIRLSTPSKNIGNKMKLIEIEKLNKYFGSGENTAHVLKD
INLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTASSGVCKIDGKETLNMTSDELSDLRQR
KFGFIFQRYNLLPALTANENVALPAIYAGMDNTSRKARANQLLEKLGLADKTGNRPNQLS
GGQQQRVSIARALMNGGEIILADEPTGALDSKSGETVLEILKDLHKEGHTIIMVTHDANI
AANASRIIEIKDGYIIRNERQQPYSEDLKLTKREYKKPRFFDQLIESFKMAINAITAHKL
RALLTMLGIVIGITSVISVVALGQGSQQQILSNINSLGTNTMTIMNGTGFGDRRANLTKN
LTISDAMMLNKQQFVDSTTPSSNLSGTVIYGNTNVTASINGVGEQFVNVKGLKMISGRFF
DADEVKLSSQVVVIDGNTKKDLGLTDPVEGKVILVDKKPLTVIGMAQESNNLNQTSLKMW
MPYTTLMQRISGEKFIDSLTVKVKDNVESQTAEKSINELLTAKHGKKDFFVMNSDTIKQT
ITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSVTERTKEIGVRMAIGAKQNNILQQFL
IEAILICLLGGIIGILFAMAIIFSFNTLGTNFKMILSPASVVLAVFCSTLIGVVFGYMPA
KNASKLNPITALAQE
>A0A0E0V3D0|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDPPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIVSVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>AAT34976|FEATURES|ARDB_deepARG|aminoglycoside|str|antibiotic inactivation|1
MRTEKEILNLVSEFAYQRSNVKIIALEGSRTNENIKKDKFQDYDFAFFVSDIECFTHEES
WLSLFGELLFIQKPEDMELFPPDLDYGYSYIMYFKDGIKMDITLINLKDLNRYFSDSDGL
VKILVDKDNLVTQEIVPDDSYYWLKKPTEREFYDCCNEFWSVSTYVAKGVFRREILFALD
HFNNILRPELLRMISWYIGFNRGFDFSLGKNYKFINKYLTDKEFNMFLATFEMNGYRKTY
QSFKLCCELFKYYSNKVSCLGNYKYPNYEKNIENFIRNNYEN
>A0A0H3NU73|FEATURES|UNIPROT_deepARG|beta_lactam|Y11_12651|antibiotic inactivation|1
MMKKSIINTLIFTSIATFPLYTLAQTKLTELQVATIVNNTLTPLLEKQGIPGMAVAVFYD
GKPQFFNYGMADIKAGRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPE
LTGSQWKDVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKRSQLTFENYMKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSASQDMVRFMQANMDPESLPAGNDKLKEAIIASQSRYFQAGDMFQGLGWEM
YSWPINPQGVIADSGNDIALKPRKVEALVPAQPAVRASWVHKTGATNGFGAYIVFIPEEK
VGIVMLANKNYPNPVRVQAAYDILQALR
>BAB37816|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MNRRRKLLIPLLFCGAMLTACDDKSAENTAAMTPEVGVVTLSPGSVNVLSELPGRTVPYE
VAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARI
TFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVS
GKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPV
QLNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQN
VLLVPQEGVTHNAQGKATALILDKDDVVKLREIEASKAIGDQWVVTSGLQAGDRVIVSGL
QRIRPGIKARAISSSQENASTESKQ
>A0A072D9H3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDLFVVAIQMGAIAAV
IYEYWGKLWGAAIGLFSGEPKGRHLGVSIIAASIPIMLVGLTFGDIVKELLFNDISVAIG
LIVGGLIIWWVEKNPPKVNAVEVENISIKEAIYIGLIQVLALIPGTSRSGATIIGGMMLG
VSRKAATEFSFFLGIPVIVGAGLLDLFKNYHIYETTQDWTVFFVGLIVSFVSALILIRVL
VAYVSKRDFMVFAWYRIASGLLILLFALTGWKLW
>A0A0Q7AW68|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAAAVTIDGHAYFFNYGVASREPNRPVTETTLFELGSVSKTFTATLGLYAQALGQLSLAD
HPSRFMPELTGRAIDRASLLELGTYTAGGLPLQVPDEVASAAQVVPYLQRFVPDAPPGAR
RLYSNVSIGLFGHLTALALQREFADAVETELLPRLGLARTFVRVPAGAMADYAWGHDGKG
QPRRVSPGVFDAEAYGVKSTAADMIRFVQLNIDASALGDTPVRRAVEGTQVGHYAVGGMV
QGLGWEQYPYPVPLPRLLQGNSEKLIFESNPATRVTSAPAGPRLFNKTGSTGGFGAYVAF
VPARRIGVVLLANRSYPIADRVRIGAAILDGLAAAAK
>A0A0F7Y0T8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKRPPHLLLATALTLAAPPLLAGDLQHSVDGVIQPLMREHGIAGMAVAVYANGQAHYFNY
GLADKASGQAVTRDTLFEVGSVSKTYTATLAALASAEGKLDLAAPASRYQPALAKAPIGS
ATVLELGAYSGDCLPLQFPDEVQTKEQTLAWFQHWQRRAEPGTQRCYSNPSLGLFGDLAA
RAQKRPFAELMTQGLLPRLGLEHTYLEVPANVRGLYAQGYDAKDKPVRVSPGPYAEQAYG
IKTSASDLLRYVQLQLQPAALDPALRQAIAITQSGYFQVGAMTQGLGWERYPYPVALDTL
LDYNGARLVREPNATRALTPALPAESAAWYNKTGATSGFGAYVAFVPSKQMGIVLLANRN
YPNEERVRAAQRIFSSLER
>A4YA86|FEATURES|UNIPROT_deepARG|beta_lactam|Sputcn32_3157|antibiotic inactivation|1
MRLFVISAVLVMSSISASPVFAASSPQKEWQETRSLDASFTQHQAKGVVVLWNENKQQGF
TNNLKRANQGFLPASTFKIPNSLIALDLGMVKDEHQVFKWDGKNRDIAAWNRDHNLISAM
KYSVVPIYQEFARQIGDARMGKMIAVFDYGNEDISGNLDSFWLDGGIRISAKEQIDFLRR
LYHNKLHVSERSQRIVKQAMLTEANSDYIIRAKTGYAVRAEPSIGWWVGWVELDDNVWFF
AMNMDMPSADGLALRQAITKEVLRQEKIIP
>A0A0J7CWQ7|FEATURES|UNIPROT_deepARG|beta_lactam|TU62_31225|antibiotic inactivation|1
MLVLNKFFNMLPYKKIVPLLFLSCATLIGCSNSNTQSEPPKQAKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSMEDLNQRILYTREDLV
NYNPITEKYVDKGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFALGDVLSTEKRNLLIDWMKRNTTGDNLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKRPIVLAILSNHEKEDAKYDDMLIAEATKI
VLDALKTSNKQ
>A0A0Q6S2S5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSRPTRSIAIACLSLLPLTAGAVDAAAVRAAVDRVIQPLMAQHDVPGMAVAVTVDGHAMF
FNYGEASKQGHVPVTENTLFELGSVSKTLTATLACHAQDLGKLSFDDHPGAYMPQLKGSA
IDRASLLELGTYTPGGLPLQFPDEVETDAQMIDYFRAWRPDAAPGTQRRYSNPSLGLFGH
VTARALGVDFADAVERRLFPALGLKHSHIRVPSGAMGDYAWGYDKTNRPVRVSPGVFDAE
TYGIKSSAVDMIRFVQENIDASVLPAPMRRAIDCTHTGYFRIGDTVQGLGWEQYRAPVTL
AALQAGNSTKMSNEPNPATRLQPPQAPPRGTLFNKTGATRGFGTYVLFVPAYRVGIVMLA
NKNYPIPARVQAAYSILGQLAP
>A9M2I7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIGFHSNHKVFEIAIQLGAVLAVVF
EYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEHLFNPLSVAVMLVL
GGLFILWVEKRQSWAEPKIADVDALRPIDALMIGVAQVFALIPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFVAAFVSGLVAVKALLR
FVSKKNYIPFAYYRIVFGIAIIILWLSGWISWE
>A0A0Q9EYM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFRSPGNTFAVLIQLGAILAILL
VYFQKLLSIALALPTSIKARRFVLSVLIAFLPAAVIGAIAHDFIKTVLFETPMLICVVLI
VGGFILYAIDHLPLKPRYTDVMDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDFTLIAVGFIAAFVAGIFVVRSLLDF
VSRRGFTPFAIWRIVVGTAGLIGLWLLG
>A0A090U8S4|FEATURES|UNIPROT_deepARG|beta_lactam|CIFAM_04_03080|antibiotic inactivation|1
MLKKRFHQTLLITAAFVFFASSSLLSARAQATPPQVQQKLAALEKQSGGRLGVALINTAD
RSQILYRADERFAMCSTSKTIVVAAVLKQSETQHDILQQKMTIKKTDLTNWNPVTEKQVN
KEMTLAELSAATLQYSDNTAMNKLLEHLGGTGNVTAFARSIGDATFRLDRTEPELNTAIP
GDERDTTSPLAMAKSLHKLTLGNALADMQRAQLVAWLKGNTTGGQSIRAGLPESWVVGDK
TGGGDYGTTNDIAVIWPEDRAPLILVTYFTQPQQDAKGRKDILAAAAKIVTEGL
>A0A0M3DUB5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFDLFKAFILGIVEGLTEFLPVSSTGHLLLLERFFGFDDDAFGKTFVVLIQLGAILAIL
SVYFAKLWRIALGMFSDPAAQRFVIGVLIAFLPAAIIGAIAHSFIKEVLFNPWVVCFTLI
AGGAVLLWVDQQDLRPRFHDATTFPLPMYLGIGLAQCLAMIPGVSRSGATIVSAMLFGSD
KRAAAEFSFFLAIPTMTGAFAYDLYKNHGQMTANNTLLVAMGFITSFVAAIIVVKTLLDY
VSRSGFALFAWWRVIVGTLGLIGLALGK
>A0A076LST7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDLHTLLNAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
VMFWRRLFGLIGIHFGRPVAREGRGQGQLTLGHIVLAMIPAVVLGLLFHDFIKSLFTPLT
VAYALVVGGLLLLAAEWLKPAQARAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGASALELYKSLPYLSLGDLPMFSVGFVTAFVVALIA
IKTFLNVIKRISFVPFAIYRFIVAAAVYLVFC
>A0A0N0TPG6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPHADKTIETHLVADPDSGPYAITTGPDGALWYTLVRGGAIGRLVPGEQPTSHALAPDSG
PTVIVTGPDDALWFTEYQAHRIGRITVDGEVTEFTPPTPECGPYGIAPGHDGALWFTEIN
ADRIGRITTDGEITEFPLPLTGAFPSAITAGPDGAMWFTLNQANAIGRITADGTVTVHPL
PTDAAGPVGLCAGPDDALWFVEIAAGQLGRITTGGEVTEFPLPDRASRPHAIVADGHGAL
WFTEWGANRVGVITTDGSIESHALPEPHAEPHGITLGPDGALWVALETGALARVTRT
>J8R5V4|FEATURES|UNIPROT_deepARG|beta_lactam|ICG_02197|antibiotic inactivation|1
MKMHSLLKVGVCVSLLGATQFVSTISSVQAERTVEQKVIKNETGTISLSQLNKNVWVHTE
LGYFNGVAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPIGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNININSVVP
GHGEVGDRGLLLHTLDLLK
>YP_001570595|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYTSEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLASFVSVLVMIVLWNAGYIIRSMHNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFLGLLVNIPVNYIFIY
GHFGMPELGGIGCGVATAAVYWVMFIAMLSYIKHARSMRDIRNEKSFGKPDSAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVNVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLSVGVCMAVVTAIFTVTLRKHIALLYNDNPEVVSLAAQLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAVLMMLRMRYLQRQPSSIILQRAAR
>A0A0E3U8Y3|FEATURES|UNIPROT_deepARG|aminoglycoside|MB84_23135|antibiotic inactivation|1
MPHLQFHIKPIGTDELTPWRSLRKDLWPQASEAEHRQETEELLSQPERYLAVIAMSPDGD
ALGFAEASIRRDYVNGCDTSPAVFLEGVYVSPLSRRMGVARALCTSVEQWGVLQGCEEFA
SDTDINNVDSQRLHKALGFAETERVVFFRKRCRTGTTR
>Q737V7|FEATURES|UNIPROT_deepARG|beta_lactam|BCE_2539|antibiotic inactivation|1
MLKIGICVGILGISLTSLEVFKGETLQVEAKEKTGKVKHKXQATHKEFSQLEKKFDAQLG
VYAIDTGTNETIAYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDLVDYSPI
TEKHIDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMSDRFETE
LNEAIPGDIRDTSTAKAIATNLKDFTVGNALPDDKRKVLTDWMKGNATGDKLIRAGVPTD
WVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEAIYDNQLIKEAAEVVIDAI
K
>K2NBR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKEIITPEAANTFKVVIQLGS
ILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPAVILGFIFEDYIDKYL
FDVRTVAVGLILGAVLMLVADWINKRKAETSSVDNMTYRQALYIGLFQCLALWPGFSRSG
STIAGGVILGLNHRAAADFTFIMAMPIMAGASLLTLVKNAQYLTPDMLPFFIVGFVSAFI
VALFVVRFFLKLINKIKLVPFAIYRIILGLILFILFM
>A0A069PAG7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSTMLRLFAAAVLSVCALPVFSQTTSADIRHIVDTAITPLMTRDDIAGMAVGVIANGET
HVFTYGVASKQTGKPVTGDTLFELGSVSKTFTATLASYAQLQGALSFSDPVSKYVPELRG
TPFGDTVTLLDLATHTPGGLPLQVPDDVHDNAQLMQYFKAWKPRYPAGTYRTYANPGIGM
LGLITAKTMRQDFDALMQQRLFPALGLTSTYIQVPAARMKDYAQGYAKDGAPVRVRPGVL
SSEAYGVKATVTDMMRFVQANMNDAASIDATWQRAIIATHTGYLVAGPMTQDPIWEQYPY
PAQLQALLDGNSPAMALEAQRVERMQPPQAPRGDVWINKTGSTNGFGAYVAFVPGQHVGI
VMLANRNIPNTERVAAAYAIVTALLDAKAGR
>M1MM88|FEATURES|UNIPROT_deepARG|multidrug|rlmN2|antibiotic target alteration|1
MKQTKTKYGKIKQILSNLKLPDYRYEQLTKAIFHQRIDNFEDMHILPKALRIALVNEFGN
NVSSVIPVFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCGFGCRFCAT
GSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILIDQNLFGL
SQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLD
EHIIHTGRRVFIAYIMLEGINDSKEHAEAVVGLLKNRGSWENLYHIDLIPYNSTNKTTFK
FQSSSAIKQFCSILKKAGISVTVRAQFGSEISAACGQLYYENEL
>A0A0B1Y1J3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTTLHIIILACVQGLAELLPVSSSAHVILAEKWLGLDPTSPDMTLMLVMLHTGTMFAVIV
YFWRSWRQTYFSSTKALWNNGVQLAVATAATGVVGLTLLYAIKHAFMGGADSFEVEHLFG
NTKLMAVSLAVAGVLIIVSSRHANTATGELTGWRALWIGAVQGLCLPFRGLSRSGATISS
GMLVGVQRRRAEEFSFALAVVLTPAVIAKEGYRFYKAYAGAAGGMLHMLAPSLLGMVFSF
IAGLVALRWLSRWLEQGRWYLFGCYCLVASAAVWMFAG
>N2JKN9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVM
YALVVGGLLLIAAECLKPKEPRARGLDDMAYRQAFMIGCFQCLALWPGFSRSGATISGGM
LMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIK
TFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A7VSM3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIILEYLKSVLFGIVQGITEWLPISSTGHLILLNQFTPLTVAADPARNQEFFDMFKVLI
QFGSILAVVVLYFHKLNPFSPKKTEREKKNTFSLWGKVLVASVPAGIIGILFNDVIDSVL
STPYVIAATLILYGVLFLILESRNKQPKVKKFSELTYQMALLIGVCQMLALIPGTSRSGA
TILGAVFLGCSRFVAAEFSFFLAIPAMLGASGVKILIFLVEGGGFSGPELGILLVGMVIS
FIVSMLAIRFLMGFIKKHDFKAFGWYRIVLGIVVVLYFALSGAQMMPV
>A0A0F5B894|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTAACESLGKAWEILLIDDGSSDSSAELMVK
ASQEAGSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQDRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPSTEESHQ
>N9P3H3|FEATURES|UNIPROT_deepARG|aminoglycoside|F895_03213|antibiotic inactivation|1
MNIMPVSESLMADWLGLRKLLWPDHDEAHLQQMQQLLQQTQSLQLLAYSDTQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPDYRRSGIATHLIQQVEAWAKPFGCTEFASDAALDN
RISHAMHQALGFHETERVVYFKKHIG
>A0A060KZ97|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPAAWVVGDKTDS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>C0DYD3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MHMNLIECRNINRYFGEDANRVHVLKDISLTIQKGDFIAIIGQSGSGKSTLMNIIGCLDS
ATSGSYQIDGVETSQMSGDELAALRRRKFGFIFQRYNLLGALSARENVALPAVYAGMDQK
ERNERATQLLADLGLEGKEDNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSGS
GEMVMEIIRGLHAKGHTIILVTHDQKIAAFANRVIEIKDGEIIADTSKNAEIPPSSVESR
AEKASWLFYKDQFVEAFKMSVQAIMSHKMRSLLTMLGIIIGIASVVSVVALGRGTQEKIL
SDISSIGTNTIGVYPGKSFGDRHRGRIRTLTIADAEAIGKQSYVDSVTPMTTSSATVTYR
NTNVTAQLYGAGEQYFNVRGIKLDQGRLFNQDDVDTAAQVVVIDPNTRKQLFPEGTNPIG
QTILFGKRPLRVIGISAEDQNGWGGGDSLQMWAPYTTVMNRISGERYISAVTVKIRDDVS
TSVAEQGIKELLLARHGQEDFFTSNSDSIKQTIEKTTGAMTLLISCIALISLVVGGIGVM
NIMLVSVTERTKEIGVRMAIGARQGNILQQFLIEAVLICLIGGAAGILLSYLIGLGFNAL
TSEFAMSFSTWSIVSAVCCSTFIGVLFGFMPAKNASKLNPIAALSRD
>A0A0X1SXT9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPKNIPFSSTLFATTLCLLSSVSCLATAATPIELKAVVDATIQPLMQEQGIPGMAVAVLA
QGKTHYFNYGVASKTGKEAVSENTLFEIGSVSKTFAATLAGYAVAQGKLSLAENASHYLP
ELRGSAFDKINVLDLGTYTAGGLPLQFPSEADSSDKMMSYFQHWKPPYPAAEQRQYSNPS
IGLFGYMAARSLGQPFDDLMEKTLLPKMGLQSTYIRVPKAQMSRYAQGYRKDNSPSRVGP
GALDSEAYGIKTTSSDLLHYVLVNMNPQQLEAPLQQAIALTHTGYYQFGNTTQGLGWELY
PYPVKLDTLTEGNSNKMLDPQKTNWFKAPQPPHADSWINKTGSTGGFGAYVAYVPAKEIG
IVILANKNYPNPLRVKAAYEVLSAVQRQ
>A0A0M8RGF8|FEATURES|UNIPROT_deepARG|beta_lactam|ADK70_19205|antibiotic inactivation|1
MRKPTSSLTRRSVLGAGLGLGGALALGSTTASAASAGTTPSENPAAVRRLRALEREHQAR
IGVFALNLATGASLLHRAHELFPMCSVFKTLAAAAVLRDLDHDGSQLARVIRYTEADVTK
SGHAPVTKDHIDTGMTIQDLCDATIRYSDNCAANLLLRELGGPTAVTRFCRSLGDPVTRL
DRWEPELNSGEPDRRTDTTSPYAIARTYQRLVLGNALNRPDRALLTDWLLRNTTTLTTFR
TGLPKGWTVADKSGGGDTYGTRNEAAITWTPDGAPVLLTALTHKPSLPTAPGDTPLIIKL
ATVLSEAVAPA
>ZP_03030905|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAAHLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGIDPAMRAENISVAQYCQMANYLAENAPLQES
>S5N8A9|FEATURES|UNIPROT_deepARG|aminoglycoside|A464_1655|antibiotic inactivation|1
MEIRKMNKTDLEHWRELRKQLWPGHPDDAHLADGEEILQADHLTSFIALDGGVVIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSCRQRGVAKQLIAAVEQWGASNGCLEMASDTSPEN
TVSQSVHQALGFEETERVIFYRRRC
>1VIE|FEATURES|ARDB_deepARG|trimethoprim|dfrB1|antibiotic target replacement|1
VFPSNATFGMGDRVRKKSGAAWQGQIVGWYCTNLTPEGYAVESEAHPGSVQIYPVAALER
IN
>V8QNF1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTFVTATAALFSHITPAAAAPSEASVKNRVDASVMPVMQHHHIPGMAVGIIDGERRYFFD
YGVASKQTQQPVTAATLFELGSISKTFTATLATYAQALGHLKLTDTTEKYLPQMQGTPFG
KVALVHLGTHTPGGFPLQVPEEIKTQTQLMSYMQEWKPPYKQGTQRTYSNPGIGMLGLIA
AKAMQQDFTTVMQNAIYAPLGLHDTYIDIPAGKMRNYAQGYTKQDAPARVSKAVLWAQAY
GAKSTSRDMLRFVQANMNMVALDSRLQKAVTDTHIAYAQTAAMTQDLIWEHYPYPVTLQA
LLKGNSAAFALQPQPVTPVVPPAAPRDDVWINKTGSTNGFGAYVAFIPARKQGIVLLANK
NYPIEDRIKIAYEILSELDARTDKKRP
>A0A086W8I6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLAIKAIIMGLVEGFTEFLPISSTGHLILMGSLIDFTGPKSVVFKIVIQAGAMLAVV
WEYRDRIARMLKGLGADPVQQRFARNVVIAFVPAAVAGVLFSSTITELLFHPVPVAIALV
LGGMLILYVERRNRLRPTAARVETVDDMSALDALKVGLAQSFALIPGTSRSGSTIIGGML
FGLSRKAATEFSFFLAMPTMLGATVYSVYKERALLSAADLPLFGLGFFAAFLSAFLCVRW
LLRYISSHDFTIFAWYRIVFGILVLVTAHFGLVTWAE
>ZP_04115750|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKERVDDMKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNK
NVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNMKVETF
YPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNI
NVVVPGHGEVGNKGLLLYTLDLLK
>A0A084DES3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MRRPLLKLSAVTRRFPAGDKDIVVLNDVNLSIHAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTARA
ERHERARELLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVLRILHELNALGHTIVIVTHDKAVARHARRIIEISDGEIVADRPNRQYADALAEAGI
DAAHTPDAAAGTPPASASASAPAPAPASASVSASAHDAAPPPGDAGTGTRARRFAAGTGR
FAEACRMAWIALVSHRLRTLLTMLGIIIGITSVVSIVAIGEGAKRYMLDEIGSIGTNTIN
IYPGADWGDSRADAIQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNVDVNALVSGVG
DRFFQARGMRFALGVAFDEDAVRRQVQVAVIDQNTRRKLFGAARNPIGEVILVDNVPCVV
IGVTADKKSAFGSVKSLNVWVPYTTASGRLFGQRHLDSITVRVRDGQPSAAAEKSLEKLM
TQRHGRKDFFTYNMDSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTR
EIGIRMAVGARQSDILQQFLVEAVLVCLLGGTIGIALSFGLGAVFSMFVAQWKMVFSAGA
IVTAFVCSTLTGVIFGFMPARNASRLDPIDALARD
>AAC77497|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQHQPDSDYLGNLLRSKTFIALAAFD
QEAVVGALAAYVLPKFEQARSEIYIYDLAVSGEHRRQGIATALINLLKHEANALGAYVIY
VQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>AAR05437|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-22|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVIAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A0A7Q221|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLRPRLAALAAAITLALGHASAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLEAPAKRYHPALAGVP
IGDATVLELGAYSADCLPLQFPDTVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLTKMGLKNTYLQVPASAQGLYAQGYDADDKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPQGLPPALAKATAITQQGYFQVGAMTQGLGWERYPYPVTL
STLIDGNSPQLIREPQATTRLQPALPALPAAWYNKTGATNGFGAYAAFVPAEQLAVVLLA
NRNYPNQARVQAAFDILSGL
>A0A0F5HPF8|FEATURES|UNIPROT_deepARG|beta_lactam|QY95_03548|antibiotic inactivation|1
MKTYTHKFSMRDVAVLILLVAVMTLTACADKDSSANVLSKEENEEEQTANTNERFIQLEK
EFDAQIGVYAIDTGTDQTIEYRPEERFAFASTYKALAAAILLKQNSLEELEKVITYTEDE
LVPYSPVTEKHVDTGMTLLELGEAAVRFSDNTAGNLLFEAVGGPQGFEQALRQIGDDVTE
ADRLEPDLNKFTPGDTRDTSTPRALATSLQVFAVGGLLSGDKRELFTDWLKGNATGDPLI
RAGAPEGWEVGDKSGAGSYGTRNDIAVVWPPNRKPIVMAVLSRHHTEDAAYDDELIAQAA
KITLNALE
>J8R3V4|FEATURES|UNIPROT_deepARG|beta_lactam|ICG_03066|antibiotic inactivation|1
MEQTCYLESLLCVRIKTGVQIGYSVLNLPLVFSIKSLKGMMILKNKRILKIGICVGILGL
SLTSLETITGGTLQVEAKEKTGQVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAYASTYKALAAGVLLQQNSIDKLNEVITYTKEDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNIVFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPAHKRNIFTEWMKGNTTGDKLIRAGVPTDWIVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVVINALR
>K2SJK9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQEAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
VGGVIMLWAERRVHTVRTETVDDMTWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFVFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKE
>A0A0P9KV77|FEATURES|UNIPROT_deepARG|polymyxin|ALO81_02621|antibiotic target alteration|0
MAQLCARHDIPVHAPEDPNHPLWIERVSKLAPDFIFSFYYRALLSEPLLACAKRGAFNLH
GSLLPRYRGRAPVNWVLVNGETETGVTLHKMVKRADAGPVFAQQRISISATDTALTLHGK
LREAAIALLSDALPSLARDQLSGTPQDESLATCFGRRTPADGLIDWSLPAARLYDLIRAV
TQPYPGAFFPVGDHKLIIWAARVEPSNNGAAPGTVISHDPLRIACGEGSLIIHAGQRGNE
GLYLSGAQLAREFGLVQGSQLRDAKMQRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEI
YGMDIGSDAIERLRAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPL
RVFELDFEENLKIVRCCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIY
SVSKQLLDRVIWAYGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTP
IRLADGGAQKRCFTDVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQ
FEAHPLRDNFPPFAGFRDVESQSFYGKGYQDVSHRKPGIDNARQLIGWAPGIALSETIGK
TLDFFLREAMAEKADQC
>D7N3Z9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLLKALILGVVEGLTEFLPISSTGHLIVLGDLLNFHSNGKVFEIAIQLGAVLAVIF
EYRQRFADIISGLGRDRKANRFVLNLAVAFVPAAVVGLLFSKQIKLYLFNPITVAAMLVL
GGFFILWVEKHQSKKKPKVMNVDDMRPIDAFVVGCAQICALVPGTSRSGSTIMGGMLWGL
ERKTATEFSFFLAVPMMIAATGYDVLKHYKLFTMQDIGLIAAGFVAAFLAGLLAVKALLK
FVASKNYVPFAYYRIVFGGLILFTWAMGWVNWAE
>A0A147FVL9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYAEMGCAGITALLNAGYEISAIFTHADTSPESHAFPSVARLAAEQGIPVYAPE
DANHPLWVDRIRTMQPDFIFSFYYRALLSDTILNCARVGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGDIVAQQRVAIDPQDNALTLHRKLVACADQLLEGALPPM
KRGEIAATPQNDAEATMVGRRTPEDGRINWELPAAKVNNLVRAVTDPWPGAFAYAGTVKF
VVWKGRVHQDAPSAKPGTVLSVEPFLIACGEGALEVVTGQSDNGVYMNGSQLAQSLGMVP
GALLYSQPVAAVKRRTRVLILGVNGFIGNHLTERLLQDDNFEVYGLDIGSDAISRFLDEP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDQHFDEDHSNLVVGPINKQRWIYSVSKQLLDRVLWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDI
RDGIEALFRIIENKHNNCDGQIVNIGNPENEASIKELAEHLLASFERHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIKNARRLLDWTPTVAMDTTIDNTLDFFLRTVELQEKP
>V4ZF97|FEATURES|UNIPROT_deepARG|beta_lactam|P355_4283|antibiotic inactivation|1
MRFNATRVAATLFVAACATATAGRAAAVTQDDLHDTVTRHIAPLMKQYAIPGMAIGIVAD
GKPQVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVARYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDSIRDDADLIRYLDAWRPEYAPGTHRKYSNVAI
GMLGWLTAKAMHEDFATLMEQRLFPALGMTHTYIDVPAARMADYAQGYTKDGKPVRMTQG
MLWQPAYGVRTTAADLLRFVQANLGMIQTAPRLQRAIERTHAGYFRAGPLTQDLIWEQYP
YPVALPTLLAGNAPKMLFDAVPASAIQPPLAPNPATWINKTGSTGGFSTYVAFVPAKRIG
IVMLANGNVPIEDRVKVAYRILGSLGDGR
>A0A069I8A9|FEATURES|UNIPROT_deepARG|beta_lactam|CF70_016075|antibiotic inactivation|1
MRHSPVRRTLLLAAASVPFTSACTSWAGRAGGSAAAQDRLAALESAAGGRLGVAALNTAS
GARISHRASERFALCSTFKVLAASAILQRSAAESGLLQRRIAYTKDELVAYSPVTGKHTG
DGMTVSELCAAALQYSDNTAANLLMKILGGPAAVTAFARSIGDDAFRLDRWETELNTAIP
GDPRDTSTPAAMSRSLQRLALGDALGAAERGRLVAWMRGNTTGATRIRAGVPADWQVADK
TGSGDYGAANDIAVAWPPGKPPVVMAIYFTQGDKDAAYRNDVLATAARIVAETIGQAGMA
>W7X0X5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVLLIKAALMGIVEGLTEFLPISSTGHLILAGSLLDFHDERAKVFEIAIQTGAIFAVI
IVYWQRLRATLLGLASQPTAQRFTLNVFIGCLPAVVLGLLLGKAIKAHLFTPTVVATAFI
LGAFVILWAERRQQARVRVHDLDDLTPLDALKVGLAQCFGLIPGTSRSGSTIIGGMLFGL
SRKVATDFSFFLGIPILIGAGAYSLYKARDLLSMADLRCLPWACCSRSSAPGCASAGCCA
TWPATASFRSPGTASPLVR
>A0A095YWP6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIVEGLTEFLPVSSTGHMIITQNLLGVPQGDEFVHAFTFIIQFGAILSVVC
LYWKRFFHIDRSPVPADCKSSFLRMIHPIRFYWLLFVGVLPAVVVGMAAKKSGLLDWLLD
SVWVVAIMLVVGGVFMLFCDKIFNKGIEENLVNEKRAFNIGLFQCLSVIPGTSRSMATIV
GGMANGLTRKRAAEFSFFLAVPTMAGATLLDLHDLLEADSSWATAHNLTMLLIGCVVSFV
VALFAMKWFVSFLTKYGFKAFGWYRIIVGAIILVMLLSGMSLNMVD
>A0A011UQM5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVFNLLEAAFLGLIEGLTEFIPVSSTGHLLLIGHFLGFESTGKTFEVLIQLGAILAILT
VYSAKLLKILTDFPRDARTRRFVFGILVAFLPAAVIGALAHGFIKSVLFETPMLVCIMLI
IGGFILLWVDQLNLRPRYHDVMDYPLPMCLAIGFIQCLAMIPGVSRSGSTIVGSLLLGAD
KRSAAEFSFFLAMPTMAGAFAYDLYKSRNILSLNDGALIGVGFVMAFISGVFVVRYLLDY
VSRHGFKLFGWWRLIVGSVGLAALLVWG
>A0A0S1RT22|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQ
PTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLRKLVNRQLPVKAAAYELADNLFEVGQADGWRLYGKTGT
>A0A077CY10|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
SSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYN
KLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGGIKKVK
QRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLD
LMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDN
KSDKPNDKLISETAKSV
>F0RDI5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILQAIILAIVEGITEYLPVSSTGHMIIVSSFFGIAQEEFTKLFTIVIQLGTILSVVVL
YFKRFFQSVDFYLKLLVAFIPAVVLGLLLSDVIDSLLENPLTVAISLVIGGVILLRVDHW
FADSEEKEITYLTALKIGFFQCLAMIPGVSRSGASIVGGMSQKLSRTVAAEFSFFLAVPT
MLGATLKKSYDFYKLGYTLTGEQINLLIIGNVVGFLVALLAIKTFIGYLSKHGFKMFGYY
RIVVGLAILAIHYFVHPLIII
>A0A0H2KX24|FEATURES|UNIPROT_deepARG|chloramphenicol|FB00_00815|antibiotic inactivation|1
MEHPVPIDLETWPRREHFEHFLHASPCTYAMTVELDVTALAAALAASSRKTYVAQVWALA
TVLNRHEEFRLRLDDAGAPAVWPVVHPAFTVLNPGRETFSAVWTPYDADFDAFHAAASAL
LAEHRTATTFFPQGAPPPNAFDVSSLPWASFTGFTLAIRDGWRHLAPIVTLGRYVERDGR
TFLPLAVQVHHAAADGFHVARLVNELQELVDDPAWLD
>AAQ90024|FEATURES|ARDB_deepARG|beta_lactam|SRT-2|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDDR
VEAAYHIVQALEKR
>A0KLU1|FEATURES|UNIPROT_deepARG|aminoglycoside|AHA_2734|antibiotic inactivation|1
MTNADWRIVPLDETLLAQWATLRQQLWPHHEMAAHLQEGAELLAAAHLNAFLVLDAQSQA
VAFADAALRHDYVNGCESSPVVYLEGVYVQPASRRRGLAQALIARVAQWGRELGCRELAS
DAAIDNLASQQLHQRLGFAETERVVFFKKALG
>1616230A|FEATURES|ARDB_deepARG|beta_lactam|r39|antibiotic inactivation|1
MLFPTARRTGFAALAALALVPAAACSGSAAPAEAEPASAEVTAEDLSGEFERLESEFDAR
LGVYAVDTGTGEEVFHRADERFGYASTHKAFTAALVLGQNTPEELEEVVTYTEEDLVDYS
PITEQHVDTGMTLLEVADAAVRHSDNTAANLLFEELGGPEGFEEDMRELGDDVISADRIE
TELNEVPPGGTRDTSTPRAMAGSLEAFVLGDVLEEGPRDVLTEMLLNNTTGDELIRAGVP
EDWRVGDKTGGGSHGSRNDIAVVWPPEDDPIVIAVMSTREQEDAEFDNALVSGATEVVVE
ALAP
>CAX85496|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYYGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRYMFQKIM
>W1UKT3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIEIIKAIILGIIEGITEWLPVSSTGHMILVDEFLQLDMSPAFKEMFFVVIQLGAIMA
VVVLYWKKIFPFSFKKKPFVQKSIIIMWIKVIIACLPAAVIGLLFDDKVNELFYNFQTVA
IMLILFGIFFIVVENYNKGKNPIANDMDQLTFKMAIIIGLFQVIAAVFPGTSRSGATILG
ALLIGVSREVAAEFTFFLAIPVMFGASLLKLVKFGFVFTGFEMIILSVGSIVAFIVSILA
IKFLVGYIKKHDFKVFGWYRIILGIILLGYYFFLR
>A0A0U2WR16|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLELLKAAFFGIVQGITEWLPISSTGHMILFEQFIHMNVSKDFWDMFLVVIQFGSILAV
VLLYFHKLNPFSPKKSPVQKRDTWSLWGKVLVAVIPAAVIGLLFDDFITDKLYGYVTVAI
TLIVYGIAFIVVENMDRTKRPTIRNFEQLDYKTALFIGVFQILALIPGTSRSGSTIIGAT
LLGCSRYVATEFSFFLAVPVMLGASLLKIVKFFIKTGIGFTGTEIGILLVGMIVAFVVSV
FAIKFLMGYIRKHDFKAFGYYRIVLGIIVIIYAVMFA
>A0A077W3M5|FEATURES|UNIPROT_deepARG|chloramphenicol|catA1|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SQDVACYGENLAYFPKGFIENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGVMLPTY
>A0A060KTL6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVIAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A0E9K3F5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPASIGKAVLLALVEGATEFIPVSSTGHQLLVGHFIGFHSPNNTFEVLIQLGAILAILL
VYFRRLLGIATALPSDPKARRFVLGILVAFLPAAIIGGLFSKLIKAYLFNPWIVCATLVA
GGLVLLVIDDTDLEVKKTDVYDFTLPMDLKIGIFQCLAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAMPTMAGAFAKDLLDNYKYLSGNDVGLIVIGFIVSFVSALFVVRFLLDYV
SRHGFWLFAWWRIIVGALGFAGLIILG
>A0A0K1TBR6|FEATURES|UNIPROT_deepARG|multidrug|cfr(B)|antibiotic target alteration|1
MQQKNKYIRIQEFLKQNKFPNYRMKQITNAIFPGRINNFNEITVLPKSLRDMLIEEFGES
ILNIVPLKAQQSTQVSKVLFGISGDEKIETVNMKYKAGWESFCISSQCGCNFGCKFCATG
DIGLKRNLTSDEITDQILYFHLQGHSIDSISFMGMGEALANVQVFDALNVLTDPALFALS
PRRLSISTIGIIPNIKKLTQNYPQVNLTFSLHSPFNEQRSELMPINERYPLSDVMDTLDE
HIRVTSRKVYIAYIMLHGVNDSIEHAKEVVNLLRGRYRSGNLYHVNIIRYNPTVSSRMRF
EEANEKCLVNFYKKLKSAGIKVTIRSQFGIDIDAACGQLYGNYQKTNSQ
>Q7UNQ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQELIRVVILAIVQGIAEFLPISSSGHLVILGSMLGELGESVTLEIILHAGTLGSILVVF
WQRIWALLLKDRRVIGLLVIGTLPAVVIGLTIKTQFPEILRSPLLAGAMLIVTGVMLIVL
GRLTPKSGTYDRLGLGAAFLVGCFQAFAILPGISRSGSTILGGRLMGLDRDDSVTFSFLL
AIPAILGATVLAIKDLLEDGSSGETSIEVLSIGAAVAFAVGIVALKWLIRWSREDRLHWF
AYWCIPAGLLVVLLNLR
>ZP_03149247|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDWMELLKAVILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGIRGRHPGGKPRLTLLHVIIGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIVADRFAKKAARAQTVDQITYKQAFLVGLVQCLSLWPGFSRSGSTIA
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTVADIPFFIAGFLSAFVFALL
AIRFFLHLINRIRLVPFAVYRIALAFIIYFLYF
>T2H7A4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAV
VWEFRGKILEVVFGLTSQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPITVATAL
VVGGVIMLWAERREHSVQVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGL
SRKASTEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFVTSFIFAMIAVRALLK
FIANHSYAAFAWYRIVFGLLILATWQFGWVDWSTAHG
>F6EF91|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTTLEALILGIIQGVFMFVPVSSTSHLALAQHWLISAGSGMPAPDSPEMILFDIIVHVGT
LVSIVIVMREPLFRLLRGLLSDARTLADGDLAGRVKSGQLMYIRLALLGTITVMVTGFLG
LAIRAFGTEVFATPALIAGALIATGAILWWTDTIGPRWRGAAQLTVWVAVAIGIAQAAAL
VPGLSRSGLTIAMALLLGLHRPLAAQFSFFVAIPTILSAAMLQGWTVIRAEELTIHLGSY
AVAFVAAAVVGAVALALVLKLLYAAKFRYFSVYVWILAVVVLIVQPATTHL
>G9Y3G3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHLLINAFILGVVEGVTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
VMFWRRLFGLIGIHFGQPPLHEGKTQGHLTLGHIILAMIPAVVMGLVFHDAIKTLFAPRT
VVYALVVGGFLLLAAEWLKPKQPRAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRFAASEFSFILAVPMMMGATALELYKSLPFLSMADLPMFAVGFVTAFIVALIA
IKTFLSVIKRISFVPFAIYRFIVAAVVYVVFL
>YP_001096294|FEATURES|ARDB_deepARG|bacitracin|BcrA|antibiotic efflux|1
MNTVIKTTNLSKIYGEQKSVDQLSITVNQGEIYGFLGRNGAGKTTTIRMLLGLIRPTYGQ
IEIFGENLFKNQKRILRRIGSIVEVPGFYENLTAKENLLINAKIIGVHKKNAIDEALEIV
GLQNENKKLVGKYSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIKSLAA
ERNITILISSHILSEIEQLADHMGIIHEGKLLEEIGIDHLRKRNRKYLEFQVSNDNKATM
LLEEHFNIFDYEVYDEGMVRVYSHLGEQGTINRMFVQNDINVLKIKMSEDRLEDYFERLV
GGGTIG
>N9NGG5|FEATURES|UNIPROT_deepARG|aminoglycoside|F898_03662|antibiotic inactivation|1
MPVSEPFLADWLQLRILLWPDHEDAHLLEMRQLLEQPHTLQLLSYNDQQQAVAMLEASIR
YEYVNGTQSSPVAFLEGIYVLPEYRRLGVASTLVQQVEHWAKQFACTEFASDAALDNTIS
HAMHRALGFQETECVVYFKKNIS
>Q4MU81|FEATURES|UNIPROT_deepARG|chloramphenicol|AQ16_186|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSLTVNVDITLLIEKVHQKEIKFYPTFIYIISRI
INKHKKFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMR
CYANVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEENKVI
LPVSLQVHHSVCDGYHASRFIEDLQKLSNSCNEWLK
>A0A0G4JR03|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTIVFAYHDMGCAGINALLEAGYTIRAIFTHADSAAENHFFGSVARIAAEKGIPVYAPD
DVNHPLWIERINAMEPDILFSFYYRVLLSDSILNCAKIGAFNLHGSLLPKYRGRAPLNWA
IANGERETGITLHRMIMRADAGDIIAQQAVNIADEDDALTLHHKLVRCARHLLADSLPAI
KQGRLEGRSQNEVEATVVRRRTPEDGRINWSLPARDIHNLVRAVTDPWPGAFTWAGSSKF
VIWKSRILSDHTQANPGTVLSADPFVIACKDGALEVLTGQKNNGVCMNGCQLAQSLGVVP
GARLCSQPAAAVKRRTRVLILGVNGFIGNHLTERLLKEENFEVFGLDISSDAISRFVGHP
RFQFVEGDVSIHSEWIEYHIKKCDVILPLVAIATPIEYTRNTLRVFELDFEENLKIIRGC
VKYGKRIIFPSTSEVYGMCTDDSFDEDHSKLVVGPINKPRWIYSVSKQLLDRIIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRVITQLILNLVEGSPIKLVDGGRQKRCFTDI
SDGIEALFRIIENKHRNCDGQIINIGNPDNEASIKELAERLLASFERHPLRASFPPFAGI
QEVESGSYYGKGYQDVEHRKPSIRNARRLLEWAPTVEMNTTIENTLDFFLRTVDLPEEP
>A0A127T4G9|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-29|antibiotic inactivation|1
MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHY
FTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQ
>A0A0Q7EAZ8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MVVLNKTKTIFCVLIGSMSLTTYVNANEIPATSIKVETAMNTAFQPLMKTYAVPGMAIGV
LYNGKSYEKYYGVQSLANAKAVNKNTLFELGSVSKIFTATAGTYAQNLGKISLQDHPGKY
IPALKNSDINQVTLLELATYTSGNLPLQFPDQIKIDAQTLKYFQDWKVKNPIGQFRQYSN
PSIGLFGEATAKAMNMPFSALLEQVIFPKLELQHTYVQVPKAQQGNYAFGYDQNNHPLRV
TAGAFDAQAYGVKSSLPDMLHFLNLNLNPDQAKAAIKPAILATHTGYFKMGGMTQALGWE
SFSYPATLNTLLESNSDRVVMQSNPVEKTLVKTGSRVFHKTGSTNGFGTYVIYIPQENFG
LVMLMNKKIPNAERIKAAYEVLNSLKQKSNP
>B2G2R3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA13|antibiotic inactivation|1
MRDSVTAEISTQLSKVLSVIEHHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVTARLDD
TTRRALFNDLLEVSAFPGESEILRAIEVTIVVHEDIRPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLIKALNETLKLWNSQPDWA
GDERNVVLTLSRIWYSAATGKIAPKDVAADWAMEHLPAQHKSVLLEARQAYLGQEEDRSV
LRADKLEEFIHFMKSEITKVLGNDV
>A0A0B4ZVM0|FEATURES|UNIPROT_deepARG|aminoglycoside|Ant3Ia|antibiotic inactivation|1
MAALMSNVKHHGEAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDL
LVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFG
EWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETL
TLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQA
YLGQEDRLASRADQLEEFVHYVKGEITKVVGK
>G8HAR0|FEATURES|UNIPROT_deepARG|beta_lactam|blaKPC-2|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>A9HXK3|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDSTLYLIKAFFLGIIEGLTEFIPVSSTGHLILIGDWINFTSSSGKVFEVVIQFGSILA
VMWIFRARLWQLIRGTLTGVPAETAFTRNLLLAFLPAAVVGAIFIKTIKQVFYHPGVVAV
TLVLGGLIMLWVERKTHHTPGDAPGAADDTASDERASAHTLEQISWKQALGVGVAQCLAM
VPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAATYDLYRNIDLLSQHDLSAIA
VGFAAAFISALVVVRAVLRFVANHTYRGFAWYRIALGIVVAAWLMTK
>A0A081RU92|FEATURES|UNIPROT_deepARG|beta_lactam|MEG1DRAFT_03063|antibiotic inactivation|1
MTKRFSVLTGGLLLAASLGAQASNTPDQSHLTNTVDKTIHSLMQEYDIPGMAIAVTFRGQ
HFFYQYGDASKENNTPVTKETIFELGSVSKTFTASLISWAQVTGAISLSDKASQHFQPIA
GSAFDNISLLNIATYTAGGLPLQFPDEIDSKSKMVNWYQHWQPKYAPGTYRQYSNPSIGL
AGYIAAQRLGKPYSMLVANQILSPLGLHHARFNVPEQDMKNYAWGYSKENKPIRVTPGVL
DEEAYGLKASAQDMISFVDANIDPSRIGDSKLAQAIRATHTGYYRVGEMTQGLGWELYHW
PVTLEQVLSGNSAQIAYQANKTTELSPPEPPTEALFINKTGATNGFGAYVAFVPQEQMGI
VLLANKNYPNEARIKAAWQILNALK
>A0A127SIA5|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIDQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>YP_403489|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELSGVGCGVATAAVYWAMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSAIILQRASR
>A0A0N0W7M7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDTAGLRDTRLDSDRPLLHLQGVSRSFMAGEREFQVLKNIDLAINAGELVAIIGAS
GSGKSTLMNILGCLDHASTGSYQVNAQETRDLDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAVYAGTPQSQRHQRAQALLTRLGLGGHLEHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEIIS
DRRTALQTLNAAEPQEATQKTLAPRRLVAGFGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGSNFGDSRAKSIETLLPADVAALN
QLYYIDSATPVVGRSMLVRYRNIDVDAQLNGVSNRYFQVRNIQLAAGITFSEQDARRQAQ
VVVLDHNTAQRLFGAGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNIWMPYETAA
GRLLGQRHLDSISVRVKDGMPSKAVEEQIKTLMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LIGGVIGIGLSYGIGYLFTLFVKQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>A0A109HKX2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMFSALLLGILEGLTEFLPVSSTGHLLIAEQWLGRRSDFFNIVIQAGAILATTLVFRQ
RLWTLATGLGDRANRDYVLKLGTAFLVTAVVGLVVRKAGWQLPESVQPVAWALVIGGVWM
LVAEHFAARMPERERVTWKVAIAVGLAQVVAGVFPGTSRSAATIFLAMLLGLSKRSAAAD
FAFLVGIPTMFAASGYSFLELYKNGMVGSEDWGDVAIAFAAAVVTGFIVVKWLLGYIKSH
RFTAFAVYRIVLGAALLLWLPAA
>A0A097SRT0|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
FFAAFCLPVFVLPETLVRVKDAEDQWGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
LLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTA
ANLLLTTIGGPKELTAFLHNKGDHVTRLDRWGPELNEAIPNDERDTTMPVAMATTLRKLL
TGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGK
PSRIVVIYTTGSQAT
>A0A0J7CWK5|FEATURES|UNIPROT_deepARG|beta_lactam|TU52_24360|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSLTSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFSQLEK
KYDARLGVYAFDTGTNETISYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITFTKED
LVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGDRVIM
SDRFETELNEAIPGDNRDTSTAKAIATNLKAFTVGNALPNHKRNILTEWMKGNATGDKLI
RAGVPTDWIVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAA
EVIVNALR
>D8AP73|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9541_02592|antibiotic inactivation|1
RFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQG
KPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWSEL
TAKQWNGITLLHLATYPAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIG
LFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGAL
DAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDW
PVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGI
VMLANKNYPNPARVTAAWQILNALQ
>A0A0E1GMP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLNAVILGIVEGLTEFLPVSSTGHMILSAKLLGLEQTSVLKCFEVVIQLGSILAVVFM
FFDRLKEDFNLWIKLAIGFVPTAIIGFLAYKHIKTFFEPSTVAYMLIIGGIVFIVVELWH
KKINYEGDTKTLHEVSFKQAFIIGLSQCFAMIPGTSRSGSTIITGLLCGLSREVAARFSF
LLAIPTMFAATAYDSYKNADIFVQNKEALWIFLVGGFMAFIVALIVIKLFLKFVSKFSYI
SFGIYRIILGSIFLIYIL
>A0A0Q7HJ09|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD29_31540|antibiotic inactivation|1
MSDHCEPGAVSPVLSGVGGDWLPVTAGESGASVFRAADATRYAKCVPAADTAGLEAERDR
IAWLSGRGVPGPRVLDWYAGDAGACLVTAAVAGVPADQVRGEDLGASWGHIADAVRRLHE
VPVASCPFRRGLDSVVDVARDVVARGAVNPEFLPVEQQRVPPAELLARLTGEIPRRRDQA
AAGTVVCHGDLCLPNIILDPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERA
RVADAEFAERYGMPLDQERLRFYLHLDPLTWG
>A0A0W0PN62|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQWNGTLFCTGLLLVSSAAFAEDNAAALDTLVQTEARKVMQENNIAGLSIAITRRGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTQSIDTYLPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPENVQNTRQLMDYFKAWQPDYLPGTYRTYANPSIGLLGV
IAARSMNMPFQEAVQQRLFPALGLNSTYISVPDEKQALYAQGYNKLDEPVRVSPGILAAE
AYGVKSSSRDLIRFVEANIGLGQHDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPIRL
DMLLAGNASAMLNTQKAEAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAERQIGIVILAN
KNYPNEERVKLAYRILQHAAPFN
>AAU89126|FEATURES|ARDB_deepARG|aminoglycoside|ANT(3'')-Ii-AAC(6')-IId|antibiotic inactivation|1
MSNAVPAEISVQLSQALNVIEHHLGSTLLAVHLYGSALDGGLKPCSDIDLLVTVTAQLDE
TVRQALFVDFLEVSASPGQSEALRALEVTIVVYGDVVPWRYPARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKARQHSLALAGSAAEDFFNPVPESDLFKALADTLKLWNSQPDWA
GDERNVVLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEAQQAYLGQGMDCLA
SRADQLTAFIYFVKHEAASLLGSTPMMSKTKLGITKYSIVTNSTDSVTLRLMTEHDLAML
YEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVAL
GSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPS
NLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>B8G5Q8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQTQSITLPRSGLFIGFAVLLAFALLITVPTNPDWWQIVVLGIVQGITEWLPISSTAHLL
LTSALLRYQGSIGGTFEIAIQFGTVCSVLLFYWRDLLDQAQALIGRGDPATIAMARKLWL
GVVIAFIPAAVVGILARNFIKAVLFESPLVIAIALIVGGIIFLWIERTRISQPATTADFT
TVSPQRALIVGIAQIFALIPGVSRSGSSIVGGLLAGFDRPTATAFSFYLAMPTLGLATIV
DLIGSLDQVQAGDWGRLLLGATVAMIVGYGGIGWLLRYIATHNFTMFGYYRIIAGVLIIG
AVIAGVL
>E2CEW7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNQTIINALILGIVEGLTEFIPVSSTGHLLLLGHFLGFESTGKTFEVLIQLGAILAILS
VYFSRLWNLATSLPNDPSSRRFVFGIFLAFLPAAIIGVMTHGFIKEVLFETPALVCSTLL
LGGLVLLWVDRLPLKPRYTDVTDYPLSLCLKIGLCQCLAMVPGVSRSGATIAGSLLMGTD
KRSAAEFSFFLAMPTMAGAFAYDLYKNRNVLSVDDLTLIGIGFVASFIAGVFVVKGLLDF
VSKHGFAPFAYWRIAVGILGFVGLYIFG
>U2NPS2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIQTIVIAIIEGLTEFLPVSSTGHMIITQNLLGVPQSDPFVHAFTFIIQFGAILSVVC
LYWKRFFSIDHTPVPEFAEMALWQRAEHSLAANAWHRLKKCFYWLRHRLSFYWLLLVGVL
PAVIVGLVAKKSGLLDWLLDSVEVVAVTLVLGGVFMLFCDRIFNKGVDENTVDWKRAFKI
GCFQCLSVIPGMSRSMATIVGGMQQKLTRKRAAEFSFFLAVPTMAGATLLDLLEMFGEEA
TWATTENIELLLLGCLIAFIVALFAMKWFVGFLTKYGFKAFGWYRIVVGLVILIMLATGH
SLVMVD
>D4CNH8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNFVEILKVIVQGLVEGFTEWLPISSTGHLMLVNALIPLHQPESYYEVFKVVIQLGAIFA
VCFRFFHELWPFARAQHSGKLAVRPAKINLWLKIIIACLPAAVLGILFDDFLDAHLNNAP
VIAIVLILYGVLFIWIERRNAKAEFPIRSVDQIELSTALLIGLFQCLALIPGTSRSGVTI
LGAMLIGVSRVCAAEFSFFLSVPIMFGASAVKLIKYFVKGGSFTGSQSFYLILAMLVAFV
VSLYCINFLLEFIRKHSFAVFGWYRILLGILVLLGTVFTFLARIL
>A0A0J9GE68|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALVIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIEVVKGLPSDPRQQRFAINVIVATIPAITLALIFGKSIKAHLFNPIVVASAFI
IGGFVILWAEWRERHRGETHDPRANALLEAAKAGAPRIETLDDLRISDAIKVGFAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKSRALLSADDLSIFA
VGFVAAFISAFFCVRWLLKFIATHDFRGFAWYRIIFGVIVLVTAYTHLIAWQA
>A0A0J8FW34|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVFNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDNSAQLLEDA
AAEDGSNVVAVILNRNYGQHAAIMAGFEQCQGEVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGMLFAVALIVLRLAFGADWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTTTTSPSDQVSS
>I6Z9I0|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADEC
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>A0A132CT40|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIVSIVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVQSVDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRFVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A127SIY2|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNRKKATIGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>A0A0A8HSL8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLDYYYALILGIIEGLTEFLPISSTGHMILGAEILGLNIDDFWRSFFIIIQLGSILAVI
FIFKEKLTQKLDIWLKLAVGFLPAGGVGFIAYKFLKEIFNGYTVATMLIIGGIIFIIIEL
KHRKKDYTIHSLDEVSYKQAFLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKVASEFSF
LLAIPTMIIATAYSIYKEPQVLSNMNNFIPLAIGFITAFVVAFVVIKIFLKLISKINFIP
FGIYRIILGFVFLYLFMSGALDISRTGV
>A0A0M7AGH9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDGQTIVNALILGVVEGLTEFIPVSSTGHLLLIGHFLGFESTGKTFEVLIQLGAILAILS
VYSARLWQLATSLPSDATSRRFVFGILIAFLPAAVIGVMAHGFIKEVLFETPALVCTTLL
VGGIILLWIDRLELSPKYTNVMDYPLSLCLKIGFCQCLAMVPGVSRSGATIAGSLLMGTD
KRSAAEFSFFLAMPTMAGAFAYDLYKNRNVISTDDVVLISIGFVASFIAGFFVVKGLLDF
VSRHGFAPFAWWRIFVGLAGFAGLYFLG
>C7CL23|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKRALAALVLSGLSPAPTPALATDPSARVAAAVEQAYRPLLKVYDVPGIAVAVTREGHS
TVFTFGLADRERQRPVTRDTLFEIGSVSKTFTATLVSYAQGLGRLSLADAPSRFLPELRG
SALDRVSLLDLGTYSAGGLPLQFPDAVTDEAAMIAYFRRWQPSAPPGTQRLYSNPSLGLF
GAAAAAAMGGDFADLMETRLFPGLGLKHSFIRVPASESERYAWGYGKDGTPIRVNPGVLD
GEAYGVKSSAADMIRFVEAHLDPTRLDPPMRQAVQGTQIGYFRVGAMVQGLGWEQFTYPV
SLERLQAGNAEPMRFEAQPAARFDPPQRPTGVTLFDKTGSTNGFGAYVAFVPAKRIGLVM
LANRAFPMPARIAAAHAVLEVLAAEEP
>A8GDR6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLTQPYEIILVDDGSSDNSADMLTA
AAEQPGSCVIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVKVAEEG
YDVVGTVRANRQDSWFRKSASRIINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLNCHER
STFIPILANTFARRTTEIEVLHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVVALSGFLLAVLLIALRLIMGPEWSGGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGEQPNHNTQEEE
>A0A0P9DTZ5|FEATURES|UNIPROT_deepARG|beta_lactam|QJ48_12835|antibiotic inactivation|1
MSKSKHSIVKICNKIALPLLFVPILLIGCAKAVNPPVTQSTEKTQAVVTSESDEFIQLEN
KFGARLGVYAIDTGTSRTIAYRPEERFAFASTYKALAAGAVLQQSSIANLDKVITYTKED
LVTYSPITEKHVETGMTLRDICDAAIRYSDNTAGNLLLKELGGPKGFETVLKKIGDNVTT
SARFETELNQAIPGDTRDTSTPIALATTLQAFTVGDVLSTDKRKLLTDWLRGNTTGAKLI
RAGAPEGWQVGDKTGAASYGTRNDIAIVWPPNRDPIIIAILSSRDKQDSAYNDDLIAQAA
KIAMDAFK
>AAZ79478|FEATURES|ARDB_deepARG|tetracycline|tetQ|antibiotic target protection|1
MRFDNASNVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITD
SMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEG
IQAQTKLLFNTLQKLQIPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLCMQTVVDGSVY
PVCSQTYIKEEYKEFVCDHDDNILERYLADSEIPPTDYWNTIIALVAKAKVYPVLHGSAM
FNIGINELMDAITSFILPPASVSDRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRI
NDSEKSIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGAEPCLIQGLSHQH
PALKSSVRPDKPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLL
EERFSVKVHFDEIKTIYKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESD
ISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYV
FRLALQQSGVDILEPMLYFELQIPQEASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPL
NTSKDYASEVSSYTKGLGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSMSLK
>A0A0S3K2C6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKLNNALLAILSLTSFVTFAKTELTVSSQLKSVVDDCAKGLINEYDIPGLAVAVTIDGKR
YFYNYGFADESKGSLVTNDTIFELGSISKTFAATLTGYAQEKGKLDMDDKVKDYIPELEN
SALGNTKLVHVATYTAGGLPLQFPSEVTNDAEMMQYYKTWKPEYEAGTKRKYSNPSIGLF
GYIGALSMKSDYTEMMETVILPELGMTNTFVDVPKDKLNNYAFGYSSEGNPVRVNPGILD
AQAYGIKSTSSDMLQYIEANMGQAQLNNDMENALEQTHIKYFNTDTFTQAVGWEGYDYPV
SLSQLLKGNSSDVILNAKPVQASESGTLGRDIWYNKTGSTGGFGAYVAYVPSEKIGIVIL
ANKNYPNAERVEAAYHIISSVVK
>A0A0D6SFY1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALLLGIVEGLTEFLPISSTGHQIIVADLIGFGGERFEAFNIIIQLGAILAVV
WEYRRKVFDIVVGLPRQRSAQRFTLNLLVAFLPAVVLGVAFADLIHHYLFNPITVATALV
IGGVIMLWAERRQHRTEADTVDEMTWKHALKVGCAQCLALIPGTSRSGATIIGGLVFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRHLFQSADLPVFALGFVVSFIFAMLAVRALLKF
IASHSYAVFAWYRIGFGLLILATWVFGVVDWSTAQA
>U7T8F3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DKATSGKYYIDGEDISDFTPDNLSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVD
HDNRMERAKKLLEKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGKIILADEPTGALDS
KSGIMVMEILNQLHEEGHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQREIKKELQED
KKSINNLKKNKFQVAKDQFFESFNMSVSAIIAHKMRSLLTMLGIIIGIASIVCVVAIGNG
SQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTDVDILEKQSYVDSVTPNSTSS
GTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALIDENTQKSLFGE
NENPIGKVILFNKKPLKIIGTVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
VKNDIDSQVAQKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVV
GGIGVMNIMLVSVTERTKEIGIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIG
WGFNSISKSFSMIFSGFSIVMAVLFSTLVGVIFGYMPAKNAAKLDPIEALSRE
>A0A080UIA4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWEIFVAAVLGIVEGLTEYAPVSSTGHMIIVDDIWLKSKSLMTPEAANTFKVVIQLGS
ILAVAIVFKDRILNLLGMKKNITSDQTKGHKLSIAQIAVGLVPATILGFLFEDYIDQYLF
SVKTVAFGLIAGAVLMLAADFMNKRKETTETVDRITYKQAIGAGLFQCLALWPGFSRSGS
TIAGGVMLGLTHRAAADFTFIMAIPIMMGASTLTLVKNWDSLNADLLPFFSVGFISAFIV
ALFVVRFFLRLINKIKLVPFAIYRIILGIVLLMIFF
>N8XWN6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWTRLWGAATGIVSGEPQGRRLGIGLILASIPIILIGLTFGQTVKELLFNNIAIAIG
LIVGGLIIIWIEKNPPQVRAQEVEDLTIKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIVGAGLLDLYQSYDVFTGTQDWVVLTVGLLVSFISALLLIRAL
VAYVAKRDFMIFAWYRIVSGLLILLFAYTGWTLW
>K5CKS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYSQKLVSIALALPTSAKARRFVLAVALAFLPAAIIGALAHDFIKTVLFETPMLICVVLI
IGGVILLAVDRMPLNPKYTDIMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGSLLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDGALIAVASSPLSSRVFLSFARSWIS
SRDGASRPSPGGASPSGRWDLSRFWS
>YP_001898234|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFAINVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
LGGFVILWAEWRERHRGETHDPRANALLEAAKAGAPRIETLDDLRISDAIKVGFAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKSRALLSADDLSIFA
VGFVAAFISAFFCVRWLLKFIATHDFRGFAWYRIIFGIIVLATAYTHLIAWQA
>R6LWF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIIKSIIFGIVEGITEWLPISSTGHMILLDEFIKMDVSDKFREMYLVVIQLGAIMAVV
LLFWWKIWPFCKENNYERHYVENKKADFLDNFRFIKQDIFIMWIKIVIACIPAVIVELAF
GNKLEEWFYNYKTVAIMLILVGIVFIIVEDKNKKNKPAVNKISDITYSIAFWIGMFQLVA
AVFPGTSRSGATIIGGLILGLSRTIAAEFTFYLAIPVMFGASLIKVIKFGLSFSALEAGI
LISGMLVAFVVSLFVIKFLMGYIKKHDFKVFGWYRIVLGALVLVYFAIA
>K0K0D0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MAVSIVEFPVGGPGAGPYGITVAPDGAVWFTEVHHGRIGRLDPAGGHTAFALPDPAGRPS
VPVVGPDGAVWFTESAGHRIGRISADGAVTAHDVPDAGPFGLTAGPDGALWCTAMNTGRV
GRITTGGEVAWFDVPGGGFPAMIASGPDGALWFALNQANAIGRVTTAGEVTTHPLPTAEA
APVGITATSDALWFVEIGAGQVGRITSDGRITEFPLPDRAARPHAIAAAPDGSCWFTEWA
SGRVGRITPDGAVETHALPGAEPHGVAVGPDGVVWVALESGTIARLTP
>R6NHJ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVVEIIKAIIFGIVEGITEWLPISSTGHLILVEQFLKFKEVSPEFWNMFQVVIQFGAILA
VVVLYFKKIWPFTKNKEKAIKKNGLLSYFDKNIMNLWGKILVGCIPAAIIGLLFDDVFEA
LFYNPFCIAIALIVFGIAFIIVENWRKDKKSAKEKSSQITYKDALIIGCFQLLAAIFPGT
SRSGATIIGGLLIGLSRPNAAEFTFYLAIPTMLGASLLKLVKFGFGFTSIELVVLLVGMI
ISFLVSLIVIKFLMSYIKKHNFKVFGYYRIILGIIVLTYFFFTKV
>A0A0C2RKX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLELHYWVAVIIGIVEGLTEFLPVSSTGHMILTQALLRIPEDNEIMKTFEVVIQLGAILA
VVVVYWKRILQLFGLAGRSAPAGKRKLNLLHILIGIIPAGLIGFLFNKTIEAKLFSPVTV
VLSLVVGGVLLIVAEKLPGRRTADTMDDITYRQAFYIGLYQILAVVWPGFSRSGATIAGG
MLSGVSRGASADFTFIMAIPLMFAATALSLLKKHDMFTPDVIGFFAVGFIVSFIVALLAV
VTFIKLVSRLKLTYFAYYRFIVAALFVLYFWVF
>YP_002451024|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVRGRKLAYFNICGVWIALNEEIHIPRKEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQERLNYYREDKPHMTFY
>E7REQ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEWFDLFKAIILGFVEGVTEFAPVSSTGHLIIVDDMWLKSQEFLGKYPANTFKIVIQLGS
ILAVVFVFWKRLFSLIGLYKIEGQQTNTRFNIVHVIIGMLPAIVLGFAFKDLIDDHLFGV
ETVIYALVAGAVLMIVADKFGPKKPTVNSLDDITYVQALKIGFVQCLSLWPGFSRSGATI
SGGVLFGLNHRVAADFTFIMAVPIMFGASLVSILKNWETLSMDYLSFYLVGFISAFVFAL
ISIRFFLKLIARIKLMPFAVYRLVLAAILAIIVFL
>M8DHR6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRVCIREYSIREASSGPYGITAGKDGEMWFTEQKGNRIGRIDANGEIVSYSIPTPNAGAM
SIIQNQAGDIWFTEYHASKIGRMSMNGHFIEYELPTENASPFGIAEGADGAIWFTQMGSG
KIGRVSQAGEVTEFELADPKSFPSFITPGPDDALWFTLNQKNAIGRITLAGEIQEYPIPT
PNSGPVGITSGPDGALWFVQIQGNKIGRMTVTGEVREFLIPTPNARPHAIVSGLHDDLWF
TEWGGNRIGQISTRGEIVEYEIPTQHAEPHGIALSPSGEIWFAEECNQIGRLGLIRE
>A0A0H3J7U9|FEATURES|UNIPROT_deepARG|bacitracin|uppP2|antibiotic target alteration|0
MDSTFILKAIIIAIVEGLTEFIPVSSTGHMILVGWAIDFRGEFAKMFEVVIQLGAIMAVV
VLYWKKIKESIVEFFKFIFTRGRKGKTGFRFGINVIAASIPMGITGALFYDKIKSKFIPE
AVIVGFIVGGVLLIIIEKVYINKAHKVESIDSITPVQVITIGLLQLLAVWPGMSRSASTI
MGGWIAGLSTPIAAEFSFFIAIPAMIGSSGKDLFEFDYSIMTPTLWIALIAGFIVAFLVA
LIVMKKFVDYLKKKPMKIFAVYRIVVGILLGVLVLIKIITLTE
>A0A0T9NE89|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLAFHDVIKSLFNPQS
VMYALVAGGLLLLAAEWFKPKNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISG
GMLVGVNRYAASEFSFILAVPMMLGASALDLYKSLHFLSWGDLPMFAVGFITAFIVALIA
IKTFLSLIKRISFVPFAIYRFIVAGAVYWVFM
>A0A0A0CVB0|FEATURES|UNIPROT_deepARG|beta_lactam|KS18_02580|antibiotic inactivation|1
MKHSPLRRSLLLAGITFPLINFAFPAWSSATPSSLHKQLAELENSTKGRLGVMLINTANG
QEIQYRGDERFPFCSTFKLILAAAVLHKSMSQPELLAKHIHYRESDLLSYAPITHKNLNQ
GMSVAQLCAATVQYSDNTAANLLIKELGGLEAVNRFTQGIDDPAFRLDRCEPDLNSAIPG
DLRDTTTPAAMAASVKKIVLGEVLGASQREQLIVWLKGNTTGDASIRAGAPAGWIVGDKT
GAGDYGTTNDVAVLWPPKGAPVVLAVYFTQPQQDAESRRDVLAAATRLVMAHLT
>A0A0A8F4N1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIRRLHEAGHTVIMVTHDPDIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A0D6IIG1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAVAVTVDGRQHFYEFGVVSKQTQAPVTRDTLFEIGSVSKTFTATLAGYAATRGVLNLDD
HPGRYLPALAGTPIDRAELRNLGTYTAGGLPLQFPESVTDDEQMIAYFQQFQPVTAPGKI
RQYSNPSVGLLGHISARALGGQFTDLMQSQILTGLGLRRSFVDVPDEAMDFYAWGYDKKN
HPVRVNPGVFDAEAYGVKSTTADMIRFIEHNIDPGALEPTLREAVKSTQVGYYKVGPMVQ
DLGWEQYPYPVALDQLLAGNSGEMAMSPQAATAIAPPSVGSALFNKTGSTDGFGAYAAFV
PERRIGIVMLANKNFPIPARVTAAHTVLDALDA
>A0A0M0WLB8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQGINHMCFSVSNLEQSITFYQKVLGAELLVKGKSTAYFNLNGLWLALNEEKNVPRSEI
QYSYTHLAFSITIESFDEAKELLKQHNVTILPGRSRDERDKKSLYFTDPDGHKFEFHTGT
LQDRLAYYQDEKPHMKFYSLKE
>ZP_04635098|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MKLPVAQYPTIAPPAITISANYPGADATTVQNTVTQVIEQNMNGIDNLLYMSSSSDSSGN
VQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVAGFISEDG
TMQQEDIADYVGSNVKDPISRTLGVGDVQLFGSQYAMRIWMDPHKLNNFKLTPVDVINAI
KVQNNQVAAGQLGGTPPVPGQELNSSIIAQTRLTNAEEFSQILLKVNTDGSQVRLKDVAI
VKLGAESYNIIARYNGKPAAGIGIKLATGANALDTSAAVKAELAKLQPFFPNGLKVVYPY
DTTPFVKISINEVVKTLIEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAILSAFG
YSINTLTMFGMVLAIGLLVDDAIVVVENVERVMQEEGLPPKEATKKSMEQIQGALVGIAM
VLSAVFIPMAFFGGATGAIYRQFSITIVSAMVLSVLVALILTPALCATMLKPITKGEHGP
STGFFGWFNRMFEKSTHHYTDSVANILRSTGRYLVIYLVIVIGMGVLFLRLPTSFLPEED
QGVFLTMVQMPAGATQERTQKVLNQVTDYYLDKEKDVVNSVFTVNGFGFSGQGQNTGLAF
VSLKNWDERPGDQNKVPAIVGRASAAFSQIKDGLVFAFNLPAIVELGTATGFDFQLIDQG
NLGHQKLTEARNQLLGMAAQHADMLVGMRPNGLEDTPQFKVEVDQEKAQALGVSISDINT
TLGSAMGGSYVNDFIDRGRVKKVYVQADAPFRMLPDDIDKWYVRNSTGQMVSFNNFSTAK
WEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMDLMQELAAKLPSGIGYDWTGMSYQERL
SGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAASLRGLNNDVYFQ
VGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLVESTLEAVRMRLRPILMTSLAFILGVLP
LVISSGAGSGAQNAVGTGVMGGMITATVLAIFFVPVFFVVVRRRFSRKSEDVEHSHAVDH
KAK
>B7NR12|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAILMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIIALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFIAPGRPVAAHEEIHHHA
>A0A108MXY6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKTLILGVVEGLTEFLPVSSTGHLIVAGSFLNFDDAHAKTFDVVIQFGAILAVC
WEYRRRITSVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILLAEARQRERGDAPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>ZP_03837173|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFRDFEAEEKLFQRRVIVAFGLVVICFGILIYNLYNLQICQHQYYTTRSNANDIKMLPV
APTRGMIYDRNGIPLVRNVTWYDISVTPYKIKDMDALIGQLTPIVDLTPDDIDQFRHELK
SSSRYRPVVLKNALTDVEIARFSVNQFHFSGVNINSYEDRQYPYGAALAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENELHGKTGYQEVEVDNHGRIVRLIKDVPP
VAGKDIHLTLDLHLQQYIESLLAGQRAAVLVEDPHDGSVLAMVSTPSYDPNPFVKGISYQ
DYNKLLQDKDLPLINRVTQGLYPPASTVKPYMAMSALLDGVITPQTSFFGAPTWTLPGTE
RHYRDWKKSGHGMLDVTKAIEESADTFFYQVAYMMGIDRINSMLSQFGYGKPTGIDLDEE
YNGLLPSREWKQKVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIVPHLL
LDEESGKTHTPYQAPEVPSQIASASSPYWGLVRQAMFGMANEPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAVALILENGGSDGVTAAP
VMRQIMDHLFVPQDNAAQTETTEQAGPIATAPPDAGIKNTYASIR
>A0A0I9QPZ9|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSLGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>A0A0D5XWV6|FEATURES|UNIPROT_deepARG|beta_lactam|PCL1606_21250|antibiotic inactivation|1
MHNKNLALPGFIAASLLAFGAGDCLAAAPRDSALKPLVDAAIRPLMQQQGIAGMAVAITV
KGQPHYFNYGLASREEKKAVDQDTLFEIGSVSKTFTATLAAYAQASGKLSLDAPASRYLP
ALQGSAFEHISVLQLGTYSGGGLPLQFPDQWDSQDKMLGYYQSWKPTFAPGAQRLYSNPS
LGLFGYLAAQSLGQPFAQAMEQRLFPALGLTHTYLQVPAAQQGHYAQGYDKDGKPVRVGP
GAMDAEAYGVKTSAADLLRFVQANLQPQALPQPWQQAIALTHTGYYQVEGMTQGLGWELY
PYPSSLDALLAGNSAQMAFEPHPTRWLNPPRAPQADTLLNKTGGTGGFGTYVLFVPGKDI
GLVLLANKNYPNAERVKVAHALLEALDKSAAVAGQP
>F1DI11|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
EAQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGG
PGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLSHALGETQR
AQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTN
>A0A0A0Q7Z1|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKSVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>C1CVN6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWVYAIVYGIVEGITEFLPISSTGHLILTGNLMGVPWSKEVKDAFEVVIQGGAILSVLV
YYWRDFLKIRHLGHDRSQQTLWTGVLVATIPAVVLGLAFGDQIQAVLFKPSVVAWALIVG
GVLMWLIESRRVQPQVHAIETIGVRRSLLIGVLQCLALVWPGFSRSASSILGGMALGLDR
PTATKFSFYLGVPTLGGAALLNLVKERELIFGEIGLLNVVLGAGVSFVVAYLAIGWLLKF
VSTNNFKGFAVYRVAVGVLILVLIATGVMSNGSLA
>X2L7X7|FEATURES|UNIPROT_deepARG|beta_lactam|act-16|antibiotic inactivation|1
LLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHYYTFGKADIAA
NKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLA
TYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGKTRLYANASIGLFGALAVKPSGMPY
EQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDM
ANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSK
VALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANK
>A0A0Q9FP13|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRINIEEYELPHIDSGPYGITTGKDGALWFTQHKANQIGRMTVDGKLTHIDLPTVNAGVL
SITSTAQGDIWFTENRVNKIGKLTVTGEITEYTLPICDSGPFGITQGYNGDIWFTEMNGN
RVGVISRDGEITEYDLPDPGSYPSFIVAGTDHALWFTQNQSNQIGRITLEGDVTTYNLPT
EKAGPVGITNGPDGALWFVEINGNKVGRITTSGVISEYPIPTPNARPHAIVTGPDDALWF
TEWGSNQIGRITVNGKITEYSIPTKNAEPHGIVVGSDQALWFAEECNKLGRLSFGQKP
>O86931|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRLWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A9R4E0|FEATURES|UNIPROT_deepARG|multidrug|mdfA|antibiotic efflux|1
MQTSFSPATRLGRRALLFPLCLVLFEFAAYIANDMIQPGMLAVVAEFNASVEWVPTSMTA
YLAGGMFLQWLLGPLSDRRGRRPVMLAGVAFFVVTCLAILLVNSIEQFIAMRFLQGIGLC
FIGAVGYATIQESFEEAVCIKITALMANVALIAPLLGPLAGAALIHVAPWQTMFVLFAVL
GAISFAGLWRAMPETASLKGEKLSVANMWRDYKQVLANRRFLCGSLALGFASLPLLAWIA
QSPVILISGEQLSTFEYGILQVPIFGALIIGNLTLARLSGKTSIPQLIRYGAGPMIVGLM
IAAGSTLYSSHAYLWMTAGLSLYAFGIGLANAGLVRLTLFASDISKGTVSAAMGMISMMI
FTLGIELAKVAYLWGDSRGFNLFNLMSGLLWLGLVMVFIRRQPEAVATE
>D6YR32|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MVNFKVSLTSLLLIATAGCSVSACAAFNQQTLTSQLETLESNSGGRLGLAVIDTADGSKY
AWRGNERFPLCSTSKVMAVAAILKKNERDPHLLDKKIHISKSDMVNYNPVTRKHIGSYMS
VAELSAAALQYSDNAAMNKLLSYLGGPQQATHFARTIGDKDFRLDRHEPGLNTAIPGDER
DTTTPSAMAESLKKVVLGTALKEEQRAKLSDWMKGNTTGSDSIKAGLPDDWIVADKTGSG
DYGSTNDIAVIWPKNHAPVILTTYFTQHDKDAATRKDVLASAAMLVADAVDK
>A0A0D0Q2G1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGSKLAYFNICGVWIALNEEAHIPRNEI
HQSYTHIAFSIEREDFECLIQRLEENDVHILQGRERDIRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFYSALTGSKPPIGEG
>A0A0Q9US36|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNMWEIFVAVILGLVEGLTEFAPVSSTGHMIIVDDLWLNSKELFGSEVANAFKVVIQLGS
ILAVVVLFWGRFMDLLGLRKLKGTSAGNGQKLNLLQIIVGLLPAGVLGLLFEDYIDDHLF
TMKTVIVGLFLGAFLMIAADKFRPKLTAETVDQITYKQAFGVGLIQCLSLWPGFSRSGST
ISGGVLLGMSYRAASDFTFIMAVPIMAGASLLKIVKYWDSFTPEVLPFFIAGFISAFIFA
LFCIRFFLILINKVKLTPFAIYRIVLAVVLLFIIW
>R4RZE1|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-155|antibiotic inactivation|1
LPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCG
AVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLL
LATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASTAATLRKLLTSQR
LSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERI
VVIYLRDTPASMAERNQQIAGIGAALIE
>A0A0B1XXS6|FEATURES|UNIPROT_deepARG|beta_lactam|PI87_26790|antibiotic inactivation|1
MFSRWSKTLALAITAGAFVMGAAQAHAELVARDDLKRVFDEAGVTGTFVLMDISGDRTYV
VDPARAARRIHPASTFKIPNSLIAFDTGAVRDDHEVIPYGGKPQPYKRWEKDMALPEAIQ
VSNVPIYQEVARRIGPARMQAYVDAFDYGNRQIGSVIDQFWLRGPLEISAFEEARFTSRL
ALKQLPVKPRTWDLVHRMLLIEKQGDAALYAKTGVATEYQPEIGWWVGWVERAGKVYAFA
LNIDMPHEADMAKRIPLGKRLMQALAVWPTP
>R5ZE29|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQTAQYIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLG
AILAVMVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNF
FVVAIMLVVYGIAFIWIEDRNRRVDPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGAT
ILGGIIVGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFIDGNTLTGGQAAILLVASVTAF
LVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLFYGAVKLIFG
>A0A077DHA6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDVWYFIKSAILGIVEGVTEFLPISSTAHLLIVGKWLSFDLDSFQLYAIVIQLGAILAV
IVLYRQRITELIVGFFTGRPSDRKLALNLILAFLPAACIGLLLNRYISQLLEGNFFVYAS
TLFLGGLVMLWVERHPVMSKAAQKDNEVAGKDLDKITWKQALVVGFAQCLAMIPGTSRSG
STIVAGMMAGIPRKVATEFSFFLAIPTMIGASTLSLIKQGAQLEVADHLYAVIIGFVLAF
VSALFVIRVLMRFLSQHSYRPFAWYRIALGLFVAVWAYWIL
>C7BQY7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNALLELQGITRSYPAGEEQVKVLDNVTLSIYAGEMVAIIGASGSGKSTLMNILGCLDKP
SGGEYRVAGQNIAELNNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAVYAGAAKTE
RRQRAIELLGRLGLEERISYRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMTILKQLCEQGHTVIIVTHDPKIAAQAQRIIEIKDGHIMSDSGSQLRKEVIKAQSVT
SKISSIRQIFGRFNEALLMAWRAMVANKMRTLLTMLGIIIGIASVVTILVIGDAAKALVL
SDIKEIATNTISVYPGEDFGSDDPVSKQALKIADVDAIKAQPYILAVSPVIEGGMRLRKG
NIDVAARVSGIGDEYFQVYAQRFAQGMNFTSDMVRRQGQVVVIDKNTQRKLFPHQKNVIG
EVILMGNMPATIVGVIAERKSAFGSDSSLHVWLPYSTMASRLMNRNYLDSITVRINDGHN
SKDAEQKIVQLLTLRHGKKDIFTYNTDMLIKTVEKTTRTLQLFLTMVAVISLIVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAILVCLVGGVLGIALSYMIAFIAQLA
LPGWRFVFQPVALLSAFACSTAIGVIFGYLPARNAARLDPIEALARE
>A0A0G1K8C4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDITAALILGLVQGITEFLPVSSSGHLVLVREFLVLDDANALAVDAVLHLATTAAISLYF
WNDIWVLIQTAIRKLGRLPVNEKDLTLLYALMIGTVPAVVAGLLLESMIEKHFTSSLLVV
AILFSAAIFFMYAEWRYYTKPPQGPLTVRRGLLVGCFQMMALLPGFSRSGATLAGGMLLG
MSRIESARFSFLLAIPITFGAGSKKLLELISLGGSVSWLPIALGAAVSFLVALVVIHFFL
DFIRRYSLWPFIWYSIVLSLLVGYVTLYV
>A0A0B4ZZ63|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
FAHFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVL
LCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAA
NLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLT
GELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKP
SRIVVIYTTGSQATMDERNRQIA
>ACB19549|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVHNPPAVEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDYGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A127S5T6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILVGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFAINVIVATIPAITLALIFGKTIKAHLFNPIVVASAFI
IGGLVILWAEWRERHRGETHDPRGNALLEAAKAGAPRVETLDDLRISDAIKVGLAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSADDLSIFG
IGFVAAFISAFFCVRWLLRFIASHDFRGFAWYRIVFGVIVLVTAYTHLIAWQA
>A0A085IA86|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETADTFEVVIQLGSILAV
VVMFWRRLFGLIGINFGRPPVHEGEGSGRLSLIHILLGMIPAVVLGLVLHDKIKSLFNPV
NVMYALIVGGLLLIAAELLKPKKPSAVGIDDMSYRQAFAIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWHFLTAADIPMFAVGFVMAFLVALV
AIKTFLQLVKRISFIPFAIYRFIVAAAVYVVFF
>A0A0U1YUF2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAREWQENKSWNVHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLELR
QAITKEVL
>A0A0M5JAJ8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGGG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>I3DZW8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELITILKAIILGFVEGLTEFAPISSTGHMIIVDDMWLKSKEFLTKYGANTFKVFIQLGS
ILAVVVAMKDRFIDLLGLGRRSKEGAEGQRRLKLSHVIVGLIPAGILGVLFEDYIDEYLF
STATVLIGLVIGAVLMIIADVFGGKNPKVHTVDQITYKQALIIGLIQCLSLWPGFSRSGA
TISGGVLTGLSHRAAADFTFIMAVPIMAGASGISLFKNIEYISFDAMPFFTVGFISAFVF
ALISIKFFFKLIDKIKLVPFAIYRILLALVIYIFYF
>K0TUP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVILELIKGIILGIVEGLTEFAPVSSTGHMILIDDMWLKSTEFLGSESAFTFKVVIQLGS
VFAAAWVFRERYFEMLHIGKYKAEPLDGVDQKPKRLNLIHIVVGMIPAGILGLLFDDVIE
KYLFSVPTVMIGLFVGAIYMIVADMYSKKVKNPKTVDQITYVQAFIIGLSQAIAMWPGFS
RSGSTISTGVLMKMNHKAASDFTFMMAVPVMLGASGLSLVKNIEFIHANQIPFYILGFLA
AFIFGLISIKLFLHLISKVKLLPFAIYRIILVIIIAILYFGFGIGHNITGA
>CAD60196.1|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ie-APH(2'')-Ia|antibiotic inactivation|1
MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFR
VIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLI
FEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DIATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKE
KAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKR
DIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNA
TTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTN
FGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD
>M1EUF7|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAMIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGGSEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>J7TQG0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDITSLLHALILGVVEGLTEFLPVSSTGHMIIVAELIGFTGDKAKTFEVVIQLGSILAV
VFLFWRRMFALIGIHFGRVPHEGQTQGKLNLLHIIIAMLPAVVLGLLLRDQIKSLFNPVN
VMYALVAGGILLIVAEVFKPKKVQATGLDDISYRQAFAIGCFQCLALWPGFSRSGATISG
GMLMGINRYTASEFSFILAVPMMMGATALDLYKSWHFLSNSDIPMFAVGFLAAFIVALIA
MKTFLSLIKRISFIPFAIYRFIVAAAVYVVFVH
>A0A126YMQ2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTLRAGRLFAAIVFSCTVSSVVQAADNTIQSEVDGVIQPLMKQYAIAGVAVGVIADGKPH
VFNYGLASVRPRKLVTGDTLFELGSVSKTFTATLAAKAQIDGDLSLSDRTSKFLPSLQNT
PFGDVTLLNLGTHTPGGLPLQVPDNVNSIDELMQYFRQWKPAYAAGTYRTYTNPGIGTLG
LITAKSMGQDFDTLMTQGLFPALGLQHSYINVPAARMKDYAQGYTKDDAPIRMKPGVLSS
EAYGIKTTAADMLRFLQANMNLVKLDPKLQRAITDTHTGYFDAGPMTQDLIWEQYPYPVA
LENLLEGNAPAMIMNATPVTQLKPAQPPRDDVWINKTGSTNGFGTYVAFIPEKRLGIVIL
TNKNIPNGARVTAAYRILESLADKAQTQ
>Q5M6A1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIMQTAQYIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIV
IQLGAILAVMVIYFKRLNPFQPGKTAREVQLTWKLWLKVVIACIPSAFFGLLLDDWMEAH
LSNFFVVAIMLVVYGIAFIWIEDRNRRVDPKVTDLARMSYKTAFYIGLFQVLSIIPGTSR
SGATILGGIIVGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFIDGNTLTGGQAAILLVAS
VTAFLVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLFYGAVKLIFG
>A0A105GQA3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILIFKTLILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRRRIASVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILLAEARQRERGEAPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>J8DHH7|FEATURES|UNIPROT_deepARG|beta_lactam|IGC_04560|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTSTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>G3BLK5|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-58|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGSVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>J7TTD1|FEATURES|UNIPROT_deepARG|chloramphenicol|IC3_00967|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMMLEEIHQKEIKFYPTFIYVISRV
INKHTEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGFFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNDGSRVM
LPVSLQVHHAVCDGYHASRFIEDLQELANTCNEWLK
>A0A0M7F131|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLP
VKAAAYELADNLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATQPNAGLRARDELVRDWPAMAGAWRP
>Q05857|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSYRLINV
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPLHDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>Q6U8D8|FEATURES|UNIPROT_deepARG|beta_lactam|BL2a_III2|antibiotic inactivation|1
MFVLNKFFTNSHKDCTRRITFMCKLIGCSNSNTPSEPPKQTKQTKQTKQIKQIKQENTGH
DSFAKLEKEYNAKLGIYALDTGTNQTIAYHSNDRFAFASTSKSLAAGALLRQNSIEALDE
GITYTREDLSNYNPITKKHVYTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILR
ETGDTVTKSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKR
NTTGDKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKKDAEYD
DKLIQTQLKSFRNSKGYE
>A0A0M0YD18|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEEQVEVLKGITLQINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDRDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVMAILHQLRDRGHTVIIVTHDPLVAAQAERVIEIHDGEIVRNPPAKHAVQGQGIQELT
VKTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLAAIQKQPWVTSATPAVSQNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNREQLNGRAQVVVLDSNTRRQLFPHKANVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKEGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTFTGVLFGWLPARNAARLDPVDALARE
>R5IKR0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIVEILKVIVLGIVEGFTEWLPISSTGHMILVDEIIHLNQPDAFKDMFLVVIQLGAILA
VAVMYFQKLNPFSPSKSARQKQATWALWIKIVIACIPAAVLGLLFDDWMEAHLYNAYVVA
ATLIIYGVLFIALENSSITANPSITKVGHVSTKTALFIGLFQLLSLVPGTSRSGSTILGA
MVLGCSRGVAAEFSFFLGIPVMFGASFLKLVKFFVKGNVLTGPQIFYTILGMAIAFGVSV
YSIQFLMGYVRRHDFKFFGYYRIILGVVVLAYFGITALAA
>C8C0S6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MSTRYKSNKLVASDGPGHPFAFYYGNDFMMKKSLCCALLLAAPFSTFAAPKTEQHIADIV
NRTITPLMKEQAIPGMAVAVIYQGKPYYFTWGKADITNNRPITQNTLFELGSVSKTFNGV
LGGDAIARGEIKLSDPVTRYWPELTGKQWQNISLLHLATYTAGGLPLQIPDEVTDKTALL
HFYQNWQPQWAPGAKRLYANSSIGLFGALAAKPSGMSYEEALTRRVLQPLKLTHTWITVP
QREQKDYAWGYHEGKPVHVFPGQLDAEAYGVKSSIIDMTRWVQANMDANQVKEKTLQQGI
ELAQSRYWRIGDMYQGLGWEMLNWPVKADSIISGSDSKVALAALPAVEVNPPAPVVKASW
VHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKL
>E8V735|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNVYLVSVILGIVEGLTEFLPVSSTAHLRLAEAALHINLADPYWKMYTIVIQLGAILALL
LLFLSKIIGFFRTFPTGERGEKTWLTHPITLTFIAFVCTAIPAKILSKKVGENLENLTVM
ALALLVGGIIMWIVDAWAARREPSTTHVEDLNIFQAVWIGLAQVLSAVVPGTSRSMATIA
SGQLAGMDRPTALEFSFLLSIPTMIAATGYSLLKALHPKAAESADTLTPLVIDAQGWIVL
IIGLAVSFVVAYVVVAWFLGWVRQRGFTIFAIYRILLGAGLLVWLHLHQ
>T1Z0T9|FEATURES|UNIPROT_deepARG|beta_lactam|bla(CTX-M)|antibiotic inactivation|1
PNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPAS
VTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQL
VTWMKGNTTGCSGAFRPGPPASWVCWGIKTRPAVANGTTNDIAVIWPKDRAPLILVHIT
>A0A0A1Q412|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIANLGKALILGLVEGGTEFIPVSSTGHLILLGHFLGFHSTGKTFEVLIQLGAILAIVL
VYFTRLLGVVLCLPTDAWARRFVVSVLVAFLPAAVLGAVLHGTIKSLFERPALVCLALIL
GGIVLLFVDRLKLRPTEDNAFRFSPMLALKIGLCQCAALFPGVSRSGATIVGALLMGTTK
RAAAEFSFFLAMPTMAGAFAYDLYKNYKLLDFSDISAIGIGFVAAFISGLFVVRFLLDYV
SRHGFALFAWWRIVVGVVGLAGLAMVG
>G5IGR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIVEILKVVFLGIVQGITEWLPISSTGHMILVDEFLKLDVTPEFMNLFLVFIQLGSILA
VVVIYWERLIPFTFKGGIKPDKEKFSMWFKILVASVPAGVVGILFDDVFTALFYNYVTVA
IMLILFGVFFIVIENYNKNRTPSVTSIPQITYRAAFWIGVFQMIAAVFPGTSRSGSTIVG
ALLIGISRTTAAEFTFFLAIPAMFGGSLLKLLKFGFSFTSGELMILFIGMLVAYLVSVVV
IKFLMEYIKKHDFKIFGWYRIVLGVIVLGYFFLAR
>A0A0P9IX57|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
LGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>ZP_04633951|FEATURES|ARDB_deepARG|beta_lactam|BL2e_y56|antibiotic inactivation|1
MKHSPLRRSLLLAGITLPLVNFSLPAWAVPTSDLLGNQLAELERNSNGRLGVTMINTANG
RKIQYRGTQRFPFCSTFKFMLAAAVLGKSQTQPGLLDKHIKYHESDLLSYAPITRKNLAH
GMTVSQLCAATMQYSDNTAANLLIKELGGVASVNAFARSIGDQVFRLDRLEPDLNTALPN
DPRDTTTPAAMADSMNKLVLGDALPVAQREQLTLWLKGNTTGANTIQAGAPADWIVGDKT
GSGDYGTTNDIAVLWPTQGAPIVLVIYFTQREKDAKPRRDVLAAATKIVLSHLSPAQ
>K2MI75|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDQTIIGALLLGILEGLTEFIPVSSTGHILLAGHFLGFESTGKAFEVLIQLGAILAILS
VYAARLWKILTDLPRDPGTRRFVLGVLIAFLPAAVVGVLAYKIIKTVLFETPMLICIMLI
LGGIVLLWVDRWAQKPRYTDITKFPLAMYFKIGLIQCLSMIPGTSRSGATIVGGLLLGAD
KRSAAEFSFFLAMPTMTGAFAYDLYKNHALLSAADLQIIAVGFIAAFVAALLVVRWLLGY
VSQHGYALFGWWRLIVGGLGLIALLAWG
>A0A0D5C9D4|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
PTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQY
SDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQT
LRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNHI
>C7BKE4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLSTLFHALILGVVEGLTEFLPVSSTGHMIIVGHLLGFTGDKAETFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGEVPHEGKTNGKLKLSHIILAMLPAVTLGLLFHDTIKSLFNPQS
VMYALVIGGVLLITAEILKPKTPTAEGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVNRYTASEFSFILAVPMMMGASGLDLYKSLHFLTAADAPVFAVGFITAFIVALIA
IKTFLTLIKRISFIPFAIYRFIVAAAVYWVFI
>F4V433|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>YP_001438541|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|0
MTALLELRDIRRSYPSGETDVEVLKGVTLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVATLNDDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAIYAGTGRAA
RQARARELLARLGLEARVGYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVIATLKQLRDRGHTVIIVTHDPDVAAQAERIIEIRDGEIISNPPPVGKRDAARLPAQP
QDAPAFGQFINSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
EDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQAIQRQPWVSSATPTVSQNLRLRYG
NVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRAQVVVIDSNARRQLFPNKANVVG
EVVLVGNMPATVIGVAEEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSITVRVKEGYD
SSEAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARKSDVLQQFLIEAVLVCLVGGALGIGLSLLIAFALQLI
LPGWEIGFSPVALLTAFLCSSATGVLFGWLPARNAARLNPVDALARE
>A0A0D1M7Z6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDPTALVAPVVLGIVEGLTEFIPVSSTGHLILTERLIGYEGRQAGIVDVVIQVGAILAV
CWLYRAKLWLVVTGLKGDAGARRFSRNVLIAFIPSVIVGGLAHDFIKQVLFSPYVVVVSL
VAGGIAIIVIERWAKRRAVVAGDVEHLSPSLALGIGLCQLLSLIPGVSRSGATIMGGVAL
GVERRAATEFSFFLAIPTMFGAATLDLYKNRDIIGVDDVMAIGVGLVVSFVVAMAVVRWL
VRYVGRHGFEPFGWYRIVFGFVVAGLLASG
>A0A075LPX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIIEFFSALIMGLVEGLTEFAPVSSTGHLIIIDDMWLKIHELFNNEVANTFIIVIQLGS
ILASVIVFWDKFMQILGIRKLQGKTESMPGKQNKFNLGIVIVGLLPAGVLGLLFDDVIDK
YLFSVWYVIVALVVGALFMIFADKVSSKKTETIDSLDGLTYKKAFLIGLFQCISLWPGFS
RSGATISGGVILGLNHRVASDFTFIMAVPIMAGASLVSLRNHLHAFTPDVIPFFIVGFIS
AFVFALIAIRTFLKIISKYKLVPFAYYRIALAIVIVIFLIIN
>E0WRE4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSQIESIQKVSIVIPVYNEQESLPILLARTSAACQLLTQPYEIILVDDGSTDDSAAILTR
AADAADSAIIAVILNRNYGQHAAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVKVAEEG
YDVVGTIRENRQDSWFRKTGSRLVNMMIQHATGKSMGDYGCMLRAYRRHIVEAMLSCHER
STFIPILANTFARRTKEITVRHAERSFGDSKYSLMKLINLMYDLVTCLTTTPLRLLSALG
SMIAVSGFMLAFLLVILRLIFGSVWAGGGVFTLFAILFMFIGAQFIGMGLLGEYIGRIYH
DVRARPRYFIEKIVRAKSAETIHKKEQPCQEKEQ
>A0A077SF84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGTLEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWSLATGLGERASRDYVLKVGVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWADVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRMLLGAALLLWLPAAAG
>A7ZZ10|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLLSAPRLGKLGDRIGPEKILITALIFSV
LLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIG
NVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>A0A0R2KCP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKKIAMIVFVTKQIAYIFNARKDQFLLDIIKSIILGIVEGITEFLPISSTGHLVLVDEFI
KMQQPKQFTDMFNVVIQLGAIMAVVVLYFHKLNPLSPKKTGREKKSTWNLWLKVIVAVLP
SAIIGLPLNDWMDEHLMNWAVVSATLIIYGILFIIVENRNEKKKSDLHARYSDLDSLPYS
IALFIGMFQVLSLIPGTSRSGATILGAILIGASRYVGTEFSFFLAIPTMFGASLLKIVKF
FAKGGSLGGEQGVILLVGMVVSFVVAYMSIRFLMNYIKNNDFKAFGWYRIILGALVIGVN
LFLL
>YP_905232|FEATURES|ARDB_deepARG|aminoglycoside|Aac2Ic|antibiotic inactivation|1
MHTEVHTARLVHTADLDSETRQGIRQMVTAAFAGDFTDHDWGHALGGMHALIWHRGAIIA
HGAVVQRRLIYRGSALRCGYVEGVAVREDWRGQGLATAVLDATEQVIRGAYELGALSSSA
GARRLYTSRGWLPWHGPTSVLSPTGPTPTPDDDGTVFVLPVDASLDTSAELMCDWRAGDV
W
>A0A017IGX2|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSLCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGITGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMLLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADNYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQIATGSIAP
ILTLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISAHYGFRAVFLVTAGVVLFNAVYSWNSLRRRRLPQVSN
>A0A0K2ZR93|FEATURES|UNIPROT_deepARG|aminoglycoside|XTPLMG728_1044|antibiotic inactivation|1
MSDGYSIRAAVAADLRAWAALRVALWPDESDAFGGVVEALQREDAANFLAFAGDGHAIGF
ADVTLRQDYVNGTDSSPVGFLEGWYVVPEWRGRGVGRALLRQVQDWTRAQGCSELASDAL
LDDAAAQAAHRACGFEESERVVYFRMPVAD
>A0A0A0Q8Q6|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-5|antibiotic inactivation|1
MRDTKFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A0B4ZVF4|FEATURES|UNIPROT_deepARG|aminoglycoside|str|antibiotic inactivation|1
MNRTNIFFGKSHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>YP_002409908|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIKISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KNNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVIGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>A0A120EBT6|FEATURES|UNIPROT_deepARG|beta_lactam|AWW70_26290|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKVGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRSGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVIVKALR
>ZP_03749779|FEATURES|ARDB_deepARG|beta_lactam|pbp2b|antibiotic target alteration|1
MLIKNEYKPQMLSGTTKTKKPLTSNGRIGLVLGAVALAFTGLLVRGVYLQTSQHEFLKNQ
GDQRFVRTLPLPASRGMITDRNGATLALSAPTESLYAMPSGMEEMPTDEQLEKLSAIADV
PVEVLKNKLSKKDKGFIYLKRQLSYEKAEEIKALGIKGIAFQKELKRHYPMGNLFAHVIG
FTNIDGKGQEGLELSREDSLRGEDGAKVVLRDNKGNIVDSLDSPRNSVPKNGQDMILSLD
QRIQTLAYDELNKAVAYHKAKAGTVVVLDAQTGEILALVNSPAYDPNQPGQANSEQRRNR
AVTDMIEPGSAMKPFTIAKALDSGKVDATDTFNTLPYKIGPATVQDTHVYPTLDVRGIMQ
KSSNVGTSKLSAMFTPKEMYDFYHDLGVGVRMHSGFPGETAGLLRSWRRWQKIEQATMSF
GYGLQLSLLQLARAYTVLTHDGELLPVSFEKQAVAPKGKRVIKASTAKKVRELMVSVTEA
GGTGTAGAVDGFDVGAKTGTARKLVNGRYVDNKHVGTFIGFAPAKNPRVIVAVTIDEPTA
NGYYGGVVAGPVFKEVMSGSLNILGVSPTKPLSNTATVKVPS
>ZP_04055725|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTILESIILAIVEGLTEFLPVSSTGHMILTQGALGMESTPFLRAFTVMIQFGAILSVVVL
YYKRFFTFRVEEGARQLPQGWQWVGRFSFYIKLLVGLIPAAVIGLLLEKQIDQLLDNVYV
VATTLFLGGIFMLFIDRIWPAQSQTAERPSYRNAFVIGCFQTIAMIPGVSRSMATIVGGL
QQRLTRRAATEFSFFLAVPTMLGATLLKGYKLLSDPVSSQMLQENWMALLVGNVVAFVVA
LLAIKFFINYVTRYGFKLFGYYRIVVGLLVLILLLCGVPLAMH
>A0A127SUJ1|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
FDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTILNRHEEFRTALDKNGQVGV
FSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAYGERKGMFAKPNPPENTF
PVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYHIPLSIQVHHAVCDGFHICR
FVNELQELINS
>A0A127KWU9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGTQALLDAGFEVAAIFTHPDSANENHFFGSVARIAAERGIPVYAPE
DVNHPLWVDRIRDLNADVIFSFYYRNLLCDNILNSARLGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVARADAGAIVAQQKVAIADSDDAMSLHRKLSEAAQTLLRSTLPTI
KAQTFTETAQDDSKASYYGRRTPEDGRLDWELPAQTLHNLVRAVSDPWPGAYSFAGTHKF
IVWKSRVRNDIAAARAGTVLSVSPLVVACAEGALEILTGQVDNGVYMQGGQLAQSLGLVA
GALLTSKPVVAVKRRTRVLILGVNGFIGNHLTERLLNDDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKVFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKEGRCDGQIINIGNPENEASIKELAEMLLASFEKHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLHWEPKVDMRQTIDETLDFFLRTVELSDEKN
A
>A0A0J7GBB8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEKSIIFYEKVLEGELLVKGRKLAYFNICGVWVALNEETHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCKSIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMTFY
>C3MCT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQKLLSIALALPTSVKARRFVFSVLIAFLPAALIGAAAHGFIKAVLFETPMLICVVLI
VGGVILYAIDRLPLQPRYTDVFDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALSFDDIGVIAIGFIAAFVAGIVVVRSLLDF
VSHRGFTPFAIWRIVVGTAGLVGLWLVG
>A0A117UKN3|FEATURES|UNIPROT_deepARG|chloramphenicol|AOQ70_18255|antibiotic inactivation|1
MFKKIDENYPRKEHFHHYMKVTRCSYSLVIDLDITKLHSILKEKKLKVYPVQIYLLARAV
QKIPEFRMDLVNDELGHWDLLHPSYTILNKETKTFSSIWTPYDENFARFYRSCVADIEAY
SESNKLFPKPHMPENMFNISSLPWIDFTSFDLNVSTDETYLLPIFTLGKFKVKEGKIILP
VAIQVHHAVCDGYHAGQYVEYLRWLIEHCEEWLDDSLGKS
>J1ELD1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLVLLAKAALMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIRATLVALPRERSAQRLVLNVLIGFLPAVVLGLLLGKAIKAHLFIPVVVASTFI
LGGFVILWAEKRPAGATRIHEVDDMSPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAMPTLIGAGVYSLYKERALLSVADIPMFATGLVFSFFSAWLCVRWLLR
YISSHSFVPFAYYRIVFGMVVLITAWGGWVRWAE
>A0A147GE02|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNMNVQPTTPLCQAAGQGEPLLCLEGVTRSFQAGERAFLALKGIDLQIHRGELVAIIGAS
GSGKSTLMNILGCLDNASAGSYRVDGQQTRDLDADALAALRRDHFGFIFQRYHLLPHLDA
LHNVEIPAVYAGMDLQRRHERAQTLLSRLGLGEHLRHRPSQLSGGQQQRVSICRALMNGG
QVILADEPTGALDSASGKEVMKILLELHAAGHTVILVTHDPQVAAHAERIIEVSDGQIVS
DRRKAAETVPARAVAPTPARPGGHRLLASLGMFREAFKMAWLALVSHRMRTLLTMLGIII
GITSVVSISAIGEGAKGYVLKDIQAIGSNTIDVYSGSNFGDSRARNIETLVPADVAALNA
LYYVDSATPVIGQGTLVRYRNLDVDVQLNGVSEHYFQVRNIPLAAGIVFSAEDARRQAQV
VVIDHNTRERLFGPAIDPLGQVILVGNLPCTVIGVTARNKNLFVASNQLNIWVPYETAAG
RVLGQRHLDSISVRIKDGVPSTRVEEEVSRVLLQRHGSKDFFTNNLDSIMQTVQKTSRSL
TLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQVDIRQQFLVEAVMVCL
LGGLVGVGLSYAVGYLFELFVKQWEMVFSPASIVMAFACSTLIGVVFGFVPARNAARLDP
IEALARD
>R9LBC0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFIVSIILAIVEGLTEFIPVSSTGHMILTAKLMGYDDQSPEMKTFEIVIQLGAILAMAW
VYRERILNLLGLSKKITVVDLNAPKGRLNLIHVLLGIAPALVVGYIFRDFIKSLFSSQTV
LWALVVGGIFMIFAEWFNKNKAVVTAQEMDQLTYKQALLIGLYQCISVLWPGFSRSGSTI
AGGMLSGASYKAAADFSFFIAIPIMCAVSAYEMLDSYRYLTSETIGYFLIGFVVAFVVAY
VVVLAFLKLIQKVQLRHFAYYRFILAALFWIFIMR
>B8ZHY1|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQIL
YRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTL
AELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERD
TSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGD
YGTTNDIAVIWPEDHAPLVLVTYFTQPHA
>A0A0J1K3A2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRVAISPDDVALTLHHKLCQAARQLLEEALPAI
KTGDYAEHPQQEAEATCFGRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCKNDRTAQPGTVISVSPLLIACADGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTAKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAISRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPENEASIQELAEMLLTCFEKHPLRNHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>A8ESX3|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MEYKKFDINSWNRKEHFEHYRNLQCSFSLTSEIEITTFLQYLKENKYKFYSSIIYLISKL
VNSTFEFRMSIKNNEIVTWDVLHPSYTIFHQKEETFSSIWSEYSDDKTIFFDEFEKDCTN
YENNKSLFPKFNIPENHFNISCLPWIKYSGFNLNLPHLNDYFQPIITIGKYDKNENKIVL
PVTIQIHHAVCDGFHVAKFINKLQEWCNEPEKYL
>J8Y0C4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVV
GAILMLFAEAKKAEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIAIPVMAGATGLDLLKSWKYLSVDDIPMFAVGFITSFLVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0C2Z080|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFDAIIIGTIEGFTEFLPISSTGHMIVASDFLGIEQSKLIKAYEVIIQLAAILAVMIL
YRDKLKPSQIVLWQKIMVAFLPLAIIGYLFKDPIKELFSIEIVAWMFIVGGVIFLIVEYF
YKEEKAHITNVDELSYKQALWIGIAQLFSFIPGTSRAGATIIGGMLLKMDRKSSAEFSFL
LAIPVMGAVSGYDLLKHYQDFIGIDYTPFVVGFVVAFVVAYITIKLFLAFLARFSFVAFG
IYRILFGIVLLAFYL
>W4S7C9|FEATURES|UNIPROT_deepARG|aminoglycoside|XPU_4042|antibiotic inactivation|1
MRAAVGADAQALLALRLALWPDADDGVAELQAALAQADASHLLVVDDADAALGFAEASVR
HDYVNGTESTPVGFLEGWYVSPAWRGRGLGRALVAAAVEWTREQGCTELASDARLDDSGA
QAAHAACGFEPTERVVYYRLQLA
>A0A0E1ZMA7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLYALILGIIEGLTEFLPISSTGHMILGTTILGIDIDEFWKSFLIIIQLGSILAVIFV
FWRKLFQGLDIWLKLAVGFFPTGVIGLFVAKYLNALFNGWVVVGMLIFGGVVFILIELAH
KNKQYRINSLEEISFKQAFCIGIFQSLAMIPGTSRSGASIIGGLLLEFNRKVAAEFSFLL
AIPTMIIATAYSIYKEPELLGNANSLIPLGIGFITAFIVAVLVIKFFLKFISKFDFIPFG
IYRIILGFVFFYLYYSGILNAGSEFKL
>B2CD76|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
GNHYSALTLGTELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRV
AGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERIQQ
I
>A0A0G6BQK6|FEATURES|UNIPROT_deepARG|aminoglycoside|neo_3|antibiotic inactivation|1
MDEHNATTDGMPLPLAWQKALADARIERQSMGVSRADVARVLRPGRPDAFLKSELIDAFS
ELGDEIARLRWLQAQGQPAPTVIATAEEAGRHWLLMSALPGRDLASSPELAPQQRVEILA
DALRGLHALPVAACPFDQRLASRLPAAQARVEAGRVDADDFDDERLGQSPQQVFAQLCST
RPDHEDLVVSHGDACLPNLMVAEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VTPLFQRYGAVADERRLAFYRLLDEFF
>A0A0N7AKL8|FEATURES|UNIPROT_deepARG|beta_lactam|blaCphA|antibiotic inactivation|1
YYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNA
YWKSIGARVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKL
RAFYAGPAHTPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIK
TVVGGHDSPLHGPELIDHYE
>A0A073KAU5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTEGPSLNLLHIIIGMIPAGILGVLFHSTIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSAADLPLFASGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>Q6D2F0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACRKIGKPWEIILVDDGSNDRSAELLTEAA
SDPEKHIIAVLLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYASQGYD
VVGTVRANRQDSLFRKLASKTINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVLHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFFGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLTTSLRDEEE
>Q0PJ59|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
FLTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVT
QQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAG
GLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMT
RRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQ
ANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGRDSKVALAA
LPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANK
>YP_001116030|FEATURES|ARDB_deepARG|multidrug|OpcM|antibiotic efflux|0
MLEDNKMDNMHNTNGLVRVAKLAAASTLLATLLAACAVGPDYKRPDVATPAAFKEAPTLA
AGEQAGTWKTAEPADAEHRGEWWKVFGDPVLDALESQALAANQNLKAAAARVEEARAATR
TARSQWFPQVGVGFGPTREGASSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVSRNV
EASRADQAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYRRTVELREEALKLVQRRF
NEGDISELDVSRAKNELASAQADAVGVARRRAASEHALAILLGKAPADFAFKETPIVPVA
VKIPAGLPSALLERRPDVAAAERAMAAANARIGLAKSAYFPKLDITGAFGYEASTLGDLF
LWSSRTFLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNL
ADLRLLDDQIRAQDAAVNASRRSATLSRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTG
AQAVSTVNLIRALGGGWGPAPTAVGDAATGKAEVAAR
>A0A0D8DUP0|FEATURES|UNIPROT_deepARG|beta_lactam|PL79_26640|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLVLTVSACASPPAAGQDVSSATSFAALERAAGGRLGVCAIDT
AGGRRVQHRADERFPFCSTFKAMLGAAVLAQSVERPGLLQQRVDVAQSDLVNYSPVSGKH
VGTGMTVAELCEAAIQYSDNSAANLAMKLIGGPSAVTAFARSIGDDTFRLDRWETELNTA
LPGDPRDTTTPAAMAASLRVLMLGDALPPAQRAQLVAWLRGNKVGDKRIRAGVPAGWQVA
DKTGTGDYGTTNDAGVIWPPSRAPIVLAVYYTQARADAKAKDDVIAAAARIAVAMFA
>V5R1F0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDENTLFEIGSLSKTFTATLASKAQQDGKLDFSAPASQYLPALKGSAFDHVTL
LNLATHTAGTPLFVPDAVKNTPQLMDWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALD
KPFSEAMEQGLLRDFGMTHTFINVPDAAMGDYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEQEVAPGWRQAINATHNGYYRSGEFTQGLMWEYYPWPSPLSRLVEGN
SSQRIMKGLATXAIVPPQPAPQAAWYNKTGSTNGFSTYAVFIPEKRIALIMLXNKWFPND
DRVKAAYAIIQELDK
>A0A0E1J7Q2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRQSRAAAPKEALP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTRVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A127GZM9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKSVQTILNQVRLTALIAASLISATVQAADSNDRLKITIDKQAKLLMKEHNIPGMAFGV
IIDGKSHFYYYGLADKKAGKPVSENTIFELGSISKTFAATLASYSELNGTLALEDTADKY
IPYLKNSAIGNTRLINLATYSTGGLPLQVPDEVENNKGLLRYYKSWQPVFPVNSKRLYSN
ASIGLFGYISALSMDSDYTQLMEEKTLPSLNMPNTFVNVPNDKMADYAFGYNAAGEPIRV
NPGMLDAEAYGIKSTISDMTHFMAANMGLVPLDKDIQQALDNNRKGYYQASTFTQGLGWE
MYPYPTKLDTLLEGNSMDVVLKPQTITTDNHPTPVLNNVWVNKTGATNGFGGYIAYIPAK
KSGIVILANKNYPNTDRVKAAYKILESSMTH
>A0A0L0GR96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
FWRRLFGLIGIHFGQRPHEGFGKGRLSLIHILLGMIPAVVLGLVFHDTIKSLFNPVNVMY
ALVVGGLLLIAAECLKPKEPRAQGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGML
MGVSRYAASEFSFLLAVPMMMGATALDLYKSIGFLTTGDIPMFAVGFVTAFIVALIAIKT
FLQLIKRISFIPFAIYRFIVAAAVYAVFM
>A0A099SH18|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLIEILKAIILGIVEGVTEWLPISSTGHMILVDQFIQLNMSEAFKEMFFVVIQLGAIIS
VIVLYWKKLIPVSFTKKASIKYDTIILWLKILTACLPAAIIGLLFDDQIDAQFYNYQTVA
VTLILYGILFIVIENRNSKLRPRINNLAQITYKTAMIIGVFQVLALIPGTSRSGATILGA
ILIGTSRTVAAEFTFFLAIPIMFGASLLKILKFGLVFTNAELVILLTGMVVAYIVSILSI
KFLVGYIKKNDFKAFGWYRIILGIIVLLYFFIMS
>A0A133I2Q5|FEATURES|UNIPROT_deepARG|aminoglycoside|WS73_11565|antibiotic inactivation|1
MTHSLAHFTIRAAEASDDDAWRRLRCALWPHADDAAHARDIARQLGAPDRHACFIASAAD
GAALGFAEVAVRRDYVNGCDTSPVLFLEGIFVAPAARRRGVARALCSAAAAWGEARGCAE
FASDAPLENAASHALHRALGFAETERAVFFRKALQRRRGGLSG
>G0AI93|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MPGRYHSPRRLISFLLLLPHYMDIILALKVLIMGLVEGFTEFLPISSTGHLILAGSLLDF
TADITREKAEVFEIAIQAGAIFAVCWEYRARIGAVLRGLTSDPKARKLVVNLVIAFVPAA
LLGLFFSKMIKEKLFAPLPVAIALIVGGFIILWVERRNKGGDRVARVESVDDMSALDALK
IGIAQAFALIPGTSRSGATIIGGMMFGLSRKAATEFSFFLAIPTLFAATIYSLYKDRALL
SAADIPLFSIGTIAAFVSAFLCVRWLLRYISSHDFTAFAWYRIVFGLVVIVTGYTGWVNW
TH
>A0A0K0SAS1|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKKNTLLKLGVCVSLLGITQFVSTISSVKAEQKLEQIVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTSKGLVLVDSSWDNKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGITALKERGIKAHSTALTAELAKNSGYEEPLGDLQTITSLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGH
GEVGDKGLLLHTLDLLK
>YP_002038873|FEATURES|ARDB_deepARG|aminoglycoside|APH(3'')-Ib|antibiotic inactivation|1
MRDRPEHNRCKSIATRFFSQVEPPPRFIRKLKEPPLNRTNIFFGESHSDWLPVRGGESGD
FVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAI
PGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPD
FLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDL
GRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLT
WG
>E1A688|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEVINWQEEQEGACLVITAIPGVPAADLSEADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A0D0JQU8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPLLRLRNLSRRFMAGDREFNALRGIDLDIHAGELVAIIGASGSGKSTLMNILGCLDHAS
AGSYQVKGQETRSLDDDVLAALRRDHFGFIFQRYHLLPHLDAVRNVEIPAVYAGTPQVAR
DQRAEALLTRLGLGGHLEHRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSASGR
EVMSILRELHAAGHTVILVTHDPKIAEHAERVIEVSDGQIVSDRRHAPGVREAPLQQIQA
APRRGWVASLGLFREAFAMAWIALISHRMRTLLTMLGIIIGITSVVSISAIGEGAKRYVL
KDIQAIGSNTIDIYAGSNFGDSRAKSIETLLPADVTALNQLYYVDSATPVVGRSMLLRYR
NLDVDAQLNGVSSRYFQVRNLRLAAGISFSDEDARRQAQVVVLDHNTAQRLFGADVNPLG
QVILVGQLPCTVIGVTADQKNLFIAGNTLNFWMPYETAAGRVLGQRHLDSISVRVKDGMP
SKAVEERINALMLQRHGTKDFFTNNLDSVMQTVDKTSRSLTLLLSLIAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAIMVCLIGGVIGIALSYGIGYLFTLF
FRQWEMVFSPLSVITAFACSTLIGVLFGFVPARNASRLDPINALARD
>A0A0C1U6M3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLILLLKAIVIAIVEGITEFIPVSSTGHMIIVGDLINFKGSFANLFEVVIQLGAILAIL
VLYWEKIISSIKGFFTGKPCGVKFWINIFVACIPVGILGFAFEDLIDKYLFNSLTVAMGL
LVGGVLMLIAEKNFKKSLKTVDIDDITTKQALKVGIFQCLALWPGMSRSSSTIIGGWVSG
LSTVAATEFSFFLAIPAMVGASGVKLIKYGGNLVLGEILTLTVGFIVAFLVSLVVVDRFI
NYLKKKPMKVFAIYRIMIALFLFALVFMNIISI
>A0A0M2VYH0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIMFMKAIILGLVEGLTEFAPVSSTGHMIIVDDMWLQSEEFLTKYVANTFKVVIQLGS
ILAVVVVFWERFMDLLHIKRKKPEQGAPAGTGRLKLGQVIVGLIPAGVLGVLFEDYVDEY
LFSTETVLIGLVAGAILMIIADKFSSKQPKVVTVDQITYKQALSVGLVQCLSLWPGFSRS
GSTISGGVLLGMSHRAAADFTFIMAVPIMFGASFLSLVKNLEYFTMDALPFFIAGFVSAF
VFALISIRFFLKLINKIKLVPFAIYRIVLAVVIYLVWF
>S5U6H8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALKFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFRKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AAD21213|FEATURES|ARDB_deepARG|bacitracin|bcrA|antibiotic efflux|1
MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQ
IEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIV
GLQHETKKLVGKFSLGMKQRLGIARALLHYPELSILDEPTNGLDPIGIKEMRRLIHSLAK
ERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVV
LMEQHSDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLI
GGGTIG
>V2TJX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILLFKAAIMGLVEGVTEFLPISSTGHLILTGQLLDFWTPEKRDMFSVAVQIGAIAAV
IYQYWNKLWGALIGAVTGDEQGRRLSINLIVATIPIMAVGLTFGETVKSYLFNAITVAVA
LIIGGFIILWAERRQHKTVSHEVEQLTFKQAALIGLIQCFALVPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHDLHIEDMEILGAGIIVAFISALLVIRALI
RYVSKHDFSVFAYYRIVFGLFILVTWWTGWVNW
>YP_002706078|FEATURES|ARDB_deepARG|multidrug|smeF|antibiotic efflux|0
MPAAGRHHLLPSGSTDGSHPMKSASLFLSIAAALALAGCSTLVPKNTAVAPAIPAQWPAE
ATQGQVADVAAVGWRDFFTDARLQQVIDQSLQNNRDLRVAVLNVERARGQYRVQRADRVP
GVAVTGQMQRQGTDAGVTEQFSAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQ
LSLVAETATAWLTYGADAQRLKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVE
TARTDAARLRGQLAQDRNALALLAGGQLDPSLLPDSIEPQLLALAPPPAGLPSDVLLQRP
DIMAAEHQLLAANANIGAARAAFFPSISLTGSIGSGSSELSNLFDSGTRVWSFLPKITLP
IFQGGKLRANLAIANADRDIALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLVDAA
EQANRLSQARYDAGLDSFVTLLDARRTAYNAQQTQLQAQLAQQANRITLYKVLGGGWHER
S
>ZP_02827405|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLMVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>A0A073HMA8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>ZP_03044893|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIADDLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPASPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0A3AJI5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNINLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
TSGSYQITGKETAKLSTDQLSELRQQRFGFIFQRYNLLSTLTAQENVALPAVYTGMAKEQ
RLQRASQLLEKLGLSHKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMKILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDHRQSLQITVREITQTT
TNRGWQFYRDQFFEALNMSINAIIAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
NAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
AAEKNVTALLLSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGVRMAIGAKQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMS
EFTMLFSTFSIVVAVLCSTLIGIIFGYVPAKNAAKLNPITALSQE
>ZP_01363657|FEATURES|ARDB_deepARG|multidrug|oprJ|antibiotic efflux|0
MNEMRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSF
IVDAELRRLVGVALDNNRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADL
SAGNRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQ
AYLSYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERN
LRQKQQAFNALVLLLGSDDAAQAIPRSPGQRPKLLQDIAPGTPSELIERRPDILAAEHRL
RARNADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSWSFLPTLTLPIFDGGRNRA
NLSLAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKA
RYESGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGG
RS
>R5Z5U5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEFIEWLKVVFLGIVEGITEWLPISSTGHMLLVDEFIKLNVSDAFKDMFFVVIQLGAIL
AVVVIFWNKMWPFQMPKESQSIIKKDRFSLWFKVVVSCIPGAAVTLLFDDYVEAHFHTPV
VIAIALIFYGIAFIIIENRNKNKVARINTLEEISYKDAFLIGVFQVLSIVPGTSRSGSTI
IGGLLMGISRVAIAEFTFFMAVPVMFGLSAIKIIKFGFNFTHTELAILIWGMVIAFTVSI
IVIKFLMSYIKKHDFKIFGWYRIILGIVVLAYFL
>J9RT00|FEATURES|UNIPROT_deepARG|beta_lactam|oxa-1|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASQLFEGTEGCFLLYDASTNAEIAQFNK
AKCAAQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVRNSAIENTIDNMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>A0A0C1Z5F9|FEATURES|UNIPROT_deepARG|beta_lactam|M445_07545|antibiotic inactivation|1
MKKLFLLLGLLVCSSATYAAKLNEDLSAIEDHITGRIGVSVWDTQTGEKWDYRGDERFPM
MSTFKTLACATMLKDMDSEKLEKNATAKVEERNMVVWSPVMDRMAGQTTRIEHACEAAML
MSDNTAANIVLRSIGGPHGVTRFLRSIGDKATRLDRFEPRLNEAKPGDKQDTTTPNAMVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAM
IWKENHKPVYISIYITETDLSLQARDQVIAQISQLVLDEYKNI
>A0A0F6W5A5|FEATURES|UNIPROT_deepARG|chloramphenicol|DB32_004935|antibiotic inactivation|1
MRCAGEEDAMTGFRAIDLGTWNRAEHFEHYIDRVPCTYSFTVHVDITSLRSALTGRGRKA
YPAQLWMLATTVQRFREFRMGFDADGALGVWDELHPAYTVFNAEAETFSGIWTRYDADFG
AFEDAATKDIAEHARATRFFPKEGRPPNSFDVSSIPWLEFSAFTLDIPRAIRHVAPIFTL
GRYVERDGRTLLPVAIQVHHAVCDGFHASRFVAALQELAAEHEAWL
>A0A120FKC5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYVNSIILGIIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWRDPRNRTYAAKLIVAFLITAILGLVVKKLGFQLPENATPIAWALIIGGIWMI
FAEWAAARRPPHKEITWLVAILVGIAQVVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAANEDWTSLGIAFIVSTIVAFIAVKWLLSYIRSNR
FTVFAIYRIILGAILLGMAALGMIA
>D6J8J5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAVEKVNVAGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>CAA50581.1|FEATURES|megares|chloramphenicol|ND00_04320|antibiotic inactivation|1
MFREMRRKRQLLPPEESLAILERMTGGTLALHGDNGYPYAVPVSYVYADGKIYFHGAVQG
HKMDAIRQHPEVSFCVVEQDRIVPAEFTTYFRSVIVFGKARILTDEVEKRAALLRLAEKY
SSGESGMQDEIDKGFDHLVMVEITVEHMTGKEAIQLVRRKGNNRWDAFPSKDVFIR
>ACO83422.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MLNEGKILPVDVSKEMKKCYIDYAMSVIAGRALPDVRDGLKPVHRRIIYSMQGLGLAPEK
GYRKCARIVGDVLGKYHPHGDTAVYEALVRMAQNFSIRYTLVDGHGNFGSVDGDGAAAMR
YTEAKMSKISMELIKDINKNTVDFIPNFDGEEEEPSVLPSRFPNLLVNGSSGIAVGMATN
IPPHNLTEVIDGIIMLIENEDVNILDLMTKIKGPDFPTSGLIVGTRGIREAYETGRGKVI
IRAKAEIEEEKGKNKIIVTEIPYQVNKARLIENMANLVKDKKINGISDLRDESDRDGMRI
VIELKRDANPNIVLNQLYKHTKLQDTFGIIMLALVNNQPQILNLKEILVNYVEFQKEVIR
RRTRFDLDKALARAHILEGLRIALDHIDEVIKLIRASKNTAEAKEGLMNNFNLSEKQAQA
ILDMKLQRLTGLEREKIEEEYKELMEKISYFREILDKEELVLSIIKEELIEIKNKYGDER
KTEIVKGEHDIDIEDLIEDKKVIVTLTHGGYIKRLDMDTYSSQKRGGKGIQATSTKQDDF
IENMFVTSTHSTILFFTNRGKVYKLKAYEIPEAGRTAKGTNIVNLIPIENNEKIQTVIGL
KDIDDMKHFVMCTRNGIIKKTEISKYSSIRKGGLNAINLREDDELIDVKMTKGNDEIIVV
TQNGYCIRFNEEDVRPMGRVATGVKAITLRKTDKAVSMDVVIEDETLLSISENGFGKRTD
IEEYPIHRRGGKGVITYKITDKTGPIVGARFVKEDDELMLVNSGDVAIRINVSEISKTSR
NAMGVKLMRTSEEEKIVAIAKIKSEDIIEEEILNEENLNEENLNEENLNEENLNEENLNE
ENLNEE
>NP_462206.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MKLFAQGATLDLTHPHVMGILNVTPDSFSDGGAHNTLIEAVKHANLMVNAGATIIDVGGE
STRPGAAEVSVEEELDRVIPVLEAIAQRFEVWISVDTSKPEVIREAARAGAHIINDVRSL
SEPGALEAAAETGLPVSLMHMQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEKAGIAKE
KLLLDPGFGFGKNLSHNYTLLARLGEFHHFNLPLLVGMSRKTMVGQLLNVGPSDRLNGSL
ACAVIAAMQGAQIIRVHDVKETVEAMRVVEATLSAKGNKRYE
>NP_274400.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MTDATIRHDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAM
HELKNNWNAAYKKSARIVGDVIGKYHPHGDTAVYDTIVRMAQNFAMRYVLIDGQGNFGSV
DGLAAAAMRYTEIRMAKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPTLLVNGSS
GIAVGMATNIPPHNLSDTVNACLRLLDAPDTEIDELIDIIQAPDFPTGATIYGLSGVREG
YKTGRGRVVMRGKTHIEPIGRNGEREAIVIDEIPYQVNKAKLVEKIGDLVREKTLEGISE
LRDESDKSGMRVVIELKRNENAEVVLNQLYKLTPLQDSFGINMVVLVDGQPRLLNLKQIL
SEFLRHRREVVTRRTLFRLKKARHEGHIAEGKAVALSNIDEIIKLIKESPNAAEAKDKLL
ARPWRSSLVEEMLTRSGLDLEMMRPEGLAANIGLKEQGYYLSEIQADAILRMSLRNLTGL
DQEEIVESYKNLMGKIIDFVDILSKPERITQIIRDELEEIKTNYGDERRSEINPFGGDIA
DEDLIPQREMVVTLTHGGYIKTQPTTDYQAQRRGGRGKQAAATKDEDFIETLFVANTHDY
LMCFTNLGKCHWIKVYKLPEGGRNSRGRPINNVIQLEEGEKVSAILAVREFPEDQYVFFA
TAQGMVKKVQLSAFKNVRAQGIKAIALKEGDYLVGAAQTGGADDIMLFSNLGKAIRFNEY
WEKSGNDEAEDADIETEISDGIEDETADSENALPSGKHGVRPSGRGSGGLRGMRLPADGK
IVSLITFAPETEESGLQVLTATANGYGKRTPIADYSRKNKGGQGNIAINTGERNGDLVAA
TLVGETDDLMLITSGGVLIRTKVEQIRETGRAAAGVKLINLDEGETLVSLERVAEDESEL
SDASVISNVTEPEVEN
>BAE77397.1|FEATURES|megares|multidrug|cpxr|antibiotic efflux|0
MNKILLVDDDRELTSLLKELLEMEGFNVIVAHDGEQALDLLDDSIDLLLLDVMMPKKNGI
DTLKALRQTHQTPVIMLTARGSELDRVLGLELGADDYLPKPFNDRELVARIRAILRRSHW
SEQQQNNDNGSPTLEVDALVLNPGRQEASFDGQTLELTGTEFTLLYLLAQHLGQVVSREH
LSQEVLGKRLTPFDRAIDMHISNLRRKLPDRKDGHPWFKTLRGRGYLMVSAS
>CBA27391.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MFSFIQVHKGMAMKLFAQGSTLELSHPHVMGILNVTPDSFSDGGQHNTLTEAVKHANAMI
NAGATIIDVGGESTRPGAAEVSVEEELSRVVPVVEALAQRFEVWVSVDTSKPEVIRESAR
VGAHIINDIRSLTEPGALEAAAETGLPVCLMHMQGQPKTMQQAPHYEDVFADVTRFFEQQ
IARCEAAGITKEKIILDPGFGFGKNLTHNYQLLARLSEFQRFEMPLLVGMSRKSMIGQLL
NVGPDQRLPGSLACAVMAAMQGAQIIRVHDVKETVEAMRVVEATLSAKDKKCYE
>AGS61252.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MSKEKFERSKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARG
ITISTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPVIRGSALKALE
GEAEWEAKIVELAEALDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
DEVEIVGIKETTKTTCTGVEMFRKLLDEGRAGENVGVLLRGTKREEIERGQVLAKPGSIN
PHNKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNVNMI
VELIHPIAMDEGLRFAIREGGRTVGAGVVAKVLG
>CBH29314.1|FEATURES|megares|trimethoprim|dfrA16|antibiotic target replacement|1
MAAKSKNGIIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
NFSTNDEGVMVFSSIQDALINLEEITDHVIVSGGGEIYKSLISKVDTLHISTVDIERDGD
IVFPEIPDTFELVFEQDFESNINYCYQIWQRVNKRLQSDLRLLSPFFAVELQKCAINLRQ
LRRALDALAHNCSQPTIRSSLL
>ABB82610.1|FEATURES|megares|beta_lactam|blaZ|antibiotic inactivation|1
LKKLIFLIAIALVLSACNSXSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHIXKDDIVAYSPILEKYVGKDITLKELIEASMAY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>CAG34240.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRVDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>NP_459974.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MMKRKILAAVIPALLAAATANAAEIYNKDGNKLDLYGKAVGRHVWTTTGDSKNADQTYAQ
IGFKGETQINTDLTGFGQWEYRTKADRAEGEQQNSNLVRLAFAGLKYAEVGSIDYGRNYG
IVYDVESYTDMAPYFSGETWGGAYTDNYMTSRAGGLLTYRNSDFFGLVDGLSFGIQYQGK
NQDNHSINSQNGDGVGYTMAYEFDGFGVTAAYSNSKRTNDQQDRDGNGDRAESWAVGAKY
DANNVYLAAVYAETRNMSIVENTVTDTVEMANKTQNLEVVAQYQFDFGLRPAISYVQSKG
KQLNGAGGSADLAKYIQAGATYYFNKNMNVWVDYRFNLLDENDYSSSYVGTDDQAAVGIT
YQF
>AAL08447.1|FEATURES|megares|chloramphenicol|catI|antibiotic inactivation|1
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
HILARLMNAHPEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIY
SNDVACYGENLAYFPKNFNENMNFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQG
DKVLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>NP_358692.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MQDKNLVNVNLTKEMKASFIDYAMSVIVARALPDVRDGLKPVHRRILYGMNELGVTPDKP
HKKSARITGDVMGKYHPHGDSSIYEAMVRMAQWWSYRYMLVDGHGNFGSMDGDSAAAQRY
TEARMSKIALEMLRDINKNTVDFVDNYDANEREPLVLPARFPNLLVNGATGIAVGMATNI
PPHNLGETIDAVKLVMDNPEVTTKDLMEVLPGPDFPTGALVMGKSGIHKAYETGKGSIVL
RSRTEIETTKTGRERIVVTEFPYMVNKTKVHEHIVRLVQEKRIEGITAVRDESNREGVRF
VIEVKRDASANVILNNLFKMTQMQTNFGFNMLAIQNGIPKILSLRQILDAYIEHQKEVVV
RRTRFDKEKAEARAHILEGLLIALDHIDEVIRIIRASETDAEAQAELMSKFKLSERQSQA
ILDMRLRRLTGLERDKIQSEYDDLLALIADLADILAKPERVSQIIKDELDEVKRKFSDKR
RTELMVGQVLSLEDEDLIEESDVLITLSNRGYIKRLDQDEFTAQKRGGRGVQGTGVKDDD
FVRELVSTSTHDHLLFFTNKGRVYRLKGYEIPEYGRTAKGLPVVNLLKLDEDESIQTVIN
VESDRSDDAYLFFTTRHGIVKRTSVKEFANIRQNGLKALNLKDEDELINVLLAEGDMDII
IGTKFGYAVRFNQSAVRGMSRIATGVKGVNLREGDTVVGASLITDQDEVLIITEKGYGKR
TVATEYPTKGRGGKGMQTAKITEKNGLLAGLMTVQGDEDLMIITDTGVMIRTNLANISQT
GRATMGVKVMRLDQDAQIVTFTTVAVAEKEEVGTENETEGEA
>AEX49909.1|FEATURES|megares|polymyxin|pmrA|antibiotic target alteration|0
MRILLAEDDLLLGDGIRAGLRLEGDTVEWVTDGVAAENALVTDEFDLLVLDIGLPRRSGL
DILRNLRHQGRLTPVLLLTARDKVADRVAGLDSGADDYLTKPFDLDELQARVRALTRRTT
GRALPQLVHGELRLDPATHQVTLSGQAVELAPREYALLRLLLENSGKVLSRNQLEQSLYG
WSGDVESNAIEVHVHHLRRKLGNQLIRTVRGIGYGIDQPAP
>CAA47093.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MYHFRSDYMNKNIKYSQNFLTNEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISK
QVTSIELDSHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKK
VVFESHASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVL
IKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVL
SIFNSYLLFNGRK
>AAA27431.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFES
LGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALL
NIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQI
VCLSPSQWLNCFLEMLEVVPEKFHPS
>ABR76005.1|FEATURES|megares|multidrug|ramR|antibiotic efflux|0
VARPKSEDKKQALLEAATAAFAQSGIAASTSAIARSAGVAEGTLFRYFATKDELLNELYL
AIKLRLVRTMIAGLDPDEKRPKENARNIWNSYIDWGVRNPMEHKAIRRMALSERITDETR
RQVKESFPELNEMCQLSVKEIFLSEAYRAFGDALFLSLAETTIEFASHDPQRAREIIALG
FEAMWHALHEADA
>CAC44895.1|FEATURES|megares|tetracycline|tetG|antibiotic efflux|1
LLIVGLDAMGLGLIMPVLPALLRELVPAEQVAGHYGALLSLYALMQVIFAPVLGQFSDAY
GRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRIVSGVTGATGAVAASTIADSTGEGSRA
RWFGYMGACYGAGMIAGPALCGMLGGISAHAPFIAAALLNGFAFLLAYIFLKETHHSHGG
TRKPVRIKPFVLFRLDDTLRGLGALFAVFFIIQLIGQVPAALWVIYGEDRFQWDTTTVGL
SLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFILLAFATQGWMVFPILLLL
AAGGVGMPALQAMLSNNVSGNKQGALQGTLTSLTNLSSIAGPLGFTALYSATAGAWNGWV
WIVGAILYLICLPILRRPFA
>YP_499066.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDSSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEE
>CAA66659.1|FEATURES|megares|beta_lactam|TEM-42|antibiotic inactivation|1
QHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGVRVGYIELDLNSGKILESFRPEER
FPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSA
AITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAA
MATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGSRGI
IAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKX
>CAH25815.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAITQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>WP_000167947.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MTKTKIMGILNVTPDSLSDGGKFNNVESAINRVKAMIDEGADIIDVGGVSTRPGHEMVSL
EEEMNRVLPVVEAIVGFDVKISVDTFRSEVAEACLKLGVDMINDQWAGLYDHRMFQIVAK
YDAEIILMHNGNGNRDEPVVEEMLTSLLAQAHQAKIAGIPSNKIWLDPGIGFAKTRNEEA
EVMARLDELVATEYPVLLATSRKRFTKKMMGYDTTPVERDEVTAATTAYGIMKGVRAVRV
HNVELNAKLAKGIDFLKENENARHNLS
>AAA24297.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDSAC
YEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYSELLLSELGQGTAD
WVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAQAAIALIDQPKTT
LDQLLDIVQGPDYPTEAEIITSRAEIRKIYENGRGSVRMRAVWKKEDGAVVISALPHQVS
GARVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIVPRSNRVDMDQVMNHLFATTDLE
KSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRRRLNYRLEKVLKRLHILEGLLVA
FLNIDEVIEIIRNEDEPKPALMSRFGLTETQAEAILELKLRHLAKLEEMKIRGEQSELEK
ERDQLQGILASERKMNNLLKKELQADAQAYGDDRRSPLQEREEAKAMSEHDMLPSEPVTI
VLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSNQPVVFVDSTGRSYAIDPITLPS
ARGQGEPLTGKLTLPPGATVDHMLMESDDQKLLMASDAGYGFVCTFNDLVARNRAGKALI
TLPENAHVMPPVVIEDASDMLLAITQAGRMLMFPVSDLPQLSKGKGNKIINIPSAEAARG
EDGLAQLYVLPPQSTLTIHVGKRKIKLRPEELQKVTGERGRRGTLMRGLQRIDRVEIDSP
RRASSGDSEE
>AEL00447.1|FEATURES|megares|quinolone|QnrB17|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>WP_000037277.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MSKKEININNYNDDAIQVLEGLDAVRKRPGMYIGSTDGAGLHHLVWEIVDNAVDEALSGF
GDRIDVTINKDGSLTVQDHGRGMPTGMHAMGIPTVEVIFTILHAGGKFGQGGYKTSGGLH
GVGSSVVNALSSWLEVEITRDGAVYKQRFENGGKPVTTLKKIGTAPKSKTGTKVTFMPDA
TIFSTTDFKYNTISERLNESAFLLKNVTLSLTDKRTDEAIEFHYENGVQDFVSYLNEDKE
ILTPVLYFEGEDNGFQVEVALQYNDGFSDNILSFVNNVRTKDGGTHETGLKSAITKVMND
YARKTGLLKEKDKNLEGSDYREGLAAVLSILVPEEHLQFEGQTKDKLGSPLARPVVDGIV
ADKLTFFLMENGELASNLIRKAIKARDAREAARKARDESRNGKKNKKDKGLLSGKLTPAQ
SKNPAKNELYLVEGDSAGGSAKQGRDRKFQAILPLRGKVVNTAKAKMADILKNEEINTMI
YTIGAGVGADFSIEDANYDKIIIMTDADTDGAHIQTLLLTFFYRYMRPLVEAGHVYIALP
PLYKMSKGKGKKEEVAYAWTDGELEELRKQFGKGATLQRYKGLGEMNADQLWETTMNPET
RTLIRVTIEDLARAERRVNVLMGDKVEPRRKWIEDNVKFTLEEATVF
>NP_275030.1|FEATURES|megares|multidrug|porB|reduced permeability to antibiotic|0
MKKSLIALTLAALPVAAMADVTLYGTIKAGVETSRSVFHQNGQVTEVTTATGIVDLGSKI
GFKGQEDLGNGLKAIWQVEQKASIAGTDSGWGNRQSFIGLKGGFGKLRVGRLNSVLKDTG
DINPWDSKSDYLGVNKIAEPEARLISVRYDSPEFAGLSGSVQYALNDNAGRHNSESYHAG
FNYKNGGFFVQYGGAYKRHHQVQEGLNIEKYQIHRLVSGYDNDALYASVAVQQQDAKLTD
ASNSHNSQTEVAATLAYRFGNVTPRVSYAHGFKGLVDDADIGNEYDQVVVGAEYDFSKRT
SALVSAGWLQEGKGENKFVATAGGVGLRHKF
>ADU81552.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MQDHLVNETKNIVEVGIDSSIEESYLAYSMSVIIGRALPDARDGLKPVHRRILYAMHELG
LTSKVAYKKSARIVGDVIGKYHPHGDNAVYDALVRMAQDFSMRLELVDGQGNFGSIDGDN
AAAMRYTEARMTKASEEILRDIDKDTIDFVPNYDDTLKEPDILPSRLPNLLVNGANGIAV
GMATSIPPHRIDEIIDALAHVLENPNAELDEILEFVKGPDFPTGGIIYGKAGIVEAYKTG
RGRVKVRAKVHVEKTKNKEIIVLDEMPFQTNKAKLVEQISDLAREKQIEGISEVRDESDR
EGIRVVIELKRDAMSEIVLNHLYKLTTMETTFSIILLAIYNKEPKIFTLLELLRLFLNHR
KTIIIRRTIFELEKAKARAHILEGYLIALDNIDEIVRLIKTSPSPEAAKNALMERFSLSE
IQSKAILEMRLQRLTGLERDKIKEEYQNLLELIDDLNGILKSEDRLNEVVKTELLEVKEQ
FSSPRRTEIQESYESIDTEDLIANEPMVVSMSYKGYVKRVDLKAYERQNRGGKGKLSGST
YEDDFIENFFVANTHDILLFITNKGQLYHLKVYKIPEASRIAMGKAIVNLISLAPNEKIM
ATLSTKDFSDERSLAFFTKNGVVKRTNLSEFGGNRSYSGIRAIVLDEGDELVGAKVVDKN
AKHLLIASYLGMFIKFPLEDVREIGRTTRGVMGIRLNENDFVVGAVVISDDSNKLLSVSE
NGLGKQTLAEAYREQSRGGKGVIGMKLTQKTGNLVSVISVDDENLDLMILTASAKMIRVS
IKDIRETGRNASGVKLINTADKVVYVNSCPKEEEPENLETSRAQNLFE
>AAA26079.1|FEATURES|megares|chloramphenicol|cmlA1|antibiotic efflux|1
MSFTAYSDPCWPWSRGRPIARSARRHVAWVAGYLCVSRFGHDRCICRRGSFWPETRVQRV
AGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRPRCVSAWLQPAVRHS
AIAMVFTARFMGSVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWALHRVRLYCSNVASGI
GVATAVSVPMALFEDSTMLLERSRQSTSAWACTARKHRNVDHFAVAAQRLGPCRVTVWTL
ATVVLGLSCVSRVKGSRGQGEHDAGRATNVGKYIKSQSLRECGKLSPNKCCSRPKTYAFR
LG
>AVM21122.1|FEATURES|megares|macrolide-lincosamide-streptogramin|rlmH|antibiotic target alteration|0
MKITILAVGKLKEKYWKQAIAEYEKRLGPYTKIDIIEVPDEKAPENMSDKEIEQVKEKEG
QRILAKIKPQSTVITLEIQGKMLSSEGLAQELNQRMTQGQSDFVFVIGGSNGLHKDVLQR
SNYALSFSKMTFPHQMMRVVLIEQVYRAFKIMRGEAYHK
>ABQ56916.1|FEATURES|megares|tetracycline|tufab|antibiotic target alteration|1
MAKEKFERKKPHVNVGTIGHVDHGKTTLTAAITTIMAKKYGGTAKAYDQIDAAPEERERG
ITISTAHVEYESASRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI
LLSRQVGVPYIVVFMNKADMVDDPELLELVEMEVRDLLSSYDFPGDDIPIVVGSALKALE
GEDSDIGVKAIEKLVETMDSYIPEPVRNIDKPFLLPIEDVFSISGRGTVVTGRVESGIVK
VGEEVEIVGIRDTQKTTCTGVEMFRKLLDEGRAGDNVGVLLRGTKRDEVERGQVLAKPGT
IKPHTKFEAEVYVLSKEEGGRHTPFFNGYRPQFYFRTTDVTGTCDLPSGVEMVMPGDNVQ
LVVSLHAPIAMDEGLRFAIREGGRTVGAGVVAKIIE
>WP_000633128.1|FEATURES|megares|multidrug|adeH|antibiotic efflux|0
MGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQ
LNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDD
NAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYF
LIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARN
RASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNA
RIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAG
VAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLR
YREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS
>CAQ87573.1|FEATURES|megares|beta_lactam|cflA|antibiotic inactivation|1
ILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQA
ALLDTPINDAQTEMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQRKGVQSYANQMTI
DLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGGCMLKD
NQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVNQYIES
TSKP
>CBK33710.1|FEATURES|megares|trimethoprim|dfrK|antibiotic target replacement|1
MKVSLIAAMDKNRVLGKENDIPWRIPKDWEYVKNTTKGYPIILGRKNLESIGRALPGRRN
IILTRDKGFSFNGCEIVHSIEDVFEICNNEEEIFIFGGEQIYNLFLPYVEKMYITKIHYE
FEGDTFFPEVNYEEWSEVSVTQGITDEKNPYTYYFHIYERKAY
>NP_463022.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ
SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVVFEIRDNKLQME
LIPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDIKHIEVPVEYIAGKVVSKD
YVDESTGELICAANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISETVRVDPTNDRL
SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLRDEIEGSGIL
SKDDIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRRVVDGVVT
DEIHYLSAIEEGNYVIAQANSNLDDEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR
GGTVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL
SEELQILEAGLFSRIRAVLVSSGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE
LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKIN
PIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQRAYDLGADVRQKVDLSTFSDDEVLRLAENLRKGMPIATPVFDGAKEAEIKELLK
LGDLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>WP_001040568.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MAKEKFDRSKEHANIGTIGHVDHGKTTLTAAIATVLAKNGDSVAQSYDMIDNAPEEKERG
ITINTSHIEYQTDKRHYAHVDCPGHADYVKNMITGAAQMDGGILVVSAADGPMPQTREHI
LLSRNVGVPALVVFLNKVDMVDDEELLELVEMEVRDLLSEYDFPGDDVPVIAGSALKALE
GDAQYEEKILELMEAVDTYIPTPERDSDKPFMMPVEDVFSITGRGTVATGRVERGQIKVG
EEVEIIGLHDTSKTTVTGVEMFRKLLDYAEAGDNIGALLRGVAREDVQRGQVLAAPGSIT
PHTEFKAEVYVLSKDEGGRHTPFFSNYRPQFYFRTTDVTGVVHLPEGTEMVMPGDNVEMT
VELIAPIAIEDGTRFSIREGGRTVGSGVVTEIIK
>YP_001708330.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAYSYTEKKRIRKNFGKLPQVMDAPYLLSIQVDSYRTFLQDGKSPKNREDIGLQAAFRSV
FPIESYSGNAALEFVEYSLGKPEFDVRECILRGSTYAAPMRVKIRLIIKDRETKSIKDVR
EQEVYMGEIPLMTENGTFVINGTERVIVSQLHRSPGVFFDHDKGKTHSSGKVLYSARIIP
YRGSWLDFEFDAKDLVYVRIDRRRKLLATVVLRALGYNNEQILNLFYEKLPVYLDMGSYQ
IDLVPERLRGEMAQFDITDNEGKVIVEQGKRINARHVRQMEAAGLTKLSVPDEYLYERIT
AEDITLRDGEVIAANTLLSHEVMVKLAEGGVKQFNILFTNDIDRGSFVADTLRADLTRDR
EEALVEIYKVMRPGEPPTKEAAENLFNNLFFSSERYDLSPVGRMKFNRRLGRPYEVGTDQ
KSREVEGILSHEDIIDVLRTLVEIRNGKGEVDDIDHLGNRRVRSVGEMTENQFRVGLVRV
ERAVKERLSQAETDNLSPQDLINAKPVAAAIKEFFGSSQLSQFMDQNNPLSEITHKRRVS
ALGPGGLTRERAGFEVRDVHQTHYGRVCPIETPEGPNIGLINSLSVYAKANDFGFLETPY
RKVVDGRVTDDVEYLSAIEEVGTVIAQADSAVDKDGNLTEEFVSVRHQGEFVRMPPEKVT
HMDVSAQQVVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRADKPLVGTGMEANVARD
SGVCVIANRGGVIEYVDASRIVIRVNEDEMVAGEAGVDIYNLIKYTRSNQNTCINQNVIV
NLGDKVARGDILADGPSTDMGELALGQNMRVAFMTWNGYNYEDSILLSERVLQEDRLTSI
HIQELSCVARDTKLGAEEITADIPNVGEAALSKLDESGIVYIGAEVTAGDILVGKVTPKG
ETQLTPEEKLLRAIFGEKAADVKDSSLRVPSGTKGTVIDVQVFTRDGLEKDDRALAIEKA
QLDSYRKDLKEEYKIFEEAARERVIRLLKGQESNGGGSTKRGDKLSEDLLSGLELVDLLE
IQPADEAIAERLTQIQVFLKEKSAEIDEKFAEKKRKLATGDELTTGVLKVVKVYLAVKRR
IQPGDKMAGRHGNKGVVSNILPVEDMPHDANGVPVDIVLNPLGVPSRMNVGQILETHLGM
AAKGLGDKIEKMLKEQRTVLELREFLDKIYNKVGGEQEDLDSLTDEEILALAGNLRAGVP
LATPVFDGAEESQIKDLLELADISRTGQTVLFDGRTGEQFDRPVTVGYMYMLKLNHLVDD
KMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVEGR
TRIYKNIVDGNHYMDPGMPESFNVLTKEIRSLGINIELKNGD
>AAB60006.1|FEATURES|megares|chloramphenicol|cmlA5|antibiotic efflux|1
MDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAY
VVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLA
MVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLP
VKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFM
GRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWALQSVLGFIAPMWLVGIGVATAVSVAP
NGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLS
CVSRVKGSRGQGEHDVVALQSAESTSNPNR
>ACQ59434.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAICTVLAKVYGGKARDFASIDNAPEERERG
ITINTSHVEYDTPNRHYAHVDCPGHADYVKNMITGAAQMDGGILVVAATDGPMPQTREHI
LLGRQVGIPYIIVFMNKCDMVDDEELLELVEMEVRELLSEYDFPGDDLPVIQGSALGALN
GEAQWEAKIVELAEALDTYIPEPERAVDMAFLMPIEDVFSIQGRGTVVTGRIERGILKVG
DEVAIVGIKETVKTTCTGVEMFRKLLDEGRAGENVGALLRGTKREEVERGQVLAKPGSIT
PHTKFESEVYVLSKDEGGRHTPFFKGYRPQFYFRTTDVTGSIELPEGVEMVMPGDNVKMV
VDLIAPIAMDEGLRFAIREGGRTVGAGVVAKIIA
>WP_050815728.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mphE|antibiotic inactivation|1
MTETSPSSPSSATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLDFRVAFARSR
DWQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYPLLPGTPGLT
VSADGTVEWHVDMASTEYARALGTFLAQLHTVDPEEAAATGIPSRTPSEVRGVWREDLTR
VAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVEGERLSAVLDWTTASVG
DPARDLMFHRSSAPPEAFAATLAAYVAGGGTLHPRLGEHAEEMFSASPLAYGLYALETGE
EEHRAAAAAALDPPDAD
>AJG01377.1|FEATURES|megares|beta_lactam|OXA-91|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEK32499.1|FEATURES|megares|streptothricin|estX|antibiotic inactivation|0
MLWSSNDVTQQGSRPKTKLYVELEGNLSMKEKVVVDKAISLYTESFGDPAHEPIILIMGA
MSSAVWWPDEFCSQLAKMGRYVIRYDHRDTGKSTSYEPGQAPYSVEELADDVVRVIDGYG
LEAAHLVGMSLGGFLSQLVALKYPKRVKSLTLIASERLADADPDMPAFDPAIIEYHQRAE
SLDWSDRDAVVAYQVGAWRINSGTAHAFDAEKIQNIAELNFDRTPNILTTFNHTTLGGGE
RWLGRLNEIAVPTLIIHGTEDPVLPYVHGLALKDAIRGSKMLTLEGTGHELHHEDWPRII
QAIKGQTS
>AAK84314.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNS
>AEL00449.1|FEATURES|megares|quinolone|QnrB29|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>WP_017780889|FEATURES|megares|tetracycline|tetE|antibiotic efflux|1
MLWGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPLLGRWSDRIGRRPVL
LLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPEESRTHWFGMM
GACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHNANQVSDELKN
ETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDGVMVGVSLAVF
GLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVITQSWMVWPVLLLLACGGI
TLPALQGIISVRVGQVAQGQLQGVLTSLTT
>ABY65242.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
DNVIEIGSGKGHFTKELVKMSRWVDSIEIDEDLCQVTQKVVKPFQNIKVIHTDILKFNFP
KNKDYKIFGNIPFNISTDIVKKIAFESNSKYSYLIVENGFAKRLQNTKRALGLLLMVELD
IRVLKKVPRAYFHPKPNVDSVLIVLERHQPLILKKDYKEYQSFVYKWVNREYRVLFTKNQ
FRQALKHANVTNINKLSK
>ACX34100.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vgaALC|antibiotic target protection|1
MKIMLEGLHIKHYVQDRLLLNINRLNIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGI
VKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQ
DLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYE
KYEKEKKRLEKAINIKEQKAQRATKKPKNLSLSEGKITGAKPYFAGKQKKLRKTVKSLET
RLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDK
MAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQN
ETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAI
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
EDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>WP_000195974.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQYTAQSLEVLSGLDPVRRRPGMYTDTSRPNHLAQEVIDNAVDEALAGHADKICVTVYK
DGSLSVEDNGRGMPVDIHPEYGQSGIEIILTKLHAGGKFSTDNYQFSGGLHGVGISVVNA
LSTRVEVEVQRQGNLYQMAFEQGEPVAPLAVLEGKAPKRATGTTVRFWPEAKYFDSPKFA
LKALKHNLKAKAVLAAGLKITYIDQINDEKIEWQFENGLVDYLMDELQDREILPNPAFVS
SGQADRAACEFAICWNVEGGEQVQESYVNLIPTAQGGTHVNGLRSGVTEALREFCELRNL
LPRNLKLSAEDVWDGVNYILSLKFQEPQFSGQTKERLSSREAANIVLNIAKDAFALWLNQ
HAEIAMQLAEMAISKAGRRLKAAKKVERKKIVSGPALPGKLADCVGQTREESELFIVEGD
SAGGSAKQARDKNFQAIMPIRGKILNTWEVSSDEVLASQEVHDIAIAIGVDPGSDDLSEL
RYGKICILADADSDGLHIATLLCALFVKHFPALVEEGHLYVAMPPLFRIDIGKDVHYALD
DEELETILKNVKGNKNPQITRFKGLGEMNAIQLRETTMDPNTRRLVQLDLDDAHLTAGLL
DKLLAKKRAADRKQWLEQKGNLADITV
>NP_359500.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MSKKEININNYNDDAIQVLEGLDAVRKRPGMYIGSTDGAGLHHLVWEIVDNAVDEALSGF
GDRIDVTINKDGSLTVQDHGRGMPTGMHAMGIPTVEVIFTILHAGGKFGQGGYKTSGGLH
GVGSSVVNALSSWLEVEITRDGAVYKQRFENGGKPVTTLKKIGTALKSKTGTKVTFMPDA
TIFSTTDFKYNTISERLNESAFLLKNVTLSLTDKRTDEAIEFHYENGVQDFVSYLNEDKE
ILTPVLYFEGEDNGFQVEVALQYNDGFSDNILSFVNNVRTKDGGTHETGLKSAITKVMND
YARKTGLLKEKDKNLEGSDYREGLAAVLSILVPEEHLQFEGQTKDKLGSPLARPVVDGIV
ADKLTFFLMENGELASNLIRKAIKARDAREAARKARDESRNGKKNKKDKGLLSGKLTPAQ
SKNPAKNELYLVEGDSAGGSAKQGRDRKFQAILPLRGKVINTAKAKMADILKNEEINTMI
YTIGAGVGADFSIEDANYDKIIIMTDADTDGAHIQTLLLTFFYRYMRPLVEAGHVYIALP
PLYKMSKGKGKKEEVAYAWTDGELEELRKQFGKGATLQRYKGLGEMNADQLWETTMNPET
RTLIRVTIEDLARAERRVNVLMGDKVEPRRKWIEDNVKFTLEEATVF
>AUX81729.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MAKLDKEQVIDNALILLNEVGIEGLTTRKLAQKIGVEQPTLYWHVKNKRALLDALAETIL
QKHHHHVLPLPNETWQDFLRNNAKSFRQALLMYRDGGKIHAGTRPSESQFETSEQQLQFL
CDAGFSLSQAVYALSSIAHFTLGSVLETQEHQESQKEREKVETDTVAYPPLLTQAVAIMD
SDNGDAAFLFVLDVMISGLETVLKSAK
>WP_000918668.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG
NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT
DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV
YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL
RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG
EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT
TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT
HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG
FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT
VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG
MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG
TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL
VKDDVYTSIHIEEYESEVRDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTLLRVPHGAGGIVLDVKVFNREEGDDT
LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL
GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG
RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL
DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD
>AAW82618.1|FEATURES|megares|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFAILFFLLITFSWKAQVVKEPENTNEEWSRSYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGLAGSLPMIKENIKKLGFNYKDIKILLLTQAHYDHTGALKDLQTETGAKFYA
DSADADVLKTGGKSDYEMGKYGATFKAIKPDILLKDQDKIKLGNTTLTLLHHPGHTKGSC
SFIFETKDENRNYKVLIANMPSVIVDRKFSEIKDYPNIQADYAYTFKAMKKLDFDLWVAS
HASQFDLHTKHKEGDPYNPQVFMDKANYFAFLNSLETDYLEKIKNDSQKK
>WP_000819088.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDSSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFENLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEE
>ADK11275.1|FEATURES|megares|beta_lactam|IMP-45|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNT
DAYLIDTPFTAKDTENLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKYSFSGVSYWLVKKKIEVFYPGSGHAPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLMSKYSKAKLVVPGHSDIGDSSLLKLTWEQTVKGFNESKK
STTAH
>AAK89233.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MAIGRDRIVDEALRLLNEVGIDKLSTRKLAERLGVQQPALYWHFRNKAELLDAINSEMLL
RYHCDRLPKPGQDWITFTLANARSIRKTLLTVRDGARLTAGTRPSVAEFADVESVLQLYV
ETGFSAEEAFGIAICITRYVVGYVLEEQGERERDRMDQHSPNTDIMAELAQFPLLAKALE
SFPTVGTVNTEAVFESGLSYLLAGMKEKLREKQSR
>BAH76064.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MRPTMRQIRSTAPISGPGDSMEQDMASIWRLGGGRTLDCSGDRVIGIVNATPDSFYDGGR
HGDVAAAVSHGLRLAGEGADMLDIGGESTRPGAAPVTDAEEIDRVVPVIAELARRLPDMP
IAVDTYRAGCATAALAAGACAVNDVSGLAFDPALLEVVAQRQPGYVLMHTKGRPDVMQRD
PRYDDVIGEILAYFEQGLTRLTRAGLPEDHVVLDPGIGFGKLSEHNLEILRNLERFTVFG
RPVYLGLSNKSFFGALLGLPVGERTVATAVASALCAGRGARLHRVHDVAAVKQALGLAAA
LAG
>CAB46686.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib9|antibiotic inactivation|1
MLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYV
ALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPS
PSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>ABX45061.1|FEATURES|megares|beta_lactam|OXA-51|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEIAYKSLEQLGIL
>CBZ41938.1|FEATURES|megares|beta_lactam|blaZ|antibiotic inactivation|1
MYALNTQNGKELSFNENKRFAYASTLKTISSAMLLEQTPYNKLDKKIHINKDDIVPYSPV
LEKYIGKEITLKKLIEATMLFSDNTANNKIIDELGGYGQVKTKLIDLGDTTTHPSRKEPD
LNFYSPKDKRDTSTPLAYGKTLKKLIADGDLSKANKDFLLNLMFKNKSGDTLIKDGAPSN
FKVMDKSGQALTYGSRNDVAFVYPDGQDKPIILVIFTNKDRKDGKPNDKIVSEVAEIVLK
NINE
>CAB11853.1|FEATURES|megares|sulfonamide|folp|antibiotic target replacement|1
MAQHTIDQTQVIHTKPSALSYKEKTLVMGILNVTPDSFSDGGKYDSLDKALLHAKEMIDD
GAHIIDIGGESTRPGAECVSEDEEMSRVIPVIERITKELGVPISVDTYKASVADEAVKAG
ASIINDIWGAKHDPKMASVAAEHNVPIVLMHNRPERNYNDLLPDMLSDLMESVKIAVEAG
VDEKNIILDPGIGFAKTYHDNLAVMNKLEIFSGLGYPVLLATSRKRFIGRVLDLPPEERA
EGTGATVCLGIQKGCDIVRVHDVKQIARMAKMMDAMLNKGGVHHG
>WP_001289569.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSEIIQDLSLEDVLGDRFGRYSKYIIQERALPDVRDGLKPVQRRILYAMYSSGNTHDKNF
RKSAKTVGDVIGQYHPHGDSSVYEAMVRLSQDWKLRHVLIEMHGNNGSIDNDPPAAMRYT
EAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGSTGISAGYATDIP
PHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKKAYESGKGRIIVR
SKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEVRDETDRTGLRIA
IELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIIDSYLNHQIEVVAN
RTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIEVYEFTEEQAEAI
VMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEELNEIKKKFKSERL
SLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVEDIGLKDGDSLLKH
QEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDEVVINVFNEKDFN
TDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRFEKDQLITVITNK
GMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMATQRGSLKRISFKI
LQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHGLINDIHKSEQYT
NGSFIVDTDDFGEVIDMYIS
>CAB11883.2|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MTGQLVQYGRHRQRRSYARISEVLELPNLIEIQTSSYQWFLDEGLREMFQDISPIEDFTG
NLSLEFIDYSLGEPKYPVEESKERDVTYSAPLRVKVRLINKETGEVKDQDVFMGDFPIMT
DTGTFIINGAERVIVSQLVRSPSVYFSGKVDKNGKKGFTATVIPNRGAWLEYETDAKDVV
YVRIDRTRKLPVTVLLRALGFGSDQEILDLIGENEYLRNTLDKDNTENSDKALLEIYERL
RPGEPPTVENAKSLLDSRFFDPKRYDLANVGRYKINKKLHIKNRLFNQRLAETLVDPETG
EILAEKGQILDRRTLDKVLPYLENGIGFRKLYPNGGVVEDEVTLQSIKIFAPTDQEGEQV
INVIGNAYIEEEIKNITPADIISSISYFFNLLHGVGDTDDIDHLGNRRLRSVGELLQNQF
RIGLSRMERVVRERMSIQDTNTITPQQLINIRPVIASIKEFFGSSQLSQFMDQTNPLAEL
THKRRLSALGPGGLTRERAGMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYAKVNRF
GFIETPYRRVDPETGKVTGRIDYLTADEEDNYVVAQANARLDDEGAFIDDSIVARFRGEN
TVVSRNRVDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMQPEAPFVGT
GMEYVSGKDSGAAVICKHPGIVERVEAKNVWVRRYEEVDGQKVKGNLDKYSLLKFVRSNQ
GTCYNQRPIVSVGDEVVKGEILADGPSMELGELALGRNVMVGFMTWDGYNYEDAIIMSER
LVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVGEDALRNLDDRGIIRIGAEVKDGD
LLVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGGGGIIHDVKVFNREDGDE
LPPGVNQLVRVYIVQKRKISEGDKMAGRHGNKGVISKILPEEDMPYLPDGTPIDIMLNPL
GVPSRMNIGQVLELHMGMAARYLGIHIASPVFDGAREEDVWETLEEAGMSRDAKTVLYDG
RTGEPFDNRVSVGIMYMIKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGDNVPEPGVPESFKVLIKELQSLGM
DVKILSGDEEEIEMRDLEDEEDAKQADGLALSGDEEPEETASADVERDVVTKE
>ABC25482.1|FEATURES|megares|beta_lactam|SHV-66|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPDNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ADI46760.1|FEATURES|megares|trimethoprim|dfrA14|antibiotic target replacement|1
MAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYAVVTRS
GWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLSTIDIEPEGD
VFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>WP_001242578.1|FEATURES|megares|glycopeptide|BRP|antibiotic inactivation|0
MRMLQSIPALPVGDIKKSIGFYCDKLGFTLVHHEDGFAVLMCNEVRIHLWEASDEGWRSR
SNDSPVCTGAESFIAGTASCRIEVEGIDELYQHIKPLGILHPNTSLKDQWWDERDFAVID
PDNNLISFFQQIKS
>AGS59331.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MFAGAANAAEMYNKDGNKVDIYGKVDVRHYFADADTKGDHESGDASRARIGFKGETQINK
DLTGFGRFEYEVKTNTTEGENKAKTRLAYAGLKFADFGSLDYGRNYGVIYDTNAWTDVLP
LWGGDSMAQTDVYMTSRTTGVLTYRNTDMFGYVDGLSFALQYQGKNNENTNNKRKDNAEA
NGDGFGFSTAYNLGWGVTLGGGYSSSARTNWQEHKSDATGKRAEAWNVGGKFEANNVYLA
AMYGETRNMNYYGDGAIANKTQNIELTAQYDFADLGIKPSLGYVQSKGKDLNNGVGGLKD
NNHDLVKYISVGSFYKFNKNMTAVVDYKINLLDEDDFTKANGVATDNVVGLGLTYQF
>AAO15534.1|FEATURES|megares|chloramphenicol|cmlA5|antibiotic efflux|1
MDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAY
VVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLA
MVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLP
VKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFM
GRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWASQSVLGFISPMWLVGIGVATAVSVAP
NGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLS
CVSRAEGSRGQGEHDVVALQSAESTSNPNR
>EED25201|FEATURES|megares|fosfomycin|FosC2|antibiotic inactivation|1
VILGLNHITIAVSDLERSLKFYRETLGFTAHAKWDNGAYLSVGELWFCLSHDEPCPKTDY
THVAFDIEPKEFEAFAKRVVSLGVEVWKQNKSEGQSLYILDPDGHKLEIHSGSLKSRLES
LRTKLYSGLVWL
>ABQ56968.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MNSEQFLGWLERKSQPASSLVFEKPLIMGVLNVTSDSFYDGGKYLSVDRAYEQAIQLIAC
GADLIDIGGESTKPGAPPVPLDVELSRVLPIIKQLRAFTDVCISIDTNKPEVMEAAINAG
AHVINDVYALRRDGALNVAAQLDVPVCLMHMKGEPRTMQENPSYPEGIMKELQHFFEERI
DKCQKAGLNRNKLILDPGFGFGKRVQDNLQLIYHLNELHSFGLPILLGVSRKSTIGAVLN
TEVEQRLIGSITLGIYAALKGTAIIRTHDVDETNQALTMINAIYQAAKEIS
>ABB62915.1|FEATURES|megares|multidrug|emrR|antibiotic efflux|0
MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMA
LITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEK
GHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQAGVVLEAMS
>AAU95769.1|FEATURES|megares|multidrug|mepB|antibiotic efflux|0
MCKSKILLKNIFSEESEVKDLTEEKYNQDYEALTFSFKEETYQSRLAKKTPTKSGYFVTC
WTKDEDNYNRPYKIEEFADYLIVAVIDDELNGYFLFPRELLVEKGILASSKYQGKMAFRV
YPKWCNQLNKTAGQTQKWQCKYFFEY
>AAA26780.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mgt|antibiotic inactivation|0
MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPRL
LADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEP
DLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYAR
FHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDW
ARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNV
EVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVAR
TLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEAGTRGPADLIEAELAAARG
>WP_001300761.1|FEATURES|megares|polymyxin|PmrB|antibiotic target alteration|0
MHFLRRPISLRQRLILTIGAILLVFELISVFWLWHESTEQIQLFEQALRDNRNNDRHIMR
EIREAVASLIVPGVFMVSLTLFICYQAVRRITRPLAELQKELEARTADNLTPIAIHSATL
EIEAVVSALNDLVSRLTSTLDNERLFTADVAHELRTPLAGVRLHLELLAKTHHIDVAPLV
ARLDQMMESVSQLLQLARAGQSFSSGNYQHVKLLEDVILPSYDELSTMLDQRQQTLLLPE
SAADITVQGDATLLRMLLRNLVENAHRYSPQGSNIMIKLQEDDGAVMAVEDEGPGIDESK
CGELSKAFVRMDSRYGGIGLGLSIVSRITQLHHGQFFLQNRQETSGTRAWVRLKKDQYVA
NQI
>EJR79613.1|FEATURES|megares|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MNTLKVKQLANKEGLNILEDSIEINESGVDFQVAHVKEQNGDKWILRIPRRRESMRHALR
EKEALEIMKKHAEFQVPDWSIFSEELIAYKQLSGVPAATIDIEQQGYIWTFNEKDVPTEY
YISLGKVLANLHSLPQQKFNSIGVEILTANELRTSMKQRMNRVKEQYHINQNLWDRWQAW
LAEDSFWPSHVGVKHGDIHPGHILIDNKNKVTGLIDWTEVGIGDVSIDFTSHYLLFGKDG
LTKLIHSYDNAGGKTWSRMDEHIIELLTTSSITVAEYAQVSGLKDMHEIAVHMLSTES
>ABB62496.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLVYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKV
YIRARAEMEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDG
MRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRRE
VVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNV
AAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVV
VTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVY
SMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVL
TEFNRLRTAGKVAIKLVEGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTG
VRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERN
GLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTAEDENVVGLQRVA
EPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE
>WP_011767147.1|FEATURES|megares|quinolone|rpoB|antibiotic target alteration|0
MAYSYTEKKRIRKSFAKRAAVLDAPFLLATQIESFASFLQAETPPESRYNQGLQAAFTSI
FPISSHSGNARLEFVQYMLGEPAFDVKECQQRGLTFASPLRARVRLVIMDREAPKETIKE
VKEQEVYMGEIPLMTTTGSFVINGTERVIVSQLHRSPGVFFEHDRGKTHSSGKLLFSARI
IPYRGSWLDFEFDPKDYLYFRVDRRRKMPVTILLRAIGMTPEEILETFHDFDAFHLSAEG
AQFELVPDRLRGEVARFDIVDPTGKVIVARDKRITAKHIRELDQAGIKMIGVPDDFVLGR
IIARNVVDPETGELLARANEEITEDLLGKLRDAGVRDLVTLYVNDLDRGAYISSTLRIDE
TADQWAARVAIYRMMRPGEPPTEEAVEALFQGLFYAPERYDLSTVGRMKFNRRAYPEKID
DKAPGWLKRFYDKVGPHGEEGEGVLANEDILAVIGVLVELRNGRGEIDDIDHLGNRRVRS
VGELAENQFRAGLVRVERAVKERLSQAESDNLMPHDLINAKPISAAIKEFFGSSQLSQFM
DQTNPLSEITHKRRVSALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSL
AVYARTNRHGFLETPYRKVTDGKVTDQIDFLSAIEEGQYVIAQANAEIGGDGALEGDLVS
CRHKGEFMLATADQVQYMDVAPGQIVSVAASLIPFLEHDDANRALMGANMQRQAVPCLRP
EKPLVGTGIERTVAVDSGTAVQAMRGGVVDYVDAQRVVVRVNDNEALAGEVGVDIYNMIK
YTRSNQNTNINQRPVVRVGDLIAKGDVIADGASTDLGELALGQNMLVAFMPWNGYNFEDS
ILISERVVADDRFTSIHVEELTVVARDTKLGPEEITRDIASLGEAQLSRLDESGIVYIGA
EVEAGDVLVGKVTPKGETQLTPEEKLLRAIFGEKASDVKDTSLRVPSGMTGTVIDVQVFT
REGIERDKRAQSIIDDQLRSFKTDLADQMRIVERDAFARIQRMIVGQKANGGPKKLAKGA
AITAEYLETLEFYHWFDIRMADEELAIQLEAVREGLEKTRKDFEQAFEIKKKKLTQGDEL
PPDVQKMVKVYLAVKRRLQPGDKMAGRHGNKGVVSKIVPVEDMPYMEDGTPVDIVLNPLG
VPSRMNIGQILETHLGWAAKGLGQKIDRLLRANAAAGEVRGLLEEIYNGSGKPEDFSEFT
DGDVIELATNLKKGVPFATPVFDGAKEEEIAKMLELAGLPVGGQVTLFDGRTGEAFERKV
TVGYKHVLKLHHLVDDKMHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAY
TLQEMLTVKSDDVTGRTKVYENIVKGEHKIDSGMPESFNVLVKEIRSLAIDIDLDRE
>CAH15608.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MVYLAKEVLPVNIEDELKQSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFAMSELGNDWN
KPYKKSARVVGDVIGKYHPHGDTAVYDTIVRMAQPFSMRYMLIDGQGNFGSVDGDAPAAM
RYTEVRMSKVAHALLADLDKETVDFSPNYDETEFAPVVLPSRIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINACIALVDEPDTSLEDLMEIIPGPDFPTAAIINGRAGIIEGYRTGKGRV
VIRARTEIETDESSGRQSIIIQELPYQVNKARLIERIAELVRDKKIEGISGLRDESDKQG
MRVVIELKRNEVADVVLNNLFAHTQMQNVFGINMVALVDGQPRTLNLKQILEYFIKHRRE
VVTRRTIFELKKARNRAHLLEGLGIALANIDEMIALIKQSSTPQDAKSALLSKIWQPGLV
KAMLEKAGSNASRPDDLTEEYGLHENGYKLSEAQAQAILELRLHRLTALEQDKIINEFEE
LLNLIKELLDILASPERLMQVIRDELIEIKSQFGDERRTEITASQEDLTIEDLITEEDVV
VTLSHQGYVKYQPITAYQAQRRGGKGKSATHVKDEDFVERLVIASTHDTLLCFSNHGKLY
WLKAYQLPQASRASRGRPIINILPLAEGEEINAMLPVREYKDGSYVFMATKKGTVKKVPL
NAFSRPRSNGIIAVDLEEDDSLVGVDITDGARDIMLFTDAGKVIRFDESKVRPMGRTARG
VRGIRVEKDQAVKSLVVVDPSGGTILTATENGYGKRTHIDEYRVSGRGGQGVISIQVTER
NGKVVRSLQVTDNDEAMLITDKGTLVRFKVNELSVIGRNTQGVRLINVSSGEAVVGMQKI
VDLGEELEEAEDSSLNAEDSSDE
>AAN75468.1|FEATURES|megares|aminocoumarin|gyrB|antibiotic target alteration|0
MYIGSTGERGLHHLVQELVDNSVDEALAGVADRIDVTILADGGVRVVDNGRGIPVGTHPV
EKRPAVEVVLTVLHAGGKFGGGGYAVSGGLHGVGLSVVNALSTRLSAEIWTDGYRWTQDY
RDGAPTAPLARHEATSRTGTSLTFWADGDIFETTEYSFETLARRFQEMAFLNRGLTLTLT
DERPSARATAAADEADSDPAAKTVSYRYDGGITDFVAYLNSRKGEPAHPSVITIAAEDTE
RLLSAEVALQWNGQYTDSVYSYANGIHTHEGGTHEEGFRTALTTVVNRYAREKKLLREKD
ANLSGEDVREGLTAIISVKLGEPQFEGQTKTKLGNTEARTFVQKIVHEHLTDWFDRNPNE
AADIVRKAIQAATARVAARKARDLTRRKGLLETAALPGKLSDCQSNDPAMSEIFVVEGDS
AGGSAKSGRNPQYQAILPIRGKILNVEKARIDKILHNQEIQALISAFGTGVHEDFDIAKL
RYHKIILMADADVDGQHINTLLLTFLFRFMRPLVEEGHVYLSRPPLYKIKWGRDHVEYAY
SDRERDVLLERGRQDGRRIKDDSIQRFKGLGEMNAEELRVTTMDPDHRVLGQVTLDDAAV
ADDLFSVLMGEDVEARRHFIQRNAKDVRFLDI
>WP_000988063.1|FEATURES|megares|aminoglycoside|AAC(3)-VIa|antibiotic inactivation|1
MMTDPRKNGDLHEPATAPATPWSKSELVRQLRDLGVRSGDMVMPHVSLRAVGPLADGPQT
LVDALIEAVGPTGNILAFVSWRDSPYEQTLGHDAPPAAIAQSWPAFDPDHAPAYPGFGAI
NEFIRTYPGCRRSAHPDASMAAIGPDAAWLVAPHEMGAAYGPRSPIARFLAHAGKILSIG
AGPDAVTALHYAEAVARIEGKRRVTYSMPLLREGKRVWVTTSDWDSNGILDEYAAPDGPD
AVERIARDYLARTRVAQGPVGGAQSRLIDAADIVSFGIEWLEARHAAPAAAALKPKQRRD
>AFN51949.1|FEATURES|megares|ethambutol|embA|antibiotic target alteration|0
MGIPGGAGTLPPEKKPQVGGIFTDLKVGAQPGLSARVDIDTRFITTPGALKKAVMLLGVL
AVLVAMVGLAALDRLSRGRTLRDWLTRYRPRVRVGFASRLADAAVIATLLLWHVIGATSS
DDGYLLTVARVAPKAGYVANYYRYFGTTEAPFDWYTSVLAQLAAVSTAGVWMRLPATLAG
IACWLIVSRFVLRRLGPGPGGLASNRVAVFTAGAVFLSAWLPFNNGLRPEPLIALGVLVT
WVLVERSIALGRLAPAAVAIIVATLTATLAPQGLIALAPLLTGARAIAQRIRRRRATDGL
LAPLAVLAAALSLITVVVFRDQTLATVAESARIKYKVGPTIAWYQDFLRYYFLTVESNVE
GSMSRRFAVLVLLFCLFGVLFVLLRRGRVAGLASGPAWRLIGTTAVGLLLLTFTPTKWAV
QFGAFAGLAGVLGAVTAFTFARIGLHSRRNLTLYVTALLFVLAWATSGINGWFYVGNYGV
PWYDIQPVIASHPVTSMFLTLSILTGLLAAWYHFRMDYAGHTEVKDNRRNRILASTPLLV
VAVIMVAGEVGSMAKAAVFRYPLYTTAKANLTALSTGLSSCAMADDVLAEPDPNAGMLQP
VPGQAFGPDGPLGGISPVGFKPEGVGEDLKSDPVVSKPGLVNSDASPNKPNAAITDSAGT
AGGKGPVGINGSHAALPFGLDPARTPVMGSYGENNLAATATSAWYQLPPRSPDRPLVVVS
AAGAIWSYKEDGDFIYGQSLKLQWGVTGPDGRIQPLGQVFPIDIGPQPAWRNLRFPLAWA
PPEADVARIVAYDPNLSPEQWFAFTPPRVPVLESLQRLIGSATPVLMDIATAANFPCQRP
FSEHLGIAELPQYRILPDHKQTAASSNLWQSSSTGGPFLFTQALLRTSTIATYLRGDWYR
DWGSVEQYHRLVPADQAPDAVVEEGVITVPGWGRPGPIRALP
>AAQ81635.1|FEATURES|megares|macrolide-lincosamide-streptogramin|Erm(38)|antibiotic target alteration|1
MQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDAGLLTITRRSRPLV
DVADRARYQALVHRVFTGRGHGMAQILQRLPTPVPRTWLRANGIAPNSLPRQLSAAQWAA
LFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVGQRQPQRGRDADAD
PDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASFDSSASTTLVSRKA
RVNGPTPPGLGDT
>CBA29682.1|FEATURES|megares|multidrug|ompF|reduced permeability to antibiotic|0
MKRNILAVVIPALLVAGAANAAEIYNKNGNKLDLYGKVTAEHDFVTSGDNTSNGDATYAQ
LGFKGETQINDQLTGYGQWEYRAYATSAESEQGANNSNRTRLAFAGLKIADAGSIDYGRN
YGIVYDVESYTDMAPSYSGMTWANYSDNFMTGRTTGVLTYRNTGFFGLADGLNFGIQYQG
KNDRDNVATSNGDGVGYSLGYDFGEGFSLIGAYSNSNRTLQQKLDDKGDRAEAWAVGAKY
DANNLYLATVYAETRNMTREADNTFANKTQNFEAIAQYQFDFGLRPSLSYVQSKGKNLTA
RGTFDGGDADLQKYVEVGAYYYFNKNFNVYVDYQINLIDNDAYARNVGIVNGRDDQVALA
ATYQF
>AAC44614.1|FEATURES|megares|beta_lactam|pbp2b|antibiotic target alteration|0
MQVYNKSFYTKKLEDNSKYTVRIASERGQIFDAKGIALTTNQSKDVITFTRSNLVSSDTM
KSVAERLATLVTLTETKVTDRQKREFYLADSANYKRVVNDLPNDKKTDKFGNKLAEATIY
NNAINAVPDEAVDYSEDELKIVYIYSHMNAVSNFSTVILKTADLTPDQIAIVAAKQKELN
GIRVAKDWERHTSDSSLSPLIGRVSSSEAGLPQEDAKDYLKKGYALNDRVGTSYLEKEYE
EELQGKHTVREITVDKEGKVDSDKIIQKGSKGNNLKLTIDLDFQKGVEDILGQQLSSEIS
GNKATYSEGMYAVVMNADTGAVLAMAGQKHEQGAQDFKADALGTITDVFTPGSVVKGATL
TAGWRSGAIYGDQVLTDQPINIASSPPITSWFTDKGSRAITATQALEYSSNTYMVQIAIK
RLGQQYVPGMSLSTDNMEKAMTTLRDTYAEFGMGVSTGLDLPGESEGYIPKNYNVANVLT
EAFGQYDSYTTIQLAQYVASIANGGKRVAPHIVGGIYDAGKNGSLGTLSSTVDTRVLNKL
SLDSKQLGIIQQGFHDVVNSGSSLATGKAMASSIIPISGKTGTAETYATDGSGNSVTTVN
LNAVAYATAKDGTKLAVGIMYPHALDWKSKAHQNAVKAIMELYQNTH
>AAT36613.1|FEATURES|megares|beta_lactam|VIM-11|antibiotic inactivation|1
MLWSSNDVTQQGSRPKTKLCRTHPHGVLMFKLLSKLLVYLTASIMAIASPLAFSVDSSGE
YPTVSEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNT
AALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEVEGSEIPT
HSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSASVLYGGCAIYELSRTSAGNVA
DADLAEWPTSIERIQQHYPEAQFVIPGHGLPGGLDLLKHTTNVVKAHTNRSVVE
>AAK91784.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vatE|antibiotic inactivation|1
MTIPDANAIYPNSAMIEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
KLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGN
DVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALEN
LAWWNKDIEWITANVPKLMQTTPTLELINSLMEK
>CAD32686.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmT|antibiotic target alteration|1
MNKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFTFELAKRCNYVTAIEID
PKLCRITKNKLIEYENFQVINKDILQFKFPKNKSYKIFGSIPYNISTDIIRKIVFESTAT
ESYLIVEYGFAKRLLNTNRSLALFLMTEVDISILSKIPREYFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRK
>WP_001152989.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MQDKNLVNVNLTKEMKASFIDYAMSVIVARALPDVRDGLKPVHRRILYGMNELGVTPDKP
HKKSARITGDVMGKYHPHGDSSIYEAMVRMAQWWSYRYMLVDGHGNFGSMDGDSAAAQRY
TEARMSKIALEMLRDINKNTVDFVDNYDANEREPLVLPARFPNLLVNGATGIAVGMATNI
PPHNLGETIDAVKLVMDNPEVTTKDLMEVLPGPDFPTGALVMGKSGIHKAYETGKGSIVL
RSRTEIETTKTGRERIVVTEFPYMVNKTKVHEHIVRLVQEKRIEGITAVRDESNREGVRF
VIEVKRDASANVILNNLFKMTQMQTNFGFNMLAIQNGIPKILSLRQILDAYIEHQKEVVV
RRTRFDKEKAEARAHILEGLLIALDHIDEVIRIIRASETDAEAQAELMSKFKLSERQSQA
ILDMRLRRLTGLERDKIQSEYDDLLALIADLADILAKPERVSQIIKDELDEVKRKFSDKR
RTELMIGQVLSLEDEDLIEESDVLITLSNRGYIKRLDQDEFTAQKRGGRGVQGTGVKDDD
FVRELVSTSTHDHLLFFTNKGRVYRLKGYEIPEYGRTAKGLPVVNLLKLDEDESIQTVIN
VESDRSDDAYLFFTTRHGIVKRTSVKEFANIRQNGLKALNLKDEDELINVLLAEGDMDII
IGTKFGYAVRFNQSAVRGMSRIATGVKGVNLREGDTVVGASLITDQDEVLIITEKGYGKR
TVATEYPTKGRGGKGMQTAKITEKNGLLAGLMTVQGDEDLMIITDTGVMIRTNLANISQT
GRATMGVKVMRLDQDAQIVTFTTVAVAEKEEVGTENETEGEAMARRARVDAELVRRGLAR
SRQQAAELIGAGKVRIDGLPAVKPATAVSDTTALTVVTDSERAWVSRGAHKLVGALEAFA
IAVAGRRCLDAGASTGGFTEVLLDRGAAHVVAADVGYGQLAWSLRNDPRVVVLERTNARG
LTPEAIGGRVDLVVADLSFISLATVLPALVGCASRDADIVPLVKPQFEVGKGQVGPGGVV
HDPQLRARSVLAVARRAQELGWHSVGVKASPLPGPSGNVEYFLWLRTQTDRALSAKGLED
AVHRAISEGP
>WP_042852888.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGNEI
DVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQSGYKTSGGLHGVGA
SVVNALSEWLEVEIHRDGNIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFKAS
TSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVGYVNEGKEVLH
DVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDYAR
RINELKTKDKNLDGNDIREGLTAVVSIRIPEELLQFEGQTKSKLGTSEARSAVDSVVADK
LPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQSKN
TDKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIHTI
GAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPPLY
KLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETRTL
IRVQVEDELRSSKRVTTLMGDKVQPRREWIEKHVEFGMQEDQSILDNSEVQVLENDQFDE
EEI
>ACO54189.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGLGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>CAA54273.1|FEATURES|megares|nitroimidazole|nimD|antibiotic inactivation|1
MFREMPRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGKIYFHSAMQG
PKVDAILRNDKVSFCVVEQDEVKPAEFTTYFRSVIVFGKARILTDENEKRNALNLLADKY
SHGEAGMEAEMAKGFNHLLMIEITVEQMTGKEAIELTRGRNGCS
>AAK60187.1|FEATURES|megares|aminoglycoside|ant3-dprime|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIGLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>NP_252960.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAYSYTEKKRIRKDFSKLPDVMDVPYLLAIQLDSYREFLQAGATKEQFRDVGLHAAFKSV
FPIISYSGNAALEYVGYRLGEPAFDVKECVLRGVTFAVPLRVKVRLIIFDRESSNKAIKD
IKEQEVYMGEIPLMTENGTFIINGTERVIVSQLHRSPGVFFDHDRGKTHSSGKLLYSARI
IPYRGSWLDFEFDPKDCVFVRIDRRRKLPASVLLRALGYSTEEILNAFYATNVFHIKGET
LNLELVPQRLRGEVASIDIKDGSGKVIVEQGRRITARHINQLEKAGVSQLEVPFDYLIGR
TIAKAIVHPATGEIIAECNTELTLDLLAKVAKAQVVRIETLYTNDIDCGPFISDTLKIDN
TSNQLEALVEIYRMMRPGEPPTKEAAETLFGNLFFSAERYDLSAVGRMKFNRRIGRTEIE
GPGVLSKEDIIDVLKTLVDIRNGKGIVDDIDHLGNRRVRCVGEMAENQFRVGLVRVERAV
KERLSMAESEGLMPQDLINAKPVAAAIKEFFGSSQLSQFMDQNNPLSEITHKRRVSALGP
GGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLATYARTNKYGFLESPYRVVK
DSLVTDEIVFLSAIEEADHVIAQASATLNEKGQLVDELVAVRHLNEFTVKAPEDVTLMDV
SPKQVVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRADKPLVGTGMERNVARDSGVC
VVARRGGVIDSVDASRVVVRVADDEVETGEAGVDIYNLTKYTRSNQNTCINQRPLVSKGD
VVARGDILADGPSTDMGELALGQNMRVAFMPWNGFNFEDSICLSERVVQEDRFTTIHIQE
LTCVARDTKLGPEEITADIPNVGEAALNKLDEAGIVYVGAEVQAGDILVGKVTPKGETQL
TPEEKLLRAIFGEKASDVKDTSLRVPTGTKGTVIDVQVFTRDGVERDSRALSIEKMQLDQ
IRKDLNEEFRIVEGATFERLRAALVGAKAEGGPALKKGTEITDDYLDGLERGQWFKLRMA
DDALNEQLEKAQAYISDRRQLLDDKFEDKKRKLQQGDDLAPGVLKIVKVYLAIKRRIQPG
DKMAGRHGNKGVVSVIMPVEDMPHDANGTPVDIVLNPLGVPSRMNVGQILETHLGLAAKG
LGEKINRMLEEQRKVAELRKFLHEIYNEIGGREENLDELGDNEILALAKNLRGGVPMATP
VFDGAKEREIKAMLKLADLPESGQMRLFDGRTGNQFERPTTVGYMYMLKLNHLVDDKMHA
RSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMY
KNIVDGDHRMEAGMPESFNVLIKEIRSLGIDIELETE
>CBB44503.1|FEATURES|megares|macrolide-lincosamide-streptogramin|vgaA|antibiotic target protection|1
MKIMLEGLHIKHYVQDRLLLNINHLKIYQNDRIGLVGKNGNGKTTLLHILYKKIVPEEGI
VKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQ
DLKNWHGAFIIVSHDRAFLDNLCTTIWEIEEGRITEYKGNYSKYVEQKELERHREDLEYE
KYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGRIKGTKPYFAGKQKKLRKTVKSLET
RLEKLESVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDK
MAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQN
ETLIRTILARMHFFRDDVYKPINVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAI
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
EDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>SEP37262.1|FEATURES|NCBI|bleomycin|bleomycin|antibiotic inactivation|0
DHATPNLPSRDFDATIAFYERLGFRAGFRDTGWMILEREGLVLEFFAYPELDPLTSWFSC
CLRLDHLAEFYAQCKAAGIPESANGNPRLHAPKAQECGGIMAALIDLDGTLLRLIAN
>WP_021505085.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRAALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_047026538.1|FEATURES|NCBI|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPREEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_044030410.1|FEATURES|NCBI|aminoglycoside|ERS381446_03540|antibiotic inactivation|1
MIVNCDHDNLDAWLALRAALWPSSSPEEHRAEMREILASPHHTAFMARGPDGVFVAFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>WP_049198488.1|FEATURES|NCBI|aminoglycoside|ERS381446_03540|antibiotic inactivation|1
MIVICDHDNLDAWLALRTALWPSSSPEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>NP_863640.1|FEATURES|NCBI|qa_compound|qacD|antibiotic efflux|0
MPYIYLIIAISTEVIGSAFLKSSEGFSKFIPSLGTIISFGICFYFLSKTMQHLPLNITYA
TWAGLGLVLTTVVSIIIFKEQINLITIVSIVLIIVGVVSLNIFGTSH
>ACI31325.1|FEATURES|NCBI|aminoglycoside|aac|antibiotic inactivation|1
MSILPVKEQDAADWLALRNLLWLADDHASEIEQYFSGGLEGLVEVLIARDATGAAVGHVE
LSIRHDLEELQGIKTGYIEGLYVAPSHRSTDLVRRFLRESEKWALEQGCSAFASDRSDRV
ITHRKFAGSAV
>WP_061723211.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLKQPIQAQQLIELLKIHYGIDIHTAQFIQGGADMNAFAYQADSETKSYFIKLKFGYHDE
INLSIIRLLHDNGVKEIIFPINTLEAKLFQQLKHFKIIAYPFIHAPNGFTQNLTGKQWKK
LGKVLRQIHETSVPTSIQQQLRKEMYSPKWREIVRSFYSQIEIDNSDDKLCAAFKSFFNQ
HSAAIHQLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNDESIYIIDWDEPMLAPKE
RDLMFVGGGIGNVWNKPHEIQYFYEGYGEVNVDKTILSYYRHERIVEDIAVYGQDLLSRI
QNNHSRLESFKYFKEMFDPNNVVEIALATE
>AEU11363.1|FEATURES|NCBI|quinolone|qnrS|antibiotic target protection|1
MEIYSHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
VADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFIS
GCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLC
HAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD
>NG_047480.1|FEATURES|NCBI|rifampin|arr|antibiotic inactivation|1
MSATATMFAQSFFHGTKAALAPGDLIAVGYRSNFTDAKSLSWVYFTGTLDAAIWGAELAG
GSGTERIYVVEPTGAIEEDPNLTDKKFPGNPTLSYRSRDPLRVIAEVTKWQAHTAQRLRE
MKEGLARLNAEGAEIID
>ABO47752.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKNWLFLAIAIFGEVVATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAY
AVWAGLGIVLVAAVAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH
>WP_023215744.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iy|antibiotic inactivation|1
MDIRQMNRTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGANKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_023224993.1|FEATURES|NCBI|aminoglycoside|LTSESEN_2493|antibiotic inactivation|1
MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCNSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_023176579.1|FEATURES|NCBI|aminoglycoside|LFZ48_07285|antibiotic inactivation|1
MDIRQMNETNLEHWRGLRKQLWPGHPDDGHLADGEEILQADHLASFVAIEDGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQQWGMNKGCREIASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>AAY52008.1|FEATURES|NCBI|glycopeptide|vanZ|antibiotic target alteration|0
MGCSGFFSSYMYALFKIIVLKFGPTVVEFLWVRLMRNSTNPECIAARLHAGNLIPLKEIS
RASDSMSGHSLLNLFGNVGIFVPLGIFLGVLAKSGKLTLAGSSLVLECTQVLFSIGKFDV
DDLILNSTGGSIGFVVYALCARL
>EZX24288.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MLFLFEEKALEVEHKVLIPELTFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQTVDSAMME
QDLTPYNDWTVMDYIIESYPEIAKVRSQLNHTDMINKYIELDGYLIEGEIVTEAKKLGIK
EEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQRAI
LFVSHDRTFLNETPDAILELSPDGAKKYIGKYDKYKQQKDIEHETLKLQYEKQQKEQAAI
EETIKKYKAWYQKAEQSASVRNPYQQKQLSKLAKRFKSKEQQLNRKLDQEHIANPNKKEK
AFSIQHHDFKSHYLVQFNHVSFAYDNRKIFEDVSFYIKRNQNVIIEGRNGTGKSTLIKLI
LGELEPTKGNITVHPELEIGYFSQDFENLNMHNTVLDEILEIPEMNEADARTILASFYFD
KDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQEKIIQLIQSFQGSV
LIVSHDDYFKSQIKDQIWTIKNHQMTHENVQVKDPINTESMKHQLKELEQYTEERNRETE
F
>WP_002436859.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MANKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKKEELNNKEIEELRDIL
NDISKK
>WP_063856526.1|FEATURES|NCBI|glycopeptide|vanA|antibiotic target alteration|1
MYRVKIAILFGGCSEEHDVSVKSAKEIANNINTEKYEPIYIGITRSGVWKMCEKPCMDWD
NENCRSAVLSPDKRMHGLLVMRDKGYQIQRIDAAFSVLHGKSGEDGAIQGLFELSGIPYV
GCDIQSSAVCMDKSLAYIIAKNDGIATPEFWVINKDDRPAAAAFTYPVFVKPARSGSSYG
VKKVNGADELDAAIESARQYDSKILIEQAVLGCEVGCAVLGNSSELIVGEVDQIRLQHGI
FRIHQEAEPEKGSENAVITIPADLSAEERGRIRDTAKKIYKALGCRGLARVDMFLQDNGR
IVLNEVNTLPGFTSYSRYPRMMVAAGITLPELIDRLIVLALK
>NG_048396.1|FEATURES|NCBI|glycopeptide|VanM|antibiotic target alteration|1
MNRLKIAILFGGCSEEHNVSVKSAAEIANNIDIGKYEPIYIGITQSGVWKTCEKPCIDWD
NEHCRSAVLSPDKKMHGLLIMQDKGYQIQRIDVVFSVLHGKSGEDGAIQGLFELSGIPYV
GCDIQSSAVCMDKSLAYIIAKNAGIATPEFQVIYKDDKPAADSFTYPVFVKPARSGSSYG
VNKVNSADELDSAIDLARQYDSKILIEQGVLGYEVGCAVLGNSFDLIVGEVDQIRLQHGI
FRIHQEAEPEKGSENATITVPAELSAEERERIKEAAKNIYKALGCRGLSRVDMFLQDNGR
IVLNEVNTMPGFTSYSRYPRMMVSAGITIPELIDHLIVLAVK
>WP_031084431.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
RLHGNQVVLRAVTGSDIGTLDRIVREPEVAAWWSPPEDYRGMLAVVFEGEVVGAVQFHEE
TDPEFRHAGIDIFLTARQHGKGLGTDTVRTLARWLVEERGHHRLTIDPAAANTAAIRCYA
GVGFKPVGIMRAYARDHRTGTWQDGLLMDLLAAELT
>WP_003950682.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTTPADTAALDRIVREPEVALWWPPPEGYERMLAVVVDGEVIGAIQFSEE
TDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTYAVRSYR
KVGFAPVGIMRAYWRNHRTGEWEDGLLMDLLAAELT
>KDH28639.1|FEATURES|NCBI|beta_lactam|blaLEN-9|antibiotic inactivation|1
MRYVRLCVISLLATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>AHW59590.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphG|antibiotic inactivation|1
MKNTDIQKLAERHGLMLSDKMKFNEMGIDFKVGFATDKDENQWLLRIPRRPDLGKQIAKE
KLILQLVCKHLTAQVPDWKIANEELVAYPLLDGKPALTYDAETYEVSWNMDKDSPNYIQS
LAKILVQLHAIPKEEVVLNGLEVTTPESLRSEISERLRLVKSELGISNDLENRYKKWLDN
DTLWPNFTKFIHGDLYAGHILTYADGNVCGIIDWSTARISDISQDFSGHLTVFGEESLKS
LISEYEKQGGKIWNMIFEQAVERAAAAPLAYGYFAVETQDEVHINGAKVQLGV
>WP_021070327.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIKDIQILALEHGLKISDDISINEMGIDFRVAFVKEVDGQNWVLRIPRRKDMIEQIQNE
SRILDLAKRNLSVHVPDWKIVSERLIAYPLLEDAPALTFDAVTHEISWNIDPNSVAYVRS
LAKSLAELHRVASDDVRKSNLKIMEPNELRTETANRIQLVKSELGISETLESRYRRWLDN
DLLWPDFTCFIHGDLYAGHVLTTKEGKVSGIIDWSTAHMGDPAMDFSGHLSVFGEDSLKL
LITEYVKQGGTIWDKIYEQSIERAAAAPLAYGAFAIECNDDRHISAAKTALGI
>BAE06301.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MDNKTYEISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRSYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>CAA73545.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MDNKTYEISSAEWEVMNIIWMKKYASANYMIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKIFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>WP_009288847.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDLK
>WP_018664415.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVVFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAMI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFIADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDLK
>WP_008665090.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLEPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMECFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGVLIIGIAIACPMITEVRKLDLK
>ACG58977.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLMTSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSALFADRIGVNHWFLLSGILIICIAIVCPMINEIRKLDLK
>WP_024399345.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFYADRIGVNHWFLLSGILIIGIAIVCPMITEIRKLDAK
>BAA03776.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphA|antibiotic inactivation|1
MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVS
AKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDS
EVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRW
QRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFG
EEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAA
>CAJ98570.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphA|antibiotic inactivation|1
MLHDTDRILKLAREAGLELAPGSLRLNEMGLDFQVAFGRDGDAVEWVLRMPRRTDVACAA
VKEAKILDYFRSRLPVAVPDWKVFSDDLIAYPSLPGNPGLTFDASTYETTWHFDQNSPVY
VETLGAALAQLHGLDTDDAISAGLSNLSIDAVRENWTRDLETVEKSFEVPAARLALWRAW
LADLSFWPTHAASVHGDLYVGHVMVKSDGTVCGIIDWSEAHIGDPGIDLAGHLKVFGEAS
LRDLLGHYEAAGGQTWPRIVEHCKMLQSAEGIRYAMFALKTGSAEHLEGAQGLLSAPGI
>WP_012816701.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|0
MTKKYLNTQNEISVFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLIKSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_031906628.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|0
MTKKYLNTQNEILAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_032488596.1|FEATURES|NCBI|nitroimidazole|nimA|antibiotic inactivation|1
MFREMRRKRQLLPPEESLAILERMTGGTLALHGDNGYPYAVPVSYVYADGKIYFHGAVQG
HKMDAIRQHPEVSFCVVEQDRIVPAEFTTYFRSVIVFGKARILTDEVEKRAALLRLAEKY
SSGESGMQDEIDKGFDHLVMVEITVEHMTGKEA
>AHK10254.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAISGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>AMP48605.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLLIAAFLLAR
>YP_002791403.1.|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGLGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_063855074.1|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPTASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_032490794.1|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHSNARPVSPADE
IRRIGPLLDALSDQMHRVSINSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>NG_048085.1|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNPTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATAGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGELRSAIAFSETLAKFRSRDARDRGLDHA
>EZK20693.1|FEATURES|NCBI|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIERIAPVLDALKADGIPVSLDSYHPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>ACN76565.1|FEATURES|NCBI|beta_lactam|CF70_016075|antibiotic inactivation|1
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTAD
GAQLGYRANERFAMNSTFKVMLASAFLAQSQDEPGLLEERLTYTRADLVTYSPVTEKHVA
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRAPVVLALYSALENQQAEARNDVLADAARIVAEWVTG
>AAC12648.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|oleI|antibiotic inactivation|0
MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQGLVARGQRVSYGITDEFGAQVKAGRA
TAVVYGFILPEEFNPEELLAEDQGSRWACSLAEAFRVLPQLRTATPTTGRDLIVYDIASW
PAPVLGRKWDIPFVQLSPTSVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAE
DGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVGCRAPSQIKGDTVGDNYTFVGPTYG
DRSHQGTWEGPGHGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADL
GEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERI
VELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGIL
AEAG
>WP_035278955.1|FEATURES|NCBI|aminoglycoside|kamB|antibiotic target alteration|1
MRRVTGKQVVDLDAAGFAAHRARYPRAVLDVGTGDGKHPQHLARERPDTLVVGLDAAKDN
MRKAATRAAAKPARGGLPNLLYVWSAAEHLPEGLTGFTELHVLMPWGSLLRGVLGSDPTM
LRGLAAACEPGAEFLVTLNLHAWQPPVPEVGEHPEPTPESAVEDLGPALAAAGWRLDTAA
YLDAAEIAALATSWTRRLNSSRDRLEVLALTGVVNP
>WP_041219811.1|FEATURES|NCBI|glycopeptide|SCO3595|antibiotic target alteration|1
MNRLKIAIIFGGCSEEHSVSVKSAQEVAKNLDLEKYEPYYIGITQNGVWKLCHFPEANWE
NSCCLPAMLAPDSGVHGLIVLEQGKYKMIPLDMVFPVLHGKFGEDGAIQGLLELSCIPYV
GCDIQSSALSMDKSLAYIVAGNARIATPNFWTFTENEDMDPDRFIYPVFVKPARSGSSFG
VTKVCREEELLSAVEIARQYDSKVLIEEAVVGSEVGCAIFGDDPDLTAGEVDQISLSHGF
FRIHQESEPENGSENSTIIVPADISTEMRLHIQETAKAIYRALGCRGLARVDMFLKEDGE
VILNEVNTLPGMTSYSRFPRMMAAAGLTFAEVIDRIVALTL
>WP_004857142.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
LDPAQPLTEAPPMSLFESWNKPIAPFQIFKNVYYVGTENLSSILIDTGKGLVLIDAGIDQ
SAEQIKGNIERLGFDIKNVKYLLNSHARLDQAGGFAKLKQWSGAQLVASPENAKMLENGA
ATDFALGAQLPFPPVKADVILKDGESIHLGRQTFTAHATPGHLPGSTSWTTKIRKNFKTY
NLIYADSLFTGGYYLINNKNYPTIVSDIEGTFSKLNAIHADIFLANKADRFDMLAKLKRL
QAGDQQAFIDPQGLQNYVKKGQDDFEKQLQ
>CDO67671|FEATURES|NCBI|beta_lactam|mecB|antibiotic target replacement|1
MKNKALAILIICICLLIAYNFVKKDEVDKIFDAIELRDSEYLNEHATFLSKSLYDKDQRY
KRMDKIDASLGIKEVKVSNVRLVQKKKNKRQYSANLNFRTKYGNFSREGNYSFEKDEITK
NWFLDWSPEVIIPGLTDRNQISIETLESFRGKILDRNGIDIAKDGIHYEVGIDIKNLNKK
NKKNISKLLSISESTLNKKLKQTWVKEGVFVPLKSYIELDDELKLGIQKYHLTVNQTKGR
VYPLREATVHLLGYVGEINAEELKNKKFKDYDEHSIVGKSGIELQYDKQLQNKDGYKVVM
TSDDALNNDEDVLLEKKPKNGQDIILTIDSKVQRSIYSHLKEDNGSGVAMNPKTGELLAL
VSYPAYDPYEFMFGISDENYKKIVNDKKEPLLNKFQTTSSPGSTQKLITSIIGLKNGTID
ASTNYNIVTKGWQRNASWGGYEVTRFEEVNGDIDLEKAIAHSDNIFFARATLDMGSEKFI
KGMKALDIGRNIPSDYYFQKGQIANPESLKNNLKNEILLADSGYGQGEILISPVQILSIY
SALINEGKMMKPKLFETTKEDIWKNHIISKDDVDILTRSMRKVVTGTHRLDAERNYAQFA
GKTGTAELKTSREEGLGAQIGWFVGYDQNNPNMMLGISVKNVENRGMSSYNARKFAEIMD
ELYENGNKKYEIDR
>WP_025159717.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNTQLMAYYRAWQPKHPVGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYIQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWREALAGTHVGYYKAGAFTQDLMWENYPYPVKLPRLIE
GNNAGMIMNGTPATVLTPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYRIIQALDKR
>WP_051139090.1|FEATURES|NCBI|aminoglycoside|AAC(6')-34|antibiotic inactivation|1
MLVQQGRLAIRVLQKSDAPVMLRWLQDERVLEFYEGRDKHFDLQTIIEVFIDDQGETTPC
LVLLDDKPLGYVQFYPLDREDKQALELPVEDVIYGLDQFIGEPDFWGLGLGTQLVLLVRD
YLITKKAAHRLVLDPQSRNSRAIACYEKCGFEKLRMLPAHEMHEGQLQDCWLMQYYPARS
NLIASSRPKI
>WP_033954903|FEATURES|NCBI|beta_lactam|blaOXA-/1-262|antibiotic inactivation|1
MRPLLFSALLLLSGRAQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMRANVSHLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>ADC79555.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAMLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLKKQRGG
>ADC79567.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDQLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLKKQRGG
>WP_016650254.1|FEATURES|NCBI|beta_lactam|MUS-2|antibiotic inactivation|1
MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGA
ILIDTPWDKDQYEPLVDYIRTNHNKEIKWVITTHFHEDRSGGLGYFNSTGAQTYTYALTN
EILKERNEPQAQHSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKS
AEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQ
HSTKND
>WP_019976234.1|FEATURES|NCBI|beta_lactam|EBR-1|antibiotic inactivation|1
MKKIVSLLTLISVFAFGQIKPIQIDSIRNNLFVYQTFNTFQGVEYNVNAMYLVTKKGIVL
FDVPWQKSQYQTLNDLLEKKYNLPVIAVFVTHSHEDRAGDLSFYNDLNIPTYASALTNTI
LRKEGKATSKFEIELGKTYTFGKEKFVVEYFGQGHTEDNVVVWFPKYKVLNGGCLIKGAD
AINLGYTGEANITEWPETMKKLVSKYPTIKQVIPGHDNWKASGHIENTFKLLENN
>WP_044291145.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAV
ELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQVR
>WP_031745439.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVLAV
ELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>WP_031701027.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAV
ELHPRRVGVLRERFLGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>WP_006597334.1|FEATURES|NCBI|tetracycline|tetB(46)|antibiotic efflux|1
MKVLKRLLSQITLYPTVFLSGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLL
QMGSFYLLVLSLGQLISYLGNRILLHGSNQVTASLRDQAFQVMQGLPISYFDDKPAGKIA
TRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLY
KVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRIL
LADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLS
RQFPNIRRSLETGSRVLAFLDQPLEADGVSELKIEKAQVVFDDVQFAYEEGKPVLQDIAF
QASPGETIALVGHTGSGKSSIMNLLYRFYDPQEGAILIDGQDIRQVSRESLRSHMGIVLQ
DPYLFTGTIASNVAMSQDHIDRDAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGE
RQLISFARTLYMNPQILILDEATSHIDTETEEIIQQAMAVLQKGRTTFIIAHRLSTIQDA
DQILVLSEGRIVERGRHEELVTQGGIYALMNAIQQTVV
>AGT57825.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|lnuE|antibiotic inactivation|1
MGKNNVTEKHLFYILDLLKDLQITYWLDGGWGVDVLTGKQQREHRDIDIDFDSQHTDKLV
KKLKEIGYITVVDWMPSRMELKHEEYGYLDIHPLDLKKDGTATQADPKGGFYLFEKDWFT
TTNYKNRKIPCISKEAQLLFHSGYELTEKDQFDIKNLNSI
>WP_011116969.1|FEATURES|NCBI|multidrug|msbA|antibiotic efflux|0
MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGISAFV
PVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLS
SGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISL
AIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATR
FHAETAKANGLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVAL
LVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEP
AERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILR
RLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQAD
VVAAVAALRADKTTVVITGNAAWQHAGTELEVA
>WP_005323423.1|FEATURES|NCBI|multidrug|tetAB|antibiotic efflux|0
MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGTGISAFV
PVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLS
SGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAAGAMVAMWSVSPWISL
AIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVAER
FHSETAKAKRLMLTHLRVEVWLGFARFCVAWLCNLAIVGLSAWMTLRGEITPGQLTSVAL
LVPPALDMAGFAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEP
AERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILR
RLGGIDAGGELPDAPLGEAGLNLSGGQRQRVALARALAADSDVLILDDPTTGLDSVTQAD
VVAAVAALRADKTTVVITGNAAWQHAGTELEVA
>CAD60196.1|FEATURES|NCBI|aminoglycoside|aac(6')-Ie|antibiotic inactivation|1
MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFR
VIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLI
FEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYD
DIATNVKAMKYLIEHYFDNFK
>AAA26057.1|FEATURES|NCBI|chloramphenicol|cmlA1|antibiotic efflux|1
MSSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWALQSVLGFIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAGSTSNPNR
>ADC34600|FEATURES|NCBI|chloramphenicol|cmlA8|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTTSTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAIGPLLGALVDTWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPIKCLNFWLYTLCYTAGMGSFFVFFSIAPGLM
MGRQGVSQLDFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWVSQSVLGFIAPMWLVGVGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIIWLLPRNTAWPVVVYCLTLATVVLGLSCVSRAKGFRGQREHDVVALQNAESTSNPNR
>ZP_10221377.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
PSLLPPPPRYMVSESAMRSVRNPKEIETESGGRLGVALVDGKGALILGFNRDERFAMCST
FKAPLAAAVLAGAEGGKFGLEGQISFAKADLLDYAPVVRKNVKRGRMSMEELAAAAVEVS
DNSAANLLLPMVGGPEGLTRFIRAHDDMVTRLDRNEPSLNENAEGDERDTTSPAAMAGLM
GRLIFRDLAPESAGKLRGWLNASTTGANRIKAGLPKGWTSGSKTGSCGTAYNDVALVKAP
SGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFVDKAQKTGLE
>WP_050571857.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>WP_023572056.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|EreB|antibiotic inactivation|1
MKNIKPLTFPFNSENNTSIKQSLFQFREYFDSSTIVGLGENSHFIKEFFKFRHQVIEFLV
TECDFDTLAFEFGFSEGLEVDKWIKSQIPFDDLDKLLSHFYYPNEFKDTLLWLRRYNQDN
NNQITFLGVDIPKNGGSYFPNFHIVSDYLQRLSIVSSDVLQKILNLAEKFDFYSTSQLAL
NLSLFDEAEHNELKALLLKVYIRLVTLQPKLESLEFQSILHLVKGLIYMNYNADAMESFI
TEKGIEGDMGAKDQYMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQR
LSMTFGEKYKAFAITNLRGETAALYPDNDYQFGFRVDKFPLDSPESDSVEFFMQELSGKE
CCLIINKSKELKNCSKIRFDSIHLKTEIVDSFDGIFLIEKSTVSEIVD
>WP_014519945.1|FEATURES|NCBI|beta_lactam|III_02866|antibiotic inactivation|1
MKKIVNSKLKLNKFKMCIFISILIFSLTGCGNVENKTSENTKPEIQYNSAFSKIESDYGV
KLGVYAFNTETNKEVTYNADKRFAYCSTFKSLISGAILQKYSSDQLKQVIKYSPKDVLSY
APVTKNHVDKGMTIEELCDAAVRFSDNTAANLLINLIGGPNGFKSALNQLGDTVTEPARI
EPELNVATPGDNRDTSTPRQLSIDLKEYTTGNILSDDKKKILIDWMSGNATGDKLIRAGA
PKDWMVSDKSGTGSYGTRNDIAIVIPPNKKPIFVAILSSKNAKDAKYDDKTISEASKIVF
DYFINTRK
>WP_032877719.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSAKLKILTLSISLVLGLPLMACQSFSQQKQQIMTQKSEQQQIASLFQNAQTSGVLVIYD
GKKIQKYGNDTSRAEHRYIPASTFKMLNALIGIQHHKTTPNEIFKWDGRKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTQEIKRVGYGNNNVGTQVDNFWLVGPLKITPVEE
VRFAYALAKQKLPFDQSTQQQVKGMLLLDEVQGAKIYAKSGWGMDVSPQVGWWTGWIEQA
NGKITAFSLNMEMSQPEHAETRKAIVYQALQQLDLLVN
>ALU64000|FEATURES|NCBI|beta_lactam|VCC-1|antibiotic inactivation|1
IEAAFEGRVGVYAINTGSGKAYSYRANERFPLCSSFKAFLAAAVLKMDQDSPGVLLEKVN
YHNRTMEPHSPITEKFQSQGMAVGELAAATLQYSDNGAANLLMEKYIKGPEGMTQFMNSI
GDTKFRLDRWELDLNSAIPGDERDTSTPKAVAESLNKLISNTVLDNYHQEIFKKWMIGNT
TGDNRIRAAVPDGWVVGDKTGTCGKYGTANDHAFILQGNNAAPLILSIYTTRKGEHMKHD
DEVIAKAARIAIENV
>WP_034662014.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKYIKWLFTGMMLMALCISQPSSTEGASPAWSVDEFLKDREGTFVIQEVKEKSPWVYN
KKRAKERFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDRWNRDHTLGSGMRDS
VVWYYQAMARDIGEERMSQWVKAIHYGNEDISGGIDQFWLSSTLRISPVEQVRFLKQLYE
ETLPFDLNAMRTVKRMMIQEEEKHGTLYGKTGSGSGIGWYVGFIKHENKTYIFATNIEGT
GIEAKEITYLILKKYHLIEASV
>WP_064497915.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKHMKWLVSSIMLMTLCIGQPSSSEGTSPAWSVDEFLKDREGTFVIQEVKEKSPWVYN
KKRANQRFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDNWNKDHTLGSGMRDS
VVWYYQAMARDIGEERMSHWVKAIHYGNEDISGGIDQFWLSSSLRISPIEQVHFLKQLYE
ESLPFDLSVMRTVKRMMIQEEEKHATLYGKTGSGSGIGWYVGFIKHENKTYIFATNIEGT
GLEAKEITYRILKKYHLIEASV
>WP_034324889.1|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKHMKWLFSGVMLMALCMSQPLSSEGTAPTWSVDDIMKDREGTFVIQEVNEKSPRVYN
KKRANKRFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDSWNRDHTLGSGMRDS
VVWYYQAMARDIGEERMSQWVKAIHYGNQDISGGIDQFWLSSTLRISPLEQVRFLKQLYE
ERLPFDRSVMKTVKRMMIQEEEENATLYGKTGSGSGIGWYVGFIKYKSKTYIFATNIEGT
GIEAKAITYRIFKKYHLIEASL
>WP_023255163.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLVLSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDIYQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPVAQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEEYAATLRAAQREYLGLEQQDWH
ILLTAVVRFVDFAKAHIPTQFT
>WP_058145124.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPAREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPAVQLLKALRYPLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAAPLRAAQREYLGLEQQDWH
ILLPAVVRFVEFAKTHIPTQFT
>WP_046093434.1|FEATURES|NCBI|aminoglycoside|aadA9|antibiotic inactivation|1
MTLSIPPSIQRQTDAACRLITHVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTIGQPLTE
AQRATLMQELLALSSPSGASAETRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPVPTAQLLKALRYPLDLWQSAADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEDYAATLRAAQREYLGLEKKDWH
ILLPTVVRFVDFAKAHIPTQFT
>WP_024130566.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLNQPLRIDDIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLR
LAARDLRDTDQRVYDICLKYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_043017862.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDENLNQPLRIDDIARHAGYSKWHLQRLFMQYKGESPGRYIRERKLL
LAARDLRDTDQKVYDICLKYGFDSQQTFTRIFTRTFSQPPGAYRKENH
>WP_061493847.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIAAHAGYSKWHLQRLFLQYKGESLGRYIRERKLS
LAARDLRDTDQRVYDICLKYGFDSQQTFTRIFTRTFNLPPGAYRRENH
>WP_020454607.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDDIAAHAGYSKWHLQRLFLHYKGESLGRYIRTRKLS
LAARDLRNTDQKVYDICLKYGFDSQQTFTRIFTRTFNQPPGAYRRENH
>WP_043001487.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLNQPLRIDDIARHAGYSKWHLQRLFLQYKGESLGRYIRERKLL
LAARDLRESDEKVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENH
>WP_034460676.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVQWIDDNLHQPLRIDDIADHAGYSKWHLQRLFMQYKGESLGRYIRERKLL
LAARDLRDTDNKVYDISLKYGFDSQQTFTRIFTRTFHQPPGRYRRDNH
>WP_049849962.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIETIVEWIDDNLHQPLRIDDIARHAGYSKWHLQRLFLQYTGKSLGRYIRDRKLL
LAARDLRDTDQRVYDICLKYGFDSQQTFTRIFTRTFKQPPGAWRKQNH
>WP_013367196.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDAIVDWIDDNLHQPLRIEDIARHAGYSKWHLQRLFVQHKGENLGRYIRKRKLL
LAAQDLRDTNQKVYDISLKYGFDSQQTFTRVFTRTFKQPPGAWRKEHQ
>WP_064548100.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELATQVIDTLVEWIDENLHQPLRIDEIARRAGYSKWHLQRLFLQHKGESLGRYIRQRKLN
LAADELCTTDQKVYDICLKYGFDSQQTFTRIFTRTFNQSPGAYRKVHH
>WP_017372583.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
SIPEQVIETLIDWIDHNLDQPLRIDDIARHAGYSKWHLQRLFLQHKGESIGRYIRTRKLH
MAARDLRNSNEKVFEICLRYGFDSQQTFTRIFTKTFHQPPGAWRKDTS
>WP_024551435.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETLTGWIDDNLHKPLRIDDVARHAGYSKWHLQRLFHHHKGESLGRYIREKKLS
LAARDLRATNEKVLDISLKYGFESQQTFTRLFTRHYSLSPGSYRRQAN
>WP_007665712.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETLTDWIDDNLHKPLRIDDIARHAGYSKWHLQRLFHHHKGESIGRYIREKKLR
LAAQDLRATNDRVLDISMKYGFDSQQTFTRLFTRKFQMSPGTWRKQGD
>WP_002436152.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETITGWIDDNLHKPLRIDEIARHAGYSKWHLQRLFQHHTGESLGRYIREKKLR
LAAQDLRQTDARVLDISLKYGFESQQSFTRLFTRKFNMSPGHYRRQGD
>CAD12765.1|FEATURES|NCBI|beta_lactam|blaIMP-12|antibiotic inactivation|1
MKKLFVLCIFLFLSITASGEVLPDLKIEKLEEGVYLHTSFEEVSGWGVVTKHGLVVLVNN
DAYLIDTPFTNKDTEKLVAWFVGRGFTIKGSVSSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKNGKVQATNSFSGVSYWLVKNKIEIFYPGPGHTQDNVVVWLPENKILFGGCFVKP
DGLGNLDDANLKAWPKSAKILMSKYGKAKLVVSGHSEIGNASLLKLTWEQAVKGLKESKK
PLLPS
>CAB94707.1|FEATURES|NCBI|beta_lactam|blaIMP-2|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGARLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYVKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPS
>AFG73659.1|FEATURES|NCBI|beta_lactam|blaIMP-28|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAAESLPDLKIERLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVGRGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVSYWLVKNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLMSKYGKAKLVVPSHSEVGDASLLKRTLEHAVKGLNESKK
PSKPS
>WP_023603253.1|FEATURES|NCBI|quinolone|QnrVC1|antibiotic target protection|1
MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFD
YCDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYIT
GCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLC
HCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD
>AAV49760.1|FEATURES|NCBI|aminoglycoside|aadA12|antibiotic inactivation|1
IEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRRAL
INDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAT
IDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNV
VLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHL
EEFIRFVKGEIIKSVG
>ACD45687.1|FEATURES|NCBI|aminoglycoside|aadA16|antibiotic inactivation|1
AEISVQLSQALNVIEHHLGSTLLAVHLYGSALDGGLKPCSDIDLLVTVTAQLDETVRQAL
FVDFLEVSASPGQSEALRALEVTIVVYGDVVPWRYPARRELQFGEWQRKDILAGIFEPAT
TDVDLAILLTKARQHSLALAGSAAEDFFNSVPESDLFKALADTLKLWNSQPDWAGDERNV
VLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEAQQAYLGQGMDCLASRADQL
TAFIYFVKHEAASLLG
>WP_005413282.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIRTPHARLWPVLTAADEPAMLKISSETEEQNSHRLLRWWNGDG
AARLLAHEGPAILIERARGDSLRQRSIKGDDDACTAILCQVLQRLHRPRSAPPAKLVCLR
TWFADLLQPRAVLPPLLEQCRSLAEGLLRDEQEIRPLHGDLHHDNVLDFGPRGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAIRLEQVCALAELERTRLLRWIAASTA
LSAVWFRDDGDPADIDETVARMALEALAER
>WP_021201775.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAICTPHARLWPVLTAAGAPAMLKISSEAEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERASGDSLRQRSIAGDDDACTTVLCQVLQRLHRPRSAPPAELVCLR
RWFADLLQPRAALPPLLEQCRSLAEGVLRDEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARVEQVTALAGLERTRLLRWVAASAG
LSAVWFRDDGDPAVVDESVARMALQALAEA
>WP_058980063.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAICTPHARLWPVLTAAGAPAMLKISSEREEQNSYRLLRWWDGDG
AARLLAHEGPAILIERAEGDSLRQRSIAGDDDACTTVLCQVLQRLHRPRSARPAELVCLR
RWFADLLQPRAALPPLLEQCRSLAEGVLRDEQEIQPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTALFSNPDLCGPGIHIATRPERFAARLEQVTALAGLERTRLLRWIAASAG
LSAVWFRDDSDPAEVDEAVARMALEALAEA
>WP_049445378.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIETPHAQLWPVLTAAGEPAMLKVSSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIDGDDDACTTLLCQVLQRLHRPRSAPPDDLVCLR
RWFVDLLQPRAALPPLLEQCRSLAEGLLRDEREIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGAGIHVATRPERFAARLEQVSALAGLERTRLLRWIAASTA
LSAVWFRDDGDPADVDEAVARMALEALAEG
>WP_049421949.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTAAGEPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIKGDDDTCTTVLCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPTLLEQCRSLAEGLLQQEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFATRLEQVGALAGLERTRLLRWIAASAG
LSAVWFRDDGDPAEVDEAVARMALEALAEG
>WP_057502846.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTIAGEPAMLKISSETEEQNSHRLLRWWEGDG
AARLLAHEGPAILIERAGGDSLRQRSIKGDDDACTTILCQVLQRLHRPRSAPPAELVCLR
RWFADLLQPRAALPPLLEQCRSLAEGLLQEEREIRPLHGDLHHDNVLDFGTRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATQPERFAARLEQVSALAGLERTRLLRWIAASAG
LSAVWFRDDGAPAEVDEAVARMALEALAEG
>WP_053449693.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGASIKTPHAQLWPVLTAAGEPAMLKVSSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERACGDSLRQRSIDGNDDACTTILCQVLQQLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSMAEELLQDEQEIRPLHGDLHHDNALDFGPRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAVRLEQVSTLAGLERARLLRWIAASMG
LSAVWFRDDGDPADVDEAVARMALEELAEG
>WP_049467360.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPSIRTPHARLWPALTASGEAVMLKVSTETEEQNGHRLLRWWNGDG
AARLLAHEGPAILIERAHGDSLRLRSIKGDDDACTVILCQVLQQLHRPRSAPPEDLVCLR
RWFADLLQPRAPLPPLLEQCRSLAMALLEDEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFHARVEQVCRLADLERARLLRWIAASAG
LSAVWFRDDGDPADIDEAVAVMALQALAEA
>WP_065198619.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGDAVQTPHARLWPVLTAAGEAAMLKVSSEPEEQHSHRLLRWWDGDG
AARLLAHEGPAILIERAHGDSLRRHAIAGADDACTTILCQVLQRLHRPRRDPPSDLVRLH
TWFADLLLPRAPLPPLLEQCRSLAGTLLQEEHEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRVFDYTTLFSNPDLCGPGIHVATRPERFAARVEQVTSLAGIERTRLLRWVAASAG
LSAVWFRDDGDPADVDESVARMALQALAEA
>AAB24284.1|FEATURES|NCBI|aminoglycoside|aac(6')-Ib4|antibiotic inactivation|1
VTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAML
NGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFN
DPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>WP_011245129.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
NQTPSISEAEWEVMKVLWKKGPQTANQVISAIQEQTDWKPKTIRTLLDRLTKKKVVGVDK
EQKIYVFFPLYSEEECKHAEAQSFVKRVYGGTVKPLLVQFLEEESLTKEELDELYAILEQ
K
>WP_047971837.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KEMPSITEAEWEVMKVLWKESPLPANKVCTAIQAHEDWNPKTIRTLLDRLTKKKVVAVNK
EQRVYTFTPLYSEHECQRAETQSFIDRIYGGTTKSLLVQFIEDETLSKEELKELREILDK
K
>WP_059103198.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
RKVPSISQSEWEVMKMLWGNAPQTANEVIASIREQTDWSPKTIRTLLDRLTKKEVIDVNK
EKKVYTFFPLYSEDECQRAETQSLIKKIHGGTMKSMLIQFIEEDSFSEEEIQELRSILDK
K
>WP_010283772.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KEIPNISESEWEVMNVLWENAPLTANDVISSLQEKTDWKPKTVRTLLDRLVQKNVIGVNK
NQRVYTFFPLYSQDECQRAEAQSFIKRIYGGALKSMLVQFVQEDSLSEEDISELRSILDE
K
>WP_014369847.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
GQVPSISEAEWEVMNVLWERAPQTANEVIACLQERTDWKPKTTRTLLDRLVKKEVVGVDQ
NQKVYTFYPLYSQSECQLAEAQSFLKRIYGGTLKSMLVQFIEEQPMSEEEMKELHTILQE
K
>WP_042531371.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
EKVPSISEAEWEVMNVLWEKSPQTANDVITSLQGQKDWKAKTVRTLLDRLVQKGVAGVNK
EQRVYTFYPLYSQDECQRAEAESFIKRIYGGTVKSMLVQFIEEDSLSEEEIEELKSILDE
K
>WP_026287266.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
NKIPTISESEWEVLKVLWQKAPQTANEIISSLPAETNWKPKTVRTLLDRLSKKEVIGVNK
DQRVYTFYPLYSQNECQRAKTESFVKRFYDGTLKSMLVQFMQDEDLSEDDIKELRAILDN
K
>WP_035396666.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
KNMPSISDAEWEVMKVLWKNPPKSASQVVTELKALVDWKPKTIRTHLDRLTKKEIIKVNR
DERLYTFTPLFSEDECKRAETNSFIKRVHDGTTKSMMLQFIEDETLTKEDLQELRSLLDE
K
>WP_024448191.1|FEATURES|NCBI|tetracycline|tetV|antibiotic efflux|1
VLAPFRFREYRLLIAAVSVSIFAEGMWAVVMALQVIELSNDPAALSLVATCLGVGLVAFV
LVGGLAADRLNQRAIIIAVEAVNTAVVAGIAVLGMVGALQIWHMAVAAAALGIAAAFFFP
AYSAILPRILPAEQLLAANGVEGMVRPVFQRAVGPAVAGLLIGATFPSLGAVAVAALFGV
GLILLVATRSSIVKNVDPQADQENPHLLRDLRDGVSFVRRTPWLLWTLLFASIFVLVVLG
PIEVLLPFIAQDRFTHGAQSYGFILAFFGVGSALGALTVSSRRMPRRYLTTMMAMWGVGS
IPLVIVGITSSFPLMALATFVIGVTDGAGMVIWGTLLQRRVPPEMLGRVSSLDFFVSLAF
MPVSFAIVGPLSKIVPMETIFLAAGIVPVLVAVVAIRAAKMHRDELTHPL
>WP_064280346.1|FEATURES|NCBI|tetracycline|tetV|antibiotic efflux|1
VLAPFRIREYRLLITAVSLSIFAEGMWAVVMALQVIELSNDPAALSLVAACLGAGLVAFV
LVGGLAADRLNQRAIIIAVEAVNTAVVAVIAVLGIVGALRIWHMAVGAAALGIAAAFFFP
AYSAILPRILPAEQLLAANGIEGMVRPVFQRAVGPAVAGLLIGATYPSLGAVTVAMLFGV
GLILLVATRPAMVKDVDPQPDQPRPHLLRDLRDGFSFVRRTPWLLWTLLFASIFVLVILG
PIEVLLPFIAQDRFTHGAQSYGFILAFFGVGSALGALTVSSRRMPRRYLTTMMAMWGAGS
IPLIVVGMTSSFPLMALATFVIGVTDGAAMVIWGTLLQRRVPPEMLGRVSSLDFFVSLAF
MPVSFAIVGPLSKVVAMETIFLAAGIVPVLLAAVAIWAAKMHRDELAHPL
>AEM62948.1|FEATURES|NCBI|tetracycline|tetL|antibiotic efflux|1
MNTPHSHSNLRHNQILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWVNSSFIL
TFSIGTAVYGKLSDQLGIKKLLLFGIIVNCFGSVIGFVGHFFFPVLILARFIQGVGAAAF
PALVMVVIARYIPKENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTII
TVPFLAKLLKQEEVIKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNI
RKVSNPFINPSLGKNVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIF
PGAMSVIVFGYIGGLLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFG
GLSFTKTVISTIVSSSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKLLPI
NAEPSTHLYSNLLLLFAGITIISWLVTIKMHKRSRGNI
>AAA98167.1|FEATURES|NCBI|tetracycline|tet(L)|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFML
TFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFSLLIMARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITII
TVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHI
RKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIF
PGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLG
GLSFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPM
EVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRD
>WP_054424918.1|FEATURES|NCBI|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAALDYTLLALSGVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAVGGLAGDISPHLPFVIAAILNACTFLMVFFLFK
PAVQAEEKPAEQKAESAGISFVTLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAMHVLFQAVVAGILAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVTGPLLFAFIFSQTQQ
SADGTVWLIGTALYGLLLAICLLIRKPAPVAAAC
>WP_063844229.1|FEATURES|NCBI|chloramphenicol|cmlv|antibiotic inactivation|1
MPLAVYILGLSAFALGTSEFMLSGLVPPIAEDMNVSIPRAGLLISAFAIGMVVGAPLLAV
ATLRLPRKTTLIALITVFGLRQMAGALAPNYAVLFASRVISALPCAGFWAVGAAVAIAMV
PVGSRARALAVMIGGLSIANVLRVPAGAFLGEHLGWASAFWAVGLASAIALVGVVTRIPR
IPLPETRPRPLKNEVAIYRDRQVLLSIAVTALAAGGVFCAFSYLAPLLTDVSGLDEAWVS
GVLGLFGIGAVVGTTIGGRVADAHLFGVLLTGISASTVFLVALALFASNPAATIVLTFLL
GVSAFYTAPALNARMFNVAGAAPTLAGATTTAAFNLGNTGGPWLGGTVIDANLGFASTAW
AGAAMTVLGLGTAALALRLTKRPAPGHVVARSRGAGGTTPSEPARGKATSSC
>WP_029188719.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRAS
EIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYKYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_004937161.1|FEATURES|NCBI|multidrug|adeS|antibiotic efflux|0
KNSIGISAQLLIMMSVLNLGITIFSFGLGYLVYGWATEKGLLDLKNACPDNFSFTSVDYL
WTFLVVLTGFLLSTFLAFRYAKRYTQPINALANVVKQIQQGNLSLRIEQQQAHIPHELMS
LIQNFNAMANQLEISVKNSTLWNAAIAHELRTPITILQGRLQGIVDGVFEADQQLHQSLL
SQVEGLSYLVEDLRTLTLVENQQFRLDIQETNLQNSIFKCFQMFQDRFEHKGLHVVFNLT
HETARCDVTRMEQVLIALFSNASRYADAGKLSITTKTTQDHWILMLEDQGPGIDEQHLEH
LFKPFYRLEESRSRSEGGTGLGLAVIYAIIEAHQGQITYTTSTDLGGSCFTILLKK
>WP_010326702.1|FEATURES|NCBI|multidrug|adeS|antibiotic efflux|0
KNSVGINFQFIIMMSLLNLGVTLLSFMIGYFVYSWAIEIGFLDFQSVNSNEFFITSVDFI
WLFLVLLTGFFLSTLLAFKYGKRYTQPISDLADVIQQIQQGNLALRIKQPHHDIPHEIKS
LIENFNAMANQLEVSVKNSTVWNAAIAHELRTPVTILQGRLQGIVDGVFIADQALHQSLL
NQVEGLSYLVEDLRTLTLIENKQLRLELEKTNLKDSIEKCLQMFHERFQFKGLTTVLNLT
DELVCVDVRRMEQVFIALFSNFLRYSNAGQINITTVTTTEHWVLTFEDEGPGINESHLEH
LFKPFYRLEDSRSRLDGGTGLGLAVIDAIIEAHQGHIYYSKSKSLGGSCFTIQLKA
>WP_016656849.1|FEATURES|NCBI|multidrug|adeR|antibiotic efflux|0
TPSSFQFDHPGKTILVVEDDYDIGDIVENYLKKSDFHVIRAMNGLQALEIQASTTVDLII
LDVKMPQMTGWDVLSTLRQNKSTPVIMLTALDQEVDKIVALRMGADDFVVKPFNPNELVA
RVQALLRRSSLTTQRQSQQTIIYKNIVINCETHHVSIKHQQHIQALNLTLTEYKILHLMA
QYPNKVFTRHELMTQCLPDSDALERTVDSHVSKLRKKLEDQKLMNLLINVRGVGYRLDQV
>WP_047737563.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYFTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQAGVTVWKDNKSEGQSLYFLDPDGHKLELHVGDLA
SRLAQCREKPYSGMRFGPGK
>WP_023231494.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHVEWDTGAYLTCGDLWVCLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLTQCRERPYSGMRFGPGK
>EKF18778.1|FEATURES|NCBI|aminoglycoside|HMPREF9710_02755|antibiotic inactivation|1
DPKEVYEVAPMPAGLSEELTGYAWARNTIGQAGGTVYRLHGKPGAPDLFLKHGRNTVAND
LVDEMVRLRWLADHVPVPIVTHFVSTSDEAWLLMTALPGETAYQAIEAHPANRVAIVDAL
AEFLRTLHTIPISSCPFTSNHAHRLGLARKRIDAGLVDEDDFDDDRDGWTAEQVWQEMQK
NLPLAPDPVVTHGDFSLDNLLILDGRVTGCVDAGRVGIADRYQDLAILWNGLGEFGEPLQ
ERFLTRYGISEMDRGKLLFHLLLDELF
>WP_063977000|FEATURES|NCBI|aminoglycoside|HMPREF9710_02755|antibiotic inactivation|1
EREQASPVMPVPSSMTASVDGYAWARDTIGESGGTVYRLHGKAGEPDLYLKHGRDAVADD
IVSEMVRLRWLAPHKVAPAVCCFVSTDSDAWLLMDALPGKTAYQLLEDCPDERMAVVDAI
TDFLRRLHDIPVVECPFNSDHHLRLALAQKRMDAGLVDTDDFDDERSGWTAQQVWRDMTA
LLPLTPDPVVTHGDYSLDNLLLRNGHVVGCIDVGRVGIADRYQDLAILWNCLGEFGPEFQ
VRMLTRYGIHDADEHKLRFHLMLDEFF
>EKU81965.1|FEATURES|NCBI|aminoglycoside|HMPREF9710_02755|antibiotic inactivation|1
NREEACRVVTVPESMSAALAGYAWARDRVGESGGAVYRLHGKPGAPDLYLKHGRHAVADA
IGDEMTRLRWLAGRMPVPAVVHFDRSADEAWLLMTAVPGRTAYQLLQADPAQHDIVVDAL
ARFLQRLHAIPTSACPFNSDHDYRLGLARSRIEAGLVDEDDFDEERAGWTARQVWDAMQA
LLPLAPDPVVTHGDYSLDNLLIVDGQVAGCIDAGRVGIADRYQDLAIAWNCLGEFGGSLQ
ERFLRQYGIAAPDRRKLQFHLMLDELF
>WP_062773153|FEATURES|NCBI|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
QRETSCAGLRFNSNLDTELHGYKWARDKVGQSGAAIYRLYDKTDAPELYLKHGTDTEADD
ITDEMIRLNWLQAFIPVPNIMYFTRTPNDAQLLTTAISGKTAFQMLEESPDAQIEIVDAL
ATFLRRLHAIAVSSCPFNSNHIFRLALAQKRMNDGLVDADDFDDERKGLSAEQVWKEMHT
LLPLSSDPVVTHGDFSLDNLIFDKGELAGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQ
KRFLQKYGMTYPDMNKLQFHLMLDEFF
>WP_056402240.1|FEATURES|NCBI|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
ERETACAPVEVPSAFAADVAGYRWSRDGVGESGATIYRLHGKAGVPERFLKHGHGTVADD
IVDELVRLRWLAGRIAVPALVRCEATADTAWLLTTALPGRTAWQILDTEPERADELVDAL
VDFLRSFHAIPVSDCPFDSGHGVRLAAARARIDAGLVDEADFDDARQGWSAGQVWDAMGR
LLPLSPDAVVTHGDFSLDNVLIDGGRVVGCIDLGRVGVADRYQDLAILGHGLDEFDAALT
RRMFDRYGIAKPEQRKIDFHLLLDELF
>ALA52629.1|FEATURES|NCBI|beta_lactam|bcl1|antibiotic inactivation|1
MLKTKITSSILVGACLLIGCSNGNEQPVSNEPEPEESVETGEAVFKALEEEYAARLGVFA
LDTGTGQTVSYRSDERFTYASAHKPLAVAVLLQQKSIEELEQLITYSADDLVNYNPITEN
HVETGMTLRELSDASIRYSDNTAANFIFDEIGGPEGFKEGLRAIGDTVTEPERIEPELNH
VEPGEIQDTSTPEALAKSLQEFALGEALPADKQELLIDWLIGNTTGDALIRAGVPEGWEV
GDKTGAGSYGTRNDIAILWPPEKEPIILAVLSSKDEKDAEYDDELIAKATEEVINLLAQT
E
>ACX94064.1|FEATURES|NCBI|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
AVALDEVSELKNLLSPLLDECTFEEVEYGQSDARVIRVLFPDRNTAYLKYASGSSAQEIL
QEHQRTRWLRTRALVPEVISYVSTSTVTILLTKALIGHNAADAADADPVIVVAEMARALR
DLHSISPDDCPFDERLHLRLKLASGRLEAGLVDEEDFDHARQGMLARDVYEQLFIQMPGA
EQLVVTHGDACPENFIFQGNAFVGFIDCGRVGLADKYQDLALASRNIDAVFGPELTNQFF
IEYGEPNPNIAKIEYYRILDEFF
>AIF29520.1|FEATURES|NCBI|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSSAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYNFLKTEKP
EEELVFSHGDLGDSNILVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>WP_030600485.1|FEATURES|NCBI|aminoglycoside|AC230_04535|antibiotic inactivation|1
MDDALRALRGRYPGCEWGAVGDGASGADVYRLRGGGRELFVKVADAKPGVGLLGEAERLA
WLAEAGISVPRVVESGGDGRVAWLVTEAVPGRPASARWPRGQRLDVAVALAGLARSLHAL
DWERCPFDRGLAVTVPQAARAVAEGSVDLEDLDEQREGWSGERLLAELERTRPADEDLVV
CHGDLCPDNVLLDPRTCEVTGLIDVGRVGRADRHSDLALVLRELAHEEDPWFGPECAAAF
LREYGRGWDGEVSEEKLAFYRLLDEFF
>WP_051208285.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Iae|antibiotic inactivation|1
NWSEFDVCKHPSLHADAAALLMNTFQAKGITSWPNIESARQTLDECIAVPNLCLGMLIDG
KLAGWVGLRPMYDKTWELHPLVVAPAQQGQGVGKALLQTLEQRAKAQGLIGIVLGTDDEL
FETSLSQTDLNGSNVLAELKRLSNRARHPFEFYQKCGYSVIGAVPNANGKNKPDIMMWKD
L
>WP_028714409.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MRGKATITADLRRLGLRPGDLVMVHVSLKALGPVEGGAIGVAQALMDAVGPDGTVMGYAS
WDRSPYEETLNGARMDEALRRDWPAFDPRTAGTYRGFGLLNQFLAELPGARRSAHPDASM
VAIGPLAGALVEPHRLGQALGEGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAVADIPG
KRRVSYEMPMLGPDGRTVWEAATDFDSNGILDCFAVEGRPDAVETIARAYVEMGRHREGV
VAAARCHLFDAQDIVAFGVEWLEKMFGS
>WP_051329242.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTEESIARNLRDLGILAGDLVMVHASLKALGPVEGGAATVLACLLQAVGPAGTLMGYAS
WDRSPYEETLDGARLDEASRRSWPGFDPATSGTYRGFGLLNQFLAEHPGARRSAHPDASM
VAVGPLAQALTEPHELGQALGEGSPLERFVRLGGKILLLGAPLDAVTALHYAEAIANIPD
KRRVTYEMPIRGKDGQVAWERCEDFDSNGILDCYAAEGRPDAVETIARAYVRLGRHQEGF
VASARCRLLDARDVVAFGVAYLERHHGA
>AAN34370.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEAIRKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGKGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRNGEVAWKTASEYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGA
>WP_058327775.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRRSITDALQKLGVQFADLLMVHASLKAIGPVEGGAETVVAALSSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDEARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAEMLTEPHELSHALGEGSPIERFVRLGGKVLLLGAPLNSVTVLHYAEAIADIPG
KRRVTYEMPMVGSDGKVVWKTAADFDSNGILDCFAIEGKPDAVETIANAYVKLGRHRGDI
VGCAQCHLFDAQDIVSFGVTYLEQHFGT
>WP_012356520.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MRNQTTITCELRSLGVHAGDLVMVHASLKAIGPVEGGAVAIVAALRDAVGPEGTLMSYAS
WDRSPYEQTLNGARMDEDDRRNWPPFDPATAGTYRGFGLLNQYLAASPGATRSAHPDASM
VALGPRARYLTEPHRLGEAFGKGSPLERFVDGGGKVLLLGAGLDSVTILHYAEAIADIPG
KRRITYEMPLRGADGHTVWEVVEEFDSNGILDCFAVEGQPDGVETMATAYVALGRHTEGQ
VGCAHCYLFDAQDIVAFGVSYLEQHHSP
>AAT34976.1|FEATURES|NCBI|aminoglycoside|str|antibiotic inactivation|1
RTEKEILNLVSEFAYQRSNVKIIALEGSRTNENIKKDKFQDYDFAFFVSDIECFTHEESW
LSLFGELLFIQKPEDMELFPPDLDYGYSYIMYFKDGIKMDITLINLKDLNRYFSDSDGLV
KILVDKDNLVTQEIVPDDSYYWLKKPTEREFYDCCNEFWSVSTYVAKGVFRREILFALDH
FNNILRPELLRMISWYIGFNRGFDFSLGKNYKFINKYLTDKEFNMFLATFEMNGYRKTYQ
SFKLCCELFKYYSNKVSCLGNYKYPNYEKNIENFIRNNYE
>WP_066163049.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RTEAEMFQIFSNFATEDERIRISMLEGSRTNNTIPKDSYQDYDVSFFVTNMSSYLKNDDW
LRAFGELIFVQKPEDMELFPAEFENYFTYIMYFADGIKVDLSLIPLTELTSYLQKSDGLI
EVLLDKDGHIEQAIVPSDEKYWLTKPSARSFDDCCNEFWSVATYVAKGLARNEFLFAVDH
LHHNIRQELLRMLSWDIGIQNGFSFSVGKNYKFIHQHLPAQQYERLLSTYATASIAQTWT
AFELCCEMFRETSRKVAQALGYPYPNYDENITKWIENTYK
>WP_057764669.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSVQEMMEIILSIAKKDERIRIVTLEGSRTNKNIPKDKFQDYDISYFVTDIDSFKSTDEW
LNAFGKRIIMQKPEDMELFPPELGNWFSYLMLFDDGNKIDLTLIPLDEAESYFLNTDGLV
EVLLDKDSSIKDTLEPTDKKFHIKKPSAKEFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMSWYIGIETNFSLSLGKNYKYLQKHLDKNDWDQLLYTFAENSYENMWQ
SLFNCYDLFRKYSKLVANKLCYDYPVYDEQITNYTQKVYH
>WP_021257631.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RKEREMMDMFIEFAKQDDRIRLATLEGSRTNINITPDAYQDYDISYFVTNLDSFKANDQW
LDAFGERLMMQKPENMELFPPELGNWFSYLILFKDGNKLDLTLIPLNEVEAYFTDSDGLV
EVLLDKDSLIPNEVVPNDVQYWIKKPTARELDDCCNEFWMVSTYVLKGLERKEILFAIDH
LHEVARPNLLRMMAWHIGAERGYTFSVGKNYKFIDRYLPPEDWETLLVTYAESSYPSMWQ
SLFTCCELFRKYSKAVAEHHGYPYPDYDRAISTYMKGIYD
>AAA22190.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMDIFLDFALNDERIRLVTLEGSRTNRNIPPDNFQDYDISYFVTDVESFKENDQW
LEIFGKRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPIREAEDYFANNDGLV
KVLLDKDSFINYKVTPNDRQYWIKRPTAREFDDCCNEFWMVSTYVVKGLARNEILFAIDH
LNEIVRPNLLRMMAWHIASQKGYSFSMGKNYKFMKRYLSNKEWEELMSTYSVNGYQEMWK
SLFTCYALFRKYSKAVSEGLAYKYPDYDEGITKYTEGIYC
>WP_059040609.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMNILIDFAKNDNRIRLVTLEGSRTNKNISPDAFQDYDISYFVTDIDSFKENDQW
LRVFGNRVMMQKPEDMELFPPEIGNWFSYLMLFEDGTKVDLTLIPINEVEDYFSNSDGLV
EVLLDKDTLIKNEVIATDRQYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMAWKIGSEQGYTFSVGKNYKFINRYLPNEDWEKLLLTYSEDGYQKMWK
SLLICYELFRKYSKAVSESLGYKYPDYDEAITKYTDHVYT
>WP_053221259.1|FEATURES|NCBI|beta_lactam|ACR52_25270|antibiotic inactivation|1
DLTLTNFKGPLYIVEDKEYVQENSMVYIGEQHITVIGATWTPATAEKLEQEIRKVSPLPI
KEVINTNYHTDRAGGNAYWRELGASIVSTQLTYDLEKSQWRSIVDFTRQGMEHYPVLEQS
LPDQVYPGDFALQNGHVRALYLGASHTEDGIFVYFPEERVLYGNCILKEKLGNMTFANRS
EYPKTLKKLQGLISSGELPVETIIAGHNSPIQSVELIDHYLNLLE
>WP_010815298.1|FEATURES|NCBI|glycopeptide|vanSB|antibiotic target alteration|0
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRAMEAQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNADTSNSVRPDFLYVVHRDDNISIVA
QSKAGMGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKHLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNIILNAVQNTPQGGEV
RIWSELGAEKCRLFILNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLKYALENTSDGVLFWLDLPLTSTL
>WP_010815684.1|FEATURES|NCBI|glycopeptide|vanSB|antibiotic target alteration|0
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPNFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYCIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPLTSTL
>WP_042988862.1|FEATURES|NCBI|beta_lactam|bthur0007_56400|antibiotic inactivation|1
VLKNKKMLKIGMCVGILGLSITSIEAFTGGPLQVEAKEKTGQVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTEWMKGNATGDKLIR
AGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIAEAAE
VVVNAFK
>WP_064056613|FEATURES|NCBI|beta_lactam|IEI_02596|antibiotic inactivation|1
ILKNKRMLKIGICVGILGLSVTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDL
VEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITMA
DRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNILTEWMKGNATGDKLIR
AGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATE
VIVKSLK
>WP_016117948.1|FEATURES|NCBI|beta_lactam|AT268_05175|antibiotic inactivation|1
ILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKEDL
VDYSPVTEKYVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITMS
DRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILKEWMKGNATGDKLIR
AGVPTDWVVGDKSGAGSYGTRNDIAVVWPPNREPIIIVILSSKDEKEATYDNQLIADATK
VIVKALR
>WP_033712221.1|FEATURES|NCBI|beta_lactam|IEQ_02112|antibiotic inactivation|1
ILKNKRLLKIGICVGILGLSLTSLETFTGGALQVEAKEKTGQVKHKKHASYKEFSQLEKK
FDARLGVYAIDTGTNRTIAYRPNERFAFASTYKAVAAGVLLQQNSTDKLNEVITYTKDDL
VEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMA
DRFETELNEAIPGDIRDTSTAKAIAINLKAFTVGNALPDHKRNILTEWMKGNATGDKLIR
AGVPTDWGVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATE
IIVNALR
>WP_030877515.1|FEATURES|NCBI|beta_lactam|BL2d_moxa|antibiotic inactivation|1
MRIRPTRRLLLGAVAPLALVPLVACGQASGSESAGSSPASAVRTSAHGSADAHEKEFRAL
EKKFDATLGVYAIDTADGQEITHRADERFAYGSTFKALQAGAILRKFSETGAKSGGGAEA
DGMDKVVHYGQDAILPNSPVTEKHVADGMSLRELCDAVVRYSDNTAANLLFDQLGGPKGL
NAVLKQLGDHTTSMDRYEQELGSAVPGDPRDTSTPRAFAEDLRAFAVEDGEKAALAPNDR
EQLNDWMSGNATGDALIRAGVPKDWKVADKSGQVKYGTRNDIAVVRPPGRAPIVVSVMSH
GDTQDAEPHDELVAEAASVVADGLK
>WP_032567550.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_065083535.1|FEATURES|NCBI|beta_lactam|blaB-15|antibiotic inactivation|1
KRLKGLLVLALGFTGLQVFGQENPDVKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTDK
GVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKM
TDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIV
KSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISEYQ
QKQKASN
>WP_034818525.1|FEATURES|NCBI|beta_lactam|BlaB|antibiotic inactivation|1
KKIKISLILALGLTSLQAFGQENPDVKIEKLRDNLYVYTTYNTFNGTKYAANAVYLVTDK
GVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKM
TDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCII
KSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINEYQ
QKQKASN
>WP_049325223.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSFFKF
NNLNNQEPTVESNSHNLNPNINTTKPVHEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLNSLLYLKYLKKQSLYLNEKEKDKINKILFNHQYKRNIVIRKAESIHSPITFWYGKYII
LIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFNIFSIVMSYNPLIHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNIPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLIPIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDHHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_031796024.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNLMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_031890271.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYFLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>OBP58430.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEA
MKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRTILLNSLQN
DTVIWDRKLVTLEPDKEKWTLTFEDKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTSDEWKSKTL
VDFQDRNSVVDFLLKKFSDWDERYKELIRVTSSFVGLATRIFPLDKSWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQ
NEIEMFKPDFTFQQLLNV
>AMP57029.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MNLLNNKKVTIIGGGPVGLTMARLLQQNDIDVTVYERDKDRQARIFGGTLDLHKTSGQEA
MKKAGLLKAYYDLALPMGVNIADEKGNILTTKNVKPENRFDNPEINRNDLRTILLNSLQN
DTVIWDRKLVTLEPDKEKWTLTFEDKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTSDEWKSKTL
VDFQDRNSVVDFLLKKFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESII
NETEMFSSDFSFQKLMNL
>CRL66316.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MTLLKNKKITIIGAGPVGLTMARLLQQNRVDVTVYERDKDRDARIFGGTLDLHRDSGQEA
MKRAGLLQTYYDLALPMGVNIADEKGNILTTKNVKPENRFDNPEINRNDLRTILLNSLQN
DTVIWDRKLVTLEPDKEKWTLTFEDKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFN
IQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTSDEWKSKTL
VDFQDRNSVVDFLLKKFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIG
DAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESII
NETEMFSSDFSFQKLMNL
>WP_062750112.1|FEATURES|NCBI|glycopeptide|vanRF|antibiotic target alteration|0
MKTISILIADDEEEIADLLAIHLEKEGYYVVKAGDGQEAIHIVETQPIDLLILDIMMPKM
DGYEVTRRIRETHNMPIIFLSAKTSDFDKVHGLVIGADDYITKPFTPIELVARVNAQLRR
FMKLNQPYTVVDPKTRLEYRGLVISLEQRTVTLYGENIELTPKEFDILYLLASHPKKVFS
VENIFKQVWGEAYFEGANTVMVHIRTLRKKLEEDKRKDKWIKTVWGVGYAFNG
>WP_060209917.1|FEATURES|NCBI|glycopeptide|vanRF|antibiotic target alteration|0
MKDISILIADDEKEIADLIALHLEKEGYHVIKVSDGEEAVHVAQTESIDLLILDIMMPKM
DGYEVASRIREQYNMPIIFLSARTSDFDKVQGLVIGADDYMTKPYSPIELVARVNAQLRR
FMKLNQSDTNKGNNPRVEYGGLVISPDQRTVTLYDESIQLTPKEFDILYLLASHPKKVFS
VENIFHQVWGEDYYEGNNTVMVHIRTLRKKMKEDKNKNKLIKTVWGVGYSFDG
>AEC49686.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(39)|antibiotic target alteration|0
MKEKVVFDNAISLYTESFGDPTDEPIILIMGAMSSAVWWPDEFCSELATMGRYVIRYDHR
DTGKSTSYEPGQAPYSVEELADDVVRVIDGYGLEAAHLVGMSLGGFLSQLVAIKYPKRVK
SLTLIASERLADADPNMPSFDPAIIEYHQRAESLDWSDRDAVVAYQVGAWRINSGTAHVF
DAEKIQKIAELNFDRTPNILTTFNHTTLGGGEKWLGRLNEIAVPALIIHGTEDPVLPYVH
GLALKDAIRGSKILKLEGSGHELHHEDWPKIIQAIREQTS
>AFQ43752.1|FEATURES|NCBI|glycopeptide|vanZA|antibiotic target alteration|0
VKILSRGLLAVYLVILIWLVLFKLQYNILSVFNYNHRSLNLNPFAAPLKLNGRINFGEMI
NNFIIFIPFGILLNVNYKRFRFLPKFTLILVFSLTAELIQFIFAIGATDIIDVITNTVGG
ILGLILYRLSNKYISSKKLDWVIIAFGTLLLMFLLYYRIFILRLIY
>AAM18213.1|FEATURES|NCBI|aminoglycoside|aadA1t|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSVIDLLVTVTVRLDETTRRA
LINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRIWHSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>AAN41437.1|FEATURES|NCBI|aminoglycoside|aadA1an|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLGETTRRA
LINDLLETSASPGEGEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRIWYSAVTGKIAPKDVAADWAMERLPARYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>CAQ51305.3|FEATURES|NCBI|aminoglycoside|aadA1bt|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LINDLLETSASPGESEILRAVEVTIVVHDDIIPRRYPAKRELQFGEWQRNDILAGIFEPA
TIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTSSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQ
LEEFVHYVKGEITKVVGK
>EEF67505.1|FEATURES|NCBI|glycopeptide|vanWG|antibiotic target alteration|1
SRRRVTEFLPFLLPLRRKQKIWCFYQKMKHDGNRYARRQAEERLPYIQYECTQGLINPDS
GYDIQYQYNKAHNLKVVSRRMQQLIIEPGEVFSFWQLARGADHDDPYRPGLGLHDGKIVP
VHGGGLCFMSELLYWMVLHTPLTVIEKHPHLVISLPANPNAEMPAGIDATIQEGWSDLKF
RNDTDQPFQLILDFDEDSVHAQFRCAQPPCYRYEVTGSALVYSRKKGKIYRTQDISRTLY
AAADGELVREEACYTSRSRIDYPLPPETEITE
>WP_020226403.1|FEATURES|NCBI|glycopeptide|vanWG|antibiotic target alteration|1
SRRRVTEFLPFLLPLRRKQKIWCFYQKMKHDGHRYARHQAENRLPYLQYECTQGLINPDS
GYDIQYQYNKAHNLKVVSRRMQQLIIEPGEVFSFWQLAQGADHDDPYLPGLGLHDGKIVP
VHGGGLCFMSELLYWMVLHTPLTVIEKHPHLVISLPANPNAEMPAGIDATIQEGWSDLKF
RNDTDMPFQLILDFDEASVHAQFRCGQPPQYRYEVLGSELIYSRKKGKIFRTQQISRTLY
DAESGEVVRQEACYTSRSRIDYPLSPDTEIIE
>BAN78519.1|FEATURES|NCBI|aminoglycoside|aacA48|antibiotic inactivation|1
NVVPCKTPDHPGWLELRLQLWPDGSTEEFLPEMAAACAEPDRFGQFLFLSPGGLAEGLVE
VALRTDYVNGTESSPVAFLEGVFVVPASRGLGIARALVAAAEGWARDRGCTEFASDAEVS
NVGSHAMHAALGFVETERVVFFRKVVA
>WP_068511193.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWLFLSAAIICEVIATSSLKSSEGFTKIAPSLLVIIGYGAAFYLLSLTLKSIPVGIAYA
VWSGLGIVLVTLVAWFMHGQKLDLWGYVGMGLIVGGVVVLNLLSKTSAH
>ACS73678.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWLFLATAIISEVIATSALESSEGFTRLVPSFIVVAGYAAAFYFLSLTLKSIPVAIAYA
VWSGLGIVLVTAIAWVLHGQKLDMWGFVGVGFIISGVAVLNLLSKASVH
>WP_047135584.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KSWLLLAVAIVGEVVATSALKSSEGFTRPIPSAIVVVGYGLAFYALSLALKSIPVGIAYA
VWAGLGIVLVTAIAWIFHGQKLDPWGFVGMGLIVSGVAVLNLLSKTSAH
>ACN22626.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWIFLAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAYA
VWAGLGIVLVAAIAWIFHGQKLDFWAFIGMGPIVSGVAVLNLLSKVGAH
>WP_000733402.1|FEATURES|NCBI|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIILVVLALILSACNSKNSTNNDIEKIEKKYGANVGMYALNTQNGKELSFNENKRFA
YASTLKTISSAMLLEQTPYNKLDKKIHINKDDIVPYSPVLEKYIGKEITLKKLIEATMLF
SDNTANNKIIDELGGYGQVKTKLIDLGDTTTHPSRKEPDLNFYSPKDKRDTSTPLAYGKT
LKKLIADGDLSKANKDFLLNLMFKNKSGDTLIKDGAPSNFKVMDKSGQALTYGSRNDVAF
VYPDGQDKPIILVIFTNKDRKDGKPNDKIVSEVAEIVLKNINE
>WP_065381445.1|FEATURES|NCBI|beta_lactam|V070_01895|antibiotic inactivation|1
MKKLIIMIASILLLSACSTADATTQDLKKVEDKYDANIGVYALNTATDEEITFNEDKRFA
YASTFKAVSSAMLLEKTPHNELNKKVHVSKEDIVPYSPVLEKFINKDITIKKLIEATMLY
SDNTANNMIIEELGGYKEVNKRLKSLDDKTTKPSRMEPELNIYDPKSNRDTSTPQAFGKT
LNKLINDGRLSKENKAFLIDLMINNKSGDTLIKKGAPKNFKVADKSGQAITYASRNDVAF
VYPKGESKPIVLVIFTNKEGKTDKPNDKVVSETAKVVLEKF
>WP_064210958.1|FEATURES|NCBI|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIILSVLLLVLSACNNKDSNNSAIDKIEKKYDANVGMYALNTQNGEELSFNEDKRFS
YASTLKAVSSAMLLEKVPSNKLDKKIHISKDDIVTYSPVLEKYVDKEITLKKLIEANMLY
SDNTANNKVIDELGGYKEVKKRLVDLGDTMTYPSRKEPDLNLYTPKDKRDTTTPSAFGKT
LNKLIIDGNLSKSNKDFLMNLMLKNKSGDTLIKDGAPSDFKVMDKSGQAVTYGSRNDVAF
IYPKGQDKPIILVIFTNKNNKDAKPNDKIVSEVAEEVLKNI
>WP_032046739.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSIIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTAKLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAASLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASTELKDLFKSGNFAWSIGPSIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMVRYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMQLNNQIELYKVLGGGTSKV
>WP_031379797.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKVAIVSRGLILSTLSIALIACVNMQAPQPAITSHIPQNFSQNHSGKTIAERSYKEFIS
DPKLLQVIEISLNNNRDLRTATLNIERVQQEYQITKNNQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGTSKI
>WP_047480810.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLLQVIEIGLNNNRDLRTATLNIERVQQEYQITKNNQLPTIGVMGSAVRQVNPSINPN
NPASTFQVGLGMTAYELDFWGRVQNLKDVALNNYLATQSASEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGYSVPQNLLPDHSIQNITIEKNFAAGLPSDLLNHRPDLKVAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASTELKDLFKSGNFAWSIGPSIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGTSKV
>WP_004708755.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNTSGKTIAEQSYKEFIS
DPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVIGSAVRQVDPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKTQLDSYHLNKKRFEVGIDSEVPLKQAQISVETARNDVATYKIQIQQ
AKNLLDLLAGHPVPQNLLPDHTIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPSVDLPIFDWGTRKANIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATDATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMKFNNQIEIYKALGGGISKR
>WP_005305392.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKVAIVSRGLVVSALSVALVACVNMQAPQPTAISHIPQNFAQNSSGTTIAEKSYKEFIS
DPKLLQVIEIGLNNNRDLRTATLNIERVQQHYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQILQ
AKNLLDLLAGSPIPENLLPSDSIKNITLEKNFAAGLPSDLLNHRPDIKAAEYGLRAAGAN
IGAAKARMFPTISLTGSTGYASTELKDLFKSGNFAWSIGPSIDLPIFDWGTRKAGIKIAE
IDQKVALSEYEKSIQTAFKEVNDALATHAHIEERLDAQRRLVSATSATYKLSMARYKAGV
DSYFTVLDAQRSAYAAQQGLLTLEQVKLNNQIEIYKVLGGGLSKE
>API65130.1|FEATURES|NCBI|beta_lactam|LEN-22|antibiotic inactivation|1
RRFACALAFTLSLPLASEAGPLMDTVGQLETEVGGRIGVVLRHTGSDWAVEHREDERFPM
ASTFKALLCGAVLSRVDRGEESLDDLVTYKATELVSYSPVTKNHVASGMSVGQLCEATVT
MSDNSAANLLLKRVDGPEGLTRFLRGLGDRVTRLDRNEPAMNEARRGDPRDTTSPSAVLK
TLDRLLFEGVLLPSSRAQLQQWMVDDKVADVLIRKHLPKGWRIADKSGAGHNGSRGIISV
IWPETGQPYLAAAYMTGSDASIKQRNAVIAEIGKAMIEEIKQR
>WP_063840271.1|FEATURES|NCBI|aminoglycoside|Aac3VIII|antibiotic inactivation|1
MDERELIERADGPVTRCRLVRDLKELGVGPGDTVMVHTRMSAVGYVVGGTQTLIGALLNA
VGDTGTLMAYCGWNDAPPYDLADWPPEWRDAARAAWPAYDTRFSEADHGVGRVPEALRHW
PGAVRSRHPDASFVAVGPAAHRLMDDHPWDDPHGPDSPLGRLTRDGGRVLLLGAPLDALT
LLHHAEALAEAPGKRYVEYEQPITVDGRRVWRRFRDVDTQTEAFPYGRVVPEGVWPFTVM
AEEMLAAGIGRTGRVGAAPSHLFEAPDVVRFGVEWIESRLGEAADG
>EKP66760.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
KKKILFTGSILLTSLSASATPLKLPDDWTQNTQPFQITENIYYVGTHGLGTYLLTSDHQA
LLIDTGLPENTKQIEQNIKKLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQ
DVRALEIGKPIGENTFQSIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWST
EVKSNGKNLNVVFPCSLSVAGNVLQNNHQYPNIVEDYRQSFKRLKNMKADIVLTSHPEVA
DVMGNKARKDAGQVNAFIQPEKLSAIVKDAEIAFEKSLVSSKS
>ENV02791.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
KKKMLFIGSILLTSLSTSAAPLKLPDNWTQNTQPFQITENIYYVGTHGLAAYLLASGHQA
LLIDTGLPENTEQIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQ
DVQALEIEKPIGENTFQTIPFTPVKVDKVIHDGEVVKLGKFRLKATLTPGHTPGCTTWST
EVKSNGENLNVVFPCSLCVAGNVLQNNHQYPNIVEDYRKSFERLKNMKADIVLTSHPEVA
DVLGNKARKDAGQPNAFIQPEKLFSIVKDAEMAFEKSLVSSHP
>ESK45647.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
KKKMLFIGSILLTSLSTSAAPLKLPDDWTQNTQPFQITENIYYVGTHGLAAYLLASGHQA
LLIDTGLPENTEKIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQ
DVKALEIGKPIGENTFQTIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWST
EIKSNGKNLTVVFPCSLSVAGNVLQNNHQYPNIVADYRKSFERLKNMKADIVLISHPEVA
DVLGNKARKDAGQTNAFIQPEKLSSIVKDAEMAFEKSLVSSHP
>ENV80847.1|FEATURES|NCBI|aminoglycoside|ANT(3'')-IIc|antibiotic inactivation|1
MSETLQLEQLTASLQQLLGEALFGIYLYGSAVDGGLGPESDLDLLVVITQALTLQQRKQL
AETLLQISHPIGAVQRALEVTIVHKDHILSGSYPLSYELQFGEWLRDELNQGVILSEHAD
PDLSILLKKAQMHHLTLLGPSFSQWSVEIPVQQLWQAMADTYPSIVAHWDEDADERNQIL
ALCRIYFSLVTNEIAPKDQAAQWVIAQLQPQHQPVLQRMSQEYKGQIAKQNWQDEYQALQ
PIVDFLSSRIDEQFKKKS
>AMJ70645.1|FEATURES|NCBI|quinolone|QnrB|antibiotic target protection|1
MTLIFESEKIGRTRFTGEKIENAIFRNCDFSGTDLTSTEFIGCQFYDRESQQGGNFNRAQ
LKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGDLDVRGIDLQGVKLDSYQISQLMERLGIVVLG
>EWG75371.1|FEATURES|NCBI|quinolone|QnrB3|antibiotic target protection|1
MALIFEGEKIGRTRFTGEKIENAIFRNCDFSGTDLTSTEFIGCQFYDRESQQGAKFTRAQ
LKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCSAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDMSGGEFSSFDWRAANFTHCDLTNSE
LGELDVRGTDLQGVKLDSYQVSQIMERLGIAIIG
>APY23733.1|FEATURES|NCBI|beta_lactam|V070_01895|antibiotic inactivation|1
MKKFFTIFVLLCVCFAYTTATASAQGLTKLEHKNDATVGVYGINTATGQTYSHNADTRFA
YASTFKAITSGLLLQQNSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQ
SDNTASNIIMEQLGGLDQLSSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHN
LQKLLTTDAVAPQQRKFLQNLMFNNKTGESLIKKGVPNSYKVGDKSGQGTTYGTRNDVAV
IYPKHQTKPIILVVFTKHQQQDAQPQDELVAQAARHAIHQLD
>WP_021459345.1|FEATURES|NCBI|beta_lactam|PC1|antibiotic inactivation|1
MKKFFTIFVLLCVCFAYTTATASAQGLTKLEHKNDATVGVYGINTATGQTYSHNADTRFA
YASTFKAITSGLLLQQNSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQ
SDNTASNIIMEQLGGLDQISSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHS
LQQLLTTDAVAPQQRKFLQNLMFNNETGDSLIKKGVPDSYKVGDKSGQGTTYGTRNDVAL
IYPKHQTKPIVLVVFTKHQQQDAQPQDELVAQAARHAIHQLD
>WP_034742152.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KAREDKLERIISWAESNSDIRAVLLTSSLVNPHAPVDDFSDLDIELVFENMQEYQANNQW
IDLFGTPISMIEEDDSYFDGKHAMKMVLYADHVKVDFKLYQKSEFIKEVHEEALPDDWDV
GYKVLIDKDDLTKDLQPPTYRSVMIHQPSEKRFRQLINDFWWDTTYVAKCLKRDDLFYAK
FMSEDVIRTDYLVPLIEWYIASTYNWKNITTNKHGRLFKKYLPEELWKQIEATFSGSNIN
DNWSALYSAADLVHELGTVLSYRLSFEYPHKLENDIRKYLDEIRS
>WP_076509785.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
KAREEKLKHIISWADNNPDIRTVLLTSSLVNPYAPVDDFSDLDIELVFENLKDYETDKKW
MHLFGDPVSMVEEDDPYFDGKHAMKMVLYSDHVKVDFKLYQKSEFVKEVQKERLPDDWDV
GYKVLIDKDHLTKDLKPPTYQSVMIRKPEEQKFQQLINDFWWDTTYVAKCLKREDLFYAK
FMSENVIRTDYLVPLIEWSVASFHDWKNMPTNKHGRLFKKYLSAELWAKVEATFSGSNIE
DNWRALYASADLVHDLGTALAENLNVEYPQKHEEDIRKYLDEVQS
>WP_062701324.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KTREEKLKQIISWAENNPDIRAVLLTSSLVNPYAPVDNFSDLDVELVFENREPYESHHEW
LSLFGTPISMIEEDDRVFEGKHAMKMVLYRDHVKVDFKLYQKVDFLAEVQQESLPEDWDV
GYKILVDKDDLTKGLKPPTYQSVMIHKPEEEEFSKLINDFWWDTTYVAKCLQRGDIFYAK
FMSENVIRTDYLVPLIEWHIAGSQGWSNITTNKHGRLFPKYLPEDLWKRVEATFSGSNIE
ENWASLLAFADLVHELGTALAGKLSFTYPDQLEKDIRNYLAEVKS
>WP_016142826.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
MKLSGLNHLTISVENVDRSFSFYKDVLGFTPRAKWNKGAYLSLGELWLCLSLDEVSISSD
YTHYCFSISEDDIDEFRQKIKLMNIHEWKNNQSEGESIYFLDPDGHKLEVHVGTLSSRLQ
SCKKNPYEGMVFFDE
>WP_000777202.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
MKLSGLNHLTISVANVDRSFNFYKDILGFTPKAKWKKGAYLSLGKLWLCLSLDEVSVSSD
YTHYCLSISEDDIDEFRQKIKLLNIREWKNNQSEGESIYFLDPDGHKLEVHVGNLSTRLE
SCRKNPYEGMVFFDE
>WP_057991970.1|FEATURES|NCBI|beta_lactam|ADC-2|antibiotic inactivation|1
MFFNQKYFFQASFITMVIGFGMNLNASEVSQNEQNIEKVVTQSFKPLMDEYGVAGMAIGV
IYNGKSYEKYYGVRSKDTNESVNSQTLFELGSLSKTFTAISGTYANNQGKISFNDHPSKY
VPALKNSEIDKVNLLELLTYTSGNLPLQFPDNIKTDKQILEYFKNWKVKNPPGTYREYSN
PSIGLFGYLTAKSMNVPFSSLLEKTVFPQLNLKHTYVNVPEAQKTNYAFGYDENNKPIRV
NPGPLSDEAYGVKSTLPDMLKFVNSNLNVDTNSPAMKKAILDTHKGYFKVSDSGMTQALG
WEMFSYPTTSEILQASNSKQILLGSNPVVKELSQPKSKVFHKTGSTNGFGAYVLFIPEEG
FGLVMLMNKKIPNVDRIKAAYNVFETLKDN
>WP_086374409.1|FEATURES|NCBI|beta_lactam|ADC-2|antibiotic inactivation|1
MIFNQKYFFQASFITMVMGFGMNLHASEVSQDEKNIEKVVTQSFKPLMDEYGVAGMAIGV
IYKGKSYEKYYGVRFKDTNESVNGQTLFELGSLSKTFTAISGTYAKNQGKISFNDQPSKY
IPALKNSEINKVNLLELLTYTSGNLPLQFPDDVKTDKQILEYFKNWKANNPPGAYREYSN
PSIGLFGYLTAKSMNVSFSSLLEEIIFPQLNLKHTYVNVPEEQKMNYAFGYDENNKPIRV
NPGPLSDEAYGVKSTLPDMLKFVKSNLNVDTNSPAMKKAILDTHKGYFKVADSGMTQALG
WEMFSYPTTSEILQASNSKQILLGLNPVVKELSQPKSKVFHKTGSTNGFGAYILFIPEED
FGLVMLMNKKIPNVDRIKAAYNVFEILKNN
>WP_085886528.1|FEATURES|NCBI|beta_lactam|NPS|antibiotic inactivation|1
MRFPASVLSRVATGLTLGLFMATASLAETPVEALSNTVARIEEQLDARVGLSLVETGSGW
SWSHREDERFLMNSTVKVPVCGAILARWDAGTLSLSEALPVRKADLVPYAPVTETRVGGT
MTLDQLCLAAIDMSDNVAANLLIGHLGGPEAVTQFFRSVGDITSRLDRIEPELNDFTPGD
ERDTTSPAAMSETLRALLLSDALSPQARGQLAEWMRHGGVTGALLRAEADDDWLILDKSG
SGSHTRNLVAVIQPDGEAPWIATMFVSDTDAEFEARNEALKDLSRAVVAVVRE
>WP_071218948.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
TGPNPNERYPIPGDNNLQFIKNTITKPNIIAGDYSYYYALNGESFEDQVLYHYEFIGTKL
MIGKFCSIASEVRFMMDGGNHRMDGSTFPFNIFGNGWEKFTPSLDQLPIKGDTIIGNDVW
IGRRATIMSGVRIGDGAIIAAEAVVVKDVEPYTIVGGNPAKDIRKRYSTEVIQELLDIKW
WDCDIEVINQYIGAIVSGDMDLLRKMRQ
>WP_031642485.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|0
MKGYVALGIAIIGEIFGTSMLKLSEGFTNIYPTIGVAIGFFIAFYTLSLSLKTLPLSLAY
AIWSGVGTALTALIGVLVWNEPFNILTFIGLVMIIGGVIILNQRSADTKTSTSD
>YP_185623.1|FEATURES|NCBI|multidrug|msbA|antibiotic efflux|1
MKKLTTILFQYKIFPVLMFLVSTGLGIIVITQNILIADFLAKIIRHQFQGLWIVLFILLG
VLLLRATVQFLNQWLGDTLAFKVKHMLRQRVIYKNNGHPIGEQMTILTENIDGLAPFYKS
YLPQVFKSMMVPLIIIIAMFFIHFNTALIMLITAPFIPLFYIIFGLKTRDESKDQMTYLN
QFSQRFLNIAKGLVTLKLFNRTEQTEKHIYDDSTQFRTLTMRILRSAFLSGLMLEFISML
GIGLVALEATLSLVVFHNIDFKTAAIAIILAPEFYNAIKDLGQAFHTGKQSEGASDVVFE
FLEQPNYNNEFLLKYEENQKPFIQLTDISFRYDDSDRLVLNDLNLEIFKGDQIALVGPSG
AGKSTLTHLIAGVYQPTIGTISTNQRDLNIGILSQQPYIFSASIKENITMFKDIENNTIE
EVLDEVGLLDKVQSFTKGINTIIGEGGEMLSGGQMRRIELCRLLVMKPDLVIFDEPATGL
DIQTEHMIQNVLFQHFKDTTMIVIAHRDNTIRHLQRRLYIENGRLIADDRNISVNITENG
DDL
>2UYX_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
ASQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSW
DDKLTKELIEMVEKKFQKRVTDVIITHAHASRIGGIKTLKERGIKAHSTALTAELAKKNG
YEEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLG
NVADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>YP_003793151.1|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNVTDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>2NXA_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
TVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKE
LIEMVEKKFQKRVTDVIITHAHADHIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGD
LQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGDLVKSTSAKDLGNVADAYV
NEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>2BFZ_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADCIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGXLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>YP_005545038.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MGLFTAGMKPAHAAEGSELKGVTLTQLAPHVWMHTSTGMADGRPVPANGLLLDTSKGIVL
IDTPWNDSLTEQLMTQINQQFPGKRMTDAIVTHAHDDRIGGLNTLYKYGVKVHSTKLTAD
FARKQGYARPLGDLKNVAKLQFGDMEMETFYPGKGHTEDNITVWLPQDKLLFGGCLIKSL
ETKEIVPTPGFYPDQWPRAVQKVMKRYQDISIVVPGHGSPGDGRLLPHTISLLKEK
>3I0V_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
TVIKNTISISQLNKNVWVHTELVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQ
KRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTNLKFG
NMKVETFYPGKGHTEDNIVVWLPQYNILVGGXCLVKSTSAKDLGNVADAYVNEWSTSIEN
VLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>YP_084742.1|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
MAEKKFKKSVTDVIITHAHADRIGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQA
ITKLKFGNMKVETFYPGKGHTEDNIVVWLPQYNMLVGGCLVKYASAKDLGNVTDAYVNEW
STSIENVLKRYENINFVVPGHGEVGDKGLLLHTLDLLKEKSEEKQFLLAFF
>ABO21418.1|FEATURES|NCBI|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIEKLRDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINE
YQQKQKASN
>WP_000069819.1|FEATURES|resfam|beta_lactam|CTX-M-45|antibiotic target alteration|0
MSNNSPKALVSERRKYKVLNTQQAKGIAENHLKSIGFNAIAISYGLPEIDDRYHVWRVPV
LREKGRIGEVVIDAYTSNVDISKSTDRQVLETATPIHTNKKLTKKEITLSELENMVIEGN
SIESLKYLPEDSVNLIFTSPPYYNAKPEYSEYSTYEEYLELMRQVIKGCHRVLSEGRFFV
LNISPVLIRRASRSESSKRIAVPFDFHKLFIEEGFEFIDDIHWVKPEGAGWAFGRGRRFA
ADRNPLQYKPVPVTEYILVYRKKTDRLIDWNIRKHPDQKAVEESKVEDGYETTNLWRINP
SRSKDHPATFPVELAEKVIKYYSFKNDVVLDPFGGSGTTGIAALNLNRRFVMMELESKYI
QVMKKRFSSFDLFTPISFIKNKDL
>WP_000093084.1|FEATURES|resfam|multidrug|cfr|antibiotic target alteration|1
MSSAVVVSSENLDGQQQSSSTPASPAAEKVNLLGMSRAELEKFFEDIGEKKFRAGQVMKW
IHQYFVTDFAEMTNISGKLRAKLEQICEIKAPEVVHRHYSKDGTRKWVFRVGEGSGSLVE
TVLIPAEDKTGSRKTLCISSQVGCALDCSFCSTGKQGFQRDLTPDEIIGQLWMANYSYME
EVPVAERERSVTNVVMMGMGEPLLNYDAVLSSMHIMLDDFAYGMSKRRVTLSTSGVVPKI
DQLAKDIDVALAISLHAPNDELRNELVPINKKYPLAQLIAACQRYIAKDGNESARKHVTI
EYVMLEGVNDQPEHAQQLLKLLKNLPSKINLIPFNPFPHAPYGRSSRNRIISFQKTLSDA
GFVCTIRQTRGDDIDAACGQLVGQVADRTRRAEQWQKKVAQRQEILRTQG
>WP_000380747.1|FEATURES|resfam|chloramphenicol|catB9|antibiotic inactivation|1
MDTPLINTPVRHWCEFEFISKTVKNPNIHIKGNYSYYSAYWDQGFERCVVRYLHDKPSTP
DKPIDQLYIGNFVCFGAECVIMMGGNQLHRPDWISTFPFDTRSFLAAGDTIIADGCWIGS
RAMIMQGVKIGEGAVVATGAVVTKDVPPYTIVGGVPAKIIKYRFPQEQIEKLLALKIYDL
DEKQVLKMREYLQTDDIDALTAHLKKLQSE
>AAB36569.1|FEATURES|resfam|chloramphenicol|chloramphenicol_phosphotransferase|antibiotic inactivation|0
MTTRMIILNGGSSAGKSGIVRCLQSVLPEPWLAFGVDSLIEAMPLKMQSAEGGIEFDADG
GVSIGPEFRALEGAWAEGVVAMARAGARIIIDDVFLGGAAAQERWRSFVGDLDVLWVGVR
CDGAVAEGRETARGDRVAGMAAKQAYVVHEGVEYDVEVDTTHKESIECAWAIAAHVVP
>NP_821962.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|0
MAIEAVPGTADLVHARIPDTTAAGMVILLNGTSSSGKTSMARALLDILDGTWFHMPVDAF
HAMRCKRDISDEELQPEIDRTAKGFHRAVAGMAAGGNNLVVDYPLSRRWRLLDLLDLLVP
EDTVLVGVRCPLPELERRESERGDRQPGLAAMQYGAVHSHELHDLDIDSSLHTPAECALR
IRDFLPDRPRPTAFETLRRTLRRPHRPTAHTPAEAGPD
>ABO21415.1|FEATURES|NCBI|beta_lactam|IND-5|antibiotic inactivation|1
MKKRIQFFMVSMMLAPMFNAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSVYLVTKK
GVVLFDVPWEKAQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGNIKEANVEQWPITIDKLKAKYSKATLIIPGHEDWKGGGHVEHTLELLNKK
>WP_002995710.1|FEATURES|NCBI|beta_lactam|CGB-1|antibiotic inactivation|1
MRFNKSIFLLLFLLTMAHSGFSQEPGLKIEKLTKDFYIYTTYVAYSGVKTSANALYMLSK
DGVILFDTPWDPDQYQPLLDSIRNRHHQEVIAVYATHSHEDRAGGFGFFNKNGIPTYATA
ATNAILKADHKPEATHLIEPDKTIHIGGKQFVIKYFGEGHTADNVVVWFPKEKILDGGCL
IKSSEAKNLGYVGEANVKEWPKTIRKIQQTFKKINWVIPGHDGWKQQGHLENTLKLLTQ
>YP_003075067.1|FEATURES|NCBI|beta_lactam|DIM-1|antibiotic inactivation|1
MRVFLVIFILFIAGDLCAGEEMPGFSVEEIEKNVFLHGSYSQVNGFGLVSSNGLVVIENK
KAFIVDTPWSEKDTINLVQWIEGRNLVLIGSISTHSHEDRTAGIKWLNAHSIPTYASALT
NELLKKDDKEVATKSFEGAELMLADGLIEAYYPGGGHTIDNIVVWLPKSQILFGGCLVRS
VDSTGLGYVGEADIKNWSSSVENVLSKYPEIKAVVPGHGKIGGLSLLTHTKKLAISALPK
LSN
>YP_002155877.1|FEATURES|NCBI|beta_lactam|DIM-1|antibiotic inactivation|1
MFKFITGIVAAFVSFNTLSAPVIKPLQFEEVTTNIFLVKSFREFKNLKSPDNPIVIDANS
LIYIDGKDAYLIDTPWNAENMPQLMTWIENRDLTLKKTVFTHFHEDQTGGLEYLQEHGFD
TYATKLTNTRLVNDNKKAATHELDAQESVLLDNKIEVFYPGPGHSKDNSVVWFPKEKVLL
GGCLMRANEVNTIGWTGDADLAQWAQSAKNVLIKYPETKLVIPGHGDIGKGTSVISHTVN
IAESL
>YP_004041894.1|FEATURES|NCBI|beta_lactam|ATN06_17210|antibiotic inactivation|1
MKPKIHLTLFVFLLSLTNLFAQTNYQLTKNKADQLDRNFAITQLTNNAFLIQSSFAANGQ
LDCNHLLIIDTKDLVLVNTPVNDSLTSVLLACIEKKFKRKVTKVIVSHFHEDSSGGLRQI
CKLGINSFGLSKTASLLKSQNKHIDFLFTSFFALDLQTLHLELFYPGAGHSIDNIVIWLP
EDKILFGGCLLKSLEAKDKGNIKDADLKAWPVSVELIKKKYQDAIIVIPGHGEIGNTSVF
EHTLKLLANN
>ACU65241.1|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILYGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPAHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>ABO21416.1|FEATURES|NCBI|beta_lactam|VIM-2|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLIVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>YP_006410297.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MKPTLRKRLSYLLLALLDFASACDREPVDRNSAGNSIFAAEIQPVIMPKNMSALRPFLFA
LLLAATAAACTFRRIDIGNDITVQRLAEGIYLYTAVDEIEGYGPVPSNGVLIVREGEAVL
LDTPVGDAQTKTLTDWAAETLRACVTTFVPNHWHSDCMGGLGYLKTLGVKSYAHRLTHSI
AQREGKPVPDIGFGDSLRLDLHGTEIRCYYFGGGHSEDNIAVWIPSAKLLFAGCMVKEMA
AQNAGNLSDAVPAAWPATLDSLLVRFPDARIVVPGHGAPGGPELIRHTKALLSEAASTDN
RRKE
>1WUO_A|FEATURES|NCBI|beta_lactam|IMP-1|antibiotic inactivation|1
AESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNAEAYLIDTPFTAKDTEKLV
TWFVERGYKIKGSISSHFHSASTGGIEWLNSRSIPTYASELTNELLKKDGKVQATNSFSG
VNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGXFIKPYGLGNLGDANIEAWPKSA
KLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKKPSKPSN
>YP_002446910.1|FEATURES|NCBI|beta_lactam|BG10_6932|antibiotic inactivation|1
MVEKKFQKRVTDFIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQT
ITSLKFGNTKVETFHPGKGRTEDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEW
STSIENVLKRYGNIDSVVPGHGEVGDRGLLLHTLDLLK
>YP_628702.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MTLFPLRWFCAGALLITLSTACTRSTPAATVERNIPVKAQSQGPDEYVLADDVSVRKLAP
GVWLHITVVTLEPFGRVSTNGLIIEDGETSLLVDTGWDARQGALLLDWARDTLRRPVRAA
VVTHFHEDRLGGVPALAPHGIPVHGLEETARIATSLGLPGPTETFAKTSTVDSLELFFPG
AGHAKDNIVVWHRDSGVLFGGCFVKDGASTNLGNVADADVAAWPASLSRTRQRFPEARVV
VPGHGQPGGPELLGHTEALLR
>YP_003270512.1|FEATURES|NCBI|beta_lactam|NDM-6|antibiotic inactivation|1
MLFRVELLSSAIAALALSAGCGAHQPAASQAPQAAATPSSTDSTDSTATDEASETGRDEL
EFTQLGEGVWMHTSWKDVPPWGPVMSNGLIVADGEGSFLIDTAWNDEQTAAILDWAEREL
GRPVRGAVFTHAHEDKMGGVGTVRARGIRTYALALSNQLAAEGGVMPAEASLRLEAGGEP
QTLGPVQVFYPGGGHTRDNIVVAVDGGVLFGGCLIRPGGTNSLGNTADADLDHWDEAVSA
VAKRFPDRSVVIPSHGPPGGRELLDQTIQLVQSDEKKP
>EAQ37928.1|FEATURES|NCBI|beta_lactam|SFB-1|antibiotic inactivation|1
MKRLLQMLGICLAVLLLHSCFDKSKYAPEPYLRPLEIIKLSDQDYMHVSYLKDGKDGYIP
CNGYIRKEGDEVFVFETPLDDSTSVQLIDFIQNDLNATIKAVMVSHAHIDGAGGVKAFNE
AGIPTYGSSKAAALLARDTITLSNTFQLKDSLMLGKTLIKMDYLGPAHTDDNAIAYLEGP
EILLGGCMIKSLEAGKGNLADANLKEWAKTVATAKYLYPDVKQVIPGHGMRGDSTLLTYT
IKMFQVEKPIIKELTNTNEQETVQL
>YP_003061440.1|FEATURES|NCBI|beta_lactam|NDM-6|antibiotic inactivation|1
MRYTLIGISLLLGFVFLSGCMHQVPVLSQQSEQSTHIEGVAEKPVEFVKLGTGVWMHTGY
KVVPPWGNIRTNGLIIERGDYSVLVDTAWNDAQTAEIVAWAKDTLQKPIRASIHTHAHSD
KMGGMDALHMLGVETFATDLTNRLAIERGLMPAKNVLNISEIGSQIEWEGLTILYPGGGH
SEDNIVVNEGVNNILFGGCMIRPGMTTSLGNIDDANLGYWSKAVENAANAFPDSQIVIPS
HGKPAGREILKNTAYIARPKLD
>CBX26623.1|FEATURES|NCBI|beta_lactam|VIM-23|antibiotic inactivation|1
SLPVHGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDV
LRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGLR
>CBX26622.1|FEATURES|NCBI|beta_lactam|VIM-23|antibiotic inactivation|1
RDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATY
ASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPVAAH
>ACI25600.1|FEATURES|NCBI|beta_lactam|SPM-1|antibiotic inactivation|1
TDRDFYSSNVLVAKMLDGTVVIVSSPFENLGTQTLMDWVAKTMKPKKVVAINTHFHLDGT
GGNEIYKKMGAETWSRDL
>ABE01852.1|FEATURES|NCBI|beta_lactam|cphA7|antibiotic inactivation|1
LTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSSKPVLEV
INTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMQSDWAEIVAFTRKGLPEYPDLPLVLPN
VVHGGDFTLQEGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYP
QTIERLKAMKLPIKTVVGGHDS
>NP_902820.1|FEATURES|NCBI|beta_lactam|cphA6|antibiotic inactivation|1
MDIKMRTVFGFAGALLGLAAAACAAQGGLALKHLKGGVYVVEDGYYAKENSVVYVGAEHV
TVVGATWTPDTARELARQIRAVTDKPIAEVVNPNYHPDRAGGNAYWKSIGARIVSTRQTA
DEMRRGWDEVVAFTRRGFPDYPALPVSLPDREHPGDFELQDGRIKAFHLGAAHTRDGIFV
HFPQERVLYGNCILKQELGNLSYADLNEYPKTLERLKLSELDFDTVIAGHLDALHGPELI
DHYQRLLKRQASDAAAERS
>3Q6V_A|FEATURES|NCBI|beta_lactam|Sfh-1|antibiotic inactivation|1
MSEKNLTLTHFKGPLYIVEDKEYVQENSMVYIGTDGITIIGATWTPETAETLYKEIRKVS
PLPINEVINTNYHTDRAGGNAYWKTLGAKIVATQMTYDLQKSQWGSIVNFTRQGNNKYPN
LEKSLPDTVFPGDFNLQNGSIRAMYLGEAHTKDGIFVYFPAERVLYGNCILKENLGNMSF
ANRTEYPKTLEKLKGLIEQGELKVDSIIAGHDTPIHDVGLIDHYLTLLEKAPK
>ABO60986.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRSTLLAFALAVALPAVHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGLVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFDAQLAKETAGAR
>BAE44414.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EDLTALLVQTADGAVLLDGGMPQMASHLISNMKVRDVAPQDLRLILLSHAHADHAGPVAE
LKRRTGAMVVANAESAVLLARGGSNDLHFGDSITFPPASTDRIIMDGEVVTVGGIAFTAH
FMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPHLVEDYRRSFATVRG
LPCDLLLTPHPGASNWNYAAGSKASDKALNCK
>CAB94702.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMAS
HLLDNMKARGVTPRDLRLILLSHAHADHAGPVAELKRRTGAKVAANAESAVLLARGGSDD
LHFGDGITYPPANADRIVMDGEVITVGGIVFTVHFMAGHTPGSTAWTWTDTRNGKPVRIA
YADSLSA
>ADC79559.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKADAT
>WP_001082958.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDIRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTGQQPQ
>YP_002148668.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFIVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQGSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_002217697.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>WP_001082980.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFLVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>WP_001082967.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLATDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>YP_002228462.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHHQESIILGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQGSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>YP_218647.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPFPPVTTDKIIHHQESIILGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQGSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>WP_001082965.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGREDFALGDALPSPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>NP_807403.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYVLFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRFTDVRYLLSSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPLVTTDKIIHNQESISLGGVTVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>YP_001204253.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
MLAATLAWTAGPAAAQSLPDFMKQVIATWNTPTEPFKVIDNIYYVGTNGLASYLITTPQG
HILIDTVMPESTALIETSIGKLGFKVADIKYVINTHAHIDHTGGLAQIKQETGAQMVAGA
KDVPLLEGGFYPGREEERYLNFPPVKVDRAVREGDTVTLGGVTLTAHETPGHSPGCTSWT
TEVKDGDATRSVIFFCSATVALNQLVGRPTYPGIVDDYKKTYAWAKTVHPDVLLAPHPEM
YGMADKRAKIADGAPNPFVKPGEFNAYLDKLEAQFNEGLAKQTAALQSGK
>WP_006580921.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKKKILFTGSILLTSLSASATPLKLPDDWTQNTQPFQITENIYYVGTHGLGTYLLTSDHQ
ALLIDTGLPENTEQIEQNIKKLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQ
QDVKALEIGKPIGENTFQSIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWS
TEVKSNGKNLNVVFPCSLSVAGNVLQNNHQYPNIVEDYRQSFKRLKNMKADIVLTSHPEV
ADVMGNKARKDAGQVNAFIQPEKLSAIVKDAEMAFEKSLVSSKP
>YP_004184760.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MLARTLLLLLAFASPLFAQMDSTWTTNHPPFRIAGDLYYVGSDDLAAYLITTPQGNILIN
TNLASSVPQIRQNIEKLGFRVADTKIMLNSQAHFDHVAGTAEMKRLTHAKVEVMEGDVVP
MESGGRKDFFFFNDPSAYFPPVKVDKVLHDGEQVSLGGTVLTAHLTAGHTMGCTTWTMQI
TEDGKTYNVVIVGGASMNGGNNLIHDPRYPTEAEDFLRAFRTLRGLPCDFFLGAHGKYFD
LKLKYPKLQAGAANPFLDPDGYKAFLDDREQAFRKELAKQTAAHK
>YP_001204321.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MMMRKIKMPMRLPATLMSTLLLALAWPVEAQVLPPNVPSKEQLANDNHLFLSLARKIFKW
EEPAEPVRIVGPIYFVGTRGLGAFLIVTSEGHILMNTGMPSSGPMIVESIRKLGFKPDDV
KLMINGHAHIDHAGAFAFMKRLTGAQLAIMKDDVAAIESGDRGDFKYADDLAYEGVTVDR
VLRDGDQIRMGDVLLTAYHTPGHTRGATTWIANLVVDGKAYLVAFPDGAGVNPGYRLAKD
PSYPGIEGDYRKTHHALEMIKPDIWLAQHNEYYDFEGKRKRAETQGVSAWIDPEGYRRFI
AGKKRAFEDEVDEELGAPKAAATSSADAPSNNR
>NP_420942.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGH
VVLDGGPNAETGKLVERNITALGFQLADVKILINTHAHYDHAGGLAQLKADTGAKLWISR
DDAPAMTAGHHIGDNIYGPTPMPAVKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWT
TAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQ
GNLLAKRQKQLRGDPNAFVDPTELARFVDASEAAFNKELARQQAAGPKR
>CAC48262.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGH
VVLHGGPNAETGKLVERNITALGFQLADLKILINTHAHYDHAGGLAQLKADTGAKLWISR
DDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWT
TAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQ
GNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPKP
>YP_001685033.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MKRAASILLALLALAQAGAARAADPANWSKPIRPYRVVGNIYYVGSEGLSAWLISSSEGH
VLLDSGPAPAGAKLIEANITALGFKLSDVKILINTHAHFDHAGGLAQLKADTGAKVWASR
PDEPALEKGQHFGDNANGLTPFAAVKVDKAFGDGQKLKLGETTLIAHLTPGHTIGCTSWT
TQVIDRGRPLNVTFPCSASVADNVLVGNSAYKTIVADYRATFATLKALPTDVMLPAHEEQ
GHLLDKRKKMLAGDVNAFIDPTELARYAATSEQAFDKELARQQGARKP
>WP_009024763.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
MDVTNKYFSGVLLPIAVGVAMTVSQPGAAQQSTALSSASDTLTKIQSLSTEADTTSFNWQ
ETFPSWFEHMEPFRLAGSGDTEIYYVGTKGLGMFFIPTTEGHIVIDGGMPGQGQLIAENI
KKLGFDAKDVRILLNTHAHIDHSGGLAELKSLTGAQLIASEGDRWALESGLIPGSEDVSY
VQSPPVTVDRVIVDGEKVIIGNLTMTARITPGHTQGCTSWTTTLQPTASAPPQEVLFFCS
ASVAANSLVNPPQYPGIVEDYHKTFALTADWEPEVFLANHGEFFDLVARHDRLSNGEASA
FHDRESFQRFRTKMKDMFEQALIAQSEEAKISAHSKEH
>ABK64103.1|FEATURES|NCBI|beta_lactam|THIN-B|antibiotic inactivation|1
MTLLAKLMLATVATMAAGTVQAKTPAPVQDKPVDCDNCKEWNAPVKPFNIYGNSWYVGTA
GLSAVLVTSPQGHILLDGALPQSAPLIVANIKALGFRIEDVKYILNSHAHWDHAGGIAAL
QRASGATVMASAAAAPVLQSGTNGKDDPQYQANPVVHVAKVSKVSLVGEGDTVKVGPLTL
TAHMTPGHTPGGTTWTWTSCEGARCLNVVYADSLNPYASGDFTYTGKGKTPDISASFEAS
IAKVAALPCDIIIPVHPGTTDVLGKAAKRSGTDNPLIDANACRAYAAEAGGLLAKRLAKE
RGVALPAEAKSAAHAH
>YP_003592397.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MTLLAPPPSRRVSAPIHLPRCSGEDATVSSSPAKRGVWRDAKHRVGGGALAALATLLLAL
APAAHADMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVILDGGPNAETGKQIE
RNIASLGFQLADVKFLINTHAHYDHAGGLAQLKADIPAAKLWISRGDEPAIEQGHHIGDN
ENGPTPMPAVKVDRAFGDGQKLKLGETSLVAHLTPGHTIGCTTWTTAVIEKGRPLNVTFP
CSLSVAGNMLVGNKGHKTIVADYRASFATMRAIPTDVVLPSHEEQGDLLAKRQKQLRGDP
NAFVDPTEMGRFVDGYEAAFNKGLARQQGVGGAQ
>ACC57876.1|FEATURES|resfam|beta_lactam|ADC-2|antibiotic inactivation|1
MSTFIPAFYFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYY
GLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQ
VNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIGLFRKVVA
LSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYG
VKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSYPATLQTL
LDSSSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPN
EERIKAAYAVLDAIKK
>WP_001159761.1|FEATURES|resfam|beta_lactam|ADC-2|antibiotic inactivation|1
MQFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGW
EEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENI
GLVMLTNKRIPNEERIKAAYAVLNAIKK
>NP_313158.1|FEATURES|resfam|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAM11671.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSDLSFEQAMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDTII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>ABA70720.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MMHKTLSCALLLVASGSTFATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYY
FTWGMADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSKYWPALSGKQ
WEGISLLNLATYTAGGLPLQVPDNITDETSLQNYYETWQPQWAPGTKRFYSNASIGMFGK
LAVKPSGMSFEQAMNKRVFQPLNLTHTWIHVPEREEKHYAWGYRDGKAVHVSPGMLDAEA
YGVKSSIKDMASWVRANMTPSEVKDASLQKGILLAQSRYLQVGDMYQGLGWEMLNWPMKA
TIAVGGSDNKVALAPLSAVEINPPAPALNSSWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPARVEAAYRILEALSVE
>O05465.1|FEATURES|NCBI|beta_lactam|A3K91_1255|antibiotic inactivation|1
MKLFTSTLTAKKSSTHKPLISLALSVLISTLLISETAQAADANDRLEQEVDKQAKQLMAQ
YQIPGMAFGIIVDGKSHFYNYGLADKQRNQPVSEDTIFELGSVSKTFAATLASYSELNGT
LSLDDTADKYIPYLKNSAIGNTKLISLVTYSAGGYHYRCLKTLENNKELLQYYKSWHPDF
PVNSKRLYSNASIGLFGYISALSMHSDYTKLIENTVLPSLKMTNTFVDVPANKMEDYAFG
YNAAGEPIRVNPGMLDAEAYGIKSTSADMTRFMAANMGLVTVDSQMQQALDNNRKGYYRT
KSFTQGLAWEMYPLPTTLQQLVEGNSTETILQPQPIQLNEPPTPVLNDVWVNKTGATNGF
GAYIAYMPAKKTGMFILANKNYPNTERVKAAYTILDSVMNN
>O69773.1|FEATURES|NCBI|beta_lactam|PROSTU_00250|antibiotic inactivation|1
MDNSMKNIFRQGRLFIALSLAMTSISAFALTQQEVDDIIKPLMKQEQIPGMSVAISVNGK
QAIYHYGVQSKQTQIPVSDRTLYEIGSLSKTFTATLATYAQIQGKLDFSQSVSHYLPELK
GSAFDNVSVMNLATHTSGLSLFVPSDIKTNDQLMAYYQKWLPDNEVGQYRSYSNLGVGLL
GIVTAKQLNMPFSQAMEKLMLPSLGLKHTYIHVPKSQEKYYAQGYNKQNQPVRLNLEILG
PEAYGLKSNAKDLIRYLEINMQSIKVAKTWQEAIENTHTGVYLTDSFVQDMMWESYPWPV
SLSQLLQGNRDDMALKPQKVELIKPAMAPEVRAYYNKTGSSNGFATYAIFIPEEKIAIVM
LSNKWIPIPQRITATYQLLEKIER
>CAC85358.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MKKSLCCALLLGVSCTTFAAPMSEKQLADVVERTITPLMKAQAVPGMAVAVIYQGKPHYF
TFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAVARGEISLSDKATKYWPELTGKQW
QCISLLDLATYTAGGLPLQVPDDVTDNASLLHFYQTWQPQYHPGSTRLYANASIGLFGAL
AVKPSGMSFEQAMTERVFKPLKLAHTWINVPPQETQHYAWGYRDGKAVHVSPGMLDAQAY
GVKTNVEDMASWVIANMTPDSVQDASLKQGITLAQSRYWRIGSMYQGLGWEMLNWPVDAK
TVVNGSDNKVALAALPVKEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKDLGIVMLAN
KSYPNPARVEAAYRILSALQP
>YP_313059.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>YP_888266.1|FEATURES|NCBI|beta_lactam|MSMEI_3884|antibiotic inactivation|1
MFTAGRICAALIVLVALISAAPTASADPSAAVARAFAPLLDQYDVPGMAVAVTVDGRQHF
YEFGVVSKQTQAPVTRDTLFEIGSVSKTFTATLAGYAATRGVLNLDDHPGRYLPALAGTP
IDRAELRNLGTYTAGGLPLQFPESVTDDEQMIAYFQQFQPVTAPGKIRQYSNPSVGLLGH
ISARALGGQFTDLMQSQILTGLGLRRSFVDVTDEAMDFYAWGYDKKNHPVRVNPGVFDAE
AYGVKSTTADMIRFIEHNIDPGALEPTLREAVKSTQVGYYKVGPMVQDLGWEQYPYPVAL
DQLLAGNSGEMAMSPQAATAIAPPSVGSALFNKTGSTDGFGAYAAFVPERRIGIVMLANK
NFPIPARVTAAHTVLDALDA
>AAZ76618.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|Erm(38)|antibiotic target alteration|1
MSKPHHGRHELGQNFLSDRRVIADIVEIVSHTTGPIIEIGAGDGALTVPLQGLVRPLTAI
EVDARRAHRLAQRTAKSTEIVVADFLRHPLPHSPHVVVGNLPFHLTTAILRRLLHGPGWT
TAVLVVQWEVARRRAAVGGATMMTAQWWPWFEFALAQKIPASSFRPRPAVDAGLLTITRR
NRPLVDSADRARYQALVHRVFTGRGRGMAQILRRLPTPVPRNWLRANGVAPNALPRQLSA
AQWAALHEATLAGTERVDRPRDVQHGRAHRRGGGEVDRPAPHHKQTRPLIGQRQPQRGGD
PDADPDDQCAAAPVTGHHQGERRDEDQADHQDRPLTGEHLADELSWRHASFDSSASTTLV
SRKARVNGPTPPGLGDT
>CAP17168.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRK
>YP_001086116.1|FEATURES|resfam|tetracycline|tet41|antibiotic efflux|1
MTHSTHISIYMGILASLYAAMQFIFSPLLGALSDRWGRRPVLLISLAGSAVNYLFLTFSH
SLILLLVGRIIAGITSANMAVASAYIVDVLHENNRAKYFGLINAMFGAGFIIGPVLGGFL
SEYGLRLPFFAAAILTGLNLLSAYFVLPETRRVTSEGKQLSTLNPFKIFAGISSIRGVLP
FVMTFFIFSAIGEVYGVCWALWGHDTFQWSGFWVGLSLGAFGLCQMLVQIFIPSHASRLL
GNRNAVLIGIACSCLALAVMAFAQSGWMIFAIMPIFALGSMGTPSLQALASQKVSADQQG
QFQGVITSTVSLASMIAPLFFSTLYFQFQKKWPGAIWLSVILIYLITLPIILYSTQPVEQ
QR
>WP_001082093.1|FEATURES|resfam|tetracycline|tet41|antibiotic efflux|1
MNRSLFIIFATIALDAIGIGLIFPILPLLLQDMTHSTHISIYMGILASLYAAMQFIFSPL
LGALSDRWGRRPVLLISLAGSAVNYLFLTFSHSLILLLVGRIIAGITSANMAVASAYIVD
VLHENNRAKYFGLINAMFGAGFIIGPVLGGFLSEYGLRLPFFAAAILTGLNLLSAYFVLP
ESRKVTLENKQLSTLNPFKIFAGISSIRGVLPLITTFFIFSAIGEVYGVCWALWGHDTFQ
WSGFWVGLSLGAFGLCQMLVQALIPSHASRLLGNRNAVLAGIACSCFALAVMAFAQSGWM
IFAIMPIFALGSMGTPSLQALASQKVSADQQGQFQGVIASTVSMASMIAPMFFSTLYFQF
QEKWPGANWLSVILIYLLTLPIILYSTRPVVQQR
>NP_253981.1|FEATURES|resfam|multidrug|NorA|antibiotic efflux|0
MSSPSLVELKAILRLAGPLIAAQLAYVAMVFTDTVMMGKLGPDALAAGGLGAVSYAFVST
FCVGVVAAVGNLVAIRHGCDDAAGAAAAARSGLWVGAALALAAGLLLWNLRPLLLVFGQA
PQTVDGAMQFLHSLTFALPGYMAFMVLRGFTSAIDRAGPVMAISVLGALANLALNYSFIE
GLFGLPRLGLAGIGLVTALVMNCMPLLLALYIRLQPAYAEYSLLRGLGRPQRAMVEEILR
LGLPIGGTYAVESGMFTVATLCMGIIGDHALAAHQIAIQAVYVAFMVPVGLSYATTYRIG
QHFGAGRLLEARRAGRVGIGFGALCMLLFAGLFWWMPEAIIGLFLDRDAPANREVAAMAV
SLLAIAAWFELFDGTQNVAMGAIRGLKDARTTFLVGLACYWLVGVPLACLLAFAAGWGAA
GVWWGLAGGLACAAIGLTLAFEWKTARLLPKATASEASALNCRAAGRGAPSARLCPGNAP
VPPTAAAD
>NP_311359.1|FEATURES|resfam|aminoglycoside|acrD|antibiotic efflux|1
MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENT
VTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQ
AVQNQGLTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGS
QYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLL
QTPEQFRDITLRVNQDGSEVRLGDVATAEMGAEKYDYLSRFNGKPASGLGVKLASGANEM
ATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQ
NFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIM
SEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVL
SVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRW
IVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTH
EKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEA
RVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLD
DSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRML
PDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMD
IMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVM
LVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEA
TLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVP
LFFVLVRRRFPLKPRPE
>WP_011764581.1|FEATURES|resfam|multidrug|mexK|antibiotic efflux|1
MSRRRGFNISAWGLAHPALVLYCLIALSLIGILAYSRLGQSEDPPFTFKIMVVRTEWPGA
SAREVEQQVTDKIEKKLQEIAQLDFVRSFSKPGESMVLVLAKDSTPAREVEGIWYQVRKK
VGDIRDYLPAGVKGPYFNDEFGDTYGNIFALVGDGISHAELKRHAEAVRGELLRVPDVGK
VSFFGEQAQRVYIELSNTKLATFGLGLADIAAALSAQNAKAGSGFFETADERIWLRPSGQ
FDDLQAIADTLIRAQGRVFRLGDVAEIRRGYVDPPSERMRFNGADAFGIGVAMRAGGDIV
ALGRHLDEAAARIEAQLPVGIRFERVADQPRAVRNSVGEFVQVLTEAVIIVMTVSLLSLG
FRTGVVVLIIIPVVLAITFLFMHLFGIGLHKISLGALIIALGLLVDDAIIAVEMMATKME
QGWERAKAASFAYTSTAMPMLSGTLVTAAGFLPIATAASSTGEYTRSIFQVTVTALLVSW
VAAVLFVPYLGYHLLPDFRARNGRPSRLAGWIGRVSPGLAARLQARASHGHAQHDEYAIY
HTPFYTRLRTLVGWCVAHRWLVIALTLASFVLSLVVFVRFVPQQFFPDSTRPELLVDLRL
AEGASHEATERAVHRLEGWLQQQEGVENFVAWLGAGSPRFYLPLDQQLAQTNFAQLVVLT
KGIAEREAVRSRLIRLFEDEAWPLRATINRLENGPPVGFPVQYRVSGQDIDTLRTIAHRV
AEAMRTDRNLSNVHLDWEEPAKSIRLKVDQDKARLLGVSSRDLASLLATSLQGTTVSEFR
EGTETIQMVLRGAGAERAHLGLLSDLAVPVSGGRSVPLAQLATLEYGFEEGVIWRRNRIP
TVTVRASLYGGTQPAVVVQQLGPQIEAIRAALPLGYRVEVGGAVEESSKGGGSVAAGVPL
FIGVVLTVLMLQLQSFSRTLLVVLTAPLGMIGVTVFLLAFNKPFGFVAMLGTIALSGMIM
RNSVILVDQIRQDVDAGRTPWDAVVEATVRRFRPIVLTAAAAILAMIPLSRSAFFGPMAV
AIMGGLTVATVLTMLFLPALYAAWYRIRRTPAPLPPAPPSGANMEAVQGARM
>WP_000671305.1|FEATURES|resfam|multidrug|mexK|antibiotic efflux|1
MKFNLSEWALNNKGIVLYFMLLLGIIGAISYSKLSQSEDPPFTFKVMVVQTYWPGATAKE
VSTLVTDRIEKELMTTGQYDKIMAYSRPGESMVTFVAKDSLTSAQIPDVWYNVRKKVNDI
RHELPSGVQGPFFNDEFGDTFGNIYVLTGKDFDYALLKEYADRLQLQLQRVKDVGKVELI
GLQDQKIWIEISNTKAVQLGIPVSAIQEALQKQNSMASAGFFETGTDRIQIRVSGQLQSV
EDIKKMPLLVGDKTIQLGDVADVYRGFSQPAQPRMRFMGDNGIGIAVSMRKGGDIIALGK
NLETEFAQLQKTLPLGMKLQKVSDQPVAVQRSIHEFVKVLAEAVIIVLLVSFFSLGFRTG
LVVAFSIPLVLAMTFAGMNLFDVGLHKISLGALILALGLLVDDAIIAVEMMAIKMEQGYS
RIKAAGFAWKTTAFPMLTGTLITAAGFLPIATAQSSTGEYTRSIFQVVTIALLVSWVAAV
LFVPYLGEKLLPDFTKTGHQAPWYVRLWARVTKKPQPQTVAISQDHHYDPYQSSFYLRFR
KMVEFCVTYRKTVIATTVGIFVLSVLMFKMVPQQFFPPSNRAEILVDLKLEEGASLTATE
QAVKKVEQFLSKQKGIDNYVAYVGTGSPRFYLPLDQQLPQASFAQFVVLASSLDDRDEIR
RSLETQIKQLLPQVRTRVSLLENGPPVGYPLQYRVSGEDLNLVRKEAQQVARVISENPNT
TNVHLDWGEPSKIISIQIDQDRARQMGVSSLDLANFLNASITGSAIEQYREKRELIEIRL
RGDKAERVEVASLASLAVPTANGTTVPLAQIAKIEYKFEDGLIWHRNRLPTITVRADIRT
NLQPATVVGELAESMDKLRAELPSGYLIEVGGTVEESARGQSSVNAGMPLFLAVVMTLLM
IQLKSLSRATIVFLTAPLGLIGVVLFLLLFNKPFGFVAMLGTIALSGMIMRNSLILIDQI
EQDRQAGHPTWEAIIDATVRRFRPIILTALAAVLAMIPLSRSIFFGPMAVAIMGGLIVAT
LLTLFFLPALYAAWFKVKKTA
>resfam_SHV-10|FEATURES|resfam|beta_lactam|SHV-10|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASRTLTAWRADER
FPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAA
AITMGDNSAANLLLRTVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPAS
MAATLRNVLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGI
VALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-22|FEATURES|resfam|beta_lactam|SHV-22|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDKVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-75|FEATURES|resfam|beta_lactam|SHV-75|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNHKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHVL-15|FEATURES|resfam|beta_lactam|SHVL-15|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKNGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACN72587.1|FEATURES|resfam|beta_lactam|SHVL-19|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLEREIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAV91756.1|FEATURES|resfam|beta_lactam|SHVL-73|antibiotic inactivation|1
LEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDQ
QLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLT
AFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQ
WMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPAS
MAERNQQI
>AAV91759.1|FEATURES|resfam|beta_lactam|SHVL-74|antibiotic inactivation|1
LEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDE
QLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLT
AFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQ
WMVADRVAGPLIRSVLPAGWFIADKPGASKRGARGIVALLGPNNKADRILVIYLRDTPAS
MAERNQQI
>2V1Z_A|FEATURES|resfam|beta_lactam|TEM1|antibiotic inactivation|1
PETLVKVKDAEDQLCRTSHRPCRVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAV
LSRIDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLT
TIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLT
LASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGRRGSRGIIAALGPDGKPSRIVV
IYTTGSRKKTDERNRQIAEIGASLIKHWGLEQKLISEEDLNSAVDHHHHHH
>WP_011078081.1|FEATURES|resfam|beta_lactam|TEML-42|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGXKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTXM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVXYPTGSQATMDERNRQIAEIGASLD
>ABQ14373.1|FEATURES|resfam|beta_lactam|TEML-52|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14416.1|FEATURES|resfam|beta_lactam|TEML-58|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATAL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14403.1|FEATURES|resfam|beta_lactam|TEML-63|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDSKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14400.1|FEATURES|resfam|beta_lactam|TEML-64|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEMHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14376.1|FEATURES|resfam|beta_lactam|TEML-66|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYLPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14381.1|FEATURES|resfam|beta_lactam|TEML-69|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKGAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14428.1|FEATURES|resfam|beta_lactam|TEML-78|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPASWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIG
>ABQ14440.1|FEATURES|resfam|beta_lactam|TEML-79|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLAKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVAIYTTGSQATMDERNRQIAEIGA
>ABQ14392.1|FEATURES|resfam|beta_lactam|TEML-92|antibiotic inactivation|1
ALIPSFAAFCLPVFAHPETLVKVKDAGDQLGARVGYIELDLNSGKILESFRPKERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14420.1|FEATURES|resfam|beta_lactam|TEML-95|antibiotic inactivation|1
ALIPFFAASCLPVLAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYPPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>WP_102607453.1|FEATURES|resfam|beta_lactam|TEM-9|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-31|FEATURES|resfam|beta_lactam|TEM-31|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
CGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-18|FEATURES|resfam|beta_lactam|TEM-18|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-124|FEATURES|resfam|beta_lactam|TEM-124|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEANRQIAEIGASLIKHW
>resfam_TEM-5|FEATURES|resfam|beta_lactam|TEM-5|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-56|FEATURES|resfam|beta_lactam|TEM-56|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-25|FEATURES|resfam|beta_lactam|TEM-25|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>ABI20745.1|FEATURES|resfam|beta_lactam|TEML-114|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EEHFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAA77064.1|FEATURES|resfam|beta_lactam|TEML-115|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFFHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABI20744.1|FEATURES|resfam|beta_lactam|TEML-118|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMAVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ABA60617.1|FEATURES|resfam|beta_lactam|TEML-119|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNGGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAC73065.1|FEATURES|resfam|beta_lactam|TEML-126|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQAAMDERNRQIAEIGASLIKHW
>CAC83818.1|FEATURES|resfam|beta_lactam|TEML-135|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWLLADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ95766.1|FEATURES|resfam|beta_lactam|TEML-136|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMEERNRQIAEIGLSLIKHW
>AAQ05031.1|FEATURES|resfam|beta_lactam|TEML-137|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADRVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAB47269.1|FEATURES|resfam|beta_lactam|TEML-139|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVDASPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_003713939.1|FEATURES|resfam|beta_lactam|TEML-147|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESLRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLATIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGSLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEML-149|FEATURES|resfam|beta_lactam|TEML-149|antibiotic inactivation|1
MSIQHFRVAALSFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLDRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD28563.1|FEATURES|resfam|beta_lactam|TEML-157|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCHTLLSRIDAGQEQLGRRARYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMPTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-1_D214X|FEATURES|resfam|beta_lactam|TEM-1_with_an_undefined_D214X_mutation_(N-23)_[_D214X]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEAXKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>ANG35171.1|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_S235A_mutation_(N-23)_[_S235A]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKAGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>1JWV_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_G238A_mutation_(N-23)_[_G238A]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAAERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>2B5R_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_V84I,_E104Y,_Y105N_mutations_(N-23)_[_V84I_E104Y_Y105N]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRID
AGQEQLGRRIHYSQNDLVYNSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>WP_000837444.1|FEATURES|resfam|multidrug|adeS|antibiotic efflux|0
MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVD
WIWLATVIFCGCIISLVIGMRLAKRFIVPINFLAEAAKKISHGDLSARAYDNRIHSAEMS
ELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSL
LNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDL
TSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRD
DLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIQYSNQGSKSVFTIKISMGHEEM
G
>YP_001706192.1|FEATURES|resfam|multidrug|smeR|antibiotic efflux|0
MKHIMLVEDEVELAHLVCDYLEAAGFEVSMFHDGQDAYTSFQQRKPNLMILDLMVPRMDG
LTICRKVREQSDLPIIMVTARTEEIDRVLGLNMGADDYVCKPFSPKELVARVQAVLRRLE
RKAEPEQNDSFRIDKAQQRIWYQQKSLSLTPTEFRLLELFLEHVGQVYSRAQLLDHINPD
SFDVADRVIDSHIKNLRRKITEVAETGNRHEWIQAVYGVGYRFEYPEE
>WP_001284653.1|FEATURES|resfam|beta_lactam|mecI|antibiotic target replacement|0
MANKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>WP_001096377.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVVWIVLVIILSFK
FLKSLLYLKYLKKQSLYLNENEKNKVDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNVPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLHNDYQILDKSKIFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPNSTYKIYLAMFGLDRHIINDENSRMSWNHKHYP
FDAWNKEQDLNTAMQNSVNWYFERISDQIPKNYTATQLKQLNYGNKNLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_001096385.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNIITTKPVQEFATDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTSFFNKNILSHSFNGKKSLLKNRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHKHYL
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNGQ
>NP_932192.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MLVFFRYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKFNNVNNQSPTVESRSHDL
NHNINTTKPVQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFKFLKSLLYLKYLKRQSLY
LNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYIILIPSSYFKSVIDKRLKY
IILHEYAHAKNRDTLHLIIFNIFSIVMSYNPLIHIVKRKIIHDNEVEADRFVLNNINKNE
FKTYAESIMDSVLNIPFFNKNILSHSFNGKKSLLKRRLINIKEANLKKQSKLIPIFICIF
TFLLMVIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNSGSFVMYSMKKDKYYIYN
EKESRKRYSPDSTYKIYLAMFGLDHHIISDKNSRMSWNHKHYPFESWNKEQDLNTAMQNS
VNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSLKISNLEQVIVFKNMMEQ
NNHFSKKAKNQLSSSLLIKKNEKYELYGNTGTGIVNGKYNNGWFVGYVITNHDKYYFATH
LSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_001096389.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLITSVVSFCFIFLLLVFFKYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVVWIVLVIILSFK
FLKSLLYLKYLKKQSLYLNENEKNKVDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTPFSNKNILSHSFNGKKSLLKSRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHKHYL
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNDQ
>WP_001141007.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MMAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFML
VNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLM
PLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIALV
AFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALIISM
VIIYLFIRRQFNITNVLLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLS
ALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTY
LIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSF
GAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRK
F
>WP_003689303.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|0
MAKMMKWSAVAAVAAAAVWGGWHYLKPEPQASYITETVRRGGISRTVSATGEISPSNLVS
VGAQASGQIKKLYVKLGQQVKKGDLIAEINSTTQTNTLDMEKSKLETYQAKLVSAQIALG
SAEKKYKRQAALWKDDATSKEDLESAQDALAAAKANVAELKALIRQSKISINTAESDLGY
TRITATMDGTVVAIPVEEGQTVNAAQSTPTIVQLANLDMMLNKMQIAEGDITKVKAGQDI
SFTILSEPDTPIKAKLDSVDPGLTTMSSGGYNSSTDTASNAVYYYARSFVPNPDGKLATG
MTTQNTVEIDGVKNVLLIPSLTVKNRGGKAFVRVLGADGKAAEREIRTGMRDSMNTEVKS
GLKEGDKVVISEITAAEQQESGERALGGPPRR
>WP_000165905.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTKQALLEVSNLVREFPAGESTIQILKGIDLTIYEGELVAIVGQSGSGKSTLMNILGCLD
RPTSGSYKVNGQETGKLEPDQLAQLRREYFGFIFQRYHLLGDLSAEGNVEVPAVYAGVTP
ADRKQRATALLTELGLGTKTQNRPSQLSGGQQQRVSIARALMNGGDVILADEPTGALDSH
SGVEVMRILRELNAAGHTIILVTHDMQVAKNATRIIEISDGEIISDRPNVPDQSLEEVKS
DPDAAPALQNKQKKGKSISAWRSTLDRLSEAFQMALLSMNAHRMRTFLTMLGIIIGIASV
VTVVALGNGSQQQILSNISSLGTNTITVFQGRGFGDNSKTANFKTLVPADADALMTQPYV
SAVSPMVSTSKTMRYQQNEANATINGVSNDYFDVKGLVFKDGQTFDQRSVRDRSQDVVID
TNTQKQFFSDGTNPIGQVVLLGSVPARIIGIVEPQTSGMGSDDTLNVYMPYTTVMSRMLG
QAHVRNIVVRINDKYSTSAAENAIVNLLTQRHGAQDIFTMNSDSIRQTIEKTTSTMTLLV
SAIAVISLVVGGIGVMNIMLVSVTERTQEIGVRMAVGARQSDILQQFLIEAILVCLIGGV
LGVLLSLGLGQLINKFAGGNFAVAYSTTSIVAAFVCSTLIGVVFGFLPAKNAAKLDPVAA
LSRE
>WP_000323365.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAYIEMKHCYKRYQVGDTEIVANRDVNFEIEKGELVIILGASGAGKSTVLNLLGGMDTND
EGEIWIDGVNIADYSSHQRTNYRRNDVGFVFQFYNLVSNLTAKENVELASEIVTDALNPD
QVLTDVGLAHRLNNFPAQLSGGEQQRVSIARAVAKNPKILLCDEPTGALDYQTGKQVLKI
LQDMSRQKGATVIIVTHNGALAPIADRVIHMHDASVKDVVLNQHPQDIDSLEY
>WP_000811482.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKQLISLKNIFRSYRNGDQELQVLKNINLEVNEGEFVAIMGPSGSGKSTLMNTIGMLDTP
TSGEYYLEGQEVAGLGEKQLAKVRNQQIGFVFQQFFLLSKLNALQNVELPLIYAGVSSSK
RRKLAEEYLDKVELTERSHHLPSELSGGQKQRVAIARALVNNPSIILADEPTGALDTKTG
NQIMQLLVDLNKEGKTIIMVTHEPEIAAYAKRQIVIRDGVISSDSAQLGKEEN
>WP_000571330.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIELKNITKTIGGKVILDNLSLRIDQGDLVAIVGKSGSGKSTLLNLLGLIDGDYSGRYEI
FGQTNLAVNSAKSQTIIREHISYLFQNFALIDDETVEYNLMLALKYVKLPKKDKLKKVEE
ILERVGLSATLHQRVSELSGGEQQRIAVARAILKPSQLILADEPTGSLDPENRDLVLKFL
LEMNREGKTVIIVTHDAYVAQQCHRVIELGEGK
>WP_011764566.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|M621_20535|antibiotic efflux|0
MLWRDFLQLALRSLTAHRLRSFLTLLGIGVGIAAVILLTSIGEGLHRFVLQEFTQFGTNI
IKVTPGKTGARGGPPGLPSTTRELTLDDAAALARAPYVTGITPTVSGNSEVRANGRVRRT
FIMGAGAQMQQVFSMRVKSGRFLPPDDAAHARAFVVLGATLKRELFGNANALGERLQIGG
ERYRVIGVMESKGQFLGIDLDDAAYIPAARALALYNRDGLMEINVTYNEGVSAARAAAEV
RKVMRARHGREDFTLTTQEDMLATLSNILGILTAAVGALGGISLLVGGVGIVTIMTIAVA
ERTAEIGLLVALGARRTTILGLFLGEAVALAAIGGAVGLAVGAGLAQLVGLAVPALPVST
PWRFVAIAEALAVLIGLTAGVLPARRAARLDPVEALRAQ
>WP_001071135.1|FEATURES|resfam|peptide|mprF|antibiotic target alteration|0
MNQEVKNKIFSILKITFATALFIFVAITLYRELSGINFKDTLVEFSKINRMSLVLLFIGG
GASLVILSMYDVILSRALKMDISLGKVLRVSYIINALNAIVGFGGFIGAGVRAMVYKNYT
HDKKKLVHFISLILISMLTGLSLLSLLIVFHVFDASLILDKITWVRWVLYVVSFFLPLFI
IYSMVRPPDKNNRFVGLYCTLVSCVEWLAAAVVLYFCGVIVDAHVSFMSFIAIFIIAALS
GLVSFIPGGFGAFDLVVLLGFKTLGVPEEKVLLMLLLYRFAYYFVPVIIALILSSFEFGT
SAKKYIEGSKYFIPAKDVTSFLMSYQKDIIAKIPSLSLAILVFFTSMIFFVNNLTIVYDA
LYDGNHLTYYILLAIHTSACLLLLLNVVGIYKQSRRAIIFAMISILLITVATFFTYASYI
LITWLAIIFVLLIVAFRRARRLKRPVRMRNIVAMLLFSLFILYVNHIFIAGTLYALDIYT
IEMHTSVLRYYFWLTILIIAIIIGMIAWLFDYQFSKVRISSKIEDCEEIINQYGGNYLSH
LIYSGDKQFFTNENKTAFLMYRYKASSLVVLGDPLGDENAFDELLEAFYNYAEYLGYDVI
FYQVTDQHMPLYHNFGNQFFKLGEEAIIDLTQFSTSGKKRRGFRATLNKFDELNISFEII
EPPFSTEFINELQHVSDLWLDNRQEMHFSVGEFNEEYLSKAPIGVMRNEENEVIAFCSLM
PTYFNDAISVDLIRWLPELDLPLMDGLYLHMLLWSKEQGYTKFNMGMATLSNVGQLHYSY
LRERLAGRVFEHFNGLYRFQGLRRYKSKYNPNWEPRFLVYRKDNSLWESLSKVMRVIRHK
>WP_001985623.1|FEATURES|resfam|triclosan|OpmH|antibiotic efflux|0
MKIKLMLVAGLWSFTSSSFALDLVETYERAKLNDPTWQANQQQFEADQLNLGLATGALLP
TVTLSGNITRNRQTVKRSNFPGVDQEGLSDALVSNTSTTKQATLSARQPLFRMDAWEGYK
QVKTSVALSEITLRLQKQDHVLNVAEAYFNVLRQQALTAAYLQEEKALLEQLNMMNAKLK
EGLVARSDVSEANAQYQNARANRIATNVQLLLAQEQLTEYIGPYQDKLAVLRSDFIFQKP
YPAQLDEWLGLAQQQNLKIQQARLQKRYAEDQRRVEKAALYPQIDAVASYGYTKQTPETL
ISTDGKFDQVGVEMNWNLFNGGRTRTSIKKASVELNKAQAQLDAAIRRANVDVKSAFMQV
DTDRAKLEARKAAMDSSALVSQASKASYNEGLKSMVDVLLAQRNAFSAKQDYLNAQYDYL
LNVLRLKAAVGQLGEKDLVELNSWLTYQ
>YP_001708355.1|FEATURES|resfam|triclosan|OpmH|antibiotic efflux|0
MKIKLMLVAGLWSFTSSSFALDLVETYERAKLNDPTWQANQQQFEADQLNLGLATGALLP
TVTLSGNITRNRQTVKRSNFPGVDQEGLSDALVSNTSTTKQATLSARQPLFRMDAWEGYK
QVKTSVALSEITLKLQKQDHVLNVAEAYFNVLRQQALTAAYLQEEKALLEQLNMMNAKLK
EGLVARSDVSEANAQYQNARANRIATNVQLLLAQEQLSEYIGPYQDKLAVLRSDFIFQKP
YPAQLDEWLGLTQQQNLKIQQARLQKRYAEDQRRVEKAALYPQIDAVASYGYTKQTPETL
ISTDGKFDQVGVEMNWNLFNGGRTRTSIKKASVELNKAQAQLDAAIRRANVDVKSAFMQV
DTDRAKLEARKAAMDSSALVSQASKASYNEGLKSMVDVLLAQRNAFSAKQDYLNAQYDYL
LNVLRLKAAVGQLGEKDLVELNSWLTYQ
>CAG25752.1|FEATURES|resfam|glycopeptide|vanRO|antibiotic target alteration|0
MRVLIVEDEPYLAEAIRDGLRLEAIAADTAGNGDTALELLSLNTYDIAVLDRDIPGPSGD
EIAKRIVASGSGLPILMLTAADRLDDKITGFELGADDYLTKPFELRELVLRLRALDRRRA
HNRPPVLEIAGLRLNPFRREVYRDDRYIALTRKQFAVLEVLVSADGGVVSAEELLERAWD
KNADPFTNAVRITVSALRKRLGEPWIITTVAGVGYRIGAAPGAGR
>CAG15006.1|FEATURES|resfam|glycopeptide|vanSO|antibiotic target alteration|0
MDRAPGLSVRLKLTLSYAGFLMLAGASLLATVWVYLLRGLPDTAMSSRGLVPIKTIVLHA
FAPATAGVLLFLLVFGLLGGWLLAGRMLAPLTRITEATRMAANGSLSHRIELDGRKDEFR
ELADAFDIMLTRLEAHIAEHQRFAANASHELRTPLAITKTLLDVARTDPARSTHELIGRL
HTVNTRAIDLTEALLLLSRADRRSFKREYVDLSLNVEEAIETLLPLAEKHGVTIEASGDI
TPTVGSRALLLQMTINLLHNAIVHNVAEERIVWVTTSVHPKSVTLTVENTGEQLSAQLVS
TLTEPFQRGTERIHHDHAGVGLGLAIVKSIAHAHDGTLTTAPRAGGGLHVTVQLPAATTP
PRN
>AAD02118.1|FEATURES|resfam|glycopeptide|vanXO|antibiotic target alteration|1
MKPTESMTDGFVFADDLVPGLRWDAKYATWDNFTGKPVDGYLVNRIVGTKALCAALERAR
DEAASLGFGLLLWDGYRPQRAVDCFLRWSQQPEDGRTKSRHYPNIARAEMFEKGYVAARS
GHSRGSTVDLTLYDLATNELVPMGGDHDLMDPVSHHGAQGLAPVEARNRQHLRSVMESCG
FKAYEYEWWHYTLADEPYPDTYFDFPIM
>CAB41447.1|FEATURES|NCBI|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRPSFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>AAD51057.1|FEATURES|NCBI|glycopeptide|vanSD|antibiotic target alteration|0
MKNRNKTSHEDDYLLFKNRLSVKILLMMVYSILIIAGVYLFILKDNFANVVVAILDSFIY
HDRDEAVAVYLRTFKAYEIWLFLIAVMGVFFMIFRRYLDSISKYFKEINRGIDTLVNEDA
NDIGLPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLAHDLKTPLSSVIGYLN
LLRDENQISEELREKYLSISLDKAERLEELINEFFEITRFNLSTSRLCTAKSI
>AAR37058.1|FEATURES|NCBI|glycopeptide|vanYD|antibiotic target alteration|0
MERQNNNENQYGRNRRKDKRRKLFFLQSSMCHARSAHSLCNFWSCVFSERE
>AAS87023.1|FEATURES|NCBI|beta_lactam|blaPLA2a|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDE
RFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQ
AMARTLRNLLTGRVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTGTPAAMDERNKQIAAIGATLVTHWSADENRP
>EAT07996.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
MKIVTALGALALLAAPASAADRQKTPAQEPAPTGNLDNLMPAAPRYLVPQSALEQVRNPK
EIEEETGGRLGVALVDRQGALLLGFNRDERFAMCSTFKAPLAAAVLTGADGGKFGLEGTI
PFGKEDVLDYAPVVKKNLKRGRMSMEELARAAVEVSDNSAANLLLPMLGGPEGLTAFMRV
HGDDVTRLDRTEPALNENAEGDPRDTTTPAAMAGLMARLFFRDLKAESADRLRAWFNASS
TGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPTGEEYILAIYLDRPTIDAKKAEAA
IAEAARAALNFVGQARKSGLE
>CAM97383.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>CAP09893.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLGKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGRVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLNALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASRTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARRIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNNRLD
>CAP09895.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
IERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNNRLD
>CAP09896.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGIPAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRRREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNNRLD
>ADH06626.1|FEATURES|NCBI|fosfomycin|FosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEKEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>YP_003084339.2|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VgaA|antibiotic target protection|1
MVLLEAKNIKHYIKDRLLLKIDELKIEHNDRIGLVGVNGSGKTTLLNILAEKFIPDEGTI
TPYAQSEILPQLKKTDAAKSGGEITQEYIQQTLNSAPALLLADEPTTNLDTDHIEWVEKK
LKRWQGAFVLVSHDREFLDALCSVIWELEDGEITEYKGNYSDYLKQKEVEKQQQQSTYEK
YEKEKKQLEKAIQLKEEKAQRATKKPKNLSASERRIKGSKPYFAKKQKKLHKTAGALETR
VEKLEKVEKIKDQPPIKMDLPNERNLKNRVIIRVEDLEGLVPKQLLWKKATFQIYGGDKL
AIIGPNGSGKTTLVKKIITQENGVTISPSVKIGYFSQNLMTLDVNKSILENVQNSSKQEE
SLIRTVLARMHFFDEDVYKPVHVLSGGERVKVALTKLLVSDINTLVLDEPTNYLDTEALK
ALENLLNEYTGSIIFVSHDRTFTENIATRILEIRNKKIEIFDGTYQQFKNRSTKKERDFQ
QEEQLLLDTKISEVLSRLSMEPSQALEKEFQNLLKEKSKLKE
>AFK31665.1|FEATURES|NCBI|tetracycline|tet32|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLTEAYRALSVLDGAVLVISAKDGVQAQTRILFHALQKMN
IPTIIFINKIDQNGIDLQRVYQSIKDKLTSDMIVMQEVSLSPQISMTDISDLDKWDMIIS
GSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFIT
ETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNG
EIVPADHACPGEIVILADDTLKLNDILGNEKLLPHKTWIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>WP_004725235.1|FEATURES|NCBI|beta_lactam|OXA-355|antibiotic inactivation|1
MSNNLFKFKIKSSVLIILSSVAFSGCVSNANLHDPASSQRTSEIPLLFNYAQTQAVFVTY
DGTQFKRYGNDLNRAKTAYIPASTFKMLNALIGLQHAKATNTEVFKWNGEKRSFPAWEKD
MTLAQAMQASAVPVYQELARRIGLDLMSQEVKRVGFGNTQIGQQVDNFWLVGPLKITPEQ
EAKFAYQLAKKTLPFDDAVQQQVKDMLYVERRGDSKLYAKSGWGMDVEPQVGWYTGWIEQ
PNGQITAFALNMHMQTGDDPAERKQLTLSILDKLGLFFYLR
>WP_004816501.1|FEATURES|NCBI|beta_lactam|OXA-355|antibiotic inactivation|1
MSNYRFKSKIKSSVLIILSSVAFSGCVSNANLHDPASSQRTSEIPLLFNYAQTQAVFVTY
DGTQFKRYGNDLNRAKTAYIPASTFKMLNALIGLQHAKATNTEVFKWNGEKRSFPAWEKD
MTLAQAMQASAVPVYQELARRIGLDLMSKEVKRVGFGNTQIGQQVDNFWLVGPLKITPEQ
EAKFAFQLANKTLPFDDAVQQQVKDMLYVERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQ
PNGQITAFALNMHMQTGDDPAERKQLTLSILDKLGLFFYLR
>WP_004867933.1|FEATURES|NCBI|beta_lactam|OXA-229|antibiotic inactivation|1
MNKKLNLALLCFLSILCAACQSNQQLSANSHTENHNTRAAEISLLFDEMHTQAVFVTYDG
QHFQSYGNALQRADTAYVPASTFKMLNALIGLQNHKATNTEVFKWDGQKRAMSIWEKDMT
LSDAMKVSAVPVYQELARRIGLDLMQKEVTRVRYGNTDIGTVVDRFWLDGPLKITPKQEA
QFAYQLATQQLPFDQNVQSQVKDMLYVESRGQSKLFAKSGLSMKNGQPDIGWYTGWVEQA
DGKIVAFSINMQMVQGLDVNSRQQATLDILDKLGIFFYL
>WP_004878009.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MRKKFKVALLCSSLCLSLGLVACHSLNSELQIAEQQKQQQKISKLFVNAKTEGVFVTYDG
QKIHEYGNALNRAQTSYIPASTFKMLNALIGIQHHKTTPNEVFKWNGEKRRFKSWEKDLT
LTEAIQASAVPIYQELARRIGLDLMASEVKRIGFGNSDIGNQVDNFWLVGPLKITPIQEV
RFTYALANEQLAFDIPVQQQVKQMLLVDQMNGTKVYAKSGWGMDVEPQVGWWTGWVEQPN
GKVTAFSLNMEMNKTEHVEARKTIVYEALQQLGLI
>WP_005201559.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MMMSKKLKCLAFFTAIFFAIPMTACQSFSQQKQQLSTQKNEQQQISSLFQSAQTSGVLVI
YDGKKIQSYGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEMFKWDGKKRAFSSWEK
DLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPV
EEVRFAYALAKQKLPFDQSTQQQVKGMLLIDEVQGTKIYAKSGWGMDVSPQVGWWTGWIE
QANGKITAFSLNMEMSRPEHAEARKAIVYQALQQLDLLAN
>KLE07522.1|FEATURES|NCBI|beta_lactam|OXA-198|antibiotic inactivation|1
MNKKIKLIFILIFSINLFANDVELENLFKKYQVEGTLVLESLNTKKVDIYNEKRANTSFS
PASTFKIPNTLIALNEGVVNKDSIIVWDKKVREFDAWNKDQTLQSAFKSSCVWCYKEFAS
KIGVEKYSKYLKELNYGNKTIGKDVTDFWLDESLRITAFEEIRFLKQLQANNLAFKQEDI
NLLKELMIDEKSENYVVRAKTGWEGKYGWYVGYVETKNDVWFFALNIDTKTKEDLAKRKA
LTLEALKTKGIIN
>KLE13731.1|FEATURES|NCBI|beta_lactam|OXA-198|antibiotic inactivation|1
MNKKIKLIFILIFSINLFANDVELENLFKKYQVEGTLVLESLNTKKVDIYNEKRANTSFS
PASTFKIPNTLIALNEGVVNKDSIIVWDKKVREFDAWNKDQTLQSAFKSSCVWCYKEFAS
KIGVEKYKKYLKELNYGNKTIGKDVTDFWLDESLRITAFEEIRFLKQLQANNLAFKQEDI
NLLKELMIDEKSENYVVRAKTGWEGKYGWYVGYVETKNDVWFFALNIDTKTKEDLAKRKA
LTLEALKTKGIID
>ALA99185.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAAPGRITERADWGKLFTAEG
VKGTIVVLDARTQTYQAYDAARAEKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKP
RRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRRYAQAKLNEVGYGNRTIGGAPDAYWVD
DSLQISAREQVDFLQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDI
GWWVGWIERDGNIASVAINIDMLSEADAPKRARIVKSVLKDLKLI
>ALA99193.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKKTLSRWRRGALALRLLGALASPVVFAMPGHAAEPAHSSAVRIAERADWGKYFADEGVK
GTVIVLDGRTQTYQAYDAARAERRMSPASTYKIFNSLLALESGALDNEREVIPWDGKPRR
VKAWNAALDLRNAFRVSCLPCYQVVSHKIPRQYAQAKLNEAGYGNRTIGRAAHAYWIDDS
LQISAREQVDFLQRLATGALPFSARSQDIVRNISIVEANVDYVLHGKTGWFTEKKPDIGW
WVGWLERDGNLTMIALNIDIQTDADAPKRARIVRNVLKDLKLI
>ALM24139.1|FEATURES|NCBI|fosfomycin|FosB3|antibiotic inactivation|1
MIKGINHITYSVSNIAKSIEFYRDILGADILVESETSAYFNLGGIWLALNEEKNIPRSEI
KYSYTHIAFTISDNDFEDWYIWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGS
LEDRLSYYKEAKPHMNFYI
>AMM74658.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AON96411.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGKTKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AQM56008.1|FEATURES|NCBI|multidrug|qepA|antibiotic efflux|1
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
ILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAALFAFASVLAALADTAALLIAARALLG
LAGATIAPSTMALIRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFW
LNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASM
AALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYL
QLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQ
GLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGS
VGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDAL
QATAWAGAVLVLVAAGLVARLLRKRPALASG
>ASK49942.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MTQHSPWYRRPVNPYLLMSVVALFLSATANLTFFDKITNTYPMAQNAGFVISTALVLFGA
MLLITVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAESKDLMN
MAFFVRIIGLGVLPSILVAWVKVDYPTLGKSLIQRAMTWGVAVVMALVPILAFSSHYASF
FREHKPLRSYVNPVMPIYSVGKLASIEYKKATAPKDTIYHAKDAVQTTTPAERKPRLVVF
VVGETARADHVQFNGYSRETFPQLAKIDNLANFSQVTSCGTSTAYSVPCMFSYLGQDDYD
VDTAKYQENVLDTLDRLGVGILWRDNNSDSKGVMDKLPASQYFDYKSATNNTICNTNPYN
ECRDVGMLVGLDDYVSTNQGKDMLIMLHQMGNHGPAYFKRYDEQFAKYTPVCEGNELAKC
EHQSLINAYDNALLATDDFIAKSIDWLKTHQANYDVAMLYVSDHGESLGENGVYLHGMPN
AFAPKEQRAVPAFFWSNNPSFTPTASDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR
>ABC17630.3|FEATURES|NCBI|quinolone|QnrB4|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAN
LKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSE
LGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG
>AUE22029.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALS
FLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLA
SITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVR
NNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGE
TARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRAN
AQDTVIDVLSHSGIKVQWFDNDSGCKGVCDRVENLTIDLKSDPKLCSGQYCFDQVLLNKL
DKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDN
TILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVP
MLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCR
>AUR80098.1|FEATURES|NCBI|polymyxin|eptA|antibiotic target alteration|1
MRITLGVMKVNLLLVLFFALVLNWPFFLRFYSVISGLEHVRAGFVISVPLVLLAALNAVF
IPFTFRWLLKPFFSLLILTGSIVSYAMLKYGVIFDASMIQNIVETNNSEATSYLNVPVVL
WFLLTGVLPMVVLWSLKVRYPANWYKGLAIRAGALAFSLLFVGGVAALYYQDYVSIGRNH
RILGKQIVPANYVNGIYKYARDVVFATPIPYQPLGTDAKVVAKGDKPTLMFLVVGETARG
KNFSMNGYEKETNPFTSQAGGVISFKDVRSCGTATAVSVPCMFSNMGRKEFDDNRARNSE
GLLDVLQRSGVSIFWKENDGGCKGVCDRVPNIEIKPKDHPQFCDKNTCYDEVVLQNLDDE
VAQMKGDKLVGFHLIGSHRPPYHQRYPDKPPPFVPDCPRSDIENCSDEELVNTYDNTIRY
TDFVIAEMITKLKKYEDKYNTALIYLSDHGESLGAMGLYLHGTPYKFAPDDQTRVPMQVW
MSPGFAKEKGMDLNCLQQKAADNRYSHDNLFSSVLGIWDVSTAVYDKQLDIFSQCRTVQ
>ASK38392.2|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPACEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>WP_000918666.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG
NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT
DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV
YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL
RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG
EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT
TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT
HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG
FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT
VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG
MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG
TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL
VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT
LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL
GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG
RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL
DVKVMDEQDNEIEMTDVDDDDVVEHKVDLQQNDAPETQKEVTD
>CAJ66881.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MPHPVTIGKRTRMSFSKIKEIADVPNLIEIQVDSYEWFLKEGLKEVFDDISPIEDYTGNL
ILEFVDYSLDDKPKYDIEECKERDATYCAPLKVKVRLINKETGEIKEQEVFMGDFPLMTE
RGTFVINGAERVIVSQLVRSPGVYYAEERDKTGKRLISSTVIPNRGAWLEYETDSNDVIS
VRVDRTRKQPVTVLLRALGIGTDAEIIDLLGEDERLSATLEKDNTKTVEEGLVEIYKKLR
PGEPPTVESASSLLNALFFDPKRYDLAKVGRYKFNKKLALCYRIMNKISAEDIINPETGE
VFVKAGEKISYDLAKAIQNAGINVVNLLMDDDKKVRVIGNNFVDIKSHIDFDIDDLNIKE
KVHYPTLKEILDGYSDEEEIKEAIKSRIKELIPKHILLDDIIASISYEFNIFYNIGNIDD
IDHLGNRRIRSVGELLQNQVRIGLSRMERVIKERMTVQDMEAITPQALVNIRPVSAAIKE
FFGSSQLSQFMDQTNPLSELTHKRRLSALGPGGLSRERAGFEVRDVHHSHYGRMCPIETP
EGPNIGLINSLGTYAKINEFGFIESPYRKFDKETSTVTDEIHYLTADEEDLFVRAQANEP
LTEDGKFVNHRVVCRTVNGAVEMVPESRVDYMDISPKQVVSVATAMIPFLENDDANRALM
GANMQRQAVPLVRREAPIIGTGIEYRAAKDSGAVVVARNSGIAERVTADEIIIKREDGNR
DRYNLLKFKRSNSGTCINQTPIINKGDQIIKGDVIADGPATDLGEVALGRNCLIAFMTWE
GYNYEDAILINERLVKEDRLSTIHIEEYECEARDTKLGPEEITRDIPNVGDSAIKNLDDR
GIIRIGAEVDSGDILVGKVTPKGETELTAEERLLRAIFGEKAREVRDTSLKVPHGESGII
VDVKVFTRENGDDLSPGVNELVRCYIAKKRKIKVGDKMAGRHGNKGVISRVLPEEDMPFM
ENGTPLDIILNPQGIPSRMNIGQVLEVHLGLAAKTLGWYVATSVFDGANEYDIMDALEEA
GYPRDGKLTLYDGRTGESFDNRITVGYMYYLKLHHLVDEKLHARSTGPYSLVTQQPLGGK
AQFGGQRFGEMEVWALEAYGAAHILQEILTVKSDDVVGRVRTYEAIVKGENIPEPGIPES
FKVLIKELQSLCLDVKVLTDEDQEIEVRESVDEDDTIGEFELDVVNHMGEVEESNIIEEI
EDDFAENAEDEDIENLEEFTEDDLFEEEIDFDSDDFDM
